PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kondo, K; Okubo, T				Kondo, Keisuke; Okubo, Toshihiro			Interregional labour migration and real wage disparities: Evidence from Japan	PAPERS IN REGIONAL SCIENCE			English	Article						J61; R12; R23; interregional labour migration; real wage disparities; regional differences in prices; structural estimation	ECONOMIC-GEOGRAPHY; INCREASING RETURNS; REGIONAL GROWTH; UNITED-STATES; MODEL	This paper empirically tests the relationships between interregional labour migration and regional real wages based on a multi-region economic geography model, which describes bilateral migration flows. In particular, this paper highlights real wage disparities in the migration analysis. Our empirical methodology contains two steps. First, we structurally estimate a gravity model using manufacturing workers' migration flows across the 47 Japanese prefectures. Second, using the estimates of the structural parameters, we examine the impact of the real wage on the net migration rate. We find that migrants respond to real wage disparities, rather than to nominal wage disparities.	[Kondo, Keisuke] Kobe Univ, Grad Sch Econ, Nada Ku, Kobe, Hyogo 6578501, Japan; [Okubo, Toshihiro] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Kondo, K (reprint author), Kobe Univ, Grad Sch Econ, Nada Ku, 2-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	keisuke.kondo@stu.kobe-u.ac.jp; okubo@econ.keio.ac.jp					Ottaviano G, 2002, INT ECON REV, V43, P409; Hanson GH, 2005, J INT ECON, V67, P1, DOI 10.1016/j.jinteco.2004.09.008; Pons J, 2007, J REGIONAL SCI, V47, P289, DOI 10.1111/j.1467-9787.2007.00510.x; Head K, 2006, REG SCI URBAN ECON, V36, P573, DOI 10.1016/j.regsciurbeco.2006.06.002; Tabuchi T, 2002, J DEV ECON, V69, P155, DOI 10.1016/S0304-3878(02)00057-3; [Anonymous], 2002, ECONOMIC POLICY; Decressin J, 1995, EUR ECON REV, V39, P1627, DOI 10.1016/0014-2921(94)00102-2; Redding S, 2004, J INT ECON, V62, P53, DOI 10.1016/j.jinteco.2003.07.001; GREENWOOD MJ, 1975, J ECON LIT, V13, P397; Crozet M, 2004, J ECON GEOGR, V4, P439, DOI 10.1093/jnlecg/lbh029; Hering L, 2010, REV ECON STAT, V92, P145, DOI 10.1162/rest.2009.11418; Pfluger M, 2010, REG SCI URBAN ECON, V40, P481, DOI 10.1016/j.regsciurbeco.2010.06.005; HARRIS JR, 1970, AM ECON REV, V60, P126; BARRO RJ, 1992, J JPN INT ECON, V6, P312, DOI 10.1016/0889-1583(92)90002-L; Barro R.J., 2004, ECONOMIC GROWTH; BLANCHARD OJ, 1992, BROOKINGS PAP ECO AC, P1; Bosker M, 2010, J ECON GEOGR, V10, P793, DOI 10.1093/jeg/lbq003; Brakman S, 2004, J REGIONAL SCI, V44, P437, DOI 10.1111/j.0022-4146.2004.00344.x; Combes PP, 2008, ECONOMIC GEOGRAPHY T; Doornik JA, 2006, INTRO TO OX; Fujita M, 1999, THE SPATIAL ECONOMY; Fujita M, 2002, ECONOMICS OF AGGLOME; Fukao K, 2000, KEIZAI KENKYU, V51, P136; Hanson GH, 1998, 6429 NBER; Head K, 2004, HANDBOOK OF REGIONAL, V4; Head K, 2011, J ECON GEOGR, V11, P281, DOI 10.1093/jeg/lbq037; Helpman E, 1998, TOPICS IN PUBLIC ECO; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Krugman P, 1991, GEOGRAPHY TRADE; Maddala G. S., 1983, LIMITED DEPENDENT AN; McFadden D, 1974, FRONTIERS OF ECONOME; Mion G, 2004, J URBAN ECON, V56, P97, DOI 10.1016/j.jue.2004.03.004; Montgomery EB, 1994, SOCIAL PROTECTION VE; OECD, 2005, OECD EMPLOYMENT OUTL; OECD, 2000, OECD EMPLOYMENT OUTL; OECD, 2000, TRENDS IN INTERNATIO; Otomo A, 1990, INTERNATIONAL HANDBO; ROGERS A, 1990, GEOGR ANAL, V22, P283; Shioji E, 2001, J JPN INT ECON, V15, P29, DOI 10.1006/jjie.2000.0461	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1056-8190	1435-5957		PAP REG SCI	Pap. Reg. Sci.	MAR	2015	94	1					67	U812		10.1111/pirs.12055		22	Economics; Environmental Studies; Geography	Business & Economics; Environmental Sciences & Ecology; Geography	CE0BM	WOS:000351467500005		
J	Takahashi, Y; Hara, K; Haranishi, Y; Terada, T; Obara, G; Sata, T				Takahashi, Yoshihiro; Hara, Koji; Haranishi, Yasunori; Terada, Tadanori; Obara, Goh; Sata, Takeyoshi			Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Central nervous system; Chronic constriction injury; Glycinergic transmission; Nociceptive transmission	ROSTRAL VENTROMEDIAL MEDULLA; THERMAL NOCICEPTION; AMINO-ACID; HYPERALGESIA; ANALGESIA; MICE; LOCALIZATION; RECEPTOR	Glycinergic transmission has an important role in regulating nociception in the spinal cord. The glycine transporter-2 (GlyT2) is localized at presynaptic terminals of glycinergic neurons and eliminates glycine from the synaptic cleft to terminate glycinergic transmission. Systemic and intrathecal administration of GlyT2 inhibitors alleviate various types of pain. Although the GlyT2s and glycine receptors are widely distributed in the central nervous system, little is known about the role of glycinergic transmission in pain perception at supraspinal regions. The present study examined the antinociceptive effect of intracerebroventricular (i.c.v.) administration of the selective GlyT2 inhibitor ALX1393 on inflammatory and neuropathic pain in experimental models. For i.c.v. administration, a guide cannula was implanted into the right lateral ventricle of male Sprague-Dawley rats. Normal rats were used to assess inflammatory nociception using the formalin test and motor function using the rotarod test. Chronic constriction injury (CCI) to the sciatic nerve was induced in the rats. The CCI rats were then used to assess mechanical, cold, and thermal hyperalgesia using the electronic von Frey test, cold plate test, and the plantar test, respectively. ADC 393 (25, 50, and 100 jug) was administered i.c.v. to examine its effects on supraspinal antinociception. Supraspinal ALX1393 in normal rats suppressed the late-phase response in the formalin test but did not affect motor performance. In the CCI rats, ALX1393 inhibited mechanical and cold hyperalgesia in a dose-dependent manner. The antihyperalgesic effects of ALX1393 (100 mu g) were reversed completely by i.c.v. pretreatment with a glycine receptor antagonist strychnine (10 mu g). These results suggest that GlyT2 contributes to nociceptive transmission at supraspinal level and that the selective GlyT2 inhibitor is a promising candidate for the treatment of inflammatory and neuropathic pain without causing motor dysfunction. (C) 2015 Elsevier Inc. All rights reserved.	[Takahashi, Yoshihiro; Hara, Koji; Haranishi, Yasunori; Terada, Tadanori; Obara, Goh; Sata, Takeyoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Anesthesiol, Kitakyushu, Fukuoka 8078555, Japan	Hara, K (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Anesthesiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	kojihara@med.uoeh-u.ac.jp			MEXT KAKENHI [23592316, 23590732, 25861403]	This study was supported by MEXT KAKENHI grant numbers 23592316 (K.H.), 23590732 (Y.H.), and 25861403 (T.T.).	Cobos EJ, 2012, PAIN, V153, P876, DOI 10.1016/j.pain.2012.01.016; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Tanabe M, 2008, ANESTHESIOLOGY, V108, P929, DOI 10.1097/ALN.0b013e31816c9044; Krowicki ZK, 2011, J PHARMACOL EXP THER, V337, P247, DOI 10.1124/jpet.110.175398; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MacLeod BA, 2010, ANESTH ANALG, V110, P1206, DOI 10.1213/ANE.0b013e3181d27da2; Zeilhofer HU, 2012, ANNU REV PHARMACOL, V52, P111, DOI 10.1146/annurev-pharmtox-010611-134636; Vandenberg RJ, 2014, TRENDS PHARMACOL SCI, V35, P423, DOI 10.1016/j.tips.2014.05.006; Centeno MV, 2009, PAIN, V145, P176, DOI 10.1016/j.pain.2009.06.014; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harvey RJ, 2013, NAT REV DRUG DISCOV, V12, P866, DOI 10.1038/nrd3893; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/ene.20349; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Hara K, 2014, EUR J PHARMACOL, V723, P459, DOI 10.1016/j.ejphar.2013.10.046; Cheng W, 2009, EUR J PHARMACOL, V614, P44, DOI 10.1016/j.ejphar.2009.04.052; Cooke JE, 2009, NEUROSCIENCE, V164, P1235, DOI 10.1016/j.neuroscience.2009.08.045; Hara K, 2014, PHARMACOL BIOCHEM BE, V125, P78, DOI 10.1016/j.pbb.2014.08.011; Hermanns H, 2008, NEUROSCI LETT, V445, P214, DOI 10.1016/j.neulet.2008.09.012; Hossaini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035293; Huang W, 2000, NEUROL RES, V22, P160; JURSKY F, 1995, J NEUROCHEM, V64, P1026; JURSKY F, 1994, J EXP BIOL, V196, P283; Kataoka K, 2013, ANESTH ANALG, V116, P1162, DOI 10.1213/ANE.0b013e318282dda7; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Mingorance-Le Meur A, 2013, BRIT J PHARMACOL, V170, P1053, DOI 10.1111/bph.12343; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Succar R, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-24; Vuong Leeza A Q, 2008, Neuropharmacology, V54, P189, DOI 10.1016/j.neuropharm.2007.05.004; Watson C, 2007, RAT BRAIN STEREOTAXI; Yaksh TL, 1997, ANESTHESIA BIOL FDN, VI, P685	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	MAR	2015	130						46	52		10.1016/j.pbb.2015.01.001		7	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CD2UE	WOS:000350933700007		
J	Kim, HJ; Yonezawa, T; Teruya, T; Woo, JT; Cha, BY				Kim, Hyo Jung; Yonezawa, Takayuki; Teruya, Toshiaki; Woo, Je-Tae; Cha, Byung-Yoon			Nobiletin, a Polymethoxy Flavonoid, Reduced Endothelin-1 Plus SCF-Induced Pigmentation in Human Melanocytes	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							STEM-CELL FACTOR; PROTEIN-KINASE-C; NF-KAPPA-B; EPIDERMAL PIGMENTATION; SIGNALING MECHANISMS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; CITRUS-UNSHIU; HUMAN SKIN; ACTIVATION	Nobiletin is a unique flavonoid having polymethoxy groups and has exhibited anti-inflammatory and antiobesity effects. Here, we examined the inhibition of nobiletin on melanogenesis induced by endothelin-1 (ET) and stem cell factor (SCF) in normal human melanocytes. Nobiletin dose dependently reduced ET plus SCF-stimulated tyrosinase activity without causing cytotoxicity. Nobiletin reduced cAMP-response element-binding protein (CREB) phosphorylation and microphthalmia-associated transcription factor (MITF) expression, which is a key transcription factor for tyrosinase expression in pigmentation induced by ET plus SCF stimulation. Nobiletin treatment effectively decreased ET plus SCF-induced Raf-1, MEK and ERK1/2 phosphorylation and also downregulated the forskolin-induced phosphorylation of CREB. Furthermore, nobiletin inhibited ET plus SCF-triggered production of melanin and expression of MITF/tyrosinase in a three-dimensional human epidermal model. In accordance with protein expression, the expression of genes related to the pigmentation was also increased in the cells stimulated with ET plus SCF and the cotreatment with nobiletin decreased obviously the ET plus SCF-triggered gene expressions of tyrosinase, PMEL, TRP1 and MITF. Nobiletin contributes to hypopigmentation by downregulating MITF and tyrosinase expression through reduced Raf-1 phosphorylation. Our findings implicate nobiletin as a potential new whitening agent.	[Kim, Hyo Jung; Yonezawa, Takayuki; Woo, Je-Tae; Cha, Byung-Yoon] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 487, Japan; [Teruya, Toshiaki] Univ Ryukyus, Fac Educ, Nishihara, Okinawa 90301, Japan; [Woo, Je-Tae] Erina Co Inc, Dept Res & Dev, Minato Ku, Tokyo, Japan	Cha, BY (reprint author), Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 487, Japan.	bycha@isc.chubu.ac.jp			Erina Co., Inc. (Tokyo, Japan); Rural Development Administration (Republic of Korea) [PJ009583]	This research was supported by an endowment from Erina Co., Inc. (Tokyo, Japan) and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009583) of Rural Development Administration (Republic of Korea).	ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Briganti S, 2003, PIGM CELL RES, V16, P101, DOI 10.1034/j.1600-0749.2003.00029.x; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Bertolotto C, 1998, MOL CELL BIOL, V18, P694; Aburjai T, 2003, PHYTOTHER RES, V17, P987, DOI 10.1002/ptr.1363; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; Zhang L, 2013, BRAIN RES BULL, V96, P45, DOI 10.1016/j.brainresbull.2013.04.009; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Park SH, 2004, CELL MOL LIFE SCI, V61, P2878, DOI 10.1007/s00018-004-4341-3; Tsatmali M, 2002, J HISTOCHEM CYTOCHEM, V50, P125; Yoon WJ, 2010, J OLEO SCI, V59, P315, DOI 10.5650/jos.59.315; Wu YQ, 2006, LIFE SCI, V78, P2689, DOI 10.1016/j.lfs.2005.10.029; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Imokawa G, 1996, BIOCHEM J, V314, P305; Imada K, 2008, BIOCHEM BIOPH RES CO, V373, P181, DOI 10.1016/j.bbrc.2008.05.171; Sheth VM, 2011, J AM ACAD DERMATOL, V65, P699, DOI 10.1016/j.jaad.2011.06.001; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; Jang SE, 2013, INT IMMUNOPHARMACOL, V17, P502, DOI 10.1016/j.intimp.2013.07.012; Wang KH, 2006, J ETHNOPHARMACOL, V106, P353, DOI 10.1016/j.jep.2006.01.010; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; Hemesath TJ, 1998, NATURE, V391, P298; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Choi SY, 2007, J ETHNOPHARMACOL, V113, P149, DOI 10.1016/j.jep.2007.05.021; Shimizu K, 2003, CHEM PHARM BULL, V51, P318, DOI 10.1248/cpb.51.318; Choi BK, 2013, CYTOTECHNOLOGY, V65, P915, DOI 10.1007/s10616-013-9555-5; Cui YJ, 2010, BIOL PHARM BULL, V33, P1814, DOI 10.1248/bpb.33.1814; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; Kim S. S., 2012, J ENZYM INHIB MED CH, V28, P685; Kobayashi S, 2006, INT J MOL MED, V17, P511; Lee N. H., 2010, INT J PHARMACEUT, V6, P37; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Lima LL, 2013, SCI WORLD J, DOI 10.1155/2013/274643; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Miyata Y, 2004, MOL CANCER THER, V3, P839; Moretti S, 1999, INT J CANCER, V84, P160, DOI 10.1002/(SICI)1097-0215(19990420)84:2<160::AID-IJC12>3.3.CO;2-I; Nakajima H, 2012, ARCH DERMATOL RES, V304, P803, DOI 10.1007/s00403-012-1248-y; Nichols Lanita A, 2011, Lipids Health Dis, V10, P36, DOI 10.1186/1476-511X-10-36; Oh MJ, 2011, ARCH DERMATOL RES, V303, P161, DOI 10.1007/s00403-010-1089-5; Ohizumi Y, 1997, JPN J PHARMACOL, V73, P263, DOI 10.1254/jjp.73.263; Sasaki K, 2002, BIOL PHARM BULL, V25, P806, DOI 10.1248/bpb.25.806; Sriwiriyanont P, 2006, LAB INVEST, V86, P1115, DOI 10.1038/labinvest.3700469; Suzuki R. D., 1996, ENDOCRINOLOGY, V137, P1627; Wakabayashi Y, 2013, J DERMATOL SCI, V69, P215, DOI 10.1016/j.jdermsci.2012.11.590; Whitman SC, 2005, ATHEROSCLEROSIS, V178, P25, DOI 10.1016/j.atherosclerosis.2004.07.034; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	MAR-APR	2015	91	2					379	386		10.1111/php.12400		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CD5JM	WOS:000351123900016		
J	Matsumoto, K; Hagiya, Y; Endo, Y; Nakajima, M; Ishizuka, M; Tanaka, T; Ogura, SI				Matsumoto, Kentaro; Hagiya, Yuichiro; Endo, Yoshio; Nakajima, Motowo; Ishizuka, Masahiro; Tanaka, Tohru; Ogura, Shun-ichiro			Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: Tumor cell response to hypoxia	PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY			English	Article						5-Aminolevulinic acid; Hypoxia; ABCB6; Coproporphyrin	ENDOGENOUS PROTOPORPHYRIN-IX; BLADDER-CANCER; PHOTODYNAMIC THERAPY; TRANSPORTER; ROLES; ABCG2; PEPT1; ALA	Background: Currently, 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD) is used to detect tumors during surgery and exploit tumor-specific accumulation of protoporphyrin IX (PpIX) after administration of ALA. In a recent study, we showed that the human ATP-binding cassette transporter ABCG2 plays a key role in the regulation of PpIX as a specific exporter. However, coproporphyrin III (CPIII) was also detected in urine after ALA administration in patients with tumor, indicating the presence of a CPIII transporter. Methods: We used two lines of human gastric cancer cells to measure the ALA-induced porphyrin metabolism. Intracellular and extracellular porphyrin levels and expressions of transporter were determined. Results: In the present study, we showed that although ABCG2 did not transport CPIII, plasma membrane ABCB6 did. Moreover, under conditions of hypoxia, the expression of ABCB6 in plasma membrane was upregulated, resulting in increased extracellular CPIII concentrations. Conclusion: These data indicate that the expression of ABCB6 in plasma membrane is important for porphyrin accumulation after ALA administration, including hypoxic conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumoto, Kentaro; Hagiya, Yuichiro; Ogura, Shun-ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Endo, Yoshio] Kanazawa Univ, Canc Res Inst, Cent Res Resource Branch, Kanazawa, Ishikawa 9201192, Japan; [Nakajima, Motowo; Ishizuka, Masahiro; Tanaka, Tohru] SBI Pharmaceut Co Ltd, Minato Ku, Tokyo 1066020, Japan	Ogura, SI (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, 4259 B47 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	sogura@bio.titech.ac.jp	ENDO, Yoshio/D-8428-2015	ENDO, Yoshio/0000-0003-0785-2006	Ministry of Education, Culture, Sports, Science and Technology [26430141, 23501305]	The authors thank Chiaki Kawada for kind technical assistance. The studies in the authors' laboratories were supported by the Grant-in-Aid for Scientific Research (C) (Nos. 26430141 and 23501305) from the Ministry of Education, Culture, Sports, Science and Technology.	KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Wyld L, 1998, BRIT J CANCER, V77, P1621, DOI 10.1038/bjc.1998.265; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Fukuhara H, 2011, INT J UROL, V18, P585, DOI 10.1111/j.1442-2042.2011.02789.x; Georgakoudi I, 1999, BRIT J CANCER, V79, P1372, DOI 10.1038/sj.bjc.6690220; Inoue K, 2013, PHOTODIAGN PHOTODYN, V10, P484, DOI 10.1016/j.pdpdt.2013.05.002; Inoue K, 2011, CANCER, V118, P1062; Ishikawa T, 2010, ADV PHARM SCI, V2010; Ishizuka M, 2011, PHOTODIAGN PHOTODYN, V8, P328, DOI 10.1016/j.pdpdt.2011.04.004; OCHIAI A, 1985, JPN J CANCER RES, V76, P1064; Tabata K, 1997, PHOTOCHEM PHOTOBIOL, V66, P842, DOI 10.1111/j.1751-1097.1997.tb03235.x	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1572-1000	1873-1597		PHOTODIAGN PHOTODYN	Photodiagnosis Photodyn. Ther.	MAR	2015	12	1					45	51		10.1016/j.pdpdt.2014.12.008		7	Oncology	Oncology	CD6IR	WOS:000351193300006		
J	Nakamura, T; Oinuma, T; Yamagishi, H; Masuyama, H; Terano, A				Nakamura, Tetsuya; Oinuma, Takeshi; Yamagishi, Hidetsugu; Masuyama, Hironori; Terano, Akira			Evaluation of a novel high-resolution magnifying videoendoscope that is capable of photodynamic diagnosis and therapy for gastric cancer	PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY			English	Article						High-resolution magnifying; videoendoscope; Photodynamic diagnosis; Photodynamic therapy; Gastric cancer	BAND IMAGING-SYSTEM; PHOTOFRIN-II; AUTOFLUORESCENCE; NEOPLASIA	Objective: To evaluate the usefulness of a novel high-resolution magnifying videoendoscope called the XG-0001 (Fujifilm, Tokyo, Japan) that is capable of PDD and PDT in experimental and clinical situations. Materials and methods: The fluorescences of three photosensitizers (i.e., porfimer sodium (Photofrin), protoporphyrin IX and talaporfin sodium (Laserphyrin)) were studied experimentally via excitation with a purple diode laser (VDL, wavelength 405 nm). Five consecutive patients with superficial early gastric cancer not indicated for surgery or other curative endoscopic treatment due to complicated serious diseases were enrolled in this study. After close endoscopic examinations, 2 mg/kg of Photofrin were intravenously injected into the patients for PDT, and 5-aminolevulinic acid (ALA; 15-20 mg/kg) was orally taken for PDD. PDD using VDL and PDT using an excimer-dye laser (630 nm, 4 mJ, 60 Hz) were performed with the XG-0001. Results: Photofrin and Laserphyrin had experimentally the lowest and highest fluorescence intensities, respectively. The five patients comprised four men and one woman with a mean age 75.2 year and an age range of 56-83 years. Two additional cancerous lesions were newly detected by magnifying pharmacoendoscopy. In each patient, PDD was successfully performed. PDT could also safely performed and CR was obtained in 71.4% (5/7) of the cancerous lesions in five patients, and no serious complications were encountered. Conclusion: The XG-0001, which is based on a simultaneous videoendoscopy method that uses an RGB color chip CCD, proved extremely useful in routine use and also in PDD and PDT for gastric cancer. (C) 2014 Elsevier B.V. All rights reserved.	[Nakamura, Tetsuya] Dokkyo Med Univ, Dept Med Informat, Sch Med, Mibu, Tochigi 3210293, Japan; [Oinuma, Takeshi] Nigamido Med Clin, Shimotsuke, Japan; [Yamagishi, Hidetsugu] Dokkyo Med Univ, Dept Pathol, Sch Med, Mibu, Tochigi 3210293, Japan; [Masuyama, Hironori] Masuyama Gastrointestinal Clin, Otawara, Japan	Nakamura, T (reprint author), Dokkyo Med Univ, Dept Med Informat, Sch Med, 811 Kita Kobayashi, Mibu, Tochigi 3210293, Japan.	nakamurt@dokkyomed.ac.jp			Ministry of Health and Welfare, Japan	This study was partially partly supported by a Grant-in-aid for scientific research from the Ministry of Health and Welfare, Japan. The authors thank to staff of Fujifilm for their valuable suggestions and technical support during the course of this study. We also thank the staff of SBI Pharmaceuticals Co., Ltd. for their support during the course of this study. The authors are grateful to Dr. Kenshi Yao for his critical review of this manuscript.	Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; Osawa H, 2008, GASTROINTEST ENDOSC, V67, P226, DOI 10.1016/j.gie.2007.06.067; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Yao K, 2002, GASTROINTEST ENDOSC, V56, P279, DOI 10.1067/mge.2002.126061; LAM S, 1990, CHEST, V97, P333, DOI 10.1378/chest.97.2.333; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Saragoni L, 2013, GASTRIC CANCER, V16, P549, DOI 10.1007/s10120-013-0233-2; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Uedo N, 2005, GASTROINTEST ENDOSC, V62, P521, DOI 10.1016/j.gie.2005.06.031; Usuda J, 2007, LUNG CANCER, V58, P317, DOI 10.1016/j.lungcan.2007.06.026; Kara MA, 2005, GASTROINTEST ENDOSC, V61, P679, DOI 10.1016/S0016-5107(04)02577-5; Bown S G, 2000, Gastrointest Endosc Clin N Am, V10, P533; Dougherty TJ, 1998, J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fukui H, 2006, GASTROINTEST ENDOSC, V64, P40, DOI 10.1016/j.gie.2006.01.072; Imaeda H, 2010, J GASTROEN HEPATOL, V25, P706, DOI 10.1111/j.1440-1746.2009.06202.x; Kawaguchi M, 1995, Diagn Ther Endosc, V1, P209, DOI 10.1155/DTE.1.209; Maki S, 2013, GASTRIC CANCER, V16, P140, DOI 10.1007/s10120-012-0160-7; Mayinger B, 1999, GASTROINTEST ENDOSC, V50, P242, DOI 10.1016/S0016-5107(99)70232-4; Mimura S, 1996, LASER SURG MED, V19, P168; Mimura S, 1998, Diagn Ther Endosc, V4, P165, DOI 10.1155/DTE.4.165; Mimura S, 2000, Diagn Ther Endosc, V6, P147, DOI 10.1155/DTE.6.147; Moghissi K, 2008, PHOTODIAGN PHOTODYN, V5, P235, DOI 10.1016/j.pdpdt.2009.01.006; Nakamura T, 1990, J Clin Laser Med Surg, V8, P63; Orth K, 2000, LANGENBECK ARCH SURG, V385, P488, DOI 10.1007/s004230000174; Osawa Hiroyuki, 2012, World J Gastrointest Endosc, V4, P356, DOI 10.4253/wjge.v4.i8.356; Petersen Bret T, 2006, Gastrointest Endosc, V63, P927, DOI 10.1016/j.gie.2006.02.044; Rimington C, 1966, Acta Med Scand Suppl, V445, P11	28	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1572-1000	1873-1597		PHOTODIAGN PHOTODYN	Photodiagnosis Photodyn. Ther.	MAR	2015	12	1					115	122		10.1016/j.pdpdt.2014.10.010		8	Oncology	Oncology	CD6IR	WOS:000351193300015		
J	Kawamura, Y; Nakao, H				Kawamura, Yoji; Nakao, Hiroya			Phase description of oscillatory convection with a spatially translational mode	PHYSICA D-NONLINEAR PHENOMENA			English	Article						Synchronization; Spatiotemporal phases; Limit torus; Phase description method; Phase reduction theory; Oscillatory convection	REACTION-DIFFUSION SYSTEMS; TAYLOR INSTABILITY; PATTERN-FORMATION; DYNAMICS; SYNCHRONIZATION; BIFURCATIONS; REDUCTION	We formulate a theory for the phase description of oscillatory convection in a cylindrical Hele Shaw cell that is laterally periodic. This system possesses spatial translational symmetry in the lateral direction owing to the cylindrical shape as well as temporal translational symmetry. Oscillatory convection in this system is described by a limit-torus solution that possesses two phase modes; one is a spatial phase and the other is a temporal phase. The spatial and temporal phases indicate the "position" and "oscillation" of the convection, respectively. The theory developed in this paper can be considered as a phase reduction method for limit-torus solutions in infinite-dimensional dynamical systems, namely, limit-torus solutions to partial differential equations representing oscillatory convection with a spatially translational mode. We derive the phase sensitivity functions for spatial and temporal phases; these functions quantify the phase responses of the oscillatory convection to weak perturbations applied at each spatial point. Using the phase sensitivity functions, we characterize the spatiotemporal phase responses of oscillatory convection to weak spatial stimuli and analyze the spatiotemporal phase synchronization between weakly coupled systems of oscillatory convection. (C) 2014 The Authors. Published by Elsevier B.V.	[Kawamura, Yoji] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokohama, Kanagawa 2360001, Japan; [Kawamura, Yoji] Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Yokohama, Kanagawa 2360001, Japan; [Nakao, Hiroya] Tokyo Inst Technol, Dept Mech & Environm Informat, Tokyo 1528552, Japan	Kawamura, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Yokohama, Kanagawa 2360001, Japan.	ykawamura@jamstec.go.jp	Kawamura, Yoji/E-3475-2014; Nakao, Hiroya/B-9264-2015	Kawamura, Yoji/0000-0002-5931-5512; Nakao, Hiroya/0000-0003-3394-0392	JSPS KAKENHI [25800222, 26120513, 26103510, 25540108]; CREST Kokubu project of JST	Y.K. is grateful to members of both the Earth Evolution Modeling Research Team and the Nonlinear Dynamics and Its Application Research Team at IFREE/JAMSTEC for fruitful comments. Y.K. is also grateful for financial support by JSPS KAKENHI Grant Number 25800222. H.N. is grateful for financial support by JSPS KAKENHI Grant Numbers 26120513, 26103510, 25540108 and CREST Kokubu project of JST.	Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Kawamura Y, 2014, PHYSICA D, V270, P20, DOI 10.1016/j.physd.2013.12.004; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Eccles FJR, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.015202; Bernardini A., 2005, THESIS U NAVARRA; Bernardini A, 2004, MATH BIOSCI ENG, V1, P339; Boubnov BM, 1995, CONVECTION ROTATING; BRAND H, 1983, PHYS REV A, V27, P1237, DOI 10.1103/PhysRevA.27.1237; BRAND HR, 1984, PROG THEOR PHYS, V71, P1096, DOI 10.1143/PTP.71.1096; Castrejon-Pita AA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.204501; Childress S., 1987, TOPICS GEOPHYS FLUID; Cross M., 2009, PATTERN FORMATION DY; CROSS MC, 1983, PHYS REV A, V27, P490, DOI 10.1103/PhysRevA.27.490; CROSS MC, 1984, PHYSICA D, V10, P299, DOI 10.1016/0167-2789(84)90181-7; Demir A, 2010, ICCAD-IEEE ACM INT, P292, DOI 10.1109/ICCAD.2010.5654185; Ei SI, 2002, PHYSICA D, V165, P176, DOI 10.1016/S0167-2789(02)00379-2; Ermentrout G. B., 1996, NEURAL COMPUT, V8, P979, DOI DOI 10.1162/NECO.1996.8.5.979; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Ermentrout GB, 2010, SIAM J APPL MATH, V70, P3039, DOI 10.1137/090775737; FAUVE S, 1987, PHYSICA D, V29, P202, DOI 10.1016/0167-2789(87)90056-X; Haberman R., 2012, APPL PARTIAL DIFFERE; HAGBERG A, 1994, NONLINEARITY, V7, P805, DOI 10.1088/0951-7715/7/3/006; Hoppensteadt F. C., 1997, WEAKLY CONNECTED NEU; Izhikevich E M, 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 1999, SIAM J APPL MATH, V59, P2193, DOI 10.1137/S0036139997330623; Kawamura Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.024101; Kawamura Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046211; Kawamura Y, 2010, CHAOS, V20, DOI 10.1063/1.3491344; Kawamura Y, 2013, CHAOS, V23, DOI 10.1063/1.4837775; Kawamura Y, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012912; Kawamura Y, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036209; Keener J.P., 2000, PRINCIPLES APPL MATH; Kilpatrick ZP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021910; KURAMOTO Y, 1984, PROG THEOR PHYS, V71, P1182, DOI 10.1143/PTP.71.1182; KURAMOTO Y, 1989, PROG THEOR PHYS SUPP, P244; KURAMOTO Y., 2003, CHEM OSCILLATIONS WA; Lappa M., 2010, THERMAL CONVECTION P; Lappa M., 2012, ROTATING THERMAL FLO; Lober J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066210; Lober J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.148305; Manneville P, 1990, DISSIPATIVE STRUCTUR; Manrubia S. C., 2004, EMERGENCE DYNAMICAL; Mikhailov A.S., 2013, ENG CHEM COMPLEXITY; Miranda JA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026303; Mori H., 1997, DISSIPATIVE STRUCTUR; Nakao H, 2012, PROC IUTAM, V5, P227, DOI 10.1016/j.piutam.2012.06.030; Nakao H, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021032; Nield D.A., CONVECTION POROUS ME; Ohta T, 2001, PHYSICA D, V151, P61, DOI 10.1016/S0167-2789(00)00227-X; OHTA T, 1987, PHYSICA D, V27, P21, DOI 10.1016/0167-2789(87)90003-0; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pomeau Y., 1979, J PHYS LETT        L, V40, P609, DOI 10.1051/jphyslet:019790040023060900; Randriamampianina A, 2006, J FLUID MECH, V561, P359, DOI 10.1017/S0022112006000711; Strogatz S., 2003, SYNC ORDER EMERGES C; Watanabe T, 2012, J FLUID MECH, V712, P219, DOI 10.1017/jfm.2012.413; Winfree AT., 2001, GEOMETRY BIOL TIME; Yadome M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056207; Zliao H., 1990, PHYS REV A, V42, P5894; Zwillinger D., 1998, HDB DIFFERENTIAL EQU	60	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2789	1872-8022		PHYSICA D	Physica D	MAR 1	2015	295						11	29		10.1016/j.physd.2014.12.007		19	Mathematics, Applied; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CE2LG	WOS:000351646500002		
J	Islam, A; Swetha, T; Karim, MR; Akhtaruzzaman, M; Han, LY; Singh, SP				Islam, Ashraful; Swetha, T.; Karim, Mohammad Rezaul; Akhtaruzzaman, Md; Han, Liyuan; Singh, Surya Prakash			Tuning of spectral response by co-sensitization in black-dye based dye-sensitized solar cell	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						black dye; co-sensitizers; dye sensitized solar cells; intensity-modulated photovoltage spectroscopy; power conversion efficiency; spectral response	METAL-FREE DYE; HIGH-EFFICIENCY; CONVERSION EFFICIENCY; ORGANIC-DYES; CHARGE RECOMBINATION; REDOX ELECTROLYTE; SURFACE-STATES; TIO2 FILMS; COSENSITIZATION; PERFORMANCE	We have systematically tuned the spectral response of black dye using the co-sensitization technique. In this study we have selected two co-sensitizers coded as AK-01 and U01. The individual overall conversion efficiencies (eta) of these co-sensitizers AK-01 and U01 are 6.20% and 6.01%, respectively. A better power conversion efficiency of 10.21% and 10.56% of DSSC was observed when black dye was co-sensitized with AK-01 and U01, respectively, compare to individual single black dye (9.18%). Both AK-01 and U01 co-sensitizers effectively overcome the light absorption of redox electrolyte and improved the dip in the incident-photon-to-current conversion efficiency spectra at 350-420 nm region compared with single black dye. Intensity-modulated photovoltage spectroscopy result shows the longer lifetime of black dye+U01 compared to the black dye which suggest the robust U01 dye sufficiently suppressed the recombination of electrons in the TiO2 with redox electrolyte without any interaction with black dye when co-adsorbed on TiO2. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Islam, Ashraful; Han, Liyuan] Natl Inst Mat Sci, Photovolta Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Swetha, T.; Singh, Surya Prakash] Indian Inst Chem Technol, Inorgan & Phys Chem Div, CSIR, Hyderabad 500607, Andhra Pradesh, India; [Karim, Mohammad Rezaul] King Saud Univ, Coll Engn, Ctr Excellence Res Engn Mat, Riyadh 11421, Saudi Arabia; [Akhtaruzzaman, Md] Univ Kebangsaan Malaysia, Solar Energy Res Inst, Bangi 43600, Selangor Darul, Malaysia	Islam, A (reprint author), Natl Inst Mat Sci, Photovolta Mat Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	ISLAM.Ashraful@nims.go.jp; spsingh@iict.res.in	Uzzaman,  Md. Akhtar/I-6267-2012		NPST program by King Saud University [10-NAN1021-02]; XII FY CSIR-INTELCOAT [CSC0114]; JSPS KAKENHI [26288113]; Ministry of Science, Technology and Innovation (MOSTI), Malaysia [03-01-02-SF1149]	This work was partly supported by NPST program by King Saud University, project No. 10-NAN1021-02. SPS thanks XII FY CSIR-INTELCOAT (CSC0114) for financial support. AI acknowledges the support of the JSPS KAKENHI grant No. 26288113. Authors also extend gratitude of the Solar Energy Research Institute (SERI) to the University Kebangsaan Malaysia (UKM) through the Escience Fund research grant with code 03-01-02-SF1149 of the Ministry of Science, Technology and Innovation (MOSTI), Malaysia for their kind contribution as well.	Akhtaruzzaman M, 2013, MATER CHEM PHYS, V142, P82, DOI 10.1016/j.matchemphys.2013.06.044; Akhtaruzzaman M, 2013, J CHEM-NY, DOI 10.1155/2013/910527; Ogura RY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086891; Hardin BE, 2011, J AM CHEM SOC, V133, P10662, DOI 10.1021/ja2042172; Akhtaruzzaman M, 2011, CHEM COMMUN, V47, P12400, DOI 10.1039/c1cc15580f; Zhang SF, 2013, J MATER CHEM A, V1, P4812, DOI 10.1039/c3ta01043k; Chen YS, 2005, NEW J CHEM, V29, P773, DOI 10.1039/b502725j; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Kuang D, 2007, LANGMUIR, V23, P10906, DOI 10.1021/la70241; Singh SP, 2013, ORG ELECTRON, V14, P1237, DOI 10.1016/j.orgel.2012.12.014; Horiuchi T, 2004, J AM CHEM SOC, V126, P12218, DOI 10.1021/ja0488277; Li RZ, 2010, J PHYS CHEM B, V114, P4461, DOI 10.1021/jp101222s; Tian HN, 2011, J MATER CHEM, V21, P10592, DOI 10.1039/c1jm10598a; Yu QJ, 2010, ACS NANO, V4, P6032, DOI 10.1021/nn101384e; Sharma GD, 2012, J MATER CHEM, V22, P18788, DOI 10.1039/c2jm33335j; Sharma GD, 2013, RSC ADV, V3, P6036, DOI 10.1039/c3ra23155k; Lee K, 2009, NAT MATER, V8, P665, DOI [10.1038/nmat2475, 10.1038/NMAT2475]; Wang YQ, 2014, ANGEW CHEM INT EDIT, V53, P10779, DOI 10.1002/anie.201406190; Ferrere S, 2002, NEW J CHEM, V26, P1155, DOI 10.1039/b203260k; Wang P, 2003, J PHYS CHEM B, V107, P14336, DOI 10.1021/jp0365965; Wang MK, 2010, NAT CHEM, V2, P385, DOI [10.1038/nchem.610, 10.1038/NCHEM.610]; Kimura M, 2012, ANGEW CHEM INT EDIT, V51, P4371, DOI 10.1002/anie.201108610; Clifford JN, 2011, J MATER CHEM, V21, P1693, DOI 10.1039/c0jm03661g; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; Sharma GD, 2013, RSC ADV, V3, P22412, DOI 10.1039/c3ra42537a; Choi H, 2008, ANGEW CHEM INT EDIT, V47, P8259, DOI 10.1002/anie.200802852; Inakazu F, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976677; Ozawa H, 2012, RSC ADV, V2, P3198, DOI 10.1039/c2ra01257j; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638; Cid JJ, 2007, ANGEW CHEM INT EDIT, V46, P8358, DOI 10.1002/anie.200703106; Gao S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.062301; Hara K., 2003, ENERGY MAT, V77, P89; Hara K., 2003, HDB PHOTOVOLTAIC SCI; Islam A, 2005, CHEM LETT, V34, P344, DOI 10.1246/cl.2005.344; Nusbaumer H, 2001, J PHYS CHEM B, V105, P10461, DOI 10.1021/jp012075a; Robertson N., 2006, ANGEW CHEM, V118, P2398, DOI 10.1002/ange.200503083	37	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAR	2015	212	3					651	656		10.1002/pssa.201431654		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CE0WP	WOS:000351530800026		
J	Shimizu, Y; Ueda, K; Takashima, H; Inaguma, Y				Shimizu, Yuhei; Ueda, Kazushige; Takashima, Hiroshi; Inaguma, Yoshiyuki			UV cathodoluminescence of Gd3+ doped and Gd3+-Pr3+ co-doped YAlO3 epitaxial thin films	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						epitaxial thin films; Gd3+; photoluminescence; pulsed laser deposition; ultraviolet cathodoluminescence; YAlO3	SINGLE-CRYSTALS; SCINTILLATION PROPERTIES; PEROVSKITE; LUMINESCENCE; EMISSION; GROWTH; YAP	Thin films of YAlO3: Gd3+ and YAlO3: Gd3+-Pr3+ were prepared on LaAlO3 (001) single crystal substrates by pulsed laser deposition (PLD). Both films were grown epitaxially and their surfaces were uniformly smooth. Under UV excitation at 216 nm, YAlO3: Gd3+ film did not show any intense photoluminescence (PL); on the other hand, YAlO3: Gd3+-Pr3+ film showed intense Gd3+ PL at 314 nm through Pr3+ 4f-5d absorption. Under electron irradiation with acceleration of 2.00 kV, both films showed UV cathodo luminescence (CL) from Gd3+ ions. In contrast to PL, the CL intensity of the YAlO3: Gd3+ film was four times greater than that of the YAlO3: Gd3+-Pr3+ film. The PL excitation spectrum of YAlO3: Gd3+ in vacuum UV region revealed the presence of an intense excitation band at 155 nm assignable to YAlO3 host absorption. This observation implied that the energy of accelerated electrons was absorbed by the host and then transferred to Gd3+. Pr3+ co-doping was found to weaken the Gd3+ emission in CL because the excitation energy absorbed by the host was transferred to not only Gd3+ but also Pr3+ accompanying visible emission and nonradiative transition in Pr3+. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Shimizu, Yuhei; Ueda, Kazushige] Kyushu Inst Technol, Grad Sch Engn, Dept Mat Sci, Kitakyushu, Fukuoka 8048550, Japan; [Takashima, Hiroshi] Natl Inst Adv Ind Sci & Technol, Elect Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Inaguma, Yoshiyuki] Gakushuin Univ, Dept Chem, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	Ueda, K (reprint author), Kyushu Inst Technol, Grad Sch Engn, Dept Mat Sci, 1-1 Sensui, Kitakyushu, Fukuoka 8048550, Japan.	kueda@che.kyutech.ac.jp; h-takashima@aist.go.jp					Lim SG, 2002, J APPL PHYS, V91, P4500, DOI 10.1063/1.1456246; Shimizu Y, 2014, THIN SOLID FILMS, V559, P23, DOI 10.1016/j.tsf.2013.11.135; Sokolska I, 2001, P SOC PHOTO-OPT INS, V4412, P236, DOI 10.1117/12.435833; Okamoto S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3159889; Zhuravleva M, 2007, OPT MATER, V30, P171, DOI 10.1016/j.optmat.2006.11.057; Shimizu Y, 2013, J LUMIN, V141, P44, DOI 10.1016/j.jlumin.2013.03.030; de Queiroz TB, 2010, OPT MATER, V32, P1480, DOI 10.1016/j.optmat.2010.06.004; TOMIKI T, 1991, J PHYS SOC JPN, V60, P1799, DOI 10.1143/JPSJ.60.1799; Arai N, 2002, APPL SURF SCI, V197, P402, DOI 10.1016/S0169-4332(02)00349-5; BRIXNER LH, 1990, J SOLID STATE CHEM, V89, P138, DOI 10.1016/0022-4596(90)90303-F; CASPERS HH, 1969, PHYS REV, V180, P329, DOI 10.1103/PhysRev.180.329; Gorbenko V, 2010, RADIAT MEAS, V45, P461, DOI 10.1016/j.radmeas.2009.12.011; Kitayama S, 2008, IOP CONF SER-MAT SCI, V1, DOI 10.1088/1757-8981/1/1/012001; Mares JA, 2005, NUCL INSTRUM METH A, V537, P271, DOI 10.1016/j.nima.2004.08.024; Ozen G, 2007, J LUMIN, V125, P223, DOI 10.1016/j.jlumin.2006.08.033; Shimizu Y, 2014, THIN SOLID FILMS, V571, P90, DOI 10.1016/j.tsf.2014.09.075; Takashima H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424438; Ueda K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.015003; Wisniewska M, 2001, P SOC PHOTO-OPT INS, V4412, P351, DOI 10.1117/12.435858; Yanagida T, 2010, NUCL INSTRUM METH A, V623, P1020, DOI 10.1016/j.nima.2010.08.022; Zhuravleva M, 2007, INORG MATER+, V43, P753, DOI 10.1134/S0020168507070163; Zorenko Y, 2011, J PHYS CONF SER, V289, DOI 10.1088/1742-6596/289/1/012029; Zorenko Y., 2013, RADIAT MEAS, V56, P56	23	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	MAR	2015	212	3					703	706		10.1002/pssa.201431778		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CE0WP	WOS:000351530800035		
J	Lan, TN; Ho, LB; Hai, TH				Tran Nguyen Lan; Le Bin Ho; Tran Hoang Hai			Electronic, magnetic, and spin-polarized transport properties of hybrid graphene/boron-nitride nanoribbons having 5-8-5 line defects at the heterojunction	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						density functional theory; boron-nitride; graphene; half-metals; half-semiconductors; spin filters	HEXAGONAL BORON-NITRIDE; HALF-METALLICITY; DIRECT GROWTH; INTERFACE; LAYERS; STATE	Using the spin-polarized density functional theory, we have investigated electronic, magnetic, and spin-polarized transport properties of hybrid boron-nitrde/graphene (BNC) nanoribbons having the BB and NN line defect at the heterojunction. Our results show that the defective systems behave as robust spin-selective half-semiconductor in the whole range of the graphene nanoribbon width considered in this work. Application of an electric field gives rise to antiferromagnetic half-metallic behavior in both systems. The range of electric field maintaining the half-metallicity is much larger for the BB line defect system than for the NN line defect system. Beyond a threshold of field intensity, the NN line defect system becomes nonmagnetic semiconductor, while the BB line defect system behaves as ferromagnetic metal with spin density located at the heterojunction. Finally, the spin-polarized transport calculation reveals that both systems can be efficient spin filters.	[Tran Nguyen Lan; Le Bin Ho; Tran Hoang Hai] VAST, Ho Chi Minh City Inst Phys, Ho Chi Minh City, Vietnam; [Tran Nguyen Lan] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	Lan, TN (reprint author), VAST, Ho Chi Minh City Inst Phys, Ho Chi Minh City, Vietnam.	lantrann@gmail.com		Bin Ho, Le/0000-0002-8816-4450	Vietnamese National Foundation for Science and Technology Development (NAFOSTED) [103.02-2011.11]	This work is supported by the Vietnamese National Foundation for Science and Technology Development (NAFOSTED) under Grant no. 103.02-2011.11.	Kan EJ, 2008, J AM CHEM SOC, V130, P4224, DOI 10.1021/ja710407t; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Kan EJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821112; Cervantes-Sodi F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165427; Pruneda JM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045422; Zheng FW, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205415; Fan YC, 2011, J APPL PHYS, V110, DOI 10.1063/1.3619800; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Son M, 2011, NANOSCALE, V3, P3089, DOI 10.1039/c1nr10504c; Ansari N, 2014, PHYS CHEM CHEM PHYS, V16, P21473, DOI 10.1039/c4cp02552k; Gao YB, 2013, NANO LETT, V13, P3439, DOI 10.1021/nl4021123; Liu YH, 2011, J PHYS CHEM A, V115, P19, DOI 10.1021/jp1101626; Ding XL, 2011, CARBON, V49, P2522, DOI 10.1016/j.carbon.2011.02.022; Ozaki T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035116; Nakamura J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205429; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Dutta S, 2008, J PHYS CHEM B, V112, P1333, DOI 10.1021/jp710637c; Chen W, 2010, J AM CHEM SOC, V132, P1699, DOI 10.1021/ja908475v; Lu J, 2014, NANO LETT, V14, P5133, DOI 10.1021/nl501900x; Ozaki T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.195113; Wang ZF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.096803; Drost R, 2014, NANO LETT, V14, P5128, DOI 10.1021/nl501895h; Ci L, 2010, NAT MATER, V9, P430, DOI 10.1038/nmat2711; Sutter P, 2012, NANO LETT, V12, P4869, DOI 10.1021/nl302398m; Liu Z, 2011, NANO LETT, V11, P2032, DOI 10.1021/nl200464j; Huang B, 2012, NANO RES, V5, P62, DOI 10.1007/s12274-011-0185-y; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Hod O, 2007, NANO LETT, V7, P2295, DOI 10.1021/nI0708922; Kan EJ, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2971187; Barone V, 2008, NANO LETT, V8, P2210, DOI 10.1021/nl080745j; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Ghosh D, 2014, J PHYS CHEM C, V118, P14670, DOI 10.1021/jp5039128; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/nmat3695, 10.1038/NMAT3695]; He J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3515921; Pruneda JM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161409; Tang SB, 2011, J PHYS CHEM C, V115, P16644, DOI 10.1021/jp204880f; Ghosh D, 2014, J MATER CHEM C, V2, P392, DOI 10.1039/c3tc31784f; Dutta S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096601; Basheer EA, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053008; Golberg D, 2004, MRS BULL, V29, P38, DOI 10.1557/mrs2004.15; Krepel D., 2013, J CHEM THEORY COMPUT, V10, P373; Lu SW, 2014, PHYSICA E, V60, P224, DOI 10.1016/j.physe.2014.03.004; Park H, 2012, J PHYS CHEM C, V116, P20054, DOI 10.1021/jp3046824; Srivastava P, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/2/025304; Wang YL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.193407; WENGSIEH Z, 1995, PHYS REV B, V51, P11229, DOI 10.1103/PhysRevB.51.11229; Zheng XH, 2010, J PHYS CHEM C, V114, P4190, DOI 10.1021/jp911203n	49	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAR	2015	252	3					573	581		10.1002/pssb.201451442		9	Physics, Condensed Matter	Physics	CD5ZY	WOS:000351168900017		
J	Le, YTH; Inagaki, TJ				Le, Yen Thi Hai; Inagaki, Takeshi J.			Density dependence of the terahertz absorption spectra in optically excited semiconductors	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						exciton Mott transition; excitons; semiconductors; terahertz spectroscopy	ELECTRON-HOLE PLASMA; TIME-DOMAIN SPECTROSCOPY; 2-COMPONENT FERMI SYSTEMS; SINGLE-PARTICLE SPECTRUM; MASS-ACTION LAW; BOSE CONDENSATION; GROUND-STATE; MICROSCOPIC THEORY; MOTT TRANSITION; QUANTUM-WELLS	We theoretically investigate the terahertz (THz) absorption spectra in optically excited direct bandgap bulk semiconductors for various electron-hole (e-h) pair densities with analyzing Coulomb interacting two-band e-h systems. The exciton Mott transition (the density ionization) can clearly be studied because, above the critical density, the exciton structures originating from the intraexciton transitions disappear and only the Drude component is obtained. The present theory also predicts that the transition energy from 1s to 2p states is almost independent of density below the exciton Mott density. We also study the interplay between the density ionization of excitons and the abrupt increase in the ionization ratio and in the e-h quasi-chemical potential owing to the quantum dissociation.	[Le, Yen Thi Hai; Inagaki, Takeshi J.] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Inagaki, TJ (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.	inagaki@ms.naist.jp			MEXT KAKENHI [21104516]	The authors would like to express his sincere thank to Professor M. Kuwata-Gonokami and Professor R. Shimano for fruitful comments. This work was supported by MEXT KAKENHI (Grant No. 21104516). Numerical computation was carried out at the Information iniTiative Center in Nara Institute of Science and Technology.	Kira M, 2006, PROG QUANT ELECTRON, V30, P155, DOI 10.1016/j.pquantelec.2006.12.002; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI [10.1109/TMTT.2004.835916, 10.1109/TMTT.2004.83516]; VANEXTER M, 1989, OPT LETT, V14, P1128; ZIMMERMANN R, 1978, PHYS STATUS SOLIDI B, V90, P175, DOI 10.1002/pssb.2220900119; Kira M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.176401; PAVESI L, 1989, PHYS REV B, V39, P10982, DOI 10.1103/PhysRevB.39.10982; MOTT NF, 1961, PHILOS MAG, V6, P287; Portnoi ME, 1999, PHYS REV B, V60, P5570, DOI 10.1103/PhysRevB.60.5570; Kaindl RA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045320; Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062; SIPE JE, 1993, PHYS REV B, V48, P11705, DOI 10.1103/PhysRevB.48.11705; Fulop JA, 2011, OPT EXPRESS, V19, P15090, DOI 10.1364/OE.19.015090; Suzuki T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.046402; Suzuki T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057401; Kaindl RA, 2003, NATURE, V423, P734, DOI 10.1038/nature01676; Ishikawa KL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201402; Parks AM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205306; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; AXT VM, 1994, Z PHYS B CON MAT, V93, P195, DOI 10.1007/BF01316963; Chu H, 1996, EUROPHYS LETT, V35, P535, DOI 10.1209/epl/i1996-00147-6; Chu H, 1996, PHYS REV B, V54, P5020, DOI 10.1103/PhysRevB.54.5020; COMBESCOT M, 1978, PHYS STATUS SOLIDI B, V86, P349, DOI 10.1002/pssb.2220860141; COMTE C, 1982, J PHYS-PARIS, V43, P1069, DOI 10.1051/jphys:019820043070106900; COMTE C, 1986, PHYS REV B, V34, P7164, DOI 10.1103/PhysRevB.34.7164; FEHRENBACH GW, 1982, PHYS REV LETT, V49, P1281, DOI 10.1103/PhysRevLett.49.1281; Fricke J, 1996, ANN PHYS-NEW YORK, V252, P479, DOI 10.1006/aphy.1996.0142; Glutsch S., 1992, PHYS REV B, V45; Grunwald T, 2009, PHYS STATUS SOLIDI C, V6, P500, DOI 10.1002/pssc.200880341; Haken H., 1958, Fortschritte der Physik, V6, DOI 10.1002/prop.19580060602; Haug H., 1994, QUANTUM THEORY OPTIC; HAUG H, 1984, PROG QUANT ELECTRON, V9, P3, DOI 10.1016/0079-6727(84)90026-0; Hayamizu YH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167403; Hendry E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.081101; Hirori H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081305; Hirori H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1598; Huber R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161314; Inagaki TJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075204; Inagaki TJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205204; Inagaki TJ, 2000, PHYS REV B, V62, P10852, DOI 10.1103/PhysRevB.62.10852; INKSON JC, 1972, J PHYS PART C SOLID, V5, P2599, DOI 10.1088/0022-3719/5/18/010; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; Kira M, 2003, PHYS STATUS SOLIDI B, V238, P443, DOI 10.1002/pssb.200303160; Kira M, 2005, EUR PHYS J D, V36, P143, DOI 10.1140/epjd/e2005-00217-3; Kremp D, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125315; Kwong NH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155205; LUNDQVIS.BI, 1967, PHYS KONDENS MATER, V6, P206, DOI 10.1007/BF02422717; LUNDQVIS.BI, 1967, PHYS KONDENS MATER, V6, P193, DOI 10.1007/BF02422716; NIKITINE S, 1984, J PHYS CHEM SOLIDS, V45, P949, DOI 10.1016/0022-3697(84)90138-0; NOZIERES P, 1982, J PHYS-PARIS, V43, P1083, DOI 10.1051/jphys:019820043070108300; Ohyama T, 1997, PHYS REV B, V56, P3871, DOI 10.1103/PhysRevB.56.3871; Saeedkia D, 2013, WOODH PUB SER ELECT, P1, DOI 10.1533/9780857096494; SCHMITTRINK S, 1988, PHYS REV B, V37, P941, DOI 10.1103/PhysRevB.37.941; Semkat D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155201; Snoke DW, 1995, PHYS REV E, V52, P5796, DOI 10.1103/PhysRevE.52.5796; STOLZ H, 1979, PHYS STATUS SOLIDI B, V94, P135, DOI 10.1002/pssb.2220940114; Stolz H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105007; Tayagaki T, 2005, J PHYS SOC JPN, V74, P1423, DOI 10.1143/JPSJ.74.1423; Wang DW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/34/345801; WYLD HW, 1963, ANN PHYS-NEW YORK, V23, P374, DOI 10.1016/0003-4916(63)90260-4; Yin XX, 2012, TERAHERTZ IMAGING FOR BIOMEDICAL APPLICATIONS: PATTERN RECOGNITION AND TOMOGRAPHIC RECONSTRUCTION, P1, DOI 10.1007/978-1-4614-1821-4; Yoshioka K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1335; Yoshioka T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256403; Yoshioka T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115314; ZIMMERMANN R, 1985, PHYS STATUS SOLIDI B, V131, P151, DOI 10.1002/pssb.2221310115; ZIMMERMANN R, 1976, PHYS STATUS SOLIDI B, V76, P191, DOI 10.1002/pssb.2220760120	65	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAR	2015	252	3					589	599		10.1002/pssb.201451191		11	Physics, Condensed Matter	Physics	CD5ZY	WOS:000351168900019		
J	Nakagomi, S; Kaneko, S; Kokubun, Y				Nakagomi, Shinji; Kaneko, Satoru; Kokubun, Yoshihiro			Crystal orientations of beta-Ga2O3 thin films formed on m-plane and r-plane sapphire substrates	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						crystals; Ga2O3; sapphire; thin films	MOLECULAR-BEAM EPITAXY; STRUCTURAL-CHARACTERIZATION; SINGLE-CRYSTALS; ZNO FILMS; C-PLANE; GROWTH; GAN; MOCVD	We have used X-ray pole figure analyses to study crystal orientations of -Ga2O3 thin films formed on (100) m-plane or (102) r-plane sapphire substrates prepared by gallium evaporation in oxygen plasma. The (-201) plane of -Ga2O3 on the (100) m-plane was inclined to be along two (110) a-planes. Crystals of (-201)-oriented -Ga2O3 exhibit six-fold symmetry in which a -Ga2O3 crystal is rotated every 60 degrees from [001] for each a-plane. In all, twelve kinds of -Ga2O3 crystals formed on m-plane sapphire substrate. Similarly, the (-201) plane of -Ga2O3 on the (102) r-plane was inclined to be along to two (113) n-plane. Crystals of (-201)-oriented -Ga2O3 exhibit three-fold symmetry with a -Ga2O3 crystal rotated every 120 degrees from the opposite direction of projection of the c-axis of each n-plane. In all, six kinds of -Ga2O3 crystals formed on the r-plane sapphire substrate. These observations can be explained by comparing oxygen atomic arrangements on the -Ga2O3 (-201) plane with those on the sapphire (110) a-plane and (113) n-plane.	[Nakagomi, Shinji; Kokubun, Yoshihiro] Ishinomaki Senshu Univ, Fac Sci & Engn, Dept Informat Technol & Elect, Ishinomaki, Miyagi 9868580, Japan; [Kaneko, Satoru] Kanagawa Ind Technol Ctr, Ebina, Kanagawa 2430435, Japan	Nakagomi, S (reprint author), Ishinomaki Senshu Univ, Fac Sci & Engn, Dept Informat Technol & Elect, Ishinomaki, Miyagi 9868580, Japan.	nakagomi@isenshu-u.ac.jp	Kaneko, Satoru/E-4842-2011	Kaneko, Satoru/0000-0003-0823-1666			Zhu T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.020226; Craven MD, 2002, APPL PHYS LETT, V81, P469, DOI 10.1063/1.1493220; Sasaki K, 2013, J CRYST GROWTH, V378, P591, DOI 10.1016/j.jcrysgro.2013.02.015; Sasaki K, 2013, IEEE ELECTR DEVICE L, V34, P493, DOI 10.1109/LED.2013.2244057; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; Nakagomi S, 2012, J CRYST GROWTH, V349, P12, DOI 10.1016/j.jcrysgro.2012.04.006; Moriyama T, 2005, JPN J APPL PHYS 1, V44, P7919, DOI 10.1143/JJAP.44.7919; Villora EG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164407; Kokubun Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432946; Paduano QS, 2013, J CRYST GROWTH, V367, P104, DOI 10.1016/j.jcrysgro.2012.12.028; Villora EG, 2004, J CRYST GROWTH, V270, P420, DOI 10.1016/j.jcrysgro.2004.06.027; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; Ding P, 2011, J CRYST GROWTH, V331, P15, DOI 10.1016/j.jcrysgro.2011.07.004; Kim JH, 2009, J VAC SCI TECHNOL B, V27, P1625, DOI 10.1116/1.3119682; Metzger T, 1996, PHYS STATUS SOLIDI B, V193, P391, DOI 10.1002/pssb.2221930213; Nakagomi S., 2011, SENSOR LETT, V9, P35; Nakagomi S, 2013, PHYS STATUS SOLIDI A, V210, P1738, DOI 10.1002/pssa.201329040; Nakagomi S, 2013, SENSOR ACTUAT B-CHEM, V187, P413, DOI 10.1016/j.snb.2013.01.020; Ohira S., 2005, J JPN ASS CRYST GROW, V32, P10; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Suzuki R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574911; Tsai TY, 2011, J ELECTROCHEM SOC, V158, pH1172, DOI 10.1149/2.073111jes; Usikov A, 2010, PHYS STATUS SOLIDI A, V207, P1295, DOI 10.1002/pssa.200983655	24	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAR	2015	252	3					612	620		10.1002/pssb.201451456		9	Physics, Condensed Matter	Physics	CD5ZY	WOS:000351168900022		
J	Watari, H; Shigyo, M; Tanabe, N; Tohda, M; Cho, KH; Kyung, PS; Jung, WS; Shimada, Y; Shibahara, N; Kuboyama, T; Tohda, C				Watari, Hidetoshi; Shigyo, Michiko; Tanabe, Norio; Tohda, Michihisa; Cho, Ki-Ho; Kyung, Park Su; Jung, Woo Sang; Shimada, Yutaka; Shibahara, Naotoshi; Kuboyama, Tomoharu; Tohda, Chihiro			Comparing the Effects of Kamikihito in Japan and Kami-Guibi-Tang in Korea on Memory Enhancement: Working Towards the Development of a Global Study	PHYTOTHERAPY RESEARCH			English	Article						Kamikihito; Kami-guibi-tang; Memory enhancement; Traditional medicine	TRADITIONAL CHINESE; SYMPTOMS; DEMENTIA; MEDICINE; CELLS; MICE	Traditional medicine is widely used in East Asia, and studies that demonstrate its usefulness have recently become more common. However, formulation-based studies are not globally understood because these studies are country-specific. There are many types of formulations that have been introduced to Japan and Korea from China. Establishing whether a same-origin formulation has equivalent effects in other countries is important for the development of studies that span multiple countries. The present study compared the effects of same-origin traditional medicine used in Japan and Korea in an in vivo experiment. We prepared drugs that had the same origin and the same components. The drugs are called kamikihito (KKT) in Japan and kami-guibi-tang (KGT) in Korea. KKT (500mg extract/kg/day) and KGT (500mg extract/kg/day) were administered to ddY mice, and object recognition and location memory tests were performed. KKT and KGT administration yielded equivalent normal memory enhancement effects. 3D-HPLC showed similar, but not identical, patterns of the detected compounds between KKT and KGT. This comparative research approach enables future global clinical studies of traditional medicine to be conducted through the use of the formulations prescribed in each country. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Watari, Hidetoshi; Shigyo, Michiko; Tanabe, Norio; Kuboyama, Tomoharu; Tohda, Chihiro] Toyama Univ, Div Neuromed Sci, Inst Nat Med, Toyama 9300194, Japan; [Watari, Hidetoshi; Shimada, Yutaka] Toyama Univ, Dept Japanese Oriental Med, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Tohda, Michihisa] Toyama Univ, Div Med Pharmacol, Inst Nat Med, Toyama 9300194, Japan; [Cho, Ki-Ho; Kyung, Park Su; Jung, Woo Sang] Kyung Hee Univ, Dept Cardiovasc & Neurol Dis, Kyung Hee Korean Med Hosp, Seoul 130702, South Korea; [Shibahara, Naotoshi] Toyama Univ, Div Kampo Diagnost, Inst Nat Med, Toyama 9300194, Japan	Tohda, C (reprint author), Toyama Univ, Div Neuromed Sci, Dept Biosci, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.	chihiro@inm.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The Regional Innovation Cluster Program, a Global Type (II) Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, partially supported this work. We thank Kracie Pharm Ltd. for providing us with KKT-Kra. We thank Dr Hyuck Jai Choi for preparing the KGT-KHU.	Tohda C, 2011, INT J NEUROSCI, V121, P641, DOI 10.3109/00207454.2011.602809; Naito R, 2006, BIOL PHARM BULL, V29, P1892, DOI 10.1248/bpb.29.1892; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248; Doos AR, 2010, J ETHNOPHARMACOL, V131, P433; Gaos J, 2013, DRUG DISCOV THER, V7, P46; Huangs JN, 2013, BEHAV BRAIN RES, V246, P11; Kims HG, 2012, CURR PHARM DESIGN, V18, P57; Kobayashis A, 2008, EVID BASE COMPL ALTE, V7, P359; Kung FC, 2012, CLIN INTERV AGING, V7, P393, DOI 10.2147/CIA.S36509; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Tohda C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03395; Tohda C, 2002, JPN J PHARMACOL, V90, P254, DOI 10.1254/jjp.90.254; Yamazaki M, 1996, BIOL PHARM BULL, V19, P791; Yus F, 2006, J INT MED RES, V34, P231	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	MAR	2015	29	3					351	356		10.1002/ptr.5250		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD4TU	WOS:000351077800005		
J	Yoon, J; Shin, KY				Yoon, Jiso; Shin, Ki-young			Mixed Effects of Legislative Quotas in South Korea	POLITICS & GENDER			English	Article							GENDER QUOTAS; REPRESENTATION		[Yoon, Jiso] Univ Kansas, Polit Sci, Lawrence, KS 66045 USA; [Shin, Ki-young] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 112, Japan; [Shin, Ki-young] Ochanomizu Univ, Inst Gender Studies, Tokyo 112, Japan	Yoon, J (reprint author), Univ Kansas, Polit Sci, Lawrence, KS 66045 USA.	jyoon@ku.edu; shin.kiyoung@ocha.ac.jp					Bauer G., 2006, WOMEN AFRICAN PARLIA; Chun Jin-young, 2014, IMPACT LEGISLATIVE G; Dahlerup Drude, 2006, WOMEN QUOTAS POLITIC; Hwang Ah-Ran, 2011, ELECTION STUDIES, V1, P100; Inter-Parliamentary Union (IPU), 2014, WOM NAT PARL; Kim Eun-Hee, 2012, SARAM KWA CHONGCHAEK, V5, P84; Kim Eun-kyung, 2010, KOREA WOMENS DEV I R; Kittilson Miki Caul, 2006, CHALLENGING PARTIES; Krook ML, 2010, INT FEM J POLIT, V12, P66, DOI 10.1080/14616740903429130; Krook ML, 2014, POLIT STUD-LONDON, V62, P2, DOI 10.1111/1467-9248.12116; Krook Mona Lena, 2009, QUOTAS WOMEN POLITIC; Lee Hyunji, PACIFIC AFF IN PRESS; Norris P, 2004, ELECTRONIC VOTING AND DEMOCRACY: A COMPARATIVE ANALYSIS, P193; Oh Yoo-seok, 2010, CURRENT TRENDS PROSP, V79, P140; Park Yoon-jung, 2014, OHMYNEWS        0204; Shin EH, 2003, ASIAN SURV, V43, P697, DOI 10.1525/as.2003.43.4.697; Shin KY, 2014, INT POLIT SCI REV, V35, P80, DOI 10.1177/0192512113508146; Yi Mi-Kyong, 1998, OPEN HOPE 10 YEARS H; Yoon Jung-Suk, 2002, CIVIL SOC SOCIAL MOV	19	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1743-923X	1743-9248		POLIT GENDER	Polit. Gend.	MAR	2015	11	1					186	195		10.1017/S1743923X14000658		10	Political Science; Women's Studies	Government & Law; Women's Studies	CD9TU	WOS:000351442100009		
J	Kurihara, Y; Tachibana, D; Yanai, S; Kitada, K; Sano, M; Wada, N; Nakagawa, K; Yamamoto, H; Hamuro, A; Nakano, A; Terada, H; Ozaki, K; Fukui, M; Koyama, M				Kurihara, Yasushi; Tachibana, Daisuke; Yanai, Sakika; Kitada, Kohei; Sano, Miho; Wada, Natsuko; Nakagawa, Kayoko; Yamamoto, Hiroko; Hamuro, Akihiro; Nakano, Akemi; Terada, Hiroyuki; Ozaki, Koji; Fukui, Mitsuru; Koyama, Masayasu			Characteristic differences and reference ranges for mitral, tricuspid, aortic, and pulmonary Doppler velocity waveforms during fetal life	PRENATAL DIAGNOSIS			English	Article							NORMAL HUMAN-FETUS; INTRAUTERINE GROWTH-RETARDATION; MYOCARDIAL PERFORMANCE INDEX; LEFT CARDIAC-FUNCTION; NET BLOOD-FLOW; GESTATIONAL-AGE; FILLING PATTERNS; TIME; ECHOCARDIOGRAPHY; ISTHMUS	ObjectivesWe aimed to construct reference ranges for time intervals of each component of cardiac flow velocity waveforms in normal fetuses, comparing those variables between right and left ventricles. MethodsIn 359 fetuses at the gestational age of 17-38weeks, the durations of atrioventricular (AV) valve opening (AVVO), AV valve closure (AVVC), total E- (total-E) and A- (total-A) waves, total ejection time (total-ET), acceleration time (acc-E for E-wave, acc-A for A-wave, and acc-ET for ejection time), and deceleration time (dec-E for E-wave, dec-A for A-wave, and dec-ET for ejection time) were studied cross sectionally. ResultsBoth right and left acc-E showed the strongest correlations with gestational age (r=0.478 and r=0.519, respectively). Left AVVO showed a stronger correlation (r=0.474) than right AVVO (r=0.282) and, conversely, right AVVC showed a stronger correlation (r=0.399) than left AVVC (r=0.195) with gestational age. Significant differences (all P values <0.001) were observed for all right and left parameters other than total-A and acc-E. ConclusionsCharacteristic differences between right and left ventricles were found in the reference ranges, suggesting the developmental properties of the fetal heart. (c) 2014 John Wiley & Sons, Ltd.	[Kurihara, Yasushi; Tachibana, Daisuke; Yanai, Sakika; Kitada, Kohei; Sano, Miho; Wada, Natsuko; Nakagawa, Kayoko; Yamamoto, Hiroko; Hamuro, Akihiro; Nakano, Akemi; Terada, Hiroyuki; Ozaki, Koji; Koyama, Masayasu] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 558, Japan; [Fukui, Mitsuru] Osaka City Univ, Grad Sch Med, Stat Lab, Osaka 558, Japan	Tachibana, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 558, Japan.	dtachibana@med.osaka-cu.ac.jp					Van Mieghem T, 2013, ULTRASOUND OBST GYN, V42, P64, DOI 10.1002/uog.12454; Harada K, 1997, AM J CARDIOL, V79, P173; RIZZO G, 1991, AM J OBSTET GYNECOL, V165, P876; SUTTON MS, 1994, BRIT HEART J, V71, P232; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Figueras F, 2003, EUR J OBSTET GYN R B, V110, P159, DOI 10.1016/S0301-2115(03)00123-4; REED KL, 1986, J AM COLL CARDIOL, V8, P391; Ghawi H, 2013, PEDIATR CARDIOL, V34, P1808, DOI 10.1007/s00246-013-0709-1; SANCHEZQUINTANA D, 1995, ANAT REC, V243, P483, DOI 10.1002/ar.1092430411; KENNY JF, 1986, CIRCULATION, V74, P1208; SUTTON MS, 1991, BRIT HEART J, V66, P285; HECHER K, 1994, ULTRASOUND OBST GYN, V4, P381, DOI 10.1046/j.1469-0705.1994.04050381.x; Chaoui R, 1998, ULTRASOUND OBST GYN, V11, P173, DOI 10.1046/j.1469-0705.1998.11030173.x; Nakagawa K, 2012, PRENATAL DIAG, V32, P803, DOI 10.1002/pd.3908; Azpuruas H, 2010, AM J OBSTET GYNECOL, V203; CARCELLERBLANCHARD AM, 1993, BRIT HEART J, V70, P457; Cook AC, 2004, PRENATAL DIAG, V24, P1032, DOI 10.1002/pd.1061; Hernandez-Andrade E, 2007, ULTRASOUND OBST GYN, V29, P321, DOI 10.1002/uog.3947; Hernandez-Andrade E, 2005, ULTRASOUND OBST GYN, V26, P227, DOI 10.1002/uog.1959; Kiseruds T, 1992, AM J OBSTET GYNECOL, V2, P389; MACHADO MVL, 1987, BRIT HEART J, V58, P15; Makikallio K, 2003, ULTRASOUND OBST GYN, V22, P351, DOI 10.1002/uog.232; Makikallio K, 2002, ULTRASOUND OBST GYN, V19, P147, DOI 10.1046/j.0960-7692.2001.00626.x; Mieghem T Van, 2009, AM J OBSTET GYNECOL, V200; Mielke G, 2000, ULTRASOUND OBST GYN, V15, P219, DOI 10.1046/j.1469-0705.2000.00078.x; Moon-Grady AJ, 2011, AM J OBSTET GYNECOL, V205; REED KL, 1989, AM J OBSTET GYNECOL, V161, P1532; Stinstra J, 2002, BJOG-INT J OBSTET GY, V109, P1235; Veille JC, 1999, AM J OBSTET GYNECOL, V180, P849, DOI 10.1016/S0002-9378(99)70655-1; Zars JH, 1984, BIOSTAT ANAL, P261	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-3851	1097-0223		PRENATAL DIAG	Prenat. Diagn.	MAR	2015	35	3					236	243		10.1002/pd.4527		8	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CD3LP	WOS:000350980300005		
J	Pastuhov, SI; Hisamoto, N; Matsumoto, K				Pastuhov, Strahil Iv; Hisamoto, Naoki; Matsumoto, Kunihiro			MAP kinase cascades regulating axon regeneration in C. elegans	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Review						MAP kinase; axon regeneration; Caenorhabditis elegans	MYELIN-ASSOCIATED GLYCOPROTEIN; SIGNAL-TRANSDUCTION PATHWAY; CAENORHABDITIS-ELEGANS; NEURITE OUTGROWTH; SCIATIC-NERVE; ADULT-RAT; IN-VIVO; TYROSINE KINASE; STRESS-RESPONSE; TAK1 MAPKKK	Mitogen-activated protein kinase (MAPK) signaling cascades are activated by diverse stimuli such as growth factors, cytokines, neurotransmitters and various types of cellular stress. Our evolving understanding of these signal cascades has been facilitated by genetic analyses and physiological characterization in model organisms such as the nematode Caenorhabditis elegans. Genetic and biochemical studies in Caenorhabditis elegans have shed light on the physiological roles of MAPK cascades in the control of cell fate decision, neuronal function and immunity. Recently it was demonstrated that MAPK signaling is also important for axon regeneration in Caenorhabditis elegans, and the use of Caenorhabditis elegans as a model system has significantly advanced our understanding of the largely conserved molecular mechanisms underlying axon regeneration. This review summarizes our current understanding of the role and regulation of MAPK signaling in Caenorhabditis elegans axon regeneration.	[Pastuhov, Strahil Iv; Hisamoto, Naoki; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Pastuhov, SI (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44177a@nucc.cc.nagoya-u.ac.jp					MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Kenney AM, 1998, J NEUROSCI, V18, P1318; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Calignano A, 1998, NATURE, V394, P277; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Chen MS, 2000, NATURE, V403, P434; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Li C, 2012, NAT NEUROSCI, V15, P551, DOI 10.1038/nn.3052; Camps M, 2000, FASEB J, V14, P6; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Valakh V, 2013, J NEUROSCI, V33, P17863, DOI 10.1523/JNEUROSCI.2196-13.2013; GrandPre T, 2000, NATURE, V403, P439; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Yan D, 2012, NEURON, V76, P534, DOI 10.1016/j.neuron.2012.08.043; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Voria I, 2006, EXP NEUROL, V197, P258, DOI 10.1016/j.expneurol.2005.10.001; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Prinjha R, 2000, NATURE, V403, P383; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Ninomiya-Tsuji J, 1999, NATURE, V398, P252; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.205.11.027; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Lindwall C, 2004, MOL CELL NEUROSCI, V27, P267, DOI 10.1016/j.mcn.2004.07.001; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Itoh A, 2009, BIOCHEM BIOPH RES CO, V383, P258, DOI 10.1016/j.bbrc.2009.04.009; APPENZEL.O, 1972, BRAIN RES, V42, P521, DOI 10.1016/0006-8993(72)90553-7; CARLSEN RC, 1982, BRAIN RES, V232, P413, DOI 10.1016/0006-8993(82)90284-0; GAUDINO G, 1994, EMBO J, V13, P3524; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Hattori A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003315; Hisamoto N, 2014, CELL REP, V9, P1628, DOI 10.1016/j.celrep.2014.10.056; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kulbatski I, 2004, J NEUROTRAUM, V21, P357, DOI 10.1089/089771504322972130; Mason MRJ, 2002, MOL CELL NEUROSCI, V20, P595, DOI 10.1006/mcne.2002.1140; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; Pastuliov S.I., 2012, NAT COMMUN, V3, pe1136; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625	65	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	2015	91	3					63	75		10.2183/pjab.91.63		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CE1JA	WOS:000351566700001		
J	Sato, E				Sato, Eimei			Intraovarian control of selective follicular growth and induction of oocyte maturation in mammals	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Review						follicular development; intraovarian regulators; oocyte maturation; oogenesis; ovarian glycosaminoglycans	HYPOTHYROID RDW RATS; GERMINAL VESICLE BREAKDOWN; ACTIVATED PROTEIN-KINASE; IN-VITRO MATURATION; MEIOTIC MATURATION; CUMULUS EXPANSION; PORCINE OOCYTES; GRANULOSA-CELLS; MOUSE OOCYTES; MAP KINASE	In newborn mammals, most of the germ cell population rests in a pool of quiescent small follicles in the ovaries. Regularly throughout adulthood, a small percentage of these oocytes and follicles grows to a certain stage of development and then either degenerates or matures and ovulates. This entire process is under both exogenous and endogenous control. Recent work, including my laboratory's, has clarified that cytokines and glycosaminoglycans are involved as exogenous and endogenous factors in ovarian follicular development, atresia, and maturation in mammals. The present article describes our contribution regarding the cytokines and ovarian glycosaminoglycans that act as intraovarian regulators of follicular development and oogenesis, including oocyte maturation, in mammals.	Inc Adm Agcy, Natl Livestock Breeding Ctr, Nishigo, Fukushima 9618511, Japan	Sato, E (reprint author), Inc Adm Agcy, Natl Livestock Breeding Ctr, Nishigo, Fukushima 9618511, Japan.	e0sato@nlbc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Rockefeller Foundation; Japan Society for the Promotion of Science; Program for the Promotion of Basic and Applied research for Innovations in Bio-oriented Industry (Brain)	I am deeply grateful for the continuous guidance and encouragement received from Prof. Emeritus Akira Iritani (Faculty of Agriculture at Kyoto University) and Dr. Samuel S. Koide (Center for Biomedical Research, The Population Council, The Rockefeller University) as well as for collaborations with colleagues and students at the Faculty of Agriculture, Kyoto University; The Rockefeller University; The Institute of Medical Science, The University of Tokyo; The Graduate School of Agricultural Science, Tohoku University; and the National Livestock Breeding Center of Japan. I also appreciate the financial support offered by the Ministry of Education, Culture, Sports, Science and Technology of Japan; The Rockefeller Foundation; The Japan Society for the Promotion of Science; and the Program for the Promotion of Basic and Applied research for Innovations in Bio-oriented Industry (Brain).	NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Berisha B, 2000, J ENDOCRINOL, V167, P371, DOI 10.1677/joe.0.1670371; Shimizu T, 2004, DOMEST ANIM ENDOCRIN, V27, P397, DOI 10.1016/j.domaniend.2004.04.001; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; GOSPODAROWICZ D, 1979, EXP EYE RES, V28, P501, DOI 10.1016/0014-4835(79)90038-1; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; RACOWSKY C, 1985, DEV BIOL, V108, P191, DOI 10.1016/0012-1606(85)90022-3; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; Nakayama T, 1996, BIOL REPROD, V55, P1299, DOI 10.1095/biolreprod55.6.1299; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; CARROLL J, 1991, J REPROD FERTIL, V92, P197; ALBERTINI DF, 1992, BIOESSAYS, V14, P97, DOI 10.1002/bies.950140205; TSAFRIRI A, 1995, ADV EXP MED BIOL, V377, P121; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Ilangumaran S, 1999, LEUKEMIA LYMPHOMA, V35, P455, DOI 10.1080/10428199909169610; DOWNS SM, 1985, P NATL ACAD SCI USA, V82, P454, DOI 10.1073/pnas.82.2.454; Jiang JY, 2003, REPRODUCTION, V125, P211, DOI 10.1530/rep.0.1250211; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; BJERSING L, 1982, ADV EXP MED BIOL, V147, P1; Chiri S, 1998, J CELL SCI, V111, P2519; DAEN FP, 1994, J REPROD FERTIL, V101, P667; DAEN FP, 1995, CELL STRUCT FUNCT, V20, P223; Daen Ferdinand P., 1997, Journal of Reproduction and Development, V43, P165, DOI 10.1262/jrd.43.165; Dekel N, 1988, MEIOTIC INHIBITION M, P87; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Gotoh Y., 1995, MOL REPROD DEV, V42, P485; GUTHRIE HD, 1995, J ANIM SCI, V73, P2834; Hiradate Y, 2011, BIOCHEM BIOPH RES CO, V415, P691, DOI 10.1016/j.bbrc.2011.10.139; Hirao Yuji, 1993, Journal of Reproduction and Development, V39, P13; Iijima K, 2005, J REPROD DEVELOP, V51, P161, DOI 10.1262/jrd.51.161; Inoue M, 1998, BIOL REPROD, V58, P130, DOI 10.1095/biolreprod58.1.130; INOUE M, 1995, ZYGOTE, V3, P265; JABLONKASHARIFF A, 1994, BIOL REPROD, V51, P531, DOI 10.1095/biolreprod51.3.531; Jiang JY, 2000, BIOL REPROD, V63, P1637, DOI 10.1095/biolreprod63.6.1637; Jiang JY, 2004, CELL TISSUE RES, V316, P349, DOI 10.1007/s00441-004-0887-5; Jiang JY, 2002, CELL TISSUE RES, V310, P93, DOI 10.1007/s00441-002-0565-4; Jiang JY, 2000, J REPROD FERTIL, V119, P193, DOI 10.1530/reprod/119.2.193; Jiang JY, 1999, J REPROD FERTIL, V116, P19; KANAYAMA I, 1990, JPN J VET SCI, V52, P199; Kanayama I., 1995, J MAMM OVA RES, V12, P101, DOI 10.1274/jmor.12.101; Kimura N, 2002, BIOL REPROD, V66, P707, DOI 10.1095/biolreprod66.3.707; LABBE JC, 1989, CELL, V57, P253, DOI 10.1016/0092-8674(89)90963-X; Larsen WJ, 1996, ZYGOTE, V4, P335; Luisi S, 2005, HUM REPROD UPDATE, V11, P123, DOI 10.1093/humupd/dmh057; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; Mattioli M, 1998, MOL REPROD DEV, V51, P445, DOI 10.1002/(SICI)1098-2795(199812)51:4<445::AID-MRD12>3.0.CO;2-L; MCNATTY KP, 1981, J ENDOCRINOL, V90, P375, DOI 10.1677/joe.0.0900375; Miyake Y, 2009, BIOL REPROD, V80, P249, DOI 10.1095/biolreprod.108.067694; Miyake Y, 2006, BIOL REPROD, V74, P501, DOI 10.1095/biolreprod.105.045641; Miyamoto Y, 1996, DEV GROWTH DIFFER, V38, P291; MOOR RM, 1986, J DAIRY SCI, V69, P927; NAITO K, 1991, J REPROD FERTIL, V93, P467; Nakai T., 1996, J MAMM OVA RES, V13, P24, DOI 10.1274/jmor.13.24; PHILLIPS DM, 1991, MOL REPROD DEV, V28, P297, DOI 10.1002/mrd.1080280313; RISEK B, 1990, J CELL BIOL, V110, P269, DOI 10.1083/jcb.110.2.269; Sato E., 1998, REPROD BIOL UPDATE N, P93; Sato E., 1995, J ANAT EMBRYOL S1, V100, P461; SATO E, 1985, CELL DIFFER DEV, V17, P169, DOI 10.1016/0045-6039(85)90484-1; SATO E, 1991, ENDOCRINOLOGY, V128, P2402; SATO E, 1984, DIFFERENTIATION, V26, P59, DOI 10.1111/j.1432-0436.1984.tb01374.x; SATO E, 1982, J ANIM SCI, V55, P873; SATO E, 1980, FERTIL STERIL, V34, P55; SATO E, 1993, ARCH HISTOL CYTOL, V56, P293, DOI 10.1679/aohc.56.293; SATO E, 1984, J EXP ZOOL, V230, P125, DOI 10.1002/jez.1402300116; Sato E., 1977, Japanese Journal of Zootechnical Science, V48, P22; Sato E., 1977, Japanese Journal of Zootechnical Science, V48, P782; SATO E, 1982, EXPERIENTIA, V38, P1248, DOI 10.1007/BF01959768; SATO E, 1995, ANAT REC, V241, P205, DOI 10.1002/ar.1092410207; SATO E, 1994, CELL STRUCT FUNCT, V19, P29; Sato E., 1982, ADV BIOSCI, V34, P203; SATO E, 1986, GAMETE RES, V13, P115, DOI 10.1002/mrd.1120130204; SATO E, 1987, INT REV CYTOL, V106, P1, DOI 10.1016/S0074-7696(08)61709-X; SATO E, 1988, Japanese Journal of Zootechnical Science, V59, P466; SATO E, 1982, ADV EXP MED BIOL, V147, P161; SATO E, 1987, BIOL REPROD, V37, P371, DOI 10.1095/biolreprod37.2.371; SATO E, 1990, MOL REPROD DEV, V26, P391, DOI 10.1002/mrd.1080260415; SATO E, 1990, Zeitschrift fuer Naturforschung Section C Journal of Biosciences, V45, P873; SATO E, 1978, J REPROD FERTIL, V54, P263; SATO E, 1990, ENDOCRINOL JAPON, V37, P413; Shimizu T, 2008, FERTIL STERIL, V89, P1563, DOI 10.1016/j.fertnstert.2007.06.043; Shimizu T, 2003, BIOL REPROD, V69, P1388, DOI 10.1095/biolreprod.103.016311; Shimizu T, 2002, BIOL REPROD, V67, P1846, DOI 10.1095/biolreprod.102.006734; SHIMODA K, 1993, DEV GROWTH DIFFER, V35, P431; Tsafriri A., 1978, P409; Yokoo M, 2002, BIOL REPROD, V67, P1165, DOI 10.1095/biolreprod.102.004903; Yokoo M, 2004, INT REV CYTOL, V235, P251, DOI 10.1016/S0074-7696(04)35006-0	89	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	2015	91	3					76	91		10.2183/pjab.91.76		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CE1JA	WOS:000351566700002		
J	Hayano, RS; Tsubkura, M; Miyazmu, M; Satou, H; Sato, K; Masaki, S; Sakuma, Y				Hayano, Ryugo S.; Tsubkura, Masaharu; Miyazmu, Makoto; Satou, Hideo; Sato, Katsumi; Masaki, Shin; Sakuma, Yu			Whole-body counter surveys of Miharu-town school children for four consecutive years after the Fukushima NPP accident	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						Fukushima Dai-ichi accident; radioactive cesium; whole-body counting; committed effective dose	NUCLEAR-POWER-PLANT; CONTAMINATION; DISASTER	Comprehensive whole-body counter surveys of Miharu-town school children have been conducted for four consecutive years, in 2011-2014. This represents the only long-term sampling-bias-free study of its type conducted after the Fukushima Dai-ichi accident. For the first time in 2014, a new device called the Babyscan, which has a low Cs-134/137 MDA of <50 Bq/body, was used to screen the children shorter than 130 cm. No child in this group was found to have detectable level of radiocesium. Using the MDAs, upper limits of daily intake of radiocesium were estimated for each child. For those screened with the Babyscan, the upper intake limits were found to be less than or similar to 1 Bq/day for Cs-137. Analysis of a questionnaire filled out by the children's parents regarding their food and water consumption shows that the majority of Miharu children regularly consume local and/or home-grown rice and vegetables. This however does not increase the body burden.	[Hayano, Ryugo S.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Tsubkura, Masaharu] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo 1130033, Japan; [Miyazmu, Makoto] Fukushirna Med Univ, Dept Radiat Hlth Management, Fukushima, Japan; [Satou, Hideo; Sato, Katsumi; Masaki, Shin; Sakuma, Yu] Hirata Cent Hosp, Fukushima, Japan; [Satou, Hideo; Sato, Katsumi; Masaki, Shin; Sakuma, Yu] Res Inst Radiat Safety Disaster Recovery Support, Fukushima, Japan	Hayano, RS (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hayano@phys.s.u-tokyo.ac.jp	Hayano, Ryugo/F-7889-2012				Tanaka S, 2012, P JPN ACAD B-PHYS, V88, P471, DOI 10.2183/pjab.88.471; Hayano RS, 2014, P JPN ACAD B-PHYS, V90, P211, DOI 10.2183/pjab.90.211; [Anonymous], 2012, RESULTS FUKUSHIMA BR; Hayano RS, 2014, J RADIOL PROT, V34, P645, DOI 10.1088/0952-4746/34/3/645; [Anonymous], 2013, AIRBORNE MONITORING; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; [Anonymous], 2014, 2 SURVEY FUKUSHIMA C; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Ishigure N, 2004, RADIAT PROT DOSIM, V109, P235, DOI 10.1093/rpd/nch048; Sourial N., 2009, J CLIN EPIDEMIOL, V3, P638; Sourial N., 2009, J CLIN EPIDEMIOL, V63, P809; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; UNSCEAR, 2013, SCIENTIFIC ANNEX A L; Yelland P.M., 2010, MATH J, V12, DOI [10.3888/tmj.12-4, DOI 10.3888/TMJ.12-4]	18	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	2015	91	3					92	98		10.2183/pjab.91.92		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CE1JA	WOS:000351566700003		
J	Ishijima, S				Ishijima, Sumio			Ca2+ and cAMP regulations of microtubule sliding in hyperactivated motility of bull spermatozoa	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						beat frequency; capacitation; ciliary movement; flagellar movement; metachronal sliding; synchronous sliding	SEA-URCHIN; SPERM FLAGELLA; TRITON X-100; MOVEMENT; CALCIUM; AXONEMES; BEAT; ADP	To reach and fertilize the egg, mammalian spermatozoa change their flagellar movement in the female reproductive tract, named hyperactivation. The biochemical analyses of the hyperactivated movement using demembranated spermatozoa defined the factors inducing this peculiar movement; namely, large asymmetrical flagellar movement observed in the early stage of the hyperactivation was induced with a high Ca2+ concentration while large symmetrical flagellar movement in the late stage of the hyperactivation was generated with low Ca2+ and high cAMP concentrations. Under these conditions, the rnicrotubule sliding of bull sperm flagella was investigated by disintegrating the sperm flagella with MgATP(2-) after extracting their plasma membrane and mitochondria. The large asymmetrical flagellar movement was caused by a long sliding displacement of a fiber of the doublet microtubules. On the other hand, the large symmetrical flagellar movement was generated by a large amount of microtubule sliding by many doublet microtubules.	[Ishijima, Sumio] Tokyo Inst Technol, Dept Bioengn, Tokyo 1528551, Japan	Ishijima, S (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Meguro Ku, 2-12-1 W3-41 O-Okayama, Tokyo 1528551, Japan.	sishijim@bio.titech.ac.jp					AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/2002.dbio.2002.0797; Nakano I, 2003, J CELL SCI, V116, P1627, DOI 10.1242/jcs.00336; Kinukawa M, 2004, REPRODUCTION, V128, P813, DOI 10.1530/rep.1.00324; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Ishijima S, 1996, J CELL SCI, V109, P2833; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; GIBBONS BH, 1972, J CELL BIOL, V54, P75, DOI 10.1083/jcb.54.1.75; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Ishijima S, 2013, CELL STRUCT FUNCT, V38, P89; BROKAW CJ, 1991, J CELL BIOL, V114, P1201, DOI 10.1083/jcb.114.6.1201; Gibbons I R, 1982, Symp Soc Exp Biol, V35, P225; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Ishijima S, 2006, MOL REPROD DEV, V73, P1129, DOI 10.1002/mrd.20420; Ishijima S, 2007, CELL MOTIL CYTOSKEL, V64, P809, DOI 10.1002/cm.20228; Ishijima S., 1992, COMP SPERMATOLOGY, P387; Ishijima S, 2011, REPRODUCTION, V142, P409, DOI 10.1530/REP-10-0445; Kaneko T, 2007, MOL REPROD DEV, V74, P478, DOI 10.1002/mrd.20630; Lesich KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094953; Lesich KA, 2008, BIOPHYS J, V95, P472, DOI 10.1529/biophysj.107.127951; LINDEMANN CB, 1975, J CELL BIOL, V65, P147, DOI 10.1083/jcb.65.1.147; Mohri H, 2012, P JPN ACAD B-PHYS, V88, P397, DOI 10.2183/pjab.88.397; Ohmuro J, 2006, MOL REPROD DEV, V73, P1412, DOI 10.1002/mrd.20521; OKUNO M, 1979, J CELL SCI, V38, P105; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; RIKMENSP.R, 1971, BIOPHYS J, V11, P446; RIKMENSPOEL R, 1978, BIOPHYS J, V23, P177; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SUGINO K, 1982, NATURE, V295, P609, DOI 10.1038/295609a0; Yanagimachi R, 1994, PHYSL REPROD, V2, P189	31	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	2015	91	3					99	108		10.2183/pjab.91.99		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CE1JA	WOS:000351566700004		
J	Okada, T; Ozaki, N				Okada, Takashi; Ozaki, Norio			What is the nature of the autism 'spectrum'?	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Editorial Material									[Okada, Takashi; Ozaki, Norio] Nagoya Univ Grad Sch Med, Dept Psychiat, Nagoya, Aichi, Japan	Okada, T (reprint author), Nagoya Univ Grad Sch Med, Dept Psychiat, Nagoya, Aichi, Japan.		Ozaki, Norio/M-8908-2014	Ozaki, Norio/0000-0002-7360-4898			Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Idring S, 2014, J AUTISM DE IN PRESS; Shishido E, 2014, PSYCHIAT CLIN NEUROS, V68, P85, DOI 10.1111/pcn.12128	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		129	130		10.1111/pcn.12276		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600001		
J	Egawa, J; Watanabe, Y; Shibuya, M; Endo, T; Sugimoto, A; Igeta, H; Nunokawa, A; Inoue, E; Someya, T				Egawa, Jun; Watanabe, Yuichiro; Shibuya, Masako; Endo, Taro; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Inoue, Emiko; Someya, Toshiyuki			Resequencing and association analysis of OXTR with autism spectrum disorder in a Japanese population	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						autism spectrum disorder; Japanese; non-synonymous variation; OXTR; resequencing	OXYTOCIN RECEPTOR GENE; BEHAVIOR	AimsThe oxytocin receptor (OXTR) is implicated in the pathophysiology of autism spectrum disorder (ASD). A recent study found a rare non-synonymous OXTR gene variation, rs35062132 (R376G), associated with ASD in a Japanese population. In order to investigate the association between rare non-synonymous OXTR variations and ASD, we resequenced OXTR and performed association analysis with ASD in a Japanese population. MethodsWe resequenced the OXTR coding region in 213 ASD patients. Rare non-synonymous OXTR variations detected by resequencing were genotyped in 213 patients and 667 controls. ResultsWe detected three rare non-synonymous variations: rs35062132 (R376G/C), rs151257822 (G334D), and g.8809426G>T (R150S). However, there was no significant association between these rare non-synonymous variations and ASD. ConclusionsOur present study does not support the contribution of rare non-synonymous OXTR variations to ASD susceptibility in the Japanese population.	[Egawa, Jun; Watanabe, Yuichiro; Shibuya, Masako; Endo, Taro; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Inoue, Emiko; Someya, Toshiyuki] Niigata Univ Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan; [Egawa, Jun] Niigata Univ, Dept Pediat Psychiat, Ctr Transdisciplinary Res, Niigata, Japan; [Watanabe, Yuichiro] Niigata Univ, Sch Med, Div Med Educ, Comprehens Med Educ Ctr,Fac Med, Niigata, Japan; [Shibuya, Masako] Niigata Univ, Hlth Adm Ctr, Headquarters Hlth Adm, Niigata, Japan; [Nunokawa, Ayako] Oojima Hosp, Niigata, Japan	Watanabe, Y (reprint author), Niigata Univ Grad Sch Med & Dent Sci, Dept Psychiat, Chuo Ku, 757 Asahimachidori Ichibancho, Niigata 9518510, Japan.	yuichiro@med.niigata-u.ac.jp					Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Campbell DB, 2011, J NEURODEV DISORD, V3, P101, DOI 10.1007/s11689-010-9071-2; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Nunokawa A, 2010, SCHIZOPHR RES, V116, P61, DOI 10.1016/j.schres.2009.10.016; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Yamasue H, 2013, BRAIN DEV-JPN, V35, P111, DOI 10.1016/j.braindev.2012.08.010; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Egawa J, 2012, PSYCHIAT RES, V196, P320, DOI 10.1016/j.psychres.2011.09.001; Ma WJ, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-22	16	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		131	135		10.1111/pcn.12205		5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600002		
J	Hasegawa, C; Kikuchi, M; Yoshimura, Y; Hiraishi, H; Munesue, T; Nakatani, H; Higashida, H; Asada, M; Oi, M; Minabe, Y				Hasegawa, Chiaki; Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Nakatani, Hideo; Higashida, Haruhiro; Asada, Minoru; Oi, Manabu; Minabe, Yoshio			Broader autism phenotype in mothers predicts social responsiveness in young children with autism spectrum disorders	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						autism spectrum disorder; Autism-spectrum Quotient; Empathy Quotient; parents; Social Responsiveness Scale	HIGH-FUNCTIONING AUTISM; NORMAL SEX-DIFFERENCES; GENERAL-POPULATION; EXECUTIVE FUNCTION; ASPERGER-SYNDROME; PARENTS; QUOTIENT; TRAITS; TWIN; SIBLINGS	AimsThe aim of this study was to identify phenotypes in mothers and fathers that are specifically associated with disturbances in reciprocal social interactions and communication in their young children with autism spectrum disorder (ASD) in a Japanese sample. MethodsAutistic traits in parents were evaluated using the Autism-spectrum Quotient (AQ), the Empathy Quotient (EQ) and the Systemizing Quotient (SQ) in 88 parents (44 mothers and corresponding fathers) of children with ASD and in 60 parents (30 mothers and corresponding fathers) of typically developing (TD) children. For the measurement of autistic traits in children, we employed the Social Responsiveness Scale (SRS). ResultsIn two of the five AQ subscales (social skills and communication), the parents of ASD children scored significantly higher than did the parents of TD children, regardless of whether the parent was a mother or a father. In addition, in mothers of ASD children, there were significant positive correlations between two of the five AQ subscales (attention-switching and communication) and the SRST-score in their children. ConclusionsThis is the first study to demonstrate that the social skills and communication subscales in the AQ are more sensitive as autism traits in a Japanese sample and to demonstrate that some autistic traits in mothers are specifically associated with disturbances in the social ability of their young children with ASD, as measured by the SRS score. Further study is necessary to determine whether these results were caused by genetic or environmental factors.	[Hasegawa, Chiaki; Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Higashida, Haruhiro; Oi, Manabu; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208641, Japan; [Kikuchi, Mitsuru; Munesue, Toshio; Nakatani, Hideo; Minabe, Yoshio] Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Asada, Minoru] Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Suita, Osaka, Japan	Kikuchi, M (reprint author), Kanazawa Univ, Res Ctr Child Mental Dev, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mitsuru@zc4.so-net.ne.jp			MEXT [24000012]; Center of Innovation Program from Japan Science and Technology Agency, JST, Japan	This study was supported by a Grant-in-Aid for Specially Promoted Research (Number 24000012) from MEXT, and was partially supported by the Center of Innovation Program from Japan Science and Technology Agency, JST, Japan. The authors declare that they have no conflicts of interest.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Happe F, 2001, J CHILD PSYCHOL PSYC, V42, P299, DOI 10.1111/1469-7610.00723; Bishop DVM, 2004, J CHILD PSYCHOL PSYC, V45, P1431, DOI 10.1111/j.1469-7610.2004.00325.x; Losh M, 2008, J NEUROPATH EXP NEUR, V67, P829, DOI 10.1097/NEN.0b013e318184482d; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BAILEY A, 1995, PSYCHOL MED, V25, P63; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Virkud YV, 2009, AM J MED GENET B, V150B, P328, DOI 10.1002/ajmg.b.30810; Scheeren AM, 2008, J AUTISM DEV DISORD, V38, P276, DOI 10.1007/s10803-007-0389-x; Constantino J.N., 2002, SOCIAL RESPONSIVENES; Hirosawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00384; Hughes C, 1997, PSYCHOL MED, V27, P209, DOI 10.1017/S0033291796004308; Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034; Kaufman A. S., 1983, KAUFMAN ASSESSMENT B; Kose S, 2013, PSYCHIAT CLIN NEUROS, V67, P20, DOI 10.1111/pcn.12005; Lord C., 1999, AUTISM DIAGNOSTIC OB; Ruta L, 2012, J AUTISM DEV DISORD, V42, P625, DOI 10.1007/s10803-011-1290-1; Valla JM, 2010, AUTISM RES, V3, P174, DOI 10.1002/aur.143; Wheelwright S, 2010, MOL AUTISM, V1, P1, DOI DOI 10.1186/2040-2392-1-1.PUBMED:20678244; Wong D, 2006, GENES BRAIN BEHAV, V5, P561, DOI 10.1111/j.1601-183X.2005.00199.x; Yoshimura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080126	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		136	144		10.1111/pcn.12210		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600003		
J	Hosokawa, M; Nakadoi, Y; Watanabe, Y; Sumitani, S; Ohmori, T				Hosokawa, Mai; Nakadoi, Yoshihiro; Watanabe, Yukina; Sumitani, Satsuki; Ohmori, Tetsuro			Association of autism tendency and hemodynamic changes in the prefrontal cortex during facial expression stimuli measured by multi-channel near-infrared spectroscopy	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						autism spectrum disorders; autism-spectrum quotient; facial recognition; near-infrared spectroscopy; prefrontal cortex	TASK; PERCEPTION; ACTIVATION; TRAITS; BRAIN	AimThe aim of this study is to examine the hemodynamic changes induced by the cognitive process of facial expression by using multi-channel near-infrared spectroscopy in healthy subjects with varying degrees of autism tendency. MethodsSubjects were 38 volunteers, 20 men and 18 women. Autism tendency was measured by the Autism Spectrum Quotient. The hemodynamic changes in the prefrontal cortex were measured by 24-channel near-infrared spectroscopy system, while subjects were asked to judge their own emotional response to standardized pictures of eight kinds of facial expressions on a computer screen. ResultsThere were significant negative correlations between Autism Spectrum Quotient scores and accuracy of fearful expression recognition as well as increases in the concentration of oxygenated hemoglobin in response to four kinds of emotional faces (fear, contempt, sadness and disgust). ConclusionOur findings suggest that the greater tendency to autism that subjects have, the more difficulty they have in recognizing a fearful expression and the less hemodynamic change in the prefrontal cortex they show in response to negative facial expressions.	[Hosokawa, Mai; Nakadoi, Yoshihiro; Watanabe, Yukina; Sumitani, Satsuki; Ohmori, Tetsuro] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Psychiat, Course Integrated Brain Sci, Tokushima, Japan	Nakadoi, Y (reprint author), Shikoku Med Ctr Children & Adults, Dept Child Psychiat, Senyuu Cyo 2-1-1, Zentsuji, Kagawa 7658507, Japan.	y-nakadoi@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported by a Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. No potential conflicts of interest are disclosed.	Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Kurita H, 2006, PSYCHIAT CLIN NEUROS, V60, P373, DOI 10.1111/j.1440-1819.2006.01516.x; Hoshi Y, 2000, COGNITIVE BRAIN RES, V9, P339, DOI 10.1016/S0926-6410(00)00006-9; WING L, 1981, PSYCHOL MED, V11, P115; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Nakadoi Y, 2012, PSYCHIAT CLIN NEUROS, V66, P26, DOI 10.1111/j.1440-1819.2011.02290.x; Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Kawakubo Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006881; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; Poljac E, 2013, AUTISM, V17, P668, DOI 10.1177/1362361312455703; Spencer MD, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.18; Wakabayashi Akio, 2004, Shinrigaku Kenkyu, V75, P78	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		145	152		10.1111/pcn.12240		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600004		
J	Hiraishi, H; Kikuchi, M; Yoshimura, Y; Kitagawa, S; Hasegawa, C; Munesue, T; Takesaki, N; Ono, Y; Takahashi, T; Suzuki, M; Higashida, H; Asada, M; Minabe, Y				Hiraishi, Hirotoshi; Kikuchi, Mitsuru; Yoshimura, Yuko; Kitagawa, Sachiko; Hasegawa, Chiaki; Munesue, Toshio; Takesaki, Natsumi; Ono, Yasuki; Takahashi, Tsutomu; Suzuki, Michio; Higashida, Haruhiro; Asada, Minoru; Minabe, Yoshio			Unusual developmental pattern of brain lateralization in young boys with autism spectrum disorder: Power analysis with child-sized magnetoencephalography	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						autism; brain lateralization; magnetoencephalography; spontaneous brain activity; young children	2-TO 5-YEAR-OLD CHILDREN; FUNCTIONAL CONNECTIVITY; LANGUAGE PERFORMANCE; EEG; COHERENCE; OSCILLATIONS; MECHANISMS; FIELDS; WAVES	AimsAutism spectrum disorder (ASD) is often described as comprising an unusual brain growth pattern and aberrant brain lateralization. Although it is important to study the pathophysiology of the developing ASD cortex, examples of physiological brain lateralization in young children with ASD have yet to be well examined. MethodsThirty-eight boys with ASD (aged 3-7 years) and 38 typically developing (TD) boys (aged 3-8 years) concentrated on video programs and their brain activities were measured non-invasively. We employed a customized child-sized magnetoencephalography system in which the sensors were located as close to the brain as possible for optimal recording in young children. To produce a credible laterality index of the brain oscillations, we defined two clusters of sensors corresponding to the right and left hemispheres. We focused on the laterality index ([left - right]/[left+right]) of the relative power band in seven frequency bands. ResultsThe TD group displayed significantly rightward lateralized brain oscillations in the theta-1 frequency bands compared to the ASD group. ConclusionsThis is the first study to demonstrate unusual brain lateralization of brain oscillations measured by magnetoencephalography in young children with ASD.	[Hiraishi, Hirotoshi; Kikuchi, Mitsuru; Yoshimura, Yuko; Kitagawa, Sachiko; Hasegawa, Chiaki; Munesue, Toshio; Higashida, Haruhiro; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208641, Japan; [Kikuchi, Mitsuru; Munesue, Toshio; Takesaki, Natsumi; Ono, Yasuki; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9208641, Japan; [Takahashi, Tsutomu; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan; [Asada, Minoru] Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Osaka, Japan	Kikuchi, M (reprint author), Kanazawa Univ, Res Ctr Child Mental Dev, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mitsuru@zc4.so-net.ne.jp			Strategic Research Program for Brain Sciences from MEXT; Center of Innovation Program from Japan Science and Technology Agency (JST) Japan;  [24000012]	This study is supported by the Strategic Research Program for Brain Sciences from MEXT and a Grant-in-Aid for Specially Promoted Research (Research Number 24000012) and is partially supported by the Center of Innovation Program from Japan Science and Technology Agency (JST) Japan. The authors declare that they have no conflicts of interest.	Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Mathewson KJ, 2012, CLIN NEUROPHYSIOL, V123, P1798, DOI 10.1016/j.clinph.2012.02.061; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Yoshimura Y, 2012, EUR J NEUROSCI, V35, P644, DOI 10.1111/j.1460-9568.2012.07998.x; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Hoeft F, 2011, ARCH GEN PSYCHIAT, V68, P295, DOI 10.1001/archgenpsychiatry.2010.153; Cornew L, 2012, J AUTISM DEV DISORD, V42, P1884, DOI 10.1007/s10803-011-1431-6; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; Courchesne E, 2001, NEUROLOGY, V57, P245; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Herculano-Houzel S, 1999, J NEUROSCI, V19, P3992; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Stroganova TA, 2007, CLIN NEUROPHYSIOL, V118, P1842, DOI 10.1016/j.clinph.2007.05.005; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; CANTOR DS, 1986, J AUTISM DEV DISORD, V16, P169, DOI 10.1007/BF01531728; Connors BW, 1997, NEURON, V18, P347, DOI 10.1016/S0896-6273(00)81236-2; DAWSON G, 1995, J ABNORM CHILD PSYCH, V23, P569, DOI 10.1007/BF01447662; HARI R, 1988, ELECTROEN CLIN NEURO, V71, P64, DOI 10.1016/0168-5597(88)90020-2; Kaufman A, 1983, CIRCLE PINES; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81; Lord C., 1999, AUTISM DIAGNOSTIC OB; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Uhlhaas Peter J, 2006, Neuron, V52, P155, DOI 10.1016/j.neuron.2006.09.020	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		153	160		10.1111/pcn.12261		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600005		
J	Ota, T; Iida, J; Nakanishi, Y; Sawada, S; Matsuura, H; Yamamuro, K; Ueda, S; Uratani, M; Kishimoto, N; Negoro, H; Kishimoto, T				Ota, Toyosaku; Iida, Junzo; Nakanishi, Yoko; Sawada, Satomi; Matsuura, Hiroki; Yamamuro, Kazuhiko; Ueda, Shotaro; Uratani, Mitsuhiro; Kishimoto, Naoko; Negoro, Hideki; Kishimoto, Toshifumi			Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						atomoxetine; functional neuroimaging study; near-infrared spectroscopy; pediatric attention-deficit; hyperactivity disorder; prefrontal hemodynamic response	DEFICIT HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER; WORKING-MEMORY; FLUENCY TASK; STROOP TASK; ACTIVATION; SCHIZOPHRENIA; CHILDREN; NIRS; PERFORMANCE	AimAtomoxetine, approved in Japan for the treatment of pediatric attention-deficit/hyperactivity disorder (ADHD) in April 2009, is a nonstimulant that is thought to act presynaptically via the inhibition of norepinephrine reuptake. Near-infrared spectroscopy is a non-invasive optical tool that can be used to study oxygenation and hemodynamic changes in the cerebral cortex. The present study examined the effects of a clinical dose of atomoxetine on changes in prefrontal hemodynamic activity in children with ADHD, as measured by near-infrared spectroscopy using the Stroop Color-Word Task. MethodsTen children with ADHD participated in the present study. We used 24-channel near-infrared spectroscopy to measure the relative concentrations of oxyhemoglobin in the frontal lobes of participants in the drug-naive condition and those who had received atomoxetine for 8 weeks. Measurements were conducted every 0.1s during the Stroop Color-Word Task. We used the ADHD Rating Scale-IV-Japanese version (Home Version) to evaluate ADHD symptoms. ResultsWe found a significant decrease in ADHD Rating Scale-IV-Japanese version scores, from 30.7 to 22.6 (P=0.003). During the Stroop Color-Word Task, we found significantly higher levels of oxyhemoglobin changes in the prefrontal cortex of participants in the atomoxetine condition compared with those in the drug-naive condition. ConclusionsThis increase in oxyhemoglobin changes might indicate an intensified prefrontal hemodynamic response induced by atomoxetine. Near-infrared spectroscopy is a sensitive tool for measuring the pharmacological effects of atomoxetine in children with ADHD.	[Ota, Toyosaku; Nakanishi, Yoko; Yamamuro, Kazuhiko; Ueda, Shotaro; Kishimoto, Naoko; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 6348521, Japan; [Iida, Junzo] Nara Med Univ, Fac Nursing, Kashihara, Nara 6348521, Japan; [Sawada, Satomi; Uratani, Mitsuhiro] Nara Prefectural Gen Rehabil Ctr, Dept Psychiat, Nara, Japan; [Matsuura, Hiroki] Tenri Hosp, Dept Psychiat, Nara, Japan; [Negoro, Hideki] Nara Med Univ, Dept Educ, Kashihara, Nara 6348521, Japan	Ota, T (reprint author), Nara Med Univ, Dept Psychiat, 840 Shijyo Cho, Kashihara, Nara 6348521, Japan.	toyosaku@naramed-u.ac.jp			JSPS KAKENHI Grant [22591285]	We wish to thank the participants for their valuable involvement with the study. The authors would also like to thank the Hitachi Medical Corporation for the skilled technical and methodical support for the ETG-4000 equipment. This study was supported by JSPS KAKENHI Grant Number 22591285 without a further role in the study design, collection, analysis, and interpretation of the data, drafting the report, or the decision to submit the paper for publication. Dr. Ota, Dr. Nakanishi, Dr. Sawada, Dr. Matsuura, Dr. Yamamuro, Dr. Ueda, Dr. Uratani, Ms. Kishimoto and Dr. Negoro have no conflict of interest, respectively. Dr. Iida has received honoraria for lecturing from Eli Lilly. Dr. Kishimoto received honoraria for lecturing from Eli Lilly.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Spencer T, 2002, J CLIN PSYCHIAT, V63, P1140; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Graf H, 2011, BIOL PSYCHIAT, V69, P890, DOI 10.1016/j.biopsych.2010.10.018; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kuwabara H, 2006, BEHAV BRAIN RES, V172, P272, DOI 10.1016/j.bbr.2006.05.020; Lesh TA, 2013, NEUROIMAGE-CLIN, V2, P590, DOI 10.1016/j.nicl.2013.04.010; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657; Gratton G, 2001, HUM BRAIN MAPP, V13, P13, DOI 10.1002/hbm.1021; Fallgatter AJ, 1997, COGNITIVE BRAIN RES, V6, P67, DOI 10.1016/S0926-6410(97)00016-5; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Weber P, 2005, J DEV BEHAV PEDIATR, V26, P105, DOI 10.1097/00004703-200504000-00005; Michelson D, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e83; Cubillo A, 2014, PSYCHOL MED, V44, P633, DOI 10.1017/S0033291713000676; Negoro H, 2010, CHILD PSYCHIAT HUM D, V41, P193, DOI 10.1007/s10578-009-0160-y; Ehlis AC, 2008, J PSYCHIATR RES, V42, P1060, DOI 10.1016/j.jpsychires.2007.11.011; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Okada K, 2013, PROG NEURO-PSYCHOPH, V43, P7, DOI 10.1016/j.pnpbp.2012.11.013; Kubota Y, 2005, SCHIZOPHR RES, V77, P65, DOI 10.1016/j.svhres.2005.01.007; Bush G, 2013, PSYCHIAT RES-NEUROIM, V211, P88, DOI 10.1016/j.pscychresns.2012.09.004; Matsuo K, 2003, PSYCHOPHYSIOLOGY, V40, P492, DOI 10.1111/1469-8986.00051; Shinba T, 2004, BIOL PSYCHIAT, V55, P154, DOI 10.1016/S0006-3223(03)00547-X; Ota T, 2013, CHILD PSYCHIAT HUM D, V44, P265, DOI 10.1007/s10578-012-0323-0; Yildiz O, 2011, CHILD PSYCHIAT HUM D, V42, P257, DOI 10.1007/s10578-010-0212-3; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Araki A, 2015, BRAIN DEV-JPN, V37, P76, DOI 10.1016/j.braindev.2014.03.011; Faraone SV, 2005, J CHILD ADOL PSYCHOP, V15, P664, DOI 10.1089/cap.2005.15.664; Friedman JI, 2008, J CLIN PSYCHOPHARM, V28, P59, DOI 10.1097/jcp.0b013e318161318f; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; Inoue Y, 2012, NEUROREPORT, V23, P55, DOI 10.1097/WNR.0b013e32834e664c; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Yamazaki K., 2003, JAPANESE GUIDELINE D, P48	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		161	170		10.1111/pcn.12251		10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600006		
J	Hirota, T; Guerrero, A; Sartorius, N; Fung, D; Leventhal, B; Ong, SH; Kaneko, H; Kim, B; Cho, SC; Skokauskas, N				Hirota, Tomoya; Guerrero, Anthony; Sartorius, Norman; Fung, Daniel; Leventhal, Bennett; Ong, Say How; Kaneko, Hitoshi; Kim, Bungnyun; Cho, Soo-Churl; Skokauskas, Norbert		Consortium Acad Child Adolescent	Child and adolescent psychiatry in the Far East	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						child and adolescent psychiatry; education; mental health service; postgraduate training; the Far East	MENTAL-HEALTH; HONG-KONG; PREVALENCE	AimDespite the general consensus on the importance of youth mental health, the scarcity of child and adolescent mental health services is prominent all over the world. Child and adolescent psychiatry (CAP) postgraduate training can play a pivotal role in increasing access to youth mental health services. In comparison to Europe and North America, however, little is reported regarding CAP training in the Far East, one of the most dynamic and rapidly developing world regions with a very young population. This paper presents an original study on the current status of academic child and adolescent psychiatry training across the Far East. MethodsWe collected data from 17 countries in the Far East using an internally distributed questionnaire to the Consortium members invited for this study, consisting of leading academic child and adolescent psychiatrists in each country. ResultsBased on informants' input, we found an overall underdevelopment of CAP postgraduate training systems despite CAP's recognition as a subspecialty in 12 of 17 of the nations or functionally self-governing areas in the Far East. Paucity of official guidelines for CAP training was also evident. All informants reported a need for additional child and adolescent mental health professionals. ConclusionThere seems to be several obstacles to the development of CAP postgraduate training in the Far East, including stigma towards mental health issues and lack of funding. International collaboration is desired to develop evidence-based and culture-tailored CAP training systems.	[Hirota, Tomoya] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA; [Guerrero, Anthony] Univ Hawaii Manoa, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Leventhal, Bennett] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Sartorius, Norman] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland; [Fung, Daniel; Ong, Say How] Inst Mental Hlth, Dept Child & Adolescent Psychiat, Singapore, Singapore; [Ong, Say How] KK Womens & Childrens Hosp, Child & Adolescent Mental Wellness Serv, Singapore, Singapore; [Kaneko, Hitoshi; Skokauskas, Norbert] Nagoya Univ, Ctr Dev Clin Psychol & Psychiat, Nagoya, Aichi 4648601, Japan; [Kim, Bungnyun; Cho, Soo-Churl] Seoul Natl Univ Hosp, Div Child & Adolescent Psychiat, Seoul 110744, South Korea; [Skokauskas, Norbert] Norwegian Univ Sci & Technol, Ctr Child & Youth Mental Hlth & Child Protect, Fac Med, N-7491 Trondheim, Norway	Skokauskas, N (reprint author), Norwegian Univ Sci & Technol, Ctr Child & Youth Mental Hlth & Child Protect, Fac Med, MTFS, Pb 8905, N-7491 Trondheim, Norway.	norbert.skokauskas@ntnu.no					Tan S, 2008, AUSTRALAS PSYCHIATRY, V16, P204, DOI 10.1080/10398560701874283; Karabekiroglu K, 2006, EUR CHILD ADOLES PSY, V15, P467, DOI 10.1007/s00787-006-0599-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Morris J, 2011, J CHILD PSYCHOL PSYC, V52, P1239, DOI 10.1111/j.1469-7610.2011.02409.x; Thomas CR, 2006, J AM ACAD CHILD PSY, V45, P1023, DOI 10.1097/01.chi.0000225353.16831.5d; Srinath S, 2010, CURR OPIN PSYCHIATR, V23, P330, DOI 10.1097/YCO.0b013e32833aa0c1; Heflinger CA, 2010, ADM POLICY MENT HLTH, V37, P61, DOI 10.1007/s10488-010-0294-z; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P613, DOI 10.1176/appi.ps.58.5.613; Lempp T, 2012, ACAD PSYCHIATR, V36, P246, DOI 10.1176/appi.ap.10120173; WONG CK, 1990, AUST NZ J PSYCHIAT, V24, P331, DOI 10.3109/00048679009077700; MCCLURE M, 1989, J AM ACAD CHILD PSY, V28, P488, DOI 10.1097/00004583-198907000-00003; McKelvey RS, 1997, AUST NZ J PSYCHIAT, V31, P114, DOI 10.3109/00048679709073807; Guerrero APS, 2013, ASIA-PAC PSYCHIAT, V5, P119, DOI 10.1111/appy.12031; Jenkins R, 2013, WORLD PSYCHIATRY, V12, P266, DOI 10.1002/wps.20073; Malloy E, 2008, ACAD PSYCHIATR, V32, P350, DOI 10.1176/appi.ap.32.5.350; MCCLURE GMG, 1987, J AM ACAD CHILD PSY, V26, P806, DOI 10.1097/00004583-198709000-00033; McKewan K, 2007, CANADIAN MED ASS J, V176, P471; Sexson SB, 2007, CHILD ADOL PSYCH CL, V16, P1, DOI 10.1016/j.chc.2006.07.008; Skokauskas N, 2011, INT PSYCHIAT, V2, P45; Tateno Masaru, 2009, Child Adolesc Psychiatry Ment Health, V3, P30, DOI 10.1186/1753-2000-3-30	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAR	2015	69	3			SI		171	177		10.1111/pcn.12248		7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD4IS	WOS:000351046600007		
J	Martin, A; Schatz, T; Versteegh, M; Miyazawa, K; Mazuka, R; Dupoux, E; Cristia, A				Martin, Andrew; Schatz, Thomas; Versteegh, Maarten; Miyazawa, Kouki; Mazuka, Reiko; Dupoux, Emmanuel; Cristia, Alejandrina			Mothers Speak Less Clearly to Infants Than to Adults: A Comprehensive Test of the Hyperarticulation Hypothesis	PSYCHOLOGICAL SCIENCE			English	Article						speech perception; psycholinguistics; language development; infant-directed speech; hyperarticulation	DIRECTED SPEECH; RECOGNITION	Infants learn language at an incredible speed, and one of the first steps in this voyage is learning the basic sound units of their native languages. It is widely thought that caregivers facilitate this task by hyperarticulating when speaking to their infants. Using state-of-the-art speech technology, we addressed this key theoretical question: Are sound categories clearer in infant-directed speech than in adult-directed speech? A comprehensive examination of sound contrasts in a large corpus of recorded, spontaneous Japanese speech demonstrates that there is a small but significant tendency for contrasts in infant-directed speech to be less clear than those in adult-directed speech. This finding runs contrary to the idea that caregivers actively enhance phonetic categories in infant-directed speech. These results suggest that to be plausible, theories of infants' language acquisition must posit an ability to learn from noisy data.	[Martin, Andrew; Miyazawa, Kouki; Mazuka, Reiko] RIKEN Brain Sci Inst, Lab Language Dev, Saitama, Japan; [Schatz, Thomas; Versteegh, Maarten; Dupoux, Emmanuel; Cristia, Alejandrina] CNRS, Lab Sci Cognit & Psycholinguist, DEC, EHESS,ENS, F-75005 Paris, France; [Schatz, Thomas] CNRS, Inst Natl Rech Informat & Automat, Ecole Normale Super, SIERRA Project Team,Dept Informat, F-75005 Paris, France; [Mazuka, Reiko] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27706 USA	Cristia, A (reprint author), CNRS, Lab Sci Cognit & Psycholinguist, DEC, EHESS,ENS, 29 Rue Ulm, F-75005 Paris, France.	alecristia@gmail.com			European Research Council [ERC-2011-AdG-295810 BOOTPHON]; Agence Nationale pour la Recherche [ANR-2010-BLAN-1901-1 BOOTLANG, ANR-10-IDEX-0001-02 PSL*, ANR-10-LABX-0087 IEC]; Fondation de France; Japan Society for the Promotion of Science (Kakenhi) [24520446]	This work was supported by the European Research Council (Grant ERC-2011-AdG-295810 BOOTPHON), the Agence Nationale pour la Recherche (Grants ANR-2010-BLAN-1901-1 BOOTLANG, ANR-10-IDEX-0001-02 PSL*, and ANR-10-LABX-0087 IEC), the Fondation de France, and the Japan Society for the Promotion of Science (Kakenhi Grant 24520446, to A. Martin).	Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; de Boer B, 2003, ACOUST RES LETT ONL, V4, P129, DOI 10.1121/1.1613311; Kirchhoff K, 2005, J ACOUST SOC AM, V117, P2238, DOI 10.1121/1.1869172; Fernald A, 2000, PHONETICA, V57, P242, DOI 10.1159/000028477; McMurray B, 2013, COGNITION, V129, P362, DOI 10.1016/j.cognition.2013.07.015; Igarashi Y, 2013, J ACOUST SOC AM, V134, P1283, DOI 10.1121/1.4812755; Cummins F, 2009, J PHONETICS, V37, P16, DOI 10.1016/j.wocn.2008.08.003; Benders T, 2013, INFANT BEHAV DEV, V36, P847, DOI 10.1016/j.infbeh.2013.09.001; Cristia A., 2013, LANGUAGE LINGUISTICS, V7, P157, DOI 10.1111/lnc3.12015; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Fisher Ronald, 1935, DESIGN EXPT; Kirchner R, 2010, J PHONETICS, V38, P540, DOI 10.1016/j.wocn.2010.07.005; Mazuka R., 2006, IEIC TECHNICAL REPOR, V106, P11; Moore B., 2003, INTRO PSYCHOL HEARIN; OShaughnessy D, 1987, SPEECH COMMUNICATION; Ramirez-Esparza N, 2014, DEVELOPMENTAL SCI, V17, P880, DOI 10.1111/desc.12172; Schatz T., 2013, INTERSPEECH 2013, P1781; Schnupp J., 2011, AUDITORY NEUROSCIENC; Sundberg U., 1998, THESIS U STOCKHOLM	19	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0956-7976	1467-9280		PSYCHOL SCI	Psychol. Sci.	MAR	2015	26	3					341	347		10.1177/0956797614562453		7	Psychology, Multidisciplinary	Psychology	CD9UJ	WOS:000351443700009		
J	Abe, T; Tokuda, Y; Watanabe, S				Abe, T.; Tokuda, Y.; Watanabe, S.			Eight-vessel disease mimicking takotsubo cardiomyopathy	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material									[Abe, T.] Tsukuba Univ Hosp, Mito Med Ctr, Dept Emergency Med, Mito Kyodo Gen Hosp, Mito, Ibaraki 3100015, Japan; [Tokuda, Y.] Tsukuba Univ Hosp, Mito Med Ctr, Dept Med, Mito Kyodo Gen Hosp, Mito, Ibaraki 3100015, Japan; [Watanabe, S.] Tsukuba Univ Hosp, Mito Med Ctr, Dept Cardiol, Mito Kyodo Gen Hosp, Mito, Ibaraki 3100015, Japan	Abe, T (reprint author), Tsukuba Univ Hosp, Mito Med Ctr, Dept Emergency Med, Mito Kyodo Gen Hosp, 3-2-7 Miyamachi, Mito, Ibaraki 3100015, Japan.	mican-philia@sunny.ocn.ne.jp					YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32; Tani S, 2009, INT J CARDIOL, V135, P202, DOI 10.1016/j.ijcard.2008.03.071; MYERBURG RJ, 1992, NEW ENGL J MED, V326, P1451, DOI 10.1056/NEJM199205283262202; Mori F, 1999, J Cardiol, V33, P191	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	MAR 1	2015	108	3					241	243		10.1093/qjmed/hcs149		3	Medicine, General & Internal	General & Internal Medicine	CE0UN	WOS:000351522900012		
J	Fujikawa, T; Takayama, K				Fujikawa, T.; Takayama, K.			Spinal cord abscess and inflammatory bowel disease	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material							EPIDURAL ABSCESS		[Fujikawa, T.] Seikeikai Hosp, Dept Internal Med, Sakai, Osaka 5900024, Japan; [Fujikawa, T.] Mitoyo Gen Hosp, Dept Internal Med, Kan Onji, Kagawa 7691601, Japan; [Takayama, K.] Seikeikai Hosp, Dept Orthopaed Surg, Sakai, Osaka 5900024, Japan	Fujikawa, T (reprint author), Seikeikai Hosp, Dept Internal Med, 4-2-10 Koryo Nakamachi, Sakai, Osaka 5900024, Japan.	tfujikawa-gi@umin.ac.jp					Reihsaus E, 2000, NEUROSURG REV, V23, P175, DOI 10.1007/PL00011954; Darouiche RO, 2006, NEW ENGL J MED, V355, P2012, DOI 10.1056/NEJMra055111; Mackenzie AR, 1998, J NEUROL NEUROSUR PS, V65, P209, DOI 10.1136/jnnp.65.2.209	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	MAR 1	2015	108	3					253	254		10.1093/qjmed/hcu181		2	Medicine, General & Internal	General & Internal Medicine	CE0UN	WOS:000351522900016		
J	Gerelchuluun, A; Manabe, E; Ishikawa, T; Sun, L; Itoh, K; Sakae, T; Suzuki, K; Hirayama, R; Asaithamby, A; Chen, DJ; Tsuboi, K				Gerelchuluun, Ariungerel; Manabe, Eri; Ishikawa, Takaaki; Sun, Lue; Itoh, Kazuya; Sakae, Takeji; Suzuki, Kenshi; Hirayama, Ryoichi; Asaithamby, Aroumougame; Chen, David J.; Tsuboi, Koji			The Major DNA Repair Pathway after Both Proton and Carbon-Ion Radiation is NHEJ, but the HR Pathway is More Relevant in Carbon Ions	RADIATION RESEARCH			English	Article							DOUBLE-STRAND BREAKS; RAY-SENSITIVE MUTANTS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; IONIZING-RADIATION; X-RAYS; INDUCTION; THERAPY; COMPLEX; PROTEIN	The purpose of this study was to identify the roles of non-homologous end-joining (NHEJ) or homologous recombination (HR) pathways in repairing DNA double-strand breaks (DSBs) induced by exposure to high-energy protons and carbon ions (C ions) versus gamma rays in Chinese hamster cells. Two Chinese hamster cell lines, ovary AA8 and lung fibroblast V79, as well as various mutant sublines lacking DNA-PKcs (V3), X-ray repair cross-complementing protein-4 [XRCC4 (XR1), XRCC3 (irs1SF) and XRCC2 (irs1)] were exposed to gamma rays (Cs-137), protons (200 MeV; 2.2 keV/mu m) and C ions (290 MeV; 50 keV/mu m). V3 and XR1 cells lack the NHEJ pathway, whereas irs1 and irs1SF cells lack the HR pathway. After each exposure, survival was measured using a clonogenic survival assay, in situ DSB induction was evaluated by immunocytochemical analysis of histone H2AX phosphorylation at serine 139 (gamma-H2AX foci) and chromosome aberrations were examined using solid staining. The findings from this study showed that clonogenic survival clearly depended on the NHEJ and HR pathway statuses, and that the DNA-PKcs(-/-) cells (V3) were the most sensitive to all radiation types. While protons and gamma rays yielded almost the same biological effects, C-ion exposure greatly enhanced the sensitivity of wild-type and HR-deficient cells. However, no significant enhancement of sensitivity in cell killing was seen after C-ion irradiation of NHEJ deficient cells. Decreases in the number of gamma-H2AX foci after irradiation occurred more slowly in the NHEJ deficient cells. In particular, V3 cells had the highest number of residual gamma-H2AX foci at 24 h after Cion irradiation. Chromosomal aberrations were significantly higher in both the NHEJ- and HR-deficient cell lines than in wild-type cell lines in response to all radiation types. Protons and gamma rays induced the same aberration levels in each cell line, whereas C ions introduced higher but not significantly different aberration levels. Our results suggest that the NHEJ pathway plays an important role in repairing DSBs induced by both clinical proton and C-ion beams. Furthermore, in C ions the HR pathway appears to be involved in the repair of DSBs to a greater extent compared to gamma rays and protons. (C) 2015 by Radiation Research Society	[Gerelchuluun, Ariungerel; Manabe, Eri; Sun, Lue; Itoh, Kazuya] Univ Tsukuba, Grad Sch Comprehens Human Sci, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Ishikawa, Takaaki; Tsuboi, Koji] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Sakae, Takeji; Suzuki, Kenshi; Tsuboi, Koji] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Ibaraki 3058575, Japan; [Hirayama, Ryoichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 260, Japan; [Asaithamby, Aroumougame; Chen, David J.] UT Southwestern Med Ctr, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX USA	Tsuboi, K (reprint author), Univ Tsukuba, Proton Med Res Ctr, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tsuboi-k@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24390287]; National Aeronautics and Space Association [NNX13AD57G]	We are indebted to Ms. Junko Zenkoh and Ms. Yoko Mori, as well as all the members of the PMRC at the University of Tsukuba for their competent technical assistance. We are also grateful to the members of the HIMAC facility at the National Institute of Radiological Sciences for their valuable help in our experiments. In addition, we thank Mr. Takamitsu Kato for providing the cell line and for his valuable advice. This work was supported in part by a Grant-in-Aid (24390287) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the National Aeronautics and Space Association (NNX13AD57G to AA and DJC). Portions of this work were approved and performed under the Research Project with Heavy Ions at NIRS-HIMAC.	ANDO K, 1985, Nippon Acta Radiologica, V45, P531; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; BELLI M, 1993, INT J RADIAT BIOL, V63, P331, DOI 10.1080/09553009314550441; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Takahashi A, 2014, RADIAT RES, V182, P338, DOI 10.1667/RR13782.1; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Koike S, 2002, J RADIAT RES, V43, P247, DOI 10.1269/jrr.43.247; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Grosse N, 2014, INT J RADIAT ONCOL, V88, P175, DOI 10.1016/j.ijrobp.2013.09.041; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Franken NAP, 2013, INT J ONCOL, V42, P1501, DOI 10.3892/ijo.2013.1857; CORNFORTH MN, 1983, SCIENCE, V222, P1141, DOI 10.1126/science.6648528; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Asaithamby A, 2011, MUTAT RES-FUND MOL M, V711, P87, DOI 10.1016/j.mrfmmm.2010.11.002; Kagawa K, 2002, INT J RADIAT ONCOL, V54, P928, DOI 10.1016/S0360-3016(02)02949-8; Gerelchuluun A, 2011, INT J RADIAT BIOL, V87, P57, DOI 10.3109/09553002.2010.518201; Nagasawa H, 2010, MUTAT RES-GEN TOX EN, V701, P12, DOI 10.1016/j.mrgentox.2010.03.003; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Wilkens JJ, 2003, MED PHYS, V30, P806, DOI 10.1118/1.1567852; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009; Hirayama R, 2009, RADIAT RES, V171, P212, DOI 10.1667/RR1490.1; BARENDSEN GW, 1994, RADIAT RES, V139, P257, DOI 10.2307/3578823; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; Belli M, 2001, ADV SPACE RES, V27, P393, DOI 10.1016/S0273-1177(01)00007-2; CHU EHY, 1969, GENETICS, V62, P359; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Fukumura A, 1998, PHYS MED BIOL, V43, P3459, DOI 10.1088/0031-9155/43/12/005; Grawunder U, 1997, NATURE, V388, P492; Hong ZS, 2013, INT J RADIAT BIOL, V89, P36, DOI 10.3109/09553002.2012.715791; International Commission on Radiation Units and Measurements, 1993, 49 ICRU; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; Kusumoto R, 2008, BIOCHEMISTRY-US, V47, P7548, DOI 10.1021/bi702325t; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Nakajima NI, 2013, PLOS ONE, P8; Nohtomi A, 2001, MED PHYS, V28, P1431, DOI 10.1118/1.1380435; SAKAGUCHI DS, 1989, DEV BIOL, V134, P158, DOI 10.1016/0012-1606(89)90086-9; SAVAGE JRK, 1976, J MED GENET, V13, P103, DOI 10.1136/jmg.13.2.103; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354	50	4	4	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	MAR	2015	183	3					345	356		10.1667/RR13904.1		12	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CE0EW	WOS:000351478300011		
J	Shigeta, S; Toyoshima, M; Kitatani, K; Ishibashi, M; Usui, T; Yaegashi, N				Shigeta, Shogo; Toyoshima, Masafumi; Kitatani, Kazuyuki; Ishibashi, Masumi; Usui, Toshinori; Yaegashi, Nobuo			Transferrin Facilitates DNA-Double Strand Breaks Via Transferrin Receptor 1 in Human Fallopian Tubal Epithelial Cells: Possible Involvement of Transferrin in Carcinogenesis	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Shigeta, Shogo; Ishibashi, Masumi; Usui, Toshinori; Yaegashi, Nobuo] Tohoku Univ, Sch Med, Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Toyoshima, Masafumi] Sendai Med Ctr, Obstet & Gynecol, Sendai, Miyagi, Japan; [Kitatani, Kazuyuki] Tohoku Univ, Sch Med, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		O-061	76A	76A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407200062		
J	Miyazaki, K; Ueno, Y; Masuda, H; Uchida, H; Maruyama, T				Miyazaki, Kaoru; Ueno, Yuki; Masuda, Hirotaka; Uchida, Hiroshi; Maruyama, Tetsuo			Decellularization of the Rat Uterus Yielded Scaffold Capable of Tissue Regeneration Without Immune Rejection Upon Allotransplantation	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Miyazaki, Kaoru; Ueno, Yuki; Masuda, Hirotaka; Uchida, Hiroshi; Maruyama, Tetsuo] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		O-086	84A	84A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407200087		
J	Morizane, M; Mishima, T; Tyurin, V; Kagan, VE; Sadovsky, Y				Morizane, Mayumi; Mishima, Takuya; Tyurin, Vladimir; Kagan, Valerian E.; Sadovsky, Yoel			CGI-58 Is a Key Regulator of Selective Trans-Placental Transfer of Long-Chain Polyunsaturated Fatty Acids (LCPUFA)	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Morizane, Mayumi; Mishima, Takuya; Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA; [Morizane, Mayumi] Kobe Univ, Dept Obstet & Gynecol, Kobe, Hyogo 657, Japan; [Tyurin, Vladimir; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		O-156	106A	107A				2	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201026		
J	Kitatani, K; Usui, T; Sriraman, SK; Toyoshima, M; Ishibashi, M; Shigeta, S; Nagase, S; Hannun, YA; Torchillin, VP; Yaegashi, N				Kitatani, Kazuyuki; Usui, Toshinori; Sriraman, Shravan K.; Toyoshima, Masafumi; Ishibashi, Masumi; Shigeta, Shogo; Nagase, Satoru; Hannun, Yusuf A.; Torchillin, Vladimir P.; Yaegashi, Nobuo			Ceramide Limits Phosphatidylinositol-3-Kinase C2 beta-Controlled Cell Motility in Ovarian Cancer: Potential of Ceramide Liposomes as Antimetastatic Agents	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kitatani, Kazuyuki; Usui, Toshinori; Yaegashi, Nobuo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kitatani, Kazuyuki; Toyoshima, Masafumi; Ishibashi, Masumi; Shigeta, Shogo; Nagase, Satoru; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Sriraman, Shravan K.; Torchillin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-030	118A	118A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201060		
J	Li, B; Takeda, T; Tsuiji, K; Tadakawa, M; Kondo, A; Yaegashi, N				Li, Bin; Takeda, Takashi; Tsuiji, Kenji; Tadakawa, Mari; Kondo, Akiko; Yaegashi, Nobuo			Improvement of Bioavailability and Apoptosis Potential of Curcumin in Combination With Epigallocatechin-3-Gallate in Leiomyosarcoma Cells	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Li, Bin; Tsuiji, Kenji; Tadakawa, Mari; Kondo, Akiko; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Takeda, Takashi] Kinki Univ, Sch Med, Res Inst Tradit Asian Med, Div Womens Hlth, Osaka 589, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-032	119A	119A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201062		
J	Okamoto, S; Niikura, H; Nagai, T; Yaegashi, N				Okamoto, Satoshi; Niikura, Hitoshi; Nagai, Tomoyuki; Yaegashi, Nobuo			Optimal Diagnostic Markers for Intra-Operative Detection of Sentinel Lymph Node Metastases in Cervical Cancer Using the One-Step Nucleic Acid Amplification (OSNA) Method	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Okamoto, Satoshi; Niikura, Hitoshi; Nagai, Tomoyuki; Yaegashi, Nobuo] Tohoku Univ, Sch Med, Obstet & Gynecol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-033	119A	119A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201063		
J	Suzuki, F; Nagase, S; Watanabe, Y; Sato, I; Utsunomiya, H; Kaiho, M; Tokunaga, H; Niikura, H; Takano, T; Sasano, H; Yaegashi, N				Suzuki, Fumihiko; Nagase, Satoru; Watanabe, Yoh; Sato, Izumi; Utsunomiya, Hiroki; Kaiho, Michiko; Tokunaga, Hideki; Niikura, Hitoshi; Takano, Tadao; Sasano, Hironobu; Yaegashi, Nobuo			MiR-34b Correlates Tumor Growth and Invasion in Uterine Serous Carcinoma	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Suzuki, Fumihiko; Nagase, Satoru; Sato, Izumi; Utsunomiya, Hiroki; Kaiho, Michiko; Tokunaga, Hideki; Niikura, Hitoshi; Takano, Tadao; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Watanabe, Yoh] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi, Japan; [Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Pathol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-035	120A	120A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201065		
J	Tsuji, K; Utsunomiya, H; Hanihara, M; Suzuki, F; Ito, K; Yaegashi, N				Tsuji, Keita; Utsunomiya, Hiroki; Hanihara, Mayu; Suzuki, Fumihiko; Ito, Kiyoshi; Yaegashi, Nobuo			The Effect of Retinoic Acid Via RARs in Endometrial Cancer	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Tsuji, Keita; Utsunomiya, Hiroki; Hanihara, Mayu; Suzuki, Fumihiko; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Ito, Kiyoshi] Int Res Inst Disaster Sci, Disaster Obstet & Gynecol, Sendai, Miyagi, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-040	121A	121A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201070		
J	Shibata, T; Sugihara, K; Akama, T; Kuo, CW; Khoo, KH; Kanayama, N; Fukuda, MN				Shibata, Toshiaki; Sugihara, Kazuhiro; Akama, Tomoya; Kuo, Chu-Wei; Khoo, Kay-Hooi; Kanayama, Naohiro; Fukuda, Michiko N.			Attenuation of Fibroblast Growth Factor Signaling By Poly-N-Acetyllactosamine Type Glycans	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Shibata, Toshiaki; Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Obstet & Gynecol, Hamamatsu, Shizuoka 4313192, Japan; [Akama, Tomoya] Kansai Med Univ, Pharmacol, Hirakata, Osaka, Japan; [Kuo, Chu-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Biol Chem, Taipei, Taiwan; [Fukuda, Michiko N.] Natl Inst Adv Ind Sci & Technol, GlycoBiol, Tsukuba, Ibaraki, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-061	128A	128A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201090		
J	Kemp, MW; Usuda, H; Miura, Y; Woodward, E; Payne, MS; Bohm, J; Jobe, AH; Kallapur, SG; Matsuda, T; Newnham, JP; Saito, M				Kemp, Matthew W.; Usuda, Haruro; Miura, Yuichiro; Woodward, Eleanor; Payne, Matthew S.; Bohm, Judith; Jobe, Alan H.; Kallapur, Suhas G.; Matsuda, Tadashi; Newnham, John P.; Saito, Masatoshi			LPS Elicits Inflammatory Changes in the Fetus Before the Amniotic Fluid in a Chronically Catheterised Ovine Model of Second Trimester Pregnancy	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kemp, Matthew W.; Miura, Yuichiro; Woodward, Eleanor; Payne, Matthew S.; Bohm, Judith; Newnham, John P.] UWA, Sch Womens & Infants Hlth, Perth, WA, Australia; [Usuda, Haruro; Matsuda, Tadashi; Saito, Masatoshi] Tohoku Univ Hosp, Div Perinatal Med, Sendai, Miyagi, Japan; [Jobe, Alan H.; Kallapur, Suhas G.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-086	135A	136A				2	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201115		
J	Katsuragi, S; Okamura, A; Miyamoto, Y; Ikeda, T				Katsuragi, Shinji; Okamura, Akira; Miyamoto, Yoshihiro; Ikeda, Tomoaki			Gender Diffrence in Influence of Birth-Weight on Cardiovascular Risks in 40 To 69 Year Old Japanese	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Katsuragi, Shinji] Sakakibara Heart Inst, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan; [Okamura, Akira; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med, Suita, Osaka, Japan; [Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Tsu, Mie 514, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-186	167A	167A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407201214		
J	Miura, Y; Saito, M; Usuda, H; Rittenschober-Bohm, J; Kannan, PS; Matsuda, T; Newnham, JP; Kemp, MW				Miura, Yuichiro; Saito, Masatoshi; Usuda, Haruo; Rittenschober-Bohm, Judith; Kannan, Paranthaman S.; Matsuda, Tadashi; Newnham, John P.; Kemp, Matthew W.			Fetal Survival, Inflammation and Lung Maturation: Ex-Vivo Uterine Environment ( EVE) Therapy Using Premature Lamb Model	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Miura, Yuichiro; Rittenschober-Bohm, Judith; Newnham, John P.; Kemp, Matthew W.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Saito, Masatoshi; Usuda, Haruo; Matsuda, Tadashi] Tohoku Univ, Grad Sch Med, Dept Perinatal Med, Sendai, Miyagi 980, Japan; [Kannan, Paranthaman S.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		T-262	191A	191A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202024		
J	Kai, K; Nasu, K; Hirakawa, T; Aoyagi, Y; Ishii, T; Uemura, T; Yano, M; Narahara, H				Kai, Kentaro; Nasu, Kaei; Hirakawa, Tomoko; Aoyagi, Yoko; Ishii, Terukazu; Uemura, Tetsuya; Yano, Mitsutake; Narahara, Hisashi			Wisteria Floribunda Agglutinin-Binding Glycan Expression Is Decreased in Endometriomata	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kai, Kentaro; Hirakawa, Tomoko; Aoyagi, Yoko; Ishii, Terukazu; Uemura, Tetsuya; Yano, Mitsutake; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan; [Nasu, Kaei] Oita Univ, Fac Med, Div Obstet & Gynecol, Support Syst Community Med, Oita 87011, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-007	207A	207A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202073		
J	Sugawara, J; Hoshiai, T; Sato, K; Nishigori, H; Arai, T; Tokunaga, H; Okamura, K; Yaegashi, N				Sugawara, Junichi; Hoshiai, Tetsuro; Sato, Kazuyo; Nishigori, Hidekazu; Arai, Takanari; Tokunaga, Hideki; Okamura, Kunihiro; Yaegashi, Nobuo			Impact of the Great East Japan Earthquake on Obstetric Emergencies in Miyagi Prefecture	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Fetomaternal Med Sci, Sendai, Miyagi 980, Japan; [Hoshiai, Tetsuro; Sato, Kazuyo; Nishigori, Hidekazu; Tokunaga, Hideki; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Arai, Takanari] Keijyu Hosp, Obstet & Gynecol, Nanao, Ishikawa, Japan; [Okamura, Kunihiro] Tohoku Kohsai Hosp, Obstet & Gynecol, Sendai, Miyagi, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-088	232A	232A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202154		
J	Sumiyoshi, K; Ikenoue, S; Ohashi, M; Ikenoue, C; Waffarn, F; Sameshima, H; DeHaene, J; Buss, C; Entringer, S; Wadhwa, P				Sumiyoshi, Kaeko; Ikenoue, Satoru; Ohashi, Masanao; Ikenoue, Chigusa; Waffarn, Feizal; Sameshima, Hiroshi; DeHaene, Jessica; Buss, Claudia; Entringer, Sonja; Wadhwa, Pathik			Association of Fetal Ultrasound-Based Measures of Body Composition Across Gestation With Newborn Adiposity.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Sumiyoshi, Kaeko; Ikenoue, Satoru; Ohashi, Masanao; Ikenoue, Chigusa; Waffarn, Feizal; DeHaene, Jessica; Buss, Claudia; Entringer, Sonja; Wadhwa, Pathik] Univ Calif Irvine, UCI DHDRP, Irvine, CA USA; [Sumiyoshi, Kaeko; Ohashi, Masanao; Sameshima, Hiroshi] Miyazaki Univ, OB GYN, Miyazaki, Japan; [Ikenoue, Satoru] Keio Univ, OB GYN, Tokyo, Japan; [Buss, Claudia; Entringer, Sonja] Charite, Inst Med Psychol, D-13353 Berlin, Germany								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-200	267A	267A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202266		
J	Katsuragi, S; Parer, JT; Ikeda, T				Katsuragi, Shinji; Parer, Julian T.; Ikeda, Tomoaki			Sinusoidal Fetal Heart Rate Patterns.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Katsuragi, Shinji] Sakakibara Heart Inst, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan; [Parer, Julian T.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Tsu, Mie 514, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-209	270A	270A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202275		
J	Sato, T; Sugawara, J; Sugiyama, T; Kurosawa, Y; Iwama, N; Ooshio, K; Metoki, H; Kurakata, M; Saito, M; Nishigori, H; Yaegashi, N				Sato, Takahiro; Sugawara, Junichi; Sugiyama, Takashi; Kurosawa, Yasuhiro; Iwama, Noriyuki; Ooshio, Kiyoka; Metoki, Hirohito; Kurakata, Michiyo; Saito, Masatoshi; Nishigori, Hidekazu; Yaegashi, Nobuo			The Change of Ocular Blood Flow Using Laser Speckle Flowgraphy During Pregnancy	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Sato, Takahiro; Sugiyama, Takashi; Kurosawa, Yasuhiro; Iwama, Noriyuki; Ooshio, Kiyoka; Kurakata, Michiyo; Saito, Masatoshi; Nishigori, Hidekazu; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Sugawara, Junichi; Metoki, Hirohito] Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-215	272A	272A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202281		
J	Hamada, H; Okae, H; Yaegashi, N; Arima, T				Hamada, Hirotaka; Okae, Hiroaki; Yaegashi, Nobuo; Arima, Takahiro			Skewed X Chromosome Inactivation in Human Placental Tissue.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Hamada, Hirotaka; Okae, Hiroaki; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Informat Genet, Sendai, Miyagi 980, Japan; [Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Obstet & Gynecol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-251	283A	283A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202316		
J	Uchikura, Y; Matsubara, K; Matsubara, Y; Mori, M; Nawa, A				Uchikura, Yuka; Matsubara, Keiichi; Matsubara, Yuko; Mori, Miki; Nawa, Akihiro			Role of High-Mobility Group A1 Protein in Human Trophoblast Invasion	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Uchikura, Yuka; Matsubara, Keiichi; Matsubara, Yuko; Mori, Miki; Nawa, Akihiro] Ehime Univ, Obstet & Gynecol, Toon, Ehime, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-267	288A	288A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202332		
J	Yasuoka, T; Matsubara, K; Mori, M; Matsubara, Y; Uchikura, Y; Nawa, A; Kondoh, E; Takagi, K; Hamada, K; Fujioka, T; Matsumoto, T				Yasuoka, Toshiaki; Matsubara, Keiichi; Mori, Miki; Matsubara, Yuko; Uchikura, Yuka; Nawa, Akihiro; Kondoh, Emi; Takagi, Katsuko; Hamada, Katsuyuki; Fujioka, Toru; Matsumoto, Takashi			Angiotensin II Receptor Subtype 2 Agonist Improves Renal Function in Preeclampsia Model Mice	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Yasuoka, Toshiaki; Matsubara, Keiichi; Mori, Miki; Matsubara, Yuko; Uchikura, Yuka; Nawa, Akihiro; Kondoh, Emi; Takagi, Katsuko; Hamada, Katsuyuki; Fujioka, Toru; Matsumoto, Takashi] Ehime Univ SOM, Obstet & Gynecol, Toon, Ehime, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-278	291A	291A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202343		
J	Onda, K; Hannan, N; Beard, S; Binder, N; Kaitu'u-Lino, T; Hastie, R; Brownfoot, F; Tuohey, L; Parry, L; Senadheera, S; Tong, S				Onda, Kenji; Hannan, Natalie; Beard, Sally; Binder, Natalie; Kaitu'u-Lino, Tu'uhevaha; Hastie, Roxanne; Brownfoot, Fiona; Tuohey, Laura; Parry, Laura; Senadheera, Sevvandi; Tong, Stephen			Proton Pump Inhibitors Decrease sFlt-1 and Soluble Endoglin Production, Quench Endothelial Dysfunction and Promote Vasodilation in Whole Blood Vessels: A Candidate Therapeutic for Severe Preeclampsia	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Onda, Kenji; Hannan, Natalie; Beard, Sally; Binder, Natalie; Kaitu'u-Lino, Tu'uhevaha; Hastie, Roxanne; Brownfoot, Fiona; Tuohey, Laura; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; [Onda, Kenji] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Hachioji, Tokyo 19203, Japan; [Parry, Laura; Senadheera, Sevvandi] Univ Melbourne, Sch Biol Sci, Parkville, Vic 3052, Australia								0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		F-288	294A	294A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202353		
J	Ishikawa, H; Sone, K; Xu, LL; Kobayashi, T; Shozu, M				Ishikawa, Hiroshi; Sone, Kunizui; Xu, Linlin; Kobayashi, Tatsuya; Shozu, Makio			Hypoxia Induces Hypoxia Inducible Factor-1 Alpha in Uterine Leiomyoma Cells.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Ishikawa, Hiroshi; Sone, Kunizui; Xu, Linlin; Kobayashi, Tatsuya; Shozu, Makio] Chiba Univ, Grad Sch Med, Reprod Med, Chiba, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-015	303A	303A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202378		
J	Tsuiji, K; Takeda, T; Li, B; Tadakawa, M; Yaegashi, N				Tsuiji, Kenji; Takeda, Takashi; Li, Bin; Tadakawa, Mari; Yaegashi, Nobuo			Inhibitory Effects of Curcumin and Nanocurcumin on Human Uterine Leiomyoma Xenograft Model In Vivo.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Tsuiji, Kenji; Li, Bin; Tadakawa, Mari; Yaegashi, Nobuo] Tohoku Univ Grad Sch Med, Obstet & Gynecol, Sendai, Miyagi, Japan; [Takeda, Takashi] Kinki Univ Sch Med, Womens Hlth, Res Inst Tradit Asian Med, Osaka, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-025	306A	306A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202388		
J	Kuwabara, Y; Katayama, A; Sugita, Y; Shirai, Y; Nakao, K; Yonezawa, M; Ouchi, N; Sawa, R; Takeshita, T				Kuwabara, Yoshimitsu; Katayama, Akira; Sugita, Yosuke; Shirai, Yuka; Nakao, Kimihiko; Yonezawa, Mirei; Ouchi, Nozomi; Sawa, Rintaro; Takeshita, Toshiyuki			The Effects of Progesterone on the Gene Expression Profile of LPS-Stimulated Cultured Human Cervical Fibroblasts.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kuwabara, Yoshimitsu; Sugita, Yosuke; Shirai, Yuka; Nakao, Kimihiko; Yonezawa, Mirei; Ouchi, Nozomi; Sawa, Rintaro; Takeshita, Toshiyuki] Nippon Med Sch, Obstet & Gynecol, Tokyo 113, Japan; [Katayama, Akira] Nippon Med Sch, Biochem & Mol Biol, Tokyo 113, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-097	329A	329A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202460		
J	Kodama, Y; Sameshima, H; Yamashita, R; Kaneko, M; Ikenoue, T				Kodama, Yuki; Sameshima, Hiroshi; Yamashita, Rie; Kaneko, Masatoki; Ikenoue, Tsuyomu			The Etiology of Periventricular Leukomalacia in Southern Japan: A Regional Population-Based Study.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kodama, Yuki; Sameshima, Hiroshi; Yamashita, Rie; Kaneko, Masatoki; Ikenoue, Tsuyomu] Miyazaki Univ, Ctr Perinatal Med, Obstet & Gynecol, Fac Med, Miyazaki, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-143	344A	344A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202506		
J	Michikata, K; Urabe, H; Tokunaga, S; Sameshima, H; Tsuyomu, I				Michikata, Kaori; Urabe, Hirotoshi; Tokunaga, Syuichi; Sameshima, Hiroshi; Tsuyomu, Ikenoue			Effect of Fetal Heart Rate Monitoring Network System in Japan.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Michikata, Kaori; Sameshima, Hiroshi] Miyazaki Univ, Obstet & Gynecol, Miyazaki, Japan; [Urabe, Hirotoshi; Tokunaga, Syuichi] Miyakonojo Hosp, Obstet & Gynecol, Miyazaki, Japan; [Tsuyomu, Ikenoue] Miyazaki Med Assoc Hosp, Obstet & Gynecol, Miyazaki, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-148	346A	346A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202511		
J	Kaneko, M; Minematsu, T; Muraoka, J; Kusumoto, K; Sameshima, H				Kaneko, Masatoki; Minematsu, Toshio; Muraoka, Junsuke; Kusumoto, Kazumi; Sameshima, Hiroshi			Usefulness of Maternal IgG Avidity for Detecting of Congenital Cytomegalovirus Infection.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Kaneko, Masatoki; Muraoka, Junsuke; Kusumoto, Kazumi; Sameshima, Hiroshi] Miyazaki Univ, Obstet & Gynecol, Miyazaki, Japan; [Minematsu, Toshio] Aisenkai Nichinan Hosp, Res Ctr Dis Control, Nichinan, Miyazaki, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-172	353A	353A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202535		
J	Saito, M; Matsuda, T; Usuda, H; Watanabe, S; Kitanishi, R; Hanita, T; Sugiyama, T; Yaegashi, N				Saito, Masatoshi; Matsuda, Tadashi; Usuda, Haruo; Watanabe, Shinpei; Kitanishi, Ryuta; Hanita, Takushi; Sugiyama, Takashi; Yaegashi, Nobuo			The Reaction of Fetal Cortisol Against Intra-Uterine Inflammation and Fetal Circulatory Insufficiency in Fetal Sheep	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Saito, Masatoshi; Matsuda, Tadashi; Usuda, Haruo; Watanabe, Shinpei; Kitanishi, Ryuta; Hanita, Takushi; Sugiyama, Takashi; Yaegashi, Nobuo] Tohoku Univ, Perinatal Care Ctr, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-211	365A	365A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202574		
J	Dong, YP; Ito, T; Velayo, C; Sugibayashi, R; Funamoto, K; Iida, K; Endo, M; Sato, N; Minato, T; Haneda, K; Oshio, S; Kawataki, M; Yaegashi, N; Kimura, Y				Dong, Yupeng; Ito, Takuya; Velayo, Clarissa; Sugibayashi, Rika; Funamoto, Kiyoe; Iida, Keita; Endo, Miyuki; Sato, Naoaki; Minato, Takahiro; Haneda, Ken; Oshio, Sayaka; Kawataki, Motoyoshi; Yaegashi, Nobuo; Kimura, Yoshitaka			Effects of Maternal Inflammation on the Fetal Brain in a Murine Model	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Dong, Yupeng; Ito, Takuya; Velayo, Clarissa; Sugibayashi, Rika; Funamoto, Kiyoe; Iida, Keita; Endo, Miyuki; Sato, Naoaki; Minato, Takahiro; Kawataki, Motoyoshi; Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Adv Interdisciplinary Biomed Engn, Sendai, Miyagi 980, Japan; [Haneda, Ken; Oshio, Sayaka; Yaegashi, Nobuo] Tohoku Univ Hosp, Dept Obstet & Gynecol, Sendai, Miyagi, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-220	368A	368A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202583		
J	Mori, M; Matsubara, K; Matsubara, Y; Uchikura, Y; Yasuoka, T; Nawa, A				Mori, Miki; Matsubara, Keiichi; Matsubara, Yuko; Uchikura, Yuka; Yasuoka, Toshiaki; Nawa, Akihiro			Stromal Derived Factor-1 alpha Is Key To Treating Neonatal Hypoxic-Ischemic Encephalopathy	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Mori, Miki; Matsubara, Keiichi; Matsubara, Yuko; Uchikura, Yuka; Yasuoka, Toshiaki; Nawa, Akihiro] Ehime Univ Hosp, Gynecl Oncol, Toon, Ehime, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-225	369A	370A				2	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202588		
J	Iwama, N; Metoki, H; Ohkubo, T; Ishikuro, M; Obara, T; Kikuya, M; Yagihashi, K; Nishigori, H; Sugiyama, T; Sugawara, J; Yaegashi, N; Hoshi, K; Suzuki, M; Kuriyama, S; Imai, Y				Iwama, Noriyuki; Metoki, Hirohito; Ohkubo, Takayoshi; Ishikuro, Mami; Obara, Taku; Kikuya, Masahiro; Yagihashi, Katsuyo; Nishigori, Hidekazu; Sugiyama, Takashi; Sugawara, Junichi; Yaegashi, Nobuo; Hoshi, Kazuhiko; Suzuki, Masakuni; Kuriyama, Shinichi; Imai, Yutaka			Home Blood Pressure Had a Stronger Predictive Power for Infant Birth Weight Than Clinic Blood Pressure: The Boshi Study.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Iwama, Noriyuki] Tohoku Univ, Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Metoki, Hirohito; Ishikuro, Mami; Obara, Taku; Kikuya, Masahiro; Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, Tokyo 173, Japan; [Yagihashi, Katsuyo; Hoshi, Kazuhiko; Suzuki, Masakuni] Suzuki Mem Hosp, Obstet & Gynecol, Iwanuma, Miyagi, Japan; [Nishigori, Hidekazu; Sugiyama, Takashi; Sugawara, Junichi; Yaegashi, Nobuo] Tohoku Univ, Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Kuriyama, Shinichi] Tohoku Univ, Div Mol Epidemiol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Imai, Yutaka] Tohoku Univ, Dept Planning Drug Dev & Clin Evaluat, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-272	383A	383A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202633		
J	Metoki, H; Iwama, N; Watanabe, Z; Ohkubo, T; Ishikuro, M; Obara, T; Kikuya, M; Sugawara, J; Kuriyama, S; Itoh, K; Hoshi, K; Suzuki, M; Satoh, M; Yaegashi, N; Imai, Y				Metoki, Hirohito; Iwama, Noriyuki; Watanabe, Zen; Ohkubo, Takayoshi; Ishikuro, Mami; Obara, Taku; Kikuya, Masahiro; Sugawara, Junichi; Kuriyama, Shinichi; Itoh, Kiyoshi; Hoshi, Kazuhiko; Suzuki, Masakuni; Satoh, Michihiro; Yaegashi, Nobuo; Imai, Yutaka			Blood Pressure and Heart Rate Among Pregnant Women Before and After the Great East Japan Earthquake (11, March, 2011) in the BOSHI Study.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Metoki, Hirohito; Ishikuro, Mami; Obara, Taku; Kikuya, Masahiro; Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Iwama, Noriyuki; Watanabe, Zen; Satoh, Michihiro; Yaegashi, Nobuo; Imai, Yutaka] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Grad Sch Med, Tokyo 173, Japan; [Kuriyama, Shinichi; Itoh, Kiyoshi] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Hoshi, Kazuhiko; Suzuki, Masakuni] Suzuki Mem Hosp, Dept Obstet & Gynecol, Iwanuma, Miyagi, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-276	385A	385A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202637		
J	Mizuno, S; Nishigori, H; Sugiyama, T; Ogishima, S; Nakaya, J; Yaegashi, N				Mizuno, Satoshi; Nishigori, Hidekazu; Sugiyama, Takashi; Ogishima, Soichi; Nakaya, Jun; Yaegashi, Nobuo			Application of Intrinsic Subtype Classification To Microarray Data From a Set of Women With Mild and Severe Pre-Eclampsia.	REPRODUCTIVE SCIENCES			English	Meeting Abstract									[Mizuno, Satoshi; Nishigori, Hidekazu; Sugiyama, Takashi; Ogishima, Soichi; Nakaya, Jun; Yaegashi, Nobuo] Tohoku Univ, Sch Med, Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Mizuno, Satoshi] Tohoku Univ, Sch Med, Med Informat, Sendai, Miyagi 980, Japan; Tohoku Univ, Bioclin Informat, Med Megabank, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAR	2015	22			1		S-277	385A	385A				1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD9GW	WOS:000351407202638		
J	Kawagoshi, A; Kiyokawa, N; Sugawara, K; Takahashi, H; Sakata, S; Satake, M; Shioya, T				Kawagoshi, Atsuyoshi; Kiyokawa, Noritaka; Sugawara, Keiyu; Takahashi, Hitomi; Sakata, Shunichi; Satake, Masahiro; Shioya, Takanobu			Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease	RESPIRATORY MEDICINE			English	Article						Home-based pulmonary rehabilitation; Physical activity; COPD; The feedback from using pedometer; Randomized controlled trial	COPD; INTERVENTION; OUTCOMES; LIFE	Purpose: We evaluated the effects of low-intensity and home-based pulmonary rehabilitation (PR) on physical activity (PA) and the feedback provided by a pedometer in stable elderly patients with chronic obstructive pulmonary disease (COPD). Methods: We assessed PA using a newly developed triaxial accelerometer (A-MES (TM), Kumamoto, Japan), which measures the time spent walking, standing, sitting and lying down. Twenty-seven elderly patients with COPD (age 74 +/- 8 yrs; %FEV1 56.6 +/- 18.7%) participated. They were randomly selected to undergo PR (pulmonary rehabilitation only) or PR + P (PR plus the feedback from using a pedometer). Their PA and pulmonary function, exercise capacity (6-min walking distance; 6MWD), quadriceps femoris muscle force (QF) were evaluated before the PR began (baseline) and at 1 year later. We compared the patients' changes in PA and other factors between the baseline values and those obtained 1 year later and analyzed therelationships between the changes in PA and other factors in the both groups. Results: The increase in the time spent walking in the PR + P group (51.3 +/- 63.7 min/day) was significantly greater than that of PR group (12.3 +/- 25.5 min/day) after the PR. The improvement rate of daily walking time after PR was significantly correlated with that of the 6MWD and QF in all subjects. Conclusions: These data suggest that low-intensity and home-based PR with the feedback from using pedometer was effective in improving PA, and the improvements of physiological factors were correlated with increased walking time in stable elderly patients with COPD. (c) 2015 Elsevier Ltd. All rights reserved.	[Kawagoshi, Atsuyoshi; Kiyokawa, Noritaka; Sugawara, Keiyu; Takahashi, Hitomi] Akita City Hosp, Dept Rehabil, Akita, Akita 0100933, Japan; [Sakata, Shunichi] Kumamoto Technol & Ind Fdn, Kumamoto, Japan; [Satake, Masahiro; Shioya, Takanobu] Akita Univ Grad Sch Hlth Sci, Dept Phys Therapy, Akita, Japan	Kawagoshi, A (reprint author), Akita City Hosp, Dept Rehabil, 4-30 Matsugaokachou, Akita, Akita 0100933, Japan.	acr00009@med.city.akita.akita.jp					Agarwal V, 2012, J CARDIOPULM REHABIL, V32, P292, DOI 10.1097/HCR.0b013e31825c4242; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Egan C, 2012, RESP MED, V106, P1671, DOI 10.1016/j.rmed.2012.08.016; Wewel AR, 2008, RESP MED, V102, P20, DOI 10.1016/j.rmed.2007.08.011; Mador MJ, 2011, J CARDIOPULM REHABIL, V31, P52, DOI 10.1097/HCR.0b013e3181ebf2ef; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; Steele BG, 2008, ARCH PHYS MED REHAB, V89, P404, DOI 10.1016/j.apmr.2007.11.003; Sewell L, 2005, CHEST, V128, P1194, DOI 10.1378/chest.128.3.1194; Sewell L, 2010, J CARDIOPULM REHABIL, V30, P329, DOI 10.1097/HCR.0b013e3181e175f2; Lindberg R, 2000, J AM DIET ASSOC, V100, P878, DOI 10.1016/S0002-8223(00)00251-0; Kagaya H, 2009, TOHOKU J EXP MED, V218, P215, DOI 10.1620/tjem.218.215; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; DECRAMER M, 1994, AM J RESP CRIT CARE, V150, P11; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P518, DOI DOI 10.1164/RCCM.166.4.518; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; ATS/ERS, 2004, STAND DIAGN MAN PAT, P8; Benzo R, 2009, J CARDIOPULM REHABIL, V29, P341, DOI 10.1097/HCR.0b013e3181be7a3c; Blok BM, 2006, PATIENT EDUC COUNS, V61, P48; Cherniack NS, REHABILITATION PATIE, P455; Cilli BR, 2004, NEW ENGL J MED, V350, P1005; Global Initiative for Chronic Obstructive Lung Disease, 2001, NHLB WHO WORKSH REP; Global Initiative for Chronic Obstructive Lung Disease, 2003, GLOB STRAT DIAGN MAN; Horowitz MB, 1996, CHEST, V109, P1169, DOI 10.1378/chest.109.5.1169; Lacasse Y, 2006, COCHRANE DB SYST REV, V18; Miura R, 2001, J J SOC RESP CARE, V10, P391; RIES AL, 1995, ANN INTERN MED, V122, P823; Sakata S, 2002, APPROACH MEASUREMENT, V12, P19; Takahashi H, 2011, JPN J COMPR REHABIL, V2, P5; World medical association declaration of HELSINKI ethical principles for medical research involving human subjects, 2008, SEOUL	31	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	MAR	2015	109	3					364	371		10.1016/j.rmed.2015.01.008		8	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CE2LL	WOS:000351647000010		
J	Kondoh, Y; Johkoh, T; Fukuoka, J; Arakawa, H; Tanaka, T; Watanabe, N; Sakamoto, K; Kataoka, K; Kimura, T; Taniguchi, H				Kondoh, Yasuhiro; Johkoh, Takeshi; Fukuoka, Junya; Arakawa, Hiroaki; Tanaka, Tomonori; Watanabe, Naohiro; Sakamoto, Koji; Kataoka, Kensuke; Kimura, Tomoki; Taniguchi, Hiroyuki			Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias	RESPIRATORY MEDICINE			English	Article						IIPs - idiopathic interstitial pneumonias; IPF - idiopathic pulmonary fibrosis; NSIP - nonspecific interstitial pneumonia; SLB - surgical lung biopsy; UCTD - undifferentiated conneaive tissue disease	COLLAGEN VASCULAR-DISEASE; PULMONARY-FIBROSIS; LUNG-DISEASE; CLASSIFICATION; PIRFENIDONE; PREVALENCE; SURVIVAL	Background: Kinder et al. proposed a broader definition of undifferentiated connective tissue disease (UCTD) and reported that the entity of nonspecific interstitial pneumonia (NSIP) is a lung manifestation of this more broadly defined UCTD. However, a retrospective study did not support their findings and its clinical significance remains unclear. Methods: We prospectively evaluated the significance of this broadly defined UCTD in idiopathic interstitial pneumonias (IIPs) in consecutive patients with surgical lung biopsy. Patients were evaluated with a symptoms check list and underwent comprehensive serologic testing as screening for UCTD. Clinical characteristics, high-resolution CT images, lung biopsy specimens, serial FVC change, and survival were analyzed. Results: Among 76 patients with IIPs, 24 patients (32%) fulfilled the UCTD criteria. Diagnosis of 24 patients with UCTD was usual interstitial pneumonia in 12 (50%), NSIP in 7 (29%), and unclassifiable interstitial lung disease (ILD) in 5 (21%). The diagnosis of 52 patients who did not have UCTD was idiopathic pulmonary fibrosis in 27 (52%), NSIP in 11(21%), unclassifiable ILD in 13 (25%) and cryptogenic organizing pneumonia in 1 (2%). One-year and two-year FVC changes showed no significant difference between UCTD and non-UCTD, however, significant differences in FVC change were observed among histopathological diagnoses both in UCTD and in non-UCTD. In multivariate survival analysis, %FVC and histopathological UIP pattern were independent predictors for survival but UCTD diagnosis was not. Conclusions: A diagnosis of UCTD was not useful in discriminating INISIP or in predicting disease progression and prognosis in our cohort of IIPs. Histopathological UIP pattern was an independent predictor for mortality irrespective of a diagnosis of UCTD. (c) 2015 Elsevier Ltd. All rights reserved.	[Kondoh, Yasuhiro; Kataoka, Kensuke; Kimura, Tomoki; Taniguchi, Hiroyuki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto City, Aichi, Japan; [Johkoh, Takeshi] Kinki Cent Hosp Mutual Aid Assoc Publ Sch Teacher, Dept Radiol, Itami, Hyogo, Japan; [Fukuoka, Junya; Tanaka, Tomonori] Nagasaki Univ Hosp, Dept Lab Pathol, Nagasaki, Japan; [Arakawa, Hiroaki] Dokkyo Univ Sch Med, Dept Radiol, Soka, Saitama, Japan; [Watanabe, Naohiro; Sakamoto, Koji] Nagoya Univ Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan	Kondoh, Y (reprint author), 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan.	konyasu2003@yahoo.co.jp			Japanese Ministry of Health and Welfare; NPO Respiratory Disease Conference	This work was supported by a grant-in-aid for interstitial lung diseases from the Japanese Ministry of Health and Welfare and by NPO Respiratory Disease Conference.	American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Fischer A, 2015, ARTHRIT CARE RES, V67, P4, DOI 10.1002/acr.22394; Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662; Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Corte TJ, 2012, EUR RESPIR J, V39, P661, DOI 10.1183/09031936.00174910; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Jegal Y, 2005, AM J RESP CRIT CARE, V171, P639, DOI 10.1164/rccm.200403-331OC; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Kinder BW, 2010, LUNG, V188, P143, DOI 10.1007/s00408-009-9226-7; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Lee JS, 2013, RESP MED, V107, P249, DOI 10.1016/j.rmed.2012.10.018; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Cottin Vincent, 2013, Eur Respir Rev, V22, P273, DOI 10.1183/09059180.00003013; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Kondoh Y, 2012, AM J RESP CRIT CARE, V185, pA6603; Medical Section of the American Lung Association, 1995, AM J RESP CRIT CARE, V152, P1107; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	25	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	MAR	2015	109	3					389	396		10.1016/j.rmed.2015.01.009		8	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CE2LL	WOS:000351647000013		
J	Nakano, Y				Nakano, Y.			HOW CAN WE POPULARIZE SPIROMETRY AND CT IN THE DIAGNOSIS OF COPD?	RESPIROLOGY			English	Meeting Abstract									[Nakano, Y.] Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga 52021, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			1	SI		5	5				1	Respiratory System	Respiratory System	CE0AI	WOS:000351463500020		
J	Nakano, Y				Nakano, Y.			CT OF COPD: EMPHYSEMA AND AIRWAY	RESPIROLOGY			English	Meeting Abstract									[Nakano, Y.] Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga 52021, Japan							Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			1	SI		7	7				1	Respiratory System	Respiratory System	CE0AI	WOS:000351463500025		
J	Ohno, Y				Ohno, Y.			MRI OF COPD	RESPIROLOGY			English	Meeting Abstract									[Ohno, Y.] Kobe Univ, Sch Med, Dept Radiol, Div Funct Imaging Res, Kobe, Hyogo, Japan; [Ohno, Y.] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			1	SI		7	7				1	Respiratory System	Respiratory System	CE0AI	WOS:000351463500027		
J	Corte, T; Cottin, V; Taniguchi, H; Richeldi, L; Collard, H; Kaye, M; Hansell, D; Bailes, Z; Schlenker-Herceg, R; Raghu, G				Corte, T.; Cottin, V; Taniguchi, H.; Richeldi, L.; Collard, H.; Kaye, M.; Hansell, D.; Bailes, Z.; Schlenker-Herceg, R.; Raghu, G.			EFFECT OF BASELINE EMPHYSEMA ON REDUCTION IN FVC DECLINE WITH NINTEDANIB IN THE INPULSIS TRIALS	RESPIROLOGY			English	Meeting Abstract									[Corte, T.] Royal Prince Alfred Hosp, Dept Resp Med, Camperdown, NSW, Australia; [Cottin, V] Univ Lyon, Louis Pradel Hosp, Lyon, France; [Taniguchi, H.] Tosei Gen Hosp, Seto, Aichi, Japan; [Richeldi, L.] Univ Southampton, Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Richeldi, L.] Univ Southampton, Clin & Expt Sci, Southampton, Hants, England; [Collard, H.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kaye, M.] Minnesota Lung Ctr Ltd, Minneapolis, MN USA; [Hansell, D.] Royal Brompton & Harefield Hosp NHS Fdn Trust, London, England; [Hansell, D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bailes, Z.] Boehringer Ingelheim Ltd, Bracknell, Berks, England; [Schlenker-Herceg, R.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Raghu, G.] Univ Washington, Seattle, WA 98195 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			2	SI	TO 114	57	57				1	Respiratory System	Respiratory System	CE0AQ	WOS:000351464400151		
J	Glaspole, I; Costabel, U; Inoue, Y; Richeldi, L; Collard, H; Stowasser, S; Tschoepe, I; Azuma, A				Glaspole, I; Costabel, U.; Inoue, Y.; Richeldi, L.; Collard, H.; Stowasser, S.; Tschoepe, I; Azuma, A.			EFFECT OF BASELINE FVC ON DECLINE IN LUNG FUNCTION WITH NINTEDANIB: RESULTS FROM THE INPULSIS TRIALS	RESPIROLOGY			English	Meeting Abstract									[Glaspole, I] Alfred Hosp, Melbourne, Vic, Australia; [Costabel, U.] Univ Duisberg Essen, Essen, Germany; [Inoue, Y.] Natl Hosp Org, Kinko Chuo Chest Med Ctr, Nagoya, Aichi, Japan; [Richeldi, L.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Collard, H.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Stowasser, S.] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Tschoepe, I] Boehringer Ingelheim France SAS, Reims, France; [Azuma, A.] Nippon Med Sch, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			2	SI	TP 066	87	87				1	Respiratory System	Respiratory System	CE0AQ	WOS:000351464400224		
J	Glaspole, I; Cottin, V; Taniguchi, H; Collard, H; Richeldi, L; Stowasser, S; Tschoepe, I; Schlenker-Herceg, R; Raghu, G				Glaspole, I; Cottin, V; Taniguchi, H.; Collard, H.; Richeldi, L.; Stowasser, S.; Tschoepe, I; Schlenker-Herceg, R.; Raghu, G.			REDUCTION IN DISEASE PROGRESSION WITH NINTEDANIB IN THE INPULSIS TRIALS	RESPIROLOGY			English	Meeting Abstract									[Glaspole, I] Alfred Hosp, Melbourne, Vic, Australia; [Cottin, V] Univ Lyon, Louis Pradel Hosp, Lyon, France; [Taniguchi, H.] Tosei Gen Hosp, Seto, Aichi, Japan; [Collard, H.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Richeldi, L.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Stowasser, S.] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Tschoepe, I] Boehringer Ingelheim France SAS, Reims, France; [Schlenker-Herceg, R.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA; [Raghu, G.] Univ Washington, Seattle, WA 98195 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	MAR	2015	20			2	SI	TP 067	88	88				1	Respiratory System	Respiratory System	CE0AQ	WOS:000351464400225		
J	Jin, L; Orvell, C; Myers, R; Rota, PA; Nakayama, T; Forcic, D; Hiebert, J; Brown, KE				Jin, Li; Orvell, Claes; Myers, Richard; Rota, Paul A.; Nakayama, Tetsuo; Forcic, Dubravko; Hiebert, Joanne; Brown, Kevin E.			Genomic diversity of mumps virus and global distribution of the 12 genotypes	REVIEWS IN MEDICAL VIROLOGY			English	Review							GENETIC-CHARACTERIZATION; ASEPTIC-MENINGITIS; SEQUENCE-ANALYSIS; SH GENE; MOLECULAR CHARACTERIZATION; VACCINE STRAIN; YOUNG-ADULTS; F-PROTEIN; OUTBREAK; IDENTIFICATION	The WHO recently proposed an updated nomenclature for mumps virus (MuV). WHO currently recognizes 12 genotypes of MuV, assigned letters from A to N (excluding E and M), which are based on the nucleotide sequences of small hydrophobic (SH) and haemagglutinin-neuraminidase (HN) genes. A total of 66 MuV genomes are available in GenBank, representing eight of the 12 genotypes. To complete this dataset, whole genomes of seven isolates representing six genotypes (D, H, I, J, K and L) and one unclassified strain were sequenced. SH and HN genes of other representative strains were also sequenced. The degree of genetic divergence, predicted amino acid substitutions in the HN and fusion (F) proteins and geographic distributions of MuV strains were analysed based on the updated dataset. Nucleotide heterogeneity between genotypes reached 20% within the SH gene, with a maximum of 9% within the HN gene. The geographic and chronologic distributions of the 12 genotypes were summarised. This review contributes to our understanding of strain diversity for wild type MuV, and the results support the current WHO nomenclature. (c) 2014 Crown copyright. Reviews in Medical Virology (c) 2014 John Wiley & Sons, Ltd.	[Jin, Li; Myers, Richard; Brown, Kevin E.] Publ Hlth England, Virus Reference Dept, Reference Microbiol Serv, London NW9 5EQ, England; [Orvell, Claes] Huddinge Univ Hosp, Div Clin Virol, Stockholm, Sweden; [Rota, Paul A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Nakayama, Tetsuo] Kitasato Inst Life Sci, Tokyo, Japan; [Forcic, Dubravko] Univ Zagreb, Ctr Res & Knowledge Transfer Biotechnol, Zagreb 41000, Croatia; [Hiebert, Joanne] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Jin, L (reprint author), Publ Hlth England, Virus Reference Dept, Reference Microbiol Serv, 61 Colindale Ave, London NW9 5EQ, England.	li.jin@phe.gov.uk					AFZAL MA, 1993, J GEN VIROL, V74, P917, DOI 10.1099/0022-1317-74-5-917; Afzal MA, 1997, ARCH VIROL, V142, P227, DOI 10.1007/s007050050073; Afzal MA, 1997, J MED VIROL, V52, P349, DOI 10.1002/(SICI)1096-9071(199708)52:4<349::AID-JMV1>3.0.CO;2-1; Agafonovs AP, 2007, EPIDEMIOL VAKCINOPRO, V5, P34; Akcali A, 2009, ARCH VIROL, V154, P1807, DOI 10.1007/s00705-009-0519-1; Ivancic-Jelecki J, 2008, INFECT GENET EVOL, V8, P603, DOI 10.1016/j.meegid.2008.04.007; Takeuchi K, 1996, VIROLOGY, V225, P156, DOI 10.1006/viro.1996.0583; Yung CF, 2011, EMERG INFECT DIS, V17, P661, DOI 10.3201/eid1704.101461; Hindiyeh MY, 2009, J CLIN MICROBIOL, V47, P560, DOI 10.1128/JCM.01756-08; Carr MJ, 2010, J CLIN MICROBIOL, V48, P3288, DOI 10.1128/JCM.00434-10; Peltola H, 2007, CLIN INFECT DIS, V45, P459, DOI 10.1086/520028; Kashiwagi Y, 1999, ARCH VIROL, V144, P593, DOI 10.1007/s007050050527; Ivancic J, 2005, VIRUS RES, V109, P95, DOI 10.1016/j.virusres.2004.11.013; Saito H, 1996, MICROBIOL IMMUNOL, V40, P271; Palacios G, 2005, J CLIN MICROBIOL, V43, P1869, DOI 10.1128/JCM.43.4.1869-1878.2005; Afzal MA, 2005, J VIROL METHODS, V126, P149, DOI 10.1016/j.jviromet.2005.01.032; Kulkarni-Kale U, 2007, VIROLOGY, V359, P436, DOI 10.1016/j.virol.2006.09.040; Anis E, 2012, EPIDEMIOL INFECT, V140, P439, DOI 10.1017/S095026881100063X; Inou Y, 2004, J MED VIROL, V73, P97, DOI 10.1002/jmv.20065; Santos CLS, 2008, J MED VIROL, V80, P323, DOI 10.1002/jmv.21068; Atrasheuskaya AV, 2007, CLIN MICROBIOL INFEC, V13, P670, DOI 10.1111/j.1469-0691.2007.01727.x; YOUNG ML, 1967, PEDIATRICS, V40, P798; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Orvell C, 1997, J GEN VIROL, V78, P3187; Santak M, 2013, EPIDEMIOL INFECT, V141, P1298, DOI 10.1017/S0950268812001896; Kimura M, 1996, ACTA PAEDIATR JAPON, V38, P205; Rota JS, 2009, J MED VIROL, V81, P1819, DOI 10.1002/jmv.21557; Watson-Creed G, 2006, CAN MED ASSOC J, V175, P483, DOI 10.1503/cmaj.060660; Bernard H., 2008, Eurosurveillance, V13, P8079; Carbone KM, 2007, FIELDS VIROLOGY, V5th, P1527; Cohen BJ, 1999, EPIDEMIOL INFECT, V123, P251, DOI 10.1017/S0950268899002782; Cuis A, 2013, PLOS ONE, V8; Cuis A, 2009, INFECT GENET EVOL, V9, P71; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Echevarria JE, 2010, J CLIN MICROBIOL, V48, P1245, DOI 10.1128/JCM.02386-09; Gershons AA, 1995, INFECT DIS FETUS NEW, P565; Hukic M., 2011, Eurosurveillance, V16, P19959; Ivancic J, 2004, VIRUS RES, V99, P121, DOI 10.1016/j.viruses.2003.11.002; Jins L, 1999, J INFECT DIS, V180, P829; Jins L, 1996, MOL CELL PROBE, V10, P191; Jins L, 2002, B WORLD HEALTH ORGAN, V80, P76; Jins L, 2004, J INFECT DIS, V189, P1001; Jins L, 2000, VIRUS RES, V70, P75; Jins L, 2005, ARCH VIROL, V150, P1909; Johnson CD, 1934, J EXP MED, V59, P1, DOI 10.1084/jem.59.1.1; Kidokoro M, 2011, J CLIN MICROBIOL, V49, P1917, DOI 10.1128/JCM.02387-10; KILHAM L, 1948, P SOC EXP BIOL MED, V69, P99; Knowles WA, 2005, TOPLEY WILSON MICROB, P744; Kuzmanovska G, 2010, EUROSURVEILLANCE, V15, P13; Lees JY, 2003, VIRUS RES, V97, P111; Lees JY, 2004, J MED VIROL, V73, P85; Liang Y, 2008, VACCINE, V26, P4276, DOI 10.1016/j.vaccine.2008.05.060; Liang Y, 2010, MICROBES INFECT, V12, P1178, DOI 10.1016/j.micinf.2010.08.004; Lims CS, 2003, J MED VIROL, V70, P287; Malik T, 2011, J VIROL, V85, P6082, DOI 10.1128/JVI.02686-10; Montes M, 2002, EPIDEMIOL INFECT, V129, P551, DOI 10.1017/S095026880200763X; Otto W, 2010, EUROSURVEILLANCE, V15, P21; Rafiefard F, 2005, SCAND J INFECT DIS, V37, P330, DOI 10.1080/00365540510031674; Reid F, 2008, J CLIN VIROL, V41, P134, DOI 10.1016/j.jcv.2007.10.009; Rubin SA, 2003, J VIROL, V77, P11616, DOI 10.1128/JVI.77.21.11616-11624.2003; Rubins SA, 2000, J VIROL, V74, P5384; Saika S, 2002, J MED VIROL, V66, P115, DOI 10.1002/jmv.2119; Saito H, 1998, MICROBIOL IMMUNOL, V42, P133; Santak M, 2006, J MED VIROL, V78, P638, DOI 10.1002/jmv.20587; Sauder Christian J, 2011, J Virol, V85, P7059, DOI 10.1128/JVI.00245-11; Savage E, 2005, BRIT MED J, V330, P1119, DOI 10.1136/bmj.330.7500.1119; Shah D, 2009, J MED VIROL, V81, P130, DOI 10.1002/jmv.21381; Shis H, 2011, J MED MICROBIOL, V60, P1496; Strohle A, 1996, ARCH VIROL, V141, P733, DOI 10.1007/BF01718331; SUGIURA A, 1991, PEDIATR INFECT DIS J, V10, P209, DOI 10.1097/00006454-199103000-00008; TANABAYASHI K, 1993, J VIROL, V67, P2928; TANABAYASHI K, 1994, VIROLOGY, V204, P851, DOI 10.1006/viro.1994.1607; Tecle T, 1998, J GEN VIROL, V79, P2929; Tecle T, 2000, ARCH VIROL, V145, P1199, DOI 10.1007/s007050070119; Tecle T, 2002, ARCH VIROL, V147, P243, DOI 10.1007/s705-002-8317-y; Tecles T, 2001, J GEN VIROL, V82, P2680; Uchida K, 2001, MICROBIOL IMMUNOL, V45, P851; Uchida K, 2003, MICROBIOL IMMUNOL, V47, P167; Vaidya SR, 2010, J VIROL METHODS, V163, P153, DOI 10.1016/j.jviromet.2009.09.006; Vaidyas SR, 2013, J MED VIROL, V85, P426; Van Den Boschs CA, 2000, EUROSURVEILLANCE, V5, P58; Whelan J, 2010, EUROSURVEILLANCE, V15, P11; WHO, 2005, WKLY EPIDEMIOL REC, V84, P418; WHO, 2013, WEEKLY EPIDEMIOLOGIC, V87, P217; Wus L, 1998, VACCINE, V16, P281; Young DF, 2009, J GEN VIROL, V90, P2731, DOI 10.1099/vir.0.013722-0	86	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1052-9276	1099-1654		REV MED VIROL	Rev. Med. Virol.	MAR	2015	25	2					85	101		10.1002/rmv.1819		17	Virology	Virology	CD5KY	WOS:000351127700003		
J	Imamura, T; Oshitani, H				Imamura, Tadatsugu; Oshitani, Hitoshi			Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections	REVIEWS IN MEDICAL VIROLOGY			English	Review							PEDIATRIC-PATIENTS; TRACT INFECTIONS; HUMAN RHINOVIRUS; CHILDREN; SEROTYPE; EVOLUTION; ILLNESS; EMERGENCE; SEQUENCE; FEATURES	We previously detected enterovirus D68 (EV-D68) in children with severe acute respiratory infections in the Philippines in 2008-2009. Since then, the detection frequency of EV-D68 has increased in different parts of the world, and EV-D68 is now recognized as a reemerging pathogen. However, the epidemiological profile and clinical significance of EV-D68 is yet to be defined, and the virological characteristics of EV-D68 are not fully understood. Recent studies have revealed that EV-D68 is detected among patients with acute respiratory infections of differing severities ranging from mild upper respiratory tract infections to severe pneumonia including fatal cases in pediatric and adult patients. In some study sites, the EV-D68 detection rate was higher among patients with lower respiratory tract infections than among those with upper respiratory tract infections, suggesting that EV-D68 infections are more likely to be associated with severe respiratory illnesses. EV-D68 strains circulating in recent years have been divided into three distinct genetic lineages with different antigenicity. However, the association between genetic differences and disease severity, as well as the occurrence of large-scale outbreaks, remains elusive. Previous studies have revealed that EV-D68 is acid sensitive and has an optimal growth temperature of 33 degrees C. EV-D68 binds to 2,6-linked sialic acids; hence, it is assumed that it has an affinity for the upper respiratory track where these glycans are present. However, the lack of suitable animal model constrains comprehensive understanding of the pathogenesis of EV-D68. (c) 2014 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd.	[Imamura, Tadatsugu; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan	Oshitani, H (reprint author), Tohoku Univ, Dept Virol, Grad Sch Med, Aoba Ku, 2-1 Seiryou Machi, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology	This work was supported by a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology.	Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Piralla A, 2012, DIAGN MICR INFEC DIS, V73, P162, DOI 10.1016/j.diagmicrobio.2012.02.019; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Wang Z, 2010, MICROB ECOL, V59, P623, DOI 10.1007/s00248-010-9636-3; Alexander DA, 2002, J VIROL, V76, P11265, DOI 10.1128/JVI.76.22.11265-11272.2002; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Brown BA, 1999, J VIROL, V73, P9969; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Stephenson J, 2014, JAMA-J AM MED ASSOC, V312, P1290, DOI 10.1001/jama.2014.13256; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Tan JZ, 2013, J VIROL, V87, P4339, DOI 10.1128/JVI.01123-12; Imamura T, 2014, INFLUENZA OTHER RESP, V8, P21, DOI 10.1111/irv.12206; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Smura T, 2010, J MED VIROL, V82, P1940, DOI 10.1002/jmv.21894; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Xiang ZC, 2014, J VIROL, V88, P6650, DOI 10.1128/JVI.03138-13; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Oberste MS, 1999, J VIROL, V73, P1941; Renois F, 2013, J CLIN MICROBIOL, V51, P640, DOI 10.1128/JCM.02640-12; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; CHATTERJ.S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; NELSON J, 1993, VIRUS RES, V29, P155; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074221; Khetsuriani Nino, 2006, MMWR Surveill Summ, V55, P1; Knipe D.M., 2013, FIELDS VIROLOGY; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Lu QB, 2013, J MED MICROBIOL, V63, P408; MCPHEE F, 1994, VIRUS RES, V34, P139, DOI 10.1016/0168-1702(94)90096-5; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Topfer L, 2014, J CRIT CARE, V29, P340, DOI 10.1016/j.jcrc.2013.12.013; Wylie KM, 2015, EMERG INFECT DIS, V21, P184, DOI 10.3201/eid2101.141605	48	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1052-9276	1099-1654		REV MED VIROL	Rev. Med. Virol.	MAR	2015	25	2					102	114		10.1002/rmv.1820		13	Virology	Virology	CD5KY	WOS:000351127700004		
J	Tanaka, N; Kinoshita, H; Takakura, A; Jamal, M; Kumihashi, M; Uchiyama, Y; Tsutsui, K; Ameno, K				Tanaka, Naoko; Kinoshita, Hiroshi; Takakura, Ayaka; Jamal, Mostofa; Kumihashi, Mitsuru; Uchiyama, Yu; Tsutsui, Kunihiko; Ameno, Kiyoshi			Combination of energy-dispersive X-ray fluorescence spectrometry (EDX) and head-space gas chromatography mass spectrometry (HS-GC/MS) is a useful screening tool for stomach contents	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						Energy-dispersive X-ray fluorescence spectrometry (EDX); toxicological screening; fenitrothion		We applied energy-dispersive X-ray fluorescence spectrometry (EDX) and head-space gas chromatography mass spectrometry (HS-GC/MS) for the toxicological screening of stomach contents, notable as employed in a case of pesticide (fenitrothion) ingestion. Elemental analysis by EDX identified high peaks corresponding to phosphorus and sulfur, and HS-GC/MS analysis identified xylene and ethybenzene in the stomach contents. Subsequent toxicological analysis detected fenitrothion at concentrations of 25.6 and 99.6 mg/g in muscle and stomach contents, respectively. We concluded that the victim ingested fenitrothion. The high peaks corresponding to phosphorus and sulfur by EDX analysis presumably were derived from fenitrothion. Our results indicate that the combination of EDX and HS-GC/MS may serve as a useful tool for screening stomach contents, providing valuable information for forensic diagnosis.	[Tanaka, Naoko; Kinoshita, Hiroshi; Takakura, Ayaka; Jamal, Mostofa; Kumihashi, Mitsuru; Uchiyama, Yu; Ameno, Kiyoshi] Kagawa Univ, Fac Med, Dept Forens Med, Kagawa 7610793, Japan; [Tsutsui, Kunihiko] Kagawa Univ, Fac Med, Dept Hlth Sci, Kagawa 7610793, Japan	Kinoshita, H (reprint author), Kagawa Univ, Fac Med, Dept Forens Med, Kita Ku, 1750-1 Miki, Kagawa 7610793, Japan.	kinochin@med.kagawa-u.ac.jp					Adachi Nobuyuki, 2009, Soud Lek, V54, P2; Ameno K, 1981, NIHON HOIGAKU ZASSHI, V35, P83; Tanaka H, 2003, BIOL PHARM BULL, V26, P457; Kinoshita H, 2013, FORENSIC SCI INT, V227, P103, DOI 10.1016/j.forsciint.2012.08.026; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Baselt RC, 2008, DISPOSITION TOXIC DR; Kinoshita H, 2014, ROM J LEG MED, V22, P117, DOI 10.4323/rjlm.2014.117; Kinoshita Hiroshi, 2013, Soud Lek, V58, P59; Kinoshita H, 2001, RES PRACT FORENS MED, V44, P155; Takahashi Motonori, 2009, Leg Med (Tokyo), V11 Suppl 1, pS411, DOI 10.1016/j.legalmed.2009.01.077; Takahashi M, 2010, LEGAL MED, V12, P132, DOI 10.1016/j.legalmed.2010.01.006; Takayasu T, 2001, J FORENSIC SCI, V46, P98; WINSTANLEY R, 1987, FORENSIC SCI INT, V35, P181, DOI 10.1016/0379-0738(87)90054-5; Yamazaki M, 2001, J FORENSIC SCI, V46, P165	14	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	MAR	2015	23	1					43	44		10.4323/rjlm.2015.43		2	Medicine, Legal	Legal Medicine	CE2JL	WOS:000351641800010		
J	Martynov, AY; Martynov, YA; Rybin, AV; Kimura, JI				Martynov, A. Yu; Martynov, Yu A.; Rybin, A. V.; Kimura, J. -I.			Role of back-arc tectonics in the origin of subduction magmas: new Sr, Nd, and Pb isotope data from Middle Miocene lavas of Kunashir Island (Kurile Island Arc)	RUSSIAN GEOLOGY AND GEOPHYSICS			English	Article						primitive lavas; radiogenic isotopes; evolution; magma generation; geodynamics; Kurile island arc	TRACE-ELEMENTS; GEOCHEMICAL VARIATIONS; MANTLE WEDGE; CONSTRAINTS; CRUST; BASALTS; COMPONENTS; SEDIMENT; LIQUIDS; DEPTH	Sr, Nd, and Pb isotope data for basaltic rocks of different ages from Kunashir Island (southern Kurile island arc) provide clues to investigate the subduction magmatic history. Signatures of a high-temperature slab component (melt and/or supercritical liquid produced by melting of slab sediments) involved in Early Miocene-Pleistocene back-arc basaltic magmatism indicate a relatively hot (> 800 degrees C) slab surface. Depleted isotope characteristics of Holocene basaltic lavas in both volcanic front and back arc indicate their origin with the participation of a cold aqueous fluid produced by dehydration of altered oceanic crust of the Pacific MORB type. The difference in geological, geochemical and isotope patterns in the Pleistocene and the Holocene lavas may be a response to stress change from extension to compression in the Kurile back-arc basin and the Kurile arc. (C) 2015, V.S. Sobolev IGM, Siberian Branch of the RAS. Published by Elsevier B.V. All rights reserved.	[Martynov, A. Yu; Martynov, Yu A.] Russian Acad Sci, Far East Geol Inst, Far Eastern Branch, Vladivostok 690022, Russia; [Rybin, A. V.] Russian Acad Sci, Inst Marine Geol & Geophys, Far Eastern Branch, Yuzhno Sakhalinsk 693022, Russia; [Kimura, J. -I.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	Martynov, AY (reprint author), Russian Acad Sci, Far East Geol Inst, Far Eastern Branch, Pr 100 Letiya Vladivostoka 159, Vladivostok 690022, Russia.	amartynov@fegi.ru			Russian Foundation for Basic Research [13-05-00100]; Far Eastern Branch of the Russian Academy of Sciences [12-III-A-08-151, 13-III-B-08-046]	The study was supported by grant 13-05-00100 from the Russian Foundation for Basic Research and was carried out as part of projects 12-III-A-08-151 and 13-III-B-08-046 of the Far Eastern Branch of the Russian Academy of Sciences.	Kogiso T, 1997, EARTH PLANET SC LETT, V148, P193, DOI 10.1016/S0012-821X(97)00018-6; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Straub SM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2002GC000408; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; PLANK T, 1993, NATURE, V362, P739, DOI 10.1038/362739a0; Pearce JA, 1999, J PETROL, V40, P1579, DOI 10.1093/petrology/40.11.1579; RYAN JG, 1995, SCIENCE, V270, P625, DOI 10.1126/science.270.5236.625; Green TH, 2000, LITHOS, V53, P165, DOI 10.1016/S0024-4937(00)00023-2; Ishizuka O, 2006, J VOLCANOL GEOTH RES, V156, P266, DOI 10.1016/j.jvolgeores.2006.03.005; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; Kessel R, 2005, NATURE, V437, P724, DOI 10.1038/nature03971; ZLOBIN TK, 1987, DOKL AKAD NAUK SSSR+, V293, P185; Peate DW, 1998, ISL ARC, V7, P479, DOI 10.1111/j.1440-1738.1998.00205.x; BAILEY JC, 1989, CONTRIB MINERAL PETR, V102, P265, DOI 10.1007/BF00373720; Portnyagin M, 2007, EARTH PLANET SC LETT, V255, P53, DOI 10.1016/j.epsl.2006.12.005; Syracuse EM, 2010, PHYS EARTH PLANET IN, V183, P73, DOI 10.1016/j.pepi.2010.02.004; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; Kimura JI, 2006, J PETROL, V47, P2185, DOI 10.1093/petrology/egl041; Ishikawa T, 1997, EARTH PLANET SC LETT, V152, P123, DOI 10.1016/S0012-821X(97)00144-1; Tollstrup D, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002847; Bailey JC, 1996, GEOCHEM J, V30, P289; Baranov B, 2002, ISL ARC, V11, P206, DOI 10.1046/j.1440-1738.2002.00366.x; Bindeman IN, 1999, EARTH PLANET SC LETT, V169, P209, DOI 10.1016/S0012-821X(99)00086-2; Chashchin A.A., 2011, PETROLOGY LAVAS GORE; Fedorchenko V.I., 1989, VOLCANISM KURILE ARC; Frolova T.I., 1985, ORIGIN ISLAND ARC VO; HAUFF F, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI DOI 10.1029/2002GC; Iizumi S., 1995, MEMOIR FS SHIMANE U, V29, P73; Iizumi S., 1994, MEMOIRS FS SHIMANE U, V28, P83; Johnson M.C., 1999, GEOCHEM GEOPHY GEOSY, V13, DOI [10.1029/999GC000014, DOI 10.1029/999GC000014]; Kimura J, 1996, J MINERALOGY PETROLO, V91, P62, DOI DOI 10.2465/GANKO.91.62; Kimura J.-I., 1995, SCI REPORT FUKUSHIMA, V56, P1; Kimura J.-I., 2003, GEOSCIENCE REPORT SH, V22, P49; Le Maitre R. W., 1989, CLASSIFICATION IGNEO; Martynov AY, 2010, ISL ARC, V19, P86, DOI 10.1111/j.1440-1738.2009.00684.x; Martynov Yu.A., 2012, PETROLOGY+, V20, P102; Martynov Yu.A., 2010, PETROLOGY+, V18, P1; [Мартынов Ю.А. Martynov Yu. A.], 2005, [Геохимия, Geokhimiya], P369; Pertermann M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000638; Piskunov B.N., 1987, GEOLOGY PETROLOGY IS; Pushcharovsky Yu.M., 1992, SUBMARINE VOLCANISM; Ruscitto DM, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003887; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Syvorotkin V.L., 1989, RIFT MAGMATISM PETRO, P180; Tararin I. A., 2000, DOKL EARTH SCI, V371, P494; Tatsumi Y., 2003, GEOPHYS MONOGR SER, V138, P277; Yoshida T., 1995, MEM GEOL SOC JPN, V44, P263; Yoshida T., 2001, TOHOKU GEOPHYS J, V36, P131; ZHURAVLEV DZ, 1985, GEOKHIMIYA+, P1723	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1068-7971	1878-030X		RUSS GEOL GEOPHYS+	Russ. Geol. Geophys.	MAR	2015	56	3					363	378		10.1016/j.rgg.2015.02.001		16	Geosciences, Multidisciplinary	Geology	CD7YZ	WOS:000351313500001		
J	Rubtsov, NB; Kartavtseva, IV; Roslik, GV; Karamysheva, TV; Pavlenko, MV; Iwasa, MA; Koh, HS				Rubtsov, N. B.; Kartavtseva, I. V.; Roslik, G. V.; Karamysheva, T. V.; Pavlenko, M. V.; Iwasa, M. A.; Koh, H. S.			Features of the B chromosome in Korean field mouse Apodemus peninsulae (Thomas, 1906) from Transbaikalia and the Far East identified by the FISH method	RUSSIAN JOURNAL OF GENETICS			English	Article							RODENTIA; EVOLUTION; MURIDAE; SYSTEM; MICRODISSECTION; POLYMORPHISM; POPULATION; MONGOLIA; MAMMALIA; ASIA	Korean field mouse (Apodemus peninsulae) is widely distributed throughout northeastern Asia, including the Russian Far East, northern China, the Korean Peninsula, Sakhalin, and Hokkaido. This mouse species is characterized by a high frequency of animals with B chromosomes differing in their number, morphology, and DNA composition in different geographical regions. For the first time a comparative analysis of DNA probes from B chromosomes with metaphase chromosomes of mice from Transbaikalia, the Far East (including the Russian Far East), Japan, and South Korea was conducted by in situ hybridization. B chromosomes in mice from the Russian Far East were shown to exhibit low variability in DNA content; however, the DNA composition of B chromosomes in species from Transbaikalia and Japan were highly variable. B chromosomes in A. peninsulae from the South Korean population demonstrate minor differences from those from the Russian Far East. We discuss the origin of B chromosomes in the studied region in comparison with previously obtained data for mice from Siberia and the Baikal region, as well as the dispersal routes of the Korean field mouse.	[Rubtsov, N. B.; Karamysheva, T. V.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Kartavtseva, I. V.; Roslik, G. V.; Pavlenko, M. V.] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok 690022, Russia; [Iwasa, M. A.] Nihon Univ, Fujisawa, Kanagawa 2528510, Japan; [Koh, H. S.] Chungbuk Univ, Dept Biol, Cheonju 361763, South Korea	Rubtsov, NB (reprint author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	rubt@bionet.nsc.ru; irina_kar52@rambler.ru; roslik_g@mail.ru; mv_pavlenko@mail.ru; iwasa.masahiro@nihon-u.ac.jp; syskoss@chungbuk.ac.kr			Russian Foundation for Basic Research [14-04-00086a]; DVO RAS [12-II-CO-06-018]	This study was partially supported by the Russian Foundation for Basic Research (research project no. 14-04-00086a) and DVO RAS no. 12-II-CO-06-018.	Abe Syuiti, 1997, Chromosome Science, V1, P7; Sakka H, 2010, BIOL J LINN SOC, V100, P797; Kartavtseva IV, 2004, CYTOGENET GENOME RES, V106, P271, DOI 10.1159/000079298; Matsubara K, 2008, CHROMOSOME RES, V16, P1013, DOI 10.1007/s10577-008-1259-x; Matsubara K, 2004, CHROMOSOME RES, V12, P383, DOI 10.1023/B:CHRO.0000034103.05528.83; Rubtsov NB, 2005, BIOL MEMBRANY, V22, P196; Serizawa K, 2002, BIOCHEM GENET, V40, P149, DOI 10.1023/A:1015841424598; BEKASOVA TS, 1975, GENETIKA+, V11, P89; Borisov YM, 2010, RUSS J GENET+, V46, P705, DOI 10.1134/S1022795410060116; BORISOV YM, 1991, TSITOLOGIYA+, V33, P106; Borisov YM, 2012, RUSS J GENET+, V48, P1020, DOI 10.1134/S1022795412060038; Burkovskii O.A., 2004, RASTITELNYY ZHUVOTNY, P238; Golovljova I, 2008, INT J MED MICROBIOL, V298, P108, DOI 10.1016/j.ijmm.2007.12.004; Gromov I.M., 1995, MLEKOPITAYUSHCHIE FA; Hayasaka D, 2001, J GEN VIROL, V82, P1319; HAYATA I, 1973, CHROMOSOMA, V42, P403, DOI 10.1007/BF00399408; Karamysheva TV, 2002, CYTOGENET GENOME RES, V96, P154, DOI 10.1159/000063027; Kartavtseva I.V., 2002, KARIOSISTEMATIKA LES; Kartavtseva Irina V., 2000, Chromosome Science, V4, P21; Kawamura Y., 1989, MEMOIRS FACULTY SCI, V54; Kirillova I.V, 2003, KRAEVEDCHESKII B PRO, P128; KOH H S, 1986, Korean Journal of Systematic Zoology, V2, P1; Leonova G.N, 2010, TIKHOOKEANSK MED ZH, P19; Mikishin Yu.A, 2010, AKTUALNYE PROBLEMY G, P432; Roslik G.V., 1998, MODERN ACHIEVEMENTS, P15; Roslik G.V., 2012, Tsitologiya, V54, P66; Roslik G.V., 2010, CELL TISSUE BIOL, V4, P77; Rubtzov NB, 2009, RUSS J GENET+, V45, P389, DOI 10.1134/S1022795409040024; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; Vasilevskii A.A., 2008, KAMENNYI VEK OSTROVA; Wang Jinxing, 2000, Acta Theriologica Sinica, V20, P289; Yastrebov V.K, 2007, B SIB OTD ROSS AKAD, P89; ZIMA J, 1995, ACTA THERIOL, V3, P75; Zlobin V.I., 2001, TIKHOOKEAN MED ZH, P75; Zlobin V.I, 2010, TERRA MEDIKA NOVA, P13	35	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1022-7954	1608-3369		RUSS J GENET+	Russ. J. Genet.	MAR	2015	51	3					278	288		10.1134/S1022795415030114		11	Genetics & Heredity	Genetics & Heredity	CE0WI	WOS:000351529900008		
J	DongSeon, H; JongHae, K; Hisanori, O				DongSeon, Hwang; JongHae, Keum; Hisanori, Ohashi			Gorenstein Q-homology projective planes	SCIENCE CHINA-MATHEMATICS			English	Article						Q-homology projective plane; Enriques surface; rational double point	DEL-PEZZO SURFACES; SINGULARITIES; QUOTIENTS; NUMBER	We present the complete list of all singularity types on Gorenstein Q-homology projective planes, i.e., normal projective surfaces of second Betti number one with at worst rational double points. The list consists of 58 possible singularity types, each except two types supported by an example.	[DongSeon, Hwang] Ajou Univ, Dept Math, Suwon 443749, South Korea; [JongHae, Keum] Korea Inst Adv Study, Sch Math, Seoul 4130722, South Korea; [Hisanori, Ohashi] Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 42788510, Japan	JongHae, K (reprint author), Korea Inst Adv Study, Sch Math, Seoul 4130722, South Korea.	dshwang@ajou.ac.kr; jhkeum@kias.re.kr; ohashi.hisanori@gmail.com			National Research Foundation of Korea - Ministry of Education [2011-0022904]; National Research Foundation of Korea - Ministry of Education, Science and Technology [2007-C00002]	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (Grant No. 2011-0022904) and the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (Grant No. 2007-C00002). The authors thank the referees for careful reading and crucial suggestions. DongSeon Hwang would like to thank Kenji Hashimoto for useful discussion.	MIYAOKA Y, 1984, MATH ANN, V268, P159, DOI 10.1007/BF01456083; ARTIN M, 1962, AM J MATH, V84, P485, DOI 10.2307/2372985; Keum J, 2008, GEOM TOPOL, V12, P2497, DOI 10.2140/gt.2008.12.2497; Barth W., 2004, COMPACT COMPLEX SURF; Belousov GN, 2008, MATH NOTES+, V83, P152, DOI 10.1134/S0001434608010185; Frapporti D, 2013, COLLECT MATH, V64, P293, DOI 10.1007/s13348-013-0084-5; FURUSHIMA M, 1986, NAGOYA MATH J, V104, P1; Hwang D, 2010, J ALGEBRAIC GEOM, V20, P495; Hwang D, T AM MATH S IN PRESS; Keum J, 2010, ACTA MATH VIETNAMICA, V35, P79; Kondo S, 1986, JAPAN J MATH, V12, P192; MIYANISHI M, 1988, J ALGEBRA, V118, P63, DOI 10.1016/0021-8693(88)90048-8; Mukai S, 2013, FIELDS I COMMUN, V67, P429; MUKAI S, 1984, INVENT MATH, V77, P383, DOI 10.1007/BF01388829; Ohashi H, 2007, PUBL RES I MATH SCI, V43, P181, DOI 10.2977/prims/1199403814; Serre J.-P., 1973, COURSE ARITHMETIC; Ye Q., 2002, JAPAN J MATH, V28, P87	17	1	1	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7283	1869-1862		SCI CHINA MATH	Sci. China-Math.	MAR	2015	58	3			SI		501	512		10.1007/s11425-015-4978-4		12	Mathematics, Applied; Mathematics	Mathematics	CD5ZI	WOS:000351167200005		
J	Daisuke, M				Daisuke, Matsushita			On base manifolds of Lagrangian fibrations	SCIENCE CHINA-MATHEMATICS			English	Article						Lagrangian fibration; singularity; base manifolds; symplectic varieties	HIGHER DIRECT IMAGES; SYMPLECTIC SINGULARITIES; DUALIZING SHEAVES; VARIETIES	We consider base spaces of Lagrangian fibrations from singular symplectic varieties. After defining cohomologically irreducible symplectic varieties, we construct an example of Lagrangian fibration whose base space is isomorphic to a quotient of the projective space. We also prove that the base space of Lagrangian fibration from a cohomologically symplectic variety is isomorphic to the projective space provided that the base space is smooth.	Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan	Daisuke, M (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	matusita@math.sci.hokudai.ac.jp			Japan Society for Promotion of Sciences [18684001]	This work was supported by Japan Society for Promotion of Sciences (Grant No. 18684001). The author express his gratitude to Professors Jun-Muk Hwang and Keiji Oguiso for their comments. The author also express his gratitude to anonymous referees for reading carefully the draft of this paper and pointing out many mistakes.	Beauville A, 2000, INVENT MATH, V139, P541, DOI 10.1007/s002229900043; Hwang JM, 2008, INVENT MATH, V174, P625, DOI 10.1007/s00222-008-0143-9; Matsushita D, 2001, TOPOLOGY, V40, P431, DOI 10.1016/S0040-9383(99)00048-8; Matsushita D, 1999, TOPOLOGY, V38, P79, DOI 10.1016/S0040-9383(98)00003-2; Greb D, 2011, PUBL MATH-PARIS, P87, DOI 10.1007/s10240-011-0036-0; SCHMID W, 1973, INVENT MATH, V22, P211, DOI 10.1007/BF01389674; Kaledin D, 2006, J REINE ANGEW MATH, V600, P135, DOI 10.1515/CRELLE.2006.089; Bayer A., 2013, ARXIV13016968; Greb D, 2011, ARXIV11105250; Griffits F, 1971, USP MAT NAUK, V26, P117; Hwang JM, 2007, ANN I FOURIER, V57, P815; Kaledin D, 2006, INVENT MATH, V164, P591, DOI 10.1007/s00222-005-0484-6; Kebekus S., 2006, GLOBAL ASPECTS COMPL, P359, DOI 10.1007/3-540-35480-8_10; KOLLAR J, 1986, ANN MATH, V124, P171, DOI 10.2307/1971390; Kollar J., 1996, RATIONAL CURVES ALGE; Markman E., 2013, ARXIV13016584; Matsushita D., 2013, ARXIV13100896; Matsushita D, 2005, AM J MATH, V127, P243, DOI 10.1353/ajm.2005.0009; Namikawa Y., 2001, ARXIV0101028; Namikawa Y, 2001, J REINE ANGEW MATH, V539, P123; Takayama S, 2000, J ALGEBRAIC GEOM, V9, P403; Yoshioka K., 2012, ARXIV12064838	22	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7283	1869-1862		SCI CHINA MATH	Sci. China-Math.	MAR	2015	58	3			SI		531	542		10.1007/s11425-014-4927-7		12	Mathematics, Applied; Mathematics	Mathematics	CD5ZI	WOS:000351167200009		
J	Batten, JA; Morgan, P; Szilagyi, PG				Batten, Jonathan A.; Morgan, Peter; Szilagyi, Peter G.			TIME VARYING ASIAN STOCK MARKET INTEGRATION	SINGAPORE ECONOMIC REVIEW			English	Article						Asia-Pacific; financial market integration; international asset pricing; systematic risk; market risk	GLOBAL FINANCIAL CRISIS; EQUITY MARKETS; EMERGING MARKETS; CURRENCY RISK; EAST-ASIA; DIVERSIFICATION; COINTEGRATION; LINKAGES; RETURNS; PRICES	We employ an asset pricing framework with varying estimation lengths to show that there has been an increasing degree of integration between Asian and international stock markets, but very little with Japan. This finding is consistent with prior studies and highlights the impact of recent regulatory and economic reform undertaken throughout the region. Our results show that instability in the asset variance structure underpins the observed varying degrees of financial market integration. In particular, modeling integration using shorter estimation periods helps explain the time varying nature of financial market integration and the benefits that may accrue to international and domestic investors.	[Batten, Jonathan A.] Monash Univ, Dept Finance, Clayton, Vic 3800, Australia; [Morgan, Peter] Asia Dev Bank Inst, Chiyoda Ku, Tokyo 1006008, Japan; [Szilagyi, Peter G.] Cent European Univ, H-1051 Budapest, Hungary; [Szilagyi, Peter G.] Univ Cambridge, Judge Business Sch, Cambridge CB2 1AG, England	Batten, JA (reprint author), Monash Univ, Dept Finance, Bldg H,Level 3,Caulfield Campus, Clayton, Vic 3800, Australia.	jabatten@ust.hk; pmorgan@adbi.org; p.szilagyi@jbs.cam.ac.uk					Carrieri F, 2007, J FINANC QUANT ANAL, V42, P915; Johansson AC, 2011, WORLD ECON, V34, P1088, DOI 10.1111/j.1467-9701.2011.01366.x; Kim SJ, 2005, J BANK FINANC, V29, P2475, DOI 10.1016/j.jbankfin.2004.09.002; BEKAERT G, 1995, J FINANC, V50, P403, DOI 10.2307/2329414; Gourinchas PO, 2006, REV ECON STUD, V73, P715, DOI 10.1111/j.1467-937X.2006.00393.x; Mendoza EG, 2009, J POLIT ECON, V117, P371; Gerlach R, 2006, J INT MONEY FINANC, V25, P974, DOI 10.1016/j.jimonfin.2006.07.002; Yu IW, 2010, J BANK FINANC, V34, P2874, DOI 10.1016/j.jbankfin.2010.02.010; Christoffersen P, 2012, REV FINANC STUD, V25, P3711, DOI 10.1093/rfs/hhs104; Arouri ME, 2012, J BANK FINANC, V36, P2473, DOI 10.1016/j.jbankfin.2012.05.004; MERTON RC, 1973, ECONOMETRICA, V41, P867, DOI 10.2307/1913811; Erdem O, 2014, EMERG MARK REV, V20, P42, DOI 10.1016/j.ememar.2014.05.004; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; Bekaert G, 2000, J FINANC, V55, P565, DOI 10.1111/0022-1082.00220; Berger D, 2011, J FINANC ECON, V101, P227, DOI 10.1016/j.jfineco.2011.02.009; Huyghebaert N, 2010, CHINA ECON REV, V21, P98, DOI 10.1016/j.chieco.2009.11.001; Bekaert G, 2007, J FINANC, V62, P1081, DOI 10.1111/j.1540-6261.2007.01231.x; Cakici N, 2013, EMERG MARK REV, V16, P46, DOI 10.1016/j.ememar.2013.03.001; Guyot A, 2014, EMERG MARK REV, V18, P101, DOI 10.1016/j.ememar.2014.01.003; Hartmann P, 2004, REV ECON STAT, V86, P313, DOI 10.1162/003465304323023831; JOHANSEN S, 1991, ECONOMETRICA, V59, P1551, DOI 10.2307/2938278; Park CY, 2011, ASIAN ECON POLICY R, V6, P176, DOI 10.1111/j.1748-3131.2011.01193.x; Dewandaru G, 2014, EMERG MARK REV, V19, P106, DOI 10.1016/j.ememar.2014.04.006; Arouri ME, 2012, ECON MODEL, V29, P382, DOI 10.1016/j.econmod.2011.11.009; Auboin M, 2012, ERSD201210 WORLD TRA, V154; Bekaert G, 1997, J FINANC ECON, V43, P29, DOI 10.1016/S0304-405X(96)00889-6; (BIS) Bank for International Settlements, 2013, TRIENN FOR EXCH SURV; Boubakri S, 2011, EMERG MARK REV, V12, P460, DOI 10.1016/j.ememar.2011.08.001; Cakici N, 2012, 2070832 FORDH U SCH; Capannell Giovanni, 2011, International Economic Journal, V25, P593; Caporale GM, 2014, INT REV FINANC ANAL, V33, P87, DOI 10.1016/j.irfa.2013.12.005; Cavoli T, 2012, J ASIA PAC ECON, V17, P514, DOI 10.1080/13547860.2012.694711; Chi J, 2006, PAC ECON REV, V11, P513, DOI 10.1111/j.1468-0106.2006.00332.x; Click R. W., 2005, Journal of Asian Economics, V16, DOI 10.1016/j.asieco.2004.11.018; De Santis G., 2003, J ECON BUS, V55, P427, DOI 10.1016/S0148-6195(03)00049-3; Dimpfl T, 2014, INT REV FINANC ANAL, V33, P10, DOI 10.1016/j.irfa.2013.07.005; Donadelli M, 2014, J INT FINANC MARK I, V32, P184, DOI 10.1016/j.intfin.2014.06.003; Garcia-Herrero A, 2009, ASIAN ECON PAP, V8, P228, DOI 10.1162/asep.2009.8.3.228; Gerard B., 2003, J ECON BUS, V55, P585, DOI 10.1016/S0148-6195(03)00055-9; Guesmi K, 2014, J INT FINANC MARK I, V28, P204, DOI 10.1016/j.intfin.2013.10.005; Guidi F, 2014, J INT FINANC MARK I, V30, P119, DOI 10.1016/j.intfin.2014.01.007; Hacibedel B, 2014, EMERG MARK REV, V21, P1, DOI 10.1016/j.ememar.2014.07.002; He HB, 2014, J INT FINANC MARK I, V33, P434, DOI 10.1016/j.intfin.2014.09.005; Hong TL, 2011, ASIAN ECON PAP, V10, P79; IMF, 2012, WOR ECON FINANC, P1; Inci AC, 2011, EURASIAN EC REV, V1, P95; Jacobs K, 2013, J BANK FINANC, V37, P378, DOI 10.1016/j.jbankfin.2012.09.005; Jeon J., 2006, ASIAN ECON PAP, V5, P73, DOI DOI 10.1162/ASEP.2006.5.1.73; Kenourgios D, 2014, INT REV FINANC ANAL, V34, P21, DOI 10.1016/j.irfa.2014.05.001; Krapl AA, 2015, INT REV FINANC ANAL, V37, P1, DOI 10.1016/j.irfa.2014.11.005; Lee HH, 2013, WORLD ECON, V36, P396, DOI 10.1111/twec.12030; Levine R., 2001, REV INT ECON, V9, P688, DOI DOI 10.1111/1467-9396.00307; Li H, 2013, J INT FINANC MARK I, V25, P88, DOI 10.1016/j.intfin.2013.01.007; Liu L, 2014, INT REV FINANC ANAL, V33, P39, DOI 10.1016/j.irfa.2013.07.009; Martin P, 2000, EUR ECON REV, V44, P1327, DOI 10.1016/S0014-2921(00)00036-2; Mink M, 2015, EMERG MARK REV, V22, P18, DOI 10.1016/j.ememar.2014.11.003; Mishra AV, 2013, J INT MONEY FINANC, V32, P169, DOI 10.1016/j.jimonfin.2012.04.004; Murray P, 2012, J ASIA PAC ECON, V17, P426, DOI 10.1080/13547860.2012.694698; Phylaktis K, 2002, J INT MONEY FINANC, V21, P879, DOI 10.1016/S0261-5606(02)00027-X; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Shiraishi T, 2000, THINKING JAPAN ASIA, V41-12, P103; SOLNIK BH, 1977, J FINANC, V32, P503, DOI 10.2307/2326783; STULZ RM, 1981, J FINANC ECON, V9, P383, DOI 10.1016/0304-405X(81)90005-2; Sugimoto K, 2014, EMERG MARK REV, V21, P201, DOI 10.1016/j.ememar.2014.09.004; Thuraisamy K, 2013, J INT FINANC MARK I, V23, P222, DOI 10.1016/j.intfin.2012.08.002; Vassalou M, 2000, J INT MONEY FINANC, V19, P433, DOI 10.1016/S0261-5606(00)00008-5; Vo XV, 2009, RES INT BUS FINANCE, V23, P90, DOI 10.1016/j.ribaf.2008.07.001; Zinna G, 2014, EMERG MARK REV, V20, P1, DOI 10.1016/j.ememar.2014.05.002	68	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0217-5908	1793-6837		SINGAP ECON REV	Singap. Econ. Rev.	MAR	2015	60	1			SI				1550006	10.1142/S021759081550006X		24	Economics	Business & Economics	CD8NI	WOS:000351351600007		
J	Wang, S; Tsuchiya, N; New, J; Hurlemann, R; Adolphs, R				Wang, Shuo; Tsuchiya, Naotsugu; New, Joshua; Hurlemann, Rene; Adolphs, Ralph			Preferential attention to animals and people is independent of the amygdala	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						change detection; amygdala; attention; eye-tracking	FACIAL EXPRESSIONS; EMOTIONAL FACES; VISUAL AWARENESS; SOCIAL COGNITION; FEARFUL FACES; BRAIN; RESPONSES; AUTISM; DAMAGE; RECOGNITION	The amygdala is thought to play a critical role in detecting salient stimuli. Several studies have taken ecological approaches to investigating such saliency, and argue for domain-specific effects for processing certain natural stimulus categories, in particular faces and animals. Linking this to the amygdala, neurons in the human amygdala have been found to respond strongly to faces and also to animals. However, the amygdala's necessary role for such category-specific effects at the behavioral level remains untested. Here we tested four rare patients with bilateral amygdala lesions on an established change-detection protocol. Consistent with prior published studies, healthy controls showed reliably faster and more accurate detection of people and animals, as compared with artifacts and plants. So did all four amygdala patients: there were no differences in phenomenal change blindness, in behavioral reaction time to detect changes or in eye-tracking measures. The findings provide decisive evidence against a critical participation of the amygdala in rapid initial processing of attention to animate stimuli, suggesting that the necessary neural substrates for this phenomenon arise either in other subcortical structures (such as the pulvinar) or within the cortex itself.	[Wang, Shuo; Adolphs, Ralph] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA; [Tsuchiya, Naotsugu] Japan Sci & Technol Agcy, Decoding & Controlling Brain Informat, Chiyoda Ku, Tokyo 1020076, Japan; [Tsuchiya, Naotsugu] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Tsuchiya, Naotsugu; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [New, Joshua] Columbia Univ Barnard Coll, Dept Psychol, New York, NY 10027 USA; [Hurlemann, Rene] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany	Wang, S (reprint author), Computat & Neural Syst, MC 114-96,1200 E Calif Blvd, Pasadena, CA 91125 USA.	wangshuo45@gmail.com	Hurlemann, Rene/G-4164-2012	Hurlemann, Rene/0000-0003-2628-565X	NSF; Pfeiffer Family Foundation; Simons Foundation; NIMH Conte Center	This research was supported by grants from NSF, the Pfeiffer Family Foundation, the Simons Foundation, and an NIMH Conte Center. We thank Claudia Wilimzig for providing some of the stimuli, Ty Basinger for creating some of the stimuli, Peter Foley for help with the statistical analysis and Mike Tyszka for providing the anatomical scans of the lesion patients. The authors declare no competing financial interests. S.W., N.T., J.N. and R.A. designed experiments. R.H. contributed two patients with amygdala lesions. S.W. and N.T. performed experiments and analyzed data. S.W. and R.A. wrote the article. All authors discussed the results and made comments on the article.	AMARAL D G, 1992, P1; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Anderson AK, 2003, J NEUROSCI, V23, P5627; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Whalen PJ, 1998, J NEUROSCI, V18, P411; Kanan C, 2009, VIS COGN, V17, P979, DOI 10.1080/13506280902771138; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Sasson N, 2007, NEUROPSYCHOLOGIA, V45, P2580, DOI 10.1016/j.neuropsychologia.2007.03.009; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; Rutishauser U, 2011, CURR BIOL, V21, P1654, DOI 10.1016/j.cub.2011.08.035; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; MacNeilage PF, 2009, SCI AM, V301, P60; Mormann F, 2011, NAT NEUROSCI, V14, P1247, DOI 10.1038/nn.2899; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Horley K, 2004, PSYCHIAT RES, V127, P43, DOI 10.1016/j.psychres.2004.02.016; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; New JJ, 2010, NEUROPSYCHOLOGIA, V48, P51, DOI 10.1016/j.neuropsychologia.2009.08.008; Hollingworth A, 2000, VIS COGN, V7, P213; Argyle M., 1973, SEMIOTICA, V7, P19, DOI DOI 10.1515/SEMI.1973.7.1.19; BAGSHAW MH, 1972, NEUROPSYCHOLOGIA, V10, P153, DOI 10.1016/0028-3932(72)90054-1; Baron-Cohen S., 2004, DEV NEUROREHABIL, V7, P73, DOI DOI 10.1080/13638490310001654790; Buchanan T., 2009, HUMAN AMYGDALA, P289; Cauchoix M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00039; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Efron B., 1994, CHAPMAN HACC CRC MON; Grimes J., 1996, PERCEPTION VANCOUVER, V5, P89; HOFER P-A, 1973, Acta Dermato-Venereologica Supplementum, V53, P1; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Kling A.S., 1992, YALE J BIOL MED, V65, P540; LeDoux J., 1996, EMOTIONAL BRAIN MYST; Olsson P., 2007, THESIS KTH ROYAL I T; Terburg D, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.46; Todd RM, 2012, J NEUROSCI, V32, P11201, DOI 10.1523/JNEUROSCI.0155-12.2012; Vrticka P, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00358; Yang E., 2012, J VIS, V12, P679, DOI DOI 10.1167/12.9.679; Yang JJ, 2012, NEUROPSYCHOLOGIA, V50, P2566, DOI 10.1016/j.neuropsychologia.2012.07.001	71	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	MAR	2015	10	3					371	380		10.1093/scan/nsu065		10	Neurosciences; Psychology; Psychology, Experimental	Neurosciences & Neurology; Psychology	CE0VI	WOS:000351526400009		
J	Ikeda, H; Callaham, MA; O'Brien, JJ; Hornsby, BS; Wenk, ES				Ikeda, Hiroshi; Callaham, Mac A., Jr.; O'Brien, Joseph J.; Hornsby, Benjamin S.; Wenk, Evelyn S.			Can the invasive earthworm, Amynthas agrestis, be controlled with prescribed fire?	SOIL BIOLOGY & BIOCHEMISTRY			English	Article						Carbon content; Forest management; Nitrogen content; delta C-13; delta N-15	TALLGRASS PRAIRIE SOILS; NORTH-AMERICAN FORESTS; SUGARCANE ECOSYSTEM; NATIVE EARTHWORMS; FEEDING ECOLOGY; ORGANIC-MATTER; OLIGOCHAETA; MEGASCOLECIDAE; DIPLOCARDIA; DELTA-N-15	Biological invasions are one of the most significant global-scale problems caused by human activities. Earthworms function as ecosystem engineers in soil ecosystems because their feeding and burrowing activities fundamentally change the physical and biological characteristics of the soils they inhabit. As a result of this "engineering," earthworm invasions can have significant effects on soil physical, chemical and biological properties. The species Amynthas agrestis (family Megascolecidae) was introduced to the United States from Asia, and has expanded its distribution range to include relatively undisturbed forests. Here, to clarify life history traits, we reared individuals under seven different conditions of food provision using litter, fragmented litter and soil, and also analyzed the stable isotope ratios of field-collected specimens to investigate their food resources in the field. Second, we examined whether prescribed fire can be used to manage invasive earthworms. We constructed eight experimental plots, each with 100 individuals of A. agrestis each, and burned half of the plots. The feeding experiment showed that the earthworms in units containing soil and some form of organic matter (litter and/or fragmented litter) produced many cocoons, indicating that litter and fragmented litter are important food resources for them. Stable isotope analyses also supported this result. During the experimental fires, average soil temperature at 5 cm depth increased by only 7.7 degrees C (average maximum of 32.2 degrees C). Litter mass was significantly reduced by the fires. Although numbers of A. agrestis and cocoons recovered from burned and unburned plots were not different, the viability of cocoons was significantly lower in burned plots. Fire may also reduce the survival rate of juveniles in the next year by depriving them of their preferred food resource. Most native earthworms in the United States live in the soil, while many invasive ones live in the litter layer and soil surface. Therefore, prescribed fire could be a viable tool for control of invasive earthworms without negatively impacting native earthworm populations. (c) 2014 Elsevier Ltd. All rights reserved.	[Ikeda, Hiroshi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Callaham, Mac A., Jr.; O'Brien, Joseph J.; Hornsby, Benjamin S.; Wenk, Evelyn S.] US Forest Serv, Ctr Forest Disturbance Sci, So Res Stn, USDA, Athens, GA USA	Ikeda, H (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	hikeda@cc.hirosaki-u.ac.jp	Ikeda, Hiroshi/B-3940-2011		JSPS [22-6882]	We thank M. Brod for facilitating our work at Chattahoochee National Forest, C.M. Stegall for helping to construct experimental beds, B. Sheko for measuring C and N contents, D. Straube for providing important information, and K. Fukumori for advice on some analyses. We also thank L.G. Callaham and M.M. Callaham for assisting with introduction of earthworms into experimental beds. This work was partially supported by Grant-in-Aid for JSPS Fellows (22-6882). Materials from the GSMNP were collected under permit number GRSM-2011-SCI-0029.	ANDERSON JM, 1995, LINKING SPECIES & ECOSYSTEMS, P94; SPAIN AV, 1990, SOIL BIOL BIOCHEM, V22, P703, DOI 10.1016/0038-0717(90)90018-U; SOTA T, 1985, ECOL ENTOMOL, V10, P315, DOI 10.1111/j.1365-2311.1985.tb00728.x; Hale CM, 2006, ECOLOGY, V87, P1637, DOI 10.1890/0012-9658(2006)87[1637:CIHFUP]2.0.CO;2; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Ryan KC, 2013, FRONT ECOL ENVIRON, V11, pE15, DOI 10.1890/120329; Uchida T, 2004, APPL SOIL ECOL, V27, P153, DOI 10.1016/j.apsoil.2004.04.003; Hendrix PF, 2006, BIOL INVASIONS, V8, P1287, DOI 10.1007/s10530-006-9022-8; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Neilson R, 2000, SOIL BIOL BIOCHEM, V32, P1053, DOI 10.1016/S0038-0717(00)00013-4; Hendrix PF, 2002, BIOSCIENCE, V52, P801, DOI 10.1641/0006-3568(2002)052[0801:EEIINA]2.0.CO;2; DiTomaso JM, 2006, WEED TECHNOL, V20, P535, DOI 10.1614/WT-05-086R1.1; Hendrix PF, 2008, ANNU REV ECOL EVOL S, V39, P593, DOI 10.1146/annurev.ecolsys.39.110707.173426; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Zhang WX, 2010, ECOLOGY, V91, P2070, DOI 10.1890/09-0979.1; Callaham MA, 2003, SOIL BIOL BIOCHEM, V35, P1079, DOI 10.1016/S0038-0717(03)00153-6; MARTIN A, 1992, OECOLOGIA, V91, P23; Callaham MA, 2003, PEDOBIOLOGIA, V47, P466, DOI 10.1016/S0031-4056(04)70223-1; Callaham MA, 2001, BIOL FERT SOILS, V34, P49, DOI 10.1007/s003740100370; Callaham Jr M.A., 2012, CUMULATIVE WATERSHED, P202; Ehrenfeld JG, 2001, ECOL APPL, V11, P1259, DOI 10.1890/1051-0761(2001)011[1259:ISATSE]2.0.CO;2; GATES G. E., 1958, AMER MUS NOVITATES, V1888, P1; GATES G E, 1982, Megadrilogica, V4, P12; Goto S., 1899, ANNOTATIONES ZOOLOGI, V3, P13; Hendrix PF, 1999, PEDOBIOLOGIA, V43, P818; IMAIZUMI Y, 1979, ANNOT ZOOL JAPON, V52, P212; Ishizuka K, 2001, B SEIKEI U, V33, P1; JAMES SW, 1989, AM MIDL NAT, V121, P78, DOI 10.2307/2425658; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jordan D, 2000, BIOL FERT SOILS, V31, P323, DOI 10.1007/s003740050663; McLean MA, 2000, SOIL BIOL BIOCHEM, V32, P351, DOI 10.1016/S0038-0717(99)00161-3; R Development Core Team, 2013, R LANG ENV STAT COMP; Reynolds John Warren, 2008, Megadrilogica, V12, P157; REYNOLDS J W, 1978, Megadrilogica, V3, P117; Richardson DR, 2009, SOUTHEAST NAT, V8, P325, DOI 10.1656/058.008.0211; Schwert D.P., 1990, P341; Snyder BA, 2011, BIOL INVASIONS, V13, P349, DOI 10.1007/s10530-010-9826-4; SOTA T, 1985, Kontyu, V53, P370; Spain A, 1997, BIOL FERT SOILS, V24, P118, DOI 10.1007/s003740050218; Uchida Tomoko, 2004, Japanese Journal of Ecology (Otsu), V54, P235; Uchida T., 2004, Edaphologia, V74, P35; Yui M, 1988, ECOLOGY WOODLAND BIR	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-0717			SOIL BIOL BIOCHEM	Soil Biol. Biochem.	MAR	2015	82						21	27		10.1016/j.soilbio.2014.12.011		7	Soil Science	Agriculture	CD8BW	WOS:000351321200003		
J	Wang, QN; Ye, XJ; Li, JM; Xiao, YZ; He, Y				Wang Qiao-nan; Ye Xu-jun; Li Jin-meng; Xiao Yu-zhao; He Yong			Estimation and Visualization of Nitrogen Content in Citrus Canopy Based on Two Band Vegetation Index (TBVI)	SPECTROSCOPY AND SPECTRAL ANALYSIS			Chinese	Article						Hyperspectral imagery; Nutrient visualization; Two band vegetation index (TBVI); Satsuma mandarin	NARROW-BAND; AIRBORNE; LEAVES; YIELD	Nitrogen is a necessary and important element for the growth and development of fruit orchards. Timely, accurate and nondestructive monitoring of nitrogen status in fruit orchards would help maintain the fruit quality and efficient production of the orchard, and mitigate the pollution of water resources caused by excessive nitrogen fertilization. This study investigated the capability of hyperspectral imagery for estimating and visualizing the nitrogen content in citrus canopy. Hyperspectral images were obtained for leaf samples in laboratory as well as for the whole canopy in the field with ImSpector V10E (Spectral Imaging Ltd., Oulu, Finland). The spectral datas for each leaf sample were represented by the average spectral data extracted from the selected region of interest (ROI) in the hyperspectral images with the aid of ENVI software. The nitrogen content in each leaf sample was measured by the Dumas combustion method with the rapid N cube (Elementar Analytical, Germany). Simple correlation analysis and the two band vegetation index (TBVI) were then used to develop the spectra data-based nitrogen content prediction models. Results obtained through the formula calculation indicated that the model with the two band vegetation index (TBVI) based on the wavelengths 811 and 856 nm achieved the optimal estimation of nitrogen content in citrus leaves (R-2 = 0. 607 1). Furthermore, the canopy image for the identified TBVI was calculated, and the nitrogen content of the canopy was visualized by incorporating the model into the TBVI image. The tender leaves, middle-aged leaves and elder leaves showed distinct nitrogen status from high to low-levels in the canopy image. The results suggested the potential of hyperspectral imagery for the nondestructive detection and diagnosis of nitrogen status in citrus canopy in real time. Different from previous studies focused on nitrogen content prediction at leaf level, this study succeeded in predicting and visualizing the nutrient content of fruit trees at canopy level. This would provide valuable information for the implementation of individual tree-based fertilization schemes in precision orchard management practices.	[Wang Qiao-nan; Ye Xu-jun; Li Jin-meng; Xiao Yu-zhao; He Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ye Xu-jun] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Ye, XJ (reprint author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	21213055@zju.edu.cn; yezising@zju.edu.cn					Thenkabail PS, 2002, PHOTOGRAMM ENG REM S, V68, P607; Furtula V, 2012, WATER RES, V46, P1079, DOI 10.1016/j.watres.2011.12.002; Goel PK, 2003, T ASAE, V46, P1235; Tang Jing, 2005, World Forestry Research, V18, P45; Li JM, 2014, SPECTROSC SPECT ANAL, V34, P212, DOI 10.3964/j.issn.1000-0593(2014)01-0212-05; Min M, 2008, COMPUT ELECTRON AGR, V63, P215, DOI 10.1016/j.compag.2008.03.004; Qiu ZhengJun, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P150; Ranjan R, 2012, INT J REMOTE SENS, V33, P6342, DOI 10.1080/01431161.2012.687473; Yang C, 2004, T ASAE, V47, P915; Ye X, 2008, BIOSYST ENG, V99, P179, DOI 10.1016/j.biosystemseng.2007.09.016	10	0	0	OFFICE SPECTROSCOPY & SPECTRAL ANALYSIS	BEIJING	NO 76 COLLAGE SOUTH RD BEIJING, BEIJING 100081, PEOPLES R CHINA	1000-0593			SPECTROSC SPECT ANAL	Spectrosc. Spectr. Anal.	MAR	2015	35	3					715	718		10.3964/j.issn.1000-0593(2015)03-0715-04		4	Spectroscopy	Spectroscopy	CD4AS	WOS:000351025600029		
J	Zhang, BY; Luo, Q; Chen, Z; Sun, JH; Xu, BY; Ju, Y; Song, GB				Zhang, Bingyu; Luo, Qing; Chen, Zhe; Sun, Jinghui; Xu, Baiyao; Ju, Yang; Song, Guanbin			Cyclic mechanical stretching promotes migration but inhibits invasion of rat bone marrow stromal cells	STEM CELL RESEARCH			English	Article							MESENCHYMAL STEM-CELLS; FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; OSTEOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; DOWN-REGULATION; CANCER CELLS; ACTIVATION; STRAIN	Bone marrow stromal cells (BMSCs, also broadly known as bone marrow-derived mesenchymal stem cells) are multipotent stem cells that have a self-renewal capacity and multilineage differentiation potential. Mechanical stretching plays a vital role in regulating the proliferation and differentiation of BMSCs. However, little is known about the effects of cyclic stretching on BMSC migration and invasion. In this study, using a custom-made cell-stretching device, we studied the effects of cyclic mechanical stretching on rat BMSC migration and invasion using a Transwell Boyden Chamber. The protein secretion of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) was detected by gelatin zymography, and the activation of focal adhesion kinase (FAK) and extracellular signal regulated kinase1/2 (ERK1/2) was measured by western blot. We found that cyclic mechanical stretching with 10% amplitude at 1 Hz frequency for 8 h promotes BMSC migration, but reduces BMSC invasion. FAK and ERK1/2 signals were activated in BMSCs after exposure to cyclic stretching. In the presence of the FAK phosphorylation blocker PF573228 or the ERK1/2 phosphorylation blocker PD98059, the cyclic-stretch-promoted migration of BMSCs was completely suppressed. On the other hand, cyclic mechanical stretching reduced the secretion of MMP-2 and MMP-9 in BMSCs, and PF573228 suppressed the cyclic-stretch-reduced secretion of MMP-2 and MMP-9. The decrease of BMSC invasion induced by mechanical stretching is partially restored by PF573228 but remained unaffected by PD98059. Taken together, these data show that cyclic mechanical stretching promotes BMSC migration via the FAK-ERK1/2 signalling pathway, but reduces BMSC invasion by decreasing secretion of MMP-2 and MMP-9 via FAK, independent of the ERK1/2 signal. (C) 2015 The Authors. Published by Elsevier B. V.	[Zhang, Bingyu; Luo, Qing; Chen, Zhe; Sun, Jinghui; Song, Guanbin] Chongqing Univ, Coll Engn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China; [Xu, Baiyao; Ju, Yang] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan	Song, GB (reprint author), Chongqing Univ, Coll Engn, Chongqing 400044, Peoples R China.	song@cqu.edu.cn			National Natural Science Foundation of China [11032012, 11102240, 11272365]; 111 Project [06023]; Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University); Ministry of Education of China [CQKLBST-2012-008]; Research Fund for the Doctoral Program of Higher Education of China [20130191110029]	This work was supported by grants from the National Natural Science Foundation of China (Nos. 11032012, 11102240, and 11272365), the 111 Project (No. 06023), the Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), the Ministry of Education of China (No. CQKLBST-2012-008), and the Research Fund for the Doctoral Program of Higher Education of China (No. 20130191110029).	Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Chen YY, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/378415; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Kang MN, 2012, CONNECT TISSUE RES, V53, P149, DOI 10.3109/03008207.2011.619284; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4; Yang N, 2014, ONCOL REP, V31, P2651, DOI 10.3892/or.2014.3120; Reis ST, 2011, INT J BIOL MARKER, V26, P255, DOI 10.5301/JBM.2011.8831; Palumbo R, 2000, CIRCULATION, V102, P225; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Ocarino NM, 2008, NITRIC OXIDE-BIOL CH, V19, P320, DOI 10.1016/j.niox.2008.08.004; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Aalinkeel R, 2011, IMMUNOL INVEST, V40, P447, DOI 10.3109/08820139.2011.557795; Tan CT, 2008, CARCINOGENESIS, V29, P1519, DOI 10.1093/carcin/bgn108; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Yamane T, 2010, CELL TISSUE RES, V340, P471, DOI 10.1007/s00441-010-0968-6; Lim ST, 2008, CELL CYCLE, V7, P2306; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Birmingham E, 2012, EUR CELLS MATER, V23, P13; Hong HS, 2012, ARCH PHARM RES, V35, P201, DOI 10.1007/s12272-012-0201-0; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Park SJ, 2012, MOL CELLS, V33, P141, DOI 10.1007/s10059-012-2192-6; Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Balakrishnan K, 2010, BLOOD, V116, P1083, DOI 10.1182/blood-2009-10-246199; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Malheiro OCD, 2009, ANAT REC, V292, P1656, DOI 10.1002/ar.20953; Ilic Dusko, 1995, Nature (London), V377, P539; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Li MX, 2008, EUR J PHARMACOL, V591, P219, DOI 10.1016/j.ejphar.2008.06.082; Li ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054592; Lin SH, 2014, MOL CELL BIOCHEM, V391, P47, DOI 10.1007/s11010-014-1986-6; Yuan L, 2012, STEM CELLS DEV, V21, P2520, DOI 10.1089/scd.2012.0010; Yuan L., 2012, J MED BIOL ENG, V33, P229; Zheng LS, 2012, J BIOMECH, V45, P2368, DOI 10.1016/j.jbiomech.2012.07.013	41	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAR	2015	14	2					155	164		10.1016/j.scr.2015.01.001		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CD4XF	WOS:000351088400003		
J	Kanaya, K; Ii, M; Okazaki, T; Nakamura, T; Horii-Komatsu, M; Alev, C; Akimaru, H; Kawamoto, A; Akashi, H; Tanaka, H; Asahi, M; Asahara, T				Kanaya, Kurando; Ii, Masaaki; Okazaki, Teiji; Nakamura, Toru; Horii-Komatsu, Miki; Alev, Cantas; Akimaru, Hiroshi; Kawamoto, Atsuhiko; Akashi, Hidetoshi; Tanaka, Hiroyuki; Asahi, Michio; Asahara, Takayuki			Sonic Hedgehog signaling regulates vascular differentiation and function in human CD34 positive cells Vasculogenic CD34(+) cells with Sonic Hedgehog	STEM CELL RESEARCH			English	Article							ENDOTHELIAL PROGENITOR CELLS; MYOCARDIAL-INFARCTION; SKELETAL-MUSCLE; VERTEBRATE LIMB; GENE-THERAPY; ANGIOGENESIS; TRANSPLANTATION; BLOOD; ARTERIOGENESIS; PROLIFERATION	Identification of pivotal factors potentially present in the in situ environment and capable of influencing the function of CD34(+) cells, which can be used for autologous cell therapy, is of paramount interest. SHh is one of the morphogens essential for embryonic vascular development as well as postnatal neovascularization, and the activation of SHh signaling with angiogenic and vascular differentiation responses in CD34(+) cells by SHh treatment differed depending on the G-CSF treatment or the background disease. SHh enhanced the migration, proliferation, adhesion, and EPC colony forming capacities of G-CSF mobilized CD34(+) cells, increasing the vasculogenic/ angiogenic potential for neovascularization. An increase in the differentiation potential of CD34(+) cells toward vascular lineages was demonstrated with SHh treatment involving TGF alpha signaling pathway. The SHh-activated G-CSF mobilized CD34(+) cells directly contributed to vascular regeneration while non-activated CD34(+) cells showed a lower regenerative capacity in a mouse ischemic hindlimb model. SHh signaling regulates human CD34(+) cell fate and function, and may potentiate the therapeutic effect of G-CSF mobilized CD34(+) cells on ischemic diseases. (C) 2015 The Authors. Published by Elsevier B.V.	[Kanaya, Kurando; Okazaki, Teiji; Akashi, Hidetoshi; Tanaka, Hiroyuki] Kurume Univ, Sch Med, Dept Surg, Fukuoka, Japan; [Nakamura, Toru] Kurume Univ, Sch Med, Dept Gastroenterol, Fukuoka, Japan; [Ii, Masaaki; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, Takatsuki, Osaka 5698686, Japan; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Hiratsuka, Kanagawa 25912, Japan; [Horii-Komatsu, Miki; Kawamoto, Atsuhiko] Inst Biomed Res & Innovat, Grp Vasc Regenerat Res, Kobe, Hyogo, Japan; [Alev, Cantas; Akimaru, Hiroshi] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan	Ii, M (reprint author), Osaka Med Coll, Fac Med, Dept Pharmacol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	masaii@art.osaka-med.ac.jp; asa777@is.icc.u-tokai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [22591555]; Riken Center for Developmental Biology Collaborative Research Fund, Kobe [08001475]	This work was supported by research funding from The Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (C) (22591555) and the Riken Center for Developmental Biology Collaborative Research Fund, Kobe (08001475).	Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Ergun S, 2011, ANTIOXID REDOX SIGN, V15, P981, DOI 10.1089/ars.2010.3507; Yamazaki M, 2008, CANCER SCI, V99, P1131, DOI 10.1111/j.1349-7006.2008.00795.x; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Link H, 1996, BLOOD, V87, P4903; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Manginas A, 2007, CATHETER CARDIO INTE, V69, P773, DOI 10.1002/ccd.21023; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; [Anonymous], 2011, FASEB J, V25, P159; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Madeddu P, 2004, FASEB J, V18, P1737, DOI 10.1096/fj.04-2192fje; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Kudo FA, 2003, INT ANGIOL, V22, P344; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; KORBLING M, 1995, BLOOD, V85, P1659; Palladino M, 2012, J VASC RES, V49, P425, DOI 10.1159/000337921; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; SUTHERLAND DR, 1993, STEM CELLS, V11, P50; Tomblyn M, 2007, BONE MARROW TRANSPL, V40, P111, DOI 10.1038/sj.bmt.1705708; Zhou Bin, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P194	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAR	2015	14	2					165	176		10.1016/j.scr.2015.01.003		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CD4XF	WOS:000351088400004		
J	Toyoda, T; Mae, SI; Tanaka, H; Kondo, Y; Funato, M; Hosokawa, Y; Sudo, T; Kawaguchi, Y; Osafune, K				Toyoda, Taro; Mae, Shin-Ichi; Tanaka, Hiromi; Kondo, Yasushi; Funato, Michinori; Hosokawa, Yoshiya; Sudo, Tomomi; Kawaguchi, Yoshiya; Osafune, Kenji			Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells	STEM CELL RESEARCH			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; EFFICIENT DIFFERENTIATION; IN-VIVO; MATURATION; GENERATION; ENDODERM; MOUSE; MICE; ORGANOGENESIS	Embryonic pancreatic bud cells, the earliest pancreas-committed cells, generated from human embryonic stem cells (hESCs) and induced pluripotent stemcells (hiPSCs) have been shown to differentiate intomature pancreatic beta-cells in vivo, indicating the feasibility of hESC/iPSC-based cell therapy for diabetes. However, the key factors required for the differentiation of these cells into pancreatic bud cells are incompletely understood. The purpose of this study was to establish culture conditions that efficiently induce PDX1(+)NKX6.1(+) pancreatic bud cells from hESCs/iPSCs. We differentiated a hESC line, KhES-3, into pancreatic lineages with a stepwise protocol recapitulating developmental process. The induction rate of PDX1(+) NKX6.1(+) cells was correlated with cell density in adherent cultures, and markedly improved with cell aggregation cultures. The positive effects of cell aggregation cultures on the differentiation of pancreatic bud cells were reproduced in multiple hESC/iPSC lines. The human PDX1(+) NKX6.1(+) cells developed into pancreatic epithelia after implantation into immunocompromised mice. Moreover, human C-peptide secretion into mouse bloodstream was stimulated by glucose challenges after in vivo maturation. Taken together, these results suggest that cultures with high cell density are crucial for the differentiation of pancreas-committed progenitor cells from hESCs/iPSCs. Our findings may be applicable for the development of hESC/iPSC-based cell therapy for diabetes. (C) 2015 The Authors. Published by Elsevier B.V.	[Toyoda, Taro; Mae, Shin-Ichi; Tanaka, Hiromi; Kondo, Yasushi; Funato, Michinori; Hosokawa, Yoshiya; Sudo, Tomomi; Kawaguchi, Yoshiya; Osafune, Kenji] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto 6068507, Japan; [Kondo, Yasushi] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, Kyoto 6068507, Japan; [Funato, Michinori] Natl Hosp Org, Nagara Med Ctr, Dept Clin Res, Gifu 5020071, Japan; [Hosokawa, Yoshiya] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Osafune, K (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	osafu@cira.kyoto-u.ac.jp			Takeda Science Foundation; Suzuken Memorial Foundation; Life Science Foundation of Japan; Japan Society for the Promotion of Science (JSPS) through its 'Funding Programme for World-Leading Innovative R&D on Science and Technology (FIRST Programme)'; Japan Science and Technology Agency (JST) through its research grant "Core Center for iPS Cell Research and Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine"	This work was supported in part by funding from the Takeda Science Foundation to T.T., the Suzuken Memorial Foundation to T.T. and the Life Science Foundation of Japan to K.O., by the Japan Society for the Promotion of Science (JSPS) through its 'Funding Programme for World-Leading Innovative R&D on Science and Technology (FIRST Programme)' to K.O. and Grant-in-Aid for Young Scientists (B) to T.T. and by the Japan Science and Technology Agency (JST) through its research grant "Core Center for iPS Cell Research and Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine" to Y.K. and K.O. T.T. wrote the first draft of the manuscript. T.T., S.M., Y.K. and K.O. contributed to manuscript edits and revisions. T.T., S.M., Y.K., M.F., Y.H., Y.K. and K.O. designed, directed, and interpreted the experiments. T.T., S.M., H.T. and T.S. performed the experiments. K.O. supervised the study. The authors thank Kanae Mitsunaga for her technical assistance in the flow cytometry analysis and Yasuhiro Nakano for providing valuable advice on this research.	Ahnfelt-Ronne J, 2012, DEVELOPMENT, V139, P33, DOI 10.1242/dev.071761; Ahnfelt-Ronne J, 2010, DIABETES, V59, P1948, DOI 10.2337/db09-1010; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Sui LN, 2013, STEM CELL REV REP, V9, P569, DOI 10.1007/s12015-013-9435-6; Villasenor A, 2012, DEV DYNAM, V241, P1008, DOI 10.1002/dvdy.23781; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Bruin JE, 2013, DIABETOLOGIA, V56, P1987, DOI 10.1007/s00125-013-2955-4; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Villasenor A, 2010, DEVELOPMENT, V137, P4295, DOI 10.1242/dev.052993; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; McCall MD, 2010, CLIN SCI, V118, P87, DOI 10.1042/CS20090072; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Crisera CA, 2000, DIABETES, V49, P936, DOI 10.2337/diabetes.49.6.936; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Fukuda A, 2006, GASTROENTEROLOGY, V130, P855, DOI 10.1053/j.gastro.2005.11.031; Hald J, 2008, J HISTOCHEM CYTOCHEM, V56, P587, DOI 10.1369/jhc.2008.950675; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Matsumoto Shinichi, 2011, Diabetes Metab J, V35, P199, DOI 10.4093/dmj.2011.35.3.199; Oster A, 1998, J HISTOCHEM CYTOCHEM, V46, P707; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; SERUP P, 1995, BIOCHEM J, V310, P997	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAR	2015	14	2					185	197		10.1016/j.scr.2015.01.007		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CD4XF	WOS:000351088400006		
J	Amemiya, N; Otake, H; Sano, T; Nakamura, T; Ogitsu, T; Koyanagi, K; Kurusu, T				Amemiya, Naoyuki; Otake, Hiroaki; Sano, Takuya; Nakamura, Taketsune; Ogitsu, Toru; Koyanagi, Kei; Kurusu, Tsutomu			Temporal behaviour of multipole components of the magnetic field in a small dipole magnet wound with coated conductors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						accelerator; coated conductor; dipole magnet; field harmonics; magnetization; multipole	NUMERICAL-ANALYSIS; AC LOSSES; SUPERCONDUCTORS	To study the influence of coated-conductor magnetization on the field quality of accelerator magnets, we made a small dipole magnet consisting of four racetrack coils wound with GdBCO coated conductors and measured its magnetic field in liquid nitrogen by using rotating pick-up coils. We focused on the dipole and sextupole components (coefficients) of the magnetic field, which vary with time owing to the decay of the magnetization of the coated conductors. About 50 min (3055 s) after the current was ramped up to 50 A, the dipole coefficient normalized by the design value of the dipole component, i.e., the value calculated with the designed coil shape and the uniform current distribution in the coated conductors, increased by 7.4 x 10(-4), and the sextupole coefficient normalized by the design value of the dipole component increased by 1.8 x 10(-4). The magnitudes of the dipole and sextupole components depended on the excitation history of the magnet. Electromagnetic field analyses were carried out to calculate the current distributions in coated conductors, considering their superconducting properties; the dipole and sextupole coefficients were then determined from the calculated current distributions. Although the analyses were based on the two-dimensional approximation of the cross-section of the magnet, the temporal behaviours as well as the hysteretic characteristics of the calculated dipole and sextupole coefficients agree qualitatively with those of the dipole and sextupole coefficients measured in the magnet.	[Amemiya, Naoyuki; Sano, Takuya; Nakamura, Taketsune] Kyoto Univ, Grad Sch Engn, Dept Elect Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Otake, Hiroaki] Toshiba Co Ltd, Power & Ind Syst Res & Dev Ctr, Fuchu, Tokyo 1838511, Japan; [Ogitsu, Toru] High Energy Accelerator Res Org, Cryogen Sci Ctr, Tsukuba, Ibaraki 3050801, Japan; [Koyanagi, Kei] Toshiba Co Ltd, Power & Ind Syst Res & Dev Ctr, Yokohama, Kanagawa 2300045, Japan; [Kurusu, Tsutomu] Toshiba Co Ltd, Nucl Energy Syst & Serv Div, Saiwai Ku, Kawasaki, Kanagawa 2128585, Japan	Amemiya, N (reprint author), Kyoto Univ, Grad Sch Engn, Dept Elect Engn, Nishikyo Ku, Kyoto 6158510, Japan.	amemiya.naoyuki.6a@kyoto-u.ac.jp	Amemiya, Naoyuki/G-2549-2012	Amemiya, Naoyuki/0000-0002-3000-864X	Japan Science and Technology Agency under the Strategic Promotion of Innovative Research and Development	This work was supported by the Japan Science and Technology Agency under the Strategic Promotion of Innovative Research and Development (S-Innovation) Program.	Ahn MC, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2237491; Amemiya N, 1997, IEEE T APPL SUPERCON, V7, P2110, DOI 10.1109/77.621008; Amemiya N, 2012, PHYSICA C, V482, P74, DOI 10.1016/j.physc.2012.05.017; Amemiya N, 1998, PHYSICA C, V310, P16, DOI 10.1016/S0921-4534(98)00427-4; Amemiya N, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/9/095001; Amemiya N, 2010, IEEE T APPL SUPERCON, V20, P364, DOI 10.1109/TASC.2010.2046629; Amemiya N, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2180295; KIM YB, 1962, PHYS REV LETT, V9, P306, DOI 10.1103/PhysRevLett.9.306; Gupta R, 2011, IEEE T APPL SUPERCON, V21, P1884, DOI 10.1109/TASC.2010.2090123; Nii M, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/9/095011; Amemiya N, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2245279; Yanagisawa Y, 2011, IEEE T APPL SUPERCON, V21, P1640, DOI 10.1109/TASC.2010.2087311; DiMarco J, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2291557; Godeke A, 2009, IEEE T APPL SUPERCON, V19, P2228, DOI 10.1109/TASC.2009.2018070; Godeke A, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/3/034022; Gu C, 2007, IEEE T APPL SUPERCON, V17, P2394, DOI 10.1109/TASC.2007.898137; Gupta R, 2011, IEEE T APPL SUPERCON, V21, P1888, DOI 10.1109/TASC.2010.2091247; Hatanaka K, 2010, NUCL INSTRUM METH A, V616, P16, DOI 10.1016/j.nima.2010.02.068; Ichiki Y, 2004, PHYSICA C, V412, P1015, DOI 10.1016/j.physc.2004.01.122; Jain Animesh K., 1997, P CERN ACC SCH CAS, P175; Kirby G, 2015, IEEE T APPL SUPERCON, V25; Lorin C, 2015, IEEE T APPL SUPERCON, V25; Mess K H, 1996, SUPERCONDUCTING ACCE, P51; Mess KH, 1996, SUPERCONDUCTING ACCE, P45, DOI 10.1142/9789814261029_0004; Miyazoe A, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2178055; Radovinsky A, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287853; Rossi L, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2364215; Russenschuck S, 2010, FIELD COMPUTATION FOR ACCELERATOR MAGNETS: ANALYTICAL AND NUMERICAL METHODS FOR ELECTROMAGNETIC DESIGN AND OPTIMIZATION, P237; Ueda H, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2232955; Ueda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2014.2299537; Wang X, 2010, IEEE T APPL SUPERCON, V20, P368, DOI 10.1109/TASC.2010.2043349; Zangenberg N, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2178995	32	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAR	2015	28	3							035003	10.1088/0953-2048/28/3/035003		17	Physics, Applied; Physics, Condensed Matter	Physics	CD4IT	WOS:000351046700009		
J	Fourie, CJ; Takahashi, A; Yoshikawa, N				Fourie, Coenrad J.; Takahashi, Akitomo; Yoshikawa, Nobuyuki			Fast and accurate inductance and coupling calculation for a multi-layer Nb process	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						inductance extraction; multi-layer process; InductEx; return current	SCALE SFQ CIRCUITS; DC-POWER LAYER; FABRICATION PROCESS; LOGIC-CIRCUITS; GROUND PLANE; STRIPLINES	Currently, fabrication processes for superconductive integrated circuits are moving to multiple wiring and shielding layers, some of which are placed below the main ground plane (GP) and device layers. The Advanced Industrial Science and Technology advanced process (ADP2) was the first such multi-layer Nb process with planarized passive transmission line and GP layers below the junction layer, and is at the time of writing still the most developed. This process allows complex circuit designs, and accurate inductance extraction helps to push the boundaries of the layouts possible. We show that the position of ground connections between ground layers influences the inductance of structures for which these GPs act as return path, and that this needs to be accounted for in modelling. However, due to the number of wiring layers and GPs, full layout modelling of large cells causes long calculation times. In this paper we discuss methods with which to reduce model size, and calibrate InductEx calculations using these methods against measured results. We show that model reduction followed by calibration results in fast calculation times while good accuracy is maintained. We also show that InductEx correctly handles coupling between conductors in a multi-layer layout, and how to model layouts to gauge unwanted coupling between power lines and single flux quantum electronics.	[Fourie, Coenrad J.] Univ Stellenbosch, Dept Elect & Elect Engn, ZA-7600 Stellenbosch, South Africa; [Takahashi, Akitomo; Yoshikawa, Nobuyuki] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan	Fourie, CJ (reprint author), Univ Stellenbosch, Dept Elect & Elect Engn, ZA-7600 Stellenbosch, South Africa.	coenrad@sun.ac.za	YOSHIKAWA, Nobuyuki/M-9117-2014	YOSHIKAWA, Nobuyuki/0000-0001-6191-6715	South African National Research Foundation [78789]	The circuits were fabricated in the clean room for analogdigital superconductivity (CRAVITY) of National Institute of Advanced Industrial Science and Technology (AIST) with the advanced process 2 (ADP2). The AIST-ADP2 is based on the Nb circuit fabrication process developed in International Superconductivity Technology Center (ISTEC). This work was supported in part by the South African National Research Foundation, grant number 78789.	Akaike H, 2007, IEEE T APPL SUPERCON, V17, P466, DOI 10.1109/TASC.2007.897701; Akaike H, 2006, PHYSICA C, V445, P946, DOI 10.1016/j.physc.2006.05.061; Akaike H, 2009, IEEE T APPL SUPERCON, V19, P594, DOI 10.1109/TASC.2009.2018033; Akaike H, 2007, SUPERCOND SCI TECH, V20, pS336, DOI 10.1088/0953-2048/20/11/S08; Takeuchi N, 2014, J APPL PHYS, V115, DOI 10.1063/1.4868336; Takagi K, 2009, IEEE T APPL SUPERCON, V19, P617, DOI 10.1109/TASC.2009.2019130; Nagasawa S, 2004, PHYSICA C, V412, P1429, DOI 10.1016/j.physc.2003.12.097; Hinode K, 2003, IEICE T ELECTRON, VE86C, P2511; Anders S, 2010, PHYSICA C, V470, P2079, DOI 10.1016/j.physc.2010.07.005; Bolkhovsky V, 2013, GOVT FURNISHED SUPER; Ehara K, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2233535; Fourie C, 2013, P 14 IEEE INT SUP EL, P1; Fourie C J, 2014, INDUCTEX VERSION 4 2; Fourie CJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2234815; Fourie CJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2231134; Fourie CJ, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/1/015016; Hashimoto Y, 2003, IEEE T APPL SUPERCON, V13, P535, DOI 10.1109/TASC.2003.813929; HENKELS WH, 1978, APPL PHYS LETT, V32, P829, DOI 10.1063/1.89940; Hidaka M, 2006, SUPERCOND SCI TECH, V19, P138; Holmes D. S., 2013, IEEE Transactions on Applied Superconductivity, V23, DOI 10.1109/TASC.2013.2244634; Kainuma T, 2011, IEEE T APPL SUPERCON, V21, P827, DOI 10.1109/TASC.2010.2096374; Kameda Y, 2007, IEEE T APPL SUPERCON, V17, P508, DOI 10.1109/TASC.2007.898718; Mizugaki Y, 2007, J APPL PHYS, V101, DOI 10.1063/1.2739221; Mizugaki Y, 2006, IEICE ELECTRON EXPR, V3, P64, DOI 10.1587/elex.3.64; Nagasawa S, 2009, PHYSICA C, V469, P1578, DOI 10.1016/j.physc.2009.05.219; Nagasawa S, 2014, IEICE T ELECTRON, VE97C, P132, DOI 10.1587/transele.E97.C.132; Satoh T, 2009, IEEE T APPL SUPERCON, V19, P167, DOI 10.1109/TASC.2009.2018188; Yamanshi Y, 2009, IEICE T ELECTRON, VE93-C, P440	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAR	2015	28	3							035013	10.1088/0953-2048/28/3/035013		10	Physics, Applied; Physics, Condensed Matter	Physics	CD4IT	WOS:000351046700019		
J	Tanaka, Y				Tanaka, Y.			Multicomponent superconductivity based on multiband superconductors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Review						soliton; fractional flux quanta; interband phase difference	HIGH-TEMPERATURE SUPERCONDUCTORS; GINZBURG-LANDAU EQUATIONS; D-WAVE SUPERCONDUCTORS; TIME-REVERSAL SYMMETRY; STRONG-COUPLING SUPERCONDUCTIVITY; NONLOCAL INPLANE RESISTANCE; BOSE-EINSTEIN CONDENSATION; VORTEX-ANTIVORTEX DYNAMICS; ANISOTROPIC ENERGY-GAP; VOLTAGE-DRIVEN REGIME	Multicomponent superconductivity is realized in multiband superconductors when an interband pairing interaction is considerably weaker than the intraband interactions. There is a new quantum phase that originates from the interband phase difference in this superconducting condensate. Firstly, we discuss the applicability of this physical viewpoint for known multiband superconductors. Secondly, topics related to the interband phase difference are treated. Finally, we mention that the Bardeen-Cooper-Schrieffer formalism and the Ginzburg-Landau formalism may not be fully guaranteed when we introduce a fluctuation in the interband phase difference mode. We also address plausible new superconducting electronics using the interband phase difference.	Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Tanaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Cent 2-3035918,1-1-1 Umezon, Tsukuba, Ibaraki 3058568, Japan.	y.tanaka@aist.go.jp					ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Agterberg DF, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214507; Agterberg DF, 1997, PHYS REV LETT, V78, P3374, DOI 10.1103/PhysRevLett.78.3374; Anishchanka A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.104504; ANNETT JF, 1996, PHYSICAL PROPERTIES, V5, P375; Babaev E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067001; MAXWELL E, 1950, PHYS REV, V78, P477, DOI 10.1103/PhysRev.78.477; Ota Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.237003; LANDAU L, 1949, PHYS REV, V75, P884, DOI 10.1103/PhysRev.75.884; Cipriani M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170401; Pathak S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.085431; XU JH, 1995, PHYS REV B, V52, P7663, DOI 10.1103/PhysRevB.52.7663; TISZA L, 1949, PHYS REV, V75, P885, DOI 10.1103/PhysRev.75.885; Koma Y, 2003, NUCL PHYS B, V648, P189, DOI 10.1016/S0550-3213(02)00997-5; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; Gurevich A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184515; Onari S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.024525; GEILIKMAN BT, 1964, SOV PHYS-SOL STATE, V5, P2605; SASAKI S, 1995, PROG THEOR PHYS, V94, P373, DOI 10.1143/PTP.94.373; REYNOLDS CA, 1950, PHYS REV, V78, P487, DOI 10.1103/PhysRev.78.487; Bitter F, 1932, PHYS REV, V41, P507, DOI 10.1103/PhysRev.41.507; Crisan A, 2003, APPL PHYS LETT, V83, P506, DOI 10.1063/1.1593824; BARDEEN J, 1965, PHYS REV, V140, P1197, DOI 10.1103/PhysRev.140.A1197; SUHL H, 1959, PHYS REV LETT, V3, P552, DOI 10.1103/PhysRevLett.3.552; YAMAJI K, 1994, PHYSICA C, V222, P349, DOI 10.1016/0921-4534(94)90553-3; LITTLEWOOD PB, 1982, PHYS REV B, V26, P4883, DOI 10.1103/PhysRevB.26.4883; Kopelevich Y, 1998, PHYS REV LETT, V80, P4048, DOI 10.1103/PhysRevLett.80.4048; TOKUYASU TA, 1990, PHYS REV B, V41, P8891, DOI 10.1103/PhysRevB.41.8891; Kondo J, 2002, J PHYS SOC JPN, V71, P1353, DOI 10.1143/JPSJ.71.1353; BIAGI KR, 1985, PHYS REV B, V32, P7165, DOI 10.1103/PhysRevB.32.7165; Choi HY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.052505; Bouquet F, 2001, EUROPHYS LETT, V56, P856, DOI 10.1209/epl/i2001-00598-7; Lin SZ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014510; KONSIN P, 1988, PHYS LETT A, V129, P339, DOI 10.1016/0375-9601(88)90345-3; Vargunin A, 2011, J SUPERCOND NOV MAGN, V24, P1127, DOI 10.1007/s10948-010-1094-0; KONDO J, 1963, PROG THEOR PHYS, V29, P1, DOI 10.1143/PTP.29.1; Mrowka F, 2003, PHYSICA C, V399, P22, DOI 10.1016/S0921-4534(03)01286-3; CHAKRAVERTY BK, 1993, PHYS REV B, V48, P4047, DOI 10.1103/PhysRevB.48.4047; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; OSHEROFF DD, 1972, PHYS REV LETT, V28, P885, DOI 10.1103/PhysRevLett.28.885; Hadjiev VG, 1998, PHYS REV B, V58, P1043, DOI 10.1103/PhysRevB.58.1043; MACVICAR ML, 1968, J APPL PHYS, V39, P1721, DOI 10.1063/1.1656421; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Carlstrom J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.134518; Yerin YS, 2010, LOW TEMP PHYS+, V36, P969, DOI 10.1063/1.3518605; Tanaka Y, 2003, PHYSICA C, V392, P161, DOI 10.1016/S0921-4534(03)01105-5; Kon LZ, 1997, J PHYS-CONDENS MAT, V9, P3821, DOI 10.1088/0953-8984/9/18/019; SOORYAKUMAR R, 1980, PHYS REV LETT, V45, P660, DOI 10.1103/PhysRevLett.45.660; Hoyuelos M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.017203; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; PARKS RD, 1964, PHYS REV, V133, pA97, DOI 10.1103/PhysRev.133.A97; Hamada N, 2001, PHYSICA C, V357, P108, DOI 10.1016/S0921-4534(01)00177-0; Morooka T, 1999, IEEE T APPL SUPERCON, V9, P3491, DOI 10.1109/77.783782; Bitter F, 1931, PHYS REV, V38, P1903, DOI 10.1103/PhysRev.38.1903; Lee WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.217002; CHEVREL R, 1971, J SOLID STATE CHEM, V3, P515, DOI 10.1016/0022-4596(71)90095-8; PESHKOV VP, 1962, SOV PHYS JETP-USSR, V14, P1031; Schmidt S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505526; Kuboki K, 1996, J PHYS SOC JPN, V65, P361, DOI 10.1143/JPSJ.65.361; Xi XX, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/11/116501; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593; Babaev E, 2012, PHYSICA C, V479, P2, DOI 10.1016/j.physc.2012.01.002; SCHAFROTH MR, 1955, PHYS REV, V100, P502, DOI 10.1103/PhysRev.100.502; Goryo J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184511; Tanaka Y, 2010, PHYSICA C, V470, P1010, DOI 10.1016/j.physc.2010.05.022; London F, 1938, PHYS REV, V54, P947, DOI 10.1103/PhysRev.54.947; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445; Silaev MA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144519; Kobayashi K, 2013, PHYSICA C, V494, P13, DOI 10.1016/j.physc.2013.04.057; Kochorbe FG, 1998, J EXP THEOR PHYS+, V87, P570, DOI 10.1134/1.558695; YAMAJI K, 1994, PHYSICA C, V235, P2221, DOI 10.1016/0921-4534(94)92332-9; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089; Hadjiev VG, 1999, PHYS STATUS SOLIDI B, V215, P483; Konsin P, 2004, SUPERCOND SCI TECH, V17, P1472, DOI 10.1088/0953-2048/17/12/019; Franz M, 1996, PHYS REV B, V53, P5795, DOI 10.1103/PhysRevB.53.5795; Limonov M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054509; FROHLICH H, 1950, PHYS REV, V79, P845, DOI 10.1103/PhysRev.79.845; Iniotakis C, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.083701; TSUNETO T, 1960, PHYS REV, V118, P1029, DOI 10.1103/PhysRev.118.1029; Leslie LS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.250401; Shirage PM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257003; TACHIKI M, 1994, PHYS REV B, V50, P7065, DOI 10.1103/PhysRevB.50.7065; NAKAJIMA K, 1990, PHYS REV LETT, V65, P1667, DOI 10.1103/PhysRevLett.65.1667; Garaud J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.017003; Maiti S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144511; REN Y, 1995, PHYS REV LETT, V74, P3680, DOI 10.1103/PhysRevLett.74.3680; Hirai M, 2004, SUPERCOND SCI TECH, V17, P423, DOI 10.1088/0953-2048/17/3/021; Vakaryuk V, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.227003; SCOTT AC, 1969, AM J PHYS, V37, P52, DOI 10.1119/1.1975404; Tanaka Y, 2001, J PHYS SOC JPN, V70, P2844, DOI 10.1143/JPSJ.70.2844; Mints RG, 2000, PHYS REV B, V61, P1623, DOI 10.1103/PhysRevB.61.1623; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Stanev V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134522; Schopohl N, 1998, PHYS REV LETT, V80, P4761, DOI 10.1103/PhysRevLett.80.4761; Tanaka Y, 2012, PHYSICA C, V483, P86, DOI 10.1016/j.physc.2012.07.012; Shanenko AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.047005; Vagov A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144514; LEGGETT AJ, 1966, PROG THEOR PHYS, V36, P901, DOI 10.1143/PTP.36.901; PISMEN LM, 1994, PHYS REV LETT, V72, P2557, DOI 10.1103/PhysRevLett.72.2557; Agterberg DF, 1999, PHYS REV B, V60, P14868, DOI 10.1103/PhysRevB.60.14868; Margine ER, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024505; Yanagisawa T, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.094718; Romaguera ARD, 2013, J MATH PHYS, V54, DOI 10.1063/1.4819247; Tanaka Y, 2013, PHYSICA C, V485, P64, DOI 10.1016/j.physc.2012.10.004; Samokhin KV, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064513; Mishonov TM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.066501; Kogan VG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014507; LEE TD, 1973, PHYS REV D, V8, P1226, DOI 10.1103/PhysRevD.8.1226; Bouquet F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047001; ESSMANN U, 1967, PHYS LETT A, VA 24, P526, DOI 10.1016/0375-9601(67)90819-5; Gomory F, 1997, SUPERCOND SCI TECH, V10, P523, DOI 10.1088/0953-2048/10/8/001; Sickinger H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.107002; Marciani M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214508; Kasamatsu K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250406; Fangohr H, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174508; PERETTI J, 1962, PHYS LETT, V2, P275, DOI 10.1016/0031-9163(62)90035-5; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; Moshchalkov V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.117001; MAKI K, 1975, PHYS REV B, V11, P2539, DOI 10.1103/PhysRevB.11.2539; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; HESS DW, 1989, J PHYS-CONDENS MAT, V1, P8135, DOI 10.1088/0953-8984/1/43/014; Nishio T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.020506; MAKI K, 1976, J LOW TEMP PHYS, V23, P351, DOI 10.1007/BF00116926; RUGGIERO ST, 1980, PHYS REV LETT, V45, P1299, DOI 10.1103/PhysRevLett.45.1299; Garaud J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.197001; Strand JD, 2010, SCIENCE, V328, P1368, DOI 10.1126/science.1187943; Ryazanov VV, 2001, PHYS REV LETT, V86, P2427, DOI 10.1103/PhysRevLett.86.2427; Babaev E, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.100512; Asai H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224507; LITTLE WA, 1962, PHYS REV LETT, V9, P9, DOI 10.1103/PhysRevLett.9.9; Gurevich A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047004; SUNG CC, 1967, J PHYS CHEM SOLIDS, V28, P1933, DOI 10.1016/0022-3697(67)90171-0; Huang Z, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872261; Son DT, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063621; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; Matsunaga R, 2014, SCIENCE, V345, P1145, DOI 10.1126/science.1254697; Mishonov T, 2002, INT J MOD PHYS B, V16, P3573, DOI 10.1142/S0217979202012074; BALIAN R, 1963, PHYS REV, V131, P1553, DOI 10.1103/PhysRev.131.1553; Tsuge Y, 2012, PHYSCS PROC, V36, P731, DOI 10.1016/j.phpro.2012.06.276; Blumberg G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.227002; Goryo J, 2007, J PHYS CONF SER, V89, P12022, DOI 10.1088/1742-6596/89/1/012022; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Doi K, 2001, J PHYS SOC JPN, V70, P167, DOI 10.1143/JPSJ.70.167; Lin SZ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177005; Bluhm H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237002; RICKAYZEN G, 1959, PHYS REV, V115, P795, DOI 10.1103/PhysRev.115.795; Yerin YS, 2013, LOW TEMP PHYS+, V39, P125, DOI 10.1063/1.4791774; Golubov AA, 1997, PHYS REV B, V55, P15146, DOI 10.1103/PhysRevB.55.15146; Jang J, 2011, SCIENCE, V331, P186, DOI 10.1126/science.1193839; Blumberg G, 2007, PHYSICA C, V456, P75, DOI 10.1016/j.physc.2007.02.011; IZYUMOV YA, 1990, PHASE TRANSIT, V20, P95, DOI 10.1080/01411599008206870; Ogino M, 1996, PHYSICA C, V258, P384, DOI 10.1016/0921-4534(95)00814-4; Tanaka Y, 2010, SOLID STATE COMMUN, V150, P1980, DOI 10.1016/j.ssc.2010.08.024; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; SALERNO M, 1982, PHYS REV B, V26, P2474, DOI 10.1103/PhysRevB.26.2474; Matsunaga R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.187002; Ichioka M, 1996, PHYS REV B, V53, P2233, DOI 10.1103/PhysRevB.53.2233; Montagne R, 2000, PHYS LETT A, V273, P239, DOI 10.1016/S0375-9601(00)00472-2; Tokunaga Y, 2000, PHYS REV B, V61, P9707, DOI 10.1103/PhysRevB.61.9707; COMBESCOT R, 1995, PHYS REV LETT, V75, P3732, DOI 10.1103/PhysRevLett.75.3732; Tanaka Y, 2014, PHYSICA C, V505, P55, DOI 10.1016/j.physc.2014.07.011; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Koshnick NC, 2007, SCIENCE, V318, P1440, DOI 10.1126/science.1148758; Dodgson MJW, 2000, PHYS REV LETT, V84, P2698, DOI 10.1103/PhysRevLett.84.2698; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; Florens S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035114; KONDO Y, 1992, PHYS REV LETT, V68, P3331, DOI 10.1103/PhysRevLett.68.3331; Stanev V, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.174520; Lin SZ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.087003; Ichioka M, 1995, J PHYS SOC JPN, V64, P4547, DOI 10.1143/JPSJ.64.4547; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; GOLUBOV AA, 1995, PHYSICA C, V243, P153, DOI 10.1016/0921-4534(94)02445-6; AKOH H, 1987, PHYS REV B, V35, P5357, DOI 10.1103/PhysRevB.35.5357; Cho YM, 2008, EUR PHYS J B, V65, P155, DOI 10.1140/epjb/e2008-00343-2; Aranson IS, 2000, PHYS REV LETT, V84, P634, DOI 10.1103/PhysRevLett.84.634; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Kasamatsu K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.150406; ANDERSON PW, 1958, PHYS REV, V112, P1900, DOI 10.1103/PhysRev.112.1900; Miu L, 1999, PHYS REV LETT, V82, P672, DOI 10.1103/PhysRevLett.82.672; Erin YS, 2008, LOW TEMP PHYS+, V34, P891, DOI 10.1063/1.3009582; Tanaka Y, 2010, J SUPERCOND NOV MAGN, V23, P253, DOI 10.1007/s10948-009-0523-4; Choi HJ, 2002, NATURE, V418, P758, DOI 10.1038/nature00898; Geurts R, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024501; Hernandez-Garcia E, 1999, INT J BIFURCAT CHAOS, V9, P2257, DOI 10.1142/S0218127499001723; SILVER AH, 1967, PHYS REV, V157, P317, DOI 10.1103/PhysRev.157.317; Tanaka Y, 2002, PHYSICA C, V378, P283, DOI 10.1016/S0921-4534(02)01428-4; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; OCTAVIO M, 1978, PHYS REV B, V17, P159, DOI 10.1103/PhysRevB.17.159; WU WC, 1995, PHYS REV LETT, V74, P158, DOI 10.1103/PhysRevLett.74.158; Donnelly RJ, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3248499; BOSTOCK J, 1973, J APPL PHYS, V44, P5567, DOI 10.1063/1.1662197; Atkins K R, 1959, LIQUID HELIUM; Babaev E, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.016501; Babaev E, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.180502; Bardeen J, 1961, PROGRESS LOW TEMPERA, V3, P170, DOI 10.1016/S0079-6417(08)60137-7; Baskaran G, 2009, CURRENT TRENDS SCI P, P279; BASKARAN G, 1988, PHYS REV B, V37, P580, DOI 10.1103/PhysRevB.37.580; Benkraouda M, 1996, PHYS REV B, V53, P438, DOI 10.1103/PhysRevB.53.438; BENNETT AJ, 1965, PHYS REV, V140, P1902, DOI 10.1103/PhysRev.140.A1902; BEREZINS.VL, 1972, SOV PHYS JETP-USSR, V34, P610; BEREZINS.VL, 1971, SOV PHYS JETP-USSR, V32, P493; BERLINSKY AJ, 1995, PHYS REV LETT, V75, P2200, DOI 10.1103/PhysRevLett.75.2200; Bersier C, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/16/164209; Bloch F, 1932, Z PHYS, V74, P295, DOI 10.1007/BF01337791; Bluhm H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.209902; Bobkov AM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.134527; Bojesen TA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.220511; CARLSON RV, 1976, J LOW TEMP PHYS, V25, P67, DOI 10.1007/BF00654825; Chibotaru LF, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.020502; Chibotaru LF, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/47001; Cho YM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180506; Chubukov AV, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.220501; Col A.D., 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.097001; Crisan A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144518; Crisan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.184517; Crisan A, 2007, APPL PHYS, V46, pL451; DEKKER C, 1989, PHYS REV B, V40, P11243, DOI 10.1103/PhysRevB.40.11243; Dias RG, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/8/085009; Donnelly R J, 1995, PHYS TODAY, V30, P30; Doria MM, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/17004; Doring S, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/8/084020; Eto M., 2014, PROG THEOR EXP PHYS, V2014; FABER TE, 1958, PROC R SOC LON SER-A, V248, P460, DOI 10.1098/rspa.1958.0256; Fenchenko V N, 2012, PHYSICA C, V480, P120; FINKELST.D, 1966, J MATH PHYS, V7, P1218, DOI 10.1063/1.1705025; Floris A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054508; FULTON TA, 1973, SOLID STATE COMMUN, V12, P57, DOI 10.1016/0038-1098(73)90345-1; GAMMEL PL, 1988, PHYS REV LETT, V61, P1666, DOI 10.1103/PhysRevLett.61.1666; Garaud J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.014507; Geilikman B. T., 1967, SOV PHYS-SOLID STATE, V9, P642; Geilikman B.T., 1963, Fizika Tverdogo Tela, V5; Geilikman B.T., 1967, Fizika Tverdogo Tela, V9; Geurts R, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214514; Geyer J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104521; Gillis S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024512; GLADSTONE G, 1969, SUPERCONDUCTIVITY, V2, P665; Golubov AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104503; GORKOV LP, 1959, SOV PHYS JETP-USSR, V9, P1364; Goryo J, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/17002; Guikema JW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104515; Gurevich A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.137003; Haas S., 2002, Physical Review B (Condensed Matter and Materials Physics), V65, DOI 10.1103/PhysRevB.65.020502; HANNAY NB, 1965, PHYS REV LETT, V14, P225, DOI 10.1103/PhysRevLett.14.225; HOUGHTON A, 1989, PHYS REV B, V40, P6763, DOI 10.1103/PhysRevB.40.6763; Hu X, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064516; Ichioka M, 1996, PHYS REV B, V53, P15316, DOI 10.1103/PhysRevB.53.15316; Ihara K.H., 1994, J APPL PHYS, V33, pL300; IMRY Y, 1975, J PHYS C SOLID STATE, V8, P567, DOI 10.1088/0022-3719/8/5/005; Ivanov IP, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.095030; Ivanov IP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021116; JAKLEVIC RC, 1965, PHYS REV, V140, P1628; Kasamatsu K, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013620; Khasanov R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.087004; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Klein MV, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014507; Kobayashi K, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.224516; Kogan VG, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.016502; Kogan VG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054515; KOGAN VG, 1981, PHYS REV B, V24, P1572, DOI 10.1103/PhysRevB.24.1572; KOIKE Y, 1980, PHYSICA B & C, V99, P503, DOI 10.1016/0378-4363(80)90286-7; Koshelev AE, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/27014; Kuplevakhsky SV, 2011, LOW TEMP PHYS+, V37, P667, DOI 10.1063/1.3660216; Leggett A., 1980, MODERN TRENDS THEORY, V115, P13, DOI 10.1007/BFb0120125; Leggett A.J., 1980, J PHYS-PARIS, V41, pC7, DOI DOI 10.1051/JPHYSCOL:1980704; Lin SZ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063021; Lin SZ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.100508; Loudon JC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144515; Loudon R, 1983, QUAMTUM THEORY LIGHT; Lounasmaa OV, 1999, P NATL ACAD SCI USA, V96, P7760, DOI 10.1073/pnas.96.14.7760; Luan L, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214530; Maksimov EG, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174504; Matsumoto M, 1995, J PHYS SOC JPN, V64, P4867, DOI 10.1143/JPSJ.64.4867; Matsunaga I M, 1995, J PHYS SOC JPN, V64, P3384; Matsumoto M, 1996, J PHYS SOC JPN, V65, P2194, DOI 10.1143/JPSJ.65.2194; MATTHEIS.LF, 1973, PHYS REV B, V8, P3719, DOI 10.1103/PhysRevB.8.3719; Miu L, 1999, PHYS REV LETT, V82, P673; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Nakajima Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.157001; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Ng TK, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/17003; Nitta M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.084711; Orlova NV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134510; Ota Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.060507; Pereira PJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144504; Peshkov V P, 1961, SOV PHYS JETP, V41, P1443; Peshkov V P, 1981, J LOW TEMP PHYS, V42, pi; Pina JC, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024512; Ponomarev YG, 2004, SOLID STATE COMMUN, V129, P85, DOI 10.1016/j.ssc.2003.09.024; Raghu S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224505; Regal C, 2006, THESIS U COLORADO; Sanna A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.020511; SCALAPIN.DJ, 1966, PHYS REV, V148, P263, DOI 10.1103/PhysRev.148.263; SCHAFROTH MR, 1958, PHYS REV, V111, P72, DOI 10.1103/PhysRev.111.72; Shen V L Y L, 1965, PHYS REV LETT, V14, P1025; Shirage PM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037004; Shivagan D.D., 2009, J PHYS C SER, V97; Sigrist M, 1999, PROG THEOR PHYS, V102, P965, DOI 10.1143/PTP.102.965; Silaev M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094515; Silaev M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.220504; SKYRME THR, 1959, PROC R SOC LON SER-A, V252, P236, DOI 10.1098/rspa.1959.0149; Stanev V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.100505; Stanley H.F., 1971, INTRO PHASE TRANSITI; Storey K J G, 2013, PHYS REV B, V88; Suzuki I S, 1988, SOLID STATE COMMUN, V106, P513; TAKAHASHI S, 1986, PHYS REV B, V33, P4620, DOI 10.1103/PhysRevB.33.4620; Takahashi Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.034701; Tanaka Y, 2003, FINAL REPORT CREATIO, P39; Tanaka Y, 2001, PHYSICA C, V357, P222, DOI 10.1016/S0921-4534(01)00212-X; Tanaka Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.114706; Tanaka Y, 2007, JPN J APPL PHYS 1, V46, P134, DOI 10.1143/JJAP.46.134; Tanaka Y, 2010, PHYSICA C, V470, P2023, DOI 10.1016/j.physc.2010.09.006; Tanaka Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017002; Tanaka Y, 2010, US Patent Application, Patent No. [2011/0063016, 20110063016]; Tanaka Y., 2008, United State Patent, Patent No. [7,400,282 B2, 7400282]; Tanaka Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.074705; Tanaka Y, 2011, PHYSICA C, V471, P747, DOI 10.1016/j.physc.2011.05.043; Tilley D R, 1990, SUPERFLUIDY SUPERCON; Tisza L, 1938, CR HEBD ACAD SCI, V207, P1186; Tisza L, 1938, NATURE, V141, P913, DOI 10.1038/141913a0; Tisza L, 1938, CR HEBD ACAD SCI, V207, P1035; Tsuei CC, 1997, NATURE, V387, P481, DOI 10.1038/387481a0; Vargunin A, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/6/065008; Wilson BJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/42/425702; Yanagisawa T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024712; Yanagisawa T., 2013, RECENT ADV SUPERCOND, P219; Yanagisawa T., 2013, RECENT ADV QUARKS RE, P113; Yanagisawa T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124704; Yerin YS, 2013, LOW TEMP PHYS+, V39, P1023, DOI 10.1063/1.4843315; Yerin YS, 2007, LOW TEMP PHYS+, V33, P401, DOI 10.1063/1.2737547; Zha GQ, 2013, J APPL PHYS, V113, DOI 10.1063/1.4808295; Zhitomirsky ME, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057001	336	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAR	2015	28	3							034002	10.1088/0953-2048/28/3/034002		28	Physics, Applied; Physics, Condensed Matter	Physics	CD4IT	WOS:000351046700003		
J	Mizuguchi, T; Kawamoto, M; Meguro, M; Okita, K; Ota, S; Ishii, M; Ueki, T; Nishidate, T; Kimura, Y; Furuhata, T; Hirata, K				Mizuguchi, Toru; Kawamoto, Masaki; Meguro, Makoto; Okita, Kenji; Ota, Shigenori; Ishii, Masayuki; Ueki, Tomomi; Nishidate, Toshihiko; Kimura, Yasutoshi; Furuhata, Tomohisa; Hirata, Koichi			The impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis	SURGERY TODAY			English	Review						Aged patients; Elderly patients; Liver resection; Morbidity; Mortality	ELDERLY-PATIENTS; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; SURGICAL-TREATMENT; PERIPHERAL CHOLANGIOCARCINOMA; COLORECTAL METASTASES; RIGHT HEPATECTOMY; PRISMA STATEMENT; AGE; HEALTH	Surgery involving elderly patients is becoming increasingly common due to the rapid aging of societies all over the world. The objective of this study was to elucidate the prognostic differences between elderly and young patients who undergo liver resection. A systematic review based on the PRISMA flow diagram was conducted. Ovid Medline and PubMed were used to search for relevant literature published between January 2000 and March 2013, and the modified MINORS score was used to assess the methodological quality. In cases of hepatocellular carcinoma and miscellaneous liver tumors, the morbidity and mortality rate did not differ significantly between the elderly and young patients. For patients with colorectal metastatic liver cancer, the mortality of the young patients was 2.7 times lower than that of elderly patients. Our review of high-quality retrospective studies was able to elucidate the clinical risks of age on the outcomes after liver surgery in specific patient populations.	[Mizuguchi, Toru; Kawamoto, Masaki; Meguro, Makoto; Okita, Kenji; Ota, Shigenori; Ishii, Masayuki; Ueki, Tomomi; Nishidate, Toshihiko; Kimura, Yasutoshi; Furuhata, Tomohisa; Hirata, Koichi] Sapporo Med Univ, Sapporo Med Univ Hosp, Sch Med, Dept Surg 1,Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Mizuguchi, T (reprint author), Sapporo Med Univ, Sapporo Med Univ Hosp, Sch Med, Dept Surg 1,Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	tmizu@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591993]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, No. 23591993 to T. Mizuguchi.	Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2; Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048; Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222; Mizuguchi T, 2014, SURG TODAY, V44, P1, DOI 10.1007/s00595-013-0534-4; Kulik U, 2011, WORLD J SURG, V35, P2063, DOI 10.1007/s00268-011-1180-x; Mazzoni G, 2007, INT J COLORECTAL DIS, V22, P77, DOI 10.1007/s00384-006-0096-7; Cauchy F, 2012, LANGENBECK ARCH SURG, V397, P681, DOI 10.1007/s00423-012-0911-2; Portolani N, 2011, JPN J CLIN ONCOL, V41, P1358, DOI 10.1093/jjco/hyr154; Aldrighetti L, 2004, AM SURGEON, V70, P453; Di Benedetto F, 2011, J AM GERIATR SOC, V59, P2282, DOI 10.1111/j.1532-5415.2011.03734.x; Cook EJ, 2012, COLORECTAL DIS, V14, P1210, DOI 10.1111/j.1463-1318.2012.02946.x; Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889; Ettorre GM, 2001, BRIT J SURG, V88, P73, DOI 10.1046/j.1365-2168.2001.01629.x; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4; Nagano Y, 2005, J AM COLL SURGEONS, V201, P511, DOI 10.1016/j.jamcollsurg.2005.05.010; Yoshimura Y, 2004, WORLD J SURG, V28, P982, DOI 10.1007/s00268-004-7344-1; Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025; Melloul E, 2012, WORLD J SURG, V36, P2161, DOI 10.1007/s00268-012-1621-1; Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547; Yeh CN, 2004, HEPATO-GASTROENTEROL, V51, P219; Straub RH, 2001, MECH AGEING DEV, V122, P1591, DOI 10.1016/S0047-6374(01)00289-5; Yeh CN, 2006, ANN SURG ONCOL, V13, P1553, DOI 10.1245/s10434-006-9085-x; Lee CR, 2012, J GASTROINTEST SURG, V16, P1736, DOI 10.1007/s11605-012-1966-7; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Caratozzolo E, 2007, G Chir, V28, P419; Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P101; Goulding MR, 2003, JAMA-J AM MED ASSOC, V289, P1371; Gruttadauria S, 2004, J SURG ONCOL, V88, P229, DOI 10.1002/jso.20154; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Mizuguchi T, 2013, WORLD J SURG, V37, P1379, DOI 10.1007/s00268-013-1989-6; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Nanashima A, 2013, SURG TODAY, V43, P485, DOI 10.1007/s00595-012-0374-7; Shimada H, 2009, LANGENBECK ARCH SURG, V394, P973, DOI 10.1007/s00423-009-0530-8; Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3; Su CW, 2012, ARCH SURG-CHICAGO, V147, P137, DOI 10.1001/archsurg.2011.288; Yeh CN, 2004, AM J SURG, V187, P559, DOI 10.1016/j.amjsurg.2003.12.051	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					259	270		10.1007/s00595-014-0863-y		12	Surgery	Surgery	CD7OT	WOS:000351280800001		
J	Hammad, A; Kaido, T; Uemoto, S				Hammad, Ahmed; Kaido, Toshimi; Uemoto, Shinji			Perioperative nutritional therapy in liver transplantation	SURGERY TODAY			English	Review						Liver transplantation; Immunonutrition; Synbiotics; Nutritional intervention; Sarcopenia	CHAIN AMINO-ACIDS; SUBJECTIVE GLOBAL ASSESSMENT; DONOR LIVER; HEPATIC-ENCEPHALOPATHY; CIRRHOTIC-PATIENTS; BODY-COMPOSITION; HEPATOCELLULAR-CARCINOMA; MALNOURISHED PATIENTS; PARENTERAL-NUTRITION; AUTONOMIC NEUROPATHY	Protein-energy malnutrition is frequently seen in patients with end-stage liver disease who undergo liver transplantation. This causes a deterioration of the patients' clinical condition and affects their post-transplantation survival. Accurate assessment of the nutritional status and adequate intervention are prerequisites for perioperative nutritional treatment. However, the metabolic abnormalities induced by liver failure make the traditional assessment of the nutritional status difficult. The methods that were recently developed for accurately assessing the nutritional status by body bioelectrical impedance may be implemented in pre-transplant management. Because preoperative malnutrition and the loss of skeletal muscle mass, called sarcopenia, have a significant negative impact on the post-transplantation outcome, it is essential to provide adequate nutritional support during all phases of liver transplantation. Oral nutrition is preferred, but tube enteral nutrition may be required to provide the necessary caloric intake. We herein discuss both bioelectrical impedance and the latest findings in the current perioperative nutritional interventions in liver transplant patients regarding synbiotics, micronutrients, branchedchain amino acid supplementation, the use of immune system modulating formulas, the fluid balance and the offering of nocturnal meals.	[Hammad, Ahmed; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Div Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Dept Surg,Sakyo Ku, Kyoto 6068507, Japan	Kaido, T (reprint author), Kyoto Univ, Div Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kaido@kuhp.kyoto-u.ac.jp					Als-Nielsen B, 2003, COCHRANE DB SYST REV, V2; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Takeshita S, 2009, NUTR RES, V29, P89, DOI 10.1016/j.nutres.2008.12.005; Barzel US, 1998, J NUTR, V128, P1051; Kawaguchi T, 2008, INT J MOL MED, V22, P589, DOI 10.3892/ijmm_00000060; Madden AM, 1997, HEPATOLOGY, V26, P40; Tsuchiya M, 2005, HEPATOL RES, V31, P95, DOI 10.1016/j.hepres.2004.11.009; Stephenson GR, 2001, TRANSPLANTATION, V72, P666, DOI 10.1097/00007890-200108270-00018; Merli M, 2010, LIVER INT, V30, P208, DOI 10.1111/j.1478-3231.2009.02135.x; Richards J, 2005, TRANSPLANT INT, V18, P461, DOI 10.1111/j.1432-2277.2004.00067.x; Plank LD, 2008, HEPATOLOGY, V48, P557, DOI 10.1002/hep.22367; Kaido T, 2012, NUTRITION, V28, P1104, DOI 10.1016/j.nut.2012.02.007; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Plauth M, 2009, CLIN NUTR, V28, P436, DOI 10.1016/j.clnu.2009.04.019; Anastacio LR, 2011, NUTRITION, V27, P931, DOI 10.1016/j.nut.2010.12.017; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Bitetto D, 2010, LIVER INT, V30, P417, DOI 10.1111/j.1478-3231.2009.02154.x; Millonig G, 2005, LIVER TRANSPLANT, V11, P960, DOI 10.1002/lt.20466; Catalano D, 2008, LIVER INT, V28, P1280, DOI 10.1111/j.1478-3231.2008.01742.x; Iida T, 2010, LIVER TRANSPLANT, V16, P1379, DOI 10.1002/lt.22165; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; PALMER M, 1991, TRANSPLANTATION, V51, P797, DOI 10.1097/00007890-199104000-00012; Figueiredo F, 2000, TRANSPLANTATION, V70, P1347, DOI 10.1097/00007890-200011150-00014; Bajaj JS, 2008, AM J GASTROENTEROL, V103, P1707, DOI 10.1111/j.1572-0241.2008.01861.x; Sanchez AJ, 2006, LIVER TRANSPLANT, V12, P1310, DOI 10.1002/lt.20894; Erickson SE, 2009, CRIT CARE MED, V37, P1, DOI 10.1097/CCM.0b013e31819292ea; Riordan SM, 2006, J HEPATOL, V45, P744, DOI 10.1016/j.jhep.2006.08.001; Shenkin A, 2006, CLIN CHEM, V52, P2177, DOI 10.1373/clinchem.2006.077412; Levy S, 2002, DIGEST DIS SCI, V47, P543, DOI 10.1023/A:1017907817423; Le Cornu KA, 2000, TRANSPLANTATION, V69, P1364, DOI 10.1097/00007890-200004150-00026; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; MULLER MJ, 1994, CLIN NUTR, V13, P145, DOI 10.1016/0261-5614(94)90093-0; MENDENHALL CL, 1993, HEPATOLOGY, V17, P564, DOI 10.1002/hep.1840170407; SWART GR, 1988, CLIN SCI, V75, P101; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Holecek M, 2010, NUTRITION, V26, P482, DOI 10.1016/j.nut.2009.06.027; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Stickel F, 2008, NUTR REV, V66, P47, DOI 10.1111/j.1753-4887.2007.00005.x; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Rayes N, 2005, AM J TRANSPLANT, V5, P125, DOI 10.1111/j.1600-6143.2004.00649.x; Bassit RA, 2002, NUTRITION, V18, P376, DOI 10.1016/S0899-9007(02)00753-0; Rayes N, 2002, TRANSPLANTATION, V74, P123, DOI 10.1097/00007890-200207150-00021; Malik SM, 2009, AM J TRANSPLANT, V9, P782, DOI 10.1111/j.1600-6143.2009.02590.x; O'Brien A, 2008, GASTROENTEROLOGY, V134, P1729, DOI 10.1053/j.gastro.2008.02.001; Lata J, 2007, EUR J GASTROEN HEPAT, V19, P1111; Metheny NA, 2007, CURR OPIN GASTROEN, V23, P178, DOI 10.1097/MOG.0b013e3280287a0f; STEGALL MD, 1995, TRANSPLANTATION, V60, P1057; Khanna S, 2007, CURR OPIN CLIN NUTR, V10, P297, DOI 10.1097/MCO.0b013e3280d646b8; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; SWART GR, 1989, BRIT MED J, V299, P1202; Senkal M, 1999, ARCH SURG-CHICAGO, V134, P1309, DOI 10.1001/archsurg.134.12.1309; Aqel BA, 2005, CLIN GASTROENTEROL H, V3, P1095, DOI 10.1053/S1542-3565(05)00531-8; Aranda-Michel J, 2001, Curr Gastroenterol Rep, V3, P362, DOI 10.1007/s11894-001-0061-0; Baskin William N, 2006, Nutr Clin Pract, V21, P40, DOI 10.1177/011542650602100140; Bellot Pablo, 2008, Gastroenterol Hepatol, V31, P508; Beyer N, 1995, MED SCI SPORTS EXERC, V6, P84; Bianchi G, 2005, CURR OPIN CLIN NUTR, V8, P83, DOI 10.1097/00075197-200501000-00013; BIANCHI GP, 1993, J INTERN MED, V233, P385; Burns D, 1995, GASTROINTEST ENDOSC, V41, P263; Butterworth RF, 2009, METAB BRAIN DIS, V24, P189, DOI 10.1007/s11011-008-9129-y; Cabre E, 2005, CURR OPIN CLIN NUTR, V8, P545, DOI 10.1097/01.mco.0000179164.56194.6f; CABRE E, 1993, AM J GASTROENTEROL, V88, P718; CABRE E, 1990, AM J GASTROENTEROL, V85, P1597; Campos ACL, 2002, CURR OPIN CLIN NUTR, V5, P297, DOI 10.1097/00075197-200205000-00010; Canzanello V J, 1997, Liver Transpl Surg, V3, P1; Chin SE, 1991, J PEDIAT CHILD HLTH, V27, P38; DRISCOLL DF, 1990, DRUGS, V40, P346, DOI 10.2165/00003495-199040030-00003; DRISCOLL DF, 1995, NUTRITION, V11, P255; DRISCOLL DF, 1994, AM J HOSP PHARM, V51, P2834; Dudrick Stanley J, 2002, J Hepatobiliary Pancreat Surg, V9, P459, DOI 10.1007/s005340200057; Durczynski A, 2013, SURG TODAY, V43, P534, DOI 10.1007/s00595-012-0268-8; Escartin A, 2005, TRANSPLANT P, V37, P3859, DOI 10.1016/j.transproceed.2005.08.050; FISCHER JE, 1971, LANCET, V2, P75; Giannini S, 2000, OSTEOPOROSIS INT, V11, P417, DOI 10.1007/s001980070109; Gloria L, 1997, AM J GASTROENTEROL, V92, P485; Green GA, 1998, J BACK MUSCULOSKELET, V10, P3; Hasse J, 1996, LIVER TRANSPLANT, V2, P81; Hay J Eileen, 2005, Clin Liver Dis, V9, P747, DOI 10.1016/j.cld.2005.07.003; Hiyama DT, 1991, TOTAL PARENTER NUTR, V2, P263; Holt RIG, 1997, AM J CLIN NUTR, V65, P534; Hoyle GE, 2011, QJM-INT J MED, V104, P35, DOI 10.1093/qjmed/hcq157; JANCZEWSKA I, 1995, SCAND J GASTROENTERO, V30, P68, DOI 10.3109/00365529509093238; Jiang H, 2007, CHINESE J CLIN NUTR, V15, P21; KAIDO T, 2010, HEPATO-GASTROENTEROL, V58, P1489; Kaido T, 2010, HEPATO-GASTROENTEROL, V57, P1522; Kaido T, 2012, WORLD J SURG, V36, P1666, DOI 10.1007/s00268-012-1529-9; Kaido T, 2009, LIVER TRANSPLANT, V15, P1420, DOI 10.1002/lt.21873; Kamalaporn P, 2005, ALIMENT PHARM THERAP, V21, P1459, DOI 10.1111/j.1365-2036.2005.02507.x; Kawamura E, 2009, LIVER TRANSPLANT, V15, P790, DOI 10.1002/lt.21758; Kume H, 2006, BIOSCI BIOTECH BIOCH, V70, P1281, DOI 10.1271/bbb.70.1281; Leo MA, 1999, AM J CLIN NUTR, V69, P1071; Maheshwari A, 2005, AUTON NEUROSCI-BASIC, V118, P135, DOI 10.1016/j.autneu.2005.02.003; Malaguarnera M, 2010, EUR J GASTROEN HEPAT, V22, P199, DOI 10.1097/MEG.0b013e328330a8d3; Marchesini G, 1996, HEPATOLOGY, V23, P1084; Marsman WA, 1996, TRANSPLANTATION, V62, P1246, DOI 10.1097/00007890-199611150-00011; MORO ML, 1990, INFECT CONT HOSP EP, V11, P27; MOSCARELLA S, 1994, EUR J GASTROEN HEPAT, V6, P633, DOI 10.1097/00042737-199407000-00014; Mullen JL, 1979, SURG FORUM, V30, P8; MULLER MJ, 1992, HEPATOLOGY, V15, P782, DOI 10.1002/hep.1840150507; MUNOZ SJ, 1991, TRANSPLANT P, V23, P1480; Nakamura I, 2004, HEPATOL RES, V29, P207, DOI 10.1016/j.hepres.2004.04.005; NOMPLEGGI DJ, 1994, HEPATOLOGY, V19, P518; Osaki N, 1993, SURGERY, V113, P403; PERIS P, 1993, BRIT J RHEUMATOL, V32, P702; Perkins James D, 2006, Liver Transpl, V12, P1012, DOI 10.1002/lt.20807; Pescovitz MD, 1996, CLIN TRANSPLANT, V10, P256; PETRIDES AS, 1989, DIABETES METAB REV, V5, P691; Plank LD, 2005, CLIN NUTR, V24, P288, DOI 10.1016/j.clnu.2004.11.007; PORAYKO MK, 1991, SEMIN LIVER DIS, V11, P305, DOI 10.1055/s-2008-1040448; REILLY J, 1990, JPEN-PARENTER ENTER, V14, P386, DOI 10.1177/0148607190014004386; RITLAND S, 1982, SCAND J GASTROENTERO, V17, P1013; Seyan AS, 2010, WORLD J GASTROENTERO, V16, P3347, DOI 10.3748/wjg.v16.i27.3347; SHANBHOGUE RLK, 1987, SURGERY, V101, P146; Shirabe K, 2011, LIVER TRANSPLANT, V17, P1073, DOI 10.1002/lt.22324; Stanley AJ, 1996, GASTROENTEROLOGY, V111, P1679, DOI 10.1016/S0016-5085(96)70033-1; Stephen MR, 1999, HEPATOLOGY, V31, P955; TAKADA Y, 1993, TRANSPLANTATION, V55, P1314, DOI 10.1097/00007890-199306000-00020; Thomas EL, 1997, HEPATOLOGY, V25, P178, DOI 10.1002/hep.510250133; THULUVATH PJ, 1989, Q J MED, V72, P737; Van den Ham ECH, 2000, TRANSPLANTATION, V69, P1591; Weseman R. A., 1998, Topics in Clinical Nutrition, V13, P27; Yamamoto T, 1996, SURG TODAY, V26, P151	127	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					271	283		10.1007/s00595-014-0842-3		13	Surgery	Surgery	CD7OT	WOS:000351280800002		
J	Igari, K; Kudo, T; Toyofuku, T; Jibiki, M; Inoue, Y				Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahito; Jibiki, Masatoshi; Inoue, Yoshinori			Comparison between endovascular repair and open surgery for isolated iliac artery aneurysms	SURGERY TODAY			English	Article						Isolated iliac artery aneurysm; Endovascular repair; Open surgery	ABDOMINAL AORTIC-ANEURYSM; MANAGEMENT	Purpose This study was performed to compare endovascular repair with conventional open repair of isolated iliac artery aneurysms (IAAs). Methods We retrospectively reviewed the charts of all patients who underwent repair of isolated IAAs between January 2008 and June 2012. Patients with infected, mycotic and ruptured iliac aneurysms and those with concurrent infrarenal abdominal aortic aneurysms greater than 30 mm in diameter were excluded from this analysis. Results A total of 32 patients were treated with isolated IAAs. There were 20 open and 12 endovascular repairs. A comparison of the length of the operation (238 +/- 84 min in the open group vs 176 +/- 72 min in the endovascular group, P = 0.03) and intraoperative blood loss (1,735 +/- 1,177 ml in the open group vs 503 +/- 711 ml in the endovascular group, P = 0.01), revealed significant differences in favor of the endovascular procedure. Postoperative complications were less common in the endovascular group, although the difference did not reach statistical significance. Conclusions The management of isolated IAAs with both endovascular and open repair can be accomplished with very low morbidity rates. Therefore, endovascular repair can be considered an alternative treatment for isolated IAAs.	[Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahito; Jibiki, Masatoshi; Inoue, Yoshinori] Tokyo Med & Dent Univ, Dept Surg, Div Vasc & Endovasc Surg, Bunkyo Ku, Tokyo 1138519, Japan	Igari, K (reprint author), Tokyo Med & Dent Univ, Dept Surg, Div Vasc & Endovasc Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	igari.srg1@tmd.ac.jp					Huang Y, 2008, J VASC SURG, V47, P1203, DOI 10.1016/j.jvs.2008.01.050; Chemelli A, 2010, J ENDOVASC THER, V17, P492, DOI 10.1583/10-3047.1; Patel NV, 2009, J VASC SURG, V49, P1147, DOI 10.1016/j.jvs.2008.11.101; Ziegler P, 2007, J VASC SURG, V46, P204, DOI 10.1016/j.jvs.2007.04.015; Santilli SM, 2000, J VASC SURG, V31, P114, DOI 10.1016/S0741-5214(00)70073-5; Maldonado TS, 2004, J VASC SURG, V40, P703, DOI 10.1016/j.jvs.2004.07.032; Boules TN, 2006, J VASC SURG, V44, P29, DOI 10.1016/j.jvs.2006.02.055; Dorigo W, 2008, EUR J VASC ENDOVASC, V35, P585, DOI 10.1016/j.ejvs.2007.11.017; Krupski WC, 1998, J VASC SURG, V28, P1, DOI 10.1016/S0741-5214(98)70194-6; Pitoulias GA, 2007, J VASC SURG, V46, P648, DOI 10.1016/j.jvs.2007.05.047; Verzini F, 2009, J VASC SURG, V49, P1154, DOI 10.1016/j.jvs.2008.11.100; Chaer RA, 2008, J VASC SURG, V47, P708, DOI 10.1016/j.jvs.2007.11.008; Hosaka A, 2011, J VASC SURG, V54, P960, DOI 10.1016/j.jvs.2011.03.266; Hu H, 2008, SURG TODAY, V38, P232, DOI 10.1007/s00595-007-3598-1; Inuzuka K, 2010, SURG TODAY, V40, P738, DOI 10.1007/s00595-009-4126-2; Matsumura JS, 2001, J VASC SURG, V33, pS150; Mehta M, 2001, J VASC SURG, V33, pS27; Molacek J, 2013, SURG TODAY, V43, P1003, DOI 10.1007/s00595-013-0488-6; Okada T, 2012, CARDIOVASC INTER RAD, V35, P59, DOI 10.1007/s00270-010-0084-8; RICHARDSON JW, 1988, J VASC SURG, V8, P165, DOI 10.1067/mva.1988.avs0080165; Sandhu Rajdeep S, 2005, Semin Vasc Surg, V18, P209, DOI 10.1053/j.semvascsurg.2005.09.007; SEEGER JM, 1992, J VASC SURG, V15, P635; Senekowitsch C, 2006, J VASC SURG, V43, P689, DOI 10.1016/j.jvs.2005.12.016; Stroumpouli E, 2007, CARDIOVASC INTER RAD, V30, P1099, DOI 10.1007/s00270-007-9133-3; Tsang JS, 2009, CARDIOVASC INTER RAD, V32, P1165, DOI 10.1007/s00270-009-9653-0; Wachenfeld-Wahl C, 2004, VASA-J VASCULAR DIS, V33, P72, DOI 10.1024/0301-1526.33.2.72; Zander T, 2009, CARDIOVASC INTER RAD, V32, P928, DOI 10.1007/s00270-009-9551-5	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					290	296		10.1007/s00595-014-0971-8		7	Surgery	Surgery	CD7OT	WOS:000351280800004		
J	Komatsu, H; Egawa, S; Motoi, F; Morikawa, T; Sakata, N; Naitoh, T; Katayose, Y; Ishida, K; Unno, M				Komatsu, Hirotake; Egawa, Shinichi; Motoi, Fuyuhiko; Morikawa, Takanori; Sakata, Naoaki; Naitoh, Takeshi; Katayose, Yu; Ishida, Kazuyuki; Unno, Michiaki			Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors	SURGERY TODAY			English	Article						Adenosquamous carcinoma; Pancreatic carcinoma; Distant metastasis; Venous invasion	SQUAMOUS-CELL CARCINOMAS; LUNG-CARCINOMA; BETA-CATENIN; ADENOCARCINOMA; CANCER; ACTIVATION; EXPRESSION; EXPERIENCE; RESECTION; STOMACH	Purpose Adenosquamous carcinoma of the pancreas is a rare subtype of pancreatic cancer. We herein describe the clinicopathological features of surgically resected cases of adenosquamous carcinoma of the pancreas. Methods From 2001 to 2011, 132 patients underwent R0 resection for Stage IIA or IIB pancreatic cancer. The survival rate, pathological features and recurrence status were reviewed. Results Out of 132 patients, 121 patients had tubular adenocarcinoma, and only seven had adenosquamous carcinoma (ASC). The incidence of ASC increased with the tumor size. The overall survival and disease-free survival periods of the patients with ASC were significantly shorter than those of patients with tubular adenocarcinoma (p = 0.0153 and p = 0.0045). The histological findings revealed more marked venous invasion in ASC compared to tubular adenocarcinoma (G1, G2 and G3). The proportion of v3 cases, which denotes the most severe venous invasion, was 31.3 % in G1, 47.3 % in G2, 60.0 % in G3 and 71.4 % in ASC cases, respectively. Other factors, including lymphatic and nerve invasion, were not correlated with the histological subtypes. The incidence of ASC was 11.1 % in the tumors more than 6 cm in diameter, and 0 % in those less than 2 cm in diameter. Conclusions We revealed that adenosquamous carcinoma of the pancreas is associated with a poor outcome, and also clarified its clinicopathological features.	[Komatsu, Hirotake; Egawa, Shinichi; Motoi, Fuyuhiko; Morikawa, Takanori; Sakata, Naoaki; Naitoh, Takeshi; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 9808574, Japan; [Ishida, Kazuyuki] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan	Unno, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	m_unno@surg1.med.tohoku.ac.jp	Unno, Michiaki/A-8633-2010; Naitoh, Takeshi/K-1693-2014	Unno, Michiaki/0000-0002-2145-6416; Naitoh, Takeshi/0000-0003-4169-6334			Castellsague X, 2006, J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Gallego MI, 2003, ONCOGENE, V22, P8498, DOI 10.1038/sj.onc.1207063; CIHAK RW, 1972, CANCER, V29, P1133, DOI 10.1002/1097-0142(197205)29:5<1133::AID-CNCR2820290503>3.0.CO;2-4; Kardon DE, 2001, MODERN PATHOL, V14, P443, DOI 10.1038/modpathol.3880332; TAKAMORI S, 1991, CANCER, V67, P649, DOI 10.1002/1097-0142(19910201)67:3<649::AID-CNCR2820670321>3.0.CO;2-B; Sternberg A, 2002, J CLIN PATHOL, V55, P17; [Anonymous], 2012, NCCN CLIN PRACTICE G; MOTOJIMA K, 1992, J SURG ONCOL, V49, P58, DOI 10.1002/jso.2930490114; Toyooka S, 2006, INT J CANCER, V118, P1588, DOI 10.1002/ijc.21500; Madura JA, 1999, ARCH SURG-CHICAGO, V134, P599, DOI 10.1001/archsurg.134.6.599; Katz MHG, 2011, J GASTROINTEST SURG, V15, P165, DOI 10.1007/s11605-010-1378-5; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Brody JR, 2009, MODERN PATHOL, V22, P651, DOI 10.1038/modpathol.2009.15; Niho S, 1999, JPN J CANCER RES, V90, P1244; Smoot RL, 2008, J AM COLL SURGEONS, V207, P368, DOI 10.1016/j.jamcollsurg.2008.03.027; Bastide K, 2010, LUNG CANCER, V68, P1, DOI 10.1016/j.lungcan.2009.11.001; NAUNHEIM KS, 1987, ANN THORAC SURG, V44, P462; Kanazawa H, 2000, AM J PATHOL, V156, P1289, DOI 10.1016/S0002-9440(10)64999-1; Monga SPS, 2002, CANCER RES, V62, P2064; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Cagir B, 1999, DIS COLON RECTUM, V42, P258, DOI 10.1007/BF02237138; Fukushima N, 2010, WHO CLASSIFICATION T, P292; HOFMANN HS, 1994, J CARDIOVASC SURG, V35, P543; Hruban RH, 2007, TUMORS PANCREAS, P165; Hsu JT, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-95; JAMIESON JD, 1981, CANCER, V47, P1516, DOI 10.1002/1097-0142(19810315)47:6+<1516::AID-CNCR2820471413>3.0.CO;2-9; Japan Pancreas Society, 2003, CLASS PANCR CARC, P29; Lee WA, 1999, PATHOL RES PRACT, V195, P747; MRSTIK C, 1992, J UROLOGY, V148, P271; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P6765, DOI 10.3748/wjg.14.6765; Rahemtullah A, 2003, CANCER CYTOPATHOL, V99, P372, DOI 10.1002/cncr.11855; Regi P, 2011, LANGENBECK ARCH SURG, V396, P217, DOI 10.1007/s00423-010-0677-3; Sobin LH, 2009, TNM CLASSIFICATION M, P132; Woo DK, 2000, PATHOL INT, V50, P690, DOI 10.1046/j.1440-1827.2000.01105.x; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	36	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					297	304		10.1007/s00595-014-0934-0		8	Surgery	Surgery	CD7OT	WOS:000351280800005		
J	Igami, T; Aoba, T; Ebata, T; Yokoyama, Y; Sugawara, G; Nagino, M				Igami, Tsuyoshi; Aoba, Taro; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Nagino, Masato			Single-incision laparoscopic cholecystectomy for cholecystitis requiring percutaneous transhepatic gallbladder drainage	SURGERY TODAY			English	Article						Single-incision laparoscopic cholecystectomy; Percutaneous transhepatic gallbladder drainage; Cholecystitis	TOKYO GUIDELINES; INITIAL-EXPERIENCE	Purpose Single-incision laparoscopic cholecystectomy (SILC) has been performed for patients with gallbladder stones but without acute cholecystitis. We report our experience of performing SILC for patients with cholecystitis requiring percutaneous transhepatic gallbladder drainage (PTGBD). Methods We performed SILC via an SILS-Port with additional 5-mm forceps through an umbilical incision in ten patients with cholecystitis requiring PTGBD. Results All procedures were completed successfully. The mean operative time was 124 min (range 78-169 min) and there were no intraoperative or postoperative complications. The mean postoperative hospital stay was 2.7 days. All patients were satisfied with the cosmetic results. Conclusions Our procedure may represent an alternative to conventional laparoscopic cholecystectomy (CLC) for patients who fervently demand the cosmetic advantages, despite cholecystitis requiring PTGBD. SILC should be performed carefully to avoid bile duct injury because the only advantage of SILC over CLC is cosmetic.	[Igami, Tsuyoshi; Aoba, Taro; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan	Igami, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	igami@med.nagoya-u.ac.jp					Antoniou SA, 2011, SURG ENDOSC, V25, P367, DOI 10.1007/s00464-010-1217-5; Yoshida M, 2007, J HEPATO-BILIARY-PAN, V14, P83, DOI 10.1007/s00534-006-1160-y; Hirano Y, 2010, WORLD J GASTROENTERO, V16, P270, DOI 10.3748/wjg.v16.i2.270; Chowbey PK, 2000, J LAPAROENDOSC ADV A, V10, P31, DOI 10.1089/lap.2000.10.31; Gangl O, 2011, LANGENBECK ARCH SURG, V396, P819, DOI 10.1007/s00423-011-0817-4; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Lai ECH, 2011, AM J SURG, V202, P254, DOI 10.1016/j.amjsurg.2010.12.009; Yamashita Y, 2007, J HEPATO-BILIARY-PAN, V14, P91, DOI 10.1007/s00534-006-1161-x; Merchant AM, 2009, J GASTROINTEST SURG, V13, P159, DOI 10.1007/s11605-008-0737-y; Khambaty F, 2011, WORLD J SURG, V35, P967, DOI 10.1007/s00268-011-0998-6; Bresadola F, 1999, EUR J SURG, V165, P29; Elsey JK, 2010, J AM COLL SURGEONS, V210, P620, DOI 10.1016/j.jamcollsurg.2009.12.030; Ersin S, 2010, SURG ENDOSC, V24, P68, DOI 10.1007/s00464-009-0543-y; Hyashi M, 2010, WORLD J SURG, V34, P2487; Iannelli A, 2010, SURG LAPARO ENDO PER, V20, pE89, DOI 10.1097/SLE.0b013e3181dbfe24; Kia MA, 2011, SURG LAPARO ENDO PER, V21, P314, DOI 10.1097/SLE.0b013e31822d00aa; Kirchniak A, 2009, SURG LAPARO ENDO PER, V19, P436; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Philipp SR, 2009, J AM COLL SURGEONS, V209, P632, DOI 10.1016/j.jamcollsurg.2009.07.020; Rawlings A, 2010, J AM COLL SURGEONS, V211, P1, DOI 10.1016/j.jamcollsurg.2010.02.038; Tsuyuguchi T, 2007, J HEPATO-BILIARY-PAN, V14, P46, DOI 10.1007/s00534-006-1155-8	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					305	309		10.1007/s00595-014-1003-4		5	Surgery	Surgery	CD7OT	WOS:000351280800006		
J	Furuhata, T; Okita, K; Nishidate, T; Ito, T; Yamaguchi, H; Ueki, T; Akizuki, E; Meguro, M; Ogawa, T; Kukita, K; Kimura, Y; Mizuguchi, T; Hirata, K				Furuhata, Tomohisa; Okita, Kenji; Nishidate, Toshihiko; Ito, Tatsuya; Yamaguchi, Hiroshi; Ueki, Tomomi; Akizuki, Emi; Meguro, Makoto; Ogawa, Tadashi; Kukita, Kazuharu; Kimura, Yasutoshi; Mizuguchi, Toru; Hirata, Koichi			Clinical feasibility of laparoscopic lateral pelvic lymph node dissection following total mesorectal excision for advanced rectal cancer	SURGERY TODAY			English	Article						Laparoscopy; Lateral pelvic lymph node dissection; Rectal cancer	COLORECTAL-CANCER; RECURRENCE; RESECTION; JAPAN	Purpose To evaluate the technical feasibility, safety and oncological outcomes of laparoscopic lateral pelvic lymph node dissection in patients with advanced low rectal cancer. Methods Laparoscopic lateral pelvic lymph node dissection was performed in 18 patients from November 2009 to September 2012. The data regarding the patient demographics, surgical outcomes and short-term oncological outcomes were analyzed. Results In all 18 patients, the procedures were completed without conversion to open surgery. The mean length of the operation was 603.7 min (473-746 min). The mean number of harvested lateral pelvic lymph nodes was 16.9 (7-27), and five patients (27.8 %) had lymph node metastases. The postoperative mortality and morbidity rates were 0 and 16.7 %, respectively. Three patients developed Grade 2 urinary retention. No local recurrence had developed after a mean follow-up period of 23.6 months. Conclusion Laparoscopic lateral pelvic lymph node dissection is technically feasible, safe and oncologically acceptable within the limitations of the short-term follow-up period.	[Furuhata, Tomohisa; Okita, Kenji; Nishidate, Toshihiko; Ito, Tatsuya; Yamaguchi, Hiroshi; Ueki, Tomomi; Akizuki, Emi; Meguro, Makoto; Ogawa, Tadashi; Kukita, Kazuharu; Kimura, Yasutoshi; Mizuguchi, Toru; Hirata, Koichi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Chuo Ku, Sapporo, Hokkaido, Japan	Furuhata, T (reprint author), Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Chuo Ku, South 1 West 16, Sapporo, Hokkaido, Japan.	furuhata@sapmed.ac.jp					Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Yano H, 2008, BRIT J SURG, V95, P33, DOI 10.1002/bjs.6061; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Kusters M, 2009, ANN SURG, V249, P229, DOI 10.1097/SLA.0b013e318190a664; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; Neudecker J, 2009, BRIT J SURG, V96, P1458, DOI 10.1002/bjs.6782; Buchanan GN, 2008, BRIT J SURG, V95, P893, DOI 10.1002/bjs.6019; Konishi T, 2011, SURG ENDOSC, V25, P2358, DOI 10.1007/s00464-010-1531-y; Liang JT, 2011, ANN SURG ONCOL, V18, P153, DOI 10.1245/s10434-010-1238-2; Moriya Y, 1997, WORLD J SURG, V21, P728; Obara Shinsaku, 2012, Gan To Kagaku Ryoho, V39, P2173; Park JS, 2011, SURG ENDOSC, V25, P3322, DOI 10.1007/s00464-011-1719-9; Takahashi T, 2000, DIS COLON RECTUM, V43, pS59, DOI 10.1007/BF02237228	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					310	314		10.1007/s00595-014-0906-4		5	Surgery	Surgery	CD7OT	WOS:000351280800007		
J	Shibutani, M; Maeda, K; Nagahara, H; Noda, E; Ohtani, H; Nishiguchi, Y; Hirakawa, K				Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Noda, Eiji; Ohtani, Hiroshi; Nishiguchi, Yukio; Hirakawa, Kosei			Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer	SURGERY TODAY			English	Article						Colorectal cancer; C-reactive protein; Stage IV; Survival	PREDICTS SURVIVAL; COLON-CANCER; LUNG-CANCER; CRP LEVELS; INFLAMMATION; CARCINOMA; INDICATOR; RESECTION; SYSTEM; RATIO	Purpose Previous studies have revealed that an elevated preoperative serum C-reactive protein (CRP) level is associated with a poor prognosis in patients with various malignant tumors. The aim of this study was to determine the clinical significance of the preoperative serum CRP level in patients with stage IV colorectal cancer. Methods We enrolled 144 patients who underwent surgery for stage IV colorectal cancer. A total of 53 patients with a serum CRP level of >= 1.0 mg/dl were classified as the high CRP individuals. The association between the preoperative serum CRP level and survival was retrospectively assessed. Results The cancer-specific survival of the patients with a high CRP level was significantly worse than that of the patients with a low CRP level. A multivariate analysis indicated that the curability (non-curative surgery), the number of organs with metastasis (more than one organ), the tumor diameter (>= 5 cm), lymphatic involvement, histological differentiation (non-differentiated) and a high CRP level (>= 1.0 mg/dl) were independent risk factors for a poor survival. Conclusions A high preoperative serum CRP level is a convenient biomarker for identifying patients with a poor prognosis for stage IV colorectal cancer.	[Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Noda, Eiji; Ohtani, Hiroshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan; [Nishiguchi, Yukio] Osaka Municipal Gen Med Ctr, Div Digest Surg, Miyakojima Ku, Osaka, Japan	Shibutani, M (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	fbxbj429@ybb.ne.jp					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Chiang SF, 2012, INT J COLORECTAL DIS, V27, P1347, DOI 10.1007/s00384-012-1459-x; NAKAZAKI H, 1992, CANCER, V70, P709, DOI 10.1002/1097-0142(19920801)70:3<709::AID-CNCR2820700328>3.0.CO;2-O; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Ishizuka M, 2009, J SURG ONCOL, V100, P38, DOI 10.1002/jso.21294; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/01.meg.0000050009.68425.1d; Toiyama Y, 2011, EXP THER MED, V2, P95, DOI 10.3892/etm.2010.175; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Ishizuka M, 2013, AM J SURG, V205, P22, DOI 10.1016/j.amjsurg.2012.04.012; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Nozoe T, 2008, SURG TODAY, V38, P597, DOI 10.1007/s00595-007-3680-8; Garcea G, 2011, WORLD J SURG, V35, P868, DOI 10.1007/s00268-011-0984-z; Toiyama Y, 2013, ONCOL LETT, V5, P1881, DOI 10.3892/ol.2013.1308; McCahill LE, 2012, J CLIN ONCOL, V30, P3223, DOI 10.1200/JCO.2012.42.4044; Lin MS, 2013, EXP THER MED, V6, P1369, DOI 10.3892/etm.2013.1350; Miki C, 2004, DIGEST DIS SCI, V49, P970, DOI 10.1023/B:DDAS.0000034556.48527.6e; Zimmerman MA, 2003, ARCH SURG-CHICAGO, V138, P220, DOI 10.1001/archsurg.138.2.220; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Ishizuka M, 2012, ANN SURG ONCOL, V19, P3422, DOI 10.1245/s10434-012-2384-5; Bystrom P, 2012, ACTA ONCOL, V51, P849, DOI 10.3109/0284186X.2012.705020; Fahmueller YN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-5; Ishizuka M, 2009, ANN SURG, V250, P268, DOI 10.1097/SLA.0b013e3181b16e24; Kemik O, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-85; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Nielsen HJ, 2000, ANN SURG ONCOL, V7, P617; Oka M, 1996, CANCER RES, V56, P2776; Read JA, 2006, NUTR CANCER, V55, P78, DOI 10.1207/s15327914nc5501_10; Sobin LH, 2009, TNM CLASSIFICATION M; Takasu C, 2013, HEPATO-GASTROENTEROL, V60, P507, DOI 10.5754/hge11425; van de Poll MCG, 2011, INT J COLORECTAL DIS, V26, P1067, DOI 10.1007/s00384-011-1187-7; Xu M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0319-4; Zacharakis M, 2010, ANTICANCER RES, V30, P653	37	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					315	321		10.1007/s00595-014-0909-1		7	Surgery	Surgery	CD7OT	WOS:000351280800008		
J	Jimi, S; Hotokezaka, M; Ikeda, T; Uchiyama, S; Hidaka, H; Maehara, N; Ishizaki, H; Chijiiwa, K				Jimi, Sei-ichiro; Hotokezaka, Masayuki; Ikeda, Takuto; Uchiyama, Shuichiro; Hidaka, Hideki; Maehara, Naoki; Ishizaki, Hidenobu; Chijiiwa, Kazuo			Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma	SURGERY TODAY			English	Article						Colorectal neoplasms; Mucinous colorectal cancer; Survival	MULTIVARIATE-ANALYSIS; COLLOID CARCINOMA; COLON-CANCER; 2 SUBTYPES; ADENOCARCINOMA; RECTUM; PATHOLOGY	Purpose To investigate the clinicopathological features and postoperative survival of patients with mucinous colorectal carcinoma (MC) and to identify the factors related to long-term survival. Methods Twenty-three patients who had undergone resection for MC at Miyazaki University Hospital from 1991 to 2006 were followed up for at least 5 years or until death. The effects of the clinicopathological variables on the 5-year cancer-specific survival were assessed by the univariate analyses. These patients' clinicopathological data were compared with those of 403 non-mucinous carcinoma (NMC) patients (102 well-differentiated adenocarcinomas, 301 moderately differentiated adenocarcinomas). Results The 5-year cancer-specific survival rate was significantly worse in MC (56.2 %) than in NMC (73.8 %; p = 0.008) cases. Univariate analyses showed the T factor, lymph node metastases, liver metastases, metastases to the distant peritoneum, remote metastases and curative resection to be significant factors predicting the survival. However, there were no significant differences in the postoperative survival in patients with stage II-IV disease. The rates of metastases to the distant peritoneum, M1, T4, a tumor size >= 5 cm and non-curative resection were higher in MC than in NMC patients. Conclusions Patients with MC had advanced stage cancer, especially with metastases to the distant peritoneum, more frequently than did the patients with NMC. To improve the survival of these patients, it is therefore important to detect MC at an early stage and to perform curative resection.	[Jimi, Sei-ichiro; Hotokezaka, Masayuki; Ikeda, Takuto; Uchiyama, Shuichiro; Hidaka, Hideki; Maehara, Naoki; Ishizaki, Hidenobu; Chijiiwa, Kazuo] Miyazaki Univ, Sch Med, Dept Surg 1, Miyazaki, Japan; [Hotokezaka, Masayuki] Junwakai Mem Hosp, Dept Surg, Miyazaki, Japan	Jimi, S (reprint author), Miyazaki Univ, Sch Med, Dept Surg 1, Miyazaki, Japan.	seiichirojimi@guitar.ocn.ne.jp					Agresti A., 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Du WB, 2004, DIS COLON RECTUM, V47, P78, DOI 10.1007/s10350-003-0014-9; Consorti F, 2000, J SURG ONCOL, V73, P70, DOI 10.1002/(SICI)1096-9098(200002)73:2<70::AID-JSO3>3.0.CO;2-J; HALVORSEN TB, 1988, J CLIN PATHOL, V41, P1068, DOI 10.1136/jcp.41.10.1068; OKUNO M, 1988, AM SURGEON, V54, P681; UMPLEBY HC, 1985, BRIT J SURG, V72, P715, DOI 10.1002/bjs.1800720915; GREEN JB, 1993, DIS COLON RECTUM, V36, P49, DOI 10.1007/BF02050301; SYMONDS DA, 1976, CANCER, V37, P1891, DOI 10.1002/1097-0142(197604)37:4<1891::AID-CNCR2820370439>3.0.CO;2-Z; Wu CS, 1996, J GASTROEN HEPATOL, V11, P77, DOI 10.1111/j.1440-1746.1996.tb00014.x; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Shin US, 2011, ANN SURG ONCOL, V18, P2232, DOI 10.1245/s10434-011-1612-8; Kanemitsu Y, 2003, DIS COLON RECTUM, V46, P160, DOI 10.1097/01.DCR.0000044721.76711.6D; Nozoe T, 2000, J SURG ONCOL, V75, P103, DOI 10.1002/1096-9098(200010)75:2<103::AID-JSO6>3.0.CO;2-C; BERG JW, 1974, J SURG ONCOL, V6, P381, DOI 10.1002/jso.2930060503; Hotokezaka M, 2008, SURG TODAY, V38, P784, DOI 10.1007/s00595-007-3723-1; Ikeda S, 2003, CLIN CANCER RES, V9, P5660; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Jass JR, 1989, HISTOLOGICAL TYPE IN; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keswani SG, 2002, AM SURGEON, V68, P871; Kubota K, 2004, HEPATO-GASTROENTEROL, V51, P142; Messerini L, 1999, HUM PATHOL, V30, P629, DOI 10.1016/S0046-8177(99)90086-2; MINSKY BD, 1987, CANCER, V60, P3103, DOI 10.1002/1097-0142(19871215)60:12<3103::AID-CNCR2820601241>3.0.CO;2-6; Parham D, 1923, ANN SURG, V77, P90; PIHL E, 1980, PATHOLOGY, V12, P439; Sobin LH, 2009, TNM CLASSIFICATION M; YAMAMOTO S, 1993, AM J SURG, V166, P257, DOI 10.1016/S0002-9610(05)80969-9	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					329	334		10.1007/s00595-014-0943-z		6	Surgery	Surgery	CD7OT	WOS:000351280800010		
J	Yasuda, T; Yano, M; Miyata, H; Yamasaki, M; Higuchi, I; Takiguchi, S; Fujiwara, Y; Doki, Y				Yasuda, Takushi; Yano, Masahiko; Miyata, Hiroshi; Yamasaki, Makoto; Higuchi, Ichiro; Takiguchi, Shuji; Fujiwara, Yoshiyuki; Doki, Yuichiro			Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with F-18-fluorodeoxyglucose positron emission tomography-positive lymph nodes	SURGERY TODAY			English	Article						Neoadjuvant chemotherapy; Esophageal squamous cell carcinoma; Lymph node metastasis; Positron emission tomography; Response evaluation; Survival benefit	RADICAL ESOPHAGECTOMY; RECURRENCE PATTERN; NERVE CHAIN; CANCER; CISPLATIN; SURGERY; TRIAL; LYMPHADENECTOMY; FLUOROURACIL; DISSECTION	Purpose F-18-fluorodeoxyglucose positron emission tomography-positive lymph nodes (PET-N positive) in patients with resectable thoracic esophageal squamous cell carcinoma (TESCC) are associated with a high rate of postoperative distant recurrence. The purpose of this study was to evaluate the systemic control and survival benefit of neoadjuvant chemotherapy (NAC, cisplatin + doxorubicin + 5-fluorouracil) in these patients. Methods Of 77 patients with resectable TESCC who were PET-N positive, we evaluated 51 treated with NAC + surgery in this study and 26 who had undergone surgery alone (SA) in a previous study. Historical comparisons of the groups were made, and the response to treatment was evaluated in the NAC group. Results The NAC group had a higher rate of pN0-1 and a lower rate of postoperative recurrence (p < 0.0001 and p < 0.024, respectively) than the SA group; however, their relapse-free survival (RFS) rates were not significantly different. The NAC group had a significantly higher RFS in cT1/T2 cases, but showed similar survival in cT3 cases. On the other hand, post-treatment PET-N-negative patients had a higher RFS (p = 0.008) and a lower rate of distant recurrence (p = 0.021), even with cT3 disease. A multi-variate analysis identified the post-treatment PET-N evaluation to be the only significant predictor of the RFS in cT3 cases. Conclusions NAC significantly suppressed postoperative recurrence in TESCC PET-N-positive patients, but the survival benefit was unclear. However, post-treatment PET-N-negative patients were likely responders to NAC.	[Yasuda, Takushi] Kinki Univ, Fac Med, Dept Surg, Osakasayama, Osaka 5898511, Japan; [Yano, Masahiko; Fujiwara, Yoshiyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg Gastroenterol, Osaka, Japan; [Miyata, Hiroshi; Yamasaki, Makoto; Higuchi, Ichiro; Takiguchi, Shuji; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan	Yasuda, T (reprint author), Kinki Univ, Fac Med, Dept Surg, 377-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan.	tyasuda@surg.med.kindai.ac.jp					Akita H, 2006, J SURG ONCOL, V93, P401, DOI 10.1002/jso.20501; Allum AH, 2009, J CLIN ONCOL, V27, P5062; Miyata H, 2006, J SURG ONCOL, V93, P477, DOI 10.1002/jso.20453; Nakagawa S, 2004, J AM COLL SURGEONS, V198, P205, DOI 10.1016/j.jamcollsurg.2003.10.005; Higuchi I, 2008, J THORAC CARDIOV SUR, V136, P205, DOI 10.1016/j.jtcvs.2008.02.016; Roth AD, 2007, J CLIN ONCOL, V25, P3217, DOI 10.1200/JCO.2006.08.0135; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; [Anonymous], 1979, WHO OFFSET PUBLICATI, P48; Chen G, 2007, WORLD J SURG, V31, P1107, DOI 10.1007/s00268-006-0551-1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Boonstra JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-181; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Dresner SM, 2000, BRIT J SURG, V87, P1426, DOI 10.1046/j.1365-2168.2000.01541.x; Fukunaga H, 2002, INT J ONCOL, V20, P691; Greene FL, 2002, AJCC CANC STAGING MA; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; Kelsen DP, 1991, SEMIN SURG ONCOL, V14, P13; Komori T, 2003, J SURG ONCOL, V82, P19, DOI 10.1002/jso.10184; Malthaner RA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001556.pub2; Paul AK, 2003, NUCL MED COMMUN, V24, P963, DOI 10.1097/01.mnm.0000090425.24184.e9; Sobin LH, 2002, TNM CLASSIFICATION M; Yasuda T, 2012, ANN SURG ONCOL, V19, P652, DOI 10.1245/s10434-011-1928-4; Yoon CY, 2003, RADIOLOGY, V227, P764	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					335	345		10.1007/s00595-014-0956-7		11	Surgery	Surgery	CD7OT	WOS:000351280800011		
J	Yoshida, N; Baba, Y; Watanabe, M; Ida, S; Ishimoto, T; Karashima, R; Iwagami, S; Imamura, Y; Sakamoto, Y; Miyamoto, Y; Baba, H				Yoshida, Naoya; Baba, Yoshifumi; Watanabe, Masayuki; Ida, Satoshi; Ishimoto, Takatsugu; Karashima, Ryuichi; Iwagami, Shiro; Imamura, Yu; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo			An original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer	SURGERY TODAY			English	Article						Scoring system; Esophageal cancer; Esophagectomy; Postoperative morbidity; Surgery	PULMONARY COMPLICATIONS; RISK-ASSESSMENT; MORTALITY; SURVIVAL; SURGERY; VOLUME; CHEMORADIOTHERAPY; PROGNOSIS; CARCINOMA; RESECTION	Purpose Postoperative morbidity remains common after esophagectomy. There are currently few tools that can be used to estimate the incidence of complications. This study aimed to create a novel scoring system for predicting postoperative morbidity. Methods A total of 365 patients who underwent elective esophagectomy with two-or three-field lymphadenectomy for esophageal cancer were retrospectively analyzed. Patients were divided into development (n = 250) and validation datasets (n = 115). A scoring system was established by specifying the expected morbidity incidence values for all independent predictors in the development dataset, after which, the reproducibility was confirmed in the validation dataset. Results The incidence of any morbidity was 44.7 %. Male sex, severe emaciation (body mass index <18), a lower performance status (grade 1 or 2), operation >= 540 min and massive bleeding (blood loss/body weight >= 20) were independent predictors of postoperative morbidity. The total of all predictive scores was calculated. The incidence of any morbidity and of severe morbidity (Clavien-Dindo classification >= IIIb) significantly correlated with the score after dividing the scores into three groups (<= 8, 10 and 11 and >= 13). This finding was also confirmed in the validation dataset. Conclusion The current scoring system is considered to be useful for predicting postoperative morbidity after esophagectomy.	[Yoshida, Naoya; Baba, Yoshifumi; Ida, Satoshi; Ishimoto, Takatsugu; Karashima, Ryuichi; Iwagami, Shiro; Imamura, Yu; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, Kumamoto 8608556, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Hsu FM, 2009, ANN SURG ONCOL, V16, P1669, DOI 10.1245/s10434-009-0401-0; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dutta S, 2011, ANN SURG ONCOL, V18, P2808, DOI 10.1245/s10434-011-1676-5; Rodgers M, 2007, ARCH SURG-CHICAGO, V142, P829, DOI 10.1001/archsurg.142.9.829; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Wright CD, 2009, J THORAC CARDIOV SUR, V137, P587, DOI 10.1016/j.jtcvs.2008.11.042; Schweigert M, 2013, AM SURGEON, V79, P754; Blank S, 2013, LANGENBECK ARCH SURG, V398, P211, DOI 10.1007/s00423-012-1034-5; Lagarde SM, 2008, ANN THORAC SURG, V85, P1938, DOI 10.1016/j.athoracsur.2008.03.014; Merkow RP, 2012, ARCH SURG-CHICAGO, V147, P1009, DOI 10.1001/2013.jamasurg.96; Ferguson MK, 2011, DIS ESOPHAGUS, V24, P510, DOI 10.1111/j.1442-2050.2011.01185.x; Bakhos CT, 2012, ANN THORAC SURG, V93, P221, DOI 10.1016/j.athoracsur.2011.07.030; Noble F, 2012, J GASTROINTEST SURG, V16, P1083, DOI 10.1007/s11605-012-1867-9; Schieman C, 2012, DIS ESOPHAGUS, V25, P645, DOI 10.1111/j.1442-2050.2011.01304.x; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Morita M, 2013, ANTICANCER RES, V33, P1641; Grotenhuis BA, 2010, ANN THORAC SURG, V90, P920, DOI 10.1016/j.athoracsur.2010.06.024; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.245561c; Grotenhuis BA, 2010, J SURG ONCOL, V101, P270, DOI 10.1002/jso.21471; Paul DJ, 2011, ANZ J SURG, V81, P700, DOI 10.1111/j.1445-2197.2010.05598.x; Yoshida N, 2014, SURG TODAY, V44, P526, DOI 10.1007/s00595-013-0577-6; Tachimori Y, 2009, J THORAC CARDIOV SUR, V137, P49, DOI 10.1016/j.jtcvs.2008.05.016; Bohanes P, 2012, J CLIN ONCOL, V30, P2265, DOI 10.1200/JCO.2011.38.8751; Dhungel B, 2010, J GASTROINTEST SURG, V14, P1492, DOI 10.1007/s11605-010-1328-2; Edge S, 2009, AJCC CANC STAGING MA; Findlay JM, 2014, ANN SURG, V259, P413, DOI 10.1097/SLA.0000000000000349; GOLDFADEN D, 1986, J THORAC CARDIOV SUR, V91, P242; Hidaka H, 2007, WORLD J SURG, V31, P1982, DOI 10.1007/s00268-007-9193-1; Koide N, 2011, ESOPHAGUS-TOKYO, V8, P107, DOI 10.1007/s10388-011-0271-y; Morita M, 2014, SURG TODAY, V44, P505, DOI 10.1007/s00595-013-0573-x; Nakamura M, 2008, LANGENBECK ARCH SURG, V393, P127, DOI 10.1007/s00423-007-0253-7; Society of Thoracic Surgeons, 2013, RISK ADJ MORB MORT E; Sunpaweravong S, 2012, ASIAN J SURG, V35, P104, DOI 10.1016/j.asjsur.2012.04.029; Takemura M, 2013, ANTICANCER RES, V33, P601; The National Cancer Institute, 2010, COMM TERM CRIT ADV E; Thompson AM, 2007, BRIT J SURG, V94, P578, DOI 10.1002/bjs.5729; Valenti V, 2011, CLIN TRANSL ONCOL, V13, P899, DOI 10.1007/s12094-011-0752-4; Yoshida N, 2013, ESOPHAGUS-TOKYO, V10, P86, DOI 10.1007/s10388-013-0369-5; Zingg U, 2011, ANN SURG ONCOL, V18, P1460, DOI 10.1245/s10434-010-1474-5	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					346	354		10.1007/s00595-014-0958-5		9	Surgery	Surgery	CD7OT	WOS:000351280800012		
J	Ichida, A; Sakamoto, Y; Akahane, M; Ishizawa, T; Kaneko, J; Aoki, T; Hasegawa, K; Sugawara, Y; Kokudo, N				Ichida, Akihiko; Sakamoto, Yoshihiro; Akahane, Masaaki; Ishizawa, Takeaki; Kaneko, Junichi; Aoki, Taku; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Kokudo, Norihiro			A successful case of pancreaticoduodenectomy with resection of the hepatic arteries preserving a single aberrant hepatic artery for a pancreatic neuroendocrine tumor: report of a case	SURGERY TODAY			English	Article						Gastrinoma; Pancreaticoduodenectomy; Arterial resection; Aberrant hepatic artery	PREOPERATIVE EMBOLIZATION; CANCER; SURGERY	A 65-year-old male with a pancreatic neuroendocrine tumor presenting with a duodenal ulcer was referred to our department. The tumor involved the common hepatic artery, gastroduodenal artery, left hepatic artery and the right posterior hepatic artery, but not the right anterior hepatic artery originating from the superior mesenteric artery. The hepatic arteries, except the aberrant right anterior hepatic artery, were embolized using coils 18 days before the surgery. The patient underwent pancreaticoduodenectomy with resection of the tumor-encased hepatic arteries, while preserving the aberrant artery. The patient was discharged uneventfully on postoperative day 13 with no ischemic complications. A histopathological examination revealed a grade 2 pancreatic neuroendocrine tumor according to the classification of the World Health Organization, and the surgical margin was negative. The patient developed hepatic metastases 16 months after surgery; hence, hepatic resection was performed. The present surgical strategy is applicable in patients with relatively low-grade pancreatic malignancies involving major hepatic arteries.	[Ichida, Akihiko; Sakamoto, Yoshihiro; Ishizawa, Takeaki; Kaneko, Junichi; Aoki, Taku; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Surg Div, Grad Sch Med,Dept Surg,Bunkyo Ku, Tokyo 1138655, Japan; [Akahane, Masaaki] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Surg Div, Grad Sch Med,Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ichida-tky@umin.ac.jp; KOKUDO-2SU@h.u-tokyo.ac.jp					Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Amano H, 2009, J HEPATO-BILIARY-PAN, V16, P850, DOI 10.1007/s00534-009-0190-7; Vellar ID, 1999, AUST NZ J SURG, V69, P816, DOI 10.1046/j.1440-1622.1999.01702.x; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Stitzenberg KB, 2008, ANN SURG ONCOL, V15, P1399, DOI 10.1245/s10434-008-9844-y; Kondo S, 2000, HEPATO-GASTROENTEROL, V47, P1447; Miyamoto N, 2004, SURG TODAY, V34, P619, DOI 10.1007/s00595-004-2785-6; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; TRAVERSO LW, 1989, AM SURGEON, V55, P421; Bosman FT, 2010, WHO CLASSIFICATION T; Cloyd JM, 2012, J SURG ONCOL, V106, P509, DOI 10.1002/jso.23082; Marangoni G, 2011, SURG 10 SCOTLAND 201, P102; Mizuno S, 2012, SURG TODAY, V42, P482, DOI 10.1007/s00595-011-0018-3; Norton JA, 2011, ARCH SURG-CHICAGO, V146, P724, DOI 10.1001/archsurg.2011.129; Sasaki Y, 2011, AM SURGEON, V77, pE269	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					363	368		10.1007/s00595-014-0837-0		6	Surgery	Surgery	CD7OT	WOS:000351280800014		
J	Ibuki, Y; Hamai, Y; Hihara, J; Taomoto, J; Kishimoto, I; Miyata, Y; Okada, M				Ibuki, Yuta; Hamai, Yoichi; Hihara, Jun; Taomoto, Junya; Kishimoto, Ichiko; Miyata, Yoshihiro; Okada, Morihito			Emergency escape surgery for a gastro-bronchial fistula with respiratory failure that developed after esophagectomy	SURGERY TODAY			English	Article						Esophageal cancer; Gastric tube ulcer; Two-stage operation	SUBTOTAL ESOPHAGECTOMY; CANCER; TUBE; COMPLICATION; REPAIR; ULCER; FLAP	A gastro-bronchial fistula (GBF) is a rare complication after esophageal reconstruction using a gastric tube, but it can cause severe pneumonia, and the surgical procedure is challenging. We herein describe a patient who was successfully managed using a two-stage operation for a GBF. Because the patient had life-threatening pneumonia and respiratory failure caused by the GBF, we first transected the duodenum, established a cervical esophagostomy and gastrostomy and placed a decompression catheter in the gastric tube without a thoracotomy. The patient recovered from pneumonia after the resolution of the salivary inflow and digestive juice reflux into the lungs through the GBF. Two months later, an esophageal bypass was achieved by reconstructing the esophagus using a long segment of pedicled jejunum. The patient was discharged 38 days thereafter. Appropriate treatment for GBF should be tailored to individual patients based on their current status and disease severity.	[Ibuki, Yuta; Hamai, Yoichi; Hihara, Jun; Taomoto, Junya; Kishimoto, Ichiko; Miyata, Yoshihiro; Okada, Morihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, Hiroshima 7348551, Japan	Hihara, J (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	x06357@yahoo.co.jp; hihara@hiroshima-u.ac.jp					AIKO S, 1993, J CLIN GASTROENTEROL, V17, pS161, DOI 10.1097/00004836-199312001-00028; Yoshida K, 2006, CLIN CANCER RES, V12, P3402, DOI 10.1158/1078-0432.CCR-05-2425; Song SW, 2006, J THORAC CARDIOV SUR, V132, P716, DOI 10.1016/j.jtevs.2006.05.030; Bartels HE, 1998, BRIT J SURG, V85, P403; Aoki Y, 2012, SURG TODAY, V42, P1088, DOI 10.1007/s00595-012-0323-5; Buskens CJ, 2001, ANN THORAC SURG, V72, P221, DOI 10.1016/S0003-4975(01)02701-1; Fayoumi S, 2007, J THORAC CARDIOV SUR, V133, P1103, DOI 10.1016/j.jtcvs.2006.10.041; Jha Pankaj K, 2003, Interact Cardiovasc Thorac Surg, V2, P6, DOI 10.1016/S1569-9293(02)00065-8; Kalmar K, 2000, EUR J CARDIO-THORAC, V18, P363, DOI 10.1016/S1010-7940(00)00520-0; Kubota H, 2009, ESOPHAGUS-TOKYO, V6, P133, DOI 10.1007/s10388-008-0183-7; Martin-Smith JD, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-20; MCDERMOTT M, 1993, J CLIN PATHOL, V46, P483, DOI 10.1136/jcp.46.5.483; Nardella JE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-69; Piessen G, 2007, DIS ESOPHAGUS, V20, P542, DOI 10.1111/j.1442-2050.2007.00706.x; Pramesh CS, 2001, DIS ESOPHAGUS, V14, P271, DOI 10.1046/j.1442-2050.2001.00201.x; Sobin LH, 2002, TNM CLASSIFICATION M; Yasuda T, 2012, DIS ESOPHAGUS, V25, P687, DOI 10.1111/j.1442-2050.2011.01309.x; Zheng YZ, 2012, WORLD J GASTROENTERO, V18, P5616, DOI 10.3748/wjg.v18.i39.5616	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					369	373		10.1007/s00595-013-0821-0		5	Surgery	Surgery	CD7OT	WOS:000351280800015		
J	Chen, FS; Nakamoto, Y; Kondo, T; Yamada, T; Sato, M; Aoyama, A; Bando, T; Date, H				Chen, Fengshi; Nakamoto, Yuji; Kondo, Takeshi; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Bando, Toru; Date, Hiroshi			Gastroparesis after living-donor lobar lung transplantation: report of five cases	SURGERY TODAY			English	Article						Complications; Gastroparesis; Living-donor lobar lung transplantation; Lung transplantation	COMPLICATIONS; MANAGEMENT	Gastroparesis is a challenging gastrointestinal complication of deceased-donor lung transplantation and heart-lung transplantation, but it has not been reported after living-donor lobar lung transplantation (LDLLT). To better understand this complication after LDLLT, we reviewed our institutional experiences. Among the 32 patients who survived for at least 3 months after LDLLT, five (16 %) developed symptomatic gastroparesis. All five patients had undergone bilateral LDLLT, and gastroparesis was diagnosed within 2 months after transplantation. Neither adult patients who received single lobar LDLLT nor pediatric patients who received either bilateral or single lobar LDLLT developed gastroparesis. Although gastroparesis-related symptoms improved after medical treatment in three patients, two patients died of complications related to gastroparesis. We conclude that gastroparesis can occur after LDLLT and may cause grave complications unless carefully managed.	[Chen, Fengshi; Kondo, Takeshi; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Bando, Toru; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan; [Nakamoto, Yuji] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan	Chen, FS (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	fengshic@kuhp.kyoto-u.ac.jp; hdate@kuhp.kyoto-u.ac.jp					Akindipe OA, 2000, CHEST, V117, P907, DOI 10.1378/chest.117.3.907; Chen FS, 2012, SURG TODAY, V42, P808, DOI 10.1007/s00595-012-0151-7; Tang DM, 2011, DM-DIS MON, V57, P74, DOI 10.1016/j.disamonth.2010.12.007; Date H, 2004, J THORAC CARDIOV SUR, V128, P933, DOI 10.1016/j.jtcvs.2004.07.032; Eagle DA, 2001, BONE MARROW TRANSPL, V28, P59, DOI 10.1038/sj.bmt.1703084; Chen F, 2011, AM J TRANSPLANT, V11, P1509, DOI 10.1111/j.1600-6143.2011.03591.x; Austin JHM, 2000, J THORAC IMAG, V15, P65, DOI 10.1097/00005382-200001000-00013; BERKOWITZ N, 1995, CHEST, V108, P1602, DOI 10.1378/chest.108.6.1602; MORGAN KG, 1980, J PHYSIOL-LONDON, V301, P229; Olufemi AA, 2000, CHEST, V111, P907; Paul S, 2009, J HEART LUNG TRANSPL, V28, P475, DOI 10.1016/j.healun.2009.02.011; Raviv Y, 2012, CLIN TRANSPLANT, V26, P133, DOI 10.1111/j.1399-0012.2011.01434.x; Shiraishi Takeshi, 2009, Gen Thorac Cardiovasc Surg, V57, P395, DOI 10.1007/s11748-008-0424-7; STARNES VA, 1994, J THORAC CARDIOV SUR, V108, P403; Toussaint E, 2012, ENDOSCOPY, V44, P772, DOI 10.1055/s-0032-1309735; Weinkauf Justin G, 2005, J Heart Lung Transplant, V24, P1444; Yiannopoulos A, 2004, J HEART LUNG TRANSPL, V23, P371, DOI 10.1016/S1053-2498(03)00188-8	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					378	382		10.1007/s00595-013-0817-9		5	Surgery	Surgery	CD7OT	WOS:000351280800017		
J	Iimuro, Y; Suzumura, K; Ohashi, K; Tanaka, H; Iijima, H; Nishiguchi, S; Hao, H; Fujimoto, J				Iimuro, Yuji; Suzumura, Kazuhiro; Ohashi, Koichiro; Tanaka, Hironori; Iijima, Hiroko; Nishiguchi, Shuhei; Hao, Hiroyuki; Fujimoto, Jiro			Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case	SURGERY TODAY			English	Article						Portal venous aneurysm; Computational flow dynamics; Extrahepatic; Reconstruction	VEIN ANEURYSM; VENOUS SYSTEM; THROMBOSIS; RUPTURE	Aneurysms in the portal venous system are relatively rare. We report the case of an extrahepatic portal venous aneurysm, detected incidentally by ultrasonography. The patient, a 75-year-old woman, was initially observed over 18 months, during which time, the aneurysm grew from 36 mm x 32 mm to 51 mm x 37 mm in size, without symptoms. Hemodynamic analysis employing computational flow dynamics technique showed obvious turbulence in the aneurysm, and the wall shear stress (WSS) against that part of the aneurysmal wall was greater than in other sites. To prevent complications such as spontaneous rupture and portal vein thrombosis, the aneurysm was resected, with reconstruction of the portal trunk. While careful follow-up is sufficient for most portal venous aneurysms, its enlargement could indicate possible spontaneous rupture. The increased WSS against part of the aneurysmal wall most likely accounts for the aneurysm enlargement in this case.	[Iimuro, Yuji; Suzumura, Kazuhiro; Ohashi, Koichiro; Fujimoto, Jiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Tanaka, Hironori; Iijima, Hiroko; Nishiguchi, Shuhei] Hyogo Coll Med, Dept Med, Nishinomiya, Hyogo 6638501, Japan; [Hao, Hiroyuki] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan	Iimuro, Y (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	siimuro@hyo-med.ac.jp					Gallego C, 2002, RADIOGRAPHICS, V22, P141; Jin B, 2005, WORLD J GASTROENTERO, V11, P2206; Cho SW, 2008, J GASTROINTEST SURG, V12, P145, DOI 10.1007/s11605-007-0313-x; THOMAS TV, 1967, SURGERY, V61, P550; Brock PA, 1997, SURGERY, V121, P105, DOI 10.1016/S0039-6060(97)90190-2; Koc Z, 2007, AM J ROENTGENOL, V189, P1023, DOI 10.2214/AJR.07.2121; BARZILAI R, 1956, ARCH SURG-CHICAGO, V72, P725; Santana P, 2002, J ULTRAS MED, V21, P701; Flis Vojko, 2003, HPB (Oxford), V5, P188, DOI 10.1080/13651820310001351; Iimuro Y, 2007, HEPATOLOGY, V46, p429A; Lall Chandana, 2012, J Clin Imaging Sci, V2, P54, DOI 10.4103/2156-7514.100377; Ma Ruichong, 2012, Int J Surg Case Rep, V3, P555, DOI 10.1016/j.ijscr.2012.07.009; Shimoda M, 2003, J GASTROINTEST SURG, V7, P683, DOI 10.1016/S1091-255X(03)00028-3	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					383	389		10.1007/s00595-014-0882-8		7	Surgery	Surgery	CD7OT	WOS:000351280800018		
J	Shimizu, K; Hashimoto, D; Abe, S; Chikamoto, A; Baba, H				Shimizu, Kenji; Hashimoto, Daisuke; Abe, Shinya; Chikamoto, Akira; Baba, Hideo			Pancreas-preserving partial duodenectomy of the distal region for large duodenal adenoma: report of a case	SURGERY TODAY			English	Article						Duodenal adenoma; Operation; Duodenectomy	SPARING DUODENECTOMY; SURGICAL-TREATMENT; LEIOMYOSARCOMA; PATHOLOGY; NEOPLASMS; TUMOR	For neoplasms in the third and fourth parts of the duodenum, a duodenectomy that preserves the pancreas may provide feasible tumor clearance while avoiding the additional dissection and pancreaticoduodenectomy. We herein describe the case of a 40-year-old male patient with an adenoma in the third part of the duodenum. The patient underwent a partial duodenectomy of the distal region, preserving the pancreas and Vater's papilla. The residual duodenum and jejunum were successfully reconstructed by an end-to-side anastomosis. We also present a review of the English literature regarding pancreas-preserving partial duodenectomy of the distal region.	[Shimizu, Kenji; Hashimoto, Daisuke; Abe, Shinya; Chikamoto, Akira; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Ammori B J, 2002, Surg Endosc, V16, P1362; Azih LC, 2013, WORLD J GASTROENTERO, V19, P511, DOI 10.3748/wjg.v19.i4.511; Cavaniglia D, 2012, AM SURGEON, V78, pE273; CHUNG RS, 1995, SURGERY, V117, P254, DOI 10.1016/S0039-6060(05)80198-9; Eisenberger C, 2004, HEPATO-GASTROENTEROL, V51, P727; KAWANO N, 1995, JPN J CLIN ONCOL, V25, P109; Keidar S, 2000, DIGEST SURG, V17, P508, DOI 10.1159/000051949; Maher MM, 1996, AM J SURG, V171, P62, DOI 10.1016/S0002-9610(99)80075-0; Orda R, 2000, DIGEST SURG, V17, P410, DOI 10.1159/000018890; Sarmiento JM, 2002, ARCH SURG-CHICAGO, V137, P562; Sarmiento JM, 2002, ARCH SURG-CHICAGO, V137, P557, DOI 10.1001/archsurg.137.5.557; Sohn T A, 1998, J Gastrointest Surg, V2, P79, DOI 10.1016/S1091-255X(98)80107-8; Spalding DRC, 2007, ANN ROY COLL SURG, V89, P130, DOI 10.1308/003588407X155815; Stauffer JA, 2013, PANCREAS, V42, P461, DOI 10.1097/MPA.0b013e3182649956; Suzuki H, 1999, J Hepatobiliary Pancreat Surg, V6, P414, DOI 10.1007/s005340050142; Waisberg Jaques, 2013, Arquivos de Gastroenterologia, V50, P3, DOI 10.1590/S0004-28032013000100002; Yamada S, 2012, SURG TODAY, V42, P857, DOI 10.1007/s00595-012-0169-x	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					390	393		10.1007/s00595-014-0868-6		4	Surgery	Surgery	CD7OT	WOS:000351280800019		
J	Sakamoto, Y; Karashima, R; Ida, S; Imamura, Y; Iwagami, S; Baba, Y; Miyamoto, Y; Yoshida, N; Baba, H				Sakamoto, Yasuo; Karashima, Ryuichi; Ida, Satoshi; Imamura, Yu; Iwagami, Shiro; Baba, Yoshifumi; Miyamoto, Yuji; Yoshida, Naoya; Baba, Hideo			Diagnostic laparoscopic biopsy for intraabdominal tumors	SURGERY TODAY			English	Article						Laparoscopic biopsy; Intraabdominal tumor	LYMPH-NODE DISSECTION; GERM-CELL TUMORS; LYMPHOPROLIFERATIVE DISEASES	Improvements in imaging technology have resulted in an increase in the incidental detection of intraabdominal tumors. Diagnostic computed tomography (CT)- and ultrasound (US)-guided biopsy, while minimally invasive, often provides specimens that are insufficient for histological evaluation. Moreover, it can be difficult to perform because the location and size of the tumor. In such cases, laparoscopic biopsy is useful because it is less invasive than laparotomy, but more reliable than imaging-guided biopsy, to obtain a sufficient specimen, regardless of the location and size of the tumor. We report a series of seven patients who underwent laparoscopic biopsy of intraabdominal tumors of unknown origin. There were no cases of conversion to laparotomy and all patients were able to resume oral intake on postoperative day 1. There were no intraoperative or postoperative complications. Thus, laparoscopic biopsy for a tumor of unknown origin is useful and minimally invasive.	[Sakamoto, Yasuo; Karashima, Ryuichi; Ida, Satoshi; Imamura, Yu; Iwagami, Shiro; Baba, Yoshifumi; Miyamoto, Yuji; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Janda M, 2010, LANCET ONCOL, V11, P772, DOI 10.1016/S1470-2045(10)70145-5; Asoglu O, 2005, MAYO CLIN PROC, V80, P625; Carver BS, 2005, NAT CLIN PRACT UROL, V2, P330, DOI 10.1038/ncpuro0226; Cowles RA, 2000, J AM COLL SURGEONS, V191, P108, DOI 10.1016/S1072-7515(00)00279-9; Diulus L, 2009, SURG ENDOSC, V23, P389, DOI 10.1007/s00464-008-9935-7; Finelli A, 2008, CURR OPIN UROL, V18, P180, DOI 10.1097/MOU.0b013e3282f4a880; Hara I, 2007, INT J UROL, V14, P466, DOI 10.1111/j.1442-2042.2007.01738.x; Kornblith AB, 2009, J CLIN ONCOL, V27, P5337, DOI 10.1200/JCO.2009.22.3529; Peter S, 2009, GASTROINTEST ENDOSC, V70, P1266, DOI 10.1016/j.gie.2009.05.031; Silecchia G, 1999, AM J SURG, V177, P325, DOI 10.1016/S0002-9610(99)00056-2; Silecchia G, 2003, WORLD J SURG, V27, P653, DOI 10.1007/s00268-003-6692-6; VANSONNENBERG E, 1981, AM J ROENTGENOL, V137, P757	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAR	2015	45	3					394	396		10.1007/s00595-014-1027-9		3	Surgery	Surgery	CD7OT	WOS:000351280800020		
J	Kogawa, T; Doi, A; Shimokawa, M; Fouad, TM; Osuga, T; Tamura, F; Mizushima, T; Kimura, T; Abe, S; Ihara, H; Kukitsu, T; Sumiyoshi, T; Yoshizaki, N; Hirayama, M; Sasaki, T; Kawarada, Y; Kitashiro, S; Okushiba, S; Kondo, H; Tsuji, Y				Kogawa, T.; Doi, A.; Shimokawa, M.; Fouad, T. M.; Osuga, T.; Tamura, F.; Mizushima, T.; Kimura, T.; Abe, S.; Ihara, H.; Kukitsu, T.; Sumiyoshi, T.; Yoshizaki, N.; Hirayama, M.; Sasaki, T.; Kawarada, Y.; Kitashiro, S.; Okushiba, S.; Kondo, H.; Tsuji, Y.			Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer	TARGETED ONCOLOGY			English	Article						Colorectal cancer; Cetuximab; Early skin reaction; Early tumor shrinkage	PLUS IRINOTECAN; RECEIVING CETUXIMAB; TRIAL; KRAS; CHEMOTHERAPY; OXALIPLATIN; LEUCOVORIN; 1ST-LINE; FLUOROURACIL; THERAPY	Cetuximab-containing treatments for metastatic colorectal cancer have been shown to have higher overall response rates and longer progression-free and overall survival than other systemic therapies. Cetuximab-related manifestations, including severe skin toxicity and early tumor shrinkage, have been shown to be predictors of response to cetuximab. We hypothesized that early skin toxicity is a predictor of response and better outcomes in patients with advanced colorectal carcinoma. We retrospectively evaluated 62 patients with colorectal adenocarcinoma who had unresectable tumors and were treated with cetuximab in our institution. Skin toxicity grade was evaluated on each treatment day. Tumor size was evaluated using computed tomography prior to treatment and 4-8 weeks after the start of treatment with cetuximab.Patients with early tumor shrinkage after starting treatment with cetuximab had a significantly higher overall response rate (P = 0.0001). Patients with early skin toxicity showed significantly longer overall survival (P = 0.0305), and patients with higher skin toxicity grades had longer progression-free survival (P = 0.0168).We have shown that early tumor shrinkage, early onset of skin toxicity, and high skin toxicity grade are predictors of treatment efficacy and/or outcome in patients with advanced colorectal carcinoma treated with cetuximab.	[Kogawa, T.; Doi, A.; Osuga, T.; Kimura, T.; Hirayama, M.; Tsuji, Y.] Tonan Hosp, KKR Sapporo Med Ctr, Dept Med Oncol, Chu Ou Ku, Sapporo, Hokkaido 0600001, Japan; [Doi, A.; Tamura, F.; Mizushima, T.; Kimura, T.; Abe, S.; Ihara, H.; Kukitsu, T.; Sumiyoshi, T.; Yoshizaki, N.; Hirayama, M.; Kondo, H.] Tonan Hosp, KKR Sapporo Med Ctr, Ctr Digest Dis, Sapporo, Hokkaido 0600001, Japan; [Sasaki, T.; Kawarada, Y.; Kitashiro, S.; Okushiba, S.] Tonan Hosp, KKR Sapporo Med Ctr, Dept Surg, Sapporo, Hokkaido 0600001, Japan; [Shimokawa, M.] Natl Hosp Org, Kyushu Canc Ctr, Dept Canc Biostat Lab, Fukuoka, Japan; [Fouad, T. M.] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt	Kogawa, T (reprint author), Tonan Hosp, KKR Sapporo Med Ctr, Dept Med Oncol, Chu Ou Ku, Kita1 Nishi6, Sapporo, Hokkaido 0600001, Japan.	tkogawa1@mdanderson.org		Fouad, Tamer/0000-0002-4168-5275	National Institutes of Health through Cancer Center Support Grant [CA16672]	Dawn Chalaire and Sarah Bronson of the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center provided the scientific editing services. This work was supported in part by the National Institutes of Health through Cancer Center Support Grant CA16672, given to The University of Texas MD Anderson Cancer Center.	Li TH, 2009, TARGET ONCOL, V4, P107, DOI 10.1007/s11523-009-0114-0; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Vincenzi B, 2011, ANN ONCOL, V22, P1141, DOI 10.1093/annonc/mdq550; Gatzemeier U, 2011, LANCET ONCOL, V12, P30, DOI 10.1016/S1470-2045(10)70278-3; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Piessevaux H, 2009, ANN ONCOL, V20, P1375, DOI 10.1093/annonc/mdp011; Rowinsky EK, 2004, J CLIN ONCOL, V22, P3003, DOI 10.1200/JCO.2004.11.061; Rizzo S, 2010, CANCER TREAT REV, V36, pS56, DOI 10.1016/S0305-7372(10)70021-9; Liu WQ, 2005, CANCER RES, V65, P46; Stintzing S, 2013, INT J CANCER, V132, P236, DOI 10.1002/ijc.27654; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Khelwatty SA, 2013, FRONT BIOSCI-LANDMRK, V18, P394, DOI 10.2741/4110; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Tabernero J, 2010, J CLIN ONCOL, V28, P1181, DOI 10.1200/JCO.2009.22.6043; Klinghammer K, 2010, CLIN CANCER RES, V16, P304, DOI 10.1158/1078-0432.CCR-09-1928; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Petrelli F, 2013, TARGET ONCOL, V8, P173, DOI 10.1007/s11523-013-0257-x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garufi C, 2010, BRIT J CANCER, V103, P1542, DOI 10.1038/sj.bjc.6605940; Ye LC, 2013, J CLIN ONCOL, V31, P1931, DOI 10.1200/JCO.2012.44.8308; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Gunnar F, 2010, LANCET ONCOL, V11, P38; Lang I, 2013, EUR J CANCER, V49, P439, DOI 10.1016/j.ejca.2012.08.023; Liu L, 2010, COLORECTAL DIS, V12, P399, DOI 10.1111/j.1463-1318.2009.01916.x; Romito F, 2010, SUPPORT CARE CANCER, V18, P329, DOI 10.1007/s00520-009-0656-9; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Zabaglo L, 2013, ANN ONCOL	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1776-2596	1776-260X		TARGET ONCOL	Target. Oncol.	MAR	2015	10	1					125	133		10.1007/s11523-014-0322-0		9	Oncology	Oncology	CE0UF	WOS:000351521900011		
J	Nagata, T; Duval, A; Crane, PR				Nagata, Toshiyuki; DuVal, Ashley; Crane, Peter R.			Engelbert Kaempfer, Genemon Imamura and the origin of the name Ginkgo	TAXON			English	Article						Deshima; Engelbert Kaempfer; Genemon Imamura; Ginkgo biloba; Nagasaki		The unusual spelling of the genus Ginkgo has long attracted scholarly interest. It is well known that Linnaeus took the name from the Amoenitatum exoticarum of Kaempfer, and that Kaempfer relied on the 17th century Japanese illustrated encyclopedia Kinmo Zui for some of the names he took for Japanese plants. But why Kaempfer transliterated the name as "Ginkgo", a pronunciation that does not exist in contemporary Japanese, has been debated. The recognition that Kaempfer's young assistant was Genemon Imamura, a native of Nagasaki, provides a new perspective. Analysis of the plant names in the Amoenitatum exoticarum and comparison with the names in the Kinmo Zui shows that Kaempfer sought to faithfully transcribe the pronunciations of Genemon's late medieval Nagasaki dialect into his transliterations. Ginkgo is one of several examples for which transliteration of the Nagasaki dialect accounts for Kaempfer's unusual spelling of a word or name.	[Nagata, Toshiyuki] Hosei Univ, Fac Biosci & Appl Chem, Koganei, Tokyo 1848584, Japan; [DuVal, Ashley; Crane, Peter R.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Duval, A (reprint author), Yale Univ, Sch Forestry & Environm Studies, 195 Prospect St, New Haven, CT 06511 USA.	ashley.duval@yale.edu					[Anonymous], 1905, BOT MAG TOKYO, V19, P224; Brown YY, 1998, BRIT LIBR J, V24, P144; Crane P. R., 2013, GINKGO TREE TIME FOR; Hori S., 1997, GINKGO BILOBA GLOBAL, P385; Imai T., 1980, DTSCH GESELLSCHAFT N, P96; Imamura A.I., 1942, RANGAKU IMAMURA EISE; Kaempfer E, 1712, AMOENITATUM EXOTIACR; Kaempfer E, 1727, HIST JAPAN TOGETHER, V1; Kaibara E., 2007, PHILOS QI RECORD GRE; Katagiri K, 1995, ORANDA TSUJI IMAMURA; Kimura Y., 1996, ZUSETSU HANA KI DAIJ; Kimura Y, 1974, NIHON SHIZENSHI SEIT; Kitamura S., 1953, KAGAKUSHI KENKYU, V26, P19; Linnaeus C., 1771, MANTISSA PLANTARUM A; Lyman B S, 1885, Science, V6, P84, DOI 10.1126/science.ns-6.130.84; Michel W., 2005, ENGELBERT KAEMPFERS; Moule A.C., 1937, TOUNG PAO, V33, P193, DOI 10.1163/156853237X00136; Nagata T, 2014, ICHO SHIZENSHI BUNKA; Nakamura T, 1666, JINMO ZUI, V17; Numata J, 1966, DTSCH GESELLSCHAFT N, P27; Rodrigues J., 1604, ARTE LINGOA IAPAM; Thunberg C. P., 1784, FLORA JAPONICA; Tucker M.E., 1989, MORAL SPIRITUAL CULT; Van der Velde P., 1995, FURTHEST GOAL ENGELB, P44	24	0	0	INT ASSOC PLANT TAXONOMY-IAPT	BRATISLAVA	C/O INST BOTANY, SLOVAK ACAD SCIENCES DUBRAVSKA CESTA 9, SK-845 23 BRATISLAVA, SLOVAKIA	0040-0262	1996-8175		TAXON	Taxon	MAR	2015	64	1					131	136				6	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	CD4XS	WOS:000351090100010		
J	Pirarat, N; Boonananthanasarn, S; Krongpong, L; Katagiri, T; Maita, M				Pirarat, Nopadon; Boonananthanasarn, Surinton; Krongpong, Laddawan; Katagiri, Takayuki; Maita, Masashi			Effect of Activated Charcoal-Supplemented Diet on Growth Performance and Intestinal Morphology of Nile Tilapia (Oreochromis niloticus)	THAI JOURNAL OF VETERINARY MEDICINE			English	Article						activated charcoal; growth performance; intestinal villi; tilapia	IN-VITRO; ESCHERICHIA-COLI; BAMBOO CHARCOAL; BINDING; GOATS; DEOXYNIVALENOL; ZEARALENONE; ADSORBENTS; EFFICACY; CARBONS	The effect of tilapia diet supplemented with activated charcoal (AC) on growth performance and intestinal morphology of Nile Tilapia was examined. The fish were divided into four groups: a control group and three AC-supplementation groups (1%, 2% and 3% of AC in diet), and fed approximately 3% of body weight twice a day for 30 days. Growth performance and intestinal villus height were measured. Results revealed that the 2% AC-supplemented diet group was significantly (P<0.05) better in terms of percentage weight gain, specific growth rate (SGR) and feed conversion ratio (FCR), among the experimental groups. The foregut and midgut villus height of the 3% and 2% AC-supplemented diet groups was similar, but was significantly higher than the control group (P<0.05). Consequently, the supplementation of diet with 2% AC was found to be the most suitable for improving the growth performance and intestinal morphology in tilapia.	[Pirarat, Nopadon] Chulalongkorn Univ, Fac Vet Sci, Dept Pathol, Bangkok 10330, Thailand; [Boonananthanasarn, Surinton] Suranaree Univ Technol, Inst Agr Technol, Nakhon Ratchasima 30000, Thailand; [Krongpong, Laddawan] Inland Feed Res Inst, Dept Fisheries, Bangkok 10900, Thailand; [Katagiri, Takayuki; Maita, Masashi] Tokyo Univ Marine Sci & Technol, Lab Fish Hlth Management, Tokyo 1088477, Japan	Pirarat, N (reprint author), Chulalongkorn Univ, Fac Vet Sci, Dept Pathol, Bangkok 10330, Thailand.	nopadonpirarat@gmail.com	MAITA, Masashi/O-1941-2014		Research and Development Center for Livestock Production Technology, Faculty of Veterinary Science, Chulalongkorn University; JSPS Asian CORE Program	The authors would like to thank Research and Development Center for Livestock Production Technology, Faculty of Veterinary Science, Chulalongkorn University for financial support. A part of this work was also supported by JSPS Asian CORE Program.	ACFS: National Bureau of Agricultural Commodity and Food Standards Ministry, 2004, GOOD AQ PRACT TIL TA; Avantaggiato G, 2004, FOOD CHEM TOXICOL, V42, P817, DOI 10.1016/j.fct.2004.01.004; Banner RE, 2000, J RANGE MANAGE, V53, P415, DOI 10.2307/4003753; Pirarat N, 2011, RES VET SCI, V91, pE92, DOI 10.1016/j.rvsc.2011.02.014; Van DTT, 2006, ANIM FEED SCI TECH, V130, P242, DOI 10.1016/j.anifeedsci.2006.01.008; Galvano F, 1996, J FOOD PROTECT, V59, P551; Bisson MG, 2001, J RANGE MANAGE, V54, P274, DOI 10.2307/4003247; Buck WB, 1986, VET MED, V73, P73; Bueno DJ, 2005, J FOOD PROTECT, V68, P613; Doll S, 2004, ARCH ANIM NUTR, V58, P311, DOI 10.1080/00039420412331273268; Edwards KDG, 1967, MED J AUSTRALIA, V18, P534; Food and Agriculture Organization of the United Nations, 2010, CULT AQ SPEC INF PRO; HATCH RC, 1982, AM J VET RES, V43, P644; JECFA: Joint FAO/WHO Expert Committee on Food Additives, 2010, 73 M 2010; Knutson HJ, 2006, SMALL RUMINANT RES, V65, P101, DOI 10.1016/j.smallrumres.2005.05.019; Levy G., 1982, ENGL J MED, V307, P676; Marks DH, 1998, BIOMATER ARTIF CELLS, V16, P135; Mekbungwan A, 2004, ANAT HISTOL EMBRYOL, V33, P11, DOI 10.1111/j.1439-0264.2004.00501.x; Mikhalovsky SV, 2006, INTERFACE SCI TECHNO, V7, P529; Naka K, 2001, J VET MED SCI, V63, P281, DOI 10.1292/jvms.63.281; PEGUES AS, 1979, INT J ARTIF ORGANS, V2, P153; Poage GW, 2000, J RANGE MANAGE, V53, P73, DOI 10.2307/4003395; Thu M, 2010, J WORLD AQUACULT SOC, V41, P255; Thu M, 2009, AQUACULTURE SCI, V57, P53; Yamauchi K, 2000, BRIT POULTRY SCI, V41, P416, DOI 10.1080/00071660050194902; Yanbo W., 2006, ANIM FEED SCI TECHNO, V127, P283, DOI DOI 10.1016/J.ANIFEEDSCI.2005.09.003; Zijlstra RT, 1997, J NUTR, V127, P118	27	0	0	CHULALONGKORN UNIV	BANGKOK	FAC VETERINARY SCI, HENRI DUNANT RD, BANGKOK, 10330, THAILAND	0125-6491			THAI J VET MED	Thai J. Vet. Med.	MAR	2015	45	1					113	119				7	Veterinary Sciences	Veterinary Sciences	CD6FL	WOS:000351184900012		
J	Kawajiri, H; Oka, K; Sakai, O; Takahashi, A; Goto, T; Kanda, K; Yaku, H				Kawajiri, Hidetake; Oka, Katsuhiko; Sakai, Osamu; Takahashi, Akiyuki; Goto, Tomoyuki; Kanda, Keiichi; Yaku, Hitoshi			Two-Stage Hybrid Repair of Kommerell Diverticulum with Supra-Aortic Debranching	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						Kommerell diverticulurn; thoracic endovascular aortic repair; hybrid arch repair	SIDED AORTIC-ARCH; ABERRANT SUBCLAVIAN ARTERY; OF-THE-LITERATURE; SURGICAL-TREATMENT; ANEURYSM; DISSECTION; REPLACEMENT; DISEASE	Objectives The surgical treatment of Kommerell diverticula is associated with high mortality and morbidity rates. In the mid-2000s, hybrid aortic arch repair was developed, and the procedure has since been used to repair Kommerell diverticula. In the present study, we focused on the postoperative outcomes of two-stage hybrid repair of Kommerell diverticula that required supra-aortic debranching (type I hybrid arch repair). Methods From August 2010 to July 2013, a total of four patients (aged 73.5 +/- 9.5 years) underwent two-stage hybrid repair (type I hybrid arch repair) for Kommerell diverticula, and their cases were retrospectively studied. All four patients had right aortic arches and aberrant left subclavian arteries. The repair procedure consisted of two stages: (1) debranching of the supra-aortic vessels via a median sternotomy; (2) exclusion of the Kommerell diverticulum by performing thoracic endovascular repair via a femoral approach and coil embolization of the orifice of the aberrant subclavian artery. Results There were no in-hospital deaths. One patient developed an acute kidney injury and required hemodialysis on postoperative day 2, although his renal function recovered within 48 hours. No strokes, paraplegia, or early aortic events were observed in our series. The mean follow-up period was 19.5 months (range, 5-47 months). All patients remained free from aortic events and endoleaks during the follow-up period. Conclusion The early and mid-term outcomes of hybrid repair for Kommerell diverticula that require supra-aortic debranching, which are less invasive and do not involve hypothermic circulatory arrest, are acceptable. However, this procedure requires the insertion of an endograft into the ascending aorta, and careful and long-term follow-up is required to confirm its efficacy.	[Kawajiri, Hidetake; Oka, Katsuhiko; Sakai, Osamu; Kanda, Keiichi; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto 6028159, Japan; [Takahashi, Akiyuki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Cardiovasc Surg, Kyoto, Japan; [Goto, Tomoyuki] Daini Okamoto Gen Hosp, Dept Cardiovasc Surg, Kyoto, Japan	Kawajiri, H (reprint author), Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kamigyo Ku, 65 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028159, Japan.	kawajiricvs@yahoo.co.jp					Canaud L, 2014, ANN SURG, V260, P389, DOI 10.1097/SLA.0000000000000585; Williams JB, 2012, J VASC SURG, V55, P1255, DOI 10.1016/j.jvs.2011.11.063; Canaud L, 2010, J THORAC CARDIOV SUR, V139, P1153, DOI 10.1016/j.jtcvs.2009.06.017; Naoum JJ, 2008, ANN THORAC SURG, V85, P1074, DOI 10.1016/j.athoracsur.2007.09.032; Ota T, 2006, J THORAC CARDIOV SUR, V131, P574, DOI 10.1016/j.jtcvs.2005.10.012; Kouchoukos NT, 2007, J THORAC CARDIOV SUR, V133, P888, DOI 10.1016/j.jtcvs.2006.12.005; Cina CS, 2004, J VASC SURG, V39, P131, DOI 10.1016/j.jvs.2003.07.021; AUSTIN EH, 1985, J VASC SURG, V2, P571, DOI 10.1067/mva.1985.avs0020571; Yokoi Y, 2013, J THORAC CARDIOV SUR, V145, pS103, DOI 10.1016/j.jtcvs.2012.11.058; Bavaria J, 2013, J THORAC CARDIOV SUR, V145, pS85, DOI 10.1016/j.jtcvs.2012.11.044; Corral JS, 2003, J VASC INTERV RADIOL, V14, P789, DOI 10.1097/01.RVI.0000079990.80153.FE; Freed K, 1997, AM J ROENTGENOL, V168, P481; Idrees J, 2014, J THORAC CARDIOV SUR, V147, P973, DOI 10.1016/j.jtcvs.2013.02.063; Kai M, 2006, J THORAC CARDIOV SUR, V132, P1473, DOI 10.1016/j.jtcvs.2006.08.033; Kawajiri H, 2014, J THORAC CARDIOV SUR, V147, P532, DOI 10.1016/j.jtcvs.2013.08.069; Kawajiri H, 2012, J VASC SURG, V56, P1727, DOI 10.1016/j.jvs.2012.05.093; Kommerell B, 1936, ROFO FORTSCHR RONTG, V54, P590; Luehr M, 2013, EUR J CARDIO-THORAC, V44, P958, DOI 10.1093/ejcts/ezt180; Tsukui H, 2014, J THORAC CARDIOV SUR, V148, P1423, DOI 10.1016/j.jtcvs.2013.11.026; Vallabhajosyula Prashanth, 2013, Ann Cardiothorac Surg, V2, P280, DOI 10.3978/j.issn.2225-319X.2013.05.09	20	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	MAR	2015	63	2					134	138		10.1055/s-0034-1396659		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CD3LC	WOS:000350978900007		
J	Abe, A; Iwamoto, K; Shimada, Y				Abe, Akio; Iwamoto, Kohei; Shimada, Yuzo			Design of Flight Control System Based on Adaptive Backstepping Method for a Space Transportation System	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						Flight Dynamics; Guidance and Control; Feedback Linearization; Backstepping; Disturbance Observer	AIRCRAFT	This paper presents a new guidance and control system based on an adaptive backstepping method for a space transportation system. In recent years, many studies of flight control systems using feedback linearization combined with timescale separation have been carried out. Since this type of control system does not depend on the design points along a predetermined trajectory, the designed system can be applied to an extensive flight region. However, in this method, control performance tends to deteriorate with changes in the control gains and parameters because it is difficult to guarantee the stability of the system. Additionally, since it is not easy to obtain prior knowledge about disturbances and aerodynamic characteristics, an estimation mechanism must be added to the system. To solve this problem, we propose an adaptive flight control system combining feedback linearization, the backstepping method, and disturbance observers. A disturbance observer is effective for estimating the effect of extraneous signals. In the proposed system, by appropriately redesigning the disturbance observer, it becomes possible to guarantee the stability of the entire system, including the estimation mechanism. Numerical simulations were performed to verify the effectiveness and robustness of the proposed system when applied to an automatic landing problem.	[Abe, Akio; Shimada, Yuzo] Nihon Univ, Coll Sci & Technol, Chiba 2748501, Japan; [Iwamoto, Kohei] Nihon Univ, Grad Sch Sci & Technol, Chiba 2748501, Japan	Abe, A (reprint author), Nihon Univ, Coll Sci & Technol, Chiba 2748501, Japan.				Japan Aerospace Exploration Agency	This research was funded in part by a contract research grant from the Japan Aerospace Exploration Agency.	Abe A., 2008, P 26 INT S SPAC TECH; Abe A., 2011, P 28 INT S SPAC TECH; Farrell J, 2005, J GUID CONTROL DYNAM, V28, P1089, DOI 10.2514/1.13030; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Baba Y., 1999, J JPN SOC AERONAUT S, V47, P122; Chen W., 1990, IEEE T IND ELECTRON, V37, P6; Costa R. R., 2003, J SPACECRAFT ROCKETS, V40, P64, DOI 10.2514/2.3916; Higashi D., 2007, NIH U COLL SCI TECHN, P93; Ishimoto S, 2000, J GUID CONTROL DYNAM, V23, P378, DOI 10.2514/2.4538; Kawaguchi J., 2008, AIAA GUID NAV CONTR; Khalil H. K., 2001, NONLINEAR SYSTEMS, P589; LANE SH, 1988, AUTOMATICA, V24, P471, DOI 10.1016/0005-1098(88)90092-1; MENON PKA, 1987, J GUID CONTROL DYNAM, V10, P67, DOI 10.2514/3.20182; Motoda T., 2007, JAXARR07005 JAP AER; NAL/NASDA ALFLEX Group, 1994, TR1252 NALNASDA ALFL; Ninomiya T., 2010, J JPN SOC AERONAUT S, V58, P219; Ninomiya T., 2011, P 49 AIRCR S; Ohtsuka Y., 2009, P CHIN AUT CONTR SOC; Schumacher C. J., 1998, AIAA GUID NAV CONTR, P1217; Shimada Y., 2010, AIAA GUID NAV CONTR; Song SH, 2003, IEEE IND ELEC, P135; Sonneveldt L., 1998, J GUID CONTROL DYNAM, V21, P726; Tanaka N, 2006, J GUID CONTROL DYNAM, V29, P671, DOI 10.2514/1.15680; Tournes C, 2001, J GUID CONTROL DYNAM, V24, P278, DOI 10.2514/2.4710; Tsukamoto T., 2011, P 49 AIRCR S; U.S. Military, 1997, UA MIL HDB	26	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					55	65				11	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900001		
J	Inada, Y; Takahashi, R				Inada, Yoshinobu; Takahashi, Ryosuke			Local Interaction Based Formation Shape Control and Its Application to Lateral Expansion	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						Formation Shape Control; Aircraft; Local Interaction		Air surveillance using multiple aircraft is an efficient method for information gathering. Aircraft distributed in a wide area, gathering data at different points simultaneously, can provide a regional database with spatial and temporal expanses. The control of flight formation using multiple aircraft was conducted to realize such efficient air surveillance using a control with three kinds of local interaction among the aircraft, i.e. "attraction," "repulsion," and "parallel orientation." The similarity between the shape of the interaction field and the formation shape realized efficient formation shape control by changing the shape of the interaction field of each aircraft without assigning the position of all vehicles. The local interaction parameters and PID control parameters were adjusted to satisfy the desirable performance of formation shape control. Consequently, the lateral expansion of the formation shape was controlled successfully with a convergence to the command value and a certain amount of robustness in formation shape control was confirmed.	[Inada, Yoshinobu] Tokai Univ, Sch Engn, Dept Aeronaut & Astronaut, Course Aerospace, Hiratsuka, Kanagawa 2591292, Japan; [Takahashi, Ryosuke] Tokai Univ, Sch Engn, Grad Sch, Course Aeronaut & Astronaut, Hiratsuka, Kanagawa 2591292, Japan	Inada, Y (reprint author), Tokai Univ, Sch Engn, Dept Aeronaut & Astronaut, Course Aerospace, Hiratsuka, Kanagawa 2591292, Japan.				JSPS KAKENHI [23360382]	This research was supported by JSPS KAKENHI Grant Number 23360382.		0	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					66	72				7	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900002		
J	Hashimoto, A; Jeong, S; Obayashi, S				Hashimoto, Akihiro; Jeong, Shinkyu; Obayashi, Shigeru			Aerodynamic Optimization of Near-future High-wing Aircraft	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						High-wing Configuration; Computational Fluid Dynamics; Multi-objective Optimization	COMPUTATIONS; SOLVER; CODE; CFD	This paper discusses aerodynamic optimization of the high-wing configuration to explore fuselage-wing shapes for the high-wing configurations of near-future aircraft, in which it will be possible to install fuel-efficient, ultrahigh-bypass ratio engines, using computational fluid dynamics simulation and the Kriging surrogate-assisted genetic algorithm. First, optimization of the fuselage upper surface is performed, with exploration of the fairing shape suitable for the high-wing configuration. Second, the aircraft nose shape is also optimized, in addition to the fuselage upper surface, to confirm the possibility of generating higher lift by the fuselage itself. Finally, both the fuselage and the wing shape are optimized to improve the lift-to-drag ratio by alleviating the shock wave over the wing, while sustaining the high lift generation of the high-wing configuration. The final optimized configuration achieves not only a lift-to-drag ratio comparable to the DLR-F6, but also a CL approximately 1.5 times higher than the DLR-F6. These results indicate the possibility of producing high-wing aircraft that not only employ fuel-efficient ultrahigh-bypass ratio engines, but also have much better aerodynamic performance than low-wing configurations.	[Hashimoto, Akihiro; Obayashi, Shigeru] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808579, Japan; [Jeong, Shinkyu] Kyung Hee Univ, Dept Mech Engn, Yongin 446701, South Korea	Hashimoto, A (reprint author), Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808579, Japan.				Kyung Hee University [KHU-20130399]	This work was supported by a grant from Kyung Hee University, 2013 (KHU-20130399). Images in the paper were created using Field View, as provided by Intelligent Light through its University Partners Program. Computations in this paper were conducted using FX1 in the JAXA Supercomputer System.	OBAYASHI S, 1995, AIAA J, V33, P1134, DOI 10.2514/3.12533; FONSECA CM, 1993, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P416; Nakahashi K, 2003, INT J NUMER METH FL, V43, P769, DOI 10.1002/fld.559; Li CN, 2008, J AIRCRAFT, V45, P258, DOI 10.2514/1.26638; Sharov D, 1998, AIAA J, V36, P484, DOI 10.2514/2.392; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Ito Y, 2004, INT J NUMER METH FL, V45, P79, DOI 10.1002/fld.669; Bonet J., 2012, 50 AIAA AER SCI M; Drake A., 2012, 50 AIAA AER SCI M; Japan Aircraft Development Corporation, 2013, WORLDW MARK FOR 2013; Jeong S., 2006, J FLUID SCI TECHNOLO, V1, P138, DOI DOI 10.1299/JFST.1.138; Lockheed Martine ERA Team, 2012, 50 AIAA AER SCI M; Mangelsdorf M., 2011, ENV RESPONSIBLE AVIA; Peigin S, 2008, AIAA J, V46, P1814, DOI 10.2514/1.35465; Sasaki D., 2005, J AEROSPACE COMPUTIN, V2, P44, DOI 10.2514/1.12909; Sobieczky H, 1998, NOTES NUMERICAL FLUI, V68, P71; Song WB, 2011, J AIRCRAFT, V48, P2114, DOI 10.2514/1.C031472; Vassberg J. C., 2005, 20054730 AIAA; Venkatakrishnan V, 1993, 930880 AIAA; Yamazaki W, 2008, INT J NUMER METH FL, V57, P417, DOI 10.1002/fld.1643	20	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					73	82				10	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900003		
J	Katsurayama, Y; Imamura, T				Katsurayama, Yohei; Imamura, Taro			Numerical Simulation of Engine Noise Shielding around Blended Wing Body Aircraft	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						Blended Wing Body Aircraft; Acoustic Shielding; Boundary Element Method		A numerical simulation of sound propagation around a blended wing body (BWB) aircraft with an open rotor engine is performed to understand the shielding effect of the engine noise. A boundary element method (BEM) code based on the Helmholtz equation is developed for this purpose. The effect of uniform flow and the surface impedance of the aircraft is analyzed in detail. The mean flow showed little effect on the amount of shielding since the approach speed is a relatively low Mach number. On the other hand, when a soft-surface condition is applied to the upper side of the aircraft, a larger amount of shielding is observed throughout the analyzed field when compared to a rigid surface case. Additionally, an effective area for applying the soft-surface condition is clarified in order to reduce the usage of such material.	[Katsurayama, Yohei; Imamura, Taro] Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo 1138656, Japan	Katsurayama, Y (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo 1138656, Japan.						Agarwal A, 2007, AIAA J, V45, P358, DOI 10.2514/1.19351; Clark L. R., 1999, 991937 AIAA; Gerhold C. H., 2004, 20042966 AIAA; Hall C. A., 2005, 1164 ISABE, P1164; Haller W., 2012, AIAA AER SCI M; Hileman J. I., 2007, 20070453 AIAA; Morris PJ, 1995, J ACOUST SOC AM, V98, P3536, DOI 10.1121/1.413786; Rienstra S. W., 2013, INTRO ACOUSTICS, P223; Stephens D. B., 2011, 20112940 AIAA; Wu T.W., 2000, BOUNDARY ELEMENT ACO; WU TW, 1994, J SOUND VIB, V175, P51, DOI 10.1006/jsvi.1994.1310; Yijun L., 2009, FAST MULTIPOLE BOUND	12	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					83	88				6	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900004		
J	Yamazaki, W				Yamazaki, Wataru			Stochastic Drag Analysis via Polynomial Chaos Uncertainty Quantification	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						Uncertainty Quantification; Polynomial Chaos; Kriging Model; Drag Breakdown	PREDICTION; DECOMPOSITION; SOLVER	In this paper, uncertainty quantification approaches are applied to an aerodynamic uncertainty quantification problem with a far-field drag breakdown approach. Two uncertainty quantification approaches, a non-intrusive polynomial chaos approach and an inexpensive Monte-Carlo simulation approach on a response surface model are compared and investigated for more advanced aerodynamic uncertainty quantification. Using the drag breakdown approach, total drag of a body can be decomposed into three physical and one unphysical drag components: wave, viscous, induced and spurious drag components. The drag source distribution can also be visualized on the flowfield using this approach. An uncertainty quantification problem of two-dimensional airfoil with four uncertain input variables is analyzed with the drag breakdown approach to extract more aerodynamic design information about its uncertainty propagation.	Nagaoka Univ Technol, Niigata 9402188, Japan	Yamazaki, W (reprint author), Nagaoka Univ Technol, Niigata 9402188, Japan.						OBAYASHI S, 1995, AIAA J, V33, P1134, DOI 10.2514/3.12533; FONSECA CM, 1993, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P416; HICKS RM, 1978, J AIRCRAFT, V15, P407, DOI 10.2514/3.58379; Wiener N, 1938, AM J MATH, V60, P897, DOI 10.2307/2371268; Xiu DB, 2003, J COMPUT PHYS, V187, P137, DOI 10.1016/S0021-9991(03)00092-5; Paparone L, 2003, AIAA J, V41, P1647, DOI 10.2514/2.7300; Yamazaki W, 2013, AIAA J, V51, P126, DOI 10.2514/1.J051633; Askey R, 1985, MEM AM MATH SOC, V54, P319; Baldwin B. S., 1978, 78257 AIAA; Beckert A, 2001, AEROSP SCI TECHNOL, V5, P125, DOI 10.1016/S1270-9638(00)01087-7; Chalot F., 2008, 20082068 AIAA; Debusschere BJ, 2004, SIAM J SCI COMPUT, V26, P698, DOI 10.1137/S1064827503427741; Dwight R.P., 2009, 20092276 AIAA; Eldred M. S., 2009, 20090976 AIAA; Ghate D., 2006, RECENT TRENDS AEROSP, P203; Gumbert C. R., 2002, 20022806 AIAA; Hosder S., 2007, 20071939 AIAA; Hosder S., 2006, 2006891 AIAA; Kusunose K., 2005, 21 CENTURY COE PROGR; Lockwood B.A., 2011, 2011885 AIAA; Lovely D., 1999, 993285 AIAA; Luckring J. M., 2003, 20030409 AIAA; Rumpfikeil M.P., 2010, 6 INT C COMP FLUID D; Rumpfkeil M.P., 2010, 20101268 AIAA; Ueno M., 2010, 20105094 AIAA; van Dam CP, 1999, PROG AEROSP SCI, V35, P751, DOI 10.1016/S0376-0421(99)00009-3; Destarac D, 2004, AEROSP SCI TECHNOL, V8, P545, DOI 10.1016/j.ast.2004.03.004; Yamazaki W, 2008, INT J NUMER METH FL, V57, P417, DOI 10.1002/fld.1643; Yamazaki W., 2010, 20104363 AIAA	29	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					89	99				11	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900005		
J	Sakai, M; Sunada, Y; Imamura, T; Rinoie, K				Sakai, Masayuki; Sunada, Yasuto; Imamura, Taro; Rinoie, Kenichi			Experimental and Numerical Studies on Flow behind a Circular Cylinder Based on POD and DMD	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						Circular Cylinder; Proper Orthogonal Decomposition; Dynamic Mode Decomposition	DYNAMIC-MODE DECOMPOSITION; SCHEME	Proper orthogonal decomposition (POD) or dynamic mode decomposition (DMD) are useful analytical techniques for describing the behavior of a complicated flow by decomposing the flow into several components called modes. In POD analysis, the flow is most efficiently decomposed into orthonormal modes in terms of energy, so most of the flow energy can be extracted using a small number of modes. On the other hand, in DMD analysis, flow structures that have specific frequencies can be observed by managing the sequence of the given time series data. In this study, POD and DMD analyses were applied to the experimental and numerical results for velocity fields around a circular cylinder, and the analytical results were compared. As a result, flow structures of POD and DMD modes from the experimental results were mostly in agreement with those from the numerical results, but differences were seen in energy distribution. In the POD analysis, the rates of energy in the numerical results were clearly divided in each pair of POD modes, but in the experimental results, they were not clear except for the first and second POD modes.	[Sakai, Masayuki; Sunada, Yasuto; Imamura, Taro; Rinoie, Kenichi] Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo 1138656, Japan	Sakai, M (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo 1138656, Japan.				JSPS KAKENHI [21360412, 25289303]	This study was supported by JSPS KAKENHI grant numbers 21360412 and 25289303.	Rowley CW, 2009, J FLUID MECH, V641, P115, DOI 10.1017/S0022112009992059; Sengupta TK, 2010, J FLUID MECH, V656, P82, DOI 10.1017/S0022112010001035; Shah MK, 2009, AIAA J, V47, P2616, DOI 10.2514/1.40095; Schmid PJ, 2011, EXP FLUIDS, V50, P1123, DOI 10.1007/s00348-010-0911-3; Schmid P, 2011, THEOR COMP FLUID DYN, V25, P249, DOI 10.1007/s00162-010-0203-9; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Chen KK, 2012, J NONLINEAR SCI, V22, P887, DOI 10.1007/s00332-012-9130-9; CHAKRAVARTHY SR, 1983, AIAA J, V21, P1241, DOI 10.2514/3.60143; JAMESON A, 1981, MATH COMPUT, V37, P385, DOI 10.2307/2007433; Shima E, 2011, AIAA J, V49, P1693, DOI 10.2514/1.J050905; Sakai M., 2014, J JAPAN SOC SPACE SC, V62, P47; Taira K., 2011, NAGARE, V30, P263; Taira K., 2011, NAGARE, V30, P115; The Visualization Society of Japan, 2002, HDB PART IM VEL, P137	14	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	MAR	2015	58	2					100	107				8	Engineering, Aerospace	Engineering	CE1GK	WOS:000351559900006		
J	Ishida, H; Kondo, T; Shimizu, T; Nozaki, T; Tanabe, K				Ishida, Hideki; Kondo, Tsunenori; Shimizu, Tomokazu; Nozaki, Taiji; Tanabe, Kazunari			Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation	TRANSPLANT INTERNATIONAL			English	Article						ABO-incompatible kidney transplantation; acute antibody-mediated rejection; antiblood type antibody; B cell-targeting protocol; chronic antibody-mediated rejection; desensitization protocol; graft loss; graft survival rate; renal transplantation; rituximab; titres	ANTIGEN-SPECIFIC IMMUNOADSORPTION; RENAL-TRANSPLANTATION; B-CELLS; LONG-TERM; ACCOMMODATION; SPLENECTOMY; RITUXIMAB; TITER; ALLOGRAFT	The purpose of this study is to examine whether postoperative antiblood type antibody rebound is attributed to kidney allograft rejection in ABO blood type-incompatible (ABO-I) living-related kidney transplantation (KTx). A total of 191 ABO-I recipients who received ABO-I living-related KTx between 2001 and 2013 were divided into two groups: Group 1 consisted of low rebound [(<= 1: 32), N = 170] and Group 2 consisted of high rebound [(>= 1: 64), N = 21], according to the levels of the rebounded antiblood type antibodies within 1 year after transplantation. No prophylactic treatment for rejection was administered for elevated antiblood type antibodies, regardless of the levels of the rebounded antibodies. Within 1 year after transplantation, T-cell-mediated rejection was observed in 13 of 170 recipients (13/170, 8%) in Group 1 and in 2 of 21 recipients (2/21, 10%) in Group 2 (Groups 1 vs. 2, P = 0.432). Antibody-mediated rejection was observed in 15 of 170 recipients (15/170, 9%) and 2 of 21 recipients (2/21, 10%) in Groups 1 and 2, respectively (P = 0.898). In this study, we found no correlation between the postoperative antiblood type antibody rebound and the incidence of acute rejection. We concluded that no treatment is necessary for rebounded antiblood type antibodies.	[Ishida, Hideki; Kondo, Tsunenori; Shimizu, Tomokazu; Nozaki, Taiji; Tanabe, Kazunari] Tokyo Womens Med Univ, Kidney Ctr, Dept Urol, Tokyo 1628666, Japan	Ishida, H (reprint author), Tokyo Womens Med Univ, Kidney Ctr, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tgphide@gol.com					Allen G, 2009, CONTRIB NEPHROL, V162, P35, DOI 10.1159/000170811; Kohei N, 2012, AM J TRANSPLANT, V12, P469, DOI 10.1111/j.1600-6143.2011.03830.x; Chung BH, 2013, NEPHRON CLIN PRACT, V124, P79, DOI 10.1159/000355855; Pierson RN, 2002, TRANSPLANTATION, V74, P79, DOI 10.1097/00007890-200207150-00014; Irei T, 2007, BLOOD, V110, P4567, DOI 10.1182/blood-2007-04-082719; Shimmura H, 2005, TRANSPLANTATION, V80, P985, DOI 10.1097/01.tp.0000173647.43616.78; Tanabe T, 2011, TRANSPL IMMUNOL, V25, P1, DOI 10.1016/j.trim.2011.05.002; Ishida H, 2000, TRANSPLANTATION, V70, P681, DOI 10.1097/00007890-200008270-00024; ALEXANDRE GPJ, 1985, TRANSPLANT P, V17, P138; CHOPEK MW, 1987, TRANSPLANT P, V19, P4553; Tanabe K, 1998, TRANSPLANTATION, V65, P224; Tobian AAR, 2010, AM J TRANSPLANT, V10, P1247, DOI 10.1111/j.1600-6143.2010.03103.x; Kamburova EG, 2013, AM J TRANSPLANT, V13, P1503, DOI 10.1111/ajt.12220; Gloor JM, 2005, TRANSPLANTATION, V80, P1572, DOI 10.1097/01.tp.0000184622.69708.c1; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Shimmura H, 2000, TRANSPLANTATION, V70, P1331, DOI 10.1097/00007890-200011150-00011; Tyden G, 2005, AM J TRANSPLANT, V5, P145, DOI 10.1111/j.1600-6143.2004.00653.x; Koch CA, 2004, J IMMUNOL, V172, P5143; Tokunaga M, 2005, RHEUMATOLOGY, V44, P176, DOI 10.1093/rheumatology/keh443; de Wit J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013016; Ishida H, 2007, AM J TRANSPLANT, V7, P1; Ishida H, 2004, TRANSPLANT P, V36, P2178, DOI 10.1016/j.transproceed.2004.08.082; Parker W, 1998, AM J PATHOL, V152, P829; Rose ML, 2012, TRANSPLANTATION, V93, P244, DOI 10.1097/TP.0b013e31823f468c; Stroopinsky D, 2012, CANCER IMMUNOL IMMUN, V61, P1233, DOI 10.1007/s00262-011-1168-2; TAKAHASHI K, 1993, TRANSPLANT P, V25, P271; Tanabe T, 2012, TRANSPLANTATION, V93, P709, DOI 10.1097/TP.0b013e31824612b5; TOMA H, 1994, UROL CLIN N AM, V21, P299; West JL, 2005, CURR DRUG TARGETS CA, V5, P223	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	MAR	2015	28	3					286	296		10.1111/tri.12482		11	Surgery; Transplantation	Surgery; Transplantation	CD3OB	WOS:000350987000005		
J	Uchiyama, M; Jin, XY; Yin, EZ; Shimokawa, T; Niimi, M				Uchiyama, Masateru; Jin, Xiangyuan; Yin, Enzhi; Shimokawa, Tomoki; Niimi, Masanori			Treadmill exercise induces murine cardiac allograft survival and generates regulatory T cell	TRANSPLANT INTERNATIONAL			English	Article						exercise; heart transplantation; immunomodulation; mouse; transplant immunology	CHRONIC HEART-FAILURE; INTRATRACHEAL DELIVERY; INTERNATIONAL SOCIETY; INDEFINITE SURVIVAL; PHYSICAL-ACTIVITY; ALPHA PRODUCTION; MICE; TRANSPLANTATION; TUMOR; GRAFTS	Exercise therapy has been associated with improvement in functional capacity and quality of life. The role of exercise therapy in heart transplant recipients is of great interest for the transplant society, although concerning the effect of exercise therapy, there is little knowledge at present. We analyzed the effects of exercise on alloimmune responses in murine cardiac allograft transplantation. CBA mice (H2(k)) underwent transplantation of C57Bl/6 (H2(b)) hearts and exercised on a treadmill. Untreated CBA recipients rejected C57Bl/6 cardiac grafts acutely (median survival time [MST], 7 days). CBA recipients treated with treadmill for 1 week after transplantation, and for 1 week both before and after transplantation prolonged allograft survivals (MSTs, 35 and 18 days, respectively). However, treadmill exercise recipients for 1 week before transplantation were not effective to allograft survival (MST, 8 days). Adoptive transfer of whole splenocytes and CD4(+) cells from treadmill exercise recipients significantly prolonged allograft survival in naive secondary recipients (MSTs, 30 and 52 days, respectively), suggesting that regulatory cells was generated after treadmill exercise. Moreover, flow cytometry studies showed that CD4(+)CD25(+)Foxp3(+) cell population increased in treadmill exercise recipients. Therefore, postoperative but not pre-operative exercise could induce prolongation of survival of fully allogeneic cardiac allografts and generate CD4(+)CD25(+)Foxp3(+) regulatory T cells.	[Uchiyama, Masateru; Shimokawa, Tomoki] Teikyo Univ, Dept Cardiovasc Surg, Tokyo 1738605, Japan; [Uchiyama, Masateru; Jin, Xiangyuan; Yin, Enzhi; Niimi, Masanori] Teikyo Univ, Dept Surg, Tokyo 1738605, Japan; [Jin, Xiangyuan; Yin, Enzhi] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiovasc & Thorac Surg, Harbin, Peoples R China	Niimi, M (reprint author), Teikyo Univ, Dept Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	mniimi@med.teikyo-u.ac.jp					Akiyama Y, 2002, TRANSPLANTATION, V74, P732, DOI 10.1097/00007890-200209150-00024; Ambrosio F, 2010, TISSUE ENG PT A, V16, P839, DOI 10.1089/ten.TEA.2009.0113; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Yeh SH, 2007, DIABETES CARE, V30, P716, DOI 10.2337/dc06-1507; WOODS JA, 1994, MED SCI SPORT EXER, V26, P1109; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Belardinelli R, 1999, CIRCULATION, V99, P1173; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; You TJ, 2013, SPORTS MED, V43, P243, DOI 10.1007/s40279-013-0023-3; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Itoh M, 1999, J IMMUNOL, V162, P5317; MACNEIL B, 1993, MED SCI SPORT EXER, V25, P922; Stehlik J, 2010, J HEART LUNG TRANSPL, V29, P1089, DOI 10.1016/j.healun.2010.08.007; Tabet JY, 2008, CIRC-HEART FAIL, V1, P220, DOI 10.1161/CIRCHEARTFAILURE.108.775460; [Anonymous], 1990, J HEART TRANSPLANT; Aramaki O, 2003, TRANSPLANTATION, V75, P217, DOI 10.1097/01.TP.0000041781.94679.A1; Aramaki O, 2005, TRANSPLANTATION, V79, P568, DOI 10.1097/01.TP.0000153151.16350.53; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Deweerdt S, 2011, NATURE, V475, pS16, DOI 10.1038/475S16a; Hoffman-Goetz L, 2003, MED SCI SPORT EXER, V35, P1828, DOI 10.1249/01.MSs.0000093621.09328.70; Horwich TB, 2009, AM HEART J, V158, pS31, DOI 10.1016/j.ahj.2009.07.016; Inoue F, 2007, TRANSPLANTATION, V84, P1288, DOI 10.1097/01.tp.0000287641.69795.cc; Kohut ML, 2005, BRAIN BEHAV IMMUN, V19, P423, DOI 10.1016/j.bbi.2005.04.006; MACNEIL B, 1993, J APPL PHYSIOL, V74, P388; Newell KA, 2006, TRANSPLANTATION, V81, P1, DOI 10.1097/01.tp.0000179149.12979.13; Niimi M, 2001, J HEART LUNG TRANSPL, V20, P1123, DOI 10.1016/S1053-2498(01)00309-6; PERROS P, 1991, CELL PROLIFERAT, V24, P517, DOI 10.1111/j.1365-2184.1991.tb01179.x; Radak Z, 2002, ANTIOXID REDOX SIGN, V4, P213, DOI 10.1089/152308602753625979; Rogers CJ, 2008, VACCINE, V26, P5407, DOI 10.1016/j.vaccine.2008.07.081; Singh MP, 2005, COMP IMMUNOL MICROB, V28, P231, DOI 10.1016/j.cimid.2005.02.001; Suzuki K, 2005, EUR J APPL PHYSIOL, V94, P514, DOI 10.1007/s00421-005-1378-4; Tanaka Y, 2010, NEUROIMMUNOMODULAT, V17, P279, DOI 10.1159/000290044; Uchiyama M, 2014, TRANSPLANTATION, V97, P301, DOI 10.1097/01.TP.0000438204.96723.8b; Uchiyama M, 2012, TRANSPL INT, V25, P357, DOI 10.1111/j.1432-2277.2011.01427.x; Valdes-Ramos R, 2010, P NUTR SOC, V69, P644, DOI 10.1017/S0029665110002533; Yano H, 2010, EUR J APPL PHYSIOL, V110, P797, DOI 10.1007/s00421-010-1560-1; Yeh SH, 2006, BRIT J SPORT MED, V40, P239, DOI 10.1136/bjsm.2005.022095; Yokoyama T, 2005, J THORAC CARDIOV SUR, V130, P1167, DOI 10.1016/j.jtcvs.2005.06.031; Zielinski MR, 2004, J APPL PHYSIOL, V96, P2249, DOI 10.1152/japplphysiol.01210.2003	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	MAR	2015	28	3					352	362		10.1111/tri.12491		11	Surgery; Transplantation	Surgery; Transplantation	CD3OB	WOS:000350987000012		
J	Nakao, M; Yamamoto, I; Yamamoto, H				Nakao, Masatsugu; Yamamoto, Izumi; Yamamoto, Hiroyasu			Successful treatment of ocular toxoplasmosis that developed four years after kidney transplantation	TRANSPLANT INTERNATIONAL			English	Letter									[Nakao, Masatsugu; Yamamoto, Izumi; Yamamoto, Hiroyasu] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan	Nakao, M (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	izumi26@jikei.ac.jp					ROTHOVA A, 1993, AM J OPHTHALMOL, V115, P517; Mikita K, 2013, DIAGN MICR INFEC DIS, V75, P155, DOI 10.1016/j.diagmicrobio.2012.10.015; Garweg JG, 2000, J CLIN MICROBIOL, V38, P996; Park YH, 2013, KOREAN J PARASITOL, V51, P393, DOI 10.3347/kjp.2013.51.4.393; Dodds EM, 2006, CURR OPIN OPHTHALMOL, V17, P557, DOI 10.1097/ICU.0b013e32801094ca; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Oniki S, 1968, Ganka, V10, P860; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; Subauste CS, 2011, OCUL IMMUNOL INFLAMM, V19, P297, DOI [10.3109/09273948.2010.605198, 10.3109/09273948.2011.605198]; Vaughan LB, 2013, TRANSPL INFECT DIS, V15, pE20, DOI 10.1111/tid.12044	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	MAR	2015	28	3					363	365		10.1111/tri.12433		3	Surgery; Transplantation	Surgery; Transplantation	CD3OB	WOS:000350987000013		
J	Sofue, T; Inui, M; Hara, T; Moritoki, M; Nishijima, Y; Kushida, Y; Nishiyama, A; Kakehi, Y; Kohno, M				Sofue, T.; Inui, M.; Hara, T.; Moritoki, M.; Nishijima, Y.; Kushida, Y.; Nishiyama, A.; Kakehi, Y.; Kohno, M.			Association Between Post-transplantation Immunoglobulin A Deposition and Reduced Allograft Function	TRANSPLANTATION PROCEEDINGS			English	Article							RECURRENT IGA NEPHROPATHY; RENAL-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; DONOR KIDNEYS; GLOMERULONEPHRITIS; PROGNOSIS; BIOPSIES; GRAFT	Background. Post-transplantation de novo and recurrent immunoglobulin A (IgA) deposition (IgAD) in the allograft is commonly observed. However, the association between post-transplantation IgAD and reduced allograft function has not been determined. We therefore investigated the association between reduced allograft function and post-transplantation IgAD using serial allograft biopsies. Methods. IgAD was retrospectively analyzed in 45 adults who underwent kidney transplantation for chronic glomerulonephritis, including IgA nephropathy, at Kagawa University Hospital. Allograft biopsy samples were obtained from per protocol biopsies obtained 1 and 3 years after transplantation, as well as from episode biopsies. Factors contributing to post-transplantation IgAD were assessed by calculating adjusted odds ratios (AORs) using logistic regression analysis. Results. Of the 45 recipients, 18 had post-transplantation allograft IgAD. The estimated glomerular filtration rates (eGFR) 1, 2, and 3 years after transplantation were lower in the recipients with than without IgAD. Urinalysis was normal in 61% of recipients with IgAD. Reduced allograft function (eGFR <40 mL/min/1.73 m(2)) 1 year after transplantation was significantly associated with post-transplantation IgAD (AOR = 34.4 [95% CI = 2.35-502], P = .01). Conversely, blood concentrations of mycophenolic acid and latent IgAD from donor kidneys were not significantly associated with post-transplantation IgAD. Conclusion. Reduced allograft function may be associated with post-transplantation IgAD in the allograft.	[Sofue, T.; Hara, T.; Moritoki, M.; Nishijima, Y.; Kohno, M.] Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Div Nephrol & Dialysis, Miki, Kagawa 7610793, Japan; [Kushida, Y.] Kagawa Univ, Fac Med, Dept Pathol, Miki, Kagawa 7610793, Japan; [Nishiyama, A.] Kagawa Univ, Fac Med, Dept Pharmacol, Miki, Kagawa 7610793, Japan; [Kakehi, Y.] Kagawa Univ, Fac Med, Dept Urol, Miki, Kagawa 7610793, Japan; [Inui, M.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Urol, Chiba, Japan	Sofue, T (reprint author), Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	sofue@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24791653]; fund for Kagawa University Young Scientists	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#24791653 to Tadashi Sofue) and the fund for Kagawa University Young Scientists 2014 (to Tadashi Sofue). We wish to thank Ms. Yoshiko Fujita for secretarial services.	Abrera-Abeleda MA, 2007, KIDNEY INT, V71, P1142, DOI 10.1038/sj.ki.5002235; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Han SS, 2010, TRANSPL INT, V23, P169, DOI 10.1111/j.1432-2277.2009.00966.x; Lai KN, 2012, NAT REV NEPHROL, V8, P275, DOI 10.1038/nrneph.2012.58; McDonald SP, 2006, TRANSPLANTATION, V82, P759, DOI 10.1097/01.tp.0000230131.66971.45; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Song D, 1998, NEPHRON, V78, P15, DOI 10.1159/000044876; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Ponticelli C, 2001, KIDNEY INT, V60, P1948, DOI 10.1046/j.1523-1755.2001.00006.x; Stuht S, 2007, AM J TRANSPLANT, V7, P377, DOI 10.1111/j.1600-6143.2006.01638.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Gough J, 2005, ARCH PATHOL LAB MED, V129, P231; Ortiz F, 2012, NEPHROL DIAL TRANSPL, V27, P2553, DOI 10.1093/ndt/gfr664; Sofue T, 2012, AM J NEPHROL, V36, P127, DOI 10.1159/000340035; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Coppo R, 2007, CLIN TRANSPLANT, V21, P728, DOI 10.1111/j.1399-0012.2007.00730.x; Bumgardner GL, 1998, TRANSPLANTATION, V65, P1053, DOI 10.1097/00007890-199804270-00008; Chandrakantan A, 2005, NEPHROL DIAL TRANSPL, V20, P1214, DOI 10.1093/ndt/gfh773; Freese P, 1999, CLIN TRANSPLANT, V13, P313, DOI 10.1034/j.1399-0012.1999.130406.x; Hara S, 2014, TRANSPL P, V46, P124, DOI 10.1016/j.transproceed.2013.07.072; Moriyama T, 2005, CLIN TRANSPLANT, V19, P41, DOI 10.1111/j.1399-0012.2005.00403.x; ODUM J, 1994, NEPHROL DIAL TRANSPL, V9, P309; Ohmacht C, 1997, TRANSPLANTATION, V64, P1493, DOI 10.1097/00007890-199711270-00024; SANFILIPPO F, 1982, TRANSPLANTATION, V33, P370, DOI 10.1097/00007890-198204000-00006; Silva F G, 1982, Transplantation, V33, P241; Sofue T, 2014, TRANSPLANTATION, V97, P104, DOI 10.1097/TP.0b013e3182a7d5b2; Sofue T, 2013, CLIN TRANSPLANT, V27, P14, DOI 10.1111/ctr.12158; Tissandie E, 2011, KIDNEY INT, V80, P1352, DOI 10.1038/ki.2011.276	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	MAR	2015	47	2					332	336		10.1016/j.transproceed.2015.01.011		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE0FT	WOS:000351480600015		
J	Sasaki, H; Sato, Y; Matsuhashi, E; Nishi, T; Hachisuka, S; Katsuoka, Y; Kudo, H; Kitajima, K; Yoshioka, M; Nakazawa, R; Miyano, S; Yazawa, M; Imai, N; Kawarazaki, H; Shibagaki, Y; Kimura, K; Chikaraishi, T				Sasaki, H.; Sato, Y.; Matsuhashi, E.; Nishi, T.; Hachisuka, S.; Katsuoka, Y.; Kudo, H.; Kitajima, K.; Yoshioka, M.; Nakazawa, R.; Miyano, S.; Yazawa, M.; Imai, N.; Kawarazaki, H.; Shibagaki, Y.; Kimura, K.; Chikaraishi, T.			Urinary Tract Reconstruction Using Uretero-Ureteral End-To-Side Anastomosis in Kidney Transplant Recipients	TRANSPLANTATION PROCEEDINGS			English	Article							TERM DEFUNCTIONALIZED BLADDER; RENAL-TRANSPLANTATION; UROLOGICAL COMPLICATIONS	Background. In kidney transplant recipients, the most widely used method for the reconstruction of the urinary pathway is ureteroneocystostomy, which may be difficult in cases with disused atrophic bladder. In this study, we evaluated kidney transplant recipients who underwent uretero-ureteral end-to-side anastomosis (UUA) in urinary reconstruction due to disused atrophic bladder. Methods. To clarify the effectiveness of this method, we retrospectively reviewed the clinical records of kidney transplant recipients in our hospital. Results. A total of 9 recipients with urinary reconstruction using UUA were evaluated. All of these patients had a history of long-term hemodialysis before transplantation, accompanied by complete anuria and small capacity of the bladder. In 4 patients, cranial native ureter was ligated, whereas it was not ligated in the remaining 5 patients. In 2 of 4 patients with cranial ligation, hydronephrosis developed in the native kidney with no further treatment being required. No patients experienced urinary tract complications including hydronephrosis in the graft, urine extravasation, or urinary tract infection in the follow-up period (757.6 +/- 491.3 days). Allograft function was maintained well in all patients (serum creatinine level, 1.08 +/- 0.23 mg/dL). Conclusions. Although UUA is not a routine method of urinary reconstruction in kidney transplantation, it can be safely performed and should be a surgical option, especially for recipients with disused atrophic bladder. The ligation of cranial native ureter may lead to hydronephrosis of the native kidney, and it is tentatively concluded that UUA without native ureteral ligation is clinically feasible.	[Sasaki, H.; Sato, Y.; Matsuhashi, E.; Nishi, T.; Hachisuka, S.; Katsuoka, Y.; Kudo, H.; Kitajima, K.; Yoshioka, M.; Nakazawa, R.; Miyano, S.; Chikaraishi, T.] St Marianna Univ, Sch Med, Dept Urol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Yazawa, M.; Imai, N.; Kawarazaki, H.; Shibagaki, Y.; Kimura, K.] St Marianna Univ, Sch Med, Dept Nephrol & Hypertens, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Sasaki, H (reprint author), St Marianna Univ, Sch Med, Dept Urol, Miyamae Ku, 2-16-1,Sugao 2 Chome, Kawasaki, Kanagawa 2168511, Japan.	sr2odet@marianna-u.ac.jp					Al Khudair WK, 1998, TRANSPLANT INT, V11, P452, DOI 10.1007/s001470050174; Makisalo H, 1997, TRANSPLANT P, V29, P152, DOI 10.1016/S0041-1345(96)00044-9; Gallentine ML, 2002, J UROLOGY, V167, P29, DOI 10.1016/S0022-5347(05)65375-X; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; THRASHER JB, 1990, J UROLOGY, V144, P1105; Dominguez J, 2000, TRANSPLANTATION, V70, P597, DOI 10.1097/00007890-200008270-00011; Butterworth PC, 1997, BRIT J UROL, V79, P499, DOI 10.1046/j.1464-410X.1997.00117.x; Streeter EH, 2002, BJU INT, V90, P627, DOI 10.1046/j.1464-4096.2002.03004.x; BENOIT G, 1994, TRANSPLANT P, V26, P287; Capocasale E, 2007, Urologia, V74, P152; Chu WCW, 2003, PEDIATR RADIOL, V33, P59, DOI 10.1007/s00247-002-0754-z; HAKIM NS, 1994, CLIN TRANSPLANT, V8, P504; Inoue T, 2011, TRANSPLANTATION, V92, P311, DOI 10.1097/TP.0b013e318223d7d6; Machado MG, 2000, J UROLOGY, V164, P1002, DOI 10.1016/S0022-5347(05)67237-0; MACLEAN LD, 1969, ARCH SURG-CHICAGO, V99, P269; Martin X, 1999, EUR UROL, V36, P450, DOI 10.1159/000020029; SALVATIERRA O, 1977, J UROLOGY, V117, P421; Salvatierra O, 1999, TRANSPLANT P, V31, P3041, DOI 10.1016/S0041-1345(99)00661-2; Ushigome H, 2008, TRANSPL P, V40, P2297, DOI 10.1016/j.transproceed.2008.06.019	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	MAR	2015	47	2					359	362		10.1016/j.transproceed.2014.12.016		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE0FT	WOS:000351480600020		
J	Sasaki, H; Suzuki, A; Kusaka, M; Fukami, N; Shiroki, R; Itoh, M; Takahashi, H; Uenishi, K; Hoshinaga, K				Sasaki, H.; Suzuki, A.; Kusaka, M.; Fukami, N.; Shiroki, R.; Itoh, M.; Takahashi, H.; Uenishi, K.; Hoshinaga, K.			Nutritional Status in Japanese Renal Transplant Recipients With Long-term Graft Survival	TRANSPLANTATION PROCEEDINGS			English	Article							CLINICAL-PRACTICE GUIDELINES; KIDNEY-TRANSPLANTATION; RISK-FACTOR; OBESITY; THERAPY; FAILURE	Background. Nutritional status affects clinical outcomes in patients with chronic renal failure. Glucose intolerance, dyslipidemia, obesity, hypertension, and a calcium phosphorus vitamin D imbalance are the major nutritional and metabolic problems that occur in posttransplant patients. In this study, we assessed the daily intake in long-term renal transplant recipients to determine whether they have sufficient nutrients based on the Japanese nutrition recommendations (recommended dietary allowances [RDA] in Japan 2010). Subjects and Methods. Thirty-one renal allograft recipients followed for >10 years (median, 16.3) were recruited. The median serum creatinine level was 1.2 g/dL (95% CI, 0.6-3.4). We estimated the intake of nutrients, including protein and salt, using a simple food frequency questionnaire. Results. The median body mass index was 20.1 kg/m(2). The median total energy intake was 1566 kcal/d (95% CI, 892-2556). The daily intake of protein and salt was 65.1 and 9.1 g/d, respectively. The calcium, iron, vitamin D, and vitamin K intakes were 423 mg, 7.0 mg/d, 9.7 mu g/d, and 197 mu g/d, respectively. Patients with dyslipidemia displayed greater amounts of lipid and calcium than those with normal lipid levels. Discussion. Our findings suggest that long-term renal transplant recipients in Japan seem to restrict caloric intake, while maintaining appropriate intake of protein, lipids, carbohydrates, and vitamins A, D, and K. However, daily calcium and iron intake were insufficient; salt intake was greater than the recommended dietary allowances in all subjects. In patients with dyslipidemia, calcium intake was lower than those in patients without dyslipidemia, although their intake of lipids was also lower than those without dyslipidemia. Conclusion. Nutritional guidance beginning during the early posttransplant phase helps to foster a healthy body mass index and nutritional balances for long-term renal transplant recipients. However, greater salt restriction was needed, and additional nutritional guidance aiming to prevent osteoporosis seems to be considered.	[Sasaki, H.; Kusaka, M.; Fukami, N.; Shiroki, R.; Hoshinaga, K.] Fujita Hlth Univ, Dept Urol, Toyoake, Aichi 4701192, Japan; [Suzuki, A.; Itoh, M.] Fujita Hlth Univ, Dept Internal Med, Div Endocrinol & Metab, Toyoake, Aichi 4701192, Japan; [Takahashi, H.] Fujita Hlth Univ, Dept Med Stat, Toyoake, Aichi 4701192, Japan; [Uenishi, K.] Kagawa Nutr Univ, Lab Physiol Nutr, Saitama, Japan	Sasaki, H (reprint author), Fujita Hlth Univ, Dept Urol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	sasakih@fujita-hu.ac.jp					de Vries APJ, 2004, AM J TRANSPLANT, V4, P1675, DOI 10.1111/j.1600-6143.2004.00558.x; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Beto JA, 2014, J ACAD NUTR DIET, V114, P1077, DOI 10.1016/j.jand.2013.12.009; Hjelmesaeth J, 2001, NEPHROL DIAL TRANSPL, V16, P1047, DOI 10.1093/ndt/16.5.1047; Zrim S, 2012, NEPHROLOGY, V17, P582, DOI 10.1111/j.1440-1797.2012.01621.x; Kasiske B, 2004, AM J TRANSPLANT, V4, P13, DOI 10.1111/j.1600-6135.2004.0355.x; Martins C, 2004, TRANSPLANT P, V36, P1650, DOI 10.1016/j.transproceed.2004.06.065; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Armstrong KA, 2005, AM J TRANSPLANT, V5, P2710, DOI 10.1111/j.1600-6143.2005.01073.x; Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1; Bia M, 2010, AM J KIDNEY DIS, V56, P189, DOI 10.1053/j.ajkd.2010.04.010; Guida B, 2013, BIOMED RES INT, DOI 10.1155/2013/363728; Lopes IM, 1999, NUTRITION, V15, P7, DOI 10.1016/S0899-9007(98)00137-3; Moreira TR, 2013, RENAL FAILURE, V35, P1199, DOI 10.3109/0886022X.2013.819735; Nishi S, 2007, CONTRIB NEPHROL, V155, P82; Pieloch D, 2014, J RENAL NUTR, V24, P50, DOI 10.1053/j.jrn.2013.07.001; Rho Mi Ra, 2013, Clin Nutr Res, V2, P1, DOI 10.7762/cnr.2013.2.1.1; Teplan V, 2009, J RENAL NUTR, V19, P95, DOI 10.1053/j.jrn.2008.10.017; Uenishi K, 2008, J NUTR SCI VITAMINOL, V54, P25, DOI 10.3177/jnsv.54.25	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	MAR	2015	47	2					367	372		10.1016/j.transproceed.2014.10.013		6	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE0FT	WOS:000351480600022		
J	Okada, N; Mizuta, K; Oshima, M; Yamada, N; Sanada, Y; Ihara, Y; Urahashi, T; Ishikawa, J; Tsuji, T; Hishikawa, S; Teratani, T; Kobayashi, E				Okada, N.; Mizuta, K.; Oshima, M.; Yamada, N.; Sanada, Y.; Ihara, Y.; Urahashi, T.; Ishikawa, J.; Tsuji, T.; Hishikawa, S.; Teratani, T.; Kobayashi, E.			A Novel Split Liver Protocol Using the Subnormothermic Oxygenated Circuit System in a Porcine Model of a Marginal Donor Procedure	TRANSPLANTATION PROCEEDINGS			English	Article							NORMOTHERMIC EXTRACORPOREAL PERFUSION; MAN RENAL-TRANSPLANTATION; MACHINE PERFUSION; DCD LIVERS; PRESERVATION; EXPERIENCE; GRAFTS; INJURY; RECIPIENTS; ISCHEMIA	Background. A merit of subnormothermic perfusion has been reported to preserve grafts from ischemic injury in animal models. The split liver technique is commonly performed to solve the shortage of liver grafts. However, there has been no study showing the effect of a split liver graft on subnormothermic perfusion. We herein investigated the split liver protocol using a subnormothermic oxygenated circuit system (Sacs). Methods. Auxiliary liver transplantation was performed in a porcine marginal donor model by using a SOCS. In the SOCS group, the portal vein and hepatic artery of the graft were cannulated, and the graft was perfused by SOCS. In the cold storage (CS) group, the graft was placed in cold preservation solution. In the preservation phase, the graft was split. Results. There were no significant differences in the biochemical markers between the SOCS and CS groups. In terms of the histology, the sinusoidal spaces were widened in the CS group 12 hours after implantation. Conclusion. We have demonstrated a possibility to use SOCS with the split liver protocol by using a porcine model. This split liver protocol using SOCS will extend the split liver criteria and rescue more patients from hepatic failure, including pediatric patients.	[Okada, N.; Mizuta, K.; Yamada, N.; Sanada, Y.; Ihara, Y.; Urahashi, T.] Jichi Med Univ, Dept Transplant Surg, Shimotsuke, Tochigi 3290498, Japan; [Oshima, M.; Ishikawa, J.; Tsuji, T.] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Hishikawa, S.; Teratani, T.; Kobayashi, E.] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi 3290498, Japan	Mizuta, K (reprint author), Jichi Med Univ, Dept Transplant Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	koimizu@jichi.ac.jp			Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University, Tochigi, Japan; Department of Biological Science and Technology, Tokyo University of Science, Chiba, Japan; Japan Society for the Promotion of Science; Strategic Research Platform for Private Universities; Ministry of Education, Culture, Sport, Science and Technology of Japan; CEO program of MEDEX	Supported by the Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University, Tochigi, Japan, and the Department of Biological Science and Technology, Tokyo University of Science, Chiba, Japan. Author Eiji Kobayashi is a chief scientific advisor to Otsuka Pharmaceutical Factory, Inc. Supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science; the Strategic Research Platform for Private Universities; a matching fund subsidy from the Ministry of Education, Culture, Sport, Science and Technology of Japan; and the CEO program of MEDEX.	Abradelo M, 2012, TRANSPL P, V44, P1513, DOI 10.1016/j.transproceed.2012.05.002; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Emre S, 2011, TRANSPL P, V43, P884, DOI 10.1016/j.transproceed.2011.02.036; Vogel T, 2012, TRANSPLANT REV-ORLAN, V26, P156, DOI 10.1016/j.trre.2011.02.004; HOWARD TK, 1990, TRANSPLANTATION, V49, P103, DOI 10.1097/00007890-199001000-00023; Olschewski P, 2010, CRYOBIOLOGY, V60, P337, DOI 10.1016/j.cryobiol.2010.03.005; CALNE RY, 1967, BRIT MED J, V4, P645; Busuttil RW, 1999, ANN SURG, V229, P313, DOI 10.1097/00000658-199903000-00003; Xu HZ, 2012, J SURG RES, V173, pE83, DOI 10.1016/j.jss.2011.09.057; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; Toso C, 2002, TRANSPLANTATION, V74, P222, DOI 10.1097/00007890-200207270-00013; Cescon M, 2009, TRANSPLANTATION, V88, P1117, DOI 10.1097/TP.0b013e3181ba1096; Tolboom H, 2012, J SURG RES, V175, P149, DOI 10.1016/j.jss.2011.03.003; Fondevila C, 2011, ANN SURG, V254, P1000, DOI 10.1097/SLA.0b013e31822b8b2f; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Cescon M, 2006, ANN SURG, V244, P805, DOI 10.1097/01.sla.0000218076.85213.60; Fondevila C, 2012, AM J TRANSPLANT, V12, P162; Garcia-Valdecasas JC, 1999, EUR SURG RES, V31, P447, DOI 10.1159/000008724; Goldfarb DA, 2012, J UROLOGY, V187, P877, DOI 10.1016/j.juro.2011.11.030; Iwai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033157; Malago M, 1997, BRIT MED BULL, V53, P860; Perk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028518; ROGIERS X, 1995, TRANSPLANTATION, V59, P1081, DOI 10.1097/00007890-199504270-00001; Starzl TE, 1968, SURGERY, V63, P549; UK Transplant, 1999, LIV ORG SHAR PRINC O; Washburn K, 2005, AM J TRANSPLANT, V5, P1652, DOI 10.1111/j.16700-6143.2005.00933.x; Wilms C, 2006, ANN SURG, V244, P865, DOI 10.1097/01.sla.0000247254.76747.f3; Yersiz H, 2003, ANN SURG, V238, P496, DOI 10.1097/01.sla.0000089852.29654.72	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	MAR	2015	47	2					419	426		10.1016/j.transproceed.2014.10.053		8	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE0FT	WOS:000351480600031		
J	Nihira, T; Manabe, K; Tadokoro, C; Ozaki, S; Nakano, K				Nihira, Takahiro; Manabe, Kazuyoshi; Tadokoro, Chiharu; Ozaki, Shingo; Nakano, Ken			Complex Impedance Measurement Applied to Short-Time Contact Between Colliding Steel Surfaces	TRIBOLOGY LETTERS			English	Article						Collision; Lubrication; Metallic contact; Residual film; Complex impedance	BOUNDARY LUBRICATION; RESIDUAL FILMS; POINT CONTACTS; IMPACT LOADS; OIL FILMS; PRESSURE; BEHAVIOR; DEFORMATION; HYDROCARBON; BALL	The complex impedance method was developed for measuring the transient behaviors of short-time contacts between colliding steel surfaces, by using an alternating current circuit with a high frequency of 500 kHz at a high sampling rate of 20 MHz. The method was applied to estimate the lubrication effects of simple test lubricants acting at a short-time contact with a duration of 110 mu s occurring between a free-falling steel ball and a stationary steel plate, where to minimize the hydrodynamic lubrication effect, the test lubricant was provided on the steel plate as a homogeneous thin film with a thickness of 30 mu m. An advantage of the method is in the detection of the beginning and end of the contact. Particularly for wet conditions, although they were apparently unclear in the output voltage signal from the circuit, the modulus of the complex impedance detected them with high accuracy. In addition, using the modulus and argument of the complex impedance, the metallic contact ratio and residual film thickness at the short-time contact can be estimated quantitatively. By using the metallic contact duration determined by the metallic contact ratio, the differences in the boundary lubrication effects were quantified for the selected base oils (i.e., n-decane, n-dodecane, n-tetradecane, and n-hexadecane) and the 30-mM oleic acid solutions dissolved in the base oils at the short-time contact, although the differences in the lubricants did not change the shape of the plastic indentation formed on the steel plate.	[Nihira, Takahiro; Manabe, Kazuyoshi; Nakano, Ken] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Tadokoro, Chiharu] Tokyo Univ Sci, Dept Mech Engn, Tokyo 1258585, Japan; [Ozaki, Shingo] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan	Nakano, K (reprint author), Yokohama Natl Univ, Fac Environm & Informat Sci, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	nakano@ynu.ac.jp					DOWSON D, 1994, WEAR, V179, P29, DOI 10.1016/0043-1648(94)90215-1; SAFA MMA, 1986, J TRIBOL-T ASME, V108, P372; HAMILTON GM, 1971, PROC R SOC LON SER-A, V322, P313, DOI 10.1098/rspa.1971.0070; ASKWITH TC, 1966, PROC R SOC LON SER-A, V291, P500, DOI 10.1098/rspa.1966.0111; LEE KM, 1973, J LUBRIC TECH-T ASME, V95, P308; DOWSON D, 1967, NATURE, V214, P947, DOI 10.1038/214947b0; Lord J, 2008, TRIBOL INT, V41, P831, DOI 10.1016/j.triboint.2007.11.006; HIRANO F, 1987, TRIBOL INT, V20, P186, DOI 10.1016/0301-679X(87)90074-0; OKABE H, 1981, ASLE TRANS, V24, P459; CAMERON A, 1980, ASLE TRANS, V23, P388; OKABE H, 1981, ASLE TRANS, V24, P467; GREW W, 1967, NATURE, V214, P429, DOI 10.1038/214429a0; ARCHARD JF, 1961, PROC R SOC LON SER-A, V261, P532, DOI 10.1098/rspa.1961.0094; CAMERON A, 1963, NATURE, V198, P475, DOI 10.1038/198475a0; CAMERON A, 1976, ASLE TRANS, V19, P195; CHRISTENSEN H, 1962, PROC R SOC LON SER-A, V266, P312, DOI 10.1098/rspa.1962.0064; GREW WJS, 1972, PROC R SOC LON SER-A, V327, P47, DOI 10.1098/rspa.1972.0030; GREW W, 1968, NATURE, V217, P481, DOI 10.1038/217481a0; IMADO K, 1994, TRIBOL T, V37, P378, DOI 10.1080/10402009408983306; Kaneta M, 2011, P I MECH ENG J-J ENG, V225, P1, DOI 10.1177/13506501JET838; Kaneta M, 2007, P I MECH ENG J-J ENG, V221, P271, DOI 10.1243/13506501JET236; Larsson R, 1995, WEAR, V190, P184, DOI 10.1016/0043-1648(96)80016-0; Manabe K, 2008, TRIBOL INT, V41, P1103, DOI 10.1016/j.triboint.2008.02.001; Nakano K, 2006, TRIBOL LETT, V22, P127, DOI 10.1007/s11249-006-9074-z; Nakano Ken, 2011, Tribology Online, V6, DOI 10.2474/trol.6.277; Ohno N., 2006, LUBR SCI, V18, P25, DOI DOI 10.1002/1S.3; OKABE H, 1982, ASLE TRANS, V25, P33; SMITH AJ, 1972, PROC R SOC LON SER-A, V328, P541, DOI 10.1098/rspa.1972.0094; Tabor D., 1949, ENGINEERING, V167, P145; Ten Napel W. E., 1970, P I MECH ENG, V185, P635	30	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	MAR	2015	57	3							29	10.1007/s11249-015-0478-5		11	Engineering, Chemical; Engineering, Mechanical	Engineering	CD4KH	WOS:000351050800015		
J	Thwe-Thwe-Win; Hirao, T; Watanabe, A; Goto, S				Thwe-Thwe-Win; Hirao, Tomonori; Watanabe, Atsushi; Goto, Susumu			Current genetic structure of teak (Tectona qrandis) in Myanmar based on newly developed chloroplast single nucleotide polymorphism and nuclear single sequence repeat markers	TROPICAL CONSERVATION SCIENCE			English	Article						gene conservation; genetic clustering; haplotypes; Myanmar; teak	MICROSATELLITE MARKERS; COMPUTER-PROGRAM; GRANDIS LF; DIVERSITY; POPULATION; DIFFERENTIATION; CONSERVATION; PROVENANCES; ADAPTATION; RESOURCES	Teak (Tectona grandis), which is among the most valuable tropical timber species, is under pressure from rapid deforestation and habitat fragmentation. Limited genetic information is available for Myanmar teak, which comes from the largest natural teak-bearing forest area in the world. To determine the phylogeographic patterns of Myanmar teak, we evaluated three newly developed chloroplast single nucleotide polymorphism (cpSNP) and 10 nuclear simple sequence repeat (nrSSR) markers in 480 individuals representing 20 natural populations. The cpSNP markers detected four haplotypes, each differing by a single mutation. The G(ST) value was lower than the N-ST value and did not reveal a phylogeographic structure of Myanmar teak. Nuclear microsatellite analysis revealed high genetic diversity with the mean expected heterozygosity (0.652). The same level of genetic differentiation (4%) was observed for both cpSNP and nrSSR markers in different groups. Conservation of the HMB, TDG, KTA, and POL populations should receive highest priority because these contribute most to the total genetic diversity. The genetic boundaries of teak observed from combining the results of cpSNP and nrSSR marker barriers suggested four potential zones in the teak seed transfer guidelines of Myanmar. In light of our findings, we discussed appropriate gene conservation strategies and proposed seed zones to safeguard the current genetic resources of Myanmar teak.	[Thwe-Thwe-Win; Goto, Susumu] Univ Tokyo, Univ Forests, Grad Sch Agr & Life Sci, Educ & Res Ctr,Bunkyo Ku, Tokyo 1138657, Japan; [Hirao, Tomonori] Independent Adm Inst, Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Juo, Ibaraki 3191301, Japan; [Watanabe, Atsushi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan	Thwe-Thwe-Win (reprint author), Univ Tokyo, Univ Forests, Grad Sch Agr & Life Sci, Educ & Res Ctr,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ttw74kk@gmail.com					Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Pons O, 1996, GENETICS, V144, P1237; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pritchard JK, 2000, GENETICS, V155, P945; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Hewitt GM, 2004, PHILOS T ROY SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Alcantara BK, 2013, REV ARVORE, V37, P747, DOI 10.1590/S0100-67622013000400018; Goudet J, 1995, J HERED, V86, P485; Rajora OP, 2001, EUPHYTICA, V118, P197, DOI 10.1023/A:1004150525384; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Fofana IJ, 2009, NEW FOREST, V37, P175, DOI 10.1007/s11056-008-9116-5; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bryant Raymond L, 1997, POLITICAL ECOLOGY FO; Gyi K. K., 1998, TEAK FUT P 2 REG SEM, P27; Hadden R. L., 2008, GEOLOGY BURMA MYANMA, P312; Hebel I, 2006, SILVAE GENET, V55, P38; KERTADIKARA AWS, 1995, THEOR APPL GENET, V90, P803, DOI 10.1007/BF00222015; King RA, 1998, MOL ECOL, V7, P1151; Koonkhunthod N, 2007, FOREST ECOL MANAG, V247, P246, DOI 10.1016/j.foreco.2007.04.053; Lowe A. J., 2010, Tropical Plant Biology, V3, P50, DOI 10.1007/s12042-010-9045-2; Maung TinMin, 2008, Small-scale Forestry, V7, P29, DOI 10.1007/s11842-008-9039-1; Minn Y, 2014, TREE GENET GENOMES, V10, P1435, DOI 10.1007/s11295-014-0772-7; Ohatani M., 2013, MOL ECOL, V22, P2264; Pandy D., 2000, UNASYLVA, V201, P1; Rosane G. C., 2003, MOL ECOL, V12, P105; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saw E. D., 2003, P INT C QUAL TIMB PR, P135; Schneider S., 2000, ARLEQUIN VERSION 2 0, P111; Shiraishi S., 1995, Journal of the Japanese Forestry Society, V77, P429; Shrestha MK, 2005, CAN J FOREST RES, V35, P1017, DOI 10.1139/X05-033; Tanah L. H., 2013, J HERED, V104, P115; Tangmitcharoen S, 1997, ANN BOT-LONDON, V79, P227, DOI 10.1006/anbo.1996.0317; Verhaegen D, 2005, MOL ECOL NOTES, V5, P945, DOI 10.1111/j.1471-8286.2005.01124.x	41	0	0	TROPICAL CONSERVATION SCIENCE	MENLO PARK	PO BOX 0291, MENLO PARK, CA 94026-0291 USA	1940-0829			TROP CONSERV SCI	Trop. Conserv. Sci.	MAR	2015	8	1					235	256				22	Biodiversity Conservation	Biodiversity & Conservation	CE1BF	WOS:000351545700018		
J	Tamura, S; Doi, S; Tamura, Y; Takahashi, K; Enomoto, H; Ozawa, T; Uchida, K				Tamura, Shinji; Doi, Shoko; Tamura, Yumiko; Takahashi, Kuniaki; Enomoto, Hirokazu; Ozawa, Tsuyoshi; Uchida, Kazuyuki			THORACOLUMBAR INTRADURAL DISC HERNIATION IN EIGHT DOGS: CLINICAL, LOW-FIELD MAGNETIC RESONANCE IMAGING, AND COMPUTED TOMOGRAPHIC MYELOGRAPHY FINDINGS	VETERINARY RADIOLOGY & ULTRASOUND			English	Article						CT myelography; dog; intradural disc herniation; MRI	INTERVERTEBRAL DISC; SUBARACHNOID SPACE; DIAGNOSIS; EXTRUSION; LEVEL	Intradural disc herniation is a rarely reported cause of neurologic deficits in dogs and few published studies have described comparative imaging characteristics. The purpose of this retrospective cross sectional study was to describe clinical and imaging findings in a group of dogs with confirmed thoracolumbar intradural disc herniation. Included dogs were referred to one of four clinics, had acute mono/paraparesis or paraplegia, had low field magnetic resonance imaging (MRI) and/or computed tomographic myelography, and were diagnosed with thoracolumbar intradural disc herniation during surgery. Eight dogs met inclusion criteria. The prevalence of thoracolumbar intradural disc herniation amongst the total population of dogs that developed a thoracolumbar intervertebral disc herniation and that were treated with a surgical procedure was 0.5%. Five dogs were examined using low-field MRI. Lesions that were suspected to be intervertebral disc herniations were observed; however, there were no specific findings indicating that the nucleus pulposus had penetrated into the subarachnoid space or into the spinal cord parenchyma. Thus, the dogs were misdiagnosed as having a conventional intervertebral disc herniation. An intradural extramedullary disc herniation (three cases) or intramedullary disc herniation (two cases) was confirmed during surgery. By using computed tomographic myelography (CTM) for the remaining three dogs, an intradural extramedullary mass surrounded by an accumulation of contrast medium was observed and confirmed during surgery. Findings from this small sample of eight dogs indicated that CTM may be more sensitive for diagnosing canine thoracolumbar intradural disc herniation than low-field MRI. (C) 2014 American College of Veterinary Radiology.	[Tamura, Shinji; Doi, Shoko; Tamura, Yumiko] Tamura Anim Clin, Saeki Ku, Hiroshima 7315132, Japan; [Takahashi, Kuniaki] Hidamari Anim Clin, Gifu 5008891, Japan; [Enomoto, Hirokazu] Enomoto Anim Hosp, Sapporo, Hokkaido, Japan; [Ozawa, Tsuyoshi] Ozawa Anim Hosp, Uji, Kyoto, Japan; [Uchida, Kazuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo, Japan	Tamura, S (reprint author), Tamura Anim Clin, Saeki Ku, 7-16 Yoshimien, Hiroshima 7315132, Japan.	cqx03426@ms8.megaegg.ne.jp					EPSTEIN NE, 1990, J SPINAL DISORD, V3, P396; SETHER LA, 1990, RADIOLOGY, V175, P207; Royal AB, 2009, VET SURG, V38, P798, DOI 10.1111/j.1532-950X.2009.00570.x; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Arnold PM, 2011, J SPINAL CORD MED, V34, P312, DOI 10.1179/2045772311Y.0000000007; Barnoon I, 2012, CAN VET J, V53, P1191; D'Andrea G, 2004, NEUROSURG REV, V27, P75, DOI 10.1007/s10143-003-0296-3; Kent M, 2011, VET RADIOL ULTRASOUN, V52, P185, DOI 10.1111/j.1740-8261.2010.01755.x; Liptak JM, 2002, VET RADIOL ULTRASOUN, V43, P272, DOI 10.1111/j.1740-8261.2002.tb01002.x; Liu CC, 2011, EUR SPINE J, V20, pS326, DOI 10.1007/s00586-011-1772-z; Luypaert R, 1986, J Belge Radiol, V69, P157; Mateo I, 2011, VET RADIOL ULTRASOUN, V52, P17, DOI 10.1111/j.1740-8261.2010.01746.x; McConnell JF, 2004, VET RADIOL ULTRASOUN, V45, P327, DOI 10.1111/j.1740-8261.2004.04062.x; Montavon P M, 1990, J Am Vet Med Assoc, V196, P783; Ozturk A, 2007, TURK NEUROSURG, V17, P134; Packer RA, 2004, VET RADIOL ULTRASOUN, V45, P523, DOI 10.1111/j.1740-8261.2004.04089.x; Pease A, 2006, VET RADIOL ULTRASOUN, V47, P254, DOI 10.1111/j.1740-8261.2006.00136.x; Poncelet L, 2011, VET REC, V168, P486, DOI 10.1136/vr.c6740; ROUSH JK, 1992, VET RADIOL ULTRASOUN, V33, P22, DOI 10.1111/j.1740-8261.1992.tb01951.x; Sanders SG, 2002, J AM VET MED ASSOC, V221, P1594, DOI 10.2460/javma.2002.221.1594; Seller GS, 2012, VET RADIOL ULTRASOUN, V53, P157; Sharp NJH, 2005, SMALL ANIMAL SPINAL, P121, DOI 10.1016/B978-0-7234-3209-8.50012-1; Suran JN, 2011, VET RADIOL ULTRASOUN, V52, P10, DOI 10.1111/j.1740-8261.2010.01734.x; Tidwell AS, 2002, VET RADIOL ULTRASOUN, V43, P319, DOI 10.1111/j.1740-8261.2002.tb01011.x; YILDIZHAN A, 1991, ACTA NEUROCHIR, V110, P160, DOI 10.1007/BF01400685	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8183	1740-8261		VET RADIOL ULTRASOUN	Vet. Radiol. Ultrasound	MAR-APR	2015	56	2					160	167		10.1111/vru.12213		8	Veterinary Sciences	Veterinary Sciences	CD9DQ	WOS:000351398100009		
J	Eusebio-Cope, A; Sun, LY; Tanaka, T; Chiba, S; Kasahara, S; Suzuki, N				Eusebio-Cope, Ana; Sun, Liying; Tanaka, Toru; Chiba, Sotaro; Kasahara, Shin; Suzuki, Nobuhiro			The chestnut blight fungus for studies on virus/host and virus/virus interactions: From a natural to a model host	VIROLOGY			English	Article						Czyphonectria parasitica; Chestnut blight fungus; dsRNA; Mycovirus; Fungal virus; Hypovirus; RNA silencing; Mycoreovirus; Model organism; Virus-host interaction	PATHOGEN CRYPHONECTRIA-PARASITICA; PROTOTYPIC HYPOVIRUS CHV1-EP713; STRANDED-RNA ACCUMULATION; ROOT-ROT FUNGUS; ROSELLINIA-NECATRIX; NEUROSPORA-CRASSA; FILAMENTOUS FUNGI; VERTICAL TRANSMISSION; ASPERGILLUS-NIDULANS; EXPRESSION VECTORS	The chestnut blight fungus, Cryphonectria parasitica, is an important plant pathogenic ascomycete. The fungus hosts a wide range of viruses and now has been established as a model filamentous fungus for studying virus/host and virus/virus interactions. This is based on the development of methods for artificial virus introduction and elimination, host genome manipulability, available host genome sequence with annotations, host mutant strains, and molecular tools. Molecular tools include subcellular distribution markers, gene expression reporters, and vectors with regulatable promoters that have been long available for unicellular organisms, cultured cells, individuals of animals and plants, and certain filamentous fungi. A comparison with other filamentous fungi such as Neurospora crassa has been made to establish clear advantages and disadvantages of C parasitica as a virus host. In addition, a few recent studies on RNA silencing vs. viruses in this fungus are introduced. (C) 2014 Elsevier Inc. All rights reserved.	[Eusebio-Cope, Ana; Tanaka, Toru; Chiba, Sotaro; Suzuki, Nobuhiro] Okayama Univ, IPSR, Kurashiki, Okayama 7100046, Japan; [Sun, Liying] Northwest A&F Univ, Coll Plant Protect, Yangling, Shananxi, Peoples R China; [Kasahara, Shin] Miyagi Univ, Dept Environm Sci, Sendai, Miyagi 982215, Japan	Suzuki, N (reprint author), Okayama Univ, IPSR, Chuou 2-20-1, Kurashiki, Okayama 7100046, Japan.	anacope2004@yahoo.com; sunly_de@126.com; dns421419@s.okayama-u.ac.jp; chiba@rib.okayama-u.ac.jp; kasahara@myu.ac.jp; nsuzuki@rib.okayama-u.ac.jp	Suzuki, Nobuhiro/B-2517-2011		Yomogi Inc.; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	A series of studies related to this paper was financially supported in part by Yomogi Inc. and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry. The authors are grateful to Drs. Hideki Kondo, Masatoki Taga, Ken-lchi Ikeda, and Satoko Kanematsu, and current and previous lab members of the Suzuki lab for fruitful discussion. We would also like to thank Drs. Daniel Rigling, Donald L Nuss, and Bradley I. Hillman for their generous gifts of the photographs of chestnut blight, plasmid constructs, fungal strains, and fruitful discussion. Plasmid clones carrying fluorescent protein genes were kindly provided by Dr. Roger Y. Tsien. The authors apologize to authors whose related articles have not been cited due to space limitation.	Allen TD, 2004, J VIROL, V78, P4145, DOI 10.1128/JVI.78.8.4145-4155.2004; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Urayama S, 2014, VIROLOGY, V448, P265, DOI 10.1016/j.virol.2013.10.022; Tanaka T, 2011, J GEN VIROL, V92, P1949, DOI 10.1099/vir.0.031138-0; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Hillman BI, 2004, ADV VIRUS RES, V63, P423, DOI 10.1016/S0065-3527(04)63007-7; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Kanematsu S, 2014, VIROLOGY, V450, P308, DOI 10.1016/j.virol.2013.12.002; Gryzenhout M, 2006, FEMS MICROBIOL LETT, V258, P161, DOI 10.1111/j.1574-6968.2006.00170.x; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Chung HJ, 2008, MOL PLANT MICROBE IN, V21, P1582, DOI 10.1094/MPMI-21-12-1582; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Choi GH, 2012, GENETICS, V190, P113, DOI 10.1534/genetics.111.133983; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Zhang DX, 2014, GENETICS, V197, P701, DOI 10.1534/genetics.114.164574; Ikeda K, 2004, MYCOL RES, V108, P626, DOI 10.1017/s0953756204000061; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Salaipeth L, 2014, J GEN VIROL, V95, P740, DOI 10.1099/vir.0.058164-0; Andrie RM, 2005, MYCOLOGIA, V97, P1152, DOI 10.3852/mycologia.97.5.1152; ANAGNOSTAKIS SL, 1982, SCIENCE, V215, P466, DOI 10.1126/science.215.4532.466; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Wickner RB, 1996, MICROBIOL REV, V60, P250; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Kondo H, 2013, ADV VIRUS RES, V86, P177, DOI 10.1016/B978-0-12-394315-6.00007-6; Dawe AL, 2013, ADV VIRUS RES, V86, P109, DOI 10.1016/B978-0-12-394315-6.00005-2; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Eusebio-Cope A, 2010, VIROLOGY, V397, P399, DOI 10.1016/j.virol.2009.11.035; Faruk MI, 2008, J VIROL, V82, P740, DOI 10.1128/JVI.02015-07; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; HEINIGER U, 1994, ANNU REV PHYTOPATHOL, V32, P581, DOI 10.1146/annurev.py.32.090194.003053; Milgroom MG, 1996, MYCOLOGIA, V88, P179, DOI 10.2307/3760921; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Milgroom MG, 2004, ANNU REV PHYTOPATHOL, V42, P311, DOI 10.1146/annurev.phyto.42.040803.140325; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; Arakawa Masao, 2002, Mycoscience, V43, P21, DOI 10.1007/s102670200004; Bartoszewska M, 2011, BIOTECHNOL LETT, V33, P1921, DOI 10.1007/s10529-011-0664-y; Billmyre RB, 2013, CHROMOSOME RES, V21, P561, DOI 10.1007/s10577-013-9388-2; Boine B, 2012, J GEN VIROL, V93, P2502, DOI 10.1099/vir.0.043869-0; CHEN BS, 1994, SCIENCE, V264, P1762, DOI 10.1126/science.8209256; Chen BS, 2000, J VIROL, V74, P7562, DOI 10.1128/JVI.74.16.7562-7567.2000; Chiba S, 2013, J VIROL, V87, P6727, DOI 10.1128/JVI.00557-13; Chiba S, 2013, J VIROL, V87, P2330, DOI 10.1128/JVI.02835-12; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; CRAVEN MG, 1993, J VIROL, V67, P6513; Dawe AL, 2003, MICROBIOL-SGM, V149, P2373, DOI 10.1099/mic.0.26371-0; Deng FY, 2007, EUKARYOT CELL, V6, P1286, DOI 10.1128/EC.00166-07; Deng FY, 2008, J VIROL, V82, P6369, DOI 10.1128/JVI.02638-07; Deng FY, 2007, EUKARYOT CELL, V6, P235, DOI 10.1128/EC.00302-06; Derkx PMF, 2001, MOL GENET GENOMICS, V266, P537, DOI 10.1007/s004380100587; Eusebio-Cope A, 2009, FUNGAL GENET BIOL, V46, P342, DOI 10.1016/j.fgb.2009.01.005; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Griffin G.J., 1986, APS MONOGRAPH SER, P1; Guo LH, 2009, NUCLEIC ACIDS RES, V37, P3645, DOI 10.1093/nar/gkp224; Hammond TM, 2008, EUKARYOT CELL, V7, P339, DOI 10.1128/EC.00355-07; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641; HILLMAN BI, 1990, PHYTOPATHOLOGY, V80, P950, DOI 10.1094/Phyto-80-950; Hillman BI, 2004, J VIROL, V78, P892, DOI 10.1128/JVI.78.2.892-898.2004; Hyodo K., 2014, J GEN PLANT PATHOL, V80; Ikeda K, 2013, APPL ENVIRON MICROB, V79, P3684, DOI 10.1128/AEM.00426-13; Jacob-Wilk D, 2006, J VIROL, V80, P6588, DOI 10.1128/JVI.02519-05; Jensen K.S., 2014, J VIROL IN PRESS; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Jiang L., 2014, VIRUS RES IN PRESS; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kasahara S, 2000, P NATL ACAD SCI USA, V97, P412, DOI 10.1073/pnas.97.1.412; Kim JM, 2010, VIRUS GENES, V41, P292, DOI 10.1007/s11262-010-0495-2; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Kondo H, 2013, VIROLOGY, V435, P201, DOI [10.1016/j.virol.2012.10.002, 10.1016/j.viro1.2012.10.002]; KUNTZEL H, 1973, P NATL ACAD SCI USA, V70, P1574, DOI 10.1073/pnas.70.5.1574; Kwon BR, 2009, APPL MICROBIOL BIOT, V83, P339, DOI 10.1007/s00253-009-1906-y; Lee KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021629; Lin HY, 2007, J VIROL, V81, P1813, DOI 10.1128/JVI.01625-06; Liu LJ, 2014, P NATL ACAD SCI USA, V111, P12205, DOI 10.1073/pnas.1401786111; Liu YC, 2007, MYCOL RES, V111, P433, DOI 10.1016/j.mycres.2006.12.006; Maruyama J, 2007, FEMS MICROBIOL LETT, V272, P1, DOI 10.1111/j.1574-6968.2007.00758.x; Mascia T, 2014, P NATL ACAD SCI USA, V111, P4291, DOI 10.1073/pnas.1315668111; McGuire IC, 2004, FUNGAL GENET BIOL, V41, P521, DOI 10.1016/j.fgb.2003.12.007; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Nuss DL, 2011, ADV VIRUS RES, V80, P25, DOI 10.1016/B978-0-12-385987-7.00002-6; Park SM, 2008, MYCOL RES, V112, P1220, DOI 10.1016/j.mycres.2008.04.001; Peever TL, 1997, PHYTOPATHOLOGY, V87, P1026, DOI 10.1094/PHYTO.1997.87.10.1026; Peever TL, 1998, PHYTOPATHOLOGY, V88, P811, DOI 10.1094/PHYTO.1998.88.8.811; POLASHOCK JJ, 1994, CURR GENET, V26, P528, DOI 10.1007/BF00309945; Roane M.K., 1986, APS MONOGRAPH, P53; Segers GC, 2006, EUKARYOT CELL, V5, P896, DOI 10.1128/EC.00373-05; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Shang JJ, 2008, FUNGAL GENET BIOL, V45, P319, DOI 10.1016/j.fgb.2007.11.002; Son M, 2013, J VIROL, V87, P10356, DOI 10.1128/JVI.01026-13; Sun LY, 2006, J GEN VIROL, V87, P3703, DOI 10.1099/vir0.82213-0; Sun LY, 2008, RNA, V14, P2557, DOI 10.1261/rna.1125408; Sun QH, 2009, P NATL ACAD SCI USA, V106, P17927, DOI 10.1073/pnas.0907552106; Suzuki N, 2002, J VIROL, V76, P7747, DOI 10.1128/JVI.76.15.7747-7759.2002; Suzuki N, 1999, J VIROL, V73, P9478; Suzuki N, 2000, J VIROL, V74, P7568, DOI 10.1128/JVI.74.16.7568-7577.2000; Suzuki Nobuhiro, 2014, Uirusu, V64, P11, DOI 10.2222/jsv.64.11; Suzuki N, 2003, J VIROL, V77, P11697, DOI 10.1128/JVI.77.21.11697-11707.2003; Tainter F. H., 1996, PRINCIPLES FOREST PA; Toews MW, 2004, CURR GENET, V45, P383, DOI 10.1007/s00294-004-0495-7; Turina M, 2007, J PLANT PATHOL, V89, P165; TUVESON RW, 1972, VIROLOGY, V47, P527, DOI 10.1016/0042-6822(72)90295-4; Westermann B, 2002, FUNGAL GENET BIOL, V36, P91, DOI 10.1016/S1087-1845(02)00019-1; Willyerd KL, 2009, APPL ENVIRON MICROB, V75, P5417, DOI 10.1128/AEM.00899-09; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Yaegashi H, 2013, VIROLOGY, V444, P409, DOI 10.1016/j.virol.2013.07.010; Yaegashi H, 2011, VIROLOGY, V409, P280, DOI 10.1016/j.virol.2010.10.014; Zhang DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108653; Zhang DX, 2013, FUNGAL GENET BIOL, V61, P1, DOI 10.1016/j.fgb.2013.08.013; Zhang R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00360; Zhang XM, 2008, P NATL ACAD SCI USA, V105, P16749, DOI 10.1073/pnas.0807225105	122	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	MAR	2015	477						164	175		10.1016/j.virol.2014.09.024		12	Virology	Virology	CE0HH	WOS:000351484600019		
J	Goto, C; Mukawa, S; Mitsunaga, T				Goto, Chie; Mukawa, Shigeyuki; Mitsunaga, Takayuki			Two Year Field Study to Evaluate the Efficacy of Mamestra brassicae Nucleopolyhedrovirus Combined with Proteins Derived from Xestia c-nigrum Granulovirus	VIRUSES-BASEL			English	Article							NUCLEAR-POLYHEDROSIS-VIRUS; ARMIGERA LEPIDOPTERA-NOCTUIDAE; SPODOPTERA-LITURA LEPIDOPTERA; VIRAL-ENHANCING ACTIVITY; BOMBYX-MORI LEPIDOPTERA; GYPSY-MOTH LEPIDOPTERA; NI GRANULOSIS-VIRUS; PSEUDALETIA-UNIPUNCTA; HELICOVERPA-ARMIGERA; OPTICAL BRIGHTENER	Japan has only three registered baculovirus biopesticides despite its long history of studies on insect viruses. High production cost is one of the main hindrances for practical use of baculoviruses. Enhancement of insecticidal effect is one possible way to overcome this problem, so there have been many attempts to develop additives for baculoviruses. We found that alkaline soluble proteins of capsules (GVPs) of Xestia c-nigrum granulovirus can increase infectivity of some viruses including Mamestra brassicae nucleopolyhedrovirus (MabrNPV), and previously reported that MabrNPV mixed with GVPs was highly infectious to three important noctuid pests of vegetables in the following order, Helicoverpa armigera, M. brassicae, and Autographa nigrisigna. In this study, small-plot experiments were performed to assess concentrations of MabrNPV and GVPs at three cabbage fields and a broccoli field for the control of M. brassicae. In the first experiment, addition of GVPs (10 mu g/mL) to MabrNPV at 10(6) OBs/mL resulted in a significant increase in NPV infection (from 53% to 66%). In the second experiment, the enhancing effect of GVP on NPV infection was confirmed at 10-times lower concentrations of MabrNPV. In the third and fourth experiments, a 50% reduction in GVPs (from 10 mu g/mL to 5 mu g/mL) did not result in a lowering of infectivity of the formulations containing MabrNPV at 10(5) OBs/mL. These results indicate that GVPs are promising additives for virus insecticides.	[Goto, Chie; Mitsunaga, Takayuki] NARO Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Mukawa, Shigeyuki] Kumiai Chem Ind Co Ltd, Life Sci Res Inst, Shizuoka 4360031, Japan	Goto, C (reprint author), NARO Agr Res Ctr, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	cgoto@affrc.go.jp; s-mukawa@kumiai-chem.co.jp; aeiou@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	We thank Hiroshi Saijo and Shohei Okuno for their contribution in the field trials. This research was supported by a Grant-in-Aid, "Development of new biorational techniques for sustainable agriculture", from the Ministry of Agriculture, Forestry and Fisheries, Japan.	Akutsu K., 1967, P US JAP SEM MICR CO, P43; ALLAWAY GP, 1984, ANN APPL BIOL, V105, P29, DOI 10.1111/j.1744-7348.1984.tb02799.x; Cisneros J, 2002, BIOL CONTROL, V23, P87, DOI 10.1006/bcon.2001.0985; Mukawa S, 2007, J ECON ENTOMOL, V100, P1075, DOI 10.1603/0022-0493(2007)100[1075:EONIAM]2.0.CO;2; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nakai Madoka, 2009, Virologica Sinica, V24, P323, DOI 10.1007/s12250-009-3057-9; HASHIMOTO Y, 1991, J GEN VIROL, V72, P2645, DOI 10.1099/0022-1317-72-11-2645; DERKSEN ACG, 1988, VIROLOGY, V167, P242, DOI 10.1016/0042-6822(88)90074-8; Boughton AJ, 2001, J ECON ENTOMOL, V94, P1045, DOI 10.1603/0022-0493-94.5.1045; Jiang JX, 2011, PEST MANAG SCI, V67, P705, DOI 10.1002/ps.2111; Lasa R, 2007, BIOL CONTROL, V40, P89, DOI 10.1016/j.biocontrol.2006.06.015; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; Chang JH, 2003, J INVERTEBR PATHOL, V84, P30, DOI 10.1016/S0022-2011(03)00121-6; Mukawa S, 2010, J ECON ENTOMOL, V103, P257, DOI 10.1603/EC09211; Arakawa T, 2002, APPL ENTOMOL ZOOL, V37, P7, DOI 10.1303/aez.2002.7; Arakawa T, 2003, J INVERTEBR PATHOL, V83, P261, DOI 10.1016/S0022-2011(03)00085-5; ARIF BM, 1995, J GEN VIROL, V76, P1, DOI 10.1099/0022-1317-76-1-1; ASAYAMA T, 1970, J INVERTEBR PATHOL, V15, P284, DOI 10.1016/0022-2011(70)90248-X; Bixby-Brosi AJ, 2012, PEST MANAG SCI, V68, P324, DOI 10.1002/ps.2252; Bonning BC, 2003, ADVANCES IN MICROBIAL CONTROL OF INSECT PESTS, P109; Choi JB, 2013, VIRUS GENES, V47, P133, DOI 10.1007/s11262-013-0922-2; DOYLE CJ, 1990, APPL ENVIRON MICROB, V56, P2704; GALLO LG, 1991, J INVERTEBR PATHOL, V58, P203, DOI 10.1016/0022-2011(91)90064-W; GIJZEN M, 1995, J INVERTEBR PATHOL, V65, P289, DOI 10.1006/jipa.1995.1044; GOTO C, 1992, J GEN VIROL, V73, P1491, DOI 10.1099/0022-1317-73-6-1491; GOTO C, 1990, APPL ENTOMOL ZOOL, V25, P135; Goto C, 1998, VIRUS GENES, V16, P199, DOI 10.1023/A:1007972108026; GOTO C, 1985, JPN J APPL ENTOMOL Z, V29, P102; Goulson D, 2000, BIOL CONTROL, V19, P232, DOI 10.1006/bcon.2000.0861; Guo H., 2013, J INSECT SCI, V13, pe12; Hosmer D.W., 2008, APPL SURVIVAL ANAL R, P416; Japan Plant Protection Association, 2013, NOYAK YOR 2013 ANN S, P749; Kamiya K, 2004, BIOL CONTROL, V31, P38, DOI 10.1016/j.biocontrol.2004.04.003; Kamiya K., 2012, B GIFU PREFECT AGR T, V12, P27; Kitazima E., 1938, B KAGOSHIMA IMP COLL, V13, P111; Kleinbaum DG, 2012, SURVIVAL ANAL SELF L, P700; Koyama R., 1959, B GOV FOR EXP STN, V112, P23; Martinez AM, 2000, BIOL CONTROL, V17, P174, DOI 10.1006/bcon.1999.0786; Mitsuhashi W, 2009, JARQ-JPN AGR RES Q, V43, P289; Mukawa S, 2011, APPL ENTOMOL ZOOL, V46, P55, DOI 10.1007/s13355-010-0007-9; Mukawa S, 2008, APPL ENTOMOL ZOOL, V43, P323, DOI 10.1303/aez.2008.323; Mukawa S, 2006, J GEN VIROL, V87, P1491, DOI 10.1099/vir.0.81853-0; OKADA M, 1977, Bulletin of the Chugoku National Agricultural Experiment Station Series E (Environment Division), V12, P1; Okuno S, 2003, BIOL CONTROL, V26, P146, DOI 10.1016/S1049-9644(02)00122-6; ROELVINK PW, 1995, J GEN VIROL, V76, P2693, DOI 10.1099/0022-1317-76-11-2693; Saito O., 1992, ANN REP SOC PLANT PR, V43, P189; SATO T, 1985, JARQ, V19, P271; Shapiro M, 2000, J ECON ENTOMOL, V93, P1633; SHAPIRO M, 1982, ANN ENTOMOL SOC AM, V75, P346; SHAPIRO M, 1992, J ECON ENTOMOL, V85, P1120; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995, DOI DOI 10.1016/J.JBIOMECH.2012.07.028; TANADA Y, 1971, J INVERTEBR PATHOL, V17, P116, DOI 10.1016/0022-2011(71)90133-9; TANADA Y, 1985, J INVERTEBR PATHOL, V45, P125; YAMAMOTO T, 1978, J INVERTEBR PATHOL, V32, P202, DOI 10.1016/0022-2011(78)90031-9; YAMAMOTO T, 1979, J GEN VIROL, V45, P371, DOI 10.1099/0022-1317-45-2-371	58	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	MAR	2015	7	3					1062	1078		10.3390/v7031062		17	Virology	Virology	CE6JP	WOS:000351943000010		
J	Takahashi, M; Nakai, M; Saito, Y; Sato, Y; Ishijima, C; Kunimi, Y				Takahashi, Maho; Nakai, Madoka; Saito, Yasumasa; Sato, Yasushi; Ishijima, Chikara; Kunimi, Yasuhisa			Field Efficacy and Transmission of Fast- and Slow-Killing Nucleopolyhedroviruses that Are Infectious to Adoxophyes honmai (Lepidoptera: Tortricidae)	VIRUSES-BASEL			English	Article							SMALLER TEA TORTRIX; BACULOVIRUS RESISTANCE; GENOMIC SEQUENCE; GRANULOSIS-VIRUS; MASS-PRODUCTION; CODLING MOTH; GENE; POPULATION; INSECTS; ECOLOGY	The smaller tea tortrix, Adoxophyes honmai (Lepidoptera: Tortricidae), is an economically important pest of tea in Japan. Previous work showed that a fast-killing nucleopolyhedrovirus (NPV) isolated from A. orana (AdorNPV) and a slow-killing NPV isolated from A. honmai (AdhoNPV) are both infectious to A. honmai larvae. Field application of these different NPVs was conducted against an A. honmai larval population in tea plants, and the control efficacy and transmission rate of the two NPVs were compared. The slow-killing AdhoNPV showed lower field efficacy, in terms of preventing damage caused by A. honmai larvae against the tea plants, than the fast-killing AdorNPV. However, AdhoNPV had a significantly higher horizontal transmission rate than AdorNPV. These results show that AdorNPV is suitable as an inundative agent, while AdhoNPV is an appropriate inoculative agent.	[Takahashi, Maho; Nakai, Madoka; Saito, Yasumasa; Kunimi, Yasuhisa] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; [Takahashi, Maho] Chiba Prefectural Agr & Forestry Res Ctr, Chiba 2660006, Japan; [Sato, Yasushi; Ishijima, Chikara] NARO Inst Vegetable & Tea Sci, Shizuoka 4288501, Japan; [Ishijima, Chikara] NARO Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan	Nakai, M (reprint author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan.	m.tkhsh188@pref.chiba.lg.jp; madoka@cc.tuat.ac.jp; saitoyassu@gmail.com; lucifer@affrc.go.jp; cishiji@affrc.go.jp; kunimi@cc.tuat.ac.jp	NAKAI, Madoka/G-1088-2013	NAKAI, Madoka/0000-0003-1929-9543	Ministry of Agriculture, Forestry, and Fisheries of Japan; Japan Society for the Promotion of Science (JSPS) [18380038]	This work was partially supported by a grant for Development of new biorational techniques for sustainable agriculture from the Ministry of Agriculture, Forestry, and Fisheries of Japan, and by the Grant-in-Aid for Scientific Research (KAKENHI) Scientific Research (B), Japan Society for the Promotion of Science (JSPS) 18380038. Authors appreciate Doreen Winstanley for the English isolate of AdorNPV, Ian Smith for critical review of this manuscript and Ms. Maki Goto for providing bioassay data.	Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Goulson D, 1997, OECOLOGIA, V109, P219, DOI 10.1007/s004420050076; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Ros VID, 2015, MOL ECOL, V24, P249, DOI 10.1111/mec.13019; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Ishii T, 2003, J INVERTEBR PATHOL, V83, P206, DOI 10.1016/S0022-2011(03)00087-9; CORY JS, 1994, NATURE, V370, P138, DOI 10.1038/370138a0; Inceoglu AB, 2006, ADV VIRUS RES, V68, P323, DOI 10.1016/S0065-3527(06)68009-3; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; HOOVER K, 1995, BIOL CONTROL, V5, P419, DOI 10.1006/bcon.1995.1050; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Bonning BC, 2003, ADVANCES IN MICROBIAL CONTROL OF INSECT PESTS, P109; Bonning BC, 1996, ANNU REV ENTOMOL, V41, P191; Burand JP, 2009, INSECT PATHOGENS: MOLECULAR APPROACHES AND TECHNIQUES, P195, DOI 10.1079/9781845934781.0195; D'Amico V, 2013, APPL ENVIRON MICROB, V79, P4056, DOI 10.1128/AEM.00152-13; Fuxa JR, 2004, AGR ECOSYST ENVIRON, V103, P27, DOI 10.1016/j.agee.2003.10.013; Gebhardt MM, 2014, P NATL ACAD SCI USA, V111, P15711, DOI 10.1073/pnas.1411089111; Harrison RL, 2009, VIRUS GENES, V38, P155, DOI 10.1007/s11262-008-0297-y; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; HOCHBERG ME, 1989, NATURE, V337, P262, DOI 10.1038/337262a0; Katsuma S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002644; Lee Y, 2001, BIOL CONTROL, V20, P84, DOI 10.1006/bcon.2000.0876; Nabeta FH, 2005, APPL ENTOMOL ZOOL, V40, P231, DOI 10.1303/aez.2005.231; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/S0042-6822(03)00599-3; Nakai M, 1997, APPL ENTOMOL ZOOL, V32, P609; SATO T, 1980, APPL ENTOMOL ZOOL, V15, P409; Szewczyk B, 2006, BIOTECHNOL ADV, V24, P143, DOI 10.1016/j.biotechadv.2005.09.001; Takahashi M, 2008, BIOL CONTROL, V46, P542, DOI 10.1016/j.biocontrol.2008.06.003; Takatsuka J, 2010, J INVERTEBR PATHOL, V105, P121, DOI 10.1016/j.jip.2010.04.010; Tamaki Y., 1991, TORTRICID PESTS THEI, P541; van Houte S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046933; YAMADA H, 1973, J INVERTEBR PATHOL, V21, P144, DOI 10.1016/0022-2011(73)90194-8	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	MAR	2015	7	3					1271	1283		10.3390/v7031271		13	Virology	Virology	CE6JP	WOS:000351943000020		
J	Yamada, E; Yoshikawa, R; Nakano, Y; Misawa, N; Koyanagi, Y; Sato, K				Yamada, Eri; Yoshikawa, Rokusuke; Nakano, Yusuke; Misawa, Naoko; Koyanagi, Yoshio; Sato, Kei			Impacts of Humanized Mouse Models on the Investigation of HIV-1 Infection: Illuminating the Roles of Viral Accessory Proteins in Vivo	VIRUSES-BASEL			English	Review							TERMINAL REPEAT SEQUENCES; DEFICIENCY SYNDROME AIDS; TYPE-1 VPU PROTEIN; PBL-SCID MICE; DOWN-REGULATION; CELL-SURFACE; DISEASE PROGRESSION; IMMUNE-SYSTEM; NEF PROTEIN; PRIMATE LENTIVIRUSES	Human immunodeficiency virus type 1 (HIV-1) encodes four accessory genes: vif, vpu, vpr, and nef. Recent investigations using in vitro cell culture systems have shed light on the roles of these HIV-1 accessory proteins, Vif, Vpr, Vpu, and Nef, in counteracting, modulating, and evading various cellular factors that are responsible for anti-HIV-1 intrinsic immunity. However, since humans are the exclusive target for HIV-1 infection, conventional animal models are incapable of mimicking the dynamics of HIV-1 infection in vivo. Moreover, the effects of HIV-1 accessory proteins on viral infection in vivo remain unclear. To elucidate the roles of HIV-1 accessory proteins in the dynamics of viral infection in vivo, humanized mouse models, in which the mice are xenotransplanted with human hematopoietic stem cells, has been utilized. This review describes the current knowledge of the roles of HIV-1 accessory proteins in viral infection, replication, and pathogenicity in vivo, which are revealed by the studies using humanized mouse models.	[Yamada, Eri; Yoshikawa, Rokusuke; Nakano, Yusuke; Misawa, Naoko; Koyanagi, Yoshio; Sato, Kei] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto 6068507, Japan; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama 3220012, Japan	Sato, K (reprint author), Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto 6068507, Japan.	eyamada@virus.kyoto-u.ac.jp; kyusyu.sinden@gmail.com; 111r5134@st.kumamoto-u.ac.jp; nmisawa@virus.kyoto-u.ac.jp; ykoyanag@virus.kyoto-u.ac.jp; ksato@virus.kyoto-u.ac.jp			CREST, Japan Science and Technology Agency; Imai Memorial Trust for AIDS Research; Ichiro Kanehara Foundation; Kanae Foundation for the Promotion of Medical Science; Suzuken Memorial Foundation; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24115008]	We would like to thank Dong Sung An (University of California, Los Angeles, CA, USA) for proofreading the manuscript and Kotubu Misawa for the dedicated supports. This work was funded in-part by CREST, Japan Science and Technology Agency (to K.S.); Imai Memorial Trust for AIDS Research (to K.S.); Ichiro Kanehara Foundation (to K.S.); Kanae Foundation for the Promotion of Medical Science (to K.S.); Suzuken Memorial Foundation (to K.S.); Uehara Memorial Foundation (to K.S.); and a Grant-in-Aid for Scientific Research on Innovative Areas 24115008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y.K.).	Adjali Oumeya, 2009, V506, P171, DOI 10.1007/978-1-59745-409-4_13; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Berkowitz RD, 1998, J IMMUNOL, V161, P3702; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Ewart GD, 1996, J VIROL, V70, P7108; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Blasius AL, 2006, J IMMUNOL, V177, P3260; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Glushakova S, 2001, J VIROL, V75, P10113, DOI 10.1128/JVI.75.21.10113-10117.2001; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Sato K, 2011, EXP BIOL MED, V236, P977, DOI 10.1258/ebm.2011.010294; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Sauter D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-103; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; SCHUBERT U, 1994, J VIROL, V68, P2260; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Salvi R, 1998, J VIROL, V72, P3646; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Sato K, 2012, J VIROL, V86, P5000, DOI 10.1128/JVI.07062-11; WILLEY RL, 1992, J VIROL, V66, P7193; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Braibant M, 2010, VIROLOGY, V405, P81, DOI 10.1016/j.virol.2010.05.026; Churchill MJ, 2006, J VIROL, V80, P1047, DOI 10.1128/JVI.80.2.1047-1052.2006; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Forget J, 1998, J MOL BIOL, V284, P915, DOI 10.1006/jmbi.1998.2206; Freed E. O., 2007, FIELDS VIROLOGY, V2, P2107; GOLDSMITH MA, 1995, J VIROL, V69, P4112; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Greenough TC, 1999, NEW ENGL J MED, V340, P236, DOI 10.1056/NEJM199901213400314; Introini A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003148; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Janeway C. A., 2005, IMMUNOBIOLOGY IMMUNE, P25; Kitamura S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00258; Kitchen SG, 1999, AIDS RES HUM RETROV, V15, P143, DOI 10.1089/088922299311565; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Kuo LS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-47; Levesque K, 2004, CURR HIV RES, V2, P51, DOI 10.2174/1570162043485086; Lewis D. J., 2014, J VIROL, V88, P11648, DOI [10.1128/JVI.01621-1425008917, DOI 10.1128/JVI.01621-1425008917]; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Merbah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050839; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; MOSIER DE, 1991, SCIENCE, V251, P791, DOI 10.1126/science.1990441; Olivieri KC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-64; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; SANDHU J, 1994, J IMMUNOL, V152, P3806; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sato K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003812; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; SCHUBERT U, 1995, J VIROL, V69, P7699; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Watkins RL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-125; Yang SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-78; Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	112	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	MAR	2015	7	3					1373	1390		10.3390/v7031373		18	Virology	Virology	CE6JP	WOS:000351943000026		
J	Rahman, IMM; Begum, ZA; Sawai, H; Ogino, M; Furusho, Y; Mizutani, S; Hasegawa, H				Rahman, Ismail M. M.; Begum, Zinnat A.; Sawai, Hikaru; Ogino, Masashi; Furusho, Yoshiaki; Mizutani, Satoshi; Hasegawa, Hiroshi			Chelant-Assisted Depollution of Metal-Contaminated Fe-Coated Sands and Subsequent Recovery of the Chemicals Using Solid-Phase Extraction Systems	WATER AIR AND SOIL POLLUTION			English	Article						Polymeric Fe-modified sand; Potentially toxic element (PTE); Wastewater treatment; Sludge decontamination; Chelant-induced washing; Solid-Phase Extraction (SPE)	MODIFIED MONTMORILLONITE ADSORBENTS; HEAVY-METALS; OPERATING VARIABLES; CHELATING-AGENTS; AQUEOUS-SOLUTION; ARSENIC REMOVAL; WATER-TREATMENT; PART II; SOIL; IRON	The disposal of potentially toxic element (PTE)-loaded sludge that is produced during industrial or commercial wastewater treatments evoke concerns because of the probability of hazardous environmental consequences. In the current work, we proposed a chelant-assisted decontamination technique of the laboratory-produced PTE-loaded (As, Cd, Pb) polymeric-Fe-coated sludge and subsequent recovery of the chelants and PTEs. The chelant options include both biodegradable (EDDS, GLDA, and HIDS) and non-biodegradable (EDTA) alternatives. The washing performance was compared and discussed in terms of the solution pH and relative stabilities of the complexes of PTEs and chelants in solution. The changes in solution pH or chelants have no significant effect on the chelant-induced removal efficiency of Cd, and the same result was observed for Pb at extreme and moderate acidic pH. The As-extraction rate is also improved with chelant in the solution despite a limited interaction between the chelant and the arsenic species in the solution. The column-packed solid-phase extraction (SPE) system, which was equipped with macrocycle, chelating resin, or ion-exchange resin, was used to explore the corresponding separation performance of the PTEs and chelant. The macrocycle-equipped SPE system shows better selectivity than other SPEs in terms of extraction and recovery performance of the PTEs regardless of the chelants. Some unique points of the proposed process are minimum environmental burden due to the use of biodegradable materials in the washing solution and cost minimization by recycling the ingredients.	[Rahman, Ismail M. M.] Univ Chittagong, Dept Appl & Environm Chemis, Fac Sci, Chittagong, Bangladesh; [Rahman, Ismail M. M.; Sawai, Hikaru; Ogino, Masashi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Begum, Zinnat A.] Southem Univ, Dept Civil Engn, Chittagong 4000, Bangladesh; [Furusho, Yoshiaki] GL Sci Inc, Shinjuku Ku, Tokyo 161130, Japan; [Mizutani, Satoshi] Osaka City Univ, Grad Sch Engn, Sumiyoshi Ku, Osaka 5588585, Japan; [Hasegawa, Hiroshi] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Rahman, IMM (reprint author), Univ Chittagong, Dept Appl & Environm Chemis, Fac Sci, Chittagong 4331, Chittagong, Bangladesh.	I.M.M.Rahman@gmail.com; Zinnat.Ara@gmail.com; hhiroshi@se.kanazawa-u.ac.jp	Rahman, Ismail/C-4869-2009; Hasegawa, Hiroshi/C-4261-2015; 	Rahman, Ismail/0000-0001-8084-5190; Hasegawa, Hiroshi/0000-0001-8210-4775; Begum, Zinnat A./0000-0003-3408-9616	Japan Society for the Promotion of Science [24310056]; Public Foundation of Chubu Science and Technology Center, Japan	The study was partially supported by the Grants-in-Aid for Scientific Research (24310056) from the Japan Society for the Promotion of Science. One of the authors, Ismail M. M. Rahman, acknowledges the financial grant from the Public Foundation of Chubu Science and Technology Center, Japan, to support his research at Kanazawa University, Japan. The authors also acknowledge the kind support from Dr. Md. Alamgir (Department of Soil Science, University of Chittagong, Chittagong 4331, Bangladesh) for the statistical analysis of the data.	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; Peters RW, 1999, J HAZARD MATER, V66, P151, DOI 10.1016/S0304-3894(99)00010-2; Kumpiene J, 2007, ENVIRON POLLUT, V145, P365, DOI 10.1016/j.envpol.2006.01.037; van Herwijnen R, 2007, ENVIRON POLLUT, V150, P347, DOI 10.1016/j.envpol.2007.01.023; Capra GF, 2014, J GEOCHEM EXPLOR, V145, P169, DOI 10.1016/j.gexplo.2014.06.007; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; Cooper C, 2002, J CHEM TECHNOL BIOT, V77, P546, DOI 10.1002/jctb.614; Ford RG, 2002, ENVIRON SCI TECHNOL, V36, P2459, DOI 10.1021/es015768d; Lim TT, 2004, J ENVIRON ENG-ASCE, V130, P59, DOI 10.1061/(ASCE)0733-9372(2004)130:(59); Jessen S, 2005, ENVIRON SCI TECHNOL, V39, P8045, DOI 10.1021/es050692x; Duffus JH, 2002, PURE APPL CHEM, V74, P793, DOI 10.1351/pac200274050793; Zou Z, 2009, ENVIRON POLLUT, V157, P229, DOI 10.1016/j.envpol.2008.07.009; Jiang JQ, 2002, CHEMOSPHERE, V47, P711, DOI 10.1016/S0045-6535(02)00011-5; Halim CE, 2004, ENVIRON SCI TECHNOL, V38, P3977, DOI 10.1021/es0350740; Cundy AB, 2008, SCI TOTAL ENVIRON, V400, P42, DOI 10.1016/j.scitotenv.2008.07.002; Begum ZA, 2012, CHEMOSPHERE, V87, P1161, DOI 10.1016/j.chemosphere.2012.02.032; Leupin OX, 2005, ENVIRON SCI TECHNOL, V39, P8032, DOI 10.1021/es050205d; Rahman IMM, 2011, CHEMOSPHERE, V82, P549, DOI 10.1016/j.chemosphere.2010.10.045; Giles DE, 2011, J ENVIRON MANAGE, V92, P3011, DOI 10.1016/j.jenvman.2011.07.018; Nowack B, 2002, ENVIRON SCI TECHNOL, V36, P4009, DOI 10.1021/es025683s; Orama M, 2002, J CHEM SOC DALTON, P4644, DOI 10.1039/b207777a; Kuan WH, 1998, WATER RES, V32, P915, DOI 10.1016/S0043-1354(97)00228-5; Kim CS, 1999, J HAZARD MATER, V69, P273, DOI 10.1016/S0304-3894(99)00115-6; Jing CY, 2003, ENVIRON SCI TECHNOL, V37, P5050, DOI 10.1021/es021027g; Jiang JQ, 2003, CHEMOSPHERE, V53, P53, DOI 10.1016/S0045-6535(03)00449-1; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Badruzzaman A, 2003, FATE ARSENIC ENV; Begum ZA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1381-4; Begum ZA, 2012, J SOLUTION CHEM, V41, P1713, DOI 10.1007/s10953-012-9901-9; Begum ZA, 2012, J CHEM ENG DATA, V57, P2723, DOI 10.1021/je3005936; Davidge J, 2001, CHEM SPEC BIOAVAILAB, V13, P129, DOI 10.3184/095422901782775390; Dubois I., 2011, P RADIOCHIM ACTA, V1s, P75; DUTRE V, 1995, J HAZARD MATER, V40, P55, DOI 10.1016/0304-3894(94)00080-Z; ELLIOTT HA, 1989, WATER AIR SOIL POLL, V45, P361; Fischer K, 2002, WATER AIR SOIL POLL, V138, P271, DOI 10.1023/A:1015566207849; Hasegawa H, 2011, WATER RES, V45, P4844, DOI 10.1016/j.watres.2011.06.036; Hong JH, 1996, WATER AIR SOIL POLL, V86, P35, DOI 10.1007/BF00279144; Horowitz AJ, 1987, APPL GEOCHEM, V2, P437, DOI DOI 10.1016/0883-2927(87)90027-8; IZATT RM, 1995, PURE APPL CHEM, V67, P1069, DOI 10.1351/pac199567071069; Jiang JQ, 1998, J CHEM TECHNOL BIOT, V73, P351, DOI 10.1002/(SICI)1097-4660(199812)73:4<351::AID-JCTB964>3.0.CO;2-S; Jiang JQ, 1996, ENVIRON TECHNOL, V17, P937; LaGrega M. D., 1994, HAZARDOUS WASTE MANA; Martell A. E., 2004, NIST STANDARD REFERE, V46; Martell A.E., 1996, METAL COMPLEXES AQUE; Mohammed A. S., 2011, BIOMANAGEMENT METAL; Polettini A, 2007, CHEMOSPHERE, V66, P866, DOI 10.1016/j.chemosphere.2006.06.023; Rahman I. M. M., 2011, APPL MOL RECOGNITION; Rahman IMM, 2011, MICROCHEM J, V98, P103, DOI 10.1016/j.microc.2010.12.005; Rahman IMM, 2013, MICROCHEM J, V110, P485, DOI 10.1016/j.microc.2013.06.006; Rahman IMM, 2013, CHEMOSPHERE, V92, P196, DOI 10.1016/j.chemosphere.2013.03.024; SCHEIDEGGER A, 1993, GEODERMA, V58, P43, DOI 10.1016/0016-7061(93)90084-X; U.S. EPA, 1996, 3052 US EPA; Vandevivere P, 2001, J ENVIRON ENG-ASCE, V127, P802, DOI 10.1061/(ASCE)0733-9372(2001)127:9(802); Ying X, 2005, J COLLOID INTERF SCI, V282, P11, DOI 10.1016/j.jcis.2004.08.057	54	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-6979	1573-2932		WATER AIR SOIL POLL	Water Air Soil Pollut.	MAR	2015	226	3							37	10.1007/s11270-015-2312-y		12	Environmental Sciences; Meteorology & Atmospheric Sciences; Water Resources	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Water Resources	CD5BO	WOS:000351102400023		
J	Tamada, K; Itoh, K; Uchida, Y; Higuchi, S; Sasayama, D; Azuma, T				Tamada, Katsuya; Itoh, Kazuyuki; Uchida, Yuko; Higuchi, Shunsuke; Sasayama, Daisuke; Azuma, Tetsushi			Relationship between the temperature and the overwintering of water lettuce (Pistia stratiotes) at Kowataike, a branch of Yodogawa River, Japan	WEED BIOLOGY AND MANAGEMENT			English	Article						overwintering in a temperate climate zone; Pistia stratiotes L; tropical floating weed; warm water discharge; water lettuce; water temperature	GROWTH; GERMINATION; SURVIVAL; SEEDS; L.	The successful overwintering of water lettuce (Araceae, Pistia stratiotes L.) is reported in Kowataike, a pond in Kyoto Prefecture, Japan, in the temperate climate zone. Overwintering was observed in the northern zone of Kowataike, where warm water discharge flows from an upstream electrical appliance factory. From December 2007 to January 2008, several overwintering water lettuce plants were observed in the northern zone where the water temperature was abnormally high (average: 21.9 degrees C; low: 19.5 degrees C). Water in the central zone of Kowataike was isolated from the warm water discharge. The temperatures here were much lower (average: 8.2 degrees C; low: 4.2 degrees C) and no water lettuce plant survived here. The overwintering in the northern zone fluctuated annually. This fluctuation appeared to be correlated with the period of warm water discharge, which varied from year to year and resulted in higher water temperatures most, but not all, of the winter. The results suggest that artificial environmental factors, such as anthropogenic warm water discharge, could enable water lettuce to overwinter. In the northern zone of Kowataike under the influence of the warm water discharge, only small water lettuce plants overwintered. This may be attributed to the presence of older plants with larger leaves that seemed to protect the small rosettes from frost. Second, the air warmed by the warm discharge accumulated in the space under the piles of dead large leaves, which created conditions similar to those of a greenhouse. These two mechanisms apparently allow the small water lettuce plants to be surrounded by moderate atmospheric conditions.	[Tamada, Katsuya; Itoh, Kazuyuki; Uchida, Yuko; Higuchi, Shunsuke; Sasayama, Daisuke; Azuma, Tetsushi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Sasayama, Daisuke] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan	Itoh, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Rokkodai 1-1, Kobe, Hyogo 6578501, Japan.	kitoh@people.kobe-u.ac.jp			Foundation of River & Watershed Environment Management, Tokyo, Japan	A grant from the Foundation of River & Watershed Environment Management, Tokyo, Japan, supported this research. We thank K. Ban (Toryo High School, Kyoto, Japan) for his field work and valuable suggestions and E. A. Atera for editing this manuscript.	Vereecken H, 2006, HYDROBIOLOGIA, V570, P205, DOI 10.1007/s10750-006-0181-5; Sajna N, 2007, AQUAT BOT, V87, P75, DOI 10.1016/j.aquabot.2007.01.012; Henry-Silva GG, 2008, HYDROBIOLOGIA, V610, P153, DOI 10.1007/s10750-008-9430-0; Kan J, 2008, SEED SCI TECHNOL, V36, P38; HARLEY KLS, 1990, AQUAT BOT, V36, P277, DOI 10.1016/0304-3770(90)90041-I; PIETERSE AH, 1981, ACTA BOT NEERL, V30, P47; Bua-ngam T., 1975, PHILIPPINE WEED SCI, V2, P11; Coelho FF, 2005, REV BIOL TROP, V53, P369; da Silva CJ, 1981, ACTA AMAZONICA, V11, P487; den Hollander NG, 1999, HYDROBIOLOGIA, V415, P21, DOI 10.1023/A:1003817213753; DEWALD LB, 1990, AQUAT BOT, V36, P263, DOI 10.1016/0304-3770(90)90040-R; DRAY FA, 1989, AQUAT BOT, V33, P155, DOI 10.1016/0304-3770(89)90029-6; Holm L. G., 1977, WORLDS WORST WEEDS; Howard GW, 1998, WETLANDS ECOLOGY MAN, V5, P215; Kadono Y., 2004, GLOBAL ENV RES, V8, P163; Kamiaka H., 1999, B WATER PLANT SOC JP, V68, P15; Kamiya K., 1995, B WATER PLANT SOC JP, V57, P22; Makino T., 1931, FLORA JAPAN; Mitra E., 1966, J ASIATIC SOC, V8, P115; Mochida M., 2001, B WATER PLANT SOC JP, V72, P1; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Sainty G. R., 1981, WATERPLANTS NEW S WA; Shimoda M., 1992, B WATER PLANT SOC JP, V46, P5; Song SQ, 2003, ACTA BOT SIN, V45, P638; Tomihisa Y., 1989, Weed Research (Tokyo), V34, P94; Yamamoto H., 1996, B WATER PLANT SOC JP, V59, P17	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-6162	1445-6664		WEED BIOL MANAG	Weed Biol. Manag.	MAR	2015	15	1					20	26		10.1111/wbm.12061		7	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CE0DJ	WOS:000351474400003		
J	Yonezawa, T; Sunohara, Y; Matsumoto, H				Yonezawa, Tomoki; Sunohara, Yukari; Matsumoto, Hiroshi			Involvement of heme synthesis in the growth stimulation of maize seedlings by 5-aminolevulinic acid	WEED BIOLOGY AND MANAGEMENT			English	Article						5-aminolevulinic acid; heme; nitrate reductase; nitrogen metabolism	DELTA-AMINOLEVULINIC-ACID; NITRATE REDUCTASE-ACTIVITY; ORYZA-SATIVA L.; PLANT-GROWTH; PHOTOSYNTHESIS; STRESS; SYSTEM; LEAVES; LIGHT; METABOLISM	The growth of maize seedlings was stimulated by shoot-applied 5-aminolevulinic acid 2days after treatment at 90 and 120molL(-1). The effects of 5-aminolevulinic acid on the activity of nitrate reductase (EC 1.6.6.2) and nitrite reductase (EC 1.7.7.1) and the chlorophyll, ammonium, heme and total free amino acid content were investigated by using maize seedlings to clarify the involvement of nitrogen metabolism and heme synthesis in the growth stimulation. 5-Aminolevulinic acid increased the level of nitrate reductase activity at 90molL(-1) and the ammonium and heme content at 90 and 120molL(-1) 2days after treatment. The total amino acid content increased by 90 and 150molL(-1) 5-aminolevulinic acid 2 and 3days after treatment, respectively. However, no significant change was observed in the activity of nitrite reductase or the chlorophyll content after the 5-aminolevulinic acid treatment. These results suggest that the enhancement of nitrogen metabolism by nitrate reductase activation is involved in the 5-aminolevulinic acid-induced stimulation of maize seedling growth. The activation of nitrate reductase might be related to an increase in the heme content following the 5-aminolevulinic acid treatment.	[Yonezawa, Tomoki; Sunohara, Yukari; Matsumoto, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Doctoral Program Life Sci & Bioengn, Tsukuba, Ibaraki 3058572, Japan	Matsumoto, H (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Doctoral Program Life Sci & Bioengn, Tsukuba, Ibaraki 3058572, Japan.	hmatsu@biol.tsukuba.ac.jp					Hotta Y, 1998, J PESTIC SCI, V23, P29; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Hotta Y, 1997, BIOSCI BIOTECH BIOCH, V61, P2025; Dayan FE, 2011, AM SCI, V99, P236; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Conway EJ, 1933, BIOCHEM J, V27, P419; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Kaiser WM, 1999, PHYSIOL PLANTARUM, V105, P385; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; MURPHY MJ, 1974, P NATL ACAD SCI USA, V71, P612, DOI 10.1073/pnas.71.3.612; Hirel B, 2005, PHYSIOL PLANTARUM, V124, P167, DOI 10.1111/j.1399-3054.2005.00510.x; Schmidt M, 2002, PLANT J, V31, P601, DOI 10.1046/j.1365-313X.2002.01382.x; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.1399-3054.2004.00319.x; OAKS A, 1977, PLANT PHYSIOL, V59, P391, DOI 10.1104/pp.59.3.391; Anten NPR, 2001, FUNCT ECOL, V15, P804, DOI 10.1046/j.0269-8463.2001.00582.x; Beyzaei Z, 2014, J PLANT GROWTH REGUL, V33, P745, DOI 10.1007/s00344-014-9422-4; Campbell WH, 1996, PLANT PHYSIOL, V111, P355; HAGEMAN RH, 1960, PLANT PHYSIOL, V35, P700, DOI 10.1104/pp.35.5.700; IWATA K, 1995, ZOOL SCI, V12, P175; KIPENOLT JA, 1980, PLANT PHYSIOL, V65, P126, DOI 10.1104/pp.65.1.126; Lim SJ, 2007, J PESTIC SCI, V32, P249, DOI 10.1584/jpestics.G07-07; Masuda T, 2006, ANAL BIOCHEM, V355, P307, DOI 10.1016/j.ab.2006.04.008; MATSUMOTO H, 1994, PESTIC BIOCHEM PHYS, V48, P214, DOI 10.1006/pest.1994.1022; MATTHEWS BF, 1975, PLANT PHYSIOL, V55, P991, DOI 10.1104/pp.55.6.991; MISHRA SN, 1983, EXPERIENTIA, V39, P1118, DOI 10.1007/BF01943138; OHYAMA T, 1980, SOIL SCI PLANT NUTR, V26, P109; Ozawa K, 2006, PLANT SCI, V170, P384, DOI 10.1016/j.plantsci.2005.09.015; REBEIZ CA, 1984, ENZYME MICROB TECH, V6, P390, DOI 10.1016/0141-0229(84)90012-7; SCHIFFMANN E, 1957, J BIOL CHEM, V225, P623; Schmied J, 2011, J PLANT PHYSIOL, V168, P1372, DOI 10.1016/j.jplph.2010.12.010; WEINSTEIN JD, 1985, ARCH BIOCHEM BIOPHYS, V237, P454, DOI 10.1016/0003-9861(85)90299-1; Wongkantrakorn N, 2009, J PESTIC SCI, V34, P89, DOI 10.1584/jpestics.G08-43; Xu F, 2010, TROP GRASSLANDS, V44, P260; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-6162	1445-6664		WEED BIOL MANAG	Weed Biol. Manag.	MAR	2015	15	1					53	60		10.1111/wbm.12064		8	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CE0DJ	WOS:000351474400006		
J	Jinjarak, Y				Jinjarak, Yothin			Supply Chains, Global Financial Shocks and Firm Behaviour towards Liquidity Needs	WORLD ECONOMY			English	Article							TRADE CREDIT CONTRACTS; INTERNATIONAL-TRADE; BUSINESS; CRISIS; INVENTORIES; NETWORKS; RETURNS; MARKETS; EXPORTS; CYCLES	Driven by the increasingly important role of supply chains in global production, this paper studies empirical association between global credit-market shocks and firm behaviour towards liquidity needs across countries and industries. Focusing on the adjustment of working-capital financing, we find two pieces of supporting evidence from international firm-level panel data covering the period 2002:I-2012:IV. First, for industries where specific investment in the input supplier-customer relationship is large, firms are more exposed to credit-market shocks. We find that measures of global credit-market shocks are negatively associated with trade receivables, trade payables and inventories, conditional on the level of contract intensity in the industries where firms operate. Second, firms in emerging markets are more vulnerable to credit-market shocks than are firms in developed countries. We are also able to verify the economic significance of sales growth, operating cash flows, cash stock and firm size in the overall adjustment. Our findings highlight the importance of balance-sheet contagion along supply chains during the 2007-09 global financial crisis.	[Jinjarak, Yothin] Univ London, Sch Oriental & African Studies, Dept Financial & Management Studies, London, England; [Jinjarak, Yothin] ADBI, Tokyo, Japan	Jinjarak, Y (reprint author), Univ London, Sch Oriental & African Studies, Dept Financial & Management Studies, London, England.						Albuquerque R., 2012, 8222 CEPR; Alfaro L., 2009, NBER INT SEM MACR 20, P243; Amiti M, 2011, Q J ECON, V126, P1841, DOI 10.1093/qje/qjr033; Nilsen JH, 2002, J MONEY CREDIT BANK, V34, P226, DOI 10.1353/mcb.2002.0032; Fisman R, 2003, J FINANC, V58, P353, DOI 10.1111/1540-6261.00527; Choi WG, 2005, J FINANC QUANT ANAL, V40, P897; Berman N, 2012, IMF ECON REV, V60, P329, DOI 10.1057/imfer.2012.13; Ng CK, 1999, J FINANC, V54, P1109, DOI 10.1111/0022-1082.00138; Lee HL, 1997, MANAGE SCI, V43, P546, DOI 10.1287/mnsc.43.4.546; Kiyotaki N, 1997, J POLIT ECON, V105, P211, DOI 10.1086/262072; Menzly L, 2010, J FINANC, V65, P1555, DOI 10.1111/j.1540-6261.2010.01578.x; Daripa A, 2011, AM ECON J-MICROECON, V3, P245, DOI 10.1257/mic.3.1.245; Tong H, 2011, REV FINANC STUD, V24, P2023, DOI 10.1093/rfs/hhq078; Rauch JE, 1999, J INT ECON, V48, P7, DOI 10.1016/S0022-1996(98)00009-9; Bougheas S, 2009, J BANK FINANC, V33, P300, DOI 10.1016/j.jbankfin.2008.07.019; Campello M, 2010, J FINANC ECON, V97, P470, DOI 10.1016/j.jfineco.2010.02.009; Chor D, 2012, J INT ECON, V87, P117, DOI 10.1016/j.jinteco.2011.04.001; HALEY CW, 1973, MANAGE SCI B-APPL, V20, P464, DOI 10.1287/mnsc.20.4.464; Koopman R, 2014, AM ECON REV, V104, P459, DOI 10.1257/aer.104.2.459; Kiyotaki N, 2002, AM ECON REV, V92, P46, DOI 10.1257/000282802320188989; Giannetti M, 2011, REV FINANC STUD, V24, P1261, DOI 10.1093/rfs/hhn096; Love I, 2007, J FINANC ECON, V83, P453, DOI 10.1016/j.jfineco.2005.11.002; Raddatz C, 2010, REV ECON STAT, V92, P985, DOI 10.1162/REST_a_00042; Fisman R, 2001, WORLD DEV, V29, P311, DOI 10.1016/S0305-750X(00)00096-6; Calomiris CW, 2012, J INT MONEY FINANC, V31, P743, DOI 10.1016/j.jimonfin.2012.01.002; Rauch JE, 2001, J ECON LIT, V39, P1177, DOI 10.1257/jel.39.4.1177; Klapper L, 2012, REV FINANC STUD, V25, P838, DOI 10.1093/rfs/hhr122; Burkart M, 2004, AM ECON REV, V94, P569, DOI 10.1257/0002828041464579; LONG MS, 1993, FINANC MANAGE, V22, P117, DOI 10.2307/3665582; Antras P., 2011, 17029 NBER; Baldwin R., 2013, 18957 NBER; Bems R., 2012, 18632 NBER; BERNANKE B, 1989, AM ECON REV, V79, P14; Brunnermeier M. K., 2008, J ECON PERSPECT, V23, P77; Cunat V, 2007, REV FINANC STUD, V20, P491, DOI 10.1093/rfs/hhl015; Demirguc-Kunt A, 2006, J BANK FINANC, V30, P2967, DOI 10.1016/j.jbankfin.2006.05.007; Escaith H, 2011, ASIA BEYOND THE GLOBAL ECONOMIC CRISIS: THE TRANSMISSION MECHANISM OF FINANCIAL SHOCKS, P73; Fabbri D., 2009, TRADE CREDIT S UNPUB; Feenstra R., 2011, 16940 NBER, V16940; GERTLER M, 1994, Q J ECON, V109, P309, DOI 10.2307/2118465; Hamilton J. D., 2008, UNDERSTANDING TED SP; Kahle K. M., 2010, 16310 NBER; KASHYAP AK, 1994, Q J ECON, V109, P565, DOI 10.2307/2118414; Manova K, 2012, 18561 NBER; Nunn N, 2007, Q J ECON, V122, P569, DOI 10.1162/qjec.122.2.569; Petersen MA, 1997, REV FINANC STUD, V10, P661, DOI 10.1093/rfs/10.3.661; SCHIFF M, 1974, J FINANC, V29, P133, DOI 10.2307/2978219; Sengupta R., 2008, EC SYN FED RES BANK, V25	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-5920	1467-9701		WORLD ECON	World Econ.	MAR	2015	38	3					425	444		10.1111/twec.12202		20	Business, Finance; Economics; International Relations	Business & Economics; International Relations	CD6DM	WOS:000351179700002		
J	Niwa, Y; Koike, M; Oya, H; Iwata, N; Kobayashi, D; Kanda, M; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Nomoto, S; Fujiwara, M; Kodera, Y				Niwa, Yukiko; Koike, Masahiko; Oya, Hisaharu; Iwata, Naoki; Kobayashi, Daisuke; Kanda, Mitsuro; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro			Method of Bilateral Pleural Drainage by Single Blake Drain After Esophagectomy	WORLD JOURNAL OF SURGERY			English	Article							CARDIAC-SURGERY; RESECTION; TRIAL	Background Clinicians often encounter left pleural effusion after esophagectomy, which sometimes necessitates thoracentesis. We have introduced a new drainage method, bilateral pleural drainage by single Blake drain (BDSD), which we have been using since April 2013. This study aims to evaluate the performance of the BDSD. Methods The BDSD method employs a 15-F Blake drain inserted from the right thoracic cavity to the left thoracic cavity across the posterior mediastinum. The conventional drain (CD) group consisted of 50 patients with a 19-F Blake drain placed in the right thoracic cavity during the period from April 2012 to March 2013. The BDSD group consisted of 54 patients treated from April 2013 to June 2014. Results The amount of total drainage in the BDSD group was significantly higher than that in the CD group (P < 0.0001). The rates of left pleural effusion and left lower lobe atelectasis in the BDSD group were significantly lower than those in the CD group (P < 0.0001 and P < 0.0001, respectively). No patients developed a left pleural effusion necessitating thoracentesis drainage in the BDSD group. Conclusions Compared with the conventional method, BDSD was able to evacuate bilateral pleural effusion more effectively, and the incidences of left pleural effusion and left atelectasis were lower. This method is therefore clinically useful after esophagectomy.	[Niwa, Yukiko; Koike, Masahiko; Oya, Hisaharu; Iwata, Naoki; Kobayashi, Daisuke; Kanda, Mitsuro; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, Nagoya, Aichi 4668550, Japan	Koike, M (reprint author), Nagoya Univ Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	dockoike@med.nagoya-u.ac.jp					Roberts N, 2006, J THORAC CARDIOV SUR, V132, P1042, DOI 10.1016/j.jtcvs.2006.06.031; Fukui Takayuki, 2009, Interact Cardiovasc Thorac Surg, V9, P645, DOI 10.1510/icvts.2009.212522; Icard P, 2006, EUR J CARDIO-THORAC, V30, P649, DOI 10.1016/j.ejcts.2006.06.032; Kamiyoshihara Mitsuhiro, 2010, Asian Cardiovasc Thorac Ann, V18, P435, DOI 10.1177/0218492310380499; Moss E, 2013, INTERACT CARDIOV TH, V17, P110, DOI 10.1093/icvts/ivt123; Nakamura Hiroshige, 2009, Interact Cardiovasc Thorac Surg, V8, P58, DOI 10.1510/icvts.2008.188086; Sakakura N, 2009, ANN THORAC SURG, V87, P1539, DOI 10.1016/j.athoracsur.2009.02.013; Sakopoulos AG, 2005, J CARDIAC SURG, V20, P574, DOI 10.1111/j.1540-8191.2005.00138.x; Takuya S, 2011, SHUJUTSU OPER, V65, P1	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAR	2015	39	3					727	731		10.1007/s00268-014-2860-0		5	Surgery	Surgery	CD6WM	WOS:000351230900027		
J	Shiba, H; Misawa, T; Fujiwara, Y; Futagawa, Y; Furukawa, K; Haruki, K; Iwase, R; Iida, T; Yanaga, K				Shiba, Hiroaki; Misawa, Takeyuki; Fujiwara, Yuki; Futagawa, Yasuro; Furukawa, Kenei; Haruki, Koichiro; Iwase, Ryota; Iida, Tomonori; Yanaga, Katsuhiko			Glasgow Prognostic Score Predicts Outcome After Surgical Resection of Gallbladder Cancer	WORLD JOURNAL OF SURGERY			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CELL LUNG-CANCER; COLORECTAL-CANCER; GASTROESOPHAGEAL CANCER; CURATIVE RESECTION; CARCINOMA; SURVIVAL; GPS; COMPLICATIONS; SURGERY	Background Systemic inflammation as evidenced by the Glasgow prognostic score (GPS) predicts cancer-specific survival in various types of cancer. The aim of this study was to evaluate the significance of GPS in therapeutic outcome after surgical resection of gallbladder cancer. Methods The subjects were 51 patients who underwent surgical resection for gallbladder cancer. For the assessment of systemic inflammatory response using the GPS, patients were classified into three groups: patients with normal albumin (>= 3.5 g/dl) and normal C-reactive protein (CRP) (<= 1.0 mg/dl) as GPS 0 (n = 38), those with low albumin (<3.5 g/dl) or elevated CRP (>1.0 mg/dl) as GPS 1 (n = 8), and those with low albumin (<3.5 g/dl) and elevated CRP (>1.0 mg/dl) as GPS 2 (n = 5). We retrospectively investigated the relation between patient characteristics including GPS, and disease-free as well as overall survival. Results In disease-free survival, advanced tumor stage based on pathology (p = 0.006), positive lymph node metastasis (p = 0.001), and GPS 1 or 2 (p = 0.006) were independent predictors of cancer recurrence in multivariate analysis. In overall survival, positive lymph node metastasis (p = 0.002) and GPS 1 or 2 (p = 0.032) were independent predictors of poor patient outcome in multivariate analyses. Conclusion The GPS in patients with gallbladder cancer is an independent prognostic predictor after surgical resection.	[Shiba, Hiroaki; Misawa, Takeyuki; Fujiwara, Yuki; Futagawa, Yasuro; Furukawa, Kenei; Haruki, Koichiro; Iwase, Ryota; Iida, Tomonori; Yanaga, Katsuhiko] Jikei Univ Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan	Shiba, H (reprint author), Jikei Univ Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	hs0817@jikei.ac.jp					Moyes LH, 2009, BRIT J CANCER, V100, P1236, DOI 10.1038/sj.bjc.6604997; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; Ito H, 2004, J GASTROINTEST SURG, V8, P183, DOI 10.1016/j.gassur.2003.10.006; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Hara M, 2007, ANTICANCER RES, V27, P3001; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Miyakawa S, 2009, J HEPATO-BILIARY-PAN, V16, P1, DOI 10.1007/s00534-008-0015-0; Lamb GWA, 2006, BRIT J CANCER, V94, P781, DOI 10.1038/sj.bjc.6603034; Furukawa K, 2012, ONCOL LETT, V4, P324, DOI 10.3892/ol.2012.722; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; Al Murri AM, 2006, BRIT J CANCER, V94, P227, DOI 10.1038/sj.bjc.6602922; D'Angelica M, 2009, ANN SURG ONCOL, V16, P806, DOI 10.1245/s10434-008-0189-3; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; Ito H, 2011, ANN SURG, V254, P320, DOI 10.1097/SLA.0b013e31822238d8; Hilmy M, 2005, BRIT J CANCER, V92, P625, DOI 10.1038/sj.bjc.6602406; Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; Fong YM, 2006, ANN SURG, V243, P767, DOI 10.1097/01.sla.0000219737.81943.4e; Fong Y, 2006, ANN SURG, V243, P771, DOI DOI 10.1097/01.SLA.0000219737.81943.4E; Fujiwara Y, 2010, ANTICANCER RES, V30, P5129; Jamieson NB, 2005, BRIT J CANCER, V92, P781; Shiba H, 2013, ANTICANCER RES, V33, P2715	25	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAR	2015	39	3					753	758		10.1007/s00268-014-2844-0		6	Surgery	Surgery	CD6WM	WOS:000351230900031		
J	Kars, M; Aubourg, C; Suarez-Ruiz, I				Kars, Myriam; Aubourg, Charles; Suarez-Ruiz, Isabel			Neoformed magnetic minerals as an indicator of moderate burial: The key example of middle Paleozoic sedimentary rocks, West Virginia	AAPG BULLETIN			English	Article							CHEMICAL REMAGNETIZATION; DEFORMATION CONDITIONS; CARBONACEOUS MATERIAL; APPALACHIAN PLATEAU; FLUID INCLUSIONS; DEVONIAN SHALES; NORTH-AMERICA; TEMPERATURE; PYRRHOTITE; CARBONATES	In order to help unravel the thermal history of middle Paleozoic sedimentary rocks in West Virginia, a rock magnetic study was conducted with a focus on the Marcellus Shale. Vitrinite reflectance, fluid inclusions microthermometry and conodont alteration index data yield contradictory burial temperature within the range 150-250 degrees C (302-482 degrees F). The characterization of magnetite and pyrrhotite may be used as an index to track burial temperature around 200 degrees C (392 degrees F). Low-temperature and room-temperature magnetic measurements were performed in order to determine the magnetic assemblage. Three magnetic assemblages were identified that were stratigraphically distributed. The goethite and nanosized magnetite (Al) assemblage is mainly found in the Clinton Group-Oriskany Sandstone stratigraphic interval (Silurian-Lower Devonian). Nanosized fraction of magnetite and probably pyrrhotite (A3) assemblage essentially constitutes the Marcellus Shale-Chemung Formation sequence (Devonian). Microsized pyrrhotite is the typical mineral for A2 that is only identified near the Alleghenian structural front. Overall, the rare occurrence of micron pyrrhotite in our samples suggests that the study area has not experienced burial temperatures higher than 200 degrees C (392 degrees F).	[Kars, Myriam; Aubourg, Charles] Univ Pau & Pays Adour, UMR CNRS TOTAL 5150, Lab Fluides Complexes & Leurs Reservoirs, F-64013 Pau, France; [Suarez-Ruiz, Isabel] Inst Nacl Carbon INCAR CSIC, Oviedo 33011, Spain	Kars, M (reprint author), Kochi Univ, Ctr Adv Marine Core Res, 8200 Monobe, Nankoku, Kochi 7838502, Japan.	jm-mkars@kochi-u.ac.jp; charles.aubourg@univ-pau.fr; isruiz@incar.csic.es			Total S.A./Universite de Pau et des Pays de l'Adour, France; University of Minnesota	This work was conducted as a part of M. Kars Ph.D. thesis supported by Total S.A./Universite de Pau et des Pays de l'Adour, France. We are grateful to the Institute for Rock Magnetism, University of Minnesota, Minneapolis, for providing instrumental facilities (MPMS and VSM) and for fruitful discussions. We benefited from a grant from the University of Minnesota for our 10-day visit at the IRM in 2011. We would like to thank the Ecole Norma le Superieure, Paris, France, when running the magnetic susceptibilities measurements, and the Instituto Nacional del Carbon, Oviedo, Spain, when performing the vitrinite reflectance measurements. We are grateful to Mark Evans from Central Connecticut University, New Britain, Connecticut, for helping us in the field preparation and for following interesting discussions. We would like to thank Rob Van der Voo, Prasanta K. Mukhopadhyay, and R. D. Elmore for reviewing this paper and the editors Stephen E. Laubach and Michael L. Sweet. Their constructive comments greatly improve this manuscript.	Abdelmalak MM, 2012, AAPG BULL, V96, P205, DOI 10.1306/07121111008; MCCABE C, 1989, J GEOPHYS RES-SOLID, V94, P10429, DOI 10.1029/JB094iB08p10429; Ozdemir O, 1996, GEOPHYS RES LETT, V23, P921, DOI 10.1029/96GL00904; DEKKERS MJ, 1989, GEOPHYS J INT, V97, P341, DOI 10.1111/j.1365-246X.1989.tb00505.x; ROCHETTE P, 1990, EARTH PLANET SC LETT, V98, P319, DOI 10.1016/0012-821X(90)90034-U; CHANNELL JET, 1994, J GEOPHYS RES-SOL EA, V99, P4613, DOI 10.1029/93JB02578; [Anonymous], 2009, 74045 ISO; DEKKERS MJ, 1989, GEOPHYS RES LETT, V16, P855, DOI 10.1029/GL016i008p00855; Brothers LA, 1996, CHEM GEOL, V130, P1, DOI 10.1016/0009-2541(96)00007-1; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Lahfid A, 2010, TERRA NOVA, V22, P354, DOI 10.1111/j.1365-3121.2010.00956.x; Muxworthy AR, 2002, EARTH PLANET SC LETT, V203, P369, DOI 10.1016/S0012-821X(02)00880-4; Rochette P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024196; Wolfers P, 2011, SOLID STATE PHENOMEN, V170, P174, DOI 10.4028/www.scientific.net/SSP.170.174; HIRT AM, 1995, TECTONOPHYSICS, V247, P121, DOI 10.1016/0040-1951(94)00176-A; Evans MA, 2010, GEOL SOC AM MEM, V206, P477, DOI 10.1130/2010.1206(21); Lafargue E, 1998, REV I FR PETROL, V53, P421; [Anonymous], 2009, 74042 ISO; JACKSON M, 1990, J GEOPHYS RES-SOLID, V95, P2753, DOI 10.1029/JB095iB03p02753; Suarez-Ruiz I, 2012, INT J COAL GEOL, V99, P54, DOI 10.1016/j.coal.2012.02.004; Guyodo Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017021; Dunlop DJ, 2000, EARTH PLANET SC LETT, V176, P107, DOI 10.1016/S0012-821X(99)00309-X; Chou YM, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004120; MCCABE C, 1989, REV GEOPHYS, V27, P471, DOI 10.1029/RG027i004p00471; SUK D, 1990, NATURE, V345, P611, DOI 10.1038/345611a0; SUK DW, 1993, J GEOPHYS RES-SOL EA, V98, P419, DOI 10.1029/92JB01323; Katz B, 2000, J GEOPHYS RES-SOL EA, V105, P851, DOI 10.1029/1999JB900309; Appel E, 2012, GEOL SOC SPEC PUBL, V371, P163, DOI 10.1144/SP371.1; Aubourg C, 2010, EARTH PLANET SC LETT, V294, P47, DOI 10.1016/j.epsl.2010.02.045; Aubourg C, 2008, EARTH PLANET SC LETT, V272, P172, DOI 10.1016/j.epsl.2008.04.038; Aubourg C, 2012, GEOL SOC SPEC PUBL, V371, P181, DOI 10.1144/SP371.4; Cairanne G., 2004, GEOPHYS J INT, V159, P907, DOI DOI 10.1111/J.1365-246X.2004.02439X; CARPENTE.RH, 1974, GEOL SOC AM BULL, V85, P451, DOI 10.1130/0016-7606(1974)85<451:PIISTA>2.0.CO;2; CRERAR DA, 1978, GEOCHIM COSMOCHIM AC, V42, P1427, DOI 10.1016/0016-7037(78)90048-0; Crouzet C, 1999, GEOLOGY, V27, P503, DOI 10.1130/0091-7613(1999)027<0503:HPTDPD>2.3.CO;2; Crouzet C, 2001, GEOPHYS J INT, V145, P771, DOI 10.1046/j.0956-540x.2001.01423.x; Dekkers M. J., 1989, PHYS EARTH PLANETARY, V57, P266, DOI [10.1016/0031-9201(89)90116-7, DOI 10.1016/0031-9201(89)90116-7]; Deville E, 2006, AAPG BULL, V90, P887, DOI 10.1306/01090605046; ELMORE RD, 1987, NATURE, V325, P428, DOI 10.1038/325428a0; Elmore RD, 2006, GEOPHYS J INT, V166, P1062, DOI 10.1111/j.1365-246X.2006.02875.x; Epstein A. G., 1977, US GEOLOGICAL SURVEY, V995, P1; Evans MA, 1999, GEOL SOC AM BULL, V111, P1841, DOI 10.1130/0016-7606(1999)111<1841:FIASIA>2.3.CO;2; EVANS MA, 1995, GEOL SOC AM BULL, V107, P327, DOI 10.1130/0016-7606(1995)107<0327:FIIVFT>2.3.CO;2; Evans MA, 2006, J STRUCT GEOL, V28, P284, DOI 10.1016/j.jsg.2005.10.004; Gillett SL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002386; JACKSON M, 1992, GEOPHYS RES LETT, V19, P781, DOI 10.1029/92GL00832; JACKSON M, 1988, GEOLOGY, V16, P592, DOI 10.1130/0091-7613(1988)016<0592:MAADPA>2.3.CO;2; JACKSON M, 1993, J GEOPHYS RES-SOL EA, V98, P6217, DOI 10.1029/92JB01319; Kars M, 2011, GEOPHYS J INT, V186, P1029, DOI 10.1111/j.1365-246X.2011.05121.x; Kars M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004104; Lambert I. B., 1973, J GEOL SOC AUSTR, V20, P205, DOI 10.1080/14400957308527910; Lewchuk MT, 2002, PHYS CHEM EARTH, V27, P1141, DOI 10.1016/S1474-7065(02)00109-2; Maher B. A., 1999, QUATERNARY CLIMATES; Manning E. B., 2012, SPECIAL PUBLICATIONS, V371, P271; Moreau MG, 2005, EARTH PLANET SC LETT, V230, P193, DOI 10.1016/j.epsl.2004.11.013; Muxworthy A. R., 2000, GEOPHYS J INT, V140, DOI [10.1046/j.1365-246x.2000.00999.x, DOI 10.1046/J.1365-246X.2000.0999.X]; Repetski J., 2005, TECHNICAL REPORT; Repetski J. E., 2008, THERMAL MATURITY PAT; ROCHETTE P, 1987, EARTH PLANET SC LETT, V84, P446, DOI 10.1016/0012-821X(87)90009-4; Schill E, 2002, J ASIAN EARTH SCI, V20, P195, DOI 10.1016/S1367-9120(01)00022-0; SUK D, 1991, GEOPHYS RES LETT, V18, P939, DOI 10.1029/91GL00916; SWEENEY JJ, 1990, AAPG BULL, V74, P1559; Tauxe L, 1996, J GEOPHYS RES-SOL EA, V101, P571, DOI 10.1029/95JB03041; Vassoyevitch N., 1970, INT GEOL REV, V12, P1276, DOI 10.1080/00206817009475359; Wehland F, 2005, PHYS EARTH PLANET IN, V153, P181, DOI 10.1016/j.pepi.2005.05.006	65	0	0	AMER ASSOC PETROLEUM GEOLOGIST	TULSA	1444 S BOULDER AVE, PO BOX 979, TULSA, OK 74119-3604 USA	0149-1423	1558-9153		AAPG BULL	AAPG Bull.	MAR	2015	99	3					389	401		10.1306/06301413006		13	Geosciences, Multidisciplinary	Geology	CC2SQ	WOS:000350195300001		
J	Tatani, K; Hiratochi, M; Nonaka, Y; Isaji, M; Shuto, S				Tatani, Kazuya; Hiratochi, Masahiro; Nonaka, Yoshinori; Isaji, Masayuki; Shuto, Satoshi			Identification of 8-Aminoadenosine Derivatives as a New Class of Human Concentrative Nucleoside Transporter 2 Inhibitors	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						8-Aminoadenosine derivatives; human concentrative nucleoside transporter 2; dietary purines; hyperuricemia; gout	PURINE-RICH FOODS; FUNCTIONAL EXPRESSION; INTESTINAL-ABSORPTION; URIC-ACID; GOUT; COTRANSPORTER; PROTEIN; CLONING; HYPERURICEMIA; FAMILY	Purine-rich foods have long been suspected as a major cause of hyperuricemia. We hypothesized that inhibition of human concentrative nucleoside transporter 2 (hCNT2) would suppress increases in serum urate levels derived from dietary purines. To test this hypothesis, the development of potent hCNT2 inhibitors was required. By modifying adenosine, an hCNT2 substrate, we successfully identified 8-aminoadenosine derivatives as a new class of hCNT2 inhibitors. Compound 12 moderately inhibited hCNT2 (IC50 = 52 +/- 3.8 mu M), and subsequent structure-activity relationship studies led to the discovery of compound 48 (IC50 = 0.64 +/- 0.19 mu M). Here we describe significant findings about structural requirements of 8-aminoadenosine derivatives for exhibiting potent hCNT2 inhibitory activity.	[Tatani, Kazuya; Hiratochi, Masahiro; Nonaka, Yoshinori; Isaji, Masayuki] Kissei Pharmaceut Co Ltd, Cent Res Labs, Nagano 3998304, Japan; [Tatani, Kazuya; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Shuto, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Tatani, K (reprint author), Kissei Pharmaceut Co Ltd, Cent Res Labs, 4365-1 Kashiwabara, Nagano 3998304, Japan.	kazuya_tatani@pharm.kissei.co.jp					EMMERSON BT, 1991, LANCET, V337, P1461, DOI 10.1016/0140-6736(91)93141-U; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058; Choi HK, 2005, ARTHRITIS RHEUM, V52, P283, DOI 10.1002/art.20761; Wang CM, 2010, BIOCHEM PHARMACOL, V79, P307, DOI 10.1016/j.bcp.2009.08.028; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; YU TF, 1982, AM J MED, V72, P95, DOI 10.1016/0002-9343(82)90593-9; Lin KC, 2000, J RHEUMATOL, V27, P1501; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707; Yamanaka H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1018, DOI 10.1080/15257770.2011.596496; Gupte A, 2009, BIOORG MED CHEM LETT, V19, P917, DOI 10.1016/j.bmcl.2008.11.112; Damaraju VL, 2009, NUCLEOS NUCLEOT NUCL, V28, P450, DOI 10.1080/15257770903044499; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; CHE MX, 1995, J BIOL CHEM, V270, P13596; Cnang C., 2004, MOL PHARM, V65, P558; Hiratochi M, 2012, EUR J PHARMACOL, V690, P183, DOI 10.1016/j.ejphar.2012.06.015; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; King KM, 2006, MOL PHARMACOL, V69, P346, DOI 10.1124/mol.105.015768; Lai YR, 2002, J BIOL CHEM, V277, P37711, DOI 10.1074/jbc.M204986200; Lang TT, 2001, MOL PHARMACOL, V60, P1143; Okayama T, 2012, J PHARMACOL EXP THER, V340, P457, DOI 10.1124/jpet.111.186296; Shin HC, 2003, BIOCHEM BIOPH RES CO, V307, P696, DOI 10.1016/S0006-291X(03)01259-2; Shoji A, 2004, ARTHRIT RHEUM-ARTHR, V51, P321, DOI 10.1002/art.20405; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAR	2015	6	3					244	248		10.1021/ml500343r		5	Chemistry, Medicinal	Pharmacology & Pharmacy	CD6IP	WOS:000351193100004		
J	Takano, R; Yoshida, M; Inoue, M; Honda, T; Nakashima, R; Matsumoto, K; Yano, T; Ogata, T; Watanabe, N; Hirouchi, M; Yoneyama, T; Ito, S; Toda, N				Takano, Rieko; Yoshida, Masao; Inoue, Masahiro; Honda, Takeshi; Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya; Ogata, Tsuneaki; Watanabe, Nobuaki; Hirouchi, Masakazu; Yoneyama, Tomoko; Ito, Shuichiro; Toda, Narihiro			Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						GPR40; agonist; insulin secretagogue; diabetes; glucose lowering	DEPENDENT INSULIN-SECRETION; TYPE-2 DIABETES-MELLITUS; SMALL-MOLECULE AGONISTS; FREE FATTY-ACIDS; HUMAN ISLETS; BETA-CELLS; RECEPTOR; GLUCOSE; TAK-875; SULFONYLUREAS	GPR40 is a G protein-coupled receptor that is predominantly expressed in pancreatic beta-cells GPR40 agonists stimulate insulin secretion in the presence of high glucose concentration. On the basis of this mechanism, GPR40 agonists are possible novel insulin secretagogues with reduced or no risk of hypoglycemia. The improvement of in vitro activity and metabolic stability of compound 1 led to the discovery of 13, (3S)-3-ethoxy-3-(4-{[(1R)-4-(trifluoromethyl)-2,3-dihydro-1-H-inden-1-yljoxy}phenyl)propanoic acid, as a potent and orally available GPR40 agonist. Compound 13 (DS-1558) was found to have potent glucose lowering effects during an oral glucose tolerance test in ZDF rats.	[Takano, Rieko; Yoshida, Masao; Inoue, Masahiro; Honda, Takeshi; Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya; Ogata, Tsuneaki; Watanabe, Nobuaki; Hirouchi, Masakazu; Toda, Narihiro] Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan; [Yoneyama, Tomoko; Ito, Shuichiro] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan	Toda, N (reprint author), Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	toda.narihiro.jw@daiichisankyo.co.jp					Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Toda N, 2013, ACS MED CHEM LETT, V4, P790, DOI 10.1021/ml400186z; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Brown SP, 2012, ACS MED CHEM LETT, V3, P726, DOI 10.1021/ml300133f; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; BROOKS DW, 1979, ANGEW CHEM INT EDIT, V18, P72, DOI 10.1002/anie.197900722; Fujii A, 1996, J AM CHEM SOC, V118, P2521, DOI 10.1021/ja954126l; McKeown SC, 2007, BIOORG MED CHEM LETT, V17, P1584, DOI 10.1016/j.bmcl.2006.12.084; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Mizuno CS, 2008, CURR MED CHEM, V15, P61; Seino Y, 2010, CURR MED RES OPIN, V26, P1013, DOI 10.1185/03007991003672551; Christiansen E, 2010, ACS MED CHEM LETT, V1, P345, DOI 10.1021/ml100106c; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Barnett A. H., 2008, BR J DIABETES VASCUL, V8, P45, DOI 10.1177/14746514080080011001; Bharate SB, 2009, EXPERT OPIN THER PAT, V19, P237, DOI 10.1517/13543770802665717; Christiansen E, 2013, ACS MED CHEM LETT, V4, P441, DOI 10.1021/ml4000673; Del Guerra S, 2005, J DIABETES COMPLICAT, V19, P60, DOI 10.1016/j.jdiacomp.2004.05.001; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Nakashima R, 2014, EUR J PHARMACOL, V737, P194, DOI 10.1016/j.ejphar.2014.05.014; Takano R, 2014, BIOORG MED CHEM LETT, V24, P2949, DOI 10.1016/j.bmcl.2014.04.065; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Zhou CY, 2010, BIOORG MED CHEM LETT, V20, P1298, DOI 10.1016/j.bmcl.2009.10.052	31	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAR	2015	6	3					266	270		10.1021/ml500391n		5	Chemistry, Medicinal	Pharmacology & Pharmacy	CD6IP	WOS:000351193100008		
J	Kuroiwa, K; Ishii, H; Matsuno, K; Asai, A; Suzuki, Y				Kuroiwa, Kenta; Ishii, Hirosuke; Matsuno, Kenji; Asai, Akira; Suzuki, Yumiko			Synthesis and Structure-Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Quinazoline; anticancer; tubulin inhibitor; colchicine binding site; structure-activity relationship study	TUBULIN-POLYMERIZATION; CANCER-CHEMOTHERAPY; INHIBITORS; QUINAZOLINES; COLCHICINE; DISCOVERY; BINDING	A quinazoline derivative PVHD121 (1a) was shown to have strong antiproliferative activity against various tumor-derived cell lines, including A549 (lung), NCI-H460 (lung), HCT116 (colon), MCF7 (breast), PC3 (prostate), and HeLa (cervical) cells with IC50 values from 0.1 to 0.3 mu M. A structure activity relationship (SAR) study at the 2- and 4-position of the quinazoline core lead to the discovery of more potent anticancer agents (14, 16, 17, 19, 24, and 31). The results of an in vitro tubulin polymerization assay and fluorescent based colchicine site competition assay with purified tubulin indicated that la inhibits tubulin polymerization by binding to the colchicine site.	[Kuroiwa, Kenta; Suzuki, Yumiko] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Ishii, Hirosuke; Matsuno, Kenji; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Asai, A (reprint author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.	aasai@u-shizuoka-ken.ac.jp; yumiko_suzuki@sophia.ac.jp					Mei QB, 2012, J MATER CHEM, V22, P6878, DOI 10.1039/c2jm15160j; Romagnoli R, 2006, J MED CHEM, V49, P6425, DOI 10.1021/jm060804a; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Joullie MM, 2011, TETRAHEDRON LETT, V52, P2136, DOI 10.1016/j.tetlet.2010.11.165; Sirisoma N, 2009, J MED CHEM, V52, P2341, DOI 10.1021/jm801315b; Smits RA, 2008, J MED CHEM, V51, P7855, DOI 10.1021/jm800876b; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Wang XF, 2014, J MED CHEM, V57, P1390, DOI 10.1021/jm4016526; Song JJ, 2005, ORG LETT, V7, P2193, DOI 10.1021/ol050568i; Marzaro G, 2012, EXPERT OPIN THER PAT, V22, P223, DOI 10.1517/13543776.2012.665876; Prinz H, 2003, J MED CHEM, V46, P3382, DOI 10.1021/jm0307685; Tahir SK, 2001, CANCER RES, V61, P5480; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Davis Ashley, 1999, Neoplasia (New York), V1, P498; Henriksen ST, 2006, TETRAHEDRON LETT, V47, P8251, DOI 10.1016/j.tetlet.2006.09.121; Regina G. L., 2013, J MED CHEM, V56, P123; SMITH RF, 1965, J ORG CHEM, V30, P1312, DOI 10.1021/jo01015a548; Suzuki Y, 1998, CHEM PHARM BULL, V46, P199	20	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAR	2015	6	3					287	291		10.1021/ml5004684		5	Chemistry, Medicinal	Pharmacology & Pharmacy	CD6IP	WOS:000351193100012		
J	Takayama, K; Mori, K; Sohma, Y; Taketa, K; Taguchi, A; Yakushiji, F; Minamino, N; Miyazato, M; Kangawa, K; Hayashi, Y				Takayama, Kentaro; Mori, Kenji; Sohma, Yuko; Taketa, Koji; Taguchi, Akihiro; Yakushiji, Fumika; Minamino, Naoto; Miyazato, Mikiya; Kangawa, Kenji; Hayashi, Yoshio			Discovery of Potent Hexapeptide Agonists to Human Neuromedin U Receptor 1 and Identification of Their Serum Metabolites	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Agonist; biodegradation site; neuromedin U; neuromedin U receptor; peptide	HOMEOSTASIS; HORMONE; ENERGY	Neuromedin U (NMU) and S (NMS) display various physiological activities, including an anorexigenic effect, and share a common C-terminal heptapeptide-amide sequence that is necessary to activate two NMU receptors (NMUR1 and NMUR2). On the basis of this knowledge, we recently developed hexapeptide agonists 2 and 3, which are highly selective to human NMUR1 and NMUR2, respectively. However, the agonists are still less potent than the endogenous ligand, hNMU. Therefore, we performed an additional structure activity relationship study, which led to the identification of the more potent hexapeptide 5d that exhibits similar NMUR1-agonistic activity as compared to hNMU. Additionally, we studied the stability of synthesized agonists, including 5d, in rat serum, and identified two major biodegradation sites: Phe(2)-Arg(3) and Arg(5)-Asn(6). The latter was more predominantly cleaved than the former. Moreover, substitution with 4-fluorophenylalanine, as in 5d, enhanced the metabolic stability at Phe(2)-Arg(3). These results provide important information to guide the development of practical hNMU agonists.	[Takayama, Kentaro; Sohma, Yuko; Taketa, Koji; Taguchi, Akihiro; Yakushiji, Fumika; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Dept Med Chem, Hachioji, Tokyo 1920392, Japan; [Mori, Kenji; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Pharmacol, Suita, Osaka 5658565, Japan	Hayashi, Y (reprint author), Tokyo Univ Pharm & Life Sci, Dept Med Chem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yhayashi@toyaku.ac.jp			Japan Society for the Promotion of Sciences (JSPS) KAKENHI [23390029, 25293188]	This research was supported in part by the Japan Society for the Promotion of Sciences (JSPS) KAKENHI, including Grants-in-Aid for Scientific Research (B) 23390029 (to Y.H.) and 25293188 (to M.M.).	Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; Ida T, 2005, ENDOCRINOLOGY, V146, P4217, DOI 10.1210/en.2005-0107; Kojima M, 2000, BIOCHEM BIOPH RES CO, V276, P435, DOI 10.1006/bbrc.2000.3502; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Hanada T, 2003, BIOCHEM BIOPH RES CO, V311, P954, DOI 10.1016/j.bbrc.2003.10.098; Takayama K, 2014, J MED CHEM, V57, P6583, DOI 10.1021/jm500599s; HASHIMOTO T, 1995, CHEM PHARM BULL, V43, P1154; Ingallinella P, 2012, BIOORGAN MED CHEM, V20, P4751, DOI 10.1016/j.bmc.2012.06.003; Kurosawa K, 1996, CHEM PHARM BULL, V44, P1880; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Neuner P., 2013, J PEPT SCI, V20, P7; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463	14	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAR	2015	6	3					302	307		10.1021/ml500494j		6	Chemistry, Medicinal	Pharmacology & Pharmacy	CD6IP	WOS:000351193100015		
J	Kobayashi, T; Furusawa, Y; Yamada, S; Akehi, M; Takenaka, F; Sasaki, T; Akahoshi, A; Hanada, T; Matsuura, E; Hirano, H; Tai, A; Kakuta, H				Kobayashi, Toshiki; Furusawa, Yuki; Yamada, Shoya; Akehi, Masaru; Takenaka, Fumiaki; Sasaki, Takanori; Akahoshi, Akiya; Hanada, Takahisa; Matsuura, Eiji; Hirano, Hiroyuki; Tai, Akihiro; Kakuta, Hiroki			Positron Emission Tomography to Elucidate Pharmacokinetic Differences of Regioisomeric Retinoid X Receptor Agonists	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Nuclear receptors; RXR; PET imaging; pharmacokinetics	T-CELL LYMPHOMA; RXR AGONIST; BEXAROTENE; MODELS; RATS; MICE	RXR partial agonist NEt-41B (2a, 6-[ethyl-(4-isobutoxy-3-isopropylphenyl)amino]pyridine-3-carboxylic acid: EC50 = 169 nM, E-max = 55%) showed a blood concentration higher than its Emax after single oral administration at 30 mg/kg to mice, and repeated oral administration at 10 mg/kg/day to KK-A(y) mice afforded antitype 2 diabetes activity without the side effects caused by RXR full agonists. However, RXR full agonist NEt-3IB (la), in which the isobutoxy and isopropyl groups of 2a are interchanged, gave a much lower blood concentration than 2a. Here we used positron emission tomography (PET) with tracers [C-11] la, [C-11]2a and fluorinated derivatives [F-18] lb, [F-18]2b, which have longer half-lives, to examine the reason why la and 2a exhibited significantly different blood concentrations. As a result, the reason for the high blood concentration of 2a after oral administration was found to be linked to higher intestinal absorbability together with lower biliary excretion, compared with la.	[Kobayashi, Toshiki; Furusawa, Yuki; Yamada, Shoya; Kakuta, Hiroki] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Yamada, Shoya] Japan Soc Promot Sci, Res Fellowship Div, Chiyoda Ku, Tokyo 1028472, Japan; [Akehi, Masaru; Takenaka, Fumiaki; Sasaki, Takanori; Akahoshi, Akiya; Hanada, Takahisa; Matsuura, Eiji] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Collaborat Res Ctr OMIC, Kita Ku, Okayama 7008558, Japan; [Hirano, Hiroyuki] SHI Accelerator Serv Ltd, Shinagawa Ku, Tokyo 1410032, Japan; [Tai, Akihiro] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Hiroshima 7270023, Japan	Kakuta, H (reprint author), Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	kakuta-h@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by a subsidy to promote science and technology in prefectures where nuclear and other power plants are located (to H.K) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	HAMACHER K, 1986, J NUCL MED, V27, P235; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Sherman SI, 2003, CLIN LYMPHOMA, V3, P249, DOI 10.3816/CLM.2003.n.006; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; Yamashita S, 2011, J NUCL MED, V52, P249, DOI 10.2967/jnumed.110.081539; Fischman AJ, 2002, CLIN PHARMACOKINET, V41, P581, DOI 10.2165/00003088-200241080-00003; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Lenhard JM, 1999, DIABETOLOGIA, V42, P545, DOI 10.1007/s001250051193; de Vries-van der Weij Jitske, 2009, Endocrinology, V150, P2368, DOI 10.1210/en.2008-1540; Kawata K, 2015, J MED CHEM, V58, P912, DOI 10.1021/jm501863r; Landreth G. E., 2013, SCIENCE, V340; Ohsawa F, 2010, ACS MED CHEM LETT, V1, P521, DOI 10.1021/ml100184k; Pileri A, 2013, IMMUNOTHERAPY-UK, V5, P427, DOI [10.2217/imt.13.15, 10.2217/IMT.13.15]; Rotstein B. H., 2014, ACS MED CHEM LETT, V6, P668; Standeven AM, 2001, BIOCHEM PHARMACOL, V62, P1501, DOI 10.1016/S0006-2952(01)00803-6; Standeven AM, 1997, BIOCHEM PHARMACOL, V54, P517, DOI 10.1016/S0006-2952(97)00209-8; Takamatsu K, 2008, CHEMMEDCHEM, V3, P780, DOI 10.1002/cmdc.200700313; Van der Mey M, 2005, BIOORGAN MED CHEM, V13, P1579, DOI 10.1016/j.bmc.2004.12.019	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAR	2015	6	3					334	338		10.1021/ml500511m		5	Chemistry, Medicinal	Pharmacology & Pharmacy	CD6IP	WOS:000351193100021		
J	Hesselholt, L				Hesselholt, Lars			The big de Rham-Witt complex	ACTA MATHEMATICA			English	Article							ALGEBRAIC K-THEORY; LAMBDA-RINGS; FIELDS	This paper gives a new and direct construction of the multi-prime big de Rham-Witt complex, which is defined for every commutative and unital ring; the original construction by Madsen and myself relied on the adjoint functor theorem and accordingly was very indirect. The construction given here also corrects the 2-torsion which was not quite correct in the original version. The new construction is based on the theory of modules and derivations over a lambda-ring which is developed first. The main result in this first part of the paper is that the universal derivation of a lambda-ring is given by the universal derivation of the underlying ring together with an additional structure depending directly on the lambda-ring structure in question. In the case of the ring of big Witt vectors, this additional structure gives rise to divided Frobenius operators on the module of Kahler differentials. It is the existence of these divided Frobenius operators that makes the new construction of the big de Rham-Witt complex possible. It is further shown that the big de Rham-Witt complex behaves well with respect to ,tale maps, and finally, the big de Rham-Witt complex of the ring of integers is explicitly evaluated.	[Hesselholt, Lars] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hesselholt, Lars] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen O, Denmark	Hesselholt, L (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Furocho, Nagoya, Aichi 4648602, Japan.	larsh@math.nagoya-u.ac.jp	Hesselholt, Lars/I-7230-2014	Hesselholt, Lars/0000-0002-3324-2407	University of Rennes; Australian National University; Lorentz Institute at Leiden; Mathematical Sciences Research Institute at Berkeley	It is a pleasure to gratefully acknowledge the hospitality and financial support of the following institutions that I have visited while working on this paper: University of Rennes, Australian National University, the Lorentz Institute at Leiden, and the Mathematical Sciences Research Institute at Berkeley. I would also like to acknowledge the mathematical debt of the work presented here to my collaboration with Ib Madsen and to conversations with Jim Borger. Finally, I would like to thank an anonymous referee for many valuable suggestions on improving the exposition.	Borger J, 2011, ALGEBR NUMBER THEORY, V5, P231; BOKSTEDT M, 1993, INVENT MATH, V111, P465, DOI 10.1007/BF01231296; ILLUSIE L, 1979, ANN SCI ECOLE NORM S, V12, P501; STIENSTRA J, 1985, J REINE ANGEW MATH, V355, P1; Borger J, 2005, ADV MATH, V194, P246, DOI 10.1016/j.aim.2004.06.006; Hesselholt L, 2003, ANN MATH, V158, P1; Atiyah Michael F., 1969, TOPOLOGY, V8, P253, DOI 10.1016/0040-9383(69)90015-9; Beck J. M., 2003, REPR THEORY APPL CAT, V2, P1; Berthelot P., 1971, LECT NOTES MATH, V225; Borger J., 2009, PREPRINT; Cartier Pierre, 1967, C R ACAD SCI PARIS A, V265, pA49; Costeanu V, 2008, DOC MATH, V13, P413; Geisser T, 2006, J AM MATH SOC, V19, P1, DOI 10.1090/S0894-0347-05-00505-9; Grothendieck Alexander, 1958, B SOC MATH FRANCE, V86, P137; Hazewinkel M., 1978, PURE APPL MATH, V78; Hesselholt L, 2004, ANN SCI ECOLE NORM S, V37, P1, DOI 10.1016/j.ansens.2003.06.001; Hesselholt L., 2001, CONT MATH, V271, P127; Hesselholt L, 2002, P INT C MATH BEIJ 20, VII; Hesselholt L, 1996, ACTA MATH-DJURSHOLM, V177, P1, DOI 10.1007/BF02392597; HILLER HL, 1981, J PURE APPL ALGEBRA, V20, P241, DOI 10.1016/0022-4049(81)90062-1; Knutson D., 1973, LECT NOTES MATH, V308; KRATZER C, 1980, COMMENT MATH HELV, V55, P233, DOI 10.1007/BF02566684; Langer A, 2004, J INST MATH JUSSIEU, V3, P231, DOI 10.1017/S1474748004000088; MacLane S., 1971, GRADUATE TEXTS MATH, V5; Mumford David, 1966, ANN MATH STUDIES, V59; Teichmuller O., 1936, NACHR GES WISS GOTT, V1, P151; VANDERKALLEN W, 1986, MATH Z, V191, P405; WILKERSON C, 1982, COMMUN ALGEBRA, V10, P311, DOI 10.1080/00927878208822717; Witt E, 1937, J REINE ANGEW MATH, V176, P126	29	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0001-5962	1871-2509		ACTA MATH-DJURSHOLM	Acta Math.	MAR	2015	214	1					135	207		10.1007/s11511-015-0124-y		73	Mathematics	Mathematics	CC7TU	WOS:000350572100003		
J	Makita, C; Nakamura, T; Takada, A; Takayama, K; Suzuki, M; Azami, Y; Kato, T; Tsukiyama, I; Hareyama, M; Kikuchi, Y; Daimon, T; Hata, M; Inoue, T; Fuwa, N				Makita, Chiyoko; Nakamura, Tatsuya; Takada, Akinori; Takayama, Kanako; Suzuki, Motohisa; Azami, Yusuke; Kato, Takahiro; Tsukiyama, Iwao; Hareyama, Masato; Kikuchi, Yasuhiro; Daimon, Takashi; Hata, Masaharu; Inoue, Tomio; Fuwa, Nobukazu			High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors	ACTA ONCOLOGICA			English	Article							BODY RADIATION-THERAPY; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; CARBON-ION THERAPY; PHASE-II; RADIOTHERAPY; VOLUME; RISK; CARCINOMA; IRRADIATION	Background. Evidence has suggested that radiation therapy with a lower dose per fraction may be a reasonable option for the treatment of centrally located non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the safety and efficacy of two proton beam therapy (PBT) protocols for stage I NSCLC and to determine prognostic factors. Material and methods. This study included patients clinically diagnosed with stage I NSCLC. Based on the location of the tumor, one of the two PBT protocols was administered. Patients with peripherally located tumors were given 66 Gy relative biological dose effectiveness (RBE) over 10 fractions (Protocol A) while patients with centrally located tumors were given 80 Gy (RBE) over 25 fractions (Protocol B). Results. Between January 2009 and May 2012, 56 eligible patients were enrolled (protocol A: 32 patients; protocol B: 24 patients). The three-year overall survival (OS), progression-free survival (PFS), and local control (LC) rates were 81.3% [95% confidence interval (CI) 75.9-86.7%], 73.4% (95% CI 67.2-79.6%), and 96.0% (95% CI 93.2-98.8%), respectively. There were no significant differences in outcomes between the two protocols. Late grade 2 and 3 pulmonary toxicities were observed in nine patients (13.4%) and one patient (1.5%), respectively; no grade 4 or 5 toxicities were observed. Sex, age, performance status, T-stage, operability, and tumor pathology were not associated with OS and PFS. Only maximum standardized uptake value (SUVmax; <5 vs. >= 5) was identified as a significant prognostic factor for OS and PFS. Conclusion. Both high-dose PBT protocols achieved high LC rates with tolerable toxicities in stage I NSCLC patients, and SUV max was a significant prognostic factor.	[Makita, Chiyoko] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Nakamura, Tatsuya; Takayama, Kanako; Suzuki, Motohisa; Azami, Yusuke; Kato, Takahiro; Tsukiyama, Iwao; Hareyama, Masato; Kikuchi, Yasuhiro] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, Koriyama, Fukushima, Japan; [Takada, Akinori] Mie Univ Hosp, Dept Radiat Oncol, Tsu, Mie, Japan; [Daimon, Takashi] Hyogo Coll Med, Div Biostat, Nishinomiya, Hyogo 6638501, Japan; [Hata, Masaharu; Inoue, Tomio] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Fuwa, Nobukazu] Hyogo Ion Beam Med Ctr, Tatsuno, Hyogo, Japan	Makita, C (reprint author), Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan.	chioko-makita@live.jp					Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0630-3016(03)00095-6; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Song SY, 2009, LUNG CANCER, V66, P89, DOI 10.1016/j.lungcan.2008.12.016; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Chang JY, 2008, INT J RADIAT ONCOL, V72, P967, DOI 10.1016/j.ijrobp.2008.08.001; Nihei K, 2006, INT J RADIAT ONCOL, V65, P107, DOI 10.1016/j.ijrobp.2005.10.031; Bush DA, 2004, CHEST, V126, P1198, DOI 10.1378/chest.126.4.1198; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Kanemoto A, 2013, ACTA ONCOL, V52, P538, DOI 10.3109/0284186X.2012.718094; Milano MT, 2009, RADIOTHER ONCOL, V91, P301, DOI 10.1016/j.radonc.2009.03.005; Iwata H, 2010, CANCER-AM CANCER SOC, V116, P2476, DOI 10.1002/cncr.24998; Chang JY, 2011, INT J RADIAT ONCOL, V80, P1350, DOI 10.1016/j.ijrobp.2010.04.049; Shioyama Y, 2003, INT J RADIAT ONCOL, V56, P7, DOI 10.1016/0360-3016(02)04416-4; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Westover KD, 2012, J THORAC ONCOL, V7, P1021, DOI 10.1097/JTO.0b013e31824de0bf; Bush DA, 2013, INT J RADIAT ONCOL, V86, P964, DOI 10.1016/j.ijrobp.2013.05.002; Fujii O, 2013, RADIOTHER ONCOL, V109, P32, DOI 10.1016/j.radonc.2013.08.038; Hata M, 2007, INT J RADIAT ONCOL, V68, P786, DOI 10.1016/j.ijrobp.2006.12.063; Kadoya N, 2011, INT J RADIAT ONCOL, V79, P1225, DOI 10.1016/j.ijrobp.2010.05.016; Kozak KR, 2006, INT J RADIAT ONCOL, V66, P691, DOI 10.1016/j.ijrobp.2006.06.041; Nair VJ, 2014, INT J RADIAT ONCOL, V88, P312, DOI 10.1016/j.ijrobp.2013.10.029; Nakayama H, 2010, INT J RADIAT ONCOL, V78, P467, DOI 10.1016/j.ijrobp.2009.07.1707; Register SP, 2011, INT J RADIAT ONCOL, V80, P1015, DOI 10.1016/j.ijrobp.2010.03.012; Satoh Y, 2014, RADIOLOGY, V270, P275, DOI 10.1148/radiol.13130652	26	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0284-186X	1651-226X		ACTA ONCOL	Acta Oncol.	MAR	2015	54	3					307	314		10.3109/0284186X.2014.948060		8	Oncology	Oncology	CC8VJ	WOS:000350646400003		
J	Fujii, O; Demizu, Y; Hashimoto, N; Takagi, M; Terashima, K; Mima, M; Jin, DC; Nagano, F; Katsui, K; Okimoto, T; Iwata, H; Niwa, Y; Yamashita, T; Akagi, T; Daimon, T; Sasaki, R; Hishikawa, Y; Abe, M; Murakami, M; Fuwa, N				Fujii, Osamu; Demizu, Yusuke; Hashimoto, Naoki; Takagi, Masaru; Terashima, Kazuki; Mima, Masayuki; Jin, Dongcun; Nagano, Fumiko; Katsui, Kuniaki; Okimoto, Tomoaki; Iwata, Hiromitsu; Niwa, Yasue; Yamashita, Tomohiro; Akagi, Takashi; Daimon, Takashi; Sasaki, Ryohei; Hishikawa, Yoshio; Abe, Mitsuyuki; Murakami, Masao; Fuwa, Nobukazu			Particle therapy for clinically diagnosed stage I lung cancer: Comparison with pathologically proven non-small cell lung cancer	ACTA ONCOLOGICA			English	Article							STEREOTACTIC BODY RADIOTHERAPY; CARBON-ION THERAPY; POSITRON-EMISSION-TOMOGRAPHY; SOLITARY PULMONARY NODULES; PROTON THERAPY; OUTCOMES; TUMORS; RISK	Background. The purpose of the present study was to present the treatment outcomes of particle therapy for indeterminate pulmonary nodules (IPNs) diagnosed as stage I non-small cell lung cancer, including a comparative analysis involving pathologically proven lung cancer (PPLC). Material and methods. A total of 54 patients (57 lesions) who underwent particle therapy for IPNs were enrolled in this study. Median patient age was 76 (range 52-87) years. T-classification was: T1a, 30; T1b, 16; and T2a, 11. Particle therapy using protons or carbon ions was delivered at total doses of 52.8-80 Gy equivalent in 4-26 fractions. The PPLC cohort included 111 patients. Results. The median follow-up time was 41 (range 7-90) months. For all IPN patients, the three-year overall survival, progression-free survival, local control and distant progression-free survival rates were 90%, 72%, 94% and 79%, respectively. Grade 2 toxicities were radiation pneumonitis (19%), dermatitis (9%), rib fracture (2%), chest wall pain (2%) and neuropathy (2%). No >= grade 3 toxicities were observed. In univariate analysis, the IPN group showed significantly better survival relative to the PPLC group. However, after adjustment for baseline imbalances between these two groups in multivariate analysis, pathological confirmation did not correlate with survival. Conclusions. Particle therapy for IPNs provided favorable outcomes with minimal toxicities, which may be comparable to those for PPLC patients. Further studies are needed to clarify the optimal management of IPN patients.	[Fujii, Osamu; Demizu, Yusuke; Hashimoto, Naoki; Takagi, Masaru; Terashima, Kazuki; Mima, Masayuki; Jin, Dongcun; Nagano, Fumiko; Katsui, Kuniaki; Okimoto, Tomoaki; Iwata, Hiromitsu; Yamashita, Tomohiro; Akagi, Takashi; Abe, Mitsuyuki; Fuwa, Nobukazu] Hyogo Ion Beam Med Ctr, Dept Radiol & Radiat Phys, Tatsuno, Hyogo 6795165, Japan; [Iwata, Hiromitsu] Nagoya City West Med Ctr, Nagoya Proton Therapy Ctr, Dept Radiat Oncol, Nagoya, Aichi, Japan; [Iwata, Hiromitsu] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Niwa, Yasue] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Daimon, Takashi] Hyogo Coll Med, Div Biostat, Nishinomiya, Hyogo 6638501, Japan; [Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Div Radiat Oncol, Kobe, Hyogo 657, Japan; [Hishikawa, Yoshio] Medipolis Proton Therapy & Res Ctr, Ibusuki, Japan; [Murakami, Masao] Dokkyo Med Univ, Ctr Radiat Oncol, Mibu, Tochigi, Japan	Fujii, O (reprint author), Hyogo Ion Beam Med Ctr, Dept Radiol, 1-2-1 Koto Shingu Cho, Tatsuno, Hyogo 6795165, Japan.	osfujii@aa.cyberhome.ne.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Boffa DJ, 2008, J THORAC CARDIOV SUR, V135, P247, DOI 10.1016/j.jtcvs.2007.07.060; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; Takeda A, 2012, LUNG CANCER, V77, P77, DOI 10.1016/j.lungcan.2012.01.006; Herder GJM, 2006, J CLIN ONCOL, V24, P1800, DOI 10.1200/JCO.2005.02.4695; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Inoue T, 2009, INT J RADIAT ONCOL, V75, P683, DOI 10.1016/j.ijrobp.2008.11.026; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI [10.7326/0003-4819-155-3-201108020-00003, 10.1059/0003-4819-155-3-201108020-00003]; Baumann P, 2008, RADIOTHER ONCOL, V88, P359, DOI 10.1016/j.radonc.2008.07.019; Matsuo Y, 2011, INT J RADIAT ONCOL, V79, P1104, DOI 10.1016/j.ijrobp.2009.12.022; Iwata H, 2010, CANCER-AM CANCER SOC, V116, P2476, DOI 10.1002/cncr.24998; Verstegen NE, 2011, RADIOTHER ONCOL, V101, P250, DOI 10.1016/j.radonc.2011.09.017; Suit H, 2010, RADIOTHER ONCOL, V95, P3, DOI 10.1016/j.radonc.2010.01.015; DOUGLAS BG, 1976, RADIAT RES, V66, P401, DOI 10.2307/3574407; Belgers EHJ, 2010, INTERACT CARDIOV TH, V10, P176, DOI 10.1510/icvts.2009.212878; Fujii O, 2013, RADIOTHER ONCOL, V109, P32, DOI 10.1016/j.radonc.2013.08.038; Gould MK, 2013, CHEST, V143, p93S; Iwata H, 2013, J THORAC ONCOL, V8, P726, DOI 10.1097/JTO.0b013e318288ab02; Kadoya N, 2011, INT J RADIAT ONCOL, V79, P1225, DOI 10.1016/j.ijrobp.2010.05.016; Liao ZX, 2011, ACTA ONCOL, V50, P745, DOI 10.3109/0284186X.2011.590148; Nomori H, 2004, LUNG CANCER-J IASLC, V45, P19, DOI 10.1016/j.lungcan.2004.01.009; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34	25	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0284-186X	1651-226X		ACTA ONCOL	Acta Oncol.	MAR	2015	54	3					315	321		10.3109/0284186X.2014.974828		7	Oncology	Oncology	CC8VJ	WOS:000350646400004		
J	Iino, Y; Yoshida, N; Kato, T; Kakizaki, K; Miyazawa, T; Kakuta, H				Iino, Yukiko; Yoshida, Naohiro; Kato, Toshinori; Kakizaki, Keiko; Miyazawa, Tetsuo; Kakuta, Hiroyuki			Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media	ACTA OTO-LARYNGOLOGICA			English	Article						Biofilm; cell invasion; clinical effects	CHRONIC RHINOSINUSITIS; MACROLIDE; BIOFILMS; EFFUSION; CHILDREN	Conclusion: Additional treatment with clarithromycin (CAM) reduced persistent middle ear inflammation after acute otitis media (AOM) caused by Haemophilus influenzae in children. CAM is a treatment option for persistent inflammation following AOM and to prevent continuing otitis media with effusion. Objective: We conducted a clinical study to evaluate a new method of treatment for persistent inflammation after AOM in children. Methods: H. influenzae-infected children with AOM were treated acutely with antimicrobial agents, after which those still demonstrating effusion of the middle ear cavity received additional treatment with carbocysteine (S-CMC) alone or S-CMC combined with clarithromycin (CAM) for 1 week. The two regimens were compared in terms of clinical effects. Results: After the initial acute treatment, many patients still showed abnormal otoscopic findings. At the completion of additional treatment, there were no significant differences between the two treatment groups. However, 1 week after completion of additional treatment, the prevalence of a diminished light reflex was significantly lower in the CAM + S-CMC group than in the S-CMC group (p = 0.017). The prevalence of redness of the tympanic membrane also tended to be lower in the combined treatment group than in those receiving a single drug (p = 0.097).	[Iino, Yukiko; Yoshida, Naohiro] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Saitama 3308503, Japan; [Kato, Toshinori] Kato Otorhinolaryngol Clin, Nishio, Aichi, Japan; [Kakizaki, Keiko] Kakizaki Otorhinolaryngol Clin, Kazo, Saitama, Japan; [Miyazawa, Tetsuo] Miyazawa Otorhinolaryngol Clin, Kasukabe, Saitama, Japan; [Kakuta, Hiroyuki] Kakuta Clin, Saitama, Japan	Iino, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	yiino@jichi.ac.jp			Taisho Toyama Pharmaceutical Company	Taisho Toyama Pharmaceutical Company was the funding source for bacteriological examination of middle ear effusions and nasopharyngeal smears, and was involved in the study conduct and analysis.	Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Dagan R, 2013, J INFECT DIS, V208, P1152, DOI 10.1093/infdis/jit289; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Cervin A, 2007, RHINOLOGY, V45, P259; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P466, DOI 10.1097/INF.0b013e3181950c74; Chen KT, 2013, AURIS NASUS LARYNX, V40, P46, DOI 10.1016/j.anl.2012.05.008; Fujita K, 2000, EUR ARCH OTO-RHINO-L, V257, P199, DOI 10.1007/s004050050222; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; HORI F, 1994, ANN OTO RHINOL LARYN, V103, P567; Hotomi M, 2004, ANN OTO RHINOL LARYN, V113, P846; Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infection and Aerosol in Otorhinolaryngology, 2013, CLIN PRACT GUID DIAG; Kitano M, 2011, PHARMACOLOGY, V87, P56, DOI 10.1159/000322837; Kudoh S, 1987, Nihon Kyobu Shikkan Gakkai Zasshi, V25, P632; Moore R A, 2001, BMC Fam Pract, V2, P3, DOI 10.1186/1471-2296-2-3; Nakamura S, 2010, ANTIMICROB AGENTS CH, V54, P757, DOI 10.1128/AAC.00524-09; Statham MM, 2005, OTOLARYNG CLIN N AM, V38, P1351, DOI 10.1016/j.otc.2005.08.005; Takaki M, 2003, LARYNGOSCOPE, V113, P1378, DOI 10.1097/00005537-200308000-00021; Uemura Y, 2013, J INFECT CHEMOTHER, V19, P902, DOI 10.1007/s10156-013-0598-5	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					217	225		10.3109/00016489.2014.975893		9	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500003		
J	Meng, HX; Ohe, R; Li, HN; Yang, SR; Kabasawa, T; Kato, T; Zhang, L; Ohtake, H; Ishida, A; Ohta, N; Jin, XM; Kakehata, S; Yamakawa, M				Meng, Hong-xue; Ohe, Rintaro; Li, Hui-ning; Yang, Su-ran; Kabasawa, Takanobu; Kato, Tomoya; Zhang, Lei; Ohtake, Hiroya; Ishida, Akihiro; Ohta, Nobuo; Jin, Xiao-ming; Kakehata, Seiji; Yamakawa, Mitsunori			Immunoglobulin and CD8(+) T-cell distribution in histologically distinctive tonsils of individuals with tonsillar focal infection	ACTA OTO-LARYNGOLOGICA			English	Article						Foxp3; PD-1; IgA nephropathy; palmoplantar pustulosis; rheumatoid arthritis; chronic tonsillitis	TONSILLECTOMY; PSORIASIS	Conclusion: This study demonstrated that the common immunological mechanism, which involves aberration of immunoglobulin and T-cell distribution in histologically distinctive tonsils, may be associated with the pathogenesis of tonsillar focal infection. Objectives: Tonsillar focal infection comprises a group of relatively common diseases combined with chronic tonsillar infection, is associated with unusual immune responses in tonsils, and may cause lesions in another distant target organ. This study aimed to investigate the distribution of inflammatory T cells and T-cell regulatory elements, such as programmed cell death-1 (PD-1) and Fork head box protein 3 (Foxp3), immunoglobulin production, and histological characteristics in tonsils from patients with tonsillar focal infection. Methods: Immunohistochemistry and reverse transcription-polymerase chain reaction (PCR) were used to compare the expression of CD8(+) T cells, immunoglobulins, and cytokines associated with immunoglobulin production in the tonsils of patients with IgA nephropathy (IgAN), palmoplantar pustulosis (PPP), rheumatoid arthritis (RA), and chronic tonsillitis. Results: The overexpression of CD8(+) T cells combined with decreased expression of Foxp3 and PD-1 and the aberration of immunoglobulin production, which may be due to the elevated expression of activation-induced deaminase (AID), B-cell-activating factor of the TNF family (BAFF), supporting isotype switching, and B-cell survival in the histologically distinctive tonsils.	[Meng, Hong-xue] Harbin Med Univ, Canc Hosp, Dept Pathol, Harbin, Peoples R China; [Meng, Hong-xue; Ohe, Rintaro; Yang, Su-ran; Kabasawa, Takanobu; Kato, Tomoya; Ohtake, Hiroya; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 9909585, Japan; [Li, Hui-ning] Hei Longjiang Univ Chinese Med, Affiliated Hosp 1, Dept Pathol, Harbin, Peoples R China; [Ishida, Akihiro; Ohta, Nobuo; Kakehata, Seiji] Yamagata Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Yamagata 9909585, Japan; [Meng, Hong-xue; Jin, Xiao-ming] Harbin Med Univ, Dept Pathol, Harbin, Peoples R China	Meng, HX (reprint author), Yamagata Univ, Fac Med, Dept Pathol Diagnost, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	k-moh@med.id.yamagata-u.ac.jp			 [25460451]	This work was supported by a Grant-in-Aid for Scientific Research (c) (25460451) in Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Elsevier Language Editing Services from Elsevier Ltd for the excellent editing of this manuscript. All of the authors have read the journal's authorship agreement and agree with the statements.	Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Sigurdardottir SL, 2013, BRIT J DERMATOL, V168, P237, DOI 10.1111/j.1365-2133.2012.11215.x; Rouaud P, 2014, J EXP MED, V211, P975, DOI 10.1084/jem.20131385; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Hou S, 2014, MUCOSAL IMMUNOL, V7, P948, DOI 10.1038/mi.2013.113; Kawano M, 2003, ARTHRITIS RHEUM, V48, P2483, DOI 10.1002/art.11212; Noda Kenji, 2007, Clin Exp Nephrol, V11, P97, DOI 10.1007/s10157-006-0450-7; Ponticelli C, 2012, NEPHROL DIAL TRANSPL, V27, P2610, DOI 10.1093/ndt/gfs093; Yokoyama M, 2004, ACTA OTO-LARYNGOL, V124, P1109, DOI 10.1080/00016480410018124	10	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					264	270		10.3109/00016489.2014.968802		7	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500010		
J	Iwahashi, T; Ogawa, M; Hosokawa, K; Mochizuki, R; Inohara, H				Iwahashi, Toshihiko; Ogawa, Makoto; Hosokawa, Kiyohito; Mochizuki, Ryuichi; Inohara, Hidenori			Computed tomographic assessment of the causal factors of unsuccessful medialization thyroplasty	ACTA OTO-LARYNGOLOGICA			English	Article						Unilateral vocal fold paralysis; outcome; implant materials; ePTFE; silicone block; hydroxyapatite	VOCAL FOLD MEDIALIZATION; REVISION THYROPLASTY; ARYTENOID ADDUCTION; NERVE PARALYSIS; LARYNGOPLASTY; IMPLANT	Conclusion: The present results demonstrate that a small implant size, undercorrection of the vocal fold, antero-posterior implant malposition, and the use of expanded polytetrafluoroethylene (ePTFE) are the primary factors that cause a poor outcome of medialization thyroplasty (MT). Objectives: To assess the postoperative laryngeal condition using computed tomography (CT) in patients with unilateral vocal fold paralysis who underwent MT alone, and to identify the primary causal factors in terms of the surgical procedures that affect the outcomes of MT. Methods: Twenty-two patients who underwent MT alone were divided into two groups based on either the maximal phonation time or the perceived vocal breathiness. Two laryngologists assessed the postoperative laryngeal CT images during sustained vowel phonation and judged whether there were abnormalities of the arytenoid cartilage position, window position, implant size, and implant position, as well as the degree of correction of the vocal fold. As implant material, a silicone block, ePTFE, and hydroxyapatite had been inserted in 2, 9, and 11 patients, respectively. Comparisons of the prevalence of abnormalities in the above mentioned factors between the different outcomes and between the types of material used for the implant were performed. Results: Twelve patients with a poor outcome and 10 with a good outcome showed 36 and 18 abnormal findings identified by either of the two laryngologists, respectively. In the poor outcome group, a smaller implant size and undercorrection of the vocal fold showed both high kappa values and a significantly higher prevalence than those in the good outcome group (p < 0.001 and p < 0.05), respectively. The comparison between material types demonstrated that the sheet-like material (ePTFE) group exhibited a significantly higher prevalence of undercorrection than the block-like material group (p < 0.05).	[Iwahashi, Toshihiko; Ogawa, Makoto; Hosokawa, Kiyohito; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan; [Iwahashi, Toshihiko; Mochizuki, Ryuichi] Osaka Kaisei Hosp, Osaka Voice Ctr, Dept Otorhinolaryngol, Osaka, Japan	Iwahashi, T (reprint author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tiwahashi@ent.med.osaka-u.ac.jp					McCulloch TM, 1998, ANN OTO RHINOL LARYN, V107, P427; CUMMINGS CW, 1993, ANN OTO RHINOL LARYN, V102, P843; Lundeberg MR, 2011, LARYNGOSCOPE, V121, P999, DOI 10.1002/lary.21455; ISSHIKI N, 1989, ANN OTO RHINOL LARYN, V98, P777; Woo P, 2001, OTOLARYNG HEAD NECK, V124, P615, DOI 10.1067/mhn.2001.116021; Maragos NE, 2001, ANN OTO RHINOL LARYN, V110, P1087; Andrews BT, 2008, OTOLARYNG HEAD NECK, V138, P226, DOI 10.1016/j.otohns.2007.10.016; NETTERVILLE JL, 1993, ANN OTO RHINOL LARYN, V102, P413; Cohen JT, 2004, OTOLARYNG HEAD NECK, V131, P236, DOI 10.1016/j.otohns.2004.03.023; Anderson TD, 2003, J VOICE, V17, P442, DOI 10.1067/S0892-1997(03)00080-8; Friedrich G, 1999, ANN OTO RHINOL LARYN, V108, P79; Hara H, 2014, ACTA OTO-LARYNGOL, V134, P620, DOI 10.3109/00016489.2014.880796; Hiramatsu H, 2008, EUR ARCH OTO-RHINO-L, V265, P725, DOI 10.1007/s00405-007-0514-7; ISSHIKI N, 1975, ACTA OTO-LARYNGOL, V80, P465, DOI 10.3109/00016487509121353; Nouwen J, 2004, ACTA OTO-LARYNGOL, V124, P732, DOI 10.1080/00016480310016875; Storck C, 2010, HEAD NECK-J SCI SPEC, V32, P1605, DOI 10.1002/hed.21370; Suehiro A, 2009, ANN OTO RHINOL LARYN, V118, P405; Yumoto E, 1999, ARCH OTOLARYNGOL, V125, P883; Zeiberg AS, 1996, AM J ROENTGENOL, V166, P293	19	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					283	289		10.3109/00016489.2014.950325		7	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500013		
J	Matsushita, N; Iguchi, H; Wada, T; Oishi, M; Teranishi, Y; Yamane, H				Matsushita, Naoki; Iguchi, Hiroyoshi; Wada, Tadashi; Oishi, Masahiro; Teranishi, Yuichi; Yamane, Hideo			A clinical study of malignant tumors of Stensen's duct	ACTA OTO-LARYNGOLOGICA			English	Article						Squamous cell carcinoma; parotidectomy; surgery; head and neck; parotid duct	SQUAMOUS-CELL CARCINOMA; OF-THE-LITERATURE; MUCOEPIDERMOID CARCINOMA; PAROTID DUCT	Conclusion: Malignant tumors of Stensen's duct are often squamous cell carcinomas. Surgery is the treatment of choice, and maintaining an adequate safety margin and performing parotidectomy may help to reduce postoperative recurrence. Objectives: Since malignant tumors of Stensen's duct are extremely rare, the number of cases is limited in single-facility studies, making it difficult to perform a sufficient number of clinical examinations. Therefore, we reviewed 26 cases with Stensen's duct malignancies to examine their clinical features. Methods: We conducted a retrospective study of 26 cases with Stensen's duct malignancies, including 1 patient whom we treated and 25 cases previously reported in the English literature, and analyzed their clinical parameters, including age, sex, affected side, chief complaint, tumor size, histopathology, treatment method, and treatment outcome. Results: Most cases were diagnosed in patients between 40 and 69 years of age. The chief complaint was swelling in the cheek in 24 patients, in 14 of whom the swelling was painful. The most common tumor diameter range was 1019 mm. Squamous cell carcinoma was the most frequent histopathology. The recurrence rate in surgical patients who did not undergo parotidectomy was 60%, whereas in patients who underwent parotidectomy, the recurrence rate was only 7%.	[Matsushita, Naoki; Iguchi, Hiroyoshi; Wada, Tadashi; Oishi, Masahiro; Teranishi, Yuichi; Yamane, Hideo] Osaka City Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Osaka 5458585, Japan	Matsushita, N (reprint author), Osaka City Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	matsushita1013@sage.ocn.ne.jp					Kapadia SB, 1996, AM J OTOLARYNG, V17, P127, DOI 10.1016/S0196-0709(96)90009-5; BEYER TE, 1956, ARCHIV OTOLARYNGOL, V63, P196; CARPENTER R, 1986, BRIT J SURG, V73, P926, DOI 10.1002/bjs.1800731129; Clairmont A A, 1979, Ann Plast Surg, V2, P158, DOI 10.1097/00000637-197902000-00010; Figi FA, 1944, ARCHIV OTOLARYNGOL, V40, P175; FRECHETTE CN, 1984, J SURG ONCOL, V27, P1, DOI 10.1002/jso.2930270102; GAISFORD JC, 1965, ARCHIV OTOLARYNGOL, V82, P45; Giger R, 2005, HEAD NECK-J SCI SPEC, V27, P829, DOI 10.1002/hed.20230; Goforth JL, 1927, AM J MED SCI, V173, P624, DOI 10.1097/00000441-192705000-00004; HAAR JG, 1991, J ORAL MAXIL SURG, V49, P81, DOI 10.1016/0278-2391(91)90272-N; Kim TB, 2009, HEAD NECK-J SCI SPEC, V31, P278, DOI 10.1002/hed.20889; LYALL D, 1954, ANN SURG, V139, P364, DOI 10.1097/00000658-195403000-00015; MAISEL B, 1959, ARCH SURG-CHICAGO, V78, P331; Munoz-Guerra MF, 2005, AM J OTOLARYNG, V26, P415, DOI 10.1016/j.amjoto.2005.05.003; OWENS OT, 1982, OTOLARYNG HEAD NECK, V90, P671; PERACCHIO R L, 1958, Oral Surg Oral Med Oral Pathol, V11, P123, DOI 10.1016/0030-4220(58)90050-1; SMITH C, 1955, JAMA-J AM MED ASSOC, V158, P724; Steiner M, 1999, ORAL SURG ORAL MED O, V87, P73, DOI 10.1016/S1079-2104(99)70298-2; Tominaga Yukiko, 2006, Radiat Med, V24, P639, DOI 10.1007/s11604-006-0078-2; VIGORITA VJ, 1980, HEAD NECK SURG, V2, P513, DOI 10.1002/hed.2890020612	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					290	294		10.3109/00016489.2014.946535		5	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500014		
J	Imai, R; Takenaka, Y; Yasui, T; Nakahara, S; Yamamoto, Y; Hanamoto, A; Takemoto, N; Fukusumi, T; Cho, H; Yamamoto, M; Inohara, H				Imai, Ryusuke; Takenaka, Yukinori; Yasui, Toshimichi; Nakahara, Susumu; Yamamoto, Yoshifumi; Hanamoto, Atsushi; Takemoto, Norihiko; Fukusumi, Takahito; Cho, Hironori; Yamamoto, Masashi; Inohara, Hidenori			Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer	ACTA OTO-LARYNGOLOGICA			English	Article						Prognosis; tumor marker; oral cavity; hypopharynx; larynx; oropharynx	CLINICAL-SIGNIFICANCE; TUMOR-MARKERS; LUNG-CANCER; SCC ANTIGEN; BIOMARKERS; SURVIVAL; CEA	Conclusions: Serum squamous cell carcinoma antigen (SCC-Ag) level was an independent prognostic factor for survival in patients with head and neck squamous cell carcinoma (HNSCC), and the prognostic value depended on the carcinoma site. Objectives: To assess the value of SCC-Ag as a prognostic indicator in patients with HNSCC and to determine the effect of primary tumor site on prognosis. Methods: We reviewed 493 patients with HNSCC between 2004 and 2012. The chi-squared test was used to assess associations between SCC-Ag levels and TNM classification. A Cox proportional hazard model was used to assess the hazard ratio of SCC-Ag at different sites for death, and it was analyzed as a continuous variable. Results: The median serum level of SCC-Ag was 1.1 ng/ml (range 0-20). SCC-Ag was significantly higher in patients with advanced T and N classification tumors. Primary sites in the oral cavity, in the hypopharynx, advanced T and N classification, distant metastasis, and SCC-Ag were negatively associated with survival in univariate analysis. Multivariate analysis revealed that SCC-Ag was a significant risk factor for overall survival in cancers of the oral cavity, hypopharynx, and larynx, but not in oropharyngeal cancer.	[Imai, Ryusuke; Takenaka, Yukinori; Yasui, Toshimichi; Nakahara, Susumu; Yamamoto, Yoshifumi; Hanamoto, Atsushi; Takemoto, Norihiko; Fukusumi, Takahito; Cho, Hironori; Yamamoto, Masashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650874, Japan	Takenaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-2 Yamadaoka, Suita, Osaka 5650874, Japan.	ytakenaka@ent.med.osaka-u.ac.jp					Rainsbury JW, 2013, HEAD NECK-J SCI SPEC, V35, P1048, DOI 10.1002/hed.22950; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Polanska H, 2014, ORAL ONCOL, V50, P168, DOI 10.1016/j.oraloncology.2013.12.008; Vassilakopoulos T, 2001, LUNG CANCER-J IASLC, V32, P137, DOI 10.1016/S0169-5002(00)00225-7; Deng ZY, 2012, CANCER SCI, V103, P2127, DOI 10.1111/cas.12009; MARGOLIS ML, 1994, CANCER, V73, P605, DOI 10.1002/1097-0142(19940201)73:3<605::AID-CNCR2820730317>3.0.CO;2-T; Strauss HG, 2002, EUR J CANCER, V38, P1987, DOI 10.1016/S0959-8049(02)00159-4; Chen HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055327; Kawaguchi H, 2000, CANCER, V89, P1413, DOI 10.1002/1097-0142(20001001)89:7<1413::AID-CNCR1>3.0.CO;2-I; Kimura Y, 2000, CANCER LETT, V155, P163, DOI 10.1016/S0304-3835(00)00423-7; Krimmel M, 1998, J CRANIO MAXILL SURG, V26, P243, DOI 10.1016/S1010-5182(98)80020-6; LARA PC, 1995, CANCER, V76, P758, DOI 10.1002/1097-0142(19950901)76:5<758::AID-CNCR2820760508>3.0.CO;2-9; Lin WH, 2011, LARYNGOSCOPE, V121, P971, DOI 10.1002/lary.21721; Molina R, 1996, TUMOR BIOL, V17, P81; Pectasides D, 1996, AM J CLIN ONCOL-CANC, V19, P271, DOI 10.1097/00000421-199606000-00013; PETRELLI NJ, 1988, J CLIN ONCOL, V6, P782; Shimada H, 2003, SURGERY, V133, P486, DOI 10.1067/msy.2003.139; Sueoka K, 2005, INT J ONCOL, V27, P1345; Williams M, 2013, CANCER-AM CANCER SOC, V119, P2391, DOI 10.1002/cncr.28055	20	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					295	301		10.3109/00016489.2014.951454		7	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500015		
J	Yokoyama, J; Yazawa, M; Yoshimoto, H; Matsuo, S; Ohba, S				Yokoyama, Junkichi; Yazawa, Masaki; Yoshimoto, Hitoshi; Matsuo, Seigo; Ohba, Shinichi			Advantages of superficial femoral vein grafts for carotid artery reconstruction following carotid artery resection in the treatment of head and neck cancer	ACTA OTO-LARYNGOLOGICA			English	Article						Surgical complications; vein graft; en bloc resection; revascularization	SAPHENOUS-VEIN; REPLACEMENT; CARCINOMA; OCCLUSION	Conclusion: Reconstruction of the carotid artery using the superficial femoral vein (SFV) is very effective due to the ease in harvesting the vessel and its optimal size and length for carotid artery replacement. Objectives: To evaluate the effectiveness of carotid artery reconstruction using the SFV. Methods: Ten patients with malignant tumors involving the carotid artery underwent carotid artery resection followed by reconstruction with the SFV. The SFV between the deep femoral vein and branches to the great saphenous vein and deep femoral vein at the popliteal region was used as a reconstructive vessel. Results: The mean length and diameter of the grafted SFVs were 13.9 cm and 11.2 mm, respectively. The mean time for acquisition of SFV was 18 min. Ultrasonography measurements indicated that the mean lumen diameter of the common carotid artery was 8.37 mm. None of the patients experienced any permanent neurologic complications. The 2-year and 5-year overall survival rates were 60% and 40%, respectively. En bloc resection of the cancer and involved carotid artery followed by reconstruction with the SFV provides effective locoregional control. Our results indicated no postoperative vascular graft thrombosis and no donor site complications.	[Yokoyama, Junkichi; Ohba, Shinichi] Juntendo Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo 113, Japan; [Yazawa, Masaki] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Yoshimoto, Hitoshi] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 2, Osaka, Japan; [Matsuo, Seigo] Moriyama Mem Hosp, Dept Neurosurg, Tokyo, Japan; [Yokoyama, Junkichi] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan	Yokoyama, J (reprint author), 113-8421,2-1-1 Hongo,Bunkyo Ku, Tokyo, Japan.	jyokoya@juntendo.ac.jp			Ministry of Education, Science, and Culture of Japan [25462693]	This study was partially supported by a research grant from the Ministry of Education, Science, and Culture of Japan (25462693)	Fung K, 2007, HEAD NECK-J SCI SPEC, V29, P425, DOI 10.1002/hed.20492; Roh JL, 2008, ACTA OTO-LARYNGOL, V128, P1370, DOI 10.1080/00016480801968518; Relic A, 2009, EUR ARCH OTO-RHINO-L, V266, P1799, DOI 10.1007/s00405-009-0946-3; Delanian S, 2004, RADIOTHER ONCOL, V73, P119, DOI 10.1016/j.radonc.2004.08.021; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; BILLER HF, 1988, LARYNGOSCOPE, V98, P181; BRENNAN JA, 1994, LARYNGOSCOPE, V104, P259; Chazono H, 2005, ACTA OTO-LARYNGOL, V125, P196, DOI 10.1080/00016480410017486; Ehrnefeld W K, 1983, Surgery, V93, P299; MATHIS JM, 1995, AM J NEURORADIOL, V16, P749; Nemeth Z, 2003, INT J ORAL MAX SURG, V32, P645, DOI 10.1054/ijom.2002.0419; Nichols Michael D, 2013, J Biomed Mater Res B Appl Biomater, V101, P1367, DOI 10.1002/jbm.b.32954; Uflacker R, 1997, ATLAS VASCULAR ANATO, P779; Wright JG, 1996, J VASC SURG, V23, P775, DOI 10.1016/S0741-5214(96)70239-2	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	2015	135	3					302	306		10.3109/00016489.2014.956336		5	Otorhinolaryngology	Otorhinolaryngology	CD6BD	WOS:000351172500016		
J	Liu, YL; Li, Y; Liu, F; Morii, M; Hu, N; Ning, HM; Wu, LK				Liu, Yaolu; Li, Yuan; Liu, Feng; Morii, Masaki; Hu, Ning; Ning, Huiming; Wu, Liangke			Monitoring of Local Plasticity using Lamb Waves	ADVANCES IN STRUCTURAL ENGINEERING			English	Article						Lamb waves; local plasticity; signal index; tensile test; wavelet analysis	FATIGUE-CRACK GROWTH; DAMAGE; DELAMINATION; MODE; IDENTIFICATION	An experimental method was developed to monitor local plasticity in metallic materials using Lamb waves. A double-edge-notched beam specimen under tensile loading was employed to induce the local plasticity in notch area. By exciting Lamb waves using actuators in two different ways, the obtained wave signals at different stress levels of the specimen were analyzed through wavelet analysis by proposing a signal index I. By virtue of the finite element analysis on the tensile behavior of the specimen, it was found that I almost kept constant under elastic deformation and rapidly increased when the local plastic deformation occurred and extended, and then stopped growing when the plastic zone was up to a certain size. Therefore, the change of I, which is attributed to the occurrence and evolution of small and local plastic zone in the notch area, can be used to effectively monitor local plasticity.	[Liu, Yaolu; Hu, Ning; Ning, Huiming; Wu, Liangke] Chongqing Univ, Dept Engn Mech, Chongqing 400044, Peoples R China; [Li, Yuan] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Liu, Feng] Hunan Univ, Coll Mech & Vehicle Engn, Changsha 412008, Hunan, Peoples R China; [Morii, Masaki; Hu, Ning] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan	Hu, N (reprint author), Chongqing Univ, Dept Engn Mech, 174 Shazhengjie, Chongqing 400044, Peoples R China.	huning@faculty.chiba-u.jp					Ritchie RO, 1999, INT J FRACTURE, V100, P55, DOI 10.1023/A:1018655917051; Farrar CR, 2007, PHILOS T R SOC A, V365, P303, DOI 10.1098/rsta.2006.1928; Kessler SS, 2002, SMART MATER STRUCT, V11, P269, DOI 10.1088/0964-1726/11/2/310; Hu N, 2008, STRUCT HEALTH MONIT, V7, P271, DOI 10.1177/1475921708090566; Nagy PB, 1998, ULTRASONICS, V36, P375, DOI 10.1016/S0041-624X(97)00040-1; Chan KS, 2003, METALL MATER TRANS A, V34, P43, DOI 10.1007/s11661-003-0207-9; Cho HJ, 2012, STRUCT HEALTH MONIT, V11, P393, DOI 10.1177/1475921711430439; Herrmann J, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204807; Hu N, 2012, STRUCT HEALTH MONIT, V11, P125, DOI 10.1177/1475921711414230; Hu N, 2008, COMPOS SCI TECHNOL, V68, P1548, DOI 10.1016/j.compscitech.2007.10.015; Hu N, 2012, MECH ADV MATER STRUC, V19, P431, DOI 10.1080/15376494.2010.528156; Kulkarni SS, 2008, STRUCT HEALTH MONIT, V7, P37, DOI 10.1177/1475921707081973; Maslouhi A, 2011, STRUCT CONTROL HLTH, V18, P790, DOI 10.1002/stc.478; Mostafa I, 1997, INT J FRACTURE, V85, P99, DOI 10.1023/A:1007490423869; Nagarajaiah Satish, 2008, Advances in Science and Technology, V56, DOI 10.4028/www.scientific.net/AST.56.277; Quaegebeur N, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/8/085005; Truong D.V., 2007, JSME INT J A, V49, P370; Yan YJ, 2004, COMPUT STRUCT, V82, P347, DOI 10.1016/j.compstruc.2003.11.002; Yi JH, 2012, ADV STRUCT ENG, V15, P955; Yuan J., 2010, P 2010 IEEE INT C ME; Zhang DY, 2012, ADV STRUCT ENG, V15, P1139	21	0	0	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	1369-4332	2048-4011		ADV STRUCT ENG	Adv. Struct. Eng.	MAR	2015	18	3					339	351		10.1260/1369-4332.18.3.339		13	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CD1IS	WOS:000350828900003		
J	Chung, JK; Plitman, E; Nakajima, S; Chow, TW; Chakravarty, M; Caravaggio, F; Gerretsen, P; Brown, EE; Iwata, Y; Mulsant, BH; Graff-Guerrero, A				Chung, Jun Ku; Plitman, Eric; Nakajima, Shinichiro; Chow, Tiffany W.; Chakravarty, Mallar; Caravaggio, Fernando; Gerretsen, Philip; Brown, Eric E.; Iwata, Yusuke; Mulsant, Benoit H.; Graff-Guerrero, Ariel			Lifetime History of Depression Predicts Increased Beta-Amyloid Accumulation in Patients with Mild Cognitive Impairment	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Meeting Abstract	Annual Meeting of the American-Association-for-Geriatric-Psychiatry	MAR 27-30, 2015	New Orleans, LA	Amer Assoc Geriatr Psychiat					[Chung, Jun Ku; Plitman, Eric; Nakajima, Shinichiro; Chow, Tiffany W.; Caravaggio, Fernando; Gerretsen, Philip; Brown, Eric E.; Mulsant, Benoit H.; Graff-Guerrero, Ariel] Univ Toronto, Toronto, ON, Canada; [Chakravarty, Mallar] McGill Univ, Montreal, PQ, Canada; [Nakajima, Shinichiro; Iwata, Yusuke] Keio Univ, Minato, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	MAR	2015	23	3		S		NR 02	S147	S150				5	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CD1IV	WOS:000350829500147		
J	Janiga, G; Berg, P; Sugiyama, S; Kono, K; Steinman, DA				Janiga, G.; Berg, P.; Sugiyama, S.; Kono, K.; Steinman, D. A.			The Computational Fluid Dynamics Rupture Challenge 2013-Phase I: Prediction of Rupture Status in Intracranial Aneurysms	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; HEMODYNAMICS; ASSOCIATION; MODELS	BACKGROUND AND PURPOSE: Rupture risk assessment for intracranial aneurysms remains challenging, and risk factors, including wall shear stress, are discussed controversially. The primary purpose of the presented challenge was to determine how consistently aneurysm rupture status and rupture site could be identified on the basis of computational fluid dynamics. MATERIALS AND METHODS: Two geometrically similar MCA aneurysms were selected, 1 ruptured, 1 unruptured. Participating computational fluid dynamics groups were blinded as to which case was ruptured. Participants were provided with digitally segmented lumen geometries and, for this phase of the challenge, were free to choose their own flow rates, blood rheologies, and so forth. Participants were asked to report which case had ruptured and the likely site of rupture. In parallel, lumen geometries were provided to a group of neurosurgeons for their predictions of rupture status and site. RESULTS: Of 26 participating computational fluid dynamics groups, 21 (81%) correctly identified the ruptured case. Although the known rupture site was associated with low and oscillatory wall shear stress, most groups identified other sites, some of which also experienced low and oscillatory shear. Of the 43 participating neurosurgeons, 39 (91%) identified the ruptured case. None correctly identified the rupture site. CONCLUSIONS: Geometric or hemodynamic considerations favor identification of rupture status; however, retrospective identification of the rupture site remains a challenge for both engineers and clinicians. A more precise understanding of the hemodynamic factors involved in aneurysm wall pathology is likely required for computational fluid dynamics to add value to current clinical decision-making regarding rupture risk.	[Janiga, G.; Berg, P.] Univ Magdeburg, Dept Fluid Dynam & Tech Flows, D-39106 Magdeburg, Germany; [Sugiyama, S.] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan; [Kono, K.] Wakayama Rosai Hosp, Dept Neurosurg, Wakayama, Japan; [Steinman, D. A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada	Janiga, G (reprint author), Univ Magdeburg, Lab Fluid Dynam & Tech Flows, Univ Pl 2, D-39106 Magdeburg, Germany.	janiga@ovgu.de		Janiga, Gabor/0000-0002-4560-9640	International Max Planck Research School Magdeburg; MidCareer Investigator award from the Heart and Stroke Foundation of Ontario	P.B. was supported by the International Max Planck Research School Magdeburg. D.A.S. was supported by a MidCareer Investigator award from the Heart and Stroke Foundation of Ontario.	Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Zhang Y, 2011, EUR NEUROL, V66, P359, DOI 10.1159/000332814; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Valen-Sendstad K, 2014, AM J NEURORADIOL, V35, P536, DOI 10.3174/ajnr.A3793; Jansen IGH, 2014, AM J NEURORADIOL, V35, P1543, DOI 10.3174/ajnr.A3901; Goubergrits L, 2012, J R SOC INTERFACE, V9, P677, DOI 10.1098/rsif.2011.0490; Curtis SL, 2012, AM J NEURORADIOL, V33, P1182, DOI 10.3174/ajnr.A2915; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Bonneville F, 2006, NEUROIMAG CLIN N AM, V16, P371, DOI 10.1016/j.nic.2006.05.001; Babiker MH, 2013, IEEE T BIO-MED ENG, V60, P1150, DOI 10.1109/TBME.2012.2228002; Teunissen LL, 1996, STROKE, V27, P544; Neugebauer M, 2013, INT J COMPUT ASS RAD, V8, P279, DOI 10.1007/s11548-012-0779-1; Qian Y, 2011, AM J NEURORADIOL, V32, P1948, DOI 10.3174/ajnr.A2655; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Kadasi LM, 2013, J NEUROINTERV SURG, V5, P201, DOI 10.1136/neurintsurg-2012-010285; Steinman DA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023382; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Berg P, J BIOMECH E IN PRESS; Kono K, 2012, NEUROSURGERY, V71, pE1202, DOI 10.1227/NEU.0b013e31826f7ede; Morita A, 2012, NEW ENGL J MED, V366, P2474; Omodaka S, 2012, CEREBROVASC DIS, V34, P121, DOI 10.1159/000339678; Oubel E, 2007, P SOC PHOTO-OPT INS, V6511, pA5112, DOI 10.1117/12.708937; Sugiyama S, 2013, NEUROSURGERY, V73, P767, DOI 10.1227/NEU.0000000000000096; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710	25	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2015	36	3					530	536		10.3174/ajnr.A4157		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CD3PL	WOS:000350990900022		
J	Ueda, Y; Enomoto, T; Sekine, M; Egawa-Takata, T; Morimoto, A; Kimura, T				Ueda, Yutaka; Enomoto, Takayuki; Sekine, Masayuki; Egawa-Takata, Tomomi; Morimoto, Akiko; Kimura, Tadashi			Japan's failure to vaccinate girls against human papillomavirus	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Article								OBJECTIVE: Human papillomavirus (HPV) vaccination has proven to be effective for prevention of HPV infection and HPV-associated precancerous cervical lesions.(1) However, HPV vaccination rates have remained flat, and whether or not to vaccinate has become a social issue. In the United States in 2013, HPV vaccine coverage for girls ages 13-17 years was only 57%.(2) A notable inhibitory factor to getting vaccinated has been reports of possible adverse effects. Safety concerns among US parents have increased (4.5% in 2008 to 16.4% in 2010), as have intentions not to vaccinate their daughters against HPV (39.8% in 2008 to 43.9% in 2010; odds ratio for trend, 1.08; 95% confidence interval, 1.04-1.13).(3) STUDY DESIGN: In Japan, financial support of the government was initiated from 2011, and recommendation was initiated in April 2013. However, Japan has failed to capitalize on the HPV vaccine's potential for cervical cancer prevention. Japanese media reports in May and June 2013 concerning the vaccine's potential for adverse effects including complex regional pain syndrome and suspension of the government's recommendation for the vaccination on June 14, 2013, have led to public distrust and a dramatic decrease in HPV vaccination rates.(4) To demonstrate the depth of the problem, we analyzed the HPV vaccine coverage for 7th-grade girls in Sakai, Japan. We looked at those who had initiated their 3-dosage series either before or after the negative media reports ran. Girls from 7-11th grade were vaccination targets, with vaccinations at the 7th-grade level being the most desirable. RESULTS: The first trimester of the Japanese school year runs from April 1 through late July; the summer break is about 6 weeks. The adverse Japanese media reports and the Ministry of Health, Labor, and Welfare suspension announcement occurred about 40 days prior to summer vacation, during which the girls in Sakai were expected to go to a clinic for HPV vaccination. During the summer vacation period of 2012, nearly half of the 7th-grade girls got an inoculation. However, in 2013, the number of girls vaccinated in May began to decrease following the news reports, and by late June it was almost 0 (Figure, A). The vaccination rates of the 7-10th graders who had an opportunity for vaccination prior to the media reports were between 57.8-74.8% (2012). However, following the adverse reports, the rate plunged from 65.4% (2012) to 3.9% (2013) (incidence rate ratio, 0.060; 95% confidence interval, 0.051-0.071) (Figure, B). The girls received HPV vaccination mostly in the 7th grade. The rate of the number of those vaccinated in 7th grade was 70.4% (7th grade: 2632; and 8-10th grade: 1105) in 2012. In 2013, not only the number of those vaccinated in 7th grade but also those in 8-10th grades decreased significantly (7th grade: 158; and 8-10th grade: 90). CONCLUSION: Improved education around the critical importance of HPV vaccine and screening for cervical cancer prevention is needed worldwide.	[Ueda, Yutaka; Egawa-Takata, Tomomi; Morimoto, Akiko; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Enomoto, Takayuki; Sekine, Masayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan	Ueda, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan.	ZVF03563@nifty.ne.jp			Health and Labor Sciences Research Grants, Japan; Merck Sharp Dohme [J550703673]; GlaxoSmithKline/Japan Vaccine	Financial support for the current study was provided by Health and Labor Sciences Research Grants, Japan.; Drs Ueda and Enomoto receive research funding from Merck Sharp & Dohme (grant no. J550703673) and GlaxoSmithKline/Japan Vaccine to conduct a different study about the carcinogenesis of gynecologic tumors. Drs Ueda, Enomoto, Sekine, and Kimura received a lecture fee from Merck Sharp & Dohme and GlaxoSmithKline/Japan Vaccine.	Darden PM, 2013, PEDIATRICS, V131, P645, DOI 10.1542/peds.2012-2384; Gilmour S, 2013, LANCET, V382, P768, DOI [10.1016/S0140-6736(13)61831-0, 10.1016/S0140-6736(13)61529-9]; Centers for Disease Control, 2014, TEEN VACC COV 2013 N; Rimer BK, 2014, ACC HPV VACC UPT URG	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	MAR	2015	212	3										2	Obstetrics & Gynecology	Obstetrics & Gynecology	CC5DC	WOS:000350377500048		
J	Mabuchi, F; Sakurada, Y; Kashiwagi, K; Yamagata, Z; Iijima, H; Tsukahara, S				Mabuchi, Fumihiko; Sakurada, Yoichi; Kashiwagi, Kenji; Yamagata, Zentaro; Iijima, Hiroyuki; Tsukahara, Shigeo			Involvement of Genetic Variants Associated With Primary Open-Angle Glaucoma in Pathogenic Mechanisms and Family History of Glaucoma	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							GENOME-WIDE ASSOCIATION; RISK-FACTORS; INTRAOCULAR-PRESSURE; SUSCEPTIBILITY LOCI; TENSION GLAUCOMA; POPULATION; PREVALENCE; EYE; IDENTIFICATION; CDKN2B-AS1	PURPOSE: To investigate the associations between the non-intraocular pressure (IOP)-related genetic variants (genetic variants associated with vulnerability of the optic nerve independent of TOP) and primary open-angle glaucoma (POAG), including normal-tension glaucoma (NTG) and high-tension glaucoma (HTG), and between the non-TOP-related genetic variants and a family history of glaucoma. DESIGN: Case-control study. METHODS: Japanese patients with NTG (n = 213) and HTG (n = 212) and 191. control subjects were genotyped for 5 non-TOP-related genetic variants predisposing to POAG near the SRBD1, ELOVL5, CDKN2B/CDKN2B-AS1, SIX1/SIX6, and ATOH7 genes. The load of these genetic variants was compared between the control subjects and patients with NTG or HTG and between the POAG patients with and without a family history of glaucoma. RESULTS: The total number of POAG risk alleles and the product of the odds ratios (POAG risk) of these genetic variants were significantly larger (P < .0025) in patients with both NTG and HTG than in the control subjects, and were significantly larger (P = .0042 and P = .023, respectively) in POAG patients with a family history of glaucoma than in those without. As the number of relatives with glaucoma increased, the total number of risk alleles and the product of the odds ratios increased (P = .012 and P = .047, respectively). CONCLUSIONS: Non-TOP-related genetic variants contribute to the pathogenesis of HTG as well as NTG. A positive family history of glaucoma in cases of POAG is thought to reflect the influence of genetic variants predisposing to POAG. (C) 2015 by Elsevier Inc. All rights reserved.	[Mabuchi, Fumihiko; Sakurada, Yoichi; Kashiwagi, Kenji; Iijima, Hiroyuki; Tsukahara, Shigeo] Univ Yamanashi, Dept Ophthalmol, Fac Med, Kofu, Yamanashi, Japan; [Iijima, Hiroyuki] Univ Yamanashi, Fac Med, Dept Hlth Sci, Kofu, Yamanashi, Japan	Mabuchi, F (reprint author), Univ Yamanashi, Dept Ophthalmol, Fac Med, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	fmabuchi@yamanashi.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [21592221]	Kenji Kashiwagi discloses the following financial activities outside the submitted work: Patents: Scanning peripheral anterior chamber depth analyzer (SPAC) and Nano-sheet. This study was supported in part by a Grant-in-Aid (Number 21592221) from the Ministry of Education, Science, Sports, and Culture, Japan.	Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918; Liu YT, 2013, INVEST OPHTH VIS SCI, V54, P6248, DOI 10.1167/iovs.13-12779; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Kong XM, 2011, OPHTHAL EPIDEMIOL, V18, P226, DOI 10.3109/09286586.2011.595040; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Wang XL, 2010, VISION RES, V50, P2391, DOI 10.1016/j.visres.2010.09.018; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69; Nag A, 2014, HUM MOL GENET, V23, P3343, DOI 10.1093/hmg/ddu050; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Burdon KP, 2012, OPHTHALMOLOGY, V119, P1539, DOI 10.1016/j.ophtha.2012.02.004; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Sun J, 2012, EYE, V26, P283, DOI 10.1038/eye.2011.243; Gramer G, 2014, INVEST OPHTH VIS SCI, V55, P259, DOI 10.1167/iovs.13-13020; Balasubbu S, 2012, INVEST OPHTH VIS SCI, V53, P1861, DOI 10.1167/iovs.11-8602; Donnelly P, 2013, HUM MOL GENET, V22, P4653, DOI 10.1093/hmg/ddt293; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Liu YT, 2010, P NATL ACAD SCI USA, V107, pE61, DOI 10.1073/pnas.0913838107; Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028; Mabuchi F, 2012, OPHTHALMOLOGY, V119, P1819, DOI 10.1016/j.ophtha.2012.02.044; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Mabuchi F, 2010, P NATL ACAD SCI USA, V107, pE90, DOI 10.1073/pnas.0914903107; McNaught AI, 2000, ARCH OPHTHALMOL-CHIC, V118, P900; Meguro A, 2010, OPHTHALMOLOGY, V117; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Ramdas WD, 2011, J MED GENET, V48, P190, DOI 10.1136/jmg.2010.083337; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	MAR	2015	159	3					437	444		10.1016/j.ajo.2014.11.023		8	Ophthalmology	Ophthalmology	CC1BV	WOS:000350077100004		
J	Oray, M; Onal, S; Bayraktar, S; Izgi, B; Tugal-Tutkun, I				Oray, Merih; Onal, Sumru; Bayraktar, Serife; Izgi, Belgin; Tugal-Tutkun, Ilknur			Nonglaucomatous Localized Retinal Nerve Fiber Layer Defects in Behcet Uveitis	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; COTTON-WOOL SPOTS; MULTIPLE-SCLEROSIS; GLAUCOMA; DISEASE; DIAGNOSIS; LESIONS	PURPOSE: To describe nonglaucomatous retinal nerve fiber layer (RNFL) defects in patients with Behcet uveitis. DESIGN: Cross-sectional study and observational case series. METHODS: We reviewed the clinical photographs of patients with Behcet uveitis (n = 259), ocular toxoplasmosis (n = 120), and multiple sclerosis (MS)-associated uveitis (n = 40) for the presence of localized RNFL defects. Behcet patients with localized RNFL defects were invited to participate in a prospective evaluation including standard automated perimetry, spectral-domain optical coherence tomography (SD OCT), and RNFL thickness analysis. Main outcome measures were the prevalence of localized RNFL defects, perimetric and SD OCT findings, and RNFL thickness analysis. RESULTS: Sixty-two patients with Behcet uveitis (24%) had localized RNFL defect(s) without any visible scar. Twenty patients (17%) with ocular toxoplasmosis had a localized RNFL defect associated with a retinochoroidal scar in all. None of the MS patients had a localized RNFL defect. Of the 19 patients (24 eyes) with RNFL defect associated with Behcet uveitis who returned for follow-up, there was a corollary thinning on SD OCT B-scan in all and a corresponding visual field defect in 83%. RNFL thickness analysis was within normal limits in 54%, but revealed thinning in the thickness profile scale in 46% and in the pie chart in 21%. CONCLUSION: In Behcet uveitis, localized RNFL defects may be caused by microvascular ischemia at the optic nerve head and/or at the posterior pole and may serve as a helpful ocular diagnostic clue and an indicator of posterior pole involvement, a risk factor for poor visual prognosis. (C) 2015 by Elsevier Inc. All rights reserved.	[Oray, Merih; Bayraktar, Serife; Izgi, Belgin; Tugal-Tutkun, Ilknur] Istanbul Univ, Istanbul Fac Med, Dept Ophthalmol, Istanbul, Turkey; [Onal, Sumru] Kochi Univ, Sch Med, Dept Ophthalmol, Kami, Kochi, Japan; [Onal, Sumru] Amer Hosp, Vehbi Koc Fdn, Dept Ophthalmol, Istanbul, Turkey	Tugal-Tutkun, I (reprint author), Istanbul Tip Fakultesi, Goz Hastaliklari AD, TR-34390 Capa, Istanbul, Turkey.	tutkun@turk.net			IRIS (Institut de Recherches Internationales Servier); Istanbul University Scientific Projects [25575, 49609]	Ilknur Tugal-Tutkun has received, financial support outside the submitted work, including honoraria from IRIS (Institut de Recherches Internationales Servier). This study was supported by the Istanbul University Scientific Projects (project number 25575). Color printing was supported with additional funding by the Istanbul University Scientific Projects (project number 49609).	CHIHARA E, 1993, OPHTHALMOLOGY, V100, P1147; Tugal-Tutkun I, 2004, AM J OPHTHALMOL, V138, P373, DOI 10.1016/j.ajo.2004.03.022; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; MCLEOD D, 1977, BRIT J OPHTHALMOL, V61, P177, DOI 10.1136/bjo.61.3.177; Tugal-Tutkun I, 2013, OCUL IMMUNOL INFLAMM, V21, P337, DOI 10.3109/09273948.2013.795228; Stanford MR, 2005, BRIT J OPHTHALMOL, V89, P812, DOI 10.1136/bjo.2004.055756; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; HOYT WF, 1973, INVEST OPHTH VISUAL, V12, P814; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P807; AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566; Jonas JB, 1996, SURV OPHTHALMOL, V40, P369, DOI 10.1016/S0039-6257(96)80065-8; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841; ATMACA LS, 1989, GRAEF ARCH CLIN EXP, V227, P340, DOI 10.1007/BF02169409; CHIHARA E, 1991, GRAEF ARCH CLIN EXP, V229, P13, DOI 10.1007/BF00172255; CHIHARA E, 1987, Folia Ophthalmologica Japonica, V38, P1001; SILMAN AJ, 1990, LANCET, V335, P1078; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P285, DOI 10.1136/bjo.78.4.285; Kallenbach K, 2007, EUR J NEUROL, V14, P841, DOI 10.1111/j.1468-1331.2007.01736.x; Kemstock C, 2012, GRAEFES ARCH CLIN EX, V250, P583; Khanifar Aziz A, 2010, Clin Ophthalmol, V4, P1007; Mahendradas Padmamalini, 2013, J Ophthalmic Inflamm Infect, V3, P35, DOI 10.1186/1869-5760-3-35; Onal Sumru, 2014, International Ophthalmology, V34, P401, DOI 10.1007/s10792-013-9822-7; SAKAMOTO M, 1995, OPHTHALMOLOGY, V102, P317; Sheets CW, 2009, J GLAUCOMA, V18, P129, DOI 10.1097/IJG.0b013e318179f83f; Soliman MAE, 2002, AM J OPHTHALMOL, V133, P187, DOI 10.1016/S0002-9394(01)01340-X; Tugal-Tutkun Ilknur, 2009, Middle East Afr J Ophthalmol, V16, P219, DOI 10.4103/0974-9233.58425; Tugal-Tutkun Ilknur, 2012, Int Ophthalmol Clin, V52, P183, DOI 10.1097/IIO.0b013e318265d56a; Yau GSK, 2013, SCI WORLD J, DOI 10.1155/2013/694613; Yu HG, 2009, OCUL IMMUNOL INFLAMM, V17, P41, DOI 10.1080/09273940802553279	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	MAR	2015	159	3					475	481		10.1016/j.ajo.2014.11.029		7	Ophthalmology	Ophthalmology	CC1BV	WOS:000350077100009		
J	Miura, M; Hong, YJ; Yasuno, Y; Muramatsu, D; Iwasaki, T; Goto, H				Miura, Masahiro; Hong, Young-Joo; Yasuno, Yoshiaki; Muramatsu, Daisuke; Iwasaki, Takuya; Goto, Hiroshi			Three-dimensional Vascular Imaging of Proliferative Diabetic Retinopathy by Doppler Optical Coherence Tomography	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							HUMAN RETINA; BLOOD-FLOW; ANGIOGRAPHY; NEOVASCULARIZATION; VOLUMES; OCT	PURPOSE: To evaluate the 3-dimensional architecture of neovascularization in proliferative diabetic retinopathy using Doppler optical coherence tomography (OCT). DESIGN: Prospective, nonrandomized clinical trial. METHODS: Seventeen eyes of 14 patients with proliferative diabetic retinopathy were prospectively studied. Prototype Doppler OCT was used to evaluate the 3-dimensional vascular architecture at vitreoretinal adhesions. RESULTS: Proliferative membranes were detected in all eyes with proliferative diabetic retinopathy by standard OCT images. Doppler OCT images detected blood flow by neovascularization of the disc in 12 eyes and neovascularization elsewhere in 11 eyes. Doppler OCT images showed the 3-dimensional extent of new vessels at various stages of neovascularization, and the extent of new vessels could be clearly confirmed at vitreoretinal adhesions. CONCLUSIONS: Doppler OCT is useful for the detection and evaluation of the 3-dimensional vascular structure of neovascularization, and can assist in the noninvasive assessment of proliferative diabetic retinopathy. (C) 2015 The Authors. Published by Elsevier Inc.	[Miura, Masahiro; Muramatsu, Daisuke; Iwasaki, Takuya] Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, Ami, Ibaraki 3000395, Japan; [Miura, Masahiro; Muramatsu, Daisuke; Iwasaki, Takuya; Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Tokyo, Japan; [Hong, Young-Joo; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki 305, Japan	Miura, M (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, 3-20-1 Chuo, Ami, Ibaraki 3000395, Japan.	m-miura@tokyo-med.ac.jp	Yasuno, Yoshiaki/F-2586-2011	Yasuno, Yoshiaki/0000-0003-1645-7948	Novartis Pharma AG, Basel, Switzerland; Tomey (Nagoya, Japan); Topcon (Tokyo, Japan); Nidek (Gamagori, Japan); Japan Society for the Promotion of Science, Tokyo, Japan [KAKENHI 24592682]	Masahiro Miura received a lecture fee from Novartis Pharma AG, Basel, Switzerland. Computational Optics Group, University of Tsukuba received funding support from Tomey (Nagoya, Japan), Topcon (Tokyo, Japan), and Nidek (Gamagori, Japan). This study is supported by a Grant-in-Aid for Scientific Research (KAKENHI 24592682) from the Japan Society for the Promotion of Science, Tokyo, Japan.	YANNUZZI LA, 1986, OPHTHALMOLOGY, V93, P611; Hong YJ, 2013, INVEST OPHTH VIS SCI, V54, P3621, DOI 10.1167/iovs.12-11184; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Leitgeb RA, 2003, OPT EXPRESS, V11, P3116; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Mariampillai A, 2010, OPT LETT, V35, P1257, DOI 10.1364/OL.35.001257; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Makita S, 2011, OPT EXPRESS, V19, P1271, DOI 10.1364/OE.19.001271; Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439; Miura M, 2011, INVEST OPHTH VIS SCI, V52, P2689, DOI 10.1167/iovs.10-6282; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Schwartz DM, 2014, OPHTHALMOLOGY, V121, P180, DOI 10.1016/j.ophtha.2013.09.002; Newman DK, 2010, EYE, V24, P441, DOI 10.1038/eye.2009.325; An L, 2008, OPT EXPRESS, V16, P11438, DOI 10.1364/OE.16.011438; Yu LF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3302806; Hendargo HC, 2013, BIOMED OPT EXPRESS, V4, P803, DOI 10.1364/BOE.4.000803; Klein T, 2013, BIOMED OPT EXPRESS, V4, P1890, DOI 10.1364/BOE.4.001890; Szkulmowska A, 2009, OPT EXPRESS, V17, P10584, DOI 10.1364/OE.17.010584; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; BARTSCH DU, 1994, EXP EYE RES, V58, P161, DOI 10.1006/exer.1994.1004; Cho H, 2013, RETINA-J RET VIT DIS, V33, P542, DOI 10.1097/IAE.0b013e3182753b6f; DAVIS MD, 1992, DIABETES CARE, V15, P1844, DOI 10.2337/diacare.15.12.1844; Hong YJ, 2012, OPT EXPRESS, V20, P2740, DOI 10.1364/OE.20.002740; Imesch PD, 1997, RETINA-J RET VIT DIS, V17, P321, DOI 10.1097/00006982-199707000-00008; Iwasaki T, 2008, BRIT J OPHTHALMOL, V92, P713, DOI 10.1136/bjo.2007.135319; Muqit MMK, 2014, BRIT J OPHTHALMOL, V98, P65, DOI 10.1136/bjophthalmol-2013-303941	27	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	MAR	2015	159	3					528	538		10.1016/j.ajo.2014.12.002		11	Ophthalmology	Ophthalmology	CC1BV	WOS:000350077100016		
J	Kimura, A; Namekata, K; Guo, XL; Noro, T; Harada, C; Harada, T				Kimura, Atsuko; Namekata, Kazuhiko; Guo, Xiaoli; Noro, Takahiko; Harada, Chikako; Harada, Takayuki			Valproic Acid Prevents NMDA-Induced Retinal Ganglion Cell Death via Stimulation of Neuronal TrkB Receptor Signaling	AMERICAN JOURNAL OF PATHOLOGY			English	Article							NORMAL-TENSION GLAUCOMA; ISCHEMIA-REPERFUSION INJURY; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE INJURY; OXIDATIVE STRESS; MOUSE MODEL; NEUROTROPHIC FACTOR; RAT MODEL; IN-VIVO; MICE	Valproic acid (VPA) is widely prescribed for treatment of epilepsy, mood disorders, migraines, and neuropathic pain. It exerts its therapeutic benefits through multiple mechanisms, including enhancement of GABAergic activity, activation of prosunrival protein kinases, and inhibition of histone deacetylase. Increasing evidence suggests that VPA possesses neuroprotective properties. We examined neuroprotective effects of VPA in an N-methyl-D-aspartate (NMDA) excitotoxicity model, which mimics some of the pathological features of glaucoma. In vivo retinal imaging using optical coherence tomography revealed that NMDA-induced retinal degeneration was suppressed in the VPA-treated retina, and histological analyses confirmed that VPA reduced retinal ganglion cell death. In vivo electrophysiological analyses demonstrated that visual impairment was prevented in the VPA-treated retina, clearly establishing both histological and functional effects of VPA. Brain-derived neurotrophic factor (BDNF) expression was up-regulated in Muller glial cells, and neuroprotective effects of VPA on retinal ganglion cells were significantly reduced in a conditional knockout mouse strain with deletion of tropomyosin receptor kinase B (TrkB), a receptor for BDNF from retinal ganglion cells. The results show that VPA stimulates BDNF up-regulation in Muller glial cells and provides direct evidence that neuronal TrkB is important in VPA-mediated neuroprotection. Also, VPA suppresses oxidative stress induced by NMDA in the retina. Our findings raise intriguing possibilities that the widely prescribed drug VPA may be useful for treatment of glaucoma.	[Kimura, Atsuko; Namekata, Kazuhiko; Guo, Xiaoli; Noro, Takahiko; Harada, Chikako; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan	Harada, T (reprint author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	harada-tk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26861479, 256400043, 25430082, 25462766, 26640048]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) [LS133]	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (26861479 to A.K., 256400043 to K.N., 25430082 to X.G., 25462766 to CR., and 26640048 to T.H.) and the Funding Program for Next Generation World-Leading Researchers (NEXT Program) (LS133 to T.H.).	Long ZM, 2013, CURR ALZHEIMER RES, V10, P261; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Zhang ZZ, 2012, CURR EYE RES, V37, P429, DOI 10.3109/02713683.2011.653616; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Zhang ZZ, 2012, NEUROSCIENCE, V224, P282, DOI 10.1016/j.neuroscience.2012.07.056; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Suda S, 2013, EUR J PHARMACOL, V707, P26, DOI 10.1016/j.ejphar.2013.03.020; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Sutter EE, 1999, VISION RES, V39, P419, DOI 10.1016/S0042-6989(98)00161-8; Almasieh M, 2011, J NEUROCHEM, V118, P1075, DOI 10.1111/j.1471-4159.2011.07382.x; Osborne NN, 2009, ACTA OPHTHALMOL, V87, P450, DOI 10.1111/j.1755-3768.2008.01459.x; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Waszkielewicz AM, 2011, CURR MED CHEM, V18, P4344; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1079/pnas.0405479101; Schuettauf F, 2002, VISION RES, V42, P2333, DOI 10.1016/S0042-6989(02)00188-8; Harada T, 2007, GENE DEV, V21, P367, DOI 10.1101/gad.1504307; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Zhang ZZ, 2011, NEUROSCI LETT, V504, P88, DOI 10.1016/j.neulet.2011.09.003; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Noh H, 2014, NEUROSCIENCE, V266, P255, DOI 10.1016/j.neuroscience.2014.02.012; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Harada T, 2002, J NEUROSCI, V22, P9228; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Cheng L, 2002, J NEUROSCI, V22, P3977; Bearse Jr MA, 1996, OSA TECHNICAL DIGEST, P105; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Hoffmann J, 2014, EXPERT REV CLIN PHAR, V7, P191, DOI 10.1586/17512433.2014.885835; Inman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065389; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PINDER RM, 1977, DRUGS, V13, P81, DOI 10.2165/00003495-197713020-00001; Semba K, 2014, NEUROSCI LETT, V581, P89, DOI 10.1016/j.neulet.2014.08.034; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.296; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.306; TIAN LM, 1994, NEUROPHARMACOLOGY, V33, P1131, DOI 10.1016/S0028-3908(05)80002-4; VANDONGEN AMJ, 1986, EPILEPSIA, V27, P177, DOI 10.1111/j.1528-1157.1986.tb03525.x; Zhang XZ, 2010, BRAIN RES BULL, V81, P3, DOI 10.1016/j.brainresbull.2009.09.003	62	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAR	2015	185	3					756	764		10.1016/j.ajpath.2014.11.005		9	Pathology	Pathology	CD0SI	WOS:000350783800016		
J	Kojima, T; Dogru, M; Higuchi, A; Nagata, T; Ibrahim, OMA; Inaba, T; Tsubota, K				Kojima, Takashi; Dogru, Murat; Higuchi, Akihiro; Nagata, Taeko; Ibrahim, Osama M. A.; Inaba, Takaaki; Tsubota, Kazuo			The Effect of Nrf2 Knockout on Ocular Surface Protection from Acute Tobacco Smoke Exposure Evidence from Nrf2 Knockout Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							DRY EYE SYNDROME; OXIDATIVE STRESS; CIGARETTE-SMOKE; RESPIRATORY-TRACT; LACRIMAL GLAND; MICE; DISEASE; CELL; DAMAGE; MODEL	Ocular surface mucosa is the first-line ocular tissue to be exposed to environmental stress. We evaluated tear functions and keratoconjunctival epithelial alterations after sidestream cigarette smoke (SCS) exposure and tried to clarify the role of the transcription factor nuclear factor erythroid 2 related factor 2 (Nfe2l2, also known as Nrf2), on the ocular surface. In wild-type and Nrf2(-/-) mice, tear volume did not change after SCS exposure. Tear film breakup time (tear stability) in Nrf2(-/-) mice was significantly shorter than that in wildtype mice after SCS exposure. Vital staining scores, including fluorescein and Rose Bengal staining, showed significantly higher values in Nrf2(-/-) mice than in wild-type mice after SCS exposure. Excessive oxidative stress accumulation was detected in Nrf2(-/-) mice after SCS exposure using immunohistochemical analysis. Immunohistochemical analysis also revealed decreased mucin 1 (Mud) and Muc5ac staining in Nrf2(-/-) mice after SCS exposure. mRNA expression levels of Mud, Muc4, and Muc5ac and of SAM-pointed domain epithelial-specific transcription factor in Nrf2(-/-) mice were lower than those in wild-type mice after SCS exposure. Mean tear IL-6 concentrations increased significantly in Nrf2(-/-) mice after SCS exposure. In conclusion, SCS exposure induced decreased tear stability, ocular surface damage, and altered conjunctival phenotype in Nrf2(-/-) mice. Nrf2 could play an important role in protection of the ocular surface against SCS exposure.	[Kojima, Takashi; Dogru, Murat; Higuchi, Akihiro; Nagata, Taeko; Ibrahim, Osama M. A.; Inaba, Takaaki; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan; [Dogru, Murat] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Japan	Dogru, M (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinano Machi 35, Tokyo 1608582, Japan.	muratodooru2012@yahoo.com			Smoking Research Foundation [FP01210115]	Supported by research grant FP01210115 from the Smoking Research Foundation.	Wakamatsu TH, 2013, INVEST OPHTH VIS SCI, V54, P201, DOI 10.1167/iovs.12-10325; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Wang Y, 2010, BONE MARROW TRANSPL, V45, P1077, DOI 10.1038/bmt.2009.312; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; NELSON JD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1049; Chia EM, 2003, CLIN EXP OPHTHALMOL, V31, P229, DOI 10.1046/j.1442-9071.2003.00634.x; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Milei J, 2007, CARDIOVASC RES, V73, P710, DOI 10.1016/j.cardiores.2006.12.007; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Rummenie VT, 2008, CYTOKINE, V43, P200, DOI 10.1016/j.cyto.2008.05.011; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Hori Y, 2004, INVEST OPHTH VIS SCI, V45, P114, DOI 10.1167/iovs.03-0903; Marko CK, 2013, AM J PATHOL, V183, P35, DOI 10.1016/j.ajpath.2013.03.017; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; DYE JA, 1994, THORAX, V49, P825, DOI 10.1136/thx.49.8.825; Gipson Ilene K, 2004, Ocul Surf, V2, P131; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Hirai N, 2006, EXP EYE RES, V82, P371, DOI 10.1016/j.exer.2005.07.009; Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019; LOFROTH G, 1989, MUTAT RES, V222, P73, DOI 10.1016/0165-1218(89)90021-9; Matsumoto Y, 2008, EYE, V22, P961, DOI 10.1038/eye.2008.78; Meltzer EO, 1994, ANN ALLERGY, V73, P8; MELTZER EO, 1994, ANN ALLERGY, V73, P381; Qi Li, 2010, J Investig Med, V58, P730, DOI 10.231/JIM.0b013e3181d88fde; Sayin N, 2014, CUTAN OCUL TOXICOL, V33, P201, DOI 10.3109/15569527.2013.832688; TAKAHASHI A, 1985, JPN J CANCER RES, V76, P324; Thomas Jyothi, 2012, Australas Med J, V5, P221, DOI 10.4066/AMJ.2012.1035; VONMEYERINCK L, 1989, EXP PATHOL-JENA, V37, P186; Ward SK, 2010, OPTOMETRY VISION SCI, V87, P367, DOI 10.1097/OPX.0b013e3181d95188; WEBER A, 1984, PREV MED, V13, P618, DOI 10.1016/S0091-7435(84)80012-2; Yuki K, 2011, INVEST OPHTH VIS SCI, V52, P4143, DOI 10.1167/iovs.10-6294	46	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAR	2015	185	3					776	785		10.1016/j.ajpath.2014.11.014		10	Pathology	Pathology	CD0SI	WOS:000350783800018		
J	Katano, T; Ootani, A; Mizoshita, T; Tanida, S; Tsukamoto, H; Ozeki, K; Kataoka, H; Joh, T				Katano, Takahito; Ootani, Akifumi; Mizoshita, Tsutomu; Tanida, Satoshi; Tsukamoto, Hironobu; Ozeki, Keiji; Kataoka, Hiromi; Joh, Takashi			Gastric Mesenchymal Myofibroblasts Maintain Stem Cell Activity and Proliferation of Murine Gastric Epithelium in Vitro	AMERICAN JOURNAL OF PATHOLOGY			English	Article							HELICOBACTER-PYLORI; STOMACH EPITHELIUM; MONGOLIAN-GERBILS; CHICKEN-EMBRYO; MOUSE STOMACH; GROWTH-FACTOR; CHIEF CELLS; NICHE; CULTURE; DIFFERENTIATION	Stem cells are influenced by a microenvironmental niche that includes mesenchymal cells. We established a novel Long-term method for primary mouse glandular stomach culture with mesenchymal myofibroblasts to investigate gastric epithelial-mesenchymal interactions. A gastric mesenchymat myofibroblast (GMF) cell Line was established from mouse glandular stomach. Glandular stomach cells from neonatal mice and GMF cells were co-cultured in a collagen get. Cultured stomach cells yielded expanding sphere-Like structures. In the GMF co-culture system, the number and size of gastrospheres were increased compared with control cultures (P = 0.009 and 0.008, respectively). Immunohistochemistry showed cells positive for human gastric mucin, HIK1083, and chromogranin A, indicating differentiation into surface mucous cells, mucous neck cells, and enteroendocrine cells, respectively. RNA in situ hybridization for Lgr5 showed Lgr5(+) stem cells in the cultured gastrospheres. Lgr5(+) cells were observed persistently in the epithelium of gastrospheres in the GMF co-culture system for 2 months. GM Fs allowed the cultured gastric epithelium to maintain active proliferation similar to that seen in vivo. Real-time quantitative RT-PCR showed that Gas1 expression was higher in GMFs (P = 0.0445), and Hoxc8, Notch1, and Sox10 expressions were higher in intestinal mesenchymal myofibroblasts (P = 0.0003, 0.0143, and 0.0488, respectively). We show the potential role of GMFs in sustaining Lgr5(+) stem cell activity and affecting normal gastric epithelial differentiation and proliferation.	[Katano, Takahito; Mizoshita, Tsutomu; Tanida, Satoshi; Tsukamoto, Hironobu; Ozeki, Keiji; Kataoka, Hiromi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Ootani, Akifumi] Saiseikai Yahata Gen Hosp, Dept Gastroenterol, Kitakyushu, Fukuoka, Japan; [Ootani, Akifumi] Saga Univ, Fac Med, Dept Internal Med, Saga 840, Japan	Mizoshita, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tmizoshi@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26460945]	Supported by a Grant-in-Aid (Kiban C, 26460945) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; KARAM SM, 1993, ANAT REC, V236, P280, DOI 10.1002/ar.1092360203; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254; Koike T, 1999, DIFFERENTIATION, V65, P13, DOI 10.1046/j.1432-0436.1999.6510013.x; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Korinek V, 1998, NAT GENET, V19, P379; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Narita T, 2000, DEVELOPMENT, V127, P981; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Mizoshita T, 2003, J CANCER RES CLIN, V129, P727, DOI 10.1007/s00432-003-0499-6; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Tatematsu M, 2005, HELICOBACTER, V10, P97, DOI 10.1111/j.1523-5378.2005.00305.x; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Biau S, 2013, BIOL OPEN, V2, P144, DOI 10.1242/bio.20123186; CHEW CS, 1994, ANNU REV PHYSIOL, V56, P445; Fukamachi H, 2013, DEV GROWTH DIFFER, V55, P786, DOI 10.1111/dgd.12102; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Ishihara K, 1996, BIOCHEM J, V318, P409; Itoh K, 2006, J GASTROENTEROL, V41, P1064, DOI 10.1007/s00535-006-1899-6; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; Katano T, 2013, BIOCHEM BIOPH RES CO, V432, P558, DOI 10.1016/j.bbrc.2013.02.051; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ootani A, 2003, AM J PATHOL, V162, P1905, DOI 10.1016/S0002-9440(10)64324-6; RATTNER DW, 1985, IN VITRO CELL DEV B, V21, P453; SANDERS MJ, 1983, AM J PHYSIOL, V245, pG641; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; TERANO A, 1982, GASTROENTEROLOGY, V83, P1280; Xie T, 2007, DEVELOPMENT, V134, P2001, DOI 10.1242/dev.002022	37	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAR	2015	185	3					798	807		10.1016/j.ajpath.2014.11.007		10	Pathology	Pathology	CD0SI	WOS:000350783800020		
J	Badescu, I; Wikberg, EC; Macdonald, LJ; Fox, SA; Vayro, JV; Sicotte, P				Badescu, Iulia; Wikberg, Eva C.; Macdonald, Lisa J.; Fox, Stephanie A.; Vayro, Josie V.; Sicotte, Pascale			Infanticide pressure and group size affect natal coat development in wild Colobus vellerosus at Boabeng-Fiema Monkey Sanctuary, Ghana	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Badescu, Iulia] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada; [Badescu, Iulia; Wikberg, Eva C.; Macdonald, Lisa J.; Fox, Stephanie A.; Vayro, Josie V.; Sicotte, Pascale] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Wikberg, Eva C.] Univ Tokyo, Dept Integrated Biosci, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		97	97				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594900126		
J	Hirasaki, E; Oishi, M				Hirasaki, Eishi; Oishi, Motoharu			Arrangement of the foot interosseous muscles in great apes	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Hirasaki, Eishi] Kyoto Univ, Primate Res Inst, Kyoto 6068501, Japan; [Oishi, Motoharu] Nippon Vet & Life Sci Univ, Sch Vet Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		166	166				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901160		
J	Kraft, TS; Venkataraman, VV; Tacey, I; Kawai, A; Endicott, KM				Kraft, Thomas S.; Venkataraman, Vivek V.; Tacey, Ivan; Kawai, Aya; Endicott, Kirk M.			Determinants of reproductive success in Batek hunter-gatherers in Peninsular Malaysia	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Kraft, Thomas S.; Venkataraman, Vivek V.] Dartmouth Coll, Biol, Hanover, NH 03755 USA; [Tacey, Ivan] Univ Lyon 2, Dept Anthropol & Sociol, F-69365 Lyon 07, France; [Kawai, Aya] Chiba Univ, Grad Sch Humanities & Social Sci, Chiba, Japan; [Endicott, Kirk M.] Dartmouth Coll, Anthropol, Hanover, NH 03755 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		194	194				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901271		
J	Leahy, RE; Crews, DE; Sone, Y; Kusano, Y				Leahy, Rachael E.; Crews, Douglas E.; Sone, Yoshiaki; Kusano, Yosuke			A Wrinkle in Time: Allostatic Load and Senescent Decline among Elderly Japanese	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Leahy, Rachael E.; Crews, Douglas E.] Ohio State Univ, Anthropol, Columbus, OH 43210 USA; [Sone, Yoshiaki] Osaka City Univ, Dept Food & Nutr, Osaka, Japan; [Kusano, Yosuke] Nagasaki Wesleyan Univ, Dept Community Dev, Nagasaki, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		199	199				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901293		
J	Melin, AD; Shirasu, M; Matsushita, Y; Myers, MS; Bergstrom, MI; Venkataraman, V; Rothman, JM; Fedigan, LM; Touhara, K; Kawamura, S				Melin, Amanda D.; Shirasu, Mika; Matsushita, Yuka; Myers, Monica S.; Bergstrom, Mackenzie I.; Venkataraman, Vivek; Rothman, Jessica M.; Fedigan, Linda M.; Touhara, Kazushige; Kawamura, Shoji			Examining the links among fruit signals, nutritional value, and the sensory behaviors of wild capuchin monkeys (Cebus capucinus)	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Shirasu, Mika; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138654, Japan; [Matsushita, Yuka; Kawamura, Shoji] Univ Tokyo, Dept Integrated Biosci, Tokyo 1138654, Japan; [Myers, Monica S.; Bergstrom, Mackenzie I.; Fedigan, Linda M.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Venkataraman, Vivek] Dartmouth Coll, Dept Sci Biol, Hanover, NH 03755 USA; [Rothman, Jessica M.] CUNY, Hunter Coll, Dept Anthropol, New York, NY USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		223	224				2	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901388		
J	Nishimura, T; Koda, H; Tokuda, IT; Wakita, M; Ito, T				Nishimura, Takeshi; Koda, Hiroki; Tokuda, Isao T.; Wakita, Masumi; Ito, Tsuyoshi			Helium experiment and vocal physiology of the phee calls in common marmosets	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Nishimura, Takeshi; Koda, Hiroki; Wakita, Masumi] Kyoto Univ, Primate Res Inst, Kyoto 6068501, Japan; [Tokuda, Isao T.] Ritsumeikan Univ, Dept Mech Engn, Kyoto, Japan; [Ito, Tsuyoshi] Univ Ryukyus, Dept Human Biol & Anat, Nishihara, Okinawa 90301, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		236	237				2	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901440		
J	Rae, TC; Johnson, PM; Yano, W; Hirasaki, E				Rae, Todd C.; Johnson, Paul M.; Yano, Wataru; Hirasaki, Eishi			Smaller posterior semicircular canals are associated with leaping in Colobus	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Rae, Todd C.; Johnson, Paul M.] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Yano, Wataru] Asahi Univ, Sch Dent, Dept Oral Anat, Mizuho, Gifu, Japan; [Hirasaki, Eishi] Kyoto Univ, Primate Res Inst, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		259	259				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594901531		
J	Seguchi, N; Quintyn, CB				Seguchi, Noriko; Quintyn, Conrad B.			Variation in body and limb proportions between Early and Archaic Americans and the prehistoric Jomon of Japan	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Seguchi, Noriko] Kyushu Univ, Dept Environm Changes, Grad Sch Social & Cultural Studies, Fukuoka 812, Japan; [Quintyn, Conrad B.] Bloomsburg Univ Penn, Dept Anthropol, Bloomsburg, PA 17815 USA; [Seguchi, Noriko] Univ Montana, Dept Anthropol, Missoula, MT 59812 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		283	283				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594902052		
J	Sellers, WI; Hirasaki, E				Sellers, William I.; Hirasaki, Eishi			Improving gait generation in fossil primates using multigoal evolutionary robotics	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Sellers, William I.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Hirasaki, Eishi] Kyoto Univ, Primate Res Inst, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		284	284				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594902055		
J	Sprague, DS; Nishikawa, M				Sprague, David S.; Nishikawa, Mari			Spatial structure in the distribution of feeding trees used by the Japanese macaques of Yakushima Island, Japan	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Sprague, David S.] Natl Inst Agroenvironm Sci, Ecosyst Informat Div, Tsukuba, Ibaraki, Japan; [Nishikawa, Mari] Kyoto Univ, Lab Human Evolut Studies, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		295	295				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594902097		
J	Wikberg, EC; Jack, KM; Campos, FA; Sato, A; Bergstrom, ML; Hiwatashi, T; Kawamura, S; Fedigan, LM				Wikberg, Eva C.; Jack, Katharine M.; Campos, Fernando A.; Sato, Akiko; Bergstrom, Mackenzie L.; Hiwatashi, Tomohide; Kawamura, Shoji; Fedigan, Linda M.			Alternative routes to reproductive success may explain male cooperation in a primate population (Cebus capucinus) with high reproductive skew	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Meeting Abstract	84th Annual Meeting of the American-Association-of-Physical-Anthropologists	MAR 25-28, 2015	St Louis, MO	Amer Assoc Phys Anthropologists					[Wikberg, Eva C.; Sato, Akiko; Hiwatashi, Tomohide; Kawamura, Shoji] Univ Tokyo, Dept Integrated Biosci, Tokyo 1138654, Japan; [Wikberg, Eva C.; Campos, Fernando A.; Bergstrom, Mackenzie L.; Fedigan, Linda M.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada; [Jack, Katharine M.] Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	MAR	2015	156			60	SI		324	324				1	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CC8CE	WOS:000350594902211		
J	Chen, S; Okahara, F; Osaki, N; Shimotoyodome, A				Chen, Shu; Okahara, Fumiaki; Osaki, Noriko; Shimotoyodome, Akira			Increased GIP signaling induces adipose inflammation via a HIF-1 alpha-dependent pathway and impairs insulin sensitivity in mice	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						adipose tissue inflammation; GIP; hypoxia; insulin resistance; macrophage	GASTRIC-INHIBITORY POLYPEPTIDE; NECROSIS-FACTOR-ALPHA; HIGH-FAT DIET; INCRETIN HORMONES; TISSUE HYPOXIA; C57BL/6J MICE; OBESITY; ADIPOCYTES; RESISTANCE; ACTIVATION	Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone secreted in response to dietary fat and glucose. The blood GIP level is elevated in obesity and diabetes. GIP stimulates proinflammatory gene expression and impairs insulin sensitivity in cultured adipocytes. In obesity, hypoxia within adipose tissue can induce inflammation. The aims of this study were 1) to examine the proinflammatory effect of increased GIP signaling in adipose tissues in vivo and 2) to clarify the association between GIP and hypoxic signaling in adipose tissue inflammation. We administered GIP intraperitoneally to misty (lean) and db/db (obese) mice and examined adipose tissue inflammation and insulin sensitivity. We also examined the effects of GIP and hypoxia on expression of the GIP receptor (GIPR) gene and proinflammatory genes in 3T3-L1 adipocytes. GIP administration increased monocyte chemoattractant protein-1 (MCP-1) expression and macrophage infiltration into adipose tissue and increased blood glucose in db/db mice. GIPR and hypoxia-inducible factor-1 alpha (HIF-1 alpha) expressions were positively correlated in the adipose tissue in mice. GIPR expression increased dramatically in differentiated adipocytes. GIP treatment of adipocytes increased MCP-1 and interleukin-6 (IL-6) production. Adipocytes cultured either with RAW 264 macrophages or under hypoxia expressed more GIPR and HIF-1 alpha, and GIP treatment increased gene expression of plasminogen activator inhibitor 1 and IL-6. HIF-1 alpha gene silencing diminished both macrophage-and hypoxia-induced GIPR expression and GIP-induced IL-6 expression in adipocytes. Thus, increased GIP signaling plays a significant role in adipose tissue inflammation and thereby insulin resistance in obese mice, and HIF-1 alpha may contribute to this process.	[Chen, Shu; Okahara, Fumiaki; Osaki, Noriko; Shimotoyodome, Akira] Kao Corp, Biol Sci Labs, Ichikai, Tochigi, Japan	Shimotoyodome, A (reprint author), 2606 Akabane, Ichikai, Tochigi 3213497, Japan.	shimotoyodome.akira@kao.co.jp			Kao Corporation	This study was supported financially by the Kao Corporation.	Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Mohammad S, 2011, J BIOL CHEM, V286, P43062, DOI 10.1074/jbc.M111.289009; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Gniuli D, 2010, DIABETOLOGIA, V53, P2233, DOI 10.1007/s00125-010-1830-9; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Jung JY, 2004, NEUROSCI LETT, V371, P85, DOI 10.1016/j.neulet.2004.06.069; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Timper K, 2013, AM J PHYSIOL-ENDOC M, V304, pE1, DOI 10.1152/ajpendo.00100.2012; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Nie YH, 2012, FASEB J, V26, P2383, DOI 10.1096/fj.11-196782; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; FLATT PR, 1983, DIABETES, V32, P433, DOI 10.2337/diabetes.32.5.433; Kihira Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093856; Kim SJ, 2011, J LIPID RES, V52, P759, DOI 10.1194/jlr.M012203; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Naitoh R, 2008, BIOCHEM BIOPH RES CO, V376, P21, DOI 10.1016/j.bbrc.2008.08.052; Nalwaya N, 2005, CHEM RES TOXICOL, V18, P486, DOI 10.1021/tx049879c; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744	39	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	MAR 1	2015	308	5					E414	E425		10.1152/ajpendo.00418.2014		12	Endocrinology & Metabolism; Physiology	Endocrinology & Metabolism; Physiology	CD1BE	WOS:000350807900008		
J	Gooijert, KER; Havinga, R; Wolters, H; Wang, R; Ling, V; Tazuma, S; Verkade, HJ				Gooijert, K. E. R.; Havinga, R.; Wolters, H.; Wang, R.; Ling, V.; Tazuma, S.; Verkade, H. J.			The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						phospholipid; cholesterol; tauro-beta-muricholate; canalicular lipid transporters; bile salt export pump (Bsep)	MDR2 P-GLYCOPROTEIN; LIVER-X-RECEPTOR; CHOLESTEROL SECRETION; KNOCKOUT MICE; DEFICIENT MICE; RAT-LIVER; ENTEROHEPATIC CIRCULATION; INTRAHEPATIC CHOLESTASIS; ORGANIC-ANIONS; CHOLIC-ACID	Human bile salt export pump (BSEP) mutations underlie progressive familial intrahepatic cholestasis type 2 (PFIC2). In the PFIC2 animal model, Bsep(-/-) mice, biliary secretion of bile salts (BS) is decreased, but that of phospholipids (PL) and cholesterol (CH) is increased. Under physiological conditions, the biliary secretion of PL and CH is positively related ("coupled") to that of BS. We aimed to elucidate the mechanism of increased biliary lipid secretion in Bsep(-/-) mice. The secretion of the BS tauro-beta-muricholic acid (T beta MCA) is relatively preserved in Bsep(-/-) mice. We infused Bsep(-/-) and Bsep(-/-) (control) mice with T beta MCA in stepwise increasing dosages (150-600 nmol/min) and determined biliary bile flow, BS, PL, and CH secretion. mRNA and protein expression of relevant canalicular transporters was analyzed in livers from noninfused Bsep(-/-) and control mice. T beta MCA infusion increased BS secretion in both Bsep(-/-) and control mice. The secreted PL or CH amount per BS, i.e., the "coupling," was continuously two- to threefold higher in Bsep(-/-) mice (P < 0.05). Hepatic mRNA expression of canalicular lipid transporters Mdr2, Abcg5, and Abcg8 was 45-55% higher in Bsep(-/-) mice (Abcg5; P < 0.05), as was canalicular Mdr2 and Abcg5 protein expression. Potential other explanations for the increased coupling of the biliary secretion of PL and CH to that of BS in Bsep(-/-) mice could be excluded. We conclude that the mechanism of increased biliary lipid secretion in Bsep(-/-) mice is based on increased expression of the responsible canalicular transporter proteins.	[Gooijert, K. E. R.; Havinga, R.; Wolters, H.; Verkade, H. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Res Lab Pediat, Groningen, Netherlands; [Wang, R.; Ling, V.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Tazuma, S.] Hiroshima Univ, Dept Gen Med & Clin Pharmacotherapy, Hiroshima, Japan	Verkade, HJ (reprint author), Beatrix Childrens Hosp, Univ Med Ctr Groningen, Pediat Gastroenterol Hepatol, POB 30-001, NL-9700 RB Groningen, Netherlands.	h.j.verkade@umcg.nl					Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Madon J, 2000, MOL PHARMACOL, V57, P634; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; Wang RX, 2003, HEPATOLOGY, V38, P1489, DOI 10.1016/j.hep.2003.09.037; Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Vos TA, 1998, HEPATOLOGY, V28, P1637, DOI 10.1002/hep.510280625; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; APSTEIN MD, 1985, DIGEST DIS SCI, V30, P253, DOI 10.1007/BF01347893; APSTEIN MD, 1982, GASTROENTEROLOGY, V83, P1120; BARNWELL SG, 1987, BIOCHIM BIOPHYS ACTA, V922, P221, DOI 10.1016/0005-2760(87)90158-5; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bloks VW, 2001, J LIPID RES, V42, P41; Boesjes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115028; CARULLI N, 1984, J CLIN INVEST, V74, P614, DOI 10.1172/JCI111459; Cui JY, 2012, AM J PHYSIOL-GASTR L, V302, pG979, DOI 10.1152/ajpgi.00370.2011; Elferink RPJO, 1998, J CLIN INVEST, V102, P1749, DOI 10.1172/JCI3597; ERIKSSON S, 1957, P SOC EXP BIOL MED, V94, P578; Fitzgerald ML, 2002, J MOL MED-JMM, V80, P271, DOI 10.1007/s00109-001-0318-y; Frijters CMG, 1997, BIOCHEM J, V321, P389; HARDISON WGM, 1981, AM J PHYSIOL, V241, pG337; HOFMANN AF, 1989, DIGEST DIS SCI, V34, pS16, DOI 10.1007/BF01536657; HOFMANN AF, 1990, HEPATOLOGY, V12, pS17; Kajihara T, 2000, J GASTROENTEROL, V35, P450, DOI 10.1007/s005350070091; KAY RE, 1961, AM J PHYSIOL, V200, P855; Koopen NR, 1999, J HEPATOL, V30, P14, DOI 10.1016/S0168-8278(99)80003-8; Miura H, 1997, J GASTROEN HEPATOL, V12, P734, DOI 10.1111/j.1440-1746.1997.tb00361.x; Nishioka T, 2004, BBA-MOL CELL BIOL L, V1636, P90, DOI 10.1016/j.bbalip.2003.08.007; Elferink RPJO, 1996, J LIPID RES, V37, P1065; ELFERINK RPJO, 1995, J CLIN INVEST, V95, P31; Perwaiz S, 2003, J LIPID RES, V44, P494, DOI 10.1194/jlr.M200394-JLR200; Plosch T, 2006, AM J PHYSIOL-GASTR L, V291, pG414, DOI 10.1152/ajpgi.00557.2005; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Remaley AT, 2002, BIOCHEM BIOPH RES CO, V295, P276, DOI 10.1016/S0006-291X(02)00652-6; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; SCHERSTE.T, 1971, EUR J CLIN INVEST, V1, P242; Suchy FJ, 2006, J PEDIATR GASTR NUTR, V43, pS10, DOI 10.1097/01.mpg.0000226385.71859.5f; VERKADE HJ, 1993, AM J PHYSIOL, V264, pG462; Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200; VERKADE HJ, 1993, HEPATOLOGY, V17, P1074, DOI 10.1016/0270-9139(93)90125-7; Verkade HJ, 2000, J GASTROENTEROL, V35, P481, DOI 10.1007/s005350070097; VERKADE HJ, 1995, HEPATOLOGY, V21, P1174; Wang RX, 2009, HEPATOLOGY, V50, P948, DOI 10.1002/hep.23089; YAMASHITA G, 1993, BIOCHEM J, V291, P173; YOUSEF I, 1992, HEPATOLOGY, V15, P438, DOI 10.1002/hep.1840150314; YOUSEF IM, 1987, AM J PHYSIOL, V252, pG84	53	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	MAR 1	2015	308	5					G450	G457		10.1152/ajpgi.00391.2014		8	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CD1EM	WOS:000350817100010		
J	Jiang, BB; Deng, QP; Huo, YQ; Li, W; Shibuya, M; Luo, JC				Jiang, Beibei; Deng, Qiuping; Huo, Yingqing; Li, Wei; Shibuya, Masabumi; Luo, Jincai			Endothelial Gab1 deficiency aggravates splenomegaly in portal hypertension independent of angiogenesis	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						Gab1; portal hypertension; splenomegaly	NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-A; HYPERDYNAMIC SPLANCHNIC CIRCULATION; GROWTH-FACTOR RECEPTORS; INDUCED LIVER FIBROSIS; KRUPPEL-LIKE FACTOR-2; SHEAR-STRESS; SIGNAL-TRANSDUCTION; SPLEEN ENLARGEMENT; CIRRHOTIC RATS	Certain pathological changes, including angiogenesis, actively contribute to the pathogenesis of splenomegaly in portal hypertension (PH), although the detailed molecular and cellular mechanisms remain elusive. In this study, we demonstrated that endothelial Grb-2-associated binder 1 (Gab1) plays a negative role in PH-associated splenomegaly independent of angiogenesis. PH, which was induced by partial portal vein ligation, significantly enhanced Gab1 expression in endothelial cells in a time-dependent manner. Compared with controls, endothelium-specific Gab1 knockout (EGKO) mice exhibited a significant increase in spleen size while their PH levels remained similar. Pathological analysis indicated that EGKO mice developed more severe hyperactive white pulp and fibrosis in the enlarged spleen but less angiogenesis in both the spleen and mesenteric tissues. Mechanistic studies showed that the phosphorylation of endothelial nitric oxide synthase ( eNOS) in EGKO mice was significantly lower than in controls. In addition, the dysregulation of fibrosis and inflammation-related transcription factors [e.g., Kruppel-like factor (KLF) 2 and KLF5] and the upregulation of cytokine genes (e.g., TNF-alpha and IL-6) were observed in EGKO mice. We thus propose that endothelial Gab1 mediates multiple pathways in inhibition of the pathogenesis of splenomegaly in PH via prevention of endothelial dysfunction and overproduction of proinflammatory/profibrotic cytokines.	[Jiang, Beibei; Deng, Qiuping; Huo, Yingqing; Luo, Jincai] Peking Univ, Inst Mol Med, Lab Vasc Biol, Beijing Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China; [Li, Wei] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Shibuya, Masabumi] Jobu Univ, Inst Physiol & Med, Takasaki, Gumma, Japan	Luo, JC (reprint author), Peking Univ, Inst Mol Med, Rm 234,New Life Sci Bldg, Beijing 100871, Peoples R China.	jincailuo@pku.edu.cn			National Basic Research Program of China [2012CB945100]; National Science Foundation of China [91339111, 81170098, 31221002]	This study was supported by research grants from the National Basic Research Program of China (2012CB945100) and the National Science Foundation of China (91339111, 81170098, and Project 31221002) to J. Luo.	Al-Busafi SA, 2012, INT J HEPATOL, V2012, P1; Iwakiri Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1074, DOI 10.1152/ajpgi.00145.2002; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Theodorakis NG, 2003, GASTROENTEROLOGY, V124, P1500, DOI 10.1016/S0016-5085(03)00280-4; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021; GUSBERG RJ, 1994, HEPATO-GASTROENTEROL, V41, P573; Angermayr B, 2006, J HEPATOL, V44, P1033, DOI 10.1016/j.jhep.2005.09.021; McCormick PA, 2000, BEST PRACT RES CL GA, V14, P1009, DOI 10.1053/bega.2000.0144; Fledderus JO, 2007, BLOOD, V109, P4249, DOI 10.1182/blood-2006-07-036020; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Geerts AM, 2008, INT J EXP PATHOL, V89, P251, DOI 10.1111/j.1365-2613.2008.00597.x; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; Abraldes JG, 2006, WORLD J GASTROENTERO, V12, P6577; Dixit M, 2005, CIRC RES, V97, P1236, DOI 10.1161/01.RES.0000195611.59811.ab; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.538882.c3; Theodorakis NG, 2009, AM J PHYSIOL-GASTR L, V297, pG792, DOI 10.1152/ajpgi.00229.2009; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Kazakov A, 2013, CARDIOVASC RES, V100, P211, DOI 10.1093/cvr/cvt181; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Yoshimura S, 2006, RESPIROLOGY, V11, P546, DOI 10.1111/j.1400-1843.2006.00894.x; Bosch J, 2008, J HEPATOL, V48, pS68, DOI 10.1016/j.jhep.2008.01.021; Abraldes JG, 2006, AM J PHYSIOL-GASTR L, V290, pG980, DOI 10.1152/ajpgi.00336.2005; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; BOSCH J, 1992, GASTROENTEROL CLIN N, V21, P1; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Cahill PA, 2001, PHARMACOL THERAPEUT, V89, P273, DOI 10.1016/S0163-7258(01)00128-0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Berzigotti A, 2008, CLIN GASTROENTEROL H, V6, P1129, DOI 10.1016/j.cgh.2008.05.004; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299; Higashi Yukihito, 2012, Nihon Rinsho, V70, P1519; Higuchi K, 2012, CIRC J, V76, P2031, DOI 10.1253/circj.CJ-11-1507; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Kumekawa M, 2008, BIOL PHARM BULL, V31, P1609, DOI 10.1248/bpb.31.1609; Leung TM, 2008, INT J EXP PATHOL, V89, P241, DOI 10.1111/j.1365-2613.2008.00590.x; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Loureiro-Silva MR, 2003, AM J PHYSIOL-GASTR L, V284, pG567, DOI 10.1152/ajpgi.00452.2002; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; MOSCHCOWITZ E, 1948, MEDICINE, V27, P187; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Ohara F, 2008, DIGEST DIS SCI, V53, P2222, DOI 10.1007/s10620-007-0112-y; Radwan DM, 2010, EGYPT J HISTOL, V33, P709; Steppan J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00278; Sun XF, 2009, AM J PHYSIOL-GASTR L, V297, pG306, DOI 10.1152/ajpgi.90703.2008; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084063; Van Steenkiste C, 2009, GASTROENTEROLOGY, V137, P2112, DOI 10.1053/j.gastro.2009.08.068; Yamaguchi S, 2007, LIFE SCI, V80, P2036, DOI 10.1016/j.lfs.2007.03.009; Zhang W, 2010, PATHOL RES PRACT, V206, P760, DOI 10.1016/j.prp.2010.07.009; Zhao JJ, 2011, ARTERIOSCL THROM VAS, V31, P1016, DOI 10.1161/ATVBAHA.111.224493	63	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	MAR 1	2015	308	5					G416	G426		10.1152/ajpgi.00292.2014		11	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CD1EM	WOS:000350817100006		
J	Kito, Y; Mitsui, R; Ward, SM; Sanders, KM				Kito, Yoshihiko; Mitsui, Retsu; Ward, Sean M.; Sanders, Kenton M.			Characterization of slow waves generated by myenteric interstitial cells of Cajal of the rabbit small intestine	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						interstitial cells of Cajal; NKCC1; pacemaker; slow wave; small intestine	MOUSE SMALL-INTESTINE; GUINEA-PIG STOMACH; SMOOTH-MUSCLE; GASTROINTESTINAL-TRACT; PACEMAKER POTENTIALS; CALCIUM-CHANNELS; C-KIT; ELECTRICAL RHYTHMICITY; MURINE INTESTINE; NKCC1	Slow waves (slow wavesICC) were recorded from myenteric interstitial cells of Cajal (ICC-MY) in situ in the rabbit small intestine, and their properties were compared with those of mouse small intestine. Rabbit slow wavesICC consisted of an upstroke depolarization followed by a distinct plateau component. Ni2+ and nominally Ca2+-free solutions reduced the rate-of-rise and amplitude of the upstroke depolarization. Replacement of Ca2+ with Sr2+ enhanced the upstroke component but decreased the plateau component of rabbit slow wavesICC. In contrast, replacing Ca2+ with Sr2+ decreased both components of mouse slow wavesICC. The plateau component of rabbit slow wavesICC was inhibited in low-extracellular-Cl- -concentration (low-[Cl-](0)) solutions and by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS), an inhibitor of Cl- channels, cyclopiazonic acid (CPA), an inhibitor of internal Ca2+ pumps, or bumetanide, an inhibitor of Na+-K+-2Cl(-) cotransporter (NKCC1). Bumetanide also inhibited the plateau component of mouse slow wavesICC. NKCC1-like immunoreactivity was observed mainly in ICC-MY in the rabbit small intestine. Membrane depolarization with a high-K+ solution reduced the upstroke component of rabbit slow wavesICC. In cells depolarized with elevated external K+, DIDS, CPA, and bumetanide blocked slow wavesICC. These results suggest that the upstroke component of rabbit slow wavesICC is partially mediated by voltage-dependent Ca2+ influx, whereas the plateau component is dependent on Ca2+-activated Cl- efflux. NKCC1 is likely to be responsible for Cl- accumulation in ICC-MY. The results also suggest that the mechanism of the upstroke component differs in rabbit and mouse slow wavesICC in the small intestine.	[Kito, Yoshihiko] Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan; [Kito, Yoshihiko; Mitsui, Retsu] Nagoya City Univ, Sch Med, Dept Cell Physiol, Mizuho Ku, Nagoya, Aichi 467, Japan; [Ward, Sean M.; Sanders, Kenton M.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Kito, Y (reprint author), Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan.	ykito@cc.saga-u.ac.jp			24th General Assembly of the Japanese Association of Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases [P01 DK41315]	This project was supported by the 24th General Assembly of the Japanese Association of Medical Sciences to Y. Kito. Funding for S. M. Ward and K. M. Sanders came from P01 DK41315 from the National Institute of Diabetes and Digestive and Kidney Diseases.	HUIZINGA JD, 1995, NATURE, V373, P347; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Strege PR, 2003, AM J PHYSIOL-GASTR L, V285, pG1111, DOI 10.1152/ajpgi.00152.2003; THUNEBERG L, 1982, ADV ANAT EMBRYOL CEL, V71, P1; Lee JH, 1999, BIOPHYS J, V77, P3034; Gibbons SJ, 2009, J CELL MOL MED, V13, P4422, DOI 10.1111/j.1582-4934.2008.00623.x; MAEDA H, 1992, DEVELOPMENT, V116, P369; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Zheng HF, 2014, AM J PHYSIOL-CELL PH, V306, pC705, DOI 10.1152/ajpcell.00390.2013; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Russell JM, 2000, PHYSIOL REV, V80, P211; Bourinet E, 1996, J NEUROSCI, V16, P4983; CHEUNG DW, 1980, J PHYSIOL-LONDON, V309, P13; CHRISTEN.J, 1966, GASTROENTEROLOGY, V50, P309; HARA Y, 1986, J PHYSIOL-LONDON, V372, P501; HARA Y, 1986, J PHYSIOL-LONDON, V372, P521; Hirst GDS, 2001, J PHYSIOL-LONDON, V535, P165, DOI 10.1111/j.1469-7793.2001.00165.x; HOTTA K, 1983, J PHYSIOL-LONDON, V336, P199; Khan N, 2008, J GEN PHYSIOL, V132, P223, DOI 10.1085/jgp.200809986; Kito Y, 2003, J PHYSIOL-LONDON, V546, P191, DOI 10.1113/jphysiol.2002.027607; Kito Y, 2014, J PHYSIOL-LONDON, V592, P4733, DOI 10.1113/jphysiol.2014.276337; Kito Y, 2007, PFLUG ARCH EUR J PHY, V454, P263, DOI 10.1007/s00424-006-0201-3; Kito Y, 2009, AM J PHYSIOL-GASTR L, V297, pG814, DOI 10.1152/ajpgi.00118.2009; Kito Y, 2007, PFLUG ARCH EUR J PHY, V455, P505, DOI 10.1007/s00424-007-0306-3; Kito Y, 2002, PFLUG ARCH EUR J PHY, V445, P202, DOI 10.1007/s00424-002-0884-z; Kito Y, 2012, 7 INT S INT CELL CAJ, P41; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Komuro T, 1996, HISTOL HISTOPATHOL, V11, P769; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; McNaughton NCL, 1997, NEUROPHARMACOLOGY, V36, P895, DOI 10.1016/S0028-3908(97)00085-3; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P176, DOI 10.1111/j.1365-2559.2006.02493.x; TORIHASHI S, 1994, HISTOCHEMISTRY, V101, P169, DOI 10.1007/BF00269542; Vanderwinden JM, 1999, MICROSC RES TECHNIQ, V47, P344, DOI 10.1002/(SICI)1097-0029(19991201)47:5<344::AID-JEMT6>3.0.CO;2-1; Wang XY, 2011, PANCREAS, V40, P137, DOI 10.1097/MPA.0b013e3181f690ff; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602; Ward SM, 1995, AM J PHYSIOL-CELL PH, V269, pC1577; Wouters M, 2006, AM J PHYSIOL-GASTR L, V290, pG1219, DOI 10.1152/ajpgi.00032.2005; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	51	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	MAR 1	2015	308	5					G378	G388		10.1152/ajpgi.00308.2014		11	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CD1EM	WOS:000350817100003		
J	Ito, K; Hirooka, Y; Sunagawa, K				Ito, Koji; Hirooka, Yoshitaka; Sunagawa, Kenji			Cardiac sympathetic afferent stimulation induces salt-sensitive sympathoexcitation through hypothalamic epithelial Na+ channel activation	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						cardiac sympathetic afferent reflex; salt; heart failure; hypothalamus; heart-brain communication	HEART-FAILURE; PARAVENTRICULAR NUCLEUS; MINERALOCORTICOID RECEPTORS; PRESSURE-OVERLOAD; SODIUM-CHANNELS; MYOCARDIAL-INFARCTION; INDUCED HYPERTENSION; BRAIN; RATS; DYSFUNCTION	The cardiac sympathetic afferent (CSA), which plays an important role in heart-brain communication for sympathoexcitation, is stimulated in heart failure. Additionally, high salt intake leads to further sympathoexcitation due to activation of hypothalamic epithelial Na+ channels (ENaCs) in heart failure. In the present study, we stimulated the CSA in adult male mice by epicardial application of capsaicin and using ethanol as a control to determine whether CSA stimulation led to activation of hypothalamic ENaCs, resulting in salt-induced sympathoexcitation. Three days after capsaicin treatment, an upregulation of hypothalamic alpha-ENaCs, without activation of mineralocorticoid receptors, was observed. We also examined expression levels of the known ENaC activator TNF-alpha. Hypothalamic TNF-alpha increased in capsaicin-treated mice, whereas intracerebroventricular infusion of the TNF-alpha blocker etanercept prevented capsaicin-induced upregulation of alpha-ENaCs. To examine brain arterial pressure (AP) sensitivity toward Na+, we performed an intracerebroventricular infusion of high Na+-containing (0.2 M) artificial cerebrospinal fluid. AP and heart rate were significantly increased in capsaicin-treated mice compared with control mice. CSA stimulation also caused excitatory responses with high salt intake. Compared with a regular salt diet, the high-salt diet augmented AP, heart rate, and 24-h urinary norepinephrine excretion, which is an indirect marker of sympathetic activity with mineralocorticoid receptor activation, in capsaicin-treated mice but not in ethanol-treated mice. Treatment with etanercept or the ENaC blocker benzamil prevented these salt-induced excitatory responses. In summary, we show that CSA stimulation leads to an upregulation of hypothalamic alpha-ENaCs mediated via an increase in TNF-alpha and results in increased salt sensitivity.	[Ito, Koji; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan	Ito, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kojiitoh@cardiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25461112]; Kyushu University Interdisciplinary Programmes in Education and Projects in Research Development	This work was supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 25461112 and a grant from Kyushu University Interdisciplinary Programmes in Education and Projects in Research Development.	Gabor A, 2012, J APPL PHYSIOL, V113, P1294, DOI 10.1152/japplphysiol.00553.2012; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Wang HJ, 2014, HYPERTENSION, V64, P745, DOI 10.1161/HYPERTENSIONAHA.114.03699; DiPetrillo K, 2004, KIDNEY INT, V65, P1676, DOI 10.1111/j.1523-1755.2004.00606.x; Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI [10.1517/14728222.12.6.717 , 10.1517/14728220802138252]; Xiao L, 2011, HYPERTENSION, V58, P1057, DOI 10.1161/HYPERTENSIONAHA.111.176636; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Ito K, 2009, CIRC RES, V104, P1004, DOI 10.1161/CIRCRESAHA.108.188995; Leenen FHH, 2010, BBA-MOL BASIS DIS, V1802, P1132, DOI 10.1016/j.bbadis.2010.03.004; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH576; Gao L, 2005, HYPERTENSION, V45, P1173, DOI 10.1161/01.HYP.0000168056.66981.c2; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Huang BS, 2011, CURR HYPERTENS REP, V13, P214, DOI 10.1007/s11906-011-0192-0; Van Huysse JW, 2012, HYPERTENSION, V60, P691, DOI 10.1161/HYPERTENSIONAHA.112.193045; Amin MS, 2005, AM J PHYSIOL-REG I, V289, pR1787, DOI 10.1152/ajpregu.00063.2005; Francis J, 2004, AM J PHYSIOL-HEART C, V287, pH791, DOI 10.1152/ajpheart.00099.2004; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Zahner MR, 2003, J PHYSIOL-LONDON, V551, P515, DOI 10.1113/jphysiol.2003.048207; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; Huang BS, 2009, AM J PHYSIOL-REG I, V296, pR994, DOI 10.1152/ajpregu.90903.2008; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Takahashi H, 2011, HYPERTENS RES, V34, P1147, DOI 10.1038/hr.2011.105; FOX AJ, 1995, NEUROSCIENCE, V67, P741, DOI 10.1016/0306-4522(95)00115-Y; Guo ZL, 2004, BRAIN RES, V1006, P36, DOI 10.1016/j.brainres.2004.01.057; Huang BS, 1996, AM J PHYSIOL-HEART C, V270, pH275; Ito K, 2013, HYPERTENS RES, V36, P513, DOI 10.1038/hr.2012.221; Ito K, 2010, J HYPERTENS, V28, P1449, DOI 10.1097/HJH.0b013e328338bb37; Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Ma F, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-31; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Qin C, 2006, AM J PHYSIOL-REG I, V291, pR1700, DOI 10.1152/ajpregu.00231.2006; Wang W, 1999, AM J PHYSIOL-HEART C, V277, pH812; Xu B, 2011, EXP PHYSIOL, V96, P295, DOI 10.1113/expphysiol.2010.055475; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhou QH, 2011, J PHARMACOL EXP THER, V339, P618, DOI 10.1124/jpet.111.185876	37	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	MAR 1	2015	308	5					H530	H539		10.1152/ajpheart.00586.2014		10	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CD1CC	WOS:000350810400017		
J	Yamanaga, K; Tsujita, K; Komura, N; Kaikita, K; Sakamoto, K; Miyazaki, T; Saito, M; Ishii, M; Tabata, N; Akasaka, T; Sato, K; Arima, Y; Kojima, S; Tayama, S; Nakamura, S; Hokimoto, S; Ogawa, H				Yamanaga, Kenshi; Tsujita, Kenichi; Komura, Naohiro; Kaikita, Koichi; Sakamoto, Kenji; Miyazaki, Takashi; Saito, Michiyo; Ishii, Masanobu; Tabata, Noriaki; Akasaka, Tomonori; Sato, Koji; Arima, Yuichiro; Kojima, Sunao; Tayama, Shinji; Nakamura, Sunao; Hokimoto, Seiji; Ogawa, Hisao			Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						coronary microcirculation; vascular resistance; vasospasm; endothelial function	MYOCARDIAL LACTATE; SPASTIC ANGINA; RESISTANCE; RESERVE; INTERMEDIATE; ERGONOVINE; ARTERIES; DISEASE	Endothelial and vascular smooth muscle dysfunction of epicardial coronary arteries play a pivotal role in the pathogenesis of vasospastic angina (VSA). However, coronary microvascular (MV) function in patients with VSA is not fully understood. In the present study, subjects without coronary obstruction were divided into two groups according to the acetylcholine provocation test: VSA group (n = 29) and non-VSA group (n = 21). Hyperemic MV resistance (hMR) was measured using a dual-sensor (Doppler velocity and pressure)-equipped guidewire, and guidewire-derived hemodynamic parameters were compared. There were no between-group differences in clinical demographics, including potential factors affecting MV function (e.g., diabetes). Although coronary flow velocity reserve was similar between the two groups [2.4 +/- 1.0 (VSA group) vs. 2.4 +/- 0.9 (non-VSA group); P = 0.8], coronary vessel resistance and hMR were significantly elevated in the VSA group compared with the non-VSA group (2.6 +/- 3.1 vs. 1.2 +/- 0.8, P = 0.04; 1.9 +/- 0.6 vs. 1.6 +/- 0.5, P = 0.03, respectively). Coronary vasospasm, older age, E/e', and estimated glomerular filtration rate were significantly associated with MV dysfunction [defined as >= median value of hMR (1.6)] in univariate analysis. Coronary vasospasm most strongly predicted higher hMR in multivariate logistic regression analysis (odds ratio, 4.61; 95% confidence interval, 0.98-21.60; P = 0.053). In conclusion, coronary MV resistance is impaired in patients with VSA compared with non-VSA patients, whereas coronary flow velocity reserve is maintained at normal levels in both groups. In vivo assessment of hMR might be a promising index of coronary MV dysfunction in patients with VSA.	[Yamanaga, Kenshi; Tsujita, Kenichi; Komura, Naohiro; Kaikita, Koichi; Sakamoto, Kenji; Miyazaki, Takashi; Saito, Michiyo; Ishii, Masanobu; Tabata, Noriaki; Akasaka, Tomonori; Sato, Koji; Arima, Yuichiro; Kojima, Sunao; Tayama, Shinji; Nakamura, Sunao; Hokimoto, Seiji; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, Kumamoto 8608556, Japan; [Nakamura, Sunao] New Tokyo Hosp, Div Cardiol, Matsudo, Chiba, Japan	Tsujita, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tsujita@kumamoto-u.ac.jp			Ministry of Education, Science, and Culture, Japan [24790769, 26461075]; Smoking Research Foundation	This work was supported by Grant-in-Aid for Young Scientists B 24790769 and Scientific Research C Grant 26461075 from the Ministry of Education, Science, and Culture, Japan (to K. Tsujita), and the Smoking Research Foundation.	Akasaka T, 1997, AM J CARDIOL, V80, P705; Luo CF, 2014, CIRC-CARDIOVASC INTE, V7, P43, DOI 10.1161/CIRCINTERVENTIONS.113.000953; DOUCETTE JW, 1992, CIRCULATION, V85, P1899; Johnson BD, 2006, EUR HEART J, V27, P1408, DOI 10.1093/eurheartj/ehl040; Tsujita K, 2013, INT J CARDIOL, V168, P2411, DOI 10.1016/j.ijcard.2013.02.002; Pries AR, 2008, CARDIOVASC RES, V80, P165, DOI 10.1093/cvr/cvn136; Meuwissen M, 2001, CIRCULATION, V103, P184; Lanza GA, 2010, CIRCULATION, V121, P2317, DOI 10.1161/CIRCULATIONAHA.109.900191; Meimoun P, 2008, J AM SOC ECHOCARDIOG, V21, P72, DOI 10.1016/j.echo.2007.05.024; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Horimoto M, 2000, CLIN CARDIOL, V23, P221; JCS Joint Working Group, 2014, CIRC J, V78, P2779; KRASNOW N, 1962, J CLIN INVEST, V41, P2075, DOI 10.1172/JCI104665; Mancini M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0316-y; Matsuo H, 2013, CIRC J, V77, P1687, DOI 10.1253/circj.CJ-13-0589; Miyao Y, 2000, J AM COLL CARDIOL, V36, P432, DOI 10.1016/S0735-1097(00)00729-4; Morikawa Y, 2011, INT J CARDIOL, V146, P334, DOI 10.1016/j.ijcard.2009.07.011; Sato K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000227; Suwaidi J A, 2000, Circulation, V101, P948; Teragawa Hiroki, 2013, World J Cardiol, V5, P1, DOI 10.4330/wjc.v5.i1.1; Verhoeff BJ, 2012, AM J PHYSIOL-HEART C, V303, pH422, DOI 10.1152/ajpheart.00003.2012	22	3	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	MAR 1	2015	308	5					H478	H484		10.1152/ajpheart.00593.2014		7	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CD1CC	WOS:000350810400012		
J	Meng, FY; Meliton, A; Moldobaeva, N; Mutlu, G; Kawasaki, Y; Akiyama, T; Birukova, AA				Meng, Fanyong; Meliton, Angelo; Moldobaeva, Nurgul; Mutlu, Gokhan; Kawasaki, Yoshihiro; Akiyama, Tetsu; Birukova, Anna A.			Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						hepatocyte growth factor; guanine nucleotide exchange factors; cytoskeleton; pulmonary endothelium; inflammation; permeability; vascular leak	HEPATOCYTE GROWTH-FACTOR; ATRIAL-NATRIURETIC-PEPTIDE; OXIDIZED PHOSPHOLIPIDS; VASCULAR-PERMEABILITY; KINASE INHIBITOR; SCATTER FACTOR; IN-VIVO; C-MET; INFLAMMATION; MECHANISM	Increased vascular endothelial permeability and inflammation are major pathological mechanisms of pulmonary edema and its life-threatening complication, the acute respiratory distress syndrome (ARDS). We have previously described potent protective effects of hepatocyte growth factor (HGF) against thrombin-induced hyperpermeability and identified the Rac pathway as a key mechanism of HGF-mediated endothelial barrier protection. However, anti-inflammatory effects of HGF are less understood. This study examined effects of HGF on the pulmonary endothelial cell (EC) inflammatory activation and barrier dysfunction caused by the gram-negative bacterial pathogen lipopolysaccharide (LPS). We tested involvement of the novel Rac-specific guanine nucleotide exchange factor Asef in the HGF anti-inflammatory effects. HGF protected the pulmonary EC monolayer against LPS-induced hyperpermeability, disruption of monolayer integrity, activation of NF-kB signaling, expression of adhesion molecules intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and production of IL-8. These effects were critically dependent on Asef. Small-interfering RNA-induced down-regulation of Asef attenuated HGF protective effects against LPS-induced EC barrier failure. Protective effects of HGF against LPS-induced lung inflammation and vascular leak were also diminished in Asef knockout mice. Taken together, these results demonstrate potent anti-inflammatory effects by HGF and delineate a key role of Asef in the mediation of the HGF barrier protective and anti-inflammatory effects. Modulation of Asef activity may have important implications in therapeutic strategies aimed at the treatment of sepsis and acute lung injury/ARDS-induced gram-negative bacterial pathogens.	[Meng, Fanyong; Meliton, Angelo; Moldobaeva, Nurgul; Mutlu, Gokhan; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Kawasaki, Yoshihiro; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan	Birukova, AA (reprint author), Univ Chicago, Lung Injury Ctr, Dept Med, Sect Pulm & Crit Med, 5841 S Maryland Ave,Off N613, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Heart, Lung, and Blood Institute [HL-107920]	This work was supported by Grant HL-107920 from the National Heart, Lung, and Blood Institute.	Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; DOSQUET C, 1992, NOUV REV FR HEMATOL, V34, pS55; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Verghese GM, 1998, AM J RESP CRIT CARE, V158, P386; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Aoki M, 2000, J Atheroscler Thromb, V7, P71; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Cheng HT, 2013, J INVEST MED, V61, P1097, DOI 10.231/JIM.0b013e3182a32fdb; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Essler M, 2000, J IMMUNOL, V164, P6543; Kawasaki Y, 2011, J BIOL CHEM, V285, P1199; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb.937; Lindsay CD, 2010, HUM EXP TOXICOL, V30, P701; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Meliton AY, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-14; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Ricard J D, 2003, Eur Respir J Suppl, V42, p2s; Rosen EM, 1995, ADV CANCER RES, V67, P257, DOI 10.1016/S0065-230X(08)60715-0; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Slotta JE, 2006, INFLAMM RES, V55, P364, DOI 10.1007/s00011-006-6013-2; SMITH CW, 1993, SEMIN HEMATOL, V30, P45; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tomita N, 2000, J Atheroscler Thromb, V7, P1; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Xiaolu Deng, 2011, Brain Res, V1387, P1, DOI 10.1016/j.brainres.2011.02.059; Xing J., 2010, MICROVASC RES, V79, P26; Xing JJ, 2012, MICROVASC RES, V83, P194, DOI 10.1016/j.mvr.2011.09.012; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9	51	2	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	MAR 1	2015	308	5					L452	L463		10.1152/ajplung.00170.2014		12	Physiology; Respiratory System	Physiology; Respiratory System	CD4OD	WOS:000351062000005		
J	Ando, M; Takei, Y				Ando, Masaaki; Takei, Yoshio			Guanylin activates Cl- secretion into the lumen of seawater eel intestine via apical Cl- channel under simulated in vivo conditions	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						guanylin; Cl- channel; transcellular Cl- secretion; water secretion; luminal MgSO4 solution	MARINE TELEOST FISH; ANGUILLA-ANGUILLA; SALINITY ADAPTATION; WATER-ABSORPTION; HCO3-SECRETION; EUROPEAN EEL; RECTAL GLAND; TRANSPORT; MECHANISMS; KIDNEY	Guanylin (GN) action on seawater eel intestine was examined under simulated in vivo conditions, where isotonic luminal fluid has low NaCl and high MgSO4 (MgSO4 Ringer). In Ussing chamber, MgSO4 Ringer induced serosa-negative potential difference (PD) even after bumetanide treatment, which is due to the higher paracellular Na+ permeability over Cl-, as confirmed by the replacement by MgCl2 (no Cl- gradient) or Na2SO4 Ringer (no Na+ gradient). Luminal GN reversed serosa-negative PD, probably by enhancing Cl- secretion into the lumen, as the GN effect was blocked by apical Cl- channel blockers [diphenylamine-2-carboxylic acid (DPC), 5-nitro-2-(3-phenylpropylamino) benzoic acid, glibenclamide but not cystic fibrosis transmembrane regulator (CFTR)(inh)-172] or replacement of luminal fluid by MgCl2 Ringer. The blockers' effect was undetectable when normal Ringer was on both sides. In the sac preparation, NaCl secretion occurred into the lumen (Na+ > Cl-), and GN further enhanced Cl- secretion (Cl- > Na+), resulting in water secretion. These GN effects were also blocked by DPC. Quantitative analyses showed that isotonic NaCl is absorbed when luminal fluid is normal Ringer, but, when luminal fluid is MgSO4 Ringer, hypertonic NaCl, almost equivalent to seawater, is secreted into the lumen after GN. These results indicate that GN stimulates the secretion of hypertonic NaCl into the lumen of seawater eel intestine, like rectal gland of marine elasmobranchs, to get rid of excess NaCl although marine teleost intestine is thought to have only absorptive-type cells with a unique Na-K-Cl cotransport system. The secreted NaCl may activate the cotransport system and further help absorb water in the final segment of seawater eel intestine.	[Ando, Masaaki; Takei, Yoshio] Univ Tokyo, Dept Marine Biosci, Atmosphere & Ocean Res Inst, Physiol Lab, Kashiwa, Chiba 2778564, Japan	Takei, Y (reprint author), Univ Tokyo, Dept Marine Biosci, Atmosphere & Ocean Res Inst, Physiol Lab, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	takei@aori.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21570078, 232470190]	This research was supported in part by Grants-in-Aid for Scientific Research (no. 21570078) to M. Ando and (no. 232470190) to Y. Takei from the Japan Society for the Promotion of Science.	ANDO M, 1980, J COMP PHYSIOL, V138, P87; Ando M, 2014, EEL PHYSL, P160; ANDO M, 1975, COMP BIOCHEM PHYS A, V51, P27, DOI 10.1016/0300-9629(75)90408-9; ANDO M, 1978, COMP BIOCHEM PHYS A, V61, P497; Ando M, 2014, AM J PHYSIOL-REG I, V307, pR653, DOI 10.1152/ajpregu.00543.2013; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Forte LR, 2004, PHARMACOL THERAPEUT, V104, P137, DOI 10.1016/pharmthera.2004.08.007; Cutler CP, 2002, BBA-BIOMEMBRANES, V1566, P92, DOI 10.1016/S0005-2736(02)00596-5; Hiroi J, 2012, RESP PHYSIOL NEUROBI, V184, P257, DOI 10.1016/j.resp.2012.07.019; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Lembo AJ, 2010, GASTROENTEROLOGY, V138, P886, DOI 10.1053/j.gastro.2009.12.050; BARRY PH, 1970, J MEMBRANE BIOL, V3, P93, DOI 10.1007/BF01868010; Geibel JP, 2005, ANNU REV PHYSIOL, V67, P471, DOI 10.1146/annurev.physiol.67.031103.153530; Genz J, 2011, AM J PHYSIOL-REG I, V300, pR895, DOI 10.1152/ajpregu.00299.2010; GREGER R, 1988, COMP BIOCHEM PHYS A, V90, P733, DOI 10.1016/0300-9629(88)90692-5; Grosell M, 2009, J EXP BIOL, V212, P1684, DOI 10.1242/jeb.027730; Grosell M, 2001, FISH PHYSIOL BIOCHEM, V24, P81, DOI 10.1023/A:1011994129743; HALM DR, 1985, J GEN PHYSIOL, V85, P843, DOI 10.1085/jgp.85.6.843; HICKMAN CP, 1968, CAN J ZOOLOG, V46, P457, DOI 10.1139/z68-063; Kalujnaia S, 2009, GEN COMP ENDOCR, V161, P103, DOI 10.1016/j.ygcen.2008.11.005; Kim YK, 2008, COMP BIOCHEM PHYS A, V151, P533, DOI 10.1016/j.cbpa.2008.07.016; Kurita Y, 2008, AM J PHYSIOL-REG I, V294, pR1402, DOI 10.1152/ajpregu.00759.2007; LORETZ CA, 1987, ZOOL SCI, V4, P933; Marshall W, 2006, PHYSL FISHES, V3, P177; Marshall WS, 2002, BBA-BIOMEMBRANES, V1566, P16, DOI 10.1016/S0005-2736(02)00584-9; Marshall WS, 2002, J EXP BIOL, V205, P745; Ruhr IM, 2014, AM J PHYSIOL-REG I, V307, pR1167, DOI 10.1152/ajpregu.00188.2014; SHEHADEH ZH, 1969, COMP BIOCHEM PHYSIOL, V30, P397, DOI 10.1016/0010-406X(69)92011-8; Sindic A, 2006, J AM SOC NEPHROL, V17, P607, DOI 10.1681/ASN.2005080818; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Takei Y, 2007, GEN COMP ENDOCR, V152, P339, DOI 10.1016/j.ygcen.2007.05.005; Takei Y, 2015, ZOOL SCI, V32, P1, DOI 10.2108/zs140142; Takei Y, 2011, MULTIFUNCTIONAL GUT, P262; Tipsmark CK, 2012, COMP BIOCHEM PHYS A, V162, P378, DOI 10.1016/j.cbpa.2012.04.020; Trischitta F, 1996, J COMP PHYSIOL B, V166, P30; Trischitta F, 2001, J COMP PHYSIOL B, V171, P85, DOI 10.1007/s003600000152; Tsukada T, 2005, ZOOL SCI, V22, P77, DOI 10.2108/zsj.22.77; Watanabe T, 2011, J EXP BIOL, V214, P1783, DOI 10.1242/jeb.051789; Wilson RW, 2002, BBA-BIOMEMBRANES, V1566, P182, DOI 10.1016/S0005-2736(02)00600-4; Yuge S, 2003, J BIOL CHEM, V278, P22726, DOI 10.1074/jbc.M303111200; Yuge S, 2006, GEN COMP ENDOCR, V149, P10, DOI 10.1016/j.ygcen.2006.04.012; Yuge S, 2007, ZOOL SCI, V24, P1222, DOI 10.2108/zsj.24.1222	42	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	MAR 1	2015	308	5					R400	R410		10.1152/ajpregu.00333.2014		11	Physiology	Physiology	CD1EC	WOS:000350816100007		
J	Iwasaki, Y; Maejima, Y; Suyama, S; Yoshida, M; Arai, T; Katsurada, K; Kumari, P; Nakabayashi, H; Kakei, M; Yada, T				Iwasaki, Yusaku; Maejima, Yuko; Suyama, Shigetomo; Yoshida, Masashi; Arai, Takeshi; Katsurada, Kenichi; Kumari, Parmila; Nakabayashi, Hajime; Kakei, Masafumi; Yada, Toshihiko			Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						nodose ganglion; oxytocin; food intake; obesity; leptin	AMPHETAMINE-REGULATED TRANSCRIPT; SHORT-TERM SATIETY; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; PLASMA OXYTOCIN; CEREBROSPINAL-FLUID; GASTRIC DISTENSION; RAT HYPOTHALAMUS; SOCIAL-BEHAVIOR; NODOSE GANGLIA	Oxytocin (Oxt), a neuropeptide produced in the hypothalamus, is implicated in regulation of feeding. Recent studies have shown that peripheral administration of Oxt suppresses feeding and, when infused subchronically, ameliorates hyperphagic obesity. However, the route through which peripheral Oxt informs the brain is obscure. This study aimed to explore whether vagal afferents mediate the sensing and anorexigenic effect of peripherally injected Oxt in mice. Intraperitoneal Oxt injection suppressed food intake and increased c-Fos expression in nucleus tractus solitarius to which vagal afferents project. The Oxt-induced feeding suppression and c-Fos expression in nucleus tractus solitarius were blunted in mice whose vagal afferent nerves were blocked by subdiaphragmatic vagotomy or capsaicin treatment. Oxt induced membrane depolarization and increases in cytosolic Ca2+ concentration ([Ca2+] (i)) in single vagal afferent neurons. The Oxt-induced [Ca2+] i increases were markedly suppressed by Oxt receptor antagonist. These Oxt-responsive neurons also responded to chole-cystokinin-8 and contained cocaine- and amphetamine-regulated transcript. In obese diabetic db/db mice, leptin failed to increase, but Oxt increased [Ca2+] i in vagal afferent neurons, and single or subchronic infusion of Oxt decreased food intake and body weight gain. These results demonstrate that peripheral Oxt injection suppresses food intake by activating vagal afferent neurons and thereby ameliorates obesity in leptin-resistant db/db mice. The peripheral Oxt-regulated vagal afferent neuron provides a novel target for treating hyperphagia and obesity.	[Iwasaki, Yusaku; Maejima, Yuko; Suyama, Shigetomo; Arai, Takeshi; Katsurada, Kenichi; Kumari, Parmila; Yada, Toshihiko] Jichi Med Univ, Dept Physiol, Div Integrat Physiol, Sch Med, Shimotsuke, Tochigi 3290498, Japan; [Yoshida, Masashi; Kakei, Masafumi] Jichi Med Univ, Sch Med, Saitama Med Ctr, Dept Med 1, Shimotsuke, Tochigi 3290498, Japan; [Nakabayashi, Hajime] Kanazawa Univ, Hlth Sci Serv Ctr, Kanazawa, Ishikawa 9201192, Japan; [Yada, Toshihiko] Natl Inst Physiol Sci, Div Adaptat Dev, Dept Dev Physiol, Aichi, Japan	Yada, T (reprint author), Jichi Med Univ, Dept Physiol, Div Integrat Physiol, Sch Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	tyada@jichi.ac.jp			Japan Society for the Promotion of Science (JSPS) [22790218, 24790221]; Jichi Medical University Young Investigator Award; The Naito Foundation; JSPS [24591341, 23126523, 23390044, 26670453]; Memorial Foundation for Female Natural Scientists; Kowa Life Science Foundation; Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [10036069]; MEXT-Supported Programs for Strategic Research Foundation at Private Universities (Cooperative Basic and Clinical Research on Circadian Medicine) [20132017]; Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan; Japan Diabetes Foundation; Salt Science Research Foundation [1434]	This work was supported by Grant-in-Aid for Young Scientist (B) (22790218, 24790221) from Japan Society for the Promotion of Science (JSPS), Jichi Medical University Young Investigator Award, and The Naito Foundation to Y. Iwasaki. A part of this study was supported by Grant-in-Aid for Scientific Research (C) (24591341) and Scientific Research on Innovative Areas (23126523) from JSPS, Memorial Foundation for Female Natural Scientists, and Kowa Life Science Foundation to Y. Maejima. This work was supported by Grant-in-Aid for Scientific Research (B) (23390044) and for Challenging Exploratory Research (26670453) from JSPS, Strategic Research Program for Brain Sciences (10036069) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), MEXT-Supported Programs for Strategic Research Foundation at Private Universities 2011-2015 (Cooperative Basic and Clinical Research on Circadian Medicine) and 20132017, Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan, a grant from Japan Diabetes Foundation, and a grant from Salt Science Research Foundation (no. 1434) to T. Yada. This study was subsidized by JKA through its promotion funds from KEIRIN RACE to T. Yada.	Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V390, P958, DOI 10.1016/j.bbrc.2009.10.085; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036; Heldsinger A, 2012, AM J PHYSIOL-GASTR L, V303, pG1042, DOI 10.1152/ajpgi.00231.2012; AMICO JA, 1988, AM J MED SCI, V296, P303, DOI 10.1097/00000441-198811000-00003; Maejima Y, 2011, AGING-US, V3, P1169; Onaka T, 2012, J NEUROENDOCRINOL, V24, P587, DOI 10.1111/j.1365-2826.2012.02300.x; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; Dockray GJ, 2009, REGUL PEPTIDES, V155, P6, DOI 10.1016/j.regpep.2009.03.015; Kagerbauer SM, 2013, J NEUROENDOCRINOL, V25, P668, DOI 10.1111/jne.12038; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; MENS WBJ, 1983, BRAIN RES, V262, P143, DOI 10.1016/0006-8993(83)90478-X; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; Iwasaki Y, 2013, NEUROPEPTIDES, V47, P19, DOI 10.1016/j.npep.2012.07.006; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Ueta Y, 2000, J AUTONOM NERV SYST, V78, P69, DOI 10.1016/S0165-1838(99)00049-1; Rinaman L, 2002, AM J PHYSIOL-REG I, V283, pR99, DOI 10.1152/ajpregu.00008.2002; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Broberger C, 1999, P NATL ACAD SCI USA, V96, P13506, DOI 10.1073/pnas.96.23.13506; Gimpl G, 2001, PHYSIOL REV, V81, P629; Welch MG, 2009, J COMP NEUROL, V512, P256, DOI 10.1002/cne.21872; Peters JH, 2006, AM J PHYSIOL-REG I, V290, pR1544, DOI 10.1152/ajpregu.00811.2005; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Bergquist F, 2008, J NEUROENDOCRINOL, V20, P677, DOI 10.1111/j.1365-2826.2008.01714.x; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Simasko SM, 2002, AM J PHYSIOL-REG I, V283, pR1303, DOI 10.1152/ajpregu.00050.2002; de Lartigue G, 2011, AM J PHYSIOL-ENDOC M, V301, pE187, DOI 10.1152/ajpendo.00056.2011; Deblon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025565; De Lartigue G, 2010, GASTROENTEROLOGY, V138, P1479, DOI 10.1053/j.gastro.2009.10.034; GALLEGO R, 1978, J NEUROPHYSIOL, V41, P1217; Garami A, 2010, EUR J PHARMACOL, V644, P61, DOI 10.1016/j.ejphar.2010.07.002; Iwasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067198; Iwasaki Y, 2012, NEUROPEPTIDES, V46, P291, DOI 10.1016/j.npep.2012.08.009; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kiss Alexander, 2005, Endocr Regul, V39, P97; Lankisch TO, 2002, AM J PHYSIOL-GASTR L, V282, pG1002, DOI 10.1152/ajpgi.00313.2001; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Nelson EE, 1998, DEV BRAIN RES, V111, P301, DOI 10.1016/S0165-3806(98)00147-3; OLSON BR, 1992, BRAIN RES, V569, P238, DOI 10.1016/0006-8993(92)90635-M; Onaka T, 1998, J NEUROENDOCRINOL, V10, P309, DOI 10.1046/j.1365-2826.1998.00209.x; Patel JD, 2008, EUR J PHARMACOL, V580, P143, DOI 10.1016/j.ejphar.2007.10.046; Peters JH, 2005, AM J PHYSIOL-REG I, V288, pR879, DOI 10.1152/ajpregu.00716.2004; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; RENAUD LP, 1987, AM J PHYSIOL, V253, pR661; VERBALIS JG, 1986, SCIENCE, V232, P1417, DOI 10.1126/science.3715453; Zhang G, 2011, AM J PHYSIOL-ENDOC M, V301, pE1004, DOI 10.1152/ajpendo.00196.2011	56	3	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	MAR 1	2015	308	5					R360	R369		10.1152/ajpregu.00344.2014		10	Physiology	Physiology	CD1EC	WOS:000350816100003		
J	Narumi, K; Hirose, T; Sato, E; Mori, T; Kisu, K; Ishikawa, M; Totsune, K; Ishii, T; Ichihara, A; Nguyen, G; Sato, H; Ito, S				Narumi, Kaori; Hirose, Takuo; Sato, Emiko; Mori, Takefumi; Kisu, Kiyomi; Ishikawa, Mayuko; Totsune, Kazuhito; Ishii, Tomonori; Ichihara, Atsuhiro; Nguyen, Genevieve; Sato, Hiroshi; Ito, Sadayoshi			A functional (pro)renin receptor is expressed in human lymphocytes and monocytes	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						(pro)renin receptor; renin-angiotensin system; lymphocytes; glomerulonephritis; human	RENIN-ANGIOTENSIN SYSTEM; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; PAI-1 EXPRESSION; GROWTH-FACTOR; GLOMERULONEPHRITIS; SECRETION; PRORENIN; KIDNEY	The renin-angiotensin system (RAS) is involved in inflammation. The signaling via the ANG II type 1 receptor in human lymphocytes and monocytes, which play key roles in pathophysiology of glomerulonephritis (GN), can enhance inflammation. However, the role of the (pro) renin receptor [(P) RR], a component of the RAS, in inflammatory reactions is unknown. We assessed whether (P) RR is expressed in human lymphocytes and monocytes by RT-PCR, Western blotting, flow cytometry, and immunohistochemistry, and whether (P) RR functions in inflammation. (P) RR mRNA and protein were expressed in human peripheral blood mononuclear cells (PBMCs). Flow cytometric analysis revealed high expression of (P) RR on monocytes. (P) RR was present on PBMCs, infiltrating lymphocytes, and macrophages around glomeruli with a crescent in anti-neutrophil cytoplasmic antibody (ANCA)-associated GN. Renin stimulation of PBMCs from healthy subjects in the presence of the ANG II type 1 receptor and ANG II type 2 receptor blockers induced ERK1/2 phosphorylation and release of IL-6 and expression of cyclooxygenase-2 (COX-2). The increases in cytokine release and COX-2 expression were inhibited in the presence of an ERK1/2 inhibitor. (P) RR knockdown by small interfering RNA in U937 cells, a human leukemic monocyte lymphoma cell line, significantly decreased ERK1/2 phosphorylation after renin stimulation. Thus (P) RR expressed in human inflammatory cells might contribute to inflammation in ANCA-associated GN.	[Narumi, Kaori; Hirose, Takuo; Sato, Emiko; Mori, Takefumi; Kisu, Kiyomi; Ishikawa, Mayuko; Sato, Hiroshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan; [Hirose, Takuo; Nguyen, Genevieve] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Hirose, Takuo; Nguyen, Genevieve] CNRS, UMR 7241, Paris, France; [Hirose, Takuo; Nguyen, Genevieve] INSERM, U1050, Paris, France; [Sato, Emiko; Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi 9808574, Japan; [Mori, Takefumi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Integrat Renal Replacement Therapy, Sendai, Miyagi 9808574, Japan; [Totsune, Kazuhito] Tohoku Fukushi Univ, Fac Synthet Welf, Dept Social Welf, Sendai, Miyagi, Japan; [Totsune, Kazuhito] Tohoku Univ, Grad Sch Pharmaceut Sci & Med, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 9808574, Japan; [Ishii, Tomonori] Tohoku Univ, Grad Sch Med, Dept Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan; [Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan	Sato, E (reprint author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	emiko@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [21390259, 22659164, 23300243, 23790242, 25461205, 25860156]; MEXT in Japan; Japan Society for the Promotion of Science (JSPS); Institut National de la Sante et de la Recherche Medicale (INSERM) under the Japan-France Research Cooperative Program; Banyu Foundation	This study was supported in part by Grants for Scientific Research (21390259, 22659164, 23300243, 23790242, 25461205, and 25860156) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; Network Medicine Global-COE Program from the MEXT in Japan; the Japan Society for the Promotion of Science (JSPS), and the Institut National de la Sante et de la Recherche Medicale (INSERM) under the Japan-France Research Cooperative Program; and a Banyu Foundation Research Grant.	El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Takahashi K, 2006, PEPTIDES, V27, P1383, DOI 10.1016/j.peptides.2005.11.004; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Lee CL, 2012, J BIOL CHEM, V287, P36999, DOI 10.1074/jbc.M112.385336; Diet F, 1996, CIRCULATION, V94, P2756; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Krop M, 2013, PFLUG ARCH EUR J PHY, V465, P87, DOI 10.1007/s00424-012-1105-z; Weiss D, 2001, CIRCULATION, V103, P448; BOHLE A, 1992, PATHOL RES PRACT, V188, P908; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; Masaki T, 2004, J AM SOC NEPHROL, V15, P1835, DOI 10.1097/01.ASN.0000130623.66271.67; FERRARIO F, 1985, KIDNEY INT, V28, P513, DOI 10.1038/ki.1985.158; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Nguyen G, 2011, CURR HYPERTENS REP, V13, P79, DOI 10.1007/s11906-010-0172-9; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Takahashi K, 2010, J NEUROENDOCRINOL, V22, P453, DOI 10.1111/j.1365-2826.2010.01980.x; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kintscher U, 2001, HYPERTENSION, V37, P587; Hirose T, 2009, AM J HYPERTENS, V22, P294, DOI 10.1038/ajh.2008.357; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; Bokemeyer D, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017576.50319.AC; Böyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Coppo M, 2008, REGUL PEPTIDES, V151, P1, DOI 10.1016/j.regpep.2008.07.010; FUKATSU A, 1991, LAB INVEST, V65, P61; Guo SH, 2008, J AM SOC NEPHROL, V19, P1168, DOI 10.1681/ASN.2007050607; HERLITZ H, 1988, INT ARCH ALLER A IMM, V85, P272; Hirose T, 2011, HYPERTENS RES, V34, P530, DOI 10.1038/hr.2010.274; Kranzhofer R, 1999, BIOCHEM BIOPH RES CO, V257, P826, DOI 10.1006/bbrc.1999.0543; Kurihara Y, 2011, CELL IMMUNOL, V270, P25, DOI 10.1016/j.cellimm.2011.03.017; Li TT, 2013, MOL IMMUNOL, V53, P414, DOI 10.1016/j.molimm.2012.09.010; OOTAKA T, 1990, J IMMUNOL METHODS, V131, P183, DOI 10.1016/0022-1759(90)90189-3; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007; Rastaldi MP, 1996, AM J KIDNEY DIS, V27, P48, DOI 10.1016/S0272-6386(96)90030-X; Shimizu M, 2006, NEPHROL DIAL TRANSPL, V21, P2380, DOI 10.1093/ndt/gfl243; Takahashi K, 2004, J CLIN ENDOCR METAB, V89, P1897, DOI 10.1210/jc.2003-031663; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Wada T, 2000, J AM SOC NEPHROL, V11, P1534; Wilde B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2923; Zhang JD, 2012, AM J PHYSIOL-RENAL, V303, pF11, DOI 10.1152/ajprenal.00050.2012; Zhang JD, 2008, AM J PHYSIOL-ENDOC M, V295, pE810, DOI 10.1152/ajpendo.90264.2008	51	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	MAR 1	2015	308	5					F487	F499		10.1152/ajprenal.00206.2014		13	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	CD1CP	WOS:000350811800012		
J	Nishimoto, M; Fujita, T				Nishimoto, Mitsuhiro; Fujita, Toshiro			Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Review						salt-sensitive hypertension; mineralocorticoid receptor; glucocorticoid receptor; Ras-related C3 botulinum toxin substrate 1; sympathetic nervous system	NA+-CL-COTRANSPORTER; SODIUM-CHLORIDE COTRANSPORTER; ARTERIAL-PRESSURE ELEVATION; SELECTIVE ALDOSTERONE BLOCKER; MAMMALIAN CIRCADIAN CLOCK; ACTIVATED PROTEIN-KINASE; DISTAL CONVOLUTED TUBULE; NERVOUS-SYSTEM ACTIVITY; CONTROLS BLOOD-PRESSURE; GROWTH-FACTOR-BETA	Although salt is a major environmental factor in the development of hypertension, the degree of salt sensitivity varies widely among individuals. The mechanisms responsible for this variation remain to be elucidated. Recent studies have revealed the involvement of two important signaling pathways in renal tubules that play key roles in electrolyte balance and the maintenance of normal blood pressure: the beta(2)-adrenergic stimulant-glucocorticoid receptor (GR)-with-no-lysine kinase (WNK) 4Na(+)-Cl- cotransporter pathway, which is active in distal convoluted tubule (DCT)1, and the Ras-related C3 botulinum toxin substrate (Rac)1-mineralocorticoid receptor (MR) pathway, which is active in DCT2, connecting tubules, and collecting ducts. beta(2)-Adrenergic stimulation due to increased renal sympathetic activity in obesity-and salt-induced hypertension suppresses histone deacetylase 8 activity via cAMP/PKA signaling, increasing the accessibility of GRs to the negative GR response element in the WNK4 promoter. This results in the suppression of WNK4 transcription followed by the activation of Na+-Cl- cotransporters in the DCT and elevated Na+ retention and blood pressure upon salt loading. Rac1 activates MRs, even in the absence of ligand binding, with this activity increased in the presence of ligand. In salt-sensitive animals, Rac1 activation due to salt loading activates MRs in DCT2, connecting tubules, and collecting ducts. Thus, GRs and MRs are independently involved in two pathways responsible for renal Na+ handling and salt-sensitive hypertension. These findings suggest novel therapeutic targets and may lead to the development of diagnostic tools to determine salt sensitivity in hypertensive patients.	[Nishimoto, Mitsuhiro; Fujita, Toshiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Clin Epigenet, Tokyo 1538904, Japan	Fujita, T (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Div Clin Epigenet, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	Toshiro.FUJITA@rcast.u-tokyo.ac.jp		Nishimoto, Mitsuhihiro/0000-0001-9542-847X	Japan Society for the Promotion of Science [21229012]; Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency	This work was supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 21229012 and by the Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency.	Alvarez-Guerra M, 2002, J HYPERTENS, V20, P721, DOI 10.1097/00004872-200204000-00031; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Komers R, 2012, CLIN SCI, V123, P635, DOI 10.1042/CS20120003; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Zennaro MC, 2001, MOL ENDOCRINOL, V15, P1586, DOI 10.1210/me.15.9.1586; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Uddin S, 2000, J BIOL CHEM, V275, P27634; Foss JD, 2013, HYPERTENSION, V61, P806, DOI 10.1161/HYPERTENSIONAHA.111.00474; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Nagase M, 2012, HYPERTENSION, V59, P500, DOI 10.1161/HYPERTENSIONAHA.111.185520; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Bentley-Lewis R, 2007, J CLIN ENDOCR METAB, V92, P4472, DOI 10.1210/jc.2007-1088; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Kobori H, 2003, HYPERTENSION, V41, P592, DOI 10.1161/01.HYP.0000056768.03657.B4; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Toka HR, 2013, PEDIATR NEPHROL, V28, P387, DOI 10.1007/s00467-012-2206-9; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Gamba G, 2012, AM J PHYSIOL-RENAL, V303, pF1573, DOI 10.1152/ajprenal.00508.2012; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; van der Lubbe N, 2012, PFLUG ARCH EUR J PHY, V463, P853, DOI 10.1007/s00424-012-1104-0; Chen DS, 1999, MOL CELL BIOL, V19, P1002; GORDON RD, 1986, HYPERTENSION, V8, P93; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Huang BS, 2011, CURR HYPERTENS REP, V13, P214, DOI 10.1007/s11906-011-0192-0; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Sato A, 2010, J HUM HYPERTENS, V24, P387, DOI 10.1038/jhh.2009.81; Richards J, 2013, AM J PHYSIOL-RENAL, V305, pF1697, DOI 10.1152/ajprenal.00472.2013; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Vidal-Petiot E, 2013, P NATL ACAD SCI USA, V110, P14366, DOI 10.1073/pnas.1304230110; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; DiBona GF, 2003, HYPERTENSION, V41, P621, DOI 10.1161/01.HYP.0000047205.52509.8A; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Fujita M, 2012, HYPERTENSION, V59, P105, DOI 10.1161/HYPERTENSIONAHA.111.182923; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Terker AS, 2014, HYPERTENSION, V64, P178, DOI 10.1161/HYPERTENSIONAHA.114.03335; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JC129850; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Liu Z, 2011, HUM MOL GENET, V20, P855, DOI 10.1093/hmg/ddq525; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Capasso G, 2008, AM J PHYSIOL-RENAL, V295, pF556, DOI 10.1152/ajprenal.00340.2007; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.000206772.78696.67; Aikawa R, 1999, CIRC RES, V84, P458; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; KASSAB S, 1995, HYPERTENSION, V25, P893; Richards J, 2014, J BIOL CHEM, V289, P11791, DOI 10.1074/jbc.M113.531095; Huang BS, 2009, AM J PHYSIOL-REG I, V296, pR994, DOI 10.1152/ajpregu.90903.2008; Higashi Y, 1997, HYPERTENSION, V30, P163; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; GUYTON AC, 1990, HYPERTENSION, V16, P725; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; BENISHAY D, 1972, EXPERIENTIA, V28, P1321, DOI 10.1007/BF01965321; BIANCHI G, 1975, CIRC RES, V36, P153; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028; CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32; CASSIS LA, 1988, HYPERTENSION, V11, P591; Chung WY, 2013, CELL SIGNAL, V25, P2469, DOI 10.1016/j.cellsig.2013.08.006; do Carmo JM, 2012, AM J PHYSIOL-REG I, V302, pR561, DOI 10.1152/ajpregu.00392.2011; DUPONT J, 1973, BIOMEDICINE, V19, P36; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; ESLER MD, 1985, J HYPERTENS, V3, P117, DOI 10.1097/00004872-198504000-00003; FUJITA T, 1992, HYPERTENSION, V20, P466; FUJITA T, 1990, HYPERTENSION, V16, P235; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; GILL JR, 1988, HYPERTENSION, V11, P312; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; Gonzalez-Santiago L, 2006, CELL DEATH DIFFER, V13, P1968, DOI 10.1038/sj.cdd.4401898; Goodfriend TL, 2002, ENDOCR RES, V28, P325, DOI 10.1081/ERC-120016804; Hadchouel J, 2010, P NATL ACAD SCI USA, V107, P18109, DOI 10.1073/pnas.1006128107; HALL JE, 1990, AM J PHYSIOL, V258, pF722; Ho HH, 2012, J CLIN HYPERTENS, V14, P569, DOI 10.1111/j.1751-7176.2012.00623.x; Jacques T, 2013, J AM SOC NEPHROL, V24, P1104, DOI 10.1681/ASN.2012080787; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; KATHOLI RE, 1983, HYPERTENSION, V5, P427; Kawakami-Mori F, 2012, AM J PHYSIOL-ENDOC M, V302, pE425, DOI 10.1152/ajpendo.00227.2011; Lai LY, 2012, PFLUG ARCH EUR J PHY, V463, P477, DOI 10.1007/s00424-011-1062-y; Li JP, 2007, J HYPERTENS, V25, P1065, DOI 10.1097/HJH.0b013e3280a8b87d; Liu J, 2011, J BIOL CHEM, V286, P22806, DOI 10.1074/jbc.M111.246249; LOUIS WJ, 1971, LANCET, V2, P1283; Luft Friedrich C., 1997, American Journal of Clinical Nutrition, V65, p612S; MACGREGOR GA, 1982, LANCET, V1, P351; Malendowicz LK, 1997, J STEROID BIOCHEM, V63, P123, DOI 10.1016/S0960-0760(97)00082-4; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; Mikhaylova IV, 2007, ENDOCRINOLOGY, V148, P386, DOI 10.1210/en.2006-0726; MORGAN T, 1978, LANCET, V1, P227; Oate SA, 1995, SCIENCE, V270, P1354, DOI 10.1126/science.270.5240.1354; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okamura H, 2010, ADV DRUG DELIVER REV, V62, P876, DOI 10.1016/j.addr.2010.06.004; Park HW, 2011, P NATL ACAD SCI USA, V108, P10750, DOI 10.1073/pnas.1104271108; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; SATO Y, 1991, AM J PHYSIOL, V260, pR941; SMIRK FH, 1958, NATURE, V182, P727, DOI 10.1038/182727a0; Sohara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024277; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; Sueta D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000035; Sun ZJ, 2013, GENET MOL RES, V12, P2332, DOI 10.4238/2013.January.4.9; Symplicity HTNI, 2010, LANCET, V376, P1903, DOI DOI 10.1016/S0140-6736(10)62039-9; van der Lubbe N, 2013, AM J PHYSIOL-RENAL, V305, pF1177, DOI 10.1152/ajprenal.00201.2013; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Westerstahl M, 2014, ACTA PAEDIATR, V103, P225, DOI 10.1111/apa.12479; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Yoshida S, 2014, NEPHRON EXP NEPHROL, V126, P16, DOI 10.1159/000358758	146	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	MAR 1	2015	308	5					F377	F387		10.1152/ajprenal.00477.2013		11	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	CD1CP	WOS:000350811800001		
J	Akhmedov, A; Ishida, M; Park, BD				Akhmedov, Anar; Ishida, Masashi; Park, B. Doug			Dissolving 4-manifolds, covering spaces and Yamabe invariant	ANNALS OF GLOBAL ANALYSIS AND GEOMETRY			English	Article						4-manifold; Dissolve; Yamabe invariant; Scalar curvature; Rosenberg conjecture	POSITIVE SCALAR CURVATURE; SPIN SYMPLECTIC 4-MANIFOLDS; 4-DIMENSIONAL MANIFOLDS; ELLIPTIC-SURFACES; WITTEN INVARIANTS; TOPOLOGY; SEIBERG; GEOGRAPHY; MINIMALITY; DIMENSION	We construct new spin and nonspin 4-manifolds with zero signature that dissolve after a connected sum with only one copy of . We use these 4-manifolds to construct new examples of 4-manifolds with negative Yamabe invariant and whose universal covers have positive Yamabe invariant. In particular, these provide new spin and nonspin counterexamples to a conjecture of Rosenberg in the case of dimension four.	[Akhmedov, Anar] Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA; [Ishida, Masashi] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan; [Park, B. Doug] Univ Waterloo, Dept Pure Math, Waterloo, ON N2L 3G1, Canada	Park, BD (reprint author), Univ Waterloo, Dept Pure Math, Waterloo, ON N2L 3G1, Canada.	akhmedov@math.umn.edu; ishida@math.sci.osaka-u.ac.jp; bdpark@uwaterloo.ca			NSF [DMS-1005741]; Japan Society for the Promotion of Science [20540090]; NSERC	Anar Akhmedov was partially supported by NSF grant DMS-1005741. Masashi Ishida was partially supported by the Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, No. 20540090. B. Doug Park was partially supported by an NSERC discovery grant.	Akbulut S, 2002, TURKISH J MATH, V26, P81; Akhmedov A, 2013, PAC J MATH, V261, P257, DOI 10.2140/pjm.2013.261.257; Akhmedov A, 2010, MATH RES LETT, V17, P483; Akhmedov A., 2008, J GOKOVA GEOM TOPOL, V2, P1; AUBIN T, 1976, J MATH PURE APPL, V55, P269; Taubes CH, 1995, MATH RES LETT, V2, P9; FREEDMAN MH, 1982, J DIFFER GEOM, V17, P357; KOBAYASHI O, 1987, MATH ANN, V279, P253, DOI 10.1007/BF01461722; SCHOEN R, 1979, MANUSCRIPTA MATH, V28, P159, DOI 10.1007/BF01647970; GROMOV M, 1980, ANN MATH, V111, P423, DOI 10.2307/1971103; Auckly D, 2003, TOPOL APPL, V127, P277, DOI 10.1016/S0166-8641(02)00063-9; Taubes CH, 1994, MATH RES LETT, V1, P809; GOMPF RE, 1991, TOPOLOGY, V30, P479, DOI 10.1016/0040-9383(91)90027-2; Bauer S, 2004, INT MAT SER, P1; Bauer S, 2004, INVENT MATH, V155, P21, DOI 10.1007/s00222-003-0289-4; Berard-Bergery L, 1983, SPECTRA RIEMANNIAN M, P9; GOMPF RE, 1995, ANN MATH, V142, P527, DOI 10.2307/2118554; GOMPF RE, 1991, J DIFFER GEOM, V34, P93; Hamilton MJD, 2006, INT MATH RES NOTICES; Hanke B, 2003, MATH Z, V245, P545, DOI 10.1007/s00209-003-0553-8; Ishida M., 2003, COMMUN ANAL GEOM, V11, P809; Jabuka S, 2008, GEOM TOPOL, V12, P1557, DOI 10.2140/gt.2008.12.1557; KWASIK S, 1990, COMMENT MATH HELV, V65, P271, DOI 10.1007/BF02566607; LeBrun C, 2009, PROG MATH, V271, P119, DOI 10.1007/978-0-8176-4743-8_6; LeBrun C, 2001, INVENT MATH, V145, P279, DOI 10.1007/s002220100148; LeBrun C, 1999, COMMUN ANAL GEOM, V7, P133; LeBrun C, 2003, NEW YORK J MATH, V9, P93; LeBrun C, 1996, MATH RES LETT, V3, P137; LEE JM, 1987, B AM MATH SOC, V17, P37, DOI 10.1090/S0273-0979-1987-15514-5; MANDELBAUM R, 1980, B AM MATH SOC, V2, P1, DOI 10.1090/S0273-0979-1980-14687-X; MANDELBAUM R, 1980, T AM MATH SOC, V260, P195, DOI 10.2307/1999883; Ozsvath P, 2004, DUKE MATH J, V121, P1; Park BD, 2002, MICH MATH J, V50, P593, DOI 10.1307/mmj/1039029984; Park J, 2002, MATH Z, V240, P405, DOI 10.1007/s002090100390; ROSENBERG J, 1986, TOPOLOGY, V25, P319, DOI 10.1016/0040-9383(86)90047-9; SCHOEN RM, 1989, LECT NOTES MATH, V1365, P120; Schoen R, 1984, J DIFFER GEOM, V20, P478; Trudinger N. S., 1968, ANN SCUOLA NORM SUP, V22, P265; Ue M, 1996, J MATH SOC JPN, V48, P333, DOI 10.2969/jmsj/04820333; USHER M, 2006, INT MATH RES NOTICES; Wall C. T. C., 1964, J LOND MATH SOC, V39, P141; Wall C. T. C., 1964, J LOND MATH SOC, Vs1-39, P131; Wolf J. A., 1984, SPACES CONSTANT CURV, V5th; Yamabe H., 1960, OSAKA MATH J, V12, P21	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0232-704X	1572-9060		ANN GLOB ANAL GEOM	Ann. Glob. Anal. Geom.	MAR	2015	47	3					271	283		10.1007/s10455-014-9445-x		13	Mathematics	Mathematics	CD1ZU	WOS:000350874000003		
J	Arasu, MV; Jung, MW; Kim, DH; Park, HS; Ilavenil, S; Al-Dhabi, NA; Choi, KC				Arasu, Mariadhas Valan; Jung, Min Woong; Kim, Da Hye; Park, Hyung Soo; Ilavenil, Soundarrajan; Al-Dhabi, Naif Abdullah; Choi, Ki Choon			Identification and phylogenetic characterization of novel Lactobacillus plantarum species and their metabolite profiles in grass silage	ANNALS OF MICROBIOLOGY			English	Article						L. plantarum; 16S rRNA gene; Shake-flask cultivation; Lactic acid; Silage fermentation	LACTIC-ACID BACTERIA; AEROBIC DETERIORATION; ALFALFA; INOCULANTS; DIGESTIBILITY; PERFORMANCE; MAIZE	Italian ryegrass (IRG), barley, and rye are types of forage that are difficult to ensile with an assurance of good quality. Therefore, the addition of lactic acid bacteria (LAB) is the best way to enhance the preservation of this silage. However, applications of LAB have been impeded due to its poor growth characteristics, the sudden decline in pH, and other non-beneficial microbial growth associated with its presence. To overcome these limitations, a new Lactobacillus sp. KCC-10 and KCC-19 strain was isolated from well-fermented IRG silage samples. Biochemical and physiological studies revealed that the strains were Gram-positive, catalase-negative, and produced gas from glucose, and produced more lactic acid in fermentation. The 16S rRNA gene-based phylogenetic affiliation was determined by using bioinformatic tools that identified Lactobacillus sp. KCC-10 and KCC-19 with 100 % sequence similarity to Lactobacillus plantarum. Novel L. plantarum strains were deposited in the Korean Collection for Type Cultures under the accession numbers KACC 91785P and KACC 91758P, respectively. The shake-flask cultivation of these new strains under aerobic, microaerobic, and anaerobic conditions showed a higher specific growth rate than that achieved using the well-studied L. plantarum KACC 91016 and KACC 91096 on MRS broth and grass juice. Lactic acid was detected as the dominant organic acid in IRG (78.45 mM), barley (51.28 mM), corn (16.28 mM), and rice paddy (11.05 mM), followed by acetic acid and succinic acid. The KCC-10 in the silage was observed to increase from 2.4 x 10(5) CFU/g per sample at day 0 to 0.58, 0.60, and 0.59 x 10(9) CFU/g at day 5 for IRG, barley, and rye, respectively. The growth of KCC-10 and KCC-19 in all the silages decreased, as the storage period increased from 5 to 50 days. Whereas, KCC-19 was noted to increase from 2.7 x 10(5) CFU/g per sample at day 0 to 0.71, 0.72, and 0.711 x 10(9) CFU/g at day 5 for IRG, barley, and rye. Among the total organic acids, lactic acid was detected as the dominant acid present in IRG, barley, and rye silages. From these results, we concluded that strains KCC-10 and KCC-19 can be used as appropriate inoculants to prolong the stability of silage and fermentation quality.	[Arasu, Mariadhas Valan; Jung, Min Woong; Park, Hyung Soo; Ilavenil, Soundarrajan; Choi, Ki Choon] Natl Inst Anim Sci, Grassland & Forage Div, RDA, Cheonan Si 330801, Chungnam, South Korea; [Kim, Da Hye] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Al-Dhabi, Naif Abdullah] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Addiriyah Chair Environm Studies, Riyadh 11451, Saudi Arabia	Choi, KC (reprint author), Natl Inst Anim Sci, Grassland & Forage Div, RDA, Cheonan Si 330801, Chungnam, South Korea.	choiwh@korea.kr			"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ008502]	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ008502)", Rural Development Administration, Republic of Korea.	WOOLFORD MK, 1975, J SCI FOOD AGR, V26, P219, DOI 10.1002/jsfa.2740260213; De Angelis M, 2008, INT J FOOD MICROBIOL, V125, P123, DOI 10.1016/j.ijfoodmicro.2008.03.043; Weinberg ZG, 1996, FEMS MICROBIOL REV, V19, P53, DOI 10.1111/j.1574-6976.1996.tb00253.x; ASHBELL G, 1988, J SCI FOOD AGR, V45, P307, DOI 10.1002/jsfa.2740450404; Winters AL, 2001, GRASS FORAGE SCI, V56, P181, DOI 10.1046/j.1365-2494.2001.00265.x; Ennahar S, 2003, APPL ENVIRON MICROB, V69, P444, DOI 10.1128/AEM.69.1.444-451.2003; Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001; Cai YM, 1999, J DAIRY SCI, V82, P520; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Arasu VM, 2013, J APPL MICROBIOL, V115, P1172, DOI DOI 10.1111/JAM.12319; Avila CLD, 2010, REV BRAS ZOOTECN, V39, P25, DOI 10.1590/S1516-35982010000100004; Bach SJ, 2002, J APPL MICROBIOL, V93, P288, DOI 10.1046/j.1365-2672.2002.01695.x; Barnett AJG, 1954, SILAGE FERMANTATION, P111; Eitan BD, 2006, APPL ENVIRON MICROB, V72, P6902; Georgieva RN, 2008, J BASIC MICROB, V48, P234, DOI 10.1002/jobm.200700355; LIN C, 1992, J DAIRY SCI, V75, P2484, DOI 10.3168/jds.S0022-0302(92)78010-2; LIN CJ, 1992, J APPL BACTERIOL, V73, P375, DOI 10.1111/j.1365-2672.1992.tb04992.x; McAllister TA, 1998, LIVEST PROD SCI, V53, P171, DOI 10.1016/S0301-6226(97)00150-4; McDonald P, 1991, BIOCH SILAGE, P20; Nakui T, 1988, B TOHOKU NATL AGR EX, V78, P173; Rodrigues PHM, 2001, REV BRAS ZOOTECN, V30, P1925, DOI 10.1590/S1516-35982001000700032; Sebastian S, 1996, J ANIM SCI, V71, P505; Arasu MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085297; Weinberg ZG, 2003, J APPL MICROBIOL, V94, P1066, DOI 10.1046/j.1365-2672.2003.01942.x	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1590-4261	1869-2044		ANN MICROBIOL	Ann. Microbiol.	MAR	2015	65	1					15	25		10.1007/s13213-014-0830-2		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CC3BP	WOS:000350219500002		
J	Takahashi, T; Takeuchi, H; Kitagawa, Y				Takahashi, Tsunehiro; Takeuchi, Hiroya; Kitagawa, Yuko			What Factors Are Necessary for the Safe and Feasible Performance of Total Gastrectomy?	ANNALS OF SURGICAL ONCOLOGY			English	Editorial Material							GASTRIC-CANCER; SPLENECTOMY; MORBIDITY		[Takahashi, Tsunehiro; Takeuchi, Hiroya; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	htakeuchi@a6.keio.jp					BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Watanabe M, 2014, ANN SURG, V260, P1034, DOI 10.1097/SLA.0000000000000781; Hirahara N, 2011, SURG LAPARO ENDO PER, V21, pE11, DOI 10.1097/SLE.0b013e31820747f2; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Costa Jr WL, 2014, ANN SUR ONCOL, DOI [10.1245/s10434-014-4212-6, DOI 10.1245/S10434-014-4212-6]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Katai Hitoshi, 2005, Gastric Cancer, V8, P137, DOI 10.1007/s10120-005-0317-8; KITANO S, 1995, SURG LAPAROSC ENDOSC, V5, P359; Nomura S, 2000, GASTRIC CANCER, V3, P97, DOI 10.1007/PL00011703; Sano T, 2010, J CLIN ONCOL S, V28, p15s; Wanebo HJ, 1997, J AM COLL SURGEONS, V185, P177, DOI 10.1016/S1072-7515(97)00047-1	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					704	705		10.1245/s10434-014-4227-z		2	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100002		
J	Arita, T; Ichikawa, D; Konishi, H; Komatsu, S; Shiozaki, A; Hiramoto, H; Hamada, J; Shoda, K; Kawaguchi, T; Hirajima, S; Nagata, H; Fujiwara, H; Okamoto, K; Otsuji, E				Arita, Tomohiro; Ichikawa, Daisuke; Konishi, Hirotaka; Komatsu, Shuhei; Shiozaki, Atsushi; Hiramoto, Hidekazu; Hamada, Junichi; Shoda, Katsutoshi; Kawaguchi, Tsutomu; Hirajima, Shoji; Nagata, Hiroaki; Fujiwara, Hitoshi; Okamoto, Kazuma; Otsuji, Eigo			Increase in Peritoneal Recurrence Induced by Intraoperative Hemorrhage in Gastrectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							PERIOPERATIVE BLOOD-TRANSFUSIONS; GASTRIC-CANCER; CURATIVE RESECTION; SURVIVAL; CARCINOMA; PROGNOSIS; SURGERY; IMPACT; TRIAL	Background. The association between intraoperative hemorrhage and the type of recurrence was examined, with a focus on peritoneal metastasis. Methods. A total of 540 patients who underwent macroscopically curative gastrectomy for advanced gastric cancers were reviewed for various clinicopathological characteristics, such as the amount of intraoperative hemorrhage and the pattern of recurrence. Additionally, adhesion assays using gastric cancer cells and mesothelial cells were performed in the presence of blood plasma to assess its effects on cell adhesion. Results. Large intraoperative hemorrhages were correlated with a higher risk of peritoneal metastasis, while small hemorrhages were not. However, there were no significant differences in the incidence of all recurrences or other types of recurrence between both groups. Multivariate analysis of all cases (T2-4) revealed that large intraoperative hemorrhages were not an independent risk factor for peritoneal recurrence (p = 0.144); however, the large hemorrhage group developed peritoneal recurrence more frequently than the small hemorrhage group in each T stage. In the adhesion assay, the ability of cancer cells and mesothelial cells to adhere to each other was enhanced by the addition of plasma to the culture medium. The addition of heparin significantly decreased the plasma-induced enhancement of cell adhesion of Kato III, but not MKN45 or MKN74. Conclusions. Advanced gastric cancer patients accompanied by a large amount of intraoperative hemorrhage are more likely to develop peritoneal recurrence, and this risk might be due, at least in part, to the increased ability of cancer cells and mesothelial cells to adhere to each other.	[Arita, Tomohiro; Ichikawa, Daisuke; Konishi, Hirotaka; Komatsu, Shuhei; Shiozaki, Atsushi; Hiramoto, Hidekazu; Hamada, Junichi; Shoda, Katsutoshi; Kawaguchi, Tsutomu; Hirajima, Shoji; Nagata, Hiroaki; Fujiwara, Hitoshi; Okamoto, Kazuma; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan	Ichikawa, D (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan.	ichikawa@koto.kpu-m.ac.jp					Jagoditsch M, 2006, DIS COLON RECTUM, V49, P1116, DOI 10.1007/s10350-006-0573-7; Hyung WJ, 2002, ANN SURG ONCOL, V9, P5, DOI 10.1245/aso.2002.9.1.5; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; BURROWS L, 1982, LANCET, V2, P662; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; DONOHUE JH, 1995, J CLIN ONCOL, V13, P1671; Lee JH, 2009, SURG ENDOSC, V23, P1759, DOI 10.1007/s00464-008-0198-0; YAMAMOTO J, 1994, SURGERY, V115, P303; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Roviello F, 2003, BRIT J SURG, V90, P1113, DOI 10.1002/bjs.4164; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Liang YX, 2013, WORLD J GASTROENTERO, V19, P5542, DOI 10.3748/wjg.v19.i33.5542; CHOI JH, 1995, ONCOLOGY, V52, P170; Dhar DK, 2000, WORLD J SURG, V24, P588; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kamei T, 2009, WORLD J SURG, V33, P1240, DOI 10.1007/s00268-009-9979-4; Rzyman W, 2003, J THORAC CARDIOV SUR, V126, P755, DOI 10.1016/S0022-5223(03)00217-4; SanchezBueno F, 1997, DIGEST DIS SCI, V42, P2072, DOI 10.1023/A:1018818517811; Sobin LH, 2009, TNM CLASSIFICATION M	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					758	764		10.1245/s10434-014-4060-4		7	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100012		
J	Emoto, S; Kitayama, J; Ishigami, H; Yamaguchi, H; Watanabe, T				Emoto, Shigenobu; Kitayama, Joji; Ishigami, Hironori; Yamaguchi, Hironori; Watanabe, Toshiaki			Clinical Significance of Cytological Status of Peritoneal Lavage Fluid During Intraperitoneal Chemotherapy for Gastric Cancer with Overt Peritoneal Dissemination	ANNALS OF SURGICAL ONCOLOGY			English	Article							PROGNOSTIC-SIGNIFICANCE; TUMOR-CELLS; S-1; CARCINOMATOSIS; METASTASIS; GASTRECTOMY; RESECTION; TRIAL	Background. A positive cytology of peritoneal lavage fluid (CY1) is a poor prognostic factor in patients with gastric cancer (GC). We have recently reported that CY1 often changes to negative (CY0) following combination chemotherapy including intraperitoneal (IP) paclitaxel (PTX), which results in marked prolongation of survival in GC patients with peritoneal dissemination (P1). Methods. A total of 95 P1 GC patients who received combination chemotherapy with S-1 and intravenous and IP PTX were enrolled. Peritoneal lavage fluid was periodically examined cytologically at the start of every cycle of chemotherapy, and the impact of CY status on patient outcome was retrospectively evaluated. Results. Seventy-three (76.8 %) of 95 patients were diagnosed as CY1 before initial treatment. Median survival time (MST) of the CY1 group was significantly shorter than that of the CY0 group (19.1 vs. 32.5 months, P = 0.033). Cytological status changed from CY1 to CY0 in 68 (93.2 %) of 73 CY1 patients during the whole treatment period and MST of patients who showed a negative change was significantly longer than that of the unchanged group (20.0 vs. 13.0 months, P = 0.0017). In 64 patients who achieved CY0 by IP PTX regimen, the median time to achieve CY0 was 1.4 months, and patients who achieved a negative change within 1 month showed a particularly good outcome (MST = 26.1 months). Conclusions. Periodic cytological examination of peritoneal lavage fluid is clinically useful to evaluate the efficacy of treatment as well as to predict the outcome of patients with P1 GC.	[Emoto, Shigenobu; Kitayama, Joji; Ishigami, Hironori; Yamaguchi, Hironori; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan	Kitayama, J (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan.	kitayama-1su@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Public Trust Surgery Research Fund, Tokyo, Japan	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Ministry of Health, Labor and Welfare of Japan, and by a grant-in-aid of the Public Trust Surgery Research Fund, Tokyo, Japan.	La Torre M, 2010, EJSO-EUR J SURG ONC, V36, P982, DOI 10.1016/j.ejso.2010.06.007; Ishigami H, 2009, ONCOLOGY-BASEL, V76, P311, DOI 10.1159/000209277; Katsuragi K, 2007, BRIT J CANCER, V97, P550, DOI 10.1038/sj.bjc.6603909; Cotte E, 2013, EJSO-EUR J SURG ONC, V39, P707, DOI 10.1016/j.ejso.2013.03.021; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Mezhir JJ, 2010, ANN SURG ONCOL, V17, P3173, DOI 10.1245/s10434-010-1183-0; Brigand C, 2004, DIGEST DIS, V22, P366, DOI 10.1159/000083600; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Lee SD, 2012, BRIT J SURG, V99, P397, DOI 10.1002/bjs.7812; Emoto S, 2012, JPN J CLIN ONCOL, V42, P1013, DOI 10.1093/jjco/hys129; Yonemura Y, 2006, EJSO, V32, P661, DOI 10.1016/j.ejso.2006.03.007; Kitayama J, 2014, ANN SURG ONCOL, V21, P539, DOI 10.1245/s10434-013-3208-y; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Lorenzen S, 2010, ANN SURG ONCOL, V17, P2733, DOI 10.1245/s10434-010-1090-4; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Association JGC., 2011, GASTRIC CANCER, V14, P101; Fujiwara Y, 2011, ANN SURG ONCOL, V18, P3726, DOI 10.1245/s10434-011-1770-8; Fujiwara Y, 2012, J SURG ONCOL, V105, P38, DOI 10.1002/jso.22057; Fushida S, 2008, ONCOL REP, V19, P1305; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kitayama J, 2014, SURG ONCOL, V23, P99, DOI 10.1016/j.suronc.2014.03.004; Leake PA, 2012, GASTRIC CANCER, V15, pS27, DOI 10.1007/s10120-011-0071-z; Matharu G, 2011, BRIT J SURG, V98, P1225, DOI 10.1002/bjs.7586; Sobin LH, 2009, TNM CLASSIFICATION M; Yonemura Y, 2012, INT J SURG ONCOL, V2012; Yonemura Y, 2009, J SURG ONCOL, V100, P311, DOI 10.1002/jso.21324	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					780	786		10.1245/s10434-014-4082-y		7	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100015		
J	Cho, H; Nakamura, J; Asaumi, Y; Yabusaki, H; Sakon, M; Takasu, N; Kobayashi, T; Aoki, T; Shiraishi, O; Kishimoto, H; Nunobe, S; Yanagisawa, S; Suda, T; Ueshima, S; Matono, S; Maruyama, H; Tatsumi, M; Seya, T; Tanizawa, Y; Yoshikawa, T				Cho, Haruhiko; Nakamura, Junichi; Asaumi, Yoshihide; Yabusaki, Hiroshi; Sakon, Masahiro; Takasu, Naoki; Kobayashi, Tatsunori; Aoki, Taro; Shiraishi, Osamu; Kishimoto, Hirofumi; Nunobe, Souya; Yanagisawa, Shinji; Suda, Takeshi; Ueshima, Shigeyuki; Matono, Satoru; Maruyama, Hiroshi; Tatsumi, Mitsutoshi; Seya, Tomoko; Tanizawa, Yutaka; Yoshikawa, Takaki			Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature	ANNALS OF SURGICAL ONCOLOGY			English	Review							PHASE-III TRIAL; GASTROESOPHAGEAL ADENOCARCINOMA; PERIOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; D2 GASTRECTOMY; SURGERY; S-1; CISPLATIN; JAPAN	Background. A pathologic complete response (pCR) can sometimes be induced by intensive or long-term neoadjuvant chemotherapy (NAC). This prognostic research study based on a systematic review of the literature evaluated the impact of a pCR on the long-term survival of gastric cancer (GC) patients. Methods. Articles were extracted from PubMed and the Japanese medical search engine "Ichu-shi,'' using the terms "GC,'' "NAC,'' and "pCR.'' Articles were selected based on the following criteria: (1) full-text case report, (2) R0 resection following NAC for locally advanced GC, and (3) pathological complete response in both the primary stomach and in the lymph nodes. A questionnaire regarding the patients' prognoses was sent to the corresponding authors of the articles selected in July 2013. Results. Twenty-four articles met the criteria. Twenty authors responded to the questionnaire. Finally, 22 patients from 20 articles were entered into the present study. The median follow-up time (range) of the survivors was 76 (range 13-161) months. Tumors that were stage III/IV (86 %: 19/22) and of an undifferentiated histology (61.9 %: 13/21) were dominant. An S1-based regimen was frequently selected for the NAC. All patients underwent R0 resection and D2/D3 lymphadenectomy. The overall survival and recurrence-free survival rates at 3 and 5 years were 96 % and 85 % and 91 % and 75 %, respectively. Conclusions. Although a pCR was a relatively rare event, a high pCR rate would be helpful to select the regimen and courses of NAC, especially when the pathological response rates are similar.	[Cho, Haruhiko; Yoshikawa, Takaki] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; [Nakamura, Junichi] Saitama Red Cross Hosp, Dept Surg, Saitama, Japan; [Asaumi, Yoshihide] Fukui Prefectural Hosp, Dept Surg, Fukui, Japan; [Yabusaki, Hiroshi] Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; [Sakon, Masahiro] Nagano Municipal Hosp, Dept Surg, Nagano, Japan; [Takasu, Naoki] Yamagata Univ, Fac Med, Dept Gastroenterol & Gen Surg, Yamagata 990, Japan; [Kobayashi, Tatsunori] Mihara Red Cross Hosp, Dept Surg, Mihara, Japan; [Aoki, Taro] Kinki Cent Hosp, Dept Surg, Kobe, Hyogo, Japan; [Shiraishi, Osamu] Kinki Univ, Sch Med, Dept Surg, Higashiosaka, Osaka 577, Japan; [Kishimoto, Hirofumi] Aizawa Hosp, Dept Surg, Matsumoto, Nagano, Japan; [Nunobe, Souya] Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Yanagisawa, Shinji] Kimitsu Chuo Hosp, Dept Surg, Kisarazu, Japan; [Suda, Takeshi] Tokyo Med Univ, Dept Surg 3, Tokyo 1608402, Japan; [Ueshima, Shigeyuki] Osaka Police Hosp, Dept Surg, Osaka, Japan; [Matono, Satoru] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Maruyama, Hiroshi] Hoshigaoka Koseinenkin Hosp, Dept Pathol, Osaka, Japan; [Tatsumi, Mitsutoshi] Hoshigaoka Koseinenkin Hosp, Dept Surg, Osaka, Japan; [Seya, Tomoko] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan; [Tanizawa, Yutaka] Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan	Yoshikawa, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	yoshikawat@kcch.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Yoshikawa T, 2014, ANN SURG ONCOL, V21, P213, DOI 10.1245/s10434-013-3055-x; Tsuburaya A, 2014, BRIT J SURG, V101, P653, DOI 10.1002/bjs.9484; Lorenzen S, 2013, ANN ONCOL, V24, P2068, DOI 10.1093/annonc/mdt141; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Yoshikawa T, 2014, SURG TODAY, V44, P11, DOI 10.1007/s00595-013-0529-1; Hasegawa S, 2013, ANN SURG ONCOL, V20, P2016, DOI 10.1245/s10434-012-2817-1; Yoshikawa T, 2009, BRIT J SURG, V96, P1015, DOI 10.1002/bjs.6665; Fields RC, 2011, BRIT J CANCER, V104, P1840, DOI 10.1038/bjc.2011.175; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Aoki T, 2008, JPN J CANC CHEMOTHER, V35, P2045; Asaumi Y, 2011, JPN J CANC CHEMOTHER, V38, P1325; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Cancer IUA, 2009, TNM CLASSIFICATION M; Fujisawa T, 2007, JPN J CANC CHEMOTHER, V34, P2297; Hiraoka K, 2007, JPN J CANC CHEMOTHER, V34, P93; Horikawa M, 2004, J JPN SURG ASS, V65, P375; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kobayashi N, 2010, JPN J CANC CHEMOTHER, V37, P1965; Kobayashi T, 2011, JPN J CANC CHEMOTHER, V38, P1329; Kurokawa Y, 2014, GASTRIC CANCER, V17, P514, DOI 10.1007/s10120-013-0294-2; Matono S, 2008, J JPN SURG ASS, V69, P815; Mori Shusuke, 2006, Gastric Cancer, V9, P136, DOI 10.1007/s10120-005-0358-z; Oshima N, 2010, JPN J CANC CHEMOTHER, V37, P697; Sakon M, 2008, JPN J CANC CHEMOTHER, V35, P1383; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Seya T, 2007, INT J CLIN ONCOL, V12, P472, DOI 10.1007/s10147-007-0682-x; Shiraishi O, 2007, JPN J GASTROENTEROL, V40, P1769; Suda T, 2007, J JPN SURG ASS, V68, P1142; Takasu N, 2009, JPN J CANC CHEMOTHER, V36, P111; Tanaka K, 2011, JPN J CANC CHEMOTHER, V38, P101; Tokunaga M, 2007, JPN J GASTROENTEROL, V40, P1479; Tsuchiya Y, 2006, JPN J CANC CHEMOTHER, V33, P807; Yabusaki h, 2002, JPN J CANC CHEMOTHER, V29, P119; Yamakawa T, 2009, J JPN SURG ASS, V70, P3571; Yanagisawa S, 2008, J JPN SURG ASS, V69, P1065	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					787	792		10.1245/s10434-014-4084-9		6	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100016		
J	Kinoshita, A; Onoda, H; Imai, N; Iwaku, A; Oishi, M; Tanaka, K; Fushiya, N; Koike, K; Nishino, H; Matsushima, M				Kinoshita, Akiyoshi; Onoda, Hiroshi; Imai, Nami; Iwaku, Akira; Oishi, Mutumi; Tanaka, Ken; Fushiya, Nao; Koike, Kazuhiko; Nishino, Hirokazu; Matsushima, Masato			The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							LYMPHOCYTE RATIO; COLORECTAL-CANCER; SURVIVAL; SYSTEM; TUMORIGENESIS; EXPRESSION; MANAGEMENT; RESECTION; SURGERY; PROTEIN	Background. The C-reactive protein/albumin (CRP/Alb) ratio is associated with outcomes in septic patients. We investigated the prognostic value of the CRP/Alb ratio in patients with hepatocellular carcinoma (HCC). Methods. We retrospectively evaluated 186 newly diagnosed HCC patients and investigated the correlations among the pretreatment CRP/Alb ratio, clinicopathological parameters, and overall survival (OS). Multivariate analyses were performed to identify the clinicopathological parameters associated with OS. Subsequently, we evaluated the prognostic value of the CRP/Alb ratio compared with other inflammation-based prognostic scores [Glasgow Prognostic Score (GPS), modified GPS (mGPS), and neutrophil lymphocyte ratio (NLR)] using the area under the curve (AUC). Results. The optimal cutoff level for the CRP/Alb ratio was 0.037. An elevated CRP/Alb ratio (C0.037) was associated with tumor progression and reduced liver functional reserve. In the multivariate analysis, the CRP/Alb ratio [hazard ratio (HR) 3.394; p<0.0001], Cancer Liver Italian Program score (HR 2.686; 95 % CI 2.122-3.401; p<0.0001), and vascular invasion (HR 3.376; 95 % CI 1.594-7.151; p = 0.001) were independently associated with OS (HR 3.394; p<0.0001). The CRP/Alb ratio had higher AUC values at 6 months (0.844), 12 months (0.863), and 24 months (0.82) compared with the GPS, mGPS, and NLR. Conclusion. The CRP/Alb ratio might be an independent prognostic marker in patients with HCC, and may have comparable prognostic ability to other established inflammation-based prognostic scores. The prognostic value of this novel inflammation-based prognostic score needs to be verified in patients with other types of cancer.	[Kinoshita, Akiyoshi; Onoda, Hiroshi; Imai, Nami; Iwaku, Akira; Oishi, Mutumi; Tanaka, Ken; Fushiya, Nao; Koike, Kazuhiko; Nishino, Hirokazu] Jikei Univ, Daisan Hosp, Div Gastroenterol & Hepatol, Komae, Tokyo, Japan; [Matsushima, Masato] Jikei Univ, Sch Med, Div Clin Epidemiol, Minato Ku, Tokyo, Japan	Kinoshita, A (reprint author), Jikei Univ, Daisan Hosp, Div Gastroenterol & Hepatol, Komae, Tokyo, Japan.	aki.kino@jikei.ac.jp					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Mocellin MC, 2013, LIPIDS, V48, P879, DOI 10.1007/s11745-013-3816-0; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; Morris-Stiff G, 2008, EJSO-EUR J SURG ONC, V34, P727, DOI 10.1016/j.ejso.2008.01.016; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Wu XS, 2014, ANN SURG ONCOL, V21, P449, DOI 10.1245/s10434-013-3292-z; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Fairclough E, 2009, CLIN MED, V9, P30; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Manghisi G, 1998, HEPATOLOGY, V28, P751; Llovet JM, 2012, J HEPATOL, V56, P908; Huang JT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0883-x; Iwaku A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0787-1; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Kinoshita A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-52; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90	36	8	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					803	810		10.1245/s10434-014-4048-0		8	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100018		
J	Uetake, H; Yasuno, M; Ishiguro, M; Kameoka, S; Shimada, Y; Takahashi, K; Watanabe, T; Muro, K; Baba, H; Yamamoto, J; Mizunuma, N; Tamagawa, H; Mochizuki, I; Kinugasa, Y; Kikuchi, T; Sugihara, K				Uetake, Hiroyuki; Yasuno, Masamichi; Ishiguro, Megumi; Kameoka, Shingo; Shimada, Yasuhiro; Takahashi, Keiichi; Watanabe, Toshiaki; Muro, Kei; Baba, Hideo; Yamamoto, Junji; Mizunuma, Nobuyuki; Tamagawa, Hiroshi; Mochizuki, Izumi; Kinugasa, Yusuke; Kikuchi, Takashi; Sugihara, Kenichi			A Multicenter Phase II Trial of mFOLFOX6 Plus Bevacizumab to Treat Liver-Only Metastases of Colorectal Cancer that are Unsuitable for Upfront Resection (TRICC0808)	ANNALS OF SURGICAL ONCOLOGY			English	Article							1ST-LINE TREATMENT; CHEMOTHERAPY; OXALIPLATIN; LEUCOVORIN; FLUOROURACIL; CETUXIMAB; SURGERY; COMBINATION; IRINOTECAN; FOLFOX4	Background. A phase II clinical trial was conducted on colorectal cancer patients with only liver metastases (focal diameter exceeds 5 cm or the number of liver metastases is >= 5; H2 . H3) to evaluate the liver resection rate and safety after 6 cycles of mFOLFOX6+bevacizumab (BV) therapy. Methods. mFOLFOX6+BV therapy was applied for 6 cycles to the patients with H2 . H3 liver only metastasis. Hepatectomy was considered after the sixth cycle as a rule, and was performed if possible. The primary endpoint was the curative hepatectomy rate (R0 resection rate). Results. Forty-six patients were registered and 45 patients were included in the efficacy analysis. Of the 19 patients rated as unresectable before therapy, 18 completed 6 cycles of mFOLFOX6+BV therapy and subsequently underwent hepatectomy (16 were R0-resected). Of the 26 initially unresectable patients, 6 underwent hepatectomy (4 were RO-resected). The overall R0resection ratewas 44.4% (20/ 45). Chemotherapy-associated grade 3 or higher adverse events included neutrophil decreased (17.4%) and leukocyte decreased (8.7%), fatigue (6.5%) etc. Only hypertension (6.5%) and venous thromboembolism (2.2%) were BV-associated grade 3 or higher adverse events. Among the 25 patients who underwent hepatectomy, intraoperative/postoperative complications included grade 3 wound infections (2 cases), biloma, delayed wound healing and intraperitoneal abscess (each 1 case). Conclusions. In colorectal cancer patients with liver-only metastases, mFOLFOX6+BV therapy yielded a high hepatectomy rate and a high percentage of initially unresectable and subsequently resectable cases. The chemotherapy associated adverse events and hepatectomy complications were both within acceptable ranges.	[Uetake, Hiroyuki; Ishiguro, Megumi] Tokyo Med & Dent Univ, Grad Sch, Dept Translat Oncol, Tokyo, Japan; [Yasuno, Masamichi] Tokyo Metropolitan Hiroo Gen Hosp, Dept Surg, Tokyo, Japan; [Kameoka, Shingo] Tokyo Womens Med Univ, Dept Surg 2, Tokyo, Japan; [Shimada, Yasuhiro] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan; [Takahashi, Keiichi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Colorectal Surg Div, Tokyo, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan; [Muro, Kei] Aichi Canc Ctr Hosp, Clin Oncol, Nagoya, Aichi 464, Japan; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Mizunuma, Nobuyuki] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan; [Tamagawa, Hiroshi] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Mochizuki, Izumi] Iwate Cent Prefectural Hosp, Dept Surg, Morioka, Iwate, Japan; [Kinugasa, Yusuke] Shizuoka Canc Ctr, Gastrointestinal Surg Div, Shizuoka, Japan; [Kikuchi, Takashi] Translat Res Informat Ctr, Dept Stat Anal, Kobe, Hyogo, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan	Uetake, H (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Translat Oncol, Tokyo, Japan.	h-uetake.srg2@tmd.ac.jp					Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Wong R, 2011, ANN ONCOL, V22, P2042, DOI 10.1093/annonc/mdq714; Sugihara K, 2012, J HEPATO-BIL-PAN SCI, V19, P523, DOI 10.1007/s00534-012-0524-8; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Garufi C, 2010, BRIT J CANCER, V103, P1542, DOI 10.1038/sj.bjc.6605940; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Folprecht G, 2013, J CLIN ONCOL, V31; Japanese Classification of Colorectal Carcinoma, 2009, JAP CLASS COL CARC, P11; Kato T, 2003, DIS COLON RECTUM, V46, pS22, DOI 10.1097/01.DCR.0000089106.71914.00	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					908	915		10.1245/s10434-014-4094-7		8	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100033		
J	Nagai, T; Niikura, H; Okamoto, S; Nakabayashi, K; Matoda, M; Utsunomiya, H; Nagase, S; Watanabe, M; Takeshima, N; Yaegashi, N				Nagai, Tomoyuki; Niikura, Hitoshi; Okamoto, Satoshi; Nakabayashi, Kadzuki; Matoda, Maki; Utsunomiya, Hiroki; Nagase, Satoru; Watanabe, Mika; Takeshima, Nobuhiro; Yaegashi, Nobuo			A New Diagnostic Method for Rapid Detection of Lymph Node Metastases Using a One-Step Nucleic Acid Amplification (OSNA) Assay in Endometrial Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							BREAST-CANCER; MOLECULAR-DETECTION; MESSENGER-RNA; TUMOR-CELLS; MULTICENTER; TRIAL	Background. To improve lymph node (LN) metastasis identification for patients with endometrial cancer (EC), this study assessed the usefulness of molecular biologic techniques using a one-step nucleic acid amplification (OSNA) assay. Methods. Using quantitative reverse transcription polymerase chain reaction (qRT-PCR), an optimal mRNA marker was selected, and its expression was compared between histopathologically positive and negative LNs using an OSNA assay. The authors determined copy number cutoff values and evaluated the diagnostic performance of this OSNA assay using sentinel lymph nodes (SLNs). They also investigated whether an OSNA assay could detect LN metastases with sensitivity and specificity equivalent to the 2-mm-interval histopathology method. Results. For analysis of EC samples, cytokeratin 19 (CK19) was selected as a useful mRNA marker for the OSNA assay. When the cutoff value was set at 250 copies (using 215 LNs from 70 patients), an OSNA assay using CK19 mRNA had a sensitivity of 93.3 %, a specificity of 99.5 %, and a concordance rate of 99.1 %. For performance evaluations using SLNs (120 histopathologically negative LNs and 17 histopathologically positive LNs from 35 patients), a OSNA assay using CK19 mRNA had a sensitivity of 82.4 %, a specificity of 99.2 %, a positive predictive value of 93.3 %, and a concordance rate of 97.1 %. Thus, an OSNA assay using CK19 mRNA provided results equivalent to those with the 2-mm-interval histopathology method. Conclusions. The study data demonstrated that an OSNA assay using CK19 mRNA was applicable for detecting LN metastases in EC. Combined analysis using an OSNA assay and SLNs may improve individualized treatments according to LN metastatic status.	[Nagai, Tomoyuki; Niikura, Hitoshi; Okamoto, Satoshi; Utsunomiya, Hiroki; Nagase, Satoru; Yaegashi, Nobuo] Tohoku Univ Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Nakabayashi, Kadzuki] Sysmex Corp, Dept Prod Dev, LS Business Unit, Kobe, Hyogo, Japan; [Matoda, Maki; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan	Nagai, T (reprint author), Tohoku Univ Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi, Japan.	niikura@med.tohoku.ac.jp			Ministry of Education, Science and Culture, Japan; Ministry of Health, Labor and Welfare, Japan; Global COE Program Special Research Grant (Tohoku University) from the Ministry of Education Science, Sports and Culture, Japan; Kurokawa Cancer Research Foundation; Uehara Memorial Foundation; Ministry of Education, Science, Sports and Culture, Japan	The authors thank Ms. Emi Endo, Ms. Aya Miyabe, Mr. Hiroyuki Shimizu, and Mr. Kengo Goto for their substantial support. This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science and Culture, Japan; a Grant-in-Aid for Scientific Research (B) and (C); a Grant-in-Aid for Young Scientists (B); a Grant-in-Aid for Exploratory Research, from the Ministry of Education, Science, Sports and Culture, Japan; a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Japan; the Global COE Program Special Research Grant (Tohoku University) from the Ministry of Education Science, Sports and Culture, Japan; Kurokawa Cancer Research Foundation, and the Uehara Memorial Foundation.	Altgassen C, GYNECOL ONCOL, V114, P284; Amezcua CA, 2006, INT J GYNECOL CANCER, V16, P1336, DOI 10.1111/j.1525-1438.2006.00528.x; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Osako T, 2011, CANCER-AM CANCER SOC, V117, P4365, DOI 10.1002/cncr.26060; Abu-Rustum NR, 2009, GYNECOL ONCOL, V115, P236, DOI 10.1016/j.ygyno.2009.07.016; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Ballester M, 2011, LANCET ONCOL, V12, P469, DOI 10.1016/S1470-2045(11)70070-5; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; [Anonymous], 2015, NCCN CLIN PRACTICE G; Tamaki Y, 2012, CANCER-AM CANCER SOC, V118, P3477, DOI 10.1002/cncr.26683; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Benedetti Panici Pierluigi, 2008, J Natl Cancer Inst, V100, P1707, DOI 10.1093/jnci/djn397; Croner RS, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-83; Fishman A, 2000, GYNECOL ONCOL, V77, P399, DOI 10.1006/gyno.2000.5781; Ji XQ, 2006, GYNECOL ONCOL, V100, P355, DOI 10.1016/j.ygyno.2005.08.041; Kumagai K, 2014, GASTRIC CANCER, V17, P273, DOI 10.1007/s10120-013-0271-9; Niikura H, 2013, GYNECOL ONCOL, V131, P299, DOI 10.1016/j.ygyno.2013.08.018; Niikura H, 2007, GYNECOL ONCOL, V105, P683, DOI 10.1016/j.ygyno.2007.01.052; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okamoto S, 2013, GYNECOL ONCOL, V130, P530, DOI 10.1016/j.ygyno.2013.06.027; Stewart CJR, 2011, INT J GYNECOL PATHOL, V30, P484, DOI 10.1097/PGP.0b013e3182158944; Yaguchi Y, 2011, ANN SURG ONCOL, V18, P2289, DOI 10.1245/s10434-011-1591-9; Yamamoto H, 2011, ANN SURG ONCOL, V18, P1891, DOI 10.1245/s10434-010-1539-5; Yamamoto N, 2013, JPN J CLIN ONCOL, V43, P264, DOI 10.1093/jjco/hys227	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	MAR	2015	22	3					980	986		10.1245/s10434-014-4038-2		7	Oncology; Surgery	Oncology; Surgery	CC7MX	WOS:000350553100043		
J	Sasada, S; Nakayama, H; Miyata, Y; Tsubokawa, N; Mimae, T; Yoshiya, T; Murakami, S; Ito, H; Okada, M				Sasada, Shinsuke; Nakayama, Haruhiko; Miyata, Yoshihiro; Tsubokawa, Norifumi; Mimae, Takahiro; Yoshiya, Tomoharu; Murakami, Shuji; Ito, Hiroyuki; Okada, Morihito			Comparison of Malignant Grade Between Pure and Partially Invasive Types of Early Lung Adenocarcinoma	ANNALS OF THORACIC SURGERY			English	Article							IASLC/ATS/ERS CLASSIFICATION; INTERNATIONAL-ASSOCIATION; PROGNOSTIC VALUE; CANCER; MICROPAPILLARY; RECURRENCE; MUTATIONS; COMPONENT; SURVIVAL; REVISION	Background. The present study investigates the malignant significance of lepidic component presence in predominantly invasive lung adenocarcinoma that comprise less than 50% lepidic growth of the tumor. Methods. Among 347 consecutive patients with completely resected clinical stage IA lung adenocarcinoma, we excluded those with adenocarcinoma in situ, minimally invasive, and lepidic predominant invasive adenocarcinoma. We finally assessed 167 patients with predominantly invasive lung adenocarcinoma. We analyzed the clinicopathologic characteristics and prognoses of patients with 49 pure invasive tumors without lepidic growth and 118 partially invasive tumors with lepidic growth. Results. Pure invasive tumors were associated with being male, small tumor size, high maximum standardized uptake, and pleural as well as lymphatic invasion. Nonetheless, the invasive component size of both tumor types was similar. The predominant subtypes of pure and partially invasive tumors, respectively, were papillary, 17 (34.7%) and 53 (44.9%); acinar, 10 (20.4%) and 51 (43.2%); solid, 19 (38.8%) and 11 (9.3%), and micropapillary 3 (6.1%) and 3 (2.5%; p < 0.001). Recurrence-free survival was significantly worse for patients with pure, compared with partially, invasive tumors (p = 0.045). Conclusions. Among predominantly invasive stage IA lung adenocarcinomas, the malignant potential was higher for pure invasive tumors, and the prognosis was poorer than for partially invasive tumors when the invasive components were of equal sizes. The presence or absence of a lepidic component reflects a difference in subtype predominance and can help to decide the malignant grade of lung adenocarcinoma. (C) 2015 by The Society of Thoracic Surgeons	Hiroshima Univ, Dept Surg Oncol, Hiroshima, Hiroshima 7348551, Japan; Kanagawa Canc Ctr Hosp, Dept Thorac Oncol, Yokohama, Kanagawa, Japan	Okada, M (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	morihito@hiroshima-u.ac.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Hung JJ, 2013, ANN SURG, V258, P1079, DOI 10.1097/SLA.0b013e31828920c0; Okada M, 2013, THORAC SURG CLIN, V23, P179, DOI 10.1016/j.thorsurg.2013.01.001; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Song Z, 2013, EJSO-EUR J SURG ONC, V39, P1262, DOI 10.1016/j.ejso.2013.08.026; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P17, DOI 10.1016/j.jtcvs.2012.11.019; Zhang J, 2013, J THORAC ONCOL, V8, P1196, DOI 10.1097/JTO.0b013e31829f09a7; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Yanagawa N, 2013, J THORAC ONCOL, V8, P612, DOI 10.1097/JTO.0b013e318287c3eb; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P580, DOI 10.1016/j.jtcvs.2013.04.032; Cha MJ, 2014, J THORAC CARDIOV SUR, V147, P921, DOI 10.1016/j.jtcvs.2013.09.045; Inoue M, 2010, EUR J CARDIO-THORAC, V37, P1445, DOI 10.1016/j.ejcts.2009.12.030; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; von der Thusen JH, 2013, J THORAC ONCOL, V8, P37, DOI 10.1097/JTO.0b013e318276274e	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					956	960		10.1016/j.athoracsur.2014.10.041		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800042		
J	Watanabe, Y; Kusumoto, M; Yoshida, A; Suzuki, K; Asamura, H; Tsuta, K				Watanabe, Yukio; Kusumoto, Masahiko; Yoshida, Akihiko; Suzuki, Kenji; Asamura, Hisao; Tsuta, Koji			Surgically Resected Solitary Cavitary Lung Adenocarcinoma: Association Between Clinical, Pathologic, and Radiologic Findings and Prognosis	ANNALS OF THORACIC SURGERY			English	Article							COMPUTED-TOMOGRAPHY; CANCER; CARCINOMA; TUMOR; FEATURES; ENTITY	Background. The incidence of cavitary lung adenocarcinoma has recently increased; despite this, little is known about its clinical features and prognosis. We, therefore, evaluated the clinicopathologic features and prognosis of this malignancy. Methods. Between 1998 and 2007, 2,316 patients without preoperative chemotherapy or radiation therapy underwent surgical resection for primary lung adenocarcinoma. Among these cases, 143 (6.2%) were diagnosed as having cavitary adenocarcinoma based on high-resolution computed tomography scans and were enrolled in our study. Results. Cavitary adenocarcinoma occurred more frequently in patients who were male (p < 0.001); who had a smoking history (p < 0.001), larger tumor size (p < 0.001), a tumor in the lower lobe (p < 0.001), lymph node metastasis (p = 0.02), advanced tumor stage (p = 0.04), postoperative recurrence (p < 0.01), and a papillary (p = 0.02) or solid predominant tumor pattern (p < 0.01); and who had vascular (p < 0.001), lymphatic (p = 0.04), or pleural invasion (p < 0.01). Kaplan-Meier analysis revealed that the overall and recurrence-free survival of patients with cavitary adenocarcinoma was significantly shorter than that of patients with noncavitary adenocarcinoma (p < 0.001). Multivariate analysis revealed that cavity formation was an independent prognostic factor in adenocarcinoma (p = 0.028). Conclusions. Cavitary adenocarcinoma has worse prognostic clinicopathologic characteristics than noncavitary adenocarcinoma. Based on this finding, cavitary and noncavitary adenocarcinoma tumors should be considered separate entities. (C) 2015 by The Society of Thoracic Surgeons	Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan; Natl Canc Ctr, Div Diagnost Radiol, Tokyo 1040045, Japan; Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan; Juntendo Univ, Sch Med, Dept Thorac Surg, Tokyo 113, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-13, 24-A-1];  [25460446]	We would like to thank Sachiko Miura and Chizu Kina for their skillful technical assistance. This work was supported in part by the National Cancer Center Research and Development Fund (26-A-13 and 24-A-1) and by a grant-in-aid for scientific research grant 25460446.	Qi YG, 2014, ONCOL LETT, V8, P285, DOI 10.3892/ol.2014.2065; Onn A, 2005, RADIOLOGY, V237, P342, DOI 10.1148/radiol.2371041650; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Kolodziejski LS, 2003, NEOPLASMA, V50, P66; Honda O, 2007, J COMPUT ASSIST TOMO, V31, P943; Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07; Xue XY, 2012, LUNG CANCER, V78, P45, DOI 10.1016/j.lungcan.2012.06.004; Miles KA, 2006, EUR J NUCL MED MOL I, V33, P22, DOI 10.1007/s00259-005-1932-7; Wang M, 2009, WORLD J SURG, V33, P497, DOI 10.1007/s00268-008-9859-3; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Usui S, 2013, LUNG CANCER, V82, P407, DOI 10.1016/j.lungcan.2013.09.001; CHAUDHUR.MR, 1973, THORAX, V28, P354, DOI 10.1136/thx.28.3.354; Coffey JR, 2008, NUCL MED COMMUN, V29, P1040, DOI 10.1097/MNM.0b013e32831089b2; Gasinska A, 2005, LUNG CANCER-J IASLC, V49, P171, DOI 10.1016/j.lungcan.2005.01.007; Winer-Muram HT, 2006, RADIOLOGY, V239, P34, DOI 10.1148/radiol.2391050343; Kobashi Yoshihiro, 2005, Int J Clin Oncol, V10, P366, DOI 10.1007/s10147-005-0498-5; Miura H, 1998, Ann Thorac Cardiovasc Surg, V4, P154; Mouroux J, 1996, ANN THORAC SURG, V61, P530, DOI 10.1016/0003-4975(95)00973-6; Pentheroudakis G, 2004, LUNG CANCER-J IASLC, V45, P349, DOI 10.1016/j.lungcan.2004.02.013; Rocha AT, 2004, CHEST, V125, P1424, DOI 10.1378/chest.125.4.1424; Sugimoto Yukihiro, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P460; Tokito Takaaki, 2014, Respir Investig, V52, P184, DOI 10.1016/j.resinv.2013.12.004; Zhang LJ, 2010, LUNG CANCER, V68, P389, DOI 10.1016/j.lungcan.2009.07.006	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					968	974		10.1016/j.athoracsur.2014.10.040		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800044		
J	Watanabe, H; Saito, H; Yokose, T; Sakuma, Y; Murakami, S; Kondo, T; Oshita, F; Ito, H; Nakayama, H; Yamada, K; Iwazaki, M				Watanabe, Hajime; Saito, Haruhiro; Yokose, Tomoyuki; Sakuma, Yuji; Murakami, Shuji; Kondo, Tetsuro; Oshita, Fumihiro; Ito, Hiroyuki; Nakayama, Haruhiko; Yamada, Kouzo; Iwazaki, Masayuki			Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma	ANNALS OF THORACIC SURGERY			English	Article							BRONCHIOLOALVEOLAR LUNG-CARCINOMA; ATYPICAL ADENOMATOUS HYPERPLASIA; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; CELL-CARCINOMA; GENE-MUTATION; CT FINDINGS; FEATURES; EGFR; CLASSIFICATION	Background. Detailed reports on mucinous adenocarcinoma (formerly "mucinous bronchioloalveolar carcinoma") have not been published. We evaluated the correlation between thin-section computed tomography findings and the clinicopathologic characteristics and prognosis of mucinous adenocarcinoma. Methods. From April 1997 to March 2008, 45 resected lung carcinomas were diagnosed as mucinous adenocarcinoma. Five cases of multiple lung cancers or ambiguous mucinous adenocarcinoma were excluded. Tumors were classified as "solitary-type" or "pneumonic-type" tumors according to the thin-section computed tomography findings. We evaluated the clinicopathologic characteristics and the epidermal growth factor receptor and KRAS gene mutation statuses and correlated the thin-section computed tomography findings with patient prognoses. Results. Thirty patients had solitary-type and 10 had pneumonic-type tumors. The lesions in 23, 14, and 3 patients were classified as pathologic stage I, stage II, and stage III, respectively. Five patients had adenocarcinoma in situ, 9 had minimally invasive adenocarcinoma, and 26 had invasive mucinous adenocarcinoma. Thirteen patients showed recurrences, which were classified as intrapulmonary metastases in all patients. The 5-year overall and relapse-free survival rates were 83.3% and 88.8%, respectively, in patients with solitary-type tumors and 20.0% and 0%, respectively, in patients with pneumonic-type tumors (p < 0.001). The median follow-up time for surviving patients was 81 months. KRAS mutations were detected in 30 patients, but epidermal growth factor receptor mutations were absent in all patients. Conclusions. Our results indicated that thin-section computed tomography findings for mucinous adenocarcinoma were useful in predicting prognosis before surgical resection. Further studies are required to improve the treatment strategy for mucinous adenocarcinoma. (C) 2015 by The Society of Thoracic Surgeons	[Watanabe, Hajime] Tokai Univ, Sch Med, Dept Surg, Div Thorac Surg, Isehara, Kanagawa 2591193, Japan; Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Dept Thorac Pathol, Yokohama, Kanagawa 2410815, Japan; Kanagawa Canc Ctr, Dept Thorac Surg, Yokohama, Kanagawa 2410815, Japan	Watanabe, H (reprint author), Tokai Univ, Sch Med, Dept Surg, Div Thorac Surg, Shimokasuya 143, Isehara, Kanagawa 2591193, Japan.	wh110193@tsc.u-tokai.ac.jp					Sakuma Y, 2007, AM J CLIN PATHOL, V128, P100, DOI 10.1309/WVXFGAFLAUX48DU6; Tsuta K, 2013, LUNG CANCER, V81, P371, DOI 10.1016/j.lungcan.2013.06.012; Tsuta K, 2006, J PATHOL, V209, P78, DOI 10.1002/path.1947; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; BARSKY SH, 1994, CANCER-AM CANCER SOC, V73, P1163, DOI 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO;2-J; Travis WD, 2005, J CLIN ONCOL, V23, P3279, DOI 10.1200/JCO.2005.15.778; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Wislez M, 2010, LUNG CANCER, V68, P185, DOI 10.1016/j.lungcan.2009.05.021; BELGRAD R, 1962, RADIOLOGY, V79, P789; Lee HY, 2009, LUNG CANCER, V65, P170, DOI 10.1016/j.lungcan.2008.11.009; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Casali C, 2010, J THORAC ONCOL, V5, P830; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Awaya H, 2004, AM J CLIN PATHOL, V121, P644, DOI 10.1039/U4WGE9EBFJN6CM8R; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Breathnach OS, 1999, CANCER, V86, P1165, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1165::AID-CNCR10>3.0.CO;2-9; Carretta A, 2001, EUR J CARDIO-THORAC, V20, P367, DOI 10.1016/S1010-7940(01)00733-3; Copin MC, 2001, HUM PATHOL, V32, P274, DOI 10.1053/hupa.2001.22752; Erman M, 2005, LUNG CANCER-J IASLC, V47, P315, DOI 10.1016/j.lungcan.2004.08.015; Furak J, 2003, EUR J CARDIO-THORAC, V23, P818, DOI 10.1016/S1010-7940(03)00084-8; Hata A, 2010, J THORAC ONCOL, V5, P1197, DOI 10.1097/JTO.0b013e3181e2a2bc; Lee KS, 1997, RADIOGRAPHICS, V17, P1345; MANNING JT, 1984, CANCER, V54, P525, DOI 10.1002/1097-0142(19840801)54:3<525::AID-CNCR2820540324>3.0.CO;2-X; Miyake H, 1995, J THORAC IMAG, V10, P96, DOI 10.1097/00005382-199521000-00003; Nakayama H, 2007, ANN THORAC SURG, V84, P1675, DOI 10.1016/j.athoracsur.2007.03.015; Regnard JF, 1998, CHEST, V114, P45, DOI 10.1378/chest.114.1.45; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Sato K, 2006, PATHOL RES PRACT, V202, P751, DOI 10.1016/j.prp.2006.07.002; Shah RN, 2002, HUM PATHOL, V33, P915, DOI 10.1053/hupa.2002.126876; Shimizu K, 2005, CHEST, V127, P871, DOI 10.1378/chest.127.3.871; Watanabe H, 2015, ANN THORAC SURG, V99, P975, DOI 10.1016/j.athoracsur.2014.10.065; Yousem SA, 2007, ARCH PATHOL LAB MED, V131, P1027	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					975	982		10.1016/j.athoracsur.2014.10.065		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800045		
J	Yamada, Y; Yoshida, S; Iwata, T; Suzuki, H; Tagawa, T; Mizobuchi, T; Kawaguchi, N; Yoshino, I				Yamada, Yoshito; Yoshida, Shigetoshi; Iwata, Takekazu; Suzuki, Hidemi; Tagawa, Tetsuzo; Mizobuchi, Teruaki; Kawaguchi, Naoki; Yoshino, Ichiro			Risk Factors for Developing Postthymectomy Myasthenia Gravis in Thymoma Patients	ANNALS OF THORACIC SURGERY			English	Article							ACETYLCHOLINE-RECEPTOR; THYMECTOMY; CLASSIFICATION; EXPERIENCE; ANTIBODY; UPDATE	Background. Thymoma patients with no prior history of myasthenia gravis (MG) occasionally have MG after thymectomy. This study aimed to identify risk factors for developing postthymectomy MG. Methods. We retrospectively reviewed the characteristics and clinical outcomes of thymoma patients without preoperative MG who underwent a thymectomy at our institute. Results. Of the 229 thymoma patients who underwent surgery from 1991 to 2011, 123 had no history of MG. The serum of all patients was analyzed for acetylcholine receptor antibodies (AchR-Ab), and 33 patients had detectable levels (greater than 0.2 nmol/L). Ten seropositive patients had MG develop postoperatively within 3 to 2,859 days, whereas 90 seronegative patients did not. Univariate analysis showed that a positive result for serum AchR-Ab (p < 0.001), type B1/B2/B3 thymoma histology (p = 0.025), and incomplete resection (p = 0.008) were risk factors for the development of MG. In patients with post-thymectomy MG, the AchR-Ab levels at the onset of MG were significantly higher than the preoperative levels (p = 0.036). The analysis of the 33 antibody-positive patients showed a significant correlation between antibody levels and the onset of disease (p = 0.003). The analysis of 12 patients with incomplete resection revealed that perioperative chemotherapy or radiotherapy reduced the risk of development of MG (p = 0.009). Conclusions. A positive result for serum AchR-Ab, type B1/B2/B3 thymoma histology, and incomplete resection were considered risk factors for the development of postthymectomy MG. Preoperative levels of serum AchR-Ab should be examined in all thymoma patients. Perioperative chemotherapy or radiotherapy for the patients with incomplete resection might reduce the risk of MG development. (C) 2015 by The Society of Thoracic Surgeons	Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan; Douwa Kai Neurol Ctr, Chiba, Japan	Yamada, Y (reprint author), Univ Zurich Hosp, Div Thorac Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	yoshito.yamada@usz.ch					Watanabe A, 2004, J THORAC CARDIOV SUR, V127, P868, DOI 10.1016/S0022-5223(03)01517-4; Okumura M, 2002, CANCER, V94, P624, DOI 10.1002/cncr.10226; OSSERMAN KE, 1971, MT SINAI J MED, V38, P497; Sanders DB, 2014, MUSCLE NERVE, V49, P483, DOI 10.1002/mus.23944; Song F, 2006, J IMMUNOL, V177, P1500; Ruffini E, 2011, EUR J CARDIO-THORAC, V40, P146, DOI 10.1016/j.ejcts.2010.09.042; Wittbrodt ET, 1997, ARCH INTERN MED, V157, P399, DOI 10.1001/archinte.157.4.399; Okumura M, 2001, AM J SURG PATHOL, V25, P103, DOI 10.1097/00000478-200101000-00012; Kondo K, 2005, EUR J CARDIO-THORAC, V28, P22, DOI 10.1016/j.ejcts.2005.03.039; Nakajima J, 2008, ANN THORAC SURG, V86, P941, DOI 10.1016/j.athoracsur.2008.04.070; Buckley C, 2001, ANN NEUROL, V50, P64, DOI 10.1002/ana.1017; Hoffacker V, 2000, BLOOD, V96, P3872; Ragheb S, 2008, ARCH NEUROL-CHICAGO, V65, P1358, DOI 10.1001/archneur.65.10.1358; CUENOUD S, 1980, NEUROLOGY, V30, P201; FERSHTAND JB, 1951, ANN INTERN MED, V34, P1025; Haroutiunian Simon, 2009, J Pain Palliat Care Pharmacother, V23, P242, DOI 10.1080/15360280903098523; He Zhicheng, 2013, J Biomed Res, V27, P62, DOI 10.7555/JBR.27.20120060; Ito M, 1992, Nihon Kyobu Geka Gakkai Zasshi, V40, P189; Jaretzki A, 2000, ANN THORAC SURG, V70, P327, DOI 10.1016/S0003-4975(00)01595-2; Kondo K, 2005, ANN THORAC SURG, V79, P219, DOI 10.1016/j.athoracsur.2004.06.090; KOSMIDIS PA, 1988, CANCER, V61, P1736, DOI 10.1002/1097-0142(19880501)61:9<1736::AID-CNCR2820610903>3.0.CO;2-T; Mao ZF, 2012, J CLIN NEUROL, V8, P161, DOI 10.3988/jcn.2012.8.3.161; Marx A, 2004, PATHOLOGY GENETICS T, P152; Meyer DM, 2009, ANN THORAC SURG, V87, P385, DOI 10.1016/j.athoracsur.2008.11.040; NAMBA T, 1978, MEDICINE, V57, P411; Obata S, 1983, Rinsho Kyobu Geka, V3, P729; Rosai J, 1999, WHO INT HIST CLASSIF; Sun XG, 2011, J CLIN NEUROSCI, V18, P57, DOI 10.1016/j.jocn.2010.05.018; Thanvi BR, 2004, POSTGRAD MED J, V80, P690, DOI 10.1136/pgmj.2004.018903; Yamada Y, 2013, J CARDIOTHORAC SURG, V10, P226	30	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1013	1019		10.1016/j.athoracsur.2014.10.068		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800050		
J	Gyoten, T; Doi, T; Nagura, S; Yamashita, A; Fukahara, K; Kotoh, K; Yoshimura, N				Gyoten, Takayuki; Doi, Toshio; Nagura, Saori; Yamashita, Akio; Fukahara, Kazuaki; Kotoh, Keiju; Yoshimura, Naoki			Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy	ANNALS OF THORACIC SURGERY			English	Editorial Material							TRANSPLANTATION; HEART	We report a patient who has survived for 13 years after surgical resection of a cardiac malignant lymphoma. A 73-year-old woman underwent partial resection of a tumor occluding the tricuspid valve, which arose from the right atrium. The pathologic diagnosis was diffuse large B cell lymphoma. She was treated with adjuvant chemotherapy for 6 months postoperatively. Since then, she has shown no evidence of recurrence, without any further treatment. To our knowledge, this is the longest surviving case of cardiac malignant lymphoma. The therapeutic strategy for this malignant cardiac tumor is discussed briefly. (C) 2015 by The Society of Thoracic Surgeons	[Gyoten, Takayuki] JA Nagano Koseiren Shinonoi Gen Hosp, Dept Cardiovasc Surg, Nagano 3888004, Japan; Toyama Univ, Dept Surg 1, Toyama 930, Japan; Bando Hosp, Dept Cardiovasc Surg, Toyama, Japan	Gyoten, T (reprint author), JA Nagano Koseiren Shinonoi Gen Hosp, Dept Cardiovasc Surg, 666-1 Shinonoiai, Nagano 3888004, Japan.	t.gyoten29@gmail.com					Rolla G, 2002, LEUKEMIA RES, V26, P117, DOI 10.1016/S0145-2126(01)00092-3; Nonami A, 2007, INT J HEMATOL, V85, P264, DOI 10.1532/IJH97.06197; Ceresoli GL, 1997, CANCER, V80, P1497, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1497::AID-CNCR18>3.0.CO;2-0; Fujita Y, 2009, CIRC J, V73, P967; Petrich A, 2011, CANCER-AM CANCER SOC, V117, P581, DOI 10.1002/cncr.25444; YUH DD, 1994, J HEART LUNG TRANSPL, V13, P538; Zakynthinos E, 2004, LEUKEMIA LYMPHOMA, V45, P2339, DOI 10.1080/10428190410001733754	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1060	1062		10.1016/j.athoracsur.2014.05.074		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800060		
J	Sakamoto, SI; Shibata, M; Murata, H; Nitta, T				Sakamoto, Shun-Ichiro; Shibata, Masafumi; Murata, Hiroshige; Nitta, Takashi			Intraoperative Cardiac Mapping in the Treatment of an Infant Congenital Fibroma	ANNALS OF THORACIC SURGERY			English	Editorial Material							VENTRICULAR-TACHYCARDIA; TUMORS	Surgical treatment for ventricular tachycardia associated with congenital cardiac tumors is rare. Intraoperative electroanatomic mapping was performed in a 23-month-old female infant to identify the arrhythmogenic substrate of the epicardium before tumor resection. Verification of the localized abnormal electrocardiogram on the tumor in the treatment of ventricular tachycardia was useful for successful partial resection and cryoablation of the giant fibroma. (C) 2015 by The Society of Thoracic Surgeons	[Sakamoto, Shun-Ichiro; Shibata, Masafumi; Murata, Hiroshige; Nitta, Takashi] Nippon Med Sch, Dept Cardiovasc Surg, Tokyo 113, Japan	Sakamoto, SI (reprint author), 1-1-5 Sendagi,Bunkyo ku, Tokyo 1138603, Japan.	saka-165@nms.ac.jp					CASSIDY DM, 1984, CIRCULATION, V69, P1103; HOLLEY DG, 1995, J AM COLL CARDIOL, V26, P516, DOI 10.1016/0735-1097(95)80031-B; Miyake CY, 2011, J AM COLL CARDIOL, V58, P1903, DOI 10.1016/j.jacc.2011.08.005; NADAS AS, 1968, AM J CARDIOL, V21, P363, DOI 10.1016/0002-9149(68)90140-9; Sakamoto SI, 2012, J INTERV CARD ELECTR, V33, P109, DOI 10.1007/s10840-011-9592-y	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1064	1066		10.1016/j.athoracsur.2014.04.130		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800062		
J	Kawaguchi, Y; Fujita, T; Hanaoka, J				Kawaguchi, Yo; Fujita, Takuya; Hanaoka, Jun			Catamenial Pneumothorax With Bullae	ANNALS OF THORACIC SURGERY			English	Editorial Material							ENDOMETRIOSIS	The physiologic mechanisms and diagnostic approach of catamenial pneumothorax remain controversial. We report 3 patients with catamenial pneumothorax with bullae. Endometrial cells in these patients were located around the bullae, suggesting a possible new mechanism for catamenial pneumothorax in which cyclic endometrial shedding in the lung causes destruction of the lining of alveolar epithelial cells and forms bullae. Because intrathoracic endometriosis is considered an underrecognized cause of secondary spontaneous pneumothorax, we performed careful histologic examination for definitive diagnosis of thoracic endometriosis. (C) 2015 by The Society of Thoracic Surgeons	[Kawaguchi, Yo] Kohka Publ Hosp, Div Gen Thorac Surg, Kohka, Shiga 5280074, Japan; Shiga Univ Med Sci, Dept Surg, Div Gen Thorac Surg, Otsu, Shiga 52021, Japan	Kawaguchi, Y (reprint author), Kohka Publ Hosp, Div Gen Thorac Surg, 1256 Matsuo Minakuchi, Kohka, Shiga 5280074, Japan.	kawaguchi1228@yahoo.co.jp					Korom S, 2004, J THORAC CARDIOV SUR, V128, P502, DOI 10.1016/j.jtcvs.2004.04.039; SHEARIN RPN, 1974, MAYO CLIN PROC, V49, P98; Flieder DB, 1998, HUM PATHOL, V29, P1495, DOI 10.1016/S0046-8177(98)90021-1; ROSSI NP, 1974, ARCH SURG-CHICAGO, V109, P173; LILLINGT.GA, 1972, J AMER MED ASSOC, V219, P1328, DOI 10.1001/jama.219.10.1328; MAURER ER, 1958, JAMA-J AM MED ASSOC, V168, P2013; VanSchil PE, 1996, ANN THORAC SURG, V62, P585, DOI 10.1016/0003-4975(96)00411-0	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1075	1078		10.1016/j.athoracsur.2014.05.056		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800067		
J	Ueyama, K; Morishima, M; Iida, J				Ueyama, Koji; Morishima, Manabu; Iida, Jun			First Report of Chronic Expanding Intrapericardial Hematoma Caused by Coronary to Pulmonary Artery Fistulas	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Ueyama, Koji; Morishima, Manabu; Iida, Jun] Kitano Hosp, Cardiac Ctr, Dept Cardiovasc Surg, Osaka, Japan	Ueyama, K (reprint author), Kitano Hosp, Cardiac Ctr, Dept Cardiovasc Surg, Kita Ku, 2-4-20 Ohgimachi, Osaka, Japan.	athleteone@gmail.com						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1084	1084		10.1016/j.athoracsur.2014.10.076		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800071		
J	Aoki, M; Ito, T				Aoki, Masakazu; Ito, Toshiaki			New Method of Posterior Scallop Augmentation for Ischemic Mitral Regurgitation	ANNALS OF THORACIC SURGERY			English	Editorial Material							LEAFLET; ANNULOPLASTY	We report a new method of posterior middle scallop (P2) augmentation for ischemic mitral regurgitation to achieve deep coaptation. First, P2 was divided straight at the center and partially detached from the annulus in a reverse T shape. Anarrowpentagon-shaped section of pericardium was sutured to the divided P2 and annular defect. The tip of the pentagon was attached directly to the papillary muscle, thus creating a very large P2 scallop. A standard-sized ring was placed. We adopted this technique in 2 patients with advanced ischemic cardiomyopathy, and no mitral regurgitation was observed during a 1-year follow-up. (C) 2015 by The Society of Thoracic Surgeons	[Aoki, Masakazu] Matsumoto Kyoritsu Hosp, Dept Cardiovasc Surg, Nagano 3908505, Japan; Japanese Red Cross Nagoya First Hosp, Dept Cardiovasc Surg, Nagoya, Aichi, Japan	Aoki, M (reprint author), Matsumoto Kyoritsu Hosp, Dept Cardiovasc Surg, Nagano 3908505, Japan.	aokim@chushin-miniren.gr.jp					Kuwahara E, 2006, CIRCULATION, V114, pI529, DOI 10.1161/CIRCULATIONAHA.105.000729; Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3; Gogoladze G, 2010, ANN THORAC SURG, V89, P1158, DOI 10.1016/j.athoracsur.2009.12.061; de Varennes B, 2009, CIRCULATION, V119, P2837, DOI 10.1161/CIRCULATIONAHA.108.831412; Ito T, 2014, EUR J CARDIO-THORAC, V45, pE227, DOI 10.1093/ejcts/ezu140; Roshanali F, 2007, ANN THORAC SURG, V84, P745, DOI 10.1016/j.athoracsur.2007.04.106	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1087	1089		10.1016/j.athoracsur.2014.09.080		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800074		
J	Tashiro, T; Wada, H; Minematsu, N; Sukehiro, Y; Kamiya, S; Osumi, M; Morishige, N				Tashiro, Tadashi; Wada, Hideichi; Minematsu, Noritoshi; Sukehiro, Yuta; Kamiya, Shinji; Osumi, Masahiro; Morishige, Noritsugu			Four-Stitch Side-to-Side Anastomosis for Sequential Coronary Artery Bypass Grafting	ANNALS OF THORACIC SURGERY			English	Editorial Material							SURGERY	Sequential bypass (SB) is an effective method of implementing complete myocardial revascularization of complex coronary stenoses. The SB allows a single graft to be used for bypass in several locations, which facilitates multi-branch revascularization. We have developed a simple SB technique, four-stitch side-to-side anastomosis, and report its clinical effectiveness in 428 patients. (C) 2015 by The Society of Thoracic Surgeons	Fukuoka Univ, Sch Med, Dept Cardiovasc Surg, Fukuoka 8140180, Japan; Saiseikai Fukuoka Gen Hosp, Dept Cardiovasc Surg, Fukuoka, Japan	Tashiro, T (reprint author), Fukuoka Univ, Sch Med, Dept Cardiovasc Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tashirot@fukuoka-u.ac.jp					Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Li JR, 2011, ANN THORAC SURG, V92, P1292, DOI 10.1016/j.athoracsur.2011.05.038; Morishige N, 2006, HEART SURG FORUM, V9, pE861, DOI 10.1532/HSF98.20061084; Schwann TA, 2009, ANN THORAC SURG, V88, P31, DOI 10.1016/j.athoracsur.2009.03.081; SHIOI K, 1984, Nagoya Journal of Medical Science, V46, P19	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1092	1094		10.1016/j.athoracsur.2014.10.074		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800076		
J	Abe, K; Kawazoe, K; Ito, J; Yamasaki, M; Kuwauchi, S; Misumi, H				Abe, Kohei; Kawazoe, Kohei; Ito, Joji; Yamasaki, Manabu; Kuwauchi, Shintaro; Misumi, Hiroyasu			Tricuspidization and Reimplantation Procedure for Unicuspid Aortic Valve With Annuloaortic Ectasia	ANNALS OF THORACIC SURGERY			English	Editorial Material								Unicuspid aortic valve is a rare anomaly. We report 2 cases of successfully treated unicuspid valves with aortic dilatations by using a tricuspidization and reimplantation procedure. Two men, 35 and 39 years old, with severe aortic regurgitation and stenosis received this procedure. The sclerotic portion of a unicuspid valve, including 2 rudimentary commissures, was resected and reconstructed with autologous pericardium to create a tricuspid valve. An aortic root was replaced with a prosthetic graft. Postoperative echocardiogram showed trivial aortic regurgitation and minimal pressure gradient. Follow-up was 32 and 34 months, respectively. These valves remained stable in these periods. Tricuspidization and reimplantation is a promising procedure. (C) 2015 by The Society of Thoracic Surgeons	[Abe, Kohei; Kawazoe, Kohei; Ito, Joji; Yamasaki, Manabu; Kuwauchi, Shintaro; Misumi, Hiroyasu] St Lukes Int Hosp, Cardiovasc Ctr, Div Cardiovasc Surg, Tokyo, Japan	Abe, K (reprint author), 9-1 Akashicho,Chuou Ku, Tokyo, Japan.	koabe@luke.ac.jp					Franciulli M, 2014, ANN THORAC SURG, V98, P823, DOI 10.1016/j.athoracsur.2014.05.024; Kawase I, 2012, ANN THORAC SURG, V94, P1180, DOI 10.1016/j.athoracsur.2012.05.016; Schafers HJ, 2008, ANN THORAC SURG, V85, P2012, DOI 10.1016/j.athoracsur.2008.02.081	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1095	1096		10.1016/j.athoracsur.2014.10.071		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800077		
J	Kajimoto, K; Yamamoto, T; Amano, A				Kajimoto, Kan; Yamamoto, Taira; Amano, Atsushi			Coronary Artery Bypass Revascularization Using Bilateral Internal Thoracic Arteries in Diabetic Patients: A Systematic Review and Meta-Analysis	ANNALS OF THORACIC SURGERY			English	Editorial Material							1ST MYOCARDIAL REVASCULARIZATION; STERNAL WOUND-INFECTION; LONG-TERM SURVIVAL; GRAFT-SURGERY; FOLLOW-UP; RANDOMIZED-TRIAL; SAPHENOUS-VEIN; MAMMARY ARTERY; SINGLE; DISEASE	This study examined the effect of coronary artery bypass graft surgery with bilateral internal thoracic artery grafting in diabetic patients. Coronary artery bypass graft surgery using skeletonized bilateral internal thoracic artery grafts was not associated with an increased risk of deep sternal wound infection or early death. Moreover, patients who underwent coronary artery bypass graft surgery using bilateral internal thoracic artery grafting had lower remote mortality and cardiac mortality. We conclude that coronary artery bypass surgery using bilateral internal thoracic artery grafts is an excellent strategy, even for diabetic patients. (C) 2015 by The Society of Thoracic Surgeons	[Kajimoto, Kan; Yamamoto, Taira; Amano, Atsushi] Juntendo Univ, Sch Med, Dept Cardiovasc Surg, Tokyo 1138421, Japan	Yamamoto, T (reprint author), Juntendo Univ, Sch Med, Dept Cardiovasc Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tyamamo@juntendo.ac.jp					Agrifoglio M, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-35; Alserius T, 2009, J THORAC CARDIOVASC, V138, P115; Stevens LM, 2005, EUR J CARDIO-THORAC, V27, P281, DOI 10.1016/j.ejcts.2004.10.048; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Lev-Ran O, 2004, ANN THORAC SURG, V77, P2039, DOI 10.1016/j.athoracsur.2003.12.061; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Kajimoto K, 2008, CIRC J, V72, P1481, DOI 10.1253/circj.CJ-07-0928; Kinoshita T, 2010, ANN THORAC SURG, V90, P1173, DOI 10.1016/j.athoracsur.2010.05.048; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Liberati A, 2009, ANN INTERN MED, V151, pW65; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Calafiore AM, 2005, ANN THORAC SURG, V80, P888, DOI 10.1016/j.athoracsur.2005.03.077; Calafiore AM, 2004, EUR J CARDIO-THORAC, V26, P542, DOI 10.1016/j.ejcts.2004.05.028; Endo M, 2003, CIRCULATION, V108, P1343, DOI 10.1161/01.CIR.0000085995.87982.6E; Frye RL, 2009, NEW ENGL J MED, V360, P2503; Gansera B, 2006, EUR J CARDIO-THORAC, V30, P318, DOI 10.1016/j.ejcts.2006.05.017; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hirotani T, 2003, ANN THORAC SURG, V76, P2017, DOI 10.1016/S0003-4975(03)00887-7; Kitamura S, 2011, CIRC J, V75, P766, DOI 10.1253/circj.CJ-10-1302; Konstanty-Kalandyk J, 2012, INTERACT CARDIOV TH, V15, P979, DOI 10.1093/icvts/ivs364; Momin AU, 2005, ANN THORAC SURG, V80, P1765, DOI 10.1016/j.athoracsur.2005.04.061; Sa MPBD, 2013, INTERACT CARDIOV TH, V16, P849, DOI 10.1093/icvts/ivt012; Tavolacci MP, 2003, J HOSP INFECT, V55, P21, DOI 10.1016/S0195-6701(03)00116-6; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Toumpoulis IK, 2006, ANN THORAC SURG, V81, P599, DOI 10.1016/j.athoracsur.2005.07.082; Wijns W, 2010, EUR HEART J, V20, P2501	33	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					1097	1104		10.1016/j.athoracsur.2014.09.045		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800078		
J	Chen, FS; Muranishi, Y; Minakata, K; Taura, K; Okabe, H; Mizota, T; Sonobe, M; Date, H				Chen, Fengshi; Muranishi, Yusuke; Minakata, Kenji; Taura, Kojiro; Okabe, Hiroshi; Mizota, Toshiyuki; Sonobe, Makoto; Date, Hiroshi			Complete Resection of a Giant Mediastinal Leiomyosarcoma	ANNALS OF THORACIC SURGERY			English	Editorial Material								Primary mediastinal leiomyosarcoma is an extremely rare malignancy, and the only opportunity for a cure lies with an aggressive surgical approach. We report a 66-year-old woman who underwent complete resection of a giant mediastinal leiomyosarcoma located on the bilateral diaphragm. The tumor encased the inferior vena cava and compressed the adjacent structures. Using cardiopulmonary bypass with 20 minutes of hepatic ischemia, the tumor was completely resected with combined resection and reconstruction of the surrounding structures. Because of the tumor size and location in the boundary area between thoracic and abdominal surgeries, the procedure necessitated the cooperation of many expert surgeons. (C) 2015 by The Society of Thoracic Surgeons	Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Anesthesia, Kyoto 6068507, Japan	Date, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp	Mizota, Toshiyuki/I-7355-2015	Mizota, Toshiyuki/0000-0003-2770-4262			Conner WC, 2004, ANN THORAC SURG, V77, P334, DOI 10.1016/S0003-4975(03)00520-4; Iwata T, 2012, ANN THORAC CARDIOVAS, V18, P140, DOI 10.5761/atcs.cr.11.01710; MORAN CA, 1994, CANCER, V74, P2251, DOI 10.1002/1097-0142(19941015)74:8<2251::AID-CNCR2820740808>3.0.CO;2-4; Burt M, 1998, J THORAC CARDIOV SUR, V115, P671, DOI 10.1016/S0022-5223(98)70333-2; D'Auito M, 2005, J THORAC CARDIOVASC, V129, P694	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					E69	E71		10.1016/j.athoracsur.2014.12.024		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800006		
J	Kitahara, H; Kudo, M; Okamoto, K; Inaba, Y; Sasaki, A; Shimizu, H				Kitahara, Hiroto; Kudo, Mikihiko; Okamoto, Kazuma; Inaba, Yu; Sasaki, Aya; Shimizu, Hideyuki			Management of Right Atrial Hemangioma in a Patient With Antithrombin Deficiency	ANNALS OF THORACIC SURGERY			English	Editorial Material								Hereditary antithrombin (AT) deficiency is an autosomal dominant inheritance disorder. Patients with AT deficiency have a high risk of thromboembolism, and intraoperative cardiopulmonary bypass management is difficult. We present the case of a 53-year-old man who was diagnosed with AT deficiency and who underwent an open heart operation for a right atrial hemangioma. We administered AT-III concentrate perioperatively to maintain his AT-III level up to 80% to establish cardiopulmonary bypass and prevent thromboembolic events postoperatively. The right atrial hemangioma was successfully excised after right atriotomy. The patient had an uneventful postoperative course and was discharged on postoperative day 14. (C) 2015 by The Society of Thoracic Surgeons	Keio Univ Hosp, Dept Cardiovasc Surg, Tokyo 1608582, Japan; Keio Univ Hosp, Div Diagnost Pathol, Tokyo 1608582, Japan	Kitahara, H (reprint author), Keio Univ Hosp, Dept Cardiovasc Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kthrhrt11@gmail.com					Maclean PS, 2007, DRUGS, V67, P1429, DOI 10.2165/00003495-200767100-00005; Balan Baskaran, 2014, Ann Card Anaesth, V17, P232, DOI 10.4103/0971-9784.135875; Fujiwara Yasue, 2013, Kyobu Geka, V66, P589; Hattori T, 2013, ANN THORAC CARDIOVAS, V19, P323, DOI 10.5761/atcs.cr.12.01981; Kipfer B, 2000, ANN THORAC SURG, V70, P977, DOI 10.1016/S0003-4975(00)01666-0; Sengodan Prasanna, 2014, J Am Coll Cardiol, V63, pe41, DOI 10.1016/j.jacc.2013.11.064	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAR	2015	99	3					E53	E55		10.1016/j.athoracsur.2014.12.032		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7TH	WOS:000350570800001		
J	Cardona, L; Miyato, Y; Itozaki, H; Jimenez, J; Vanegas, N; Sato-Akaba, H				Cardona, Lorena; Miyato, Yuji; Itozaki, Hideo; Jimenez, Jovani; Vanegas, Nelson; Sato-Akaba, Hideo			Remote Detection of Ammonium Nitrate by Nuclear Quadrupole Resonance using a Portable System	APPLIED MAGNETIC RESONANCE			English	Article							STATE FREE-PRECESSION; N-14; HYDROCHLORIDE; EXPLOSIVES; NQR	This paper shows the advances in the development of a portable system for remote detection of ammonium nitrate by nuclear quadrupole resonance. Three different probe coils were constructed and compared in terms of the signal intensity and the noise rejection under different environments, using the developed system. For the gradiometer probe coil, which showed the best performance in terms of noise rejection, the '90A degrees' equivalent pulse was determined for different distances between the sample and the probe, and the remote detection of ammonium nitrate was achieved not only in a shielded room inside the laboratory, but also in the outdoors. The system was capable of detecting 200 g ammonium nitrate at 3 cm apart from the probe within 12 s with a steady-state free precession pulse sequence. The comparable results were obtained with a free induction decay sequence in 25 min for the total acquisition time. The compact size of the system will allow the applications for the substance detection in the outdoors especially for landmines made from ammonium nitrate and fuel oil mixtures instead of military explosives.	[Cardona, Lorena; Jimenez, Jovani] Univ Nacl Colombia, Sch Mines, Dept Computat & Decis Sci, Medellin, Antioquia, Colombia; [Miyato, Yuji; Itozaki, Hideo; Sato-Akaba, Hideo] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan; [Vanegas, Nelson] Univ Nacl Colombia, Sch Mines, Dept Mech Engn, Medellin, Antioquia, Colombia	Sato-Akaba, H (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan.	lcardon0@unal.edu.co; jajimen1@unal.edu.co; nvanegas@unal.edu.co; akaba@sup.ee.es.osaka-u.ac.jp		Jimenez Builes, Jovani Alberto/0000-0001-7598-7696	Japan Society for the Promotion of Science [26702007]	We thank Ms. Yui Otagaki (Osaka University) for useful collaboration making the NQR probe and Dr. Jamie Barras (King's college London) for reading and improving the manuscript. This work was mainly supported by a grant from the Japan Society for the Promotion of Science (26702007 to H. Sato-Akaba). L. Cardona thanks the Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS) and Enlaza Mundos (Program of the mayor of Medellin-Colombia, created to fund studies and academic internships abroad).	Ostafin M, 2007, MEASUREMENT, V40, P43, DOI 10.1016/j.measurement.2006.04.003; Barras J, 2004, APPL MAGN RESON, V25, P411, DOI 10.1007/BF03166538; CARR HY, 1958, PHYS REV, V112, P1693, DOI 10.1103/PhysRev.112.1693; Bielecki Z, 2012, METROL MEAS SYST, V19, P3, DOI 10.2478/v10178-012-0001-3; Barras J, 2012, APPL MAGN RESON, V43, P511, DOI 10.1007/s00723-012-0320-2; Barras J, 2012, ANAL CHEM, V84, P8970, DOI 10.1021/ac3015643; Blinc R, 2004, APPL MAGN RESON, V25, P523, DOI 10.1007/BF03166546; CARDONA LORENA, 2014, Dyna rev.fac.nac.minas, V81, P115, DOI 10.15446/dyna.v81n183.37441; Garroway AN, 2001, IEEE T GEOSCI REMOTE, V39, P1108, DOI 10.1109/36.927420; Grechishkin V.S., 1997, PHYS-USP, V167, P413, DOI 10.1070/PU1997v040n04ABEH000229; GYNGELL ML, 1989, J MAGN RESON, V81, P474, DOI 10.1016/0022-2364(89)90083-8; Hashi K, 2003, JPN J APPL PHYS 2, V42, pL1481, DOI 10.1143/JJAP.42.L1481; Hibbs A.D., 1998, IEE C PUBL, V458, P138; International Campaign to Ban Landmines, LANDM MON, P37; Itozaki H., 2009, ANTIPERSONNEL LANDMI, P148; MUNSAT T, 1995, APPL PHYS LETT, V66, P2180, DOI 10.1063/1.113939; Prescott DW, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757931; Rudakov TN, 2012, APPL MAGN RESON, V43, P557, DOI 10.1007/s00723-012-0330-0; Rudakov TN, 1998, J PHYS D APPL PHYS, V31, P1251, DOI 10.1088/0022-3727/31/10/017; Sato-Akaba H, 2014, SOLID STATE NUCL MAG, V63-64, P30, DOI 10.1016/j.ssnmr.2014.09.002; SELIGER J, 1989, Z PHYS B CON MAT, V77, P439, DOI 10.1007/BF01453795; Shinohara J, 2012, SOLID STATE NUCL MAG, V43-44, P27, DOI 10.1016/j.ssnmr.2012.02.003; Shinohara J, 2011, SOLID STATE NUCL MAG, V40, P121, DOI 10.1016/j.ssnmr.2011.08.005; YESINOWSKI JP, 1995, ANAL CHEM, V67, P2256, DOI 10.1021/ac00109a053	24	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	MAR	2015	46	3					295	307		10.1007/s00723-014-0623-6		13	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CC3XJ	WOS:000350284300005		
J	Tarkanyi, F; Ditroi, F; Takacs, S; Hermanne, A; Al-Abyad, M; Yamazaki, H; Baba, M; Mohammadi, MA				Tarkanyi, F.; Ditroi, F.; Takacs, S.; Hermanne, A.; Al-Abyad, M.; Yamazaki, H.; Baba, M.; Mohammadi, M. A.			New activation cross section data on longer lived radio-nuclei produced in proton induced nuclear reaction on zirconium	APPLIED RADIATION AND ISOTOPES			English	Article						Proton activation; Cross section measurement; Yield calculation; Nb; Zr and Y radioisotopes	EXCITATION-FUNCTIONS; NATURAL ZIRCONIUM; NIOBIUM; ZR; YTTRIUM; ISOTOPES; TANTALUM; ELEMENTS; ALPHA; SR	The excitation functions of Nb-96, Nb-95m, Nb-95g, Nb-92m, Nb-91m, Nb-90, Zr-95, Zr-89, Zr-88, Zr-86, Y-88, Y-87m, Y-87g, Y-86 were measured up to 70 MeV proton energy by using the stacked foil technique and the activation method. The new data were compared with the critically analyzed experimental data in the literature and with the TALYS based model results in TENDL-2013 library. The possible role of the investigated reactions in the production of medically relevant Nb-90, Nb-95m, Zr-89, and Y-88 radionuclides is discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Tarkanyi, F.; Ditroi, F.; Takacs, S.] Hungarian Acad Sci ATOMKI, Inst Nucl Res, Debrecen, Hungary; [Hermanne, A.] VUB, Cyclotron Lab, Brussels, Belgium; [Al-Abyad, M.] Atom Energy Author, Nucl Res Ctr, Dept Phys, Cyclotron Facil, Cairo 13759, Egypt; [Yamazaki, H.; Baba, M.; Mohammadi, M. A.] Tohoku Univ, Cyclotron & Radioisotope Ctr CYRIC, Sendai, Miyagi 980, Japan	Ditroi, F (reprint author), Hungarian Acad Sci ATOMKI, Inst Nucl Res, Debrecen, Hungary.	ditroi@atomki.hu					ABE K, 1984, J NUCL MATER, V123, P972, DOI 10.1016/0022-3115(84)90203-4; Al-Abyad M, 2012, APPL RADIAT ISOTOPES, V70, P257, DOI 10.1016/j.apradiso.2011.07.019; Khandaker MU, 2009, APPL RADIAT ISOTOPES, V67, P1341, DOI 10.1016/j.apradiso.2009.02.031; Uddin MS, 2007, RADIOCHIM ACTA, V95, P187, DOI 10.1524/ract.2007.95.4.187; Tel E, 2010, PRAMANA-J PHYS, V74, P931, DOI 10.1007/s12043-010-0085-9; KONSTANTINOV IO, 1986, SOV ATOM ENERGY+, V60, P390, DOI 10.1007/BF01125768; Uddin MS, 2008, NUCL INSTRUM METH B, V266, P13, DOI 10.1016/j.nimb.2007.10.010; MUMINOV VA, 1980, SOV ATOM ENERGY+, V49, P540, DOI 10.1007/BF01121617; Cai CH, 2006, NUCL SCI ENG, V153, P93; Michel R, 1997, NUCL INSTRUM METH B, V129, P153, DOI 10.1016/S0168-583X(97)00213-9; Batij V.G., 1985, P 35 ANN C NUCL SPEC, P85; BLASER JP, 1951, HELV PHYS ACTA, V24, P441; BLOSSER HG, 1955, PHYS REV, V100, P1340, DOI 10.1103/PhysRev.100.1340; Broeders CHM, 2007, APPL RADIAT ISOTOPES, V65, P1249, DOI 10.1016/j.apradiso.2007.04.002; Busse S, 2002, RADIOCHIM ACTA, V90, P1, DOI 10.1524/ract.2002.90.1_2002.1; Capote R, 2012, COORDINATED RES PROG; Delaunay-Olkowsky J., 1963, NUCL PHYS, V47, P266, DOI 10.1016/0029-5582(63)90872-1; Dityuk A.I., 1998, NEW VERSION ADV COMP; Dmitriev P. P., 1981, VOPROSY ATOMNOJ NAUK, V5, P43; Dmitriev P.P., 1983, VOP AT NAUKI TEKH YK, V2, P57; Gorpinich O.K., 1988, P 38 ANN C NUCL SPEC, P310; Gul K., 2001, P IAEA TECDOC 1211 V; IAEA, 2004, FUS EV NUCL DAT LIB; IAEA-NDS, 2010, THIN LAYER ACTIVATIO; International-Bureau-of-Weights-and-Measures, 1993, GUID EXPR UNC MEAS; ISSHIKI M, 1984, J RADIOANAL NUCL CH, V82, P135, DOI 10.1007/BF02227336; KANTELO MV, 1976, PHYS REV C, V14, P64, DOI 10.1103/PhysRevC.14.64; Kondratev S.N., 1991, ATOM ENERGY, V71, P325; Koning A. J., 2007, P INT C NUCL DAT SCI, P211; Koning A.J., 2012, TENDL 2013 TALYS BAS; Kuzmenko V.A., 1987, P 38 ANN C NUCL SPEC, P311; Levkovskii V.N., 1991, CROSS SECTIONS ACTIV; Lindhard J., 1977, STOPPING RANGES IONS, V33; Murakami M, 2014, APPL RADIAT ISOTOPES, V90, P149, DOI 10.1016/j.apradiso.2014.03.014; Naik H, 2014, J RADIOANAL NUCL CH, V299, P1335, DOI 10.1007/s10967-013-2848-5; Nickles R J, 1991, Acta Radiol Suppl, V376, P69; NuDat, 2011, NUDAT2 DAT 2 6; Qaim M., 2001, TECHNICAL REPORT SER, V473, P1; REGNIER S, 1982, PHYS REV C, V26, P931, DOI 10.1103/PhysRevC.26.931; Ren WT, 2011, NUCL INSTRUM METH B, V269, P472, DOI 10.1016/j.nimb.2010.12.072; Roughton N. A., 1979, Atomic Data and Nuclear Data Tables, V23, DOI 10.1016/0092-640X(79)90004-4; Sadeghi M, 2011, INT J MOD PHYS E, V20, P1775, DOI 10.1142/S0218301311019520; Schwerer O, 2008, IAEANDS206; Shubin Y.N., 1998, NDS204 IAEA; SKAKUN EA, 1987, SOV J NUCL PHYS+, V46, P17; Tarkanyi F., 2004, AIP C P, P1658; Tarkanyi F, 2004, NUCL INSTRUM METH B, V217, P373, DOI 10.1016/j.nimb.2003.11.084; Tarkanyi F., 2001, BEAM MONITORS REACTI; Uddin MS, 2005, APPL RADIAT ISOTOPES, V63, P367, DOI 10.1016/j.apradiso.2005.04.006; Vysotsky O.N., 1991, P 41 C NUCL SPECTR N, P486	50	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	MAR	2015	97						149	169		10.1016/j.apradiso.2014.12.029		21	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CC7AQ	WOS:000350520500024		
J	Leonova, GN; Kondratov, IG; Maystrovskaya, OS; Takashima, I; Belikov, SI				Leonova, Galina N.; Kondratov, Ilya G.; Maystrovskaya, Olga S.; Takashima, Ikuo; Belikov, Sergei I.			Louping ill virus (LIV) in the Far East	ARCHIVES OF VIROLOGY			English	Article							TICK-BORNE ENCEPHALITIS; SPRING-SUMMER ENCEPHALITIS; AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; NEGISHI VIRUS; IDENTIFICATION; FLAVIVIRUSES; GENOME; JAPAN; POLYPROTEIN	This study focused on finding, culturing, and identifying the biological and genetic characteristics of three louping ill virus (LIV) strains in the south of the Russian Far East. The Primorye-155-77 and Primorye-20-79 virus strains were isolated from Ixodes persulcatus ticks, and the Primorye-185-91 strain was isolated from the blood of a person after a tick bite. According to the hemagglutination and neutralization tests, Primorye-155-77, Primorye-20-79 and Primorye-185-91 had weak reactivity with antibodies in an antiserum against tick-borne encephalitis virus. In Primorye-155-77 and Primorye-20-79, the sequences of the 5' ends of the 2456-nucleotide-long viral RNA including the 5' untranslated region (UTR) and genes of the capsid protein, prM protein and envelope E protein were determined. The complete genome sequence of Primorye-185-91 was determined. The E protein gene of the Negishi strain differed from those of three analyzed strains, as there were mutations resulting in the replacement of three amino acids: Ala163Thr, Asp193Asn and Ala313Thr. The homology of Primorye-185-91 to LIV 369/T2 was 97.57 %, and to the Penrith strain, it was 98.36 %. Phylogenetic analysis showed that Primorye-155-77, Primorye-20-79 and Primorye-185-91 are related to LI/A and LI/K strains isolated in England and Scotland and to the Negishi strain; these strains have a common progenitor. Negishi-like strains were represented by one subtype of louping ill virus, i.e. the British subtype (LIV-Brit). The possibility is discussed of a single introduction of the virus to the Far Eastern region (Japan and Primorsky Krai) from a single natural locus more than 50 years ago.	[Leonova, Galina N.; Maystrovskaya, Olga S.] Russian Acad Med Sci, Inst Epidemiol & Microbiol, Siberian Branch, Vladivostok 690087, Russia; [Kondratov, Ilya G.; Belikov, Sergei I.] Russian Acad Sci, Limnol Inst, Siberian Branch, Irkutsk 664003, Russia; [Takashima, Ikuo] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Leonova, GN (reprint author), Russian Acad Med Sci, Inst Epidemiol & Microbiol, Siberian Branch, Selskaya Str 1, Vladivostok 690087, Russia.	galinaleon41@gmail.com			International Scientific Technical Center Project [4006]; Integration project of SB RAS [141]	The work was supported by the International Scientific Technical Center Project No. 4006 and the Integration project of SB RAS No. 141.	ANDO K, 1952, Kitasato Arch Exp Med, V24, P557; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Ternovoi VA, 2007, EMERG INFECT DIS, V13, P1574, DOI 10.3201/eid1310.070158; Takashima I, 1997, J CLIN MICROBIOL, V35, P1943; Leonova GN, 2013, VIROLOGY, V443, P89, DOI 10.1016/j.virol.2013.04.029; VENUGOPAL K, 1992, VIROLOGY, V190, P515, DOI 10.1016/0042-6822(92)91245-P; Belikov SI, 2010, RUSS J GENET+, V46, P315, DOI 10.1134/S1022795410030087; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calisher CH, 2014, ARCH VIROL, DOI [10.1007/s00705-014:2008-4, DOI 10.1007/S00705-014:2008-4]; Casals J, 1962, S SCAV PRAH, P53; Cherkassky BL, 2008, GLOBAL EPIDEMIOLOGY, P446; GAO GF, 1994, J GEN VIROL, V75, P609, DOI 10.1099/0022-1317-75-3-609; GAO GF, 1993, J GEN VIROL, V74, P109, DOI 10.1099/0022-1317-74-1-109; Gao GF, 1997, ACTA VIROL, V41, P259; Gaunt MW, 1997, ARCH VIROL, V142, P1181, DOI 10.1007/s007050050151; Gritsun TS, 1997, VIRUS RES, V49, P27, DOI 10.1016/S0168-1702(97)01451-2; Heinz FC, 2003, VACCINE, V21; Heinz FX, 2000, VIRUS TAXONOMY, P859; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; King AMQ, 2012, 9 REP INT COMM TAX V, P1003; Korenberg E, 2013, INFECT NATURAL FOCAL, P463; LVOV DK, 1974, VOP VIRUSOL+, P538; Leonova GN, 1990, VOP VIRUSOL+, V5, P399; Leonova GN, 2009, ARCH VIROL, V154, P811, DOI 10.1007/s00705-009-0376-y; Leonova GN, 1991, ZH MIKROBIOL EPIDEMI, V3, P35; LEVKOVICH E N, 1967, P245; MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8; Marston DA, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00454-13, DOI 10.1128/GENOMEA.00454-13]; McLEAN D M, 1959, Can Med Assoc J, V80, P708; REED L. J., 1938, AMER JOUR HYG, V27, P493; OGAWA M, 1973, J NEUROL SCI, V19, P363, DOI 10.1016/0022-510X(73)90100-7; OKUNO T, 1961, JPN J MED SCI BIOL, V14, P51; PLETNEV AG, 1990, VIROLOGY, V174, P250, DOI 10.1016/0042-6822(90)90073-Z; PLETNEV AG, 1989, BIOORG KHIM+, V15, P1504; Safronov PF, 1991, MOL GENET, V4, P23; Sambrook J., 1989, MOL CLONING LAB MANU; SHIU SYW, 1991, VIROLOGY, V180, P411, DOI 10.1016/0042-6822(91)90048-G; Smith CEG, 1981, CRC HDB SERIES ZOO B, VI, P191; Takeda T, 1998, J MED ENTOMOL, V35, P227; Takeda T, 1999, AM J TROP MED HYG, V60, P278; Ueda M., 1980, Japanese Journal of Veterinary Research, V28, P51; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; White DS, 2001, NY ACAD SCI, P374; Yun Seok-Min, 2012, Osong Public Health Res Perspect, V3, P213, DOI 10.1016/j.phrp.2012.10.004; Yun SM, 2009, VECTOR-BORNE ZOONOT, V9, P287, DOI 10.1089/vbz.2008.0085; Zilber L. A., 1939, ARCHIV BIOLOGICHESKIKH NATIK [ARCH SCI BIOL] [ LENINGRAD], V56, P9	48	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAR	2015	160	3					663	673		10.1007/s00705-014-2310-1		11	Virology	Virology	CC4BI	WOS:000350295300004		
J	Utsumi, T; Wahyuni, RM; Lusida, MI; Yano, Y; Priambada, NP; Amin, M; Purwono, PB; Istimagfiroh, A; Soetjipto; Brule, A; Hotta, H; Hayashi, Y				Utsumi, Takako; Wahyuni, Rury Mega; Lusida, Maria Inge; Yano, Yoshihiko; Priambada, Nur Purba; Amin, Mochamad; Purwono, Priyo Budi; Istimagfiroh, Anittaqwa; Soetjipto; Brule, Aurelien; Hotta, Hak; Hayashi, Yoshitake			Full genome characterization and phylogenetic analysis of hepatitis B virus in gibbons and a caretaker in Central Kalimantan, Indonesia	ARCHIVES OF VIROLOGY			English	Article							ORANGUTANS PONGO-PYGMAEUS; NONHUMAN-PRIMATES; MOLECULAR EPIDEMIOLOGY; INFECTION; VARIANTS; SUBGENOTYPES; HEPADNAVIRUS; PREVALENCE; MUTATIONS; GENOTYPES	Hepatitis B virus (HBV) from gibbons was characterized, and the possibility of horizontal transmission between gibbons and humans was examined in a gibbon rehabilitation center in Central Kalimantan, Indonesia. Ten gibbons that were positive for the hepatitis B surface antigen (HBsAg) on arrival and 13 caretakers for those gibbons were included in this study. The duration of stay at the rehabilitation center ranged from 1 to 10 years. Serological and molecular analyses were performed. Six gibbons were positive for HBsAg, whereas HBV DNA was detected in all ten of the gibbons sampled. On the other hand, HBsAg was detected in only 1 of the 13 caretakers. HBV samples from seven gibbons and from the one infected human were chosen for complete genome sequencing. A phylogenetic analysis revealed that the cluster of gibbon strains in this study was distinct from strains previously reported from other countries. In the pre-S1 region, we found a unique amino acid residue substitution (P89K), three insertions between T87 and L88 in the genomes of three gibbons, and a 33-nucleotide deletion at the start of pre-S1 that is common in non-human primates. The caretaker sample was identified as HBV subgenotype B3, the most common type in Indonesia. For the complete HBV sequences, the similarity between gibbons in this study and other non-human primate and human HBV isolates was 90-91.9 % and 85.5-89.6 %, respectively. In conclusion, the gibbon HBV genotype was influenced by geographic location and species. To the best of our knowledge, this is the first report characterizing the HBV genes and genomes of indigenous gibbons in Indonesia.	[Utsumi, Takako; Wahyuni, Rury Mega; Lusida, Maria Inge; Amin, Mochamad; Purwono, Priyo Budi; Istimagfiroh, Anittaqwa; Soetjipto] Airlangga Univ, Inst Trop Dis, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Surabaya, Indonesia; [Utsumi, Takako; Yano, Yoshihiko; Hotta, Hak; Hayashi, Yoshitake] Kobe Univ, Ctr Infect Dis, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Priambada, Nur Purba; Brule, Aurelien] Kalaweit Gibbon Conservat Ctr & Sanctuary, Cent Kalimantan, Indonesia	Utsumi, T (reprint author), Airlangga Univ, Inst Trop Dis, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Surabaya, Indonesia.	tutsumi@people.kobe-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported by a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. We are grateful to the Kalaweit Gibbon Conservation Center and Sanctuary, Central Kalimantan, Indonesia, for their valuable help. In addition, we would like to thank Prof. Masashi Mizokami, at the National Center for Global Health and Medicine, for his valuable suggestions.	Aiba N, 2003, VIRUS GENES, V27, P219, DOI 10.1023/A:1026387614162; Sugauchi F, 2001, J GEN VIROL, V82, P883; Locarnini S, 2013, SEMIN CANCER BIOL, V23, P561, DOI 10.1016/j.semcancer.2013.08.006; Abe A, 1999, J CLIN MICROBIOL, V37, P2899; Heriyanto DS, 2012, J MED VIROL, V84, P44, DOI 10.1002/jmv.22266; Utama A, 2009, WORLD J GASTROENTERO, V15, P4028, DOI 10.3748/wjg.15.4028; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Grethe S, 2000, J VIROL, V74, P5377, DOI 10.1128/JVI.74.11.5377-5381.2000; Lanford RE, 2000, J VIROL, V74, P2955, DOI 10.1128/JVI.74.6.2955-2959.2000; Li WG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-60; Noppornpanth S, 2003, J GEN VIROL, V84, P147, DOI 10.1099/vir.0.18531-0; Norder H, 1996, VIROLOGY, V218, P214, DOI 10.1006/viro.1996.0181; Sall AA, 2005, J GEN VIROL, V86, P333, DOI 10.1099/vir.0.80274-0; Sa-Nguanmoo P, 2009, ACTA VIROL, V53, P73, DOI 10.4149/av_2009_02_73; Sa-Nguanmoo P, 2008, J MED PRIMATOL, V37, P277, DOI 10.1111/j.1600-0684.2008.00290.x; Seeger C, 2013, FIELDS VIROLOGY, P2185; Starkman SE, 2003, VIROLOGY, V314, P381, DOI 10.1016/S0042-6822(03)00430-6; Verschoor EJ, 2001, J GEN VIROL, V82, P893; Warren KS, 1998, J MED PRIMATOL, V27, P33; Warren KS, 1999, J VIROL, V73, P7860; Yuan Q, 2010, J CLIN MICROBIOL, V48, P357, DOI 10.1128/JCM.01781-09	24	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAR	2015	160	3					685	692		10.1007/s00705-014-2323-9		8	Virology	Virology	CC4BI	WOS:000350295300006		
J	Takahashi, K; Inoshima, Y; Ishiguro, N				Takahashi, Kenichi; Inoshima, Yasuo; Ishiguro, Naotaka			Role of cell death in the propagation of PrPSc in immune cells	ARCHIVES OF VIROLOGY			English	Article							FOLLICULAR DENDRITIC CELLS; RESISTANT PRION PROTEIN; SCRAPIE; TRANSMISSION; MACROPHAGES; CONVERSION; DISEASES; ISOFORM	A number of studies have suggested that macrophages, dendritic cells, and follicular dendritic cells play an important role in the propagation of PrPSc. Both accumulation and proteolysis of PrPSc have been demonstrated in peripheral macrophages. Macrophages may act as reservoirs for PrPSc particles if the cells die during transient PrPSc propagation. However, whether cell death plays a role in PrPSc propagation in macrophages remains unclear. In this study, we investigated the possibility of propagation and transmission of PrPSc between dead immune cells and living neural cells. We found that under specific conditions, transient PrPSc propagation occurs in dead cells, indicating that interaction between PrPC and PrPSc on plasma membrane lipid rafts might be important for PrPSc propagation. Co-culturing of killed donor PrPSc-infected macrophages with recipient N2a-3 neuroblastoma cells accelerated PrPSc transmission. Our results suggest that cell death may play an important role in PrPSc propagation, whereas transient PrPSc propagation in macrophages has little effect on PrPSc transmission.	[Takahashi, Kenichi; Inoshima, Yasuo; Ishiguro, Naotaka] Gifu Univ, Fac Appl Biol Sci, Lab Food & Environm Hyg, Vet Med, Gifu, Japan	Ishiguro, N (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Food & Environm Hyg, Vet Med, 1-1 Yanagido, Gifu, Japan.	ishiguna@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [22380165]; Ministry of Health, Labour, and Welfare of Japan	This work was supported by a grant (22380165) from the Ministry of Education, Culture, Sports, Science, and Technology and by a grant from the Ministry of Health, Labour, and Welfare of Japan.	Andreoletti Q, 2000, J GEN VIROL, V81, P3115; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Sassa Y, 2010, MICROBIOL IMMUNOL, V54, P763, DOI 10.1111/j.1348-0421.2010.00272.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Tanaka Y, 2012, CELL IMMUNOL, V279, P145, DOI 10.1016/j.cellimm.2012.11.007; Beringue Vincent, 2002, Dev Immunol, V9, P19, DOI 10.1080/10446670290030981; Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; CHANDLER RL, 1963, LANCET, V2, P1165; DUBOWCHIK GM, 1994, BBA-BIOMEMBRANES, V1191, P103, DOI 10.1016/0005-2736(94)90237-2; Elhelaly AE, 2013, BIOCHEM BIOPH RES CO, V439, P340, DOI 10.1016/j.bbrc.2013.08.085; Elhelaly AE, 2012, ARCH VIROL, V158, P651; Haïk Stépahne, 2004, Trends Mol Med, V10, P107; Herrmann LM, 2003, AM J PATHOL, V162, P1075, DOI 10.1016/S0002-9440(10)63904-1; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; SHINAGAWA M, 1986, J GEN VIROL, V67, P1745, DOI 10.1099/0022-1317-67-8-1745; Uryu M, 2007, MICROBIOL IMMUNOL, V51, P661	26	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAR	2015	160	3					693	699		10.1007/s00705-014-2320-z		7	Virology	Virology	CC4BI	WOS:000350295300007		
J	Shirai, K; Hayasaka, D; Kitaura, K; Takasaki, T; Morita, K; Suzuki, R; Kurane, I				Shirai, Kenji; Hayasaka, Daisuke; Kitaura, Kazutaka; Takasaki, Tomohiko; Morita, Kouichi; Suzuki, Ryuji; Kurane, Ichiro			Qualitative differences in brain-infiltrating T cells are associated with a fatal outcome in mice infected with Japanese encephalitis virus	ARCHIVES OF VIROLOGY			English	Article							TICK-BORNE ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; WEST-NILE; TRANSCRIPTION FACTOR; FLAVIVIRUS INFECTIONS; MONOCLONAL-ANTIBODIES; PERIPHERAL INFECTION; FAS LIGAND; RECEPTOR; LYMPHOCYTES	Japanese encephalitis (JE) is the most important form of viral encephalitis in Asia. The critical factors determining mortality and severity of JE virus (JEV) infection remain unclear. We identified brain-infiltrating T cells associated with a fatal outcome of JEV infection in mice. Dying mice were defined as those that lost more than 25 % of their body weight by day 13 and died by day 21, while surviving mice were defined as those that lost less than 10 % by day 13, based on the result of the survival time course study. Two groups of five mice that demonstrated brain virus titers of > 1 x 10(6) pfu/g were randomly selected from the dying and surviving groups and used in the analyses. Cytokine patterns in brains were first examined, revealing a higher ratio of Th1-related cytokine genes in dying mice. The expression levels of CD3, CD8, CD25, and CD69 increased in JEV-infected mice relative to mock-infected mice. However, expression levels of these cell-surface markers did not differ between the two groups. T-cell receptor (TCR) usage and complementary determining region 3 (CDR3) sequences were analyzed in the brain-infiltrating T cells. T cells expressing VA8-1, VA10-1, and VB2-1 increased in both groups. However, the dominant T-cell clones as defined by CDR3 amino acid sequence differed between the two groups. The results indicate that the outcome of JEV infection, death or survival, was determined by qualitative differences in infiltrating T-cell clones with unique CDR3 amino acid sequences.	[Shirai, Kenji; Kitaura, Kazutaka; Takasaki, Tomohiko; Kurane, Ichiro] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan; [Shirai, Kenji; Kitaura, Kazutaka; Suzuki, Ryuji] Natl Hosp Org, Sagamihara Natl Hosp, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 2520392, Japan; [Shirai, Kenji; Kurane, Ichiro] Univ Tsukuba, Inst Basic Med Sci, Dept Infect Biol, Tsukuba, Ibaraki 3058575, Japan; [Hayasaka, Daisuke; Morita, Kouichi] Nagasaki Univ, GCOE Program, Dept Virol, Inst Trop Med, Nagasaki 8528523, Japan	Kurane, I (reprint author), Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.	kurane@nih.go.jp			Institute of Tropical Medicine, Nagasaki University, Japan [25-ippan-2, 26-ippan-15]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790457]	This work was supported by the Cooperative Research Grants 25-ippan-2 and 26-ippan-15 from the Institute of Tropical Medicine, Nagasaki University, Japan and Young Scientists B Grant-in-Aid for Scientific Research 24790457 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alliot F, 1996, DEV BRAIN RES, V95, P140, DOI 10.1016/0165-3806(96)00101-0; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Kishikawa H, 2001, J IMMUNOL, V167, P4414; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVf.01136-07; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Brien JD, 2008, J IMMUNOL, V181, P8568; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Takada K, 2000, ARCH VIROL, V145, P523, DOI 10.1007/s007050050043; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; MuraliKrishna K, 1996, J GEN VIROL, V77, P705, DOI 10.1099/0022-1317-77-4-705; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Yoshida R, 2000, IMMUNOGENETICS, V52, P35, DOI 10.1007/s002510000248; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Biswas SM, 2009, J GEN VIROL, V90, P818, DOI 10.1099/vir.0.008045-0; Chiba N, 1999, VACCINE, V17, P779, DOI 10.1016/S0264-410X(98)00262-X; Fujii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056296; Fujii Y, 2011, VIRAL IMMUNOL, V24, P291, DOI 10.1089/vim.2011.0017; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; FUJISAKI Y, 1983, NATL I ANIM HEALTH Q, V23, P21; Hayasaka D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071643; Kasahara Toshihiko, 2006, Journal of Toxicological Sciences, V31, P509, DOI 10.2131/jts.31.509; KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663; KUMAR R, 1990, ARCH DIS CHILD, V65, P1227; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037; MATHUR A, 1983, J GEN VIROL, V64, P805, DOI 10.1099/0022-1317-64-4-805; Matsutani T, 1997, HUM IMMUNOL, V56, P57, DOI 10.1016/S0198-8859(97)00102-X; MURALIKRISHNA K, 1994, J GEN VIROL, V75, P799, DOI 10.1099/0022-1317-75-4-799; OMRI B, 1994, INT IMMUNOL, V6, P377, DOI 10.1093/intimm/6.3.377; Robinson DS, 2002, CURR BIOL, V12, pR322, DOI 10.1016/S0960-9822(02)00830-8; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; VINCE V, 1969, J NEUROL SCI, V9, P109, DOI 10.1016/0022-510X(69)90064-1; Wang FM, 1998, P NATL ACAD SCI USA, V95, P5217, DOI 10.1073/pnas.95.9.5217; YOKOYAMA WM, 1988, J IMMUNOL, V141, P369; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597	62	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAR	2015	160	3					765	775		10.1007/s00705-014-2154-8		11	Virology	Virology	CC4BI	WOS:000350295300015		
J	Van, TTB; Yoshida, S; Miki, K; Kondo, A; Kamei, K				Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kondo, Akihiro; Kamei, Kaeko			Complete genome sequence of a filamentous bacteriophage, RS611, that infects the phytopathogen Ralstonia solanacearum	ARCHIVES OF VIROLOGY			English	Article								Filamentous bacteriophage RS611 (I center dot RS611), which infects the phytopathogen Ralstonia solanacearum, had a circular single-stranded DNA genome that was characterized as an Ff-type phage belonging to the family Inoviridae. The I center dot RS611 genome was composed of 6386 bases with a G + C content of 62.1 % and contained 11 putative open reading frames. The I center dot RS611 genome showed high similarity to those of Ralstonia phages RSS0 and RSS1. However, approximately 900-nucleotide deletions were found in the region corresponding to open reading frames 10 and 11 of I center dot RSS0 and I center dot RSS1.	[Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Kondo, Akihiro] Hiyoshi Corp, Omihachiman, Shiga 5238555, Japan	Kamei, K (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	kame@kit.ac.jp					Kawasaki T, 2007, J BACTERIOL, V189, P5792, DOI 10.1128/JB.00540-07; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Askora A, 2009, VIROLOGY, V384, P69, DOI 10.1016/j.virol.2008.11.007; Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Murugaiyan S, 2011, J APPL MICROBIOL, V110, P296, DOI 10.1111/j.1365-2672.2010.04882.x; Addy HS, 2012, PHYTOPATHOLOGY, V102, P244, DOI 10.1094/PHYTO-10-11-0277; Yamada T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00325; Yamada T., 2012, BACTERIOPHAGES, P113	9	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAR	2015	160	3					865	867		10.1007/s00705-014-2316-8		3	Virology	Virology	CC4BI	WOS:000350295300028		
J	Mukai, T; Gallant, R; Ishida, S; Kittaka, M; Yoshitaka, T; Fox, DA; Morita, Y; Nishida, K; Rottapel, R; Ueki, Y				Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Kittaka, Mizuho; Yoshitaka, Teruhito; Fox, David A.; Morita, Yoshitaka; Nishida, Keiichiro; Rottapel, Robert; Ueki, Yasuyoshi			Loss of SH3 Domain-Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor-Driven and Collagen-Induced Arthritis in Mice	ARTHRITIS & RHEUMATOLOGY			English	Article							3BP2 ADAPTER PROTEIN; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION; COMPUTED-TOMOGRAPHY; RECEPTOR ACTIVATOR; TRANSGENIC MICE; FACTOR-ALPHA; CHERUBISM; CELLS; RANKL	Objective. SH3 domain-binding protein 2 (SH3BP2) is a signaling adapter protein that regulates the immune and skeletal systems. The present study was undertaken to investigate the role of SH3BP2 in arthritis using 2 experimental mouse models, i.e., human tumor necrosis factor alpha-transgenic (hTNF-Tg) mice and mice with collagen-induced arthritis (CIA). Methods. First, Sh3bp2(-/-) and wild-type (Sh3bp2(+/+)) mice were crossed with hTNF-Tg mice. Inflammation and bone loss were examined by clinical inspection and histologic and micro-computed tomography analysis, and osteoclastogenesis was evaluated using primary bone marrow-derived macrophage colony-stimulating factor-dependent macrophages (BMMs). Second, CIA was induced in Sh3bp2(-/-) and Sh3bp2(+/+) mice, and the incidence and severity of arthritis were evaluated. Anti-mouse type II collagen (CII) antibody levels were measured by enzyme-linked immunosorbent assay, and lymph node cell responses to CII were determined. Results. SH3BP2 deficiency did not alter the severity of joint swelling but did suppress bone erosion in the hTNF-Tg mouse model. Bone loss at the talus and tibia was prevented in Sh3bp2(-/-)/hTNF-Tg mice compared to Sh3bp2(+/+)/hTNF-Tg mice. RANKL- and TNF alpha-induced osteoclastogenesis was suppressed in Sh3bp2(-/-) mouse BMM cultures. NF-ATc1 nuclear localization in response to TNF alpha was decreased in Sh3bp2(-/-) mouse BMMs compared to Sh3bp2(+/+) mouse BMMs. In the CIA model, SH3BP2 deficiency suppressed the incidence of arthritis and this was associated with decreased anti-CII antibody production, while antigen-specific T cell responses in lymph nodes were not significantly different between Sh3bp2(+/+) and Sh3bp2(-/-) mice. Conclusion. SH3BP2 deficiency prevents loss of bone via impaired osteoclastogenesis in the hTNF-Tg mouse model and suppresses the induction of arthritis via decreased autoantibody production in the CIA model. Therefore, SH3BP2 could potentially be a therapeutic target in rheumatoid arthritis.	[Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Kittaka, Mizuho; Yoshitaka, Teruhito; Ueki, Yasuyoshi] Univ Missouri, Kansas City, MO 64108 USA; [Ishida, Shu] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Fox, David A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Morita, Yoshitaka] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Rottapel, Robert] Univ Toronto, Toronto, ON, Canada; [Rottapel, Robert] St Michaels Hosp, Toronto, ON M5B 1W8, Canada	Ueki, Y (reprint author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, 650 East 25th St, Kansas City, MO 64108 USA.	uekiy@umkc.edu			Japan Rheumatism Foundation; Kawasaki Medical School [26-75]; Canadian Institute for Health Research; NIH [R01-DE-020835]	Supported by the Japan Rheumatism Foundation (Rheumatology Traveling Fellowship to Dr. Mukai), Kawasaki Medical School (Research Project Grant 26-75 to Dr. Morita), the Canadian Institute for Health Research (grant to Dr. Rottapel), and the NIH (grant R01-DE-020835 to Dr. Ueki).	Ainsua-Enrich E, 2012, J IMMUNOL, V189, P2727, DOI 10.4049/jimmunol.1200380; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JC1200215582; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Cross A, 2003, ARTHRITIS RHEUM, V48, P2796, DOI 10.1002/art.11253; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; KEFFER J, 1991, EMBO J, V10, P4025; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chen G, 2012, J IMMUNOL, V189, P2138, DOI 10.4049/jimmunol.1103184; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Desla Fuente MA, 2006, MOL CELL BIOL, V26, P5214; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Geusens P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3375; GuezGuez A, 2010, J BIOL CHEM, V285, P20952, DOI 10.1074/jbc.M109.091124; Hayward Michael D., 2007, BMC Physiology, V7, P13, DOI 10.1186/1472-6793-7-13; HENDRICH C, 1991, ARTHRITIS RHEUM, V34, P423, DOI 10.1002/art.1780340407; Jevremovic D, 2001, J IMMUNOL, V166, P7219; Kawamoto T, 2011, J ORTHOP RES, V29, P1521, DOI 10.1002/jor.21408; MALONE DG, 1987, ARTHRITIS RHEUM, V30, P130, DOI 10.1002/art.1780300202; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mukai T, 2014, J BONE MINER RES, V29, P618; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Papadaki ME, 2012, ORPHANET J RARE D S1, V7, pS6; Proulx ST, 2007, ARTHRITIS RHEUM, V56, P4024, DOI 10.1002/art.23128; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; SEKI N, 1988, J IMMUNOL, V140, P1477; Southgate J, 1998, J CLIN PATHOL, V51, P831; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Vander Cruyssen B, 2005, AUTOIMMUN REV, V4, P468; Wang CCJ, 2010, BONE, V46, P1306, DOI 10.1016/j.bone.2010.01.380	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAR	2015	67	3					656	667		10.1002/art.38975		12	Rheumatology	Rheumatology	CC4DG	WOS:000350300400010		
J	Chapple, J				Chapple, Julian			Mission accomplished? School mission statements in NZ and Japan: what they reveal and conceal	ASIA PACIFIC EDUCATION REVIEW			English	Article						Mission statements; New Zealand; Japan; Primary education; Education policy	PHYSICAL-EDUCATION; CURRICULUM-DEVELOPMENT; POLICY	Primary schooling, where the majority of students start learning formally about social interaction and civic expectations, reflects much about a nations' approach to education and the goals for their citizens. After a brief comparison of the purpose of education in both New Zealand and Japan, through the use of textual and content analysis, this paper firstly analyzes school mission (vision) statements to explore the degree of diversity that exists within the public school sector in New Zealand and Japan. One hundred and fifty primary school mission statements in New Zealand and Japan were examined and grouped according to content and common themes based on a modified and simplified version of Stemler and Bebell (The school mission statement: values, goals, and identities in American education, Routledge, New York 2012)'s rubric. Next, the results of this survey were compared with a previous Japanese one (BERD) (School education statements. The present state of education 2010), then cross-culturally by an examination of the main concepts that emerged in both countries. Finally, the paper attempts to shed light on the overall differences that exist between the two nations' primary education systems and what these reveal about its role in the respective societies in terms of the fostering of citizens for potential future contribution in the world.	Ryukoku Univ, Fac Int Studies, Fushimi Ku, Kyoto 6128577, Japan	Chapple, J (reprint author), Ryukoku Univ, Fac Int Studies, Fushimi Ku, Room 4-437,67 Tsukamoto Cho, Kyoto 6128577, Japan.	Julian@world.ryukoku.ac.jp					Adler M. J., 1982, PAIDEIA PROPOSAL ED; Penney D, 2004, SPORT EDUC SOC, V9, P269, DOI 10.1080/1357332042000233985; Morphew CC, 2006, J HIGH EDUC, V77, P456, DOI 10.1353/jhe.2006.0025; Ball S, 2008, ED DEBATE POLICY POL; Barnett R., 1992, IMPROVING HIGHER ED; BERD, 2010, GAKK KYOIK MOK KYOIK; Birnbaum R, 2000, MANAGEMENT FADS HIGH; Burrows L., 2003, IT TAKES 2 FEET TEAC, P13; Carruthers J. K., 1981, MISSION REV FDN STRA; Crawshaw M., 2001, NEOLIBERALISM NZ ED; Doherty R. A., 2007, CRITICAL STUDIES ED, V48, P269, DOI [10.1080/17508480701494275, DOI 10.1080/17508480701494275]; Drucker P, 1973, MANAGEMENT TASKS RES; Eitel D., 1987, J CONTINUING HIGHER, V35, P2; Fish R., JAPAN RECENT TRENDS; Fugazzotto S., 2009, INNOVATIVE HIGHER ED, V34, P285; Gard M., 2009, HLTH PHYS ED CONT IS, P183; Harmon D., 2005, ELEMENTARY ED; Jones R. S., 2011, OECD EC DEP WORKING; Keeling M., 2013, KNOWLEDGE QUEST, V42, P30; Keller G., 1983, ACAD STRATEGY MANAGE; Kuenssberg S., 2011, QUALITY HIGHER ED, V17, P279; Lake S., 2011, PLANNING HIGHER ED, V39, P5; MacDonald D., 2009, HLTH PHYS ED, P248; Mallard T., 2004, PHYS ACTIVITY PRIMAR; Martin W. B., 1982, COLL CHARACTER RENEW; Martin W. B., 1985, OPPORTUNITY ADVERSIT; May H., 2011, I AM 5 I GO SCH EARL; McGee C., 1997, TEACHERS CURRICULUM; MEXT, REF COMP ED; MEXT, 2013, 2 PLAN PROM ED; MEXT, 2009, SHIN GAK SHID YOR IK; MEXT, 2006, BAS ACT ED; Ministry of Education, 2014, INITIATIVES; Ministry of Education, 2007, NZ CURR; Ministry of Education, NAT ED GOALS; Ministry of Health, 2013, NZ HLTH SURV; Nakai K., 2012, DEBATE JAPANS ACAD D; NIER, 2012, WAG NO GAKK KYOIK SE; OZDEM G, 2011, ED SCI THEORY PRACTI, V11, P1887; Peeke G., 1994, MISSION CHANGE I MIS; Penney D, 2008, EUR PHYS EDUC REV, V14, P33, DOI 10.1177/1356336X07085708; Peters M. A., 2001, SITES J S PACIFIC CU, V37, P32; Peters T. J., 1982, SEARCH EXCELLENCE LE; Petrie K, 2011, EUR PHYS EDUC REV, V17, P325, DOI 10.1177/1356336X11416729; Small D., 2009, 37 ANN C ANZCIES U N; Stallworth Williams L., 2008, J BUS COMMUN, V45, P94, DOI DOI 10.1177/0021943607313989; Stemler S. E., 2012, SCH MISSION STATEMEN; Stemler SE, 2011, EDUC ADMIN QUART, V47, P383, DOI 10.1177/0013161X10387590; Takayama K, 2009, ASIA PAC J EDUC, V29, P125, DOI 10.1080/02188790902857149; Tokunaga T., 2013, ED POLICY REFORM TRE, P245; Wylie C., 2009, TOMORROWS SCH 20 YEA	51	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1598-1037	1876-407X		ASIA PAC EDUC REV	Asia Pac. Educ. Rev.	MAR	2015	16	1					137	147		10.1007/s12564-015-9360-2		11	Education & Educational Research	Education & Educational Research	CD0YQ	WOS:000350800700011		
J	Tsuboi, A; Terazawa-Watanabe, M; Kazumi, T; Fukuo, K				Tsuboi, Ayaka; Terazawa-Watanabe, Mayu; Kazumi, Tsutomu; Fukuo, Keisuke			Associations of decreased serum transthyretin with elevated high-sensitivity CRP, serum copper and decreased hemoglobin in ambulatory elderly women	ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION			English	Article						copper; low-grade inflammation; hemoglobin; postprandial triglyceridemia; transthyretin	ACYLATION-STIMULATING PROTEIN; MIDDLE-AGED WOMEN; CARDIOVASCULAR-DISEASE; PERITONEAL-DIALYSIS; HEMODIALYSIS; PREALBUMIN; MORTALITY; SURVIVAL; ALBUMIN; RISK	Background: Transthyretin (TTR). a sensitive indicator of malnutrition and inflammation, has been shown to be associated with mortality in elderly population. Methods: We examined relationships between serum TTR and a range of risk factors for mortality in 185 free-living elderly women. Blood was drawn between breakfast and lunch. Results: TTR was correlated negatively with age (r= -0.30, p<0.001). After controlling for age, TTR was negatively associated with log high-sensitivity CRP (hsCRP) and serum copper. It was positively associated with albumin, serum iron and hemoglobin. In addition, TTR was positively correlated with systolic and diastolic blood pressure and postprandial triglyceride (TG). In multiple regression analysis for TTR as a dependent variable, hemoglobin (standardized beta, 0.244), serum copper (standardized beta, -0.134), postprandial TG (standardized beta, 0.223) and log hsCRP (standardized beta, -0.190) emerged as determinants of TTR independently of age, albumin, serum iron, systolic and diastolic blood pressure, and explained 22.8% of TTR variability. Conclusions: Subclinical low-grade inflammation, elevated serum copper and decreased hemoglobin were associated with decreased serum TTR in community-living elderly Japanese women and may represent important confounders of the relationship between low TTR and mortality in the elderly. The positive association of TTR with postprandial TG warrants further investigation.	[Tsuboi, Ayaka; Terazawa-Watanabe, Mayu; Kazumi, Tsutomu; Fukuo, Keisuke] Mukogawa Womens Univ, Postgrad Sch Food Sci & Nutr, Nishinomiya, Hyogo 6638558, Japan; [Kazumi, Tsutomu; Fukuo, Keisuke] Mukogawa Womens Univ, Dept Food Sci & Nutr, Sch Human Environm Sci, Nishinomiya, Hyogo 6638558, Japan; [Kazumi, Tsutomu; Fukuo, Keisuke] Mukogawa Womens Univ, Res Inst Nutr Sci, Nishinomiya, Hyogo 6638558, Japan; [Kazumi, Tsutomu] Myodani Hosp, Ctr Diabet, Tarumi Ku, Kobe, Hyogo, Japan	Kazumi, T (reprint author), Mukogawa Womens Univ, Res Inst Nutr Sci, 6-46 Ikebiraki Cho, Nishinomiya, Hyogo 6638558, Japan.	kazumi@mukogawa-u.ac.jp			KAKENHI of Japan Society for the Promotion of Science [21300260]	We are indebted to all the participants for their dedicated and conscientious collaboration. This study was supported by KAKENHI (21300260) of a Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; CATCHATOURIAN R, 1980, BLOOD, V55, P625; Scantlebury T, 1998, J BIOL CHEM, V273, P20903, DOI 10.1074/jbc.273.33.20903; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Tsuboi A, 2014, ASIA PAC J CLIN NUTR, V23, P239, DOI 10.6133/apjcn.2014.23.2.04; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P273, DOI 10.1002/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-X; Wu B, 2009, ENDOCR J, V56, P773, DOI 10.1507/endocrj.K08E-332; Djousse L, 2002, CIRCULATION, V106, P2919, DOI 10.1161/01.CIR.0000042673.07632.76; Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x; Panichi V, 2004, J NEPHROL, V17, P715; Mocchegiani E, 2012, AGE, V34, P539, DOI 10.1007/s11357-011-9252-2; AVRAM MM, 1995, AM J KIDNEY DIS, V26, P209, DOI 10.1016/0272-6386(95)90176-0; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; Cianflone K, 1989, J BIOL CHEM, V64, P426; Easter RN, 2010, VASC MED, V15, P61, DOI 10.1177/1358863X09346656; Ford ES, 2000, AM J EPIDEMIOL, V151, P1182; Henze A, 2012, DIABETES CARE, V35, P2365, DOI 10.2337/dc12-0455; Hirose N, 1997, Nihon Ronen Igakkai Zasshi, V34, P324; Ingenbleek Y, 2002, CLIN CHEM LAB MED, V40, P1281, DOI 10.1515/CCLM.2002.222; Iso H, 2009, ATHEROSCLEROSIS, V207, P291, DOI 10.1016/j.atherosclerosis.2009.04.020; LOCKITCH G, 1983, J PEDIATR-US, V102, P304, DOI 10.1016/S0022-3476(83)80548-4; Mittman N, 2001, AM J KIDNEY DIS, V38, P1358, DOI 10.1053/ajkd.2001.29256; Moreno T, 1998, SCI TOTAL ENVIRON, V217, P21, DOI 10.1016/S0048-9697(98)00158-2; Myron Johnson A, 2007, Clin Chem Lab Med, V45, P419, DOI 10.1515/CCLM.2007.051; Rambod M, 2008, AM J CLIN NUTR, V88, P1485, DOI 10.3945/ajcn.2008.25906; Saleh J, 1998, J LIPID RES, V39, P884; Sergi G, 2006, EUR J CLIN NUTR, V60, P203, DOI 10.1038/sj.ejcn.1602289; Sinun A, 2008, BIOL CHEM, V389, P257, DOI [10.1515/BC.2008.034, DOI 10.1515/BC.2008.034]; Sreedhara R, 1996, AM J KIDNEY DIS, V28, P937, DOI 10.1016/S0272-6386(96)90398-4; Tanaka M, 2012, J ATHEROSCLER THROMB, V19, P633; World Health Organization (WHO), 1968, NUTR AN	34	0	0	H E C PRESS, HEALTHY EATING CLUB PTY LTD	MCKINNON	PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA	0964-7058			ASIA PAC J CLIN NUTR	Asia Pac. J. Clin. Nutr.	MAR	2015	24	1					83	89		10.6133/apjcn.2015.24.1.18		7	Nutrition & Dietetics	Nutrition & Dietetics	CD1IJ	WOS:000350828000011		
J	Barnett, R; Warren, SJ; Banerji, M; McMahon, RG; Hewett, PC; Mortlock, DJ; Simpson, C; Venemans, BP; Ota, K; Shibuya, T				Barnett, R.; Warren, S. J.; Banerji, M.; McMahon, R. G.; Hewett, P. C.; Mortlock, D. J.; Simpson, C.; Venemans, B. P.; Ota, K.; Shibuya, T.			The spectral energy distribution of the redshift 7.1 quasar ULAS J1120+0641	ASTRONOMY & ASTROPHYSICS			English	Article						cosmology: observations; quasars: individual: ULAS J1120+0641; galaxies: star formation; galaxies: high-redshift	DIGITAL SKY SURVEY; SUPERMASSIVE BLACK-HOLES; ACTIVE GALACTIC NUCLEI; SIMILAR-TO 6; FALL EQUATORIAL STRIPE; PALOMAR-GREEN QUASARS; STAR-FORMATION RATE; THAN 6.5 QUASARS; 158 MU-M; LUMINOSITY FUNCTION	We present new observations of the highest-redshift quasar known, ULAS J1120+0641, redshift z = 7.084, obtained in the optical, at near-, mid-, and far-infrared wavelengths, and in the sub-mm. We combine these results with published X-ray and radio observations to create the multiwavelength spectral energy distribution (SED), with the goals of measuring the bolometric luminosity L-bol, and quantifying the respective contributions from the AGN and star formation. We find three components are needed to fit the data over the wavelength range 0.12-1000 mu m: the unobscured quasar accretion disk and broad-line region, a dusty clumpy AGN torus, and a cool 47K modified black body to characterise star formation. Despite the low signal-to-noise ratio of the new long-wavelength data, the normalisation of any dusty torus model is constrained within +/- 40%. We measure a bolometric luminosity L-bol = 2.6 +/- 0.6 x 10(47) erg s(-1) = 6.7 +/- 1.6 x 10(13) L-circle dot, to which the three components contribute 31%; 32%; 3%, respectively, with the remainder provided by the extreme UV < 0.12 mu m. We tabulate the best-fit model SED. We use local scaling relations to estimate a star formation rate (SFR) in the range 60-270 M-circle dot/yr from the [C II] line luminosity and the 158 mu m continuum luminosity. An analysis of the equivalent widths of the [C II] line in a sample of z > 5.7 quasars suggests that these indicators are promising tools for estimating the SFR in high-redshift quasars in general. At the time observed the black hole was growing in mass more than 100 times faster than the stellar bulge, relative to the mass ratio measured in the local universe, i.e. compared to M-BH/M-bulge similar or equal to 1.4 x 10(-3), for ULAS J1120+0641 we measure. (M)(BH) over dot = (M)(bulge) over dot similar or equal to 0.2.	[Barnett, R.; Warren, S. J.; Mortlock, D. J.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Banerji, M.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Banerji, M.; McMahon, R. G.; Hewett, P. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Banerji, M.; McMahon, R. G.; Ota, K.] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Mortlock, D. J.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Simpson, C.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Venemans, B. P.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Ota, K.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Shibuya, T.] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan	Barnett, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, Prince Consort Rd, London SW7 2AZ, England.	rhys.barnett09@imperial.ac.uk	McMahon, Richard/G-4260-2012	McMahon, Richard/0000-0001-8447-8869	Leverhulme Trust; ERC grant "Cosmic Dawn"; NASA; University of California, Los Angeles; Jet Propulsion Laboratory/California Institute of Technology - National Aeronautics and Space Administration; Canada Foundation for Innovation	We are grateful to Cristian Leipski for correspondence on PACS and SPIRE data reduction and photometry, to Bruno Altieri who produced the unimap PACS image, to Ros Hopwood for additional expert advice on the Herschel data, to Jim Geach for advice on processing the SCUBA-2 data, and to Tom Kerr for much help through the UKIRT service programme. S.W. gratefully acknowledges the support of the Leverhulme Trust through the award of a Leverhulme Research Fellowship. B.P.V. acknowledges funding through the ERC grant "Cosmic Dawn". Based in part on data collected at Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. The United Kingdom Infrared Telescope was operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK. Some of the data reported here were obtained as part of the UKIRT Service Programme. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This publication makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by the National Aeronautics and Space Administration. Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. The James Clerk Maxwell Telescope has historically been operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the United Kingdom, the National Research Council of Canada and the Netherlands Organisation for Scientific Research. Additional funds for the construction of SCUBA-2 were provided by the Canada Foundation for Innovation.	Ahn CP, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/17; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Regan JA, 2009, MON NOT R ASTRON SOC, V396, P343, DOI 10.1111/j.1365-2966.2009.14579.x; Haas M, 2003, ASTRON ASTROPHYS, V402, P87, DOI 10.1051/0004-6361:20030110; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; ELVIS M, 1994, ASTROPHYS J SUPPL S, V95, P1, DOI 10.1086/192093; LOEB A, 1994, ASTROPHYS J, V432, P52, DOI 10.1086/174548; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Chapin EL, 2013, MON NOT R ASTRON SOC, V430, P2545, DOI 10.1093/mnras/stt052; Vestergaard M, 2009, ASTROPHYS J, V699, P800, DOI 10.1088/0004-637X/699/1/800; Jiang LH, 2009, ASTRON J, V138, P305, DOI 10.1088/0004-6256/138/1/305; Piazzo L, 2012, IEEE T IMAGE PROCESS, V21, P3687, DOI 10.1109/TIP.2012.2197009; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Beelen A, 2006, ASTROPHYS J, V642, P694, DOI 10.1086/500636; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Walter F, 2009, NATURE, V457, P699, DOI 10.1038/nature07681; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; Kauffmann G, 2000, MON NOT R ASTRON SOC, V311, P576, DOI 10.1046/j.1365-8711.2000.03077.x; Simpson C, 2014, MON NOT R ASTRON SOC, V442, P3454, DOI 10.1093/mnras/stu1116; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P289, DOI [10.1111/j.1365-2966.2006.10467.x, 10.1111/j.1365-2966.10467.x]; Bolton JS, 2011, MON NOT R ASTRON SOC, V416, pL70, DOI 10.1111/j.1745-3933.2011.01100.x; Savage RS, 2007, ASTROPHYS J, V661, P1339, DOI 10.1086/515393; Maddox N, 2012, MON NOT R ASTRON SOC, V424, P2876, DOI 10.1111/j.1365-2966.2012.21427.x; Fan XH, 2001, ASTRON J, V121, P54, DOI 10.1086/318033; Blain AW, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/113; Bouwens R. J., 2011, APJ, V737, P90; Croom SM, 2004, MON NOT R ASTRON SOC, V349, P1397, DOI 10.1111/j.1365-2966.2004.07619.x; da Cunha E, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/13; De Rosa G, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/145; Dietrich M, 2003, ASTROPHYS J, V589, P722, DOI 10.1086/374662; Dietrich M, 2003, ASTROPHYS J, V596, P817, DOI 10.1086/378045; Fan XH, 2004, ASTRON J, V128, P515, DOI 10.1086/422434; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Holland WS, 2013, MON NOT R ASTRON SOC, V430, P2513, DOI 10.1093/mnras/sts612; Honig SF, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200912676; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Krawczyk CM, 2013, ASTROPHYS J SUPPL S, V206, DOI 10.1088/0067-0049/206/1/4; Leipski C, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/154; Leipski C, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/103; Lutz D., 2011, ASTRON ASTROPHYS, V532, pA90; McGreer ID, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/105; Momjian E, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/6; Moretti A, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201323051; Natarajan P, 2014, GEN RELAT GRAVIT, V46, DOI 10.1007/s10714-014-1702-6; Netzer H, 2007, ASTROPHYS J, V666, P806, DOI 10.1086/520716; Nguyen HT, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014680; Ott S, 2010, ASTR SOC P, V434, P139; Ouchi M, 2004, ASTROPHYS J, V611, P660, DOI 10.1086/422207; Page MJ, 2014, MON NOT R ASTRON SOC, V440, pL91, DOI 10.1093/mnrasl/slu022; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Roussel H, 2013, PUBL ASTRON SOC PAC, V125, P1126, DOI 10.1086/673310; Sargsyan L, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/15; Sargsyan L, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/171; Venemans BP, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/2/L25; Venemans BP, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/24; Venkatesan A, 2004, MON NOT R ASTRON SOC, V349, pL43, DOI 10.1111/j.1365-2966.2004.07754.x; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Wang R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/44; Wang R, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/101; Willott CJ, 2003, ASTROPHYS J, V587, pL15, DOI 10.1086/375126; Willott CJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/13	70	2	2	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAR	2015	575								A31	10.1051/0004-6361/201425153		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3LA	WOS:000350249100031		
J	Campana, S; Salvaterra, R; Ferrara, A; Pallottini, A				Campana, Sergio; Salvaterra, Ruben; Ferrara, Andrea; Pallottini, Andrea			Missing cosmic metals revealed by X-ray absorption towards distant sources	ASTRONOMY & ASTROPHYSICS			English	Article						gamma-ray burst: general; galaxies: active; galaxies: halos intergalactic medium; X-rays: general	STAR-FORMATION HISTORY; REDSHIFT INTERGALACTIC MEDIUM; ABSORBING COLUMN DENSITY; XMM-NEWTON; CHEMICAL ENRICHMENT; COSMOLOGICAL SIMULATIONS; CIRCUMGALACTIC MEDIUM; PHYSICAL CONDITIONS; COMPLETE SAMPLE; BARYON BUDGET	The census of heavy elements (metals) produced by all stars through cosmic times up to present-day is limited to less than or similar to 50%; of these only half are still found within their parent galaxy. The majority of metals is expelled from galaxies into the circumgalactic (or even more distant, intergalactic) space by powerful galactic winds, leaving unpleasant uncertainty on the amount, thermal properties and distribution of these key chemical species. These dispersed metals unavoidably absorb soft X-ray photons from distant sources. We show that their integrated contribution can be detected in the form of increasing X-ray absorption with distance, for all kinds of high-energy cosmic sources. Based on extensive cosmological simulations, we assess that similar to 10% of all cosmic metals reside in the intergalactic medium. Most of the X-ray absorption arises instead from a few discrete structures along the line of sight. These extended structures, possibly pin-pointing galaxy groups, contain million degree, metal-enriched gas, 100-1000 times denser than the cosmic mean. An additional similar to 10% of cosmic metals could reside in this phase.	[Campana, Sergio] Osserv Astron Brera, INAF, I-23807 Merate, LC, Italy; [Salvaterra, Ruben] IASF Milano, INAF, I-20133 Milan, Italy; [Ferrara, Andrea; Pallottini, Andrea] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Ferrara, Andrea] Univ Tokyo, Todai Inst Adv Study, Kavli IPMU WPI, Chiba 2778583, Japan	Campana, S (reprint author), Osserv Astron Brera, INAF, Via E Bianchi 46, I-23807 Merate, LC, Italy.	sergio.campana@brera.inaf.it		Pallottini, Andrea/0000-0002-7129-5761; Campana, Sergio/0000-0001-6278-1576; Salvaterra, Ruben/0000-0002-9393-8078			Oppenheimer BD, 2006, MON NOT R ASTRON SOC, V373, P1265, DOI 10.1111/j.1365-2966.2006.10989.x; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Planelles S, 2014, MON NOT R ASTRON SOC, V438, P195, DOI 10.1093/mnras/stt2141; Young M, 2009, ASTROPHYS J SUPPL S, V183, P17, DOI 10.1088/0067-0049/183/1/17; Campana S, 2012, MON NOT R ASTRON SOC, V421, P1697, DOI 10.1111/j.1365-2966.2012.20428.x; Haardt F, 1996, ASTROPHYS J, V461, P20, DOI 10.1086/177035; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; De Luca A, 2004, ASTRON ASTROPHYS, V419, P837, DOI 10.1051/0004-6361:20034421; Wilkins SM, 2008, MON NOT R ASTRON SOC, V385, P687, DOI 10.1111/j.1365-2966.2008.12885.x; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Liang CJ, 2014, MON NOT R ASTRON SOC, V445, P2061, DOI 10.1093/mnras/stu1901; Menard B, 2010, MON NOT R ASTRON SOC, V405, P1025, DOI 10.1111/j.1365-2966.2010.16486.x; Pallottini A, 2014, MON NOT R ASTRON SOC, V440, P2498, DOI 10.1093/mnras/stu451; Teyssier R, 2002, ASTRON ASTROPHYS, V385, P337, DOI 10.1051/0004-6361:20011817; Kobayashi C, 2007, MON NOT R ASTRON SOC, V376, P1465, DOI 10.1111/j.1365-2966.2007.11555.x; Oppenheimer BD, 2012, MON NOT R ASTRON SOC, V420, P829, DOI 10.1111/j.1365-2966.2011.20096.x; Mulchaey JS, 1996, ASTROPHYS J, V456, pL5, DOI 10.1086/309861; Simionescu A, 2011, SCIENCE, V331, P1576, DOI [10.1126/science.1200331, 10.1126/science.1195970]; Tumlinson J, 2011, SCIENCE, V334, P948, DOI 10.1126/science.1209840; Page KL, 2005, MON NOT R ASTRON SOC, V364, P195, DOI 10.1111/j.1365-2966.2005.09550.x; Oppenheimer BD, 2008, MON NOT R ASTRON SOC, V387, P577, DOI 10.1111/j.1365-2966.2008.13280.x; Peeples MS, 2010, MON NOT R ASTRON SOC, V404, P1281, DOI 10.1111/j.1365-2966.2010.16383.x; Bouche N, 2005, MON NOT R ASTRON SOC, V364, P319, DOI 10.1111/j.1365-2966.2005.09570.x; ISOBE T, 1986, ASTROPHYS J, V306, P490, DOI 10.1086/164359; Choudhury TR, 2001, MON NOT R ASTRON SOC, V322, P561; Sun M, 2009, ASTROPHYS J, V693, P1142, DOI 10.1088/0004-637X/693/2/1142; Werner N, 2013, NATURE, V502, P656, DOI 10.1038/nature12646; Ferrara A, 2005, ASTROPHYS J, V634, pL37, DOI 10.1086/498845; Campana S, 2010, MON NOT R ASTRON SOC, V402, P2429, DOI 10.1111/j.1365-2966.2009.16006.x; Theuns T, 1998, MON NOT R ASTRON SOC, V301, P478, DOI 10.1046/j.1365-8711.1998.02040.x; Tornatore L, 2007, MON NOT R ASTRON SOC, V382, P1050, DOI [10.1111/j.l365-2966.2007.12070.x, 10.1111/j.1365-2966.2007.12070.x]; Rasera Y, 2006, ASTRON ASTROPHYS, V445, P1, DOI 10.1051/0004-6361:20053116; Asplund M., 2013, ARA A, V47, P481; Aubert D., 2008, MNRAS, V387, P295; Barai P., 2013, MNRAS, V430, P3213; Behar E., 2011, APJ, V734, P26; Bouche N., 2007, MNRAS, V378, P525; Bouche N., 2007, MNRAS, V367, pP16; Campana S, 2014, MON NOT R ASTRON SOC, V441, P3634, DOI 10.1093/mnras/stu831; Corral A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015227; Danforth C. W., 2014, APJ; DONE C, 1992, ASTROPHYS J, V395, P275, DOI 10.1086/171649; Eitan A, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/29; Ford A. B., 2013, MNRAS, V444, P1260; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Humphrey PJ, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/11; Larson D, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/16; Lehner N, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/119; Li LX, 2008, MON NOT R ASTRON SOC, V388, P1487, DOI 10.1111/j.1365-2966.2008.13488.x; Menard B, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/116; Miralda-Escude J, 2000, ASTROPHYS J, V530, P1; Nicastro F, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/90; Pagel BEJ, 2008, ASTR SOC P, V390, P483; Pallottini A, 2013, MON NOT R ASTRON SOC, V434, P3293, DOI 10.1093/mnras/stt1249; Peeples MS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/54; Pettini M, 1999, ASTROPHYS J, V510, P576, DOI 10.1086/306635; Prochaska J. X., 2011, APJ, V740, P91; Saez C, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/53; Salvaterra R, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/68; SHAPIRO PR, 1980, ASTROPHYS J, V241, P1, DOI 10.1086/158313; Shull JM, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/49; Shull JM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/23; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Starling RLC, 2013, MON NOT R ASTRON SOC, V431, P3159, DOI 10.1093/mnras/stt400; Stocke JT, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/148; Tilton EM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/112; Vignali C, 2003, ASTRON J, V125, P2876, DOI 10.1086/374998; Werk JK, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/8	68	3	3	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAR	2015	575								A43	10.1051/0004-6361/201425083		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3LA	WOS:000350249100043		
J	Mernier, F; de Plaa, J; Lovisari, L; Pinto, C; Zhang, YY; Kaastra, JS; Werner, N; Simionescu, A				Mernier, F.; de Plaa, J.; Lovisari, L.; Pinto, C.; Zhang, Y. -Y.; Kaastra, J. S.; Werner, N.; Simionescu, A.			Abundance and temperature distributions in the hot intra-cluster gas of Abell 4059	ASTRONOMY & ASTROPHYSICS			English	Article						X-rays: galaxies: clusters; galaxies: clusters: general; galaxies: clusters: intracluster medium; intergalactic medium; galaxies: abundances; supernovae: general	XMM-NEWTON OBSERVATIONS; X-RAY SPECTROSCOPY; INTRACLUSTER MEDIUM; ELEMENTAL ABUNDANCES; GALAXY CLUSTERS; CHEMICAL EVOLUTION; METAL ENRICHMENT; INTERGALACTIC MEDIUM; PERSEUS CLUSTER; IA SUPERNOVAE	Using the EPIC and RGS data from a deep (200 ks) XMM-Newton observation, we investigate the temperature structure (kT and sigma(T)) and the abundances of nine elements (O, Ne, Mg, Si, S, Ar, Ca, Fe, and Ni) of the intra-cluster medium (ICM) in the nearby (z = 0 : 046) cool-core galaxy cluster Abell 4059. Next to a deep analysis of the cluster core, a careful modelling of the EPIC background allows us to build radial profiles up to 12' (similar to 650 kpc) from the core. Probably because of projection e ff ects, the temperature ICM is not found to be in single phase, even in the outer parts of the cluster. The abundances of Ne, Si, S, Ar, Ca, and Fe, but also O are peaked towards the core. The elements Fe and O are still significantly detected in the outermost annuli, which suggests that the enrichment by both type Ia and core-collapse SNe started in the early stages of the cluster formation. However, the particularly high Ca/Fe ratio that we find in the core is not well reproduced by the standard SNe yield models. Finally, 2D maps of temperature and Fe abundance are presented and confirm the existence of a denser, colder, and Fe-rich ridge south-west of the core, previously observed by Chandra. The origin of this asymmetry in the hot gas of the cluster core is still unclear, but it might be explained by a past intense ram-pressure stripping event near the central cD galaxy.	[Mernier, F.; de Plaa, J.; Kaastra, J. S.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Mernier, F.; Kaastra, J. S.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Lovisari, L.; Zhang, Y. -Y.] Argelander Inst Astron, D-53121 Bonn, Germany; [Pinto, C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Werner, N.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Werner, N.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Simionescu, A.] JAXA, ISAS, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Mernier, F (reprint author), SRON Netherlands Inst Space Res, Sorbonnelaan 2, NL-3584 CA Utrecht, Netherlands.	F.Mernier@sron.nl			DFG [LO 2009/1-1]; German BMWi through the Verbundforschung [50 OR 1304]; ESA member states; USA (NASA); NWO; Netherlands Organisation for Space Research	This work is a part of the CHEERS (Chemical Evolution RGS cluster Sample) collaboration. We would like to thank its members and the anonymous referee for their feedback and discussions. F.M. thanks Huub Rottgering and Darko Donevski for useful discussions. L.L. acknowledges support by the DFG through grant LO 2009/1-1. Y.Y.Z. acknowledges support by the German BMWi through the Verbundforschung under grant 50 OR 1304. This work is based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA member states and the USA (NASA). The SRON Netherlands Institute for Space Research is supported financially by NWO, the Netherlands Organisation for Space Research.	Andernach H, 2005, ASTR SOC P, V329, P283; Million ET, 2011, MON NOT R ASTRON SOC, V418, P2744, DOI 10.1111/j.1365-2966.2011.19664.x; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Reiprich TH, 2002, ASTROPHYS J, V567, P716, DOI 10.1086/338753; Sato K, 2007, PUBL ASTRON SOC JPN, V59, P299; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; de Plaa J, 2007, ASTRON ASTROPHYS, V465, P345, DOI 10.1051/0004-6361:20066382; Simionescu A, 2010, MON NOT R ASTRON SOC, V405, P91, DOI 10.1111/j.1365-2966.2010.16450.x; Peterson JR, 2003, ASTROPHYS J, V590, P207, DOI 10.1086/374830; Hickox RC, 2006, ASTROPHYS J, V645, P95, DOI 10.1086/504070; Simionescu A, 2009, ASTRON ASTROPHYS, V495, P721, DOI 10.1051/0004-6361:200811071; De Luca A, 2004, ASTRON ASTROPHYS, V419, P837, DOI 10.1051/0004-6361:20034421; Cattaneo A, 2007, MON NOT R ASTRON SOC, V376, P1547, DOI 10.1111/j.1365-2966.2007.11512.x; Leccardi A, 2008, ASTRON ASTROPHYS, V487, P461, DOI 10.1051/0004-6361:200810113; GUNN JE, 1972, ASTROPHYS J, V176, P1, DOI 10.1086/151605; Willingale R, 2013, MON NOT R ASTRON SOC, V431, P394, DOI 10.1093/mnras/stt175; Tamura T, 2004, ASTRON ASTROPHYS, V420, P135, DOI 10.1051/0004-6361:20040103; Zhang YY, 2009, ASTROPHYS J, V699, P1178, DOI 10.1088/0004-637X/699/2/1178; Tamura T, 2009, ASTROPHYS J LETT, V705, pL62, DOI 10.1088/0004-637X/705/1/L62; Moretti A, 2009, ASTRON ASTROPHYS, V493, P501, DOI 10.1051/0004-6361:200811197; Kaastra JS, 2004, ASTRON ASTROPHYS, V413, P415, DOI 10.1051/0004-6361:20031512; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Werner N, 2013, NATURE, V502, P656, DOI 10.1038/nature12646; Diehl S, 2006, MON NOT R ASTRON SOC, V368, P497, DOI 10.1111/j.1365-2966.2006.10125.x; Heinz S, 2002, ASTROPHYS J, V569, pL79, DOI 10.1086/340688; Simionescu A, 2009, ASTRON ASTROPHYS, V493, P409, DOI 10.1051/0004-6361:200810225; Badenes C, 2006, ASTROPHYS J, V645, P1373, DOI 10.1086/504399; Baumgartner V, 2009, ASTRON NACHR, V330, P898, DOI 10.1002/asna.200911258; CASH W, 1979, ASTROPHYS J, V228, P939, DOI 10.1086/156922; Choi YY, 2004, ASTROPHYS J, V606, P185, DOI 10.1086/382941; De Grandi S, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423928; de Plaa J, 2013, ASTRON NACHR, V334, P416, DOI 10.1002/asna.201211870; de Plaa J, 2006, ASTRON ASTROPHYS, V452, P397, DOI 10.1051/0004-6361:20053864; DEYOUNG DS, 1978, ASTROPHYS J, V223, P47, DOI 10.1086/156234; FABIAN AC, 1994, ANNU REV ASTRON ASTR, V32, P277, DOI 10.1146/annurev.aa.32.090194.001425; Frank KA, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/46; Gnedin NY, 1998, MON NOT R ASTRON SOC, V294, P407, DOI 10.1046/j.1365-8711.1998.01156.x; Huang ZP, 1998, ASTROPHYS J, V496, P728, DOI 10.1086/305406; Iakubovskyi D., 2013, THESIS; Ichinohe Y., 2014, MNRAS UNPUB; Jansen F., 2001, Astronomy & Astrophysics, V365, DOI 10.1051/0004-6361:20000036; Kaastra J. S., 1996, UV XRAY SPECTROSCOPY, P411; Kaastra JS, 2001, ASTRON ASTROPHYS, V365, pL99, DOI 10.1051/0004-6361:20000041; Kapferer W, 2005, ASTRON ASTROPHYS, V438, P87, DOI 10.1051/0004-6361:20052753; Kuntz KD, 2008, ASTROPHYS J, V674, P209, DOI 10.1086/524719; Lehmer BD, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/46; Lodders K., 2009, LANDOLT BORNSTEIN, V44, DOI DOI 10.1007/978-3-540-88055-4_; Lovisari L, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015400; Matsushita K, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/200913432; Mitchell R.J., 1976, MNRAS, V175; Miyaji T, 2003, ASTRON NACHR, V324, P24, DOI 10.1002/asna.200310007; Moretti A, 2003, ASTRON ASTROPHYS, V408, P431, DOI [10.1051/0004-6361:200301012, 10.1051/0004-6361:20031012]; Mulchaey JS, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L34; Mushotzky R, 1996, ASTROPHYS J, V466, P686, DOI 10.1086/177541; Ohashi T., 1995, AIP C SER, V255, P336; Paterno-Mahler R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/114; Peterson JR, 2001, ASTRON ASTROPHYS, V365, pL104, DOI 10.1051/0004-6361:20000021; Pinto C, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425278; Read AM, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201423422; Reynolds CS, 2008, ASTROPHYS J, V679, P1181, DOI 10.1086/587456; Schellenberger G, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201424085; Schindler S, 2005, ASTRON ASTROPHYS, V435, pL25, DOI 10.1051/0004-6361:200500107; Simionescu A, 2008, ASTRON ASTROPHYS, V482, P97, DOI 10.1051/0004-6361:20078749; Snowden S. L., 2013, XMM ESAS COOKBOOK; Tamura T, 2001, ASTRON ASTROPHYS, V379, P107, DOI 10.1051/0004-6361:20011317; Werner N, 2006, ASTRON ASTROPHYS, V449, P475, DOI 10.1051/0004-6361:20053868; Zhang YY, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015830	67	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAR	2015	575								A37	10.1051/0004-6361/201425282		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3LA	WOS:000350249100037		
J	Wu, R; Madden, C; Galliano, F; Wilson, CD; Kamenetzky, J; Lee, MY; Schirm, M; Hony, S; Lebouteiller, V; Spinoglio, L; Cormier, D; Glenn, J; Maloney, PR; Pereira-Santaella, M; Remy-Ruyer, A; Baes, M; Boselli, A; Bournaud, F; De Looze, I; Hughes, TM; Panuzzo, P; Rangwala, N				Wu, R.; Madden, C.; Galliano, F.; Wilson, C. D.; Kamenetzky, J.; Lee, M. -Y.; Schirm, M.; Hony, S.; Lebouteiller, V.; Spinoglio, L.; Cormier, D.; Glenn, J.; Maloney, P. R.; Pereira-Santaella, M.; Remy-Ruyer, A.; Baes, M.; Boselli, A.; Bournaud, F.; De Looze, I.; Hughes, T. M.; Panuzzo, P.; Rangwala, N.			Spatially resolved physical conditions of molecular gas and potential star formation tracers in M83, revealed by the Herschel SPIRE FTS	ASTRONOMY & ASTROPHYSICS			English	Article						galaxies: individual: M 83; galaxies: starburst; galaxies: spiral; galaxies: ISM; techniques: imaging spectroscopy; submillimeter: ISM	CO-TO-H-2 CONVERSION FACTOR; FOURIER-TRANSFORM SPECTROMETER; LOW-METALLICITY ENVIRONMENTS; LUMINOUS INFRARED GALAXIES; NEARBY DISK GALAXIES; MEUDON PDR CODE; H-II REGIONS; INTERSTELLAR-MEDIUM; FORMATION LAW; SPITZER OBSERVATIONS	We investigate the physical properties of the molecular and ionized gas, and their relationship to the star formation and dust properties in M 83, based on submillimeter imaging spectroscopy from within the central 3.5' (similar to 4 kpc in diameter) around the starburst nucleus. The observations use the Fourier Transform Spectrometer (FTS) of the Spectral and Photometric Imaging REceiver (SPIRE) onboard the Herschel Space Observatory. The newly observed spectral lines include [CI] 370 mu m, [CI] 609 mu m, [NII] 205 mu m, and CO transitions from J = 4-3 to J = 13-12. Combined with previously observed J = 1-0 to J = 3-2 transitions, the CO spectral line energy distributions are translated to spatially resolved physical parameters, column density of CO, N(CO), and molecular gas thermal pressure, Pth, with a non-local thermal equilibrium (non-LTE) radiative transfer model, RADEX. Our results show that there is a relationship between the spatially resolved intensities of [NIT] 205 pm and the surface density of the star formation rate (SFR), Sigma(SFR). This relation, when compared to integrated properties of ultra-luminous infrared galaxies (ULIRGs), exhibits a different slope, because the [NII] 205 mu m distribution is more extended than the SFR. The spatially resolved [CI] 370 pm, on the other hand, shows a generally linear relationship with Sigma(SFR) and can potentially be a good SFR tracer. Compared with the dust properties derived from broad-band images, we find a positive trend between the emissivity of CO in the J = 1-0 transition with the average intensity of interstellar radiation field (ISRF), < U >. This trend implies a decrease in the CO-to-H-2 conversion factor, X-CO, when < U > increases. We estimate the gas-to-dust mass ratios to be 77 +/- 33 within the central 2 kpc and 93 +/- 19 within the central 4 kpc of M 83, which implies a Galactic dust-to-metal mass ratio within the observed region of M 83. The estimated gas-depletion time for the M 83 nucleus is 1.13 +/- 0.6 Gyr, which is shorter than the values for nearby spiral galaxies found in the literature (similar to 2.35 Gyr), most likely due to the young nuclear starbursts. A linear relationship between Pth and the radiation pressure generated by < U >, P-rad, is found to be P-th approximate to 30 P-rad which signals that the ISRF alone is insufficient to sustain the observed CO transitions. The spatial distribution of Pth reveals a pressure gradient, which coincides with the observed propagation of starburst activities and the alignment of (possibly background) radio sources. We discover that the off-centered (from the optical nucleus) peak of the molecular gas volume density coincides well with a minimum in the relative aromatic feature strength, indicating a possible destruction of their carriers. We conclude that the observed CO transitions are most likely associated with mechanical heating processes that are directly or indirectly related to very recent nuclear starbursts.	[Wu, R.; Madden, C.; Galliano, F.; Lee, M. -Y.; Hony, S.; Lebouteiller, V.; Remy-Ruyer, A.; Bournaud, F.] CEA Saclay, Lab AIM, F-91191 Gif Sur Yvette, France; [Wu, R.] Univ Tokyo, Dept Astron, JSPS, Bunkyo Ku, Tokyo 1130033, Japan; [Wilson, C. D.; Schirm, M.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Kamenetzky, J.; Glenn, J.; Maloney, P. R.; Rangwala, N.] Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80303 USA; [Spinoglio, L.; Pereira-Santaella, M.] INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Cormier, D.; Pereira-Santaella, M.] Ctr Astrobiol CSIC, Madrid 28850, Spain; [Cormier, D.] Heidelberg Univ, Zentrum Astron, Inst Theoret Astrophys, D-69120 Heidelberg, Germany; [Baes, M.; De Looze, I.; Hughes, T. M.] Univ Ghent, Sterrenkundig Observ, B-9000 Ghent, Belgium; [Boselli, A.] Univ Aix Marseille, Lab Astrophys Marseille, F-13388 Marseille 13, France; [Boselli, A.] CNRS, UMR 7326, F-13388 Marseille 13, France; [Panuzzo, P.] Observ Paris Lab GEPI, F-92195 Meudon, France	Wu, R (reprint author), CEA Saclay, Lab AIM, F-91191 Gif Sur Yvette, France.	ronin.wu@cea.fr		Spinoglio, Luigi/0000-0001-8840-1551	Canadian Space Agency; Natural Sciences and Engineering Research Council of Canada; NASA [NAS5-26555]; NASA Office of Space Science [NNX13AC07G]; CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); UKSA (UK); NASA (USA); Thales Alenia Space (Cannes); Astrium (Friedrichshafen);  [140500000638]	We would like to thank the anonymous referee for the constructive comments. R.W. would like to thank Dr. Estelle Bayet, Dr. Kelly Foyle, Dr. Andreas A. Lundgren, Dr. Kazuyuki Muraoka and Dr. Glenn R. Petitpas for generously sharing their data, and Dr. George Bendo, Dr. Horacio Dottori, and Dr. Eric Pellegrini for fruitful discussions. Special thanks go to the members of the Herschel SPIRE Instrument Control Centre (ICC) for their continuous support throughout the project. This research was supported in part by the Grant-in-Aid for Scientific Research for the Japan Society of Promotion of Science (140500000638). This research was also supported by grants from the Canadian Space Agency and the Natural Sciences and Engineering Research Council of Canada (PI: C. D. Wilson). The FUV data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts. This research has made use of data from HerMES project (http://hermes.sussex.ac.uk). HerMES is a Herschel Key Programme utilising Guaranteed Time from the SPIRE instrument team, ESAC scientists and a mission scientist. The HerMES data was accessed through the Herschel Database in Marseille (HeDaM: http://hedam.lam.fr) operated by CeSAM and hosted by the Laboratoire d'Astrophysique de Marseille. This research made use of Astropy, a community-developed core Python package for Astronomy (Robitaille et al. 2013). SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and including Univ. Lethbridge (Canada); NAOC (China); CEA, LAM (France); IFSI, Univ. Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC, Univ. Sussex (UK); and Caltech, JPL, NHSC, Univ. Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES, CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC, UKSA (UK); and NASA (USA). The Herschel spacecraft was designed, built, tested, and launched under a contract to ESA managed by the Herschel/Planck Project team by an industrial consortium under the overall responsibility of the prime contractor Thales Alenia Space (Cannes), and including Astrium (Friedrichshafen) responsible for the payload module and for system testing at spacecraft level, Thales Alenia Space (Turin) responsible for the service module, and Astrium (Toulouse) responsible for the telescope, with in excess of a hundred subcontractors.	Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Bendo GJ, 2012, MON NOT R ASTRON SOC, V423, P197, DOI 10.1111/j.1365-2966.2012.20784.x; Walter F, 2008, ASTRON J, V136, P2563, DOI 10.1088/0004-6256/136/6/2563; Bresolin F, 2002, ASTROPHYS J, V572, P838, DOI 10.1086/340371; Rubin RH, 2007, MON NOT R ASTRON SOC, V377, P1407, DOI 10.1111/j.1365-2966.2007.11714.x; Rieke GH, 2004, ASTROPHYS J SUPPL S, V154, P25, DOI 10.1086/422717; BLITZ L, 1982, ASTROPHYS J SUPPL S, V49, P183, DOI 10.1086/190795; LACY JH, 1994, ASTROPHYS J, V428, pL69, DOI 10.1086/187395; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Strong AW, 1996, ASTRON ASTROPHYS, V308, pL21; Gordon KD, 2008, ASTROPHYS J, V682, P336, DOI 10.1086/589567; Galliano F, 2003, ASTRON ASTROPHYS, V407, P159, DOI [10.1051/0004-6361:20030814, 10.1051/0041-6361:20030814]; Mac Low MM, 2004, REV MOD PHYS, V76, P125, DOI 10.1103/RevModPhys.76.125; Boulanger F, 1996, ASTRON ASTROPHYS, V312, P256; WRIGHT EL, 1991, ASTROPHYS J, V381, P200, DOI 10.1086/170641; Kaufman MJ, 1999, ASTROPHYS J, V527, P795, DOI 10.1086/308102; Yang BH, 2010, ASTROPHYS J, V718, P1062, DOI 10.1088/0004-637X/718/2/1062; Narayanan D, 2011, MON NOT R ASTRON SOC, V418, P664, DOI 10.1111/j.1365-2966.2011.19516.x; Madden SC, 2006, ASTRON ASTROPHYS, V446, P877, DOI [10.1051/0004-6361:20053890, 10.1051/004-6361:20053890]; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; Wolfire MG, 2010, ASTROPHYS J, V716, P1191, DOI 10.1088/0004-637X/716/2/1191; Calzetti D, 2004, ASTRON J, V127, P1405, DOI 10.1086/382095; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; LEQUEUX J, 1994, ASTRON ASTROPHYS, V292, P371; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Grenier IA, 2005, SCIENCE, V307, P1292, DOI 10.1126/science.1106924; Kennicutt RC, 2007, ASTROPHYS J, V671, P333, DOI 10.1086/522300; Le Petit F, 2006, ASTROPHYS J SUPPL S, V164, P506, DOI 10.1086/503252; Martin CL, 2004, ASTROPHYS J SUPPL S, V150, P239, DOI 10.1086/379661; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; Aniano G, 2011, PUBL ASTRON SOC PAC, V123, P1218; BENNETT CL, 1994, ASTROPHYS J, V434, P587, DOI 10.1086/174761; Glover SCO, 2012, MON NOT R ASTRON SOC, V421, P9, DOI 10.1111/j.1365-2966.2011.19648.x; Lundgren AA, 2004, ASTRON ASTROPHYS, V413, P505, DOI 10.1051/0004-6361:20031507; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Thim F, 2003, ASTROPHYS J, V590, P256, DOI 10.1086/374888; Soria R, 2003, ASTRON ASTROPHYS, V410, P53, DOI 10.1051/0004-6361:20031074; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Martin DC, 2005, ASTROPHYS J, V619, pL1, DOI 10.1086/426387; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Boselli A, 2002, ASTRON ASTROPHYS, V384, P33, DOI [10.1051/0004-6361:20011747, 10.1051/0004-6361:2001174]; Bayet E, 2006, ASTRON ASTROPHYS, V460, P467, DOI 10.1051/0004-6361:20053872; Bevington P. R., 2003, DATA REDUCTION ERROR; Bigiel F, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L13; Boissier S, 2005, ASTROPHYS J, V619, pL83, DOI 10.1086/423668; Brauher JR, 2008, ASTROPHYS J SUPPL S, V178, P280, DOI 10.1086/590249; Comte G., 1981, Astronomy & Astrophysics Supplement Series, V44; Crosthwaite LP, 2002, ASTRON J, V123, P1892, DOI 10.1086/339479; Dale DA, 2001, ASTRON J, V122, P1736, DOI 10.1086/323308; Dong H, 2008, ASTRON J, V136, P479, DOI 10.1088/0004-6256/136/1/479; Dopita MA, 2010, ASTROPHYS J, V710, P964, DOI 10.1088/0004-637X/710/2/964; Dopita MA, 1996, ASTROPHYS J SUPPL S, V102, P161, DOI 10.1086/192255; Dottori H, 2010, ASTROPHYS J LETT, V717, pL42, DOI 10.1088/2041-8205/717/1/L42; DUFOUR RJ, 1980, ASTROPHYS J, V236, P119, DOI 10.1086/157725; Elmegreen BG, 2007, ASTROPHYS J, V668, P1064, DOI 10.1086/521327; Elmegreen DM, 1998, ASTRON J, V116, P2834, DOI 10.1086/300657; Foyle K, 2012, MON NOT R ASTRON SOC, V421, P2917, DOI 10.1111/j.1365-2966.2012.20520.x; GALLAIS P, 1991, ASTRON ASTROPHYS, V243, P309; Galliano F, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117952; Galliano F., 2005, ASTRON ASTROPHYS, V434, P19; Gerin M, 2000, ASTROPHYS J, V537, P644, DOI 10.1086/309072; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Hao CN, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/124; Harris J, 2001, ASTRON J, V122, P3046, DOI 10.1086/324230; Hong S., 2011, APJ, V731, P21; Israel FP, 2001, ASTRON ASTROPHYS, V371, P433, DOI 10.1051/0004-6361:20010354; Israel FP, 2002, ASTRON ASTROPHYS, V383, P82, DOI 10.1051/0004-6361:20011736; Jankowski P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2008216; Jarrett TH, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/6; Kamenetzky J, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/70; Koyama H., 1999, APJ, V532, P21; Kramer C, 2005, ASTRON ASTROPHYS, V441, P961, DOI 10.1051/0004-6361:20053358; Leroy AK, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/19; Leroy AK, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/12; Levrier F, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201218865; Liszt HS, 1998, ASTRON ASTROPHYS, V339, P561; LOREN RB, 1978, ASTROPHYS J, V225, pL81, DOI 10.1086/182798; Lu N, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/2/L23; Maddox L. A., 2006, AJ, V132, P32; Makiwa G, 2013, APPL OPTICS, V52, P3864, DOI 10.1364/AO.52.003864; Maloney PR, 1999, ASTROPHYS SPACE SCI, V266, P207, DOI 10.1023/A:1002694926293; Markwardt CB, 2009, ASTR SOC P, V411, P251; Muraoka K, 2009, ASTROPHYS J, V706, P1213, DOI 10.1088/0004-637X/706/2/1213; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Panuzzo P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014558; Papadopoulos PP, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/10; Pellegrini EW, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L19; Pereira-Santaella M, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/55; Petitpas GR, 1998, ASTROPHYS J, V503, P219, DOI 10.1086/305975; Pety J, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/43; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Pineda JL, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201118321; Rangwala N, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/94; Robitaille TP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322068; Sakamoto K, 2004, ASTROPHYS J, V616, pL59, DOI 10.1086/420845; Sandstrom KM, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/5; Schruba A, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/37; Soria R., 2002, ASTRON ASTROPHYS, V384, P15; Spinoglio L, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/108; SPIRE Instrument Control Center (ICC), 2014, SPECTR PHOT IM REC S; Swinyard B. M., 2014, MNRAS, V18, P20; Thatte N., 2000, ASTRON ASTROPHYS, V364, P8; Vogler A, 2005, ASTRON ASTROPHYS, V441, P491, DOI 10.1051/0004-6361:20042342; Wu R, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/111; Wu R., 2013, ASTRON ASTROPHYS, V556, P116; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053; Zhao YH, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L13	109	2	2	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAR	2015	575								A88	10.1051/0004-6361/201423847		28	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3LA	WOS:000350249100088		
J	Xie, Y; Nakanishi, T; Natarajan, K; Safren, L; Hamburger, AW; Hussain, A; Ross, DD				Xie, Yi; Nakanishi, Takeo; Natarajan, Karthika; Safren, Lowell; Hamburger, Anne W.; Hussain, Arif; Ross, Douglas D.			Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						Breast cancer resistance protein (BCRP)/ABCG2; Promoter; CREB; Ovarian cancer; Breast cancer; Prostate cancer	PROSTATE-CANCER; BINDING PROTEIN; ACQUIRED-RESISTANCE; GENE-EXPRESSION; CREB; KINASE; THERAPY; ACTIVATION; CASCADE; PHOSPHORYLATION	Phosphorylated cyclic-AMP (cAMP) response element binding protein (p-CREB) is a downstream effector of a variety of important signaling pathways. We investigated whether the human BCRP promoter contains a functional cAMP response element (CRE). 8Br-cAMP, a cAMP analogue, increased the activity of a BCRP promoter reporter construct and BCRP mRNA in human carcinoma cells. Epidermal growth factor receptor (EGFR) pathway activation also led to an increase in p-CREB and in BCRP promoter reporter activity via two major downstream EGFR signaling pathways: the phosphotidylinosito1-3-kinase (PI3K)/AKT pathway and the mitogen-activated protein kinase (MAPK) pathway. EGF treatment increased the phosphorylation of EGFR, AKT, ERR and CREB, while simultaneously enhancing BCRP mRNA and functional protein expression. EGF-stimulated CREB phosphorylation and BCRP induction were diminished by inhibition of EGFR, PI3K/AKT or RAS/MAPK signaling. CREB silencing using RNA interference reduced basal levels of BCRP mRNA and diminished the induction of BCRP by EGF. Chromatin immunoprecipitation assays confirmed that a putative CRE site on the BCRP promoter bound p-CREB by a point mutation of the CRE site abolished EGF-induced stimulation of BCRP promoter reporter activity. Furthermore, the CREB co-activator, cAMP-regulated transcriptional co-activator (CRTC2), is involved in CREB-mediated BCRP transcription: androgen depletion of LNCaP human prostate cancer cells increased both CREB phosphorylation and CRTC2 nuclear translocation, and enhanced BCRP expression. Silencing CREB or CRTC2 reduced basal BCRP expression and BCRP induction under androgen-depletion conditions. This novel CRE site plays a central role in mediating BCRP gene expression in several human cancer cell lines following activation of multiple cancer-relevant signaling pathways. Published by Elsevier B.V.	[Xie, Yi; Natarajan, Karthika; Hamburger, Anne W.; Hussain, Arif; Ross, Douglas D.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Nakanishi, Takeo] Kanazawa Univ, Sch Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan; [Safren, Lowell] Univ Maryland, Greenebaum Canc Ctr, Schnaper Summer Internship Program, Baltimore, MD 21201 USA; [Hamburger, Anne W.; Hussain, Arif; Ross, Douglas D.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Hussain, Arif; Ross, Douglas D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hussain, Arif; Ross, Douglas D.] Baltimore VA Med Ctr, Baltimore, MD 21201 USA; [Ross, Douglas D.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Ross, DD (reprint author), Univ Maryland, Sch Med, Greenebaum Canc Ctr, 655 West Baltimore St Room 9-031 BRB, Baltimore, MD 21201 USA.	dross@som.umaryland.edu			Department of Veterans' Affairs; National Cancer Institute of the National Institutes of Health (USA) [1R01CA138583]	Dr. Ross' and Dr. Hussain's research is supported by Merit Review Awards from the Department of Veterans' Affairs. Dr. Hamburger's research is supported by grant 1R01CA138583 from the National Cancer Institute of the National Institutes of Health (USA).	Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Choi YH, 2011, J BIOL CHEM, V286, P34199, DOI 10.1074/jbc.M111.247684; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Mikhailova M, 2008, ADV EXP MED BIOL, V617, P397, DOI 10.1007/978-0-387-69080-3_38; Nakanishi T, 2003, CLIN CANCER RES, V9, P3320; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Chaft JE, 2012, MOL CANCER THER, V11, P485, DOI 10.1158/1535-7163.MCT-11-0692; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Morgillo F, 2007, DIFFERENTIATION, V75, P788, DOI 10.1111/j.1432-0436.2007.00200.x; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Davis S, 2000, J NEUROSCI, V20, P4563; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Roach M, 2014, CANCER-AM CANCER SOC, V120, P1620, DOI 10.1002/cncr.28594; Imai Y, 2005, CANCER RES, V65, P596; Tan Y, 1996, EMBO J, V15, P4629; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; Kang S, 2008, J BIOL CHEM, V283, P4652, DOI 10.1074/jbc.M709673200; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; Meyer zu Schwabedissen H.E., 2006, DRUG METAB DISPOS, V34, P524, DOI DOI 10.1124/DMD.105.007591; Natarajan K, 2011, BBA-GENE REGUL MECH, V1809, P295, DOI 10.1016/j.bbagrm.2011.06.004; Rychahou PG, 2006, ANN SURG, V243, P833, DOI 10.1097/01.sla.0000220040.66012.a9; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tang Y, 2006, CLIN CANCER RES, V12, P169, DOI 10.1158/1078-0432.CCR-05-1388; Xie Y, 2013, BBA-GENE REGUL MECH, V1829, P1288, DOI 10.1016/j.bbagrm.2013.10.008	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAR	2015	1849	3					317	327		10.1016/j.bbagrm.2015.01.003		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CD2RY	WOS:000350927900009		
J	Ding, Y; Yamashita, Y; Jones, J; Jaffe, R				Ding, Yan; Yamashita, Youhei; Jones, Jeremy; Jaffe, Rudolf			Dissolved black carbon in boreal forest and glacial rivers of central Alaska: assessment of biomass burning versus anthropogenic sources	BIOGEOCHEMISTRY			English	Article						Boreal forest; Glacial rivers; Dissolved organic carbon; Dissolved black carbon; BPCA; Global warming	ORGANIC-MATTER; SOILS; CHARCOAL; TRANSPORT; DISCHARGE; DYNAMICS; MOBILITY; SEAWATER; NITROGEN; OCEANS	Boreal forests are thought to be an important source and sink for pyrogenic carbon, or black carbon (BC), as fire is very common in this type of ecosystem. However, the reported soil BC content in boreal forests is low, suggesting active removal processes of soil BC possibly through transfer to the dissolved phase. In this study, dissolved black carbon (DBC) concentrations from samples collected from streams in Alaska boreal forest watersheds and in glacial rivers are reported. The DBC levels, as well as its degree of polycondensation, in glacial rivers are much lower than those from boreal forest streams. This suggests source differences (fossil fuel vs. forest fires) as a possible reason for these molecular variations. Our hypothesis is that DBC in boreal forest watersheds is mostly generated from forest fires, while glacial rivers will receive a higher relative contribution of BC from atmospheric deposition, resulting in a more fossil fuel like molecular signature of DBC in the latter. To test the source hypothesis, we compared the DBC molecular characteristics of samples from boreal rives and glacier-fed streams with additional samples from locations isolated from significant fire-derived inputs, where atmospheric deposition of anthropogenic soot may be important. Based on this comparative approach, we suggest that anthropogenic BC, associated with small soot particles, is the most prominent source of DBC in the glacial rivers. A linear positive correlation between dissolved organic carbon (DOC) and DBC concentrations was observed for both boreal forest and glacial samples, once again confirming that DOC and DBC dynamics are closely coupled. The ever increasing export of DOC associated DBC from high latitude boreal forests and glaciers as a result of global warming, may impact DOC quality and ultimately trophic dynamics in the receiving marine environment.	[Ding, Yan; Jaffe, Rudolf] Florida Int Univ, Southeast Environm Res Ctr, Miami, FL 33199 USA; [Ding, Yan; Jaffe, Rudolf] Florida Int Univ, Dept Chem & Biochem, North Miami, FL 33027 USA; [Yamashita, Youhei] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Jones, Jeremy] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Jones, Jeremy] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA	Jaffe, R (reprint author), Florida Int Univ, Dept Chem & Biochem, 3000 NE 151st St, North Miami, FL 33027 USA.	jaffer@fiu.edu	Yamashita, Youhei/A-3858-2012	Yamashita, Youhei/0000-0002-9415-8743	National Science Foundation [DBI-0620409]; FIU graduate school; George Barley Endowment	This work was funded through the National Science Foundation as a supplement to the FCE-LTER (DBI-0620409) and through the BNZ-LTER program. YD thanks the FIU graduate school for a doctoral evidence acquisition (DEA) fellowship. The authors thank D. McKnight for helpful comments on the original manuscript, N. Jaffe for assistance with field sample collection, and A. Balser for generating the sampling map. Additional support for this project was provided through the George Barley Endowment to RJ. This is SERC contribution 697.	Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230; Jurado E, 2008, ATMOS ENVIRON, V42, P7931, DOI 10.1016/j.atmosenv.2008.07.029; Schneider MPW, 2010, ORG GEOCHEM, V41, P1082, DOI 10.1016/j.orggeochem.2010.07.001; Roth PJ, 2012, ORG GEOCHEM, V46, P66, DOI 10.1016/j.orggeochem.2012.01.012; Guggenberger G, 2008, GLOBAL CHANGE BIOL, V14, P1367, DOI 10.1111/j.1365-2486.2008.01568.x; Stubbins A, 2012, NAT GEOSCI, V5, P198, DOI [10.1038/ngeo1403, 10.1038/NGEO1403]; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Stubbins A, 2012, BIOGEOSCIENCES, V9, P1661, DOI 10.5194/bg-9-1661-2012; Cooke WF, 1996, J GEOPHYS RES-ATMOS, V101, P19395, DOI 10.1029/96JD00671; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Preston CM, 2006, BIOGEOSCIENCES, V3, P397; Alvarez-Salgado XA, 1998, MAR CHEM, V62, P325, DOI 10.1016/S0304-4203(98)00037-1; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Druffel ERM, 2004, MAR CHEM, V92, P197, DOI 10.1016/j.marchem.2004.06.026; Ding Y, 2014, BIOGEOCHEMISTRY, V119, P259, DOI 10.1007/s10533-014-9964-3; MEYBECK M, 1982, AM J SCI, V282, P401; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Dittmar T, 2008, ORG GEOCHEM, V39, P396, DOI 10.1016/j.orggeochem.2008.01.015; Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003; Kim Y, 2005, ATMOS ENVIRON, V39, P3513, DOI 10.1016/j.atmosenv.2005.02.050; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Kane ES, 2010, BIOGEOCHEMISTRY, V100, P39, DOI 10.1007/s10533-009-9403-z; Neff JC, 2005, CAN J FOREST RES, V35, P2178, DOI 10.1139/X05-154; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Ohlson M, 2009, NAT GEOSCI, V2, P692, DOI 10.1038/NGEO617; Dittmar T, 2012, NAT GEOSCI, V5, P618, DOI [10.1038/ngeo1541, 10.1038/NGEO1541]; Cawley KM, 2012, MAR FRESHWATER RES, V63, P1098, DOI 10.1071/MF12028; Czimczik CI, 2003, GLOBAL BIOGEOCHEM CY, V17; Ding Y, 2013, CHEMOSPHERE, V90, P2257; Dittmar T, 2012, LIMNOL OCEANOGR, V57, P1171, DOI 10.4319/lo.2012.57.4.1171; Dolinova I, 2006, ENVIRON SCI TECHNOL, V40, P7668; Fastie CL, 2003, J GEOPHYS RES-ATMOS, V108, P13; Glaser B, 1998, ORG GEOCHEM, V29, P811, DOI 10.1016/S0146-6380(98)00194-6; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Harden JW, 2004, GLOBAL BIOGEOCHEM CY, V18, P14; Hinzman L. D., 2006, ALASKAS CHANGING BOR, P39; Hinzman LD, 2003, J GEOPHYS RES, V108, P6; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; NIST, 2007, CERT AN SRM 1649A UR; NIST, 2009, CERT AN SRM 1649B UR; Oswood MW, 2006, ALASKAS CHANGING BOR, P147; PENNER JE, 1993, ATMOS ENVIRON A-GEN, V27, P1277, DOI 10.1016/0960-1686(93)90255-W; Wada T, 2011, ARCT ANTARCT ALP RES, V43, P632, DOI 10.1657/1938-4246-43.4.632; Wozniak AS, 2008, ATMOS CHEM PHYS, V8, P5099; Ziolkowski LA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043963	47	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-2563	1573-515X		BIOGEOCHEMISTRY	Biogeochemistry	MAR	2015	123	1-2					15	25		10.1007/s10533-014-0050-7		11	Environmental Sciences; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Geology	CC9GC	WOS:000350675300002		
J	Matsuura, R; Arimitsu, T; Yunoki, T; Kimura, T; Yamanaka, R; Yano, T				Matsuura, R.; Arimitsu, T.; Yunoki, T.; Kimura, T.; Yamanaka, R.; Yano, T.			Effects of heat exposure in the absence of hyperthermia on power output during repeated cycling sprints	BIOLOGY OF SPORT			English	Article						anaerobic exercise; electromyogram; core temperature; performance; cycling; maximal effort	LOCOMOTOR MUSCLE FATIGUE; ACTIVE WARM-UP; EXERCISE PERFORMANCE; SURFACE EMG; ANTICIPATORY REDUCTION; HEALTHY HUMANS; TEMPERATURE; INTENSITY; DRIVE	The aim of this study was to investigate the effects of heat exposure in the absence of hyperthermia on power output during repeated cycling sprints. Seven males performed four 10-s cycling sprints interspersed by 30 s of active recovery on a cycle ergometer in hot-dry and thermoneutral environments. Changes in rectal temperature were similar under the two ambient conditions. The mean 2-s power output over the 1st-4th sprints was significantly lower under the hot-dry condition than under the thermoneutral condition. The amplitude of the electromyogram was lower under the hot-dry condition than under the thermoneutral condition during the early phase (0-3 s) of each cycling sprint. No significant difference was observed for blood lactate concentration between the two ambient conditions. Power output at the onset of a cycling sprint during repeated cycling sprints is decreased due to heat exposure in the absence of hyperthermia.	[Matsuura, R.] Joetsu Univ Educ, Grad Sch Educ, Specialized Subject Fields Educ, Living & Hlth Sci Educ, Joetsu 9438512, Japan; [Arimitsu, T.; Yamanaka, R.] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo 1150056, Japan; [Yunoki, T.; Yano, T.] Hokkaido Univ, Fac Educ, Dept Human Dev Sci, Kita Ku, Sapporo, Hokkaido 0600811, Japan; [Kimura, T.] Sapporo Med Univ, Sch Hlth Sci, Div Phys Therapy 2, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Matsuura, R (reprint author), Joetsu Univ Educ, Grad Sch Educ, Specialized Subject Fields Educ, Living & Hlth Sci Educ, 1 Yamayashiki Machi, Joetsu 9438512, Japan.	matsuura@juen.ac.jp					ASMUSSEN E, 1945, ACTA PHYSIOL SCAND, V10, P1, DOI 10.1111/j.1748-1716.1945.tb00287.x; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Gaoua N, 2011, INT J HYPERTHER, V27, P10, DOI 10.3109/02656736.2010.519371; LAKOMY HKA, 1986, ERGONOMICS, V29, P509, DOI 10.1080/00140138608968287; SARGEANT AJ, 1987, EUR J APPL PHYSIOL O, V56, P693, DOI 10.1007/BF00424812; Hautier CA, 2000, MED SCI SPORT EXER, V32, P839, DOI 10.1097/00005768-200004000-00017; Matsuura Ryouta, 2006, Journal of Physiological Anthropology, V25, P267, DOI 10.2114/jpa2.25.267; Almudehki F, 2012, J SCI MED SPORT, V15, P148, DOI 10.1016/j.jsams.2011.07.009; BALSOM PD, 1992, INT J SPORTS MED, V13, P528, DOI 10.1055/s-2007-1021311; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Hayes M, 2014, INT J SPORT PHYSIOL, V9, P387, DOI [10.1123/ijspp.2012-0247, 10.1123/IJSPP.2012-0247]; Ball D, 1999, EUR J APPL PHYSIOL O, V79, P360, DOI 10.1007/s004210050521; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Bishop D, 2009, J SCI MED SPORT, V12, P196, DOI 10.1016/j.jsams.2007.05.013; Cheuvront SN, 2006, MED SCI SPORT EXER, V38, P1093, DOI 10.1249/01.mss.0000222838.74015.15; Girard O, 2013, EUR J APPL PHYSIOL, V113, P359, DOI 10.1007/s00421-012-2444-3; Girard O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061793; Matsuura R, 2007, EUR J APPL PHYSIOL, V101, P409, DOI 10.1007/s00421-007-0512-x; Stewart D, 2003, EUR J APPL PHYSIOL, V89, P509, DOI 10.1007/s00421-003-0798-2	23	0	0	INST SPORT	WARSAW 45	TRYLOGII 2, POB 30,, 01-892 WARSAW 45, POLAND	0860-021X			BIOL SPORT	Biol. Sport	MAR	2015	32	1					15	20		10.5604/20831862.1125286		6	Sport Sciences	Sport Sciences	CD5IG	WOS:000351120600003		
J	Manandhar, Y; Bahadur, KCT; Wang, W; Uzawa, T; Aigaki, T; Ito, Y				Manandhar, Yasodha; Bahadur, K. C. Tara; Wang, Wei; Uzawa, Takanori; Aigaki, Toshiro; Ito, Yoshihiro			In vitro selection of a peptide aptamer that changes fluorescence in response to verotoxin	BIOTECHNOLOGY LETTERS			English	Article						Fluorescence; In vitro selection; Peptide aptamer; Sensing molecule; Verotoxin	RIBOSOME DISPLAY; SIGNALING APTAMERS; AMINO-ACID; PROTEIN; RNA; LIBRARIES; ENZYME; DESIGN	A peptide aptamer that changes fluorescence upon binding to verotoxin was selected in vitro using ribosome display with a tRNA carrying an environment-sensitive fluorescent probe. The aptamer specifically bound to verotoxin with a dissociation constant (K (d)) of 3.94 +/- A 1.6 A mu M, and the fluorescence decreased by 78 % as the verotoxin concentration was increased. The selected peptide can be used for detection of verotoxin.	[Manandhar, Yasodha; Bahadur, K. C. Tara; Wang, Wei; Uzawa, Takanori; Aigaki, Toshiro; Ito, Yoshihiro] RIKEN, Nano Med Engn Lab, Wako, Saitama 3510198, Japan; [Manandhar, Yasodha; Aigaki, Toshiro; Ito, Yoshihiro] Tokyo Metropolitan Univ, Grad Sch Biol Sci, Tokyo 1920397, Japan; [Uzawa, Takanori; Ito, Yoshihiro] RIKEN Ctr Emergent Mat Sci, Emergent Bioengn Mat Res Team, Wako, Saitama 3510198, Japan	Ito, Y (reprint author), RIKEN, Nano Med Engn Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yasodha@riken.jp; kunwar.tara@gmail.com; wwang@riken.jp; tuzawa@riken.jp; aigaki-toshiro@tmu.ac.jp; y-ito@riken.jp	Uzawa, Takanori/B-2980-2010; Ito, Yoshihiro/F-4370-2012		Japan Society for the Promotion of Science [22220009]; Cannon Foundation	The research is financially supported by a Grant-in-Aid for Scientific Research (S) of KAKENHI 22220009 from the Japan Society for the Promotion of Science "and The Cannon Foundation". We are grateful for the support received from the Brain Science Institute (BSI) Research Resource Center for sequencing, HPLC purification and mass spectrum analysis.	Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; GILARDI G, 1994, ANAL CHEM, V66, P3840, DOI 10.1021/ac00093a047; Liu MZ, 2012, CHEM COMMUN, V48, P11871, DOI 10.1039/c2cc36618e; Ito Y, 2013, BIOMATERIALS, V34, P7565, DOI 10.1016/j.biomaterials.2013.06.037; Li SW, 2002, J AM CHEM SOC, V124, P9972, DOI 10.1021/ja026789q; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Wang W, 2014, CHEM COMMUN, V50, P2962, DOI 10.1039/c3cc47624c; Uzawa T, 2013, CHEM COMMUN, V49, P1786, DOI 10.1039/c2cc36348h; Tada S, 2014, BIOMATERIALS, V35, P3497, DOI 10.1016/j.biomaterials.2014.01.010; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Borrebaeck CAK, 2000, IMMUNOL TODAY, V21, P379, DOI 10.1016/S0167-5699(00)01683-2; Jespers L, 2004, PROTEIN ENG DES SEL, V17, P709, DOI 10.1093/protein.gzh083; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Li Z, 2014, J BIOSCI BIOENG, V117, P501, DOI 10.1016/j.jbiosc.2013.10.005; Li Z, 2013, BIOTECHNOL LETT, V35, P39, DOI 10.1007/s10529-012-1049-6; Muranaka N, 2006, NUCLEIC ACIDS RES, V34, P1; Wang W, 2011, J BIOSCI BIOENG, V112, P515, DOI 10.1016/j.jbiosc.2011.07.011; Yamada Y, 2006, BIOORGAN MED CHEM, V14, P77, DOI 10.1016/j.bmc.2004.07.052; Yamazaki M, 2001, MICROBIOL IMMUNOL, V45, P621	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	MAR	2015	37	3					619	625		10.1007/s10529-014-1719-7		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC5JL	WOS:000350394800017		
J	Nishimura, Y; Takahashi, K; Ohtani, T; Ikeda-Sugita, R; Kasai, K; Okazaki, Y				Nishimura, Yukika; Takahashi, Katsuyoshi; Ohtani, Toshiyuki; Ikeda-Sugita, Reina; Kasai, Kiyoto; Okazaki, Yuji			Dorsolateral prefrontal hemodynamic responses during a verbal fluency task in hypomanic bipolar disorder	BIPOLAR DISORDERS			English	Article						bipolar disorder; executive function; hypomanic symptoms; near-infrared spectroscopy (NIRS); prefrontal cortex	NEAR-INFRARED SPECTROSCOPY; REDUCED FRONTOPOLAR ACTIVATION; BRAIN ACTIVATION; I DISORDER; SPATIAL REGISTRATION; CORTEX ACTIVATION; INHIBITION TASK; MOOD DISORDERS; FUNCTIONAL MRI; RATING-SCALE	ObjectivesNeuroimaging studies have suggested prefrontal dysfunction in response to cognitive activation in bipolar disorder (BD). However, its characteristics in manic states have not been well understood. Thus, we compared prefrontal hemodynamic responses during a cognitive task between hypomanic and depressive states in BD. We then longitudinally compared hypomanic and subsequent euthymic states. MethodsThe prefrontal function of 27 patients with BD (11 hypomanic and 16 depressed) and 12 age- and gender-matched healthy controls (HCs) was evaluated using near-infrared spectroscopy (NIRS) during a verbal fluency task (VFT). Hypomanic symptoms were assessed using the Young Mania Rating Scale. Among the 11 hypomanic patients, eight participated in the second NIRS measurement after their hypomanic symptoms resolved. ResultsVFT performance did not differ among hypomanic, depressed, and HC groups. Both BD groups exhibited significantly lower activation during the VFT than HCs in the broader bilateral prefrontal cortex. Hemodynamic changes in the left dorsolateral prefrontal cortex (DLPFC) in the hypomanic patients with BD were significantly larger than those in the depressed patients. In addition, hypomanic symptom severity was positively correlated with activation in the left DLPFC and frontopolar cortex in patients with BD. Follow-up measurement of the hypomanic patients revealed that prefrontal activation was decreased after hypomanic symptoms resolved. ConclusionsCombining cross-sectional and longitudinal assessments, the present results suggest that prefrontal hemodynamic responses associated with cognitive activation differ between hypomanic and depressive states in BD. NIRS measurement could be a useful tool for objectively evaluating state-dependent characteristics of prefrontal hemodynamics in BD.	[Nishimura, Yukika; Ohtani, Toshiyuki] Tokyo Metropolitan Matsuzawa Hosp, Dept Clin Lab, Setagaya Ku, Tokyo, Japan; [Nishimura, Yukika; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; [Takahashi, Katsuyoshi; Ikeda-Sugita, Reina; Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Setagaya Ku, Tokyo, Japan; [Ohtani, Toshiyuki] Chiba Univ, Safety & Hlth Org, Chiba, Japan; [Okazaki, Yuji] Michino O Hosp, Nagasaki, Japan	Nishimura, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ynishimu-mie@umin.ac.jp			Ministry of Health, Labour, and Welfare [H23-seishin-ippan-002]; NCNP [23-10, 26-3]; JSPS/MEXT [23118001, 23118004]; Takeda Science Foundation	We would like to thank the participants in this study, as well as Ms. Tomoe Higuchi, Ms. Tamiko Yasui, Ms. Tomoe Uchiyama, and Ms. Akiko Tsurumi, who provided support for the NIRS measurements. We are also grateful for the cooperation of the staff of Tokyo Metropolitan Matsuzawa Hospital. This study was supported by the Ministry of Health, Labour, and Welfare (Health and Labour Science Research Grants for Comprehensive Research on Disability, Health, and Welfare, H23-seishin-ippan-002) (YN and TO); an Intramural Research Grant (23-10 and 26-3) for Neurological and Psychiatric Disorders of NCNP (YN and TO); the JSPS/MEXT [Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network and Adolescent Mind & Self-Regulation; 23118001 and 23118004)] to KK; and the Takeda Science Foundation (YN). This work was partly the result of the 'Development of biomarker candidates for social behavior' project carried out under the Strategic Research Program for Brain Sciences by the MEXT.	Altshuler LL, 2012, BIPOLAR BRAIN INTEGR, P53; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Allin MPG, 2010, PSYCHOL MED, V40, P2025, DOI 10.1017/S0033291710000127; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Hafeman DM, 2012, BIPOLAR DISORD, V14, P375, DOI 10.1111/j.1399-5618.2012.01023.x; Fleck DE, 2012, MOL PSYCHIATR, V17, P325, DOI 10.1038/mp.2010.108; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Michael N, 2003, PSYCHOPHARMACOLOGY, V168, P344, DOI 10.1007/s00213-003-1440-z; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Matsuo K, 2002, PSYCHOL MED, V32, P1029, DOI 10.1017/S0033291702005974; Strakowski SM, 2005, AM J PSYCHIAT, V162, P1697, DOI 10.1176/appi.ajp.162.9.1697; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Ryan KA, 2012, BIPOLAR DISORD, V14, P527, DOI 10.1111/j.1399-5618.2012.01032.x; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Koike S, 2011, SCHIZOPHR RES, V132, P54, DOI 10.1016/j.schres.2011.07.014; Meyer SE, 2004, DEV PSYCHOPATHOL, V16, P461, DOI 10.1017/S095457940404461X; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Noda T, 2012, J PSYCHIATR RES, V46, P905, DOI 10.1016/j.jpsychires.2012.04.001; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Matsuo K, 2004, J AFFECT DISORDERS, V82, P85, DOI 10.1016/j.jad.2003.10.004; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; Bermpohl F, 2009, BIPOLAR DISORD, V11, P70, DOI 10.1111/j.1399-5618.2008.00648.x; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Berk M, 2008, J AFFECT DISORDERS, V106, P153, DOI 10.1016/j.jad.2007.06.011; Kono T, 2007, NEUROSCI RES, V57, P504, DOI 10.1016/j.neures.2006.12.007; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Kakimoto Y, 2009, PSYCHIAT CLIN NEUROS, V63, P491, DOI 10.1111/j.1440-1819.2009.01988.x; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Lim CS, 2013, NEUROSCI BIOBEHAV R, V37, P418, DOI 10.1016/j.neubiorev.2013.01.003; Townsend JD, 2012, BIPOLAR DISORD, V14, P442, DOI 10.1111/j.1399-5618.2012.01020.x; Wingo AP, 2009, BIPOLAR DISORD, V11, P113, DOI 10.1111/j.1399-5618.2009.00665.x; Gruber SA, 2008, J AFFECT DISORDERS, V105, P253, DOI 10.1016/j.jad.2007.04.014; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; Strakowski SM, 2008, EARLY INTERV PSYCHIA, V2, P225, DOI 10.1111/j.1751-7893.2008.00082.x; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Curtis VA, 2007, BIPOLAR DISORD, V9, P358, DOI 10.1111/j.1399-5618.2007.00422.x; Curtis VA, 2001, J AFFECT DISORDERS, V66, P111, DOI 10.1016/S0165-0327(00)00240-8; Ehlis AC, 2014, NEUROIMAGE, V85, P478, DOI 10.1016/j.neuroimage.2013.03.067; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Homae F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00093; Hulvershorn LA, 2012, BIOL PSYCHIAT, V71, P603, DOI 10.1016/j.biopsych.2011.10.038; Keener Matthew T, 2007, Curr Psychiatry Rep, V9, P512, DOI 10.1007/s11920-007-0070-2; Kubota Y, 2009, PSYCHOL MED, V39, P1265, DOI 10.1017/S0033291708004364; Levy B, 2011, J PSYCHIATR RES, V45, P1048, DOI 10.1016/j.jpsychires.2011.01.005; Li CT, 2012, BIPOLAR DISORD, V14, P831, DOI 10.1111/bdi.12017; Maina G, 2007, J CLIN PSYCHIAT, V68, P207; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Matsubara T, 2014, NEUROIMAGE, V85, P489, DOI 10.1016/j.neuroimage.2013.04.098; Matsuo K, 2007, BIPOLAR DISORD, V9, P876; McIntosh AM, 2008, AM J PSYCHIAT, V165, P378, DOI 10.1176/appi.ajp.2007.07020365; Phillips BD, 2008, THYROID, V18, P651, DOI 10.1089/thy.2008.0263; Sawa M, 2013, NEUROPSYCHOBIOLOGY, V67, P103, DOI 10.1159/000345161; Schecklmann M, 2011, PSYCHIAT RES-NEUROIM, V194, P378, DOI 10.1016/j.pscychresns.2011.01.016; Silverstone Peter H, 2005, Ann Gen Psychiatry, V4, P14, DOI 10.1186/1744-859X-4-14; Tabares-Seisdedos R, 2008, J AFFECT DISORDERS, V109, P286, DOI 10.1016/j.jad.2007.12.234; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126	73	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-5647	1399-5618		BIPOLAR DISORD	Bipolar Disord.	MAR	2015	17	2					172	183		10.1111/bdi.12252		12	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD2KI	WOS:000350906500006		
J	Kawada, T				Kawada, Tomoyuki			Relationship between metabolic syndrome and psychiatric disorders in patients with bipolar disorder or schizophrenia	BIPOLAR DISORDERS			English	Letter						bipolar disorder; metabolic syndrome; schizophrenia	DIETARY		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Dipasquale S, 2013, J PSYCHIATR RES, V47, P197, DOI 10.1016/j.jpsychires.2012.10.005; Bly MJ, 2014, BIPOLAR DISORD, V16, P277, DOI 10.1111/bdi.12160; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Salvi V, 2012, J AFFECT DISORDERS, V136, P599, DOI 10.1016/j.jad.2011.10.025	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-5647	1399-5618		BIPOLAR DISORD	Bipolar Disord.	MAR	2015	17	2					233	234		10.1111/bdi.12279		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CD2KI	WOS:000350906500012		
J	Otsuki, H; Yoshioka, T; Shimizu, T; Nakanishi, Y; Fujio, K; Murao, W; Uehara, S; Fujio, K				Otsuki, H.; Yoshioka, T.; Shimizu, T.; Nakanishi, Y.; Fujio, K.; Murao, W.; Uehara, S.; Fujio, K.			The impact of calcium phosphate stones on transurethral lithotripsy	BJU INTERNATIONAL			English	Meeting Abstract	Singapore-Urological-Association Meeting (UROFAIR)	MAR 12-14, 2015	Suntec, SINGAPORE	Singapore Urol Assoc					[Otsuki, H.; Yoshioka, T.; Shimizu, T.; Nakanishi, Y.; Fujio, K.; Murao, W.; Uehara, S.; Fujio, K.] Abiko Toho Hosp, Dept Urol, Abiko, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	MAR	2015	115			3	SI	MP-12	11	11				1	Urology & Nephrology	Urology & Nephrology	CB8QV	WOS:000349896700027		
J	Omori, Y; Shimbori, M; Watanabe, H; Oiwa, Y; Yokoyama, H; Iwabuchi, T; Kawano, Y; Hariu, K; Yamamoto, R; Shiga, Y				Omori, Y.; Shimbori, M.; Watanabe, H.; Oiwa, Y.; Yokoyama, H.; Iwabuchi, T.; Kawano, Y.; Hariu, K.; Yamamoto, R.; Shiga, Y.			Setting the platform for the dissemination of HoLEP (holmium laser enucleation of the prostate) as the new reference procedure in the treatment of benign prostatic hyperplasia	BJU INTERNATIONAL			English	Meeting Abstract	Singapore-Urological-Association Meeting (UROFAIR)	MAR 12-14, 2015	Suntec, SINGAPORE	Singapore Urol Assoc					[Omori, Y.; Shimbori, M.; Watanabe, H.; Oiwa, Y.; Yokoyama, H.; Iwabuchi, T.; Kawano, Y.; Hariu, K.; Yamamoto, R.; Shiga, Y.] Yamato Hosp, Tokyo Nephro Urol Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	MAR	2015	115			3	SI	VP-02	29	29				1	Urology & Nephrology	Urology & Nephrology	CB8QV	WOS:000349896700055		
J	Ishito, N; Sako, T; Yokoyama, S; Shiotsuka, Y; Ichikawa, T; Yamamoto, Y; Takamoto, H				Ishito, N.; Sako, T.; Yokoyama, S.; Shiotsuka, Y.; Ichikawa, T.; Yamamoto, Y.; Takamoto, H.			TAP 1 day training course as a nephrostomy and PNL training method	BJU INTERNATIONAL			English	Meeting Abstract	Singapore-Urological-Association Meeting (UROFAIR)	MAR 12-14, 2015	Suntec, SINGAPORE	Singapore Urol Assoc					[Ishito, N.; Sako, T.; Yokoyama, S.; Shiotsuka, Y.; Ichikawa, T.; Yamamoto, Y.; Takamoto, H.] Kurashiki Med Ctr, Dept Urol, Kurashiki, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	MAR	2015	115			3	SI	UP-21	40	40				1	Urology & Nephrology	Urology & Nephrology	CB8QV	WOS:000349896700089		
J	Yamanaka, H; Saito, S				Yamanaka, Hidetoshi; Saito, Shiro			Salutation	BRACHYTHERAPY			English	Editorial Material									[Yamanaka, Hidetoshi] Kurosawa Hosp, Inst Prevent Med, Implantat Study Grp, Gunma, Japan; [Saito, Shiro] Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan	Yamanaka, H (reprint author), Kurosawa Hosp, Inst Prevent Med, Implantat Study Grp, Gunma, Japan.						J-POPS, 2014, INT J CLIN ONCOL; SHIP, 2010, BMC CANCER, V10, P572; TRIP, 2012, BMC CANCER, V12, P110	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	MAR-APR	2015	14	2					109	110				2	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CC9RO	WOS:000350708600001		
J	Yorozu, A; Kuroiwa, N; Takahashi, A; Toya, K; Saito, S; Nishiyama, T; Yagi, Y; Tanaka, T; Shiraishi, Y; Ohashi, T				Yorozu, Atsunori; Kuroiwa, Nobuko; Takahashi, Akane; Toya, Kazuhito; Saito, Shiro; Nishiyama, Toru; Yagi, Yasuto; Tanaka, Tomoki; Shiraishi, Yutaka; Ohashi, Toshio			Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patients	BRACHYTHERAPY			English	Article; Proceedings Paper	International Symposium on 10th Anniversary of Permanent Prostate Brachytherapy	JAN 17-18, 2014	JAPAN			Brachytherapy; Iodine-125; Prostate cancer; Radiotherapy; Dose-response; Low-dose-rate; Permanent seed implantation	DOSE-RESPONSE ANALYSIS; AMERICAN BRACHYTHERAPY; ANDROGEN DEPRIVATION; I-125 BRACHYTHERAPY; RADIATION-THERAPY; CANCER; INTERMEDIATE; MULTICENTER; ULTRASOUND; VALUES	PURPOSE: To report outcomes for men treated with iodine-125 (I-125) prostate brachytherapy (BT) at a single institution in Japan. METHODS AND MATERIALS: Between 2003 and 2009, 1313 patients (median age, 68 years) with clinically localized prostate cancer were treated with (IBT)-I-125. Median prostate-specific antigen level was 7.6 ng/mL (range, 1.1-43.3). T-stage was T1c in 60%, T2 in 39%, and T3 in 1% of patients. The Gleason score was <7, 7, and >7 in 49%, 45%, and 6% of patients, respectively. Neoadjuvant androgen deprivation therapy was used in 40% of patients and combined external beam radiotherapy of 45 Gy in 48% of patients. Postimplant dosimetry was performed after 30 days after implantation, with total doses converted to the biologically effective dose. Survival functions were calculated by the Kaplan-Meier method and Cox hazard model. RESULTS: Median followup was 67 months (range, 6-126). The 7-year biochemical freedom from failure for low-, intermediate-, and selected high-risk prostate cancers were 98%, 93%, and 81%, respectively (p < 0.001). Multivariate analysis identified the Gleason score, initial prostate-specific antigen level, positive biopsy rate, dose, and neoadjuvant androgen deprivation therapy as predictors for biochemical freedom from failure. The 7-year actuarial developing Grade 3+ genitourinary and gastrointestinal toxicity was 2% and 0.3%, respectively. Forty-four percent patients with normal baseline potency retained normal erectile function at 5 years. CONCLUSIONS: 1251 prostate BT is a highly effective treatment option for low-, intermediate-, and selected high-risk prostate cancers. Side effects were tolerable. An adequate dose may be required to achieve successful biochemical control. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Yorozu, Atsunori; Kuroiwa, Nobuko; Takahashi, Akane; Toya, Kazuhito] Natl Hosp Org, Dept Radiol, Tokyo Med Ctr, Tokyo, Japan; [Saito, Shiro; Nishiyama, Toru; Yagi, Yasuto] Natl Hosp Org, Dept Urol, Tokyo Med Ctr, Tokyo, Japan; [Tanaka, Tomoki; Shiraishi, Yutaka; Ohashi, Toshio] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan	Yorozu, A (reprint author), Tokyo Med Ctr, Dept Radiol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	ayorozu@aol.com					Sylvester JE, 2011, INT J RADIAT ONCOL, V81, P376, DOI 10.1016/j.ijrobp.2010.05.042; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Davis BJ, 2012, BRACHYTHERAPY, V11, P6, DOI 10.1016/j.brachy.2011.07.005; Zelefsky MJ, 2008, BRACHYTHERAPY, V7, P1, DOI 10.1016/j.brachy.2007.12.002; Forsythe K, 2012, INT J RADIAT ONCOL, V83, P630, DOI 10.1016/j.ijrobp.2011.06.2013; Stone NN, 2007, INT J RADIAT ONCOL, V69, P1472, DOI 10.1016/j.ijrobp.2007.05.002; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Taira AV, 2011, INT J RADIAT ONCOL, V79, P1336, DOI 10.1016/j.ijrobp.2010.01.005; Ohashi T, 2013, RADIOTHER ONCOL, V109, P241, DOI 10.1016/j.radonc.2013.09.022; Zelefsky MJ, 2012, BRACHYTHERAPY, V11, P245, DOI 10.1016/j.brachy.2011.08.003; Grimm P, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2011.10827.x; Chan EK, 2014, BRACHYTHERAPY, V13, P46; Crook J, 2011, INT J RADIAT ONCOL, V81, P96; Crook Juanita M, 2005, Brachytherapy, V4, P186, DOI 10.1016/j.brachy.2005.01.002; Hanada T, 2014, BRACHYTHERAPY, V13, P311, DOI 10.1016/j.brachy.2013.12.001; Kao J, 2008, INT J RADIAT ONCOL, V70, P96, DOI 10.1016/j.ijrobp.2007.06.067; Kestin LL, 2002, J UROLOGY, V168, P1994, DOI 10.1097/01.ju.0000033329.22922.b9; Konaka H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-110; Morris WJ, 2014, BRACHYTHERAPY, V13, P32; Nishimura S, 2013, INT J CLIN ONCOL; Ohashi Toshio, 2005, Int J Clin Oncol, V10, P262, DOI 10.1007/s10147-005-0507-8; Ohashi T, 2006, JPN J CLIN ONCOL, V36, P285, DOI 10.1093/jjco/hyl008; Ohashi T, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-13; Ohashi T, 2007, BRACHYTHERAPY, V6, P246, DOI 10.1016/j.brachy.2007.08.006; Saito S, 2014, INT J CLIN ONCOL; Shiraishi Y, 2011, INT J RADIAT ONCOL, V81, pE127, DOI 10.1016/j.ijrobp.2011.01.012; Spadinger I, 2014, BRACHYTHERAPY, V13, P44, DOI 10.1016/j.brachy.2013.11.010; Spratt DE, 2013, BRACHYTHERAPY, V12, P389, DOI 10.1016/j.brachy.2013.07.004; Stock RG, 2006, INT J RADIAT ONCOL, V64, P527, DOI 10.1016/j.ijrobp.2005.07.981; Stone NN, 2014, BRACHYTHERAPY, V13, P42, DOI 10.1016/j.brachy.2013.11.009; Yoshida K, 2013, JPN J CLIN ONCOL, V43, P383, DOI 10.1093/jjco/hys240; Zelefsky MJ, 2014, J UROL	32	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	MAR-APR	2015	14	2					111	117		10.1016/j.brachy.2014.06.008		7	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CC9RO	WOS:000350708600002		
J	Yamada, Y; Masui, K; Iwata, T; Naitoh, Y; Yamada, K; Miki, T; Okihara, K				Yamada, Yasuhiro; Masui, Koji; Iwata, Tsuyoshi; Naitoh, Yasuyuki; Yamada, Kei; Miki, Tsuneharu; Okihara, Koji			Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: Outcome and toxicity	BRACHYTHERAPY			English	Article; Proceedings Paper	International Symposium on 10th Anniversary of Permanent Prostate Brachytherapy	JAN 17-18, 2014	JAPAN			Anti-androgen deprivation therapy; Brachytherapy; Intermediate risk; Prostate cancer	DOSE-RATE BRACHYTHERAPY; EXTERNAL-BEAM RADIATION; PRIMARY GLEASON PATTERN; BIOCHEMICAL FAILURE; HORMONAL-THERAPY; SCORE; RADIOTHERAPY; GUIDELINES; EXPERIENCE; IMPACT	OBJECTIVES: To evaluate the interim outcomes of low-dose-rate permanent brachytherapy (PB) combined with short-term androgen deprivation therapy (ADT) in Japanese men with intermediate-risk prostate cancer excluding those with a Gleason score of 4 + 3. METHODS: The Protocol-intermediate-risk group (Protocol-IRG) was defined as clinical stage T1c-T2c, Gleason score of 3 + 4, or lower and prostatic-specific antigen (PSA) level lower than 20 ng/mL. A total of 308 patients underwent brachytherapy in the protocol-IRG group (n = 152) or in the low-risk group (n = 156). Patients in Protocol-IRG had received at least 6 months of ADT before and after PB. Supplemental external beam radiotherapy was not used. Planned followup by PSA was carried out every 3 months for the first 2 years and every 6 months thereafter. The PSA failure was defined as nadir + 2 ng/mL. Patients' Expanded Prostate Cancer Index Composite was recorded before and 3 years after treatment. RESULTS: The median followup was 68 and 68 months for the protocol-MG and the low-risk groups, respectively. The 5-year biological disease-free survival rates in the low-risk and protocol-IRG groups were 94.8 and 94.6%, respectively. As far as survival rates were concerned, there were no significant differences between the two groups. Overall satisfaction and sexual function at 3 years after PB had significantly improved compared with pretreatment (p = 0.01 and p = 0.01, respectively). CONCLUSIONS: In intermediate-risk prostate patients, excluding those with a biopsy Gleason score of 4 + 3, brachytherapy with short-term ADT can be an effective treatment option for Japanese men. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Yamada, Yasuhiro; Iwata, Tsuyoshi; Naitoh, Yasuyuki; Miki, Tsuneharu; Okihara, Koji] Kyoto Prefectural Univ Med, Dept Urol, Kyoto 6028566, Japan; [Masui, Koji; Yamada, Kei] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto 6028566, Japan	Okihara, K (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	okiharakoji@hotmail.com					Davis BJ, 2012, BRACHYTHERAPY, V11, P6, DOI 10.1016/j.brachy.2011.07.005; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; Stock RG, 2013, BJU INT, V112, pE44, DOI 10.1111/bju.12166; Morris WJ, 2013, CANCER-AM CANCER SOC, V119, P1537, DOI 10.1002/cncr.27911; Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Shilkrut M, 2013, CANCER-AM CANCER SOC, V119, P681, DOI 10.1002/cncr.27784; Ohashi T, 2013, RADIOTHER ONCOL, V109, P241, DOI 10.1016/j.radonc.2013.09.022; Gaztanaga M, 2013, INT J UROL, V20, P142, DOI 10.1111/j.1442-2042.2012.03120.x; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Akaza Hideyuki, 2013, Cancer Biology Medicine, V10, P187, DOI 10.7497/j.issn.2095-3941.2013.04.002; Bittner N, 2013, BRACHYTHERAPY, V12, P14, DOI 10.1016/j.brachy.2012.05.002; Herbert C, 2012, RADIOTHER ONCOL, V103, P228, DOI 10.1016/j.radonc.2012.01.006; Kobayashi K, 2013, J RADIAT RES, V54, P479, DOI 10.1093/jrr/rrs126; Koukourakis G, 2009, ADV UROL, V2009; Marumo K, 2001, INT J UROL, V8, P53, DOI 10.1046/j.1442-2042.2001.00258.x; Masumori N, 1999, UROLOGY, V54, P344; Merrick GS, 2006, INT J RADIAT ONCOL, V65, P669, DOI 10.1016/j.ijrobp.2006.01.030; Miki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-572; Miyake H, 2013, UROL ONCOL-SEMIN ORI, V31, P1511, DOI 10.1016/j.urolonc.2012.05.001; Morris WJ, 2014, BRACHYTHERAPY, V13, P32, DOI 10.1016/j.brachy.2013.08.006; Okihara K, 2014, INT J UROL, V21, P271, DOI 10.1111/iju.12245; Stock RG, 2012, BJU INT, V110, P1257, DOI 10.1111/j.1464-410X.2012.11057.x; Takegami M, 2005, JPN J UROL, V96, P657; Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X; Vordermark D, 2008, NEW ENGL J MED, V359, P201	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	MAR-APR	2015	14	2					118	123		10.1016/j.brachy.2014.09.001		6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CC9RO	WOS:000350708600003		
J	Tanaka, N; Asakawa, I; Hasegawa, M; Fujimoto, K				Tanaka, Nobumichi; Asakawa, Isao; Hasegawa, Masatoshi; Fujimoto, Kiyohide			Urethral toxicity after LDR brachytherapy: Experience in Japan	BRACHYTHERAPY			English	Article; Proceedings Paper	International Symposium on 10th Anniversary of Permanent Prostate Brachytherapy	JAN 17-18, 2014	JAPAN			Prostate cancer; Genitourinary toxicity; LDR brachytherapy; J-POPS	I-125 PERMANENT BRACHYTHERAPY; LOCALIZED PROSTATE-CANCER; DOSE-RATE BRACHYTHERAPY; TAMSULOSIN; SURVIVAL; DISEASE; TRIAL; SEED	Urinary toxicity is common after low-dose-rate (LDR) brachytherapy, and the resolution of urinary toxicity is a concern. In particular, urinary frequency is the most common adverse event among the urinary toxicities. We have previously reported that approximately 70% of patients experience urinary frequency during the first 6 months after seed implantation. Most urinary adverse events were classified as Grade 1, and Grade 2 or higher adverse events were rare. The incidence of urinary retention was approximately 2-4%. A high International Prostate Symptom Score before seed implantation was an independent predictor of acute urinary toxicity of Grade 2 or higher. Several previous reports from the United States also supported this trend. In Japan, LDR brachytherapy was legally approved in 2003. A nationwide prospective cohort study entitled Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation was initiated in July 2005. It is an important issue to limit urinary toxicities in patients who undergo LDR brachytherapy. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Tanaka, Nobumichi; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Kashihara, Nara 6348522, Japan; [Asakawa, Isao; Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan	Tanaka, N (reprint author), Nara Med Univ, Dept Urol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	sendo@naramed-u.ac.jp					Keyes M, 2006, INT J RADIAT ONCOL, V64, P825, DOI 10.1016/j.ijrobp.2005.04.056; Sylvester J, 2013, BRACHYTHERAPY, V12, P375, DOI 10.1016/j.brachy.2012.07.002; Tanaka N, 2009, UROLOGY, V74, P407, DOI 10.1016/j.urology.2008.12.062; Kuban DA, 2011, INT J RADIAT ONCOL, V79, P1310, DOI 10.1016/j.ijrobp.2010.01.006; Critz FA, 2013, J UROLOGY, V189, P878, DOI 10.1016/j.juro.2012.10.061; Reese AC, 2012, UROLOGY, V80, P1075, DOI 10.1016/j.urology.2012.07.040; Crook J, 2010, INT J RADIAT ONCOL, V77, P496, DOI 10.1016/j.ijrobp.2009.04.078; Elshaikh MA, 2005, INT J RADIAT ONCOL, V62, P164, DOI 10.1016/j.ijrobp.2004.09.036; Marshall RA, 2014, UROL ONCOL, V32, p38e1; Saito S, 2014, INT J CLIN ONCOL; Shimizu N, 2014, WORLD J UROL; Tanaka N, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-25; Tanaka N, 2010, BRACHYTHERAPY, V9, P300, DOI 10.1016/j.brachy.2009.07.013; Tanaka N, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-107; Tsumura H, 2011, INT J RADIAT ONCOL, V81, pE385, DOI 10.1016/j.ijrobp.2011.04.026; Zilli T, 2011, INT J RADIAT ONCOL, V81, pE377, DOI 10.1016/j.ijrobp.2011.02.037	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	MAR-APR	2015	14	2					131	135		10.1016/j.brachy.2014.09.009		5	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CC9RO	WOS:000350708600005		
J	Satoh, T; Dokiya, T; Yamanaka, H; Saito, S; Ishiyama, H; Itami, J; Shibuya, H; Nakano, T; Shigematsu, N; Aoki, M; Egawa, S; Hashimoto, M; Nishimura, T; Yorozu, A				Satoh, Takefumi; Dokiya, Takushi; Yamanaka, Hidetoshi; Saito, Shiro; Ishiyama, Hiromichi; Itami, Jun; Shibuya, Hitoshi; Nakano, Takashi; Shigematsu, Naoyuki; Aoki, Manabu; Egawa, Shin; Hashimoto, Mitsuyasu; Nishimura, Tetsuo; Yorozu, Atsunori			Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan	BRACHYTHERAPY			English	Article; Proceedings Paper	International Symposium on 10th Anniversary of Permanent Prostate Brachytherapy	JAN 17-18, 2014	JAPAN			Prostate cancer; Brachytherapy; Cremation; Radiation safety	BRACHYTHERAPY	PURPOSE: If a prostate cancer patient treated with 1251 brachytherapy dies within 12 months after the treatment, prostate removal before cremation is recommended to avoid problems related to radioactivity in the ashes, such as inhalation of airborne particulate matter by crematorium staff or nearby residents. To provide guidance for such cases, a manual prepared under the editorial supervision of several professional associations was issued in 2008 in Japan. Herein, we investigated the incidence and causes of death, and the actions taken subsequent to death, among prostate cancer patients who died within 12 months after 1251 brachytherapy over a 10-year period in Japan; and we compared the results before and after the manual was issued. METHODS AND MATERIALS: Data extracted from the Japan Radioisotope Association database for the period from September 2003 to the end of December 2013 were used. RESULTS: Of 27,976 patients who underwent 1251 brachytherapy during the specified period, 79 died within 12 months after implantation, including 3 who died in the 2011 earthquake and tsunami. The prostate and brachytherapy source were retrieved at autopsy from 69 of the 79 patients. Autopsy could not be performed on the other 10 patients, 2 of whom died in the earthquake. Autopsy and retrieval of the brachytherapy source were significantly more common after issuance of the manual than before (22/28 cases before; 47/49 cases after; p = 0.021). CONCLUSION: In most cases of early death after 1251 brachytherapy in Japan, the brachytherapy source was retrieved. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Satoh, Takefumi; Dokiya, Takushi; Yamanaka, Hidetoshi; Saito, Shiro; Itami, Jun; Shibuya, Hitoshi; Nakano, Takashi; Shigematsu, Naoyuki; Aoki, Manabu; Egawa, Shin; Hashimoto, Mitsuyasu; Nishimura, Tetsuo; Yorozu, Atsunori] Japan Radioisotope Assoc, Working Grp Promot Permanent Seed Implantat Thera, Med Sci & Pharmaceut Comm, Subcomm Brachytherapy, Tokyo, Japan; [Satoh, Takefumi] Kitasato Univ, Dept Urol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Dokiya, Takushi] Saitama Med Univ, Dept Radiat Oncol, Ctr Comprehens Canc, Saitama, Japan; [Yamanaka, Hidetoshi] Kurosawa Hosp, Inst Prevent Med, Gunma, Japan; [Saito, Shiro] Natl Hosp Org, Dept Urol, Tokyo Med Ctr, Tokyo, Japan; [Ishiyama, Hiromichi] Kitasato Univ, Dept Radiat Oncol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Itami, Jun] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; [Shibuya, Hitoshi] Tokyo Med & Dent Univ, Dept Radiol, Tokyo, Japan; [Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gumma 371, Japan; [Shigematsu, Naoyuki] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Aoki, Manabu] Jikei Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Hashimoto, Mitsuyasu] Int Univ Hlth & Welf, Dept Radiol Sci, Otawara, Tochigi, Japan; [Nishimura, Tetsuo] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka, Japan; [Yorozu, Atsunori] Natl Hosp Org, Tokyo Med Ctr, Dept Radiol, Tokyo, Japan	Satoh, T (reprint author), Kitasato Univ, Dept Urol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	tsatoh@kitasato-u.ac.jp					International Commission on Radiological Protection, 2005, ANN ICRP, V98, P3; Japanese Society for Therapeutic Radiology and Oncology the Japanese Urological Association the Japan Radiological Society the Japanese Society of Pathology and the Japan Radioisotope Association, 2008, MAN ACT EARL DEATH C; Japanese Society for Therapeutic Radiology and Oncology/Japanese Urological Association/Japan Radiological Society, 2003, GUID SAF CONTR PERM; Nath R, 1997, MED PHYS, V24, P1557, DOI 10.1118/1.597966; Que W, 2001, J Appl Clin Med Phys, V2, P174, DOI 10.1120/1.1385868; Satoh T, 2012, BRACHYTHERAPY, V11, P192, DOI 10.1016/j.brachy.2011.06.009; Sodue T, 2012, CANC STAT REPORT 201, P70	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	MAR-APR	2015	14	2					136	141		10.1016/j.brachy.2014.08.043		6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CC9RO	WOS:000350708600006		
J	Wang, R; Yoshida, K; Toki, T; Sawada, T; Uechi, T; Okuno, Y; Sato-Otsubo, A; Kudo, K; Kamimaki, I; Kanezaki, R; Shiraishi, Y; Chiba, K; Tanaka, H; Terui, K; Sato, T; Iribe, Y; Ohga, S; Kuramitsu, M; Hamaguchi, I; Ohara, A; Hara, J; Goi, K; Matsubara, K; Koike, K; Ishiguro, A; Okamoto, Y; Watanabe, K; Kanno, H; Kojima, S; Miyano, S; Kenmochi, N; Ogawa, S; Ito, E				Wang, RuNan; Yoshida, Kenichi; Toki, Tsutomu; Sawada, Takafumi; Uechi, Tamayo; Okuno, Yusuke; Sato-Otsubo, Aiko; Kudo, Kazuko; Kamimaki, Isamu; Kanezaki, Rika; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Terui, Kiminori; Sato, Tomohiko; Iribe, Yuji; Ohga, Shouichi; Kuramitsu, Madoka; Hamaguchi, Isao; Ohara, Akira; Hara, Junichi; Goi, Kumiko; Matsubara, Kousaku; Koike, Kenichi; Ishiguro, Akira; Okamoto, Yasuhiro; Watanabe, Kenichiro; Kanno, Hitoshi; Kojima, Seiji; Miyano, Satoru; Kenmochi, Naoya; Ogawa, Seishi; Ito, Etsuro			Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						bone marrow failure; Diamond-Blackfan; genetic analysis; erythropoiesis; childhood	RIBOSOMAL-PROTEIN GENES; JAPANESE PATIENTS; CELLS; RPS19; ABNORMALITIES; ZEBRAFISH; SUBUNITS; REGISTRY; DEFECTS; S19	Diamond-Blackfan anaemia is a congenital bone marrow failure syndrome that is characterized by red blood cell aplasia. The disease has been associated with mutations or large deletions in 11 ribosomal protein genes including RPS7, RPS10, RPS17, RPS19, RPS24, RPS26, RPS29, RPL5, RPL11, RPL26 and RPL35A as well as GATA1 in more than 50% of patients. However, the molecular aetiology of many Diamond-Blackfan anaemia cases remains to be uncovered. To identify new mutations responsible for Diamond-Blackfan anaemia, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions involving known Diamond-Blackfan anaemia genes except for RPS7, RPL26, RPS29 and GATA1. Here, we identified a de novo splicing error mutation in RPL27 and frameshift deletion in RPS27 in sporadic patients with Diamond-Blackfan anaemia. In vitro knockdown of gene expression disturbed pre-ribosomal RNA processing. Zebrafish models of rpl27 and rps27 mutations showed impairments of erythrocyte production and tail and/or brain development. Additional novel mutations were found in eight patients, including RPL3L, RPL6, RPL7L1T, RPL8, RPL13, RPL14, RPL18A and RPL31. In conclusion, we identified novel germline mutations of two ribosomal protein genes responsible for Diamond-Blackfan anaemia, further confirming the concept that mutations in ribosomal protein genes lead to Diamond-Blackfan anaemia.	[Wang, RuNan; Toki, Tsutomu; Kanezaki, Rika; Terui, Kiminori; Sato, Tomohiko; Ito, Etsuro] Hirosaki Univ Grad Sch Med, Dept Paediat, Hirosaki, Aomori, Japan; [Yoshida, Kenichi; Okuno, Yusuke; Sato-Otsubo, Aiko; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Yoshida, Kenichi; Okuno, Yusuke; Sato-Otsubo, Aiko; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumour Biol, Kyoto, Japan; [Sawada, Takafumi; Uechi, Tamayo; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan; [Kudo, Kazuko] Shizuoka Childrens Hosp, Div Haematol & Oncol, Shizuoka, Japan; [Kamimaki, Isamu] Saitama Natl Hosp, Dept Paediat, Wako, Saitama, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Iribe, Yuji; Kanno, Hitoshi] Tokyo Womens Med Univ, Dept Transfus Med & Cell Proc, Tokyo, Japan; [Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Perinatal & Paediat Med, Fukuoka, Japan; [Kuramitsu, Madoka; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan; [Ohara, Akira] Toho Univ, Omori Hosp, Dept Transfus, Tokyo, Japan; [Hara, Junichi] Osaka City Gen Hosp, Dept Haematol & Oncol, Osaka, Japan; [Goi, Kumiko] Univ Yamanashi, Dept Paediat, Kofu, Yamanashi, Japan; [Matsubara, Kousaku] Nishi Kobe Med Ctr, Dept Paediat, Kobe, Hyogo, Japan; [Koike, Kenichi] Shinshu Univ Sch Med, Dept Paediat, Matsumoto, Nagano, Japan; [Ishiguro, Akira] Div Haematol, Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Okamoto, Yasuhiro] Kagoshima Univ, Dept Paediat, Kagoshima, Japan; [Watanabe, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Paediat, Kyoto, Japan; [Kojima, Seiji] Nagoya Univ Grad Sch Med, Dept Paediat, Nagoya, Aichi, Japan	Kenmochi, N (reprint author), Hirosaki Univ Grad Sch Med, Dept Paediat, 53 Honcho, Hirosaki, Aomori 0368562, Japan.	eturou@cc.hirosaki-u.ac.jp			Research on Measures for Intractable Diseases Project; Health and Labor Sciences Research grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI: 25291003]	We thank T. Kudo and A. Mikami for their technical assistance. This work was supported by the Research on Measures for Intractable Diseases Project and Health and Labor Sciences Research grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare, by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan and by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI: 25291003).	Draptchinskaia N, 1999, NAT GENET, V21, P169; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Torihara H, 2011, BRIT J HAEMATOL, V152, P648, DOI 10.1111/j.1365-2141.2010.08535.x; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Gazda HT, 2012, HUM MUTAT, V33, P1037, DOI 10.1002/humu.22081; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; McGowan KA, 2011, SEMIN HEMATOL, V48, P106, DOI 10.1053/j.seminhematol.2011.02.001; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Lipton JM, 2006, PEDIATR BLOOD CANCER, V46, P558, DOI 10.1002/pbc.20642; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Willig TN, 1999, BLOOD, V94, P4294; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Gerrard G, 2013, BRIT J HAEMATOL, V162, P530, DOI 10.1111/bjh.12397; Konno Y, 2010, HAEMATOL-HEMATOL J, V95, P1293, DOI 10.3324/haematol.2009.020826; Kuramitsu M, 2012, BLOOD, V119, P2376, DOI 10.1182/blood-2011-07-368662; Mirabello L, 2014, BLOOD, V124, P24, DOI 10.1182/blood-2013-11-540278; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037	32	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	MAR	2015	168	6					854	864		10.1111/bjh.13229		11	Hematology	Hematology	CD4HN	WOS:000351043400010		
J	Mori, S; Amano, S; Furukawa, T; Shirai, T; Noda, K				Mori, S.; Amano, S.; Furukawa, T.; Shirai, T.; Noda, K.			Effect of secondary particles on image quality of dynamic flat panels in carbon ion scanning beam treatment	BRITISH JOURNAL OF RADIOLOGY			English	Article							REAL-TIME; TUMOR TRACKING; RADIOTHERAPY; THERAPY; MOTION; LUNG; PROTON; PATTERN; MARKERS; SYSTEM	Objective: Real-time markerless tumour tracking using radiographic fluoroscopic imaging is one of the better solutions to improving respiratory-gated radiotherapy. However, particle beams cause secondary particles from patients, which could affect radiographs. Here, we evaluated the quality of radiographs during carbon ion pencil beam scanning (CPBS) irradiation for respiratory gating. Methods: A water phantom and chest phantom were used. The phantoms were irradiated with CPBS at 290 MeV n(-1) from orthogonal directions. Dose rates were 3.4x10(8), 1.14x10(8) and 3.79x10(7) particles per second. A dynamic flat panel detector (DFPD) was installed on the upstream (DFPD1) or downstream (DFPD2) side of the vertical irradiation port. DFPD images were acquired during CPBS at 15.00, 7.50 and 3.75 frames per second (fps). Charge on the DFPD was cleaned using fast readout technique every 30 fps. DFPD images were acquired during CPBS with radiographic exposure, and results with and without fast readout technique were compared. Results: Secondary particles were visualized as spots or streak-like shapes. Capture of secondary particles from the horizontal beam direction was lower with fast readout technique than without it. With regard to beam irradiation direction dependency, CPBS from the horizontal direction resulted in a greater magnitude of secondary particles reaching DFPD2 than reaching DFPD1. When CPBS was delivered from the vertical direction, however, the magnitude of secondary particles on both DFPDs was very similar. Conclusion: Fast readout technique minimized the effect of secondary particles on DFPD images during CPBS. Advances in knowledge: This technique may be useful for markerless tumour tracking for respiratory gating.	[Mori, S.; Furukawa, T.; Shirai, T.; Noda, K.] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Med Phys Res Program, Chiba 260, Japan; [Amano, S.] Chiba Univ, Res Ctr Frontier Med Engn, Chiba, Japan	Mori, S (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Med Phys Res Program, Chiba 260, Japan.	shinshin@nirs.go.jp			SM	This article was funded by author SM.	Sharp GC, 2004, PHYS MED BIOL, V49, P425, DOI 10.1088/0031-9155/49/3/006; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Mori S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130163; Ruan D, 2009, PHYS MED BIOL, V54, P4777, DOI 10.1088/0031-9155/54/15/009; Robert C, 2013, PHYS MED BIOL, V58, P2879, DOI 10.1088/0031-9155/58/9/2879; Knopf AC, 2011, PHYS MED BIOL, V56, P7257, DOI 10.1088/0031-9155/56/22/016; Berbeco RI, 2004, PHYS MED BIOL, V49, P243, DOI 10.1088/0031-9155/49/2/005; Cui Y, 2007, PHYS MED BIOL, V52, P6229, DOI 10.1088/0031-9155/52/20/010; Combs SE, 2013, RADIOTHER ONCOL, V108, P132, DOI 10.1016/j.radonc.2013.06.026; [Anonymous], 2008, RADIOTHERAPY EQUIPME; Murphy MJ, 2004, SEMIN RADIAT ONCOL, V14, P91, DOI 10.1053/j.semradonc.2003.10.005; Bert C, 2011, PHYS MED BIOL, V56, pR113, DOI 10.1088/0031-9155/56/16/R01; Benchetrit G, 2000, RESP PHYSIOL, V122, P123, DOI 10.1016/S0034-5687(00)00154-7; Berbeco RI, 2005, PHYS MED BIOL, V50, P4481, DOI 10.1088/0031-9155/50/19/004; Furukawa T, 2010, MED PHYS, V37, P5672, DOI 10.1118/1.3501313; Graeff C, 2012, MED PHYS, V39, P6004, DOI 10.1118/1.4749964; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-59; HUGELIN A, 1989, RESPIRATORY CONTROL : A MODELING PERSPECTIVE, P353; Korreman SS, 2008, RADIOTHER ONCOL, V86, P61, DOI 10.1016/j.radonc.2007.10.038; Liang PJ, 1995, ADV EXP MED BIOL, V393, P117; Mori Shinichiro, 2012, J Appl Clin Med Phys, V13, P3926, DOI 10.1120/jacmp.v13i6.3926; Mori S, 2014, J RADIAT RES, V55, P948, DOI 10.1093/jrr/rru032; Nuyttens JJ, 2006, ACTA ONCOL, V45, P961, DOI 10.1080/02841860600902205; Smith AR, 2009, MED PHYS, V36, P556, DOI 10.1118/1.3058485	24	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	MAR	2015	88	1047							UNSP 20140567	10.1259/bjr.20140567		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD2CY	WOS:000350882800009		
J	Tanaka, R; Takamori, M; Uchiyama, Y; Nishikawa, RM; Shiraishi, J				Tanaka, R.; Takamori, M.; Uchiyama, Y.; Nishikawa, R. M.; Shiraishi, J.			Using breast radiographers' reports as a second opinion for radiologists' readings of microcalcifications in digital mammography	BRITISH JOURNAL OF RADIOLOGY			English	Article							COMPUTER-AIDED DETECTION; SCREENING MAMMOGRAMS; PERFORMANCE; VARIABILITY; VALIDATION; DIAGNOSIS; OBSERVER; PROGRAM; CAD	Objective: The aim of this study was to investigate a practical method for incorporating radiographers' reports with radiologists' readings of digital mammograms. Methods: This simulation study was conducted using data from a free-response receiver operating characteristic observer study obtained with 75 cases (25 malignant, 25 benign and 25 normal cases) of digital mammograms. Each of the rating scores obtained by six breast radiographers was utilized as a second opinion for four radiologists' readings with the radiographers' reports. A logical "OR" operation with various criteria settings was simulated for deciding an appropriate method to select a radiographer's report in all combinations of radiologists and radiographers. The average figure of merit (FOM) of the radiologists' performances was statistically analysed using a jackknife procedure (JAFROC) to verify the clinical utility of using radiographers' reports. Results: Potential improvement of the average FOM of the radiologists' performances for identifying malignant microcalcifications could be expected when using radiographers' reports as a second opinion. When the threshold value of 2.6 in Breast Imaging-Reporting and Data System (BI-RADS (R)) assessment was applied to adopt/reject a radiographer's report, FOMs of radiologists' performances were further improved. Conclusion: When using breast radiographers' reports as a second opinion, radiologists' performances potentially improved when reading digital mammograms. It could be anticipated that radiologists' performances were improved further by setting a threshold value on the BIRADS assessment provided by the radiographers. Advances in knowledge: For the effective use of a radiographer's report as a second opinion, radiographers' rating scores and its criteria setting for adoption/rejection would be necessary.	[Tanaka, R.] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Dept Radiol Technol, Kanazawa, Ishikawa, Japan; [Takamori, M.] Ishikawa Prefectural Hosp, Dept Radiol, Kanazawa, Ishikawa, Japan; [Uchiyama, Y.; Shiraishi, J.] Kumamoto Univ, Fac Life Sci, Dept Med Phys, Kumamoto, Japan; [Nishikawa, R. M.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Tanaka, R (reprint author), Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Dept Radiol Technol, Kanazawa, Ishikawa, Japan.	rie44@mhs.mp.kanazawa-u.ac.jp			Foundation for Promotion of Cancer Research	This study was partially supported by the Foundation for Promotion of Cancer Research. RMN receives royalties from Hologic (TM) Inc.	American College of Radiology, 2003, ACR BIRADS BREAST IM; Bennett RL, 2012, CLIN RADIOL, V67, P114, DOI 10.1016/j.crad.2011.06.015; Chakraborty DP, 2008, ACAD RADIOL, V15, P1554, DOI 10.1016/j.acra.2008.07.018; Boyer B, 2009, EUR J RADIOL, V69, P24, DOI 10.1016/j.ejrad.2008.07.042; Gilbert FJ, 2006, RADIOLOGY, V241, P47, DOI 10.1148/radiol.2411051092; Van den Biggelaar FJHM, 2008, BREAST, V17, P85, DOI 10.1016/j.breast.2007.07.035; Gur D, 2003, RADIOLOGY, V228, P10, DOI 10.1148/radiol.2281020709; Jiang YL, 2006, ACAD RADIOL, V13, P84, DOI 10.1016/j.acra.2005.09.086; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Wivell G, 2003, CLIN RADIOL, V58, P63, DOI 10.1053/crad.2002.1087; Rao VM, 2010, J AM COLL RADIOL, V7, P802, DOI 10.1016/j.jacr.2010.05.019; [Anonymous], REP MIN HLTH LAB WEL; Doi K, 1999, EUR J RADIOL, V31, P97, DOI 10.1016/S0720-048X(99)00016-9; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Beam CA, 1996, ACAD RADIOL, V3, P891, DOI 10.1016/S1076-6332(96)80296-0; Chaudhuri A., 2010, METHODS SAMPLE SELEC; Cole EB, 2012, AM J ROENTGENOL, V199, pW392, DOI 10.2214/AJR.11.7255; Duijm LEM, 2008, EUR J CANCER, V44, P1223, DOI 10.1016/j.ejca.2008.03.003; Duijm LEM, 2007, J NATL CANCER I, V99, P1162, DOI 10.1093/jnci/djm050; Friedenberg RM, 2000, RADIOLOGY, V215, P630; Heath M., 2001, P 5 INT WORKSH DIG M, P212; Heath M., 1998, DIGITAL MAMMOGRAPHY, V13, P457; NHS Breast Screening Programme, 2011, ANN REV 2011; Paterson AM, 2004, RADIOGRAPHY, V10, P205, DOI 10.1016/j.radi.2004.03.004; Pauli R, 1996, BRIT J RADIOL, V69, P10; Shiraishi Junji, 2013, Radiol Phys Technol, V6, P35, DOI 10.1007/s12194-012-0166-1; The College of Radiographers, 2006, MED IM INT CLIN REP; The College of Radiographers, 1997, REP RAD VIS PAP; The College of Radiographers, 2013, PREL CLIN EV CLIN RE; The Royal College of Radiologists, 2011, STAND REC REP INT IM	31	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	MAR	2015	88	1047							20140565	10.1259/bjr.20140565		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD2CY	WOS:000350882800008		
J	Fukuda, T; Nakamura, K; Fukuda-Ohashi, N; Yahagi, N				Fukuda, Tatsuma; Nakamura, Kensuke; Fukuda-Ohashi, Naoko; Yahagi, Naoki			How Long Should Resuscitative Efforts Be Continued in Adult Out-of-Hospital Cardiac Arrest?	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							CARDIOPULMONARY-RESUSCITATION; GUIDELINES; ETHICS	The neurological prognosis of out-of-hospital cardiac arrest (OHCA) is extremely poor, particularly in patients who require prolonged cardiopulmonary resuscitation (CPR). However, the upper limit of CPR duration is unclear. We present a case of a 51-year-old man with nonhypothermic OHCA. He was discharged without neurological sequelae despite long duration CPR lasting 143 minutes, which is the longest duration among adult nonhypothermic OHCA cases reported. There are some patients for whom CPR duration might not be associated with prognosis. To determine when to terminate resuscitative efforts or whether more lifesaving medical resources should be provided, a prognostic indicator other than CPR duration is needed.	[Fukuda, Tatsuma; Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Ibaraki, Japan; [Fukuda-Ohashi, Naoko; Yahagi, Naoki] Univ Tokyo, Dept Emergency & Crit Care Med, Grad Sch Med, Tokyo 1138655, Japan	Fukuda, T (reprint author), Univ Tokyo, Dept Emergency & Crit Care Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tatsumafukuda-jpn@umin.ac.jp					Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Lippert FK, 2010, RESUSCITATION, V81, P1445, DOI 10.1016/j.resuscitation.2010.08.013; Kim WY, 2014, RESUSCITATION, V85, P1042, DOI 10.1016/j.resuscitation.2014.04.005; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	MAR	2015	31	3							364.e1	10.1016/j.cjca.2014.11.028		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD1GQ	WOS:000350823400001		
J	Kotani, K				Kotani, Kazuhiko			Neutrophil/Lymphocyte Ratio and the Oxidative Stress Burden	CANADIAN JOURNAL OF CARDIOLOGY			English	Letter									Jichi Med Univ, Shimotsuke, Japan	Kotani, K (reprint author), Jichi Med Univ, Shimotsuke, Japan.	kazukotani@jichi.ac.jp					Vassalle C, 2012, CLIN CHEM LAB MED, V50, P1463, DOI 10.1515/cclm-2011-0919; Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/01.mol.0000083762.66245.51; Arbel Y, 2014, CAN J CARDIOL, V30, P1177, DOI 10.1016/j.cjca.2014.05.010; Kotani Kazuhiko, 2012, Int J Prev Med, V3, P428	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	MAR	2015	31	3							365.e9	10.1016/j.cjca.2014.11.026		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD1GQ	WOS:000350823400011		
J	Kobara, H; Oryu, M; Mori, H; Fujihara, S; Nishiyama, N; Goda, Y; Chiyo, T; Matsunaga, T; Ayaki, M; Yachida, T; Nakatsu, T; Masaki, T				Kobara, Hideki; Oryu, Makoto; Mori, Hirohito; Fujihara, Shintaro; Nishiyama, Noriko; Goda, Yasuhiro; Chiyo, Taiga; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Nakatsu, Toshiaki; Masaki, Tsutomu			Tissue sampling using a submucosal tunnelling technique for indefinite gastric amyloidosis	CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material							ENDOSCOPY		[Kobara, Hideki; Oryu, Makoto; Mori, Hirohito; Fujihara, Shintaro; Nishiyama, Noriko; Goda, Yasuhiro; Chiyo, Taiga; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Nakatsu, Toshiaki; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Miki, Kagawa 7610793, Japan	Kobara, H (reprint author), Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kobara@med.kagawa-u.ac.jp					Sumiyama K, 2007, GASTROINTEST ENDOSC, V65, P688, DOI 10.1016/j.gie.2006.07.030; Kobara H, 2014, ENDOSCOPY, V46, pE660, DOI 10.1055/s-0034-1390840; Kobara H, 2013, GASTROINTEST ENDOSC, V77, P141, DOI 10.1016/j.gie.2012.08.008; Kamata Tsugumasa, 2012, J Med Case Rep, V6, P231, DOI 10.1186/1752-1947-6-231; Nfoussi Haifa, 2010, Tunis Med, V88, P670	5	0	0	PULSUS GROUP INC	OAKVILLE	2902 S SHERIDAN WAY, OAKVILLE, ONTARIO L6J 7L6, CANADA	0835-7900			CAN J GASTROENTEROL	Can. J. Gastroenterol. Hepatol.	MAR	2015	29	2					70	71				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD0JY	WOS:000350759800004		
J	Harada, M; Horiguchi, T; Masuda, M				Harada, Megumi; Horiguchi, Tatsuya; Masuda, Mikiya			The Equivariant Cohomology Rings of Peterson Varieties in All Lie Types	CANADIAN MATHEMATICAL BULLETIN-BULLETIN CANADIEN DE MATHEMATIQUES			English	Article						equivariant cohomology; Peterson varieties; flag varieties; Monk's formula; Giambelli's formula		Let G be a complex semisimple linear algebraic group and let Pet be the associated Peterson variety in the flag variety G/B. The main theorem of this note gives an efficient presentation of the equivariant cohomology ring H-S(*)(Pet) of the Peterson variety as a quotient of a polynomial ring by an ideal J generated by quadratic polynomials, in the spirit of the Borel presentation of the cohomology of the flag variety. Here the group S congruent to C* is a certain subgroup of a maximal torus T of G. Our description of the ideal J uses the Cartan matrix and is uniform across Lie types. In our arguments we use the Monk formula and Giambelli formula for the equivariant cohomology rings of Peterson varieties for all Lie types, as obtained in the work of Drellich. Our result generalizes a previous theorem of Fukukawa-Harada-Masuda, which was only for Lie type A.	[Harada, Megumi] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada; [Horiguchi, Tatsuya; Masuda, Mikiya] Osaka City Univ, Dept Math, Sumiyoshi Ku, Osaka 5588585, Japan	Harada, M (reprint author), McMaster Univ, Dept Math & Stat, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	megumi.harada@math.mcmaster.ca; d13sar0z06@ex.media.osaka-cu.ac.jp; masuda@sci.osaka-cu.ac.jp			NSERC; Ontario Early Researcher Award; Canada Research Chair (Tier 2) Award; Japan Society for the Promotion of Science Invitation Fellowship for Research in Japan [L-13517]; JSPS [25400095]	The first author is supported in part by an NSERC Discovery Grant (Individual), an Ontario Early Researcher Award, a Canada Research Chair (Tier 2) Award, and a Japan Society for the Promotion of Science Invitation Fellowship for Research in Japan (Fellowship ID L-13517). The first author additionally thanks the Osaka City University Advanced Mathematics Institute for its hospitality, which made this collaboration possible. The third author is partially supported by a JSPS Grant-in-Aid for Scientific Research 25400095.	Abe H., ARXIV14113065; Billey SC, 1999, DUKE MATH J, V96, P205, DOI 10.1215/S0012-7094-99-09606-0; Brion M, 2004, MICH MATH J, V52, P189, DOI 10.1307/mmj/1080837743; Drellich E., ARXIV13113014; Fukukawa Y., 1832, ARXIV110418 IN PRESS; Fukukawa Y., ARXIV12075229; Fulcukawa Y., ARXIV131086 IN PRESS; Harada M., ARXIV10072750; Humphreys J., 1990, CAMBRIDGE STUD ADV M, V29; Humphreys J. E., 1978, GRADUATE TEXTS MATH, V9; Kostant B., 1996, SELECTA MATH, V2, P43, DOI 10.1007/BF01587939; Precup M, 2013, SEL MATH-NEW SER, V19, P903, DOI 10.1007/s00029-012-0109-z; Rietsch K, 2003, J AM MATH SOC, V16, P363; Stanley R. P., 1996, COMBINATORICS COMMUT	14	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-4395	1496-4287		CAN MATH BULL	Can. Math. Bul.-Bul. Can. Math.	MAR	2015	58	1					80	90		10.4153/CMB-2014-048-0		11	Mathematics	Mathematics	CC3QQ	WOS:000350264500010		
J	Hasegawa, K				Hasegawa, Kei			Essential Commutants of Semicrossed Products	CANADIAN MATHEMATICAL BULLETIN-BULLETIN CANADIEN DE MATHEMATIQUES			English	Article						essential commutant; semicrossed product	TOEPLITZ-OPERATORS; VONNEUMANN ALGEBRAS; COMPACT-OPERATORS; CROSSED-PRODUCTS; MODULO	Let alpha: G curved right arrow M be a spatial action of a countable abelian group on a "spatial" von Neumann algebra M and let S be its unital subsemigroup with G = S-1 S. We explicitly compute the essential commutant and the essential fixed-points, modulo the Schatten p-class or the compact operators, of the w*-semicrossed product of M by S when M' contains no non-zero compact operators. We also prove a weaker result when M is a von Neumann algebra on a finite dimensional Hilbert space and (G, S) = (Z, Z(+)), which extends a famous result due to Davidson (1977) for the classical analytic Toeplitz operators.	Kyushu Univ, Grad Sch Math, Fukuoka 8190395, Japan	Hasegawa, K (reprint author), Kyushu Univ, Grad Sch Math, Fukuoka 8190395, Japan.	ma213034@math.kyushu-u.ac.jp					HAAGERUP U, 1975, MATH SCAND, V37, P271; Brown A., 1963, J REINE ANGEW MATH, V213, P89; DAVIDSON KR, 1977, J FUNCT ANAL, V24, P291, DOI 10.1016/0022-1236(77)90060-X; DOUGLAS R. G., 1998, GRADUATE TEXTS MATH, V179; Hewiit E., 1979, ABSTRACT HARMONIC AN, VI; Hiai F., 1997, BANACH CTR PUBLICATI, V38, P119; HOOVER TB, 1977, P AM MATH SOC, V62, P293, DOI 10.2307/2041031; Johnson B.E., 1972, J FUNCT ANAL, V11, P39, DOI 10.1016/0022-1236(72)90078-X; Kakariadis ETA, 2012, J OPERAT THEOR, V67, P379; LOEBL RI, 1978, J FUNCT ANAL, V29, P214, DOI 10.1016/0022-1236(78)90007-1; MCASEY M, 1979, T AM MATH SOC, V248, P381, DOI 10.2307/1998973; Muhly PS, 2000, AM J MATH, V122, P1121, DOI 10.1353/ajm.2000.0047; POPA S, 1987, J FUNCT ANAL, V71, P393, DOI 10.1016/0022-1236(87)90011-5; SAITO KS, 1990, MATH PROC CAMBRIDGE, V108, P539, DOI 10.1017/S0305004100069425; Takesaki M., 2003, ENCYCL MATH SCI, V125; Xia JB, 2009, T AM MATH SOC, V361, P5163	16	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-4395	1496-4287		CAN MATH BULL	Can. Math. Bul.-Bul. Can. Math.	MAR	2015	58	1					91	104		10.4153/CMB-2014-057-x		14	Mathematics	Mathematics	CC3QQ	WOS:000350264500011		
J	Baron, B; Kitagawa, T; Nakamura, K; Kuramitsu, Y				Baron, Byron; Kitagawa, Takao; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro			Isolation of a Growth Factor Stress-induced Pancreatic Cancer Sub-population: Insight into Changes Due to Micro-environment	CANCER GENOMICS & PROTEOMICS			English	Article						Pancreatic cancer; cancer sub-population; micro-environment; proteomics	DIFFERENTIAL DISPLAY ANALYSIS; ENDOPLASMIC-RETICULUM STRESS; 14-3-3 SIGMA PROTEIN; PROTEOMIC ANALYSIS; HEPATOCELLULAR-CARCINOMA; UP-REGULATION; TUMOR-CELLS; NUTRIENT DEPRIVATION; DOWN-REGULATION; EXPRESSION	Background: Micro-environment plays a crucial role in determining the phenotypes within a tumor. Materials and Methods: In order to understand how the micro-environment affects pancreatic cancer, KLM1 cells were cultured under growth factor stress by culturing in foetal bovine serum (FBS)-free and reduced (1%) medium over several passages to mimic the core of a solid tumor with low vascularisation. Results: Proteomic analysis on these conditioned pancreatic cancer cells, called KLM1-S, compared to the parent cell line KLM1 revealed that a number of proteins including alpha-enolase, GAPDH, GRP78, HSP60 and STIP-1 were dysregulated. Additionally, KLM1-S cells exhibited a 250-fold increase in half-maximal inhibitory concentration (IC50) over the parent cell line KLM1. Conclusion: By decreasing their replication rate and levels of intracellular reactive oxygen species (ROS), KLM1-S cells are able to resist gemcitabine (GEM). The results obtained suggest that in KLM1 different phenotypes are a result of cellular plasticity rather than a committed transformation.	[Baron, Byron] Univ Malta, Fac Med & Surg, Dept Anat & Cell Biol, Msida, Malta; [Baron, Byron; Kitagawa, Takao; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro] Grad Sch Med, Dept Biochem & Funct Prote, Yamaguchi, Japan; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan Shi, Japan	Baron, B (reprint author), Grad Sch Med, Dept Biochem & Funct Prote, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	angenlabs@gmail.com					Sun HC, 2007, INT J ONCOL, V30, P1359; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; AZNAVOORIAN S, 1990, J CELL BIOL, V110, P1427, DOI 10.1083/jcb.110.4.1427; Tanaka T, 2008, ELECTROPHORESIS, V29, P2651, DOI 10.1002/elps.200700847; Ohtani H, 1998, PATHOL INT, V48, P1, DOI 10.1111/j.1440-1827.1998.tb03820.x; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; Akakura N, 2001, CANCER RES, V61, P6548; Izuishi K, 2000, CANCER RES, V60, P6201; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Qi T, 2008, J CLIN PATHOL, V61, P49, DOI 10.1136/jcp.2006.044735; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Wang Q, 2005, CANCER DETECT PREV, V29, P544, DOI 10.1016/j.cdp.2005.09.010; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Kuramitsu Y, 2010, ANTICANCER RES, V30, P4459; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Rao RV, 2002, FEBS LETT, V514, P122; Zhong H, 2000, CANCER RES, V60, P1541; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Hayashi E, 2009, PROTEOM CLIN APPL, V3, P1338, DOI 10.1002/prca.200900091; Li Zhaomin, 2010, BMC Cancer, V10, P598, DOI 10.1186/1471-2407-10-598; Miyake K, 2008, PANCREAS, V36, P1; Piselli P, 2000, ANTICANCER RES, V20, P825; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Takashima M, 2006, PROTEOMICS, V6, P3894, DOI 10.1002/pmic.200500346; Tsuruo T, 2001, CANCER RES, V61, P6548; Walsh N, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-3; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004	41	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	1109-6535	1790-6245		CANCER GENOM PROTEOM	Cancer Genomics Proteomics	MAR-APR	2015	12	2					49	55				7	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CD3TY	WOS:000351006200001		
J	Baron, B; Fujioka, T; Kitagawa, T; Maehara, SI; Maehara, Y; Nakamura, K; Kuramitsu, Y				Baron, Byron; Fujioka, Tsuyoshi; Kitagawa, Takao; Maehara, Shin-Ichiro; Maehara, Yoshihiko; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro			Comparative Proteomic Analysis of Two Stress-management Strategies in Pancreatic Cancer	CANCER GENOMICS & PROTEOMICS			English	Article						Pancreatic cancer; stress-induced; stress response; proteomics	ACTIVATED PROTEIN-KINASE; ALPHA-ENOLASE; HEPATOCELLULAR-CARCINOMA; LAMIN A/C; CELL-GROWTH; PHASE-II; GEMCITABINE; CALMODULIN; EXPRESSION; SURVIVAL	Background: It is known that cancers adopt different strategies to cope with stress and overcome adverse micro-environmental conditions. Such strategies are also applicable to chemo-therapeutic treatment, which could subsequently result in chemo-resistance. Materials and Methods: In order to investigate known stress-evasion strategies observed in pancreatic cancer, the stress-resistant KLM1-derived cell lines KLM1-R (Gemcitabine (GEM)induced stress) and KLM1-S (growth factor restriction-induced stress) were employed. Comparative proteomics were employed between for the two cell lines that were also compared against the parent cell line KLM1. Results: Proteomic analysis revealed changes in the expression levels of 6 proteins, namely: transitional endoplasmic reticulum ATPase, lamin A/C, PDZ and LIM protein 1, calmodulin, heat shock protein 60 and alpha enolase. Resistance to GEM of KLM1-R and KLM1-S was found to be comparable, with KLM1-S cells exhibiting close to 1.5-fold higher half-maximal inhibitory concentration (IC50) compared to KLM1-R cells. Conclusion: These results suggest that KLM1-R can be used as a model of directly-acquired chemoresistance (responding directly to evade GEM treatment), while KLM1-S is a good model of indirectly-acquired chemoresistance (formed in response to having to survive with less availability of growth factors), additionally gaining a selective advantage upon GEM treatment.	[Baron, Byron] Univ Malta, Fac Med & Surg, Dept Anat & Cell Biol, Msida, Malta; [Baron, Byron; Fujioka, Tsuyoshi; Kitagawa, Takao; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro] Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 7558505, Japan; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan, Japan; [Maehara, Shin-Ichiro; Maehara, Yoshihiko] Kyushyu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan	Baron, B (reprint author), Grad Sch Med, Dept Biochem & Funct Prote, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	angenlabs@gmail.com					Koizumi K, 2005, ANTICANCER RES, V25, P3347; Nishimatsu H, 2001, CIRC RES, V89, P63, DOI 10.1161/hh1301.092498; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Tanaka T, 2008, ELECTROPHORESIS, V29, P2651, DOI 10.1002/elps.200700847; Agrelo R, 2005, J CLIN ONCOL, V23, P3940, DOI 10.1200/JCO.2005.11.650; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Dhayat S, 2011, INT J CANCER, V129, P1031, DOI 10.1002/ijc.26078; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Qi T, 2008, J CLIN PATHOL, V61, P49, DOI 10.1136/jcp.2006.044735; Tomaino B, 2011, J PROTEOME RES, V10, P105, DOI 10.1021/pr100213b; Wang Zhiwei, 2011, Nat Rev Gastroenterol Hepatol, V8, P27, DOI 10.1038/nrgastro.2010.188; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Carmichael J, 1996, BRIT J CANCER, V73, P101, DOI 10.1038/bjc.1996.18; Mikuriya K, 2007, INT J ONCOL, V30, P849; Maehara S, 2004, INT J CANCER, V112, P184, DOI 10.1002/ijc.20304; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Gonzalez-Suarez I, 2009, CELL CYCLE, V8, P3860, DOI 10.4161/cc.8.23.10092; Habiro A, 2004, BIOCHEM BIOPH RES CO, V316, P71, DOI 10.1016/j.bbrc.2004.02.017; Piselli P, 2000, ANTICANCER RES, V20, P825; RASMUSEN CD, 1990, ENVIRON HEALTH PERSP, V84, P31, DOI 10.2307/3430702; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Takashima M, 2006, PROTEOMICS, V6, P3894, DOI 10.1002/pmic.200500346; Zhao L, 2008, J CELL BIOCHEM, V103, P471, DOI 10.1002/jcb.21409; Zhou WD, 2010, J PROTEOME RES, V9, P2929, DOI 10.1021/pr901109w	35	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	1109-6535	1790-6245		CANCER GENOM PROTEOM	Cancer Genomics Proteomics	MAR-APR	2015	12	2					83	87				5	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CD3TY	WOS:000351006200006		
J	Arita-Okubo, S; Kim-Kaneyama, JR; Lei, XF; Fu, WG; Ohnishi, K; Takeya, M; Miyauchi, A; Honda, H; Itabe, H; Miyazaki, T; Miyazaki, A				Arita-Okubo, Shigeko; Kim-Kaneyama, Joo-ri; Lei, Xiao-Feng; Fu, Wen-Guang; Ohnishi, Koji; Takeya, Motohiro; Miyauchi, Aya; Honda, Hirokazu; Itabe, Hiroyuki; Miyazaki, Takuro; Miyazaki, Akira			Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis	CARDIOVASCULAR RESEARCH			English	Article						Atherosclerosis; Microvilli-like structures; Endothelial cells	LEUKOCYTE ADHESION; CELLS; PROTEIN; VCAM-1; ICAM-1; ACTIN; MICE; FLOW	The adhesion of circulating monocytes to endothelial cells (ECs) is an early and critical event in the formation of atherosclerotic plaques. Hydrogen peroxide-inducible clone 5 (Hic-5) serves as an adaptor molecule in cell adhesion complexes. However, the role of endothelial Hic-5 in monocyte-EC interaction and atherogenesis remains unclear. We examined the roles of endothelial Hic-5 in monocyte-EC interaction and atherogenesis using mouse models of atherosclerosis and cultured human umbilical vein endothelial cells (HUVECs). Hic-5 was expressed in ECs, but not in monocytes/macrophages. An ex vivo monocyte adhesion assay revealed that adhesion of THP-1 monocytes to aortas isolated from Apoe(-/-) and LDLR-/- mice stimulated by TNF-alpha or oxidized LDL was suppressed by Hic-5 deficiency. Scanning electron microscopic observations of aortas harvested from Apoe(-/-) mice revealed that TNF-alpha- or oxidized LDL-induced microvilli-like structures were markedly suppressed by Hic-5 deficiency. Relative Hic-5 deficiency suppressed 60% of the atherosclerotic lesions in aortas from Apoe(-/-) and LDLR-/- mice. In contrast, overexpression of Hic-5 in HUVECs promoted induction of microvilli-like structures and adherence of THP-1 cells in an adhesion receptor such as intercellular adhesion molecule-1- and vascular cell adhesion molecule-1-dependent manner. Hic-5 in ECs plays an important role in the formation of microvilli-like structures and in the interaction between ECs and monocytes, leading to monocyte recruitment and subsequent development of atherosclerosis.	[Arita-Okubo, Shigeko; Kim-Kaneyama, Joo-ri; Lei, Xiao-Feng; Fu, Wen-Guang; Miyauchi, Aya; Miyazaki, Takuro; Miyazaki, Akira] Showa Univ, Dept Biochem, Sch Med, Shinagawa Ku, Tokyo 1428555, Japan; [Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cell Pathol, Kumamoto, Japan; [Honda, Hirokazu] Showa Univ, Div Nephrol, Dept Med, Koto Toyosu Hosp, Tokyo 1428555, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Mol Biol, Div Biol Chem, Tokyo 1428555, Japan	Kim-Kaneyama, JR (reprint author), Showa Univ, Dept Biochem, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shuri@pharm.showa-u.ac.jp			Japan Society for the Promotion of Science [26860588, 26461149, 26461368]; Showa University Medical Foundation; Japan Heart Foundation; Dr Hiroshi Irisawa and Aya Irisawa Memorial Research Grant; Takeda Science Foundation; MEXT (Ministry of Education, Culture, Sports, Science and Technology)	This work was supported by Grants-in-Aid for Young Scientists (B) (26860588 to X.-F.L.) and Scientific Research (C) (26461149 to J.-r.K.-K. and 26461368 to A.M.) from the Japan Society for the Promotion of Science, Showa University Medical Foundation, Japan Heart Foundation, the Dr Hiroshi Irisawa and Aya Irisawa Memorial Research Grant, and a research grant from the Takeda Science Foundation. This work was also supported in part by the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-16.	BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Kim-Kaneyama J, 2012, J ATHEROSCLER THROMB, V19, P601; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Carman CV, 2003, J IMMUNOL, V171, P6135; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Kim-Kaneyama JR, 2012, J THROMB HAEMOST, V10, P1867, DOI 10.1111/j.1538-7836.2012.04856.x; Lei XF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000747; Walski M, 2002, J PHYSIOL PHARMACOL, V53, P713; Weinbaum S, 2001, BIORHEOLOGY, V38, P119; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	23	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0008-6363	1755-3245		CARDIOVASC RES	Cardiovasc. Res.	MAR 1	2015	105	3					361	371		10.1093/cvr/cvv003		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD3VY	WOS:000351013000014		
J	Satapathy, A; Gadge, ST; Kusumawati, EN; Harada, K; Sasaki, T; Nishio-Hamane, D; Bhanage, BM				Satapathy, Anilkumar; Gadge, Sandip T.; Kusumawati, Etty N.; Harada, Kei; Sasaki, Takehiko; Nishio-Hamane, Daisuke; Bhanage, Bhalchandra M.			Synthesis of Polyester Amide by Carbonylation-Polycondensation Reaction Using Immobilized Palladium Metal Containing Ionic Liquid on SBA-15 as a Phosphine-Free Catalytic System	CATALYSIS LETTERS			English	Article						Heterogeneous catalysis; Carbonylation; XPS; Polyester amide; Ligand-free; Palladium	KHARASCH ADDITION-REACTION; CROSS-COUPLING REACTIONS; TERMINAL ALKYNES; EFFICIENT; CARBON; ALKOXYCARBONYLATION; AMINOCARBONYLATION; ALCOHOLS; PD/C	A novel and simple method for the synthesis of aromatic linear polyester amides has been developed by the carbonylation-polycondensation reaction of aromatic diiodides and aminohydroxy compounds in the presence of ImmPd-IL@SBA-15 catalytic system. Polyester amides with moderate intrinsic viscosity were synthesized in excellent yields using the ImmPd-IL@SBA-15 catalyst and represents efficient heterogeneous and phosphine-free approach for the synthesis of various linear polyester amide derivatives. The ImmPd-IL@SBA-15 catalyst solves the basic problem of catalyst recovery and furnishes good to excellent yield of desired product within short reaction time. The recycled catalyst was characterized using the XPS and TEM analysis. The catalyst was recycled four times without significant loss in activity.	[Satapathy, Anilkumar; Gadge, Sandip T.; Bhanage, Bhalchandra M.] Inst Chem Technol, Dept Chem, Bombay 400019, Maharashtra, India; [Satapathy, Anilkumar] Reliance Ind Ltd, Raigad 410220, Maharashtra, India; [Kusumawati, Etty N.] Univ Tokyo, Grad Sch Sci, Dept Chem, Kashiwa, Chiba 2778561, Japan; [Harada, Kei; Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Nishio-Hamane, Daisuke] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Bhanage, BM (reprint author), Inst Chem Technol, Dept Chem, N Parekh Marg, Bombay 400019, Maharashtra, India.	bm.bhanage@gmail.com	Sasaki, Takehiko/E-8160-2014	Sasaki, Takehiko/0000-0001-6190-4087	Reliance Industries Limited; CSIR (Council of Scientific and Industrial Research) New Delhi, India; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS; DST under the Japan-India Science Cooperative Program [DST/INT/JSPS/P-152/2013]	The author AKS is thankful to Reliance Industries Limited for providing the research Grant. We are also thankful to Mr. A. K. Kelkar from Reliance Industries limited for the generous help. The authors STG is thankful to CSIR (Council of Scientific and Industrial Research) New Delhi, India for providing senior research fellowship. XPS measurements were conducted in Research Hub for Advanced Nano Characterization, the University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work is supported by JSPS and DST under the Japan-India Science Cooperative Program (Project No. DST/INT/JSPS/P-152/2013).	Gadge ST, 2012, ADV SYNTH CATAL, V354, P2049, DOI 10.1002/adsc.201200041; KUBOTA Y, 1994, B CHEM SOC JPN, V67, P563, DOI 10.1246/bcsj.67.563; Pollet P, 2014, GREEN CHEM, V16, P1034, DOI 10.1039/c3gc42302f; Khedkar MV, 2011, ADV SYNTH CATAL, V353, P3415, DOI 10.1002/adsc.201100460; Gadge ST, 2013, SYNLETT, V24, P981, DOI 10.1055/s-0032-1316896; Gadge ST, 2013, J ORG CHEM, V78, P6793, DOI 10.1021/jo401038e; Patil NM, 2014, CATAL LETT, V144, P1803, DOI 10.1007/s10562-014-1362-x; Gu YL, 2009, ADV SYNTH CATAL, V351, P817, DOI 10.1002/adsc.200900043; Gadge ST, 2014, RSC ADV, V4, P10367, DOI 10.1039/c3ra46273k; YONEYAMA M, 1988, MACROMOLECULES, V21, P1908, DOI 10.1021/ma00185a004; Pereira MMA, 2012, CURR ORG CHEM, V16, P1680; Khedkar MV, 2013, ACS CATAL, V3, P287, DOI 10.1021/cs300719r; Sasaki T, 2008, J MOL CATAL A-CHEM, V279, P200, DOI 10.1016/j.molcata.2007.06.009; Khedkar MV, 2014, J MOL CATAL A-CHEM, V385, P91, DOI 10.1016/j.molcata.2014.01.018; Kulkarni SM, 2004, J MOL CATAL A-CHEM, V207, P97, DOI 10.1016/S1381-1169(03)00498-9; Barbee R. B., 1989, U. S. Pat, Patent No. 4855397; Casagrande F., 1993, US Pat, Patent No. 5185424; de la Fuente V, 2012, CHEM COMMUN, V48, P1695, DOI 10.1039/c2cc17124d; Forsch C. J., 1945, US Pat, Patent No. 2386454; Gaymans G. J., 1996, US Pat, Patent No. 5510451; Khedkar M. V., 2010, EUR J ORG CHEM, V36, P6981; Kulkarni SM, 2001, CHEM COMMUN, P1276, DOI 10.1039/b103438n; Sasaki T, 2005, CHEM COMMUN, P2506, DOI 10.1039/b500349k; Serrano PJM, 1998, POLYMER, V39, P83, DOI 10.1016/S0032-3861(97)00232-2; Shalaby S. W., 1980, US Pat, Patent No. 4226243; Wang YM, 2005, MICROPOR MESOPOR MAT, V84, P127, DOI 10.1016/j.micromeso.2005.05.024; Zhong CM, 2006, J CATAL, V242, P357, DOI 10.1016/j.jcat.2006.06.020	27	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	MAR	2015	145	3					824	833		10.1007/s10562-015-1489-4		10	Chemistry, Physical	Chemistry	CC9GS	WOS:000350677000011		
J	Shimizu, K				Shimizu, Ken-ichi			Heterogeneous catalysis for the direct synthesis of chemicals by borrowing hydrogen methodology	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							MEERWEIN-PONNDORF-VERLEY; ASYMMETRIC TRANSFER HYDROGENATION; SUPPORTED RUTHENIUM HYDROXIDE; N-HETEROCYCLIC CARBENE; ASTERISK-IR COMPLEX; CHEMOSELECTIVE TRANSFER HYDROGENATION; SECONDARY BENZYLIC ALCOHOLS; DIRECT ALPHA-ALKYLATION; ONE-STEP AMINATION; ONE-POT SYNTHESIS	The development of heterogeneous catalysts for green chemical synthesis is a growing area in catalysis and green-sustainable chemistry. This review summarizes recent examples of hydrogen transfer-type reactions using supported transition metal catalysts with special emphasis on the direct synthesis of chemicals by borrowing hydrogen methodology. The highlighted reactions are: (1) transfer hydrogenation of carbonyl compounds, (2) transfer dehydrogenation of alcohols, (3) N-alkylation of amines or NH3 with alcohols, (4) alkylation of acidic CH2 or CH3 group with alcohols, (5) self-and cross-alkylation of alcohols, (6) N- or C3-alkylation of indoles with alcohols, (7) synthesis of quinolines from nitroarenes and alcohols, (8) synthesis of thioethers from thiols and alcohols, and (9) cross-alkylation of amines with different amines. These catalytic reactions have a common mechanistic feature: a domino dehydrogenation-condensation-hydrogenation sequence of alcohols (or amines) and nucleophiles. A key concept in the catalyst design in some of the systems is the multifunctionality of metal-loaded acidic and/or basic metal oxides, in which the acid and/or base sites selectively catalyze the condensation reactions, and the metal site catalyzes the transfer dehydrogenation of alcohol (or amines) and transfer hydrogenation of the condensation products as intermediates. In comparison with the recent examples of organometallic catalysis with borrowing hydrogen methodology, the advantages of heterogeneous catalysis are discussed in terms of catalytic efficiency and sustainability.	[Shimizu, Ken-ichi] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan; [Shimizu, Ken-ichi] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Katsura, Kyoto 6158520, Japan	Shimizu, K (reprint author), Hokkaido Univ, Catalysis Res Ctr, N-21,W-10, Sapporo, Hokkaido 0010021, Japan.	kshimizu@cat.hokudai.ac.jp	Shimizu, Ken-ichi/A-5241-2012		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26289299]; MEXT program "Elements Strategy Initiative to Form Core Research Center"	This work was supported by Grant-in-Aids for Scientific Research B (26289299) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and by a MEXT program "Elements Strategy Initiative to Form Core Research Center".	Alonso F, 2009, CHEMCATCHEM, V1, P75, DOI 10.1002/cctc.200900045; Alonso F, 2008, TETRAHEDRON, V64, P1847, DOI 10.1016/j.tet.2007.11.093; Alonso F, 2008, J CATAL, V260, P113, DOI 10.1016/j.jcat.2008.09.009; Bahn S, 2011, CHEMCATCHEM, V3, P1853, DOI 10.1002/cctc.201100255; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; Shimizu K, 2009, ANGEW CHEM INT EDIT, V48, P3982, DOI 10.1002/anie.200901057; Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Kwon MS, 2005, ANGEW CHEM INT EDIT, V44, P6913, DOI 10.1002/anie.200502422; Grigg R, 2009, TETRAHEDRON, V65, P4375, DOI 10.1016/j.tet.2009.03.065; Nishimura S, 2013, GREEN CHEM, V15, P2026, DOI 10.1039/c3gc40405f; Jensen T, 2009, J ORG CHEM, V74, P3990, DOI 10.1021/jo900341w; Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n; Torres G, 2007, APPL CATAL A-GEN, V317, P161, DOI 10.1016/j.apcata.2006.10.010; Hollmann D, 2007, CHEM-ASIAN J, V2, P403, DOI 10.1002/asia.200600391; Cho CS, 2001, J ORG CHEM, V66, P9020, DOI 10.1021/jo0108459; Subramanian T, 2012, CATAL SCI TECHNOL, V2, P296, DOI 10.1039/c1cy00383f; Ohta H, 2011, ORG LETT, V13, P3892, DOI 10.1021/ol201422s; Park JC, 2010, J PHYS CHEM C, V114, P6381, DOI 10.1021/jp1003215; Ousmane M, 2014, J CATAL, V309, P439, DOI 10.1016/j.jcat.2013.10.003; He W, 2011, CHEM-EUR J, V17, P13308, DOI 10.1002/chem.201101725; Yu JQ, 2003, CHEM COMMUN, P678, DOI 10.1039/b300074p; Hollmann D, 2007, ANGEW CHEM INT EDIT, V46, P8291, DOI 10.1002/anie.200703119; Imm S, 2010, ANGEW CHEM INT EDIT, V49, P8126, DOI 10.1002/anie.201002576; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Bahn S, 2010, CHEM-EUR J, V16, P3590, DOI 10.1002/chem.200903144; Kim JW, 2009, J CATAL, V263, P205, DOI 10.1016/j.jcat.2009.01.020; WATANABE Y, 1981, TETRAHEDRON LETT, V22, P2667, DOI 10.1016/S0040-4039(01)92965-X; Shimizu K, 2013, ACS CATAL, V3, P112, DOI 10.1021/cs3007473; Shi F, 2009, J AM CHEM SOC, V131, P1775, DOI 10.1021/ja807681v; Climent MJ, 2014, ACS CATAL, V4, P870, DOI 10.1021/cs401052k; Kaneda K, 2006, B CHEM SOC JPN, V79, P981, DOI 10.1246/bcsj.79.981; Reddy MM, 2013, GREEN CHEM, V15, P3474, DOI 10.1039/c3gc41345d; Cho CS, 2005, J MOL CATAL A-CHEM, V240, P55, DOI 10.1016/j.molcata.2005.06.043; Dixit M, 2013, CATAL COMMUN, V33, P80, DOI 10.1016/j.catcom.2012.12.027; Bartoszewicz A, 2012, CHEM-EUR J, V18, P14510, DOI 10.1002/chem.201201845; Shimizu K, 2011, CATAL SCI TECHNOL, V1, P331, DOI 10.1039/c0cy00077a; Yamada YMA, 2006, ORG LETT, V8, P1375, DOI 10.1021/ol060166q; Sawaguchi T, 2011, CHEM LETT, V40, P1055, DOI 10.1246/cl.2011.1055; Koda K, 2009, CHEM LETT, V38, P838, DOI 10.1246/cl.2009.838; Cho CS, 2005, B KOR CHEM SOC, V26, P1611; Tamura M, 2012, CHEM LETT, V41, P1397, DOI 10.1246/cl.2012.1397; Kantam ML, 2006, ADV SYNTH CATAL, V348, P1970, DOI 10.1002/adsc.200505497; Lofberg C, 2006, J ORG CHEM, V71, P8023, DOI 10.1021/jo061113p; Fujita K, 2003, TETRAHEDRON LETT, V44, P2687, DOI 10.1016/S0040-4039(03)00371-X; Polshettiwar V, 2009, GREEN CHEM, V11, P127, DOI 10.1039/b815058c; Kantam ML, 2008, ADV SYNTH CATAL, V350, P2231, DOI 10.1002/adsc.200800342; Stratakis M, 2012, CHEM REV, V112, P4469, DOI 10.1021/cr3000785; Maiti D, 2011, CHEM SCI, V2, P57, DOI 10.1039/c0sc00330a; Cui XJ, 2013, CHEM-EUR J, V19, P3665, DOI 10.1002/chem.201203417; Cano R, 2011, J ORG CHEM, V76, P5547, DOI 10.1021/jo200559h; Andrushko N, 2010, CHEMCATCHEM, V2, P640, DOI 10.1002/cctc.201000046; Shi RJ, 2010, GREEN CHEM, V12, P108, DOI 10.1039/b919807p; NISHIMOTO SI, 1983, J AM CHEM SOC, V105, P7180, DOI 10.1021/ja00362a032; Geukens I, 2014, APPL CATAL A-GEN, V469, P373, DOI 10.1016/j.apcata.2013.09.044; Corma A, 2013, CHEM-EUR J, V19, P17464, DOI 10.1002/chem.201302226; Liu HH, 2012, J CATAL, V292, P130, DOI 10.1016/j.jcat.2012.05.007; Sun J, 2012, CATAL COMMUN, V24, P30, DOI 10.1016/j.catcom.2012.03.010; Kose O, 2010, ORG BIOMOL CHEM, V8, P896, DOI 10.1039/b914618k; da Costa AP, 2008, ORGANOMETALLICS, V27, P1305, DOI 10.1021/om701186u; Martinez R, 2009, ORG BIOMOL CHEM, V7, P2176, DOI 10.1039/b901929d; Dowson GRM, 2013, ANGEW CHEM INT EDIT, V52, P9005, DOI 10.1002/anie.201303723; MURAHASHI SI, 1978, J AM CHEM SOC, V100, P348, DOI 10.1021/ja00469a093; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; BAIKER A, 1985, CATAL REV, V27, P653, DOI 10.1080/01614948508064235; Kimura H, 2011, CATAL REV, V53, P1, DOI 10.1080/01614940.2011.556913; Imm S, 2011, ANGEW CHEM INT EDIT, V50, P7599, DOI 10.1002/anie.201103199; Climent MJ, 2012, RSC ADV, V2, P16, DOI 10.1039/c1ra00807b; Ruiz JR, 2007, CATAL COMMUN, V8, P1036, DOI 10.1016/j.catcom.2006.10.007; Obora Y, 2012, J ORG CHEM, V77, P9429, DOI 10.1021/jo3019347; Ramanathan A, 2006, J MOL CATAL A-CHEM, V260, P62, DOI 10.1016/j.molcata.2006.06.057; Felpin FX, 2008, CHEMSUSCHEM, V1, P718, DOI 10.1002/cssc.200800110; Gladiali S, 2006, CHEM SOC REV, V35, P226, DOI 10.1039/b513396c; Yamaguchi K, 2008, CHEM-EUR J, V14, P11480, DOI 10.1002/chem.200801655; Kwon MS, 2009, J ORG CHEM, V74, P2877, DOI 10.1021/jo8026609; Zhu YZ, 2004, J CATAL, V227, P1, DOI 10.1016/j.jcat.2004.05.037; Kawahara R, 2010, J AM CHEM SOC, V132, P15108, DOI 10.1021/ja107274w; Kuwahara T, 2012, ORG LETT, V14, P4703, DOI 10.1021/ol302145a; Siddiki SMAH, 2013, CHEM-EUR J, V19, P14416, DOI 10.1002/chem.201302464; GRIGG R, 1981, TETRAHEDRON LETT, V22, P4107, DOI 10.1016/S0040-4039(01)82078-5; Sheldon RA, 2012, CHEM SOC REV, V41, P1437, DOI 10.1039/c1cs15219j; Santoro F, 2014, RSC ADV, V4, P2596, DOI 10.1039/c3ra44364g; Shimizu K, 2011, GREEN CHEM, V13, P3096, DOI 10.1039/c1gc15835j; Matsu-ura T, 2006, J ORG CHEM, V71, P8306, DOI 10.1021/jo061400t; Marr AC, 2012, CATAL SCI TECHNOL, V2, P279, DOI 10.1039/c1cy00338k; Cui XJ, 2011, CHEM-EUR J, V17, P1021, DOI 10.1002/chem.201001915; Wang F, 2013, ACS CATAL, V3, P890, DOI 10.1021/cs400255r; Alonso F, 2011, ACCOUNTS CHEM RES, V44, P379, DOI 10.1021/ar1001582; He L, 2010, CHEM-EUR J, V16, P13965, DOI 10.1002/chem.201001848; Adair GRA, 2005, TETRAHEDRON LETT, V46, P8233, DOI 10.1016/j.tetlet.2005.09.083; Musa S, 2013, ADV SYNTH CATAL, V355, P3077, DOI 10.1002/adsc.201300656; Taguchi K, 2004, J AM CHEM SOC, V126, P72, DOI 10.1021/ja037552c; Fujita K, 2005, ORG LETT, V7, P4017, DOI 10.1021/ol051517o; Cha JS, 2006, ORG PROCESS RES DEV, V10, P1032, DOI 10.1021/op068002c; Zotova N, 2012, GREEN CHEM, V14, P226, DOI 10.1039/c1gc16118k; Makarov IS, 2013, J ORG CHEM, V78, P6593, DOI 10.1021/jo4008699; Ruano JLG, 2009, CHEM COMMUN, P404, DOI 10.1039/b816846f; Ikariya T, 2007, ACCOUNTS CHEM RES, V40, P1300, DOI 10.1021/ar700134q; Martinez R, 2006, TETRAHEDRON, V62, P8982, DOI 10.1016/j.tet.2006.07.012; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Climent MJ, 2011, CHEM REV, V111, P1072, DOI 10.1021/cr1002084; Cano R, 2013, TETRAHEDRON LETT, V54, P3394, DOI 10.1016/j.tetlet.2013.04.062; Kozlowski JT, 2013, ACS CATAL, V3, P1588, DOI 10.1021/cs400292f; Ishida T, 2012, APPL CATAL A-GEN, V413, P261, DOI 10.1016/j.apcata.2011.11.017; Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b; Zhang Y, 2011, TETRAHEDRON LETT, V52, P1334, DOI 10.1016/j.tetlet.2011.01.059; Pingen D, 2010, ANGEW CHEM INT EDIT, V49, P8130, DOI 10.1002/anie.201002583; Wang LD, 2011, TETRAHEDRON LETT, V52, P7103, DOI 10.1016/j.tetlet.2011.10.100; He L, 2009, CHEM-EUR J, V15, P11833, DOI 10.1002/chem.200901261; ZASSINOVICH G, 1992, CHEM REV, V92, P1051, DOI 10.1021/cr00013a015; Siddiki SMAH, 2015, GREEN CHEM, V17, P173, DOI 10.1039/c4gc01419g; Martinez R, 2005, TETRAHEDRON LETT, V46, P3683, DOI 10.1016/j.tetlet.2005.03.158; Blank B, 2009, CHEM-EUR J, V15, P3790, DOI 10.1002/chem.200802318; Liu X, 2013, CHEMSUSCHEM, V6, P604, DOI 10.1002/cssc.201200804; Whitney S, 2007, ORG LETT, V9, P3299, DOI 10.1021/ol071274v; Shimizu K, 2013, ACS CATAL, V3, P998, DOI 10.1021/cs4001267; Prades A, 2008, CHEM-EUR J, V14, P11474, DOI 10.1002/chem.200801580; Radhakrishan R, 2011, ACS CATAL, V1, P1631, DOI 10.1021/cs200299v; Malacea R, 2010, COORDIN CHEM REV, V254, P729, DOI 10.1016/j.ccr.2009.09.033; Viciano M, 2007, ORGANOMETALLICS, V26, P6050, DOI 10.1021/om7007919; Fujita KI, 2008, TETRAHEDRON, V64, P1943, DOI 10.1016/j.tet.2007.11.083; Chaudhari C, 2013, TETRAHEDRON LETT, V54, P6490, DOI 10.1016/j.tetlet.2013.09.077; Yamaguchi R, 2010, HETEROCYCLES, V81, P1093, DOI 10.3987/REV-09-665; Cho CS, 2003, ORGANOMETALLICS, V22, P3608, DOI 10.1021/om030307h; Kim S, 2009, TETRAHEDRON, V65, P1461, DOI 10.1016/j.tet.2008.12.005; Gunanathan C, 2008, ANGEW CHEM INT EDIT, V47, P8661, DOI 10.1002/anie.200803229; Lubinu MC, 2011, CHEM-EUR J, V17, P82, DOI 10.1002/chem.201002704; Corma A, 2010, CHEM-EUR J, V16, P254, DOI 10.1002/chem.200901501; Motokura K, 2004, J AM CHEM SOC, V126, P5662, DOI 10.1021/ja049181l; Imm S, 2010, CHEM-EUR J, V16, P2705, DOI 10.1002/chem.200903261; Yamaguchi K, 2005, CHEM-EUR J, V11, P6574, DOI 10.1002/chem.200500539; Liu GH, 2011, CATAL COMMUN, V12, P655, DOI 10.1016/j.catcom.2010.12.021; Shimizu K, 2009, CHEMCATCHEM, V1, P497, DOI 10.1002/cctc.200900209; Gunanathan C, 2013, SCIENCE, V341, P249, DOI 10.1126/science.1229712; Yamaguchi K, 2010, CHEM-EUR J, V16, P7199, DOI 10.1002/chem.201000149; Chaudhari C, 2014, CATAL SCI TECHNOL, V4, P1064, DOI 10.1039/c3cy00911d; WATANABE Y, 1984, B CHEM SOC JPN, V57, P435, DOI 10.1246/bcsj.57.435; Shimizu K, 2011, RSC ADV, V1, P1310, DOI 10.1039/c1ra00560j; Corma A, 2003, J CATAL, V215, P294, DOI 10.1016/S0021-9517(03)00014-9; JOHNSTONE RAW, 1985, CHEM REV, V85, P129, DOI 10.1021/cr00066a003; Obora Y, 2014, ACS CATAL, V4, P3972, DOI 10.1021/cs501269d; Fischer A, 2008, CHEMSUSCHEM, V1, P444, DOI 10.1002/cssc.200800019; Michlik S, 2010, CHEM-EUR J, V16, P13193, DOI 10.1002/chem.201001871; Prades A, 2008, ORGANOMETALLICS, V27, P4254, DOI 10.1021/om800377m; Baruwati B, 2009, TETRAHEDRON LETT, V50, P1215, DOI 10.1016/j.tetlet.2009.01.014; Baumann W, 2013, CHEM-EUR J, V19, P17702, DOI 10.1002/chem.201302774; BOYLE WJ, 1982, ORGANOMETALLICS, V1, P1003, DOI 10.1021/om00067a020; Cano R, 2012, CHEM COMMUN, V48, P7628, DOI 10.1039/c2cc33101b; Chaudhari C, 2014, TOP CATAL, V57, P1042, DOI 10.1007/s11244-014-0268-6; Chorghade R, 2013, ORG LETT, V15, P5698, DOI 10.1021/ol4027107; Corma A, 2011, J CATAL, V279, P319, DOI 10.1016/j.jcat.2011.01.029; DEANGELIS F, 1977, SYNTHESIS-STUTTGART, P335; El-Molla SA, 2006, APPL CATAL A-GEN, V298, P103, DOI 10.1016/j.apcata.2005.09.029; Fischer A, 1999, ANGEW CHEM INT EDIT, V38, P351, DOI 10.1002/(SICI)1521-3773(19990201)38:3<351::AID-ANIE351>3.0.CO;2-0; Fujita K, 2005, SYNLETT, P560, DOI 10.1055/s-2005-862381; Gonzalez-Arellano C, 2010, GREEN CHEM, V12, P1281, DOI 10.1039/c003410j; Gracia MJ, 2009, ORG BIOMOL CHEM, V7, P4821, DOI 10.1039/b913695a; GRIGG R, 1981, J CHEM SOC CHEM COMM, P611, DOI 10.1039/c39810000611; Hammond C, 2013, CHEMCATCHEM, V5, P2983, DOI 10.1002/cctc.201300253; Hayashi M, 2000, GREEN CHEM, V2, P257, DOI 10.1039/b003887n; Hayes KS, 2001, APPL CATAL A-GEN, V221, P187, DOI 10.1016/S0926-860X(01)00813-4; He JL, 2010, CHEM LETT, V39, P1182, DOI 10.1246/cl.2010.1182; He L, 2011, ANGEW CHEM INT EDIT, V50, P10216, DOI 10.1002/anie.201104089; Huang L, 2008, J MOL CATAL A-CHEM, V288, P109, DOI 10.1016/j.molcata.2008.03.026; Keresszegi C, 2001, NEW J CHEM, V25, P1163, DOI 10.1039/b102463a; Kidwai M, 2006, TETRAHEDRON LETT, V47, P4161, DOI 10.1016/j.tetlet.2006.04.048; Kim I., 2013, CATAL SCI TECHNOL, V3, P239; Kimura H, 2005, APPL CATAL A-GEN, V287, P191, DOI 10.1016/j.apcata.2005.03.041; Largeron M, 2009, ORG LETT, V11, P883, DOI 10.1021/ol802885b; Likhar PR, 2009, EUR J ORG CHEM, P5383, DOI 10.1002/ejoc.200900628; Linciano P, 2013, SYNLETT, V24, P2249, DOI 10.1055/s-0033-1339667; Liu X, 2014, ACCOUNTS CHEM RES, V47, P793, DOI 10.1021/ar400165j; Miyazawa A, 2006, TETRAHEDRON LETT, V47, P1437, DOI 10.1016/j.tetlet.2005.12.075; Mohapatra SK, 2002, ORG LETT, V4, P4297, DOI 10.1021/ol026926p; Morita M, 2007, CHEM COMMUN, P2850, DOI 10.1039/b702293j; Motokura K, 2006, CHEM-EUR J, V12, P8228, DOI 10.1002/chem.200600317; NAOTA T, 1989, J AM CHEM SOC, V111, P5954, DOI 10.1021/ja00197a073; Neelakandeswari N, 2012, J MOL CATAL A-CHEM, V356, P90, DOI 10.1016/j.molcata.2011.12.029; Nixon TD, 2009, DALTON T, P753, DOI 10.1039/b813383b; Noyori R, 1997, ACCOUNTS CHEM RES, V30, P97, DOI 10.1021/ar9502341; Obora Y., 2011, SYNLETT, V2011, P30; Ogawa S, 2014, CHEM COMMUN, V50, P2491, DOI 10.1039/c3cc49626k; Peeters A, 2014, APPL CATAL A-GEN, V469, P191, DOI 10.1016/j.apcata.2013.09.051; Saidi O., 2009, ANGEW CHEM INT EDIT, V48, P737; Selvam P, 2004, ADV SYNTH CATAL, V346, P542, DOI 10.1002/adsc.200303175; Selvam P, 2004, TETRAHEDRON LETT, V45, P2003, DOI 10.1016/j.tetlet.2003.12.091; Shimizu K, 2012, CATAL SCI TECHNOL, V2, P730, DOI 10.1039/c2cy00476c; Shimura K, 2012, GREEN CHEM, V14, P2983, DOI 10.1039/c2gc35836k; Shimura K, 2013, APPL CATAL A-GEN, V462, P137, DOI 10.1016/j.apcata.2013.04.040; Su FZ, 2008, CHEM COMMUN, P3531, DOI 10.1039/b807608a; Upadhya TT, 1997, CHEM COMMUN, P1119, DOI 10.1039/a701518f; Yamaguchi K, 2010, SYNLETT, P2365, DOI 10.1055/s-0030-1258565; Yamakawa T, 2004, CATAL COMMUN, V5, P291, DOI 10.1016/j.catcom.2004.03.004; Yoshida K, 2010, APPL CATAL A-GEN, V379, P38, DOI 10.1016/j.apcata.2010.02.028; Yu XC, 2011, ORG LETT, V13, P6184, DOI 10.1021/ol202582c; Zaccheria F, 2005, CHEM COMMUN, P253, DOI 10.1039/b413634a	196	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.	MAR 1	2015	5	3					1412	1427		10.1039/c4cy01170h		16	Chemistry, Physical	Chemistry	CC9JJ	WOS:000350685400005		
J	Chatterjee, M; Chatterjee, A; Ishizaka, T; Kawanami, H				Chatterjee, Maya; Chatterjee, Abhijit; Ishizaka, Takayuki; Kawanami, Hajime			Rhodium-mediated hydrogenolysis/hydrolysis of the aryl ether bond in supercritical carbon dioxide/water: an experimental and theoretical approach	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							C-O BOND; AQUEOUS-PHASE; DIPHENYL ETHER; CLEAVAGE; HYDRODEOXYGENATION; GUAIACOL; LIGNIN; HYDROGENATION; NICKEL; WATER	The use of supercritical carbon dioxide (scCO(2))/water for the conversion of diphenyl ether was investigated over Rh/C catalysts to achieve the cleavage of C-O bond under mild reaction conditions. In the studied reaction system, ethereal C-O bond was cleaved by hydrogenolysis and hydrolysis, which was strongly hampered if the reaction was conducted individually in CO2 or in water. A combined effect was desirable to achieve targeted cleavage because of the beneficial effect of a mild acidic environment generated through the dissolution of CO2 in water. Optimization of hydrogen pressure suggested a competition between diphenyl ether and hydrogen as the reaction rate (TOF) was significantly decreased with increased hydrogen pressure. In addition, the role of water was also evaluated and prompted the requirement of a suitable amount of water for cleavage. Mechanistic investigations through theoretical calculations together with experimental analysis illustrated that hydrogenolysis and hydrolysis were two reaction paths responsible for the rapture of the C-O bond.	[Chatterjee, Maya; Ishizaka, Takayuki; Kawanami, Hajime] AIST, Organ Synth Team, Res Ctr Compact Chem Syst, Miyagino Ku, Sendai, Miyagi 9838551, Japan; [Kawanami, Hajime] Japan Sci & Technol, CREST, Kawaguchi, Saitama, Japan; [Chatterjee, Abhijit] BIOVIA, Shinagawa Ku, Tokyo 1416020, Japan	Chatterjee, M (reprint author), AIST, Organ Synth Team, Res Ctr Compact Chem Syst, Miyagino Ku, 4-2-1 Nigatake, Sendai, Miyagi 9838551, Japan.	c-maya@aist.go.jp; h-kawanami@aist.go.jp			Japan-U.S. cooperation project for research and standardization of Clean Energy Technologies; Ministry of Economy, Trade and Industry (METI), Japan; CREST, Japan Science and Technology (JST)	H. Kawanami is funded by the Japan-U.S. cooperation project for research and standardization of Clean Energy Technologies, The Ministry of Economy, Trade and Industry (METI), Japan and CREST, Japan Science and Technology (JST).	Liu AH, 2012, CATAL TODAY, V194, P38, DOI 10.1016/j.cattod.2012.05.012; KAMAT SV, 1995, CRIT REV BIOTECHNOL, V15, P41, DOI 10.3109/07388559509150531; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Roosen C, 2007, GREEN CHEM, V9, P455, DOI 10.1039/b613345b; He JY, 2012, J AM CHEM SOC, V134, P20768, DOI 10.1021/ja309915e; DELLEY B, 1991, J CHEM PHYS, V94, P7245, DOI 10.1063/1.460208; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Wang XY, 2012, CHEMSUSCHEM, V5, P1455, DOI 10.1002/cssc.201200040; Bykova MV, 2013, KINET CATAL+, V54, P40, DOI 10.1134/S0023158413010023; [Anonymous], 1990, CHEM PHYS, DOI DOI 10.1063/1.458452; Nichols JM, 2010, J AM CHEM SOC, V132, P12554, DOI 10.1021/ja106101f; Holmes JD, 1999, J PHYS CHEM B, V103, P5703, DOI 10.1021/jp990745v; Van Duzee EM, 1935, J AM CHEM SOC, V57, P147; Olcese RN, 2013, ENERG FUEL, V27, P975, DOI 10.1021/ef301971a; He JY, 2014, J CATAL, V309, P280, DOI 10.1016/j.jcat.2013.09.012; Wu SK, 2013, ACS SUSTAIN CHEM ENG, V1, P349, DOI 10.1021/sc300157d; Zhao C, 2012, ANGEW CHEM INT EDIT, V51, P5935, DOI 10.1002/anie.201108306; Son S, 2010, ANGEW CHEM INT EDIT, V49, P3791, DOI 10.1002/anie.201001293; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Merte LR, 2012, SCIENCE, V336, P889, DOI 10.1126/science.1219468; Chatterjee M, 2013, CHEM COMMUN, V49, P4567, DOI 10.1039/c3cc41522h; Cheng HY, 2013, APPL CATAL A-GEN, V455, P8, DOI 10.1016/j.apcata.2013.01.028; Sergeev AG, 2012, J AM CHEM SOC, V134, P20226, DOI 10.1021/ja3085912; Roberts VM, 2010, CHEMCATCHEM, V2, P1407, DOI 10.1002/cctc.201000181; Sheldon RA, 2005, GREEN CHEM, V7, P267, DOI 10.1039/b418069k; Fedorov A, 2013, CHEM SCI, V4, P1640, DOI 10.1039/c3sc22256j; Beceke A. D., 1988, J CHEM PHYS, V88, P2547; Chatterjee M, 2012, ADV SYNTH CATAL, V354, P2009, DOI 10.1002/adsc.201200103; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; Ghampson IT, 2012, APPL CATAL A-GEN, V439, P111, DOI 10.1016/j.apcata.2012.06.047; Harmsen P. F. H., 2010, BIOSYNERGY; Holmes JD, 1998, LANGMUIR, V14, P6371, DOI 10.1021/la9806956; Kirk-Othmer, 2001, ENCY CHEM TECHNOLOGY; Klamt A., 1993, J CHEM SOC P2, V2, P798; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lin H.-W., 2013, RSC ADV, V3, P1722; Luo Y. R., 2007, COMPREHENSIVE HDB CH; Olcese R, 2013, APPL CATAL B-ENVIRON, V129, P528, DOI 10.1016/j.apcatb.2012.09.043; SISKIN M, 1991, ENERG FUEL, V5, P770, DOI 10.1021/ef00029a028; Yao K., 2013, ANGEW CHEM INT EDIT, V52, P1	40	2	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.	MAR 1	2015	5	3					1532	1539		10.1039/c4cy01417k		8	Chemistry, Physical	Chemistry	CC9JJ	WOS:000350685400020		
J	Muthukrishnan, A; Nabae, Y; Chang, CW; Okajimaa, T; Ohsaka, T				Muthukrishnan, Azhagumuthu; Nabae, Yuta; Chang, Cha Wen; Okajimaa, Takeyoshi; Ohsaka, Takeo			A high-performance Fe and nitrogen doped catalyst derived from diazoniapentaphene salt and phenolic resin mixture for oxygen reduction reaction	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							ELECTROLYTE FUEL-CELLS; HEAT-TREATED POLYACRYLONITRILE; RAY ABSORPTION-SPECTROSCOPY; CARBON ALLOY CATALYSTS; RING-DISC ELECTRODE; ELECTROCATALYTIC ACTIVITY; ACTIVE-SITES; CATHODE CATALYSTS; METAL CATALYST; O-2 REDUCTION	A high-performance ORR catalyst has been synthesised by pyrolysis of quaternary nitrogen-containing 4a,8a-diazoniapentaphene dibromide (DAP), phenolic resin and FeBr2 mixture. The catalyst (Fe/DAP) was characterized by XPS, SEM and TEM analysis. The ORR activity was studied using rotating ring-disk electrode voltammetry (RRDE) and the onset potential of ORR was found to be 0.95 V vs. RHE in 0.5 M H2SO4 solution, which is very close to that of the state-of-the-art Pt/C catalyst. The stability of the catalyst was studied using LD and SSD tests and found to be highly stable even after 11 110 potential-steps in the LD test. The kinetic and mechanistic analyses of the ORR on the catalyst indicate that the ORR, as a whole, follows a 4-electron (parallel) pathway. The relative changes in the nitrogen content after the durability test was estimated using N 1s XPS spectra which may be associated with the activity loss after the durability test. The loss of ORR activity was observed after the acid washing of the catalyst which suggests the role of Fe in the direct 4-electron reduction of O-2.	[Muthukrishnan, Azhagumuthu; Okajimaa, Takeyoshi; Ohsaka, Takeo] Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Nabae, Yuta; Chang, Cha Wen] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Muthukrishnan, A (reprint author), Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, G1-5,4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	ohsaka@echem.titech.ac.jp	AZHAGUMUTHU, MUTHUKRISHNAN/I-9728-2014	AZHAGUMUTHU, MUTHUKRISHNAN/0000-0001-9971-0093	New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The EPMA and TEM measurements were carried out in the Center for Advanced Materials Analysis in Tokyo Institute of Technology. The authors thank Dr. T. Fuchigami and Dr. Zhang Da for helpful discussions.	Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Takenaka S, 2004, J CATAL, V222, P520, DOI 10.1016/j.jcat.2003.11.017; PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6; ALONSOVANTE N, 1995, ELECTROCHIM ACTA, V40, P567, DOI 10.1016/0013-4686(94)00377-D; Nabae Y, 2014, J MATER CHEM A, V2, P11561, DOI 10.1039/c4ta01828a; Ma GX, 2011, J PHYS CHEM C, V115, P25148, DOI 10.1021/jp208257r; Niwa H, 2009, J POWER SOURCES, V187, P93, DOI 10.1016/j.jpowsour.2008.10.064; Yano H, 2010, PHYS CHEM CHEM PHYS, V12, P3806, DOI 10.1039/b923460h; Robson MH, 2013, ELECTROCHIM ACTA, V90, P656, DOI 10.1016/j.electacta.2012.11.025; Gojkovic SL, 1999, ELECTROCHIM ACTA, V45, P889, DOI 10.1016/S0013-4686(99)00294-7; Stamenkovic V, 2003, J ELECTROANAL CHEM, V554, P191, DOI 10.1016/S0022-0728(03)00177-3; OHMS D, 1992, J POWER SOURCES, V38, P327, DOI 10.1016/0378-7753(92)80122-R; Chung HT, 2010, ELECTROCHEM COMMUN, V12, P1792, DOI 10.1016/j.elecom.2010.10.027; Nabae Y, 2014, CATAL SCI TECHNOL, V4, P1400, DOI 10.1039/c4cy00119b; Chen Z, 2010, ELECTROCHIM ACTA, V55, P4799, DOI 10.1016/j.electacta.2010.03.057; Bezerra CWB, 2007, J POWER SOURCES, V173, P891, DOI 10.1016/j.jpowsour.2007.08.028; Kundu S, 2009, J PHYS CHEM C, V113, P14302, DOI 10.1021/jp811320d; Lefevre M, 2003, ELECTROCHIM ACTA, V48, P2749, DOI 10.1016/S0013-4686(03)00393-1; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Lalande G, 1996, J POWER SOURCES, V61, P227, DOI 10.1016/S0378-7753(96)02356-7; Arrigo R, 2008, CHEM COMMUN, P4891, DOI 10.1039/b812769g; ALVES MCM, 1992, J PHYS CHEM-US, V96, P10898, DOI 10.1021/j100205a054; Nagaiah TC, 2010, ELECTROCHEM COMMUN, V12, P338, DOI 10.1016/j.elecom.2009.12.021; Liu G, 2010, ELECTROCHIM ACTA, V55, P2853, DOI 10.1016/j.electacta.2009.12.055; Claude E, 1998, J APPL ELECTROCHEM, V28, P57; MARKOVIC NM, 1994, J ELECTROANAL CHEM, V377, P249, DOI 10.1016/0022-0728(94)03467-2; Matter PH, 2006, J CATAL, V239, P83, DOI 10.1016/j.jcat.2006.01.022; Lefevre M, 2002, J PHYS CHEM B, V106, P8705, DOI 10.1021/jp020267f; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Ohma A, 2011, ECS TRANSACTIONS, V41, P775, DOI 10.1149/1.3635611; Subramanian NP, 2009, J POWER SOURCES, V188, P38, DOI 10.1016/j.jpowsour.2008.11.087; Ozaki J, 2010, ELECTROCHIM ACTA, V55, P1864, DOI 10.1016/j.electacta.2009.10.037; HSUEH KL, 1983, J ELECTROANAL CHEM, V153, P79, DOI 10.1016/S0022-0728(83)80007-2; Wang HB, 2012, ACS CATAL, V2, P781, DOI 10.1021/cs200652y; Faubert G, 1996, ELECTROCHIM ACTA, V41, P1689, DOI 10.1016/0013-4686(95)00423-8; Rao CV, 2010, J PHYS CHEM LETT, V1, P2622, DOI 10.1021/jz100971v; Jaouen F, 2003, J PHYS CHEM B, V107, P1376, DOI 10.1021/jp021634q; Chen Z, 2009, J PHYS CHEM C, V113, P21008, DOI 10.1021/jp908067v; Reddy ALM, 2010, ACS NANO, V4, P6337, DOI 10.1021/nn101926g; Paulus UA, 2001, J ELECTROANAL CHEM, V495, P134, DOI 10.1016/S0022-0728(00)00407-1; GUPTA S, 1989, J APPL ELECTROCHEM, V19, P19, DOI 10.1007/BF01039385; Wu G, 2013, CHEM COMMUN, V49, P3291, DOI 10.1039/c3cc39121c; Wu G, 2011, J MATER CHEM, V21, P11392, DOI 10.1039/c0jm03613g; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Wu G, 2010, CHEM COMMUN, V46, P7489, DOI 10.1039/c0cc03088k; Wakabayashi N, 2005, J ELECTROANAL CHEM, V574, P339, DOI 10.1016/j.jelechem.2004.08.013; Jaouen F, 2009, J PHYS CHEM C, V113, P15422, DOI 10.1021/jp900837e; Bezerra CWB, 2008, ELECTROCHIM ACTA, V53, P4937, DOI 10.1016/j.electacta.2008.02.012; Bouwkamp-Wijnoltz AL, 2002, J PHYS CHEM B, V106, P12993, DOI 10.1021/jp0266087; BRADSHER CK, 1964, J ORG CHEM, V29, P856, DOI 10.1021/jo01027a021; Chokai M, 2010, J POWER SOURCES, V195, P5947, DOI 10.1016/j.jpowsour.2010.01.012; Cote R, 1998, J ELECTROCHEM SOC, V145, P2411; DAMJANOV.A, 1966, J CHEM PHYS, V45, P4057, DOI 10.1063/1.1727457; Krapcho AP, 2004, J HETEROCYCLIC CHEM, V41, P291; Ma YJ, 2014, ELECTROCHIM ACTA, V142, P317, DOI 10.1016/j.electacta.2014.07.130; Muthukrishnan A, 2015, CATAL SCI TECHNOL, V5, P475, DOI 10.1039/c4cy01001a; Nallathambi V, 2011, ELECTROCHEM SOLID ST, V14, pB55, DOI 10.1149/1.3566065; Niwa H, 2013, J POWER SOURCES, V223, P30, DOI 10.1016/j.jpowsour.2012.09.031; Peng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01765; Wood TE, 2008, J POWER SOURCES, V178, P510, DOI 10.1016/j.jpowsour.2007.10.093	61	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.	MAR 1	2015	5	3					1764	1774		10.1039/c4cy01429d		11	Chemistry, Physical	Chemistry	CC9JJ	WOS:000350685400044		
J	Haneda, M; Kaneko, T; Kamiuchi, N; Ozawa, M				Haneda, Masaaki; Kaneko, Takahiro; Kamiuchi, Naoto; Ozawa, Masakuni			Improved three-way catalytic activity of bimetallic Ir-Rh catalysts supported on CeO2-ZrO2	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							OXYGEN STORAGE CAPACITY; LA-CONTAINING ZRO2; RHODIUM CATALYSTS; CO ADSORPTION; NO-CO-C3H6-O-2 REACTIONS; OXIDATIVE ATMOSPHERE; IRIDIUM CATALYST; SOLID-SOLUTION; NO; REDUCTION	The addition of a small amount of Ir caused a significant increase in not only CO and C3H6 oxidation activity but also NO reduction activity of Rh/CeO2-ZrO2 with a Ce/Zr molar ratio of 1/4 for NO-CO-C3H6-H-2-O-2 reaction under stoichiometric conditions. The optimum Ir/Rh atomic ratio was 1/9. The Ir additive was found to suppress the preferential oxidation of CO and C3H6 by O-2, leading to an improvement in the efficiency of CO and C3H6 utilization for NO reduction. Catalyst characterization such as H-2-TPR and X-ray absorption spectroscopy (XANES and EXAFS) revealed that the Rh species in the Ir-Rh/CeO2-ZrO2 samples is mainly present as Rh2O3 nanoparticles and that the addition of a small amount of Ir (Ir/Rh = 1/9) can improve the reducibility of Rh2O3 nanoparticles. On the basis of surface analysis by XPS and FT-IR spectroscopy following CO adsorption and STEM observation, the formation of Ir-Rh nanoparticles composed of finely-divided Ir species on the surface of Rh particles with a size of 1 nm was considered to be responsible for the high catalytic activity of Ir-Rh/CeO2-ZrO2 for NO-CO-C3H6-H-2-O-2 reaction. Ir-Rh/CeO2-ZrO2 with Ir-Rh loading of 0.3 wt% still showed high catalytic performance, which is comparable with that of 0.5 wt% Rh/CeO2-ZrO2, minimizing Rh usage.	[Haneda, Masaaki; Kaneko, Takahiro] Nagoya Inst Technol, Adv Ceram Res Ctr, Gifu 5070071, Japan; [Kamiuchi, Naoto] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Ozawa, Masakuni] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Haneda, M (reprint author), Nagoya Inst Technol, Adv Ceram Res Ctr, 10-6-29 Asahigaoka, Gifu 5070071, Japan.	haneda.masaaki@nitech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24651077]	This study was supported by a Grant-in-Aid for Scientific Research (no. 24651077) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank Ms. Atsuki Kon, Ms. Chizuko Tanaka, Ms. Sachi Ikemoto and Dr. Chizuko Maeda of JFE Techno-Research Corporation for their assistance in XAFS and STEM/HAADF/EDS measurements.	Tanabe T, 2012, CATAL TODAY, V184, P219, DOI 10.1016/j.cattod.2011.10.005; Park JY, 2012, CATAL TODAY, V181, P133, DOI 10.1016/j.cattod.2011.05.031; Hinokuma S, 2011, CATAL TODAY, V175, P593, DOI 10.1016/j.cattod.2011.03.008; Heo I, 2012, APPL CATAL B-ENVIRON, V121, P75, DOI 10.1016/j.apcatb.2012.03.032; Haneda M, 2008, J CATAL, V259, P223, DOI 10.1016/j.jcat.2008.08.007; SHELEF M, 1994, CATAL REV, V36, P433, DOI 10.1080/01614949408009468; Pitkaaho S, 2012, APPL CATAL B-ENVIRON, V126, P215, DOI 10.1016/j.apcatb.2012.07.025; TRAUTMANN S, 1994, J CATAL, V150, P335, DOI 10.1006/jcat.1994.1352; Kim JR, 2009, J CATAL, V263, P123, DOI 10.1016/j.jcat.2009.02.001; Hamada H, 2012, APPL CATAL A-GEN, V421, P1, DOI 10.1016/j.apcata.2012.02.005; Liu Y, 2008, J CATAL, V256, P192, DOI 10.1016/j.jcat.2008.03.009; Kondarides DI, 2000, J CATAL, V191, P147, DOI 10.1006/jcat.1999.2785; Si R, 2004, J PHYS CHEM B, V108, P12481, DOI 10.1021/jp048084b; Amiridis MD, 2004, TOP CATAL, V28, P141, DOI 10.1023/B:TOCA.0000024343.67581.b3; Bernal S, 1999, CATAL TODAY, V50, P175, DOI 10.1016/S0920-5861(98)00503-3; SOLYMOSI F, 1980, J CATAL, V62, P253, DOI 10.1016/0021-9517(80)90453-4; Fujitani T, 2005, J PHYS CHEM B, V109, P17603, DOI 10.1021/jp053092t; Kawabata H, 2014, CATAL SCI TECHNOL, V4, P697, DOI 10.1039/c3cy00838j; Bourane A, 2002, J PHYS CHEM B, V106, P2665, DOI 10.1021/jp0137322; SOLYMOSI F, 1990, J PHYS CHEM-US, V94, P7250, DOI 10.1021/j100381a054; Kamiuchi N, 2013, CATAL TODAY, V201, P79, DOI 10.1016/j.cattod.2012.04.039; Cao L, 2009, CATAL COMMUN, V10, P1192, DOI 10.1016/j.catcom.2009.01.015; CAVANAGH RR, 1981, J CHEM PHYS, V74, P4150, DOI 10.1063/1.441544; CHAN SC, 1988, J CATAL, V113, P164, DOI 10.1016/0021-9517(88)90245-X; Chen W., 2011, CHEMPHYSCHEM, V11, P2515; Damynova S., 2008, APPL CATAL A-GEN, V337, P86, DOI DOI 10.1016/J.APCATA.2007.12.005); Dimick PS, 2009, APPL CATAL B-ENVIRON, V89, P1, DOI 10.1016/j.apcatb.2008.11.025; Dohmae K, 2005, SURF INTERFACE ANAL, V37, P115, DOI 10.1002/sia.1944; Ferrandon M, 2006, APPL CATAL A-GEN, V311, P135, DOI 10.1016/j.apcata.2006.06.014; Nakamura I, 2009, CATAL SURV ASIA, V13, P22, DOI 10.1007/s10563-009-9064-x; Hadjiivanov K, 2003, J MOL STRUCT, V661, P459, DOI 10.1016/j.molstruc.2003.09.007; Haneda M, 2010, J CATAL, V273, P39, DOI 10.1016/j.jcat.2010.04.021; Haneda M, 2013, CHEM LETT, V42, P60, DOI 10.1246/cl.2013.60; Haneda M, 2011, APPL CATAL A-GEN, V394, P239, DOI 10.1016/j.apcata.2011.01.006; Haneda M, 2005, J CATAL, V229, P197, DOI 10.1016/j.jcat.2004.10.022; Ikeue K, 2010, B CHEM SOC JPN, V83, P291, DOI 10.1246/bcsj.20090256; Jollie D., 2010, PLATINUM 2010, P44; Kawabata H, 2013, CHEM COMMUN, V49, P4015, DOI 10.1039/c3cc00006k; KUMMER JT, 1980, PROG ENERG COMBUST, V6, P177, DOI 10.1016/0360-1285(80)90006-4; Lafaye G, 2004, LANGMUIR, V20, P10612, DOI 10.1021/la049692l; Machida M, 2009, CHEM MATER, V21, P1796, DOI 10.1021/cm9005844; MARTIN D, 1995, APPL CATAL A-GEN, V131, P297, DOI 10.1016/0926-860X(95)00130-1; Music S, 2003, MATER LETT, V57, P4509, DOI 10.1016/S0167-577X(03)00352-5; Rasko J, 1999, CATAL LETT, V58, P27, DOI 10.1023/A:1019053228217; Reneme Y, 2012, APPL CATAL B-ENVIRON, V111, P424, DOI 10.1016/j.apcatb.2011.10.030; Renzas JR, 2011, CATAL LETT, V141, P235, DOI 10.1007/s10562-010-0462-5; RICE CA, 1981, J CHEM PHYS, V74, P6487, DOI 10.1063/1.440987; Shinjoh H, 2009, CATAL SURV ASIA, V13, P184, DOI 10.1007/s10563-009-9076-6; Tanimoto K, 2013, B CHEM SOC JPN, V86, P1327, DOI 10.1246/bcsj.20130183; VANSLOOTEN RF, 1990, J CATAL, V122, P429, DOI 10.1016/0021-9517(90)90296-V; Vayssilov GN, 2002, J AM CHEM SOC, V124, P3783, DOI 10.1021/ja011688y; Vedyagin AA, 2013, TOP CATAL, V56, P1008, DOI 10.1007/s11244-013-0064-8; YASHIMA M, 1994, J AM CERAM SOC, V77, P1067, DOI 10.1111/j.1151-2916.1994.tb07270.x; Zhong FL, 2009, CATAL LETT, V133, P125, DOI 10.1007/s10562-009-0147-0	54	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.	MAR 1	2015	5	3					1792	1800		10.1039/c4cy01502a		9	Chemistry, Physical	Chemistry	CC9JJ	WOS:000350685400047		
J	Katada, N; Sota, S; Morishita, N; Okumura, K; Niwa, M				Katada, Naonobu; Sota, Satoko; Morishita, Nami; Okumura, Kazu; Niwa, Miki			Relationship between activation energy and pre-exponential factor normalized by the number of Bronsted acid sites in cracking of short chain alkanes on zeolites	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							MONOMOLECULAR CRACKING; MOLECULAR-SIEVES; Y-ZEOLITE; N-HEXANE; IRMS-TPD; COMPENSATION; MORDENITE; AMMONIA; HZSM-5; EXPLANATION	The rates of the reaction of C3 to C8 linear and C4 and C5 monomethyl-branched alkanes catalysed by various zeolites (FAU, *BEA, MFI and MOR) were analysed. The pre-exponential factor, normalized by the number of Bronsted acid sites, showed a compensatory change in the activation energy. The lower activation energy gave a lower pre-exponential factor, indicating the compensation effect between the activation energy and entropy. The relationship between the pre-exponential factor and the activation energy was common in the reaction of butane, pentane, hexane, octane and 2-methylbutane over various catalysts, while propane and 2-methylpropane had pre-exponential factors lower than those observed in the reactions of other alkanes.	[Katada, Naonobu; Sota, Satoko; Morishita, Nami] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan; [Okumura, Kazu] Kogakuin Univ, Fac Engn, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan; [Niwa, Miki] Nagoya Ind Sci Res Inst, Dept Res, Nagoya, Aichi 4640819, Japan	Katada, N (reprint author), Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, 4-101 Koyama Cho Minami, Tottori 6808552, Japan.	katada@chem.tottori-u.ac.jp			JSPS KAKENHI [26630412]	The samples of H-ZSM-5 (20, 35, 62 and 126) were kindly supplied by Prof. Toshiyuki Yokoi and Prof. Takashi Tatsumi, Chemical Resources Laboratory, Tokyo Institute of Technology. This study was partly supported by JSPS KAKENHI grant number 26630412.	OLSON DH, 1980, J CATAL, V61, P390, DOI 10.1016/0021-9517(80)90386-3; Katada N, 2010, APPL CATAL A-GEN, V373, P208, DOI 10.1016/j.apcata.2009.11.022; van Bokhoven JA, 2001, J CATAL, V202, P129, DOI 10.1006/jcat.2001.3265; Eder F, 1997, ZEOLITES, V18, P75, DOI 10.1016/S0144-2449(96)00127-3; Niwa M, 2013, CATAL SCI TECHNOL, V3, P1919, DOI 10.1039/c3cy00195d; Katada N, 2004, J MOL CATAL A-CHEM, V211, P119, DOI 10.1016/j.molcata.2003.10.001; Eder F, 1997, J PHYS CHEM B, V101, P5414, DOI 10.1021/jp9706487; Niwa M, 2012, CATAL TODAY, V185, P17, DOI 10.1016/j.cattod.2011.09.028; INOUE Y, 1993, J AM CHEM SOC, V115, P10637, DOI 10.1021/ja00076a023; Maesen TLM, 2006, J CATAL, V237, P278, DOI 10.1016/j.jcat.2005.11.007; Borges P, 2005, J MOL CATAL A-CHEM, V229, P127, DOI 10.1016/j.molcata.2004.11.012; Bhan A, 2008, J CATAL, V253, P221, DOI 10.1016/j.jcat.2007.11.003; Niwa M, 2005, J PHYS CHEM B, V109, P18749, DOI 10.1021/jp051304g; Bucko T, 2011, J CATAL, V279, P220, DOI 10.1016/j.jcat.2011.01.022; LEFFLER JE, 1955, J ORG CHEM, V20, P1202, DOI 10.1021/jo01126a009; Sandoval-Diaz LE, 2012, J CATAL, V294, P89, DOI 10.1016/j.jcat.2012.07.009; Babitz SM, 1999, APPL CATAL A-GEN, V179, P71, DOI 10.1016/S0926-860X(98)00301-9; Suzuki K, 2007, J CATAL, V250, P151, DOI 10.1016/j.jcat.2007.05.024; AUROUX A, 1993, APPL CATAL A-GEN, V93, P181, DOI 10.1016/0926-860X(93)85192-R; Bond GC, 1999, CATAL TODAY, V49, P41, DOI 10.1016/S0920-5861(98)00406-4; Cheung TK, 1997, CHEM ENG SCI, V52, P4607, DOI 10.1016/S0009-2509(97)00302-3; CORMA A, 1993, J CATAL, V142, P97, DOI 10.1006/jcat.1993.1192; Galway A. K., 1977, ADV CATAL, V26, P247, DOI 10.1016/S0360-0564(08)60072-3; Glasstone S., 1941, THEORY RATE PROCESSE; HAAG WO, 1994, STUD SURF SCI CATAL, V84, P1375; Haag W.O., 1984, P 8 INT C CAT BERL, V2, P305; Katada N, 2000, J PHYS CHEM B, V104, P7561, DOI 10.1021/jp000906r; Kotrel S, 1999, J PHYS CHEM B, V103, P818, DOI 10.1021/jp982538l; Leffler J. E., 1989, RATES EQUILIBRIA ORG; Longstaff DC, 2012, ENERG FUEL, V26, P801, DOI 10.1021/ef201535h; Maxwell I., 2001, STUD SURF SCI CATAL, V137, P747, DOI DOI 10.1016/S0167-2991(01)80259-7; Niwa M, 2012, CATAL TODAY, V198, P12, DOI 10.1016/j.cattod.2012.03.077; Okumura K, 2011, APPL CATAL A-GEN, V405, P8, DOI 10.1016/j.apcata.2011.07.007; PATTERSON WR, 1994, J CATAL, V146, P310, DOI 10.1016/0021-9517(94)90035-3; SCHERZER J, 1989, CATAL REV, V31, P215, DOI 10.1080/01614948909349934	35	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.	MAR 1	2015	5	3					1864	1869		10.1039/c4cy01483a		6	Chemistry, Physical	Chemistry	CC9JJ	WOS:000350685400055		
J	Saito, Y; Abiko, R; Kishida, A; Kuwahara, Y; Yamamoto, Y; Yamamoto, F; Fukumoto, M; Ohkubo, Y				Saito, Yohei; Abiko, Ryo; Kishida, Akira; Kuwahara, Yoshikazu; Yamamoto, Yumi; Yamamoto, Fumihiko; Fukumoto, Manabu; Ohkubo, Yasuhito			Loss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R	CELL BIOCHEMISTRY AND FUNCTION			English	Article						radiation; radioresistance; hepatocellular carcinoma; cetuximab	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; MEDIATES RADIORESISTANCE; FACTOR-ALPHA; NECK-CANCER; RADIATION; HEAD; RADIOTHERAPY	Acquired radioresistance of cancer cells interferes with radiotherapy and increases the probability of cancer recurrence. HepG2-8960-R, which is one of several clinically relevant radioresistant (CRR) cell lines, has a high tolerance to the repeated clinically relevant doses of X-ray radiation. In this study, HepG2-8960-R had slightly lower cell proliferation ability than HepG2 in the presence of FBS. In particular, epidermal growth factor (EGF) hardly enhanced cell proliferation and DNA synthesis in HepG2-8960-R. Additionally, EGF could not induce the activation of Erk1/2, because the expression of EGF receptor (EGFR) protein decreased in HepG2-8960-R in accordance with the methylation of the EGFR promoter region. Therefore, cetuximab did not inhibit HepG2-8960-R cell proliferation. Our study showed that HepG2-8960-R had radioresistant and cetuximab-resistant abilities. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Saito, Yohei; Abiko, Ryo; Kishida, Akira; Yamamoto, Yumi; Yamamoto, Fumihiko; Ohkubo, Yasuhito] Tohoku Pharmaceut Univ, Dept Radiopharm, Sendai, Miyagi, Japan; [Kuwahara, Yoshikazu; Fukumoto, Manabu] Tohoku Univ, Inst Dev Aging & Canc, Dept Pathol, Sendai, Miyagi 980, Japan	Saito, Y (reprint author), Tohoku Pharmaceut Univ, Dept Radiopharm, Sendai, Miyagi, Japan.	ysaito@tohoku-pharm.ac.jp			Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	This study was partly supported by the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University.	Angs KK, 2002, CANCER RES, V62, P7350; Grana TM, 2002, CANCER RES, V62, P4142; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Benavente S, 2009, CLIN CANCER RES, V15, P1585, DOI 10.1158/1078-0432.CCR-08-2068; Song PP, 2012, LIVER INT, V32, P1053, DOI 10.1111/j.1478-3231.2012.02792.x; Feng FY, 2007, CLIN CANCER RES, V13, P2512, DOI 10.1158/1078-0432.CCR-06-2582; Okano S, 2013, JPN J CLIN ONCOL, V43, P476, DOI 10.1093/jjco/hyt030; Itabashi H, 2008, HEPATOL RES, V38, P601, DOI 10.1111/j.1872-034X.2007.00304.x; Hawkins MA, 2006, CANCER, V106, P1653, DOI 10.1002/cncr.21811; Chaudhry MA, 2012, DNA CELL BIOL, V31, P908, DOI 10.1089/dna.2011.1509; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; SCHMIDTULLRICH RK, 1994, INT J RADIAT ONCOL, V29, P813; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Zeng ZC, 2005, INT J RADIAT ONCOL, V63, P1067, DOI 10.1016/j.ijrobp.2005.03.058; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Balaban N, 1996, BBA-MOL CELL RES, V1314, P147, DOI 10.1016/S0167-4889(96)00068-7; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chuma M, 2011, J GASTROEN HEPATOL, V26, P1123, DOI 10.1111/j.1440-1746.2011.06745.x; DERYNCK R, 1987, CANCER RES, V47, P707; Griffin S, 2009, HEALTH TECHNOL ASSES, V13, P49, DOI 10.3310/hta13suppl1/08; Kavanagh BD, 1995, CLIN CANCER RES, V1, P1557; Kims SH, 2012, RADIAT ONCOL J, V30, P146, DOI [10.3857/roj.2012.30.3.146, DOI 10.3857/ROJ.2012.30.3.146]; Kira S, 1997, LIVER, V17, P177; Kuwahara Y, 2009, CANCER SCI, V100, P747, DOI 10.1111/j.1349-7006.2009.01082.x; Lavin Martin F., 1999, International Journal of Radiation Biology, V75, P1201; Lees IJ, 2011, JPN J CLIN ONCOL, V41, P882, DOI [10.1093/jjco/hyr053, DOI 10.1093/JJCO/HYR053]; Lees JM, 1993, P NATL ACAD SCI USA, V90, P5742; Mas JX, 2011, J EXP CLIN CANC RES, V30, P35, DOI [10.1186/1756-9966-30-35, DOI 10.1186/1756-9966-30-35]; Nagothu KK, 2004, AM J PHYSIOL-GASTR L, V287, pG541, DOI 10.1152/ajpgi.00365.2003; Nicholson RI, 2001, EUR J CANCER, V37, pS9; Sirák I, 2008, Klin Onkol, V21, P338	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0263-6484	1099-0844		CELL BIOCHEM FUNCT	Cell Biochem. Funct.	MAR	2015	33	2					73	79		10.1002/cbf.3090		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CD6NL	WOS:000351205900004		
J	Touhara, K				Touhara, Kazushige			Chemosensory signals, receptors, and behavior	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138654, Japan; [Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, JST ERATO Touhara Chemosensory Signal Project, Tokyo 1138654, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					211	211				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600009		
J	Gotow, N; Kobayakawa, T				Gotow, Naomi; Kobayakawa, Tatsu			Specificities of chemical senses among sensory modalities	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Gotow, Naomi; Kobayakawa, Tatsu] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					215	216				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600022		
J	Yoshihara, Y				Yoshihara, Yoshihiro			Olfactory neural circuitry mediating reproductive behavior in zebrafish	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					228	229				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600058		
J	Kawai, M; Cao, LL; Uneyama, H				Kawai, Misako; Cao, Lili; Uneyama, Hisayuki			Development of a simple taste test using whole mouth tasting method	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Kawai, Misako; Cao, Lili; Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Innovat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					246	247				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600102		
J	Jouhanneau, M; Goudet, C; Moussu, C; Cornilleau, F; Tashiro, T; Mori, K; Keller, M				Jouhanneau, Melanie; Goudet, Camille; Moussu, Chantal; Cornilleau, Fabien; Tashiro, Takuya; Mori, Kenji; Keller, Matthieu			Peripubertal exposure to male odors influences female puberty and adult expression of male-directed odor preference in mice	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Jouhanneau, Melanie; Goudet, Camille; Moussu, Chantal; Cornilleau, Fabien; Keller, Matthieu] Univ Tours, CNRS, UMR INRA 7247, Physiol Reprod & Comportements, Nouzilly, France; [Tashiro, Takuya; Mori, Kenji] RIKEN Res Cluster Innovat, Program Drug Discovery & Med Technol Platforms, Saitama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					247	247				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600103		
J	Shin, M; Yasumatsu, K; Takai, S; Shigemura, N; Yoshida, R; Takiguchi, S; Nakamura, S; Ninomiya, Y				Shin, Misa; Yasumatsu, Keiko; Takai, Shingo; Shigemura, Noriatsu; Yoshida, Ryusuke; Takiguchi, Soichi; Nakamura, Seiji; Ninomiya, Yuzo			Involvement of CCK in normal gustatory responses to bitter compounds	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Shin, Misa; Yasumatsu, Keiko; Takai, Shingo; Shigemura, Noriatsu; Yoshida, Ryusuke; Ninomiya, Yuzo] Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan; [Shin, Misa; Nakamura, Seiji] Kyushu Univ, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci, Fukuoka 812, Japan; [Takiguchi, Soichi] Natl Kyushu Canc, Inst Clin Res, Fukuoka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					259	260				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600133		
J	Ito, K; Takayanagi-Koma, M; Takahashi, K; Wang, LQ; Tonoike, M; Kuriki, S				Ito, Kanetoshi; Takayanagi-Koma, Miyuki; Takahashi, Kaori; Wang, Li-qun; Tonoike, Mitsuo; Kuriki, Shinya			Addition of pleasant odor can change brain response to unpleasant odor	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Ito, Kanetoshi; Takayanagi-Koma, Miyuki; Takahashi, Kaori] TAKASAGO Int Corp, Tokyo, Japan; [Wang, Li-qun; Kuriki, Shinya] Tokyo Denki Univ, Tokyo, Japan; [Tonoike, Mitsuo] Aino Univ, Takatsuki, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					260	261				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600136		
J	Miwa, T; Yamamoto, J; Teraguchi, K; Kinoshita, Y; Ymamda, K; Noda, T; Harita, M; Shiga, H; Sugiyama, E; Ono, K; Kawai, M				Miwa, Takaki; Yamamoto, Junpei; Teraguchi, Kanako; Kinoshita, Yuko; Ymamda, Kentaro; Noda, Takuya; Harita, Masayuki; Shiga, Hideaki; Sugiyama, Eriko; Ono, Kaori; Kawai, Misako			Changes in smell and taste function in the elderly	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Miwa, Takaki; Yamamoto, Junpei; Teraguchi, Kanako; Kinoshita, Yuko; Ymamda, Kentaro; Noda, Takuya; Harita, Masayuki; Shiga, Hideaki] Kanazawa Med Univ, Dept Otorhinolaryngol, Kanazawa, Ishikawa, Japan; [Sugiyama, Eriko; Ono, Kaori; Kawai, Misako] Ajinomoto Co Inc, Inst Food Sci & Technol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					261	261				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600137		
J	Yasumatsu, K; Sako, N; Ninomiya, Y				Yasumatsu, Keiko; Sako, Noritaka; Ninomiya, Yuzo			Analysis of whole nerve responses in the chorda tympani nerve from mice after daily intake of sweet solution	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Sect Oral Neurosci, Grad Sch, Fukuoka 812, Japan; [Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Div Sensory Physiol, Res & Dev Ctr Taste & Odor Sensing, Fukuoka 812, Japan; [Sako, Noritaka] Asahi Univ, Dept Oral Physiol, Sch Dent, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					263	264				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600143		
J	Klein, AH; Joe, CL; Davoodi, A; Tranngyuen, M; Takechi, K; Carstens, MI; Carstens, E				Klein, Amanda H.; Joe, Christopher L.; Davoodi, Auva; Tranngyuen, Minh; Takechi, Kenichi; Carstens, Mirela Iodi; Carstens, E.			Eugenol and carvacrol elicit oral irritation and enhance warmth and heat pain via effects on primary sensory neurons in rats	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Joe, Christopher L.; Davoodi, Auva; Tranngyuen, Minh; Carstens, Mirela Iodi; Carstens, E.] Univ Calif Davis, Neurobiol Physiol & Behav, Davis, CA USA; [Klein, Amanda H.] Johns Hopkins Univ, Neurosurg, Baltimore, MD USA; [Takechi, Kenichi] Ehime Med Sch, Anesthesiol, Matsuyama, Ehime, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					267	268				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600153		
J	Utsugi, C; Miyazono, S; Osada, K; Sasajima, H; Noguchi, T; Matsuda, M; Kashiwayanagi, M				Utsugi, Chizuru; Miyazono, Sadaharu; Osada, Kazumi; Sasajima, Hitoshi; Noguchi, Tomohiro; Matsuda, Mitsuyoshi; Kashiwayanagi, Makoto			Impaired neurogenesis in the subventricular zone and olfactory functions by soft-diet feeding were recovered by hard-diet feeding	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Utsugi, Chizuru; Matsuda, Mitsuyoshi] Asahikawa Med Univ, Dept Oral & Maxillofacial Surg, Asahikawa, Hokkaido 0788510, Japan; [Utsugi, Chizuru; Miyazono, Sadaharu; Sasajima, Hitoshi; Noguchi, Tomohiro; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Asahikawa, Hokkaido 0788510, Japan; [Osada, Kazumi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Biol, Tohbetu 0610293, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					276	277				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600175		
J	Kawasaki, H; Sekizaki, Y; Sekine, Y; Nonaka, M				Kawasaki, Hiroya; Sekizaki, Yuka; Sekine, Yuki; Nonaka, Masahiko			Temporal dominance of sensations (TDS) analysis of binary taste mixtures	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Kawasaki, Hiroya; Sekizaki, Yuka; Sekine, Yuki; Nonaka, Masahiko] Ajinomoto Co Inc, Inst Innovat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					277	277				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600176		
J	Kojima, T; Isono, K; Hamada, T; Munakata, Y; Takada, S; Furuyama, A				Kojima, Tadayuki; Isono, Kunio; Hamada, Tomohiro; Munakata, Yoshiei; Takada, Satosi; Furuyama, Akira			Inactivation of Gr5a-expressing taste neurons disrupts multiple taste modalities in the ingestion behavior of Drosophila	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Kojima, Tadayuki; Hamada, Tomohiro; Takada, Satosi] Ohu Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Koriyama, Fukushima 9638611, Japan; [Isono, Kunio] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Munakata, Yoshiei; Furuyama, Akira] Ohu Univ, Sch Dent, Dept Oral Funct & Mol, Koriyama, Fukushima 9638611, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					278	279				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600180		
J	Nishizumi, H; Sakano, H				Nishizumi, Hirofumi; Sakano, Hitoshi			A Proximity Model for Synapse Formation of Mitral Cells in the Olfactory Bulb	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Nishizumi, Hirofumi; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					284	284				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600192		
J	Ohtubo, Y; Ogata, T				Ohtubo, Yoshitaka; Ogata, Takahiro			Density of taste receptor cell types in mouse circumvallate taste buds	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Ohtubo, Yoshitaka; Ogata, Takahiro] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Ogata, Takahiro] ASTEC Co Ltd, Shime, Fukuoka 8112207, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					285	285				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600195		
J	Saito, H; Yamaki, M; Isono, K; Shirakawa, H; Goto, T; Komai, M				Saito, Hiroki; Yamaki, Michiko; Isono, Kunio; Shirakawa, Hitoshi; Goto, Tomoko; Komai, Michio			Analysis of human TAS2R variations underlying individual difference in the food preference and bitter taste evaluation	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Saito, Hiroki; Yamaki, Michiko; Isono, Kunio; Shirakawa, Hitoshi; Goto, Tomoko; Komai, Michio] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan			Shirakawa, Hitoshi/D-1406-2009					0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					289	289				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600203		
J	Shiga, H; Taki, J; Okuda, K; Watanabe, N; Tonami, H; Kinuya, S; Furukawa, M; Miwa, T				Shiga, H.; Taki, J.; Okuda, K.; Watanabe, N.; Tonami, H.; Kinuya, S.; Furukawa, M.; Miwa, T.			Assessment of peripheral olfactory nerve image in patients with idiopathic olfactory impairments in comparison to healthy volunteers	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Shiga, H.; Miwa, T.] Kanazawa Med Univ, Otorhinolaryngol, Kanazawa, Ishikawa, Japan; [Taki, J.; Kinuya, S.] Kanazawa Univ, Grad Sch Med Sci, Biotracer Med, Kanazawa, Ishikawa 9201192, Japan; [Okuda, K.] Kanazawa Med Univ, Phys, Kanazawa, Ishikawa, Japan; [Watanabe, N.; Tonami, H.] Kanazawa Med Univ, Diagnost & Therapeut Radiol, Kanazawa, Ishikawa, Japan; [Furukawa, M.] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					291	291				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600207		
J	Ito, K; Takayanagi-Koma, M; Takahashi, K; Awazu, S; Akama, H				Ito, Kanetoshi; Takayanagi-Koma, Miyuki; Takahashi, Kaori; Awazu, Shunji; Akama, Hiroyuki			Odor Hedonics Related Brain Activation: An fMRI Study	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Ito, Kanetoshi; Takayanagi-Koma, Miyuki; Takahashi, Kaori] Takasago Int Corp, Hiratsuka, Kanagawa 2540073, Japan; [Awazu, Shunji] Jissen Womens Univ, Shibuya Ku, Tokyo 1508538, Japan; [Akama, Hiroyuki] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					292	293				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600211		
J	Tanabe, N; Morita, H; Isono, K				Tanabe, Noriko; Morita, Hiromi; Isono, Kunio			Electrophysiological and behavioral analysis of Drosophila taste perception by selective inactivation of the gustatory receptor neurons	CHEMICAL SENSES			English	Meeting Abstract	24th Annual Meeting of the European-Chemoreception-Research-Organization (ECRO)	SEP 10-13, 2014	Dijon, FRANCE	European Chemorecept Res Org					[Tanabe, Noriko] Fukuoka Tenjin Med Rehabil Acad, Fukuoka, Japan; [Morita, Hiromi; Isono, Kunio] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAR	2015	40	3					293	293				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CD3WX	WOS:000351015600212		
J	Chiang, YD; Dutta, S; Chen, CT; Huang, YT; Lin, KS; Wu, JCS; Suzuki, N; Yamauchi, Y; Wu, KCW				Chiang, Ya-Dong; Dutta, Saikat; Chen, Ching-Tien; Huang, Yu-Tzu; Lin, Kuen-Song; Wu, Jeffrey C. S.; Suzuki, Norihiro; Yamauchi, Yusuke; Wu, Kevin C. -W.			Functionalized Fe3O4@ Silica Core-Shell Nanoparticles as Microalgae Harvester and Catalyst for Biodiesel Production	CHEMSUSCHEM			English	Article						biodiesel; core-shell nanostructure; microalgae; paramagnetic nanoparticle; transesterification	CELL DISRUPTION; BIOMASS; EXTRACTION; CONVERSION; CELLULOSE; CHEMICALS; WATER; ACID; CELLULASES; SYSTEM	Core-shell Fe3O4@silica magnetic nanoparticles functionalized with a strong base, triazabicyclodecene (TBD), were successfully synthesized for harvesting microalgae and for one-pot microalgae-to-fatty acid methyl ester (FAME, or so-called biodiesel) conversion. Three types of algae oil sources (i.e., dried algae, algae oil, and algae concentrate) were used and the reaction conditions were optimized to achieve the maximum biodiesel yield. The results obtained in this study show that our TBD-functionalized Fe3O4@silica nanoparticles could effectively convert algae oil to biodiesel with a maximum yield of 97.1%. Additionally, TBD-Fe3O4@silica nanoparticles act as an efficient algae harvester because of their adsorption and magnetic properties. The method presented in this study demonstrates the wide scope for the use of covalently functionalized core-shell nanoparticles for the production of liquid transportation fuels from algal biomass.	[Chiang, Ya-Dong; Dutta, Saikat; Chen, Ching-Tien; Wu, Jeffrey C. S.; Wu, Kevin C. -W.] Natl Taiwan Univ, Dept Chem Engn, Taipei, Taiwan; [Huang, Yu-Tzu] Chung Yuan Christian Univ, Dept Bioenvironm Engn, Chungli 32023, Taiwan; [Lin, Kuen-Song] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli 32023, Taiwan; [Suzuki, Norihiro] NIMS, ICYS, Tsukuba, Ibaraki 3050047, Japan; [Yamauchi, Yusuke] NIMS, World Premier Int WPI Res Ctr Mat, Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Chiang, YD (reprint author), Natl Taiwan Univ, Dept Chem Engn, 1,Sec 4,RooseVelt Rd, Taipei, Taiwan.	kevinwu@ntu.edu.tw	Yamauchi, Yusuke/D-2780-2015; Dutta, Saikat/L-9970-2014; Wu, Jeffrey/B-6210-2011	Wu, Jeffrey/0000-0002-2231-3118	Ministry of Science and Technology (MOST) of Taiwan [101-2628-E-002-015-MY3, 101-2623-E-002-005-ET, 101-2923-E-002-012-MY3, 103-2218-E-002-101]; National Taiwan University [101R7842, 102R7740]; Center of Strategic Materials Alliance for Research and Technology (SMART Center), National Taiwan University [102R104100]	This research was supported by the Ministry of Science and Technology (MOST) of Taiwan (101-2628-E-002-015-MY3, 101-2623-E-002-005-ET, 101-2923-E-002-012-MY3, and 103-2218-E-002-101), National Taiwan University (101R7842 and 102R7740), and Center of Strategic Materials Alliance for Research and Technology (SMART Center), National Taiwan University (102R104100).	Ruppert AM, 2012, ANGEW CHEM INT EDIT, V51, P2564, DOI 10.1002/anie.201105125; Ji N, 2008, ANGEW CHEM INT EDIT, V47, P8510, DOI 10.1002/anie.200803233; Farooq W, 2013, GREEN CHEM, V15, P749, DOI 10.1039/c3gc36767c; Deng Y, 2008, J AM CHEM SOC, V130, P28, DOI 10.1021/ja0777584; Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819; Lee YC, 2013, CHEMCATCHEM, V5, P2153, DOI 10.1002/cctc.201300219; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Kim J, 2013, BIOTECHNOL ADV, V31, P862, DOI 10.1016/j.biotechadv.2013.04.006; An DL, 2012, CHEM-EUR J, V18, P2938, DOI 10.1002/chem.201103262; de Boer K, 2012, J APPL PHYCOL, V24, P1681, DOI 10.1007/s10811-012-9835-z; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; Serrano-Ruiz JC, 2011, CHEM SOC REV, V40, P5266, DOI 10.1039/c1cs15131b; Shirvani T, 2011, ENERG ENVIRON SCI, V4, P3773, DOI 10.1039/c1ee01791h; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Halim R, 2012, BIOTECHNOL ADV, V30, P709, DOI 10.1016/j.biotechadv.2012.01.001; Yoo G, 2014, GREEN CHEM, V16, P312, DOI 10.1039/c3gc41695j; Mondal J, 2012, DALTON T, V41, P6173, DOI 10.1039/c2dt30106g; Luo C, 2007, ANGEW CHEM INT EDIT, V46, P7636, DOI 10.1002/anie.200702661; Singh A, 2011, BIORESOURCE TECHNOL, V102, P10, DOI 10.1016/j.biortech.2010.06.032; Cheng JH, 2014, CHEM ENG J, V239, P242, DOI 10.1016/j.cej.2013.11.023; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; Prochazkova G, 2013, COLLOID SURFACE B, V112, P213, DOI 10.1016/j.colsurfb.2013.07.053; Kim J, 2012, BIORESOURCE TECHNOL, V123, P164, DOI 10.1016/j.biortech.2012.08.010; Meloni D, 2011, APPL CATAL B-ENVIRON, V102, P505, DOI 10.1016/j.apcatb.2010.12.032; Xu LX, 2011, BIORESOURCE TECHNOL, V102, P5113, DOI 10.1016/j.biortech.2011.01.066; Gallezot P, 2008, CHEMSUSCHEM, V1, P734, DOI 10.1002/cssc.200800091; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; Farkade VD, 2006, BIOCHEM ENG J, V31, P25, DOI 10.1016/j.bej.2006.05.015; Giri S., 2005, ANGEW CHEM, V117, P5166, DOI 10.1002/ange.200501819; Huang YT, 2013, J NANOSCI NANOTECHNO, V13, P2117, DOI 10.1166/jnn.2013.6877; Huang YT, 2014, INT J ENVIRON SCI TE, V11, P703, DOI 10.1007/s13762-013-0251-y; Igarashi K, 2013, NAT CHEM BIOL, V9, P350, DOI 10.1038/nchembio.1237; Ji N., 2008, ANGEW CHEM, V120, P8638, DOI 10.1002/ange.200803233; Luo C, 2007, ANGEW CHEM, V119, P7780, DOI DOI 10.1002/ANGE.200702661; Palkovits R., 2012, ANGEW CHEM, V124, P2614; SAVE SS, 1994, CHEM ENG J BIOCH ENG, V55, pB67, DOI 10.1016/0923-0467(94)06062-2	37	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	MAR	2015	8	5					789	794		10.1002/cssc.201402996		6	Chemistry, Multidisciplinary	Chemistry	CC9BD	WOS:000350661600006		
J	Chandra, D; Abe, N; Takama, D; Saito, K; Yui, T; Yagi, M				Chandra, Debraj; Abe, Naoto; Takama, Daisuke; Saito, Kenji; Yui, Tatsuto; Yagi, Masayuki			Open Pore Architecture of an Ordered Mesoporous IrO2 Thin Film for Highly Efficient Electrocatalytic Water Oxidation	CHEMSUSCHEM			English	Article						electrocatalysis; iridium oxide; mesoporous materials; nanostructure engineering; water oxidation	OXYGEN EVOLUTION REACTION; IRIDIUM OXIDE; HARD-TEMPLATE; ELECTRODE; PERFORMANCE; CRYSTALLIZATION; DEPOSITION; CATALYST; CHLORINE; STORAGE	We report the first accessible channel-like open pore architecture of ordered 2D hexagonal mesoporous IrO2 films and its utilization as an efficient anode for electrocatalytic water oxidation. A well-ordered mesostructure of circa 7nm pores were obtained by a facile one-pot soft-templating strategy, employing a [Ir(OH)(6)](2-) precursor stabilized by a triblock copolymer PluronicF127 as a pore-directing template. A mesoporous IrO2 film calcined at 400 degrees C (approximate to 70nm thick) affords a high surface area of 512m(2)cm(-3) and 2times higher O-2 evolution during the electrocatalytic water oxidation relative to an untemplated IrO2 coating film.	[Chandra, Debraj; Abe, Naoto; Takama, Daisuke; Saito, Kenji; Yui, Tatsuto; Yagi, Masayuki] Niigata Univ, Dept Mat Sci & Technol, Fac Engn, Niigata 9502181, Japan; [Yagi, Masayuki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci PRESTO, Kawaguchi, Saitama 3320012, Japan	Chandra, D (reprint author), Niigata Univ, Dept Mat Sci & Technol, Fac Engn, 8050 Ikarashi 2, Niigata 9502181, Japan.	debraj.chandra@gs.niigata-u.ac.jp; yagi@eng.niigata-u.ac.jp	Chandra, Debraj/M-9408-2015; Yui, Tatsuto/A-9399-2008	Chandra, Debraj/0000-0002-5408-5092; Yui, Tatsuto/0000-0002-7526-3521	JST PRESTO program; Ministry of Education, Culture, Sports, Science and Technology [24350028]; JSPS	This work was partially supported by the JST PRESTO program and Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (No. 24350028). D.C. thanks JSPS for providing a postdoctoral fellowship.	Nakagawa T, 2009, J PHYS CHEM C, V113, P12958, DOI 10.1021/jp9060076; Shim JH, 2012, ANAL CHEM, V84, P3827, DOI 10.1021/ac300573b; Moser M, 2013, ACS CATAL, V3, P2813, DOI 10.1021/cs400553t; Guerrini E, 2007, J SOLID STATE ELECTR, V11, P939, DOI 10.1007/s10008-006-0238-4; El Sawy EN, 2009, J MATER CHEM, V19, P8244, DOI 10.1039/b914662h; Meulenkamp EA, 1999, J PHYS CHEM B, V103, P7831, DOI 10.1021/jp9914673; Wen RT, 2014, SOL ENERG MAT SOL C, V120, P151, DOI 10.1016/j.solmat.2013.08.035; Tilley SD, 2010, ANGEW CHEM INT EDIT, V49, P6405, DOI 10.1002/anie.201003110; Yagi M, 2005, J ELECTROANAL CHEM, V579, P83, DOI 10.1016/j.jelechem.2005.01.030; Meng XJ, 2009, J MATER CHEM, V19, P1894, DOI 10.1039/b815165b; Zhao YX, 2011, SMALL, V7, P2087, DOI 10.1002/smll.201100485; Hong DC, 2012, ENERG ENVIRON SCI, V5, P5708, DOI 10.1039/c2ee02964b; Cook TR, 2010, CHEM REV, V110, P6474, DOI 10.1021/cr100246c; Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t; Jiao F, 2007, ADV MATER, V19, P657, DOI 10.1002/adma.200602499; Fukuzumi S, 2013, CHEMSUSCHEM, V6, P1834, DOI 10.1002/cssc.201300361; Chandra D, 2013, ANGEW CHEM INT EDIT, V52, P12606, DOI 10.1002/anie.201306004; Chandra D, 2011, PHYS CHEM CHEM PHYS, V13, P12529, DOI 10.1039/c1cp21060b; Korlann SD, 2005, J AM CHEM SOC, V127, P12516, DOI 10.1021/ja045446k; Zhao YX, 2011, J PHYS CHEM LETT, V2, P402, DOI 10.1021/jz200051c; Yagi M, 2005, J PHYS CHEM B, V109, P21489, DOI 10.1021/jp0550208; Shi YF, 2009, NANO LETT, V9, P4215, DOI 10.1021/nl902423a; Lee Y, 2012, J PHYS CHEM LETT, V3, P399, DOI 10.1021/jz2016507; Hu W, 2012, J MATER CHEM, V22, P6010, DOI 10.1039/c2jm16506f; ATANASOSKA L, 1990, VACUUM, V40, P91, DOI 10.1016/0042-207X(90)90127-K; Hu JM, 2004, INT J HYDROGEN ENERG, V29, P791, DOI 10.1016/j.ijhydene.2003.09.007; Hammond C, 2013, CHEM-EUR J, V19, P13193, DOI 10.1002/chem.201301596; Ortel E, 2011, CHEM MATER, V23, P3201, DOI 10.1021/cm200761f; Chandra D, 2010, MICROPOR MESOPOR MAT, V128, P34, DOI 10.1016/j.micromeso.2009.07.024; Nakagawa T, 2009, J AM CHEM SOC, V131, P15578, DOI 10.1021/ja9063298; Zukalova M, 2005, NANO LETT, V5, P1789, DOI 10.1021/nl051401l; Wu ZX, 2010, J AM CHEM SOC, V132, P12042, DOI 10.1021/ja104379a; Walcarius A, 2002, CHEM MATER, V14, P2757, DOI 10.1021/cm021117k; Dahl S, 2012, NAT MATER, V11, P100, DOI 10.1038/nmat3233; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; TRASATTI S, 1984, ELECTROCHIM ACTA, V29, P1503, DOI 10.1016/0013-4686(84)85004-5; HUANG YS, 1989, SOLID STATE COMMUN, V70, P517, DOI 10.1016/0038-1098(89)90942-3; Tsuji E, 2011, ELECTROCHIM ACTA, V56, P2009, DOI 10.1016/j.electacta.2010.11.062; Liao PC, 1997, THIN SOLID FILMS, V301, P7, DOI 10.1016/S0040-6090(96)09545-4; Youngblood WJ, 2009, J AM CHEM SOC, V131, P926, DOI 10.1021/ja809108y; Chandra D., 2013, ANGEW CHEM, V125, P12838; Chandra D, 2011, LANGMUIR, V27, P11436, DOI 10.1021/la2013123; Chen YM, 2012, THIN SOLID FILMS, V520, P2409, DOI 10.1016/j.tsf.2011.09.074; Cheng YJ, 2008, CHEM MATER, V20, P6580, DOI 10.1021/cm703669d; Hara M, 2000, CHEM COMMUN, P1903, DOI 10.1039/b003246h; Kuo LM, 2014, SENSOR ACTUAT B-CHEM, V193, P687, DOI 10.1016/j.snb.2013.11.109; Kuwabara T, 2008, J PHYS CHEM C, V112, P3774, DOI 10.1021/jp7098416; Lee Y, 2012, J PHYS CHEM C, V116, P18550, DOI 10.1021/jp306900m; Li GF, 2012, CHEMSUSCHEM, V5, P858, DOI 10.1002/cssc.201100519; Liu DQ, 2008, ELECTROCHEM SOLID ST, V11, pA206, DOI 10.1149/1.2977787; Menzel N, 2013, ACS CATAL, V3, P1324, DOI 10.1021/cs4000238; Thanawala SS, 2008, APPL SURF SCI, V254, P5164, DOI 10.1016/j.apsusc.2008.02.054; Tilley S. D., 2010, ANGEW CHEM, V122, P6549, DOI 10.1002/ange.201003110; Yang PD, 1999, CHEM MATER, V11, P2813, DOI 10.1021/cm990185c; Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8; Zou S., 1999, LANGMUIR, V16, P754	57	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	MAR	2015	8	5					795	799		10.1002/cssc.201402911		5	Chemistry, Multidisciplinary	Chemistry	CC9BD	WOS:000350661600007		
J	Yamaguchi, S; Matsuo, T; Motokura, K; Sakamoto, Y; Miyaji, A; Baba, T				Yamaguchi, Sho; Matsuo, Takeaki; Motokura, Ken; Sakamoto, Yasuharu; Miyaji, Akimitsu; Baba, Toshihide			Mechanistic Studies on the Cascade Conversion of 1,3-Dihydroxyacetone and Formaldehyde into alpha-Hydroxy-gamma-butyrolactone	CHEMSUSCHEM			English	Article						biomass; homogeneous catalysis; reaction mechanisms; reactive intermediates; tin	TIN-CATALYZED CONVERSION; ALDOL-TYPE REACTION; LACTIC-ACID; ALKYL LACTATES; TRIOSE SUGARS; SN-BETA; BIOMASS; ZEOLITE; DIHYDROXYACETONE; CHEMICALS	The chemical synthesis of commercially and industrially important products from biomass-derived sugars is absolutely vital to establish biomass utilization as a sustainable alternative source of chemical starting materials. -Hydroxy--butyrolactone is a useful synthetic intermediate in pharmaceutical chemistry, and so novel biomass-related routes for its production may help to validate this eco-friendly methodology. Herein, we report the specific catalytic activity of homogeneous tin halides to convert the biomass-derived triose sugar 1,3-dihydroxyacetone and formaldehyde into -hydroxy--butyrolactone. A detailed screening of catalysts showed the suitability of tin catalysts for this reaction system, and isotope experiments using [D-2]paraformaldehyde, substrate screening, and time profile measurements allowed us to propose a detailed reaction pathway. In addition, to elucidate the activated species in this cascade reaction, the effect of additional water and the influence of additional BrOnsted acids on the reaction preferences for the formation of -hydroxy--butyrolactone, lactic acid, and vinyl glycolate were investigated. The active form of the Sn catalyst was investigated by (SnNMR)-Sn-119 spectroscopy.	[Yamaguchi, Sho; Matsuo, Takeaki; Motokura, Ken; Sakamoto, Yasuharu; Miyaji, Akimitsu; Baba, Toshihide] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Yamaguchi, S (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Midori Ku, 4259-G1-14 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	tbaba@chemenv.titech.ac.jp	Motokura, Ken/C-3894-2015	Motokura, Ken/0000-0002-0066-5139			Guo Q, 2013, CHEMSUSCHEM, V6, P1352, DOI 10.1002/cssc.201300160; Yamaguchi S, 2014, CHEM COMMUN, V50, P4600, DOI 10.1039/c4cc00954a; Fukuoka A, 2006, ANGEW CHEM INT EDIT, V45, P5161, DOI 10.1002/anie.200601921; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Weber AL, 2006, P NATL ACAD SCI USA, V103, P12713, DOI 10.1073/pnas.0602320103; Dijkmans J, 2013, GREEN CHEM, V15, P2777, DOI 10.1039/c3gc41239c; Kofoed J, 2005, ORG BIOMOL CHEM, V3, P1850, DOI 10.1039/b501512j; Marshall AL, 2010, CHEM-EUR J, V16, P4970, DOI 10.1002/chem.200903028; Castillo JA, 2010, ADV SYNTH CATAL, V352, P1039, DOI 10.1002/adsc.200900772; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Dusselier M, 2013, ENERG ENVIRON SCI, V6, P1415, DOI 10.1039/c3ee00069a; Corma A, 2002, J AM CHEM SOC, V124, P3194, DOI 10.1021/ja012297m; Taarning E, 2009, CHEMSUSCHEM, V2, P625, DOI 10.1002/cssc.200900099; Yan N, 2006, J AM CHEM SOC, V128, P8714, DOI 10.1021/ja062468t; Dusselier M, 2013, ACS CATAL, V3, P1786, DOI 10.1021/cs400298n; Holm MS, 2010, SCIENCE, V328, P602, DOI 10.1126/science.1183990; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Dapsens PY, 2013, CHEMSUSCHEM, V6, P831, DOI 10.1002/cssc.201200703; [Anonymous], 2012, ANGEW CHEM, V124, P11906; Hammond C, 2012, ANGEW CHEM INT EDIT, V51, P11736, DOI 10.1002/anie.201206193; Simonov AN, 2007, ADV SPACE RES, V40, P1634, DOI 10.1016/j.asr.2007.08.002; [Anonymous], 2006, ANGEW CHEM, V118, P5285; Rasrendra CB, 2011, CHEMSUSCHEM, V4, P768, DOI 10.1002/cssc.201000457; BLUNDEN SJ, 1987, J ORGANOMET CHEM, V325, P141, DOI 10.1016/0022-328X(87)80395-9; Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Roman-Leshkov Y, 2011, ACS CATAL, V1, P1566, DOI 10.1021/cs200411d; Bermejo-Deval R, 2012, ACS CATAL, V2, P2705, DOI 10.1021/cs300474x; Li L, 2011, GREEN CHEM, V13, P1175, DOI 10.1039/c0gc00923g; Dusselier M, 2013, CHEMCATCHEM, V5, P569, DOI 10.1002/cctc.201200476; Luo HY, 2012, ACS CATAL, V2, P2695, DOI 10.1021/cs300543z; Benner S. A., 2010, COLD SPRING HARBOR P; Bitzer RS, 2005, J BRAZIL CHEM SOC, V16, P963, DOI 10.1590/S0103-50532005000600012; BLACKBURN C, 1983, CAN J CHEM, V61, P1981, DOI 10.1139/v83-342; BURKE JJ, 1961, J AM CHEM SOC, V83, P326, DOI 10.1021/ja01463a016; Hayashi Y, 2005, CHEM COMMUN, P2716, DOI 10.1039/b501964h; Kamm B., 2006, BIOREFINERIES IND PR, V1; MAO XA, 1989, INORG CHIM ACTA, V156, P177; MITCHELL TN, 1976, ORG MAGN RESONANCE, V8, P34, DOI 10.1002/mrc.1270080109; QUINKERT G, 1993, TETRAHEDRON LETT, V34, P6885, DOI 10.1016/S0040-4039(00)91821-5; Rowicki T, 2006, IND ENG CHEM RES, V45, P1259, DOI 10.1021/ie050774u; SAIMOTO H, 1995, TETRAHEDRON LETT, V36, P937, DOI 10.1016/0040-4039(94)02377-N; SHIGEMASA Y, 1994, TETRAHEDRON LETT, V35, P1263, DOI 10.1016/0040-4039(94)88039-5; Wang JC, 2011, APPL CATAL B-ENVIRON, V107, P135, DOI 10.1016/j.apcatb.2011.07.006; Wang TF, 2010, ORG BIOMOL CHEM, V8, P4757, DOI 10.1039/c0ob00125b	45	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	MAR	2015	8	5					853	860		10.1002/cssc.201403100		8	Chemistry, Multidisciplinary	Chemistry	CC9BD	WOS:000350661600017		
J	Quanjer, PH; Kubota, M; Kobayashi, H; Omori, H; Tatsumi, K; Kanazawa, M; Stanojevic, S; Stocks, J; Cole, TJ				Quanjer, Philip H.; Kubota, Masaru; Kobayashi, Hirosuke; Omori, Hisamitsu; Tatsumi, Koichiro; Kanazawa, Minoru; Stanojevic, Sanja; Stocks, Janet; Cole, Tim J.			Secular Changes in Relative Leg Length Confound Height-Based Spirometric Reference Values	CHEST			English	Article							LUNG-FUNCTION; JAPANESE-CHILDREN; RACIAL DIFFERENCE; GROWTH; AGE; EQUATIONS; WEIGHT; TRENDS; BORN	BACKGROUND: Most but not all data from different ethnic groups fit the Global Lung Function Initiative (GLI) spirometric reference model. This study investigates to what extent discrepancies are caused by secular changes in body proportions. METHODS: FEV (1) and FVC from 20,336 healthy Japanese subjects (13,492 women) aged 17 to 95 years were compared with GLI-2012 reference values for Europeans. Data on the sitting height/standing height ratio (Cormic index) in 17-year-old students, collected from 1949 to 2012 in successive birth cohorts, were used to assess secular changes in body frame. The cohort-specific Cormic index was used to assess how variation in body frame affected pulmonary function. RESULTS: FEV (1) and FVC were lower than GLI-2012 reference values, with values progressively falling until age 35 to 40 years and then rising to European levels in the elderly. The Cormic index rose until 1942, then fell, with a nadir in the 1970s, before rising again until 1995. Nearly one-half of the spirometric variability from predicted values could be explained by differences in the Cormic index between birth cohorts. CONCLUSIONS: In low-income countries, improving health conditions are likely to drive increases in height and changes in relative leg length similar to those observed in Japan and, thus, to a change in body frame. This implies that height-based prediction equations for such populations will need to be periodically updated.	[Quanjer, Philip H.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pulm Dis, NL-3015 CE Rotterdam, Netherlands; [Quanjer, Philip H.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Paediat,Div Resp Med, NL-3015 CE Rotterdam, Netherlands; [Kubota, Masaru] Kitasato Univ, Dept Resp Med, Sch Med, Kanagawa, Japan; [Kobayashi, Hirosuke] Kitasato Univ, Grad Sch Med Sci, Kanagawa, Japan; [Omori, Hisamitsu] Kumamoto Univ, Dept Biomed Lab Sci, Fac Life Sci, Chuo Ku, Kumamoto, Kumamoto, Japan; [Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba, Chiba, Japan; [Kanazawa, Minoru] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama, Japan; [Stanojevic, Sanja] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Stanojevic, Sanja] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Stocks, Janet] UCL, Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, Portex Unit, London, England; [Cole, Tim J.] UCL, Inst Child Hlth, Populat Policy & Practice Programme, London, England	Quanjer, PH (reprint author), Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pulm Dis, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	pquanjer@gmail.com	Cole, Tim/B-7883-2008	Cole, Tim/0000-0001-5711-8200			Ali MA, 2000, AM J HUM BIOL, V12, P405, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<405::AID-AJHB11>3.0.CO;2-M; Larnkjaer A, 2006, ACTA PAEDIATR, V95, P754, DOI 10.1080/08035250600527323; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Quanjer PH, 2014, EUR RESPIR J, V44, P905, DOI 10.1183/09031936.00054014; Gohlke B, 2009, DTSCH ARZTEBL INT, V106, P377, DOI 10.3238/arztebl.2009.0377; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Harik-Khan RI, 2004, AM J EPIDEMIOL, V160, P893, DOI 10.1093/aje/kwh297; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; Bonner R, 2013, AM J RESP CRIT CARE, V188, P515, DOI 10.1164/rccm.201212-2208LE; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; Harik-Khan RI, 2001, AM J RESP CRIT CARE, V164, P1647; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Whitrow MJ, 2008, AM J RESP CRIT CARE, V177, P1262, DOI 10.1164/rccm.200706-867OC; Cole T J, 2003, Econ Hum Biol, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Eveleth PB, 1976, WORLDWIDE VARIATION; Fulambarker A, 2010, CHEST, V137, P1398, DOI 10.1378/chest.09-1911; Grasgruber P, 2013, J HUMAN SPORT EXERCI, V8, P120; Kubota Masaru, 2014, Respir Investig, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Murata M, 2000, AM J CLIN NUTR, V72, P1379; Nakaoka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060793; Rigby RA, 2005, APPL STAT, V54, P507; Smith SM, 2013, ARCH DIS CHILD, V98, P269, DOI 10.1136/archdischild-2012-302391; TSUZAKI S, 1989, ANN HUM BIOL, V16, P429, DOI 10.1080/03014468900000552; van Leer E M, 1992, Ann Epidemiol, V2, P611	28	2	2	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	MAR	2015	147	3					792	797		10.1378/chest.14-1365		6	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CC5RC	WOS:000350419200058		
J	Nagai, T; Kohsaka, S; Fukuda, K				Nagai, Toshiyuki; Kohsaka, Shun; Fukuda, Keiichi			Late Gadolinium Enhancement in Sarcoidosis Ventricular Wall Stress Should Not Be Overlooked Response	CHEST			English	Letter							CARDIAC SARCOIDOSIS		[Nagai, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Kohsaka, Shun; Fukuda, Keiichi] Keio Univ, Sch Med, Tokyo, Japan	Nagai, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	nagai@ncvc.go.jp	Fukuda, Keiichi/L-3777-2013				Greulich S, 2013, JACC-CARDIOVASC IMAG, V6, P501, DOI 10.1016/j.jcmg.2012.10.021; Patel AR, 2011, EUR J HEART FAIL, V13, P1231, DOI 10.1093/eurjhf/hfr099; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Ise T, 2014, HEART, V100, P1165, DOI 10.1136/heartjnl-2013-305187; Nagai T, 2014, CHEST, V146, P1064, DOI 10.1378/chest.14-0139	5	0	0	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	MAR	2015	147	3					E119	E119		10.1378/chest.14-2996		1	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CC5RC	WOS:000350419200020		
J	Lin, ZR; Wang, XD; Yuan, X; Shibukawa, N; Noguchi, T				Lin Zhirong; Wang Xudong; Yuan Xin; Shibukawa, Naoki; Noguchi, Taro			Investigation and Improvement of the Staggered Labyrinth Seal	CHINESE JOURNAL OF MECHANICAL ENGINEERING			English	Article						labyrinth seal; numerical simulation; viscous dissipation; sealing mechanism	LEAKAGE MEASUREMENTS; FLOW VISUALIZATION; CAVITIES	Recent studies on staggered labyrinth seals have focused on the effects of different parameters, such as the pressure ratio and rotational speed on the leakage flow rate. However, few investigations pay sufficient attention to flow details and the sealing mechanism, which would be of practical importance in designing seals having higher performance. This paper establishes a theoretical model to study the seal mechanism, thus revealing that leakage is determined by the pressure ratio and geometric structure. Numerical simulation is implemented to illustrate details of the flow field within the seal structure. Viscous dissipation is used to quantitatively investigate the contribution that each location makes to the seal performance, revealing that orifices and stagnation points are the most important positions in the seal. structure, generating the most dissipation. The orifice is carefully studied by using the theoretical model. Experiments for different pressure ratios are conducted and the results match well with those of the theoretical model and numerical simulation, verifying the theoretical model and analysis of the seal mechanism. Three new designs, based on a good understanding of the seal mechanism, are presented, with one reducing leakage by 24.5%.	[Lin Zhirong; Wang Xudong; Yuan Xin] Tsinghua Univ, Minist Educ, Key Lab Thermal Sci & Power Engn, Beijing 100084, Peoples R China; [Shibukawa, Naoki; Noguchi, Taro] Toshiba Corp Power Syst Co, Kawasaki, Kanagawa 2128585, Japan	Yuan, X (reprint author), Tsinghua Univ, Minist Educ, Key Lab Thermal Sci & Power Engn, Beijing 100084, Peoples R China.	linzhirong@tsinghua.edu.cn; wxd891209@126.com; yuanxin@tsinghua.edu.cn; taro.noguchi@toshiba.co.jp; taro.noguchi@toshiba.co.jp			National Natural Science Foundation of China [51136003]	Supported by National Natural Science Foundation of China(Grant No. 51136003)	Buckingham E, 1914, PHYS REV, V4, P345, DOI 10.1103/PhysRev.4.345; Rhode DL, 1997, J TURBOMACH, V119, P839; Rhode DL, 2001, J ENG GAS TURB POWER, V123, P604, DOI 10.1115/1.1377873; CHILDS DW, 1986, J ENG GAS TURB POWER, V108, P325; Childs D. W., 1993, TURBOMACHINERY ROTOR; DENECKE J, 2008, ASME TURB EXP 2008 P; DENECKE J, 2005, ASME TURB EXP 2005 P; ESER D, 1995, INT J ENG SCI, V33, P2309, DOI 10.1016/0020-7225(95)00072-6; Gao J, 2013, CHIN J MECH ENG-EN, V26, P69, DOI 10.3901/CJME.2013.01.069; GREITZER E M, 2007, INTERNAL FLOW CONCEP; Gurevich M.I., 1966, THEORY JETS IDEAL FL; HUANG S Q, 2014, J ENG GAS TURB POWER, V136, P1; LI Z G, 2011, J ENG GAS TURB POWER, V133, P1; PAOLILLO R, 2007, ASME TURB EXP 2007 P; Rhode DL, 1997, J TURBOMACH, V119, P844; White F.M, 1998, FLUID MECH; Willenborg K, 2001, J TURBOMACH, V123, P815, DOI 10.1115/1.1397304; WITTIG SLK, 1983, J ENG POWER-T ASME, V105, P305; YAN X, 2009, J TURBOMACH, V131, P1; YUCEL U., 1996, LEAKAGE SWIRL VELOCI; ZLATINOV M B, 2012, J TURBOMACH, V134, P1	21	0	0	EDITORIAL OFFICE CHINESE JOURNAL MECHANICAL ENGINEERING	BEIJING	22 BAIWANZHUANG DAJIE, BEIJING, 100037, PEOPLES R CHINA	1000-9345	2192-8258		CHIN J MECH ENG-EN	Chin. J. Mech. Eng.	MAR	2015	28	2					402	408		10.3901/CJME.2015.0106.005		7	Engineering, Mechanical	Engineering	CD4BS	WOS:000351028200022		
J	Kang, CX; Kuba, T; Hao, AM; Iseri, Y; Li, CJ; Zhang, ZJ				Kang Caixia; Kuba, Takahiro; Hao Aimin; Iseri, Yasushi; Li Chunjie; Zhang Zhenjia			Oxidative stress responses of submerged macrophyte Vallisneria asiatica to different concentrations of cyanobacteria	CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY			English	Article						algal bloom; physiological response; macrophyte restoration; Vallisneria asiatica	NATANS LOUR. HARA; MICROCYSTIN-LR; CERATOPHYLLUM-DEMERSUM; SUPEROXIDE-DISMUTASE; MEDICAGO-SATIVA; EUTROPHIC LAKE; SHALLOW LAKE; PHYTOPLANKTON; CYANOTOXINS; NUTRIENTS	In a 10-day aquarium experiment, this investigation examines macrophyte restoration in eutrophic Lake Taihu, the physiological effects of different plant biomass levels and of increasing natural cyanobacterial concentrations on a submerged macrophyte, Vallisneria asiatica. Cyanobacterial stress suppressed the superoxide dismutase (SOD) activity of the plant's leaves and induced the catalase (CAT) and peroxidase (POD) activities of its roots. The soluble protein content in V. asiatica decreased with an increase in natural cyanobacterial concentrations, whereas the malonaldehyde (MDA) increased significantly at chlorophyll a (Chl a) concentrations of 222 and 262 mu g/L in water. V. asiatica adapted to the stress caused by cyanobacterial concentrations by adjusting its antioxidant defense system to remove the excessive reactive oxygen species when the algal Chl a concentration was > 109 mu g/L. Additionally, high biomass of V. asiatica (2 222 g FW/m(2)) can inhibit the reproduction of cyanobacteria more significantly than low biomass (1 111 g FW/m(2)). High biomass of V. asiatica increased the oxidative stress in an individual plant when the initial Chl a concentration in the water reached 222 and 262 mu g/L, as expressed by the increased MDA in leaves, compared with low biomass of V. asiatica. This provides a basis for controlling cyanobacterial concentrations and V. asiatica biomass for the recovery of V. asiatica in eutrophic Lake Taihu.	[Kang Caixia; Kuba, Takahiro] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Hao Aimin] Kyushu Univ, Res Inst East Asia Environm, Nishi Ku, Fukuoka 8190395, Japan; [Iseri, Yasushi] West Japan Engn Consultants Inc, Chuo Ku, Fukuoka 8100004, Japan; [Li Chunjie; Zhang Zhenjia] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China	Kang, CX (reprint author), Kyushu Univ, Grad Sch Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kangcaixia123@163.com			Research Institute for East Asia Environments of Kyushu University; Mitsubishi Corporation in Japan	Supported by the Research Institute for East Asia Environments of Kyushu University and Mitsubishi Corporation in Japan	Alscher R G, 2002, EXP BOT, V53, p1 331; Buryskova B, 2006, AQUAT TOXICOL, V80, P346, DOI 10.1016/j.aquatox.2006.10.001; Schalles JF, 1998, J PHYCOL, V34, P383, DOI 10.1046/j.1529-8817.1998.340383.x; SCHRIVER P, 1995, FRESHWATER BIOL, V33, P255, DOI 10.1111/j.1365-2427.1995.tb01166.x; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Codd GA, 1995, WATER SCI TECHNOL, V32, P149, DOI 10.1016/0273-1223(95)00692-3; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Wang C, 2008, AQUAT TOXICOL, V87, P88, DOI 10.1016/j.aquatox.2008.01.009; Chen YW, 2003, HYDROBIOLOGIA, V506, P273, DOI 10.1023/B:HYDR.0000008604.09751.01; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463; Liao BH, 2005, ENVIRON INT, V31, P891, DOI 10.1016/j.envint.2005.05.029; Peuthert A, 2010, TOXICON, V56, P411, DOI 10.1016/j.toxicon.2010.04.004; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Pflugmacher S, 2004, AQUAT TOXICOL, V70, P169, DOI 10.1016/j.aquatox.2004.06.010; Creed JC, 1997, J EXP MAR BIOL ECOL, V212, P211, DOI 10.1016/S0022-0981(96)02748-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; Pflugmacher S, 2002, ENVIRON TOXICOL, V17, P407, DOI 10.1002/tox.10071; Cao T, 2004, J FRESHWATER ECOL, V19, P279, DOI 10.1080/02705060.2004.9664542; Asada K., 1999, ANNU REV PLANT PHYS, V50, P83; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Britto DT, 2002, PLANT PHYSIOL, V159, P567; Carmichael WW, 1997, ADV BOT RES, V27, P211; Cao HS, 2005, INT REV HYDROBIOL, V90, P347, DOI 10.1002/iroh.200410783; [楚建周 CHU Jianzhou], 2006, [生态环境, Ecology and Environment], V15, P702; Foyer CH, 1999, SCIENCE, V284, P599, DOI 10.1126/science.284.5414.599; Ge J, 2012, B ENVIRON CONTAM TOX, V89, P67, DOI 10.1007/s00128-012-0633-8; Greenfield R E, 1954, BIOL CHEM, V209, P355; Hao A M, 2011, ECOL CIVIL ENG, V14, P115; He Jun, 2008, Hupo Kexue, V20, P790; He S Y, 2007, WATER RESOUR PROT, V23, P78; Li DH, 2009, CHIN J OCEANOL LIMN, V27, P38, DOI 10.1007/s00343-009-0038-7; Li JinCai, 2002, Horticultural Research (Japan), V1, P279, DOI 10.2503/hrj.1.279; Peuthert A, 2008, TOXICON, V52, P84, DOI 10.1016/j.toxicon.2008.04.172; Shibata S, 2006, LANDSC ECOL ENG, V2, P13, DOI 10.1007/s11355-006-0031-7; Xie YH, 2005, FRESHWATER BIOL, V50, P391, DOI 10.1111/j.1365-2427.2004.01327.x; Yin Y, 2008, ENVIRON TOXICOL, V23, P328, DOI 10.1002/tox.20330	41	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, 100717, PEOPLES R CHINA	0254-4059	1993-5005		CHIN J OCEANOL LIMN	Chin. J. Oceanol. Limnol.	MAR	2015	33	2					364	371		10.1007/s00343-015-4084-z		8	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CD5VP	WOS:000351156800009		
J	Ikeda, Y; Sasaki, H; Ohtsu, T; Shiraishi, T; Tahara, Y; Shibata, S				Ikeda, Yuko; Sasaki, Hiroyuki; Ohtsu, Teiji; Shiraishi, Takuya; Tahara, Yu; Shibata, Shigenobu			Feeding and adrenal entrainment stimuli are both necessary for normal circadian oscillation of peripheral clocks in mice housed under different photoperiods	CHRONOBIOLOGY INTERNATIONAL			English	Article						Adrenal; biological rhythm; feeding; photoperiod	GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; RHYTHMS; MOUSE; PHASE; ADJUSTMENT; MAMMALS; LIVER; RAT; GLUCOCORTICOIDS	The mammalian circadian rhythm is entrained by multiple factors, including the light-dark cycle, the organism's feeding pattern and endocrine hormones such as glucocorticoids. Both a central clock (the suprachiasmatic nucleus, or SCN) and peripheral clocks (i.e. in the liver and lungs) in mice are entrained by photoperiod. However, the factors underlying entrainment signals from the SCN to peripheral clocks are not well known. To elucidate the role of entrainment factors such as corticosterone and feeding, we examined whether peripheral clock rhythms were impaired by adrenalectomy (ADX) and/or feeding of 6 meals per day at equal intervals under short-day, medium-day and long-day photoperiods (SP, MP and LP, respectively). We evaluated the waveform and phase of circadian rhythms in the liver, kidney and salivary gland by in vivo imaging of PER2:: LUCIFERASE knock-in mice. In intact mice, the waveforms of the peripheral clocks were similar among all photoperiods. The phases of peripheral clocks were well adjusted by the timing of the "lights-off''-operated evening (E) oscillator but not the "lights-on''-operated morning (M) oscillator. ADX had almost no effect on the rhythmicity and phase of peripheral clocks, regardless of photoperiod. To reduce the feeding-induced signal, we placed mice on a restricted feeding regimen with 6 meals per day (6 meals RF). This caused advances of the peripheral clock phase in LP-housed mice (2-5 h) and MP-housed mice (1-2 h) but not SP-housed mice. Thus, feeding pattern may affect the phase of peripheral clocks, depending on photoperiod. More specifically, ADX + 6 meals RF mice showed impairment of circadian rhythms in the kidney and liver but not in the salivary gland, regardless of photoperiod. However, the impairment of peripheral clocks observed in ADX + 6 meals RF mice was reversed by administration of dexamethasone for 3 days. The phase differences in the salivary gland clock among SP-, MP-and LP-housed mice became very small following treatment with ADX + 6 meals RF, suggesting that the effect of photoperiod was reduced by ADX and 6 meals RF. Because the SCN rhythm (as evaluated by PER2 immunohistochemistry) was not disrupted by ADX + 6 meals RF, impairment of peripheral clocks in these mice was not because of impaired SCN clock function. In addition, locomotor activity rhythm and modifications of the feeding pattern may not be completely responsible for determining the phase of peripheral clocks. Thus, this study demonstrates that the phase of peripheral clocks responds to a photoperiodic lights-off signal, and suggests that signals from normal feeding patterns and the adrenal gland are necessary to maintain the oscillation and phase of peripheral clocks under various photoperiods.	[Ikeda, Yuko; Sasaki, Hiroyuki; Ohtsu, Teiji; Shiraishi, Takuya; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Shibata, S (reprint author), Waseda Univ, Dept Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan.	shibatas@waseda.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300278]	The authors have no conflicts of interest to declare. This study was partially supported by a Grant-in-Aid for Scientific Research (B) (23300278) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S.S.).	Almon RR, 2008, AM J PHYSIOL-REG I, V295, pR1031, DOI 10.1152/ajpregu.90399.2008; Mahoney MM, 2010, INT J ENDOCRINOL, DOI 10.1155/2010/813764; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Koyanagi S, 2006, MOL ENDOCRINOL, V20, P573, DOI 10.1210/me.2005-0165; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Hirao A, 2010, AM J PHYSIOL-GASTR L, V299, pG1045, DOI 10.1152/ajpgi.00330.2010; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Menaker M, 2013, CURR OPIN NEUROBIOL, V23, P741, DOI 10.1016/j.conb.2013.03.003; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Castillo C, 2011, NEUROSCIENCE, V182, P169, DOI 10.1016/j.neuroscience.2011.02.003; Hayasaka N, 2007, ENDOCRINOLOGY, V148, P3316, DOI 10.1210/en.2007-0010; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Johnston JD, 2005, J NEUROENDOCRINOL, V17, P459, DOI 10.1111/j.1365-2826.2005.01326.x; Kuroda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00711; Otsuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039090; Parkanova D, 2012, EUR J NEUROSCI, V35, P1446, DOI 10.1111/j.1460-9568.2012.08045.x; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Sosniyenko S, 2010, AM J PHYSIOL-REG I, V298, pR959, DOI 10.1152/ajpregu.00561.2009; Sumova A, 2007, J BIOL RHYTHM, V22, P259, DOI 10.1177/0748730407301052	39	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	MAR	2015	32	2					195	210		10.3109/07420528.2014.962655		16	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CD3TP	WOS:000351005100005		
J	Matsuo, H; Iwamoto, A; Otsuka, T; Hishida, Y; Akiduki, S; Aoki, M; Furuse, M; Yasuo, S				Matsuo, Haruka; Iwamoto, Ayaka; Otsuka, Tsuyoshi; Hishida, Yukihiro; Akiduki, Saori; Aoki, Mami; Furuse, Mitsuhiro; Yasuo, Shinobu			Effects of time of L-ornithine administration on the diurnal rhythms of plasma growth hormone, melatonin, and corticosterone levels in mice	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian clock; glucocorticoid; growth hormone; melatonin; mice; pituitary gland	CIRCADIAN-RHYTHMS; PINEAL-GLAND; DECARBOXYLASE ACTIVITY; SLEEP; SYSTEM; BRAIN; LIGHT; RATS; PITUITARY; RELEASE	The synthesis and secretion of many hormones such as growth hormone (GH), melatonin, and corticosterone, exhibit temporal variations over each day and night. Oral administration of several nutritional factors, including L-ornithine, modulates these hormonal secretions and induces an acute increase in plasma GH levels. However, the impact of L-ornithine on the diurnal rhythms of hormone secretion remains unclear. In this study, we evaluated whether the diurnal rhythms of plasma GH, melatonin, and corticosterone secretion were altered by the daily administration of L-ornithine as well as the timing of the administration, in CBA/N mice. Our results showed that the plasma GH levels that peaked at light phase were amplified by L-ornithine (500 mg/kg) administered at Zeitgeber time (ZT) 22, but not at ZT10. Additionally, L-ornithine (1000 mg/kg) administered at ZT22 advanced the onset of the nocturnal rise of melatonin, which resulted in the elongation of the melatonin peak. On the other hand, L-ornithine (500 and 1000 mg/kg) administered at ZT10, but not at ZT22, suppressed the diurnal rhythm peaks of plasma corticosterone. The effects of L-ornithine on plasma GH rhythms lasted for at least 2 days after cessation of the daily administration. Running wheel activity during the active phase was slightly elevated by L-ornithine administration at ZT22, but the overall patterns were only slightly affected. L-Ornithine levels in the plasma and hypophysis after a single administration of L-ornithine at ZT22 were lower than those after administration at ZT10, suggesting that the metabolic rate of L-ornithine differs between day and night. In conclusion, our data suggest that a daily administration of L-ornithine regulates the diurnal rhythms of GH, melatonin, and corticosterone in a manner dependent on administration time, which might be related to the diurnal rhythms of L-ornithine metabolism.	[Matsuo, Haruka; Iwamoto, Ayaka; Otsuka, Tsuyoshi; Furuse, Mitsuhiro; Yasuo, Shinobu] Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Fukuoka 8128581, Japan; [Hishida, Yukihiro; Akiduki, Saori; Aoki, Mami] Kyowa Hakko Bio Co Ltd, Healthcare Prod Dev Ctr, Ibaraki, Japan	Yasuo, S (reprint author), Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	syasuo@brs.kyushu-u.ac.jp			Japanese Society for the Promotion of Science [24780286, 24650490, 23248046]; Faculty of Agriculture, Kyushu University	We thank Dr. Masayuki Iigo in Utsunomiya University for technical assistance for the melatonin radioimmunoassay. This work was in part supported by Grants-in-Aid for Young Scientists (B) (No.24780286) to S.Y., Challenging Exploratory Research (No.24650490) and Scientific Research (A) (No. 23248046) to M.F. from the Japanese Society for the Promotion of Science. The cost of publication was supported in part by the Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University.	Tujioka K, 2012, J NUTR SCI VITAMINOL, V58, P297; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; Jager K, 2013, AMINO ACIDS, V44, P423, DOI 10.1007/s00726-012-1348-1; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Chou TC, 2003, J NEUROSCI, V23, P10691; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; BUCCI L, 1990, NUTR RES, V10, P239, DOI 10.1016/S0271-5317(05)80265-9; Omori K, 2012, SLEEP BIOL RHYTHMS, V10, P38, DOI 10.1111/j.1479-8425.2011.00515.x; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Sage D, 2004, J BIOL RHYTHM, V19, P144, DOI 10.1177/0748730403261894; Arendt J., 1995, MELATONIN MAMMALIAN; ARNOLD MA, 1982, J NEUROSCI, V2, P674; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210; DONNADIEU M, 1985, J CLIN ENDOCR METAB, V60, P1132; Gardi J, 1999, AM J PHYSIOL-REG I, V277, pR1339; Kalsbeek A, 1999, NEUROSCIENCE, V91, P453, DOI 10.1016/S0306-4522(98)00635-6; Kokubo Takeshi, 2013, Biopsychosoc Med, V7, P6, DOI 10.1186/1751-0759-7-6; Kurata K, 2012, NEUROSCI LETT, V506, P287, DOI 10.1016/j.neulet.2011.11.024; Kurata K, 2011, NUTR NEUROSCI, V14, P243, DOI 10.1179/1476830511Y.0000000018; Kurata K, 2011, NEUROSCIENCE, V172, P226, DOI 10.1016/j.neuroscience.2010.10.076; Lee JY, 1998, J KOREAN SOC ENDOCRI, V13, P313; Miyazaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055452; Ohdo S, 2010, ADV DRUG DELIVER REV, V62, P859, DOI 10.1016/j.addr.2010.01.006; O'Kane RL, 2006, AM J PHYSIOL-ENDOC M, V291, pE412, DOI 10.1152/ajpendo.00007.2006; Pandi-Perumal SR, 2007, PROG NEURO-PSYCHOPH, V31, P1, DOI 10.1016/j.pnpbp.2006.06.020; ROSENSTEIN RE, 1990, BRAIN RES BULL, V25, P339, DOI 10.1016/0361-9230(90)90080-J; SABRY I, 1991, J PINEAL RES, V11, P86, DOI 10.1111/j.1600-079X.1991.tb00461.x; Shim S, 1997, PHYSIOL BEHAV, V62, P1365, DOI 10.1016/S0031-9384(97)00354-5; SOLIMAN KFA, 1982, NEUROSCI LETT, V33, P285, DOI 10.1016/0304-3940(82)90386-X; Veldhuis JD, 2008, J CLIN ENDOCR METAB, V93, P3597, DOI 10.1210/jc.2008-0620; WILLOUGHBY JO, 1978, BRAIN RES, V151, P413, DOI 10.1016/0006-8993(78)90899-5; Wu T, 2008, J NEUROSCI RES, V86, P3246, DOI 10.1002/jnr.21769	37	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	MAR	2015	32	2					225	234		10.3109/07420528.2014.965312		10	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CD3TP	WOS:000351005100007		
J	Lip, GYH; Rushton-Smith, SK; Goldhaber, SZ; Fitzmaurice, DA; Mantovani, LG; Goto, S; Haas, S; Bassand, JP; Camm, AJ; Ambrosio, G; Jansky, P; Al Mahmeed, W; Oh, S; van Eickels, M; Raatikainen, P; Steffel, J; Oto, A; Kayani, G; Accetta, G; Kakkar, AK				Lip, Gregory Y. H.; Rushton-Smith, Sophie K.; Goldhaber, Samuel Z.; Fitzmaurice, David A.; Mantovani, Lorenzo G.; Goto, Shinya; Haas, Sylvia; Bassand, Jean-Pierre; Camm, Alan John; Ambrosio, Giuseppe; Jansky, Petr; Al Mahmeed, Wael; Oh, Seil; van Eickels, Martin; Raatikainen, Pekka; Steffel, Jan; Oto, Ali; Kayani, Gloria; Accetta, Gabriele; Kakkar, Ajay K.		GARFIELD-AF Investigators	Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation	CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES			English	Article						atrial fibrillation; embolism; sex; stroke; women	EURO HEART SURVEY; ISCHEMIC-STROKE; RISK-FACTOR; PREDICTING STROKE; CLINICAL-TRIALS; FEMALE SEX; COHORT; WOMEN; THERAPY; THROMBOEMBOLISM	Background-Among patients with atrial fibrillation (AF), women are at higher risk of stroke than men. Using prospective cohort data from a large global population of patients with nonvalvular AF, we sought to identify any differences in the use of anticoagulants for stroke prevention in women and men. Methods and Results-This was a prospective multicenter observational registry with 858 randomly selected sites in 30 countries. A total of 17 184 patients with newly diagnosed (<= 6 weeks) nonvalvular AF and >= 1 additional investigator-defined stroke risk factor(s) were recruited (March 2010 to June 2013). The main outcome measure was the use of anticoagulants (vitamin K antagonists, factor Xa inhibitors, and direct thrombin inhibitors) for stroke prevention at AF diagnosis. Of 17 184 patients enrolled, 43.8% were women. More women than men were at moderate-to-high risk of stroke (CHADS(2) score >= 2: 65.1% versus 54.7%). Rates of anticoagulant use were not different overall (60.9% of men versus 60.8% of women) and in patients with a CHADS(2) score >= 2 (adjusted odds ratio for women versus men, 1.00; 95% confidence interval, 0.92-1.09). In patients at low risk (CHA(2)DS(2)-VASc of 0 in men and 1 in women), 41.8% of men and 41.1% of women received an anticoagulant. In patients at high risk (CHA(2)DS(2)-VASc score >= 2), 35.4% of men and 38.4% of women did not receive an anticoagulant. Conclusions-These contemporary global data show that anticoagulant use for stroke prevention is no different in men and women with nonvalvular AF. Thromboprophylaxis was, however, suboptimal in substantial proportions of men and women, with underuse in those at moderate-to-high risk of stroke and overuse in those at low risk.	[Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Rushton-Smith, Sophie K.; Kayani, Gloria; Accetta, Gabriele; Kakkar, Ajay K.] Thrombosis Res Inst, London SW3 6LR, England; [Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Fitzmaurice, David A.] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England; [Mantovani, Lorenzo G.] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan; [Haas, Sylvia] Tech Univ Munich, Inst Expt Oncol & Therapy Res, Haemostasis & Thrombosis Res Grp, D-80290 Munich, Germany; [Bassand, Jean-Pierre] Besancon Univ Hosp, Dept Cardiol, Besancon, France; [Camm, Alan John] St Georges Univ London, Dept Clin Sci, London, England; [Ambrosio, Giuseppe] Univ Perugia, Sch Med, Div Cardiol, I-06100 Perugia, Italy; [Jansky, Petr] Motol Univ Hosp, Dept Cardiovasc Surg, Prague, Czech Republic; [Al Mahmeed, Wael] Sheikh Khalifa Med City, Div Adult Cardiol, Abu Dhabi, U Arab Emirates; [Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [van Eickels, Martin] Bayer HealthCare Pharmaceut, Global Med Affairs, Berlin, Germany; [Raatikainen, Pekka] Tampere Univ Hosp, Heart Ctr Co, Tampere, Finland; [Steffel, Jan] Univ Zurich Hosp, Dept Cardiol, Cardiac Arrhythmia Unit, CH-8091 Zurich, Switzerland; [Oto, Ali] Hacettepe Univ, Dept Cardiol, Ankara, Turkey	Lip, GYH (reprint author), Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	g.y.h.lip@bham.ac.uk	Moia, Marco/J-2888-2015; Verheugt, F.W.A./H-8105-2014; Libis, Roman/O-9193-2015; 	Moia, Marco/0000-0002-7041-7755; Libis, Roman/0000-0003-0130-990X; Volpe, Massimo/0000-0002-9642-8380	Thrombosis Research Institute, London, United Kingdom; Bayer Pharma AG, Berlin, Germany	The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation was sponsored by the Thrombosis Research Institute, London, United Kingdom. Funding of the registry was provided through an educational research grant from Bayer Pharma AG, Berlin, Germany. The funding source had no involvement in the data collection, data analysis, or data interpretation. The authors had full access to all the data, and the corresponding author had final responsibility for the decision to submit for publication.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Hart RG, 1999, STROKE, V30, P1223; Gomberg-Maitland M, 2006, EUR HEART J, V27, P1947, DOI 10.1093/eurheartj/ehl103; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Pancholy SB, 2014, AM J CARDIOL, V113, P485, DOI 10.1016/j.amjcard.2013.10.035; Avgil TM, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI DOI 10.1001/JAMA.2012.3490; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Friberg L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3522; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kim ESH, 2009, ARTERIOSCL THROM VAS, V29, P279, DOI 10.1161/ATVBAHA.108.179796; Olesen JB, 2012, CHEST, V141, P147, DOI 10.1378/chest.11-0862; Osseby GV, 2004, PREV MED, V38, P121, DOI 10.1016/j.ypmed.2003.09.002; Stenestrand U, 2005, CIRCULATION, V112, P3225, DOI 10.1161/CIRCULATIONAHA.105.552984; Sullivan RM, 2012, AM J CARDIOL, V110, P1799, DOI 10.1016/j.amjcard.2012.08.014; Volgman AS, 2009, GENDER MED, V6, P419, DOI 10.1016/j.genm.2009.09.008	27	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7705	1941-7713		CIRC-CARDIOVASC QUAL	Circ.-Cardiovasc. Qual. Outcomes	MAR	2015	8	2		1			S12	S20		10.1161/CIRCOUTCOMES.114.001556		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD0MK	WOS:000350767800003		
J	Nishii, K; Nakamura, H; Orsolini, YJ				Nishii, Kazuaki; Nakamura, Hisashi; Orsolini, Yvan J.			Arctic summer storm track in CMIP3/5 climate models	CLIMATE DYNAMICS			English	Article						Arctic; Cyclone; Storm track; Climate change; Climate model	NORTHERN-HEMISPHERE; MOISTURE TRANSPORT; SEA-ICE; REANALYSIS; SYSTEM; OCEAN; TEMPERATURE; VARIABILITY; ATLANTIC; DATASET	Model performance and future projection of Arctic summertime storm-track activity and associated background states are assessed on the basis of Coupled Model Intercomparison Project Phase 3 (CMIP3)/5 (CMIP5) climate models. Despite some improvement in the CMIP5 models relative to the CMIP3 models, most of the climate models underestimate summertime storm-track activity over the Arctic Ocean compared to six reanalysis data sets as measured locally as the variance of subweekly fluctuations of sea level pressure. Its large inter-model spread (i.e., model-to-model differences) is correlated with that of the intensity of the Beaufort Sea High and the lower-tropospheric westerlies in the Arctic region. Most of the CMIP3/5 models project the enhancement of storm-track activity over the Arctic Ocean off the eastern Siberian and Alaskan coasts, the region called the Arctic Ocean Cyclone Maximum, in association with the strengthening of the westerlies in the warmed climate. A model with stronger enhancement of the storm-track activity tends to accompany stronger land-sea contrast in surface air temperature across the Siberian coast, which reflects greater surface warming over the continent and slower warming over the Arctic Ocean. Other processes, however, may also be likely to contribute to the future changes of the storm-track activity, which gives uncertainty in the projection by multiple climate models. Our analysis suggests that further clarification of those processes that influence storm-track activity over the Arctic is necessary for more reliable future projections of the Arctic climate.	[Nishii, Kazuaki; Nakamura, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Orsolini, Yvan J.] NILU Norwegian Inst Air Res, N-2027 Kjeller, Norway	Nishii, K (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	nishii@atmos.rcast.u-tokyo.ac.jp; hisashi@atmos.rcast.u-tokyo.ac.jp; yvan.orsolini@nilu.no			Japanese Ministry of Environment [A-1201]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2205]; MEXT; Norwegian Research Council [193690]; "Data Integration and Analysis System" Fund (DIAS)	KN and HN are supported in part by the Japanese Ministry of Environment through the Environment Research and Technology Development Fund A-1201 and by Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research in Innovative Areas 2205. KN is supported by MEXT also through the GRENE Arctic Climate Change Research Project. YO is supported by the Norwegian Research Council East Asian DecCen Project (193690). We acknowledge the World Climate Research Program's Working Group on Coupled Modeling, which is responsible for CMIP, and we thank all contributing climate modeling groups. The U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provided coordination and support for CMIP, and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also acknowledge the "Data Integration and Analysis System" Fund (DIAS) for National Key Technology and the Innovative Program of Climate Change Projection for the 21st Century ("Kakushin" program) from MEXT.	Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Chang EKM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018578; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Brayshaw DJ, 2008, J ATMOS SCI, V65, P2842, DOI 10.1175/2008JAS2657.1; Serreze MC, 2011, J CLIMATE, V24, P159, DOI 10.1175/2010JCLI3636.1; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; O'Gorman PA, 2010, P NATL ACAD SCI USA, V107, P19176, DOI 10.1073/pnas.1011547107; Zappa G, 2013, J CLIMATE, V26, P5846, DOI 10.1175/JCLI-D-12-00573.1; Serreze MC, 1988, J CLIMATE, V1, P1276, DOI 10.1175/1520-0442(1988)001<1276:SAITAB>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Woollings T, 2012, NAT GEOSCI, V5, P313, DOI [10.1038/ngeo1438, 10.1038/NGEO1438]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Cattiaux J, 2013, CLIM DYNAM, V41, P2889, DOI 10.1007/s00382-013-1731-y; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684; Zhang XD, 2013, NAT CLIM CHANGE, V3, P47, DOI [10.1038/NCLIMATE1631, 10.1038/nclimate1631]; Long ZX, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016985; Ulbrich U, 2008, J CLIMATE, V21, P1669, DOI 10.1175/2007JCLI1992.1; Inoue J, 2013, GEOPHYS RES LETT, V40, P864, DOI 10.1002/grl.50207; Saha S, 2006, J CLIMATE, V19, P3483, DOI 10.1175/JCLI3812.1; Lambert SJ, 2006, CLIM DYNAM, V26, P713, DOI 10.1007/s00382-006-0110-3; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Chang EKM, 2013, J CLIMATE, V26, P246, DOI 10.1175/JCLI-D-11-00707.1; Lang C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014300; Tilinina N, 2014, GEOPHYS RES LETT, V41, P1766, DOI 10.1002/2013GL058924; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Zappa G, 2013, J CLIMATE, V26, P5379, DOI 10.1175/JCLI-D-12-00501.1; Bengtsson L, 2006, J CLIMATE, V19, P3518, DOI 10.1175/JCLI3815.1; Serreze MC, 2001, J CLIMATE, V14, P1550, DOI 10.1175/1520-0442(2001)014<1550:TAFZAS>2.0.CO;2; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Serreze MC, 2008, J CLIMATE, V21, P1048, DOI 10.1175/2007JCLI1810.1; Harvey BJ, 2014, CLIM DYNAM, V43, P1171, DOI 10.1007/s00382-013-1883-9; Hoskins B. J., 1985, J ROY METEOR SOC, V111, P877, DOI [10.1002/qj.49711147002, DOI 10.1002/QJ.49711147002]; Inoue J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037380; Jungclaus JH, 2010, CLIM DYNAM, V34, P265, DOI 10.1007/s00382-009-0569-9; Mizuta R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053032; Ogi M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004514; Ogi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029897; Orsolini YJ, 2009, ATMOS OCEANIC SCI LE, V2, P62; Oshima K, 2004, POLAR METEOROL GLACI, V18, P30; Oshima K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027389; Screen JA, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015847; Simmonds I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039810; Simmonds I, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054259; Sorteberg A, 2007, CLIM DYNAM, V29, P131, DOI 10.1007/S00382-006-0222-9; Sorteberg A, 2008, TELLUS A, V60, P570, DOI 10.1111/j.1600-0870.2008.00314.x	50	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	MAR	2015	44	5-6					1311	1327		10.1007/s00382-014-2229-y		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CC4ZC	WOS:000350364500009		
J	Webb, MJ; Lock, AP; Bodas-Salcedo, A; Bony, S; Cole, JNS; Koshiro, T; Kawai, H; Lacagnina, C; Selten, FM; Roehrig, R; Stevens, B				Webb, Mark J.; Lock, Adrian P.; Bodas-Salcedo, Alejandro; Bony, Sandrine; Cole, Jason N. S.; Koshiro, Tsuyoshi; Kawai, Hideaki; Lacagnina, Carlo; Selten, Frank M.; Roehrig, Romain; Stevens, Bjorn			The diurnal cycle of marine cloud feedback in climate models	CLIMATE DYNAMICS			English	Article						Diurnal cycle; Cloud feedback; Climate change	LIQUID WATER PATH; STRATOCUMULUS; SIMULATIONS; PARAMETERIZATION; VARIABILITY; CIRCULATION; FUTURE; OCEANS; ECMWF	We examine the diurnal cycle of marine cloud feedback using high frequency outputs in CFMIP-2 idealised uniform +4 K SST perturbation experiments from seven CMIP5 models. Most of the inter-model spread in the diurnal mean marine shortwave cloud feedback can be explained by low cloud responses, although these do not explain the model responses at the neutral/weakly negative end of the feedback range, where changes in mid and high level cloud properties are more important. All of the models show reductions in marine low cloud fraction in the warmer climate, and these are in almost all cases largest in the mornings when more cloud is present in the control simulations. This results in shortwave cloud feedbacks being slightly stronger and having the largest inter-model spread at this time of day. The diurnal amplitudes of the responses of marine cloud properties to the warming climate are however small compared to the inter-model differences in their diurnally meaned responses. This indicates that the diurnal cycle of cloud feedback is not strongly relevant to understanding inter-model spread in overall cloud feedback and climate sensitivity. A number of unusual behaviours in individual models are highlighted for future investigation.	[Webb, Mark J.; Lock, Adrian P.; Bodas-Salcedo, Alejandro] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Bony, Sandrine] Inst Pierre Simon Laplace, Lab Meteorol Dynam, Paris, France; [Cole, Jason N. S.] Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Koshiro, Tsuyoshi; Kawai, Hideaki] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Lacagnina, Carlo; Selten, Frank M.] Royal Netherlands Meteorol Inst, KNMI, NL-3730 AE De Bilt, Netherlands; [Roehrig, Romain] CNRM, Toulouse, France; [Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Webb, MJ (reprint author), Met Off Hadley Ctr, FitzRoy Rd, Exeter EX1 3PB, Devon, England.	mark.webb@metoffice.gov.uk	Stevens, Bjorn/A-1757-2013	Stevens, Bjorn/0000-0003-3795-0475	Joint DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]; European Union [244067]	We would like to thank Knut von Salzen and William Ingram for helpful comments on the manuscript, and Mark Ringer and Tim Andrews for useful discussions. This work was supported by the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101). The research leading to these results has received funding from the European Union, Seventh Framework Programme (FP7/2007-2013) under grant agreement number 244067 via the EU Cloud Intercomparison and Process Study Evaluation project (EUCLIPSE). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. For CMIP the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We would like to acknowledge in particular Philip Bentley, Alejandro Bodas-Salcedo, Sandrine Bony, Jason Cole, Herve Douville, Jean-Louis Dufresne, Hideaki Kawai, Jamie Kettleborough, Tsuyoshi Koshiro, Carlo Lacagnina, Marc Salzmann, Frank Selten, Yoko Tsushima, Sophie Tyteca, and Jonny Williams for their efforts in preparing cfSites outputs from the models.	Andrews T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032273; Zhang MH, 2008, J CLIMATE, V21, P4859, DOI 10.1175/2008JCLI2237.1; Randall DA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Wu TW, 2010, CLIM DYNAM, V34, P123, DOI 10.1007/s00382-008-0487-2; Klein SA, 1999, MON WEATHER REV, V127, P2514, DOI 10.1175/1520-0493(1999)127<2514:VASOFC>2.0.CO;2; Vial J, 2013, CLIM DYNAM, V41, P3339, DOI 10.1007/s00382-013-1725-9; Lacagnina C, 2014, CLIM DYNAM, V43, P2777, DOI 10.1007/s00382-014-2093-9; Gregory J, 2008, J CLIMATE, V21, P58, DOI 10.1175/2007JCLI1834.1; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; von Salzen K, 2013, ATMOS OCEAN, V51, P104, DOI 10.1080/07055900.2012.755610; Webb MJ, 2013, CLIM DYNAM, V40, P677, DOI 10.1007/s00382-012-1336-x; Zhang YY, 2005, Q J ROY METEOR SOC, V131, P1567, DOI 10.1256/qj.04.103; Roehrig R, 2013, J CLIMATE, V26, P6471, DOI 10.1175/JCLI-D-12-00505.1; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; O'Dell CW, 2008, J CLIMATE, V21, P1721, DOI 10.1175/2007JCLI1958.1; Bony S, 2001, J ATMOS SCI, V58, P3158, DOI 10.1175/1520-0469(2001)058<3158:APOTCA>2.0.CO;2; Lin PF, 2013, ADV ATMOS SCI, V30, P819, DOI 10.1007/s00376-012-2137-1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; He J, 2014, GEOPHYS RES LETT, V41, P2614, DOI 10.1002/2014GL059435; Jiang JH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017237; Zelinka MD, 2013, J CLIMATE, V26, P5007, DOI 10.1175/JCLI-D-12-00555.1; Soden BJ, 2004, J CLIMATE, V17, P3661, DOI 10.1175/1520-0442(2004)017<3661:OTUOCF>2.0.CO;2; Bouniol D, 2012, J APPL METEOROL CLIM, V51, P534, DOI 10.1175/JAMC-D-11-051.1; Hazeleger W, 2010, B AM METEOROL SOC, V91, P1357, DOI 10.1175/2010BAMS2877.1; RANDALL DA, 1991, J ATMOS SCI, V48, P40, DOI 10.1175/1520-0469(1991)048<0040:DVOTHC>2.0.CO;2; Webb M, 2001, CLIM DYNAM, V17, P905, DOI 10.1007/s003820100157; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Wood R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015371; Bentsen M, 2012, GEOSCI MODEL DEV DIS, V5, P2843, DOI [10.5194/gmdd-5-2843-2012, DOI 10.5194/GMDD-5-2843-2012]; Bony S, 2011, CLIVAR EXCH, V56, P2; Bretherton CS, 2006, US CLIVAR VARIATIONS, V4, P7; Duynkerke PG, 2004, Q J ROY METEOR SOC, V130, P3269, DOI 10.1256/qj.03.139; Hazeleger W, 2012, CLIM DYNAM, DOI [10.1007/s00382-011-1228-5ed, DOI 10.1007/S00382-011-1228-5ED]; Hourdin F, 2013, CLIM DYNAM, V40, P2167, DOI 10.1007/s00382-012-1411-3; Kawai H, 2006, SOLA, V2, P17, DOI 10.2151/sola.2006-005; Li J, 2010, J ATMOS SCI, V67, P2372, DOI 10.1175/2010JAS3282.1; Mapes B, 2009, J CLIMATE, V22, P244, DOI 10.1175/2008JCLI2203.1; Ringer MA, 2006, GEOPHYS RES LETT, V33, P7; Seethala C, 2010, J GEOPHYS RES-ATMOS, V115, DOI [10.1029/2009JD012612, 10.1029/2009JD012662]; Stevens B, 2013, J ADV MODEL EARTH SY; Taylor KE, 2011, AM METEOR SOC B, DOI [10.1175/BAMS-D-11-00094.1, DOI 10.1175/BAMS-D-11-00094.1]; Teixeira J, 2011, J CLIMATE, V24, P5223, DOI 10.1175/2011JCLI3672.1; Voldoire A., 2012, CLIM DYNAM, V40, P2091, DOI [10.1007/s00382-011-1259-y, DOI 10.1007/S00382-011-1259-Y]; Yukimoto S., 2011, 64 MET RES I; Zelinka MD, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013817; Zhang MH, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2012MS000182	47	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	MAR	2015	44	5-6					1419	1436		10.1007/s00382-014-2234-1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CC4ZC	WOS:000350364500015		
J	Ohnishi, T; Shiraishi, H; Fukaya, S; Tanaka, T; Watanabe, S				Ohnishi, T.; Shiraishi, H.; Fukaya, S.; Tanaka, T.; Watanabe, S.			Verruciform xanthoma: report of three patients with comparative dermoscopic study	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article								We report three cases of verruciform xanthoma (VX) in male patients aged 82, 88 and 39 years, respectively. The clinical appearance was of a mulberry-like area consisting of small papillae, which is typical of and specific to VX, and the diagnosis were histologically confirmed in all cases. Dermoscopy revealed that each surface papilla contained linear or hairpin vessels, which were surrounded by a marginal whitish rim. These structures are thought to correspond to dilated vessels in dermal papillae and papillated acanthotic epidermis, respectively. Furthermore, observation under compression (similar to diascopy) revealed yellow dots and debris, reflecting lipid-laden foam cells. In order to compare these findings with those of other disorders with similar findings, two patients with xanthogranuloma, six with sebaceous naevus, and three with senile sebaceous hyperplasia were examined. The dermoscopic findings in these patients were not similar to those of VX. Therefore, we believe that the above dermoscopic findings are specific to VX and could be helpful in diagnosis.	[Ohnishi, T.; Shiraishi, H.; Fukaya, S.; Tanaka, T.; Watanabe, S.] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo 1738605, Japan	Ohnishi, T (reprint author), Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, 11-1,Kaga 2, Tokyo 1738605, Japan.	ohnishi@med.teikyo-u.ac.jp					Aghassi D, 2000, J AM ACAD DERMATOL, V43, P49, DOI 10.1067/mjd.2000.105566; Kishi A, 2005, J VISUAL DERMATOL, V4, P346; Ohnishi T, 2014, AUSTRALAS J DERMATOL, V55, pE21, DOI 10.1111/ajd.12023; Palmer A, 2007, DERMATOLOGY, V215, P256, DOI 10.1159/000106586; Takizawa H, 2001, CLIN EXP DERMATOL, V26, P730, DOI 10.1046/j.1365-2230.2001.00926-5.x; Tanaka T, 2010, EUR J DERMATOL, V20, P132, DOI 10.1684/ejd.2010.0832	6	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	MAR	2015	40	2					156	159		10.1111/ced.12503		4	Dermatology	Dermatology	CD6CK	WOS:000351176400011		
J	Kanoto, M; Toyoguchi, Y; Hosoya, T; Kuchiki, M; Sugai, Y				Kanoto, M.; Toyoguchi, Y.; Hosoya, T.; Kuchiki, M.; Sugai, Y.			Radiological Image Features of the Atypical Teratoid/Rhabdoid Tumor in Adults: A Systematic Review	CLINICAL NEURORADIOLOGY			English	Review						Atypical teratoid/rhabdoid tumor; Primitive neuroectodermal tumor; CT; MRI; Angiography	MALIGNANT RHABDOID TUMOR; CENTRAL-NERVOUS-SYSTEM; PRIMITIVE NEUROECTODERMAL TUMOR; BRAIN; CT; PATIENT; CHILDREN; SPINE	Atypical teratoid/rhabdoid tumor (AT/RT) occurs in children less than 3 years old, and has a very poor prognosis. AT/RT seldom occurs in adult. We have experienced four cases of AT/RT at our institute. The purpose of this study is to evaluate the radiological image findings of adult-onset AT/RT and to conduct a systematic review. Image findings of four AT/RTs in our institute were retrospectively evaluated by an experienced neuroradiologist. If the images were unavailable, image findings were evaluated from the former image interpretation report. We assembled papers of adult-onset AT/RT (n = 38) and evaluated the image findings. AT/RT occurs in a variety of sites (spinal region, pineal region, suprasellar region, jugular foramen, and so on). High density on computed tomography (CT) was seen in 10 of 11 cases; mixed intensity in T2-weighted image was seen in 13 of 18 cases; and high intensity on diffusion-weighted image (DWI) was seen in 3 of 3 cases. Contrast enhancement was observed in all cases in which images were available. We have experienced four adult-onset AT/RT cases at our institute and have evaluated image findings through systematic review. The image findings of high density on CT, high intensity on DWI, with low apparent diffusion coefficient, and a heterogenous component should lead to an inclusion of AT/RT in the differential diagnosis of a tumor; these findings may be able to suggest AT/RT; however, they cannot make the diagnosis.	[Kanoto, M.; Toyoguchi, Y.; Hosoya, T.; Kuchiki, M.; Sugai, Y.] Yamagata Univ, Dept Diagnost Radiol, Fac Med, Yamagata 9909585, Japan	Kanoto, M (reprint author), Yamagata Univ, Dept Diagnost Radiol, Fac Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	mkanoto@med.id.yamagata-u.ac.jp			Global Center of Excellence program of the Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid from the Global Center of Excellence program of the Japan Society for the Promotion of Science. We are permitted to publish by ECR 2013 (European Congress of Radiology), Poster C-0765 titled "Image Findings of Atypical Teratoid/Rhabdoid Tumors in Adult." DOI: 10.1594/ecr2013/C-0765.	Chacko G, 2007, J NEURO-ONCOL, V84, P217, DOI 10.1007/s11060-007-9361-z; Makuria AT, 2008, J NEURO-ONCOL, V88, P321, DOI 10.1007/s11060-008-9571-z; Meyers SP, 2006, AM J NEURORADIOL, V27, P962; Yamashita Y, 2009, NEUROL RES, V31, P940, DOI 10.1179/174313209X382520; HAAS JE, 1981, HUM PATHOL, V12, P646, DOI 10.1016/S0046-8177(81)80050-0; Samaras V, 2009, CLIN NEUROPATHOL, V28, P1; Ingold B, 2006, ACTA NEUROPATHOL, V111, P56, DOI 10.1007/s00401-005-1112-7; Horger M, 2009, AM J ROENTGENOL, V193, P1384, DOI 10.2214/AJR.09.2486; Takahashi K, 2011, BRAIN TUMOR PATHOL, V28, P71, DOI 10.1007/s10014-010-0008-y; Niwa T, 2009, MAGN RESON MED SCI, V8, P135; Eran A, 2010, PEDIATR RADIOL, V40, P1254, DOI 10.1007/s00247-009-1429-9; Arrazola J, 2000, NEURORADIOLOGY, V42, P363; Ashraf R, 1997, MED PEDIATR ONCOL, V28, P223, DOI 10.1002/(SICI)1096-911X(199703)28:3<223::AID-MPO14>3.0.CO;2-F; CALDEMEYER KS, 1994, PEDIATR NEUROSURG, V21, P232, DOI 10.1159/000120841; Douglas-Akinwande AC, 2009, ACAD RADIOL, V16, P1356, DOI 10.1016/j.acra.2009.05.004; Endo S, 2013, NEUROPATHOLOGY, V33, P185, DOI 10.1111/j.1440-1789.2012.01336.x; Erickson ML, 2005, J NEURO-ONCOL, V74, P311, DOI 10.1007/s11060-004-7560-4; Fisher BJ, 1996, CAN J NEUROL SCI, V23, P257; Fuller CE, 2001, HUM PATHOL, V32, P1102, DOI 10.1053/hupa.2001.28252; Han L, 2011, AM J NEURORADIOL, V32, P103, DOI 10.3174/ajnr.A2361; Han SR, 2007, J CLIN NEUROSCI, V14, P55, DOI 10.1016/j.jocn.2006.03.034; HORN M, 1992, ACTA NEUROPATHOL, V83, P445; Jose P, 2003, J NEUROONCOL, V61, P121; Kachhara R, 2003, NEUROL INDIA, V51, P273; Kanoto M, POSTER, DOI [10.1594/ecr2013/C-0765, DOI 10.1594/ECR2013/C-0765]; Kawaguchi T, 2004, ACTA NEUROCHIR, V146, P1033, DOI 10.1007/s00701-004-0313-5; Kuge A, 2012, BRAIN TUMOR PATHOL, V29, P177, DOI 10.1007/s10014-011-0075-8; Kuge A, 2000, NEUROL SURG TOKYO, V28, P351; Lutterbach J, 2001, J NEURO-ONCOL, V52, P49, DOI 10.1023/A:1010683416555; Mirone G, 2009, J CLIN NEUROSCI, V16, P1495, DOI 10.1016/j.jocn.2009.02.011; Mutou J, 2011, NEUROL MED-CHIR, V51, P449; Nishio S, 1998, ACTA NEUROCHIR, V140, P207, DOI 10.1007/s007010050087; Raisanen J, 2004, DIAGN CYTOPATHOL, V31, P60, DOI 10.1002/dc.20064; Raisanen J, 2005, BRAIN PATHOL, V15, P23; Rezanko T, 2006, NEUROPATHOLOGY, V26, P57, DOI 10.1111/j.1440-1789.2006.00624.x; Shonka Nicole A, 2011, J Clin Med Res, V3, P85, DOI 10.4021/jocmr535w; Sugita Y, 1999, PATHOL INT, V49, P1114, DOI 10.1046/j.1440-1827.1999.00988.x; Warmuth-Metz M, 2008, NEURORADIOLOGY, V50, P447, DOI 10.1007/s00234-008-0369-7; Zarovnaya EL, 2007, J NEURO-ONCOL, V84, P49, DOI 10.1007/s11060-007-9339-x	39	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	MAR	2015	25	1					55	60		10.1007/s00062-013-0282-2		6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CD1ZK	WOS:000350873000008		
J	Nakajima, A; Inoue, E; Shimizu, Y; Kobayashi, A; Shidara, K; Sugimoto, N; Seto, Y; Tanaka, E; Taniguchi, A; Momohara, S; Yamanaka, H				Nakajima, Ayako; Inoue, Eisuke; Shimizu, Yoko; Kobayashi, Akiko; Shidara, Kumi; Sugimoto, Naoki; Seto, Yohei; Tanaka, Eiichi; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi			Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis	CLINICAL RHEUMATOLOGY			English	Article						Comorbidity; Methotrexate; Physical function; Quality of life; Rheumatoid arthritis; Treatment strategy	MODIFYING ANTIRHEUMATIC DRUGS; LARGE OBSERVATIONAL COHORT; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; MORTALITY; VALIDATION; RECOMMENDATIONS; CLASSIFICATION; QUESTIONNAIRE; MANAGEMENT	To clarify the impact of comorbidities on treatment strategies and outcomes in patients with rheumatoid arthritis (RA) using a large observational RA cohort, the presence of comorbidities was assessed using the Charlson Comorbidity Index (CCI). Changes in medication, disease activity by Disease Activity Score-28 joint count (DAS28) over 6 months, disability assessed by the Japanese version of the Health Assessment Questionnaire (J-HAQ), and quality of life by EuroQOL-5-Dimensions (EQ-5D) over 1 year in patients with high disease activity (DAS28 > 5.1) at baseline were assessed according to age-adjusted CCI (CCIA) and categorized into four groups (CCIA 0, 1-2, 3-4, and a parts per thousand yen5). Among 5,317 patients, 975 patients (18.3 %) had at least one comorbidity listed by CCI. DAS28, J-HAQ, and EQ-5D increased in severity with increased CCIA levels. Among patients with high disease activity (n = 267), treatment with methotrexate and/or biologics and improved DAS28 scores, shown by attenuated intensity, were associated with increased CCIA levels. J-HAQ improved from 1.29 +/- 0.31 to 0.87 +/- 0.37 in 1 year in the CCIA 0 group. The adjusted difference (standard error) in J-HAQ at 1 year in CCIA 1-2, 3-4, and a parts per thousand yen5 groups was worse than J-HAQ in the CCIA 0 group by 0.32 (0.09, p < 0.001), 0.45 (0.10, p < 0.001), and 0.45 (0.15, p < 0.01), respectively. The magnitude of improvement of EQ-5D was significantly attenuated with increasing CCIA levels. Thus, patients with comorbidities may not experience the same degree of benefit from recent RA treatments compared with patients without comorbidities in daily practice.	[Nakajima, Ayako; Inoue, Eisuke; Shimizu, Yoko; Kobayashi, Akiko; Shidara, Kumi; Sugimoto, Naoki; Seto, Yohei; Tanaka, Eiichi; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan	Nakajima, A (reprint author), Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, 10-22 Kawada Cho, Tokyo 1620054, Japan.	ayakonkj@ior.twmu.ac.jp			Abbvie; Astellas; Bristol-Myers Squibb; Chugai; Eisai; Mitsubishi Tanabe; Pfizer; Takeda; Jannsen	Shigeki Momohara speaker fee from Abbvie, Astellas, Bristol-Myers Squibb, Chugai, Eisai, Mitsubishi Tanabe, Pfizer, and Takeda; Hisashi Yamanaka speaker fee from Abbvie, Astellas, Bristol-Myers Squibb, Chugai, Eisai, Jannsen, Mitsubishi Tanabe, Pfizer and Takeda; All other authors: None.	Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Radovits BJ, 2009, RHEUMATOLOGY, V48, P906, DOI 10.1093/rheumatology/kep129; Radner H, 2010, ANN RHEUM DIS, V69, P536, DOI 10.1136/ard.2009.118430; Lieffers JR, 2011, CANCER-AM CANCER SOC, V117, P1957, DOI 10.1002/cncr.25653; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Yamanaka H, 2013, MOD RHEUMATOL, V23, P1, DOI 10.1007/s10165-012-0702-1; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Wolfe F, 2007, SCAND J RHEUMATOL, V36, P172, DOI 10.1080/03009740601153774; Seto Y, 2013, MOD RHEUMATOL, V23, P1179, DOI 10.1007/s10165-012-0816-5; Welsing PMJ, 2005, ARTHRITIS RHEUM, V52, P2616, DOI 10.1002/art.21259; Radner H, 2011, RHEUMATOLOGY, V50, P381, DOI 10.1093/rheumatology/keq334; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Hyrich K, 2006, ANN RHEUM DIS, V65, P895, DOI 10.1136/ard.2005.043158; Iikuni N, 2008, RHEUMATOLOGY, V47, P519, DOI 10.1093/rheumatology/ken047; Nakajima A, 2011, MOD RHEUMATOL, V21, P594, DOI 10.1007/s10165-011-0457-0; PINCUS T, 1994, ANN INTERN MED, V120, P26; Ranganath VK, 2013, RHEUMATOLOGY, V52, P1809, DOI 10.1093/rheumatology/ket224; Tanaka E, 2013, MOD RHEUMATOL, V23, P742, DOI 10.1007/s10165-012-0729-3; Yamanaka Hisashi, 2007, Mod Rheumatol, V17, P283, DOI 10.1007/s10165-007-0587-6	33	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	MAR	2015	34	3					441	449		10.1007/s10067-014-2750-8		9	Rheumatology	Rheumatology	CC9GX	WOS:000350677600005		
J	Sawng, YW; Lee, J; Motohashi, K				Sawng, Yeong-Wha; Lee, Jungmann; Motohashi, Kazuyuki			Digital convergence service from the viewpoint of provider and user factors using technology acceptance and diffusion model	CLUSTER COMPUTING-THE JOURNAL OF NETWORKS SOFTWARE TOOLS AND APPLICATIONS			English	Article						Adoption and diffusion; IT convergence service; Usefulness perception; Reuse intention; Hofstede's cultural model; Internet Protocol Television (IPTV)	CULTURE; PRODUCTS; BEHAVIOR; COUNTRY; TRUST	Convergence diffuses new business models and derives significant changes across global industrial activities. As such, convergence is emerging as a hot issue within IT industries nowadays. Particularly, digital convergence is creating yet another distinct blue ocean, as computers are evolving from their combination with communications to their combination with broadcasting and communications involving media contents. The objective of this study is to examine the differentiated characteristics of IT convergence service vis-A -vis the exiting IT service from the viewpoint of service providers and service users, and to define the cultural difference between the two nations (South Korea and Japan) based on Hofstede's cultural model (2001, 2005). Thus, using (1989) TAM (Technology Acceptance Model) theory, represented by IS adaption and use, and (2003) IS success model, this study developed a research model in the form of a structural equation. This model is based conceptually on the viewpoint of (1992, 2003) acceptance and diffusion, and on the viewpoint of (2002) use and diffusion, and was designed based on theory of reasoned action and theory of planned behavior considering the service user's personal attitude and behavior elements. In order to perform a statistical verification of this research model, the representative analysis tool for a structural equation, the partial least squares method, was used. As a result of such statistical analysis, it was confirmed that that there was a significant change in consumers' perception and behaviors regarding the acceptance and diffusion of innovations according to cultural difference between the two nations. In addition, subsequent diverse implications were derived, and as such, this study made a significant contribution to the development of future research on convergence innovation services.	[Sawng, Yeong-Wha] Konkuk Univ, Dept Management Technol, William F Miller Sch Management Technol, Seoul, South Korea; [Lee, Jungmann] Hoseo Univ, Dept IT Management, Cheonan, South Korea; [Motohashi, Kazuyuki] Univ Tokyo, Dept Technol Management Innovat, Grad Sch Engn, Tokyo, Japan	Lee, J (reprint author), Hoseo Univ, Dept IT Management, Cheonan, South Korea.	sawng@konkuk.ac.kr; mann@hoseo.edu; motohashi@tmi.t.u-tokyo.ac.jp			Konkuk University	This paper was supported by Konkuk University in 2013.	Adner R., 2000, WHARTON MANAGING EME, P57; Altgeld J., 2007, WHITEPAPER IPTV VOD; Hofstede G, 2010, J INT BUS STUD, V41, P1339, DOI 10.1057/jibs.2010.31; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Harris LC, 2004, J RETAILING, V80, P139, DOI 10.1016/j.jretai.2004.04.002; Lederer AL, 2000, DECIS SUPPORT SYST, V29, P269, DOI 10.1016/S0167-9236(00)00076-2; de Mooij M, 2002, J RETAILING, V78, P61, DOI 10.1016/S0022-4359(01)00067-7; Shih CF, 2004, J MARKETING, V68, P59, DOI 10.1509/jmkg.68.1.59.24029; [Anonymous], 1951, GEN THEORY ACTION; PARASURAMAN A, 1994, J MARKETING, V58, P111, DOI 10.2307/1252255; Chin WW, 1998, QUANT METH SER, P295; Gefen D, 2003, MIS QUART, V27, P51; Tellis GJ, 2003, MARKET SCI, V22, P188, DOI 10.1287/mksc.22.2.188.16041; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9; Hofstede G, 2004, CROSS-CULT RES, V38, P52, DOI 10.1177/1069397103259443; Bonometti R., 2002, J GLOB COMPET, V10, P124; Commons John R., 1931, AM ECON REV, V21, P648; Davis F. D., 1989, MIS Q, V13, P318, DOI DOI 10.2307/249008; De Mooij Marieke, 2010, GLOBAL MARKETING ADV; DeLone W., 1992, INFORMATION SYSTEMS, V3, P60, DOI DOI 10.1287/ISRE.3.1.60; DICKERSON MD, 1983, J CONSUM RES, V10, P225, DOI 10.1086/208961; Duysters G., 1998, INT J EC BUSINESS, V5, P355; Eurostat, 2002, EUR SPEND THEIR TIM; Fishbein M., 1975, BELIEF ATTITUDE INTE; GATIGNON H, 1985, J CONSUM RES, V11, P849, DOI 10.1086/209021; Gerard J.T., 2009, J INT MARKETING, V17, P1; Hair J. F. Jr., 1998, MULTIVARIATE DATA AN; Hall Edward T., 1976, CULTURE; Han EunJung, 2010, [The Journal of Society for e-Business Studies, 한국전자거래학회지], V15, P219; Harmer T, 2007, CLUSTER COMPUT, V10, P277, DOI 10.1007/s10586-007-0030-y; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hofstede G., 2005, CULTURES ORG SOFTWAR; Hofstede G., 2001, CULTURES CONSEQUENCE; Kluckhohn FR, 1961, VARIATIONS VALUE ORI; Marios K., 2002, INFORM SYST RES, V13, P205; Melinda L.A., 2010, J BUS RES, V63, P71; Mick D., 1998, J MARKETING, V54, P1; Moore G., 1991, CROSSING CHASM; Moore G. C., 1991, INFORM SYST RES, V2, P173, DOI DOI 10.1287/ISRE.2.3.192; Nguyen T.-D., 2013, J NETW SOFTW TOOLS A, DOI [10.1007/s10586-013-0324-15, DOI 10.1007/S10586-013-0324-15]; Peter J., 1981, J MARKETING RES, V16, P6; Robertson T, 1971, INNOVATIVE BEHAV COM; Rogers E., 2003, DIFFUSION INNOVATION; ROGERS EM, 1962, PUBLIC OPIN QUART, V26, P435, DOI 10.1086/267118; Rogers Everett, 1995, DIFFUSION INNOVATION; Rosanna G., 2002, J PRODUCTION MANAGEM, V19, P110; Tung G.S., 2011, AUST J BUS MANAG RES, V1, P30; Yeniyurt S, 2003, INT MARKET REV, V20, P377, DOI 10.1108/02651330310485153	49	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-7857	1573-7543		CLUSTER COMPUT	Cluster Comput.	MAR	2015	18	1					293	308		10.1007/s10586-014-0347-2		16	Computer Science, Information Systems; Computer Science, Theory & Methods	Computer Science	CC5JS	WOS:000350395500026		
J	Zhang, TR				Zhang, Tanran			Uniformization of a Once-Punctured Annulus	COMPUTATIONAL METHODS AND FUNCTION THEORY			English	Article						Uniformization; Hyperbolic metric; Punctured annulus; Collar; Extremal length	LENGTHS	The universal cover or the covering group of a hyperbolic Riemann surface is important but hard to express explicitly. It can be, however, detected by the uniformization and a suitable description of . Beardon proposed five different ways to describe twice-punctured disks using fundamental domain, hyperbolic length, collar and extremal length in 2012. We parameterize a once-punctured annulus in terms of five parameter pairs and give explicit formulas about the hyperbolic structure and the complex structure of . Several degenerate cases are also treated.	[Zhang, Tanran] Soochow Univ, Dept Math, Suzhou 215006, Peoples R China; [Zhang, Tanran] Tohoku Univ, Grad Sch Informat Sci, Div Math, Aoba Ku, Sendai, Miyagi 9808579, Japan	Zhang, TR (reprint author), Soochow Univ, Dept Math, 1 Shizi St, Suzhou 215006, Peoples R China.	xubu3@163.com					Anderson GD, 1997, CONFORMAL INVARIANTS; BASMAJIAN A, 1990, ANN ACAD SCI FENN A1, V15, P65; Beardon A.F., 1983, GEOMETRY DISCRETE GR, V91; Beardon AF, 2012, COMPUT METH FUNCT TH, V12, P585; Buser P., 1992, PROGR MATH, V106; Byrd P.F., 1954, HDB ELLIPTIC INTEGRA; Farkas H.M., 2001, THETA CONSTANTS RIEM, V37; HEJHAL DA, 1974, MATH Z, V137, P7, DOI 10.1007/BF01213931; HEMPEL JA, 1988, P AM MATH SOC, V103, P513, DOI 10.2307/2047171; HEMPEL JA, 1989, B AUST MATH SOC, V39, P369; Hempel J.A., 1989, J LOND MATH SOC, V40, P269; Keen L., 2007, LONDON MATH SOC STUD, V68; Lehto O., 1973, GRUNDLEHREN MATH; MASKIT B, 1985, ANN ACAD SCI FENN-M, V10, P381; NEVANLINNA R., 1970, ANAL FUNCTIONS; Ohtsuka M., 1970, DIRICHLET PROBLEMS E; Sugawa T., 1998, COMPLEX VARIABLES, V36, P311, DOI 10.1080/17476939808815116	17	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-9447	2195-3724		COMPUT METH FUNCT TH	Comput. Methods Funct. Theory	MAR	2015	15	1					75	91		10.1007/s40315-014-0095-6		17	Mathematics, Applied; Mathematics	Mathematics	CC9FY	WOS:000350674900005		
J	Nakamoto, T; Arimura, H; Nakamura, K; Shioyama, Y; Mizoguchi, A; Hirose, T; Honda, H; Umezu, Y; Nakamura, Y; Hirata, H				Nakamoto, Takahiro; Arimura, Hidetaka; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Mizoguchi, Asumi; Hirose, Taka-aki; Honda, Hiroshi; Umezu, Yoshiyuki; Nakamura, Yasuhiko; Hirata, Hideki			A computerized framework for monitoring four-dimensional dose distributions during stereotactic body radiation therapy using a portal dose image-based 2D/3D registration approach	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Stereotactic body radiation therapy; Four-dimensional dose distribution; 2D/3D registration; Optimization	IMRT VERIFICATION; ELECTRON-DENSITY; PROSTATE-CANCER; RADIOTHERAPY; CONVOLUTION; MOTION; RECONSTRUCTION; TOMOGRAPHY; 4D-CT	A computerized framework for monitoring four-dimensional (4D) dose distributions during stereotactic body radiation therapy based on a portal dose image (PDI)-based 2D/3D registration approach has been proposed in this study. Using the PDI-based registration approach, simulated 4D "treatment" CT images were derived from the deformation of 3D planning CT images so that a 2D planning PDI could be similar to a 2D dynamic clinical PDI at a breathing phase. The planning PDI was calculated by applying a dose calculation algorithm (a pencil beam convolution algorithm) to the geometry of the planning CT image and a virtual water equivalent phantom. The dynamic clinical PDIs were estimated from electronic portal imaging device (EPID) dynamic images including breathing phase data obtained during a treatment. The parameters of the affine transformation matrix were optimized based on an objective function and a gamma pass rate using a Levenberg-Marquardt (LM) algorithm. The proposed framework was applied to the EPID dynamic images of ten lung cancer patients, which included 183 frames (mean: 18.3 per patient). The 4D dose distributions during the treatment time were successfully obtained by applying the dose calculation algorithm to the simulated 4D "treatment" CT images. The mean +/- standard deviation (SD) of the percentage errors between the prescribed dose and the estimated dose at an isocenter for all cases was 3.25 +/- 4.43%. The maximum error for the ten cases was 14.67% (prescribed dose: 1.50 Gy, estimated dose: 1.72 Gy), and the minimum error was 0.00%. The proposed framework could be feasible for monitoring the 4D dose distribution and dose errors within a patient's body during treatment. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakamoto, Takahiro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Div Med Quantum Sci, Fukuoka 8128582, Japan; [Arimura, Hidetaka; Hirata, Hideki] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci, Fukuoka 8128582, Japan; [Nakamura, Katsumasa; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Shioyama, Yoshiyuki] Saga Heavy Ion Med Accelerator Tosu, Saga, Japan; [Mizoguchi, Asumi] Kurume Univ Hosp, Fukuoka, Japan; [Hirose, Taka-aki; Umezu, Yoshiyuki; Nakamura, Yasuhiko] Kyushu Univ Hosp, Fukuoka 812, Japan	Arimura, H (reprint author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	arimurah@med.kyushu-u.ac.jp			Ministry Education, Culture, Sports Science and Technology (MEXT) [24103707]	This research was partially supported by the Ministry Education, Culture, Sports Science and Technology (MEXT), via a Grant-in-Aid for Scientific Research on Innovative Areas, 24103707, 2012-2013.	Anai Shigeo, 2011, Radiol Phys Technol, V4, P173, DOI 10.1007/s12194-011-0118-1; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; AHNESJO A, 1989, MED PHYS, V16, P577; Keall P, 2004, SEMIN RADIAT ONCOL, V14, P81, DOI 10.1053/j.semradonc.2003.10.006; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Admiraal MA, 2008, RADIOTHER ONCOL, V86, P55, DOI 10.1016/j.radonc.2007.11.022; Bortfeld T, 2004, SEMIN RADIAT ONCOL, V14, P41, DOI 10.1053/j.semradonc.2003.10.011; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431; Seco J, 2006, MED PHYS, V33, P540, DOI 10.1118/1.2161407; van Elmpt WJC, 2006, MED PHYS, V33, P2426, DOI 10.1118/1.2207315; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Guckenberger M, 2007, INT J RADIAT ONCOL, V69, P276, DOI 10.1016/j.ijrobp.2007.04.074; Renner WD, 2003, MED PHYS, V30, P2996, DOI 10.1118/1.1610771; Saw CB, 2005, MED DOSIM, V30, P145, DOI 10.1016/j.meddos.2005.05.001; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Sham E, 2008, MED PHYS, V35, P3317, DOI 10.1118/1.2936335; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; Low DA, 2003, MED PHYS, V30, P2455, DOI 10.1118/1.1598711; Arimura H, 2012, J RADIAT RES, V53, P961, DOI 10.1093/jrr/rrs043; Battista Jerry J., 1992, Australasian Physical and Engineering Sciences in Medicine, V15, P159; Chen J, 2006, MED PHYS, V33, P584, DOI 10.1118/1.2168294; Flampouri S, 2006, PHYS MED BIOL, V51, P2763, DOI 10.1088/0031-9155/51/11/006; Gendrin C, 2012, RADIOTHER ONCOL, V102, P274, DOI 10.1016/j.radonc.2011.07.031; Levenberg K., 1944, Quarterly of Applied Mathematics, V2; MACKIE TR, 1985, MED PHYS, V12, P188, DOI 10.1118/1.595774; McNutt TR, 1996, MED PHYS, V23, P1381, DOI 10.1118/1.597872; Mizoguchi A, 2013, IEICE T D, VJ96-D, P813; Nielsen HB, 1999, IMMREP199905; Partridge M, 2002, MED PHYS, V29, P1847, DOI 10.1118/1.1494988; Press W. H., 1986, NUMERICAL RECIPES; Rosu M, 2007, MED PHYS, V34, P233, DOI 10.1118/1.2400624; Steciw S, 2005, MED PHYS, V32, P600, DOI 10.1118/1.1843471; Vassil AD, 2010, UROLOGY, V76, P1138; Xu L, 2008, IEEE ENG MED BIO, P5382; Yang M, 2008, MED PHYS, V35, P1932, DOI 10.1118/1.2905030	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	MAR	2015	40						1	12		10.1016/j.compmedimag.2014.12.003		12	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	CD2SE	WOS:000350928500001		
J	Kan, H; Miyati, T; Mase, M; Osawa, T; Ohno, N; Kasai, H; Arai, N; Kawano, M; Shibamoto, Y				Kan, Hirohito; Miyati, Tosiaki; Mase, Mitsuhito; Osawa, Tomoshi; Ohno, Naoki; Kasai, Harumasa; Arai, Nobuyuki; Kawano, Makoto; Shibamoto, Yuta			Dynamic state of water molecular displacement of the brain during the cardiac cycle in idiopathic normal pressure hydrocephalus	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Magnetic resonance imaging; Diffusion weighted imaging; Idiopathic normal pressure hydrocephalus; q-space	CEREBRAL-BLOOD-FLOW; SHUNT SURGERY; DIFFUSION; MRI; MANAGEMENT; GUIDELINES; PATTERN; IMAGES	The predictive accuracy of iNPH diagnoses could be increased using a combination of supplemental tests for iNPH. To evaluate the dynamic state of water displacement during the cardiac cycle in idiopathic normal pressure hydrocephalus (iNPH), we determined the change in water displacement using q-space analysis of diffusion magnetic resonance image. ECG-triggered single-shot diffusion echo planar imaging was used. Water displacement was obtained from the displacement probability profile calculated by Fourier transform of the signal decay fitted as a function of the reciprocal spatial vector q. Then maximum minus minimum displacement (delta-displacement), of all cardiac phase images was calculated. We assessed the delta-displacement in white matter in patients with iNPH and atrophic ventricular dilation (atrophic VD), and in healthy volunteers (control group). Delta-displacement in iNPH was significantly higher than those in the atrophic VD and control. This shows that water molecules of the white matter in iNPH are easily fluctuated by volume loading of the cranium during the cardiac cycle, due to the decrease in intracranial compliance. There was no significant correlation between delta-displacement and displacement. The delta-displacement and the displacement do not necessarily yield the same kind of information. Delta-displacement demonstrated to obtain biophysical information about fluctuation. This analysis may be helpful in the understanding physiology and pathological condition in iNPH and the assisting in the diagnosis. (C) 2015 Elsevier Ltd. All rights reserved.	[Kan, Hirohito; Kasai, Harumasa; Arai, Nobuyuki; Kawano, Makoto; Shibamoto, Yuta] Nagoya City Univ Hosp, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678602, Japan; [Kan, Hirohito; Miyati, Tosiaki; Ohno, Naoki] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Mase, Mitsuhito; Osawa, Tomoshi] Nagoya City Univ Hosp, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 4678602, Japan	Miyati, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	gpx246@yahoo.co.jp; ramiyati@mhs.mp.kanazawa-u.ac.jp; mitmase@med.nagoya-cu.ac.jp; car66220@pop02.odn.ne.jp; nohno@med.kanazawa-u.ac.jp; hhkasai@gmail.com; rarai51@med.nagoya-cu.ac.jp; rakawano@med.nagoya-cu.ac.jp; yshiba@med.nagoya-cu.ac.jp			JSPS KAKENHI [24601009]	We are grateful for valuable discussions with Dr. Noam Alperin (Department of Radiology, University of Miami, Miami, FL, USA). This work was supported by JSPS KAKENHI (24601009).	Alperin NJ, 2000, RADIOLOGY, V217, P877; Miyati T, 2007, J MAGN RESON IMAGING, V26, P274, DOI 10.1002/jmri.20999; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Kristensen B, 1996, J NEUROL NEUROSUR PS, V60, P282, DOI 10.1136/jnnp.60.3.282; Kahlon B, 2002, J NEUROL NEUROSUR PS, V73, P721, DOI 10.1136/jnnp.73.6.721; Mori E, 2012, NEUROL MED-CHIR, V52, P775; Bateman GA, 2008, AM J NEURORADIOL, V29, P198, DOI 10.3174/ajnr.A0739; Yoon B, 2009, APPL RADIAT ISOTOPES, V67, P1377, DOI 10.1016/j.apradiso.2009.02.080; Walchenbach R, 2002, J NEUROL NEUROSUR PS, V72, P503; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Marmarou A, 2005, J NEUROSURG, V102, P987, DOI 10.3171/jns.2005.102.6.0987; Verrees M, 2004, AM FAM PHYSICIAN, V70, P1071; Marmarou A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000168188.25559.0E; Bashat DB, 2005, J MAGN RESON IMAGING, V21, P203; Bradley WG, 2004, AM J NEURORADIOL, V25, P1479; Corkill RG, 2003, CLIN NEUROL NEUROSUR, V105, P193, DOI 10.1016/S0303-8467(03)00010-6; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Latt J, 2007, MAGN RESON MATER PHY, V20, P213, DOI 10.1007/s10334-007-0085-z; Mayzel-Oreg O, 2007, J NEUROL SCI, V257, P105, DOI 10.1016/j.jns.2007.01.048; Miyati T, 2003, EUR RADIOL, V13, P1019, DOI 10.1007/s00330-002-1697-3; Nakamura Tomoya, 2009, Radiol Phys Technol, V2, P133, DOI 10.1007/s12194-009-0056-3; Norris DG, 2001, J MAGN RESON IMAGING, V13, P486, DOI 10.1002/jmri.1072; Nunes RG, 2005, J MAGN RESON, V177, P102, DOI 10.1016/j.jmr.2005.07.005; Ohno N, 2011, RADIOLOGY, V261, P560, DOI 10.1148/radiol.11101860; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Tsunoda A, 2002, J NEUROL NEUROSUR PS, V73, P552, DOI 10.1136/jnnp.73.5.552; Tullberg M, 2001, AM J NEURORADIOL, V22, P1665	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	MAR	2015	40						88	93		10.1016/j.compmedimag.2014.12.004		6	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	CD2SE	WOS:000350928500008		
J	Wang, JC; Suenaga, H; Liao, HG; Hoshi, K; Yang, LJ; Kobayashi, E; Sakuma, I				Wang, Junchen; Suenaga, Hideyuki; Liao, Hongen; Hoshi, Kazuto; Yang, Liangjing; Kobayashi, Etsuko; Sakuma, Ichiro			Real-time computer-generated integral imaging and 3D image calibration for augmented reality surgical navigation	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Integral imaging; 3D image calibration; Augmented reality; Surgical navigation; Stereo tracking	LAPAROSCOPIC PARTIAL NEPHRECTOMY; NEEDLE INSERTION; DISPLAY SYSTEM; OVERLAY; REGISTRATION; GUIDANCE; RECONSTRUCTION; PHOTOGRAPHY	Autostereoscopic 3D image overlay for augmented reality (AR) based surgical navigation has been studied and reported many times. For the purpose of surgical overlay, the 3D image is expected to have the same geometric shape as the original organ, and can be transformed to a specified location for image overlay. However, how to generate a 3D image with high geometric fidelity and quantitative evaluation of 3D image's geometric accuracy have not been addressed. This paper proposes a graphics processing unit (GPU) based computer-generated integral imaging pipeline for real-time autostereoscopic 3D display, and an automatic closed-loop 3D image calibration paradigm for displaying undistorted 3D images. Based on the proposed methods, a novel AR device for 3D image surgical overlay is presented, which mainly consists of a 3D display, an AR window, a stereo camera for 3D measurement, and a workstation for information processing. The evaluation on the 3D image rendering performance with 2560 x 1600 elemental image resolution shows the rendering speeds of 50-60 frames per second (fps) for surface models, and 5-8 fps for large medical volumes. The evaluation of the undistorted 3D image after the calibration yields sub-millimeter geometric accuracy. A phantom experiment simulating oral and maxillofacial surgery was also performed to evaluate the proposed AR overlay device in terms of the image registration accuracy, 3D image overlay accuracy, and the visual effects of the overlay. The experimental results show satisfactory image registration and image overlay accuracy, and confirm the system usability. (C) 2014 Elsevier Ltd. All rights reserved.	[Wang, Junchen; Yang, Liangjing; Kobayashi, Etsuko; Sakuma, Ichiro] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Suenaga, Hideyuki; Hoshi, Kazuto] Tokyo Univ Hosp, Dept Oral Maxillofacial Surg Dent & Orthodont, Tokyo 113, Japan; [Liao, Hongen] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China	Wang, JC (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo, Japan.	wangjunchen@gmail.com; liao@tsinghua.edu.cn	Wang, Junchen/D-2421-2014	Wang, Junchen/0000-0002-0916-9932			Shekhar R, 2010, SURG ENDOSC, V24, P1976, DOI 10.1007/s00464-010-0890-8; Fichtinger G, 2005, IEEE T BIO-MED ENG, V52, P1415, DOI 10.1109/TBME.2005.851493; Arimoto H, 2001, OPT LETT, V26, P157, DOI 10.1364/OL.26.000157; Okano F, 1997, APPL OPTICS, V36, P1598, DOI 10.1364/AO.36.001598; Martinez-Cuenca R, 2009, P IEEE, V97, P1067, DOI 10.1109/JPROC.2009.2016816; Masamune K, 2008, LECT NOTES COMPUT SC, V5128, P385, DOI 10.1007/978-3-540-79982-5_42; Liao H, 2004, IEEE T INF TECHNOL B, V8, P114, DOI 10.1109/TITB.2004.826734; Su LM, 2009, UROLOGY, V73, P896, DOI 10.1016/j.urology.2008.11.040; Stern A, 2006, P IEEE, V94, P591, DOI 10.1109/JPROC.2006.870696; Liao HE, 2010, COMPUT MED IMAG GRAP, V34, P46, DOI 10.1016/j.compmedimag.2009.07.003; Liao HE, 2010, IEEE T BIO-MED ENG, V57, P1476, DOI 10.1109/TBME.2010.2040278; Park JH, 2009, APPL OPTICS, V48, pH77, DOI 10.1364/AO.48.000H77; Dodgson NA, 2005, COMPUTER, V38, P31, DOI 10.1109/MC.2005.252; Wang JC, 2014, IEEE T BIO-MED ENG, V61, P1295, DOI 10.1109/TBME.2014.2301191; Kim Y, 2007, APPL OPTICS, V46, P3766, DOI 10.1364/AO.46.003766; Hong SH, 2004, OPT EXPRESS, V12, P483, DOI 10.1364/OPEX.12.000483; Fitzpatrick JM, 2001, IEEE T MED IMAGING, V20, P917, DOI 10.1109/42.952729; Teber D, 2009, EUR UROL, V56, P332, DOI 10.1016/j.eururo.2009.05.017; Nicolau S, 2011, SURG ONCOL, V20, P189, DOI 10.1016/j.suronc.2011.07.002; Krempien R, 2008, INT J RADIAT ONCOL, V70, P944, DOI 10.1016/j.ijrobp.2007.10.048; Collier R., 2013, OPTICAL HOLOGRAPHY; Engel Klaus Jurgen, 2001, P ACM SIGGRAPH EUROG, P9, DOI DOI 10.1145/383507.383515; Ferrari V, 2009, IEEE T BIO-MED ENG, V56, P2627, DOI 10.1109/TBME.2009.2028013; Figl M, 2005, IEEE T MED IMAGING, V24, P1492, DOI 10.1109/TMI.2005.856746; Lambooij M, 2009, J IMAGING SCI, V53; Liao HG, 2005, OPT LETT, V30, P613, DOI 10.1364/OL.30.000613; Lippmann G., 1908, J PHYS THEOR APPL, V7, P821, DOI 10.1051/jphystap:019080070082100; Osorio A, 2010, PROC SPIE, V7625, DOI 10.1117/12.844039; Wen R, 2013, INT J COMPUT ASS RAD, V8, P1015, DOI 10.1007/s11548-013-0897-4	29	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	MAR	2015	40						147	159		10.1016/j.compmedimag.2014.11.003		13	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	CD2SE	WOS:000350928500015		
J	Yang, L; Wang, J; Ando, T; Kubota, A; Yamashita, H; Sakuma, I; Chiba, T; Kobayashi, E				Yang, L.; Wang, J.; Ando, T.; Kubota, A.; Yamashita, H.; Sakuma, I.; Chiba, T.; Kobayashi, E.			Vision-based endoscope tracking for 3D ultrasound image-guided surgical navigation	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Vision-based tracking; Surgical navigation; Ultrasound imaging; Endoscopy; Minimally invasive fetal surgery	TWIN TRANSFUSION SYNDROME; CAMERA CALIBRATION; SURGERY; INTERVENTIONS; REGISTRATION; TECHNOLOGY	This work introduces a self-contained framework for endoscopic camera tracking by combining 3D ultrasonography with endoscopy. The approach can be readily incorporated into surgical workflows without installing external tracking devices. By fusing the ultrasound-constructed scene geometry with endoscopic vision, this integrated approach addresses issues related to initialization, scale ambiguity, and interest point inadequacy that may be faced by conventional vision-based approaches when applied to fetoscopic procedures. Vision-based pose estimations were demonstrated by phantom and ex vivo monkey placenta imaging. The potential contribution of this method may extend beyond fetoscopic procedures to include general augmented reality applications in minimally invasive procedures. (C) 2014 Elsevier Ltd. All rights reserved.	[Yang, L.; Wang, J.; Ando, T.; Kubota, A.; Sakuma, I.; Kobayashi, E.] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Yamashita, H.; Chiba, T.] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan	Yang, L (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo, Japan.	yl.liangjing@gmail.com	Wang, Junchen/D-2421-2014	Wang, Junchen/0000-0002-0916-9932	JSPS KAKENHI [20345268]; Translational Systems Biology and Medicine Initiative (TSBMI)	This work was supported by JSPS KAKENHI (Grant number 20345268) and Grant for Translational Systems Biology and Medicine Initiative (TSBMI).	Heikkila J, 2000, IEEE T PATTERN ANAL, V22, P1066, DOI 10.1109/34.879788; Ren HL, 2012, IEEE T INF TECHNOL B, V16, P106, DOI 10.1109/TITB.2011.2164088; Lepetit V, 2009, INT J COMPUT VISION, V81, P155, DOI 10.1007/s11263-008-0152-6; West JB, 2004, IEEE T MED IMAGING, V23, P533, DOI 10.1109/TMI.2004.825614; Rossi AC, 2008, AM J OBSTET GYNECOL, V198, P147, DOI 10.1016/j.ajog.2007.09.043; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Cleary K, 2010, ANNU REV BIOMED ENG, V12, P119, DOI 10.1146/annurev-bioeng-070909-105249; Zhang R, 1999, IEEE T PATTERN ANAL, V21, P690; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Ren HL, 2012, IEEE-ASME T MECH, V17, P210, DOI 10.1109/TMECH.2010.2095504; Mountney P, 2006, LECT NOTES COMPUT SC, V4190, P347; Baud D, 2013, AM J OBSTET GYNECOL, V208, P197; Bouguet Jean-Yves, 2004, CAMERA CALIBRATION T; Bruner JP, 1998, PLACENTA, V19, P81, DOI 10.1016/S0143-4004(98)90102-3; Burschka D, 2005, MED IMAGE ANAL, V9, P413, DOI 10.1016/j.media.2005.05.005; Chang SKY, 2011, ANN ACAD MED SINGAP, V40, P231; Elfring R, 2010, COMPUT AIDED SURG, V15, P1, DOI 10.3109/10929081003647239; Fowler SF, 2002, J PEDIATR SURG, V37, P1700, DOI 10.1053/jpsu.2002.36699; Grasa OG, 2009, MED IMAGE COMPUTING, V2; Harada K, 2009, MINIM INVASIV THER, V18, DOI 10.1080/13645700802655661; Ishiyama A, 2011, MED ENG PHYS, V33, P381, DOI 10.1016/j.medengphy.2010.11.006; Janne H., 1997, IEEE COMP SOC C COMP; Kim K, 2011, SURG ENDOSC, V25, P2029, DOI 10.1007/s00464-010-1498-8; Kubota A, 2014, 28 INT C EXH COMP AS; Liao H, 2009, MINIM INVASIV THER, V18, P332, DOI 10.3109/13645700903201217; Liao HG, 2009, IFMBE PROC, V25, P206; Lorensen W. E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI DOI 10.1145/37402.37422; Mirota DJ, 2011, ANNU REV BIOMED ENG, V13, P297, DOI 10.1146/annurev-bioeng-071910-124757; Mung J, 2011, MED IMAGE COMPUTING, P153; Noonan DP, 2009, INT C ROB AUT, P4463; RAUSKOLB R, 1979, ENDOSCOPY, V11, P107; Reeff M, 2006, GI JAHRESTAGUNG, V2006, P467; Sato I, 2012, INT J COMPUT ASSIST, P1; Stoll J, 2012, IEEE T MED IMAGING, V31; Weinmann M, 2011, ISPRS J PHOTOGRAMM, V66, pS62, DOI 10.1016/j.isprsjprs.2011.09.010; Wengert C., 2006, BILDVERARBEITUNG MED, P419, DOI 10.1007/3-540-32137-3_85; Yamashita H, 2012, SUPER EYES HANDS FUT; Yang L, 2013, IEEE INT C ENG MED B, P1411; Yang L, 2013, MIAR AE CAI, P107; Yang L, 2013, INT J CARS S1, V8, pS152; Yang L, 2014, INT J MED R IN PRESS; Zhang Z., 1999, P 7 IEEE INT C COMP, V1, P666, DOI DOI 10.1109/ICCV.1999.791289	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	MAR	2015	40						205	216		10.1016/j.compmedimag.2014.09.003		12	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	CD2SE	WOS:000350928500020		
J	Faust, O; Yu, WW; Acharya, UR				Faust, Oliver; Yu, Wenwei; Acharya, U. Rajendra			The role of real-time in biomedical science: A meta-analysis on computational complexity, delay and speedup	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Real-time; Computational complexity; Speedup; Delay; Health care systems	MAGNETIC-RESONANCE; MAXIMUM-LIKELIHOOD; SURFACE ELECTROMYOGRAPHY; PARALLEL COMPUTATION; SURGICAL SIMULATION; SPECTRAL ESTIMATION; FEATURE-EXTRACTION; ADJOINT FUNCTIONS; ALGORITHM; GPU	Purpose: The concept of real-time is very important, as it deals with the realizability of computer based health care systems. Method: In this paper we review biomedical real-time systems with a meta-analysis on computational complexity (CC), delay (Delta) and speedup (S-p). Results: During the review we found that, in the majority of papers, the term real-time is part of the thesis indicating that a proposed system or algorithm is practical. However, these papers were not considered for detailed scrutiny. Our detailed analysis focused on papers which support their claim of achieving real-time, with a discussion on CC or S-p. These papers were analyzed in terms of processing system used, application area (AA), CC, Delta, S-p, implementation/algorithm (I/A) and competition. Conclusions: The results show that the ideas of parallel processing and algorithm delay were only recently introduced and journal papers focus more on Algorithm (A) development than on implementation (I). Most authors compete on big O notation (O) and processing time (PT). Based on these results, we adopt the position that the concept of real-time will continue to play an important role in biomedical systems design. We predict that parallel processing considerations, such as SI, and algorithm scaling, will become more important. (C) 2015 Elsevier Ltd. All rights reserved.	[Faust, Oliver] Habib Univ, Sch Sci & Engn, Karachi, Pakistan; [Yu, Wenwei] Chiba Univ, Chiba, Japan; [Acharya, U. Rajendra] Ngee Ann Polytech, Singapore, Singapore	Faust, O (reprint author), Habib Univ, Sch Sci & Engn, Karachi, Pakistan.	oliver.faust@gmail.com					Abdulghani A.M., 2011, MED BIOL ENG COMPUT, V50, P1; Acharya U.R., 2011, COMPUT METHOD BIOMEC, V16, P1; Aganj I., 2011, MAGN RESON MED, V67, P1167; Aguilar-Pelaez E, 2012, IEEE T BIO-MED ENG, V59, P3197, DOI 10.1109/TBME.2012.2218600; Ahmadi A, 2011, IEEE ENG MED BIO, P4426, DOI 10.1109/IEMBS.2011.6091098; Andrews S, 2010, LECT NOTES COMPUT SC, V6363, P9; Ostlund N, 2007, J ELECTROMYOGR KINES, V17, P549, DOI 10.1016/j.jelekin.2006.06.002; Wang LS, 2011, PHYS MED BIOL, V56, P6291, DOI 10.1088/0031-9155/56/19/009; Ku CT, 2010, IEEE T BIO-MED ENG, V57, P1399, DOI 10.1109/TBME.2009.2037605; Chor B, 2005, BIOINFORMATICS, V21, pI97, DOI 10.1093/bioinformatics/bti1027; Holobar A, 2004, MED BIOL ENG COMPUT, V42, P487, DOI 10.1007/BF02350989; Raghunathan S, 2010, J NEUROSCI METH, V193, P106, DOI 10.1016/j.jneumeth.2010.08.008; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Guo CL, 2010, IEEE T BIO-MED ENG, V57, P1856, DOI 10.1109/TBME.2010.2043358; McEntyre J, 2001, CAN MED ASSOC J, V164, P1317; Jacques R, 2010, COMPUT METH PROG BIO, V98, P285, DOI 10.1016/j.cmpb.2009.07.004; Antoniol G, 1997, IEEE T BIO-MED ENG, V44, P105, DOI 10.1109/10.552239; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Zhao DY, 2010, ARTIF INTELL MED, V49, P127, DOI 10.1016/j.artmed.2010.03.004; Men CH, 2009, PHYS MED BIOL, V54, P6565, DOI 10.1088/0031-9155/54/21/008; de Greef M, 2009, MED PHYS, V36, P4095, DOI 10.1118/1.3190156; Borkar S, 2011, COMMUN ACM, V54, P67, DOI 10.1145/1941487.1941507; Chan ADC, 2005, IEEE T BIO-MED ENG, V52, P121, DOI 10.1109/TBME.2004.836492; Heyne S, 2009, BIOINFORMATICS, V25, P2095, DOI 10.1093/bioinformatics/btp065; Lloyd S, 2000, NATURE, V406, P1047, DOI 10.1038/35023282; Cullen D, 2011, MOL BIOTECHNOL, V49, P19, DOI 10.1007/s12033-010-9371-5; Wei LY, 2005, IEEE T MED IMAGING, V24, P1278, DOI 10.1109/TMI.2005.855435; Zviagintsev A, 2005, I IEEE EMBS C NEUR E, P162; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Hesser J, 1997, MAGN RESON MATER PHY, V5, P87, DOI 10.1007/BF02592237; Lampe J, 2012, PHYS MED BIOL, V57, P1113, DOI 10.1088/0031-9155/57/4/1113; Sehgal MSB, 2005, BIOINFORMATICS, V21, P2417, DOI 10.1093/bioinformatics/bti345; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Cocco S, 2009, P NATL ACAD SCI USA, V106, P14058, DOI 10.1073/pnas.0906705106; Asen JP, 2014, IEEE T ULTRASON FERR, V61, P76, DOI [10.1109/TUFFC.2014.6689777, 10.1109/TUFFC.2014.2880]; Schaller S, 2003, IEEE T MED IMAGING, V22, P846, DOI 10.1109/TMI.2003.815073; Logesparan L, 2012, MED BIOL ENG COMPUT, V50, P659, DOI 10.1007/s11517-012-0904-x; Morris RW, 2002, MED ENG PHYS, V24, P515, DOI 10.1016/S1350-4533(02)00060-7; Gopalakrishna V, 2010, IEEE T BIO-MED ENG, V57, P2053, DOI 10.1109/TBME.2010.2047644; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Jonic S, 1999, IEEE T BIO-MED ENG, V46, P300, DOI 10.1109/10.748983; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Armato A., 2011, J REAL-TIME IMAGE PR, P1; ATHAN SP, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P980, DOI 10.1109/IEMBS.1994.415243; Bai EW, 2009, AUTOMATICA, V45, P736, DOI 10.1016/j.automatica.2008.09.023; Berger Theodore W, 2008, IEEE Rev Biomed Eng, V1, P157, DOI 10.1109/RBME.2008.2008687; Bhandarkar SM, 2001, GENETICS, V157, P1021; Bohs L.N., 1991, IEEE T BIOMED ENG, V38, P280; Borelli F.F., 2013, BMC BIOINFORMATICS, V14, P1; Brouse CJ, 2012, IEEE ENG MED BIO, P3813, DOI 10.1109/EMBC.2012.6346798; Buttazzo GC, 2011, HARD REAL-TIME COMPUTING SYSTEMS: PREDICTABLE SCHEDULING ALGORITHMS AND APPLICATIONS, THIRD EDITION, P1, DOI 10.1007/978-1-14614-0676-1; Cardenas-Barrera JL, 1999, IEEE T BIO-MED ENG, V46, P62, DOI 10.1109/10.736756; Cazzaniga P., 2014, BIOMED RES INT, V2013, P1; Celebi OC, 2010, COMPUT METH PROG BIO, V97, P99, DOI 10.1016/j.cmpb.2009.05.007; Cerutti Sergio, 2009, IEEE Rev Biomed Eng, V2, P9, DOI 10.1109/RBME.2009.2034698; Chelliyil RG, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960018; Chen B, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq891; Chen WF, 2011, IEEE T VIS COMPUT GR, V17, P2144, DOI 10.1109/TVCG.2011.164; Chen Y., 2013, BIOMED ENG ONLINE, V12, P1; Choi C, 2012, IEEE ENG MED BIO, P5638; Churbanov A., 2008, BMC BIOINF S9, V9, P1; Cobelli Claudio, 2009, IEEE Reviews in Biomedical Engineering, V2, DOI 10.1109/RBME.2009.2036073; Conforto S, 1999, MED ENG PHYS, V21, P225, DOI 10.1016/S1350-4533(99)00049-1; Coupe P., 2008, IEEE T MED IMAGING, V27, P425; Dandekar O., 2006, EMBS 06 28 ANN INT C, P1425; Davies S, 2012, NEURAL NETWORKS, V32, P3, DOI 10.1016/j.neunet.2012.02.018; Dharmaraj C.D., 2009, J BIOMED IMAGING, V2009, P1; Dhawan Atam P, 2010, IEEE Rev Biomed Eng, V3, P69, DOI 10.1109/RBME.2010.2081975; Dorn B., 2011, ALGORITHM MOL BIOL, V6, P1; Duan Q, 2010, COMPUT METH PROG BIO, V98, P223, DOI 10.1016/j.cmpb.2009.09.001; Dymond P. W., 1980, 21st Annual Symposium on Foundations of Computer Science, DOI 10.1109/SFCS.1980.22; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Eric L., 2010, BMC BIOINFORMATICS, V11, P1; Farooq U, 2010, IEEE ENG MED BIO, P4582, DOI 10.1109/IEMBS.2010.5626023; Fasano A, 2011, IEEE ENG MED BIO, P981; Faust O., 2012, J MECH MED BIOL, V12; Faust O, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500334; Faust Oliver, 2012, IEEE Rev Biomed Eng, V5, P15, DOI 10.1109/RBME.2012.2184750; Feng S, 2012, IEEE ENG MED BIO, P1102; Fernandez-Delgado M, 2011, IEEE T NEURAL NETWOR, V22, P1837, DOI 10.1109/TNN.2011.2169086; Fish PJ, 1997, MED BIOL ENG COMPUT, V35, P561, DOI 10.1007/BF02510961; Gerencser L, 2002, IEEE T BIO-MED ENG, V49, P1094, DOI 10.1109/TBME.2002.802007; Gibson S, 2008, IEEE ENG MED BIO, P5015, DOI 10.1109/IEMBS.2008.4650340; Gilles B, 2006, LECT NOTES COMPUT SC, V4190, P289; Gonzalez JS, 2000, ARTIF INTELL MED, V19, P75, DOI 10.1016/S0933-3657(99)00051-2; Govil M., 2008, BMC BIOINF S6, V9, P1; Hadjileontiadis LJ, 2009, IEEE T BIO-MED ENG, V56, P718, DOI 10.1109/TBME.2008.2011747; Hadjileontiadis LJ, 2003, MED BIOL ENG COMPUT, V41, P445, DOI 10.1007/BF02348088; Han B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S5; Hayes J.P., 2002, COMPUTER ARCHITECTUR; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Husoy JH, 2002, IEEE T BIO-MED ENG, V49, P1287, DOI 10.1109/TBME.2002.804591; Hwang K., 1984, MCGRAW HILL COMPUTER; Iniewski K., 2008, VLSI CIRCUITS BIOMED; Jacquemet Vincent, 2008, IEEE Rev Biomed Eng, V1, P94, DOI 10.1109/RBME.2008.2008242; Jeon Y, 2013, COMPUT BIOL MED, V43, P1011, DOI 10.1016/j.compbiomed.2013.05.007; Jin F, 2011, IEEE T BIO-MED ENG, V58, P3078, DOI 10.1109/TBME.2011.2160721; Karadayi K., 2009, IEEE REV BIOMEDICAL, V2, P23, DOI 10.1109/RBME.2009.2034132; Kelton W. D., 2000, SIMULATION MODELING; Khorshidtalab A, 2013, PHYSIOL MEAS, V34, P1563, DOI 10.1088/0967-3334/34/11/1563; Kim SH, 2009, IEEE ENG MED BIO, P436; Kirk D. B., 2010, PROGRAMMING MASSIVEL; Knuth D. E., 2006, ART COMPUTER PROGRAM; Kolodny R, 2004, P NATL ACAD SCI USA, V101, P12201, DOI 10.1073/pnas.0404383101; Koo JJ, 2009, IEEE T IMAGE PROCESS, V18, P2735, DOI 10.1109/TIP.2009.2028926; Krishna C. M., 1999, REAL TIME SYSTEMS; Laine Andrew F, 2008, IEEE Rev Biomed Eng, V1, P4, DOI 10.1109/RBME.2008.2008221; Lebsack ET, 2002, IEEE T BIO-MED ENG, V49, P41, DOI 10.1109/10.972838; Li J, 2009, IEEE ENG MED BIO, P5685, DOI 10.1109/IEMBS.2009.5333110; Li PC, 2002, ULTRASONIC IMAGING, V24, P215; Li WXY, 2012, IEEE ENG MED BIO, P4579, DOI 10.1109/EMBC.2012.6346986; Li WXY, 2013, IEEE T BIOMED CIRC S, V7, P489, DOI 10.1109/TBCAS.2012.2228261; Li Y, 2002, STUD HEALTH TECHNOL, V85, P261; Liu YQ, 2008, ST HEAL T, V132, P260; Lucas Jr H.C., 1981, IMPLEMENTATION KEY S; Luo YR, 2011, IEEE ENG MED BIO, P353; Manis G., 2009, Journal of Medical Engineering & Technology, V33, P110, DOI 10.1080/03091900701292265; Manolopoulou I, 2012, J COMPUT BIOL, V19, P745, DOI 10.1089/cmb.2012.0038; Martinez-Zarzuela M, 2013, COMPUT METH PROG BIO, V112, P189, DOI 10.1016/j.cmpb.2013.07.005; Marucci E.A., 2014, BIOMED RES INT; Menor M., 2013, BMC GENOMICS S2, V14, P1; Meyer F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-226; Moore G., 1975, EL DEV M 1975 INT, V21, p11 ; Moore G. E., 1965, CRAMMING MORE COMPON; Moschovakis Yiannis, 2001, MATH UNLIMITED 2001, P919; Mountney J, 2010, IEEE ENG MED BIO, P2674, DOI 10.1109/IEMBS.2010.5626626; Niederer P., 2003, MED MEETS VIRTUAL RE, V94, P103; Niemenlehto P. -H., 2009, Journal of Medical Engineering & Technology, V33, P349, DOI 10.1080/03091900802323613; Nijim YW, 1996, IEEE T MED IMAGING, V15, P555, DOI 10.1109/42.511758; Nizami Shermeen, 2013, IEEE Rev Biomed Eng, V6, P127, DOI 10.1109/RBME.2013.2243724; Nizami S., 2013, IEEE REV BIOMED ENG, V1, P127; Noergaard T., 2005, EMBEDDED SYSTEMS ARC; Olkkonen H., 2002, SIGNATURE, V8, P199; Oppenheim AV, 1999, DISCRETE TIME SIGNAL, V5; Otten DM, 2005, PHYSIOL MEAS, V26, P503, DOI 10.1088/0967-3334/26/4/015; Paraskevopoulou SE, 2013, J NEUROSCI METH, V215, P29, DOI 10.1016/j.jneumeth.2013.01.012; Parikh NJ, 2004, P ANN INT IEEE EMBS, V26, P1475; Park IM, 2012, NEURAL COMPUT, V24, P2223, DOI 10.1162/NECO_a_00309; Phan John H, 2012, IEEE Rev Biomed Eng, V5, P74, DOI 10.1109/RBME.2012.2212427; Prakash J, 2013, MED PHYS, V40, DOI 10.1118/1.4792459; Qiu T., 2012, IEEE T IMAGE PROCESS, V22, P80; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042492; Santhanam AP, 2012, INT J COMPUT ASS RAD, V7, P705, DOI 10.1007/s11548-012-0672-y; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schaller C, 2009, LECT NOTES COMPUT SC, V5761, P549; Shi J., 2012, MED BIOL ENG COMPUT, P1; SHIN KG, 1995, IEEE T CONTR SYST T, V3, P218, DOI 10.1109/87.388130; Sinha S., 2011, 2011 INT S VLSI DES, P1; Stankovic J.A., 1992, REAL TIME COMPUTING, P155; Stella F., 2012, J BIOMED INFORM, V45, P1108; Suhail Y, 2004, P ANN INT IEEE EMBS, V26, P4552; Sun J., 2012, IEEE T IMAGE PROCESS, V22, P402; Sundareshan MK, 2002, APPL OPTICS, V41, P7464, DOI 10.1364/AO.41.007464; Taur Y., 2009, FUNDAMENTALS MODERN; Teixeira CA, 2010, ULTRASONICS, V50, P32, DOI 10.1016/j.ultras.2009.07.005; Thomas MA, 2004, J DIGIT IMAGING, V17, P189, DOI 10.1007/s10278-004-1000-z; Trayanova Natalia, 2010, IEEE Rev Biomed Eng, V3, P12, DOI 10.1109/RBME.2010.2082250; Trayanova Natalia, 2011, IEEE Rev Biomed Eng, V4, P89, DOI 10.1109/RBME.2011.2173761; VAITKUS PJ, 1988, ULTRASOUND MED BIOL, V14, P673, DOI 10.1016/0301-5629(88)90024-5; van Aart E., 2011, J BIOMED IMAGING, V2011, P1; Vigueras G., 2013, INT J NUMER METHODS, V30, P117; Wang L., 2012, J BIOMED OPT, V17; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091315; Wang May Dongmei, 2011, IEEE Rev Biomed Eng, V4, P3, DOI 10.1109/RBME.2011.2177935; Warrick Jay W, 2008, IEEE Rev Biomed Eng, V1, P75, DOI 10.1109/RBME.2008.2008241; Woergoetter F., 1999, NEURAL COMPUT, V11, P381; Wright J., 2008, BMC SYST BIOL, V2, P1; Xiang YP, 2002, COMPUT BIOL MED, V32, P85, DOI 10.1016/S0010-4825(01)00036-1; Xiao WJ, 2009, IEEE ENG MED BIO, P6926; Xu F., 2010, COMPUT METH PROG BIO, V98, P261; Xu R., 2010, IEEE REV BIOMED ENG, V3, P120; Xue H, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-102; Yamada H., 1962, Institute of Radio Engineers Transactions on Electronic Computers, VEC-11; Yoo S, 2007, PHYS MED BIOL, V52, P815, DOI 10.1088/0031-9155/52/3/020; Yoo S, 2003, PHYS MED BIOL, V48, P4077, DOI 10.1088/0031-9155/48/24/006; Yu B., 2012, BIOMED ENG ONLINE, V11, P1; Yu HB, 2011, J CRANIOFAC SURG, V22, P648, DOI 10.1097/SCS.0b013e318207f2e8; Zeng K., 2007, INT J BIOMED IMAGING, V2007, P1, DOI DOI 10.1155/2007/29160; Zhang C, 1997, COMPUT APPL BIOSCI, V13, P565; Zhang WL, 2013, BIOMED RES INT, DOI 10.1155/2013/414069; Zumsteg ZS, 2005, IEEE T NEUR SYS REH, V13, P272, DOI 10.1109/TNSRE.2005.854307	181	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	MAR 1	2015	58						73	84		10.1016/j.compbiomed.2014.12.024		12	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CD2XC	WOS:000350941300009		
J	Nakahata, K; Kawamura, G; Yano, T; Hirose, S				Nakahata, K.; Kawamura, G.; Yano, T.; Hirose, S.			Three-dimensional numerical modeling of ultrasonic wave propagation in concrete and its experimental validation	CONSTRUCTION AND BUILDING MATERIALS			English	Article						Ultrasonic wave; Image-based modeling; Finite integration technique; Concrete material; Multiple scattering and attenuation; Simulation; Validation	SIMULATIONS; SCATTERING; POROSITY; MEDIA	To understand the characteristics of ultrasonic wave propagation in concrete more completely, we propose a time domain simulation tool based on the finite integration technique (FIT) and an image-based modeling approach. When modeling ultrasonic wave propagation in concrete, it is important to introduce three-dimensional mesoscopic and microscopic structures because ultrasonic waves in solids are transmitted by mechanical interaction between adjacent media. In this paper, wave velocity, center frequency, and attenuation of ultrasonic waves in concrete are evaluated quantitatively by comparing the waveforms obtained by FIT simulation with those obtained by experimental measurement. It was observed that these factors were in good agreement between the simulation and measurements. It was also observed that amplitude of the transmitted signal was sensitive to the allocation pattern of the aggregates. Thus, attenuation due to multiple scattering by aggregates is more dominant than the attenuation by intrinsic absorption and geometrical spreading in concrete. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakahata, K.; Kawamura, G.; Yano, T.] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime 7908577, Japan; [Hirose, S.] Tokyo Inst Technol, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan	Nakahata, K (reprint author), Ehime Univ, Dept Civil & Environm Engn, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	nakahata@cee.ehime-u.ac.jp			Ministry of Education, Culture, Science and Technology, Japan [24246078]	This work was supported in part by a Grant-in-Aid for Scientific Research (A) No. 24246078 from the Ministry of Education, Culture, Science and Technology, Japan.	Aki K., 1980, QUANTITATIVE SEISMOL; Schabowicz K, 2014, ARCH CIV MECH ENG, V14, P295, DOI 10.1016/j.acme.2013.10.006; CARCIONE JM, 1988, GEOPHYS J INT, V95, P597, DOI 10.1111/j.1365-246X.1988.tb06706.x; FELLINGER P, 1995, WAVE MOTION, V21, P47, DOI 10.1016/0165-2125(94)00040-C; Acciani G, 2010, NONDESTRUCT TEST EVA, V25, P289, DOI 10.1080/10589751003658057; Stucky P, 2001, IEEE T ULTRASON FERR, V48, P6, DOI 10.1109/58.895895; Chekroun M, 2009, SPRINGER PROC PHYS, V128, P317; Courant P, 1967, IBM J RES DEV, V11, P215; Graves RW, 1996, B SEISMOL SOC AM, V86, P1091; Jing H., 2014, SENS TRANSDUCERS, V162, P238; Nakahata K., 2012, P 6 EUR C COMP METH, P4285; Nakahata Kazuyuki, 2012, Journal of Computational Science and Technology, V6, DOI 10.1299/jcst.6.28; Schmerr L. W., 1998, FUNDAMENTALS ULTRASO; Schubert F, 2004, ULTRASONICS, V42, P781, DOI 10.1016/j.ultras.2004.01.040; Schubert F, 2001, J COMPUT ACOUST, V9, P1543, DOI 10.1142/S0218396X01000978; Terada K, 1997, COMPUT MECH, V20, P331, DOI 10.1007/s004660050255; WINKLER KW, 1986, GEOPHYSICS, V51, P183, DOI 10.1190/1.1442031; Wittmann FH, 1983, FRACTURE MECH CONCRE; Yaman IO, 2006, COMPUT CONCRETE, V3, P423; Yaman IO, 2002, MATER STRUCT, V35, P102, DOI 10.1007/BF02482109; Yim HJ, 2013, CONSTR BUILD MATER, V47, P502, DOI 10.1016/j.conbuildmat.2013.05.070	21	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-0618	1879-0526		CONSTR BUILD MATER	Constr. Build. Mater.	MAR 1	2015	78						217	223		10.1016/j.conbuildmat.2014.12.049		7	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CD2SS	WOS:000350929900023		
J	Zhang, YX; Bai, S; Zhang, QB; Xie, HB; Zhang, XM				Zhang, Yongxing; Bai, Shu; Zhang, Qingbin; Xie, Haibo; Zhang, Xueming			Failure behavior of strain hardening cementitious composites for shear strengthening RC member	CONSTRUCTION AND BUILDING MATERIALS			English	Article						Shear failure behavior; SHCC strengthening layer; Crack pattern; Shear load carrying capacity	REPAIR; PERFORMANCE; TENSILE; BEAMS	This paper presented a experimental investigation into the advantage of RC member with shear strengthening using strain hardening cementitious composites (SHCC), focused on the crack pattern of SHCC strengthening layer and its obvious advantage for increasing the shear load carrying capacity of the strengthened RC member. Especially, the shear failed SHCC member was also adopted to reflect the reduced multiple fine crack distribution in SHCC strengthening layer. Moreover, the contributions of matrix and reinforcing fiber for shear load carrying capacity of SHCC strengthening layer were also calibrated respectively, and the shear load carrying capacity of SHCC strengthening layer was assumed as the sum of load carried by matrix and reinforcing fiber. This work provided experimental foundations for RC member with shear strengthening using SHCC. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, Yongxing] Nanjing Forestry Univ, Sch Civil Engn, Nanjing 210037, Jiangsu, Peoples R China; [Zhang, Yongxing] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Bai, Shu] Hunan Prov Commun Planning Survey & Design Inst, Changsha 410008, Hunan, Peoples R China; [Zhang, Qingbin; Xie, Haibo] Changsha Univ Sci & Technol, Sch Civil Engn, Changsha 410004, Hunan, Peoples R China; [Zhang, Xueming] Cent S Univ, Sch Civil Engn, Changsha 410075, Hunan, Peoples R China	Zhang, XM (reprint author), Cent S Univ, Sch Civil Engn, 22 South Shaoshan Rd, Changsha 410075, Hunan, Peoples R China.	zhangxm@csu.edu.cn			National Natural Science Foundation of China [51408124, 51378505]; Natural Science Foundation of Jiangsu Province [BK20140629]; Priority Academic Program Development of Jiangsu Higher Education Institutions	The author would like to acknowledge the support from National Natural Science Foundation of China (No. 51408124 and 51378505), Natural Science Foundation of Jiangsu Province (No. BK20140629), and a projected funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Li VC, 2000, ENG FRACT MECH, V65, P317, DOI 10.1016/S0013-7944(99)00117-4; Martinola G, 2010, CEMENT CONCRETE COMP, V32, P731, DOI 10.1016/j.cemconcomp.2010.07.001; Hussein M, 2012, CEMENT CONCRETE COMP, V34, P1061, DOI 10.1016/j.cemconcomp.2012.06.004; [Anonymous], 2008, CONCR ENG SER, V82; Horii H, 1998, P FRAMCOS 1 FRACT ME, P1739; Kamal A, 2008, CEMENT CONCRETE COMP, V30, P863, DOI 10.1016/j.cemconcomp.2008.08.003; Kanakubo T, 2010, P FRAMCOS 7, P1623; Kunieda M, 2006, J ADV CONCR TECHNOL, V4, P19, DOI 10.3151/jact.4.19; Li HD, 2009, J WUHAN UNIV TECHNOL, V24, P677, DOI 10.1007/s11595-009-4677-5; Li VC, 2004, ACI MATER J, V101, P242; Lim YM, 1997, CEMENT CONCRETE COMP, V19, P373, DOI 10.1016/S0958-9465(97)00026-7; Shin SK, 2007, CEMENT CONCRETE COMP, V29, P465, DOI 10.1016/j.cemconcomp.2007.02.005; Suryanto E, 2010, J ADV CONCR TECHNOL, V8, P239; Zhang YX, 2013, MAG CONCRETE RES, V65, P1486, DOI 10.1680/macr.13.00215; Zhang YX, 2014, ENG FRACT MECH, V121, P11, DOI 10.1016/j.engfracmech.2014.03.012	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-0618	1879-0526		CONSTR BUILD MATER	Constr. Build. Mater.	MAR 1	2015	78						470	473		10.1016/j.conbuildmat.2015.01.037		4	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CD2SS	WOS:000350929900050		
J	Nakajima, S; Izumida, M				Nakajima, Sadahiko; Izumida, Mutsumi			Effect of Credit Card Logos on the Consumer Item Price Estimated by Japanese College Students	CURRENT PSYCHOLOGY			English	Article						Credit card; Perceived value; Consumer behavior	BEHAVIOR; STIMULI; USAGE	Although Feinberg (1986, Journal of Consumer Research, 13, 348-356) has demonstrated that people's estimated prices of consumer items are increased by credit card logos presented with the items, subsequent studies sometimes failed to replicate this effect. Feinberg (1990, Psychological Reports, 67, 331-334) has argued that people's attitude toward credit cards determines their effect on the estimated price. To test this hypothesis, we conducted an experiment with Japanese college students, to whom credit card use is not common, as participants. For credit card holders (n = 28), the average estimate of item price was 39.5 % higher in the logo present group than in the logo absent group. In contrast, the average estimates were equivalent between the logo present and absent groups of nonholders (n = 60). These results are congruent with Feinberg's hypothesis and accord with the fact that the favorability of credit cards was positive for the card holders, while it was neutral for the nonholders. We discussed beneficial implications for product advertising in countries where credit card is prestigious.	[Nakajima, Sadahiko; Izumida, Mutsumi] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Nakajima, S (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan.	nakajima@kwansei.ac.jp			MEXT (Ministry of Culture, Sports, Science and Technology, Japan)	The data analyzed here were collected by the second author. The first author designed and supervised the experimentation, analyzed the data, and prepared the manuscript with a grant from MEXT (Ministry of Culture, Sports, Science and Technology, Japan) for Strategic Formation of Research Bases at Private Universities.	Abdul-Muhmin A. G., 2007, J FINANCIAL SERVICES, V12, P219, DOI 10.1057/palgrave.fsm.4760074; Ahmed Z. U., 2010, ASIA PACIFIC J MARKE, V22, P528, DOI [10.1108/13555851011090547, DOI 10.1108/13555851011090547]; McCall M, 1996, J APPL PSYCHOL, V81, P609, DOI 10.1037/0021-9010.81.5.609; Prelec D, 2001, MARKET LETT, V12, P5, DOI 10.1023/A:1008196717017; Raghubir P, 2008, J EXP PSYCHOL-APPL, V14, P213, DOI 10.1037/1076-898X.14.3.213; LYNN M, 1993, J APPL SOC PSYCHOL, V23, P678, DOI 10.1111/j.1559-1816.1993.tb01109.x; Cabinet Office of Japan, 2010, DAI 4 KAI HIK GEN NI; FEINBERG RA, 1990, PSYCHOL REP, V67, P331, DOI 10.2466/PR0.67.5.331-334; FEINBERG RA, 1986, J CONSUM RES, V13, P348, DOI 10.1086/209074; GARRITY K, 1990, J APPL SOC PSYCHOL, V20, P168, DOI 10.1111/j.1559-1816.1990.tb00405.x; Wickramasinghe V, 2009, INT J CONSUM STUD, V33, P436, DOI 10.1111/j.1470-6431.2009.00779.x; HUNT JM, 1990, PSYCHOL REP, V67, P323; Japan Consumer Credit Association, 2010, NIH NO SHOH SHIN TOU; JCB Brand Marketing Group, 2011, KUR KAD NI KANS SOUG; Kaynak E., 2001, J FINANCIAL SERVICES, V6, P24, DOI 10.1057/palgrave.fsm.4770038; Khare A., 2012, ASIA PACIFIC J MARKE, V24, P236, DOI 10.1108/13555851211218048; Lie C, 2010, PSYCHOL REC, V60, P399; Maysami R. C., 2008, J SERV MARK, V22, P267, DOI DOI 10.1108/08876040810881678; McCall M, 2004, PSYCHOL REP, V95, P331, DOI 10.2466/pr0.95.1.331-337; Monger J. E., 1997, PRICING STRATEGY PRA, V5, P142, DOI 10.1108/09684909710184635; Norum PS, 2008, INT J CONSUM STUD, V32, P269, DOI 10.1111/j.1470-6431.2008.00678.x; Sharpe Deanna L., 2012, J FAMILY EC ISSUES, V33, P156, DOI [DOI 10.1007/S10834-012-9309-0, 10.1007/s10834-012-9309-0]; Shimp TA, 2000, J BUS RES, V48, P17, DOI 10.1016/S0148-2963(98)00071-X; Tumedi C. B., 2012, INT J BUSINESS ADM, V3, P60, DOI [10.5430/ijba.v3n6p60, DOI 10.5430/IJBA.V3N6P60]; Wang LL, 2011, J ECON PSYCHOL, V32, P179, DOI 10.1016/j.joep.2010.11.006	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	MAR	2015	34	1					50	57		10.1007/s12144-014-9239-0		8	Psychology, Multidisciplinary	Psychology	CD0ZJ	WOS:000350802900004		
J	Ota, S; Kawano, S				Ota, Shuhei; Kawano, Shigeyuki			Life Cycle and Lectin-Binding Patterns in the Chytrid Fungus Chytriomyces hyalinus	CYTOLOGIA			English	Article						Chytrid; Chytriomyces hyalinus; Lectin; Life cycle	PHYLUM BLASTOCLADIOMYCOTA; CONJUGATED LECTINS; CHYTRIDIOMYCOTA; PHYLOGENY; EVOLUTION; CELLS	Chytrids are an early diverging group of fungi possessing a flagellated spore stage in their life cycle. Chytrid infections in amphibian species and algae are currently a major problem worldwide. Lectin binding patterns are key factors involved in host-parasite interactions. However, there are no analyses of the lectin binding pattern for core chytrids (e.g., species belonging to Chytridiales). Here we present time-lapse observations of the early development of the vegetative stage and lectin binding patterns to examine sugar composition during the asexual life cycle of the core chytrid Chytriomyces hyalinus ATCC 28165. The lectin binding assay showed that the signal of wheat germ agglutinin was detected in the chytrid cell wall and basal part of the rhizoidal system, but not in the zoospore and rhizoid system. This result indicated that N-acetyl-D-glucosamine was accumulated highly at the basal part of the rhizoid system in C. hyalinus.	[Ota, Shuhei; Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Kawano, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	kawano@k.u-tokyo.ac.jp		Ota, Shuhei/0000-0003-4349-3047	JSPS KAKENHI [25840135]; JST-CREST program	This study was supported by JSPS KAKENHI Grant Number 25840135 to SO and the JST-CREST program to SK.	Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Hoffman Y, 2008, MYCOL RES, V112, P70, DOI [10.1016/j.mycres.2007.09.002, 10.1016/i.mycres.2007.09.002]; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Doumecq ML, 2014, EXP PARASITOL, V147, P48, DOI 10.1016/j.exppara.2014.09.009; Gutman J, 2011, FUNGAL BIOL-UK, V115, P803, DOI 10.1016/j.funbio.2011.06.006; KARLING JS, 1945, AM J BOT, V32, P362, DOI 10.2307/2437353; Letcher PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056232; MILLER CE, 1981, AM J BOT, V68, P342, DOI 10.2307/2442770; MOORE ED, 1973, MYCOLOGIA, V65, P145, DOI 10.2307/3757795; Shimizu Takashi, 2006, Cytologia (Tokyo), V71, P69, DOI 10.1508/cytologia.71.69; Tien CJ, 2005, PROTOPLASMA, V225, P225, DOI 10.1007/s00709-005-0092-8; Wigglesworth-Cooksey B, 2005, APPL ENVIRON MICROB, V71, P428, DOI 10.1128/AEM.71.1.428-435.2005	16	0	0	UNIV TOKYO CYTOLOGIA	TOKYO	TOSHIN BLDG, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113-0031, JAPAN	0011-4545			CYTOLOGIA	Cytologia	MAR	2015	80	1					125	129		10.1508/cytologia.80.125		5	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CD2PZ	WOS:000350922800018		
J	Hasegawa, T; Nakajima, T; Ishida, T; Kudo, A; Kawakami, A				Hasegawa, Tomoya; Nakajima, Teruhiro; Ishida, Takashi; Kudo, Akira; Kawakami, Atsushi			A diffusible signal derived from hematopoietic cells supports the survival and proliferation of regenerative cells during zebrafish fin fold regeneration	DEVELOPMENTAL BIOLOGY			English	Article						Zebrafish; Fin fold; Regeneration; Apoptosis; Myeloid; cloche; tal1	TISSUE REGENERATION; CAUDAL FIN; WOUND EPIDERMIS; DIFFERENTIATION; EXPRESSION; BLASTEMA; PATHWAYS; KINASE; GROWTH; DEATH	Multicellular organisms maintain body integrity by constantly regenerating tissues throughout their lives; however, the overall mechanism for regulating regeneration remains an open question. Studies of limb and fin regeneration in teleost fish and urodeles have shown the involvement of a number of locally activated signals at the wounded site during regeneration. Here, we demonstrate that a diffusible signal from a distance also play an essential role for regeneration. Among a number of zebrafish mutants, we found that the zebrafish cloche (clo) and tal1 mutants, which lack most hematopoietic tissues, displayed a unique regeneration defect accompanying apoptosis in primed regenerative tissue. Our analyses of the mutants showed that the cells in the primed regenerative tissue are susceptible to apoptosis, but their survival is normally supported by the presence of hematopoietic tissues, mainly the myeloid cells. We further showed that a diffusible factor in the wild-type body fluid mediates this signal. Thus, our study revealed a novel mechanism that the hematopoietic tissues regulate tissue regeneration through a diffusible signal. (C) 2014 Elsevier Inc. All rights reserved.	[Hasegawa, Tomoya; Nakajima, Teruhiro; Ishida, Takashi; Kudo, Akira; Kawakami, Atsushi] Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kawakami, A (reprint author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, B27 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	atkawaka@bio.titech.ac.jp					Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pase L, 2012, CURR BIOL, V22, P1818, DOI 10.1016/j.cub.2012.07.060; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Liao W, 2000, DEVELOPMENT, V127, P4303; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Mohamad N, 2005, BIOCELL, V29, P149; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Campbell LJ, 2008, CELL MOL LIFE SCI, V65, P73, DOI 10.1007/s00018-007-7433-z; Gauron C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02084; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Langenau DM, 2005, BLOOD, V105, P3278, DOI 10.1182/blood-2004-08-3073; Miura M, 2011, DEV GROWTH DIFFER, V53, P125, DOI 10.1111/j.1440-169X.2010.01228.x; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAR 1	2015	399	1					80	90		10.1016/j.ydbio.2014.12.015		11	Developmental Biology	Developmental Biology	CC9RS	WOS:000350709300008		
J	Sekine, K; Furusawa, T; Hatakeyama, M				Sekine, Kazuki; Furusawa, Tadashi; Hatakeyama, Masatsugu			The boule gene is essential for spermatogenesis of haploid insect male	DEVELOPMENTAL BIOLOGY			English	Article						boule (bol); DAZ; Spermatogenesis; Haplodiploidy; RNAi	ATHALIA-ROSAE HYMENOPTERA; GERM-CELL DEVELOPMENT; CDC25 HOMOLOG TWINE; SPERMATID DIFFERENTIATION; PROTEIN BOULE; DROSOPHILA SPERMATOGENESIS; EVOLUTIONARY GENETICS; NASONIA-VITRIPENNIS; APIS-MELLIFERA; DAZ-FAMILY	boule (bol), a member of the Deleted in Azoospermia (DAZ) gene family plays an important role in meiosis (reductional maturation divisions) in a spermatogenesis-specific manner in animals by regulating translation of the downstream cell division cycle 25 (cdc25) phosphatase mRNA. Orthologues of bat are conserved among animals and found in the genomes of hymenopteran insects, in which the general mode of reproduction is haplodiploidy: female is diploid and male is haploid. In this mode of reproduction, haploid males produce haploid sperm through non-reductional maturation divisions. The question thus arises of whether the bol gene actually functions during spermatogenesis in these haploid males. In this study, we identified two transcriptional isoforms of bat orthologue (Ar bat and Ar bol-2), and one cdc25 orthologue (Ar cdc25) in the hymenopteran sawfly, Athalia rosae. Ar bol was expressed exclusively in the testis when maturation divisions occurred, while Ar bol-2 was expressed ubiquitously. Knockdown of all bat transcripts (both Ar bat and Ar bol-2) resulted in a lack of mature sperm, whereas males with sole knockdown of Ar bol-2 were able to produce a small number of mature sperm. The cell cycle was arrested before maturation divisions in the testis in which all hot transcripts were knocked down, as revealed by flow cytometry. Although no mature sperm was produced, sperm elongation was partially observed when Ar cdc25 alone was knocked down. These results indicate that Ar bat is essential for the entry and progression of maturation divisions and sperm differentiation in haploid males. (C) 2015 Elsevier Inc. All rights reserved.	[Sekine, Kazuki; Hatakeyama, Masatsugu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Furusawa, Tadashi] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki 3058602, Japan	Hatakeyama, M (reprint author), Natl Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	sawfly@affrc.go.jp			 [23-7977];  [25292202]	We thank Drs. K. Tojo, M. Sawa, M. Sumitani, D.S. Yamamoto, and K. Kasashima for valuable comments and discussion, Drs. D. Kageyama, T. Kayukawa, S. Tomita, and N. Yoshiyama for technical advice, and Ms. Y. Yagihashi for sawfly laboratory stock maintenance. This study was supported in part by a Grant-in-Aid for JSPS Fellows to K.S. (No. 23-7977) and a Grant-in-Aid for Scientific Research (B) to M.H. (No. 25292202).	Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Karashima T, 2000, DEVELOPMENT, V127, P1069; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; HOAGE TR, 1968, J ULTRA MOL STRUCT R, V24, P6, DOI 10.1016/S0022-5320(68)80014-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Joiner MLA, 2004, J NEUROGENET, V18, P341, DOI 10.1080/01677060490490477435; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Houston DW, 2000, DEVELOPMENT, V127, P447; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; Maines JZ, 1999, NAT CELL BIOL, V1, P171; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; NAITO T, 1991, J HERED, V82, P101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bergner LM, 2010, DNA CELL BIOL, V29, P487, DOI 10.1089/dna.2009.0989; CASTRILLON DH, 1993, GENETICS, V135, P489; Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; COURTOT C, 1992, DEVELOPMENT, V116, P405; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; Cruz-Landim C., 1980, CARYOLOGIA, V33, P1; Eirin-Lopez J. M., 2011, INT J EVOL BIOL; Fujiwara Y, 2004, J HERED, V95, P81, DOI 10.1093/jhered/esh009; Hatakeyama M, 2000, J EXP ZOOL, V286, P181, DOI 10.1002/(SICI)1097-010X(20000201)286:2<181::AID-JEZ10>3.0.CO;2-2; HOGGE MAF, 1975, J SUBMICR CYTOL PATH, V7, P81; Karlsson-Rosenthal Christina, 2006, Trends Cell Biol, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kuales G, 2011, DEV BIOL, V357, P117, DOI 10.1016/j.ydbio.2011.06.030; Lin TY, 1996, DEVELOPMENT, V122, P1331; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Mikhaylova LM, 2006, P NATL ACAD SCI USA, V103, P11975, DOI 10.1073/pnas.0605087103; MILLAR JBA, 1992, CELL, V68, P407, DOI 10.1016/0092-8674(92)90177-E; Nishiyama T, 2010, OOGENESIS UNIVERSAL, P357; OISHI K, 1993, GENETICA, V88, P119, DOI 10.1007/BF02424468; SAWA M, 1989, ZOOL SCI, V6, P541; SAWA M, 1989, ZOOL SCI, V6, P549; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Shah C., 2010, PLOS GENET, V6; Sharma G. P., 1961, J R MICROSC SOC, V79, P337; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; Sumitani M, 2005, INSECT BIOCHEM MOLEC, V35, P231, DOI 10.1016/j.ibmb.2004.12.006; Vangompel MJ, 2011, SPERMATOGENESIS, V1, P36, DOI DOI 10.4161/SPMG.1.1.14659; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Warren J. H., 2010, SCIENCE, V327, P343; WHITECOOPER H, 1993, J CELL SCI, V106, P1035; Yamamoto DS, 2008, MECH DEVELOP, V125, P996, DOI 10.1016/j.mod.2008.08.004; Yoshiyama N, 2013, J INSECT PHYSIOL, V59, P400, DOI 10.1016/j.jinsphys.2013.01.009	54	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAR 1	2015	399	1					154	163		10.1016/j.ydbio.2014.12.027		10	Developmental Biology	Developmental Biology	CC9RS	WOS:000350709300014		
J	Matsukawa, S; Miwata, K; Asashima, M; Michiue, T				Matsukawa, Shinya; Miwata, Kyoko; Asashima, Makoto; Michiue, Tatsuo			The requirement of histone modification by PRDM12 and Kdm4a for the development of pre-placodal ectoderm and neural crest in Xenopus	DEVELOPMENTAL BIOLOGY			English	Article						Histone modification; PRDM12; Kdm4a; Pre-placodal ectoderm; Neural crest; Xenopus	VERTEBRATE CRANIAL PLACODES; CELL FATE; RETINOIC ACID; PLATE BORDER; LYSINE 9; GENES; SPECIFICATION; INDUCTION; JMJD2A; H3	In vertebrates, pre-placodal ectoderm and neural crest development requires morphogen gradients and several transcriptional factors, while the involvement of histone modification remains unclear. Here, we report that histone-modifying factors play crucial roles in the development of pre-placodal ectoderm and neural crest in Xenopus. During the early neurula stage, PRDM12 was expressed in the lateral pre-placodal ectoderm and repressed the expression of neural crest specifier genes via methylation of histone H3K9. ChIP-qPCR analyses indicated that PRDM12 promoted the occupancy of the trimethylated histone H3K9 (H3K9me3) on the Foxd3, Slug, and Sox8 promoters. Injection of the PRDM12 MO inhibited the expression of presumptive trigeminal placode markers and decreased the occupancy of H3K9me3 on the Foxd3 promoter. Histone demethylase Kdm4a also inhibited the expression of presumptive trigeminal placode markers in a similar manner to PRDM12 MO and could compensate for the effects of PRDM12. ChIP-qPCR analyses revealed that promotion of the occupancy of H3K9me3 on the Foxd3, Slug, and Sox8 promoters was inhibited by Kdm4a overexpression. Taken together, these data indicate that histone modification was essential for pre-placodal ectoderm and neural crest development. (C) 2015 Elsevier Inc. All rights reserved.	[Matsukawa, Shinya; Michiue, Tatsuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Sci Biol, Meguro Ku, Tokyo 1538902, Japan; [Miwata, Kyoko; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan	Michiue, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Sci Biol, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	tmichiue@bio.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [25127704, 26440115]; JSPS [120800000402]	We thank Dr. N. Sudo for the technical advice and Drs. K. Tanegashima and S. Yamashita for their invaluable comments on this manuscript. This work was supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI #25127704 and #26440115). S. M. is also supported by the JSPS for Young Scientists (#120800000402).	Woda JM, 2003, DEVELOPMENT, V130, P331, DOI 10.1242/dev.00212; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Yang CM, 2013, CELL STRUCT FUNCT, V38, P195; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Berry WL, 2012, INT J ONCOL, V41, P1701, DOI 10.3892/ijo.2012.1618; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; MILNER CM, 1993, BIOCHEM J, V290, P811; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Ling BMT, 2012, MOL BIOL CELL, V23, P4778, DOI 10.1091/mbc.E12-04-0311; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Reid AG, 2004, LEUKEMIA, V18, P178, DOI 10.1038/sj.leu.2403162; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev01516; Kim KC, 2003, CANCER RES, V63, P7619; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Zhang HL, 1997, MOL CELL BIOL, V17, P2920; Dincer Z, 2013, CELL REP, V5, P1387, DOI 10.1016/j.celrep.2013.10.048; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; NISHIMATSU S, 1992, BIOCHEM BIOPH RES CO, V186, P1487, DOI 10.1016/S0006-291X(05)81574-8; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Strobl-Mazzulla PH, 2010, DEV CELL, V19, P460, DOI 10.1016/j.devcel.2010.08.009; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Theveneau E, 2012, DEV BIOL, V366, P34, DOI [10.1016/j.ydbio.2011.12.041, 10.1016/j.ydbio2011.12.041]; de Souza FSJ, 1999, EMBO J, V18, P6062, DOI 10.1093/emboj/18.21.6062; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Hu N, 2012, GENE DEV, V26, P2380, DOI 10.1101/gad.198747.112; Kaji T, 2004, DEV BIOL, V276, P523, DOI 10.1016/j.ydbio.2004.09.020; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Matsuo-Takasaki M, 2005, DEVELOPMENT, V132, P3885, DOI 10.1242/dev.01959; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pieper M, 2012, DEVELOPMENT, V139, P1175, DOI 10.1242/dev.074468; Plouhinec J. L., 2013, DEV BIOL, V15, P461; Reichert S, 2013, DEVELOPMENT, V140, P4435, DOI 10.1242/dev.098707; Saint-Jeannet Jean-Pierre, 2014, Dev Biol, V389, P13, DOI 10.1016/j.ydbio.2014.02.011; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Tanibe M, 2008, INT J DEV BIOL, V52, P893, DOI 10.1387/ijdb.082683mt	52	5	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAR 1	2015	399	1					164	176		10.1016/j.ydbio.2014.12.028		13	Developmental Biology	Developmental Biology	CC9RS	WOS:000350709300015		
J	Ehara, T; Kamei, Y; Yuan, XM; Takahashi, M; Kanai, S; Tamura, E; Tsujimoto, K; Tamiya, T; Nakagawa, Y; Shimano, H; Takai-Igarashi, T; Hatada, I; Suganami, T; Hashimoto, K; Ogawa, Y				Ehara, Tatsuya; Kamei, Yasutomi; Yuan, Xunmei; Takahashi, Mayumi; Kanai, Sayaka; Tamura, Erina; Tsujimoto, Kazutaka; Tamiya, Takashi; Nakagawa, Yoshimi; Shimano, Hitoshi; Takai-Igarashi, Takako; Hatada, Izuho; Suganami, Takayoshi; Hashimoto, Koshi; Ogawa, Yoshihiro			Ligand-Activated PPAR alpha-Dependent DNA Demethylation Regulates the Fatty Acid beta-Oxidation Genes in the Postnatal Liver	DIABETES			English	Article							TRANSCRIPTION FACTOR; RECEPTOR-ALPHA; METHYLATION; EXPRESSION; GLYCOSYLASE; PROMOTERS; DNMT3A; ROLES; BIRTH; MILK	The metabolic function of the liver changes sequentially during early life in mammals to adapt to the marked changes in nutritional environment. Accordingly, hepatic fatty acid -oxidation is activated after birth to produce energy from breast milk lipids. However, how it is induced during the neonatal period is poorly understood. Here we show DNA demethylation and increased mRNA expression of the fatty acid -oxidation genes in the postnatal mouse liver. The DNA demethylation does not occur in the fetal mouse liver under the physiologic condition, suggesting that it is specific to the neonatal period. Analysis of mice deficient in the nuclear receptor peroxisome proliferator-activated receptor (PPAR) and maternal administration of a PPAR ligand during the gestation and lactation periods reveal that the DNA demethylation is PPAR dependent. We also find that DNA methylation of the fatty acid -oxidation genes are reduced in the adult human liver relative to the fetal liver. This study represents the first demonstration that the ligand-activated PPAR-dependent DNA demethylation regulates the hepatic fatty acid -oxidation genes during the neonatal period, thereby highlighting the role of a lipid-sensing nuclear receptor in the gene- and life-stage-specific DNA demethylation of a particular metabolic pathway.	[Ehara, Tatsuya; Tamura, Erina; Tsujimoto, Kazutaka; Tamiya, Takashi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo, Japan; [Ehara, Tatsuya] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Nutr Res Dept, Zama, Kanagawa, Japan; [Kamei, Yasutomi; Yuan, Xunmei; Takahashi, Mayumi; Kanai, Sayaka; Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Bunkyo Ku, Tokyo, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Fac Med, Dept Internal Med Metab & Endocrinol, Tsukuba, Ibaraki, Japan; [Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Takai-Igarashi, Takako] Tohoku Med Megabank Org, Dept Hlth Record Informat, Aoba Ku, Sendai, Miyagi, Japan; [Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan; [Suganami, Takayoshi] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo, Japan; [Hashimoto, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Bunkyo Ku, Tokyo, Japan	Ogawa, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo, Japan.	ogawa.mem@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Ono Medical Foundation; Naito Foundation; Nestle Nutrition Council, Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Ministry of Health, Labor, and Welfare of Japan. This work was also supported by research grants from Ono Medical Foundation, The Naito Foundation, and Nestle Nutrition Council, Japan.	Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Kersten S, 2000, NATURE, V405, P421; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Francois CA, 1998, AM J CLIN NUTR, V67, P301; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Brauner P, 2001, PEDIATR RES, V49, P440, DOI 10.1203/00006450-200103000-00022; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; Huang W., 2009, NAT PROTOC, V4, P44, DOI DOI 10.1038/NPR0T.2008.211; Kobayashi Y, 2012, PEDIATR NEPHROL, V27, P2233, DOI 10.1007/s00467-012-2248-z; MAYOR F, 1985, BIOL NEONATE, V48, P185; Panning Barbara, 2008, Journal of Biology (London), V7, P301, DOI 10.1186/jbiol95; PEREZCASTILLO A, 1987, AM J PHYSIOL, V253, pE536; PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7; Rakhshandehroo M, 2010, PPAR RES, V2010, P2010; Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784; Takahashi M, 2013, BIOCHEM BIOPH RES CO, V434, P873, DOI 10.1016/j.bbrc.2013.04.041; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241	37	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	MAR	2015	64	3					775	784		10.2337/db14-0158		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CC3GX	WOS:000350235900019		
J	Kodama, K; Toda, K; Morinaga, S; Yamada, S; Butte, AJ				Kodama, Keiichi; Toda, Kyoko; Morinaga, Shojiroh; Yamada, Satoru; Butte, Atul J.			Anti-CD44 Antibody Treatment Lowers Hyperglycemia and Improves Insulin Resistance, Adipose Inflammation, and Hepatic Steatosis in Diet-Induced Obese Mice	DIABETES			English	Article							MACROPHAGE INFILTRATION; CD44; OSTEOPONTIN; RECEPTOR; TISSUE; CONTRIBUTES; COMPONENT; ETA-1; LINKS	Type 2 diabetes (T2D) is a metabolic disease affecting >370 million people worldwide. It is characterized by obesity-induced insulin resistance, and growing evidence has indicated that this causative link between obesity and insulin resistance is associated with visceral adipose tissue inflammation. However, using anti-inflammatory drugs to treat insulin resistance and T2D is not a common practice. We recently applied a bioinformatics methodology to open public data and found that CD44 plays a critical role in the development of adipose tissue inflammation and insulin resistance. In this report, we examined the role of CD44 in T2D by administering daily injections of anti-CD44 monoclonal antibody (mAb) in a high-fat-diet mouse model. Four weeks of therapy with CD44 mAb suppressed visceral adipose tissue inflammation compared with controls and reduced fasting blood glucose levels, weight gain, liver steatosis, and insulin resistance to levels comparable to or better than therapy with the drugs metformin and pioglitazone. These findings suggest that CD44 mAb may be useful as a prototype drug for therapy of T2D by breaking the links between obesity and insulin resistance.	[Kodama, Keiichi; Butte, Atul J.] Stanford Univ, Dept Pediat, Sch Med, Div Syst Med, Stanford, CA 94305 USA; [Kodama, Keiichi; Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Toda, Kyoko] Kitasato Univ, Div Biomed Res Ctr, Biomed Lab, Kitasato Inst Hosp,Minato Ku, Tokyo, Japan; [Morinaga, Shojiroh] Kitasato Univ, Kitasato Inst Hosp, Dept Diagnost Pathol, Minato Ku, Tokyo, Japan; [Yamada, Satoru] Kitasato Univ, Kitasato Inst Hosp, Diabet Ctr, Minato Ku, Tokyo, Japan	Kodama, K (reprint author), Stanford Univ, Dept Pediat, Sch Med, Div Syst Med, Stanford, CA 94305 USA.	kkodama@stanford.edu; abutte@stanford.edu			Howard Hughes Medical Institute; National Library of Medicine [R01-LM009719]; Stanford University Office of Technology Licensing; Lucile Packard Foundation for Children's Health	This work was supported by grants from the Howard Hughes Medical Institute, the National Library of Medicine (R01-LM009719), the Stanford University Office of Technology Licensing, and the Lucile Packard Foundation for Children's Health.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Chapman J, 2010, PLOS ONE, V5; Egan CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065247; Fogelstrand P, 2013, DIABETES, V62, P1816, DOI 10.2337/db13-0261; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kang HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058417; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Liu L, 2013, ENDO 2013 15 18 JUN; Toda K, 2012, J JAPAN DIABETES SOC, V55, P5213	25	6	6	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	MAR	2015	64	3					867	875		10.2337/db14-0149		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC3GX	WOS:000350235900027		
J	Hashimoto, S; Kubota, N; Sato, H; Sasaki, M; Takamoto, I; Kubota, T; Nakaya, K; Noda, M; Ueki, K; Kadowaki, T				Hashimoto, Shinji; Kubota, Naoto; Sato, Hiroyuki; Sasaki, Motohiro; Takamoto, Iseki; Kubota, Tetsuya; Nakaya, Keizo; Noda, Mitsuhiko; Ueki, Kohjiro; Kadowaki, Takashi			Insulin Receptor Substrate-2 (Irs2) in Endothelial Cells Plays a Crucial Role in Insulin Secretion	DIABETES			English	Article							ISLET BLOOD-FLOW; RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME-INHIBITION; DEPENDENT DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; HYPERTENSIVE PATIENTS; PANCREATIC-ISLETS; CILAZAPRIL TREATMENT; SKELETAL-MUSCLE; RISK-FACTORS	Endothelial cells are considered to be essential for normal pancreatic -cell function. The current study attempted to demonstrate the role of insulin receptor substrate-2 (Irs2) in endothelial cells with regard to insulin secretion. Endothelial cell-specific Irs2 knockout (ETIrs2KO) mice exhibited impaired glucose-induced, arginine-induced, and glucagon-induced insulin secretion and showed glucose intolerance. In batch incubation and perifusion experiments using isolated islets, glucose-induced insulin secretion was not significantly different between the control and the ETIrs2KO mice. In contrast, in perfusion experiments, glucose-induced insulin secretion was significantly impaired in the ETIrs2KO mice. The islet blood flow was significantly impaired in the ETIrs2KO mice. After the treatment of these knockout mice with enalapril maleate, which improved the islet blood flow, glucose-stimulated insulin secretion was almost completely restored to levels equal to those in the control mice. These data suggest that Irs2 deletion in endothelial cells leads to a decreased islet blood flow, which may cause impaired glucose-induced insulin secretion. Thus, Irs2 in endothelial cells may serve as a novel therapeutic target for preventing and ameliorating type 2 diabetes and metabolic syndrome.	[Hashimoto, Shinji; Kubota, Naoto; Sato, Hiroyuki; Sasaki, Motohiro; Takamoto, Iseki; Kubota, Tetsuya; Nakaya, Keizo; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Kubota, Naoto; Takamoto, Iseki; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, TSBMI, Tokyo, Japan; [Kubota, Naoto; Kubota, Tetsuya; Kadowaki, Takashi] Natl Inst Hlth & Nutr, Clin Nutr Program, Tokyo 162, Japan; [Kubota, Naoto; Kubota, Tetsuya] Rikagaku Kenkyusho RIKEN Ctr Integrat Med Sci, Lab Metab Homeostasis, Kanagawa, Japan; [Kubota, Tetsuya] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan	Kadowaki, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.	nkubota-tky@umin.ac.jp; kadowaki-3im@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [18209033, 20229008]	This work was supported by a grant for Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grant-in-Aid to T.Ka. for Scientific Research in Priority Areas (A) (18209033) and (S) (20229008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anneren C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1183, DOI 10.1152/ajpendo.00168.2006; Nystrom T, 2012, FREE RADICAL BIO MED, V53, P1017, DOI 10.1016/j.freeradbiomed.2012.06.031; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Carlsson PO, 1998, DIABETOLOGIA, V41, P127, DOI 10.1007/s001250050880; Zanchetti A, 2002, J HYPERTENS, V20, P2099, DOI 10.1097/00004872-200211000-00001; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; Dai CH, 2013, DIABETES, V62, P4144, DOI 10.2337/db12-1657; Kubota T, 2003, CIRCULATION, V107, P3073, DOI 10.1161/01.CIR.0000070937.52035.25; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; GANS ROB, 1991, EUR J CLIN INVEST, V21, P527, DOI 10.1111/j.1365-2362.1991.tb01405.x; Goren H Joseph, 2005, Curr Diabetes Rev, V1, P309, DOI 10.2174/157339905774574301; HAENNI A, 1994, AM J HYPERTENS, V7, P615; Huang Z, 2007, CLIN SCI, V112, P69, DOI 10.1042/CS20060176; Iwase M, 2005, EUR J PHARMACOL, V518, P243, DOI 10.1016/j.ejphar.2005.05.044; Jacob S, 1996, METABOLISM, V45, P535, DOI 10.1016/S0026-0495(96)90021-9; JANSSON L, 1994, DIABETES METAB REV, V10, P407; JANSSON L, 1981, ACTA PHYSIOL SCAND, V113, P371, DOI 10.1111/j.1748-1716.1981.tb06909.x; JAUCH KW, 1987, EUR J CLIN INVEST, V17, P448, DOI 10.1111/j.1365-2362.1987.tb01141.x; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Lender D, 1999, AM J HYPERTENS, V12, P298, DOI 10.1016/S0895-7061(98)00259-3; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; McFarlane SI, 2003, AM J CARDIOL, V91, p30H, DOI 10.1016/S0002-9149(03)00432-6; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; MOREL Y, 1995, J CARDIOVASC PHARM, V26, P306, DOI 10.1097/00005344-199508000-00017; Movassat J, 2008, AM J PHYSIOL-ENDOC M, V294, pE168, DOI 10.1152/ajpendo.00501.2007; PAOLISSO G, 1992, J HUM HYPERTENS, V6, P175; Reaven GM, 2009, DIABETES VASC DIS RE, V6, P133, DOI 10.1177/1479164109336038; SANTORO D, 1992, HYPERTENSION, V20, P181; SHAMISS A, 1995, AM J HYPERTENS, V8, P276, DOI 10.1016/0895-7061(94)00181-A; SHIEH SM, 1992, AM J HYPERTENS, V5, P506; SPARROW RA, 1989, J ANAT, V163, P75; Suzuki K, 2008, CLIN EXP HYPERTENS, V30, P309, DOI 10.1080/10641960802269927; SUZUKI M, 1995, CLIN EXP HYPERTENS, V17, P1257, DOI 10.3109/10641969509037407; TORLONE E, 1991, DIABETOLOGIA, V34, P119, DOI 10.1007/BF00500383; Wang L, 2013, MOL CELL ENDOCRINOL, V381, P261, DOI 10.1016/j.mce.2013.08.008	45	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	MAR	2015	64	3					876	886		10.2337/db14-0432		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CC3GX	WOS:000350235900028		
J	Johnson, C; Hargrove, L; Graf, A; Kennedy, L; Hodges, K; Harris, R; Francis, T; Ueno, Y; Francis, H				Johnson, Christopher; Hargrove, Laura; Graf, Allyson; Kennedy, Lindsey; Hodges, Kyle; Harris, Rachel; Francis, Taylor; Ueno, Yoshiyuki; Francis, Heather			Histamine restores biliary mass following carbon tetrachloride-induced damage in a cholestatic rat model	DIGESTIVE AND LIVER DISEASE			English	Article						Biliary epithelium; Damage; Homeostasis; Mitosis; Restoration	BILE-DUCT LIGATION; PROLIFERATIVE CAPACITY; LARGE CHOLANGIOCYTES; GENE-EXPRESSION; LIVER-DISEASE; H-1 RECEPTOR; PATHWAY; CELLS; H-2-RECEPTOR; MICE	Background: Bile duct ligation coupled with carbon tetrachloride induces apoptosis of large but not small cholangiocytes. Histidine decarboxylase regulates histamine synthesis. We have shown that: (i) cholangiocytes express histidine decarboxylase and secrete histamine and (ii) histamine stimulates biliary growth. Aims: To demonstrate that histidine decarboxylase/histamine regulates cholangiocyte homeostasis after carbon tetrachloride treatment. Methods: In vivo, normal and bile duct ligated rats were treated with saline or histamine (0.5 mg/kg body weight) and given carbon tetrachloride by gavage 2 days before sacrifice. Serum, liver blocks and large cholangiocytes were obtained. Histidine decarboxylase, bile duct mass and proliferation were measured in liver sections and in cholangiocytes. Apoptosis was measured by immunohistochemistry and gene expression. Histamine levels were evaluated in serum. In vitro, large cholangiocytes were treated with carbon tetrachloride in the absence/presence of histamine before evaluating proliferation. Results: After bile duct ligation there was enhanced ductal mass, histidine decarboxylase expression and serum histamine levels. Carbon tetrachloride treatment enhanced biliary apoptosis, and decreased histidine decarboxylase and serum histamine levels and biliary proliferation, changes that were restored by histamine. In vitro, cholangiocytes treated with carbon tetrachloride had a lower proliferative capacity that was reversed when cells were pre-treated with histamine. Conclusion: Histidine decarboxylase may be a key regulator of cholangiocyte homeostasis during biliary injury. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.	[Francis, Heather] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Hargrove, Laura; Graf, Allyson; Kennedy, Lindsey; Hodges, Kyle; Harris, Rachel; Francis, Taylor; Francis, Heather] BaylorScott & White, Scott & White Digest Dis Res Ctr, Waco, TX USA; [Johnson, Christopher; Francis, Heather] Texas A&M Univ HSC, Temple, TX USA; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan; [Ueno, Yoshiyuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Francis, H (reprint author), Texas A&M HSC Univ COM, Dept Internal Med, Cent Texas Vet Hlth Care Syst, BaylorScott & White, 1901 S Vet Mem Dr 151,Bldg 205,Off 1R58, Temple, TX 76504 USA.	hfrancis@medicine.tamhsc.edu					ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355; Nguyen T, 2001, MOL PHARMACOL, V59, P427; Francis H, 2004, J HEPATOL, V41, P528, DOI 10.1016/j.jhep.2004.06.009; Francis H, 2012, GUT, V61, P753, DOI 10.1136/gutjnl-2011-300007; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x; Ahmadi A, 2011, FUND CLIN PHARMACOL, V25, P72, DOI 10.1111/j.1472-8206.2009.00810.x; LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289; Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533; ALPINI G, 1994, AM J PHYSIOL, V266, pG922; Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Francis HL, 2012, LAB INVEST, V92, P282, DOI 10.1038/labinvest.2011.158; Francis H, 2010, DIGEST LIVER DIS, V42, P529, DOI 10.1016/j.dld.2010.02.016; Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767; El-Mahdy NA, 2013, J IMMUNOTOXICOL, V10, P9, DOI 10.3109/1547691X.2012.684158; Dickenson JM, 2002, BRIT J PHARMACOL, V135, P1967, DOI 10.1038/sj.bjp.0704664; FAROUK M, 1992, GASTROENTEROLOGY, V102, P963; GITTLEN SD, 1990, GUT, V31, P96, DOI 10.1136/gut.31.1.96; Hodges K, 2012, TRANSL GASTROINTEST, V1, P138; ISHII M, 1989, GASTROENTEROLOGY, V97, P1236; Karavodin L, 2003, DRUG CHEM TOXICOL, V26, P35, DOI 10.1081/DCT-120017556; Lim HD, 2005, J PHARMACOL EXP THER, V314, P1310, DOI 10.1124/jpet.105.087965; Lleo A, 2013, DIGEST LIVER DIS, V45, P630, DOI 10.1016/j.dld.2013.01.005; Masaki T, 2005, FASEB J, V19, P1245, DOI 10.1096/fj.04-3195com; Meng FY, 2014, AM J PATHOL, V184, P662, DOI 10.1016/j.ajpath.2013.11.008; MITSUHASHI M, 1989, J BIOL CHEM, V264, P18356; Onori P, 2009, J INT CANC, V125, P565; RUTENBUR.AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517; UMEZU K, 1985, BIOCHEM PHARMACOL, V34, P2007; Valcheva-Kuzmanova Stefka V, 2004, Folia Med (Plovdiv), V46, P36	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	MAR	2015	47	3					211	217		10.1016/j.dld.2014.12.006		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB9SL	WOS:000349972600007		
J	Kucharski, D; Kirchner, G; Otsubo, T; Koidl, F				Kucharski, Daniel; Kirchner, Georg; Otsubo, Toshimichi; Koidl, Franz			A method to calculate zero-signature satellite laser ranging normal points for millimeter geodesy - a case study with Ajisai	EARTH PLANETS AND SPACE			English	Article						Satellite laser ranging; Ajisai; Satellite geodesy; Zero-signature satellite; Normal point	SPIN AXIS ORIENTATION; RATE SLR DATA; NANOSATELLITE BLITS; SYSTEM	High repetition-rate satellite laser ranging (SLR) offers new possibilities for the post-processing of the range measurements. We analyze 11 years of kHz SLR passes of the geodetic satellite Ajisai delivered by Graz SLR station (Austria) in order to improve the accuracy and precision of the principal SLR data product - normal points. The normal points are calculated by three different methods: 1) the range residuals accepted by the standard 2.5 sigma filter, 2) the range residuals accepted by the leading edge filter and 3) the range residuals given by the single corner cube reflector (CCR) panels of Ajisai. A comparison of the statistical parameters of the obtained results shows that the selection of the range measurements from the leading edge of the SLR data distribution allows to minimize the satellite signature effect and to reduce the average single-shot RMS per normal point from 15.44 to 4.85 mm. The optical distance between the leading edge mean reflection point and the satellite's center of mass is 1,023 mm, RMS = 1.7 mm. Further, in addition, we utilize the complete attitude model of Ajisai during the post-processing which enables selection of the range measurements to the single CCR panels of the satellite and the formation of the normal points which most closely approximate the physical distance between the ground station and the center of mass of Ajisai. This method eliminates the satellite signature effect from the distribution of the post-fit range residuals and further improves the average single-shot RMS per normal point to 3.05 mm. The normal point RMS per pass is reduced from 2.97 to 0.06 mm - a value expected for a zero-signature satellite.	[Kucharski, Daniel] Korea Astron & Space Sci Inst, Space Sci Div, Taejon 305348, South Korea; [Kirchner, Georg; Koidl, Franz] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Otsubo, Toshimichi] Hitotsubashi Univ, Kunitachi, Tokyo 1868601, Japan	Kucharski, D (reprint author), Korea Astron & Space Sci Inst, Space Sci Div, 776 Daedeok Daero, Taejon 305348, South Korea.	daniel@drdk.org; georg.kirchner@oeaw.ac.at; t.otsubo@r.hit-u.ac.jp; franz.koidl@oeaw.ac.at					Pearlman MR, 2002, ADV SPACE RES, V30, P135, DOI 10.1016/S0273-1177(02)00277-6; Dunn P, 1999, GEOPHYS RES LETT, V26, P1489, DOI 10.1029/1999GL900260; Mendes VB, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020308; Moore P, 2003, ADV SPACE RES, V31, P1927, DOI 10.1016/S0273-1177(03)00170-4; Kucharski D, 2012, ADV SPACE RES, V50, P1473, DOI 10.1016/j.asr.2012.07.018; Appleby G, 1995, P ANN EUR M ROYAL GR, P18; Appleby GM, 1993, P 8 INT WORKSH LAS R; Arnold DA, 1979, 382 SMITHS ASTR OBS; Fitzmaurice MW, 1977, PRELAUNCH TESTING LA, P1062; Hashimoto H, 2012, J GEODETIC SOC JPN, V58, P9, DOI 10.11366/sokuchi.58.9; Kirchner G, 2008, P 16 INT WORKSH LAS, P370; Kirchner G, 1995, P ANN EUR M MUN, P73; Kirchner G., 2004, P 14 INT WORKSH LAS, P501; Kucharski D, 2010, ADV SPACE RES, V46, P251, DOI 10.1016/j.asr.2010.03.029; Kucharski D, 2011, ADV SPACE RES, V48, P1335, DOI 10.1016/j.asr.2011.06.016; Kucharski D, 2010, IEEE T GEOSCI REMOTE, V48, P1629, DOI 10.1109/TGRS.2009.2031229; Kucharski D, 2013, ADV SPACE RES, V51, P162, DOI 10.1016/j.asr.2012.09.018; Kucharski D, 2011, ADV SPACE RES, V48, P343, DOI 10.1016/j.asr.2011.03.027; Kucharski D, 2013, ADV SPACE RES, V51, P912, DOI 10.1016/j.asr.2012.10.008; Neubert R, 1995, P 9 INT WORKSH LAS R, P7; Otsubo T, 2000, IEEE T GEOSCI REMOTE, V38, P1417, DOI 10.1109/36.843036; Otsubo T, 1998, P 11 INT WORKSH LAS, P674; Otsubo T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002209; Parkhomenko N, 2013, P 18 INT WORKSH LAS, P13; Plag HP, 2009, GLOBAL GEODETIC OBSERVING SYSTEM: MEETING THE REQUIREMENTS OF A GLOBAL SOCIETY ON A CHANGING PLANET IN 2020, P1, DOI 10.1007/978-3-642-02687-4; SASAKI M, 1987, IEEE T GEOSCI REMOTE, V25, P526, DOI 10.1109/TGRS.1987.289830; Sinclair AT, 1995, P ANN EUROLAS M, P31; Sinclair AT, 1993, P 8 INT WORKSH LAS R, p[2, 43]; Vasiliev VP, 2007, INT LAS RANG SERV WO	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1880-5981			EARTH PLANETS SPACE	Earth Planets Space	MAR 1	2015	67								34	10.1186/s40623-015-0204-4		10	Geosciences, Multidisciplinary	Geology	CC9GB	WOS:000350675200001		
J	Suzuki, K; Izumo, M; Kamijima, R; Mizukoshi, K; Takai, M; Kida, K; Yoneyama, K; Nobuoka, S; Yamada, H; Akashi, YJ				Suzuki, Kengo; Izumo, Masaki; Kamijima, Ryo; Mizukoshi, Kei; Takai, Manabu; Kida, Keisuke; Yoneyama, Kihei; Nobuoka, Sachihiko; Yamada, Hidehiro; Akashi, Yoshihiro J.			Influence of Pulmonary Vascular Reserve on Exercise-Induced Pulmonary Hypertension in Patients with Systemic Sclerosis	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						exercise echocardiography; pulmonary hypertension	ARTERY SYSTOLIC PRESSURE; DOPPLER-ECHOCARDIOGRAPHY; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; CARDIAC-OUTPUT; STROKE VOLUME; RECOMMENDATIONS; QUANTIFICATION; SCLERODERMA; GUIDELINES	BackgroundExercise-induced pulmonary hypertension (PH) is considered as an early preclinical functional phase of resting PH in systemic sclerosis (SSc). In this study, we investigated the prevalence of exercise-induced PH in patients with SSc and evaluated the influence of pulmonary vascular reserve on exercise-induced PH. MethodsThis prospective study included 568 SSc patients. The patients with interstitial lung disease and those with left ventricular dysfunction were excluded (n=50); finally, 518 patients underwent simple exercise echocardiography using a Master's two-step. Systolic pulmonary artery pressure (SPAP), the ratio of early diastolic transmitral flow velocity to early diastolic mitral annular velocity (E/e') and pulmonary vascular resistance (PVR) were measured before and after exercise. PVR (the difference between rest and post) was used for the assessment of pulmonary vascular reserve. All patients were stratified into the no exercise-induced PH (SPAP<50mmHg) or exercise-induced PH (SPAP 50mmHg, n=133) group. ResultsOf the study patients, 27% patients were identified as having exercise-induced PH. PVR was higher in the exercise-induced PH than no exercise-induced PH group (0.20.3 vs. 0.4 +/- 0.4WU, P<0.0001). A weak correlation was found between postexercise SPAP and postexercise E/e' (r=0.31, P<0.0001), whereas a strong correlation was found between postexercise SPAP and postexercise PVR (r=0.62, P<0.0001). The analyzed data demonstrated that PVR was independently associated with exercise-induced PH (odds ratio, 3.435; 95% CI, 1.013-11.650, P=0.033). ConclusionsThe present study demonstrated that exercise-induced PH was common in patients with SSc. Exercise-induced PH might be closely associated with the factors affecting reduced pulmonary vascular reserve in patients with SSc.	[Suzuki, Kengo; Izumo, Masaki; Kamijima, Ryo; Mizukoshi, Kei; Takai, Manabu; Kida, Keisuke; Yoneyama, Kihei; Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa 2168511, Japan; [Nobuoka, Sachihiko] St Marianna Univ, Sch Med, Dept Lab Med, Kawasaki, Kanagawa 2168511, Japan; [Yamada, Hidehiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Rheumatol & Allergy, Kawasaki, Kanagawa 2168511, Japan	Suzuki, K (reprint author), St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	kengo@marianna-u.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			AHLBORG G, 1995, J APPL PHYSIOL, V78, P2294; ALSABBAGH MR, 1989, J RHEUMATOL, V16, P1038; Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101; Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Suzuki K, 2013, J CARDIOL, V62, P176, DOI 10.1016/j.jjcc.2013.04.007; Crosswhite P, 2010, J HYPERTENS, V28, P201, DOI 10.1097/HJH.0b013e328332bcdb; D'Alto M, 2011, HEART, V97, P112, DOI 10.1136/hrt.2010.203471; Bossone E, 2013, J AM SOC ECHOCARDIOG, V26, P1, DOI 10.1016/j.echo.2012.10.009; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Huez S, 2007, EUR RESPIR J, V30, P928, DOI 10.1183/09031936.00025607; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Lewis GD, 2013, CIRCULATION, V128, P1470, DOI 10.1161/CIRCULATIONAHA.112.000667; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Gargani L, 2013, AM HEART J, V165, P200, DOI 10.1016/j.ahj.2012.10.020; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Baptista R, 2013, ECHOCARDIOGR-J CARD, V30, P378, DOI 10.1111/echo.12063; CHRISTIE J, 1987, CIRCULATION, V76, P539; FISHMAN AP, 1976, CIRC RES, V38, P221; GRANATH A, 1964, ACTA MED SCAND, V176, P447; Lau EMT, 2011, EUR HEART J, V32, P2489, DOI 10.1093/eurheartj/ehr160; Reeves JT, 1989, PULMONARY VASCULAR P; STEBBINS CL, 1994, AM J PHYSIOL, V266, pR118; Vachiéry J-L, 2009, Eur Respir Rev, V18, P162, DOI 10.1183/09059180.00003209	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	MAR	2015	32	3					428	435		10.1111/echo.12690		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CC8ZA	WOS:000350655900004		
J	Miyata, Y; Nomata, K; Ohba, K; Matsuo, T; Hayashi, N; Sakamoto, I; Uetani, M; Sakai, H				Miyata, Y.; Nomata, K.; Ohba, K.; Matsuo, T.; Hayashi, N.; Sakamoto, I.; Uetani, M.; Sakai, H.			Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: A single-centre study of 163 patients	EJSO			English	Article						Preoperative treatment; Chemotherapy; Radiotherapy; Bladder cancer; Adverse events; Prognosis	RADICAL CYSTECTOMY; URINARY-BLADDER; CARCINOMA; CISPLATIN; 5-FLUOROURACIL; IRRADIATION; RADIATION; SURVIVAL; INFUSION	Introduction: Patients with muscle-invasive bladder cancer (MIBC) often undergo various preoperative treatments to improve survival; however, their efficacy and safety remain unclear. Materials and methods: The anti-tumour effects and adverse events were evaluated in 163 MIBC patients who received systemic chemotherapy (SC, n = 34), intra-arterial chemotherapy (IAC, n = 50), or combined IAC and radiotherapy (IAC + R, n = 79). Results: Pathological complete responses were observed in 17.6%, 22.0%, and 43.0% of patients in the SC, IAC, and IAC + R groups, respectively, with respective 5-year overall survival rates of 42.0%, 46.7%, and 50.3%. Multivariate analysis showed that successful IAC + R protocol administration was a significant predictor for survival (hazard ratio = 0.16, p = 0.028). The incidence of severe adverse events was higher in the IAC + R group (36.7%) than in the SC (9.8%) and IAC groups (16.0%). Conclusions: IAC + R was useful for patients with MD3C. Successful completion and optimal patient selection were important for this treatment strategy. (C) 2014 The Authors. Published by Elsevier Ltd.	[Miyata, Y.; Nomata, K.; Ohba, K.; Matsuo, T.; Sakai, H.] Nagasaki Univ Hosp, Dept Urol, Nagasaki, Japan; [Hayashi, N.; Sakamoto, I.; Uetani, M.] Nagasaki Univ Hosp, Dept Radiol, Nagasaki, Japan	Miyata, Y (reprint author), Nagasaki Univ, Sch Biomed Sci, Dept Nephrourol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	int.doc.miya@m3.dion.ne.jp			Japan Society for the Promotion of Science [25462487]	None of the authors has any relationship with other individtials, organizations, and companies that could inappropriately influence the work reported in this study. This original study was not supported by any founding source or companies. However, this study was supported in part by a Grant-in-Aid from Japan Society for the Promotion of Science (No. 25462487).	Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; George L, 2004, UROLOGY, V64, P488, DOI 10.1016/j.urology.2004.04.088; Kaufman DS, 2009, UROLOGY, V73, P833, DOI 10.1016/j.urology.2008.09.036; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Dalbagni G, 2001, J UROLOGY, V165, P1111, DOI 10.1016/S0022-5347(05)66440-3; Asadauskiene J, 2010, MED LITH, V46, P305; Biagioli MC, 2013, CANCER CONTROL, V20, P188; Coppin CML, 1996, J CLIN ONCOL, V14, P2901; Danesi DT, 2004, CANCER, V101, P2540, DOI 10.1002/cncr.20654; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Kageyama Y, 2000, JPN J CLIN ONCOL, V30, P553, DOI 10.1093/jjco/hyd138; Maarouf AM, 2010, BJU INT, V107, P1605; Miyanaga N, 2007, JPN J CLIN ONCOL, V37, P852, DOI 10.1093/jjco/hym129; Mokarim A, 1997, CANCER, V80, P1776, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1776::AID-CNCR12>3.0.CO;2-2; MONTIE JE, 1984, J UROLOGY, V131, P477; Nieuwenhuijzen JA, 2014, EJSO-EUR J SURG ONC, V40, P1677, DOI 10.1016/j.ejso.2013.12.017; Perdona S, 2008, CANCER, V112, P75, DOI 10.1002/cncr.23137; RAGHAVAN D, 1990, NEW ENGL J MED, V322, P1129, DOI 10.1056/NEJM199004193221607; ROTMAN M, 1987, CANCER, V59, P710, DOI 10.1002/1097-0142(19870215)59:4<710::AID-CNCR2820590408>3.0.CO;2-U; RUSSELL KJ, 1990, INT J RADIAT ONCOL, V19, P693; STEWART DJ, 1983, CANCER RES, V43, P917; Sumiyoshi Y, 1998, Int J Urol, V5, P225, DOI 10.1111/j.1442-2042.1998.tb00594.x	22	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	MAR	2015	41	3					361	367		10.1016/j.ejso.2014.07.043		7	Oncology; Surgery	Oncology; Surgery	CC6YM	WOS:000350514900013		
J	Kito, M; Yoshimura, Y; Isobe, K; Aoki, K; Momose, T; Suzuki, S; Tanaka, A; Sano, K; Akahane, T; Kato, H				Kito, M.; Yoshimura, Y.; Isobe, K.; Aoki, K.; Momose, T.; Suzuki, S.; Tanaka, A.; Sano, K.; Akahane, T.; Kato, H.			Clinical outcome of deep-seated atypical lipomatous tumor of the extremities with median-term follow-up study	EJSO			English	Article						Atypical lipomatous tumor; Extremities; Surgical method	WELL-DIFFERENTIATED LIPOSARCOMA; SURGICAL-TREATMENT; SOFT-TISSUE; TRUNK WALL; CLASSIFICATION; CYTOGENETICS; SARCOMA; MASSES; SYSTEM	Aims: There is no consensus on the best surgical treatment for deep-seated atypical lipomatous tumor (ALT) of the extremities; furthermore, the appropriate duration for follow-tip observation remains unclear. We investigated clinical and functional median-term outcomes in the primary operations for ALT of the extremities in order to find its best treatment methods and observation periods. Methods: From 1996 to 2009, we diagnosed 41 patients with deep-seated ALT of the extremities. Wide resection was performed on 11 patients and marginal resection was performed on 30 patients. The minimum follow-up was 5 years (median, 8.5; range, 5-17.4). Patients were evaluated for their local recurrence, dedifferentiation, and post-operative function using the ISOLS/MSTS scoring system. Results: Recurrence and dedifferentiation rates were both 0% for the wide resection group, while the rates were 23% (7/30) and 3% (1/30) for the marginal resection group, respectively. Median duration before recurrence was 7.2 years (range, 4.0-14.2). Local recurrence-free survival rate was significantly higher in the wide resection group (P = 0.013). In the marginal resection group, 10% (3/30) of the cases showed residual tumor. The localization of these tumors was all intermuscular. The ISOLS/MSTS scores were 98% (range, 90-100) for wide resection and 99% (range, 93-100) for marginal resection, with no statistical difference (P = 0.694). No ALT-related deaths occurred during the observation period. Conclusions: In addition to long-term (at least 8 years) of continuous observation, a wide resection is necessary in order to prevent recurrence, dedifferentiation, and residual tumor. (C) 2014 Elsevier Ltd. All rights reserved.	[Kito, M.; Yoshimura, Y.; Isobe, K.; Aoki, K.; Momose, T.; Suzuki, S.; Tanaka, A.; Kato, H.] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 3908621, Japan; [Sano, K.] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Akahane, T.] Shinshu Ueda Med Ctr, Dept Orthopaed Surg, Ueda, Nagano 3868610, Japan	Kito, M (reprint author), Shinshu Univ, Sch Med, Dept Orthopaed Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	mune0527@yahoo.co.jp					Weaver J, 2010, MODERN PATHOL, V23, P1301, DOI 10.1038/modpathol.2010.106; AZUMI N, 1987, AM J SURG PATHOL, V11, P161, DOI 10.1097/00000478-198703000-00001; Gerrand CH, 2001, J BONE JOINT SURG BR, V83B, P1149, DOI 10.1302/0301-620X.83B8.12028; Kooby DA, 2004, ANN SURG ONCOL, V11, P78, DOI 10.1245/ASO.2004.03.058; Kimura H, 2013, INT J CLIN EXP PATHO, V6, P1306; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Coindre JM, 2010, VIRCHOWS ARCH, V456, P167, DOI 10.1007/s00428-009-0815-x; LUCAS DR, 1994, AM J CLIN PATHOL, V102, P677; WEISS SW, 1992, AM J SURG PATHOL, V16, P1051, DOI 10.1097/00000478-199211000-00003; Gaskin CM, 2004, AM J ROENTGENOL, V182, P733; Sommerville SMM, 2005, ANZ J SURG, V75, P803, DOI 10.1111/j.1445-2197.2005.03519.x; Bassett MD, 2005, CANCER, V103, P409, DOI 10.1002/cncr.20779; Billing V, 2008, J BONE JOINT SURG BR, V90B, P929, DOI 10.1302/0301-620X.90B7.20348; Brisson M, 2013, SKELETAL RADIOL, V42, P635, DOI 10.1007/s00256-012-1517-z; Dei Tos AP, 2013, WHO CLASSIFICATION T, V4th, P33; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Kemp MA, 2011, J HAND SURG-AM, V36A, P94, DOI 10.1016/j.jhsa.2010.09.032; KINDBLOM LG, 1982, ACTA PATH MICRO IM A, V90, P27; Kubo T, 2006, SURG ONCOL, V15, P167, DOI 10.1016/j.suronc.2006.11.004; Mavrogenis AF, 2011, ORTHOPEDICS, V34, P893; Panzarella MJ, 2005, SKELETAL RADIOL, V34, P272, DOI 10.1007/s00256-004-0884-5; Rozental TD, 2002, CLIN ORTHOP RELAT R, P203; Smith CA, 2012, J SURG RES, V175, P12, DOI 10.1016/j.jss.2011.07.024; Yamamoto N, 2012, ANTICANCER RES, V32, P1821	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	MAR	2015	41	3					400	406		10.1016/j.ejso.2014.11.044		7	Oncology; Surgery	Oncology; Surgery	CC6YM	WOS:000350514900019		
J	Uehara, K; Ito, Z; Yoshino, Y; Arimoto, A; Kato, T; Nakamura, H; Imagama, S; Nishida, Y; Nagino, M				Uehara, K.; Ito, Z.; Yoshino, Y.; Arimoto, A.; Kato, T.; Nakamura, H.; Imagama, S.; Nishida, Y.; Nagino, M.			Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer	EJSO			English	Article						Local recurrence; Rectal cancer; Bony resection; Sacrectomy	TOTAL MESORECTAL EXCISION; MEDIAN FOLLOW-UP; PREOPERATIVE RADIOTHERAPY; ABDOMINOSACRAL RESECTION; IRRADIATED PATIENTS; RANDOMIZED-TRIAL; SURVIVAL; EXENTERATION; SURGERY; IMPACT	Background: In the current era of total mesorectal excision, local relapse remains a main cause of recurrence. Although standard treatment for locally recurrent rectal cancer (LRRC) has not been established, R0 resection represents the only potentially curative treatment. However, extended surgery accompanying. bony pelvic resection is technically demanding and is still challenging. Methods: Studied were 35 patients with LRRC who underwent combined resection of bony pelvis between August 2006 and October 2013. Safety and prognostic factors for survival were analyzed. Median follow-up was 33 months. Results: Sacrectomy was performed in 32 patients and 3 patients underwent combined resection of the pubis and ischium. The dominant operative procedure was total pelvic exenteration in 30 (86%) patients. R0 resection was achieved in 27 (77%) patients. No patients died. Pelvic sepsis was the most frequent complication (40%). Recurrence developed in 20 (57%), with the lung the most frequent site (10 patients). Three-year local relapse-free survival (LRFS) and disease-free survival (DFS) were 72.1% and 32.7%, respectively. On multivariate analysis, R1 resection was the only independent risk factor for local recurrence (p = 0.010), and concomitant liver metastasis and initial non sphincter-preserving surgery were independent predictors of worse DFS (p = 0.008 and p = 0.042, respectively). Conclusions: Aggressive surgical treatment combined with bony resection for carefully selected patients with LRRC was safe with a high rate of R0 resection and favorable LRFS. However, DFS was not satisfactory even after RU resection and the main cause was lung metastasis. Preventing distant recurrence might be a key to improve survival. (C) 2014 Elsevier Ltd. All rights reserved.	[Uehara, K.; Arimoto, A.; Kato, T.; Nakamura, H.; Nagino, M.] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan; [Ito, Z.; Imagama, S.; Nishida, Y.] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Nagoya, Aichi 4648601, Japan; [Yoshino, Y.] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan	Uehara, K (reprint author), Nagoya Grad Sch Med, Dept Surg, Div Surg Oncol, Showa Ku, 65 Tsurumai cho, Nagoya, Aichi 4668550, Japan.						Alberda WJ, 2014, ANN SURG ONCOL, V21, P520, DOI 10.1245/s10434-013-3306-x; Wells BJ, 2007, ANN SURG ONCOL, V14, P390, DOI 10.1245/s10434-006-9119-4; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Dozois EJ, 2011, J SURG ONCOL, V103, P105, DOI 10.1002/jso.21774; Rahbari NN, 2011, ANN SURG, V253, P522, DOI 10.1097/SLA.0b013e3182096d4f; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Milne T, 2013, ANN SURG, V258, P1007, DOI 10.1097/SLA.0b013e318283a5b6; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Bhangu A, 2012, BRIT J SURG, V99, P1453, DOI 10.1002/bjs.8881; Moriya Y, 2004, DIS COLON RECTUM, V47, P2047, DOI 10.1007/s10350-004-0714-9; Sagar PM, 2009, BRIT J SURG, V96, P191, DOI 10.1002/bjs.6464; Bosman SJ, 2014, EJSO-EUR J SURG ONC, V40, P699, DOI 10.1016/j.ejso.2014.02.233; Bouchard P, 2010, ANN SURG ONCOL, V17, P1343, DOI 10.1245/s10434-009-0861-2; Colibaseanu DT, 2014, DIS COLON RECTUM, V57, P47, DOI 10.1097/DCR.0000000000000015; HEALD RJ, 1979, BRIT J HOSP MED, V22, P277; Moriya Y, 2013, ATLAS ADV OPERATIVE, P430; Pacelli F, 2010, ANN SURG ONCOL, V17, P152, DOI 10.1245/s10434-009-0737-5; Uehara K, 2007, BRIT J SURG, V94, P1530, DOI 10.1002/bjs.5696; Uehara K, 2012, JPN J CLIN ONCOL, V42, P58, DOI 10.1093/jjco/hyr169; Wright JD, 2010, CANCER-AM CANCER SOC, V116, P2486, DOI 10.1002/cncr.25067	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	MAR	2015	41	3					413	420		10.1016/j.ejso.2014.11.005		8	Oncology; Surgery	Oncology; Surgery	CC6YM	WOS:000350514900021		
J	Hoshi, Y; Ito, Y; Kato, T; Shitanda, I; Itagaki, M				Hoshi, Yoshinao; Ito, Yusuke; Kato, Takayoshi; Shitanda, Isao; Itagaki, Masayuki			Interpretation of Negative Resistance Observed in Electrochemical Impedance during Copper Electrodeposition Containing Thiourea	ELECTROCHEMISTRY			English	Article						Copper Electrodeposition; Thiourea; Electrochemical Impedance Spectroscopy; Faraday Impedance	POLYETHYLENE-GLYCOL; CHLORIDE-IONS; ELECTROPLATING BATH; ORGANIC ADDITIVES; AC-IMPEDANCE; 4,5-DITHIAOCTANE-1,8-DISULFONIC ACID; SULFATE ELECTROLYTES; DAMASCENE PROCESS; DEPOSITION; MECHANISM	The effect of the thiourea on the electrochemical impedance during copper electrodeposition was investigated using a rotating ring disk electrode. The rest potential of the copper electrode measured in the solution containing thiourea was shifted to less noble due to the adsorption of thiourea. The cathode polarization curve of the copper electrode demonstrated that the current density of the copper electrode decreased remarkably because of an increase in the concentration of thiourea. The Nyquist plot of impedance spectrum in the presence of the thiourea described the capacitive loop, which was related to the time constant of the charge transfer resistance and the electric double layer capacitance, in the high frequency range and a part of the large locus crossing the imaginary axis in the low frequency range. This low frequency locus is related to negative resistance which contributes to "leveler" effect. In order to clarify the negative resistance, the theoretical equations of the Faraday impedance were derived. We proposed the four steps of the copper electrodepostion reactions in the presence of thiourea. (C) The Electrochemical Society of Japan, All rights reserved.	[Hoshi, Yoshinao; Ito, Yusuke; Kato, Takayoshi; Shitanda, Isao; Itagaki, Masayuki] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Hoshi, Yoshinao; Shitanda, Isao; Itagaki, Masayuki] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Hoshi, Y (reprint author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	hoshi-y@rs.tus.ac.jp					Long JG, 2006, J ELECTROCHEM SOC, V153, pC258, DOI 10.1149/1.2168050; Hebert KR, 2005, J ELECTROCHEM SOC, V152, pC283, DOI 10.1149/1.1878372; Pasquale MA, 2008, ELECTROCHIM ACTA, V53, P5891, DOI 10.1016/j.electacta.2008.03.073; HEALY JP, 1992, J ELECTROANAL CHEM, V338, P167, DOI 10.1016/0022-0728(92)80421-Y; SUAREZ DF, 1992, J APPL ELECTROCHEM, V22, P1002, DOI 10.1007/BF01029577; Soares DM, 2002, J ELECTROANAL CHEM, V532, P353, DOI 10.1016/S0022-0728(02)01050-1; HEALY JP, 1992, J ELECTROANAL CHEM, V338, P155, DOI 10.1016/0022-0728(92)80420-9; TURNER DR, 1962, J ELECTROCHEM SOC, V109, P798, DOI 10.1149/1.2425558; MATTSSON E, 1959, T FARADAY SOC, V55, P1586, DOI 10.1039/tf9595501586; Shao W, 2007, J ELECTROCHEM SOC, V154, pD201, DOI 10.1149/1.2434682; Kelly JJ, 1998, J ELECTROCHEM SOC, V145, P3472, DOI 10.1149/1.1838829; Hebert KR, 2005, J ELECTROCHEM SOC, V152, pC324, DOI 10.1149/1.1882112; Gabrielli C, 2006, ELECTROCHIM ACTA, V51, P1462, DOI 10.1016/j.electacta.2005.02.127; Leung TYB, 2000, J ELECTROCHEM SOC, V147, P3326, DOI 10.1149/1.1393902; Burke LD, 2008, J ELECTROCHEM SOC, V155, pD285, DOI 10.1149/1.2837824; CHASSAING E, 1984, ELECTROCHIM ACTA, V29, P649, DOI 10.1016/0013-4686(84)87124-8; Donepudi VS, 2001, ELECTROCHEM SOLID ST, V4, pC13, DOI 10.1149/1.1342144; Dow WP, 2005, J ELECTROCHEM SOC, V152, pC77, DOI 10.1149/1.1849935; Fabian CP, 2009, J ELECTROCHEM SOC, V156, pD400, DOI 10.1149/1.3176879; Famdon E. E., 1995, J APPL ELECTROCHEM, V25, P574; FARMER JC, 1985, J ELECTROCHEM SOC, V132, P2640, DOI 10.1149/1.2113639; FLEISCHMANN M, 1983, J ELECTROANAL CHEM, V157, P359, DOI 10.1016/S0022-0728(83)80362-3; Gabrielli C, 2007, J ELECTROCHEM SOC, V154, pD163, DOI 10.1149/1.2426897; GAUVIN WH, 1952, J ELECTROCHEM SOC, V99, P71, DOI 10.1149/1.2779668; Goldbach S, 1998, ELECTROCHIM ACTA, V44, P323, DOI 10.1016/S0013-4686(98)00112-1; Hasegawa M, 2005, J ELECTROCHEM SOC, V152, pC221, DOI 10.1149/1.1867672; HEALY JP, 1992, J ELECTROANAL CHEM, V338, P179, DOI 10.1016/0022-0728(92)80422-Z; HOLZLE MH, 1995, J ELECTROCHEM SOC, V142, P3741; Itagaki M., 2003, J SURF FINISH SOC JP, V54, P293; Kang M, 2003, J ELECTROCHEM SOC, V150, pC426, DOI 10.1149/1.1572152; KE B, 1959, J ELECTROCHEM SOC, V106, P382, DOI 10.1149/1.2427364; Kelly JJ, 1998, J ELECTROCHEM SOC, V145, P3477, DOI 10.1149/1.1838830; Kelly JJ, 1999, J ELECTROCHEM SOC, V146, P2540, DOI 10.1149/1.1391968; Li YB, 2009, J ELECTROCHEM SOC, V156, pD119, DOI 10.1149/1.3071603; Moffat TP, 2004, J ELECTROCHEM SOC, V151, pC262, DOI 10.1149/1.1651530; NAGY Z, 1995, J ELECTROCHEM SOC, V142, pL87, DOI 10.1149/1.2044254; O'Mullane AP, 2008, J ELECTROCHEM SOC, V155, pD538, DOI 10.1149/1.2936177; Papapanayiotou D, 1998, J ELECTROCHEM SOC, V145, P3366, DOI 10.1149/1.1838813; PEARSON IM, 1968, ELECTROCHIM ACTA, V13, P2021, DOI 10.1016/0013-4686(68)80112-4; Quinet M, 2009, ELECTROCHIM ACTA, V54, P1529, DOI 10.1016/j.electacta.2008.09.052; REID JD, 1987, J ELECTROCHEM SOC, V134, P1389, DOI 10.1149/1.2100677; Schultz ZD, 2006, J ELECTROCHEM SOC, V153, pC97, DOI 10.1149/1.2139952; Taephaisitphongse P, 2001, J ELECTROCHEM SOC, V148, pC492, DOI 10.1149/1.1376636; YOON S, 1994, PLAT SURF FINISH, V81, P65; YUNG EK, 1989, J ELECTROCHEM SOC, V136, P206, DOI 10.1149/1.2096587	45	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAR	2015	83	3					142	149		10.5796/electrochemistry.83.142		8	Electrochemistry	Electrochemistry	CD4BT	WOS:000351028300002		
J	Sakamoto, M; Nohara, S; Miyatake, K; Uchida, M; Watanabe, M; Uchida, H				Sakamoto, Masaru; Nohara, Shinji; Miyatake, Kenji; Uchida, Makoto; Watanabe, Masahiro; Uchida, Hiroyuki			Effects of SiO2 Nanoparticles Incorporated into Poly(Arylene Ether Sulfone Ketone) Multiblock Copolymer Electrolyte Membranes on Fuel Cell Performance at Low Humidity	ELECTROCHEMISTRY			English	Article						Polymer Electrolyte Fuel Cell; Sulfonated Poly(Arylene Ether Sulfone Ketone) Membrane; SiO2 Nanoparticles; Water Back-Diffusion	PROTON-EXCHANGE MEMBRANES; HYBRID MEMBRANE; PARTICLES; OPERATION; PEFCS; ACID	To improve the performances of fuel cells at low humidity, we have prepared composite electrolyte membranes by incorporating SiO2 nanoparticles into poly(arylene ether sulfone ketone) (SPESK) membrane. SiO2 particles were able to be dispersed in SPESK highly uniformly on the nanometer scale by the use of a commercial SiO2-dimethylacetamide sol. The SiO2/SPESK cell exhibited improved I-E performance at 53% relative humidity (RH) and 80 degrees C. It was found that such an improvement was due to the reduction of the ohmic resistance and the oxygentransport overpotential at high current densities, probably because the SiO2 nanoparticles promoted the backdiffusion of water generated at the cathode catalyst layer toward the anode. Both the ohmic resistance and the oxygen-transport overpotential were reduced further by using a thin (ca. 12 mu m) SiO2/SPESK membrane, resulting in remarkably high performances at 53% RH and 30% RH. (C) The Electrochemical Society of Japan, All rights reserved.	[Sakamoto, Masaru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Nohara, Shinji; Miyatake, Kenji; Uchida, Hiroyuki] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008510, Japan; [Nohara, Shinji; Miyatake, Kenji; Uchida, Makoto; Watanabe, Masahiro; Uchida, Hiroyuki] Univ Yamanashi, Fuel Cell Nanomaterials Ctr, Kofu, Yamanashi 4008510, Japan	Uchida, H (reprint author), Univ Yamanashi, Fuel Cell Nanomaterials Ctr, Takeda 4, Kofu, Yamanashi 4008510, Japan.	m-watanabe@yamanashi.ac.jp; h-uchida@yamanashi.ac.jp	Kenji, Miyatake/B-4436-2012		New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was supported by funds for the "Research on Nanotechnology for High Performance Fuel Cells (HiPer-FC)" Project from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The authors thank Prof. Donald A. Tryk (Fuel Cell Nanomaterials Center, University of Yamanashi) for his kind advice.	Miyatake K, 2005, ELECTROCHEMISTRY, V73, P12; Yoda T, 2009, ELECTROCHIM ACTA, V54, P4328, DOI 10.1016/j.electacta.2009.02.099; Watanabe M, 1998, J PHYS CHEM B, V102, P3129, DOI 10.1021/jp973477e; Uchida H, 2003, J ELECTROCHEM SOC, V150, pA57, DOI 10.1149/1.1523412; Watanabe M, 1996, J ELECTROCHEM SOC, V143, P3847, DOI 10.1149/1.1837307; Bae B, 2010, MACROMOLECULES, V43, P2684, DOI 10.1021/ma100291z; Hagihara H, 2006, ELECTROCHIM ACTA, V51, P3979, DOI 10.1016/j.electacta.2005.11.012; Miyake N, 2001, J ELECTROCHEM SOC, V148, pA898, DOI 10.1149/1.1383071; Jung DH, 2002, J POWER SOURCES, V106, P173, DOI 10.1016/S0378-7753(01)01053-9; Miyatake K, 2007, ANGEW CHEM INT EDIT, V46, P6646, DOI 10.1002/anie.200701100; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Bae B, 2011, ACS APPL MATER INTER, V3, P2786, DOI 10.1021/am200579z; Bae B, 2010, ANGEW CHEM INT EDIT, V49, P317, DOI 10.1002/anie.200905355; Inoue N, 2013, ELECTROCHIM ACTA, V88, P807, DOI 10.1016/j.electacta.2012.10.134; Nunes SP, 2002, J MEMBRANE SCI, V203, P215, DOI 10.1016/S0376-7388(02)00009-1; Kim JD, 2003, ELECTROCHIM ACTA, V48, P3633, DOI 10.1016/S0013-4686(03)00484-5; Okanishi T, 2011, ELECTROCHIM ACTA, V56, P8989, DOI 10.1016/j.electacta.2011.07.137; Peighambardoust SJ, 2010, INT J HYDROGEN ENERG, V35, P9349, DOI 10.1016/j.ijhydene.2010.05.017; Rodgers MP, 2008, J MEMBRANE SCI, V325, P346, DOI 10.1016/j.memsci.2008.07.045; Sakamoto M, 2014, ELECTROCHIM ACTA, V137, P213, DOI 10.1016/j.electacta.2014.05.159; Silva VS, 2005, J POWER SOURCES, V140, P34, DOI 10.1016/j.jpowsour.2004.08.004; Watanabe M., 1995, U. S. Patent, Patent No. [5,472,799, 5472799]	22	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAR	2015	83	3					150	154		10.5796/electrochemistry.83.150		5	Electrochemistry	Electrochemistry	CD4BT	WOS:000351028300003		
J	Miyamoto, Y; Yamada, Y; Shimazaki, H; Shimada, K; Nokami, T; Nishiwaki, K; Kashimufta, S; Matsumoto, K				Miyamoto, Yu; Yamada, Yuki; Shimazaki, Hayato; Shimada, Kazuaki; Nokami, Toshiki; Nishiwaki, Keiji; Kashimufta, Shigenori; Matsumoto, Kouichi			Esterification of Carboxylic Acids with Alkyl Halides Using Electroreduction	ELECTROCHEMISTRY			English	Article						Carboxylate Ion; Alkyl Halide; S(N)2 Mechanism; Esterification	SOLVENT-FREE CONDITIONS; TETRABUTYLAMMONIUM FLUORIDE; IN-SITU; ESTERS; CONVERSION	Esterification of carboxylic acids with alkyl halides using electroreduction has been investigated. The reaction of carboxylic acids, such as benzoic acid, 3-phenylpropanoic acid, nonanoic acid, cinnamic acid, and 1-naphthoic acid, under electrochemical reduction conditions followed by the addition of alkyl halides afforded the corresponding esters in moderate to good yields. The reactions proceeded via the S(N)2 mechanism of the alkyl halide, with the carboxylate ion bearing the ammonium ion as the counter cation, which was generated and accumulated from the carboxylic acid. The generation of the carboxylate ion intermediate is essential, and it appears to have high reactivity because the counter cation of the carboxylate ion intermediate is an ammonium ion. (C) The Electrochemical Society of Japan, All rights reserved.	[Miyamoto, Yu; Yamada, Yuki; Shimazaki, Hayato; Shimada, Kazuaki; Kashimufta, Shigenori; Matsumoto, Kouichi] Kinki Univ, Dept Chem, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Nokami, Toshiki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Nishiwaki, Keiji] Kinki Univ, Fac Pharm, Dept Pharmaceut Sci, Higashiosaka, Osaka 5778502, Japan	Matsumoto, K (reprint author), Kinki Univ, Dept Chem, Fac Sci & Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	kmatsumo@chem.kindai.ac.jp					Sperry JB, 2006, CHEM SOC REV, V35, P605, DOI 10.1039/b512308a; Tschaen BA, 2013, ORG LETT, V15, P500, DOI 10.1021/ol303298g; Moeller KD, 2000, TETRAHEDRON, V56, P9527, DOI 10.1016/S0040-4020(00)00840-1; Travis BR, 2003, ORG LETT, V5, P1031, DOI 10.1021/ol0340078; Yoshida J, 2008, CHEM REV, V108, P2265, DOI 10.1021/cr0680843; Francke R, 2014, CHEM SOC REV, V43, P2492, DOI 10.1039/c3cs60464k; Chen HH, 2014, TETRAHEDRON, V70, P212, DOI 10.1016/j.tet.2013.11.085; Fisher TJ, 2010, TETRAHEDRON LETT, V51, P5615, DOI 10.1016/j.tetlet.2010.08.068; Zhao YS, 2008, J AM CHEM SOC, V130, P9429, DOI 10.1021/ja801116s; Liu C, 2011, ANGEW CHEM INT EDIT, V50, P5144, DOI 10.1002/anie.201008073; FUCHIGAMI T, 1986, B CHEM SOC JPN, V59, P2873, DOI 10.1246/bcsj.59.2873; AWATA T, 1985, CHEM LETT, P371, DOI 10.1246/cl.1985.371; Cardellini F, 2014, SYNTHETIC COMMUN, V44, P3248, DOI 10.1080/00397911.2014.933353; Hanzawa Y, 2013, J OLEO SCI, V62, P29, DOI 10.5650/jos.62.29; Matsumoto K, 2008, ANGEW CHEM INT EDIT, V47, P2506, DOI 10.1002/anie.200705748; Matsumoto K, 2014, J OLEO SCI, V63, P539, DOI 10.5650/jos.ess13199; Nielsen M. F., 2004, ORGANIC ELECTROCHEMI, P470; Ooi T, 2001, TETRAHEDRON LETT, V42, P9245, DOI 10.1016/S0040-4039(01)02035-4; Ooi T, 2001, HETEROCYCLES, V54, P593; Otera J., 2010, ESTERIFICATION METHO; SHONO T, 1986, J ORG CHEM, V51, P546, DOI 10.1021/jo00354a030; Utley JHP, 2001, ORGANIC ELECTROCHEMI, P1227	22	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	MAR	2015	83	3					161	164		10.5796/electrochemistry.83.161		4	Electrochemistry	Electrochemistry	CD4BT	WOS:000351028300005		
J	Chang, G; Shu, HH; Huang, QW; Oyama, M; Ji, K; Liu, X; He, YB				Chang, Gang; Shu, Honghui; Huang, Qiwei; Oyama, Munetaka; Ji, Kai; Liu, Xiong; He, Yunbin			Synthesis of highly dispersed Pt nanoclusters anchored graphene composites and their application for non-enzymatic glucose sensing	ELECTROCHIMICA ACTA			English	Article						Graphene; Pt nanoclusters; Non-enzymatic sensor; Glucose oxidation; Electro-catalytic activity	METHANOL OXIDATION; ELECTROCHEMICAL DETECTION; CARBON NANOTUBES; BIMETALLIC NANODENDRITES; ASSISTED SYNTHESIS; OXYGEN REDUCTION; FUEL-CELLS; PLATINUM; NANOPARTICLES; SENSOR	A facile and clean method by using ascorbic acid as mild reductant was developed to synthesize nanocomposites of graphene and platinum nanoclusters (PtNCs/graphene), in which Polyvinyl-Pyrrolidone (PVP) was added during the one-step reductive process so as to improve the dispersity of PtNCs on the graphene and decrease the size of PtNCs. By several characterization methods such as X-ray diffraction (XRD), field-emission scanning electron microscopy (FE-SEM), transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS), we demonstrated that Pt nanoclusters have successfully anchored on the surface of graphene sheets with average diameter of 22 nm. It was found that with the assistant of PVP, Pt nanoclusters appeared with smaller particle size and narrower particle size distribution. Cyclic voltammetry and amperometric methods were used to evaluate the electro-catalytic activity of the synthesized nanocomposites toward the oxidation of glucose in neutral media (0.1 M PBS, pH 7.4). The PtNCs/graphene exhibited a rapid response time (about 3 s), a broad linear range (1 mM to 25 mM), good stability, and sensitivity estimated to be 1.21 mu A cm(-2) mM(-1) (R = 0.995, 71.9 mu A cm(-2) mM(-1) vs. geometric area). Additionally, the impact from the oxidation of interferences can be effectively limited by choosing the appropriate detection potential. These results indicated a great potential of PtNCs/graphene in fabricating novel non-enzymatic glucose sensors with high performance. (C) 2015 Elsevier Ltd. All rights reserved.	[Chang, Gang; Shu, Honghui; Huang, Qiwei; Ji, Kai; Liu, Xiong; He, Yunbin] Hubei Univ, Fac Mat Sci & Engn, Hubei Collaborat Innovat Ctr Adv Organ Chem Mat, Key Lab Green Preparat & Applicat Funct Mat,Minis, Wuhan 430062, Peoples R China; [Oyama, Munetaka] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158520, Japan	Chang, G (reprint author), Hubei Univ, Fac Mat Sci & Engn, Hubei Collaborat Innovat Ctr Adv Organ Chem Mat, Key Lab Green Preparat & Applicat Funct Mat,Minis, 368 Youyi Ave, Wuhan 430062, Peoples R China.	gchanghubei@gmail.com; ybhe@hubu.edu.cn	He, Yunbin/A-9391-2008; Oyama, Munetaka/D-6541-2014	He, Yunbin/0000-0002-7179-4392; Oyama, Munetaka/0000-0001-7422-9914	National Natural Science Foundation of China [51102085, 61274010]; Program for New Century Excellent Talents in University, Ministry of Education of China [NCET-09-0135]	This work was financially supported by the National Natural Science Foundation of China (No. 51102085,61274010), Program for New Century Excellent Talents in University, Ministry of Education of China (NCET-09-0135).	Zhang YZ, 2011, ELECTROCHIM ACTA, V56, P8746, DOI 10.1016/j.electacta.2011.07.094; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Xu C, 2008, J PHYS CHEM C, V112, P19841, DOI 10.1021/jp807989b; Gao HC, 2011, ACS APPL MATER INTER, V3, P3049, DOI 10.1021/am200563f; Chang G, 2014, APPL SURF SCI, V288, P524, DOI 10.1016/j.apsusc.2013.10.064; Bai H, 2011, ADV MATER, V23, P1089, DOI 10.1002/adma.201003753; Guo SJ, 2010, ACS NANO, V4, P3959, DOI 10.1021/nn100852h; Wietecha MS, 2012, J POWER SOURCES, V198, P30, DOI 10.1016/j.jpowsour.2011.09.073; Nie HG, 2011, BIOSENS BIOELECTRON, V30, P28, DOI 10.1016/j.bios.2011.08.022; Borodko Y, 2006, J PHYS CHEM B, V110, P23052, DOI 10.1021/jp063338+; Zhang H, 2011, ELECTROCHIM ACTA, V56, P7064, DOI 10.1016/j.electacta.2011.05.118; Niu XH, 2013, ANAL CHEM, V85, P3561, DOI 10.1021/ac3030976; Rong LQ, 2007, TALANTA, V72, P819, DOI 10.1016/j.talanta.2006.12.037; Li YM, 2009, ELECTROCHEM COMMUN, V11, P846, DOI 10.1016/j.elecom.2009.02.009; Ji K, 2012, ELECTROCHIM ACTA, V85, P84, DOI 10.1016/j.electacta.2012.08.086; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Chen XM, 2010, BIOSENS BIOELECTRON, V25, P1803, DOI 10.1016/j.bios.2009.12.035; Kuila T, 2011, BIOSENS BIOELECTRON, V26, P4637, DOI 10.1016/j.bios.2011.05.039; Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g; Guo SJ, 2010, ACS NANO, V4, P547, DOI 10.1021/nn9014483; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y; Kou R, 2009, ELECTROCHEM COMMUN, V11, P954, DOI 10.1016/j.elecom.2009.02.033; Xiao F, 2012, ACS NANO, V6, P100, DOI 10.1021/nn202930m; Wu GH, 2013, TALANTA, V105, P379, DOI 10.1016/j.talanta.2012.10.066; Chen AC, 2010, CHEM REV, V110, P3767, DOI 10.1021/cr9003902; Zhou YG, 2009, ELECTROCHEM COMMUN, V11, P216, DOI 10.1016/j.elecom.2008.11.010; Li M, 2014, BIOSENS BIOELECTRON, V56, P223, DOI 10.1016/j.bios.2014.01.030; Shen QM, 2008, J PHYS CHEM C, V112, P16385, DOI 10.1021/jp8060043; Wang J, 2008, ANAL CHEM, V80, P997, DOI 10.1021/ac701790z; Hsin YL, 2007, J AM CHEM SOC, V129, P9999, DOI 10.1021/ja072367a; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Park S, 2003, ANAL CHEM, V75, P3046, DOI 10.1021/ac0263465; Xiao F, 2009, BIOSENS BIOELECTRON, V24, P3481, DOI 10.1016/j.bios.2009.04.045; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Cheng TM, 2010, ACS APPL MATER INTER, V2, P2773, DOI 10.1021/am100432a; Liu MH, 2011, J CATAL, V278, P1, DOI 10.1016/j.jcat.2010.11.009; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Niu XH, 2012, TALANTA, V99, P1062, DOI 10.1016/j.talanta.2012.07.039; Yuan JH, 2005, ADV FUNCT MATER, V15, P803, DOI 10.1002/adfm.200400321; Shu HH, 2014, ELECTROCHIM ACTA, V132, P524, DOI 10.1016/j.electacta.2014.04.031; Borodko Y, 2007, J PHYS CHEM C, V111, P6288, DOI 10.1021/jp068742n; Seger B, 2009, J PHYS CHEM C, V113, P7990, DOI 10.1021/jp900360k; Bo XJ, 2010, TALANTA, V82, P85, DOI 10.1016/j.talanta.2010.03.063; Meng L, 2009, ANAL CHEM, V81, P7271, DOI 10.1021/ac901005p; Holt-Hindle P, 2008, ELECTROCHEM COMMUN, V10, P1438, DOI 10.1016/j.elecom.2008.07.042; Hossain MJ, 2012, CATAL TODAY, V183, P101, DOI 10.1016/j.cattod.2011.10.008; Jia WZ, 2007, LANGMUIR, V23, P11896, DOI 10.1021/la7020269; Rathod D, 2010, SENSOR ACTUAT B-CHEM, V143, P547, DOI 10.1016/j.snb.2009.09.064; Shi JJ, 2013, CATAL COMMUN, V41, P101, DOI 10.1016/j.catcom.2013.07.012; Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wei G, 2011, J PHYS CHEM C, V115, P11453, DOI 10.1021/jp202324q	53	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	MAR 1	2015	157						149	157		10.1016/j.electacta.2015.01.085		9	Electrochemistry	Electrochemistry	CC5ZZ	WOS:000350445500020		
J	Chen, L; Li, HH; Yoshitake, H; Qi, L; Gu, NY; Wang, HY				Chen, Lu; Li, Hehe; Yoshitake, Hideya; Qi, Li; Gu, Ningyu; Wang, Hongyu			Low-temperature performance of aqueous electrochemical capacitors based on manganese oxides	ELECTROCHIMICA ACTA			English	Article						Manganese oxides; Electrochemical capacitors; Pseudo-capacitance; Low operating temperature; Charge transfer resistance	CHARGE STORAGE MECHANISM; ACTIVATED CARBON ELECTRODES; SUPERCAPACITOR APPLICATIONS; MNO2; ELECTROLYTES; BEHAVIOR; DIOXIDE; LAMBDA-MNO2; SURFACE; WATER	This paper involves preparation of four different crystal phases (delta, gamma, alpha and lambda) of MnO2 by redox, solid reaction, hydrothermal routes and delithiation of LiMn2O4, respectively. The obtained MnO2 samples have been characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM) and the Brunauer-Emmett-Teller (BET) method for micro-structural, morphological and porosity studies. Cyclic voltammetric and galvanostatic tests were carried out to evaluate their capacitive properties in an anti-freezing aqueous electrolyte at different operating temperatures ranging from 25 to -35 degrees C. The delta-MnO2 prepared by a redox method exhibits the best electrochemical performances when conducted either in the single electrode tests (from 174.7 to 148.6 F g(-1)) or in the capacitor measurements (from 47.4 to 42 F g(-1)) as the operating temperature decreased from 25 degrees C down to the low temperature of -35 degrees C. Moreover, electrochemical impedance spectroscopy has been investigated and the activation energy values of different impedance components have been analyzed. It has been discovered that the operation temperature has more effect on the charge transfer resistance than diffusion resistance. To some degrees, these results have guiding significance for the low-temperature applications of manganese oxides-based electrochemical capacitors. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Lu; Gu, Ningyu] Nanchang Univ, Dept Chem, Nanchang 330031, Peoples R China; [Li, Hehe; Qi, Li; Wang, Hongyu] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Peoples R China; [Yoshitake, Hideya] Yamagata Univ, Fac Engn, Yonezawa, Yamagata 9928510, Japan; [Wang, Hongyu] Changzhou Inst Energy Storage Mat & Devices, Changzhou 213000, Peoples R China	Gu, NY (reprint author), Nanchang Univ, Dept Chem, Nanchang 330031, Peoples R China.	nygu@ncu.edu.cn			National Basic Research Program of China [2012CB932800]; National Natural Science Foundation [21363015]; Science & Technology Office of Jiangsu Province [BE2013006-3)]	We gratefully acknowledge the financial support of this research by the National Basic Research Program of China (2012CB932800), National Natural Science Foundation (No. 21363015) and Science & Technology Office of Jiangsu Province (BE2013006-3).	Adekunle AS, 2011, ELECTROANAL, V23, P971, DOI 10.1002/elan.201000597; Roberts AJ, 2013, PHYS CHEM CHEM PHYS, V15, P3518, DOI 10.1039/c3cp50359c; Pandolfo AG, 2006, J POWER SOURCES, V157, P11, DOI 10.1016/j.jpowsour.2006.02.065; Amatucci GG, 2001, J ELECTROCHEM SOC, V148, pA940, DOI 10.1149/1.1383777; Reddy RN, 2003, J POWER SOURCES, V124, P330, DOI 10.1016/S0378-7753(03)00600-1; Chun SE, 2006, ELECTROCHIM ACTA, V51, P6479, DOI 10.1016/j.electacta.2006.04.034; Toupin M, 2004, CHEM MATER, V16, P3184, DOI 10.1021/cm049649j; Kuo SL, 2006, J ELECTROCHEM SOC, V153, pA1317, DOI 10.1149/1.2197667; Ghaemi M, 2008, ELECTROCHIM ACTA, V53, P4607, DOI 10.1016/j.electacta.2007.12.040; Kim H, 2003, J ELECTROCHEM SOC, V150, pD56, DOI 10.1149/1.1541675; Portet C, 2004, ELECTROCHIM ACTA, V49, P905, DOI 10.1016/j.electacta.2003.09.043; Khomenko V, 2006, J POWER SOURCES, V153, P183, DOI 10.1016/j.jpowsour.2005.03.210; Xu NC, 2009, ACTA CHIM SINICA, V67, P2566; Toupin M, 2002, CHEM MATER, V14, P3946, DOI 10.1021/cm020408q; Chang JK, 2007, J POWER SOURCES, V166, P590, DOI 10.1016/j.jpowsour.2007.01.036; Yuan AB, 2009, ELECTROCHIM ACTA, V54, P1021, DOI 10.1016/j.electacta.2008.08.057; McKeown DA, 1999, J PHYS CHEM B, V103, P4825, DOI 10.1021/jp990096n; Hu CC, 2006, NANO LETT, V6, P2690, DOI 10.1021/nl061576a; Devaraj S, 2008, J PHYS CHEM C, V112, P4406, DOI 10.1021/jp7108785; Hung KS, 2009, J POWER SOURCES, V193, P944, DOI 10.1016/j.jpowsour.2009.01.083; Zhou HS, 2005, ANGEW CHEM INT EDIT, V44, P797, DOI 10.1002/anie.200460937; Sugimoto W, 2006, ELECTROCHIM ACTA, V52, P1742, DOI 10.1016/j.electacta.2006.02.054; Brock SL, 1998, CHEM MATER, V10, P2619, DOI 10.1021/cm980227h; Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782; Pang SC, 2000, J ELECTROCHEM SOC, V147, P444, DOI 10.1149/1.1393216; Donne SW, 2010, J POWER SOURCES, V195, P367, DOI 10.1016/j.jpowsour.2009.06.103; Xue Y, 2008, MATER LETT, V62, P3884, DOI 10.1016/j.matlet.2008.05.014; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; de Levie R., 1963, ELECTROCHIM ACTA, V8, P751, DOI 10.1016/0013-4686(63)80042-0; Devaraj S, 2005, ELECTROCHEM SOLID ST, V8, pA373, DOI 10.1149/1.1922869; DEWOLFF PM, 1959, ACTA CRYSTALLOGR, V12, P341, DOI 10.1107/S0365110X59001001; Gao JC, 2014, CHEM J CHINESE U, V35, P608, DOI 10.7503/cjcu20130676; HUNTER JC, 1981, J SOLID STATE CHEM, V39, P142, DOI 10.1016/0022-4596(81)90323-6; Juliang X., 2012, THIN SOLID FILMS, V520, P5952; Lee MT, 2007, J ELECTROCHEM SOC, V154, pA875, DOI 10.1149/1.2755880; Liu C, 2010, ADV MATER, V22, pE28, DOI 10.1002/adma.200903328; Yin J, 2013, ELECTROCHIM ACTA, V88, P208, DOI 10.1016/j.electacta.2012.10.047	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	MAR 1	2015	157						333	344		10.1016/j.electacta.2014.09.161		12	Electrochemistry	Electrochemistry	CC5ZZ	WOS:000350445500043		
J	Takada, M; Fukui, Y; Matsuura, Y; Sato, M; Takada, H				Takada, Masumi; Fukui, Yuta; Matsuura, Yasuyuki; Sato, Motohiko; Takada, Hiroki			Peripheral viewing during exposure to a 2D/3D video clip: effects on the human body	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Body sway; Stabilogram; Stereoscopic image; Simulator sickness questionnaire; SSQ	AUTONOMIC RESPONSES; STEREO DISPLAYS; ACCOMMODATION	Symptoms of three-dimensional (3D) sickness, such as intoxication and eye fatigue, have been observed in subjects viewing 3D films and vary according to the image quality and visual environment. In addition, the influence of stereoscopic vision on the incidence of 3D sickness has not been explored sufficiently. Therefore, it is important to examine the safety of viewing virtual 3D content. The present study examines the effects of peripheral vision on reported motion sickness during exposure to 2D/3D video clips for 1 min and for 1 min afterwards in human subjects. Stabilograms were recorded during exposure to video clips with or without visual pursuit of a 3D object and compared, and subjects were administered the simulator sickness questionnaire after stabilometry. There were no significant main effects of solidity of the visual stimulous (2D/3D) and the vision method (visual pursuit/peripheral viewing) in accordance with the two-way analysis of variance of the sway values, although the sway values during the 2D/3D video clips were higher than in control subjects. A consistent trend in the main effect of stability was observed. Further, the sway values changed remarkably after the 3D video clip was viewed peripherally and produced a persistent instability in equilibrium function. The questionnaire findings also significantly changed after the subjects viewed the video clips peripherally. Subjective exacerbation and deterioration of equilibrium function were observed after peripheral viewing of 3D video clips. This persistent influence may result when subjects view a poorly depicted background element peripherally, which generates depth perception that contradicts daily experience.	[Takada, Masumi; Sato, Motohiko; Takada, Hiroki] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 4801195, Japan; [Fukui, Yuta; Takada, Hiroki] Univ Fukui, Dept Human & Artificial Intelligent Syst, Grad Sch Engn, Fukui, Fukui 9108507, Japan; [Matsuura, Yasuyuki] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan	Takada, M (reprint author), Aichi Med Univ, Dept Physiol, Nagakute, Aichi 4801195, Japan.	masumasu@aichi-med-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24300046, 26350004]; Hori Information Science Promotion Foundation	The authors would like to thank Olympus Memory Works, Inc., for their beautiful 3D video clips. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research (B) Number 24300046, (C) Number 26350004, and the Hori Information Science Promotion Foundation.	COLLINS JJ, 1993, EXP BRAIN RES, V95, P308; WANN JP, 1995, VISION RES, V35, P2731, DOI 10.1016/0042-6989(95)00018-U; Patterson R, 2009, J SOC INF DISPLAY, V17, P987, DOI 10.1889/JSID17.12.987; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Himi N, 2004, AUTON NEUROSCI-BASIC, V116, P46, DOI 10.1016/j.autneu.2004.08.008; Miyao M, 1996, ERGONOMICS, V39, P1294, DOI 10.1080/00140139608964549; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192; Shiomi T, 2013, J SOC INF DISPLAY, V21, P120, DOI 10.1002/jsid.156; Fujikake K, 2009, LECT NOTES COMPUT SC, V5622, P41, DOI 10.1007/978-3-642-02771-0_5; Hollander M., 1973, NONPARAMETRIC STAT M; Holomes S. R., 2001, J PSYCHOPHYSIOL, V15, P35; Hong H, 2010, SPIE NEWSROOM, DOI [10.1117/2.1201007.003109, DOI 10.1117/2.1201007.003109]; Kaga K, 1992, STRUCTURE OF VERTIGO; Kakeya H, 2007, P SOC PHOTO-OPT INS, V6490; Kato Z, 1999, METHODS MEASURE FUNC; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI DOI 10.1207/S15327108IJAP0303_; Kojima T, 2013, INT J BIOSCI BIOCH B, V3, P635; Malik AS, 2011, P IGI GLOBAL HERSHEY; Miyao M, 2011, P IMID, P149; Nagata S, 2002, T TVRSJ, V7, P239; Okawa T, 1995, EQUILIBRIUM RES, V54, P296; Okawa T., 1995, EQUILIBRIUM RES, V55, P283; Patterson R, 2009, J SOC INF DISPLAY, V17, P443, DOI 10.1889/JSID17.5.443; Scibora L. M., 2007, P VIMS 2007, P18; Sugiura A, 2011, DISPLAYS, V32, P219, DOI 10.1016/j.displa.2011.04.001; Suzuki J., 1996, EQUILIBRIUM RES, V55, P64; Tahara H., 2002, US Patent, Patent No. [US7404693B2, 7404693B2]; Takada H., 2001, FORMA, V16, P17; Takada H, 2004, ENV MED, V47, P85; Takada H., 2007, P VIMS 2007, P178; Takada H, 2003, EQUILIBRIUM RES, V62, P168; Takada M., 2011, P IMID, P737; Takada M., 2012, J SPORTS MED DOPING, V2, DOI [10.4172/2161-0673.1000112, DOI 10.4172/2161-0673.1000112]; Takada M, 2013, INT J BIOSCI BIOCH B, V2, P389; Yasui R, 2006, P SOC PHOTO-OPT INS, V6055, p0Y1; Yoshikawa K, 2013, LNCS, V8010, P336	37	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					79	89		10.1007/s12199-014-0424-4		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500001		
J	Sekizuka-Kagami, N; Shimada, K; Tabuchi, N; Nakamura, H				Sekizuka-Kagami, Naomi; Shimada, Keiko; Tabuchi, Noriko; Nakamura, Hiroyuki			Association between the sense of coherence 13-item version scale score of pregnant women in the second trimester of pregnancy and threatened premature birth	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Pregnant women; Stress; Sense of coherence; Threatened premature birth	PRETERM BIRTH; PSYCHOSOCIAL FACTORS; GROWTH-RETARDATION; STRESS; DELIVERY; ANXIETY; WEIGHT; DEPRESSION; LABOR	The purpose of this study is to determine whether the score of the sense of coherence 13-item version (SOC-13) scale in the second trimester of pregnancy is associated with threatened premature birth. All the subjects gave their informed written consent before their participation in the study. A self-reported questionnaire survey was conducted on the pregnant women at approximately 18 weeks of pregnancy. The questionnaire consisted of items on demographic characteristics, perinatal abnormalities, stress perception scale (SPS), and SOC-13 scale. Approximately 30 weeks of pregnancy after the first survey, we surveyed whether any treatment had been provided for threatened premature birth during the course of the current pregnancy. The study period was from December 2007 to February 2010. One hundred and seventy-seven pregnant women participated in the study, but only the data from 151 pregnant women were analyzed. Forty-three (28.5 %) pregnant women had threatened premature birth and received some treatment. Logistic regression analysis was carried out with threatened premature birth as the dependent variable and age, childbirth history, smoking habit, history of miscarriage or premature birth in previous pregnancies, SPS score, and SOC-13 scale score as the independent variables. It was shown that SOC-13 scale score affected threatened premature birth (p < 0.001) and that a low SOC-13 scale score was associated with threatened premature birth. This study suggests that the SOC-13 scale score in the second trimester of pregnancy could be of great value in clinical health care of pregnant women with a risk of threatened premature birth in the subsequent course of pregnancy.	[Sekizuka-Kagami, Naomi; Shimada, Keiko; Tabuchi, Noriko] Kanazawa Univ, Dept Nursing, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Dept Environm & Prevent Med, Fac Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan	Sekizuka-Kagami, N (reprint author), Kanazawa Univ, Dept Nursing, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	sekky@mhs.mp.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19791686]; Japan Academy of Midwifery Research-Aid Grant	The authors would like to thank the participants and medical staff who cooperated in this study. This study was part of a research supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Young Scientists (B) from 2007 to 2011 [Nos. 19791686] and a Japan Academy of Midwifery Research-Aid Grant 2009.	Amano I, 1995, 26 JAP NUR SOC INCL, P135; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Sekizuka Naomi, 2006, Environmental Health and Preventive Medicine, V11, P199, DOI 10.1007/BF02905279; Misra DP, 2001, PAEDIATR PERINAT EP, V15, P110, DOI 10.1046/j.1365-3016.2001.00333.x; Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Nakao M, 2001, PSYCHOTHER PSYCHOSOM, V70, P50, DOI 10.1159/000056225; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Nordentoft M, 1996, AM J PUBLIC HEALTH, V86, P347, DOI 10.2105/AJPH.86.3.347; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Goldenberg RL, 1997, ACTA OBSTET GYN SCAN, V76, P19; Oz Y, 2009, J PSYCHOSOM OBST GYN, V30, P29, DOI 10.1080/01674820802546196; Sjostrom H, 2004, ACTA OBSTET GYN SCAN, V83, P1112, DOI 10.1111/j.0001-6349.2004.00153.x; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Antonovsky A, 2001, UNRAVELING MYSTERY H, P19; Clayton JH, 2008, PSYCHOSOM MED, V70, P57; Wadhwa P D, 2001, Matern Child Health J, V5, P119, DOI 10.1023/A:1011353216619; Field T, 2007, J CHILD ADOLES SUBST, V17, P111, DOI 10.1300/J029v17n01_06; Hillhouse EW, 2002, REPRODUCTION, V124, P323; Hobel CJ, 2004, CLIN OBSTET GYNECOL, V47, P856, DOI 10.1097/01.grf.0000142512.38733.8c; Kiuchi C, 2001, JPN J PERINATAL CARE, V20, P966; Kossakowska-Petrycka Karolina, 2007, Ginekol Pol, V78, P544; LARSSON G, 1987, J ADV NURS, V12, P441; Lazarus RS, 1994, PSYCHOL STRESS COGNI, P3; LEVI R, 1989, J PSYCHOSOM OBST GYN, V10, P221, DOI 10.3109/01674828909016696; Mackey MC, 2000, J ADV NURS, V32, P666, DOI 10.1046/j.1365-2648.2000.01526.x; Makrigiannakis A, 2003, BIOCHEM PHARMACOL, V65, P917, DOI 10.1016/S0006-2952(02)01547-2; Maternal Tokyo Metropolitan Center Child Health Service, 1997, STAT MAT NEON CAR TO; Ogawa Y, 2001, JPN J HYG, V55, P597; ORR ST, 1992, J DEV BEHAV PEDIATR, V13, P343; Petridou E, 2001, BRIT J OBSTET GYNAEC, V108, P598, DOI 10.1111/j.1471-0528.2001.00140.x; PRITCHARD CW, 1994, SOC SCI MED, V38, P89, DOI 10.1016/0277-9536(94)90303-4; Rice F, 2007, ACTA PSYCHIAT SCAND, V116, P154, DOI 10.1111/j.1600-0447.2007.01042.x; Riecher-Rossler A, 2003, ACTA PSYCHIAT SCAND, V108, P51, DOI 10.1034/j.1600-0447.108.s418.11.x; Sekizuka N, 2007, JPN J MATERN HLTH, V48, P106; Sekizuka Naomi, 2009, Environmental Health and Preventive Medicine, V14, P276, DOI 10.1007/s12199-009-0096-7; Suzuki K, 2007, J OBSTET GYNAECOL RE, V33, P438, DOI 10.1111/j.1447-0756.2007.00557.x; Takegata M, 2014, ARCH WOMEN MENT HLTH, V17, P403, DOI 10.1007/s00737-014-0415-x; Togari T, 2008, JPN J HLTH HUM ECOL, V74, P71; Waldenstrom U, 1993, BIRTH-ISS PERINAT C, V5, P688; YAMAZAKI Y., 1999, QUAL NURS, V5, P81	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					90	96		10.1007/s12199-014-0436-0		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500002		
J	Uchiyama, H				Uchiyama, Hidekazu			A study on the existence of Vibrio cholerae non-O1 in the river	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Vibrio cholerae; River water; Flora; Ecology; Environmental microbacteria	CHESAPEAKE BAY; WATERS; SEDIMENTS; TOXIN	The aim of the present study is Vibrio cholerae non-O1 existing in river. Bacteria are known to inhabit all kinds of environment. Vibrionaceae is widely distributed in environmental water. Vibrio spp. have been identified as a cause of toxicity in fish and shellfish. One condition affecting the survival of pathogenic microorganisms in environmental water is the salt concentration, and they have been reported to inhabit brackish water. However, V. cholerae non-O1 has also been detected in fresh water, and its properties suggest that it can survive in river water. Sampling was performed 4 times at 4 points during a 5-month period from July to November at about 1-month intervals from the Sagami River in 1985. River water bacteria were identified, and V. cholera non-O1 isolated. I investigated the relationship between the bacterial flora in river water and the detection of V. cholerae non-O1. There were significant differences in the composition of bacterial flora with and without the isolation of V. cholerae non-O1 (Chi-square test) (chi (2) = 24.70 > 22.0 (p = 0.005), df = 8). A correlation between changes in the composition of the river water bacterial flora and detection of V. cholerae non-O1 was identified. Therefore, V. cholerae non-O1 exists in the river.	Hamamatsu Univ, Publ Hlth Lab, Dept Hlth Dietet, Fac Hlth Promot Sci,Kita Ku, Hamamatsu, Shizuoka 4312102, Japan	Uchiyama, H (reprint author), Hamamatsu Univ, Publ Hlth Lab, Dept Hlth Dietet, Fac Hlth Promot Sci,Kita Ku, 1230 Miyakodacho, Hamamatsu, Shizuoka 4312102, Japan.	uchi@hm.tokoha-u.ac.jp					American Public Health Association, 1980, STAND METH EX WA 900, P789; KAPER J, 1979, APPL ENVIRON MICROB, V37, P91; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.198.4315.394-a; HOOD MA, 1982, APPL ENVIRON MICROB, V43, P578; Colwell RR, 1984, VIBRIOS ENV; Cowan S.T., 1974, MANUAL IDENTIFICATIO; CRAIG JP, 1981, INFECT IMMUN, V34, P90; Educational committee of Japanese society for bacteriology, 1981, EX METH VIBR CHOL EN, P9; Fukumi H., 1980, SCI KARADA, V92, P20; GARAY E, 1985, APPL ENVIRON MICROB, V50, P426; KENYON JE, 1983, APPL ENVIRON MICROB, V46, P1232; Lin F-YC, 1986, J CLIN MICROBIOL, V46, P1232; LIN S, 1974, APPL MICROBIOL, V28, P288; MAEDA S, 1980, Japanese Journal of Limnology, V41, P163; Miwatani T., 1976, VIBRIO PARAHAEMOLYTI; MORIKAWA K, 1984, Japanese Journal of Limnology, V45, P69; NAIR GB, 1988, APPL ENVIRON MICROB, V54, P3180; RHODES JB, 1986, APPL ENVIRON MICROB, V51, P1216; Simidu U, 1987, NIHON BISEIBUTSU SEI, V1, P65; Takita S, 1980, JPN J PUBLIC HLTH, V27, P535; TANAKA N, 1977, Japanese Journal of Limnology, V38, P41; Uchiyama H., 1998, JPN J INFECT DIS, V72, P218; Uchiyama H., 1997, JPN J PUBLIC HLTH, V44, P547; Uchiyama H, 2000, Environ Health Prev Med, V4, P199, DOI 10.1007/BF02931258; Uchiyama H, 1989, JPN J INFECT DIS, V63, P1313; WILLIAMS LA, 1985, APPL ENVIRON MICROB, V50, P1490; WILSON R, 1981, AM J EPIDEMIOL, V114, P293	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					97	101		10.1007/s12199-014-0430-6		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500003		
J	Katayama, A; Miyatake, N; Nishi, H; Hashimoto, H; Uzike, K; Sakano, N; Tanaka, K; Koumoto, K				Katayama, Akihiko; Miyatake, Nobuyuki; Nishi, Hiroyuki; Hashimoto, Hiroo; Uzike, Kazuhiro; Sakano, Noriko; Tanaka, Keiko; Koumoto, Kiichi			Evaluation of psychological distress using the K6 in patients on chronic hemodialysis	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Psychological distress; HRQOL; Hemodialysis; K6 questionnaire; EQ-5D questionnaire	CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; MENTAL-HEALTH; DIALYSIS PATIENTS; SCREENING SCALES; POPULATION; JAPANESE; PERFORMANCE; DEPRESSION; ILLNESS	The aim of this study was to evaluate psychological distress in patients on chronic hemodialysis. A total of 72 patients on chronic hemodialysis were enrolled in this study. We evaluated psychological distress by using the K6 questionnaire, health-related quality of life (HRQOL) by using the EQ-5D questionnaire, and clinical parameters. Among the 72 patients, we also evaluated changes in K6 scores in 58 patients at 1-year follow-up. The mean K6 score was 3.7 +/- A 3.7 and 2 subjects (2.8 %) were defined as having psychological distress. K6 scores were significantly correlated with body fat percentage, albumin level, and EQ-5D scores in total subjects. K6 scores were also significantly and negatively correlated with EQ-5D scores in men and women. In the 1-year follow-up group, changes in K6 scores were weakly and negatively correlated with changes in EQ-5D scores. Psychological distress was closely associated with HRQOL in patients on chronic hemodialysis. Coping strategies for psychological distress might be useful in improving HRQOL in patients on hemodialysis.	[Katayama, Akihiko; Miyatake, Nobuyuki; Tanaka, Keiko] Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan; [Nishi, Hiroyuki; Hashimoto, Hiroo; Uzike, Kazuhiro; Koumoto, Kiichi] Innoshima Gen Hosp, Onomichi, Hiroshima 7222323, Japan; [Sakano, Noriko] Okayama Univ, Dept Gerontol Res, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan	Katayama, A (reprint author), Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan.	kata@med.kagawa-u.ac.jp			Okayama Medical Foundation	This study was supported by Research Grant from the Okayama Medical Foundation.	Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Mittal SK, 2001, NEPHROL DIAL TRANSPL, V16, P1387, DOI 10.1093/ndt/16.7.1387; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Zalai D, 2012, SEMIN DIALYSIS, V25, P428, DOI 10.1111/j.1525-139X.2012.01100.x; IWATA N, 1994, JPN J PSYCHIAT NEUR, V48, P547; Chiang HH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-78; Davison SN, 2013, J PAIN SYMPTOM MANAG, V45, P170, DOI 10.1016/j.jpainsymman.2012.02.019; Esaki S, 2010, J JPN SOC DIAL THER, V43, P487; Katayama A, 2014, ENVIRON HEALTH PREV, V19, P220, DOI 10.1007/s12199-014-0380-z; Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076; Li Y, 2014, J AFFECT DISORDERS, V157, P1, DOI 10.1016/j.jad.2013.12.040; Mahdavi Ali, 2013, N Am J Med Sci, V5, P536, DOI 10.4103/1947-2714.118917; Martinez BB, 2014, SAO PAULO MED J, V132, P23, DOI 10.1590/1516-3180.2014.1321606; Miyamae Y, 2013, JAPAN HLTH, V6, P985; Miyoshi Y, 2014, J YONAGO MED ASSOC, V65, P19; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P1480, DOI 10.2215/CJN.01240210; Preljevic VT, 2011, GEN HOSP PSYCHIAT, V33, P454, DOI 10.1016/j.genhosppsych.2011.06.010; Sakano N, 2012, OPEN J NURS, V2, P23, DOI [10.4236/ojn.2012.21004, DOI 10.4236/OJN.2012.21004]; Suzue T, 2011, HEALTH, V3, P748; Yu HD, 2010, J CLIN NURS, V19, P658, DOI 10.1111/j.1365-2702.2009.03071.x	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					102	107		10.1007/s12199-014-0432-4		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500004		
J	Goto, Y; Yokokawa, H; Fukuda, H; Naito, T; Hisaoka, T; Isonuma, H				Goto, Yoko; Yokokawa, Hirohide; Fukuda, Hiroshi; Naito, Toshio; Hisaoka, Teruhiko; Isonuma, Hiroshi			Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Vital capacity; Restrictive respiratory dysfunction; Obesity; Metabolic syndrome; Lifestyle-related disorder	NUTRITION EXAMINATION; METABOLIC SYNDROME; NATIONAL-HEALTH; LUNG-FUNCTION; OBESITY; ASSOCIATION; DISEASE; DYSFUNCTION; MEN	This study aimed to examine the associations between obesity and percentage vital capacity (%VC), as well as lifestyle-related disorders, among Japanese participants of a voluntary health checkup. Subjects were 7,892 individuals who participated in a medical health checkup from January to December 2007. Multivariate logistic regression analysis was performed to assess associations between low %VC (< 80) and body mass index (BMI) and waist circumference (WC), as well as lifestyle-related disorders. Medical histories of hypertension and dyslipidemia were more frequent in the low %VC group than in the normal %VC group in both sexes. In men, BMI was significantly associated with low %VC (25.0 a parts per thousand currency sign C2 < 27.5, odds ratio (OR) = 2.10; 27.5 a parts per thousand currency sign C3 < 30.0, OR = 2.23; C4 a parts per thousand yen 30.0, OR = 3.46) relative to the first category (C1 < 25.0). A significant association was also observed between WC and low %VC (85 a parts per thousand currency sign C2 < 90, OR = 1.40; 90 a parts per thousand currency sign C3 < 95, OR = 1.55; 95 a parts per thousand currency sign C4, OR = 2.51; relative to C1 < 85.0 cm). In women, BMI was significantly associated with low %VC in C3 and C4 (C3, OR = 2.05; C4, OR = 2.84), and WC was significantly associated with low %VC in C4 (C4, OR = 2.32). Our results suggest that obesity may be associated with restrictive pulmonary function and underscore the importance of maintaining ideal body weight for the prevention of restrictive pulmonary dysfunction.	[Goto, Yoko; Yokokawa, Hirohide; Fukuda, Hiroshi; Naito, Toshio; Hisaoka, Teruhiko; Isonuma, Hiroshi] Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, Tokyo 1138421, Japan	Yokokawa, H (reprint author), Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yokokawa@pa3.so-net.ne.jp			 [24590816]	The authors thank the participants who underwent the voluntary medical checkup and the data collection staff at Yaesu Medical Heath Checkup Center. This study was funded by a 2012 Grant-in-Aid for Scientific Research (C) (No. 24590816).	WARNICK GR, 1990, CLIN CHEM, V36, P15; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Lazarus R, 1997, CHEST, V111, P891, DOI 10.1378/chest.111.4.891; Weiner P, 1998, THORAX, V53, P39; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Canoy D, 2004, AM J EPIDEMIOL, V159, P1140, DOI 10.1093/aje/kwh155; Chlif M, 2005, INT J OBESITY, V29, P1478, DOI 10.1038/sj.ijo.0803030; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Ministry of Health Labour and Welfare, 2013, REP HLTH NUTR SURV 2; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Oda E, 2009, INTERNAL MED, V48, P1201, DOI 10.2169/internalmedicine.48.2085; Oda Eiji, 2009, Environmental Health and Preventive Medicine, V14, P284, DOI 10.1007/s12199-009-0098-5; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Sakuta H, 2006, Can Respir J, V13, P79; Scarlata S, 2008, RESP MED, V102, P1349, DOI 10.1016/j.rmed.2008.02.021; The Specific Committee of the Japanese Respiratory Society on the lung physiology, 2004, RESP FUNCT TEST GUID, P20	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					108	115		10.1007/s12199-014-0431-5		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500005		
J	Nishide, R; Ando, M; Funabashi, H; Yoda, Y; Nakano, M; Shima, M				Nishide, Ritsuko; Ando, Michiko; Funabashi, Hidemitsu; Yoda, Yoshiko; Nakano, Masataka; Shima, Masayuki			Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Follow-up; Hs-CRP; Low-grade-inflammation; Obesity; School children	C-REACTIVE PROTEIN; INTERNATIONAL GROWTH REFERENCES; LIPOPROTEIN-CHOLESTEROL RATIO; INTIMA-MEDIA THICKNESS; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; SENSITIVITY; INFLAMMATION	To investigate the association of serum lipids and high-sensitivity C-reactive protein (hs-CRP) with obesity in school children and to explore whether hs-CRP levels could be used to predict the presence or absence of obesity 12 months later. The subjects were school children (6-11 years old) in Japan. Blood sampling and physical measurements were performed in school (2001); low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, and hs-CRP levels were measured. Data from children who could be followed 12 months later were analyzed. Subjects weighing 20 % or more over his/her standard weight were regarded as obese, and the association of obesity with serum parameters was analyzed. Data from 612 subjects were analyzed (follow-up rate, 75.4 %). The mean of each serum parameter was significantly higher (inverse for HDL-C; lower) in obese than that in non-obese children. Logistic regression analysis for obesity at baseline showed that the odds ratio (OR) of hs-CRP was the highest [OR, 2.15; 95 % confidence interval (CI), 1.65-2.78 for an interquartile rage (IQR) increase]; the association with triglycerides and LDL-C/HDL-C was significant. At the 12-month follow-up, the OR of high hs-CRP remained the highest of all serum parameters (2.09; 95 % CI, 1.63-2.69 for an IQR increase). High levels of triglycerides, LDL-C/HDL-C, and hs-CRP increased the risk of obesity in school children. Hs-CRP is considered to be a better predictor of obesity 12 months later than is LDL-C/HDL-C.	[Nishide, Ritsuko; Nakano, Masataka] Mie Univ, Dept Community & Geriatr Nursing, Fac Med, Tsu, Mie 5148507, Japan; [Nishide, Ritsuko; Yoda, Yoshiko; Shima, Masayuki] Hyogo Coll Med, Dept Publ Hlth, Nishinomiya, Hyogo 6638501, Japan; [Ando, Michiko] Clin Supreme Court Justice Japan, Chiyoda Ku, Tokyo, Japan; [Funabashi, Hidemitsu] Mastudo City Hosp, Dept Respirol, Matsudo, Chiba, Japan; [Funabashi, Hidemitsu] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan	Nishide, R (reprint author), Mie Univ, Dept Community & Geriatr Nursing, Fac Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ritsuko@nurse.medic.mie-u.ac.jp		Shima, Masayuki/0000-0002-8783-7879			Fernandez ML, 2008, J AM COLL NUTR, V27, P1; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ridker PM, 2001, CIRCULATION, V103, P1813; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Ford ES, 2003, CIRCULATION, V108, P1053, DOI 10.1161/01.CIR.0000080913.81393.B8; COLE TJ, 1995, ARCH DIS CHILD, V73, P25; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Flegal KM, 2001, AM J CLIN NUTR, V73, P1086; de Winter RJ, 1999, CARDIOVASC RES, V42, P240, DOI 10.1016/S0008-6363(99)00018-8; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.8030.A8; Giannini C, 2009, EUR J ENDOCRINOL, V161, P73, DOI 10.1530/EJE-09-0042; Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70; Lambert M, 2004, CLIN CHEM, V50, P1762, DOI 10.1373/clinchem.2004.036418; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129; Soldin OP, 2004, CLIN CHIM ACTA, V342, P211, DOI 10.1016/j.cccn.2004.01.002; Bovet P, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-65; Hiura M, 2003, HYPERTENS RES, V26, P541, DOI 10.1291/hypres.26.541; Ikiuo K, 2010, J CHILD HLTH, V69, P6; Japanese Society of School Health (supervised by School Health Education Division Sports and Youth Bureau Ministry of Education Culture Sports Science and Technology-Japan), 2006, STUD HLTH DIAGN MAN, P41; Kanaka-Gantenbein C, 2008, CLIN CHEM, V54, P1176, DOI 10.1373/clinchem.2007.099002; Kawai T, 2013, LAB MED MECH ABNORMA, P179; Kihara S., 2010, J JPN COLL ANGIOL, V50, P549; Kimura T, 2010, CIRC J, V74, P1392, DOI 10.1253/circj.CJ-09-0849; Kurebayashi N, 2011, CIRC J, V75, P1960, DOI 10.1253/circj.CJ-11-0019; Magnussen CG, 2009, J AM COLL CARDIOL, V53, P860, DOI 10.1016/j.jacc.2008.09.061; Mushtaq MU, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-31; Nappo A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000101; Ohlsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049404; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rifai N, 1999, CLIN CHEM, V45, P2136; Roh EJ, 2007, J KOREAN MED SCI, V22, P192; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P159, DOI 10.1007/s12199-009-0080-2; Saltevo Juha, 2007, Diab Vasc Dis Res, V4, P328, DOI 10.3132/dvdr.2007.060; Shima M, 2007, J EPIDEMIOL, V17, P169, DOI 10.2188/jea.17.169; Yoshida T, 2006, J CLIN ENDOCR METAB, V91, P2133, DOI 10.1210/jc.2005-2856	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					116	122		10.1007/s12199-014-0433-3		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500006		
J	Cui, XY; Lu, X; Hisada, A; Fujiwara, Y; Katoh, T				Cui, Xiaoyi; Lu, Xi; Hisada, Aya; Fujiwara, Yuki; Katoh, Takahiko			The correlation between mental health and multiple chemical sensitivity: a survey study in Japanese workers	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Mental health; Multiple chemical sensitivity; Other chemical sensitivity; Quick Environmental Exposure and Sensitivity Inventory; Japanese workers	IDIOPATHIC ENVIRONMENTAL INTOLERANCES; CHRONIC-FATIGUE-SYNDROME; POPULATION; SYMPTOMS; PREVALENCE; EXPOSURE; MCS	This study was designed to determine the correlation between mental health and multiple chemical sensitivity (MCS). The present study was conducted at two companies in 2011; both in Kyushu, Japan. The "subjective symptoms" subscale of the "Self-diagnosis Checklist for Assessment of Workers' Accumulated Fatigue" was used as a mental health subscale. To determine if multiple chemical exposure has an impact on mental health, we composed an original path model using structural equation analysis. Our final path model can be regarded as good: CMIN/DF = 1.832, CFI = 0.996, and RMSEA = 0.038, AIC = 71.158. As expected, chemical sensitivity and other chemical sensitivity scores predicted the health effects of multiple chemical exposure (beta = 0.19, 0.64). Mental health was predicted by symptom severity and life impact (beta = 0.56 and 0.12), which were both affected by multiple chemical exposure (beta = 0.38 and 0.89, respectively). As far as we are aware, this is the first study using path analysis to explore whether MCS can indicate mental health in worker populations worldwide, and we found a significant causal relationship between them. This could indicate that more focus should be placed on the impact of MCS on mental health in future investigations.	[Cui, Xiaoyi; Lu, Xi; Hisada, Aya; Fujiwara, Yuki; Katoh, Takahiko] Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan	Cui, XY (reprint author), Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, Chuo Ku, 1-1-1 Honjou, Kumamoto 8608556, Japan.	bjcxy860508@hotmail.com			Ministry of Health, Labour and Welfare of Japan [H23-Kenki-Ippan-010]	This work was supported in part by Grants-in-aid for Research on Health Security Control (H23-Kenki-Ippan-010) from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/). We express our sincere appreciation to the staff members of the Department of Public Health, Faculty of Life Sciences, Kumamoto University.	Bornschein S, 2002, PSYCHOL MED, V32, P1387, DOI 10.1017/S0033291702006554; Jason LA, 2000, PSYCHOSOM MED, V62, P655; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Hojo S, 2003, TOXICOL IND HEALTH, V19, P41, DOI 10.1191/0748233703th180oa; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73; Davidoff AL, 2000, ARCH ENVIRON HEALTH, V55, P165; BASCOM R, 1992, TOXICOL IND HEALTH, V8, P221; Saito M, 2005, PSYCHOSOM MED, V67, P318, DOI 10.1097/01.psy.0000155676.69030.28; Ashford NA, 1997, CHEM EXPOSURES LOW L; BELL IR, 1994, TOXICOL IND HEALTH, V10, P277; Black DW, 2000, ARCH INTERN MED, V160, P1169, DOI 10.1001/archinte.160.8.1169; Bornschein S, 2001, J INTERN MED, V250, P309, DOI 10.1046/j.1365-2796.2001.00870.x; Davidoff AL, 1996, ARCH ENVIRON HEALTH, V51, P201; Fiedler N, 1996, PSYCHOSOM MED, V58, P38; Hausteiner C, 2006, J OCCUP ENVIRON MED, V48, P76, DOI 10.1097/01.jom.0000182207.68987.d7; Ishikawa S, 1999, ALLERGOL IMMUNOL, V6, P90; Katerndahl DA, 2012, ANN FAM MED, V10, P357, DOI 10.1370/afm.1346; Lax MB, 1995, ARCH ENVIRON HEALTH, V50, P425; Leznoff A., 1997, TOXICOL LETT, V99, P438; Moen BE, 2005, PSYCHONEUROENDOCRINO, V30, P1039, DOI 10.1016/j.psyneuen.2005.03.020; Otsuka Y, 2010, INT J PSYCHOL COUNS, V2, P65; Reid S, 1999, J ROY SOC MED, V92, P616; STAUDENMAYER H, 1993, ANN ALLERGY, V71, P538; STEWART DE, 1985, CAN MED ASSOC J, V133, P1001; Tonori H, 2001, TOHOKU J EXP MED, V193, P115, DOI 10.1620/tjem.193.115	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					123	129		10.1007/s12199-014-0434-2		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500007		
J	Michikawa, T; Ueda, K; Takeuchi, A; Tamura, K; Kinoshita, M; Ichinose, T; Nitta, H				Michikawa, Takehiro; Ueda, Kayo; Takeuchi, Ayano; Tamura, Kenji; Kinoshita, Makoto; Ichinose, Takamichi; Nitta, Hiroshi			Coarse particulate matter and emergency ambulance dispatches in Fukuoka, Japan: a time-stratified case-crossover study	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Particulate matter; Coarse particle; Short-term exposure; Emergency ambulance dispatches; Case-crossover design	AIR-POLLUTION; ASIAN DUST; INFLAMMATORY MEDIATORS; EPIDEMIOLOGIC EVIDENCE; FINE PARTICULATE; DAILY MORTALITY; PARTICLES; HEALTH; EXPOSURE; VISITS	There is no conclusive evidence of adverse health effects caused by short-term exposure to coarse particulate matter, so in this case-crossover study we looked for an association between exposure and emergency ambulance dispatches (as a proxy of acute health outcomes). We used data on emergency ambulance dispatches in Fukuoka City, Japan between 2005 and 2010. After excluding ambulance dispatches related to external injuries and pregnancy/childbirth, we analyzed data on 176,123 dispatches. Citywide daily mean concentrations of suspended particulate matter (SPM) and fine particulate matter (PM2.5) were calculated from ambient monitoring data, and the differences between concentrations of SPM and PM2.5 were used as an exposure surrogate of coarse particulate matter. Using a conditional logistic regression model, we estimated the ambient temperature and relative humidity adjusted odds ratios (ORs) per 10 mu g/m(3) increase in coarse particulate matter. The average daily concentration of coarse particulate matter over the study period was 9.9 mu g/m(3), representing 33 % of the total concentration of SPM. Elevated concentrations of coarse particulate matter were associated with an increase in respiratory disease-related emergency ambulance dispatches for adults aged 65 years or older (9,716 dispatches, OR for lag0-1 = 1.065, 95 % confidence interval = 1.023-1.109). After additional adjustment for exposure to PM2.5, we observed a statistically non-significant increased risk (OR = 1.035, 0.986-1.086). We found weak evidence of adverse effects of short-term exposure to coarse particulate matter on human health.	[Michikawa, Takehiro; Ueda, Kayo; Takeuchi, Ayano; Tamura, Kenji; Nitta, Hiroshi] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Ueda, Kayo] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Takeuchi, Ayano] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Kinoshita, Makoto] Environm Bur Fukuoka City, Fukuoka, Japan; [Ichinose, Takamichi] Oita Univ Nursing & Hlth Sci, Dept Hlth Sci, Oita, Japan	Michikawa, T (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	tmichikawa@nies.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25241015]	We appreciate the help Mr. Hiromi Hayashi (Environmental Bureau of Fukuoka City, Fukuoka, Japan) gave us in acquiring data. We would also like to thank Ms. Noriko Shidai (National Institute for Environmental Studies, Tsukuba, Japan) for her assistance with our work. This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25241015).	Ueda Kayo, 2010, Environmental Health and Preventive Medicine, V15, P350, DOI 10.1007/s12199-010-0150-5; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Pozzi R, 2003, TOXICOLOGY, V183, P243, DOI 10.1016/S0300-483X(02)00545-0; Alexis NE, 2006, J ALLERGY CLIN IMMUN, V117, P1396, DOI 10.1016/j.jaci.2006.02.030; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Lippmann M, 2009, CRIT REV TOXICOL, V39, P865, DOI 10.3109/10408440903300080; Ilabaca M, 1999, J AIR WASTE MANAGE, V49, P154; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.edu.0000181315.18836.9d; Tong HY, 2010, CARDIOVASC TOXICOL, V10, P259, DOI 10.1007/s12012-010-9082-y; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Michikawa T, 2015, J EPIDEMIOL COMMUN H, V69, P86, DOI 10.1136/jech-2014-203961; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Malig BJ, 2013, AM J EPIDEMIOL, V178, P58, DOI 10.1093/aje/kws451; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Gerlofs-Nijland ME, 2007, INHAL TOXICOL, V19, P1055, DOI 10.1080/08958370701626261; Volckens J, 2009, ENVIRON SCI TECHNOL, V43, P4595, DOI 10.1021/es900698a; Hagihara A, 2013, INTERN EMERG MED, V8, P431, DOI 10.1007/s11739-013-0956-4; Japanese Ministry of the Environment, 2009, ENV QUAL STAND JAP A; Ng CFS, 2014, J EPIDEMIOL, V24, P15, DOI 10.2188/jea.JE20130051; Takahra K, 1997, FUKUOKASHIHOKANKEN 2, V22, P128; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; US EPA - National Center Environ Assessment, 2009, INT SCI ASS PART MAT	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					130	136		10.1007/s12199-014-0439-x		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500008		
J	Yamamoto, BA; Kitano, N				Yamamoto, Beverley A.; Kitano, Naomi			Designing a safeguarding tool for Japanese professionals to identify, understand and respond to adolescent sexual behaviours	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Review						Safeguarding; Adolescents; Sexual behaviours; Risk taking; Diagnostic tool		This study sought to construct a developmental and context-sensitive framework that could be used to identify, understand and respond to adolescent sexual behaviours. We reviewed work being conducted on adolescent sexual development, health and safety, interviewed UK-based professionals working on sexual health and child protection, and, having identified the Traffic Light Tool (TLT) designed by Family Planning Queensland and then developed by Brook in the UK, we conducted expert interviews. Finally, we reviewed in-house consultation, training and evaluation documentation provided by Brook. We identified the Traffic Light Safeguarding Project as offering a framework for thinking about and responding to youth sexuality. The concept of safeguarding allows us to go beyond the narrower mandate of child protection, and link up the activities of different stakeholders working around child and adolescent sexual health. We were able to confirm that the TLT was functioning as an effective safeguarding tool to: (1) identify and respond to adolescent sexual behaviours, and (2) support professionals to communicate confidently with adolescents about sexuality and risk taking. We confirmed the possibilities for developing a Japanese version of the tool. A safeguarding perspective can help us to move away from a narrowly risk-based approach to child and adolescent sexuality. Development and dissemination of a Japanese version of the TLT can help professionals distinguish between healthy (normal) and unhealthy (risky) sexual behaviours at each developmental stage and more confidently respond to these behaviours.	[Yamamoto, Beverley A.; Kitano, Naomi] Osaka Univ, Grad Sch Human Sci, Suita, Osaka 5650871, Japan; [Kitano, Naomi] Wakayama Med Univ, Dept Publ Hlth, Sch Med, Wakayama, Japan	Yamamoto, BA (reprint author), Osaka Univ, Grad Sch Human Sci, 1-2 Yamadaoka, Suita, Osaka 5650871, Japan.	bevyamamoto@hus.osaka-u.ac.jp			Japan Society of the Promotion of Science [24510377]; Brook UK; Family Planning Queensland	This research was funded by the Japan Society of the Promotion of Science (Grant-in Aid Number 24510377). We have received generous advice and support from Brook UK and Family Planning Queensland. We would also like to thank the two schools and one health centre that have allowed us to workshop the tool in the UK.	Alldred P, 2007, GET REAL SEX POLITIC, P7; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Arai L, 2009, TEENAGE PREGNANCY MA, P5; Duncan S., 2010, TEENAGE PARENTHOOD W; Friedrich W, 2003, SEXUAL DEV CHILDHOOD, P107; Hara J., 2007, 6 JAP ASS SEX ED, p[13, 19]; HM Government, 2013, WORK TOG SAF CHILDR, P7; Ministry of Health Labour and Welfare, 2013, SUYOYAK OYAK 21 SAIS, P3; Ministry of Health Labour and Welfare, 2006, SUYOYAK OYAK 21 CHUK, p[8, 28]; Royal College of Paediatrics and Child Health, 2014, INT DOC, P3; Saotome T, 2010, JMAJ, V53, P279; Smith GD, 1997, BRIT MED J, V315, P1641; Social Exclusion Unit, 1999, TEEN PREGN REP SOC E; Tsurugi Y, 2004, JASS P, V1, P22; World Health Organization, 2006, DEF SEX HLTH REP TEC; Yamamoto B, 2009, WAK OYA E NO KOS SHI; Yamamoto BA, 2005, I CONT JAPANESE STUD, V3, P1	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					141	145		10.1007/s12199-014-0438-y		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500010		
J	Katayama, A; Miyatake, N; Nishi, H; Uzike, K; Sakano, N; Hashimoto, H; Koumoto, K				Katayama, Akihiko; Miyatake, Nobuyuki; Nishi, Hiroyuki; Uzike, Kazuhiro; Sakano, Noriko; Hashimoto, Hiroo; Koumoto, Kiichi			Evaluation of physical activity and its relationship to health-related quality of life in patients on chronic hemodialysis (vol 19, pg 220, 2014)	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Correction									[Katayama, Akihiko; Miyatake, Nobuyuki; Sakano, Noriko] Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan; [Nishi, Hiroyuki; Uzike, Kazuhiro; Hashimoto, Hiroo; Koumoto, Kiichi] Innoshima Gen Hosp, Onomichi, Hiroshima 7222323, Japan	Katayama, A (reprint author), Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan.	kata@med.kagawa-u.ac.jp					AKIHIKO K, 2014, ENV HLTH PREV MED, V19, P220, DOI DOI 10.1007/S12199-014-0380-Z	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAR	2015	20	2					158	158		10.1007/s12199-015-0442-x		1	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD2DX	WOS:000350885500015		
J	Liu, C; Wang, QX; Zou, CJ; Hayashi, Y; Yasunari, T				Liu, Chen; Wang, Qinxue; Zou, Chunjing; Hayashi, Yoshitsugu; Yasunari, Tetsuzo			Recent trends in nitrogen flows with urbanization in the Shanghai megacity and the effects on the water environment	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article; Proceedings Paper	2nd International Conference on Water, Energy, and Environment (ICWEE)	SEP 21-24, 2013	Kusadasi, TURKEY	Izmir Katip Celebi Univ, Amer Univ Sharjah, United Arab Emirates Univ		Urbanization; Nitrogenflow; Water environment; Lifestyle; Production style; Shanghai	RAPID URBANIZATION; REGIONAL NITROGEN; CHANGJIANG RIVER; RURAL-AREAS; CHINA; IMPACT; AGROECOSYSTEMS; ECOSYSTEMS; URBAN	The objectives of this study are to diagnose and prevent environmental problems that threaten urban sustainability, the impact of changes in lifestyle (diet, domestic sanitation, and motorization), and production style (agriculture, industry, and services) with the rapid urbanization on regional nitrogen (N) flows, and the water environment was quantitatively evaluated. The megacity Shanghai was chosen as a case study to investigate the temporal changes in nitrogen flow during 1980-2008 by a multidisciplinary approach (a field survey, a regional nitrogen mass balance model, input-output analysis, etc.). Although the total potential nitrogen load in Shanghai has decreased in the 2000s and water pollution problems seem to have improved, the problem has shifted and expanded to affect a wider area through the food/product chain and water/air movement. Further effective solutions that aim at material cycles are necessary and have to be implemented on a large scale.	[Liu, Chen] Inst Global Environm Strategies, Hayama, Kanagawa 2400115, Japan; [Wang, Qinxue] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Zou, Chunjing] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Urbanizat & Ecol Restorat, Shanghai 200062, Peoples R China; [Hayashi, Yoshitsugu] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yasunari, Tetsuzo] Res Inst Human & Nat, Kita Ku, Kyoto 6038047, Japan	Liu, C (reprint author), Inst Global Environm Strategies, 2108-11 Kamiyamaguchi, Hayama, Kanagawa 2400115, Japan.	c-liu@iges.or.jp					[Anonymous], 2001, SHANGHAI STAT YB; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; [Anonymous], 1981, SHANGHAI STAT YB; Wang JY, 2008, ENVIRON POLLUT, V152, P387, DOI 10.1016/j.envpol.2007.06.050; [Anonymous], 2009, SHANGHAI STAT YB; Gu BJ, 2012, ENVIRON POLLUT, V171, P30, DOI 10.1016/j.envpol.2012.07.015; Li MT, 2007, ESTUAR COAST SHELF S, V71, P3, DOI 10.1016/j.ecss.2006.08.013; Kaye JP, 2005, GLOBAL CHANGE BIOL, V11, P575, DOI 10.1111/j1365-2486.2005.00921.x; Fissore C, 2011, ECOL APPL, V21, P619, DOI 10.1890/10-0386.1; Liu C, 2008, NUTR CYCL AGROECOSYS, V80, P19, DOI 10.1007/s10705-007-9118-2; Baker Lawrence A., 2009, P69, DOI 10.1007/978-0-387-84891-4_5; Department of Industrial and Transport Statistics of National Bureau of Statistics, 1991, CHIN EN STAT YB; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033982; Ge HZ, 1999, SURFACE WATER POLLUT; Gu BJ, 2009, ECOL APPL, V19, P974, DOI 10.1890/08-0027.1; Helmer R., 1997, WATER POLLUTION CONT; Li ZP, 2005, TEMPLE J SCI TECHNOL, P375; Liu C, 2012, J SCI FOOD AGR, V92, P1046, DOI 10.1002/jsfa.4725; Liu C, 2014, ENVIRON SCI POLLUT R, V21, P1905, DOI 10.1007/s11356-013-2006-1; Liu C, 2009, BIOGEOCHEMISTRY, V94, P175, DOI 10.1007/s10533-009-9317-9; Liu C, 2014, WATER ENVIRON RES, V86, P433, DOI 10.2175/106143013X13807328849819; Liu C, 2008, AGR ECOSYST ENVIRON, V125, P84, DOI 10.1016/j.agee.2007.12.001; Ministry of Water Resources of China, 2007, CHIN WAT RES B; Ministry of Water Resources of China, 1997, CHIN WAT RES B; Ministry of Water Resources of China, 2002, CHIN WAT RES B; National Bureau of Statistics of China, 1998, CHIN STAT YB ENV; National Bureau of Statistics of China, 2005, CHIN STAT YB ENV; The China Science Center of International Eurasian Academy of Sciences China Association of Mayors and UN-HABITAT, 2012, STAT CHIN CIT 2012 2; Yin Z., 2005, COMPUTERS ENV URBAN, V29, P197, DOI 10.1016/j.compenvurbsys.2003.10.001; [周婕成 Zhou Jiecheng], 2009, [环境污染与防治, Environmental Pollution & Control], V31, P30	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	MAR	2015	22	5					3431	3440		10.1007/s11356-014-3825-4		10	Environmental Sciences	Environmental Sciences & Ecology	CC4NY	WOS:000350331300022		
J	Ito, A				Ito, Akinori			Atmospheric Processing of Combustion Aerosols as a Source of Bioavailable Iron	ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS			English	Article							ACID MOBILIZATION; OXALIC-ACID; DUST; DISSOLUTION; SOLUBILITY; OCEAN; SPECIATION; PARTICLES; IMPACT; DEPOSITION	Atmospheric processing of combustion aerosols may promote transformation of insoluble iron into soluble forms. Here, an explicit scheme for iron dissolution of combustion aerosols due to photochemical reactions with inorganic and organic acids in solution is implemented in an atmospheric chemistry transport model to estimate the atmospheric sources of bioavailable iron. The model results suggest that deposition of soluble iron from combustion sources contributes more than 40% of the total soluble iron deposition over significant portions of the open ocean in the Southern Hemisphere. A sensitivity simulation using half the iron dissolution rate for combustion aerosols results in relatively small decreases in soluble iron deposition in the ocean, compared with the large uncertainties associated with iron solubility at emission. More accurate quantification of the soluble iron burdens near the source regions and the open ocean is needed to improve the process-based understanding of the chemical modification of iron-containing minerals.	JAMSTEC, Yokohama Inst Earth Sci, Yokohama, Kanagawa 2360001, Japan	Ito, A (reprint author), JAMSTEC, Yokohama Inst Earth Sci, Yokohama, Kanagawa 2360001, Japan.	akinorii@jamstec.go.jp	Ito, Akinori/M-9599-2014		Program for Risk Information on Climate Change (MEXT)	Support for this research was provided by Program for Risk Information on Climate Change (MEXT). All of the numerical simulations were performed using the SGI ICE X at the JAMSTEC.	Liu XH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005674; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; Rotman DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003155; Wozniak AS, 2013, MAR CHEM, V154, P24, DOI 10.1016/j.marchem.2013.04.011; [Anonymous], 2015, ENVIRON SCI TECH LET, V2, P70, DOI [10.1021/acs.estlett.5600007Environ, DOI 10.1021/ACS.ESTLETT.5600007]; Lin G, 2014, ATMOS CHEM PHYS, V14, P5451, DOI 10.5194/acp-14-5451-2014; Lanzl CA, 2012, LANGMUIR, V28, P15797, DOI 10.1021/la3022497; Hamer M, 2003, SOIL SCI SOC AM J, V67, P654; Oakes M, 2012, ENVIRON SCI TECHNOL, V46, P6637, DOI 10.1021/es300701c; Cheize M, 2012, ANAL CHIM ACTA, V736, P45, DOI 10.1016/j.aca.2012.05.011; Chen HH, 2013, ENVIRON SCI TECHNOL, V47, P10312, DOI 10.1021/es401285s; Schroth AW, 2009, NAT GEOSCI, V2, P337, DOI 10.1038/NGEO501; Xu L, 2012, ATMOS CHEM PHYS, V12, P9479, DOI 10.5194/acp-12-9479-2012; Ito A, 2014, ATMOS CHEM PHYS, V14, P3441, DOI 10.5194/acp-14-3441-2014; Ito A, 2010, ATMOS CHEM PHYS, V10, P9237, DOI 10.5194/acp-10-9237-2010; Sholkovitz ER, 2009, GEOCHIM COSMOCHIM AC, V73, P3981, DOI 10.1016/j.gca.2009.04.029; Ito A, 2011, BIOGEOSCIENCES, V8, P1679, DOI 10.5194/bg-8-1679-2011; Ito A, 2012, J METEOROL SOC JPN, V90A, P167, DOI 10.2151/jmsj.2012-A09; Fu HB, 2012, ENVIRON SCI TECHNOL, V46, P11119, DOI 10.1021/es302558m; Furukawa T, 2011, ATMOS CHEM PHYS, V11, P4289, DOI 10.5194/acp-11-4289-2011; Takahashi Y, 2013, ATMOS CHEM PHYS, V13, P7695, DOI 10.5194/acp-13-7695-2013; Ito A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD006556; Paris R, 2010, ATMOS CHEM PHYS, V10, P4273, DOI 10.5194/acp-10-4273-2010; Brandt F, 2003, GEOCHIM COSMOCHIM AC, V67, P1451, DOI 10.1016/S0016-7037(02)01293-0; Chen H, 2012, ENVIRON SCI TECHNOL, V46, P2112, DOI 10.1021/es204102f; Chuang PY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021946; Feng Y., 2007, GEOPHYS RES, V112; Fishwick MP, 2014, GLOBAL BIOGEOCHEM CY, V28, P1235, DOI 10.1002/2014GB004921; Guieu C., 2005, Geophysical Research Letters, V32, DOI 10.1029/2005GL022962; Hajima T., 2014, PROGR EARTH PLANETAR, V1, P29; Ito A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050455; Ito A., 2015, ATMOS ENVIRON, DOI [10.1016/j.atmosenv.2015.01.031., DOI 10.1016/J.ATMOSENV.2015.01.031]; Ito A, 2013, GLOBAL BIOGEOCHEM CY, V27, P1, DOI 10.1029/2012GB004378; Johnson MS, 2013, GEOSCI MODEL DEV, V6, P1137, DOI 10.5194/gmd-6-1137-2013; Kieber RJ, 2003, ENVIRON SCI TECHNOL, V37, P4610, DOI 10.1021/es030345s; Kumar A, 2010, TELLUS B, V62, P125, DOI 10.1111/j.1600-0889.2009.00448.x; Luo C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002964; Meskhidze N, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005082; Takahama S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009810; ZHANG Y, 1985, LANGMUIR, V1, P201, DOI 10.1021/la00062a004; ZUO YG, 1992, ENVIRON SCI TECHNOL, V26, P1014, DOI 10.1021/es00029a022	41	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2328-8930			ENVIRON SCI TECH LET	Environ. Sci. Technol. Lett.	MAR	2015	2	3					70	75		10.1021/acs.estlett.5b00007		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CD3XO	WOS:000351017300005		
J	Namiki, S; Otani, T; Seike, N; Satoh, S				Namiki, Sayuri; Otani, Takashi; Seike, Nobuyasu; Satoh, Shinobu			DIFFERENTIAL UPTAKE AND TRANSLOCATION OF beta-HCH AND DIELDRIN BY SEVERAL PLANT SPECIES FROM HYDROPONIC MEDIUM	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						beta-HCH; Dieldrin; Cucurbita pepo; Root concentration factor; Transpiration stream concentration factor	PERSISTENT ORGANIC POLLUTANTS; SYSTEMIC FUNGICIDE; ROOT UPTAKE; SOIL; CUCURBITA; BARLEY; HERBICIDES; CHEMICALS; FAMILIES; CUCUMBER	To compare the uptake and translocation of hydrophobic organic chemicals by plant species, the authors performed uptake experiments with -1,2,3,4,5,6-hexachlorocyclohexane (-HCH) and 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-endo-1,4-exo-5,8-dimethanonaphthalene (dieldrin) using 5 species: Hordeum vulgare, Glycine max, Solanum lycopersicum, Brassica oleracea, and Cucurbita pepo. The present study evaluated uptake ability using root concentration factor (RCF) and translocation ability by transpiration stream concentration factor (TSCF). The RCFs of -HCH and dieldrin did not differ remarkably among species, except that the RCF of -HCH in B. oleracea was high. The TSCFs of -HCH and dieldrin were high in C. pepo, which was not superior in uptake as estimated by RCF. The TSCF of dieldrin in C. pepo was decreased in darkness and was markedly decreased by heating of roots. These results support the hypothesis that transport proteins produced in the root contribute to dieldrin translocation. In contrast, TSCF of -HCH was not decreased by these treatments. Therefore, translocation of -HCH might not need the contribution of transport proteins. It is possible that C. pepo has a certain function to transport hydrophobic organic chemicals smoothly in root tissues. Environ Toxicol Chem 2015;34:536-544. (c) 2014 SETAC	[Namiki, Sayuri; Satoh, Shinobu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Otani, Takashi; Seike, Nobuyasu] Natl Inst Agroenvironm Sci, Organochem Div, Tsukuba, Ibaraki 305, Japan	Otani, T (reprint author), Natl Inst Agroenvironm Sci, Organochem Div, Tsukuba, Ibaraki 305, Japan.	otanit@affrc.go.jp					Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Gao YZ, 2009, ENVIRON SCI TECHNOL, V43, P6190, DOI 10.1021/es900662d; Dettenmaier EM, 2009, ENVIRON SCI TECHNOL, V43, P324, DOI 10.1021/es801751x; Sun H, 2010, MOL BIOL REP, V37, P2215, DOI 10.1007/s11033-009-9707-z; Burken JG, 1998, ENVIRON SCI TECHNOL, V32, P3379, DOI 10.1021/es9706817; Trapp S, 2000, PEST MANAG SCI, V56, P767, DOI 10.1002/1526-4998(200009)56:9<767::AID-PS198>3.3.CO;2-H; HSU FC, 1990, PLANT PHYSIOL, V93, P1573, DOI 10.1104/pp.93.4.1573; Namiki S, 2013, SOIL SCI PLANT NUTR, V59, P669, DOI 10.1080/00380768.2013.813833; JONES RJ, 1970, J EXP BOT, V21, P714, DOI 10.1093/jxb/21.3.714; RAWSON HM, 1977, PLANTA, V134, P5, DOI 10.1007/BF00390086; BRIGGS GG, 1982, PESTIC SCI, V13, P495, DOI 10.1002/ps.2780130506; Gent MPN, 2007, ENVIRON TOXICOL CHEM, V26, P2467, DOI 10.1897/06-257.1; Hashimoto Y, 2005, J PESTIC SCI, V30, P397, DOI 10.1584/jpestics.30.397; HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110; Inui H, 2013, PLANT PHYSIOL, V161, P2128, DOI 10.1104/pp.112.213645; Japanese Standards Association, 1999, K0312 JAP STAND ASS; Mackay D, 1997, ILLUSTRATED HDB PHYS, VV, P334; Murano H, 2010, ENVIRON TOXICOL CHEM, V29, P2269, DOI 10.1002/etc.288; Murano H, 2010, ENVIRON TOXICOL CHEM, V29, P142, DOI 10.1002/etc.10; Organisation for Economic Co-operation and Development, 2000, ORG EC COOP DEV SER, V23, P6; Otani T, 2007, SOIL SCI PLANT NUTR, V53, P86, DOI 10.1111/j.1747-0765.2007.00102.x; Seike N, 2007, ORGANOHALOGEN COMPD, V69, P28; SHONE MGT, 1974, J EXP BOT, V25, P401, DOI 10.1093/jxb/25.2.401; SHONE MGT, 1974, J EXP BOT, V25, P390, DOI 10.1093/jxb/25.2.390; slund Whitfield, 2007, SCI TOTAL ENVIRON, V374, P1; TRAPP S, 1991, CHEMOSPHERE, V22, P327, DOI 10.1016/0045-6535(91)90321-4; White JC, 2001, ENVIRON TOXICOL CHEM, V20, P2047, DOI 10.1897/1551-5028(2001)020<2047:PFMATO>2.0.CO;2	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	MAR	2015	34	3					536	544		10.1002/etc.2815		9	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CC3XH	WOS:000350284100008		
J	Nagai, T; Taya, K				Nagai, Takashi; Taya, Kiyoshi			ESTIMATION OF HERBICIDE SPECIES SENSITIVITY DISTRIBUTION USING SINGLE-SPECIES ALGAL TOXICITY DATA AND INFORMATION ON THE MODE OF ACTION	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Pesticide; Ecological risk assessment; Primary producer; Green algae	ECOLOGICAL RISKS; CLASSIFICATION	Although species sensitivity distribution (SSD) is a key concept for quantitative ecological risk assessment, its application is limited owing to a lack of sufficient data for the analysis, especially on the toxicity of herbicides for primary producers. The authors developed a method of herbicide SSD estimation using single-species toxicity data and information on the herbicide mode of action. The authors' method was based on 2 assumptions: the slopes of the SSD of the same MOA herbicides are the same and the relative sensitivities of standard algae in the SSD of the same MOA herbicides are the same. The 2 parameters of log-normal SSD, mean sensitivity, and variation in sensitivity, for 92 herbicides were determined to establish the estimation model. Mean sensitivities were linearly correlated with logarithmic 50% effect concentrations (EC50) for standard algae. The average of variations in sensitivity significantly differed among MOA, and variations in sensitivity were constant independently of EC50 values for standard algae for the same MOA herbicides. These results were all consistent with the assumptions of the SSD estimation method. The outcome was validated by comparing the estimated SSDs using the proposed method with the generated SSDs using toxicity data which were independent of method development. These SSDs were consistent, and considering MOA information improved the accuracy of estimating SSD markedly. Environ Toxicol Chem 2015;34:677-684. (c) 2014 SETAC	[Nagai, Takashi; Taya, Kiyoshi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan	Nagai, T (reprint author), Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan.	nagait@affrc.go.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [C-1102]	The present study was supported by the Environment Research and Technology Development Fund (C-1102) of the Ministry of the Environment, Japan.	Raimondo S, 2010, ENVIRON SCI TECHNOL, V44, P7711, DOI 10.1021/es101630b; [Anonymous], 1995, GUID DOC AQ EFF ASS; Luttik R, 1997, ENVIRON TOXICOL CHEM, V16, P1785, DOI 10.1897/1551-5028(1997)016<1785:EFFSSO>2.3.CO;2; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI 10.1897/1551-5028(1996)015<0031:ERAOAI>2.3.CO;2; Dyer SD, 2006, ENVIRON SCI TECHNOL, V40, P3102, DOI 10.1021/es051738p; Naito W, 2006, ENVIRON MONIT ASSESS, V115, P451, DOI 10.1007/s10661-006-7239-8; Chevre N, 2006, ENVIRON SCI TECHNOL, V40, P426, DOI 10.1021/es050239l; Tremolada P, 2004, AQUAT TOXICOL, V67, P87, DOI 10.1016/j.aquatox.2003.12.003; Vaal M, 1997, CHEMOSPHERE, V35, P1311, DOI 10.1016/S0045-6535(97)00167-7; Sabater S, 2007, ANAL BIOANAL CHEM, V387, P1425, DOI 10.1007/s00216-006-1051-8; de Zwart Dick, 2005, Integr Environ Assess Manag, V1, P123, DOI 10.1897/IEAM_2004-015.1; Dobbins L., 2010, EXPLORATION METHODS; Erickson R, 2011, EPA600R12019; Giddings JM, 2012, INTEGR ENVIRON ASSES, V9, P308; Giddings JM, 2000, RISK ANAL, V20, P545, DOI 10.1111/0272-4332.205052; Herbicide Resistance Action Committee, 2005, CLASS HERB ACC MOD A; Moore DRJ, 2009, INTEGR ENVIRON ASSES, V6, P102; Nagai T, 2011, JAP J RISK ANAL, V20, P279; Nagai T, 2012, J PESTIC SCI, V37, P233, DOI 10.1584/jpestics.D11-047; Posthuma L, 2002, SPECIES SENSITIVITY; Sala S, 2012, ECOTOXICOLOGY, V21, P1050, DOI 10.1007/s10646-012-0858-7; TenBrook P L, 2008, REV ENVIRON CONTAM T, V199, P19; Thursby G, 2011, EPAHQ201108980012; US Environmental Protection Agency, 2005, PEST EC EFF DAT GUID; Van den Brink PJ, 2006, HUM ECOL RISK ASSESS, V12, P645, DOI DOI 10.1080/10807030500430559; Watanabe H, 2008, PESTICIDE RISK ASSES, P167	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	MAR	2015	34	3					677	684		10.1002/etc.2828		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CC3XH	WOS:000350284100023		
J	Oda, S; Yurimoto, H; Nitta, N; Sasano, Y; Sakai, Y				Oda, Saori; Yurimoto, Hiroya; Nitta, Nobuhisa; Sasano, Yu; Sakai, Yasuyoshi			Molecular Characterization of Hap Complex Components Responsible for Methanol-Inducible Gene Expression in the Methylotrophic Yeast Candida boidinii	EUKARYOTIC CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CCAAT-BINDING; NF-Y; TRANSCRIPTIONAL REGULATION; HANSENULA-POLYMORPHA; PROTEIN-PRODUCTION; SUBUNIT; ACTIVATION; REGULATOR; CONTAINS	We identified genes encoding components of the Hap complex, CbHAP2, CbHAP3, and CbHAP5, as transcription factors regulating methanol-inducible gene expression in the methylotrophic yeast Candida boidinii. We found that the Cbhap2 Delta, Cbhap3 Delta, and Cbhap5 Delta gene-disrupted strains showed severe growth defects on methanol but not on glucose and nonfermentable carbon sources such as ethanol and glycerol. In these disruptants, the transcriptional activities of methanol-inducible promoters were significantly decreased compared to those of the wild-type strain, indicating that CbHap2p, CbHap3p, and CbHap5p play indispensable roles in methanol-inducible gene expression. Further molecular and biochemical analyses demonstrated that CbHap2p, CbHap3p, and CbHap5p localized to the nucleus and bound to the promoter regions of methanol-inducible genes regardless of the carbon source, and heterotrimer formation was suggested to be necessary for binding to DNA. Unexpectedly, distinct from Saccharomyces cerevisiae, the Hap complex functioned in methanol-specific induction rather than glucose derepression in C. boidinii. Our results shed light on a novel function of the Hap complex in methanol-inducible gene expression in methylotrophic yeasts.	[Oda, Saori; Yurimoto, Hiroya; Nitta, Nobuhisa; Sasano, Yu; Sakai, Yasuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Sakai, Yasuyoshi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto, Japan; [Sakai, Yasuyoshi] Japan Sci & Technol Agcy, Adv Low Carbon Technol Res & Dev Program, Chiyoda Ku, Tokyo, Japan	Sakai, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.	ysakai@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22310046, 25281063]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency	This research was supported in part by grants-in-aid for scientific research (B) (22310046 and 25281063 to H.Y.) from the Japan Society for the Promotion of Science. It was also supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency.	Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sakai Y, 1996, BBA-GENE STRUCT EXPR, V1308, P81, DOI 10.1016/0167-4781(96)00075-9; Mattanovich D, 2012, METHODS MOL BIOL, V824, P329, DOI 10.1007/978-1-61779-433-9_17; SAKAI Y, 1992, J BACTERIOL, V174, P5988; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; SAKAI Y, 1991, J BACTERIOL, V173, P7458; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Cheon SA, 2012, J MICROBIOL, V50, P341, DOI 10.1007/s12275-012-2097-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vogl T, 2013, NEW BIOTECHNOL, V30, P385, DOI 10.1016/j.nbt.2012.11.010; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; HAHN S, 1988, MOL CELL BIOL, V8, P655; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Hernandez H, 2011, MICROBIOL-SGM, V157, P879, DOI 10.1099/mic.0.044974-0; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; McNabb DS, 1997, MOL CELL BIOL, V17, P7008; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; Sasano Y, 2007, J BIOSCI BIOENG, V104, P86, DOI 10.1263/jbb.104.86; Sasano Y, 2010, FEMS YEAST RES, V10, P535, DOI 10.1111/j.1567-1364.2010.00640.x; Sasano Y, 2008, EUKARYOT CELL, V7, P527, DOI 10.1128/EC.00403-07; Schoonooghe Steve, 2012, Methods Mol Biol, V907, P325, DOI 10.1007/978-1-61779-974-7_19; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; TANI Y, 1985, AGR BIOL CHEM TOKYO, V49, P2699; XING YY, 1993, EMBO J, V12, P4647; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Yurimoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P793, DOI 10.1271/bbb.80825; Yurimoto H, 2011, INT J MICROBIOL, V2011, DOI DOI 10.1155/2011/101298; Zhai ZY, 2012, YEAST, V29, P293, DOI 10.1002/yea.2909	39	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1535-9778	1535-9786		EUKARYOT CELL	Eukaryot. Cell	MAR	2015	14	3					278	285		10.1128/EC.00285-14		8	Microbiology; Mycology	Microbiology; Mycology	CC9CT	WOS:000350666000008		
J	Ogawa, M; Saito, K; Sohmiya, M				Ogawa, Makoto; Saito, Kanji; Sohmiya, Minoru			Possible Roles of the Spatial Distribution of Organic Guest Species in Mesoporous Silicas to Control the Properties of the Hybrids	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Review						Mesoporous materials; Host-guest systems; Nanostructures; Heterogeneous catalysis; Surface chemistry	SURFACTANT MESOSTRUCTURED MATERIALS; ETHYLENE POLYMERIZATION CATALYSTS; THIN-FILMS; FUNCTIONAL-GROUPS; SITE-ISOLATION; POROUS SILICA; SELECTIVE FUNCTIONALIZATION; ENGINEERING NANOSPACES; LUMINESCENT MOLECULES; ALIGNED MESOCHANNELS	Mesoporous silicas are promising materials for the construction of host-guest hybrids by the accommodation of functional unit/guest species into the mesopore, and moreover, by hierarchical assembly with controlled location, density, and orientation. Precisely designed structures open up the versatile functions of mesoporous silicas and their host-guest systems. In this microreview, the spatial distribution (location, density, and orientation) of the organic functional units/guest species in mesoporous silicas (mainly one-dimensional cylindrical) is discussed to highlight the present status of the host-guest chemistry of mesoporous silicas.	[Ogawa, Makoto; Saito, Kanji] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698050, Japan; [Ogawa, Makoto; Sohmiya, Minoru] Waseda Univ, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan	Ogawa, M (reprint author), Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Nishiwaseda 1-6-1, Tokyo 1698050, Japan.	waseda.ogawa@gmail.com			Waseda University [2013B-054, 2013B-055]	This work was financially supported by Waseda University as special research projects (grant numbers 2013B-054 and 2013B-055).	Miyata H, 2007, MICROPOR MESOPOR MAT, V101, P296, DOI 10.1016/j.micromeso.2006.12.023; Innocenzi P, 2009, CHEM MATER, V21, P2555, DOI 10.1021/cm900288x; Ogawa M, 1997, B CHEM SOC JPN, V70, P2593, DOI 10.1246/bcsj.70.2593; Hicks JC, 2006, CHEM MATER, V18, P5022, DOI 10.1021/cm061382w; Yamauchi Y, 2005, J MATER CHEM, V15, P1137, DOI 10.1039/b418478e; Melero JA, 2006, CHEM REV, V106, P3790, DOI 10.1021/cr050994h; Miyata H, 2004, NAT MATER, V3, P651, DOI 10.1038/nmat1184; McKittrick MW, 2004, J AM CHEM SOC, V126, P3052, DOI 10.1021/ja031725g; Morishige K, 1998, J CHEM PHYS, V108, P7821, DOI 10.1063/1.476218; Fukumoto H, 2006, CHEM MATER, V18, P1226, DOI 10.1021/cm052359y; Zhou ZY, 2007, J MATER CHEM, V17, P2428, DOI 10.1039/b618834f; Okabe A, 2002, ANGEW CHEM INT EDIT, V41, P3414, DOI 10.1002/1521-3773(20020916)41:18<3414::AID-ANIE3414>3.0.CO;2-T; Sohmiya M, 2011, MICROPOR MESOPOR MAT, V142, P363, DOI 10.1016/j.micromeso.2010.12.023; Hillhouse HW, 1997, CHEM MATER, V9, P1505, DOI 10.1021/cm970140g; Schreiber A, 2001, PHYS CHEM CHEM PHYS, V3, P1185, DOI 10.1039/b010086m; Mbaraka IK, 2006, J CATAL, V244, P78, DOI 10.1016/j.jcat.2006.09.001; Lai JP, 2010, CHEM COMMUN, V46, P7370, DOI 10.1039/c0cc02914a; Ruiz-Hitzky E, 2011, CHEM SOC REV, V40, P801, DOI 10.1039/c0cs00052c; Sohmiya M, 2007, J PHYS CHEM B, V111, P8836, DOI 10.1021/jp064654r; Yano K, 2004, J MATER CHEM, V14, P1579, DOI 10.1039/b313712k; WULFF G, 1986, J AM CHEM SOC, V108, P1089, DOI 10.1021/ja00265a045; Ogawa M, 1998, CHEM MATER, V10, P1382, DOI 10.1021/cm970770i; OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003; Miyata H, 2000, CHEM MATER, V12, P49, DOI 10.1021/cm990506k; Rat M, 2008, MICROPOR MESOPOR MAT, V112, P26, DOI 10.1016/j.micromeso.2007.09.010; Shiba K, 2013, J NANOSCI NANOTECHNO, V13, P2483, DOI 10.1166/jnn.2013.7423; Ogawa M, 1996, CHEM COMMUN, P1149, DOI 10.1039/cc9960001149; Ogawa M, 2002, LANGMUIR, V18, P744, DOI 10.1021/la011429m; Kimura M, 2001, J AM CHEM SOC, V123, P2438, DOI 10.1021/ja004034i; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Yokoi T, 2006, J AM CHEM SOC, V128, P13664, DOI 10.1021/ja065071y; Johansson E, 2007, J AM CHEM SOC, V129, P14437, DOI 10.1021/ja075323a; Peng HS, 2006, J AM CHEM SOC, V128, P5304, DOI 10.1021/ja0575732; Ogawa M, 1998, ADV MATER, V10, P1077, DOI 10.1002/(SICI)1521-4095(199810)10:14<1077::AID-ADMA1077>3.0.CO;2-Q; Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n; Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362; Ogawa M, 2014, DALTON T, V43, P10340, DOI 10.1039/c4dt00147h; Ide Y, 2011, J COLLOID INTERF SCI, V358, P245, DOI 10.1016/j.jcis.2011.02.018; Sohmiya M, 2011, B CHEM SOC JPN, V84, P617, DOI 10.1246/bcsj.20100364; Choi M, 2005, J AM CHEM SOC, V127, P1924, DOI 10.1021/ja044907z; Minoofar PN, 2002, J AM CHEM SOC, V124, P14388, DOI 10.1021/ja020817n; Hoffmann F, 2011, CHEM SOC REV, V40, P608, DOI 10.1039/c0cs00076k; Ide Y, 2010, J AM CHEM SOC, V132, P16762, DOI 10.1021/ja1083514; Yamaguchi A, 2004, NAT MATER, V3, P337, DOI 10.1038/nmat1107; Rac B, 2006, J MOL CATAL A-CHEM, V244, P46, DOI 10.1016/j.molcata.2005.08.043; Minoofar P, 2003, J SOL-GEL SCI TECHN, V26, P571, DOI 10.1023/A:1020719904150; Mal NK, 2003, CHEM MATER, V15, P3385, DOI 10.1021/cm0343296; Lebeau B, 2011, CHEM SOC REV, V40, P886, DOI 10.1039/c0cs00106f; Wu SH, 2013, CHEM SOC REV, V42, P3862, DOI 10.1039/c3cs35405a; Tran-Thi TH, 2011, CHEM SOC REV, V40, P621, DOI 10.1039/c0cs00021c; Tolbert SH, 1997, SCIENCE, V278, P264, DOI 10.1126/science.278.5336.264; Tagaya M, 2006, CHEM LETT, V35, P108, DOI 10.1246/cl.2006.108; Suzuki K, 2004, J AM CHEM SOC, V126, P462, DOI 10.1021/ja038250d; Inagaki S, 2009, ANGEW CHEM INT EDIT, V48, P4042, DOI 10.1002/anie.200900266; Lunn JD, 2009, CHEM MATER, V21, P3638, DOI 10.1021/cm901025n; Stein A, 2000, ADV MATER, V12, P1403, DOI 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X; Kecht J, 2008, CHEM MATER, V20, P7207, DOI 10.1021/cm801484r; Hicks JC, 2006, LANGMUIR, V22, P2676, DOI 10.1021/la053024y; Yoo S, 2006, CHEM MATER, V18, P2935, DOI 10.1021/cm0520564; Doshi DA, 2000, SCIENCE, V290, P107, DOI 10.1126/science.290.5489.107; Yoshikawa T, 2002, B CHEM SOC JPN, V75, P2589, DOI 10.1246/bcsj.75.2589; [Anonymous], 2006, HANDBOOK OF CLAY SCI; Ikegame M, 2003, ANGEW CHEM INT EDIT, V42, P2154, DOI 10.1002/anie.200250800; Angelatos AS, 2008, LANGMUIR, V24, P4224, DOI 10.1021/la703647y; Yonemitsu M, 1997, CHEM MATER, V9, P2679, DOI 10.1021/cm970334w; Yamamoto Y, 2014, CHEM SCI, V5, P639, DOI 10.1039/c3sc51959g; Diaz I, 2003, CHEM MATER, V15, P1073, DOI 10.1021/cm0203565; Kuroda K, 2014, CHEM MATER, V26, P211, DOI 10.1021/cm4023387; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Yu KQ, 2004, ORGANOMETALLICS, V23, P4089, DOI 10.1021/om049765w; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; de Juan F, 2000, ADV MATER, V12, P430, DOI 10.1002/(SICI)1521-4095(200003)12:6<430::AID-ADMA430>3.0.CO;2-3; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; OGAWA M, 1994, J AM CHEM SOC, V116, P7941, DOI 10.1021/ja00096a079; Mizoshita N, 2011, CHEM SOC REV, V40, P789, DOI 10.1039/c0cs00010h; OGAWA M, 1995, CHEM REV, V95, P399, DOI 10.1021/cr00034a005; Yoshida A, 2003, RES CHEM INTERMEDIAT, V29, P721, DOI 10.1163/156856703322601735; Kelly TL, 2008, LANGMUIR, V24, P9809, DOI 10.1021/la8013688; Ryoo R, 2000, J PHYS CHEM B, V104, P11465, DOI 10.1021/jp002597a; Huang W, 2008, NANO LETT, V8, P2027, DOI 10.1021/nl801325m; Ogawa M, 1995, LANGMUIR, V11, P4639, DOI 10.1021/la00012a011; Soler-Illia GJAA, 2011, CHEM SOC REV, V40, P1107, DOI 10.1039/c0cs00208a; Yang PD, 2000, SCIENCE, V287, P465, DOI 10.1126/science.287.5452.465; Yui T, 2014, ACS APPL MATER INTER, V6, P1992, DOI 10.1021/am405065a; McKittrick MW, 2003, CHEM MATER, V15, P1132, DOI 10.1021/cm020952z; Acosta EJ, 2004, ADV MATER, V16, P985, DOI 10.1002/adma.200306323; Tagaya M, 2008, PHYS CHEM CHEM PHYS, V10, P6849, DOI 10.1039/b807593j; Ogawa M, 2007, CHEM LETT, V36, P462, DOI 10.1246/cl.2007.462; Chan SH, 2003, MACROMOLECULES, V36, P8910, DOI 10.1021/ma035174q; Clark JH, 2006, DALTON T, P4297, DOI 10.1039/b607831a; Fukuoka A, 2003, CHEM COMMUN, P284, DOI 10.1039/b210828c; Lu YF, 1997, NATURE, V389, P364; Habib S, 2007, J MOL CATAL A-CHEM, V271, P117, DOI 10.1016/j.molcata.2007.02.022; Hernandez R, 2001, J AM CHEM SOC, V123, P1248, DOI 10.1021/ja003634e; Hicks JC, 2008, INORG CHIM ACTA, V361, P3024, DOI 10.1016/j.ica.2008.01.002; Hong CY, 2009, J MATER CHEM, V19, P5155, DOI 10.1039/b820534e; Hwang KO, 1998, J MATER CHEM, V8, P2153, DOI 10.1039/a801932k; Hwang KO, 1995, MAT SCI ENG C-BIOMIM, V3, P137, DOI 10.1016/0928-4931(95)00117-4; Ikegame M., 2003, ANGEW CHEM, V115, P2204, DOI 10.1002/ange.200250800; Inagaki S., 2009, ANGEW CHEM, V121, P4102; Jang JS, 2001, CHEM COMMUN, P83, DOI 10.1039/b006197m; Kelly TL, 2010, LANGMUIR, V26, P421, DOI 10.1021/la9020178; Lunn JD, 2010, CHEM COMMUN, V46, P2926, DOI 10.1039/b927487a; Moller K, 1998, CHEM MATER, V10, P1841, DOI 10.1021/cm980020o; Nader MH, 2007, J PHYS CHEM C, V111, P13564, DOI 10.1021/jp073609w; Nakamura T., COMMUNICATION; Ogawa M, 2001, C T COL I S, V4, P209; Ogawa M., 1998, ANN REP C, V94, P209, DOI DOI 10.1039/PC094209; Ogawa M, 2000, CHEM COMMUN, P2441, DOI 10.1039/b007767o; Ogawa M, 2002, J PHOTOCH PHOTOBIO C, V3, P129, DOI 10.1016/S1389-5567(02)00023-0; Ogawa M, 2002, CHEM LETT, P632, DOI 10.1246/cl.2002.632; Okabe A., 2002, ANGEW CHEM, V114, P3564, DOI 10.1002/1521-3757(20020916)114:18<3564::AID-ANGE3564>3.0.CO;2-9; Roduner E, 2006, NANOSCOPIC MATERIALS: SIZE-DEPENDENT PHENOMENA, pV, DOI 10.1039/9781847557636-FP005; Sharifi M, 2011, LANGMUIR, V27, P5516, DOI 10.1021/la2000188; Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030; TANEV PT, 1994, NATURE, V368, P321, DOI 10.1038/368321a0; Thomas J. M., 2012, DESIGN AND APPLICATI; Tuel A, 1999, MICROPOR MESOPOR MAT, V27, P151, DOI 10.1016/S1387-1811(98)00250-9; WULFF G, 1987, REACT POLYM, V6, P299, DOI 10.1016/0167-6989(87)90101-2; Zhao DY, 1998, CHEM COMMUN, P2499, DOI 10.1039/a804649b	120	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	MAR	2015		7			SI		1126	1136		10.1002/ejic.201402651		11	Chemistry, Inorganic & Nuclear	Chemistry	CD0LO	WOS:000350764600006		
J	Narumi, T; Watanabe, T; Kadowaki, S; Takahashi, T; Yokoyama, M; Kinoshita, D; Honda, Y; Funayama, A; Nishiyama, S; Takahashi, H; Arimoto, T; Shishido, T; Miyamoto, T; Kubota, I				Narumi, Taro; Watanabe, Tetsu; Kadowaki, Shinpei; Takahashi, Tetsuya; Yokoyama, Miyuki; Kinoshita, Daisuke; Honda, Yuki; Funayama, Akira; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Kubota, Isao			Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure	EUROPEAN JOURNAL OF INTERNAL MEDICINE			English	Article						Heart failure; Cachexia; Sarcopenia; Prognosis	OBESITY PARADOX; BODY-MASS; SKELETAL-MUSCLE; CACHEXIA; METABOLISM; DIAGNOSIS; MORTALITY; SURVIVAL; DISEASE	Background and Aim: Chronic heart failure (CHF) is a major cause of morbidity and mortality, and cardiac cachexia and sarcopenia are serious complications associated with weight loss and increased catabolism. Fat-free mass index (FFMI) is an indicator of resting energy expenditure and is used for the clinical diagnosis of sarcopenia. In the present study, we investigated the impact of sarcopenia, as evaluated by FFMI, on cardiac prognosis in patients with CHF. Methods and results: We calculated FFMI in 267 CHF patients who were prospectively followed until they died due to cardiac event, or until they were re-hospitalized. Fat-free mass (FFM) was estimated by the formula [FFM (kg) - 7.38 + 0.02908 x urinary creatinine (mg/day)] and normalized by the square of the patient's height in meters to calculate FFMI. During the follow-up periods, there were 83 cardiac events, including 19 cardiac deaths. FFMI was lower in patients with cardiac events than in those without (17.0 kg/m(2) vs. 17.6 kg/m(2), P = 0.045). Multivariate Cox hazard analysis revealed that decreased FFMI was associated with an unfavorable outcome (adjusted hazard ratio 0.68, 95% confidence interval 0.47-0.98). The patients were divided into two groups according to their median FFMI. The Kaplan-Meier analysis revealed that significantly higher cardiac event rate was observed in the low-FFMI group (log-rank test, P = 0.017). Conclusions: Decreased FFMI was associated with an unfavorable prognosis in patients with CHF. (C) 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.	[Narumi, Taro; Watanabe, Tetsu; Kadowaki, Shinpei; Takahashi, Tetsuya; Yokoyama, Miyuki; Kinoshita, Daisuke; Honda, Yuki; Funayama, Akira; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Shishido, Tetsuro; Miyamoto, Takuya; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan	Watanabe, T (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	tewatana@med.id.yamagata-u.ac.jp			Ministry of Education Culture, Sport, Science, and Technology [25860580]	The authors would like to express their gratitude to the staff at the Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan, for their cooperation while we conducted this study. Research described in this manuscript was supported in part by a grant-in-aid for Scientific Research (No. 25860580) from the Ministry of Education Culture, Sport, Science, and Technology.	McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; FORBES GB, 1987, NUTR REV, V45, P225; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Habbu A, 2006, AM J CARDIOL, V98, P944, DOI 10.1016/j.amjcard.2006.04.039; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; DREXLER H, 1992, CIRCULATION, V85, P1751; MANCINI DM, 1992, CIRCULATION, V85, P1364; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1061/CIRCULATIONHA.105.555573; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; von Haehling S, 2007, CARDIOVASC RES, V73, P298, DOI 10.1016/j.cardiores.2006.08.018; Kumakura H, 2010, J VASC SURG, V52, P110, DOI 10.1016/j.jvs.2010.02.008; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Narumi T, 2013, J CARDIOL, V62, P307, DOI 10.1016/j.jjcc.2013.05.007; Berry C, 2000, EUR HEART J, V21, P521, DOI 10.1053/euhj.1999.1882; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Narumi T, 2014, EXCLI J, V13, P516; Pureza Vincent, 2013, Curr Heart Fail Rep, V10, P307, DOI 10.1007/s11897-013-0153-9; Shah R, 2014, J AM COLL CARDIOL, V63, P778, DOI 10.1016/j.jacc.2013.09.072; Wannamethee SG, 2014, INT J CARDIOL, V171, P49, DOI 10.1016/j.ijcard.2013.11.043	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0953-6205	1879-0828		EUR J INTERN MED	Eur. J. Intern. Med.	MAR	2015	26	2					118	122		10.1016/j.ejim.2015.01.008		5	Medicine, General & Internal	General & Internal Medicine	CD1HS	WOS:000350826300008		
J	Blake, EA; Kodama, M; Yunokawa, M; Ross, MS; Ueda, Y; Grubbs, BH; Matsuo, K				Blake, Erin A.; Kodama, Michiko; Yunokawa, Mayu; Ross, Malcolm S.; Ueda, Yutaka; Grubbs, Brendan H.; Matsuo, Koji			Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Review						Epithelial ovarian cancer; Ovarian cancer; Pregnancy; Review	OF-THE-LITERATURE; MUCINOUS CYSTADENOCARCINOMA; PSEUDOMUCINOUS CYSTADENOCARCINOMA; SEROUS CYSTADENOCARCINOMA; COMBINATION CHEMOTHERAPY; CARBOPLATIN CHEMOTHERAPY; PLATINUM CHEMOTHERAPY; PRIMARY CARCINOMA; UNITED-STATES; TUMORS	Although cancer diagnosed during pregnancy is rare, epithelial cell type ovarian cancers (EOCs) comprise approximately one quarter to one half of cases of ovarian malignancy diagnosed during pregnancy. The behavior of EOC during pregnancy and its, implications for maternal and fetal outcomes is not well understood. In order to better define these outcomes, a systematic literature search was conducted in PubMed/MEDLINE using entry keywords "pregnancy" and "ovarian cancer" for the period from 1955 to 2013. The literature search identified 105 cases eligible for analysis. Clinical characteristics, pregnancy outcome, tumor characteristics, clinical management, and survival outcomes were all evaluated. Serious adverse events were defined as complications related to EOC that resulted in severe morbidity or mortality for the mother and/or fetus. The mean age of cases was 31.6 years. The most common histology was serous (47.6%), followed by mucinous (27.6%) and endometrioid types (10.5%). The most common presenting symptom was abdominal or pelvic pain (26.7%) while incidentally detected tumors accounted for one third of cases. The majority of cases were stage I at diagnosis (63.8%) followed by stage III disease (24.8%), and the median tumor size was 12 cm. Live births occurred in 81.3% of cases, and of the remainder 72.2% were due to elective termination. Intrapartum surgery primarily took place in the second trimester (43%) with fetal conservation in 61.9% of operations. Over half of cases received chemotherapy (55.2%), approximately one third of which received it during the pregnancy (36.2%). Among the 21 cases treated with chemotherapy during pregnancy, there was no association with small for gestational age or fetal malformations. Serious adverse events occurred in 21.9% of cases, of which the most common was tumor rupture during pregnancy (10.5%). Three (2.9%) maternal death following surgery during pregnancy and five (6.4%) neonatal deaths were reported. Gestational age at tumor diagnosis (2-year overall survival rate, 1st trimester 94.6%, 2nd trimester 88.8%, and 3rd trimester 72.9%, p = 0.041) type of histology (serous 88.1%, mucinous 84.6%, endometrioid 89.5%, clear cell 100%, mixed type 75.0%, and undifferentiated 30.0%, p < 0.01), stage (stage I 96.9%, stage II 85.7%, stage III 56.3%, and stage IV 25.0%, p < 0.01), and serious adverse events (yes versus no, 68.1% versus 92.2%, p = 0.041) were significantly related to maternal overall survival in univariate analysis. In multivariate analysis, stage III/IV disease remained the independent prognostic factor associated with decreased maternal overall survival (stage III, hazard ratio 44.6, p <0.01; and stage IV, hazard ratio 399, p < 0.01). In conclusion, although the majority of EOC cases during pregnancy resulted in live birth, maternal and neonatal mortality needs to be considered in the counseling and management of these pregnancies. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Blake, Erin A.] Univ Colorado, Dept Obstet & Gynecol, Boulder, CO 80309 USA; [Kodama, Michiko; Ueda, Yutaka] Osaka Univ, Dept Obstet & Gynecol, Grad Sch Med, Osaka, Japan; [Yunokawa, Mayu] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan; [Ross, Malcolm S.] Univ Pittsburgh, Med Ctr, Dept Obstet & Gynecol, Pittsburgh, PA USA; [Grubbs, Brendan H.] Univ So Calif, Maternal Fetal Med, Los Angeles, CA 90033 USA; [Grubbs, Brendan H.] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Matsuo, Koji] Univ So Calif, Gynecol Oncol, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Matsuo, Koji] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Matsuo, K (reprint author), Univ So Calif, Div Gynecol Oncol, Dept Obstet & Gynecol, Los Angeles Cty Med Ctr, 2020 Zonal Ave,IRD520, Los Angeles, CA 90033 USA.	koji.matsuo@gmail.com					Akhter N, 2013, Mymensingh Med J, V22, P599; Amant F, 2012, CURR OPIN ONCOL, V24, P580, DOI 10.1097/CCO.0b013e328354e754; AMICO JC, 1957, AM J OBSTET GYNECOL, V74, P920; AngelMuller E, 1996, INT J GYNECOL OBSTET, V53, P55, DOI 10.1016/S0020-7292(96)80010-5; Schmeler KM, 2005, OBSTET GYNECOL, V105, P1098, DOI 10.1097/01.AOG.0000157465.996339.e5; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Irving JA, 2006, MODERN PATHOL, V19, P17, DOI 10.1038/modpathol.3800475; Quirk JT, 2005, GYNECOL ONCOL, V97, P519, DOI 10.1016/j.ygyno.2005.02.007; Blake EA, 2014, EUR J OBSTET GYN R B, V175, P1, DOI 10.1016/j.ejogrb.2013.12.025; Olson SH, 2001, OBSTET GYNECOL, V98, P212, DOI 10.1016/S0029-7844(01)01457-0; Amant F, 2014, INT J GYNECOL CANCER, V24, P394, DOI 10.1097/IGC.0000000000000062; HESS LW, 1988, AM J OBSTET GYNECOL, V158, P1029; Grimm D, 2014, EUR J CANCER, V50, P963, DOI 10.1016/j.ejca.2013.12.020; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Marcus CS, 2014, J CANCER, V5, P25, DOI 10.7150/jca.7810; [Anonymous], 2009, INT J GYNAECOL OBSTE, V105, P3; ZEMLICKIS D, 1992, ARCH INTERN MED, V152, P573, DOI 10.1001/archinte.152.3.573; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Gezginc K, 2011, INT J GYNECOL OBSTET, V115, P140, DOI 10.1016/j.ijgo.2011.05.025; [Anonymous], 2013, OBSTET GYNECOL, V121, P911; Smith LH, 2001, AM J OBSTET GYNECOL, V184, P1504, DOI 10.1067/mob.2001.114867; Morgan RJ, 2013, J NATL COMPR CANC NE, V11, P1199; Antonelli N M, 1996, Obstet Gynecol Surv, V51, P125, DOI 10.1097/00006254-199602000-00022; Antonelli N M, 1996, Obstet Gynecol Surv, V51, P135, DOI 10.1097/00006254-199602000-00023; Bayhan G, 1999, EUR J GYNAECOL ONCOL, V20, P231; BETSON JR, 1958, OBSTET GYNECOL, V12, P589; BOSTOCK J, 1974, P ROY SOC MED, V67, P13; CASELNOV.DA, 1968, OBSTET GYNECOL, V32, P826; CHUNG A, 1973, OBSTET GYNECOL, V41, P211; Colavita M., 1996, European Journal of Gynaecological Oncology, V17, P522; CREASMAN WT, 1971, OBSTET GYNECOL, V38, P111; Day A, 1958, CAN MED ASSOC J, V15, P941; DGANI R, 1988, ISRAEL J MED SCI, V24, P241; Dobashi M, 2012, ONCOL LETT, V3, P577, DOI 10.3892/ol.2011.545; Doi D, 2009, ARCH GYNECOL OBSTET, V280, P633, DOI 10.1007/s00404-009-0950-2; Eishi Ali, 2012, Pak J Biol Sci, V15, P341; Ferrandina G, 2005, GYNECOL ONCOL, V97, P693, DOI 10.1016/j.ygyno.2005.02.011; Foersterling DL, 1999, GYNECOL ONCOL, V72, P425, DOI 10.1006/gyno.1998.5265; Gambino A, 2011, EUR J GYNAECOL ONCOL, V32, P40; Geijteman Eric C T, 2014, Obstet Gynecol, V124, P454, DOI 10.1097/AOG.0000000000000389; Gilani MM, 2007, INT J GYNECOL CANCER, V17, P1140, DOI 10.1111/j.1525-1438.2007.00917.x; Gottheil Stephanie, 2013, J Obstet Gynaecol Can, V35, P1020; GRAFF G, 1971, OBSTET GYNECOL, V37, P218; GREENE WL, 1959, OBSTET GYNECOL, V14, P349; Griffin W T, 1966, Mo Med, V63, P286; Hasegawa T, 2011, J OBSTET GYNAECOL RE, V37, P650, DOI 10.1111/j.1447-0756.2010.01412.x; He SY, 2012, ARCH GYNECOL OBSTET, V286, P989, DOI 10.1007/s00404-012-2490-4; HENDERSON CE, 1993, GYNECOL ONCOL, V49, P92, DOI 10.1006/gyno.1993.1092; Ishioka SI, 2007, INT J CLIN ONCOL, V12, P375, DOI 10.1007/s10147-007-0655-0; KING LA, 1991, GYNECOL ONCOL, V41, P78, DOI 10.1016/0090-8258(91)90259-8; Kobayashi F, 1996, GYNECOL ONCOL, V62, P309, DOI 10.1006/gyno.1996.0233; Kodama M, EUR J OBSTET GYNEC C, V181 C, P145; Kwon YS, 2010, J KOREAN MED SCI, V25, P230, DOI 10.3346/jkms.2010.25.2.230; Li XA, 2011, AM J MED SCI, V341, P181, DOI 10.1097/MAJ.0b013e3181f99ca4; LUTZ MH, 1977, AM J OBSTET GYNECOL, V129, P536; Machado F, 2007, GYNECOL ONCOL, V105, P446, DOI 10.1016/j.ygyno.2007.01.002; Makrydimas G, 2003, EUR J GYNAECOL ONCOL, V24, P438; MALFETANO JH, 1990, OBSTET GYNECOL, V75, P545; Malhotra N, 2010, ARCH GYNECOL OBSTET, V281, P959, DOI 10.1007/s00404-009-1294-7; Mantovani G, 2007, EUR J OBSTET GYN R B, V131, P238, DOI 10.1016/j.ejogrb.2006.04.006; MATSUYAMA T, 1989, INT J GYNECOL OBSTET, V28, P61, DOI 10.1016/0020-7292(89)90545-6; Mendez LE, 2003, OBSTET GYNECOL, V102, P1200, DOI 10.1016/S0029-7844(03)00698-7; Moran BJ, 2007, LANCET ONCOL, V8, P536, DOI 10.1016/S1470-2045(07)70171-7; Morice P, 2012, LANCET, V379, P495, DOI 10.1016/S0140-6736(11)61814-X; Ohara N., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P123; Otton G, 2001, INT J GYNECOL CANCER, V11, P413, DOI 10.1046/j.1525-1438.2001.01047.x; PATSNER B, 1989, GYNECOL ONCOL, V33, P112, DOI 10.1016/0090-8258(89)90614-8; Picone O, 2004, GYNECOL ONCOL, V94, P600, DOI 10.1016/j.ygyno.2004.05.030; Rahman MS, 2002, ACTA OBSTET GYN SCAN, V81, P260; Rouzi AA, 2009, ARCH GYNECOL OBSTET, V280, P823, DOI 10.1007/s00404-009-0992-5; Sasa H, 1998, INT J GYNECOL OBSTET, V60, P283, DOI 10.1016/S0020-7292(97)00255-5; Sathanandan M, 1977, Ceylon Med J, V22, P178; SAWADA M, 1990, JPN J CLIN ONCOL, V20, P199; Serkies Krystyna, 2011, Arch Gynecol Obstet, V283 Suppl 1, P97, DOI 10.1007/s00404-011-1855-4; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith ER, 2013, OBSTET GYNECOL, V122, P481, DOI 10.1097/AOG.0b013e31828a845a; SOMMERS GM, 1985, GYNECOL ONCOL, V21, P364, DOI 10.1016/0090-8258(85)90276-8; Sood AK, 2001, GYNECOL ONCOL, V83, P599, DOI 10.1006/gyno.2001.6439; Tabata T, 2008, INT J GYNECOL CANCER, V18, P181, DOI 10.1111/j.1525-1438.2007.00974.X; TAWA K, 1964, AM J OBSTET GYNECOL, V90, P511; Tinkanen H, 2001, ACTA OBSTET GYN SCAN, V80, P476, DOI 10.1034/j.1600-0412.2001.080005476.x; Ueda M, 1996, INT J GYNECOL OBSTET, V55, P59, DOI 10.1016/0020-7292(96)02718-X; VANDESSEL T, 1988, BRIT J OBSTET GYNAEC, V95, P527; WADE ME, 1963, AM J OBSTET GYNECOL, V85, P919; White K C, 1972, Trans Pac Coast Obstet Gynecol Soc, V40, P104; WILLIAMS SF, 1985, CLIN PERINATOL, V12, P609; Zagouri F, 2013, OBSTET GYNECOL, V121, P337, DOI [http://10.1097/AOG.0b013e31827c5822, 10.1097/AOG.0b013e31827c5822]; Zhao XY, 2006, INT J GYNECOL CANCER, V16, P8, DOI 10.1111/j.1525-1438.2006.00422.x; Zivanovic A, 2011, VOJNOSANIT PREGL, V68, P181, DOI 10.2298/VSP1102181Z	92	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	MAR	2015	186						97	105		10.1016/j.ejogrb.2015.01.010		9	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CD1KZ	WOS:000350835100018		
J	Fukihara, J; Kondoh, Y; Taniguchi, H; Kimura, T; Kataoka, K; Matsuda, T; Yokoyama, T; Ono, K; Kashima, Y; Fukuoka, J				Fukihara, Jun; Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kimura, Tomoki; Kataoka, Kensuke; Matsuda, Toshiaki; Yokoyama, Toshiki; Ono, Kenzo; Kashima, Yukio; Fukuoka, Junya			Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease	EUROPEAN RESPIRATORY JOURNAL			English	Letter							PANCREATITIS		[Fukihara, Jun; Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kimura, Tomoki; Kataoka, Kensuke; Matsuda, Toshiaki; Yokoyama, Toshiki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi 4898642, Japan; [Ono, Kenzo] Tosei Gen Hosp, Dept Pathol, Seto, Aichi 4898642, Japan; [Kashima, Yukio; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 852, Japan	Kondoh, Y (reprint author), Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan.	lung@tosei.or.jp					Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; SHERRICK AD, 1994, CHEST, V106, P484, DOI 10.1378/chest.106.2.484; Ryu JH, 2012, EUR RESPIR J, V39, P180, DOI 10.1183/09031936.00025211; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Matsui S, 2013, RESPIROLOGY, V18, P480, DOI 10.1111/resp.12016; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Zen Y, 2009, AM J SURG PATHOL, V33, P1886, DOI 10.1097/PAS.0b013e3181bd535b; Hasegawa Hirotsugu, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P317; Ishida M, 2014, INTERNAL MED, V53, P493, DOI 10.2169/internalmedicine.53.0154; Ito M, 2009, EUR RESPIR J, V33, P680, DOI 10.1183/09031936.00051408; Matsui Shoko, 2009, Nihon Kokyuki Gakkai Zasshi, V47, P139; Pifferi M, 2013, CHEST, V144, P669, DOI 10.1378/chest.12-3088; Watanabe N, 2014, RESPIRATION, V87, P469, DOI 10.1159/000358098	15	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	MAR	2015	45	3					842	845		10.1183/09031936.00130314		5	Respiratory System	Respiratory System	CC9OX	WOS:000350701200034		
J	Hieber, M; Murata, M				Hieber, Matthias; Murata, Miho			THE L-P-APPROACH TO THE FLUID-RIGID BODY INTERACTION PROBLEM FOR COMPRESSIBLE FLUIDS	EVOLUTION EQUATIONS AND CONTROL THEORY			English	Article						Fluid rigid body interaction; moving domain; compressible fluid; strong L-P-solution; Lagragian formulation	VISCOUS-FLUID; WEAK SOLUTIONS; MOTION; BODIES; WELLPOSEDNESS; EXISTENCE; EQUATIONS; FORCES; FLOW	Consider the system of equations describing the motion of a rigid body immersed in a viscous, compressible fluid within the barotropic regime. It is shown that this system admits a unique, local strong solution within the L-P-setting.	[Hieber, Matthias] Tech Univ Darmstadt, Dept Math, D-64289 Darmstadt, Germany; [Hieber, Matthias] Univ Pittsburgh, Pittsburgh, PA 15261 USA; [Murata, Miho] Waseda Univ, Grad Sch Sci & Engn, Dept Pure & Appl Math, Shinjuku Ku, Tokyo 1698555, Japan	Hieber, M (reprint author), Tech Univ Darmstadt, Dept Math, Schlossgartenstr 7, D-64289 Darmstadt, Germany.	hieber@mathematik.tu-darmstadt.de; m-murata@ruri.waseda.jp			Japanese-German Graduate Externship JGGE; DFG International Research Training Group [IRTG 1529]	This work was supported by the Japanese-German Graduate Externship JGGE and by the DFG International Research Training Group IRTG 1529. The second author is a JSPS Research Fellow.	Cumsille P, 2006, MATH METHOD APPL SCI, V29, P595, DOI 10.1002/mma.702; Desjardins B, 2000, COMMUN PART DIFF EQ, V25, P1399; Feireisl E, 2003, ARCH RATION MECH AN, V167, P281, DOI 10.1007/s00205-002-0242-5; Denk R, 2007, MATH Z, V257, P193, DOI 10.1007/s00209-007-0120-9; Feireisl E, 2008, NONLINEARITY, V21, P1349, DOI 10.1088/0951-7715/21/6/012; Cumsille P, 2008, CZECH MATH J, V58, P961; Bahouri H, 2011, FOURIER ANAL NONLINE; Bemelmanns J., 2013, MEM AM MATH SOC, V226; Boulakia M, 2009, ANN I H POINCARE-AN, V26, P777, DOI 10.1016/j.anihpc.2008.02.004; Conca C, 2000, COMMUN PART DIFF EQ, V25, P1019; Denk R, 2003, MEM AM MATH SOC, V166, P788; Desjardins B, 1999, ARCH RATION MECH AN, V146, P59, DOI 10.1007/s002050050136; Ducomet B, 2013, DISCRETE CONT DYN-S, V6, P1193, DOI 10.3934/dcdss.2013.6.1193; Galdi G. P., 2002, HDB MATH FLUID DYNAM, V1, P653; GALDI GP, 2002, INT MAT SER, P121; Geissert M, 2013, T AM MATH SOC, V365, P1393; Gotze K., 2012, OPERATOR THEORY ADV, V221, P373; Gunzburger M., 2000, J MATH FLUID MECH, V2, P219, DOI 10.1007/PL00000954; Hoffmann K-H, 1999, ADV MATH SCI APPL, V9, P633; Inoue A., 1977, Journal of the Faculty of Science, University of Tokyo, Section 1A (Mathematics), V24; Murata M, 2014, NONLINEAR ANAL-THEOR, V106, P86, DOI 10.1016/j.na.2014.04.012; Novotny A., 2004, INTRO MATH THEORY CO; San Martin J., 2008, ARCH RATION MECH AN, V188, P429, DOI DOI 10.1007/S00205-007-0092-2; Serre D., 1987, JAPAN J APPL MATH, V4, P99; Shibata Y., PREPRINT; SOBOLEVSKII PE, 1975, DOKL AKAD NAUK SSSR+, V225, P1271; STROHMER G., 1989, ANALYSIS, V9, P1; Takahashi T., 2003, ADV DIFFERENTIAL EQU, V8, P1499; Takahashi T., 2004, J MATH FLUID MECH, V6, P53, DOI 10.1007/s00021-003-0083-4; Weinberger H. F., 1973, P S PURE MATH, V23, P421	30	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	2163-2480			EVOL EQU CONTROL THE	Evol. Equ. Control Theory	MAR	2015	4	1					69	87		10.3934/eect.201.5.4.69		19	Mathematics, Applied; Mathematics	Mathematics	CD0IY	WOS:000350756100005		
J	Suga, K; Saito, A; Akagawa, K				Suga, Kei; Saito, Ayako; Akagawa, Kimio			ER stress response in NG108-15 cells involves upregulation of syntaxin 5 expression and reduced amyloid beta peptide secretion	EXPERIMENTAL CELL RESEARCH			English	Article						Amyloid precursor protein (APP); Amyloid-beta (A beta); Endoplasmic reticulum stress; SNARE proteins; Stress response; Syntaxin 5	ENDOPLASMIC-RETICULUM STRESS; GOLGI INTERMEDIATE COMPARTMENT; UNFOLDED-PROTEIN RESPONSE; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PRE-GOLGI; NEURODEGENERATIVE DISEASES; PRESENILIN HOLOPROTEINS; NEURONAL CELLS; TRANSPORT	Endoplasmic reticulum (ER) stress plays a role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). We previously showed that manipulation of the ER Golgi-soluble N-ethylmaleimide-sensitive factor-attachment protein receptors (ER Golgi SNARE) syntaxin 5 (Syx5) causes changes in Golgi morphology and the processing of AD-related proteins. To understand the pathophysiologic significance of these phenomena, we examined whether the expression of Syx5 is altered by ER stress. De novo synthesis of ER Golgi SNARE Syx5 and Bet1 was induced by various ER stressors. Elevated expression of Syx5 and Ber1 was associated with increased levels of these proteins in vesicular components, including ER Golgi-intermediate-compartment/vesicular tubular clusters. In addition, ER stress diminished amyloid beta (A beta) peptide secretion. Knockdown of Syx5 expression enhanced the secretion of A beta peptides under condition without ER stress. Moreover, diminished beta (A beta) peptide secretion resulting from ER stress was significantly reversed by Syx5 knockdown. These findings suggest that Syx5 plays important roles in beta-amyloid precursor protein processing and in the ER stress response that precedes apoptotic cell death and may be involved in the crosstalk between these two pathways. (C) 2015 Elsevier Inc. All rights reserved.	[Suga, Kei; Saito, Ayako; Akagawa, Kimio] Kyorin Univ, Sch Med, Dept Cell Physiol, Mitaka, Tokyo 1818611, Japan	Suga, K (reprint author), Kyorin Univ, Sch Med, Dept Cell Physiol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	ksuga@ks.kyorin-u.ac.jp			Japan Society for the Promotion of Science [19300133, 24300142, 19500327, 25430072]; Promotion and Mutual Aid Cooperation Program for private schools in Japan; Kyorin University School of Medicine	This study was supported in part by grants-in-aid from the Japan Society for the Promotion of Science to KA. (Nos. 19300133 and 24300142) and to KS. (Nos. 19500327 and 25430072), by a grant from the Promotion and Mutual Aid Cooperation Program for private schools in Japan (to K.A.), and by a grant from the Kyorin University School of Medicine (to KS.).	Suga K, 2009, J BIOCHEM, V146, P905, DOI 10.1093/jb/mvp138; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053; Rechards M, 2003, TRAFFIC, V4, P553, DOI 10.1034/j.1600-0854.2003.t01-1-00114.x; Suga K, 2005, J NEUROCHEM, V94, P425, DOI 10.1111/j.1471-4159.2005.03210.x; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Suga K, 2004, BIOCHEM J, V381, P619, DOI 10.1042/BJ20040618; DASCHER C, 1994, J BIOL CHEM, V269, P29363; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Stieber A, 1996, AM J PATHOL, V148, P415; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Takahashi K, 2009, J NEUROCHEM, V109, P1324, DOI 10.1111/j.1471-4159.2009.06067.x; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Suga K, 2003, J BIOCHEM, V133, P325, DOI 10.1093/jb/mvg044; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Domingues SCTS, 2007, ANN NY ACAD SCI, V1096, P184, DOI 10.1196/annals.1397.085; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hong W., 2013, TRENDS CELL BIOL, V24, P35; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; INOUE A, 1992, BIOCHEM BIOPH RES CO, V187, P1144, DOI 10.1016/0006-291X(92)91316-I; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Nyfeler B, 2003, BIOCHEM BIOPH RES CO, V304, P599, DOI 10.1016/S0006-291X(03)00634-X; ORCI L, 1991, CELL, V64, P1183; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; Selivanova A, 2006, BIOCHEM BIOPH RES CO, V350, P220, DOI 10.1016/j.bbrc.2006.09.043; Sun NK, 2012, BIOCHEM J, V444, P303, DOI 10.1042/BJ20112223; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; Volchuk A, 2004, MOL BIOL CELL, V15, P1506, DOI 10.1091/mbc.E03-08-0625; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Zhang T, 1997, J CELL BIOL, V139, P1157, DOI 10.1083/jcb.139.5.1157; Zhong WB, 2011, EXP CELL RES, V317, P2353, DOI 10.1016/j.yexcr.2011.05.028	57	3	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAR 1	2015	332	1					11	23		10.1016/j.yexcr.2015.01.001		13	Oncology; Cell Biology	Oncology; Cell Biology	CD0QN	WOS:000350779100002		
J	Mansour, MA; Asano, E; Hyodo, T; Akter, KA; Takahashi, M; Hamaguchi, M; Senga, T				Mansour, Mohammed A.; Asano, Eri; Hyodo, Toshinori; Akter, K. A.; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition	EXPERIMENTAL CELL RESEARCH			English	Article						Colorectal cancer; SATB2; Invadopodia; Palladin	ACTIN-ASSOCIATED PROTEIN; COLORECTAL-CANCER; SATB2; EXPRESSION; INVASION; DIFFERENTIATION; IDENTIFICATION; METASTASIS; 2Q32-Q33; GENE	Invadopodia are specialized actin-based microdomains of the plasma membrane that combine adhesive properties with matrix degrading activities. Proper functioning of the bone, immune, and vascular systems depend on these organelles, and their relevance in cancer cells is linked to tumor metastasis. The elucidation of the mechanisms driving invadopodia formation is a prerequisite to understanding their role and ultimately to controlling their functions. Special AT-rich sequence-binding protein 2 (SATB2) was reported to suppress tumor cell migration and metastasis. However, the mechanism of action of SATB2 is unknown. Here, we show that SATB2 inhibits invadopodia formation in HCT116 cells and that the molecular scaffold palladin is inhibited by exogenous expression of SATB2. To confirm this association, we elucidated the function of palladin in HCT116 using a knock down strategy. Palladin knock down reduced cell migration and invasion and inhibited invadopodia formation. This phenotype was confirmed by a rescue experiment. We then demonstrated that palladin expression in SATB2-expressing cells restored invasion and invadopodia formation. Our results showed that SATB2 action is mediated by palladin inhibition and the SATB2/palladin pathway is associated with invadopodia formation in colorectal cancer cells. (C) 2014 Elsevier Inc. All rights reserved.	[Mansour, Mohammed A.; Asano, Eri; Hyodo, Toshinori; Akter, K. A.; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Mansour, Mohammed A.] Tanta Univ, Fac Sci, Dept Chem, Biochem Sect, Tanta, Egypt; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan	Mansour, MA (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	biomansour@hotmail.com; tsenga@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]	We would like to thank the members of the Division of Cancer Biology for their helpful discussions and Dr. Yoshihiko Yamakita (Nagoya University, Japan) for gelatin degradation assay. This research was funded by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23107010 to T. Senga).	Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Chin YR, 2011, CELL ADHES MIGR, V5, P211, DOI 10.4161/cam.5.3.15790; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Eberhard J, 2012, BRIT J CANCER, V106, P931, DOI 10.1038/bjc.2012.34; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Gong YM, 2014, MOL CELL BIOCHEM, V387, P227, DOI 10.1007/s11010-013-1888-z; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Asano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029338; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Jin L, 2011, J MUSCLE RES CELL M, V32, P7, DOI 10.1007/s10974-011-9246-9; Liu TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040704; Maeda M, 2009, FEBS J, V276, P2775, DOI 10.1111/j.1742-4658.2009.07001.x; Rosenfeld J, 2009, J CHROMATOGR SCI, V47, P1; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; von Nandelstadh P, 2014, MOL BIOL CELL, V25, P2556, DOI 10.1091/mbc.E13-11-0667	27	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAR 1	2015	332	1					78	88		10.1016/j.yexcr.2014.12.003		11	Oncology; Cell Biology	Oncology; Cell Biology	CD0QN	WOS:000350779100008		
J	Geis, C; Ritter, C; Ruschil, C; Weishaupt, A; Grunewald, B; Stoll, G; Holmoy, T; Misu, T; Fujihara, K; Hemmer, B; Stadelmann, C; Bennett, JL; Sommer, C; Toyka, KV				Geis, Christian; Ritter, Christian; Ruschil, Christoph; Weishaupt, Andreas; Gruenewald, Benedikt; Stoll, Guido; Holmoy, Trygve; Misu, Tatsuro; Fujihara, Kazuo; Hemmer, Bernhard; Stadelmann, Christine; Bennett, Jeffrey L.; Sommer, Claudia; Toyka, Klaus V.			The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model	EXPERIMENTAL NEUROLOGY			English	Article						Neuromyelitis optica; Aquaporin 4; EAAT2; NMDA receptor; Astrocyte; Intrathecal passive transfer	OPTICA-IMMUNOGLOBULIN-G; NMDA RECEPTOR ENCEPHALITIS; EATON MYASTHENIC SYNDROME; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; NMO-IGG; INTRAVENOUS IMMUNOGLOBULINS; MECHANISMS; LESIONS; ANTIBODY	Neuromyelitis optica (NMO) is causally linked to autoantibodies (ABs) against aquaporin 4 (AQP4). Here, we focused on the pathogenic effects exclusively mediated by human ABs to AQP4 in vivo. We performed cell-free intrathecal (i.th.) passive transfer experiments in Lewis rats using purified patient NMO immunoglobulin G (IgG) and various recombinant human anti-AQP4 IgG-ABs via implanted i.th. catheters. Repetitive application of patient NMO IgG fractions and of recombinant human anti-AQP4 ABs induced signs of spinal cord disease. Magnetic resonance imaging (MRI) revealed longitudinal spinal cord lesions at the site of application of anti-AQP4 IgG. Somatosensory evoked potential amplitudes were reduced in symptomatic animals corroborating the observed functional impairment. Spinal cord histology showed specific IgG deposition in the grey and white matter in the affected areas. We did not find inflammatory cell infiltration nor activation of complement in spinal cord areas of immunoglobulin deposition. Moreover, destructive lesions showing axon or myelin damage and loss of astrocytes and oligodendrocytes were all absent. Immunoreactivity to AQP4 and to the excitatory amino acid transporter 2 (EAAT2) was markedly reduced whereas immunoreactivity to the astrocytic marker glial fibrillary acid protein (GFAP) was preserved. The expression of the NMDA-receptor NR1 subunit was down-regulated in areas of IgG deposition possibly induced by sustained glutamatergic overexcitation. Disease signs and histopathology were reversible within weeks after stopping injections. We conclude that in vivo application of ABs directed at AQP 4 can induce a reversible spinal cord disease in recipient rats by inducing distinct histopathological abnormalities. These findings may be the experimental correlate of "penumbra-like" lesions recently reported in NMO patients adjacent to effector-mediated tissue damage. (C) 2014 Elsevier Inc. All rights reserved.	[Geis, Christian; Ritter, Christian; Ruschil, Christoph; Weishaupt, Andreas; Gruenewald, Benedikt; Stoll, Guido; Sommer, Claudia; Toyka, Klaus V.] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Geis, Christian; Ritter, Christian; Ruschil, Christoph; Weishaupt, Andreas; Gruenewald, Benedikt; Stoll, Guido; Sommer, Claudia; Toyka, Klaus V.] Univ Wurzburg, Clin Res Grp Multiple Sclerosis & Neuroimmunol, D-97080 Wurzburg, Germany; [Geis, Christian; Gruenewald, Benedikt] Jena Univ Hosp, Hans Berger Dept Neurol, D-07747 Jena, Germany; [Geis, Christian; Gruenewald, Benedikt] Jena Univ Hosp, Integrated Res & Treatment Ctr Sepsis Control & C, D-07747 Jena, Germany; [Holmoy, Trygve] Univ Oslo, Dept Neurol, Akershus Univ Hosp, N-0318 Oslo, Norway; [Holmoy, Trygve] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Misu, Tatsuro; Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut & Neurol, Sendai, Miyagi 9808577, Japan; [Hemmer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, D-81675 Munich, Germany; [Hemmer, Bernhard] Munich Cluster Syst Neurol SyNergy, D-81675 Munich, Germany; [Stadelmann, Christine] Univ Med Ctr Gottingen, Inst Neuropathol, D-37099 Gottingen, Germany; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	Geis, C (reprint author), Jena Univ Hosp, Hans Berger Dept Neurol, Erlanger Allee 101, D-07747 Jena, Germany.	christian.geis@med.uni-jena.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002	Interdisciplinary Clinical Research Center (IZKF) of the University of Wilrzburg School of Medicine [N-151]; Merck-Serono, Germany; Integrated Research and Treatment Center for Sepsis Control and Care (CSCC); intramural University Research Funds of the University of Wurzburg School of Medicine; Guthy-Jackson Research Foundation; National Institutes of Health [EY022936]; University of Wilrzburg Medical School	This work was supported by a grant from the Interdisciplinary Clinical Research Center (IZKF) of the University of Wilrzburg School of Medicine (to CG N-151), a neuroimmunology research grant by Merck-Serono, Germany (K.V.T. and C.G.), by the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC, Jena to C.G.) and by intramural University Research Funds of the University of Wilrzburg School of Medicine. J.L.B. was supported by grants from the Guthy-Jackson Research Foundation and the National Institutes of Health (EY022936). K.V.T. is the recipient of a senior professorship awarded by the University of Wurzburg Medical School. The authors declare no competing financial interests. We thank L Biko, H. Bruenner, B. Dekant, S. Hellmig, V. Michels, C. Staudenmaier, and C. Varallyay for expert technical assistance. This project was inspired by Professor John Prineas, Sydney. We are grateful to Professor Hans Lassmann, Vienna, for helpful discussions and critical comments.	Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Blanc F, 2008, ARCH NEUROL-CHICAGO, V65, P84, DOI 10.1001/archneurol.2007.16; Bendszus M, 2008, BRAIN, V131, P2341, DOI 10.1093/brain/awn156; Ratelade J, 2012, ACTA NEUROPATHOL, V123, P861, DOI 10.1007/s00401-012-0986-4; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Gleichman AJ, 2012, J NEUROSCI, V32, P11082, DOI 10.1523/JNEUROSCI.0064-12.2012; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Geis C, 2010, BRAIN, V133, P3166, DOI 10.1093/brain/awq253; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Tradtrantip L, 2012, FASEB J, V26, P2197, DOI 10.1096/fj.11-201608; Geis C, 2012, J NEURAL TRANSM, V119, P981, DOI 10.1007/s00702-012-0773-3; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; FUKUNAGA H, 1983, P NATL ACAD SCI-BIOL, V80, P7636, DOI 10.1073/pnas.80.24.7636; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Wrzos C, 2014, ACTA NEUROPATHOL, V127, P523, DOI 10.1007/s00401-013-1220-8; Asavapanumas N, 2014, ACTA NEUROPATHOL, V127, P539, DOI 10.1007/s00401-013-1204-8; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Ratelade J, 2011, J BIOL CHEM, V286, P45156, DOI 10.1074/jbc.M111.297275; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Tradtrantip L, 2013, ANN NEUROL, V73, P77, DOI 10.1002/ana.23741; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Buchwald B, 2005, MUSCLE NERVE, V31, P487, DOI 10.1002/mus.20269; Buchwald B, 2002, ANN NEUROL, V51, P673, DOI 10.1002/ana.10205; Crane JM, 2011, J NEUROIMMUNOL, V236, P93, DOI 10.1016/j.jneuroim.2011.05.001; Geis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016775; Hinson S. R., 2012, P NATL ACAD SCI US, V109; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Rossi A, 2012, GLIA, V60, P2027, DOI 10.1002/glia.22417; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638	44	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2015	265						8	21		10.1016/j.expneurol.2014.12.015		14	Neurosciences	Neurosciences & Neurology	CD3ZH	WOS:000351021900002		
J	Hashimoto, K				Hashimoto, Kenji			Targeting the sigma-1 receptor chaperone in the treatment of perinatal brain injury	EXPERIMENTAL NEUROLOGY			English	Editorial Material						Perinatal brain injury; Glutamate excitotoxicity; NMDA receptor; Sigma-1 receptor; Inflammation; Endoplasmic reticulum; Mitochondria	4-PHENYL-1-(4-PHENYLBUTYL) PIPERIDINE PPBP; AGONISTS PROVIDE NEUROPROTECTION; TRANSIENT FOCAL ISCHEMIA; NITRIC-OXIDE PRODUCTION; H-3 IFENPRODIL BINDING; IN-VIVO; COGNITIVE DEFICITS; THERAPEUTIC DRUGS; NMDA RECEPTOR; RAT-BRAIN	Glutamate-induced excitotoxicity via the N-methyl-D-aspartate (NMDA) receptor is an important factor in the pathogenesis of perinatal brain injury. The sigma-1 receptor on the endoplasmic reticulum (ER) has been known to affect the function of the NMDA receptor. 4-Phenyl-1-(4-phenylbutyl)piperidine (PPBP) has been investigated as a sigma-1 receptor agonist for several decades. An article using PPBP in a model of preterm brain injury was published in Experimental Neurology. The authors reported that PPBP protected against glutamateinduced excitotoxicity in primary hippocampal neurons. Furthermore, the systemic administration of PPBP significantly reduced microglial activation and lesion size in cortical gray and white matter after the excitotoxic insult in neonatal mice. This study suggests that sigma-1 receptor agonists could be potential preventive and therapeutic drugs for perinatal brain injury, although a pharmacological experiment using a sigma-I receptor antagonist was not performed. This commentary aims to highlights the key findings of this article in a broader context, emphasizing the future potential therapeutic applications in patients with perinatal brain injury. (C) 2015 Elsevier Inc. All rights reserved.	Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Niitsu T, 2012, CURR PHARM DESIGN, V18, P875; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Li SX, 2014, NEUROBIOL DIS, V62, P124, DOI 10.1016/j.nbd.2013.09.004; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Goyagi T, 2001, STROKE, V32, P1613; Hashimoto K, 2013, PSYCHOPHARMACOLOGY, V227, P375, DOI 10.1007/s00213-013-3092-y; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Zhang YL, 2012, BRAIN RES, V1431, P13, DOI 10.1016/j.brainres.2011.10.053; Balasuriya D, 2013, J NEUROSCI, V33, P18219, DOI 10.1523/JNEUROSCI.3360-13.2013; Pabba M, 2014, J NEUROSCI, V34, P11325, DOI 10.1523/JNEUROSCI.0458-14.2014; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Bhardwaj A, 1998, STROKE, V29, P2404; GLENNON RA, 1991, J MED CHEM, V34, P3360, DOI 10.1021/jm00116a003; Goyagi T, 2003, ANESTH ANALG, V96, P532, DOI 10.1213/01.ANE.0000042668.28032.9F; HASHIMOTO K, 1995, EUR J PHARMACOL, V273, P307, DOI 10.1016/0014-2999(94)00763-W; HASHIMOTO K, 1994, EUR J PHARM-MOLEC PH, V266, P67, DOI 10.1016/0922-4106(94)90211-9; Hashimoto K., 2010, CLIN PSYCHOPHARMACOL, V8; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; HASHIMOTO K, 1993, EUR J PHARMACOL, V236, P159, DOI 10.1016/0014-2999(93)90241-9; Hashimoto K., 2015, J PHARM SCI IN PRESS; HASHIMOTO K, 1995, SYNAPSE, V20, P85, DOI 10.1002/syn.890200112; Hindmarch I, 2010, HUM PSYCHOPHARM CLIN, V25, P193, DOI 10.1002/hup.1106; Ishima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037989; Miller SP, 2013, LANCET NEUROL, V12, P16, DOI 10.1016/S1474-4422(12)70292-2; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; TAKAHASHI H, 1995, STROKE, V26, P1676; Takahashi H, 1996, STROKE, V27, P2120; Tan F, 2010, NEUROPHARMACOLOGY, V59, P416, DOI 10.1016/j.neuropharm.2010.05.014; Tsai SYA, 2014, EXPERT OPIN THER TAR, V18, P1461, DOI 10.1517/14728222.2014.972939; Wegleiter K, 2014, EXP NEUROL, V261, P501, DOI 10.1016/j.expneurol.2014.07.022; Yang S, 2009, ANESTH ANALG, V108, P964, DOI 10.1213/ane.0b013e318192442c; Yang SF, 2007, ANESTH ANALG, V104, P1179, DOI 10.1213/01.ane.0000260267.71185.73; Yang ZJ, 2010, EXP NEUROL, V221, P166, DOI 10.1016/j.expneurol.2009.10.019	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2015	265						118	121		10.1016/j.expneurol.2014.12.019		4	Neurosciences	Neurosciences & Neurology	CD3ZH	WOS:000351021900012		
J	Ota, M; Leopold, F; Noda, R; Maeno, K				Ota, Masanori; Leopold, Friedrich; Noda, Ryusuke; Maeno, Kazuo			Improvement in spatial resolution of background-oriented schlieren technique by introducing a telecentric optical system and its application to supersonic flow	EXPERIMENTS IN FLUIDS			English	Article							DENSITY-MEASUREMENTS; FIELD	A telecentric optical system is applied to the background-oriented schlieren (BOS) technique to improve accuracy, overcoming the drawbacks of conventional diverging light observation. This paper describes the optical arrangement and formula for telecentric BOS measurement and presents measurement results obtained by the colored-grid background-oriented schlieren technique to confirm the theoretical prediction. The application of the new approach for a large-scale supersonic wind tunnel test is reported.	[Ota, Masanori; Noda, Ryusuke] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan; [Leopold, Friedrich] French German Res Inst St Louis ISL, F-68301 St Louis, France; [Maeno, Kazuo] Kisarazu Natl Coll Technol, Chiba 2920041, Japan	Ota, M (reprint author), Chiba Univ, Grad Sch Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	ota@faculty.chiba-u.jp			JSPS KAKENHI [23760764, 25420848]	This work was supported by JSPS KAKENHI Grant Numbers 23760764 and 25420848. The authors thank Prof. T. Abe and the technical stuff at JAXA/ISAS for their support in the experiments.	Dalziel SB, 2000, EXP FLUIDS, V28, P322, DOI 10.1007/s003480050391; Goldhahn E, 2007, EXP FLUIDS, V43, P241, DOI 10.1007/s00348-007-0331-1; Richard H, 2001, MEAS SCI TECHNOL, V12, P1576, DOI 10.1088/0957-0233/12/9/325; Onu K, 2003, EXP FLUIDS, V35, P24, DOI 10.1007/S00348-003-0609-X; Venkatakrishnan L, 2004, EXP FLUIDS, V37, P237, DOI 10.1007/s00348-004-0807-1; Meier GEA, 2002, EXP FLUIDS, V33, P181, DOI 10.1007/s00348-002-0450-7; Hargather MJ, 2012, OPT LASER ENG, V50, P8, DOI 10.1016/j.optlaseng.2011.05.012; Ardian BG, 2013, J VIS, V16, P201; Glazyrin F. N., 2012, Optoelectronics, Instrumentation and Data Processing, V48, DOI 10.3103/S8756699012030132; Kindler K, 2007, EXP FLUIDS, V43, P233, DOI 10.1007/s00348-007-0328-9; Klinge F, 2003, P 4 PAC S FLOW VIS I, P1; Konrath R, 2002, EXP FLUIDS, V33, P703, DOI 10.1007/s00348-002-0531-7; Leopold F, 2006, P 12 INT S FLOW VIS; Leopold F, 2012, P 15 INT S FLOW VIS; Meier GEA, 1999, Deutsche Patentschrift, Patent No. [DE 19942856 B4, 19942856]; Ota M, 2012, INT J AEROSP INNOV, V4, P1; Ota M, 2012, P 15 INT S FLOW VIS; Ota M, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/104011; Sims JL, 1964, SP3004 NASA; Venkatakrishnan L, 2009, EXP FLUIDS, V47, P463, DOI 10.1007/s00348-009-0676-8	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	MAR	2015	56	3							48	10.1007/s00348-015-1919-5		10	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CC9KF	WOS:000350688000001		
J	Zhang, ZL; Shimizu, Y; Kawarabayasi, Y				Zhang, Zilian; Shimizu, Yasuhiro; Kawarabayasi, Yutaka			Characterization of the amino acid residues mediating the unique amino-sugar-1-phosphate acetyltransferase activity of the archaeal ST0452 protein	EXTREMOPHILES			English	Article						Archaea; Thermophiles; Acetyltransferase; Mutation; Reaction center; Thermophilic enzyme	ESCHERICHIA-COLI; URIDYLTRANSFERASE; IDENTIFICATION; SITES	The ST0452 protein from the thermophilic archaean Sulfolobus tokodaii has been identified as an enzyme with multiple sugar-1-phosphate nucleotidylyltransferase and amino-sugar-1-phosphate acetyltransferase (amino-sugar-1-P AcTase) activities. Analysis of the protein showed that in addition to glucosamine-1-phosphate (GlcN-1-P) AcTase activity, it possesses unique galactosamine-1-phosphate (GalN-1-P) AcTase activity not detected in any other proteins. Comparison of the crystal structures of the ST0452 protein and GlmU from Escherichia coli (EcGlmU), which possesses only GlcN-1-P AcTase activity, showed that the overall sequence identity between these two proteins is less than 25 %, but the amino acid residues predicted to comprise the catalytic center of EcGlmU are conserved in the ST0452 protein. To understand the molecular mechanism by which the ST0452 amino-sugar-1-P AcTase activity recognizes two independent substrates, several ST0452 substitution and truncation mutant proteins were constructed and analyzed. We found that His308 is essential for both GalN-1-P and GlcN-1-P AcTase activities, whereas Tyr311 and Asn331 are important only for the GalN-1-P AcTase activity. In addition, deletion of the C-terminal 5 or 11 residues showed that the 11-residue C-terminal region exerts a modest stimulatory effect on GalN-1-P AcTase activity but dramatically suppresses GlcN-1-P AcTase activity. This region also appears to make an important contribution to the thermostability of the entire ST0452 protein. Systematic deletions from the C-terminus also demonstrated that the C-terminal region with the beta-helix structure has an important role mediating the trimerization of the ST0452 protein. This is the first report of an analysis of a thermostable archaeal enzyme exhibiting multiple amino-sugar-1-P AcTase activities.	[Zhang, Zilian] Xiamen Univ, Inst Marine Microbes & Ecospheres, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China; [Shimizu, Yasuhiro; Kawarabayasi, Yutaka] Kyushu Univ, Fac Agr, Lab Funct Genom Extremophiles, Higashi Ku, Fukuoka, Fukuoka 8128581, Japan; [Kawarabayasi, Yutaka] Natl Inst Adv Ind Sci & Technol, Inst Hlth Res, Amagasaki, Hyogo 6610974, Japan	Kawarabayasi, Y (reprint author), Kyushu Univ, Fac Agr, Lab Funct Genom Extremophiles, Higashi Ku, Hakozaki 6-10-1, Fukuoka, Fukuoka 8128581, Japan.	kawarabayasi.yutaka@nifty.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Institute for Fermentation, Osaka (IFO)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. It was also supported in part by the Institute for Fermentation, Osaka (IFO).	LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RAETZ CRH, 1993, J BACTERIOL, V175, P5745; Bricnkkotter A, 2000, MOL MICROBIOL, V37, P125; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; Jagtap PKA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390765; Konopka JB, 2012, SCIENTIFICA, V2012, DOI DOI 10.6064/2012/489208; Kotnik M, 2007, CURR PHARM DESIGN, V13, P2283; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; Ramakrishnan V, 1997, J BACTERIOL, V179, P1505; Zhang ZL, 2007, J BIOCHEM, V141, P553, DOI 10.1093/jb/mvm058; Zhang ZL, 2010, J BACTERIOL, V192, P3287, DOI 10.1128/JB.01683-09	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	MAR	2015	19	2					417	427		10.1007/s00792-014-0727-9		11	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC4FH	WOS:000350306200018		
J	Miyashita, Y; Ohmae, E; Nakasone, K; Katayanagi, K				Miyashita, Yurina; Ohmae, Eiji; Nakasone, Kaoru; Katayanagi, Katsuo			Effects of salt on the structure, stability, and function of a halophilic dihydrofolate reductase from a hyperhalophilic archaeon, Haloarcula japonica strain TR-1	EXTREMOPHILES			English	Article						Dihydrofolate reductase; Enzymatic function; Haloarcula japonica; Halophilic protein; Preferential interaction; Salt effect	ESCHERICHIA-COLI; HALOFERAX-VOLCANII; CELL-DIVISION; PROTEIN; ARCHAEBACTERIUM; ENZYMES; EXPRESSION; MECHANISM; ACID; DENATURATION	The effects of salt on the structure, stability, and enzymatic function of a novel dihydrofolate reductase (HjDHFR P1) from a hyperhalophilic archaeon, Haloarcula japonica strain TR-1 living in a Japanese saltern, were studied using ultraviolet absorption, circular dichroism (CD), and fluorescence spectroscopy. HjDHFR P1 had a partial structure at pH 8.0 in the absence of NaCl, and the addition of NaCl (0-500 mM concentration) induced significant structural formation to HjDHFR P1. The addition of NADPH, which is a coenzyme for its catalytic reaction, and lowering the pH from 8 to 6 also induced the same CD change, indicating the formation of the NADPH-binding site in HjDHFR P1. The NaCl dependence of thermal and urea-induced unfolding measurements suggested that protein stability increased depending on NaCl concentration regardless of structural formation, and HjDHFR P1 achieved the same stability as Escherichia coli DHFR at 750 mM NaCl. Halophilic characteristics were also observed for enzymatic function, although its structure had already formed under the conditions that enzymatic activity was measured at due to the presence of NADPH. These results suggest that the halophilic mechanism on structural stability and function was caused by factors other than structural formation, which are suggested to be the contributions of preferential interactions between the protein and salt ions and the specific binding of salt ions.	[Miyashita, Yurina; Ohmae, Eiji; Katayanagi, Katsuo] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Nakasone, Kaoru] Kinki Univ, Sch Engn, Dept Biotechnol & Chem, Higashihiroshima 7392116, Japan	Ohmae, E (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ohmae@hiroshima-u.ac.jp			JSPS KAKENHI Grant [24570186]; Sasagawa Scientific Research Grant from the Japan Science Society [26-315]	We thank Tomoko Amimoto and the Natural Science Center for Basic Research and Development of Hiroshima University for the use and technical assistance of ESI-MS apparatus. This work was supported financially by a JSPS KAKENHI Grant (No. 24570186 to E. O.) and a Sasagawa Scientific Research Grant from the Japan Science Society (No. 26-315 to Y. M.).	Allers Thorsten, 2010, Bioeng Bugs, V1, P288, DOI 10.4161/bbug.1.4.11794; Ohmae E, 2005, J BIOCHEM, V137, P643, DOI 10.1093/jb/mvi079; ARAKAWA T, 1984, BIOCHEMISTRY-US, V23, P5912, DOI 10.1021/bi00320a004; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Wright DB, 2002, J MOL BIOL, V323, P327, DOI 10.1016/S0022-2836(02)00916-6; Gulevsky AK, 2013, CRYOLETTERS, V34, P62; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Ohmae E, 2013, BBA-PROTEINS PROTEOM, V1834, P2782, DOI 10.1016/j.bbapap.2013.09.024; SCHLICK T, 1994, BIOPHYS J, V67, P2146; TAKASHINA T, 1990, SYST APPL MICROBIOL, V13, P177; Onodera M, 2013, BIOSCI BIOTECH BIOCH, V77, P281, DOI 10.1271/bbb.120693; WOODY RW, 1977, MACROMOL REV, V12, P181; Ohmae E, 2012, BBA-PROTEINS PROTEOM, V1824, P511, DOI 10.1016/j.bbapap.2012.01.001; Dias CL, 2010, CRYOBIOLOGY, V60, P91, DOI 10.1016/j.cryobiol.2009.07.005; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Ausman T, 1989, J BIOL CHEM, V264, P18878; BACCANARI D, 1975, BIOCHEMISTRY-US, V14, P5267, DOI 10.1021/bi00695a006; Binbuga B, 2007, PROTEIN SCI, V16, P1783, DOI 10.1110/ps.072950407; BLECHER O, 1993, EUR J BIOCHEM, V216, P199, DOI 10.1111/j.1432-1033.1993.tb18133.x; Danson MJ, 1997, COMP BIOCHEM PHYS A, V117, P307, DOI 10.1016/S0300-9629(96)00268-X; Gloss LM, 2008, J MOL BIOL, V376, P1451, DOI 10.1016/j.jmb.2007.12.056; HAMAMOTO T, 1988, FEMS MICROBIOL LETT, V56, P221, DOI 10.1111/j.1574-6968.1988.tb03181.x; HOLZWART.G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; HORIKOSHI K, 1993, EXPERIENTIA, V49, P497, DOI 10.1007/BF01955151; Huennekens FM, 1996, PROTEIN SCI, V5, P1201; Ishibashi M, 2013, EXTREMOPHILES, V17, P585, DOI 10.1007/s00792-013-0541-9; [Рам Каран Karan Ram.], 2011, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V76, P840; Murakami C, 2011, EXTREMOPHILES, V15, P165, DOI 10.1007/s00792-010-0345-0; Murakami C, 2010, J BIOCHEM, V147, P591, DOI 10.1093/jb/mvp206; Nakamura S, 2011, EXTREMOPHILES HDB, P363, DOI 10.1007/978-4-431-53898-1_17; NISHIYAMA Y, 1992, FEMS MICROBIOL LETT, V99, P43; Ohmae E, 2013, EXTREMOPHILES, V17, P701, DOI 10.1007/s00792-013-0556-2; Ohmae E, 1996, J BIOCHEM-TOKYO, V120, P946; Oren A, 2002, EXTREMOPHILES, V6, P217, DOI 10.1007/s007920100241; Ortega G, 2011, SCI REP, V10, P1; Ortenberg R, 2000, MOL MICROBIOL, V35, P1493, DOI 10.1046/j.1365-2958.2000.01815.x; Ozawa K, 2005, EXTREMOPHILES, V9, P281, DOI 10.1007/s00792-005-0443-6; Pace C N, 1986, Methods Enzymol, V131, P266; Pieper U, 1998, STRUCTURE, V6, P75, DOI 10.1016/S0969-2126(98)00009-4; Sinha R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00165; STONE SR, 1982, BIOCHEMISTRY-US, V21, P3757, DOI 10.1021/bi00259a006; TAKASHINA T, 1994, BIODIVERS CONSERV, V3, P632, DOI 10.1007/BF00114206; Wakai S, 2013, J BIOL CHEM, V288, P29247, DOI 10.1074/jbc.M113.502963	45	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	MAR	2015	19	2					479	493		10.1007/s00792-015-0732-7		15	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC4FH	WOS:000350306200023		
J	Masaki, Y; Hirajima, T; Sasaki, K; Okibe, N				Masaki, Yusei; Hirajima, Tsuyoshi; Sasaki, Keiko; Okibe, Naoko			Bioreduction and immobilization of hexavalent chromium by the extremely acidophilic Fe(III)-reducing bacterium Acidocella aromatica strain PFBC	EXTREMOPHILES			English	Article						Acidophile; Hexavalent chromium; Bioreduction; Bioremediation; Acidocella aromatica	SHEWANELLA-ONEIDENSIS MR-1; VITRO CR(VI) REDUCTION; FERRIC IRON REDUCTION; CHROMATE REDUCTION; THIOBACILLUS-FERROOXIDANS; HETEROTROPHIC BACTERIA; ACIDIPHILIUM-CRYPTUM; PSEUDOMONAS-PUTIDA; REDUCING BACTERIUM; CONTAMINATED SOIL	The extremely acidophilic, Fe(III)-reducing heterotrophic bacterium Acidocella aromatica strain PFBC was tested for its potential utility in bioreduction of highly toxic heavy metal, hexavalent chromium, Cr(VI). During its aerobic growth on fructose at pH 2.5, 20 A mu M Cr(VI) was readily reduced to Cr(III), achieving the final Cr(VI) concentration of 0.4 A mu M (0.02 mg/L), meeting the WHO drinking water guideline of 0.05 mg/L. Despite of the highly inhibitory effect of Cr(VI) on cell growth at higher concentrations, especially at low pH, Cr(VI) reduction activity was readily observed in growth-decoupled cell suspensions under micro-aerobic and anaerobic conditions. Strain PFBC was not capable of anaerobic growth via dissimilatory reduction of Cr(VI), such as reported for Fe(III). In the presence of both Cr(VI) and Fe(III) under micro-aerobic condition, microbial Fe(III) reduction occurred only upon complete disappearance of Cr(VI) by its reduction to Cr(III). Following Cr(VI) reduction, the resultant Cr(III), supposedly present in the form of cationic Cr (III) (OH2) (6) (3+) , was partially immobilized on the negatively charged cell surface through biosorption. When Cr(III) was externally provided, rather than microbially produced, it was poorly immobilized on the cell surface. Cr(VI) reducing ability was reported for the first time in Acidocella sp. in this study, and its potential role in biogeochemical cycling of Cr, as well as its possible utility in Cr(VI) bioremediation, in highly acidic environments/solutions, were discussed.	[Masaki, Yusei; Hirajima, Tsuyoshi; Sasaki, Keiko; Okibe, Naoko] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Nishi Ku, Fukuoka 8190395, Japan	Okibe, N (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	okibe@mine.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23810024]; Kurita Water and Environment Foundation (KWEF) [23001]; Kyushu University P and P program; Kyushu University Advanced Graduate Program in Global Strategy for Green Asia	This work was partly supported by grants from the Japan Society for the Promotion of Science (JSPS: No. 23810024), Kurita Water and Environment Foundation (KWEF: No. 23001), and the Kyushu University P and P program. The XAFS experiments were performed at Kyushu University Beamline (SAGA-LS/BL06: No. 2013IIK018). Y. Masaki is grateful for financial assistance provided by the Kyushu University Advanced Graduate Program in Global Strategy for Green Asia. Ac. aromatica PFBC was kindly provided by Prof. D. B. Johnson (University of Bangor, UK).	Allegretti P, 2006, J BIOTECHNOL, V122, P55, DOI 10.1016/j.jbiotec.2065.08.031; Camargo FAO, 2003, APPL MICROBIOL BIOT, V62, P569, DOI 10.1007/s00253-003-1291-x; Fendorf SE, 1996, ENVIRON SCI TECHNOL, V30, P1614, DOI 10.1021/es950618m; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P726; Zakaria ZA, 2007, J HAZARD MATER, V146, P30, DOI 10.1016/j.jhazmat.2006.11.052; Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b; Mangaiyarkarasi MSM, 2011, SAUDI J BIOL SCI, V18, P157, DOI 10.1016/j.sjbs.2010.12.003; He MY, 2011, J HAZARD MATER, V185, P682, DOI 10.1016/j.jhazmat.2010.09.072; He ZG, 2009, J HAZARD MATER, V163, P869, DOI 10.1016/j.jhazmat.2008.07.041; Belchik SM, 2011, APPL ENVIRON MICROB, V77, P4035, DOI 10.1128/AEM.02463-10; JOHNSON DB, 1991, APPL ENVIRON MICROB, V57, P207; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; WANG PC, 1989, APPL ENVIRON MICROB, V55, P1665; Xu L, 2012, APPL BIOCHEM BIOTECH, V166, P933, DOI 10.1007/s12010-011-9481-y; Puzon GJ, 2005, ENVIRON SCI TECHNOL, V39, P2811, DOI 10.1021/es048967g; Guha H, 2003, CHEMOSPHERE, V52, P175, DOI 10.1016/S0045-6535(03)00104-8; RAI D, 1989, SCI TOTAL ENVIRON, V86, P15, DOI 10.1016/0048-9697(89)90189-7; Francis CA, 2000, APPL ENVIRON MICROB, V66, P543, DOI 10.1128/AEM.66.2.543-548.2000; Fredrickson JK, 2000, APPL ENVIRON MICROB, V66, P2006, DOI 10.1128/AEM.66.5.2006-2011.2000; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; McLean JS, 2000, ENVIRON MICROBIOL, V2, P611, DOI 10.1046/j.1462-2920.2000.00143.x; Jones RM, 2013, EXTREMOPHILES, V17, P841, DOI 10.1007/s00792-013-0566-0; Chardin B, 2002, APPL MICROBIOL BIOT, V60, P352, DOI 10.1007/s00253-002-1091-8; SHEN H, 1993, APPL ENVIRON MICROB, V59, P3771; Dhal B, 2013, J HAZARD MATER, V250, P272, DOI 10.1016/j.jhazmat.2013.01.048; Zhu WJ, 2008, MICROBIOL RES, V163, P616, DOI 10.1016/j.micres.2006.09.008; Barrera-Diaz CE, 2012, J HAZARD MATER, V223, P1, DOI 10.1016/j.jhazmat.2012.04.054; Bencheikh-Latmani R, 2007, ENVIRON SCI TECHNOL, V41, P214, DOI 10.1021/es0622655; Chai LY, 2009, J ENVIRON SCI HEAL A, V44, P615, DOI 10.1080/10934520902784690; Chovanec P, 2012, FRONT MICROBIOL, V3, P1; Cornelis R, 2005, HDB ELEMENTAL SPECIA; Coupland K, 2008, FEMS MICROBIOL LETT, V279, P30, DOI 10.1111/j.1574-6968.2007.00998.x; Cummings DE, 2007, ENVIRON SCI TECHNOL, V41, P146, DOI 10.1021/es061333k; Dey Satarupa, 2010, Journal of Water Resource and Protection, V2, DOI 10.4236/jwarp.2010.24044; Elangovan R, 2010, APPL BIOCHEM BIOTECH, V160, P81, DOI 10.1007/s12010-008-8515-6; Garcia S, 2006, POLYHEDRON, V25, P1483, DOI 10.1016/j.poly.2005.10.008; Hawley EL, 2005, CHROMIUM 6 HDB, P275; Ibrahim ASS, 2012, EXTREMOPHILES, V16, P659, DOI 10.1007/s00792-012-0464-x; ISHIBASHI Y, 1990, APPL ENVIRON MICROB, V56, P2268; Jacobs JA, 2005, CHROMIUM 6 HDB, P275; Joutey NT, 2014, ENVIRON SCI POLLUT R, V21, P3060, DOI 10.1007/s11356-013-2249-x; Leita L, 2011, GEODERMA, V164, P122, DOI 10.1016/j.geoderma.2011.05.013; Magnuson TS, 2010, BIOMETALS, V23, P1129, DOI 10.1007/s10534-010-9360-y; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Noroozifar M, 2003, ANAL SCI, V19, P705, DOI 10.2116/analsci.19.705; Opperman DJ, 2007, J APPL MICROBIOL, V103, P1907, DOI 10.1111/j.1365-2672.2007.03429.x; Patra RC, 2010, SOIL BIOL BIOCHEM, V42, P1857, DOI 10.1016/j.soilbio.2010.07.005; QuiIntana A, 2001, BIOCHEM ENG J, V9, P11; Sarangi A, 2008, BIORESOURCE TECHNOL, V99, P4130, DOI 10.1016/j.biortech.2007.08.059; Sisti F, 1996, BIOTECHNOL LETT, V18, P1477, DOI 10.1007/BF00129358; Soni SK, 2013, ENVIRON SCI POLLUT R, V20, P1661, DOI 10.1007/s11356-012-1178-4; Sparks D.L., 2002, ENV SOIL CHEM; TANDON RK, 1984, TALANTA, V31, P227, DOI 10.1016/0039-9140(84)80059-4; Viamajala S, 2002, BIOTECHNOL PROGR, V18, P290, DOI 10.1021/bp0202968	54	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	MAR	2015	19	2					495	503		10.1007/s00792-015-0733-6		9	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC4FH	WOS:000350306200024		
J	Zhang, BB; Wang, DG; Guo, FF; Xuan, C				Zhang, Bei-bei; Wang, Dao-gang; Guo, Fen-fen; Xuan, Chao			Mitochondrial membrane potential and reactive oxygen species in cancer stem cells	FAMILIAL CANCER			English	Review						Mitochondrial membrane potential; Reactive oxygen species; Cancer stem cells	MYELOGENOUS LEUKEMIA STEM; SIDE POPULATION CELLS; HUMAN TUMOR-CELLS; PROGENITOR CELLS; SMALL-MOLECULE; ACHILLES-HEEL; APOPTOSIS; METABOLISM; RESISTANCE; GROWTH	Cancer stem cells (CSCs) are believed as the initiators of the occurrence, development and recurrence of malignant tumors. Targeting this unique cell population would provide a less toxic approach than regular chemotherapeutic agents that kill bulk rapid proliferating tumor cells and also normal cells which divide rapidly. To date, major research effort has been aimed at identifying and eradicating CSC population. The metabolism heterogeneity of mitochondria in CSCs shows a big promise for cancer research. Of them, mitochondrial membrane potential (Delta psi m), reflecting the functional status of the mitochondrion is proved to be highly related to cancer malignancy. Reactive oxygen species, mainly produced from mitochondria, are also increased in many types of cancer cells. However, their statuses in CSCs remain poorly understood. Here we shall review the mitochondrial membrane potential and reactive oxygen species of CSCs and propose the novel potential targets for cancer therapy.	[Zhang, Bei-bei] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan; [Wang, Dao-gang] Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China; [Guo, Fen-fen] Qingdao Women & Childrens Hosp, Dept Clin Lab, Qingdao, Peoples R China; [Xuan, Chao] Qingdao Univ, Dept Clin Lab, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China	Wang, DG (reprint author), Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China.	gxcmuwdg@126.com					Kong Q, 1998, MED HYPOTHESES, V51, P405, DOI 10.1016/S0306-9877(98)90036-6; Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Liu L, 2011, MED ONCOL, V28, P835, DOI 10.1007/s12032-010-9529-9; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.jmito.2007.05.002; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Yu M, 2007, TOXICOL LETT, V170, P83, DOI 10.1016/j.toxlet.2007.02.013; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Heerdt BG, 2003, CANCER RES, V63, P6311; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Gerber JM, 2011, AM J HEMATOL, V86, P31, DOI 10.1002/ajh.21915; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Kai K, 2010, BREAST CANCER-TOKYO, V17, P80, DOI 10.1007/s12282-009-0176-y; SZATROWSKI TP, 1991, CANCER RES, V51, P794; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pans.0400067101; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999; Dayem Ahmed Abdal, 2010, Cancers (Basel), V2, P859, DOI 10.3390/cancers2020859; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Fleischman AG, 2012, BLOOD, V119, P3376, DOI 10.1182/blood-2012-02-406751; Hockenbery DM, 2002, CANCER CELL, V2, P1, DOI 10.1016/S1535-6108(02)00087-9; Kim YS, 2013, ANTICANCER RES, V33, P4469; Klein BY, 1996, J CELL BIOCHEM, V60, P139, DOI 10.1002/(SICI)1097-4644(19960101)60:1<139::AID-JCB16>3.0.CO;2-K; Modica-Napolitano JS, 2003, CANCER LETT, V198, P59, DOI 10.1016/S0304-3835(03)00274-X; MODICANAPOLITANO JS, 1987, CANCER RES, V47, P4361; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007; Yahata T, 2008, STEM CELLS, V26, P3228, DOI 10.1634/stemcells.2008-0552	54	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-9600	1573-7292		FAM CANCER	Fam. Cancer	MAR	2015	14	1					19	23		10.1007/s10689-014-9757-9		5	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CD6AQ	WOS:000351171000003		
J	Park, H; Han, SS; Sako, Y; Pack, CG				Park, Hweon; Han, Sung-Sik; Sako, Yasushi; Pack, Chan-Gi			Dynamic and unique nucleolar microenvironment revealed by fluorescence correlation spectroscopy	FASEB JOURNAL			English	Article						nucleolar organization; diffusion coefficient; crowding effect; ATP depletion; actinomycin D	LIVING CELL-NUCLEI; CHROMATIN; MOBILITY; DIFFUSION; PROTEINS; LAMIN; ORGANIZATION; RNA; SUBCOMPARTMENTS; ACCESSIBILITY	Organization and functions of the nucleolus is maintained by mobilities and interactions of nucleolar factors. Because the nucleolus is a densely packed structure, molecular crowding effects determined by the molecular concentrations and mobilities in the nucleolus should also be important for regulating nucleolar organization and functions. However, such molecular property of nucleolar organization is not fully understood. To understand the biophysical property of nucleolar organization, the diffusional behaviors of inert green fluorescent protein (GFP) oligomers with or without nuclear localization signals (NLSs) were analyzed under various conditions by fluorescence correlation spectroscopy. Our result demonstrates that the mobility of GFPs inside the nucleolus and the nucleoplasm can be represented by single free diffusion under normal conditions, even though the mobility in the nucleolus is considerably slower than that in the chromatin region. Moreover, the free diffusion of GFPs is found to be significantly size-and NLS-dependent only in the nucleolus. Interestingly, themobility in the nucleolus is highly sensitive to ATP depletion, as well as actinomycin D (ActD) treatment. In contrast, the ultra-structure of the nucleolus was not significantly changed by ATP depletion but was changed by ActD treatment. These results suggest that the nucleolus behaves similarly to an open aqueous-phase medium with an increased molecular crowding effect that depends on both energy and transcription.	[Park, Hweon; Han, Sung-Sik] Korea Univ, Dept Life Sci, Seoul 136701, South Korea; [Sako, Yasushi] RIKEN, Cellular Informat Lab, Wako, Saitama, Japan; [Pack, Chan-Gi] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Han, SS (reprint author), Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 136701, South Korea.	shan@korea.ac.kr; changipack@amc.seoul.kr			Fund for Seeds of Collaborative Research from RIKEN, Japan [29100]	The authors thank Hiromi Sato (RIKEN, Wako) for technical assistance provided with the gene sequencing and cloning. C.G.P. was partly supported by the FY2012 Fund for Seeds of Collaborative Research from RIKEN (29100), Japan.	Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Phair RD, 2000, NATURE, V404, P604; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Jacob MD, 2013, MOL BIOL CELL, V24, P2943, DOI 10.1091/mbc.E13-04-0223; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Gorisch S, 2005, HISTOCHEM CELL BIOL, V123, P217, DOI 10.1007/s00418-005-0752-y; Chen DY, 2005, J CELL BIOL, V168, P41; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Pack C, 2006, BIOPHYS J, V91, P3921, DOI [10.1529/biophysj.105.079467, 10.1529/biophysj.106.079467]; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083410; Cardoso MC, 2012, CURR OPIN CELL BIOL, V24, P79, DOI 10.1016/j.ceb.2011.12.009; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Delloye-Bourgeois C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002456; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Finch RA, 1996, BIOCHEM BIOPH RES CO, V222, P553, DOI 10.1006/bbrc.1996.0782; Hayashi K, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13136-6; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Kiesslich T, 2003, J BIOCHEM BIOPH METH, V57, P247, DOI 10.1016/S0165-022X(03)00102-7; LEBEL S, 1987, J CELL BIOL, V105, P1099, DOI 10.1083/jcb.105.3.1099; Lee KE, 2009, J ELECTRON MICROSC, V58, P305, DOI 10.1093/jmicro/dfp019; Lide D.R., 2000, CRC HDB CHEM PHYS; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Wachsmuth M, 2008, BBA-MOL CELL RES, V1783, P2061, DOI 10.1016/j.bbamcr.2008.07.022	49	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					837	848		10.1096/fj.14-254110		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	WOS:000350633000011		
J	Watanabe, S; Sato, K; Hasegawa, N; Kurihara, T; Matsutani, K; Sanada, K; Hamaoka, T; Fujita, S; Iemitsu, M				Watanabe, Shinya; Sato, Koji; Hasegawa, Natsuki; Kurihara, Toshiyuki; Matsutani, Kenji; Sanada, Kiyoshi; Hamaoka, Takafumi; Fujita, Satoshi; Iemitsu, Motoyuki			Serum C1q as a novel biomarker of sarcopenia in older adults	FASEB JOURNAL			English	Article						aging; fibrosis; skeletal muscle; resistance training	SKELETAL-MUSCLE; SATELLITE CELLS; RESISTANCE EXERCISE; AGE; INFLAMMATION; EXPRESSION; RESPONSES; STRENGTH; PATHWAY; FRAILTY	Aging-induced elevation in C1q secretion activates the Wnt signaling pathway in muscles, leading to the development of muscle fibrosis. However, the association between serum C1q level and muscle mass and strength remains unclear in humans. The aim of the study was to elucidate whether serum C1q level is associated with aging-and resistance training-induced changes in muscle mass and strength. First, in a cross-sectional study, we investigated the association between serum C1q level and muscle mass and strength in 131 healthy subjects, aged 20-81 yr. Second, in an intervention study, we examined the association between the effects of serum C1q level and muscle mass and strength on 12wk resistance training in 11 healthy older adults (60-81 yr). In the cross-sectional study, serum C1q level increased with aging and was negatively correlated with muscle mass and strength. Furthermore, 12 wk resistance training in older adults reduced the age-associated elevation in serum C1q levels. The training effect of serum C1q level significantly correlated with the change in the cross-sectional area of the thigh (r = -0.703; P < 0.01). Serum C1q level may reflect loss of muscle mass; therefore, C1q may be a novel biomarker of sarcopenia.	[Watanabe, Shinya; Sato, Koji; Hasegawa, Natsuki; Kurihara, Toshiyuki; Matsutani, Kenji; Sanada, Kiyoshi; Hamaoka, Takafumi; Fujita, Satoshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Iemitsu, M (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	iemitsu@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [26282199, 25560378, 22680050]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI #26282199 and #25560378 to M.I. and #22680050 to S.F.). The authors declare no conflicts of interest.	Haddad F, 2002, J APPL PHYSIOL, V93, P394, DOI 10.1152/japplphysiol.01153.2001; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Fujita S, 2009, DIABETOLOGIA, V52, P1889, DOI 10.1007/s00125-009-1430-8; Legoedec J, 1997, MOL IMMUNOL, V34, P735, DOI 10.1016/S0161-5890(97)00093-X; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; TENNER AJ, 1986, BIOCHEM J, V233, P451; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Gasier HG, 2011, ACTA PHYSIOL, V201, P381, DOI 10.1111/j.1748-1716.2010.02183.x; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; PETRY F, 1991, J IMMUNOL, V147, P3988; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Walport MJ, 2001, NEW ENGL J MED, V344, P1058	30	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1003	1010		10.1096/fj.14-262154		8	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	WOS:000350633000024		
J	Murai, Y; Shiratori, T; Kumagai, I; Ruhs, PA; Fischer, P				Murai, Yuichi; Shiratori, Takahisa; Kumagai, Ichiro; Ruehs, Patrick A.; Fischer, Peter			Effective viscosity measurement of interfacial bubble and particle layers at high volume fraction	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Bubbles; Particles; Multiphase flow; Rheology; Effective viscosity	DRAG REDUCTION; RHEOLOGICAL PROPERTIES; DILUTE SUSPENSIONS; FLUIDIZED-BEDS; AQUEOUS FOAMS; FLOW; DEFORMATION; STRESS; SIMULATION; EMULSION	An experimental method for measuring the effective viscosity of two dimensional dispersion systems is proposed. The method is based on interfacial rheology, which was originally developed to investigate surface active adsorption layers such as protein film formed at liquid-liquid interfaces. Bubbles or rigid particles at around 50% of volume fraction in liquid are positioned in the gap between a rotating disk and a stationary cylindrical container. With this configuration, shear-rate dependent effective viscosities of bubble and particle layers were investigated. Steep shear-thinning property is observed for spherical bubble systems in the shear rate regime from 10(-1) to 10(2) s(-1). This is explained by topological transition from regular to random arrangement of the bubbles at the interface. For rigid particle systems, the viscosity starts from high value due to solid contact friction, then decreases sharply due to fluidization process until inter-particle collision lead to an increase of the viscosity. (C) 2014 Elsevier Ltd. All rights reserved.	[Murai, Yuichi; Shiratori, Takahisa] Hokkaido Univ, Fac Engn, Lab Flow Control, Sapporo, Hokkaido 0608628, Japan; [Kumagai, Ichiro] Meisei Univ, Sch Sci & Engn, Tokyo 1918506, Japan; [Ruehs, Patrick A.; Fischer, Peter] ETH, Inst Food Nutr & Hlth, CH-8092 Zurich, Switzerland	Murai, Y (reprint author), Hokkaido Univ, Fac Engn, Div Energy & Environm Syst, Lab Flow Control, N13W8, Sapporo, Hokkaido 0608628, Japan.	murai@eng.hokudai.ac.jp	Murai, Yuichi/G-4716-2012		Japan Society for Promotion of Science (JSPS KAKENHI) [24246033]	The authors are grateful for financial support from the Japan Society for Promotion of Science (JSPS KAKENHI, No. 24246033). We also acknowledge E.J. Windhab, Y. Takeda, Y. Tasaka, Y. Oishi, Y. Aikawa, and T. Kimura for their technical supports and fruitful advises.	Erni P, 2003, REV SCI INSTRUM, V74, P4916, DOI 10.1063/1.1614433; LEGNER HH, 1984, PHYS FLUIDS, V27, P2788, DOI 10.1063/1.864592; Cromer M, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4805089; Erni P, 2011, SOFT MATTER, V7, P7586, DOI 10.1039/c1sm05263b; Olmos E, 2003, CHEM ENG SCI, V58, P2113, DOI 10.1016/S0009-2509(03)00013-7; Hohler R, 2005, J PHYS-CONDENS MAT, V17, pR1041, DOI 10.1088/0953-8984/17/41/R01; Llewellin EW, 2005, J VOLCANOL GEOTH RES, V143, P205, DOI 10.1016/j.jvolgeores.2004.09.018; Housiadas KD, 2004, PHYS FLUIDS, V16, P1581, DOI 10.1063/1.1689971; DARTON RC, 1974, T I CHEM ENG-LOND, V52, P301; Xu Q, 2003, COLLOID SURFACE A, V216, P175, DOI 10.1016/S0927-7757(02)00547-2; Kragel J, 2010, CURR OPIN COLLOID IN, V15, P246, DOI 10.1016/j.cocis.2010.02.001; Stickel JJ, 2005, ANNU REV FLUID MECH, V37, P129, DOI 10.1146/annurev.fluid.36.050802.122132; Sagis LMC, 2011, REV MOD PHYS, V83, P1367, DOI 10.1103/RevModPhys.83.1367; Tsuchiya K, 1997, CHEM ENG SCI, V52, P3053, DOI 10.1016/S0009-2509(97)00127-9; Fischer P, 2007, CURR OPIN COLLOID IN, V12, P196, DOI 10.1016/j.cocis.2007.07.014; Morris JF, 2009, RHEOL ACTA, V48, P909, DOI 10.1007/s00397-009-0352-1; BATCHELOR GK, 1972, J FLUID MECH, V56, P401, DOI 10.1017/S0022112072002435; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; Tisne P, 2003, INT J MULTIPHAS FLOW, V29, P841, DOI 10.1016/S0301-9322(03)00038-7; DOI M, 1991, J CHEM PHYS, V95, P1242, DOI 10.1063/1.461156; Fox RO, 2012, ANNU REV FLUID MECH, V44, P47, DOI 10.1146/annurev-fluid-120710-101118; Batchelor GK, 1967, VISCOSITY DILUTE SUS, P246; Breugem WP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2792323; Briceno MI, 2003, INT J MULTIPHAS FLOW, V29, P1817, DOI 10.1016/j.ijmultiphaseflow.2003.10.001; Cervantes-Martinez A, 2005, J COLLOID INTERF SCI, V292, P544, DOI 10.1016/j.jcis.2005.06.007; CHOI SJ, 1975, PHYS FLUIDS, V18, P420, DOI 10.1063/1.861167; Denkov ND, 2006, COLLOID SURFACE A, V282, P329, DOI 10.1016/j.colsurfa.2006.04.028; Einstein A, 1906, ANN PHYS-BERLIN, V19, P289; Gutam KJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4812800; HAN CD, 1980, J RHEOL, V24, P213, DOI 10.1122/1.549562; Kang SY, 1997, PHYS FLUIDS, V9, P1540, DOI 10.1063/1.869481; Kuwagi K, 1999, INT J MULTIPHAS FLOW, V25, P175, DOI 10.1016/S0301-9322(98)00039-1; L'vov VS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.174502; Lespiat R, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3335816; MOONEY M, 1951, J COLL SCI IMP U TOK, V6, P162, DOI 10.1016/0095-8522(51)90036-0; Morris JF, 2002, PHYS FLUIDS, V14; Muller-Fischer N, 2008, EXP FLUIDS, V45, P917, DOI 10.1007/s00348-008-0509-1; Murai Y, 2008, FLUID DYN RES, V40, P565, DOI 10.1016/j.fluiddyn.2007.12.009; Murai Y, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1773-x; Pal R, 2003, EARTH PLANET SC LETT, V207, P165, DOI 10.1016/S0012-821X(02)01104-4; Rust AC, 2002, J NON-NEWTON FLUID, V104, P53, DOI 10.1016/S0377-0257(02)00013-7; Sato Y., 1975, International Journal of Multiphase Flow, V2, DOI 10.1016/0301-9322(75)90030-0; SCHOWALT.WR, 1968, J COLLOID INTERF SCI, V26, P152, DOI 10.1016/0021-9797(68)90307-X; Yea K, 2013, PHYS FLUIDS, V25	44	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	MAR	2015	41						121	128		10.1016/j.flowmeasinst.2014.10.006		8	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CD2XJ	WOS:000350942000016		
J	Shimada, T; Doihara, R; Terao, Y				Shimada, Takashi; Doihara, Ryouji; Terao, Yoshiya			Investigation into calibration performance of small volume prover for hydrocarbon flow	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Flowmeter; Calibration; Small volume prover; Uncertainty		Several kinds of commercial flowmeters, namely, Coriolis flowmeters, turbine meters, ultrasonic flowmeters, and positive displacement flowmeters, have been calibrated using the primary standard for hydrocarbon flow measurement in Japan (which is based on static and gravimetric methods with a flying start and finish) and a small volume prover (SVP) at the same calibration condition in order to investigate the performance of the SVP. The differences in calibration results for the mechanical flowmeters between the primary standard and the SW apparently depend on the flow rate, although the results show agreement within 0.04%. The computer-based flowmeters, which have a time delay in the output pulse signal, indicated larger differences due to the effect of the sudden flow rate change caused by the proving action of the SVP at larger flow damping times. (C) 2015 Elsevier Ltd. All rights reserved.	Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Shimada, T (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	t-shimada@aist.go.jp					Tombs M, 2006, FLOW MEAS INSTRUM, V17, P371, DOI 10.1016/j.flowmeasinst.2006.07.007; [Anonymous], 727831998 ISO; [Anonymous], 727841998 ISO; Clark C, 2006, FLOW MEAS INSTRUM, V17, P39, DOI 10.1016/j.flowmeasinst.2005.08.001; Shimada T, 2010, FLOW MEAS INSTRUM, V21, P462, DOI 10.1016/j.flowmeasinst.2010.06.003; [Anonymous], 97701989 ISO; Baker R.C., 2000, FLOW MEASUREMENT HDB; Clark C, 2006, FLOW MEAS INSTRUM, V17, P391, DOI 10.1016/j.flowmeasinst.2006.07.002; Elliott K, 2004, P 22 N SEA FLOW MEAS; Hamrock BJ, 2004, FUNDAMENTALS FLUID F; Johnson AN, 2010, P 15 INT FLOW MEAS C; Nicholson S, 1997, 01497 NEL, V014, P1; Shimada T, 2003, FLOW MEAS INSTRUM, V14, P89, DOI 10.1016/S0955-5986(03)00016-5; Shimada T, 2004, P 12 INT FLOW MEAS C; Shimada T, 2001, P NCSL INT WORKSH S; Shimada T, 2007, J FLUID SCI TECHNOL, V2, P23, DOI 10.1299/jfst.2.23; Shimada T, 2003, P 11 INT FLOW MEAS C; Shimada T, 2006, P 6 INT S FLUID FLOW; The American Petroleum Institute (API), 1993, MAN PETR MEAS STAND; The American Petroleum Institute (API), 2005, MAN PETR MEAS STAND; Wright J, 2012, CAL LAB INT J METROL, V19, P30	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	MAR	2015	41						174	180		10.1016/j.flowmeasinst.2014.12.005		7	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CD2XJ	WOS:000350942000022		
J	Li, WJ; Xue, QY; Yabuta, K				Li, Wenjuan; Xue, Qingying; Yabuta, Kozo			Weighted version of Carleson measure and multilinear Fourier multiplier	FORUM MATHEMATICUM			English	Article						Weighted Carleson measure; weighted norm inequalities; multilinear Fourier multiplier		In this paper, we first establish some results about weighted Carleson measure, and then apply them to multilinear Fourier multiplier. By using a different method from the one used by Fujita and Tomita (2012), we obtain some weighted result of multilinear multiplier operators by considering the missing parts of their results in the end-point cases such as from L-2(omega) x L-infinity(omega) x L-infinity(omega) to L-2(omega), using weighted Carleson measure theory and employing the multilinear interpolation theory.	[Li, Wenjuan; Xue, Qingying] Beijing Normal Univ, Sch Math Sci, Lab Math & Complex Syst, Minist Educ, Beijing 100875, Peoples R China; [Yabuta, Kozo] Kwansei Gakuin Univ, Math Sci Res Ctr, Sanda 6691337, Japan	Xue, QY (reprint author), Beijing Normal Univ, Sch Math Sci, Lab Math & Complex Syst, Minist Educ, Beijing 100875, Peoples R China.	li@math.uni-kiel.de; gyxue@bnu.edu.cn			NSFC [10701010, 10931001]; Beijing Natural Science Foundation [1102023]; Program for Changjiang Scholars and Innovative Research Team in University; Japan Society for the Promotion of Science [23540228]	The second named author was supported partly by NSFC (Grant No. 10701010), NSFC (Key program Grant No. 10931001), Beijing Natural Science Foundation (Grant: 1102023), Program for Changjiang Scholars and Innovative Research Team in University. The third named author was supported partly by Grant-in-Aid for Scientific Research (C) No. 23540228, Japan Society for the Promotion of Science.	COIFMAN RR, 1975, T AM MATH SOC, V212, P315, DOI 10.2307/1998628; Fujita M, 2012, T AM MATH SOC, V364, P6335; Tomita N, 2010, J FUNCT ANAL, V259, P2028, DOI 10.1016/j.jfa.2010.06.010; DEFRANCIA JLR, 1986, ADV MATH, V62, P7, DOI 10.1016/0001-8708(86)90086-1; Grafakos L, 2012, J REINE ANGEW MATH, V668, P133, DOI 10.1515/CRELLE.2011.137; BERGH J., 1976, INTERPOLATION SPACES; Coifman R. R., 1978, ASTERISQUE, V57, P1; Coifman R. R., 1978, ANN I FOURIER, V28, P177; Grafakos L., CANAD J MAT IN PRESS; Journe J.-L., 1983, LECT NOTES MATH, V994; Lacey M, 1999, ANN MATH, V149, P475, DOI 10.2307/120971; Lacey M, 1997, ANN MATH, V146, P693, DOI 10.2307/2952458; Lu S, 2006, SINGULAR INTEGRALS R; Mihlin S.G., 1956, DOKL AKAD NAUK SSSR, V109, P701; DEFRANCIA JLR, 1984, AM J MATH, V106, P533, DOI 10.2307/2374284	15	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	MAR	2015	27	2					787	805		10.1515/forum-2012-0083		19	Mathematics, Applied; Mathematics	Mathematics	CC8UF	WOS:000350643200005		
J	Atsumi, H; Tanabe, T; Shikama, T				Atsumi, H.; Tanabe, T.; Shikama, T.			TRAPPING STATE OF HYDROGEN ISOTOPES IN CARBON AND GRAPHITE INVESTIGATED BY THERMAL DESORPTION SPECTROMETRY	FUSION SCIENCE AND TECHNOLOGY			English	Article							TRANSPORT	Thermal desorption spectrometry (TDS) has been investigated to obtain fundamental information of tritium behavior in graphite and carbon materials especially at high temperatures. 29 brands of graphite, HOPG, glassy carbon and CFC materials charged with deuterium gas are tested up to the temperature of 1735 K with a heating rate of 0.1 K/s. TDS spectra have five peaks at 600-700 K, around 900 K, 1200 K, 1300-1450 K and 1600-1650 K The amounts of released deuterium have been compared with crystallographic parameters derived from XRD analysis. Reduction of tritium retention and inventories are discussed.	[Atsumi, H.] Kinki Univ, Dept Elect & Elect Engn, Higashiosaka, Osaka 5778502, Japan; [Tanabe, T.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Shikama, T.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Atsumi, H (reprint author), Kinki Univ, Dept Elect & Elect Engn, Kowakae 3-4-1, Higashiosaka, Osaka 5778502, Japan.	atsumi@ele.kindai.ac.jp			JSPS [22017006]	This work was supported by JSPS Grant-in-Aid for Scientific Research on Priority Areas, Grant Number 22017006.	Niwase K, 2002, PHIL MAG LETT, V82, P401, DOI 10.1080/09500830210137416; LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844; Harris PJF, 2005, CRIT REV SOLID STATE, V30, P235, DOI 10.1080/10408430500406265; Atsumi H, 2009, J NUCL MATER, V390-91, P581, DOI 10.1016/j.jnucmat.2009.01.112; Atsumi H, 2003, J ALLOY COMPD, V356, P705, DOI 10.1016/S0925-8388(03)00290-1; Atsumi H, 2013, J NUCL MATER, V442, pS746, DOI 10.1016/j.jnucmat.2013.03.041; Atsumi H, 2003, PHYS SCRIPTA, VT103, P77, DOI 10.1238/Physica.Topical.103a00077; Atsumi H, 2009, J NUCL MATER, V386-88, P379, DOI 10.1016/j.jnucmat.2008.12.135; Atsumi H, 2003, J NUCL MATER, V313, P543, DOI 10.1016/S0022-3115(02)01464-2; Atsumi H, 2013, J NUCL MATER, V438, pS963, DOI 10.1016/j.jnucmat.2013.01.209; Piazza G, 2007, J NUCL MATER, V367, P1438, DOI 10.1016/j.jnucmat.2007.04.039; Tanabe T, 2006, FUSION ENG DES, V81, P139, DOI 10.1016/j.fusengdes.2005.08.083; YAMASHINA T, 1991, APPL SURF SCI, V48-9, P483, DOI 10.1016/0169-4332(91)90379-X	13	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					245	249				5	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900003		
J	Baglan, N; Kim, SB; Cossonnet, C; Croudace, IW; Fournier, M; Galeriu, D; Warwick, PE; Momoshima, N; Ansoborlo, E				Baglan, N.; Kim, S. B.; Cossonnet, C.; Croudace, I. W.; Fournier, M.; Galeriu, D.; Warwick, P. E.; Momoshima, N.; Ansoborlo, E.			ORGANICALLY BOUND TRITIUM ANALYSIS IN ENVIRONMENTAL SAMPLES	FUSION SCIENCE AND TECHNOLOGY			English	Article								Many methods allow analysing the various forms of tritium in environmental samples; however, there are no published standard methods for measuring organically bound tritium (OBT). Furthermore, there are no certified reference materials of OBT for environmental samples. In environmental samples (plants and animals), the measurement of the various tritium fractions requires extraction of the free water, often through freeze drying processes. Combustion of the dry sample is then carried out to recover organically bound tritium in the combustion water. By measuring these water fractions, the tissue-free water tritium (TFWT) and the OBT concentration can be assessed However, these techniques are tricky and sometimes not available in all monitoring labs. Indeed, most of them measure only the TFWT fraction in food samples, such as wine or milk. Researches to promote the use of validated procedures are on-going in several countries. However, for almost all comparison exercise organisers it is difficult on a yearly basis to provide the samples and to realise the statistical treatment of the results. Therefore, to improve OBT analytical skills, an international task group devoted to the improvement of OBT analytical procedures was created to overcome these limitations. For the first exercise about 20 labs from 8 countries were registered The samples, specially-prepared potatoes, were provided in March 2013 to each participant. Technical information and results from this first exercise are discussed here for all the labs which have realised the five replicates necessary to allow a reliable statistical treatment. From this work an optimised procedure can start to be developed to deal with OBT analysis and will guide subsequent planned OBT trials by the international group.	[Baglan, N.] CEA DAM DIF, F-91297 Arpajon, France; [Kim, S. B.] AECL, Chalk River Labs, Chalk River, ON K0J 1J0, Canada; [Cossonnet, C.] IRSN PRP ENV STEME LMRE, F-91400 Orsay, France; [Croudace, I. W.; Warwick, P. E.] Univ Southampton, NOC, GAU Radioanalyt, Southampton SO14 3ZH, Hants, England; [Fournier, M.] IRSN DG DMQ, F-92262 Fontenay Aux Roses, France; [Galeriu, D.] Horia Hulubei Inst Phys & Nucl Engn, IFIN HH, RO-077125 Bucharest, Romania; [Momoshima, N.] Kyushu Univ, Radioisotope Ctr, Higashi Ku, Fukuoka 8128581, Japan; [Ansoborlo, E.] CEA DEN DRCP CETAMA, F-30207 Bagnols Sur Ceze, France	Baglan, N (reprint author), CEA DAM DIF, F-91297 Arpajon, France.	Nicolas.BAGLAN@CEA.FR					BAGLAN N., 2012, RADIOPROTECTION, V48, P127; Kim SB, 2013, J ENVIRON RADIOACTIV, V126, P83, DOI 10.1016/j.jenvrad.2013.07.011	2	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					250	253				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900004		
J	Edao, Y; Kawamura, Y; Kurata, R; Fukada, S; Takeishi, T; Hayashi, T; Yamanishi, T				Edao, Y.; Kawamura, Y.; Kurata, R.; Fukada, S.; Takeishi, T.; Hayashi, T.; Yamanishi, T.			MEASUREMENT OF TRITIUM PENETRATION THROUGH CONCRETE MATERIAL COVERED BY VARIOUS PAINTS COATING	FUSION SCIENCE AND TECHNOLOGY			English	Article							TRITIATED-WATER; HYDROPHOBIC PAINTS	The present study aims at obtaining fundamental data on tritium migration in porous materials, which include soaking effect, interaction between tritium and cement paste coated with paints and transient tritium sorption in porous cement. The amounts of tritium penetrated into or released from cement paste with epoxy and urethane paint coatings were measured. The tritium penetration amounts were increased with the HTO exposure time. Time to achieve a saturated value of tritium sorption was more than 60 days for cement paste coated with epoxy paint and with urethane paint, while that for cement paste without any paint coating took 2 days to achieve it. The effect of tritium permeation reduction by the epoxy paint was higher than that of the urethane. Although their paint coatings were effective for reduction of tritium penetration through the cement paste which was exposed to HTO for a short period, it was found that the amount of tritium trapped in the paints became large for a long period. Tritium penetration rates were estimated by an analysis of one-dimensional diffusion in the axial direction of a thickness of a sample. Obtained data were helpful for evaluation of tritium contamination and decontamination.	[Edao, Y.; Kawamura, Y.; Kurata, R.; Hayashi, T.; Yamanishi, T.] Japan Atom Energy Agcy, Tritium Technol Grp, Fus Res & Dev Directorate, Tokai, Ibaraki 3191195, Japan; [Fukada, S.; Takeishi, T.] Kyushu Univ, Dept Adv Energy Engn Sci, Fukuoka 8168580, Japan	Edao, Y (reprint author), Japan Atom Energy Agcy, Tritium Technol Grp, Fus Res & Dev Directorate, 2-4 Shirane Shirakata, Tokai, Ibaraki 3191195, Japan.	edao.yuki@jaea.go.jp			Japan Society for the Promotion of Science [24246153]	This work was also supported by Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (A) Grant Number 24246153). The authors wish to acknowledge this funding support.	Edao Y, 2012, FUSION ENG DES, V87, P995, DOI 10.1016/j.fusengdes.2012.02.058; Fukada S, 2012, FUSION ENG DES, V87, P54, DOI 10.1016/j.fusengdes.2011.09.001; Inagaki Y., 2000, J PLASMA FUSION RES, V76, P1044; Iwai Y, 2011, J NUCL MATER, V417, P1187, DOI 10.1016/j.jnucmat.2010.12.298; NUMATA S, 1990, J NUCL MATER, V171, P350, DOI 10.1016/0022-3115(90)90381-V; NUMATA S, 1990, J NUCL MATER, V171, P373, DOI 10.1016/0022-3115(90)90383-X; ONO F, 1992, FUSION TECHNOL, V21, P827	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					320	323				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900021		
J	Fukada, S; Katayama, K; Takeishi, T; Edao, Y; Kawamura, Y; Hayashi, T; Yamanishi, T				Fukada, Satoshi; Katayama, K.; Takeishi, T.; Edao, Y.; Kawamura, Y.; Hayashi, T.; Yamanishi, T.			CORRELATION OF RATES OF TRITIUM MIGRATION THROUGH POROUS CONCRETE	FUSION SCIENCE AND TECHNOLOGY			English	Article							HYDROPHOBIC PAINTS	What affects tritium migration through porous concrete walls coated with a hydrophobic paint is reviewed from the viewpoint of tritium safety. Being taken into consideration of multi-structural concrete composed of aggregates, sand, water and cement which contents are CaO, SiO2, Al2O3, Fe2O3, MgO, CaSO4 and so on, tritium path is discussed in terms of the HTO diffusivity and adsorption coeffcient on porous walls. Measures to predict rates of tritium leak from laboratory walls to the environment and residual tritium amounts in concrete are estimated based on previous data. Three cases of accidental or chronic tritium release to laboratory air are discussed using the diffusion-adsorption model.	[Fukada, Satoshi; Katayama, K.; Takeishi, T.] Kyushu Univ, Fukuoka 8168580, Japan; [Edao, Y.; Kawamura, Y.; Hayashi, T.; Yamanishi, T.] JAEA TPL, Tokai, Ibaraki 3191184, Japan	Fukada, S (reprint author), Kyushu Univ, 6-1 Kasuga Koen, Fukuoka 8168580, Japan.	sfukada@nucl.kyushu-u.ac.jp					Edao Y, 2012, FUSION ENG DES, V87, P995, DOI 10.1016/j.fusengdes.2012.02.058; Fukada S, 2012, FUSION ENG DES, V87, P54, DOI 10.1016/j.fusengdes.2011.09.001; Fukada S, 2011, FUSION SCI TECHNOL, V60, P1061; MILLER JM, 1993, EURO NUCL SCI TECH, V1, P131; Nishikawa M, 2006, FUSION SCI TECHNOL, V50, P521; NUMATA S., 1990, J NUCL MATER, V171, P371; Takata H, 2008, FUSION SCI TECHNOL, V54, P223	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					339	342				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900026		
J	Hatano, Y; Alimov, VK; Spitsyn, AV; Bobyr, NP; Cherkez, DI; Abe, S; Ogorodnikova, OV; Klimov, NS; Khripunov, BI; Golubeva, AV; Chernov, VM; Oyaidzu, M; Yamanishi, T; Matsuyama, M				Hatano, Y.; Alimov, V. Kh.; Spitsyn, A. V.; Bobyr, N. P.; Cherkez, D. I.; Abe, S.; Ogorodnikova, O. V.; Klimov, N. S.; Khripunov, B. I.; Golubeva, A. V.; Chernov, V. M.; Oyaidzu, M.; Yamanishi, T.; Matsuyama, M.			TRITIUM RETENTION IN REDUCED-ACTIVATION FERRITIC/MARTENSITIC STEELS	FUSION SCIENCE AND TECHNOLOGY			English	Article							DEUTERIUM; TUNGSTEN; PLASMA	The effects of displacement damage, plasma exposure and heat loads on T retention in reduced-activation ferritic/martensitic (RAFM) steels were investigated by exposing the steels to DT gas at 473 K Despite enormous change in surface morphology, T retention in the heat-loaded specimen was comparable with that in the unloaded specimen. The exposure to plasma resulted in a drastic increase in T retention at the surface and/or sub surface. However, the T trapped at the surface/subsurface was easily removed by maintaining the specimens in air at similar to 300 K Formation of radiation-induced defects led to a significant increase in T retention, and T trapped in the defects was not removed at similar to 300 K These observations suggest that displacement damages have the largest effects on T retention at similar to 473 K	[Hatano, Y.; Alimov, V. Kh.; Abe, S.; Matsuyama, M.] Toyama Univ, Toyama 9308555, Japan; [Alimov, V. Kh.; Ogorodnikova, O. V.] EURATOM, Max Planck Inst Plasmaphys, D-85748 Garching, Germany; [Spitsyn, A. V.; Bobyr, N. P.; Cherkez, D. I.; Khripunov, B. I.; Golubeva, A. V.] NRC Kurcharov Inst, RU-123182 Moscow, Russia; [Klimov, N. S.] SRC RF TRINITI, Troitsk 142190, Moscow Region, Russia; [Chernov, V. M.] JSC AA Bochvar High Technol Res Inst Inorgan Mat, Moscow, Russia; [Oyaidzu, M.; Yamanishi, T.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Hatano, Y (reprint author), Toyama Univ, Gofuku 3190, Toyama 9308555, Japan.	hatano@ctg.u-toyama.ac.jp	Spitsyn, Alexander/A-2989-2014		Japan Atomic Energy Agency [25K286]	This study is supported in part by the Japan Atomic Energy Agency under the Joint Work contract #25K286, as a part of Broader Approach activities. The authors would like to thank Dr. H. Tanigawa, JAEA, for F82H samples and Profs. N. Yoshida and H. Watanabe, Kyushu University, for their help in TEM observations.	ALIMOV V. KH., PHYS SCR IN PRESS; Ogorodnikova OV, 2013, J NUCL MATER, V442, P518, DOI 10.1016/j.jnucmat.2013.07.024; Matsuyama M, 2002, J NUCL MATER, V307, P729, DOI 10.1016/S0022-3115(02)01266-7; [Anonymous], 1996, ANN BOOK ASTM STAND, V12.02, P8; Huang Q, 2013, J NUCL MATER, V442, pS2, DOI 10.1016/j.jnucmat.2012.12.039; Arkhipov II, 1996, J NUCL MATER, V233, P1202, DOI 10.1016/S0022-3115(96)00043-8; Klimov NS, 2013, J NUCL MATER, V438, pS241, DOI 10.1016/j.jnucmat.2013.01.036; Nakamura H, 2007, FUSION SCI TECHNOL, V52, P1012; Saitoh H, 1998, J NUCL MATER, V258, P1404, DOI 10.1016/S0022-3115(98)00144-5; Takagi I, 2013, J NUCL MATER, V442, pS33, DOI 10.1016/j.jnucmat.2013.04.057; Ueda Y, 2003, J NUCL MATER, V313, P32, DOI 10.1016/S0022-3115(02)01329-6	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					361	364				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900031		
J	Hayashi, T; Nakamura, H; Kawamura, Y; Iwai, Y; Isobe, K; Yamada, M; Suzuki, T; Kurata, R; Oyaizu, M; Edao, Y; Yamanishi, T				Hayashi, Takumi; Nakamura, Hirofumi; Kawamura, Yoshinori; Iwai, Yasunori; Isobe, Kanetsugu; Yamada, Masayuki; Suzuki, Takumi; Kurata, Rie; Oyaizu, Makoto; Edao, Yuki; Yamanishi, Toshihiko			RECENT PROGRESS ON TRITIUM TECHNOLOGY RESEARCH AND DEVELOPMENT FOR A FUSION REACTOR IN JAPAN ATOMIC ENERGY AGENCY	FUSION SCIENCE AND TECHNOLOGY			English	Article							WATER; JAEA	JAEA has two tritium handling laboratories, such as Tritium Processing Laboratory (TPL) in Tokai and DEMO R&D building in Rokkasho. Specially, TPL has been accumulated a gram level tritium safety handling experiences without any accidental tritium release to the environment for more than 25years. At the Grate East Japan Earthquake 2011, TPL received many effects, such as building surface crack etc., however, tritium confinement function was successfully maintained with adequate safety interlock actions and almost all safety related effects will be recovered within March 2014. Recently, our activities have been focused to the I) ITER Detritiation system R&D task; 2) DEMO R&D tasks in Broader Approach (BA) activities, such as a) tritium accountancy, b) tritium interactions with various materials, and c) tritium durability; and 3) Recovery works from the Grate East Japan Earthquake 2011.	[Hayashi, Takumi; Nakamura, Hirofumi; Kawamura, Yoshinori; Iwai, Yasunori; Isobe, Kanetsugu; Yamada, Masayuki; Kurata, Rie; Edao, Yuki] Japan Atom Energy Agcy, Tritium Technol Grp, Tokai, Ibaraki 3191195, Japan; [Suzuki, Takumi; Oyaizu, Makoto; Yamanishi, Toshihiko] Japan Atom Energy Agcy, Tritium Technol Grp, Rokkasho, Aomori 0393212, Japan	Hayashi, T (reprint author), Japan Atom Energy Agcy, Tritium Technol Grp, Tokai, Ibaraki 3191195, Japan.	hayashi.takumi@jaea.gojp					Kawamura Y, 2012, FUSION ENG DES, V87, P1253, DOI 10.1016/j.fusengdes.2012.02.125; Kawamura Y, 2013, FUSION ENG DES, V88, P2255, DOI 10.1016/j.fusengdes.2013.05.021; Hayashi T, 2012, FUSION ENG DES, V87, P1333, DOI 10.1016/j.fusengdes.2012.03.009; Iwai Y, 2008, FUSION ENG DES, V83, P1410, DOI 10.1016/j.fusengdes.2008.06.032; Kawamura Y, 2013, J NUCL MATER, V442, pS455, DOI 10.1016/j.jnucmat.2012.11.003; Oyaizu M., 2013, CONTRIBUTED PAPER OF; Yamanishi T, 2011, FUSION SCI TECHNOL, V60, P1083; Yamanishi T, 2008, FUSION SCI TECHNOL, V54, P45	8	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					365	370				6	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900032		
J	Higaki, M; Otsuka, T; Tokunaga, K; Hashizume, K; Ezato, K; Suzuki, S; Enoeda, M; Akiba, M				Higaki, M.; Otsuka, T.; Tokunaga, K.; Hashizume, K.; Ezato, K.; Suzuki, S.; Enoeda, M.; Akiba, M.			DETERMINATION OF HYDROGEN DIFFUSION COEFFICIENTS IN F82H BY HYDROGEN DEPTH PROFILING WITH A TRITIUM IMAGING PLATE TECHNIQUE	FUSION SCIENCE AND TECHNOLOGY			English	Article							ACTIVATION MARTENSITIC STEELS	Hydrogen diffusion coefficients in a reduced activation ferritic/martensitic steel (F82H) and an oxide dispersion strengthened F82H (ODS-F82H) have been determined from depth profiles of plasma-loaded hydrogen with a tritium imaging plate technique (TIPT) in the temperature range from 298 K to 523 K Data of hydrogen diffusion coefficients, D, in F82H are summarized as D [m(2) s(-1)] =1.1x 10(-7)exp(-16[kJ mol(-1)]/RT). The present data indicate almost no trapping effect on hydrogen diffusion due to an excess entry of energetic hydrogen by the plasma loading, which results in saturation of the trapping sites at the surface and even in the bulk. In the case of ODS-F82H, data of hydrogen diffusion coefficients are summarized as D [m(2) s(-1)] =2.2 x10(-2)exp(-30[kJ mol(-1)/RT) indicating a remarkable trapping effect on hydrogen diffusion caused by tiny oxide particles in the bulk of F82H.	[Higaki, M.; Otsuka, T.; Hashizume, K.] Kyushu Univ, Interdisciplinary Grad Sch Engn & Sci, Fukuoka 8168580, Japan; [Tokunaga, K.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan; [Ezato, K.; Suzuki, S.; Enoeda, M.; Akiba, M.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan	Higaki, M (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn & Sci, 6-1 Kasuga Kouen, Fukuoka 8168580, Japan.	higaki@aees.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Chikada T, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063023; Serra E, 1997, J NUCL MATER, V245, P108, DOI 10.1016/S0022-3115(97)00021-4; Perevezentsev AN, 2008, J NUCL MATER, V372, P263, DOI 10.1016/j.jnucmat.2007.03.215; Nakamura H, 2006, FUSION ENG DES, V81, P1339, DOI 10.1016/j.fusengdes.2005.10.009; Otsuka T, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014035; Otsuka T, 2011, J NUCL MATER, V417, P1135, DOI 10.1016/j.jnucmat.2010.12.101; Schliefer F, 2000, J NUCL MATER, V283, P540, DOI 10.1016/S0022-3115(00)00312-3; Shiba K, 2004, J NUCL MATER, V329, P243, DOI 10.1016/j.jnucmat.2004.04.018; TANABE T., 1984, J JPN I MET, V25, P1	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					379	381				3	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900035		
J	Honda, T; Katayama, K; Uehara, K; Takeishi, T; Fukada, S				Honda, Takuya; Katayama, Kazunari; Uehara, Keiichiro; Takeishi, Toshiharu; Fukada, Satoshi			PERCOLATION BEHAVIOR OF TRITIATED WATER INTO A SOIL PACKED BED	FUSION SCIENCE AND TECHNOLOGY			English	Article							TRITIUM	A large amount of cooling water is used in a D-T fusion reactor. The cooling water will contain tritium with high concentration because tritium can permeate metal walls at high temperature easily. A development of tritium handling technology for confining tritiated water in the fusion facility is an important issue. In addition, it is also important to understand tritium behavior in environment assuming severe accidents. In this study, percolation experiments of tritiated water in soil packed bed were carried out and tritium behavior in soil was discussed. Six soil samples were collected in Hakozaki campus of Kyushu University. These particle densities were same degree as that of general soils and moisture contents were related to BET surface area. For two soil samples used in the percolation experiment of tritiated water, saturated hydraulic conductivity agreed well with the estimating value by Creager. Tritium retention ratio in the soil packed bed was larger than water retention. This is considered to be due to an effect of tritium sorption on the surface of soil particles. The isotope exchange capacity estimated by assuming that H/T ratio of supplied tritiated water and H/T ratio of surface water of soil particle was equal was comparable to that on cement paste and mortar which were obtained by exposure of tritiated water vapor.	[Honda, Takuya; Katayama, Kazunari; Uehara, Keiichiro; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Takeishi, Toshiharu] Kyushu Univ, Fac Engn, Fukuoka 8190395, Japan	Honda, T (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasuga Koen, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp			KAKENHI [25709087]	This work is supported by KAKENHI Grant-in-Aid for Young Scientists (A) 25709087.	CREAGER W. P., 1945, ENG DAMS, VIII, P645; Furuichi K, 2007, J NUCL MATER, V367, P1243, DOI 10.1016/j.jnucmat.2007.03.227; Nakamura H, 2006, FUSION ENG DES, V81, P1339, DOI 10.1016/j.fusengdes.2005.10.009; Nakashio N, 1998, FUSION TECHNOL, V33, P287; NISHIKAWA M, 1989, J NUCL MATER, V161, P182, DOI 10.1016/0022-3115(89)90481-9	5	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					382	385				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900036		
J	Hoshino, T; Ochiai, K; Edao, Y; Kawamura, Y				Hoshino, Tsuyoshi; Ochiai, Kentaro; Edao, Yuki; Kawamura, Yoshinori			EVALUATION OF TRITIUM RELEASE PROPERTIES OF ADVANCED TRITIUM BREEDERS	FUSION SCIENCE AND TECHNOLOGY			English	Article							BLANKET; ITER	Li2TiO3 advanced tritium breeders with excess Li (Li2+xTiO3+y) are stable in a reducing atmosphere at high temperatures. Although the tritium release properties of tritium breeders are documented in databases for DEMO blanket design, no in situ examination under fusion neutron (DT neutron) irradiation has been performed In this study, a preliminary examination of the tritium release properties of advanced tritium breeders was performed, and DT neutron irradiation experiments were performed at the fusion neutronics source (FNS) facility in JAEA. Considering the tritium release characteristics, the optimum grain size after sintering is <5 mu m. From the results of the optimization of granulation conditions, prototype Li(2+)xTiO(3+y) pebbles with optimum grain size (<5 mu m) were successfully fabricated The Li(2+)xTiO(3+y) pebbles exhibited good tritium release properties similar to the Li2TiO3 pebbles. In particular, the released amount of HT gas for easier tritium handling was higher than that of HTO water.	[Hoshino, Tsuyoshi] Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res, Rokkasho Fus Inst, Rokkasho, Aomori 0393212, Japan; [Ochiai, Kentaro] Japan Atom Energy Agcy, Fus Neutron Grp, Dept Blanket Syst Res, Tokai, Ibaraki 3191195, Japan; [Edao, Yuki; Kawamura, Yoshinori] Japan Atom Energy Agcy, Tritium Technol Grp, Dept Blanket Syst Res, Tokai, Ibaraki 3191195, Japan	Hoshino, T (reprint author), Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res, Rokkasho Fus Inst, 2-166 Obuchi, Rokkasho, Aomori 0393212, Japan.	hoshino.tsuyoshi@jaea.go.jp					Tanigawa H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055021; Giancarli L, 2007, J NUCL MATER, V367, P1271, DOI 10.1016/j.jnucmat.2007.03.234; Hoshino T, 2009, FUSION ENG DES, V84, P956, DOI 10.1016/j.fusengdes.2008.12.049; Hoshino T, 2007, FUSION ENG DES, V82, P2269, DOI 10.1016/j.fusengdes.2007.07.005; Hanada T, 2011, J NUCL MATER, V417, P735, DOI 10.1016/j.jnucmat.2010.12.130; Hoshino T, 2012, FUSION ENG DES, V87, P486, DOI 10.1016/j.fusengdes.2012.01.005; Roux N, 1998, FUSION ENG DES, V41, P31, DOI 10.1016/S0920-3796(97)00140-3; Roux N, 1996, J NUCL MATER, V233, P1431, DOI 10.1016/S0022-3115(96)00136-5; Hoshino T, 2002, FUSION ENG DES, V61-62, P353, DOI 10.1016/S0920-3796(02)00216-8; Hoshino T, 2011, J NUCL MATER, V417, P684, DOI 10.1016/j.jnucmat.2010.12.128; KOPASZ P., 1994, NUCL MAT, V212-215, P927	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					386	389				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900037		
J	Kawano, T; Ohashi, H; Hamada, Y; Jamsranjav, E				Kawano, T.; Ohashi, H.; Hamada, Y.; Jamsranjav, E.			COMPARATIVE TESTING OF VARIOUS FLOW-CELL DETECTORS FABRICATED USING CAF(2) SOLID SCINTILLATOR	FUSION SCIENCE AND TECHNOLOGY			English	Article								A monitoring system based on a flow-cell detector was developed for measuring the tritium concentration in water. The flow-cell detector was fabricated using a granular CaF2 solid scintillator. This system does not use a liquid scintillation cocktail and does not generate radioactive organic liquid waste. Moreover, continuous real-time measurements are possible, in contrast to a liquid scintillation counting system, which requires batch measurements. For further development of the system, four flow-cell detectors were fabricated. They included a single 3-mm-diameter cell, three 3-mm-diameter cells in series, a single 5-mm-diameter cell, and three 5-mm-diameter cells in series. Continuously flowing water containing tritium at various concentrations was passed through the flow cells, and tritium count were measured for 600 and 10000 s. Investigating the relation between the count rate and concentration, the three 5-mm-diameter cells were most sensitive, with a linear relation maintained down to approximately 2 Bq/mL and 10 Bq/mL for 10000- and 600-s measurements, respectively.	[Kawano, T.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ohashi, H.; Hamada, Y.; Jamsranjav, E.] ATOX Co Ltd, Chuo Ku, Tokyo 1040041, Japan	Kawano, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, Oroshi Cho 322-6, Toki, Gifu 5095292, Japan.	kawano.takao@nifs.ac.jp					Kawano T, 2011, FUSION SCI TECHNOL, V60, P952; KNOLL GLENN F., 2010, RAD DETECTION MEASUR, P223; L'ANNUNZIATA MICHAEL F., 2003, HDB RADIOACTIVITY AN, p[347, 347]; MARTIN JAMES E., 2006, PHYS RAD PROTECTION, P579	4	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					404	407				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900041		
J	Kawano, T; Isozumi, S; Isozumi, Y; Tosaki, M; Tanaka, M; Sugiyama, T				Kawano, T.; Isozumi, S.; Isozumi, Y.; Tosaki, M.; Tanaka, M.; Sugiyama, T.			EFFECT OF AIR ON ENERGY AND RISE-TIME SPECTRA MEASURED BY PROPORTIONAL GAS COUNTER	FUSION SCIENCE AND TECHNOLOGY			English	Article								Air exerts a negative effect on radiation detection using a gas counter because oxygen contained in air has a high electron attachment coefficient and can trap electrons from electron-ion pairs created by ionization from incident radiation in counting gas. This reduces radiation counts. The present study examined the influence of air on energy and rise-time spectra measurements using a proportional gas counter. In addition, a decompression procedure method was proposed to reduce the influence of air and its effectiveness was investigated. For the decompression procedure, the counting gas inside the gas counter was decompressed below atmospheric pressure before radiation detection. For the spectrum measurement, methane as well as various methane and air mixtures were used as the counting gas to determine the effect of air on energy and rise-time spectra. Results showed that the decompression procedure was effective for reducing or eliminating the influence of air on spectra measurement using a proportional gas counter.	[Kawano, T.; Tanaka, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Isozumi, S.] IsoShieldJP Co Ltd, Uji, Kyoto 6110002, Japan; [Isozumi, Y.; Tosaki, M.] Kyoto Univ, Radioisotope Res Ctr, Kyoto 6068501, Japan; [Sugiyama, T.] Nagoya Univ, Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kawano, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	kawano.takao@nifs.ac.jp					AOYAMA T, 1992, NUCL INSTRUM METH A, V322, P170, DOI 10.1016/0168-9002(92)90026-Z; Curzio G, 2005, NUCL INSTRUM METH A, V537, P672, DOI 10.1016/j.nima.2004.07.287; Kawano T, 2008, FUSION SCI TECHNOL, V54, P189; THE JAPAN RADIOISOTOPE ASSOCIATION, 2005, IS STAT BOOK, P256; Von Engel A., 1965, IONIZED GASES, P86	5	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					408	411				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900042		
J	Kobayashi, K; Torikai, Y; Saito, M; Alimov, V; Miya, N; Ikeda, Y				Kobayashi, Kazuhiro; Torikai, Yuji; Saito, Makiko; Alimov, Vladimir; Miya, Naoyuki; Ikeda, Yoshitaka			BEHAVIOR OF TRITIUM IN THE VACUUM VESSEL OF JT-60U	FUSION SCIENCE AND TECHNOLOGY			English	Article							AMBIENT-TEMPERATURE; SS316; TRANSPORT; RELEASE	Disassembly of the JT-60U torus was started in 2010 after 18 years D-2 operations. In future the vacuum vessel will be treated as non-radioactive ones after the clearance procedure under the Japanese regulation depending on the tritium (T) contamination level. Note that the vessel was manufactured from Inconel 625 steel. Therefore, it was very important to study the hydrogen isotope behavior in Inconel 625 from viewpoint of the clearance procedure. Inconel 625 specimen was exposed to the D-2 (92.8 %) T-2 (7.2 %) gas mixture at 573 K for 5 hours. The tritium release from the specimen at 298 K was controlled for about I year. After that a part of tritium remaining in the specimen was released by heating up to 1073 K Other part of tritium trapped in the specimen was measured by chemical etching method. Most of the chemical form of the released tritium was HTO. The contaminated specimen by tritium was released continuously the diffusible tritium under the ambient condition. In the tritium release experiment, the amount of desorbed tritium was about 99% during I year. It was considered that the tritium in Inconel 625 was released easily. From these results, the behavior of tritium in the vacuum vessel of the JT-60U torus will be evaluated and discussed.	[Kobayashi, Kazuhiro; Miya, Naoyuki; Ikeda, Yoshitaka] Japan Atom Energy Agcy, JT Safety Assessment Grp 60, Naka, Ibaraki 3110193, Japan; [Torikai, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Gofuku, Toyama 9308555, Japan; [Saito, Makiko; Alimov, Vladimir] Japan Atom Energy Agcy, ITER Project Management Grp, Naka, Ibaraki 3110193, Japan	Kobayashi, K (reprint author), Japan Atom Energy Agcy, JT Safety Assessment Grp 60, Naka, Ibaraki 3110193, Japan.	kobayashi.kazuhiro@jaea.go.jp					Naoe S, 2008, FUSION SCI TECHNOL, V54, P515; Torikai Y, 2002, FUSION SCI TECHNOL, V41, P736; Torikai Y, 2005, FUSION SCI TECHNOL, V48, P177; Penzhorn RD, 2006, J NUCL MATER, V353, P66, DOI 10.1016/j.jnucmat.2006.03.004; Kamada Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104010; ISAYAMA A., 2011, NUCL FUSION, V51, P1; REITER F., 1993, EUR 1512 EN, Patent No. 1512; Saito M, 2011, FUSION SCI TECHNOL, V60, P1459; TANABE T, 1984, J NUCL MATER, V123, P1568, DOI 10.1016/0022-3115(84)90304-0; Torikai Y, 2007, J NUCL MATER, V363, P462, DOI 10.1016/j.jnucmat.2007.01.043	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					428	431				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900047		
J	Kotoh, K; Kubo, K; Takashima, S; Moriyama, S; Tanaka, M; Sugiyama, T				Kotoh, Kenji; Kubo, Kotaro; Takashima, Shoji; Moriyama, Sho-taro; Tanaka, Masahiro; Sugiyama, Takahiko			LONGITUDINAL DISPERSION COEFFICIENT DEPENDING ON SUPERFICIAL VELOCITY OF HYDROGEN ISOTOPES FLOWING IN COLUMN PACKED WITH ZEOLITE PELLETS AT 77.4 K	FUSION SCIENCE AND TECHNOLOGY			English	Article							PRESSURE SWING ADSORPTION; BEDS; BEHAVIOR	Authors have been developing a cryogenic pressure swing adsorption system for hydrogen isotope separation. In the problem of its design and operation, it is necessary to predict the concentration profiles developing in packed beds of adsorbent pellets. The profiling is affected by the longitudinal dispersion of gas flowing in packed beds, in addition to the mass transfer resistance in porous media of adsorbent pellets. In this work, an equation is derived for estimating the packed-bed dispersion coefficient of hydrogen isotopes, by analyzing the breakthrough curves of trace D-2 or HD replacing H-2 adsorbed in synthetic zeolite particles packed columns at the liquefied nitrogen temperature 77.4 K Since specialized for hydrogen isotopes, this equation can be expected to estimate the dispersion coefficients more reliable for the cryogenic hydrogen isotope adsorption process, than the existing equations.	[Kotoh, Kenji] Kyushu Univ, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan; [Kotoh, Kenji; Kubo, Kotaro; Takashima, Shoji; Moriyama, Sho-taro] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Tanaka, Masahiro] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sugiyama, Takahiko] Nagoya Univ, Fac Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kotoh, K (reprint author), Kyushu Univ, Fac Engn, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	kotoh@nucl.kyushu-u.ac.jp			National Institute for Fusion Science, Japan (NIPS) [NIFS12KESA009, NIFS13KOBA029]	This work was supported by a grant from National Institute for Fusion Science, Japan (NIPS) with budgets NIFS12KESA009 and NIFS13KOBA029.	EDWARDS MF, 1968, CHEM ENG SCI, V23, P109, DOI 10.1016/0009-2509(68)87056-3; TSOTSAS E, 1988, CHEM ENG PROCESS, V24, P15, DOI 10.1016/0255-2701(88)87002-8; Delgado JMPQ, 2006, HEAT MASS TRANSFER, V42, P279, DOI 10.1007/s00231-005-0019-0; Kotoh K, 2005, FUSION SCI TECHNOL, V48, P148; Kotoh K, 2009, FUSION SCI TECHNOL, V56, P184; Kotoh K, 2010, FUSION ENG DES, V85, P1928, DOI 10.1016/j.fusengdes.2010.06.029; Kotoh K, 2011, FUSION ENG DES, V86, P2799, DOI 10.1016/j.fusengdes.2011.04.008; Poling B.E., 2001, PROPERTIES GASES LIQ; RUTHVEN D. M., 1984, PRINCIPLES ADSORPTIO, P235; SOUERS P. C., 1986, HYDROGEN PROPERTIES, P32	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					439	442				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900050		
J	Matsuda, S; Katayama, K; Shimozori, M; Fukada, S; Ushida, H; Nishikawa, M				Matsuda, Shohei; Katayama, Kazunari; Shimozori, Motoki; Fukada, Satoshi; Ushida, Hiroki; Nishikawa, Masabumi			HYDROGEN PERMEATION BEHAVIOR THROUGH F82H AT HIGH TEMPERATURE	FUSION SCIENCE AND TECHNOLOGY			English	Article							PURGE GAS; WATER; BED	F82H is a primary candidate of structural material and coolant pipe material in a blanket of a fusion reactor. Understanding tritium permeation behavior through F82H is important. In a normal operation of a fusion reactor, the temperature of F82H will be controlled below 550 degrees C because it is considered that F82H can be used up to 30,000 hours at 550 degrees C. However, it is necessary to assume the situation where F82H is heated over 550 degrees C in a severe accident. In this study, hydrogen permeation behavior through F82H was investigated in the temperature range from 500 degrees C to 800 degrees C. In some cases, water vapor was added in a sample gas to investigate an effect of water vapor on hydrogen permeation. The permeability of hydrogen in the temperature range from 500 degrees C to 700 degrees C agreed well with the permeability reported by E. Serra et al. The degradation of the permeability by water vapor was not observed. After the hydrogen permeation reached in a steady state at 700 degrees C, the F82H sample was heated to 800 degrees C. The permeability of hydrogen through F82H sample which was once heated up to 800 degrees C was lower than that of the original one.	[Matsuda, Shohei; Katayama, Kazunari; Shimozori, Motoki; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 812, Japan; [Ushida, Hiroki] Kyushu Univ, Fac Engn, Energy Sci & Engn, Fukuoka 812, Japan; [Nishikawa, Masabumi] UTM, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia	Matsuda, S (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 812, Japan.	kadzu@nucl.kyushu-u.ac.jp					Shiba K, 2011, FUSION ENG DES, V86, P2895, DOI 10.1016/j.fusengdes.2011.06.005; Kawamura Y, 1996, J NUCL MATER, V230, P287, DOI 10.1016/0022-3115(96)00168-7; Nakashima N, 2002, FUSION SCI TECHNOL, V41, P1044; NISHIKAWA M, 1990, J NUCL MATER, V174, P121, DOI 10.1016/0022-3115(90)90430-U; Serra E, 1998, MATER SCI TECH SER, V14, P573; Tsuru D, 2008, FUSION ENG DES, V83, P1747, DOI 10.1016/j.fusengdes.2008.06.056	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAR	2015	67	2					467	470				4	Nuclear Science & Technology	Nuclear Science & Technology	CD0PR	WOS:000350776900057		
J	Murn, J; Zarnack, K; Yang, YJ; Durak, O; Murphy, EA; Cheloufi, S; Gonzalez, DM; Teplova, M; Curk, T; Zuber, J; Patel, DJ; Ule, J; Luscombe, NM; Tsai, LH; Walsh, CA; Shi, Y				Murn, Jernej; Zarnack, Kathi; Yang, Yawei J.; Durak, Omer; Murphy, Elisabeth A.; Cheloufi, Sihem; Gonzalez, Dilenny M.; Teplova, Marianna; Curk, Tomaz; Zuber, Johannes; Patel, Dinshaw J.; Ule, Jernej; Luscombe, Nicholas M.; Tsai, Li-Huei; Walsh, Christopher A.; Shi, Yang			Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt	GENES & DEVELOPMENT			English	Article						RNA-binding proteins; cell morphology; gene expression program; neurons; translation; Unkempt	DENDRITIC SPINE MORPHOGENESIS; HELPER T-CELLS; MESSENGER-RNA; NUCLEOTIDE-RESOLUTION; MUSCLEBLIND PROTEINS; TRANSLATION; GENOME; ACTIVATION; SYNAPSE; MOTIFS	Cellular morphology is an essential determinant of cellular function in all kingdoms of life, yet little is known about how cell shape is controlled. Here we describe a molecular program that controls the early morphology of neurons through a metazoan-specific zinc finger protein, Unkempt. Depletion of Unkempt in mouse embryos disrupts the shape of migrating neurons, while ectopic expression confers neuronal-like morphology to cells of different nonneuronal lineages. We found that Unkempt is a sequence-specific RNA-binding protein and identified its precise binding sites within coding regions of mRNAs linked to protein metabolism and trafficking. RNA binding is required for Unkempt-induced remodeling of cellular shape and is directly coupled to a reduced production of the encoded proteins. These findings link post-transcriptional regulation of gene expression with cellular shape and have general implications for the development and disease of multicellular organisms.	[Murn, Jernej; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Zarnack, Kathi; Luscombe, Nicholas M.] European Bioinformat Inst, EMBL, Cambridge CB10 1SD, England; [Zarnack, Kathi] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Luscombe, Nicholas M.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Walsh, Christopher A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Yang, Yawei J.; Murphy, Elisabeth A.; Gonzalez, Dilenny M.; Walsh, Christopher A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Durak, Omer; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Durak, Omer; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Cheloufi, Sihem] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Cheloufi, Sihem] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Teplova, Marianna; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana 1000, Slovenia; [Zuber, Johannes] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Ule, Jernej] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Luscombe, Nicholas M.] UCL, Dept Genet Environm & Evolut, UCL Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England; [Luscombe, Nicholas M.] Technol Grad Univ, Okinawa Inst Sci, Okinawa 9040495, Japan	Shi, Y (reprint author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	murn.jemej@gmail.com; yang_shi@hms.harvard.edu	Ule, Jernej/C-6315-2013	Ule, Jernej/0000-0002-2452-4277	Nancy Lurie Marks Post-doctoral Fellowship; EMBL Interdisciplinary Postdocs (EIPOD) fellowship; Stuart H.Q. and Victoria Quan Fellowship; National Institute of General Medical Sciences [T32GM007753]; National Institute of Neurological Disorders and Stroke [R01 NS032457, R01 NS35129]; Manton Center for Orphan Disease Research; National Institutes of Health [GM058012, CA118487, MH096066]	We thank Yoichiro Sugimoto, Andrea D'Ambrogio, Tom Chittenden, and Angeles Fernandez-Gonzales for advice and assistance with the experiments; Timothy Mitchison, Julian Konig, Linda Van Aelst, Marc Kirschner, Nicholas Ingolia, David Pellman, David van Vactor, John Flanagan, and members of the Shi laboratory for discussion and comments on the manuscript; Crt Gorup for his work on the iCount pipeline; and Francois Guillemot for the pCAGGS-IRES-RFP vector. This study was supported by the Nancy Lurie Marks Post-doctoral Fellowship (J.M.), an EMBL Interdisciplinary Postdocs (EIPOD) fellowship (K.Z.), Stuart H.Q. and Victoria Quan Fellowship (Y.J.Y.), National Institute of General Medical Sciences grant T32GM007753 (Y.J.Y.), National Institute of Neurological Disorders and Stroke grants R01 NS032457 and R01 NS35129 (C.A.W.), the Manton Center for Orphan Disease Research (C.A.W.), and National Institutes of Health grants GM058012, CA118487, and MH096066 (Y.S.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. Y.S. is an American Cancer Society Research Professor. Y.S. is also a co-founder of Constellation Pharmaceuticals, Inc., and a member of its scientific advisory board.	Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; MOHLER J, 1992, GENETICS, V131, P377; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Avet-Rochex A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004624; Brummer A, 2013, RNA, V19, P1317, DOI 10.1261/rna.037531.112; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Klein ME, 2013, P NATL ACAD SCI USA, V110, P3125, DOI 10.1073/pnas.1209811110; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Ule J, 2011, JOVE-J VIS EXP, V50, P2638; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI [10.1073/pnas.0804583105, 10.1073/pnas.0804S83105]; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067	49	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	MAR 1	2015	29	5					501	512		10.1101/gad.258483.115		12	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	CD6HV	WOS:000351191100005		
J	Prakash, D; Deepak; Singh, PC; Singh, CK; Tewari, S; Arima, M; Frimmel, HE				Prakash, Divya; Deepak; Singh, Praveen Chandra; Singh, Chandra Kant; Tewari, Suparna; Arima, Makoto; Frimmel, Hartwig E. .			Reaction textures and metamorphic evolution of sapphirine-spinel-bearing and associated granulites from Diguva Sonaba, Eastern Ghats Mobile Belt, India	GEOLOGICAL MAGAZINE			English	Article						sapphirine-spinel-bearing granulite; corona and symplectite textures; phase equilibriamodelling; high-pressure - ultrahigh-temperature metamorphism; Eastern Ghats Mobile Belt; India	P-T PATH; HIGH-TEMPERATURE METAMORPHISM; ZIRCON U-PB; CONTINENTAL-CRUST; UHT METAMORPHISM; SOUTHERN INDIA; ALUMINOUS GRANULITES; QUARTZ ASSEMBLAGE; HIGH-PRESSURES; ENDERBY LAND	The Diguva Sonaba area (Vishakhapatnam district, Andhra Pradesh, South India) represents part of the granulite-facies terrain of the Eastern Ghats Mobile Belt. The Precambrian metamorphic rocks of the area predominantly consist of mafic granulite (+/- garnet), khondalite, leptynite (+/- garnet, biotite), charnockite, enderbite, calc-granulite, migmatic gneisses and sapphirine-spinel-bearing granulite. The latter rock type occurs as lenticular bodies in khondalite, leptynite and calc-granulite. Textural relations, such as corroded inclusions of biotite within garnet and orthopyroxene, resorbed hornblende within pyroxenes, and coarse-grained laths of sillimanite, presumably pseudomorphs after kyanite, provide evidence of either an earlier episode of upper-amphibolite-facies metamorphism or they represent relics of the prograde path that led to granulite-facies metamorphism. In the sapphirinespinel- bearing granulite, osumilite was stable in addition to sapphirine, spinel and quartz during the thermal peak of granulite-facies metamorphism but the assemblage was later replaced by Crd-Opx- Qtz-Kfs-symplectite and a variety of reaction coronas during retrograde overprint. Variable amounts of biotite or biotite + quartz symplectite replaced orthopyroxene, cordierite and Opx-Crd-Kfs- Qtz-symplectite at an even later retrograde stage. Peak metamorphic conditions of c. 1000 degrees C and c. 12 kbar were computed by isopleths of X-Mg in garnet and X-Al in orthopyroxene. The sequence of reactions as deduced from the corona and symplectite assemblages, together with petrogenetic grid and pseudosection modelling, records a clockwise P-T evolution. The P-T path is characteristically T-convex suggesting an isothermal decompression path and reflects rapid uplift followed by cooling of a tectonically thickened crust.	[Prakash, Divya; Deepak; Singh, Praveen Chandra; Singh, Chandra Kant; Tewari, Suparna] Banaras Hindu Univ, Ctr Adv Study Geol, Varanasi 221005, Uttar Pradesh, India; [Arima, Makoto] Yokohama Natl Univ, Inst Geol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Frimmel, Hartwig E. .] Univ Wurzburg, Inst Geog & Geol, D-97074 Wurzburg, Germany; [Frimmel, Hartwig E. .] Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa	Prakash, D (reprint author), Banaras Hindu Univ, Ctr Adv Study Geol, Varanasi 221005, Uttar Pradesh, India.	dprakashbhu@gmail.com			Ministry of Earth Sciences, (MoES) New Delhi [P-07-578]; DFG (Deutsche Forschungsgemeinschaft) [Fr 2183/7-1]	Discussions with, and numerous helpful suggestions by, ProfessorR. K. Lal are deeply appreciated. The authors acknowledge the detailed technical advice given by J. A. D. Connolly on the use of the Perple_X software. The manuscript benefitted from constructive reviews by M. Okrusch and the editor. This work was financially supported by the Ministry of Earth Sciences, (MoES) New Delhi, under the research project (P-07-578), and by the DFG (Deutsche Forschungsgemeinschaft; grant No. Fr 2183/7-1).	ACKERMAND D, 1987, J METAMORPH GEOL, V5, P323, DOI 10.1111/j.1525-1314.1987.tb00388.x; Adjerid Z, 2013, J METAMORPH GEOL, V31, P505, DOI 10.1111/jmg.12031; AFTALION M., 2000, GEOL SURV INDIA SPEC, V57, P26; DASGUPTA S, 1995, J PETROL, V36, P435; Shaw RK, 1998, J METAMORPH GEOL, V16, P189, DOI 10.1111/j.1525-1314.1998.00073.x; KRETZ R, 1983, AM MINERAL, V68, P277; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Sengupta P, 1999, J PETROL, V40, P1065, DOI 10.1093/petrology/40.7.1065; THOMPSON AB, 1984, J PETROL, V25, P929; Korhonen FJ, 2013, PRECAMBRIAN RES, V234, P322, DOI 10.1016/j.precamres.2012.12.001; Brandt S, 2011, J PETROL, V52, P1813, DOI 10.1093/petrology/egr032; DASGUPTA S, 1991, CONTRIB MINERAL PETR, V109, P130, DOI 10.1007/BF00687206; Korhonen FJ, 2011, GONDWANA RES, V20, P764, DOI 10.1016/j.gr.2011.05.006; BHOWMIK SK, 1995, EUR J MINERAL, V7, P689; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; ELLIS DJ, 1980, CONTRIB MINERAL PETR, V74, P201, DOI 10.1007/BF01132005; Holland T, 1996, AM MINERAL, V81, P1425; Rickers K, 2001, PRECAMBRIAN RES, V112, P183, DOI 10.1016/S0301-9268(01)00146-2; HENSEN BJ, 1986, CONTRIB MINERAL PETR, V92, P362, DOI 10.1007/BF00572165; Bose S, 2011, GEOL SOC AM BULL, V123, P2031, DOI 10.1130/B30336.1; PAUL DK, 1990, J GEOL, V98, P253; Raith M, 1997, J METAMORPH GEOL, V15, P379, DOI 10.1111/j.1525-1314.1997.00027.x; SENGUPTA P, 1991, J METAMORPH GEOL, V9, P451, DOI 10.1111/j.1525-1314.1991.tb00539.x; Mezger K, 1999, PRECAMBRIAN RES, V94, P251, DOI 10.1016/S0301-9268(98)00118-1; Benisek A, 2010, CONTRIB MINERAL PETR, V160, P327, DOI 10.1007/s00410-009-0480-8; White RW, 2001, J METAMORPH GEOL, V19, P139, DOI 10.1046/j.0263-4929.2000.00303.x; Bhattacharya S, 2002, CONTRIB MINERAL PETR, V143, P175, DOI 10.1007/s00410-001-0341-6; Dasgupta S, 2013, PRECAMBRIAN RES, V227, P247, DOI 10.1016/j.precamres.2012.04.005; LAL RK, 1987, J PETROL, V28, P1139; Holland T, 2001, J PETROL, V42, P673, DOI 10.1093/petrology/42.4.673; Gupta S, 2000, J METAMORPH GEOL, V18, P683, DOI 10.1046/j.1525-1314.2000.00288.x; Yoshida M, 2003, GEOL SOC SPEC PUBL, P57; BERG JH, 1976, AM MINERAL, V61, P29; Bhattacharya S, 2003, J GEOL SOC LONDON, V160, P39, DOI 10.1144/0016-764902-063; Bose S, 2006, LITHOS, V92, P506, DOI 10.1016/j.lithos.2006.03.062; Bose S, 2000, J METAMORPH GEOL, V18, P223; Bose S, 2007, GONDWANA RES, V11, P492, DOI 10.1016/j.gr.2006.07.003; CHATTERJ.ND, 1972, CONTRIB MINERAL PETR, V36, P49, DOI 10.1007/BF00372834; Condie K.C., 2005, EARTH EVOLVING PLANE; Das K, 2011, GEOL J, V46, P217, DOI 10.1002/gj.1246; Dasgupta S, 2008, PRECAMBRIAN RES, V162, P1, DOI 10.1016/j.precamres.2007.07.008; Dasgupta S, 1997, CONTRIB MINERAL PETR, V129, P182, DOI 10.1007/s004100050331; DASGUPTA S, 1994, J PETROL, V35, P433; DASGUPTA S, 1993, MINERAL MAG, V57, P113, DOI 10.1180/minmag.1993.057.386.11; DASGUPTA S., 2003, SPECIAL PUBLICATIONS, V206, P131; Dasgupta S, 1999, J METAMORPH GEOL, V17, P765; DASGUPTA S, 1992, J METAMORPH GEOL, V10, P777, DOI 10.1111/j.1525-1314.1992.tb00122.x; Dharma Rao C. V., 2012, GEOSCIENCE FRONTIERS, V3, P9; FONAREV V. I., 1995, MEM GEOL SOC INDIA, V34, P111; GREW ES, 1980, J PETROL, V21, P39; HENSEN BJ, 1972, CONTRIB MINERAL PETR, V35, P331, DOI 10.1007/BF00371314; HORMANN P. K., 1980, B GEOL SURV FINLAND, V308, P1; KAMINENI DC, 1988, AM MINERAL, V73, P692; KUMAR N., 2004, J INDIAN GEOPHYS UNI, V8, P97; LAL R. K., 2003, MEMOIR GEOLOGICAL SO, V52, P61; LAL RK, 1984, NEUES JB MINER ABH, V150, P121; LONKER SW, 1981, AM J SCI, V281, P1056; Mohan A, 2003, J ASIAN EARTH SCI, V22, P101, DOI 10.1016/S1367-91200(02)00181-5; Mohan A, 1997, P INDIAN AS-EARTH, V106, P115; Mukhopadhyay AK, 1997, J METAMORPH GEOL, V15, P719, DOI 10.1111/j.1525-1314.1997.00051.x; Mukhopadhyay D, 2009, J GEOL SOC INDIA, V73, P489; NOWICKI T. E., 1995, S AFR J GEOL, V98, P191; Pal S, 1997, P INDIAN AS-EARTH, V106, P77; Ramakrishnan M., 1998, GEOL SURV INDIA SPEC, P1; RAO A. T., 1995, GONDWANA RES GROUP M, V2, P109; Rao CVD, 2011, GEOL J, V46, P240, DOI 10.1002/gj.1251; RUTTER E. H., 1997, DEFORMATION ENHANCED, P82; SANDIFORD M, 1986, AM MINERAL, V71, P946; Sarkar S, 2003, GEOLOGY, V31, P51, DOI 10.1130/0091-7613(2003)031<0051:VHDCAW>2.0.CO;2; SCHREYER W, 1969, AM J SCI, V267, P371; SCHREYER W., 1967, CONTRIB MINERAL PETR, V14, P343, DOI 10.1007/BF00373812; SEN SK, 1995, J METAMORPH GEOL, V13, P287, DOI 10.1111/j.1525-1314.1995.tb00219.x; SENGUPTA A. P., 1996, J SE ASIAN EARTH SCI, V14, P185; SENGUPTA A. P., 1997, J METAMORPH GEOL, V15, P551; SENGUPTA A. P., 1997, BEIHEFTE EUROPEAN J, V9; SENGUPTA P, 1990, J PETROL, V31, P971; Shaw RK, 1996, CONTRIB MINERAL PETR, V126, P169, DOI 10.1007/s004100050242; Tajcmanova L, 2009, J METAMORPH GEOL, V27, P153, DOI 10.1111/j.1525-1314.2009.00812.x; Upadhyay D, 2009, J GEOL, V117, P665, DOI 10.1086/606036; Upadhyay D, 2006, CONTRIB MINERAL PETR, V151, P434, DOI 10.1007/s00410-006-0069-4; Vinogradov A.P., 1964, 22ND INT GEOL C DELH, V10, P553	81	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0016-7568	1469-5081		GEOL MAG	Geol. Mag.	MAR	2015	152	2					316	340		10.1017/S0016756814000399		25	Geosciences, Multidisciplinary	Geology	CC7RX	WOS:000350567200008		
J	Matsumoto, M				Matsumoto, Mitsuo			Application of the Constrained Interpolation Profile (CIP) scheme to two-dimensional single-phase hydrothermal reservoir simulations	GEOTHERMICS			English	Article						Constrained Interpolation Profile (CIP) scheme; Advection; Numerical dispersion; Numerical reservoir simulation	CUBIC-POLYNOMIAL INTERPOLATION; OSCILLATION PREVENTING SCHEME; SEMI-LAGRANGIAN SCHEME; HYPERBOLIC-EQUATIONS; ADVECTION EQUATION; RATIONAL-FUNCTION; UNIVERSAL SOLVER	The Constrained Interpolation Profile (CIP) scheme is applied to two-dimensional single-phase numerical simulations of hydrothermal reservoirs for effectively controlling numerical dispersion. The advection terms of the equations for the conservation of mass, enthalpy, and a tracer are solved using the CIP scheme and the non-advection terms, using the finite difference method. The CIP scheme successfully reproduces the high-contrast temperature distribution during cold water reinjection into a hydrothermal reservoir. The flow of a tracer injected into the same reservoir with little dilution is also simulated successfully. In both problems, the conventional first-order upstream difference scheme suffers from severe numerical dispersion. (C) 2014 Elsevier Ltd. All rights reserved.	Idemitsu Kosan Co Ltd, Explorat & Prod Dept, Chiyoda Ku, Tokyo 1008321, Japan	Matsumoto, M (reprint author), Idemitsu Kosan Co Ltd, Explorat & Prod Dept, Chiyoda Ku, 3-1-1 Marunouchi, Tokyo 1008321, Japan.	mitsuo.matsumoto@idemitsu.com					HOOPES JA, 1967, J GEOPHYS RES, V72, P3595, DOI 10.1029/JZ072i014p03595; Yabe T, 2001, MON WEATHER REV, V129, P332, DOI 10.1175/1520-0493(2001)129<0332:AECSLS>2.0.CO;2; YABE T, 1991, COMPUT PHYS COMMUN, V66, P233, DOI 10.1016/0010-4655(91)90072-S; Xiao F, 1996, COMPUT PHYS COMMUN, V94, P103, DOI 10.1016/0010-4655(96)00008-2; Oldenburg CM, 2000, GEOTHERMICS, V29, P1, DOI 10.1016/S0375-6505(99)00048-6; Nakamura T, 2001, J COMPUT PHYS, V174, P171, DOI 10.1006/jcph.2001.6888; Xiao F, 1996, COMPUT PHYS COMMUN, V93, P1, DOI 10.1016/0010-4655(95)00124-7; Croucher AE, 2004, GEOTHERMICS, V33, P503, DOI 10.1016/j.geothermics.2003.09.013; Faust C.R., 1977, 77234 US GEOL SURV; IAPWS, 2001, SUPPL REL BACKW EQ P; IAPWS, 2004, SUPPL REL BACKW EQ P; IAPWS, 2004, REV SUPPL REL BACKW; IAPWS, 2009, REV REL IPAWS FORM 1; IAPWS, 2005, SUPPL REL BACKW EQ S; IAPWS, 1997, REV REL IAPS FORM 19; IAPWS (The International Association for the Properties of Water and Steam), 2007, REV REL IAPWS IND FO; Javandel I., 1984, GROUNDWATER TRANSPOR, V10; Kipp Jr K.L., 2008, 6A25 US GEOL SURV; Matsumoto M., 2011, J GEOTHERM RES SOC J, V33, P155; Nakamura T., 2001, CFD J, P574; Pritchett J.W., 1995, P WORLD GEOTH C 95 F, P2959; Pruess K., 1999, LBNL43134; Tanaka R, 2000, COMPUT PHYS COMMUN, V126, P232, DOI 10.1016/S0010-4655(99)00473-7; Yabe T, 2004, J COMPUT PHYS, V194, P57, DOI 10.1016/j.jcp.2003.08.019; YABE T, 1991, COMPUT PHYS COMMUN, V66, P219, DOI 10.1016/0010-4655(91)90071-R	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0375-6505	1879-3576		GEOTHERMICS	Geothermics	MAR	2015	54						10	22		10.1016/j.geothermics.2014.10.005		13	Energy & Fuels; Geosciences, Multidisciplinary	Energy & Fuels; Geology	CD2YC	WOS:000350943900002		
J	Hebig, KH; Zeilfelder, S; Ito, N; Machida, I; Marui, A; Scheytt, TJ				Hebig, K. H.; Zeilfelder, S.; Ito, N.; Machida, I.; Marui, A.; Scheytt, T. J.			Study of the effects of the chaser in push-pull tracer tests by using temporal moment analysis	GEOTHERMICS			English	Article						Gravel pack; Porosity; Tracer test; Single-well test; Aquifer characterization; Japan	SITU AEROBIC COMETABOLISM; SINGLE-WELL; CONTAMINATED AQUIFER; SOUS-FORETS; TRANSPORT; SULFATE; GROUNDWATER; REDUCTION; INJECTION; VELOCITY	"Push-pull" tracer tests are a suitable tracer test method for hydrochemical characterization of an aquifer in a single-well setting (e.g. in deep geothermal systems). A known amount of selected solutes as conservative and reactive tracers is injected into the aquifer ("push") and afterwards extracted ("pull"). In many cases, a so-called "chaser", which is just original groundwater without any added solutes, is injected directly after the injection of the test solution. Its objective is to push the test solution out of the bore-hole into the aquifer and therefore to minimize the influence of the gravel pack on the shape of the breakthrough curve. The influence of the chaser on the tracer breakthrough curve is unknown so far. Also, the determination of the appropriate volume for the chaser is a difficult task if at all applied. A first experiment was conducted with the objective to compare three push pull tests with similar injection volumes, two tests with and one without a chaser. Results show that the application of a chaser lowers the main peak concentration. However, it does not alter the tailing of the breakthrough curve nor does it have a negative influence on tracer mass recovery. In a second experiment, a new method was developed to determine the optimal chaser volume by testing seven different chaser injection volumes combined with temporal moment analysis. As a result, the application of a chaser is recommended, when reactions of injected solutes within the open well or the gravel pack should be avoided. If a chaser is used, the new method mentioned above can easily be used to determine the required chaser injection volume. The experiments were conducted at the Hamasato test site in Horonobe (Hokkaido, Japan). (C) 2014 Elsevier Ltd. All rights reserved.	[Hebig, K. H.; Zeilfelder, S.; Scheytt, T. J.] Tech Univ Berlin, Dept Appl Geosci, Hydrogeol Res Grp, D-10587 Berlin, Germany; [Ito, N.] NEWJEC Inc, Koto Ku, Tokyo 1360071, Japan; [Machida, I.; Marui, A.] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan	Hebig, KH (reprint author), Tech Univ Berlin, Dept Appl Geosci, Hydrogeol Res Grp, BH 3-2,Ernst Reuter Pl 1, D-10587 Berlin, Germany.	klaus.hebig-schubert@tu-berlin.de; sarah.zeilfelder@tu-berlin.de; itonr@newjec.co.jp; i-machida@aist.go.jp; marui.01@aist.go.jp; traugott.scheytt@tu-berlin.de	Hebig-Schubert, Klaus/I-1818-2015	Hebig-Schubert, Klaus/0000-0001-6687-9298			Davis BM, 2002, J CONTAM HYDROL, V58, P129, DOI 10.1016/S0169-7722(02)00010-4; Schroth MH, 2005, GROUND WATER, V43, P280, DOI 10.1111/j.1745-6584.2005.0002.x; Istok JD, 1997, GROUND WATER, V35, P619, DOI 10.1111/j.1745-6584.1997.tb00127.x; TOMICH JF, 1973, J PETROL TECHNOL, V25, P211; Novakowski KS, 1998, WATER RESOUR RES, V34, P1351, DOI 10.1029/98WR00292; Addy K, 2002, J ENVIRON QUAL, V31, P1017; McGuire JT, 2002, ENVIRON SCI TECHNOL, V36, P2693, DOI 10.1021/es015615q; Haggerty R, 1998, GROUND WATER, V36, P314, DOI 10.1111/j.1745-6584.1998.tb01097.x; Cunningham JA, 2001, ENVIRON SCI TECHNOL, V35, P1663, DOI 10.1021/es001722t; Kleikemper J, 2002, APPL ENVIRON MICROB, V68, P1516, DOI 10.1128/AEM.68.4.1516-1523.2002; Azizian MF, 2005, WATER SCI TECHNOL, V52, P35; Becker M.W., 2003, WATER RESOUR RES, V39; Cunningham JA, 1998, WATER RESOUR RES, V34, P1415, DOI 10.1029/98WR00702; Ghergut I., 2007, P 32 WORKSH GEOTH RE; Gringarten A.C., 1978, PURE APPL GEOPHYS, P117; HALL SH, 1991, GROUND WATER, V29, P171, DOI 10.1111/j.1745-6584.1991.tb00506.x; Hebig KH, 2012, HYDROGEOL J, V20, P227, DOI 10.1007/s10040-011-0815-1; Hellerich LA, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002112; Herfort M., 2003, EOS T AGU, V84, P2003; Ikawa R, 2014, HYDROGEOL J, V22, P987, DOI 10.1007/s10040-014-1106-4; Istok JD, 1999, GROUND WATER, V37, P589, DOI 10.1111/j.1745-6584.1999.tb01146.x; Jung Y., 2012, WATER RESOUR RES, V47; Kehrer P, 2007, Z DTSCH GES GEOWISS, V158, P119, DOI 10.1127/1860-1804/2007/0158-0119; Kim Y, 2004, GROUND WATER, V42, P329, DOI 10.1111/j.1745-6584.2004.tb02681.x; LEAP DI, 1988, WATER RESOUR RES, V24, P993, DOI 10.1029/WR024i007p00993; Luthy L, 2000, APPL ENVIRON MICROB, V66, P712, DOI 10.1128/AEM.66.2.712-717.2000; Meigs LC, 2001, WATER RESOUR RES, V37, P1113, DOI 10.1029/2000WR900335; MOLZ FJ, 1985, WATER RESOUR RES, V21, P1497, DOI 10.1029/WR021i010p01497; Nordqvist R, 2012, HYDROGEOL J, V20, P519, DOI 10.1007/s10040-011-0820-4; PAUWELS H, 1992, APPL GEOCHEM, V7, P243, DOI 10.1016/0883-2927(92)90040-A; Pauwels H, 1997, APPL GEOCHEM, V12, P661, DOI 10.1016/S0883-2927(97)00021-8; Riemann K, 2002, HYDROGEOL J, V10, P357, DOI 10.1007/s10040-002-0197-5; Schroth MH, 2001, J CONTAM HYDROL, V51, P179, DOI 10.1016/S0169-7722(01)00128-0; Vandenbohede A, 2008, HYDROLOG SCI J, V53, P844, DOI 10.1623/hysj.53.4.844	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0375-6505	1879-3576		GEOTHERMICS	Geothermics	MAR	2015	54						43	53		10.1016/j.geothermics.2014.11.004		11	Energy & Fuels; Geosciences, Multidisciplinary	Energy & Fuels; Geology	CD2YC	WOS:000350943900005		
J	Pambudi, NA; Itoi, R; Yamashiro, R; Alam, BYCSSS; Tusara, L; Jalilinasrabady, S; Khasani, J				Pambudi, Nugroho Agung; Itoi, Ryuichi; Yamashiro, Rie; Alam, Boy Yoseph C. S. S. Syah; Tusara, Loren; Jalilinasrabady, Saeid; Khasani, Jaelani			The behavior of silica in geothermal brine from Dieng geothermal power plant, Indonesia	GEOTHERMICS			English	Article						Silica; Scaling; Geothermal; Dieng; Indonesia; Power plant		Silica scaling in the Dieng geothermal power plant was investigated experimentally. We conducted two kinds of polymerization experiments to examine the behavior of silica in brine along the canals at production wellpads. Acid-treated and untreated brines were sampled along the canal to understand the effects of acidification on silica polymerization and deposition. Chemical analysis of the Dieng brine indicated high silica and salt concentrations. Silica concentrations of acid-treated brine showed that acidification successfully suppresses the deposition of silica along the canal, preventing it from fulfilling its purpose of depositing as much silica as possible. In contrast, significant silica polymerization occurred along the canal when the brine was not acidified. Batch experiments for silica polymerization at constant temperature indicated that both concentrations of total and monomeric silica decrease quickly in early times followed by gradual decrease with time. (C) 2015 Elsevier Ltd. All rights reserved.	[Pambudi, Nugroho Agung; Itoi, Ryuichi; Yamashiro, Rie; Alam, Boy Yoseph C. S. S. Syah; Tusara, Loren; Jalilinasrabady, Saeid] Kyushu Univ, Dept Earth Resources Engn, Fukuoka 8190395, Japan; [Pambudi, Nugroho Agung] Sebelas Maret Univ, Teacher Training & Educ Fac, Dept Mech Engn Educ, Surakarta 57126, Indonesia; [Jalilinasrabady, Saeid] Akita Univ, Fac Int Resources Sci, Akita 0108502, Japan; [Khasani, Jaelani] Gadjah Mada Univ, Dept Mech & Ind Engn, Yogyakarta 55281, Indonesia	Pambudi, NA (reprint author), Kyushu Univ, Dept Earth Resources Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	pambudi@kyudai.jp		pambudi, agung/0000-0001-9496-3710	PT Geo Dipa Energi; GCOE program, Kyushu University	The authors thank PT Geo Dipa Energi for their support with research activities at the Dieng power plant and the data provided. The authors also thank the GCOE program, Kyushu University for financial support.	Carlos E.G., 2012, SHORT COURS GEOTH DE; Gallup DL, 2002, GEOTHERMICS, V31, P415, DOI 10.1016/S0375-6505(02)00004-4; Hauksson T., 1986, GEOTHERM RESOUR COUN, V10, P377; Itoi R., 1989, GEOTHERMICS, V18, DOI 10.1016/0375-6505(89)90022-9; Nollet Leo M.L., 1948, HDB WATER ANAL; Rothbaum H.P., 1979, GEOTHERMICS, V8, P1, DOI 10.1016/0375-6505(79)90062-2; Takahashi Y., 1988, J GEOTHERMAL RES SOC, V10, P225; Thorhallsson S, 2005, WORKSH DEC MAK GEOTH; WERES O, 1981, GEOTHERMICS, V10, P255, DOI 10.1016/0375-6505(81)90009-2; Yokoyama T., 1987, P 9 NZ GEOTH WORKSH	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0375-6505	1879-3576		GEOTHERMICS	Geothermics	MAR	2015	54						109	114		10.1016/j.geothermics.2014.12.003		6	Energy & Fuels; Geosciences, Multidisciplinary	Energy & Fuels; Geology	CD2YC	WOS:000350943900011		
J	Nagafuku, M; Sato, T; Sato, S; Shimizu, K; Taira, T; Inokuchi, JI				Nagafuku, Masakazu; Sato, Takashige; Sato, Saya; Shimizu, Kyoko; Taira, Toshio; Inokuchi, Jin-Ichi			Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3	GLYCOBIOLOGY			English	Article						adipogenesis; GM3 ganglioside; inflammatory cytokines; insulin resistance; macrophages	NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; GLYCOSPHINGOLIPID SYNTHESIS; METABOLIC SYNDROME; OBESITY; MACROPHAGE; MICE; DIFFERENTIATION; SENSITIVITY; INFLAMMATION	Ganglioside GM3 (Siaa2-3Gal beta 1-4Glc beta 1-1Cer) has been known to participate in insulin signaling by regulating the association of the insulin receptor in caveolae microdomains (lipid rafts), which is essential for the execution of the complete insulin metabolic signaling in adipocytes. Macrophagesecreted factors including proinflammatory cytokines, tumor necrosis factor-alpha and interleukin-1 beta, in adipose tissues have been known to limit the local adipogenesis and induce insulin resistance; however, the interplay between adipocytes and macrophages upon regulation of GM3 expression is not clear. GM3 was virtually absent in primary adipocytes differentiated from macrophage-depleted mesenteric stromal vesicular cells, which accompanies enhancement of insulin signaling and adipogenesis. We found that the expression of GM3 is governed by soluble factors including steady-state levels of proinflammatory cytokines secreted from resident macrophages. The direct involvement of GM3 in insulin signaling is demonstrated by the fact that embryonic fibroblasts obtained from GM3 synthase (GM3S)-deficient mice have increased insulin signaling, when compared with wild-type embryonic fibroblasts, which in turn leads to enhanced adipogeneis. In addition, GM3 expression in primary adipocytes is increased under proinflammatory conditions as well as in adipose tissue of diet-induced obese mice. Moreover, GM3S-deficient mice fed high-fat diets become obese but are resistant to the development of insulin resistance and chronic low-grade inflammatory states. Thus, GM3 functions as a physiological regulatory factor of the balance between homeostatic and pathological states in adipocytes by modulating insulin signaling in lipid rafts.	[Nagafuku, Masakazu; Sato, Takashige; Sato, Saya; Inokuchi, Jin-Ichi] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Sato, Takashige] Cosmo Bio Co Ltd, Tokyo 1350016, Japan; [Shimizu, Kyoko; Taira, Toshio] Primary Cell Co Ltd, Sapporo, Hokkaido 0010021, Japan	Inokuchi, JI (reprint author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jin@tohoku-pharm.ac.jp			MEXT, Japan [23110002]; Mizutani Research Foundation for Glycoscience; Naito Foundation; ONO Medical Research Foundation; Uehara Memorial Foundation; MEXT	This work was supported by research grants for a Grant-in-Aid for Scientific Research (B) (to J.-I.I.) and for Scientific Research on Innovative Areas (No. 23110002 to K.K.) from MEXT, Japan (J.-I.I.), the Mizutani Research Foundation for Glycoscience (J.-I.I.), The Naito Foundation (J.-I.I.), the ONO Medical Research Foundation (J.-I.I.) and the Uehara Memorial Foundation (J.-I.I.). This work was also supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Wang XQ, 2014, J INVEST DERMATOL, V134, P1446, DOI 10.1038/jid.2013.532; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Sunderkotter C, 2004, J IMMUNOL, V172, P4410; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Couet J, 1997, J BIOL CHEM, V272, P6525; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Inokuchi J, 2014, GLYCOCONJUGATE J, V31, P193, DOI 10.1007/s10719-013-9516-4; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Ailhaud G, 2006, CR BIOL, V329, P570, DOI 10.1016/j.crvi.2005.12.012; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Li YM, 1997, J IMMUNOL METHODS, V201, P183, DOI 10.1016/S0022-1759(96)00224-4; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Feve B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007; Blumer RME, 2008, METABOLISM, V57, P1655, DOI 10.1016/j.metabol.2008.07.020; Chalwa A, 2011, NAT REV IMMUNOL, V11, P738; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Inokuchi J, 2014, HDB GLYCOSYLTRANSFER, P675; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; NAKAMURA K, 1991, J BIOCHEM-TOKYO, V110, P832; Neta R, 1992, Immunol Ser, V56, P499; Samaan MC, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-29; Sato T, 2008, CELL BIOL INT, V32, P1397, DOI 10.1016/j.cellbi.2008.08.010; Shimizu, 2006, CELL BIOL INT, V30, P381; STEPHENS JM, 1992, J MOL ENDOCRINOL, V9, P61; Suganami T, 2011, J LEUCOCYTE BIOL, V88, P33; Suzawa T, 2003, NAT CELL BIOL, V5, P224; SUZUKI M, 1986, CARBOHYD RES, V151, P213, DOI 10.1016/S0008-6215(00)90342-2; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Ye J, 2007, AM J PHYSIOL-ENDOC M, V293, pE111; Yew NS, 2010, HEPATOLOGY, V50, P85; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106	58	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	MAR	2015	25	3					303	318		10.1093/glycob/cwu112		16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD2JG	WOS:000350902900007		
J	Hirota, K; Keino, H; Inoue, M; Ishida, H; Hirakata, A				Hirota, Kazunari; Keino, Hiroshi; Inoue, Makoto; Ishida, Hitoshi; Hirakata, Akito			Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						microRNA; Vitreous humor; Proliferative diabetic retinopathy; Macular hole	MICROVASCULAR ENDOTHELIAL-CELLS; GROWTH-FACTOR; TUMOR ANGIOGENESIS; RENAL FIBROSIS; NONCODING RNAS; MIR-21; BIOMARKERS; CANCER	MicroRNAs (miRNAs) are small noncoding RNAs which regulate the activities of target mRNAs. We compared the expression profiles of the miRNAs in the vitreous of eyes with macular hole (MH) to that in eyes with proliferative diabetic retinopathy (PDR). Vitreous and whole blood samples were collected from four patients with MH and from four patients with PDR. We assayed for 168 miRNAs in the vitreous and serum samples by the microRNA PCR Panel method. The mean number of miRNAs expressed in the vitreous was 63 (55-69) in eyes with MH and 86 (65-117) in eyes with PDR. The mean number of miRNAs expressed in the serum was 162 (159-167) in the MH patients and 142 (115-160) in the PDR patients. Twenty-six miRNAs were expressed in the vitreous of both MH and PDR eyes. Although there was no significant difference in the levels of 20 of the 26 (73 %) miRNAs expressed in both MH and PDR eyes, six of 26 miRNAs (24 %) (hsa-miR-15a, hsa-miR320a, hsa-miR-320b, hsa-miR-93, hsa-miR-29a, and hsa-miR-423-5p) were expressed significantly more highly in PDR eyes. In addition, the mean fold changes of three miRNAs, hsa-miR-23a, hsa-miR-320a, and hsa-miR-320b, in the vitreous to serum were significantly higher in the PDR group than in the MH group. The expression of several miRNAs related to angiogenesis and fibrosis was expressed significantly higher in the vitreous of eyes with PDR. Further studies are needed to understand the role played by the miRNAs in the biological function of the eye.	[Hirota, Kazunari; Keino, Hiroshi; Inoue, Makoto; Hirakata, Akito] Kyorin Univ, Sch Med, Dept Ophthalmol, Mitaka, Tokyo 1818611, Japan; [Ishida, Hitoshi] Kyorin Univ, Sch Med, Dept Internal Med 3, Mitaka, Tokyo 1818611, Japan	Hirota, K (reprint author), Kyorin Univ, Sch Med, Dept Ophthalmol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	hirota@eye-center.org			Kyorin University, Tokyo, Japan	This work was supported by Grant for Scientific Research from Kyorin University, Tokyo, Japan.	Anand Sudarshan, 2013, Vasc Cell, V5, P2, DOI 10.1186/2045-824X-5-2; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Schraermeyer U, 2013, EXPERT OPIN BIOL TH, V13, P157, DOI 10.1517/14712598.2012.748741; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Ragusa M, 2013, MOL VIS, V19, P430; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Salam A, 2011, ACTA OPHTHALMOL, V89, P405, DOI 10.1111/j.1755-3768.2010.02079.x; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Fiorentino L, 2013, ACTA DIABETOL, V50, P965, DOI 10.1007/s00592-013-0492-8; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Tomankova T, 2012, SCAND J IMMUNOL, V75, P129, DOI 10.1111/j.1365-3083.2011.02650.x; Zhao Y, 2013, TOXICOL LETT, V223, P35, DOI 10.1016/j.toxlet.2013.08.020; Boon RA, 2012, CIRC RES, V111, P1388, DOI 10.1161/CIRCRESAHA.112.280529; Kanwar Jagat R, 2010, Front Biosci (Schol Ed), V2, P1113; Li R., 2014, INT J ENDOCRINOL, V2014, DOI DOI 10.1155/2014/593956; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Tuo JS, 2014, AM J OPHTHALMOL, V157, P728, DOI 10.1016/j.ajo.2013.12.014	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2015	253	3					335	342		10.1007/s00417-014-2692-5		8	Ophthalmology	Ophthalmology	CC6WR	WOS:000350510200002		
J	Hasegawa, T; Okamoto, M; Masuda, N; Ueda, T; Ogata, N				Hasegawa, Taiji; Okamoto, Masahiro; Masuda, Naonori; Ueda, Tetsuo; Ogata, Nahoko			Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Central serous chorioretinopathy; Optical coherence tomography; Photoreceptor outer segment length; Visual outcome	OPTICAL COHERENCE TOMOGRAPHY; OUTER SEGMENT LENGTH; TERM-FOLLOW-UP; PHOTODYNAMIC THERAPY; PHOTORECEPTOR LAYER; RETINAL SENSITIVITY; MACULAR EDEMA; RESOLUTION; ACUITY	To determine whether significant correlations exist between the foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy (CSC). We retrospectively reviewed the medical records of patients who had a complete resolution of the serous retinal detachment (SRD) and had an intact ellipsoid zone in the fovea in the spectral-domain optical coherence tomographic (SD-OCT) images. Twenty-five eyes with CSC (CSC group) and 18 unaffected fellow eyes (control group) of 23 patients were evaluated. The eyes in the CSC group were divided into those with (n = 11) and those without (n = 14) visual disturbances after resolution of the SRD. The thickness of each retinal layer at the fovea was measured in the SD-OCT images. The photoreceptor outer segment (OS) length in the CSC group was significantly shorter than that in the control group (p = 0.0003). In addition, the photoreceptor OS length in the visual disturbances group was significantly shorter and the duration of SRD was significantly longer than that in the no visual disturbances group (p = 0.0230, p = 0.0021, respectively). The photoreceptor OS length is a good parameter to indicate the integrity of the foveal photoreceptors in eyes with a resolved CSC.	[Hasegawa, Taiji; Okamoto, Masahiro; Masuda, Naonori; Ueda, Tetsuo; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara 6348522, Japan	Hasegawa, T (reprint author), Nara Med Univ, Dept Ophthalmol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	taijiha@naramed-u.ac.jp					Iida T, 2003, RETINA-J RET VIT DIS, V23, P1, DOI 10.1097/00006982-200302000-00001; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; Mohammad S, 2011, OPHTHALMOLOGY, V118, P1645, DOI 10.1016/j.ophtha.2011.01.037; Ojima Y, 2010, JPN J OPHTHALMOL, V54, P55, DOI 10.1007/s10384-009-0766-4; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Wang MSM, 2002, AM J OPHTHALMOL, V133, P787, DOI 10.1016/S0002-9394(02)01438-1; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Ojima Y, 2007, OPHTHALMOLOGY, V114, P2197, DOI 10.1016/j.ophtha.2007.02.015; FICKER L, 1988, BRIT J OPHTHALMOL, V72, P829, DOI 10.1136/bjo.72.11.829; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; Ojima Y, 2008, AM J OPHTHALMOL, V146, P77, DOI 10.1016/j.ajo.2008.02.016; KLEIN ML, 1974, ARCH OPHTHALMOL-CHIC, V91, P247; CELESIA GG, 1994, J CLIN NEUROPHYSIOL, V11, P482, DOI 10.1097/00004691-199409000-00003; Fujita K, 2012, AM J OPHTHALMOL, V154, P579, DOI 10.1016/j.ajo.2012.03.043; Yap EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P689; Scholl HPN, 2012, ARCH OPHTHALMOL-CHIC, V130, P1554; Eandi CM, 2005, RETINA-J RET VIT DIS, V25, P417, DOI 10.1097/00006982-200506000-00004; Gass JD, 1967, AM J OPHTHALMOL S, V63, P1; GILBERT CM, 1984, BRIT J OPHTHALMOL, V68, P815, DOI 10.1136/bjo.68.11.815; Hasegawa T, 2014, AM J OPHTHALMOL, V157, P390, DOI 10.1016/j.ajo.2013.10.007; Hata M, 2013, RETINA-J RET VIT DIS, V33, P296, DOI 10.1097/IAE.0b013e31826710a0; PU GAW, 1984, J NEUROSCI, V4, P1559; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004	24	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2015	253	3					343	350		10.1007/s00417-014-2695-2		8	Ophthalmology	Ophthalmology	CC6WR	WOS:000350510200003		
J	Ijiri, S; Sugiyama, K				Ijiri, Shigeyuki l; Sugiyama, Kazuhisa			Short-term efficacy of intravitreal aflibercept for patients with treatment-na < ve polypoidal choroidal vasculopathy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Aflibercept; Polypoidal choroidal vasculopathy; Treatment-naive; Indocyanine green angiography	MACULAR DEGENERATION; PHOTODYNAMIC THERAPY; GROWTH-FACTOR; VEGF TRAP; JAPANESE PATIENTS; RANIBIZUMAB; BEVACIZUMAB; OUTCOMES; NEOVASCULARIZATION; RESISTANT	To evaluate the short-term efficacy of aflibercept monotherapy for patients with treatment-na < ve polypoidal choroidal vasculopathy (PCV). Prospective, consecutive case series. Thirty-three consecutive eyes of 33 symptomatic PCV patients (17 men, 16 women, mean age 75 +/- 8.7 years), not treated previously, received an intravitreal injection of 2.0 mg of aflibercept monthly for 3 months. Changes in best-corrected visual acuity (BCVA), optical coherence tomography (OCT) findings, and indocyanine green angiography (ICGA) findings 3 months after initial injection were evaluated. Compared with baseline, mean BCVA at 3-month visit significantly improved (0.40 +/- 0.34 vs 0.22 +/- 0.20 log minimum angle of resolution [logMAR] unit, P < 12 0.001). Eight eyes (24 %) showed improvement in BCVA a parts per thousand yenaEuro parts per thousand 0.3 logMAR unit, and no eyes (0 %) showed a decrease in BCVA of a parts per thousand yenaEuro parts per thousand 0.3 logMAR unit. Mean foveal thickness improved significantly (348 +/- 184 mu m at baseline vs 194 +/- 32 mu m at 3-month visit, P < 15 0.001). At 3-month visit, 31 eyes (97 %) achieved dry macula evaluated on OCT. Polypoidal lesions disappeared completely on ICGA in 16 eyes (48 %), and the number and/or the size of polypoidal lesions decreased in nine eyes (27 %). The remaining eight eyes (24 %) had unchanged polypoidal lesions. A branching vascular network remained and was unchanged in diameter in all 27 eyes in which it was detected at baseline. Intravitreal aflibercept was well-tolerated in patients with treatment-na < ve PCV over the short-term.	[Ijiri, Shigeyuki l; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa 9208641, Japan	Ijiri, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa 9208641, Japan.	ijiri@p1.coralnet.or.jp					Akaza E, 2011, JPN J OPHTHALMOL, V55, P39, DOI 10.1007/s10384-010-0886-x; Bakall B, 2013, AM J OPHTHALMOL, V156, P15, DOI 10.1016/j.ajo.2013.02.017; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003; Chang AA, 2014, OPHTHALMOLOGY, V121, P188, DOI 10.1016/j.ophtha.2013.08.035; Ho VY, 2013, AM J OPHTHALMOL, V156, P23, DOI 10.1016/j.ajo.2013.02.009; Yonekawa Y, 2013, AM J OPHTHALMOL, V156, P29, DOI 10.1016/j.ajo.2013.03.030; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Kumar N, 2013, RETINA-J RET VIT DIS, V33, P1605, DOI 10.1097/IAE.0b013e31828e8551; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Koizumi H, 2011, BRIT J OPHTHALMOL, V95, P1555, DOI 10.1136/bjophthalmol-2011-300285; Uyama M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1035; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Tano Yasuo, 2009, Nippon Ganka Gakkai Zasshi, V113, P1098; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Lai TYY, 2009, RETINA-J RET VIT DIS, V29, P750, DOI 10.1097/IAE.0b013e31819ed6bd; Hikichi T, 2010, AM J OPHTHALMOL, V150, P674, DOI 10.1016/j.ajo.2010.05.026; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, NIPPON GANKA GAKKAI, V109, P417; Miura Masahiro, 2013, Clin Ophthalmol, V7, P1591, DOI 10.2147/OPTH.S50634; Wakabayashi T, 2008, BRIT J OPHTHALMOL, V92, P936, DOI 10.1136/bjo.2007.132357; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yuzawa M, 2003, JPN J OPHTHALMOL, V47, P379, DOI 10.1016/S0021-5155(03)00042-X	33	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2015	253	3					351	357		10.1007/s00417-014-2707-2		7	Ophthalmology	Ophthalmology	CC6WR	WOS:000350510200004		
J	Yunoki, T; Tabuchi, Y; Hayashi, A; Kondo, T				Yunoki, Tatsuya; Tabuchi, Yoshiaki; Hayashi, Atsushi; Kondo, Takashi			BAG3 protects against hyperthermic stress by modulating NF-kappa B and ERK activities in human retinoblastoma cells	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Retinoblastoma; Hyperthermia; BAG3; NF-kappa B; ERK	HEAT-SHOCK FACTOR-1; CANCER-CELLS; INDUCED APOPTOSIS; INTRAOCULAR RETINOBLASTOMA; HEPATOCELLULAR-CARCINOMA; PROTEASOME INHIBITION; EXPRESSION; KINASE; SENSITIVITY; ACTIVATION	BCL2-associated athanogene 3 (BAG3), a co-chaperone of HSP70, is a cytoprotective and anti-apoptotic protein that acts against various stresses, including heat stress. Here, we examined the effect of BAG3 on the sensitivity of human retinoblastoma cells to hyperthermia (HT). We examined the effects of BAG3 knockdown on the sensitivity of Y79 and WERI-Rb-1cells to HT (44 A degrees C, 1 h) by evaluating apoptosis and cell proliferation using western blotting, real-time quantitative PCR (qPCR), flow cytometry, and a WST-8 assay kit. Furthermore, we examined the effects of activating nuclear factor-kappa B (NF-kappa B) and extracellular signal-regulated kinase (ERK) using western blotting and real time qPCR. HT induced considerable apoptosis along with the activation of caspase-3 and chromatin condensation. The sensitivity of Y79 and WERI-Rb-1 cells to HT was significantly enhanced by BAG3 knockdown. Compared to HT alone, the combination of BAG3 knockdown and HT reduced phosphorylation of the inhibitors of kappa B alpha (I kappa B alpha) and p65, a subunit of NF-kappa B, and degraded I kappa B kinase gamma (IKK gamma) during the recovery period after HT. Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK after HT treatment, and the ERK inhibitor U0126 significantly improved the viability of the cells treated with a combination of BAG3 knockdown and HT. The silencing of BAG3 seems to enhance the effects of HT, at least in part, by maintaining HT-induced inactivity of NF-kappa B and the phosphorylation of ERK. These findings indicate that BAG3 may be a potential molecular target for modifying the outcomes of HT in retinoblastoma.	[Yunoki, Tatsuya; Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Yunoki, Tatsuya; Hayashi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Ophthalmol, Toyama 9300194, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 9300194, Japan	Yunoki, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, 2630 Sugitani, Toyama 9300194, Japan.	yunokiki@med.u-toyama.ac.jp			Japan Society for the Promotion of Science [24310046]	This study was supported in part by a Grant-in-Aid for Scientific Research B (24310046) from the Japan Society for the Promotion of Science.	Abramson DH, 2004, OPHTHALMOLOGY, V111, P984, DOI 10.1016/j.ophtha.2003.08.035; Aktas M, 2007, EUR J OBSTET GYN R B, V133, P100, DOI 10.1016/j.ejogrb.2006.05.005; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231; Ammirante M, 2010, P NATL ACAD SCI USA, V107, P7497, DOI 10.1073/pnas.0907696107; Suzuki M, 2011, CANCER LETT, V303, P65, DOI 10.1016/j.canlet.2011.01.019; Lin P, 2009, AM J OPHTHALMOL, V148, P192, DOI 10.1016/j.ajo.2009.04.004; Shields CL, 1999, ARCH OPHTHALMOL-CHIC, V117, P885; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Mattson D, 2004, INT J HYPERTHER, V20, P224, DOI 10.1080/02656730310001619956; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Kariya A, 2013, INT J MOL MED, V32, P195, DOI 10.3892/ijmm.2013.1366; Furusawa Y, 2012, APOPTOSIS, V17, P102, DOI 10.1007/s10495-011-0660-7; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; Yunoki T, 2013, CANCER LETT, V335, P52, DOI 10.1016/j.canlet.2013.01.049; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Falco A, 2012, ONCOGENE, V31, P5153, DOI 10.1038/onc.2012.17; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Shields CL, 1997, OPHTHALMOLOGY, V104, P2101; Choi EK, 2003, INT J HYPERTHER, V19, P431, DOI 10.1080/0265673021000017118; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; MacCarthy A, 2006, EUR J CANCER, V42, P2092, DOI 10.1016/j.ejca.2006.06.003; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Wang HQ, 2009, BRIT J PHARMACOL, V158, P1405, DOI 10.1111/j.1476-5381.2009.00455.x; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Chuma M, 2014, CARCINOGENESIS, V35, P272, DOI 10.1093/carcin/bgt343; Shields CL, 2014, CURR OPIN OPHTHALMOL, V25, P374, DOI 10.1097/ICU.0000000000000091; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Aravindan N, 2009, MOL CELL BIOCHEM, V327, P29, DOI 10.1007/s11010-009-0039-z; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Du ZX, 2008, BIOCHEM BIOPH RES CO, V369, P894, DOI 10.1016/j.bbrc.2008.02.112; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Inomata M, 2002, INT J HYPERTHER, V18, P50, DOI 10.1080/02656730110087068; Kokura S, 2003, CANCER LETT, V201, P89, DOI 10.1016/S0304-9835(03)00463-4; Pajonk F, 2005, CANCER RES, V65, P4836, DOI 10.1158/0008-5472.CAN-03-2749; Park JB, 2011, PHYTOMEDICINE, V18, P843, DOI 10.1016/j.phymed.2011.01.025; PARK SJ, 2013, ASIAN WOMEN, V29, P1; Poulaki V, 2002, AM J PATHOL, V161, P2229, DOI 10.1016/S0002-9440(10)64499-9; Qu Y, 2011, J CLIN PATHOL, V64, P695, DOI 10.1136/jclinpath-2011-200017; Rosati A, 2012, BBA-REV CANCER, V1826, P365, DOI 10.1016/j.bbcan.2012.06.001; Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330; Staibano S, 2010, TUMOR BIOL, V31, P461, DOI 10.1007/s13277-010-0055-3; Tabuchi Y, 2013, INT J MOL SCI, V14, P22721, DOI 10.3390/ijms141122721; Wang C Y, 1996, Science, V274, P784; Wang HQ, 2008, BIOCHEM BIOPH RES CO, V365, P381, DOI 10.1016/j.bbrc.2007.11.001; Xia HQ, 2006, INT J HYPERTHER, V22, P613, DOI 10.1080/02656730601012508; Xiao H, 2014, LAB INVEST, V94, P252, DOI 10.1038/labinvest.2013.151; Yunoki T, 2013, INVEST OPHTH VIS SCI, V54, P8353, DOI 10.1167/iovs.13-12618; Zhang Y, 2012, ONCOL REP, V27, P109, DOI 10.3892/or.2011.1486	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2015	253	3					399	407		10.1007/s00417-014-2874-1		9	Ophthalmology	Ophthalmology	CC6WR	WOS:000350510200009		
J	Nakashima, KI; Inoue, T; Fukushima, A; Hirakawa, S; Kojima, S; Tanihara, H				Nakashima, Kei-Ichi; Inoue, Toshihiro; Fukushima, Ayako; Hirakawa, Saori; Kojima, Sachi; Tanihara, Hidenobu			Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Oozing; Anterior segment optical coherent tomography; Bleb; Trabeculectomy; Glaucoma	MITOMYCIN-C; AQUEOUS-HUMOR; RISK-FACTORS; POINT-LEAK; TRABECULECTOMY	To explore the features of filtering blebs exhibiting transconjunctival oozing via three-dimensional anterior segment optical coherence tomography (3D AS-OCT). In this cross-sectional study, 131 eyes of 131 patients exhibiting filtering blebs were examined. Of those, 20 eyes were excluded as flat-shaped, non-functioning bleb. Transconjunctival oozing was defined as transconjunctival aqueous egress evident on the bleb surface, in the absence of any point leak observable using a slit-lamp, as confirmed by application of digital pressure. Total bleb height, the height of the fluid-filled cavity, and bleb wall thickness and density were measured using 3D AS-OCT. Patient age, the etiology of glaucoma, postoperative follow-up period, number of glaucoma medication classes prescribed, intraocular pressure (IOP), grade of bleb vascularity, and bleb parameters were compared in eyes with and without bleb oozing. Sixty (54.0 %) of 111 eyes excluding non-functioning flat blebs exhibited oozing; mean IOP value (11.7 +/- 4.5 vs. 14.8 +/- 4.0 mmHg) and bleb vascularity grade (1.5 +/- 0.7 vs. 2.4 +/- 1.0) were lower than those of eyes without oozing. Total bleb height (1.1 +/- 0.4 vs. 0.9 +/- 0.4 mm), bleb wall thickness (0.7 +/- 0.4 vs. 0.5 +/- 0.3 mm), and bleb wall density (131.3 +/- 45.7 vs. 180.9 +/- 39.8 optical density units) differed significantly between the two groups (oozing vs. non-oozing). Transconjunctival oozing after trabeculectomy with MMC was associated with a low IOP, low-level bleb vascularity, an elevated total bleb height, a thicker bleb wall, and low bleb wall density.	[Nakashima, Kei-Ichi; Inoue, Toshihiro; Fukushima, Ayako; Hirakawa, Saori; Kojima, Sachi; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto 8608556, Japan	Inoue, T (reprint author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	noel@da2.so-net.ne.jp			JSPS KAKENHI [23390403, 23659814, 23791994]	This work was supported in part by JSPS KAKENHI Grant Numbers 23390403, 23659814, and 23791994. The funding organization had no role in the design or conduct of this research.	Matsuo H, 2002, AM J OPHTHALMOL, V133, P456, DOI 10.1016/S0002-9394(01)01432-5; Yamamoto T, 2014, OPHTHALMOLOGY, V121, P1001, DOI 10.1016/j.ophtha.2013.11.025; Soltau JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P338; Song A, 2002, OPHTHALMOLOGY, V109, P985, DOI 10.1016/S0161-6420(02)00965-X; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Anand N, 2006, BRIT J OPHTHALMOL, V90, P175, DOI 10.1136/bjo.2005.077800; Solus JF, 2012, OPHTHALMOLOGY, V119, P703, DOI 10.1016/j.ophtha.2011.09.046; Inoue T, 2012, INVEST OPHTH VIS SCI, V53, P8288, DOI 10.1167/iovs.12-10941; Hu CY, 2003, OPHTHALMOLOGY, V110, P345, DOI 10.1016/S0161-6420(02)01739-6; Kojima S, 2014, J GLAUCOMA, V23, P312, DOI 10.1097/IJG.0b013e3182741ee6; Matsuo H, 2005, EYE, V19, P23, DOI 10.1038/sj.eye.6701422; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2015	253	3					439	445		10.1007/s00417-014-2872-3		7	Ophthalmology	Ophthalmology	CC6WR	WOS:000350510200014		
J	Yane, K; Maguchi, H; Katanuma, A; Takahashi, K; Osanai, M; Kin, T; Takaki, R; Matsumoto, K; Gon, K; Matsumori, T; Tomonari, A; Nojima, M				Yane, Kei; Maguchi, Hiroyuki; Katanuma, Akio; Takahashi, Kuniyuki; Osanai, Manabu; Kin, Toshifumi; Takaki, Ryo; Matsumoto, Kazuyuki; Gon, Katsushige; Matsumori, Tomoaki; Tomonari, Akiko; Nojima, Masanori			Feasibility, Efficacy, and Predictive Factors for the Technical Success of Endoscopic Nasogallbladder Drainage: A Prospective Study	GUT AND LIVER			English	Article						Acute cholecystitis; Endoscopic retrograde cholangiopancreatography; Gallbladder drainage	INTERVAL LAPAROSCOPIC CHOLECYSTECTOMY; TRANSPAPILLARY GALLBLADDER DRAINAGE; ACUTE ACALCULOUS CHOLECYSTITIS; CRITICALLY ILL PATIENTS; PERCUTANEOUS CHOLECYSTOSTOMY; RISK; ASPIRATION	Background/Aims: Several studies have shown the usefulness of endoscopic nasogallbladder drainage (ENGBD) in patients with acute cholecystitis. However, the procedure is difficult, and factors that affect technical success have not yet been clarified. We conducted a prospective study to evaluate the technical feasibility, efficacy, and predictive factors for the technical success of ENGBD in patients with acute cholecystitis. Methods: All patients with moderate or severe acute cholecystitis who were enrolled underwent ENGBD between April 2009 and April 2011. Patients with surgically altered anatomy or pancreatobiliary malignancies were excluded. The primary outcomes included technical success, clinical success, and complications. Factors that could affect the technical success were also examined. Results: Of the 27 patients who underwent ENGBD during the study period, technical success was achieved in 21 (78%) and clinical improvement was achieved in 20 (95%). Early complications were encountered in four patients (15%). Gallbladder wall thickness (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.08 to 2.47) and age (OR, 1.16; 95% CI, 1.00 to 1.35) were effective predictors of technical failure. Conclusions: ENGBD was effective in resolving acute cholecystitis; however, this modality was technically challenging and had a limited success rate. Because of technical difficulties, ENGBD should be reserved for limited indications.	[Yane, Kei; Maguchi, Hiroyuki; Katanuma, Akio; Takahashi, Kuniyuki; Osanai, Manabu; Kin, Toshifumi; Takaki, Ryo; Matsumoto, Kazuyuki; Gon, Katsushige; Matsumori, Tomoaki; Tomonari, Akiko] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido 0068555, Japan; [Nojima, Masanori] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Adv Med Promot, Tokyo, Japan	Yane, K (reprint author), Teine Keijinkai Hosp, Ctr Gastroenterol, Teine Ku, 1-40 Maeda 1 Jo 12 Chome, Sapporo, Hokkaido 0068555, Japan.	k.yane3@gmail.com					Mutignani M, 2009, ENDOSCOPY, V41, P539, DOI 10.1055/s-0029-1214727; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Chopra S, 2001, AM J ROENTGENOL, V176, P1025; Itoi T, 2008, GASTROINTEST ENDOSC, V68, P455, DOI 10.1016/j.gie.2008.02.052; Tsuyuguchi T, 2013, J HEPATO-BIL-PAN SCI, V20, P81, DOI 10.1007/s00534-012-0570-2; Itoi T, 2010, GASTROINTEST ENDOSC, V71, P1038, DOI 10.1016/j.gie.2010.01.026; Yamashita Y, 2013, J HEPATO-BIL-PAN SCI, V20, P89, DOI 10.1007/s00534-012-0567-x; Spira RM, 2002, AM J SURG, V183, P62, DOI 10.1016/S0002-9610(01)00849-2; Lau H, 2006, SURG ENDOSC, V20, P82, DOI 10.1007/s00464-005-0100-2; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; BLOCH RS, 1985, ARCH SURG-CHICAGO, V120, P669; Ito K, 2004, AM J ROENTGENOL, V183, P193; FERETIS C, 1993, ENDOSCOPY, V25, P392, DOI 10.1055/s-2007-1010347; FRAZEE RC, 1989, MAYO CLIN PROC, V64, P163; JOHLIN FC, 1993, GASTROINTEST ENDOSC, V39, P645; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kiviniemi H, 1998, INT SURG, V83, P299; Kjaer DW, 2007, ENDOSCOPY, V39, P304, DOI 10.1055/s-2007-966335; Nakatsu T, 1997, J HEPATOBILIARY PANC, V4, P31, DOI 10.1007/BF01211341; Ogawa O, 2008, CAN J GASTROENTEROL, V22, P681; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Patterson EJ, 1996, SURG ENDOSC-ULTRAS, V10, P1185, DOI 10.1007/s004649900275; Toyota N, 2006, J HEPATO-BILIARY-PAN, V13, P80, DOI 10.1007/s00534-005-1062-4; VANSONNENBERG E, 1992, RADIOLOGY, V183, P167	25	2	2	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	MAR	2015	9	2					239	246		10.5009/gnl14070		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CC7HQ	WOS:000350538700020		
J	Kuwatani, M; Kawakami, H; Abe, Y; Kawahata, S; Kawakubo, K; Kubo, K; Sakamoto, N				Kuwatani, Masaki; Kawakami, Hiroshi; Abe, Yoka; Kawahata, Shuhei; Kawakubo, Kazumichi; Kubo, Kimitoshi; Sakamoto, Naoya			A Unique Use of a Double-Pigtail Plastic Stent: Correction of Kinking of the Common Bile Duct Due to a Metal Stent	GUT AND LIVER			English	Article						Common bile duct neoplasms; Cholangiopancreatography, endoscopic retrograde; Stents; Adverse effects; Cholangitis		A 72-year-old man with jaundice by ampullary adenocarcinonria was treated at our hospital. For biliary decompression, a transpapillary, fully covered, self-expandable metal stent (FCSEMS) was deployed. Four days later, the patient developed acute. cholangitis. Endoscopic carbon dioxide cholangiography revealed kinking of the common bile duct above the proximal end of the FCSEMS. A 7-F double-pigtail plastic stent was therefore placed through the FCSEMS to correct the kink, straightening the common bile duct (CBD) and improving cholangitis. This is the first report of a unique use of a double-pigtail plastic stent to correct CBD kinking. The placement of a double-pigtail plastic stent can correct CBD kinking, without requiring replacement or addition of a FCSEMS, and can lead to cost savings.	[Kuwatani, Masaki; Kawakami, Hiroshi; Abe, Yoka; Kawahata, Shuhei; Kawakubo, Kazumichi; Kubo, Kimitoshi; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 0608638, Japan	Kuwatani, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	mkuwatan@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Isayama H, 2011, DIGEST ENDOSC, V23, P310, DOI 10.1111/j.1443-1661.2011.01124.x; Itoi T, 2010, GASTROINTEST ENDOSC, V71, P1038, DOI 10.1016/j.gie.2010.01.026; Almadi MA, 2013, CLIN GASTROENTEROL H, V11, P27, DOI 10.1016/j.cgh.2012.10.019; Fabbri C, 2014, WORLD J GASTROENTERO, V20, P8424, DOI 10.3748/wjg.v20.i26.8424; Nakai Y, 2011, DIGEST ENDOSC, V23, P49, DOI 10.1111/j.1443-1661.2010.01043.x; Okamoto T, 2006, GASTROINTEST ENDOSC, V63, P792, DOI 10.1016/j.gie.2005.05.015; Park JK, 2011, AM J GASTROENTEROL, V106, P1761	7	0	0	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	MAR	2015	9	2					251	252		10.5009/gnl14286		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CC7HQ	WOS:000350538700022		
J	Okumura, K; Tsukamoto, H; Tsuboi, H; Hirayama, H; Kamiya, H; Watarai, M; Ishiki, R; Murohara, T				Okumura, Kenji; Tsukamoto, Hideto; Tsuboi, Hideyuki; Hirayama, Haruo; Kamiya, Haruo; Watarai, Masato; Ishiki, Ryoji; Murohara, Toyoaki		Samurai Study Investigators	High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness	HEART AND VESSELS			English	Article						Intima-media thickness; Pitavastatin; HDL cholesterol; Lipoproteins	CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; DOSE SIMVASTATIN THERAPY; TYPE-2 DIABETIC SUBJECTS; FAMILIAL HYPERCHOLESTEROLEMIA; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; JAPANESE PATIENTS; ARTERY INTIMA; J-LIT	This study is a prospective multicenter study designed to investigate the effects of lipid-lowering therapy with pitavastatin on atherosclerotic plaque in patients with coronary heart disease, and to determine which factor is more closely associated with plaque regression. Participants (n = 63) were treated with pitavastatin for 12 months, and the carotid intima-media thickness (IMT) was measured by ultrasound before and after treatment. Mean IMT slightly but significantly decreased (from 0.99 +/- A 0.33 to 0.94 +/- A 0.28 mm for overall, P = 0.01) regardless of the presence of pretreatment with other statins. There were no significant relations with hs-CRP, malondialdehyde-LDL, LDL cholesterol, and smaller LDL cholesterol levels despite their decrease by pitavastatin. Decreases in mean IMT were observed significantly more frequently in subjects with high on-treatment HDL cholesterol levels than with low HDL cholesterol levels (P = 0.017). The change in mean IMT tended to be inversely correlated with increments in HDL cholesterol and apolipoprotein A-I. The IMT regression was more often observed in the absence of diabetes and metabolic syndrome. In conclusion, we demonstrated that treatment with pitavastatin attenuated atherosclerotic plaque. This effect was associated with the level of HDL cholesterol, and was stronger in the absence of diabetes and metabolic syndrome in our ischemic heart disease patients.	[Okumura, Kenji; Tsukamoto, Hideto] Toki Municipal Gen Hosp, Dept Cardiol, Gifu 5095193, Japan; [Tsuboi, Hideyuki] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan; [Hirayama, Haruo] Nagoya Daini Red Cross Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Kamiya, Haruo] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Watarai, Masato] Anjo Kosei Hosp, Cardiovasc Ctr, Anjo, Japan; [Ishiki, Ryoji] Toyota Mem Hosp, Dept Internal Med, Toyota, Japan; [Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Okumura, K (reprint author), Toki Municipal Gen Hosp, Dept Cardiol, 703-24 Tokiguchi,Tokitsu Cho, Gifu 5095193, Japan.	kenji@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		KOWA Pharmaceutical Co. Ltd. (Tokyo, Japan)	We thank all participants of this Secondary SAMURAI Study (Statin therapy against multi-lipoprotein profiling and atherosclerosis) for their co-operation and patience throughout the trial. The Department of Cardiology of the Nagoya University Graduate School of Medicine received an unrestricted research grant support from KOWA Pharmaceutical Co. Ltd. (Tokyo, Japan).	Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Bernard S, 2005, DIABETES CARE, V28, P1158, DOI 10.2337/diacare.28.5.1158; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oikawa S, 2007, ATHEROSCLEROSIS, V191, P440, DOI 10.1016/j.atherosclerosis.2006.04.017; Boekholdt SM, 2013, CIRCULATION, V128, P1504, DOI 10.1161/CIRCULATIONAHA.113.002670; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Mabuchi H, 2002, CIRC J, V66, P1096, DOI 10.1253/circj.66.1096; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Beishuizen ED, 2004, DIABETES CARE, V27, P2887, DOI 10.2337/diacare.27.12.2887; Cortellaro M, 2002, THROMB HAEMOSTASIS, V88, P41; Nolting PRWD, 2003, ARCH INTERN MED, V163, P1837; Kawakami K, 2001, CAN J CARDIOL, V17, P660; Koba Shinji, 2008, J Atheroscler Thromb, V15, P250; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Nozue T, 2014, HEART VESSELS, V29, P456, DOI 10.1007/s00380-013-0387-1; Ogita M, 2014, HEART VESSELS, V29, P35, DOI 10.1007/s00380-013-0330-5; Ono K, 2009, ULTRASOUND MED BIOL, V35, P193, DOI 10.1016/j.ultrasmedbio.2008.08.011; Smilde TJ, 1997, CLIN SCI, V93, P317; Takahashi R, 2010, J ATHEROSCLER THROMB, V17, P1282; Takahashi R, 2012, INT HEART J, V53, P29, DOI 10.1536/ihj.53.29; Taylor AJ, 2002, CIRCULATION, V106, P2055, DOI 10.1161/01.CIR.0000034508.55617.65	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					154	161		10.1007/s00380-013-0466-3		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500002		
J	Takayama, T; Hiro, T; Ueda, Y; Saito, S; Kodama, K; Komatsu, S; Hirayama, A				Takayama, Tadateru; Hiro, Takafumi; Ueda, Yasunori; Saito, Satoshi; Kodama, Kazuhisa; Komatsu, Sei; Hirayama, Atsushi			Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy	HEART AND VESSELS			English	Article						Pitavastatin; Angioscopy; Intravascular ultrasound; Arterial remodeling; Plaque regression	RANDOMIZED CONTROLLED-TRIAL; DRUG-ELUTING STENT; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; COMPENSATORY ENLARGEMENT; RADIOFREQUENCY DATA; STATIN TREATMENT; YELLOW PLAQUES; ATHEROSCLEROSIS; ATORVASTATIN	This study aimed to clarify the relationships between arterial remodeling patterns and plaque volume regression or stabilization. The TOGETHAR trial is a prospective open-label trial designed to assess coronary plaque regression and stabilization with multiple plaque imaging modalities following 52 weeks of pitavastatin treatment (2 mg/day). Coronary plaques were observed in 46 patients with both angioscopy and intravascular ultrasound at baseline and after 52 weeks of drug treatment. We divided these patients into three groups according to their remodeling indices (RI). Group P consisted of patients with a baseline RI > 1.05, Group M of patients with a baseline RI of 0.95-1.05, and Group N of patients with a baseline RI < 0.95 and then evaluated differences in coronary plaque volume changes and yellow grade among the three groups. In the positive remodeling group, whose remodeling index (RI) exceeded 1.05 at baseline, RI and percent atheroma volume (PAV) were significantly reduced (RI 1.14 +/- A 0.07 to 1.05 +/- A 0.10, p = 0.010, PAV 47.3 +/- A 8.3 to 45.3 +/- A 7.3 mm(3), p = 0.048). There was no relationship between baseline RI and the change in yellow grade of plaque. RI increased without significant change of PAV or a decrease in lumen volume in group N, with RI below 0.95 at baseline. Plaques with positive remodeling were more likely to have plaque volume regression by pitavastatin than those without in patients with coronary artery disease. Moreover, plaques with positive and negative remodeling were changed into those with intermediate remodeling by pitavastatin. Pitavastatin might induce not only plaque regression or stabilization, but also conformational normalization of vessel structure.	[Takayama, Tadateru; Hiro, Takafumi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Med, Div Cardiol,Itabashi Ku, Tokyo 1738610, Japan; [Ueda, Yasunori] Keiai Hosp, Div Cardiovasc Med, Tokyo, Japan; [Saito, Satoshi] Osaka Police Hosp, Cardiovasc Div, Osaka, Japan; [Kodama, Kazuhisa; Komatsu, Sei] Amagasaki Cent Hosp, Cardiovasc Ctr, Amagasaki, Hyogo, Japan	Takayama, T (reprint author), Nihon Univ, Sch Med, Dept Med, Div Cardiol,Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	ccutaka@med.nihon-u.ac.jp			Kowa Co. Ltd.	This study was funded by Kowa Co. Ltd.	Tani S, 2012, HEART VESSELS, V27, P143, DOI 10.1007/s00380-011-0130-8; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nakamura M, 2001, J AM COLL CARDIOL, V37, P63, DOI 10.1016/S0735-1097(00)01097-4; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Nishioka T, 1996, J AM COLL CARDIOL, V27, P1571, DOI 10.1016/0735-1097(96)00071-X; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Nozue T, 2012, AM HEART J, V163, P191, DOI 10.1016/j.ahj.2011.11.004; Kubo T, 2008, JACC-CARDIOVASC INTE, V1, P74, DOI 10.1016/j.jcin.2007.11.001; Dohi T, 2011, J ATHEROSCLER THROMB, V18, P231; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Schoenhagen P, 2001, J AM COLL CARDIOL, V38, P297, DOI 10.1016/S0735-1097(01)01374-2; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Takayama T, 2009, CIRC J, V73, P2110; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Ueda Y, 2004, AM HEART J, V148, P333, DOI 10.1016/j.ahj.2004.03.047; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Abela GS, 2011, AM J CARDIOL, V107, P1710, DOI 10.1016/j.amjcard.2011.02.336; Ohtani T, 2006, J AM COLL CARDIOL, V47, P2194, DOI 10.1016/j.jacc.2006.01.064; Jimenez-Quevedo P, 2009, DIABETES, V58, P209, DOI 10.2337/db08-0376; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Higo T, 2009, JACC-CARDIOVASC IMAG, V2, P616, DOI 10.1016/j.jcmg.2008.12.026; Hirayama A, 2009, CIRC J, V73, P718; Hirayama A, 2011, CIRC J, V75, P1448, DOI 10.1253/circj.CJ-10-1035; Kawano T, 2008, INT J CARDIOL, V125, P74, DOI 10.1016/j.ijcard.2007.02.044; Kodama K, 2000, INTERNAL MED, V39, P333, DOI 10.2169/internalmedicine.39.333; Kodama K, 2010, CIRC J, V74, P1922, DOI 10.1253/circj.CJ-10-0038; Komatsu S, 2006, INT J CARDIOL, V113, P288, DOI 10.1016/j.ijcard.2005.09.049; Komatsu S, 2007, INT J CARDIOL, V123, pE12, DOI 10.1016/j.ijcard.2006.11.106; Nozue T, 2014, HEART VESSELS, V29, P456, DOI 10.1007/s00380-013-0387-1; Oyabu J, 2006, AM HEART J, V152, P1168, DOI 10.1016/j.ahj.2006.07.025; PASTERKAMP G, 1995, CIRCULATION, V91, P1444; Schoenhagen P, 2002, AM J CARDIOL, V89, P1354, DOI 10.1016/S0002-9149(02)02346-9; Suzuki Hideo, 2003, J Atheroscler Thromb, V10, P109; Taguchi I, 2013, AM J CARDIOL, V111, P1246, DOI 10.1016/j.amjcard.2013.01.265; Ueda Y, 2001, J AM COLL CARDIOL, V38, P1916, DOI 10.1016/S0735-1097(01)01673-4; Ueda Y, 1997, Cardiologia, V42, P827	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					169	176		10.1007/s00380-014-0468-9		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500004		
J	Takayama, T; Hiro, T; Ueda, Y; Saito, S; Kodama, K; Komatsu, S; Hirayama, A				Takayama, Tadateru; Hiro, Takafumi; Ueda, Yasunori; Saito, Satoshi; Kodama, Kazuhisa; Komatsu, Sei; Hirayama, Atsushi			Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy (vol 30, pg 169, 2015)	HEART AND VESSELS			English	Correction									[Takayama, Tadateru; Hiro, Takafumi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan; [Ueda, Yasunori] Osaka Police Hosp, Cardiovasc Div, Osaka, Japan; [Saito, Satoshi] Keiai Hosp, Div Cardiovasc Med, Tokyo, Japan; [Kodama, Kazuhisa; Komatsu, Sei] Amagasaki Cent Hosp, Cardiovasc Ctr, Amagasaki, Hyogo, Japan	Takayama, T (reprint author), Nihon Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	ccutaka@med.nihon-u.ac.jp					Takayama T, 2015, HEART VESSELS, V30, P169, DOI 10.1007/s00380-014-0468-9	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					177	177		10.1007/s00380-014-0517-4		1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500005		
J	Tamaki, W; Tsuda, E; Takehiro, I; Tanaka, N; Fujieda, M				Tamaki, Wataru; Tsuda, Etsuko; Takehiro, Igarashi; Tanaka, Norio; Fujieda, Mikiya			Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients after Kawasaki disease: a right parasternal approach	HEART AND VESSELS			English	Article						Right parasternal approach; Coronary artery aneurysm; Coronary artery lesion; Two-dimensional echocardiography; Abnormal Q wave	COMPUTED-TOMOGRAPHY; LESIONS; ABNORMALITIES; ADULTS; YOUNG	We report the importance of evaluating the right coronary artery (RCA) by two-dimensional echocardiography (2DE) in the acute phase of Kawasaki disease (KD), based on our experience with three patients whose coronary artery lesions (CAL) involving the RCA were missed in the acute phase of KD. Two patients had asymptomatic occlusion of the RCA, and it was speculated that one patient had a cardiac arrest due to CAL of the RCA. An abnormal Q wave in lead III in all 3 patients had indicated stenotic lesions of the RCA. Because it is difficult to diagnose CAL by 2DE in the late period, it is essential to identify the proximal RCA using a right parasternal approach while the patient is lying in the right lateral position.	[Tamaki, Wataru; Tsuda, Etsuko; Takehiro, Igarashi] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; [Tanaka, Norio] Natl Cerebral & Cardiovasc Ctr, Dept Physiol Lab, Suita, Osaka 5658565, Japan; [Fujieda, Mikiya] Kochi Univ, Kochi Med Sch, Dept Pediat, Kochi 780, Japan	Tamaki, W (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tamakiw@kochi-u.ac.jp					Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Kanamaru H, 2005, AM J CARDIOL, V95, P522, DOI 10.1016/j.amjcard.2004.10.011; Yagi S, 2005, CIRC J, V69, P870, DOI 10.1253/circj.69.870; Tsuda E, 2005, PEDIATR CARDIOL, V26, P73, DOI 10.1007/s00246-004-0698-1; Suzuki A, 1996, J AM COLL CARDIOL, V27, P291, DOI 10.1016/0735-1097(95)00447-5; Atsuko S, 2006, CARDIOL YOUNG, V16, P563; Hiraishi S, 2000, HEART, V83, P400, DOI 10.1136/heart.83.4.400; Nakamura Y, 2008, J EPIDEMIOL, V18, P167, DOI 10.2188/jea.JE2008001; Sato Y, 2004, HEART VESSELS, V19, P297, DOI 10.1007/s00380-003-0758-0; Suzuki A, 1997, PROG PEDIATR CARDIOL, V6, P211, DOI 10.1016/S1058-9813(97)00192-6; SUZUKI A, 1987, Heart and Vessels, V3, P159, DOI 10.1007/BF02058793; TATARA K, 1989, Heart and Vessels, V5, P47, DOI 10.1007/BF02058358; Tsuda E, 2011, PEDIATR CARDIOL, V32, P176, DOI 10.1007/s00246-010-9838-y; Tsuda E, 2005, CARDIOL YOUNG, V15, P481, DOI 10.1017/S1047951105001344	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					178	185		10.1007/s00380-014-0476-9		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500006		
J	Anzai, A; Maekawa, Y; Kodaira, M; Mogi, S; Arai, T; Kawakami, T; Kanazawa, H; Hayashida, K; Yuasa, S; Kawamura, A; Fukuda, K				Anzai, Atsushi; Maekawa, Yuichiro; Kodaira, Masaki; Mogi, Satoshi; Arai, Takahide; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Kawamura, Akio; Fukuda, Keiichi			Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians	HEART AND VESSELS			English	Article						Optimal medical therapy; Acute coronary syndrome; Percutaneous coronary intervention; Octogenarians	ACUTE MYOCARDIAL-INFARCTION; CONTROLLED TRIAL; ELUTING STENTS; MORTALITY; OUTCOMES	The proportion of elderly acute coronary syndrome (ACS) patients who receive optimal medical therapy (OMT) after percutaneous coronary intervention (PCI) and whether OMT affects their long-term outcomes remain unclear. We retrospectively investigated 405 ACS patients who underwent stent implantation between 2005 and 2009, and compared the outcomes between patients < 80 years of age vs. a parts per thousand yen80 years of age. The prescription rate of the recommended medical agents for ACS in both groups during hospitalization and 2 years after admission was also retrieved. Among the enrolled study population, 75 patients (19%) were aged a parts per thousand yen80 years. These elderly patients had a higher 2-year mortality compared with patients aged < 80 years group. The prescription rate of beta-blockers, angiotensin-blocking drugs, and statins tended to be lower in patients aged a parts per thousand yen80 years than in those aged < 80 years. Furthermore, among patients a parts per thousand yen80 years of age, those who received OMT had better clinical outcome of 2-year mortality compared to those without OMT. Elderly patients with ACS treated by PCI are at substantially higher risk of adverse events than younger patients. However, they are less likely to receive OMT. PCI with OMT might improve the clinical outcomes of elderly ACS patients.	[Anzai, Atsushi; Maekawa, Yuichiro; Kodaira, Masaki; Mogi, Satoshi; Arai, Takahide; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo 1608582, Japan	Maekawa, Y (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ymaekawa@a5.keio.jp					Anderson Jeffrey L, 2007, J Am Coll Cardiol, V50, pe1, DOI 10.1016/j.jacc.2007.02.013; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Valente S, 2008, CIRC J, V72, P67, DOI 10.1253/circj.72.67; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Buja P, 2012, HEART VESSELS, V27, P553, DOI 10.1007/s00380-011-0194-5; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Chen ZM, 2005, LANCET, V366, P1622; Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4; Mukherjee D, 2002, CIRCULATION, V106, P1909, DOI 10.1161/01.CIR.0000035649.39669.CE; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Kobayashi Y, 2003, AM J CARDIOL, V92, P443, DOI 10.1016/S0002-9149(03)00663-5; Maekawa Y, 2011, ANGIOLOGY, V62, P620, DOI 10.1177/0003319711403733; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rosato S, 2013, HEART VESSELS, V28, P684, DOI 10.1007/s00380-012-0302-1; Shirasawa K, 2011, HEART VESSELS, V26, P385, DOI 10.1007/s00380-010-0067-3; Wenger N K, 1994, Heart Dis Stroke, V3, P401	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					186	192		10.1007/s00380-014-0474-y		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500007		
J	Yamamoto, Y; Shirakabe, A; Hata, N; Kobayashi, N; Shinada, T; Tomita, K; Yamamoto, M; Tsurumi, M; Matsushita, M; Okazaki, H; Yokoyama, S; Asai, K; Mizuno, K; Shimizu, W				Yamamoto, Yoshiya; Shirakabe, Akihiro; Hata, Noritake; Kobayashi, Nobuaki; Shinada, Takuro; Tomita, Kazunori; Yamamoto, Masanori; Tsurumi, Masafumi; Matsushita, Masato; Okazaki, Hirotake; Yokoyama, Shinya; Asai, Kuniya; Mizuno, Kyoichi; Shimizu, Wataru			Seasonal variation in patients with acute heart failure: prognostic impact of admission in the summer	HEART AND VESSELS			English	Article						Heart failure; Season; Clinical profiles; Epidemiologic methods; Prognosis	CARDIOVASCULAR-RESPONSES; BLOOD-PRESSURE; CURRENT STATE; HOSPITALIZATION; CARPERITIDE; MORBIDITY; MORTALITY	There have been few reports discussing the clinical significance of the season of admission of acute heart failure (AHF) patients. The data of 661 patients with AHF admitted to the intensive care unit were analyzed. Patients were assigned to a summer admission (Group-S, n = 113, between July and September), a winter admission (Group-W, n = 214, between December and February), or to the other seasons admission group (Group-O, n = 334). We evaluated the relationships between the seasonal variations and the clinical profiles, and the long-term prognosis. There were significantly more patients with cardiomyopathy and New York Heart Association class 4, and the serum levels of total bilirubin were significantly higher in Group-S (85.8, 24.8 %, and 0.60 [0.50-0.90]) than in Group-W (75.2, 15.4 %, and 0.60 [0.40-0.78]). The left ventricular ejection fraction on admission was significantly reduced and intravenous administration of dobutamine was used more frequently in Group-S (30.0 [25.0-46.0], 31.9 %) than in Group-W (34.4 [25.2-48.0], 20.6 %) and Group-O (35.0 [25.0-46.0], 19.8 %). The multivariate Cox regression model found that summer admission was independently associated with cardiovascular death (HR: 1.58, 95 % CI 1.01-2.48; p = 0.044) and heart failure (HF) events (HR: 1.55, 95 % CI 1.05-2.28; p = 0.028). The Kaplan-Meier curves showed that the cardiovascular death rate was significantly higher in Group-S than in Group-W and Group-O, and the HF events were significantly higher in Group-S than in Group-O. The summer admission AHF patients included sicker patients, and the prognosis in these patients was worse than in the patients admitted at other times.	[Yamamoto, Yoshiya; Shirakabe, Akihiro; Hata, Noritake; Kobayashi, Nobuaki; Shinada, Takuro; Tomita, Kazunori; Yamamoto, Masanori; Tsurumi, Masafumi; Matsushita, Masato; Okazaki, Hirotake; Yokoyama, Shinya] Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit ICU, Chiba 2701694, Japan; [Asai, Kuniya; Mizuno, Kyoichi; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan	Shirakabe, A (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit ICU, 1715 Kamagari, Chiba 2701694, Japan.	s6042@nms.ac.jp		Kobayashi, Nobuaki/0000-0001-6757-4779			Gallerani M, 2011, CLIN CARDIOL, V34, P389, DOI 10.1002/clc.20895; Stewart S, 2002, J AM COLL CARDIOL, V39, P760, DOI 10.1016/S0735-1097(02)01685-6; Shirakabe A, 2011, J CARDIOL, V57, P107, DOI 10.1016/j.jjcc.2010.10.004; Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; Hata N, 2008, CIRC J, V72, P1787, DOI 10.1253/circj.CJ-08-0130; Inglis SC, 2008, EUR J HEART FAIL, V10, P540, DOI 10.1016/j.ejheart.2008.03.008; Manfredini R, 2004, CLIN APPL THROMB-HEM, V10, P39, DOI 10.1177/107602960401000106; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x; KEATINGE WR, 1964, J APPL PHYSIOL, V19, P1145; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684; Argiles A, 1998, NEW ENGL J MED, V339, P1364, DOI 10.1056/NEJM199811053391904; BRENNAN PJ, 1982, BRIT MED J, V285, P919; Díaz Alejandro, 2007, Congest Heart Fail, V13, P263, DOI 10.1111/j.1527-5299.2007.07124.x; Gorman S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1788, DOI 10.1039/c2pp25108f; Gotsman I, 2010, CARDIOLOGY, V117, P268, DOI 10.1159/000323511; Hamaguchi S, 2014, HEART VESSELS, V29, P328, DOI 10.1007/s00380-013-0359-5; Hattori H, 2013, HEART VESSELS, V28, P345, DOI 10.1007/s00380-012-0252-7; HAYWARD JM, 1976, CARDIOVASC RES, V10, P691, DOI 10.1093/cvr/10.6.691; Hori M, 2014, HEART VESSELS, V29, P238, DOI 10.1007/s00380-013-0340-3; Iwaya S, 2014, HEART VESSELS, V29, P470, DOI 10.1007/s00380-013-0394-2; Manfredini R, 2008, J THORAC CARDIOV SUR, V135, P442, DOI 10.1016/j.jtcvs.2007.10.032; Matsushita M, 2013, J CARDIOL, V61, P210, DOI 10.1016/j.jjcc.2012.10.004; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Nieminen MS, 2005, AM J CARDIOL, V96, p5G, DOI 10.1016/j.amjcard.2005.07.015; Ogawa M, 2007, CIRC J, V71, P455, DOI 10.1253/circj.71.455; Oktay C, 2009, ANN ACAD MED SINGAP, V38, P1081; Shirakabe A, 2010, J CARDIOL, V56, P339, DOI 10.1016/j.jjcc.2010.07.007; WESTHEIM A, 1992, CLIN PHYSIOL, V12, P95, DOI 10.1111/j.1475-097X.1992.tb00296.x	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					193	203		10.1007/s00380-013-0461-8		11	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500008		
J	Sato, T; Yamauchi, H; Suzuki, S; Yoshihisa, A; Yamaki, T; Sugimoto, K; Kunii, H; Nakazato, K; Suzuki, H; Saitoh, SI; Takeishi, Y				Sato, Takamasa; Yamauchi, Hiroyuki; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Serum cholinesterase is an important prognostic factor in chronic heart failure	HEART AND VESSELS			English	Article						Clinical outcome; Cholinesterase; Malnutrition; Liver function	TUMOR-NECROSIS-FACTOR; SOCIETY-OF-CARDIOLOGY; EJECTION FRACTION; VENTILATORY RESPONSE; AMERICAN-SOCIETY; POOR-PROGNOSIS; ECHOCARDIOGRAPHY; GUIDELINES; MORTALITY; EXERCISE	We determine the importance of indicators of nutrition including lymphocyte, total protein, albumin, cholinesterase and body mass index, and compare the prognostic significance in chronic heart failure (CHF). We examined consecutive 465 CHF patients (376 males, age 62 +/- A 14 years) who underwent cardiopulmonary exercise testing, echocardiography and blood examination including indicators of nutrition at the same time in our hospital. The patients were followed up [median period 766 days (interquartile range 500-1060)] to register cardiac deaths and rehospitalization due to worsening heart failure. There were 180 cardiac events during the follow-up periods. Patients with cardiac events had lower cholinesterase level than those without events (P < 0.001). On the receiver operating characteristic analysis, the best cut-off value for cholinesterase was 240 U/l (area under the curve 0.720). In the Kaplan-Meier analysis, patients with cholinesterase < 240 U/l had significantly higher cardiac event rates than those with cholinesterase > 240 U/l. Multivariable Cox proportional hazards model demonstrated that NYHA class III [hazard ratio (HR): 1.688, 95 % confidence interval (CI) 1.062-2.684, P = 0.027], eGFR (HR: 0.983, 95 % CI 0.971-0.995, P = 0.006), sodium concentration (HR: 0.947, 95 % CI 0.897-0.999, P < 0.046), log BNP (HR: 1.880, 95 % CI 1.509-2.341, P < 0.001), cholinesterase (HR: 0.996, 95 % CI 0.993-0.998, P = 0.002) and exertional periodic breathing (HR: 1.619, 95 % CI 1.098-2.388, P = 0.015) were independent factors to predict adverse clinical outcomes. Serum cholinesterase level was an important prognostic factor in CHF.	[Sato, Takamasa; Yamauchi, Hiroyuki; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan	Sato, T (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	takamasa@fmu.ac.jp			Japan Society for the Promotion of Science [23700613, 247591100]; Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan	We received helpful advice for statistical analyses from Dr. Tetsuya Ohira in Department of Epidemiology and Dr. Hajime Iwasa in Department of Public Health, Fukushima Medical University. This study was supported in part by Grants-In-Aid for Scientific Research (Nos. 23700613 and 247591100) from the Japan Society for the Promotion of Science and grants-in-aid from the Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan.	Ponikowski P, 2001, CIRCULATION, V103, P967; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519; Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332; Ambrosy AP, 2012, EUR J HEART FAIL, V14, P302, DOI 10.1093/eurjhf/hfs007; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Gerhard-Herman M, 2006, J AM SOC ECHOCARDIOG, V19, P955, DOI 10.1016/j.echo.2006.04.019; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; TRACEY KJ, 1990, J CLIN INVEST, V86, P2014, DOI 10.1172/JCI114937; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Charach G, 2011, AM J CARDIOL, V107, P1353, DOI 10.1016/j.amjcard.2010.12.049; Kalantar-Zadeh K, 2008, AM J CARDIOL, V101, p89E, DOI 10.1016/j.amjcard.2008.03.007; Lee KS, 2007, J AM SOC ECHOCARDIOG, V20, P773, DOI 10.1016/j.echo.2007.03.002; MCMURRAY J, 1991, BRIT HEART J, V66, P356; Otaki Y, 2013, HEART VESSELS, V28, P735, DOI 10.1007/s00380-012-0312-z; Rosalki SB, 1999, CLIN HEPATOLOGY, P503; Yang HY, 2013, HEART VESSELS, V28, P721, DOI 10.1007/s00380-012-0299-5; Zipes DP, 2005, PROGNOSIS BRAUNWALDS, P551	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					204	210		10.1007/s00380-014-0469-8		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500009		
J	Arao, K; Fujiwara, T; Taniguchi, Y; Jinnouchi, H; Sasai, H; Matsumoto, M; Funayama, H; Ako, J; Momomura, S				Arao, Kenshiro; Fujiwara, Takayuki; Taniguchi, Yousuke; Jinnouchi, Hiroyuki; Sasai, Harue; Matsumoto, Mitsunari; Funayama, Hiroshi; Ako, Junya; Momomura, Shin-ichi			Implications of pentraxin 3 levels in patients with acute aortic dissection	HEART AND VESSELS			English	Article						Acute aortic dissection; Inflammation; Pentraxin 3; Pleural fluid accumulation	C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; AMYLOID-P COMPONENT; LONG PENTRAXIN; OXYGENATION IMPAIRMENT; CARDIOVASCULAR-DISEASE; INNATE IMMUNITY; PTX3; MARKER; CELLS	Acute aortic dissection (AAD) causes transient inflammation with occasional pleural fluid (PF) accumulation. Although pentraxin 3 (PTX3) is a vascular inflammation-related biomarker, little is known about PTX3 levels in patients with AAD. We explored the serial changes in plasma PTX3 levels and the association of peak levels with the amount of PF accumulation. Consecutive patients (n = 41) with Stanford type B AAD were enrolled, and blood samples for the measurements of serum albumin, plasma PTX3 and high-sensitivity C-reactive protein (CRP) were collected daily until 7 days after symptom onset. PF accumulation on computed tomography imaging on the third hospital day was divided into 3 grades (I: none or slight, II: mild in the uni- or bilateral pleural cavity, III: moderate or more). PTX3 and CRP levels were analyzed after logarithmic transformation because of their skewed distributions. Peak PTX3 and CRP levels were observed at 4.3 +/- A 2.1 and 4.7 +/- A 2.0 days after symptom onset, and their values were 12.2 [interquartile range (IQR), 8.2-20.9] ng/mL and 12.0 (IQR, 8.6-15.2) mg/dL, respectively. On univariate analysis, the peak level of PTX3 had a negative correlation with the minimum level of serum albumin, and a positive correlation with PF grade and duration of intensive care unit stay. On multivariate analysis, the peak level of PTX3 was correlated with PF grade (P = 0.037). In conclusion, the peak level of PTX3 in patients with AAD was associated with the amount of transient PF accumulation, which may be associated with inflammatory vascular permeability.	[Arao, Kenshiro; Fujiwara, Takayuki; Taniguchi, Yousuke; Jinnouchi, Hiroyuki; Sasai, Harue; Matsumoto, Mitsunari; Funayama, Hiroshi; Ako, Junya; Momomura, Shin-ichi] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, Saitama 3308503, Japan	Arao, K (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	araon@omiya.jichi.ac.jp					Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Akerfeldt T, 2010, INFLAMMATION, V34, P367; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Peri G, 2000, CIRCULATION, V102, P636; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; ALLES VV, 1994, BLOOD, V84, P3483; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Mantovani A, 2003, VACCINE, V21, pS43, DOI 10.1016/S0264-410X(03)00199-3; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; LEE GW, 1993, J IMMUNOL, V150, P1804; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Sakakura K, 2010, HYPERTENSION, V55, P422, DOI 10.1161/HYPERTENSIONAHA.109.143131; Arao K, 2009, CIRC J, V73, P1523; Jo Y, 2008, HEART VESSELS, V23, P334, DOI 10.1007/s00380-008-1048-7; Kotooka N, 2008, ATHEROSCLEROSIS, V197, P368, DOI 10.1016/j.atherosclerosis.2007.05.031; Kotooka N, 2007, INT J CARDIOL, V130, P19; Morikawa Shigeru, 2004, J Atheroscler Thromb, V11, P62; Okina N, 2013, HEART VESSELS, V28, P330, DOI 10.1007/s00380-012-0257-2; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Soeki T, 2014, HEART VESSELS, V29, P653, DOI 10.1007/s00380-013-0400-8; Sugano Y, 2005, INT J CARDIOL, V102, P39, DOI 10.1016/j.ijcard.2004.03.076	31	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					211	217		10.1007/s00380-014-0470-2		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500010		
J	Takata, M; Amiya, E; Watanabe, M; Ozeki, A; Watanabe, A; Kawarasaki, S; Nakao, T; Hosoya, Y; Uno, K; Saito, A; Murasawa, T; Ono, M; Nagai, R; Komuro, I				Takata, Munenori; Amiya, Eisuke; Watanabe, Masafumi; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Uno, Kansei; Saito, Aya; Murasawa, Takahide; Ono, Minoru; Nagai, Ryozo; Komuro, Issei			Brachial artery diameter has a predictive value in the improvement of flow-mediated dilation after aortic valve replacement for aortic stenosis	HEART AND VESSELS			English	Article						Aortic stenosis; Flow-mediated dilation; Brachial artery diameter; Aortic valve replacement	ENDOTHELIAL DYSFUNCTION; HEART-FAILURE; SHEAR-STRESS; DISEASE; SCLEROSIS; ECHOCARDIOGRAPHY; ASSOCIATION; EVENTS; LESION; SIZE	Aortic stenosis (AS) is the most common valvular disease and aortic valve replacement (AVR) is one of its most effective interventions. AS affects not only the left ventricle, but also vascular function beyond the stenotic valve, which can lead to various types of vascular dysfunction. However, research evaluating the effect of AS on aortic vascular function is limited. In this study, we investigated clinical meaning to evaluate endothelial function in subjects with AS. From April 2011 to April 2012, 20 consecutive adult patients with degenerative AS (mean age, 74.7 +/- A 7.4 years; range 50-83 years) who underwent AVR at our institution were included in the study. We measured flow-mediated dilation (FMD) to evaluate the effect of AS on endothelial function. The difference between brachial artery diameter (BAD) before (4.0 +/- A 0.7 mm) and after AVR (3.9 +/- A 0.6 mm) was not significant (p = 0.043), but FMD significantly improved after AVR (from 3.1 +/- A 1.8 to 6.0 +/- A 2.7 %, p < 0.0001). We also analyzed FMD x BAD index, endogenous vasodilatory capability independent of BAD, resulting that it also significantly increased after AVR (12.3 +/- A 7.0-22.5 +/- A 9.3, p < 0.0001). We divided patients into two groups by pre- to post-AVR change in FMD (Delta FMD); large-Delta FMD group [Delta FMD > 3.0 % (median value)] and small-Delta FMD group (Delta FMD < 3.0 %). There were no significant changes in age, blood pressure, heart rate, B-type natriuretic peptide, or echocardiographic parameters in either group. In contrast, BAD was significantly larger in the small Delta FMD group (4.3 +/- A 0.7 mm) than in the large Delta FMD group (3.7 +/- A 0.7 mm) (p = 0.030). In addition, cardio-thoracic ratio was significantly greater in the small Delta FMD group (58.4 +/- A 7.1 %) than in the large Delta FMD group (53.7 +/- A 4.6 %) (p = 0.048). Receiver operating characteristic curve analysis of BAD to differentiate large and small Delta FMD demonstrated an area under the curve of 0.750 (p = 0.059) and that optimal cutoff for BAD was 4.28 mm (70 % sensitivity, 80 % specificity). AVR in subjects with AS is associated with a significant improvement in FMD in the brachial artery. Measurement of the BAD may be helpful in distinguishing whether the impairment of FMD in AS derives from a stenotic valve or vascular remodeling.	[Takata, Munenori; Amiya, Eisuke; Watanabe, Masafumi; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Tokyo 1138655, Japan; [Uno, Kansei] Univ Tokyo, Computat Diagnost Radiol & Prevent Med, Tokyo, Japan; [Saito, Aya; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Tokyo, Japan; [Murasawa, Takahide] Univ Tokyo, Dept Med Engn, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Sch, Shimotsuke, Japan	Amiya, E (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Tokyo 1138655, Japan.	amiyae-tky@umin.ac.jp			Japan Society for the Promotion of Science (JSPS)	This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program.	Fukuta H, 2007, AM J CARDIOL, V99, P62, DOI 10.1016/j.amjcard.2006.07.067; Bonow RO, 1998, CIRCULATION, V98, P1949; OTTO CM, 1994, CIRCULATION, V90, P844; Ras RT, 2013, INT J CARDIOL, V168, P344, DOI 10.1016/j.ijcard.2012.09.047; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630; Schumm J, 2011, AM HEART J, V161, P893, DOI 10.1016/j.ahj.2011.02.015; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Phinikaridou A, 2013, CIRC-CARDIOVASC IMAG, V6, P302, DOI 10.1161/CIRCIMAGING.112.000176; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Poggianti E, 2003, J AM COLL CARDIOL, V41, P136, DOI 10.1016/S0735-1097(02)02622-0; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONHA.105.590018; Rosca M, 2011, EUR J ECHOCARDIOGR, V12, P850, DOI 10.1093/ejechocard/jer120; Holubkov R, 2002, AM HEART J, V143, P802, DOI 10.1067/mhj.2002.121735; Aronow WS, 1998, AM J CARDIOL, V81, P647, DOI 10.1016/S0002-9149(97)00966-1; Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Blais C, 2001, AM J CARDIOL, V88, P45, DOI 10.1016/S0002-9149(01)01584-3; Chenevard R, 2006, HEART, V92, P1862, DOI 10.1136/hrt.2006.087437; Dibble CT, 2012, CHEST, V142, P1399, DOI 10.1378/chest.12-0028; Fang ZY, 2002, AM HEART J, V143, P383, DOI 10.1067/mhj.2002.120780; Garcia D, 2005, AM J PHYSIOL-HEART C, V288, pH1874, DOI 10.1152/ajpheart.00754.2004; GOTOH T, 1995, AM J CARDIOL, V76, P928, DOI 10.1016/S0002-9149(99)80263-X; Hildick-Smith DJR, 2000, J AM COLL CARDIOL, V36, P1889, DOI 10.1016/S0735-1097(00)00947-5; Kodali SK, 2012, CIRCULATION, V125, P975, DOI 10.1161/CIRCULATIONAHA.111.087965; Mizia-Stec K, 2007, ECHOCARDIOGR-J CARD, V24, P1051, DOI 10.1111/j.1540-8175.2007.00531.x; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Rieck AE, 2012, HYPERTENSION, V60, P90, DOI 10.1161/HYPERTENSIONAHA.112.194878; Rossi A, 2014, HEART VESSELS, V29, P776, DOI 10.1007/s00380-013-0433-z; Takata M, 2013, HEART VESSELS, DOI [10.1007/s00380-013-0393, DOI 10.1007/S00380-013-0393]; Watanabe S, 2013, CIRC J, V77, P1018, DOI 10.1253/circj.CJ-12-1043; Yamaura Y, 2004, AM J CARDIOL, V94, P837, DOI 10.1016/j.amjcard.2004.06.015	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					218	226		10.1007/s00380-014-0475-x		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500011		
J	Fujiki, A; Yoshioka, R; Sakabe, M				Fujiki, Akira; Yoshioka, Ryozo; Sakabe, Masao			Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG	HEART AND VESSELS			English	Article						Idiopathic ventricular fibrillation; Long QT syndrome; QT interval; QT-RR relation; Torsades de pointes	IDIOPATHIC VENTRICULAR-FIBRILLATION; HEART-RATE; INTERVAL; LONG; RECORDINGS; FAILURE	QT-RR linear regression consists of two parameters, slope and intercept, and the aim of this study was to evaluate repolarization dynamics using the QT-RR linear regression slope and intercept relationship during 24-h Holter ECG. This study included 466 healthy subjects (54.6 +/- A 14.6 years; 200 men and 266 women) and 17 patients with ventricular arrhythmias, consisted of 10 patients with idiopathic ventricular fibrillation (IVF) and 7 patients with torsades de pointes (TDP). QT and RR intervals were measured from ECG waves based on a 15-s averaged ECG during 24-h Holter recording using an automatic QT analyzing system. The QT interval dependence on the RR interval was analyzed using a linear regression line for each subject ([QT] = A[RR] + B; where A is the slope and B is the y-intercept). The slope of the QT-RR regression line in healthy subjects was significantly greater in women than in men (0.185 +/- A 0.036 vs. 0.161 +/- A 0.033, p < 0.001) and the intercept was significantly smaller in women than in men (0.229 +/- A 0.028 vs. 0.240 +/- A 0.027, p < 0.001). A scatter diagram of the QT-RR regression line slope and intercept among healthy subjects demonstrated a statistically significant negative correlation (B = -0.62A + 0.34, r = -0.79). Distribution of both scatter diagrams of the slope and the intercept of the QT-RR regression line in patients with IVF and TDP was different from healthy subjects (left corner for IVF and upward shift for TDP). The slope and intercept relationship of the QT-RR linear regression line based on 24-h Holter ECG may become a simple useful marker for abnormality of ventricular repolarization dynamics.	[Fujiki, Akira; Yoshioka, Ryozo; Sakabe, Masao] Shizuoka Red Cross Hosp, Div Cardiol, Aoi Ku, Shizuoka 4200853, Japan	Fujiki, A (reprint author), Shizuoka Red Cross Hosp, Div Cardiol, Aoi Ku, 8-2 Otemachi, Shizuoka 4200853, Japan.	afujiki@szrc.org					Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Nakashima K, 2013, HEART VESSELS, V28, P126, DOI 10.1007/s00380-012-0235-8; MERRI M, 1992, CIRCULATION, V85, P1816; Malik M, 2002, HEART, V87, P220, DOI 10.1136/heart.87.3.220; Viskin S, 2009, HEART RHYTHM, V6, P711, DOI 10.1016/j.hrthm.2009.02.044; Indik JH, 2006, HEART RHYTHM, V3, P1003, DOI 10.1016/j.hrthm.2006.05.023; Topilski I, 2007, J AM COLL CARDIOL, V49, P320, DOI 10.1016/j.jacc.2006.08.058; Fujiki A, 1999, J CARDIOVASC ELECTR, V10, P214, DOI 10.1111/j.1540-8167.1999.tb00662.x; Takenaka K, 2003, CIRCULATION, V107, P838, DOI 10.1161/01.CIR.0000048142.58076.A2; Bando S, 2013, HEART VESSELS, DOI [10.1007/800380-013-0406-2, DOI 10.1007/800380-013-0406-2]; Cygankiewicz I, 2008, J CARDIOVASC ELECTR, V19, P1066, DOI 10.1111/j.1540-8167.2008.01210.x; EMORI T, 1995, PACE, V18, P1909, DOI 10.1111/j.1540-8159.1995.tb03840.x; Fujiki A, 2011, CIRC J, V75, P274, DOI 10.1253/circj.CJ-10-0654; Fujiki A, 2004, J CARDIOVASC ELECTR, V15, P59, DOI 10.1046/j.1540-8167.2004.03396.x; Iacoviello M, 2007, J AM COLL CARDIOL, V50, P225, DOI 10.1016/j.jacc.2007.02.071; Smetana P, 2004, J CARDIOVASC ELECTR, V15, P1147, DOI 10.1046/j.1540-8167.2004.04076.x; Sugao M, 2006, HEART, V92, P201, DOI 10.1136/hrt.2004.059071; Suto F, 2007, AM J PHYSIOL-HEART C, V292, pH1782, DOI 10.1152/ajpheart.00932.2006; Watanabe E, 2007, HEART RHYTHM, V4, P999, DOI 10.1016/j.hrthm.2007.04.019	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					235	240		10.1007/s00380-014-0471-1		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500013		
J	Kurosawa, T; Kotani, J; Matsuyama, T; Ishibashi-Ueda, H				Kurosawa, Takafumi; Kotani, Jun-ichi; Matsuyama, Taka-aki; Ishibashi-Ueda, Hatsue			A case of active peri-stent inflammation after sirolimus-eluting stent implantation	HEART AND VESSELS			English	Article						Drug-eluting stent; Inflammation; Pathology; Percutaneous coronary intervention	INTRAVASCULAR ULTRASOUND ANALYSIS; ROTATIONAL ATHERECTOMY; MALAPPOSITION; THROMBOSIS; APPOSITION; ANGIOPLASTY	We report an autopsy case of a coronary aneurysm with massive adventitial inflammation post-percutaneous coronary intervention with sirolimus-eluting stent (SES) insertion in the left circumflex (LCX) coronary artery for ischemic heart disease 3 years prior to death. The internal elastic membrane was disrupted opposite the site of the eccentric LCX plaque due to injury during stenting, and the adventitia showed massive inflammatory cell infiltration, mainly consisting of eosinophils. The LCX showed aneurysmal dilatation with inflammatory cell infiltration. Inappropriate SES implantation attracted chronic inflammation. Chronic inflammation can lead to the development of coronary artery aneurysms.	[Kurosawa, Takafumi; Matsuyama, Taka-aki; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Div Pathol, Suita, Osaka, Japan; [Kotani, Jun-ichi] Osaka Univ, Grad Sch Med, Div Cardiovasc Med, Suita, Osaka 5650871, Japan	Kotani, J (reprint author), Osaka Univ, Grad Sch Med, Div Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shamallv8@aol.com					SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267; Hong MK, 2004, CIRCULATION, V109, P881, DOI 10.1161/01.CIR.0000116751.88818.10; KOVACH JA, 1993, J AM COLL CARDIOL, V22, P1024; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; FITZGERALD PJ, 1992, CIRCULATION, V86, P64; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Ako J, 2005, J AM COLL CARDIOL, V46, P1002, DOI 10.1016/j.jacc.2005.05.068; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; MINTZ GS, 1992, CIRCULATION, V86, P1383; Hong MK, 2006, CIRCULATION, V113, P414, DOI 10.1161/CIRCULATIONAHA.105.563403; Hoffmann R, 1999, AM J CARDIOL, V83, P1170, DOI 10.1016/S0002-9149(99)00053-3; Ikuta S, 2014, HEART VESSELS, V29, P320, DOI 10.1007/s00380-013-0376-4; Mintz GS, 2003, CIRCULATION, V107, P2660, DOI 10.1161/01.CIR.0000074778.46065.24; Neishi Y, 2014, HEART VESSELS, V29, P699, DOI 10.1007/s00380-013-0431-1; Shah VM, 2002, CIRCULATION, V106, P1753, DOI 10.1161/01.CIR.0000035239.90657.B1; Tanabe K, 2005, CIRCULATION, V111, P900, DOI 10.1161/01.CIR.0000155607.54922.16	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					270	273		10.1007/s00380-013-0465-4		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500018		
J	Maruyama, K; Chinda, J; Kabara, M; Nakagawa, N; Fujino, T; Takeuchi, T; Hasebe, N				Maruyama, Keisuke; Chinda, Junko; Kabara, Maki; Nakagawa, Naoki; Fujino, Takayuki; Takeuchi, Toshiharu; Hasebe, Naoyuki			Successful percutaneous transluminal angioplasty for the treatment of renovascular hypertension with an atrophic kidney	HEART AND VESSELS			English	Article						Renovascular hypertension; Percutaneous transluminal renal angioplasty; Atrophic kidney; Renal vein sampling	RENAL-ARTERY STENOSIS; DISEASE; REVASCULARIZATION; PREVALENCE	Renovascular hypertension is an important cause of secondary hypertension. We present the case of a 61-year-old man with renovascular hypertension caused by chronic total occlusion of the left renal artery resulting in an atrophic kidney. Although renography indicated almost no residual function of the left kidney, renal vein sampling showed a significant increase of renin secretion in the left kidney. The endocrine function of the left kidney was believed to be preserved; thus, we performed percutaneous transluminal renal angioplasty with stent placement. After the procedure, the patient's blood pressure decreased gradually to within the normal range without adverse events. The laboratory data on endocrine function and the renography findings drastically improved. Percutaneous transluminal renal angioplasty is a promising therapeutic procedure for renovascular hypertension with an atrophic kidney.	[Maruyama, Keisuke; Chinda, Junko; Kabara, Maki; Nakagawa, Naoki; Fujino, Takayuki; Takeuchi, Toshiharu; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan	Maruyama, K (reprint author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido, Japan.	maru824@asahikawa-med.ac.jp					Adel Seyed Mohammad Hassan, 2011, J Cardiovasc Dis Res, V2, P36, DOI 10.4103/0975-3583.78585; Alchi B, 2006, HYPERTENS RES, V29, P203, DOI 10.1291/hypres.29.203; Kalra PA, 2005, KIDNEY INT, V68, P293, DOI 10.1111/j.1523-1755.2005.00406.x; Bourgault M, 2013, CLIN J AM SOC NEPHRO, V8, P392, DOI 10.2215/CJN.05570612; Hirsch AT, 2006, J VASC INTERV RADIOL, V17, P1383, DOI 10.1097/01.RVI.0000240426.53079.46; La Batide-Alanore A, 2001, J AM SOC NEPHROL, V12, P1235; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; Saito T, 2013, HEART VESSELS, V28, P323, DOI 10.1007/s00380-012-0254-5; Olin JW, 2011, J VASC SURG, V53, P826, DOI 10.1016/j.jvs.2010.10.066; Beck AW, 2010, J VASC SURG, V51, P380, DOI 10.1016/j.jvs.2009.08.088; Dworkin LD, 2009, NEW ENGL J MED, V361, P1972, DOI 10.1056/NEJMcp0809200; Fujita K, 2013, HEART VESSELS, V28, P264, DOI 10.1007/s00380-012-0262-5; Kuroda S, 2000, STROKE, V31, P61; Mounier-Vehier C, 2002, J ENDOVASC THER, V9, P863, DOI 10.1583/1545-1550(2002)009<0863:RAIARD>2.0.CO;2; Nagata Y, 2010, INTERNAL MED, V49, P215, DOI 10.2169/internalmedicine.49.2629; Preston RA, 1997, J HYPERTENS, V15, P1365, DOI 10.1097/00004872-199715120-00001; Thomaz MJ, 2010, INT BRAZ J UROL, V36, P159, DOI 10.1590/S1677-55382010000200005; Tullis MJ, 1999, AM J KIDNEY DIS, V33, P675, DOI 10.1016/S0272-6386(99)70218-0	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAR	2015	30	2					274	279		10.1007/s00380-013-0457-4		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5WX	WOS:000351160500019		
J	Taira, K; Yazawa, R; Watanabe, A; Ishikawa, Y; Okamoto, M; Takahashi, A; Asai, F				Taira, K.; Yazawa, R.; Watanabe, A.; Ishikawa, Y.; Okamoto, M.; Takahashi, A.; Asai, F.			Syphacia muris infection delays the onset of hyperglycemia in WBN/Kob-Lepr(fa) rats, a new type 2 diabetes mellitus model	HELMINTHOLOGIA			English	Article						WBN/Kob-Lepr(fa) rats; type 2 diabetes mellitus; Syphacia muris	INSULIN-RESISTANCE; PANCREATITIS; OBESITY; WBN/KOB; GLUCOSE; STRAIN; MICE	Diabetes mellitus is one of the most common endocrine disorders and its continuous global increase is due to factors as population growth, urbanization, aging, and increasing prevalence of obesity and physical inactivity. The effect of pinworm infection on the development of hyperglycemia was examined in WBN/K-Lepr(fa) (fa/fa) rats, a new model of the obese type 2 diabetes mellitus (T2DM) with pancreatitis. The rats were orally administered Syphacia muris eggs (infected group) and distilled water (control group). Hyperglycemia onset in the infected group was significantly delayed compared to the control group. Neither body weight nor intake of food and water were affected by S. muris infection. This study demonstrated that S. muris infection delayed the onset of T2DM in fa/fa rats and suggested that elucidation of the underlying mechanism and relevant pathways in the helminth-mediated protection may lead to the development of a new strategy to prevent diabetes mellitus.	[Taira, K.; Takahashi, A.] Azabu Univ, Sch Vet Med, Parasitol Lab, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Yazawa, R.; Watanabe, A.; Ishikawa, Y.; Asai, F.] Azabu Univ, Sch Vet Med, Pharmacol Lab, Sagamihara, Kanagawa 2525201, Japan; [Okamoto, M.] Azabu Univ, Sch Vet Med, Lab Vet Immunol, Sagamihara, Kanagawa 2525201, Japan	Taira, K (reprint author), Azabu Univ, Sch Vet Med, Parasitol Lab, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	asai@azabu-u.ac.jp			Azabu University	This study was supported in part by a research project grant awarded by Azabu University. The authors wish to thank Dr. Masakazu Shiota for his insightful discussions.	Akimoto T, 2008, BIOCHEM BIOPH RES CO, V366, P556, DOI 10.1016/j.bbrc.2007.12.003; Akimoto T, 2010, EXP ANIM TOKYO, V59, P623, DOI 10.1538/expanim.59.623; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Akimoto T, 2012, J VET MED SCI, V74, P65, DOI 10.1292/jvms.11-0168; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; STAHL W, 1961, SCIENCE, V133, P576, DOI 10.1126/science.133.3452.576-a; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Kaji N, 2012, J VET MED SCI, V74, P1185, DOI 10.1292/jvms.12-0045; Fonseca V, 2010, PRINCIPLES OF DIABETES MELLITUS, SECOND EDITION, P203, DOI 10.1007/978-0-387-09841-8_13; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Nagakubo D, 2014, COMPARATIVE MED, V64, P121; NAKAMA K, 1985, ACTA DIABETOL LAT, V22, P335, DOI 10.1007/BF02624752; Okuno A, 2013, J VET MED SCI, V75, P1557, DOI 10.1292/jvms.13-0230; Shiota Masakazu, 2012, Methods Mol Biol, V933, P103, DOI 10.1007/978-1-62703-068-7_8; TAFFS L F, 1976, Laboratory Animals (London), V10, P1, DOI 10.1258/002367776780948862; Torre I, 2013, HELMINTHOLOGIA, V50, P27, DOI 10.2478/s11687-013-0104-8; TSUCHITANI M, 1985, LAB ANIM, V19, P200, DOI 10.1258/002367785780893575	23	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0440-6605	1336-9083		HELMINTHOLOGIA	Helminthologia	MAR	2015	52	1					58	62		10.1515/helmin-2015-0010		5	Parasitology; Zoology	Parasitology; Zoology	CC5SY	WOS:000350424900009		
J	Arase, Y; Heianza, Y; Hara, S; Ohmoto-Sekine, Y; Amakawa, K; Tsuji, H; Ogawa, K; Saito, K; Kodama, S; Ikeda, K; Kumada, H; Kobayashi, T; Sone, H				Arase, Yasuji; Heianza, Yoriko; Hara, Shigeko; Ohmoto-Sekine, Yuki; Amakawa, Kazuhisa; Tsuji, Hiroshi; Ogawa, Kyoko; Saito, Kazumi; Kodama, Satoru; Ikeda, Kenji; Kumada, Hiromitsu; Kobayashi, Tetsuro; Sone, Hirohito			Potential impact of joint association of alanine aminotransferase and gamma-glutamyltransferase on insulin resistance in Japan: The Toranomon Hospital Health Management Center Study 19 (TOPICS 19)	HEPATOLOGY RESEARCH			English	Article						fatty liver; insulin resistance; liver enzyme; OGTT	FASTING PLASMA-GLUCOSE; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; METABOLIC SYNDROME; LIVER-ENZYMES; DIABETES-MELLITUS; FOLLOW-UP; RISK; PREDICTS; WOMEN	AimTo investigate the potential impact of joint association of alanine aminotransferase (ALT) and -glutamyltransferase (GGT) on insulin resistance and -cell dysfunction in healthy Japanese individuals with a normal range of liver enzymes. MethodsThis study included 1010 individuals (545 men and 465 women) aged 20-89 years who underwent an oral glucose tolerance test for health screening. Participants were divided into four groups on the basis of median values for ALT and GGT: (i) both ALT and GGT low (both-low); (ii) ALT high and GGT low (ALT-high); (iii) ALT low and GGT high (GGT-high); and (iv) both ALT and GGT high (both-high). Logistic regression analysis was used to investigate the relationship between liver enzyme and insulin dynamics, such as Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR) and insulinogenic index (IGI). The insulin resistance was defined when HOMA-IR was 2.5 or more. IGI of less than 0.4 was considered to be decreased early-phase insulin secretion. ResultsMean values of HOMA-IR in men was 1.5 in the both-low group, 1.8 in ALT-high, 1.8 in GGT-high and 2.8 in both-high. The mean HOMA-IR in women was 1.3 in the both-low group, 1.3 in ALT-high, 1.6 in GGT-high and 2.0 in both-high. HOMA-IR in the both-high group was significantly higher than that in the both-low group regardless of the difference of sex. Multivariate analysis showed that insulin resistance occurred when the patient had high liver enzymes. ConclusionCombining the two liver function markers would be effective for identifying individuals with insulin resistance.	[Arase, Yasuji; Heianza, Yoriko; Hara, Shigeko; Ohmoto-Sekine, Yuki; Amakawa, Kazuhisa; Tsuji, Hiroshi; Ogawa, Kyoko; Saito, Kazumi; Kodama, Satoru; Kobayashi, Tetsuro; Sone, Hirohito] Toranomon Gen Hosp, Dept Hlth Management Ctr, Tokyo 1058470, Japan; [Arase, Yasuji; Heianza, Yoriko; Hara, Shigeko; Ohmoto-Sekine, Yuki; Amakawa, Kazuhisa; Tsuji, Hiroshi; Ogawa, Kyoko; Saito, Kazumi; Kodama, Satoru; Kobayashi, Tetsuro; Sone, Hirohito] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan; [Arase, Yasuji; Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo 1058470, Japan; [Heianza, Yoriko; Saito, Kazumi; Kodama, Satoru] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Ibaraki, Japan; [Sone, Hirohito] Niigata Univ, Fac Med, Dept Internal Med, Niigata, Japan	Arase, Y (reprint author), Toranomon Gen Hosp, Dept Hlth Management Ctr, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	es9y-ars@asahi-net.or.jp			Japanese Ministry of Health, Labor and Welfare	THE PRESENT WORK was supported in part by the Japanese Ministry of Health, Labor and Welfare.	MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI 10.2337/dc07-2159; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Heianza Y, 2013, AM J CLIN NUTR, V97, P561, DOI 10.3945/ajcn.112.043364; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Kawamura Y, 2012, AM J GASTROENTEROL, V107, P253, DOI 10.1038/ajg.2011.327; Wang CS, 2012, J FORMOS MED ASSOC, V111, P201, DOI 10.1016/j.jfma.2011.04.004; Sone H, 2013, DIABETOLOGIA, V56, P1021, DOI 10.1007/s00125-012-2810-z; Osawa H, 1996, J CLIN ULTRASOUND, V24, P25, DOI 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N; Andre P, 2007, DIABETES CARE, V30, P2355, DOI 10.2337/dc07-0440; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Andre P, 2005, DIABETES METAB, V31, P542, DOI 10.1016/S1262-3636(07)70229-X; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Arase Y, 2009, J GASTROENTEROL, V44, P1064, DOI 10.1007/s00535-009-0091-1; Ardigo D, 2005, METABOLISM, V54, P1566, DOI 10.1016/j.metabol.2005.05.027; Bianchi C, 2010, DIABETES-METAB RES, V26, P181, DOI 10.1002/dmrr.1069; Dois Y, 2007, OBESITY SILVER SPRIN, V15, P1841; Gaos F, 2012, BIOMED ENVIRON SCI, V25, P30; Heianza Y, 2013, J CLIN ENDOCR METAB, V98, P1051, DOI 10.1210/jc.2012-3092; Hus FB, 2004, DIABETES, V53, P693; Ioannou GN, 2005, GASTROENTEROLOGY, V128, P627, DOI 10.1043/j.gastro.2004.12.004; Lees DH, 2004, FREE RADICAL RES, V38, P535; Lees DH, 2003, CLIN CHEM, V49, P1358; Lims JS, 2004, FREE RADIC BIOL MED, V37, P1018; Lonardo A, 2006, J HEPATOL, V44, P190, DOI 10.1016/j.jhep.2005.06.018; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; Pauls TG, 2005, AM FAM PHYSICIAN, V71, P1105; Tanaka K, 2014, HEPATOL RES, V44, P1196, DOI 10.1111/hepr.12293; TESCHKE R, 1977, BIOCHEM BIOPH RES CO, V75, P718, DOI 10.1016/0006-291X(77)91531-5; Xus Y, 2011, J DIABETES, V3, P38	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					247	258		10.1111/hepr.12343		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300001		
J	Do, SH; Yamada, H; Fujimoto, M; Ohisa, M; Matsuo, J; Akita, T; Katayama, K; Nguyen, NV; Miyakawa, Y; Tanaka, J				Son Huy Do; Yamada, Hiroko; Fujimoto, Mayumi; Ohisa, Masayuki; Matsuo, Junko; Akita, Tomoyuki; Katayama, Keiko; Nhon Van Nguyen; Miyakawa, Yuzo; Tanaka, Junko			High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam	HEPATOLOGY RESEARCH			English	Article						general population; hepatitis B virus; hepatitis C virus; seroepidemiology; Vietnam	LIVER-DISEASE; RURAL VIETNAM; JAPAN; GENOTYPE; CARRIERS	AimVietnam is one of the countries with the highest mortality from liver cancer, which is mostly attributed to hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. For planning preventive strategies against these infections, we investigated prevalences of HBV and HCV infections among adults living in Binh Thuan, Vietnam. MethodsOur study consisted of a serological survey for HBV and HCV infections and a questionnaire survey on their risk factors. The sample size was calculated based on anticipated rate of hepatitis B surface antigen (HBsAg). Subjects were randomly sampled using a multistage method. Confirmation and family-tree surveys were conducted to examine persistent HBV infection and intrafamilial HBV transmission, respectively. ResultsA total of 509 adults, comprised of 230 men (45.2%) and 279 women (54.8%), were enrolled. Prevalences of HBsAg, hepatitis B surface antibody and hepatitis B core antibody were 15.3%, 60.3% and 71.7%, respectively. Most HBV DNA positive sera were classified as genotype B (75.3%) and C (11.7%). Of HBsAg positive subjects, 96.7% were persistently infected and one acutely HBV infected person was identified. Family-tree surveys suggested that horizontal extrafamilial HBV transmission might have been frequent. Prevalences of anti-HCV and HCV RNA were 3.3% and 1.8%, respectively. HCV genotype 6a was prominent (55.6%). ConclusionIn Binh Thuan, prevalences of HBV and HCV infections are high, HBV genotype B and HCV genotype 6a are predominant, and horizontal HBV transmission may still occur. Therefore, raising the coverage of a universal HBV vaccination program may be an effective liver cancer control in Vietnam.	[Son Huy Do; Yamada, Hiroko; Fujimoto, Mayumi; Ohisa, Masayuki; Matsuo, Junko; Akita, Tomoyuki; Katayama, Keiko; Tanaka, Junko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima 7348551, Japan; [Miyakawa, Yuzo] Miyakawa Mem Res Fdn, Tokyo, Japan; [Son Huy Do; Nhon Van Nguyen] Dept Hlth, Phan Thiet City, Binh Thuan Prov, Vietnam	Tanaka, J (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	jun-tanaka@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Satake Fund, Hiroshima University, Japan	THIS WORK WAS supported in part by grants for the Research on Hepatitis of the Ministry of Health, Labor and Welfare and by the Satake Fund, Hiroshima University, Japan. We thank the staff of the Health Center of La Gi town, Binh Thuan province for collaborating in this study. The authors are grateful to Ms Yuko Go for laboratory analysis, and assistance in processing and testing serum samples.	Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; [Anonymous], 2012, GLOB 2012 EST CANC I; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Gish RG, 2012, J GASTROEN HEPATOL, V27, P238, DOI 10.1111/j.1440-1746.2011.06974.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Duong Thai Hong, 2009, Asian Pac J Cancer Prev, V10, P97; Hayashi K, 2009, INTERVIROLOGY, V52, P22, DOI 10.1159/000210835; Hipgrave DB, 2003, AM J TROP MED HYG, V69, P288; Huys TT, 2004, J MED VIROL, V74, P228; Kaos J, 2006, CURR HEPAT REP, V5, P5; Kobayashi M, 2014, J GASTROENTEROL, V49, P538, DOI 10.1007/s00535-013-0821-2; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Nguyens TB, 2009, Y HOC TRANH PHO HO C, V13, P243; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Satos T, 2014, HEPATOL RES; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; World Health Organization, 2002, HEP B; World Health Organization, 2003, HEP C	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					259	268		10.1111/hepr.12350		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300002		
J	Eguchi, Y; Kitajima, Y; Hyogo, H; Takahashi, H; Kojima, M; Ono, M; Araki, N; Tanaka, K; Yamaguchi, M; Matsuda, Y; Ide, Y; Otsuka, T; Ozaki, I; Ono, N; Eguchi, T; Anzai, K				Eguchi, Yuichiro; Kitajima, Yoichiro; Hyogo, Hideyuki; Takahashi, Hirokazu; Kojima, Motoyasu; Ono, Masafumi; Araki, Norimasa; Tanaka, Kenichi; Yamaguchi, Miyuki; Matsuda, Yayoi; Ide, Yasushi; Otsuka, Taiga; Ozaki, Iwata; Ono, Naofumi; Eguchi, Takahisa; Anzai, Keizo		Japan Study Grp NAFLD JSG-NAFLD	Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)	HEPATOLOGY RESEARCH			English	Article						fatty liver; glucagon-like peptide-1; liraglutide; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; steatohepatitis	GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; OPEN-LABEL TRIAL; HEPATIC STEATOSIS; PARALLEL-GROUP; PANCREATIC-CANCER; INCRETIN HORMONES; GLP-1 ANALOG; EFFICACY; SAFETY	AimNon-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome, is associated with an increased risk of developing lifestyle-related diseases including type 2 diabetes, cardiovascular disease and cerebral vessel disease. No current drug therapy provides the ideal effects of decreasing hepatic inflammation while simultaneously improving liver fibrosis. Liraglutide is a glucagon-like peptide-1 receptor agonist that affects the histological findings in patients with non-alcoholic steatohepatitis (NASH). This study was conducted to evaluate the effect and action of liraglutide for biopsy-proven NASH. MethodsAfter lifestyle modification intervention for 24 weeks, subjects whose hemoglobin A1c levels failed to improve to less than 6.0% and/or whose alanine aminotransferase levels were not lower than baseline, received liraglutide at 0.9mg/body per day for 24weeks. ResultsOf 27 subjects, 26 completed the lifestyle modification intervention. Nineteen subjects received liraglutide therapy for 24weeks. Body mass index, visceral fat accumulation, aminotransferases and glucose abnormalities improved significantly. Repeated liver biopsy was performed in 10 subjects who continued liraglutide therapy for 96 weeks. Six subjects showed decreased histological inflammation as determined by NASH activity score and stage determined by Brunt classification. We saw no significant adverse events during therapy with liraglutide. ConclusionOur pilot study demonstrated that treatment with liraglutide had a good safety profile and significantly improved liver function and histological features in NASH patients with glucose intolerance.	[Eguchi, Yuichiro] Saga Med Sch, Div Hepatol, Saga 8498501, Japan; [Kitajima, Yoichiro; Takahashi, Hirokazu; Kojima, Motoyasu; Yamaguchi, Miyuki; Matsuda, Yayoi; Ide, Yasushi; Otsuka, Taiga; Ozaki, Iwata; Anzai, Keizo] Saga Med Sch, Dept Internal Med, Saga 8498501, Japan; [Kitajima, Yoichiro; Araki, Norimasa; Tanaka, Kenichi; Ono, Naofumi; Eguchi, Takahisa] Eguchi Hosp, Gastroenterol Clin, Saga, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan	Takahashi, H (reprint author), Saga Med Sch, Dept Internal Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	hepatology28@msn.com					Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Brubaker PL, 2010, ENDOCRINOLOGY, V151, P1984, DOI 10.1210/en.2010-0115; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Gier B, 2013, JAMA INTERN MED, V173, P539, DOI 10.1001/jamainternmed.2013.3374; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Yoshizumi T, 1999, RADIOLOGY, V211, P283; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Ozaki N, 2000, NAT CELL BIOL, V2, P805; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Bode B, 2012, DIABETES RES CLIN PR, V97, P27, DOI 10.1016/j.diabres.2011.12.015; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Yilmaz Y, 2012, ACTA GASTRO-ENT BELG, V75, P240; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Buse John B, 2009, Lancet, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Armstrong MJ, 2013, ALIMENT PHARM THER, V37, P234, DOI 10.1111/apt.12149; Bailey T, 2013, AM J MED, V126, pS10, DOI 10.1016/j.amjmed.2013.06.009; Brunts EM, 2005, HEPATOLOGY, V45, P1313; Cuthbertsons DJ, 2012, PLOS ONE, V7; FUJIMOTO K, 1992, AM J MED SCI, V303, P145, DOI 10.1097/00000441-199203000-00002; Itou Minoru, 2012, Case Rep Gastroenterol, V6, P538, DOI 10.1159/000341510; Kahals H, 2013, CLIN ENDOCRINOL OXF; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Ministry of Health Labour and Welfare, 2006, EX PHYS ACT REF HLTH; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ohki T, 2012, THESCIENTIFICWORLDJO, V2012; Ozas N, 2009, J GASTROENTEROL, V4, P1203; Peterson GE, 2010, INT J CLIN PRACT, V64, P35, DOI 10.1111/j.1742-1241.2010.02498.x; Phillips LK, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2012.06491.x; Rosss SA, 2013, CURR MED RES OPIN, V12, P1617; Shyangdan DS, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-20	53	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					269	278		10.1111/hepr.12351		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300003		
J	Morimoto, M; Numata, K; Kondo, M; Kobayashi, S; Ohkawa, S; Hidaka, H; Nakazawa, T; Okuwaki, Y; Okuse, C; Matsunaga, K; Suzuki, M; Morita, S; Taguri, M; Tanaka, K				Morimoto, Manabu; Numata, Kazushi; Kondo, Masaaki; Kobayashi, Satoshi; Ohkawa, Shinichi; Hidaka, Hisashi; Nakazawa, Takahide; Okuwaki, Yusuke; Okuse, Chiaki; Matsunaga, Kotaro; Suzuki, Michihiro; Morita, Satoshi; Taguri, Masataka; Tanaka, Katsuaki			Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis	HEPATOLOGY RESEARCH			English	Article						adverse drug reaction; age; dose; hepatocellular carcinoma; propensity score; sorafenib	THERAPEUTIC DECISIONS; TUMOR PROGRESSION; CLINICAL-PRACTICE; SOLID TUMORS; TOXICITY; CANCER; BEVACIZUMAB; COMBINATION; SARCOPENIA; GIDEON	AimPatients with hepatocellular carcinoma (HCC) who receive an initial full dose of sorafenib (800mg/day) often require a decreased dose (400mg/day) or discontinuation of therapy because of severe adverse events. We conducted a retrospective analysis of patients with HCC to compare the safety and efficacy of full- to half-dose sorafenib. MethodsWe reviewed the medical records of 218 consecutive patients with intermediate or advanced stage HCC who received half (n=73) or full-dose sorafenib (n=145) between 2009 and 2012 at four institutions. A propensity score-matching analysis was used to adjust for potential bias. ResultsMultivariate logistic regression analysis showed that increased age was an independent factor for the selection of initial half-dose sorafenib (odds ratio, 1.10; 95% confidence interval, 1.05-1.15; P<0.001). Fifty-eight patients each in the half-dose and full-dose groups were selected for propensity score matching. The incidence of grade 3-4 severe adverse effects was lower in the half-dose group (47.4% vs 66.7%, P=0.037). In contrast, the median progression-free survival (PFS) and overall survival (OS) rates were not significantly different (half-dose group, 3.8 and 10.2 months; full-dose group, 2.5 and 8.8 months; P=0.143 and 0.911, respectively). ConclusionPropensity score-matched analyses indicate that initial half-dose sorafenib treatment led to fewer severe adverse effects and a comparable survival benefit compared with a full dose in select patients with HCC, particularly for those of advanced age.	[Morimoto, Manabu; Numata, Kazushi; Kondo, Masaaki; Tanaka, Katsuaki] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Morita, Satoshi; Taguri, Masataka] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Morimoto, Manabu; Kobayashi, Satoshi; Ohkawa, Shinichi] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa 2418515, Japan; [Hidaka, Hisashi; Nakazawa, Takahide; Okuwaki, Yusuke] Kitasato Univ, Sch Med, Dept Gastroenterol, Internal Med, Sagamihara, Kanagawa 228, Japan; [Okuse, Chiaki; Matsunaga, Kotaro; Suzuki, Michihiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan	Morimoto, M (reprint author), Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Med Oncol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	m-morimoto@kcch.jp			Yokohama City University	THIS WORK WAS supported in part by a research grant from Yokohama City University.	El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Azad NS, 2009, CLIN CANCER RES, V15, P1411, DOI 10.1158/1078-0432.CCR-08-1141; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Lencioni R, 2010, INT J CLIN PRACT, V64, P1034, DOI 10.1111/j.1742-1241.2010.02414.x; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Sacco R, 2012, EXPERT REV ANTICANC, V12, P869, DOI [10.1586/era.12.58, 10.1586/ERA.12.58]; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Wang SX, 2010, TARGET ONCOL, V5, P59, DOI 10.1007/s11523-010-0133-x; Ogasawara S, 2011, HEPATOL INT, V5, P850, DOI 10.1007/s12072-010-9249-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Kawaoka T, 2012, ONCOLOGY-BASEL, V83, P192, DOI 10.1159/000341347; Lencioni R, 2014, INT J CLIN PRACT, V68, P609, DOI 10.1111/ijcp.12352; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Kudo M, 2012, DIGEST DIS, V30, P609, DOI 10.1159/000343091; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Jain L, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-95; Kims JE, 2012, ONCOLOGY, V82, P119; lavarone M, 2011, HEPATOLOGY, V54, P2055; Mirs O, 2012, PLOS ONE, V7; Montella L, 2013, ONCOLOGY-BASEL, V84, P265, DOI 10.1159/000345558; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456; Yaus T, 2009, CANCER, V115, P428	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					279	287		10.1111/hepr.12354		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300004		
J	Sato, M; Tateishi, R; Yasunaga, H; Horiguchi, H; Yoshida, H; Fushimi, K; Koike, K				Sato, Masaya; Tateishi, Ryosuke; Yasunaga, Hideo; Horiguchi, Hiromasa; Yoshida, Haruhiko; Fushimi, Kiyohide; Koike, Kazuhiko			Variceal hemorrhage: Analysis of 9987 cases from a Japanese nationwide database	HEPATOLOGY RESEARCH			English	Article						Child-Pugh score; diagnosis procedure combination; in-hospital mortality; nationwide database; variceal hemorrhage	PROCEDURE-COMBINATION-DATABASE; IMPROVED SURVIVAL; CIRRHOSIS; COMPLICATIONS; PREVALENCE	AimGastroesophageal variceal hemorrhage is an important complication of cirrhosis. We investigated the in-hospital mortality and its risk factors after variceal hemorrhage in a large sample population, using a nationwide Japanese database. MethodsData on the patients with variceal hemorrhage were collected for a total of 39 months from a nationwide administrative database covering approximately 1000 hospitals in Japan. The risk factors for fatal outcome after variceal hemorrhage were analyzed with receiver-operator curves (ROC) and univariate and multivariate logistic regression. Comorbidities were assessed with the Charlson Comorbidity Index. ResultsWe identified 9987 patients with variceal hemorrhage from a total of 20.3million inpatients in the database. The median age was 63 years and 68.8% were male. The overall in-hospital mortality was 16.8% (1676 cases). In univariate analysis, Child-Pugh class was the strongest predictor; the area under the ROC of Child-Pugh score for predicting in-hospital mortality was 0.802. In multivariate analysis, increased in-hospital mortality was significantly associated with male sex (vs female: odds ratio [OR]=1.19, P=0.01), older age, Child-Pugh class B or C (B vs A: OR=2.80, P<0.001; C vs A: OR=20.1, P<0.001) and higher Charlson Comorbidity Index (6 vs 5; OR=1.29, P<0.001). ConclusionIn spite of recent advances in the treatment of variceal hemorrhage, the in-hospital mortality remained as high as 16%. Poor liver function was the most important predictor, suggesting that liver failure after variceal hemorrhage might have been the cause of death.	[Sato, Masaya; Tateishi, Ryosuke; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138655, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Tateishi, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tateishi-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labor and Welfare, Japan [H22-Policy-031]; Ministry of Education, Culture, Sports, Science and Technology [22390131]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from Council for Science and Technology Policy, Japan [0301002001001]; Ministry of Health, Labor and Welfare	THIS WORK WAS supported by a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labor and Welfare, Japan (grant no.: H22-Policy-031); a Grant-in-Aid for Scientific Research B from the Ministry of Education, Culture, Sports, Science and Technology (grant no.: 22390131); the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan (grant no.: 0301002001001); and Health Sciences Research Grants from The Ministry of Health, Labor and Welfare (Research on Hepatitis).	D'Amico G, 2003, HEPATOLOGY, V38, P599, DOI 10.1053/jhep.2003.50385; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Chalasani N, 2003, AM J GASTROENTEROL, V98, P653, DOI 10.1016/S0002-9270(02)06016-1; SARIN SK, 1992, HEPATOLOGY, V16, P1343, DOI 10.1002/hep.1840160607; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; El-Serag HB, 2000, AM J GASTROENTEROL, V95, P3566; Feus F, 1995, LANCET, V346, P1056; GRAHAM DY, 1981, GASTROENTEROLOGY, V80, P800; Groszmanns RJ, 1999, SCHIFFS DIS LIVER, V84, P538; Nidegger D, 2003, J HEPATOL, V39, P509, DOI 10.1016/S0168-8278(03)00322-2; Yasunaga H, 2010, UROLOGY, V76, P548, DOI 10.1016/j.urology.2010.03.021; Yasunaga H, 2010, INTERNAL MED, V49, P1965, DOI 10.2169/internalmedicine.49.3843	14	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					288	293		10.1111/hepr.12357		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300005		
J	Matsumoto, M; Matsuura, T; Aoki, K; Maehashi, H; Iwamoto, T; Ohkawa, K; Yoshida, K; Yanaga, K; Takada, K				Matsumoto, Michinori; Matsuura, Tomokazu; Aoki, Katsuhiko; Maehashi, Haruka; Iwamoto, Takeo; Ohkawa, Kiyoshi; Yoshida, Kiyotsugu; Yanaga, Katsuhiko; Takada, Koji			An efficient system for secretory production of fibrinogen using a hepatocellular carcinoma cell line	HEPATOLOGY RESEARCH			English	Article						bioartificial liver; blood-borne pathogens; blood transfusion; fibrinogen; human cell line; radial flow bioreactor	RADIAL-FLOW BIOREACTOR; RECOMBINANT HUMAN FIBRINOGEN; CHEMICALLY-DEFINED MEDIUM; LONG-TERM CULTURE; BIOARTIFICIAL LIVER; PLASMA-PROTEINS; ALPHA-CHAIN; ACID; DIFFERENTIATION; INTERLEUKIN-6	AimDespite an increasing demand, blood products are not always safe because most are derived from blood donations. One possible solution is the development and commercialization of recombinant fibrinogen, but this process remains poorly developed. This study aimed to develop an effective production system for producing risk-free fibrinogen using human hepatocellular cell lines and serum-free media. MethodsThree human liver cancer cell lines (HepG2, FLC-4 and FLC-7) were cultivated in a serum-supplemented medium or two serum-free media (ASF104N and IS-RPMI) to compare their fibrinogen secretion abilities. Fibrinogen subunit gene expression was estimated by quantitative polymerase chain reaction. Massive fibrinogen production was induced using a 5-mL radial flow bioreactor (RFB) while monitoring glucose metabolism. Subsequently, fibrinogen's biochemical characteristics derived from these cells were analyzed. ResultsFLC-7 cell culture combined with IS-RPMI resulted in significantly better fibrinogen production (21.6g/10(7) cells per day). ASF104N had more positive effects on cell growth compared with IS-RPMI, whereas fibrinogen production was more efficient with IS-RPMI than with ASF104N. Changing the medium from ASF104N to IS-RPMI led to significantly increased fibrinogen gene expression and glucose consumption. In the RFB culture, the fibrinogen secretion rate of FLC-7 cells reached 0.73g/mL per day during a 42-day cultivation period. The subunit composition and clot formation activity of FLC-7 cell-derived fibrinogen corresponded to those of plasma fibrinogen. ConclusionThe FLC-7 cell culture system is suitable for large-scale fibrinogen preparation production.	[Matsumoto, Michinori; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan; [Matsumoto, Michinori; Aoki, Katsuhiko; Ohkawa, Kiyoshi; Yoshida, Kiyotsugu; Takada, Koji] Jikei Univ, Sch Med, Dept Biochem, Tokyo 1058461, Japan; [Matsuura, Tomokazu; Maehashi, Haruka] Jikei Univ, Sch Med, Dept Lab Med, Tokyo 1058461, Japan; [Iwamoto, Takeo] Jikei Univ, Sch Med, Core Res Facil, Tokyo 1058461, Japan; [Takada, Koji] Jikei Univ, Sch Med, Dept Nat Sci, Div Biol, Tokyo 1058461, Japan	Matsumoto, M (reprint author), Jikei Univ, Dept Surg, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	mmatsumoto4@jikei.ac.jp			Japan Health Sciences Foundation [KHC1202]	THIS WORK WAS supported by a Grant-in-Aid from The Japan Health Sciences Foundation (Research on Publicly Essential Drugs and Medical Devices, KHC1202).	LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; KELLY JH, 1989, IN VITRO CELL DEV B, V25, P217; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Redman CM, 2001, ANN NY ACAD SCI, V936, P480; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308; KASZA A, 1994, BIOL CHEM H-S, V375, P779; NAKABAYASHI H, 1984, GANN, V75, P151; Fukaya KI, 2001, IN VITRO CELL DEV-AN, V37, P266; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; BAUMANN H, 1989, J BIOL CHEM, V264, P8046; BINNIE CG, 1993, BIOCHEMISTRY-US, V32, P107, DOI 10.1021/bi00052a015; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CLEVENGER FW, 1993, AM J SURG, V165, pS68, DOI 10.1016/S0002-9610(05)81209-7; FARRELL DH, 1993, J BIOL CHEM, V268, P10351; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Hasumura S, 1988, Hum Cell, V1, P98; Homma S, 1990, Hum Cell, V3, P152; Iwahori T, 2003, HEPATOLOGY, V37, P665, DOI 10.1053/jhep.2003.50094; Kawada M, 1998, IN VITRO CELL DEV-AN, V34, P109; Kojs A, 1993, BIOL CHEM H-S, V374, P193; Kosuge M, 2007, LIVER INT, V27, P101, DOI 10.1111/j.1478-3231.2006.01410.x; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Laurent T, 2012, J CELL PHYSIOL, V227, P2898, DOI 10.1002/jcp.23033; Matsuura T, 1998, INT J ARTIF ORGANS, V21, P229; MOSESSON MW, 1983, ANN NY ACAD SCI, V408, P97, DOI 10.1111/j.1749-6632.1983.tb23237.x; Nagamori S, 2000, J GASTROENTEROL, V35, P493, DOI 10.1007/s005350070071; NICODEME E, 1995, ARTERIOSCL THROM VAS, V15, P1660; Roys SN, 1991, J BIOL CHEM, V266, P4758; Satake M, 2004, INT J HEMATOL, V80, P306, DOI 10.1532/IJH97.04118; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2375; Tojo N, 2008, PROTEIN EXPRES PURIF, V59, P289, DOI 10.1016/j.pep.2008.02.010; WATT KWK, 1979, BIOCHEMISTRY-US, V18, P5410, DOI 10.1021/bi00591a024; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					315	325		10.1111/hepr.12353		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300008		
J	Kishina, M; Koda, M; Tokunaga, S; Miyoshi, K; Fujise, Y; Kato, J; Matono, T; Sugihara, T; Murawaki, Y				Kishina, Manabu; Koda, Masahiko; Tokunaga, Shiho; Miyoshi, Kennichi; Fujise, Yuki; Kato, Jun; Matono, Tomomitsu; Sugihara, Takaaki; Murawaki, Yoshikazu			Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound	HEPATOLOGY RESEARCH			English	Article						contrast-enhanced ultrasound; conventional ultrasound; enhanced computed tomography; liver abscess; perfluorobutane	HEPATOCELLULAR-CARCINOMA; LESIONS; ULTRASONOGRAPHY; CT	AimThe purpose of this study was to evaluate the usefulness of contrast-enhanced ultrasound (CEUS) with Sonazoid (perfluorobutane) in patients with liver abscess. Sonazoid is a contrast agent with a low mechanical index and is phagocytosed by Kupffer cells. MethodsTwenty-two patients with liver abscess were evaluated with conventional US, real-time CEUS with Sonazoid, and enhanced computed tomography (CT). After 0.5mL of Sonazoid was administrated i.v., CEUS images in the vascular and post-vascular phases were observed. ResultsConventional US showed hypoechoic lesions in 13 (59.1%), isoechoic in four (18.2%), hyperechoic in two (9.1%), mixed echoic in two (9.1%) and undetected in one (4.8%) patient. CEUS showed perilesional enhancement in 19 (86.4%) lesions in the vascular phase and well-defined unenhanced areas in 22 (100%) lesions in the post-vascular phase. CEUS revealed that 18 abscesses were cystic type and three were honeycomb type. Twenty-one abscesses (95.5%) had clearer appearances on CEUS than on conventional US in regard to the extent of necrotic or liquefied lesions seen. We could confirm reduction of the lesions after therapy in 13 (92.9%) of 14 patients followed up by CEUS. ConclusionMost of the liver abscesses showed perilesional enhancement in the vascular phase and unenhanced areas in the post-vascular phase. The appearance of liver abscesses was clearer on CEUS than on conventional US. CEUS with Sonazoid can be a more effective diagnostic and therapeutic tool for liver abscess.	[Kishina, Manabu; Koda, Masahiko; Tokunaga, Shiho; Miyoshi, Kennichi; Fujise, Yuki; Kato, Jun; Matono, Tomomitsu; Sugihara, Takaaki; Murawaki, Yoshikazu] Tottori Univ, Div Med & Clin Sci, Dept Multidisciplinary Internal Med, Sch Med, Yonago, Tottori 6838504, Japan	Koda, M (reprint author), Tottori Univ, Div Med & Clin Sci, Dept Multidisciplinary Internal Med, 36-1 Nishi Machi, Yonago, Tottori 6838504, Japan.	masakoda@grape.med.tottori-u.ac.jp					Mortele KJ, 2004, RADIOGRAPHICS, V24, P937, DOI 10.1148/rg.244035719; Catalano O, 2004, AM J ROENTGENOL, V182, P447; Morin SHX, 2007, WORLD J GASTROENTERO, V13, P5963; Bartolotta TV, 2009, ABDOM IMAGING, V34, P193, DOI 10.1007/s00261-008-9378-6; Mita K, 2010, WORLD J GASTROENTERO, V16, P4187, DOI 10.3748/wjg.v16.i33.4187; Meloni MF, 2008, J ULTRAS MED, V27, P1511; Nakano H, 2008, WORLD J GASTROENTERO, V14, P3207, DOI 10.3748/wjg.14.3207; Ding H, 2005, J ULTRAS MED, V24, P285; Kawamoto S, 1998, RADIOGRAPHICS, V18, P827; Zerem E, 2007, AM J ROENTGENOL, V189, pW138, DOI 10.2214/AJR.07.2173; Huis JYH, 2007, RADIOLOGY, V242; Kims KW, 2004, ULTRASOUND MED BIOL, V30, P725; KULIGOWSKA E, 1982, AM J ROENTGENOL, V138, P253; Lees SH, 2008, AM J ROENTGENOL, V190, P616; Lius G-J, 2008, J ULTRAS MED, V27, P657; Mandai M, 2011, BRIT J RADIOL, V84, P499, DOI 10.1259/bjr/38682601; Pearce N W, 2003, HPB (Oxford), V5, P91, DOI 10.1080/13651820310001126; Petri A, 2002, LANGENBECK ARCH SURG, V387, P27, DOI 10.1007/s00423-002-0279-9	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					337	342		10.1111/hepr.12347		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300010		
J	Kakisaka, K; Kooka, Y; Oikawa, T; Suzuki, A; Oikawa, K; Kuroda, H; Kasai, K; Takikawa, Y				Kakisaka, Keisuke; Kooka, Yohei; Oikawa, Takayoshi; Suzuki, Akiko; Oikawa, Kanta; Kuroda, Hidekatsu; Kasai, Kazuhiro; Takikawa, Yasuhiro			Bimodal peaks of liver stiffness in a case of drug-induced liver injury	HEPATOLOGY RESEARCH			English	Article						acoustic radiation force impulse intrahepatic cholestasis; shear wave velocity; virtual touch tissue quantification	RADIATION FORCE IMPULSE; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; FIBROSIS; CHOLESTASIS; INFECTION; FAILURE	A 69-year-old male complained of general fatigue and presented with elevation of liver enzymes without any cause of liver injury. We diagnosed him with hepatocellular drug-induced liver injury (DILI). Liver stiffness, which was evaluated according to the shear wave velocity (SWV) using virtual touch tissue quantification, was serially observed during hospitalization. A fast SWV was noted on the date of admission, indicating a hard degree of liver stiffness. The SWV gradually decreased until the 20th hospital day. However, the patient's liver enzymes again became elevated on the 20th hospital day, and the SWV simultaneously increased in association with a rise in the total bilirubin level. The laboratory data for the second peak of the SWV indicated mixed-type DILI; therefore, the patient's pathological state transitioned from the hepatocellular type to the mixed type. A liver biopsy performed before discharge revealed a state of recovery from acute inflammation without fibrotic changes. We conclude that the second peak of the SWVmay be affected by the presence of intrahepatic cholestasis. We herein report the occurrence of bimodal peaks of liver stiffness in a patient with DILI. In such cases, each peak of liver stiffness may be the result of a different pathological mechanism, namely acute inflammation versus acute intrahepatic cholestasis. Although the detailed mechanisms underlying the development of liver stiffness due to intrahepatic cholestasis remain unclear, this case presented a limitation of virtual touch tissue quantification for evaluation of liver stiffness as fibrosis marker in the liver with intrahepatic cholestasis.	[Kakisaka, Keisuke; Kooka, Yohei; Oikawa, Takayoshi; Suzuki, Akiko; Oikawa, Kanta; Kuroda, Hidekatsu; Kasai, Kazuhiro; Takikawa, Yasuhiro] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hepatol, Morioka, Iwate 0208505, Japan	Kakisaka, K (reprint author), Iwate Med Univ, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	keikaki@iwate-med.ac.jp					Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Lupsor M, 2009, J GASTROINTEST LIVER, V18, P303; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Harata M, 2011, HEPATOL RES, V41, P423, DOI 10.1111/j.1872-034X.2011.00797.x; Frulio N, 2009, HEPATOLOGY, V50, P1674, DOI 10.1002/hep.23109; Hirschfield GM, 2009, CURR OPIN GASTROEN, V25, P175, DOI 10.1097/MOG.0b013e32832914b4; Hopper I, 2012, EUR J HEART FAIL, V14, P621, DOI 10.1093/eurjhf/hfs044; Kuroda H, 2010, HEPATO-GASTROENTEROL, V57, P1203; Kuroda H, 2012, J CLIN ULTRASOUND, V40, P99, DOI 10.1002/jcu.20893; Takaki S, 2014, HEPATOL RES, V44, P280, DOI 10.1111/hepr.12129	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					343	348		10.1111/hepr.12341		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300011		
J	Sato, H; Tomita, K; Yasue, C; Umeda, R; Ebinuma, H; Ogata, S; Du, WL; Soga, S; Maruta, K; Yasutake, Y; Narimatsu, K; Usui, S; Watanabe, C; Komoto, S; Teratani, T; Suzuki, T; Yokoyama, H; Saito, H; Nagao, S; Hibi, T; Miura, S; Kanai, T; Hokari, R				Sato, Hirokazu; Tomita, Kengo; Yasue, Chihiro; Umeda, Rumiko; Ebinuma, Hirotoshi; Ogata, Sho; Du, Wenlin; Soga, Shigeyoshi; Maruta, Koji; Yasutake, Yuichi; Narimatsu, Kazuyuki; Usui, Shingo; Watanabe, Chikako; Komoto, Shunsuke; Teratani, Toshiaki; Suzuki, Takahiro; Yokoyama, Hirokazu; Saito, Hidetsugu; Nagao, Shigeaki; Hibi, Toshifumi; Miura, Soichiro; Kanai, Takanori; Hokari, Ryota			Pregnant woman with non-comatose autoimmune acute liver failure in the second trimester rescued using medical therapy: A case report	HEPATOLOGY RESEARCH			English	Article						autoimmune hepatitis; continuous hemodiafiltration; non-comatose acute liver failure; plasma exchange; prednisolone; pregnancy	FULMINANT HEPATIC-FAILURE; CORTICOSTEROID USE; JAPAN; PREDICTION; PROGNOSIS; DISEASE; RISK	We present the case of a 25-year-old woman at 16 weeks of gestation who presented with non-comatose autoimmune acute liver failure and was at high risk of developing fulminant hepatitis. Predictive formulas indicated a high probability of developing fulminant hepatitis. Unenhanced computed tomography showed marked hepatic atrophy and broadly heterogeneous hypoattenuating areas. The course of her illness was subacute, and the etiology of liver injury was unclear. Considering all of the above, we predicted a poor prognosis. Plasma exchange (PE) and continuous hemodiafiltration (CHDF) therapy were initiated just after admission. A few days after admission, a high titer (x80) of antinuclear antibody was noted. Because autoimmune hepatitis (AIH) was considered a cause of liver failure, treatment with moderate prednisolone (30mg/day) doses was administrated, with careful consideration of her pregnancy. Thereafter, her laboratory findings and clinical course gradually improved without the need for liver transplantation. A liver biopsy at 18 days after admission indicated a diagnosis of AIH. She continued the pregnancy and delivered a healthy baby without any complications. Eventually, prednisolone doses were decreased to 10mg, after which her liver function worsened. The second liver biopsy also indicated a diagnosis of AIH. Accordingly, low-dose prednisolone and azathioprine doses (50mg/day) were administrated to recover her liver function, after which her liver function regained normalcy. This case illustrates that a pregnant woman with non-comatose autoimmune acute liver failure in the first or second trimester of pregnancy and her fetus can be rescued by PE/CHDF therapy and safe moderate doses of prednisolone.	[Sato, Hirokazu; Tomita, Kengo; Yasue, Chihiro; Maruta, Koji; Yasutake, Yuichi; Narimatsu, Kazuyuki; Usui, Shingo; Watanabe, Chikako; Komoto, Shunsuke; Nagao, Shigeaki; Miura, Soichiro; Hokari, Ryota] Natl Def Med Coll, Dept Internal Med, Div Gastroenterol & Hepatol, Tokorozawa, Saitama 3598513, Japan; [Ogata, Sho] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Saitama 3598513, Japan; [Soga, Shigeyoshi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3598513, Japan; [Umeda, Rumiko; Ebinuma, Hirotoshi; Teratani, Toshiaki; Suzuki, Takahiro; Hibi, Toshifumi; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Du, Wenlin] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Yokoyama, Hirokazu] Keio Univ, Sch Med, Hlth Ctr, Tokyo, Japan; [Saito, Hidetsugu] Keio Univ, Fac Pharm, Grad Sch Pharmaceut Sci, Tokyo, Japan	Tomita, K (reprint author), Natl Def Med Coll, Dept Internal Med, Div Gastroenterol & Hepatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	kengo@ndmc.ac.jp					Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Yamagishi Y, 2009, J GASTROENTEROL, V44, P615, DOI 10.1007/s00535-009-0045-7; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; Yasui S, 2012, HEPATOL RES, V42, P42, DOI 10.1111/j.1872-034X.2011.00892.x; Iwai H, 1998, CRIT CARE MED, V26, P873, DOI 10.1097/00003246-199805000-00021; Hviid A, 2011, CAN MED ASSOC J, V183, P796, DOI 10.1503/cmaj.101063; Yamagishi Y, 2005, J GASTROEN HEPATOL, V20, P1843, DOI 10.1111/j.1440-1746.2005.03949.x; Brucato A, 2010, INT J CARDIOL, V144, P413, DOI 10.1016/j.ijcard.2009.03.028; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Takahashi H, 2011, HEPATOL RES, V41, P498, DOI 10.1111/j.1872-034X.2011.00808.x; Carmichael SL, 1999, AM J MED GENET, V86, P242, DOI 10.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U; Takikawa Y, 2009, J HEPATOL, V51, P1021, DOI 10.1016/j.jhep.2009.09.011; Asos S, 1992, J TOXICOL SCI, V17, P241; Inoue K, 2010, TRANSPL P, V42, P4109, DOI 10.1016/j.transproceed.2010.09.073; Kurtoğlu Selim, 2011, J Clin Res Pediatr Endocrinol, V3, P160, DOI 10.4274/jcrpe.v3i3.31; Lis LJ, 2006, THER APHER DIAL, V10, P160; Lis LJ, 2004, WORLD J GASTROENTERO, V10, P2984; Maddukuri VC, 2012, CASE REP TRANSPLANT, V2012, DOI [10.1155/2012/484080, DOI 10.1155/2012/484080]; Ohta Kouichi, 2007, Nippon Ganka Gakkai Zasshi, V111, P959; Ostensens M, 2006, ARTHRITIS RES, V8, P2; Yasuda Hiroshi, 2007, Nihon Rinsho, V65 Suppl 8, P545; Yoshiba M, 2002, J GASTROENTEROL, V37, P916, DOI 10.1007/s005350200154	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					349	355		10.1111/hepr.12344		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300012		
J	Kuramitsu, K; Fukumoto, T; Fukushima, K; Iwasaki, T; Tominaga, M; Matsui, T; Kawakami, F; Itoh, T; Ku, Y				Kuramitsu, Kaori; Fukumoto, Takumi; Fukushima, Kenji; Iwasaki, Takeshi; Tominaga, Masahiro; Matsui, Toshimitsu; Kawakami, Fumi; Itoh, Tomoo; Ku, Yonson			Severe post-transplant lymphoproliferative disorder after living donor liver transplantation	HEPATOLOGY RESEARCH			English	Article						chemotherapy; Epstein-Barr virus; liver transplantation; post-transplant lymphoproliferative disorder	EPSTEIN-BARR-VIRUS; SOLID-ORGAN TRANSPLANTATION; OF-THE-LITERATURE; T-CELL LYMPHOMA; CARDIAC LYMPHOMA; DISTINCT ENTITY; RISK-FACTORS; INVOLVEMENT; CHILDREN; DISEASE	Post-transplant lymphoproliferative disorder (PTLD) is a well-known complication after transplantation. A living donor liver transplantation was performed on a 31-year-old man for fulminant hepatitis. He again developed liver dysfunction after 7months. He was diagnosed as having acute cellular rejection and the steroid pulse therapy introduced resulted in little improvement. He gradually developed a high fever and right axillary lymphadenopathy appeared. Chest computed tomography (CT) was performed revealing small lung nodules and axillary lymphadenopathy. Because his serological status for Epstein-Barr virus was positive, PTLD was highly suspected and immunosuppression treatment was withdrawn with little improvement. One week later, he developed tachycardia. Chest CT was re-performed revealing an infiltration to the left cardiac chamber. For diagnosis, axillary lymph node biopsy was performed and during the procedure, he developed ventricular tachycardia (VT). Immunohistological staining revealed PTLD of T lymphocytes, and chemotherapy was introduced on the same day he developed VT. After two cycles of tetrahydropyranyl, adriamycin, cyclophosphamide, vincristine, prednisolone and etoposide treatment, he completely recovered. This is a first case report of severe PTLD with VT, and our case implies the feasibility of chemotherapy after the appearance of dissemination symptoms.	[Kuramitsu, Kaori; Fukumoto, Takumi; Fukushima, Kenji; Iwasaki, Takeshi; Tominaga, Masahiro; Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 6500017, Japan; [Matsui, Toshimitsu] Kobe Univ, Grad Sch Med, Dept Med, Kobe, Hyogo 6500017, Japan; [Kawakami, Fumi; Itoh, Tomoo] Kobe Univ, Grad Sch Med, Div Diagnost Pathol, Dept Pathol, Kobe, Hyogo 6500017, Japan	Fukumoto, T (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fukumoto@med.kobe-u.ac.jp					Chinen K, 2005, ANN HEMATOL, V84, P498, DOI 10.1007/s00277-005-1009-5; PETERSEN CD, 1976, AM J MED SCI, V272, P161, DOI 10.1097/00000441-197609000-00005; Kremers WK, 2006, AM J TRANSPLANT, V6, P1017, DOI 10.1111/j.1600-6143.2006.01294.x; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; Chinnock R, 2012, AM J TRANSPLANT, V12, P3061, DOI 10.1111/j.1600-6143.2012.04197.x; Yang J, 2000, BLOOD, V96, P4055; Nelson BP, 2000, AM J SURG PATHOL, V24, P375, DOI 10.1097/00000478-200003000-00006; Choquet S, 2007, HAEMATOL-HEMATOL J, V92, P273, DOI 10.3324/haematol.10595; WALKER RC, 1995, CLIN INFECT DIS, V20, P1346; Dotti G, 2002, TRANSPLANTATION, V74, P1095, DOI 10.1097/00007890-200210270-00007; Dror Y, 1999, TRANSPLANTATION, V67, P990, DOI 10.1097/00007890-199904150-00010; Domingo-Domenech E, 2001, HAEMATOLOGICA, V86, P715; Jain A, 2002, ANN SURG, V236, P429, DOI 10.1097/01.SLA.0000033429.89429.89424.F8; Ceresoli GL, 1997, CANCER, V80, P1497, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1497::AID-CNCR18>3.0.CO;2-0; PENN I, 1991, TRANSPLANT P, V23, P1101; Leblond V, 1998, J CLIN ONCOL, V16, P2052; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Duvoux C, 2002, TRANSPLANTATION, V74, P1103, DOI 10.1097/01.TP.000031543.16208.1C; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Caos S, 1999, PEDIATR TRANSPLANT, V3, P22; Collins MH, 2001, PEDIATR TRANSPLANT, V5, P250, DOI 10.1034/j.1399-3046.2001.005004250.x; Collins MH, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e89; DAMORE ESG, 1991, CANCER, V68, P1285, DOI 10.1002/1097-0142(19910915)68:6<1285::AID-CNCR2820680618>3.0.CO;2-5; George TI, 2005, PEDIATR BLOOD CANCER, V44, P270, DOI 10.1002/pbc.20231; Gutherys SL, 2003, TRANSPLANTATION, V75, P1603; Harris NL, 2001, PATHOLOGY GENETICS T, P264; Jabs WJ, 2001, J CLIN MICROBIOL, V39, P564, DOI 10.1128/JCM.39.2.564-569.2001; LIEDTKE AJ, 1971, AM J MED, V50, P816, DOI 10.1016/0002-9343(71)90190-2; Lims WH, 2006, NEPHROLOGY, V11, P355; Nathanson S, 2002, PEDIATR NEPHROL, V17, P668, DOI 10.1007/s00467-002-0880-8; Nees R, 2011, TRANSPLANTATION, V92, P190; Rees L, 1998, LANCET, V352, P789, DOI 10.1016/S0140-6736(05)60684-8; Swerdlow SH, 2007, AM J CLIN PATHOL, V127, P887, DOI 10.1309/LYXN3RGF7D7KPYG0; TERRY LN, 1970, CANCER, V25, P1003, DOI 10.1002/1097-0142(197005)25:5<1003::AID-CNCR2820250503>3.0.CO;2-W; VANGORP J, 1994, CANCER, V73, P3064, DOI 10.1002/1097-0142(19940615)73:12<3064::AID-CNCR2820731227>3.0.CO;2-0; VanBuskirk AM, 2001, TRANSPLANT P, V33, P1834, DOI 10.1016/S0041-1345(00)02700-7; Wang LC, 2000, BONE MARROW TRANSPL, V26, P893, DOI 10.1038/sj.bmt.1702610	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	MAR	2015	45	3					356	362		10.1111/hepr.12345		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3QL	WOS:000350994300013		
J	Kano, N; Miyake, H; Sasaki, K; Kawashima, T				Kano, Naokazu; Miyake, Hideaki; Sasaki, Keishi; Kawashima, Takayuki			Oxidative Bond Cleavage of the Silicon-Silicon Bond of a Pentacoordinated Disilicate	HETEROATOM CHEMISTRY			English	Article							CONTAINING CYCLIC-COMPOUNDS; ELECTRON-TRANSFER REACTION; THERMAL-DISSOCIATION; DISILANES; SILYLENE; GENERATION; REACTIVITY; CHEMISTRY; STEREOCHEMISTRY; BEHAVIOR	The SiSi bond of a pentacoordinated disilicate was readily cleaved by treatment with 2,3-dichloro-5,6-dicyano-p-benzoquinone in the presence of sodium carbonate under mild conditions. The bond cleavage did not proceed under the same conditions after conversion of the disilicate into the corresponding monoanionic silylsilicate and neutral disilane by protonation. The difference in the charges of the SiSi bond compounds affects the reactivity toward an oxidant, resulting in the SiSi bond cleavage, considering that all of these compounds have a bond between pentacoordinated silicon atoms.	[Kano, Naokazu; Miyake, Hideaki; Sasaki, Keishi; Kawashima, Takayuki] Univ Tokyo, Dept Chem, Grad Sch Sci, Tokyo 1130033, Japan	Kano, N (reprint author), Univ Tokyo, Dept Chem, Grad Sch Sci, Tokyo 1130033, Japan.	kano@chem.s.u-tokyo.ac.jp; kawashima.t@gunma-u.ac.jp	Kano, Naokazu/E-7403-2010	Kano, Naokazu/0000-0002-7019-0378	Yamada Science Foundation;  [19.6461]	Contract grant sponsor: Yamada Science Foundation.; Contract grant sponsor: Grants-in-Aid for JSPS Fellows.; Contract grant number: 19.6461.	Al-Kaysi RO, 2005, J AM CHEM SOC, V127, P1620, DOI 10.1021/ja0432564; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; Akasaka T, 1999, J ORG CHEM, V64, P566, DOI 10.1021/jo981689h; TOKITOH N, 1993, J AM CHEM SOC, V115, P10428, DOI 10.1021/ja00075a096; El-Sayed I, 1999, J AM CHEM SOC, V121, P5095, DOI 10.1021/ja982943q; SUZUKI H, 1995, B CHEM SOC JPN, V68, P2471, DOI 10.1246/bcsj.68.2471; Tamao K, 1999, CHEM LETT, P335; PEROZZI EF, 1981, J ORG CHEM, V46, P1049, DOI 10.1021/jo00319a001; HIYAMA T, 1983, J ORG CHEM, V48, P912, DOI 10.1021/jo00154a043; Sen SS, 2010, J AM CHEM SOC, V132, P1123, DOI 10.1021/ja9091374; Wagler J, 2004, ORGANOMETALLICS, V23, P6066, DOI 10.1021/om040096w; OLAH GA, 1979, ANGEW CHEM INT EDIT, V18, P612, DOI 10.1002/anie.197906121; Armbruster F, 2009, DALTON T, P5612, DOI 10.1039/b906333a; Bitto F, 2013, EUR J INORG CHEM, P2954, DOI 10.1002/ejic.201300109; Brook M. A., 2000, SILICON ORGANIC ORGA, P97; Chuit C, 1999, CHEMISTRY OF HYPERVALENT COMPOUNDS, P81; Hatanaka Y, 2003, J ORGANOMET CHEM, V685, P207, DOI 10.1016/S0022-328X(03)00652-1; Herzog U, 1999, MAIN GROUP MET CHEM, V22, P19; Herzog U, 1997, J ORGANOMET CHEM, V533, P73, DOI 10.1016/S0022-328X(96)06823-4; Ishikawa M, 2001, ORGANOMETALLICS, V20, P1059, DOI 10.1021/om000909q; ISHIKAWA M, 1992, ORGANOMETALLICS, V11, P483, DOI 10.1021/om00037a082; Kako M, 2000, B CHEM SOC JPN, V73, P2403, DOI 10.1246/bcsj.73.2403; Kako M, 1998, COORDIN CHEM REV, V176, P87, DOI 10.1016/S0010-8545(98)00145-3; Kano N, 2010, NAT CHEM, V2, P112, DOI [10.1038/nchem.513, 10.1038/NCHEM.513]; Kano N, 2014, ORGANOMETALLICS, V33, P2358, DOI 10.1021/om500291k; Kano N, 2005, ORGANOMETALLICS, V24, P2823, DOI 10.1021/om050321p; KIRA M, 1989, J AM CHEM SOC, V111, P3747, DOI 10.1021/ja00192a041; Knopf C, 2002, J ORGANOMET CHEM, V662, P14, DOI 10.1016/S0022-328X(02)01856-9; Lenormand H, 2013, ORG LETT, V15, P748, DOI 10.1021/ol3033048; Mori A, 1997, SYNLETT, P693; Naka A, 2001, ORGANOMETALLICS, V20, P1204, DOI 10.1021/om000908y; Naka A, 2004, ORGANOMETALLICS, V23, P2397, DOI 10.1021/om0305081; NAKADAIRA Y, 1991, CHEM LETT, P327, DOI 10.1246/cl.1991.327; Saeki T, 2003, ORGANOMETALLICS, V22, P3299, DOI 10.1021/om030190x; SAKURAI H, 1971, B CHEM SOC JPN, V44, P1167, DOI 10.1246/bcsj.44.1167; SAKURAI H, 1965, J AM CHEM SOC, V87, P4001, DOI 10.1021/ja01095a052; SEYFERTH D, 1984, J ORGANOMET CHEM, V271, P337, DOI 10.1016/0022-328X(84)85187-6; STEVENSON WH, 1985, J AM CHEM SOC, V107, P6340, DOI 10.1021/ja00308a030; Tamao K, 2000, J ORGANOMET CHEM, V600, P118, DOI 10.1016/S0022-328X(00)00144-3; Tamao K, 1995, ADV ORGANOMETALLIC C, V38, P1; TAMAO K, 1995, J AM CHEM SOC, V117, P11592, DOI 10.1021/ja00151a030; Tamao K, 1999, ANGEW CHEM INT EDIT, V38, P3316, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3316::AID-ANIE3316>3.0.CO;2-9; Tavcar S., 2010, ORGANOMETALLICS, V29, P3930; Toshimitsu A, 2001, J AM CHEM SOC, V123, P9210, DOI 10.1021/ja0160602; TSUJI Y, 1992, ORGANOMETALLICS, V11, P2353, DOI 10.1021/om00043a015; Tsutsui S, 2004, ORGANOMETALLICS, V23, P5659, DOI 10.1021/om049306v; Williams NA, 2003, DALTON T, P236, DOI 10.1039/b207987a	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	MAR	2015	26	2					183	186		10.1002/hc.21245		4	Chemistry, Multidisciplinary	Chemistry	CD3MD	WOS:000350981800008		
J	Sasaki, M; Nakanuma, Y				Sasaki, Motoko; Nakanuma, Yasuni			Cellular senescence in biliary pathology: Special emphasis on expression of a polycomb group protein EZH2 and a senescent marker p16(INK4a) in bile ductular tumors and lesions	HISTOLOGY AND HISTOPATHOLOGY			English	Review						EZH2; p16(INK4a); Cholangiolocellular carcinoma; Bile duct adenoma; Ductular reaction	ONCOGENE-INDUCED SENESCENCE; EPITHELIAL-CELLS; INTRAHEPATIC CHOLANGIOCARCINOMA; REPLICATIVE SENESCENCE; HEPATOCELLULAR-CARCINOMA; DECREASED EXPRESSION; OXIDATIVE STRESS; LIVER-DISEASE; CIRRHOSIS; PROGRESSION	A subgroup of intrahepatic cholangiocarcinoma and combined hepatocellular- cholangiocarcinoma contain a component of cholangiolocellular carcinoma, which is composed of small bile ductular cells. Ductular reaction, a reactive lesion at the portal tract interface comprising increased bile ductules, is frequently seen in chronic advanced liver diseases. Bile duct adenoma, a benign tumor/tumorous lesion is also composed of bile ductular cells. Differential diagnosis among these bile ductular tumors/lesions is sometimes difficult. Given overexpression of a polycomb group protein EZH2 in intrahepatic cholangiocarcinoma and high expression of senescence-associated p16(INK4a) in ductular reactions, we plan to apply immunostaining for EZH2 and p16(INK4a) for differential diagnosis of these bile ductular tumors/lesions. The expression of EZH2 was seen in all cases of cholangiolocellular carcinomas, while it was not observed in bile duct adenomas or ductular reactions. In contrast, the expression of p16(INK4a) was seen in most bile duct adenomas and all ductular reactions, whereas it was barely seen in cholangiolocellular carcinomas. A borderline between cholangiolocellular carcinoma and the surrounding ductular reaction was clearly highlighted by the reverse expression pattern of EZH2 and p16(INK4a). In conclusion, immunostaining for EZH2 and p16(INK4a) may be useful for differential diagnosis for bile ductular tumors/lesions.	[Sasaki, Motoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208460, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208460, Japan.	m8sasaki@med.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [24590409]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (24590409). There is no conflict of interest regarding this study.	Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Xu J, 2012, LIVER INT, V32, P1156, DOI 10.1111/j.1478-3231.2012.02783.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Hughes NR, 2010, AM J SURG PATHOL, V34, P1312, DOI 10.1097/PAS.0b013e3181ead722; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; HASEBE T, 1995, VIRCHOWS ARCH, V426, P209; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Yamaguchi J, 2009, LAB INVEST, V89, P1018, DOI 10.1038/labinvest.2009.65; Jacobs JJL, 1999, NATURE, V397, P164; Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sasaki M, 2008, J PATHOL, V215, P175, DOI 10.1002/path.2345; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; Brodsky W Y, 1977, Int Rev Cytol, V50, P275; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8; Chiba M, 2011, J CLIN PATHOL, V64, P564, DOI 10.1136/jcp.2011.090175; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Goodman ZD, 2012, MACSWEENS PATHOLOGY, P761; Hajosi-Kalcakosz S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-86; Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.02.010; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; Nakanuma Y, 2010, WHO CLASSIFICATION T, P217; Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552; Sasaki M, 2003, HUM PATHOL, V34, P1337, DOI 10.1016/j.humpath.2003.07.012; Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6; Sasaki M, 2012, DIGEST DIS SCI, V57, P660, DOI 10.1007/s10620-011-1929-y; Sasaki M, 2014, AM J SURG PATHOL, V38, P364, DOI 10.1097/PAS.0000000000000125; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260; Theise ND, 2010, WHO CLASSIFICATION T, P225; Wanless IR, 2012, MACSWEENS PATHOLOGY, P601; Xu J, 2011, HISTOPATHOLOGY, V59, P1090, DOI 10.1111/j.1365-2559.2011.04058.x	54	1	1	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAR	2015	30	3					267	275		10.14670/HH-30.267		9	Cell Biology; Pathology	Cell Biology; Pathology	CD6MS	WOS:000351203800002		
J	Saito, T; Ando, R; Ohira, T; Hoshiya, T; Tamura, K				Saito, Tsubasa; Ando, Ryo; Ohira, Toko; Hoshiya, Toru; Tamura, Kazutoshi			Ocular lesions induced in infant rats by busulfan	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Busulfan; Infant rat; Ocular lesion; Rosette-like structure; Cataract	METHYL-N-NITROSOUREA; SPRAGUE-DAWLEY RATS; CENTRAL-NERVOUS-SYSTEM; RETINAL DYSPLASIA; INDUCED CATARACT; CELL APOPTOSIS; FETUSES; MECHANISM; SEQUENCE; MYLERAN	Although busulfan, a bifunctional alkylating agent, is known to induce cataracts in infant rats, the full nature of busulfan-induced ocular lesions has not yet been shown. In order to clarify this point, 6-day-old rats were treated with a single dose of 20 mg/kg busulfan and the ocular tissue was histopathologically and immunohistochemically examined at 1, 2, 4, 7 and 12 days after treatment (DAT). As a result, in the nuclear layer (NL) of the peripheral retina, apoptotic cells significantly increased at 1 DAT and peaked at 2 DAT when cell proliferating activity was depressed. At 4 DAT, the NL showed wavy deformation with formation of rosette-like structures, and these changes progressed prominently at 12 DAT. In addition, a significant reduction in the retinal thickness due to decreased thickness of NL or inner NL was detected at 2 and 4 DAT. On the other hand, in the germinative zone of the lens equator, apoptotic lens epithelial cells significantly increased from 2 to 7 DAT, resulting in partial loss of lens epithelial cells at 7 and 12 DAT. At 12 DAT, prominent swelling and vacuolation of lens fibers were observed in the area from the equatorial zone to the posterior pole, indicating the development of cataract. The present results strongly suggest that prominent apoptosis in component cells was the initial and essential event underlying the development of busulfan-induced ocular lesions in infant rats.	[Saito, Tsubasa; Ando, Ryo; Ohira, Toko; Hoshiya, Toru; Tamura, Kazutoshi] BoZo Res Ctr Inc, Div Pathol, Gotemba Labs, Gotemba, Shizuoka 4120039, Japan	Saito, T (reprint author), BoZo Res Ctr Inc, 1284 Kamado, Gotemba, Shizuoka 4120039, Japan.	tsubasa-saito@outlook.jp					SHIVELY JN, 1970, INVEST OPHTH VISUAL, V9, P888; Mertins SD, 2004, MOL CANCER THER, V3, P849; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Yoshizawa K, 2000, TOXICOL PATHOL, V28, P555, DOI 10.1177/019262330002800408; Li WC, 1996, FREE RADICAL BIO MED, V20, P301, DOI 10.1016/0891-5849(96)02050-3; DAHLGREN S, 1972, ACTA MED SCAND, V192, P129; De Beer E.J., 1956, J NUTR, V10, P157; FUJIWARA H, 1980, ACTA PATHOL JAPON, V30, P375; Furukawa S, 2007, HISTOL HISTOPATHOL, V22, P389; GLUCKSMANN A., 1936, BRIT JOUR OPHTHALMOL, V20, P497, DOI 10.1136/bjo.20.9.497; HAMMING NA, 1976, A GRAEF ARCH KLIN EX, V200, P139, DOI 10.1007/BF00414363; Honda Akane, 1993, Nippon Ganka Gakkai Zasshi, V97, P1242; Iwamoto Takuya, 2004, Cancer Science, V95, P454, DOI 10.1111/j.1349-7006.2004.tb03231.x; Kaida T, 1999, OPHTHALMOLOGICA, V213, P397, DOI 10.1159/000027462; Kiuchi K, 2002, EXP TOXICOL PATHOL, V54, P181, DOI 10.1078/0940-2993-00253; Kuwata M, 2009, IN VIVO, V23, P555; LIGHT AE, 1967, TOXICOL APPL PHARM, V10, P459, DOI 10.1016/0041-008X(67)90086-5; Miki K, 2007, IN VIVO, V21, P739; MIKULICICH AG, 1963, INVEST OPHTH VISUAL, V2, P344; MILLAR BC, 1986, BIOCHEM PHARMACOL, V35, P1163, DOI 10.1016/0006-2952(86)90155-3; Nagai H, 1972, Bull Tokyo Dent Coll, V13, P103; Nambu H., 1998, J TOXICOL PATHOL, V11, P127, DOI 10.1293/tox.11.127; Naruse T, 2007, DEV GROWTH DIFFER, V49, P533, DOI 10.1111/j.1440-169x.2007.00949.x; Ohira T, 2013, EXP TOXICOL PATHOL, V65, P523, DOI 10.1016/j.etp.2012.03.001; Ohira T, 2013, EXP TOXICOL PATHOL, V65, P789, DOI 10.1016/j.etp.2012.11.005; Ohira T, 2009, J TOXICOL PATHOL, V22, P167, DOI 10.1293/tox.22.167; Otsuji M, 2005, BIRTH DEFECTS RES A, V73, P461, DOI 10.1002/bdra.20115; PERCY DH, 1977, INVEST OPHTH VIS SCI, V16, P353; Probin V, 2006, J PHARMACOL EXP THER, V319, P551, DOI 10.1124/jpet.106.107771; RAVINDRA.MP, 1972, BRIT MED J, V1, P218; Ritter CA, 2002, BRIT J PHARMACOL, V137, P1100, DOI 10.1038/sj.bjp.0704972; SOLOMON C, 1955, ARCH OPHTHALMOL-CHIC, V54, P850; SOYSAL T, 1993, ACTA HAEMATOL-BASEL, V90, P213; Ueno M, 2002, EXP TOXICOL PATHOL, V54, P91, DOI 10.1078/0940-2993-00239; Valdez BC, 2010, LEUKEMIA RES, V34, P364, DOI 10.1016/j.leukres.2009.08.014; Yang JH, 2000, CURR EYE RES, V20, P441, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT441	37	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAR	2015	30	3					321	330		10.14670/HH-30.321		10	Cell Biology; Pathology	Cell Biology; Pathology	CD6MS	WOS:000351203800006		
J	Yamamoto-Kataoka, S; Ebihara, K; Aizawa-Abe, M; Nishio, M; Kusakabe, T; Yamamoto, Y; Aotani, D; Sakai, T; Zhao, M; Ebihara, C; Gumbilai, VMJ; Hosoda, K; Suzuki, A; Nakao, K				Yamamoto-Kataoka, S.; Ebihara, K.; Aizawa-Abe, M.; Nishio, M.; Kusakabe, T.; Yamamoto, Y.; Aotani, D.; Sakai, T.; Zhao, M.; Ebihara, C.; Gumbilai, V. M. J.; Hosoda, K.; Suzuki, A.; Nakao, K.			Leptin Improves Fatty Liver Independently of Insulin Sensitization and Appetite Suppression in Hepatocyte-Specific Pten-Deficient Mice with Insulin Hypersensitivity	HORMONE AND METABOLIC RESEARCH			English	Article						nonalcoholic fatty liver disease; metabolic syndrome; insulin resistance; hyperphagia; pair feeding; AMP-activated protein kinase	ACTIVATED PROTEIN-KINASE; OVEREXPRESSING LEPTIN; REPLACEMENT THERAPY; METABOLIC SYNDROME; SKELETAL-MUSCLE; NONALCOHOLIC STEATOHEPATITIS; GENERALIZED LIPODYSTROPHY; GLUCOSE-METABOLISM; TRANSGENIC MICE; MOUSE MODEL	Nonalcoholic fatty liver disease (NAFLD) is recognized as the hepatic component of the metabolic syndrome. Although NAFLD is a major cause of cirrhosis and cancer of the liver of unknown cause, no established pharmacological treatment for NAFLD has been established yet. It has been reported that leptin treatment improved fatty liver dramatically as well as insulin resistance and hyperphagia in patients with lipodystrophy. However, it is unclear whether leptin improves fatty liver independently of these metabolic improvements. We investigated the liver effect of leptin independently of insulin sensitization and appetite suppression using hepatocyte-specific Pten-deficient (AlbCrePtenff) mouse, a model of severe fatty liver with insulin hypersensitivity. Male AlbCrePtenff mice were infused subcutaneously with leptin (20 ng/g/h) for 2 weeks using osmotic minipumps. Leptin infusion effectively reduced liver weight, liver triglyceride content, and glutamate pyruvate transaminase (GPT) concentrations as well as food intake and body weight without the change of plasma insulin concentration in AlbCrePtenff mice. Pair-feeding also reduced body weight but not liver triglyceride content. Pair feeding reduced alpha 1 and alpha 2 AMP-activated protein kinase (AMPK) activities and PGC1 alpha gene expression in the liver, while leptin infusion unchanged them. The present study clearly demonstrated that leptin improve fatty liver independently of insulin sensitization and suppression of food intake. It was suggested that leptin improves fatty liver by stimulation of beta-oxidation in the liver. The present study might provide a further understanding on the mechanism of metabolic effect of leptin.	[Yamamoto-Kataoka, S.; Ebihara, K.; Aizawa-Abe, M.; Kusakabe, T.; Yamamoto, Y.; Aotani, D.; Sakai, T.; Zhao, M.; Ebihara, C.; Gumbilai, V. M. J.; Hosoda, K.; Nakao, K.] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto, Japan; [Ebihara, K.; Aizawa-Abe, M.; Hosoda, K.] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Sakyo Ku, Kyoto 6068507, Japan; [Nishio, M.; Suzuki, A.] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Higashi Ku, Fukuoka 812, Japan; [Kusakabe, T.; Aotani, D.; Nakao, K.] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Sakyo Ku, Kyoto, Japan; [Hosoda, K.] Kyoto Univ, Grad Sch Med, Dept Hlth & Sci, Sakyo Ku, Kyoto, Japan	Ebihara, K (reprint author), Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kebihara@kuhp.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Uehara Memorial Foundation	We thank Keiko Hayashi for technical assistance. The authors also acknowledge Yoko Koyama for secretarial assistance. This work was supported by research grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Ministry of Health, Labor and Welfare, and Uehara Memorial Foundation.	Ebihara K, 2004, NEW ENGL J MED, V351, P615, DOI 10.1056/NEJM200408053510623; Javor ED, 2005, HEPATOLOGY, V41, P753, DOI 10.1002/hep.20672; [Anonymous], 2002, CIRCULATION, V106, P3143; Winder WW, 1997, J APPL PHYSIOL, V82, P219; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ebihara K, 1999, DIABETES, V48, P2028, DOI 10.2337/diabetes.48.10.2028; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Liang CP, 2001, J BIOL CHEM, V276, P49066, DOI 10.1074/jbc.M107250200; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI 10.1172/JCI200215001; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyanaga F, 2003, DIABETOLOGIA, V46, P1329, DOI 10.1007/s00125-003-1193-6; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Ebihara K, 2007, J CLIN ENDOCR METAB, V92, P532, DOI 10.1210/jc.2006-1546; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Simha V, 2003, DIABETES CARE, V26, P30, DOI 10.2337/diacare.26.1.30; Masuzaki H, 1999, DIABETES, V48, P1615, DOI 10.2337/diabetes.48.8.1615; Matsuoka N, 2001, AM J PHYSIOL-ENDOC M, V280, pE334; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Tsochatzis E, 2008, ALIMENT PHARM THERAP, V27, P80, DOI 10.1111/j.1365-2036.2007.03538.x	31	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	MAR	2015	47	3					168	175		10.1055/s-0034-1395531		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CD0DA	WOS:000350739300002		
J	Tachibana, K; Sakurai, K; Yokoh, H; Ishibashi, T; Ishikawa, K; Shirasawa, T; Yokote, K				Tachibana, K.; Sakurai, K.; Yokoh, H.; Ishibashi, T.; Ishikawa, K.; Shirasawa, T.; Yokote, K.			Mutation in Insulin Receptor Attenuates Oxidative Stress and Apoptosis in Pancreatic Beta-Cells Induced by Nutrition Excess: Reduced Insulin Signaling and ROS	HORMONE AND METABOLIC RESEARCH			English	Article						insulin resistance; manganese superoxide dismutase; endoplasmic reticulum stress	ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; RESISTANCE; ISLET; MICE; PROTECTS; PROLIFERATION; DISRUPTION; SURVIVAL; OBESITY	Type 2 diabetes results from the failure of beta-cells to adequately compensate for insulin resistance. Although the reduction of beta-cell mass is because of increased cell death and/or inadequate replication or neogenesis, the mechanism underlying beta-cell mass reduction is not fully understood. Here, we clarify the role of insulin signaling pathway in the beta-cell apoptosis using insulin resistant model mice. Wild-type mice and those carrying a mutation in the insulin receptor (mIR) were fed either regular chow or a high-fat diet for 6 weeks and subsequently investigated for beta-cell apoptosis, endoplasmic reticulum stress, and oxidative stress. Insulin tolerance tests revealed that mIR mice fed a high-fat diet (mIRHF) had higher insulin resistance. Beta-cell apoptosis was increased 2-fold in the wild-type mice fed a high-fat diet (wHF) compared with control mice, whereas beta-cell apoptosis in mIRHF mice did not increase compared with that in mIR mice. The expression of endoplasmic reticulum stress markers in isolated islets did not differ between the groups. Staining of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal in islets of wHF mice significantly increased, but the staining in mIRHF mice was not different from that in control group. Gene expression of the antioxidant enzyme MnSOD was significantly higher in mIRHF mice than those in the other 3 groups. A mutation in the insulin receptor attenuated the oxidative stress and apoptosis in beta-cells even though high caloric nutrient was loaded. Our results suggest that reduced insulin signaling protects beta-cells thorough decline of oxidative stress.	[Tachibana, K.; Sakurai, K.; Yokoh, H.; Ishibashi, T.; Ishikawa, K.; Yokote, K.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Shirasawa, T.] Tokyo Metropolitan Inst Gerontol, Mol Gerontol, Tokyo, Japan; [Shirasawa, T.] Juntendo Univ, Grad Sch Med, Dept Aging Control Med, Tokyo, Japan	Sakurai, K (reprint author), 1-8-1 Inohana,Chuo Ku, Chiba 2608670, Japan.	kenichis-cib@umin.org					Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kaneto H, 2005, J MOL MED-JMM, V83, P429, DOI 10.1007/s00109-005-0640-x; Bertera S, 2003, DIABETES, V52, P387; Baba T, 2005, J BIOL CHEM, V280, P16417, DOI 10.1074/jbc.M500924200; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Numazawa S, 2008, AM J PHYSIOL-CELL PH, V295, pC468, DOI 10.1152/ajpcell.00203.2008; Withers DJ, 1998, NATURE, V391, P900; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Honda Y, 1999, FASEB J, V13, P1385; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Li XY, 2004, J BIOL CHEM, V279, P765, DOI 10.1074/jbc.M307907200; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; Ogino J, 2006, J ENDOCRINOL, V190, P739, DOI 10.1377/joe.1.06849; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Cerf ME, 2007, MED SCI MONITOR, V13, pRA12; Hofer T, 2006, FREE RADICAL RES, V40, P707, DOI 10.1080/10715760500525807; Kikuchi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032249; Krautbauer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086866; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; Pedulla M, 2007, J CELL PHYSIOL, V212, P432, DOI 10.1002/jcp.21034; Szot GL, 2007, J VIS EXP, V7, P255	38	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	MAR	2015	47	3					176	183		10.1055/s-0034-1389990		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CD0DA	WOS:000350739300003		
J	Kurashige, T; Shimamura, M; Yasui, K; Mitsutake, N; Matsuse, M; Nakashima, M; Minami, S; Eguchi, S; Nagayama, Y				Kurashige, T.; Shimamura, M.; Yasui, K.; Mitsutake, N.; Matsuse, M.; Nakashima, M.; Minami, S.; Eguchi, S.; Nagayama, Y.			Studies on Expression of Aldehyde Dehydrogenase in Normal and Cancerous Tissues of Thyroids	HORMONE AND METABOLIC RESEARCH			English	Article						stem cells; immunohistochemistry; thyroid cancer	STEM-CELLS; DIFFERENTIATION	Recently published articles have reported the controversial data regarding expression of aldehyde dehydrogenase isozyme 1A1 (ALDH1A1), a potential candidate marker for normal and cancer stem cells (CSCs), in thyroid tissues. These data prompted us to re-evaluate expression of ALDH1A1 in normal and cancerous thyroid tissues by 2 different means. The first method was immunohistochemistry with 2 different anti-ALDH1A1 antibodies from distinct companies. Following validating the integrity of these 2 antibodies by Western blotting with ALDH-expressing and nonexpressing cancer cell lines and immunohistochemistry with breast and colon tissues, we report here significant and comparable expression of ALDH1A1 in both normal and cancerous thyroid tissues with both antibodies. Next, relative expression levels of ALDH isozymes were evaluated by reverse transcription-polymerase chain reaction (RT-PCR), revealing that ALDH1A1 was the most highly expressed isozyme followed by ALDH9A1 and relative expression patterns of isozymes were very similar in normal and cancerous tissues. All these data demonstrate that thyroid cells of normal and cancer origins do express ALDH1A1 and to a lesser extent 9A1. Further study will be necessary to study functional significance of ALDH1A1 in the function and behaviors of thyroid normal and cancer stem cells.	[Kurashige, T.; Shimamura, M.; Yasui, K.; Nagayama, Y.] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, Nagasaki 8528523, Japan; [Mitsutake, N.; Matsuse, M.] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan; [Nakashima, M.] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki 8528523, Japan; [Minami, S.; Eguchi, S.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528523, Japan	Nagayama, Y (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	nagayama@nagasaki-u.ac.jp		Mitsutake, Norisato/0000-0002-2744-8046	Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	van den Hoogen C, 2011, CLIN EXP METASTAS, V28, P615, DOI 10.1007/s10585-011-9395-7; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Ginestier C, 2009, CELL CYCLE, V8, P3297; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697 , 10.1517/17425250802102627]; Malehmir M, 2012, MOL CELL ENDOCRINOL, V348, P260, DOI 10.1016/j.mce.2011.09.002; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Shimamura M, 2014, ENDOCR J, V6, P481	16	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	MAR	2015	47	3					194	199		10.1055/s-0034-1387770		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CD0DA	WOS:000350739300005		
J	Kushiro, T; Kario, K; Saito, I; Teramukai, S; Mori, Y; Okuda, Y; Shimada, K				Kushiro, Toshio; Kario, Kazuomi; Saito, Ikuo; Teramukai, Satoshi; Mori, Yoshihiro; Okuda, Yasuyuki; Shimada, Kazuyuki			Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension	HYPERTENSION RESEARCH			English	Article						aging; blood pressure monitoring; masked hypertension; pulse pressure; white coat hypertension	ISOLATED SYSTOLIC HYPERTENSION; PULSE PRESSURE; GENERAL-POPULATION; JAPANESE SOCIETY; METAANALYSIS; GUIDELINES; MANAGEMENT; DISEASE; RISK; MEDOXOMIL	Few large-scale studies have evaluated the effectiveness of angiotensin receptor blockers in patients with masked hypertension (MH) and white coat hypertension (WCH) based on age using real-world blood pressure (BP) data. We used data from the Home BP measurement with Olmesartan Naive patients to Establish Standard Target BP (HONEST) study to investigate the effectiveness of olmesartan-based treatment by patient age (<65 years of age, n = 9817; 65-74 years of age, n = 6792; >= 75 years of age, n = 4732), focusing on morning home BP (strongly associated with cardiovascular disease and useful for MH and WCH diagnosis). Sixteen weeks of treatment changed morning home BP (mean systolic/diastolic) by -18.1/-9.7, -15.9/-7.4 and -14.2/-6.4 mm Hg and clinic BP by -20.1/-11.3, -17.3/-8.7 and -15.4/-7.2 mm Hg, in these age groups, respectively (P<0.0001). Pulse pressure decreased (-7.8 to -8.8 mm Hg, P<0.0001). Patients aged. 80 years experienced similar BP and pulse pressure changes. In patients aged. 75 years, mean morning and clinic BP after 16 weeks was 137.5/74.8 and 129.7/70.4 mm Hg, respectively, in MH patients and 132.3/72.2 and 139.7/72.7 mm Hg, respectively, in WCH patients. Regardless of age, only elevated clinic or home BP values decreased to target ranges. The incidence of adverse effects associated with excessive BP lowering was low in all of the age groups. In conclusion, our study suggests that olmesartan-based treatment was safe and useful for managing MH, WCH and sustained hypertension in elderly patients. The lack of a placebo group was a limitation of the study.	[Kushiro, Toshio] Life Planning Ctr Fdn, Tokyo 1080073, Japan; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Saito, Ikuo] Keio Univ, Kanagawa, Japan; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Grad Sch Med Sci, Kyoto, Japan; [Okuda, Yasuyuki] Daiichi Sankyo, Tokyo, Japan; [Shimada, Kazuyuki] Shin Oyama City Hosp, Oyama, Tochigi, Japan	Kushiro, T (reprint author), Life Planning Ctr Fdn, Minato Ku, Sasakawa Hall,3-12-12 Mita, Tokyo 1080073, Japan.	lpc-kushiro@r8.dion.ne.jp			Daiichi Sankyo	We gratefully acknowledge the numerous investigators, fellows, nurses and research coordinators who participated in the HONEST study at each of the study sites. We also gratefully acknowledge their contribution to the study. TK, KK, IS, ST and KS have received honoraria from Daiichi Sankyo. KK has received research funding from Daiichi Sankyo. YM and YO are employees of Daiichi Sankyo. The study was supported by funding for data collection and statistical analysis by Daiichi Sankyo.	MULLER JE, 1989, CIRCULATION, V79, P733; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Fagard RH, 2007, J HYPERTENS, V25, P2193; Kario K, 2013, J HUM HYPERTENS, V27, P721, DOI 10.1038/jhh.2013.68; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Saito I, 2008, J CLIN HYPERTENS, V10, P272, DOI 10.1111/j.1751-7176.2008.07460.x; Nasothimiou EG, 2012, HYPERTENS RES, V35, P750, DOI 10.1038/hr.2012.19; Fukuhara M, 2013, STROKE, V44, P1512, DOI 10.1161/STROKEAHA.111.000704; Messerli FH, 2006, ANN INTERN MED, V144, P884; Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Hansen TW, 2007, J HYPERTENS, V25, P1554, DOI 10.1097/HJH.0b013e3281c49da5; Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004; Saito I, 2013, HYPERTENS RES, V36, P177, DOI 10.1038/hr.2012.160; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Fagard RH, 2007, ARCH INTERN MED, V167, P1884, DOI 10.1001/archinte.167.17.1884; Hanninen MRA, 2012, J HYPERTENS, V30, P705, DOI 10.1097/HJH.0b013e328350a69b; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Bulpitt CJ, 2013, HYPERTENSION, V61, P89, DOI 10.1161/HYPERTENSIONAHA.112.191791; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Makino H, 2009, CLIN EXP NEPHROL, V13, P187, DOI 10.1007/s10157-009-0188-0; Franklin S S, 2000, Curr Hypertens Rep, V2, P253, DOI 10.1007/s11906-000-0008-0; Giles TD, 2004, AM J HYPERTENS, V17, P690, DOI 10.1016/j.amjihper.2004.05.003; Imai Y, 2001, J HYPERTENS, V19, P179, DOI 10.1097/00004872-200102000-00003; Izzo JL, 2000, BLOOD PRESS MONIT, V5, pS7; Kario Kazuomi, 2013, Drugs R D, V13, P63, DOI 10.1007/s40268-013-0006-8; Kario K, 2003, CIRCULATION, V108, pe72; Saito I, 2009, J CLIN THER MED, V25, P141	32	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					178	185		10.1038/hr.2014.156		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300002		
J	Nakano, C; Morimoto, S; Nakahigashi, M; Kusabe, M; Ueda, H; Someya, K; Ichihara, A; Iwasaka, T; Shiojima, I				Nakano, Chikara; Morimoto, Satoshi; Nakahigashi, Mitsutaka; Kusabe, Makiko; Ueda, Hiroko; Someya, Kazunori; Ichihara, Atsuhiro; Iwasaka, Toshiji; Shiojima, Ichiro			The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease	HYPERTENSION RESEARCH			English	Article						chronic kidney disease; glomerular filtration rate; cardiovascular disease; endothelial function	CARDIOVASCULAR-DISEASE; PROGNOSTIC-SIGNIFICANCE; VASCULAR INJURY; RISK-FACTOR; HYPERTENSION; PROGRESSION; NEPHROPATHY; SYSTEM; IMPACT; MODEL	Visit-to-visit blood pressure variability has been shown to be an independent risk factor for cardiovascular diseases. High visit-to-visit blood pressure variability and endothelial dysfunction are observed in patients with chronic kidney disease. It is therefore assumed that high variability in visit-to-visit blood pressure measurements may be associated with endothelial dysfunction in these patients. The present study investigated the associations between visit-to-visit blood pressure variability and renal and endothelial function in patients with chronic kidney disease. We analyzed 150 consecutive patients with predialysis chronic kidney disease who visited our outpatient clinic from January 2006 to December 2010. The study examined the relationships between variability in visit-to-visit systolic blood pressure levels or mean systolic blood pressure (M SBP) and estimated glomerular filtration rate (eGFR) and flow-mediated dilation, an index of endothelial function. Variability in visit-to-visit systolic blood pressure showed a significant negative association with eGFR, independent of age, hemoglobin A1c, low-density lipoprotein (LDL) cholesterol and uric acid, whereas M SBP did not. Similarly, variability in SBP showed a significant negative association with flow-mediated dilation, independent of age, eGFR, HbA1c, LDL cholesterol and M SBP. These data indicate that variability in visit-to-visit blood pressure measurements is associated with impaired renal and endothelial function in patients with chronic kidney disease. This finding suggests that reducing blood pressure fluctuations might have beneficial effects in patients with chronic kidney disease, although this point needs to be addressed by future studies.	[Nakano, Chikara; Morimoto, Satoshi; Nakahigashi, Mitsutaka; Kusabe, Makiko; Ueda, Hiroko; Someya, Kazunori; Iwasaka, Toshiji; Shiojima, Ichiro] Kansai Med Univ, Dept Internal Med 2, Osaka, Japan; [Morimoto, Satoshi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Shinjuku Ku, Tokyo 1628666, Japan	Morimoto, S (reprint author), Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	smorimoto@endm.twmu.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Kawai T, 2012, HYPERTENS RES, V35, P239, DOI 10.1038/hr.2011.170; Tomiyama H, 2008, HYPERTENS RES, V31, P2019, DOI 10.1291/hypres.31.2019; Laurent S, 2012, J HYPERTENS, V30, pS3, DOI 10.1097/HJH.0b013e328353e501; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; HATA T, 1982, CLIN EXP HYPERTENS, V4, P341, DOI 10.3109/10641968209060747; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; LUSCHER TF, 1987, HYPERTENSION, V9, P193; Morimoto S, 2009, AM J NEPHROL, V30, P55, DOI 10.1159/000201416; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145; Eto M, 2003, HYPERTENS RES, V26, P991, DOI 10.1291/hypres.26.991; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Chen XG, 2013, HYPERTENS RES, V36, P361, DOI 10.1038/hr.2012.204; Shimbo D, 2013, AM J HYPERTENS, V26, P896, DOI 10.1093/ajh/hpt040; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Chan DT, 2013, AM J HYPERTENS, V26, P1155, DOI 10.1093/ajh/hpt077; Persson F, 2008, SCAND J CLIN LAB INV, V68, P731, DOI 10.1080/00365510802187226; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; Okada H, 2013, HYPERTENS RES, V36, P996, DOI 10.1038/hr.2013.66; Iguchi T, 2013, HYPERTENS RES, V36, P691, DOI 10.1038/hr.2013.35; Kario K, 2007, J HYPERTENS, V25, P1573, DOI 10.1097/HJH.0b013e32825fea8a; Miyagi T, 2014, HYPERTENS RES, V37, P863, DOI 10.1038/hr.2014.60; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Xie W, 2014, HYPERTENS RES, V37, P960, DOI 10.1038/hr.2014.93	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					193	198		10.1038/hr.2014.163		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300004		
J	Kim-Mitsuyama, S; Ogawa, H; Matsui, K; Jinnouchi, T; Jinnouchi, H; Arakawa, K				Kim-Mitsuyama, Shokei; Ogawa, Hisao; Matsui, Kunihiko; Jinnouchi, Tomio; Jinnouchi, Hideaki; Arakawa, Kikuo		OSCAR Study Grp	Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: Subanalysis of the OSCAR study	HYPERTENSION RESEARCH			English	Article						combination; CVD; eGFR; high-dose ARB	ANGIOTENSIN RECEPTOR BLOCKERS; GLOMERULAR-FILTRATION-RATE; CALCIUM-CHANNEL BLOCKER; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; EPISODIC HYPERTENSION; COMBINATION THERAPY; GENERAL-POPULATION; SERUM CREATININE	The OSCAR study was a multicenter prospective randomized study that examined the relative benefit of combined ARB (olmesartan 20 mg per day) plus calcium channel blocker (CCB) therapy vs. high-dose ARB monotherapy (olmesartan 40 mg per day) for prevention of cardiovascular events in elderly Japanese hypertensive patients. The present subanalysis of patients enrolled in the OSCAR study (n=1078) was performed to assess whether baseline eGFR coupled with cardiovascular disease (CVD) could predict the relative benefit of these two treatments. Patients with baseline CVD (n=769) and patients without baseline CVD (n=309) were divided into two groups based on baseline eGFR; (i) patients with eGFR of <60 ml min(-1) 1.73 m(-2) and (ii) those with eGFR of >= 60 ml min(-1) 1.73 m(-2). There was a significant treatment-subgroup interaction among these four subgroups in relation to the incidence of primary outcome events (P=0.007 for interaction). In patients with CVD and with eGFR of <60 ml min(-1) 1.73 m(-2), ARB plus CCB therapy was associated with a lower incidence of primary events than high-dose ARB therapy and the difference of the relative risk was statistically significant (hazard ratio: 3.525, 95% confidence interval (CI): 1.676-7.412, P<0.001). The greater benefit of ARB plus CCB therapy vs. high-dose ARB therapy in this subgroup was associated with less visit-to-visit variability of systolic BP and diastolic BP. In conclusion, baseline eGFR coupled with baseline CVD seems to be a predictor of the relative efficacy of ARB plus CCB therapy vs. high-dose ARB therapy in the elderly hypertensive patients. ARB plus CCB therapy appears to be superior to high-dose ARB therapy for preventing cardiovascular events in the patients with CVD and with eGFR of <60 ml min(-1) 1.73 m(-2).	[Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Matsui, Kunihiko] Kumamoto Univ Hosp, Dept Community Med, Kumamoto, Japan; [Jinnouchi, Tomio; Jinnouchi, Hideaki] Jinnouchi Clin, Diabet Care Ctr, Kumamoto, Japan; [Arakawa, Kikuo] Fukuoka Univ, Sch Med, Dept Internal Med 2, Fukuoka 81401, Japan	Kim-Mitsuyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, 1-1-1 Honjyo, Kumamoto 8608556, Japan.	mitsuyam@gpo.kumamoto-u.ac.jp			Japan Heart Foundation	Funding Sources: This work was supported by a grant from the Japan Heart Foundation. Clinical Trial Registration: http://www.clinicaltrials.gov (number NCT00134160).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kim S, 2000, PHARMACOL REV, V52, P11; Ogawa H, 2012, AM J MED, V125, P981, DOI 10.1016/j.amjmed.2011.12.010; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Hollenberg NK, 2007, J HYPERTENS, V25, P1921, DOI 10.1097/HJH.0b013e328277596e; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Mancia G, 2013, BLOOD PRESSURE, V22, P193, DOI 10.3109/08037051.2013.812549; Kim-Mitsuyama S, 2013, KIDNEY INT, V83, P167, DOI 10.1038/ki.2012.326; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Wachtell K, 2003, ANN INTERN MED, V139, P901; Levey AS, 1999, ANN INTERN MED, V130, P461; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Weber MA, 2010, J AM COLL CARDIOL, V56, P77, DOI 10.1016/j.jacc.2010.02.046; Jamerson KA, 2011, HYPERTENSION, V57, P174, DOI 10.1161/HYPERTENSIONAHA.110.159939; Jamerson KA, 2010, NEW ENGL J MED, V363, P98, DOI 10.1056/NEJMc1001410; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Ogawa H, 2009, HYPERTENS RES, V32, P575, DOI 10.1038/hr.2009.60; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Rakugi H, 2013, HYPERTENS RES, V36, P947, DOI 10.1038/hr.2013.63; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	34	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					199	207		10.1038/hr.2014.164		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300005		
J	Akter, S; Jesmin, S; Iwashima, Y; Hideaki, S; Rahman, MA; Islam, MM; Moroi, M; Shimojo, N; Yamaguchi, N; Miyauchi, T; Kawano, S; Mizutani, T; Kawano, Y				Akter, Shamima; Jesmin, Subrina; Iwashima, Yoshio; Hideaki, Sakuramoto; Rahman, Md Arifur; Islam, Md Majedul; Moroi, Masao; Shimojo, Nobutake; Yamaguchi, Naoto; Miyauchi, Takashi; Kawano, Satoru; Mizutani, Taro; Kawano, Yuhei			Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women	HYPERTENSION RESEARCH			English	Article						endothelin-1; hypertensive; rural women; South Asian	METABOLIC SYNDROME; BLOOD-PRESSURE; PLASMA; NOREPINEPHRINE; EPIDEMIOLOGY; DISRUPTION; SEROTONIN; BLOCKADE; ARTERIES; HUMANS	Endothelin-1 (ET-1) is a potential marker of the endothelial dysfunction, which has been shown to be elevated in hypertensive subjects. No previous study has investigated the circulatory level of ET-1 and hypertension in a South Asian country. The present study assessed the circulating levels of ET-1 in subjects with or without hypertension and further examined the association of ET-1 with clinical and metabolic parameters. A total of 2543 rural Bangladeshi women with a mean age of 44.5 years were studied using a cross-sectional survey. Multiple regressions were used to examine the association between the circulatory ET-1 levels and hypertension. The prevalence of hypertension was 29.3%. The ET-1 levels were significantly higher in the hypertensive (mean 3.08 pg ml(-1), s.e. (0.19)) than in the non-hypertensive subjects (mean 2.01 pg ml(-1), s.e. (0.03)) (P=0.001). After adjusting for age, the ET-1 level had significant positive associations with the diastolic blood pressure (P=0.002), systolic blood pressure (P=0.001), mean arterial pressure (P=0.002) and fasting blood glucose (P=0.002). In a tertile analysis, we found that hypertension in the subjects was significantly increased as the levels of ET-1 increased (P for the trend=0.001). In a stepwise multiple regression analysis, after adjusting for age and all other potential variables, we found that the mean arterial pressure and the fasting plasma levels have significant associations with the ET-1 level. The present study demonstrates that there is a higher concentration of ET-1 among the hypertensive subjects in an apparently healthy population of Bangladeshi rural women. The relationship between ET-1 and hypertension requires further investigation to define the clinical utility and predictive value of serum ET-1 levels for hypertension for a South Asian population.	[Akter, Shamima; Jesmin, Subrina; Hideaki, Sakuramoto; Islam, Md Majedul; Shimojo, Nobutake; Miyauchi, Takashi; Kawano, Satoru; Mizutani, Taro] Univ Tsukuba, Inst Clin Med, Fac Med, Tsukuba, Ibaraki 305, Japan; [Akter, Shamima; Jesmin, Subrina; Rahman, Md Arifur; Islam, Md Majedul] HDRCRP, Dhaka, Bangladesh; [Akter, Shamima; Jesmin, Subrina; Moroi, Masao] Natl Ctr Global Hlth & Med NCGM, Shinjuku Ku, Tokyo, Japan; [Iwashima, Yoshio; Kawano, Yuhei] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Yamaguchi, Naoto] Ibaraki Prefectural Univ, Ctr Hlth Sci, Ami, Ibaraki, Japan	Jesmin, S (reprint author), Univ Tsukuba, Grad Sch Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	jsubrina@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [23406037, 23406016, 23406029, 24406026, 25305034]; Japan Society for the Promotion of Science; World Diabetes Foundation, Denmark [WDF11-610]	This work was supported by a Grant-in-Aid for Scientific Research (overseas academic) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23406037, 23406016, 23406029, 24406026 and 25305034) and the Japan Society for the Promotion of Science. A current project (WDF11-610) on gestational diabetes from the World Diabetes Foundation, Denmark to Health and Disease Research Center of Rural Peoples also supported a part of this work.	Amoroso A, 1996, Riv Eur Sci Med Farmacol, V18, P33; Faraco G, 2013, HYPERTENSION, V62, P759, DOI 10.1161/HYPERTENSIONAHA.113.01761; KIOWSKI W, 1991, CIRCULATION, V83, P469; HAYNES WG, 1994, LANCET, V344, P852, DOI 10.1016/S0140-6736(94)92827-4; Vuurmans TJL, 2003, HYPERTENSION, V41, P1253, DOI 10.1161/01.HYP.0000072982.70666.E8; Shohet RV, 2004, P NATL ACAD SCI USA, V101, P2088, DOI 10.1073/pnas.0307159101; MILLER WL, 1989, J CLIN INVEST, V83, P317, DOI 10.1172/JCI113876; SHICHIRI M, 1990, HYPERTENSION, V15, P493; SAITO Y, 1990, NEW ENGL J MED, V322, P205; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; KOHNO M, 1990, AM J MED, V88, P614, DOI 10.1016/0002-9343(90)90527-K; DAVENPORT AP, 1990, CLIN SCI, V78, P261; Dawes KE, 1996, INT J BIOCHEM CELL B, V28, P229, DOI 10.1016/1357-2725(95)00124-7; DOHI Y, 1991, HYPERTENSION, V18, P543; ECHIZEN H, 1984, LIFE SCI, V34, P1581, DOI 10.1016/0024-3205(84)90613-1; Ergul S, 1996, HYPERTENSION, V28, P652; He J, 1997, MED CLIN N AM, V81, P1077, DOI 10.1016/S0025-7125(05)70568-X; Hirai Y, 2004, J HYPERTENS, V22, P713, DOI 10.1097/01.hjh.0000098295.36684.49; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Januszewicz A, 1994, J Cardiovasc Risk, V1, P81, DOI 10.1097/00043798-199406000-00013; Jesmin S, 2013, THROMB HAEMOSTASIS, V109, P696, DOI 10.1160/TH12-09-0654; KHRAIBI AA, 1993, MAYO CLIN PROC, V68, P42; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Piatti PM, 2000, METABOLISM, V49, P748, DOI 10.1053/meta.2000.6257; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; SUZUKI N, 1990, BIOCHEM BIOPH RES CO, V167, P941, DOI 10.1016/0006-291X(90)90614-S; YANG ZH, 1990, CIRCULATION, V82, P188	31	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					208	212		10.1038/hr.2014.160		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300006		
J	Nagahama, K; Inoue, T; Kohagura, K; Kinjo, K; Ohya, Y				Nagahama, Kazufumi; Inoue, Taku; Kohagura, Kentaro; Kinjo, Kozen; Ohya, Yusuke			Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan	HYPERTENSION RESEARCH			English	Article						cardiovascular risk factors; cohort study; epidemiology; metabolic syndrome; uric acid	INSULIN-RESISTANCE; CARDIOVASCULAR RISK; FREE-RADICALS; HYPERURICEMIA; DISEASE; MEN; HYPERINSULINEMIA; POPULATION; CAPACITY; OBESITY	The purpose of this study was to examine the associations between serum uric acid (SUA) levels and the incidences of hypertension and metabolic syndrome (MetS) in a large screened cohort of Japanese men and women. We evaluated 4812 subjects (males, 2528; females, 2284; mean age, 47.5 years) who underwent health checkups between 2006 and 2010 and were free of hypertension and MetS in 2006. After 4 years, 618 (13%), 764 (16%) and 158 (3%) subjects developed hypertension, MetS and hypertension with MetS, respectively. Increased SUA levels were significantly and positively associated with the incidences of hypertension, MetS and hypertension with MetS. Compared with the first quartile of SUA levels, the odds ratios (95% confidence intervals) for the third and fourth quartiles, respectively, were as follows: 1.5 (1.1-2.1; P=0.0128) and 1.8 (1.2-2.5; P=0.0022) for hypertension, 1.3 (0.9-1.9; P=0.1910) and 1.8 (1.2-2.7; P=0.0039) for MetS and 2.7 (1.1-6.6; P=0.0276) and 3.2 (1.3-8.0; P=0.0115) for hypertension with MetS. In conclusion, increased SUA levels were significantly and independently associated with the incidences of hypertension and MetS in subjects without hypertension or MetS at baseline. Increased SUA levels might also be correlated with the incidence of hypertension with MetS.	[Nagahama, Kazufumi; Kohagura, Kentaro; Ohya, Yusuke] Univ Ryukyus, Dept Cardiovasc Med Nephrol & Neurol, Grad Sch Med, Nishihara, Okinawa 9030125, Japan; [Inoue, Taku] Univ Ryukyus Hosp, Grad Sch Med, Ctr Residency & Fellowship Program, Okinawa, Japan; [Kinjo, Kozen] Okinawa Gen Hlth Assoc, Okinawa, Japan	Nagahama, K (reprint author), Univ Ryukyus, Dept Cardiovasc Med Nephrol & Neurol, Grad Sch Med, 207 Uehara, Nishihara, Okinawa 9030125, Japan.	orch2970@med.u-ryukyu.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928; Nyyssonen K, 1997, ATHEROSCLEROSIS, V130, P223, DOI 10.1016/S0021-9150(96)06064-9; Nagahama K, 2014, HYPERTENS RES, V37, P232, DOI 10.1038/hr.2013.137; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Edwards NL, 2009, CURR OPIN RHEUMATOL, V21, P132, DOI 10.1097/BOR.0b013e3283257b96; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Bruce KD, 2009, POSTGRAD MED J, V85, P614, DOI 10.1136/pgmj.2008.078014; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642; Yahyaoui R, 2008, J CLIN ENDOCR METAB, V93, P2230, DOI 10.1210/jc.2007-2467; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; POLLARE T, 1990, METABOLISM, V39, P167, DOI 10.1016/0026-0495(90)90071-J; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Arcucci O, 2007, J HYPERTENS, V25, P2296; AUCHSCHWELK W, 1989, HYPERTENSION, V13, P859; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; Guideline Revising Committee of Japanese Society of Gout and Nucleic Acid Metabolism, 2010, REV GUID MAN HYP GOU; Hara S, 2011, METABOLISM, V24, P281; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Reaven GM, 2011, J INTERN MED, V269, P127, DOI 10.1111/j.1365-2796.2010.02325.x; Schmidt MI, 1996, METABOLISM, V45, P699, DOI 10.1016/S0026-0495(96)90134-1; SWISLOCKI ALM, 1989, AM J HYPERTENS, V2, P419; The Japanese Committee on the Criteria for MetS, 2005, NIPPON NAIKA GAKKAI, V94, P749; VasquezVivar J, 1996, BIOCHEM J, V314, P869; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Yamamoto Y, 2002, HYPERTENS RES, V25, P717	39	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					213	218		10.1038/hr.2014.161		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300007		
J	Yamori, Y; Sagara, M; Mizushima, S; Liu, LJ; Ikeda, K; Nara, Y				Yamori, Yukio; Sagara, Miki; Mizushima, Shunsaku; Liu, Longjian; Ikeda, Katsumi; Nara, Yasuo		CARDIAC Study Grp	An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations	HYPERTENSION RESEARCH			English	Article						cardiovascular disease risk factors; cross-sectional studies; magnesium; middle-aged	SPONTANEOUSLY HYPERTENSIVE RATS; INTRALYMPHOCYTIC FREE CALCIUM; OLDER US WOMEN; BLOOD-PRESSURE; DIETARY MAGNESIUM; METABOLIC SYNDROME; SERUM MAGNESIUM; HEART-DISEASE; TAURINE; LIPIDS	Serum, plasma and dietary magnesium (Mg) have been reported to be inversely associated with cardiovascular disease risk factors. We examined the associations between the 24-h urinary Mg/creatinine (Cre) ratio and cardiovascular disease risk factors, such as body mass index (BMI), blood pressure (BP), serum total cholesterol (TC) and prevalence of obesity, hypertension and hypercholesterolemia. A cross-sectional analysis was conducted among 4211 participants (49.7% women) aged 48-56 years in 50 population samples from 22 countries in the World Health Organization-coordinated Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study (1985-1994). In linear regression analyses, Mg/Cre ratio was inversely associated with BMI, systolic BP (SBP), diastolic BP (DBP) and TC (P for linear trend <0.001 for each). These associations were not markedly altered by adjustment for traditional risk factors, urinary markers or cohort effects. Multivariate-adjusted mean values for the subjects in the highest Mg/Cre ratio quintile were 6.3, 3.4, 5.3 and 4.6% lower than those for the subjects in the lowest quintile for BMI, SBP, DBP and TC (P<0.001, respectively). The prevalence of obesity, hypertension and hypercholesterolemia was 2.10 (95% confidence interval: 1.50, 2.95), 1.55 (1.25, 1.92) and 2.06 (1.63, 2.62) times higher (P<0.001, respectively) among the subjects in the lowest Mg/Cre ratio quintile than in the subjects in the highest quintile. These associations were not appreciably altered by adjustment for potential confounding variables. In conclusion, higher 24-h urinary Mg/Cre ratio was associated with lower cardiovascular disease risk factors, including BMI, BP, TC, obesity, hypertension and hypercholesterolemia.	[Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo 6638143, Japan; [Yamori, Yukio; Sagara, Miki] Res Inst Prod Dev, Lab Prevent Nutr Med, Kyoto, Japan; [Yamori, Yukio; Sagara, Miki; Mizushima, Shunsaku; Liu, Longjian; Ikeda, Katsumi; Nara, Yasuo] Int Former WHO Collaborating, Ctr Res Primary Prevent Cardiovascular Dis, Kyoto, Japan; [Mizushima, Shunsaku] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Kanagawa, Japan; [Liu, Longjian] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Ikeda, Katsumi] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan	Yamori, Y (reprint author), Mukogawa Womens Univ, Inst World Hlth Dev, 4-16 Edagawa Cho, Nishinomiya, Hyogo 6638143, Japan.	yamori@cardiacstudy.com			Ministry of Education, Culture, Sports, Science and Technology; Japanese government	This study was supported partly by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese government and by donations to the WHO from over 300 000 individuals and companies in total, but it had no relationship with the industry. We thank all the principal investigators and their colleagues in the 50 study sites of the CARDIAC Study. On behalf of WHO-CARDIAC Study Group, this article is dedicated to late Dr Hiroshi Nakajima, Emeritus Director General, WHO, who designated the WHO-Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases in 1983 to initiate this worldwide epidemiological survey and passed away on 26 January 2013.	ADACHI M, 1993, CLIN EXP PHARMACOL P, V20, P587, DOI 10.1111/j.1440-1681.1993.tb01745.x; ADACHI M, 1994, CLIN EXP HYPERTENS, V16, P317, DOI 10.3109/10641969409072219; Hatzistavri LS, 2009, AM J HYPERTENS, V22, P1070, DOI 10.1038/ajh.2009.126; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; YAMORI Y, 1984, CLIN EXP HYPERTENS A, V6, P1161, DOI 10.3109/10641968409039588; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Sontia B, 2007, ARCH BIOCHEM BIOPHYS, V458, P33, DOI 10.1016/j.abb.2006.05.005; Chiuve SE, 2011, AM J CLIN NUTR, V93, P253, DOI 10.3945/ajcn.110.002253; Joosten MM, 2013, HYPERTENSION, V61, P1161, DOI 10.1161/HYPERTENSIONAHA.113.01333; Nielsen FH, 2010, NUTR REV, V68, P333, DOI 10.1111/j.1753-4887.2010.00293.x; He K, 2006, CIRCULATION, V113, P1675, DOI 10.1161/CIRCULATIONAHA.105.588327; Yamori Y, 2009, ADV EXP MED BIOL, V643, P13, DOI 10.1007/978-0-387-75681-3_2; Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Al-Delaimy WK, 2004, J AM COLL NUTR, V23, P63; Brown L, 1999, AM J CLIN NUTR, V69, P30; Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438; Bo S, 2008, CURR OPIN LIPIDOL, V19, P50, DOI 10.1097/MOL.0b013e3282f33ccc; Ascherio A, 1996, HYPERTENSION, V27, P1065; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; JOFFRES MR, 1987, AM J CLIN NUTR, V45, P469; Chacko SA, 2010, DIABETES CARE, V33, P304, DOI 10.2337/dc09-1402; Chiuve SE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000114; Fukuda M, 1987, PREVENTION CARDIOVAS, P127; Kestelooty H, 2011, AM J EPIDEMIOL, V174, P44, DOI 10.1093/aje/kwr049; Khan AM, 2010, AM HEART J, V160, P715, DOI 10.1016/j.ahj.2010.06.036; Liu LJ, 2001, HYPERTENS RES, V24, P145, DOI 10.1291/hypres.24.145; Olatunji L A, 2007, Pathophysiology, V14, P11, DOI 10.1016/j.pathophys.2006.09.004; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720; Randell EW, 2008, ATHEROSCLEROSIS, V196, P413, DOI 10.1016/j.atherosclerosis.2006.11.024; SimonsMorton DG, 1997, HYPERTENSION, V29, P930; Song YQ, 2006, AM J CARDIOL, V98, P1616, DOI 10.1016/j.amjcard.2006.07.040; Truswell A. Stewart, 1995, Current Opinion in Lipidology, V6, P14, DOI 10.1097/00041433-199502000-00004; Ueshima K, 2005, MAGNESIUM RES, V18, P275; WHO Collaborating Center on Primary Prevention of Cardiovascular Diseases Izumo Japan and Cardiovascular Diseases Unit WHO, 1986, CARD DIS AL COMP CAR; WHO-CARDIAC Study group, 1990, J CARDIOVASC PHAR S8, V16, pS75; YAMORI Y, 1990, J CARDIOVASC PHARM, V16, pS43, DOI 10.1097/00005344-199000168-00018; Yamori Y, 1989, NEW HORIZONS PREVENT; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S21	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAR	2015	38	3					219	225		10.1038/hr.2014.158		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD0AU	WOS:000350733300008		
J	Nakashika, T; Takiguchi, T; Ariki, Y				Nakashika, Toru; Takiguchi, Tetsuya; Ariki, Yasuo			Voice Conversion Using RNN Pre-Trained by Recurrent Temporal Restricted Boltzmann Machines	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Deep Learning; recurrent neural network; recurrent temporal restricted Boltzmann machine (RTRBM); speaker specific features; voice conversion	SPEECH RECOGNITION	This paper presents a voice conversion (VC) method that utilizes the recently proposed probabilistic models called recurrent temporal restricted Boltzmann machines (RTRBMs). One RTRBM is used for each speaker, with the goal of capturing high-order temporal dependencies in an acoustic sequence. Our algorithm starts from the separate training of one RTRBM for a source speaker and another for a target speaker using speaker-dependent training data. Because each RTRBM attempts to discover abstractions to maximally express the training data at each time step, as well as the temporal dependencies in the training data, we expect that the models represent the linguistic-related latent features in high-order spaces. In our approach, we convert (match) features of emphasis for the source speaker to those of the target speaker using a neural network (NN), so that the entire network (consisting of the two RTRBMs and the NN) acts as a deep recurrent NN and can be fine-tuned. Using VC experiments, we confirm the high performance of our method, especially in terms of objective criteria, relative to conventional VC methods such as approaches based on Gaussian mixture models and on NNs.	[Nakashika, Toru] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan; [Takiguchi, Tetsuya; Ariki, Yasuo] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan	Nakashika, T (reprint author), Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan.	nakashika@me.cs.scitec.kobe-u.ac.jp					Abe M., 1988, P ICASSP, P655; Lee CH, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P2254; Nakamura K, 2012, SPEECH COMMUN, V54, P134, DOI 10.1016/j.specom.2011.07.007; Toda T, 2007, IEEE T AUDIO SPEECH, V15, P2222, DOI 10.1109/TASL.2007.907344; McDermott E, 2007, IEEE T AUDIO SPEECH, V15, P203, DOI 10.1109/TASL.2006.876778; [Anonymous], 2001, ACOUST SPEECH SIG PR; Mohamed AR, 2012, IEEE T AUDIO SPEECH, V20, P14, DOI 10.1109/TASL.2011.2109382; KUREMATSU A, 1990, SPEECH COMMUN, V9, P357, DOI 10.1016/0167-6393(90)90011-W; [Anonymous], 1998, ACOUST SPEECH SIG PR; Cho K, 2011, LECT NOTES COMPUT SC, V6791, P10; VALBRET H, 1992, SPEECH COMMUN, V11, P175, DOI 10.1016/0167-6393(92)90012-V; Ling ZH, 2013, IEEE T AUDIO SPEECH, V21, P2129, DOI 10.1109/TASL.2013.2269291; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Boulanger-Lewandowski N., 2012, P INT C MACH LEARN; Chen L.-H., 2013, P INTERSPEECH, P3052; Desai S, 2009, INT CONF ACOUST SPEE, P3893, DOI 10.1109/ICASSP.2009.4960478; Deselaers Th., 2009, P 4 WORKSH STAT MACH, P233, DOI 10.3115/1626431.1626476; Freund Y., 1994, UNSUPERVISED LEARNIN; Jian ZH, 2007, SNPD 2007: EIGHTH ACIS INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, ARTIFICIAL INTELLIGENCE, NETWORKING, AND PARALLEL/DISTRIBUTED COMPUTING, VOL 1, PROCEEDINGS, P210; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Kunikoshi A., 2009, P INTERSPEECH, P308; Ling Z., 2006, P BLIZZ CHALL WORKSH; Ling ZH, 2012, IEEE T AUDIO SPEECH, V20, P1492, DOI 10.1109/TASL.2011.2182511; Milner B., 2002, P ICSLP DENV CO US, P2421; Nair V., 2009, ADV NEURAL INF PROCE, V22, P1339; Nakashika T., 2013, P INTERSPEECH, P369; Nakashika T., 2014, P IEEE INT C AC SPEE, P7939; Pascanu R., 2012, ARXIV12115063; Saito D., 2011, P INTERSPEECH, P653; Saito D, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1728; Smolensky P., 1986, PARALLEL DISTRIB PRO, V1; Stylianou Y, 1998, IEEE T SPEECH AUDI P, V6, P131, DOI 10.1109/89.661472; Sutskever I., 2008, NIPS, V21, P2008; Takashima R, 2012, 2012 IEEE WORKSHOP ON SPOKEN LANGUAGE TECHNOLOGY (SLT 2012), P313, DOI 10.1109/SLT.2012.6424242; Taylor G. W., 2006, ADV NEURAL INF PROCE, V19, P1345; Toda T, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P2446; Tomoki T., 2007, IEICE T INF SYST, V90, P816; Veaux C, 2011, P INTERSPEECH, P2765; Wu Y.-J., 2004, P IEEE INT C AC SPEE, P629; Wu Z., 2013, P IEEE CHIN SUMM INT, P104; Wu Z., 2013, P 8 ISCA SPEECH SYNT	42	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	MAR	2015	23	3					580	587		10.1109/TASLP.2014.2379589		8	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CD2AO	WOS:000350876100015		
J	Naganawa, J; Wangchuk, K; Kim, M; Aoyagi, T; Takada, J				Naganawa, Jun-ichi; Wangchuk, Karma; Kim, Minseok; Aoyagi, Takahiro; Takada, Jun-ichi			Simulation-Based Scenario-Specific Channel Modeling for WBAN Cooperative Transmission Schemes	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Channel modeling; cooperative transmission scheme; finite-difference time-domain (FDTD) method; wireless body area network (WBAN)	BODY-AREA NETWORKS; 2.45 GHZ; COMMUNICATION CHANNELS; PROPAGATION CHANNEL; ANTENNAS; MOVEMENTS; SPECTRUM	Wireless body area networks (WBANs) are an emerging technology for realizing efficient healthcare and remote medicine for the aging society of the future. In order to improve the reliability of WBAN systems and support its various applications, channel modeling and performance evaluation are important. This paper proposes a simulation-based channel modeling for evaluating the performance of WBAN cooperative transmission schemes. The time series of path losses among seven on-body nodes are generated by the finite-difference time-domain method for seven body motions. The statistical parameters of the path loss for all the motions are also obtained. The generated path loss is then applied to the evaluation of the two-hop decode-and-forward relaying scheme, yielding an improvement in transmit power. From the evaluation of body motion, useful insights are obtained such as which relay links are more robust than others. Finally, the proposed approach is validated through comparison with a measurement-based approach.	[Naganawa, Jun-ichi; Wangchuk, Karma; Kim, Minseok; Takada, Jun-ichi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Int Dev Engn, Tokyo 1528552, Japan; [Aoyagi, Takahiro] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Human Syst Sci, Tokyo 1528552, Japan	Naganawa, J (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Int Dev Engn, Tokyo 1528552, Japan.	naga@ap.ide.titech.ac.jp; karmawangchu@ap.ide.titech.ac.jp; mskim@ieee.org; aoyagi@cradle.titech.ac.jp; takada@ide.titech.ac.jp			Japan Society for the Promotion of Science [22360150, 25008831]	This work was supported by the Grant-In-Aid for Scientific Research (B)(22360150) and Grant-in-Aid for JSPS Fellows (25008831) from the Japan Society for the Promotion of Science.	Akhoondzadeh-Asl L, 2013, IEEE T ANTENN PROPAG, V61, P882, DOI 10.1109/TAP.2012.2224833; Alves T, 2011, IEEE T ANTENN PROPAG, V59, P1269, DOI 10.1109/TAP.2010.2096184; Liu LF, 2013, IEEE ANTENN WIREL PR, V12, P186, DOI 10.1109/LAWP.2013.2245094; Zhao Y, 2006, IEEE T MICROW THEORY, V54, P1827, DOI 10.1109/TMTT.2006.8720; Kim M, 2012, IEEE T ANTENN PROPAG, V60, P5364, DOI 10.1109/TAP.2012.2207937; Nooruddin FS, 2003, IEEE T VIS COMPUT GR, V9, P191, DOI 10.1109/TVCG.2003.1196006; Hanson MA, 2009, COMPUTER, V42, P58, DOI 10.1109/MC.2009.5; Lea A, 2009, IEEE T ANTENN PROPAG, V57, P3619, DOI 10.1109/TAP.2009.2031917; [Anonymous], 2014, BINVOX 3D MESH VOXEL; Hall PS, 2007, IEEE ANTENN PROPAG M, V49, P41, DOI 10.1109/MAP.2007.4293935; Reusens E, 2009, IEEE T INF TECHNOL B, V13, P933, DOI 10.1109/TITB.2009.2033054; Abbasi QH, 2012, IEEE T INF TECHNOL B, V16, P221, DOI 10.1109/TITB.2011.2177526; Dumanli S, 2011, IEEE T ANTENN PROPAG, V59, P3910, DOI 10.1109/TAP.2011.2163786; Cao HS, 2009, IEEE COMMUN MAG, V47, P84; Cotton SL, 2009, IEEE T WIREL COMMUN, V8, P6, DOI 10.1109/T-WC.2009.070788; Hara S, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P2254, DOI 10.1109/PIMRC.2011.6139919; Ryckaert J, 2004, ELECTRON LETT, V40, P543, DOI 10.1049/el:20040386; [Anonymous], 1996, WAVEFRONT OBJ SPECIF; van Roy S, 2013, IEEE T ANTENN PROPAG, V61, P2200, DOI 10.1109/TAP.2012.2231917; [Anonymous], 2010, POSER; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; [Anonymous], 2012, 8021562012 IEEE; Wang Q, 2009, IEEE T ANTENN PROPAG, V57, P991, DOI 10.1109/TAP.2009.2014526; Smith DB, 2011, ANN TELECOMMUN, V66, P187, DOI 10.1007/s12243-010-0233-8; Aoyagi T, 2011, IEICE T COMMUN, VE94B, P2496, DOI 10.1587/transcom.E94.B.2496; Balanis C. A., 1982, ANTENNA THEORY ANAL; Balanis C. A., 1989, ADV ENG ELECTROMAGNE; Bari R. D., 2003, WIRELESS MOBILE COMM, V61, P351; Chandra R, 2012, IEEE ENG MED BIO, P4533, DOI 10.1109/EMBC.2012.6346975; Chen M., 2010, J SPECIAL ISSUES MOB, V16, P171; Cotton SL, 2009, IEEE T ANTENN PROPAG, V57, P943, DOI 10.1109/TAP.2009.2014521; D'Errico R., 2011, IEEE INT C COMM KYOT; Fort A, 2005, IEEE ICC, P2840; Gallo M, 2011, IEEE T ANTENN PROPAG, V59, P623, DOI 10.1109/TAP.2010.2093498; Hall P., 2006, ANTENNAS PROPAGATION; Kim M, 2009, IEEE ANTENN WIREL PR, V8, P1250, DOI 10.1109/LAWP.2009.2036570; Kim M., 2012, 6 EUR C ANT PROP PRA; Liu L., 2011, P 5 EUR C ANT PROP E, P2972; Liu LF, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/362521; Maskooki A, 2013, IEEE T MICROW THEORY, V61, P2995, DOI 10.1109/TMTT.2013.2271760; Michalopoulou A, 2012, IEEE T ANTENN PROPAG, V60, P4014, DOI 10.1109/TAP.2012.2201073; Michalopoulou A., 2011, P 5 EUR C ANT PROP E, P2982; Momoda M., 2013, 7 INT S MED INF COMM; Nechayev YI, 2010, IET MICROW ANTENNA P, V4, P722, DOI 10.1049/iet-map.2009.0094; Noetscher G, 2011, IEEE ANTENN PROPAG M, V53, P118, DOI [10.1109/MAP.2011.6097301, 10.1109/MAP.2011.6097302]; Proakis J., 1989, DIGITAL COMMUNICATIO; Roblin C, 2011, ANN TELECOMMUN, V66, P157, DOI 10.1007/s12243-010-0231-x; Smith David B., 2012, IEEE Wireless Communications Letters, V1, DOI 10.1109/WCL.2012.041612.120047; Taflove A., 2005, COMPUTATIONAL ELECTR; Uusitupa T., 2012, Proceedings of the 2012 6th European Conference on Antennas and Propagation (EuCAP), DOI 10.1109/EuCAP.2012.6206558; Uusitupa T, 2013, IEEE T ANTENN PROPAG, V61, P6168, DOI 10.1109/TAP.2013.2281369; van Roy S, 2010, IEEE T ANTENN PROPAG, V58, P163, DOI 10.1109/TAP.2009.2036280; Wangchuk K., 2013, 7 INT S MED INF COMM; Yuce MR, 2012, WIRELESS BODY AREA NETWORKS: TECHNOLOGY, IMPLEMENTATION, AND APPLICATIONS, P1	54	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194			IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	MAR	2015	19	2					559	570		10.1109/JBHI.2014.2326424		12	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Computer Science; Mathematical & Computational Biology; Medical Informatics	CD4YB	WOS:000351091200019		
J	Nakao, M; Hosokawa, M; Imai, Y; Ueda, N; Hatanaka, T; Kirita, T; Matsuda, T				Nakao, Megumi; Hosokawa, Mamoru; Imai, Yuichiro; Ueda, Nobuhiro; Hatanaka, Toshihide; Kirita, Tadaaki; Matsuda, Tetsuya			Volumetric Fibular Transfer Planning With Shape-Based Indicators in Mandibular Reconstruction	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Fibular transfer; mandibular reconstruction; shape indicator and volume manipulation; surgical planning	COMPUTER-AIDED-DESIGN; VASCULARIZED FIBULA; FLAP; STEREOLITHOGRAPHY; SIMULATION; SURGERY	In preoperative planning for mandibular reconstructive surgery, it is necessary to determine the osteotomy lines for fibular shaping and the proper placement of fibular segments in the mandible. Although virtual surgical planning has been utilized in preoperative decision making, current software designs require manual operation and a trial-and-error process to refine the reconstruction plan. We have developed volumetric fibular transfer simulation software that can quickly design a preoperative plan based on direct volume manipulation and quantitative comparison with the patient's original mandible. We propose three quantitative shape indicators-volume ratio, contour error, and maximum projection-for symmetrical lesions of the mandible, and have implemented a parallel computation algorithm for the semiautomatic placement of fibular segments. Using this virtual planning software, we conducted a retrospective study of the computed tomography data from nine patients. We found that combining direct volume manipulation with real-time local search of placement improved the applicability of the planning system to optimize mandibular reconstruction.	[Nakao, Megumi; Hosokawa, Mamoru; Matsuda, Tetsuya] Kyoto Univ, Kyoto 6068501, Japan; [Imai, Yuichiro; Ueda, Nobuhiro; Hatanaka, Toshihide; Kirita, Tadaaki] Nara Med Univ, Nara 6348521, Japan	Nakao, M (reprint author), Kyoto Univ, Kyoto 6068501, Japan.	megumi@i.kyoto-u.ac.jp; mhosokawa@sys.i.kyoto-u.ac.jp; yimai@nmu-gw.naramed-u.ac.jp; n-ueda@naramed-u.ac.jp; thatanak@naramed-u.ac.jp; tkirita@naramed-u.ac.jp; tetsu@i.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21680044]	This work was supported by the Grant-in-Aid for Scientific Research for Young Scientists (A) (21680044) from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Foster RD, 1999, HEAD NECK-J SCI SPEC, V21, P66, DOI 10.1002/(SICI)1097-0347(199901)21:1<66::AID-HED9>3.0.CO;2-Z; Shen Y, 2012, OR SURG OR MED OR PA, V114, P175, DOI 10.1016/j.tripleo.2011.06.030; Wang WH, 2013, J CRANIO MAXILL SURG, V41, P417, DOI 10.1016/j.jcms.2012.11.008; Antony AK, 2011, PLAST RECONSTR SURG, V128, P1080, DOI 10.1097/PRS.0b013e31822b6723; Valente F, 2009, INT J ORAL MAX IMPL, V24, P234; Hirsch DL, 2009, J ORAL MAXIL SURG, V67, P2115, DOI 10.1016/j.joms.2009.02.007; Roser SM, 2010, J ORAL MAXIL SURG, V68, P2824, DOI 10.1016/j.joms.2010.06.177; Foley BD, 2013, J ORAL MAXIL SURG, V71, pE111, DOI 10.1016/j.joms.2012.08.022; Bottino A, 2012, IEEE T BIO-MED ENG, V59, P3439, DOI 10.1109/TBME.2012.2217496; Cabral B., 1994, P 1994 S VOL VIS, P91, DOI 10.1145/197938.197972; Chen XJ, 2010, CLIN IMPLANT DENT R, V12, P181, DOI 10.1111/j.1708-8208.2009.00160.x; FLEMMING AFS, 1990, BRIT J PLAST SURG, V43, P403, DOI 10.1016/0007-1226(90)90003-I; Imanishi K, 2010, INT J COMPUT ASS RAD, V5, P461, DOI 10.1007/s11548-010-0413-z; Juergens P, 2009, J ORAL MAXIL SURG, V67, P2167, DOI 10.1016/j.joms.2009.04.104; Kahler R, 2002, VISUAL COMPUT, V18, P481, DOI 10.1007/s00371-002-0174-y; Kimsal J, 2011, J ORAL MAXILLOFAC SU, V69, P1798; Lee T Y, 1999, IEEE Trans Inf Technol Biomed, V3, P214; Levoy M., 1990, ACM T GRAPHIC, V9, P256; Nakao M, 2010, IEEE PAC VIS SYMP, P161; Okada T., 2008, IEEE T BIOMED ENG, V56, P749; Rohner D, 2013, J CRANIO MAXILL SURG, V41, P382, DOI 10.1016/j.jcms.2012.10.021; Shah JP, 2002, ARCH OTOLARYNGOL, V128, P604; Sink J, 2012, J RECONSTR MICROSURG, V28, P395, DOI 10.1055/s-0032-1315762; Tepper O, 2012, PLAST RECONSTR SURG, V130, P192; Wang WH, 2012, J CRANIO MAXILL SURG, V40, P599, DOI 10.1016/j.jcms.2011.10.017; Yamanaka Y, 2010, J PLAST RECONSTR AES, V63, P1751, DOI 10.1016/j.bjps.2010.03.001; Zheng GS, 2012, OR SURG OR MED OR PA, V113, P712, DOI 10.1016/j.oooo.2012.01.034	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194			IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	MAR	2015	19	2					581	589		10.1109/JBHI.2014.2320720		9	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Computer Science; Mathematical & Computational Biology; Medical Informatics	CD4YB	WOS:000351091200021		
J	Tanakamaru, S; Kitamura, Y; Yamazaki, S; Tokutomi, T; Takeuchi, K				Tanakamaru, Shuhei; Kitamura, Yuta; Yamazaki, Senju; Tokutomi, Tsukasa; Takeuchi, Ken			Highly Reliable Coding Methods for Emerging Applications: Archive and Enterprise Solid-State Drives (SSDs)	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Archive; enterprise; NAND flash memory; reliability; solid-state drive; SSD	NAND FLASH MEMORIES; CELL; INTERFERENCE; CODES	This paper proposes highly reliable coding methods for applications in two extreme conditions. n-out-of-8 level cell (nLC) is proposed for archival applications which require significantly long data-retention time with small write/erase cycle. On the other hand, for applications with large write/erase cycle and short data-retention time (enterprise application, etc.), universal asymmetric coding (UAC) is proposed. nLC reduces the number of memory states to improve the reliability with low cost overhead. In 7LC, the bit-error rate (BER) reduction will be 79% after 1k-year data retention while seven memory states are efficiently used out of eight states. By considering nLC with error-correcting codes (ECCs), the optimum number of cell levels (n) can be determined to minimize the bit-cost with given acceptable data-retention time. In UAC, the coding method is changed according to the write/erase cycle and data-retention time to keep the BER low. As a result, BER is reduced by 52% at maximum, compared with the original random pattern.	[Tanakamaru, Shuhei] Chuo Univ, Res & Dev Initiat, Tokyo 1128551, Japan; [Tanakamaru, Shuhei] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Kitamura, Yuta; Yamazaki, Senju; Tokutomi, Tsukasa; Takeuchi, Ken] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan	Tanakamaru, S (reprint author), Chuo Univ, Res & Dev Initiat, Tokyo 1128551, Japan.	tanakamaru@takeuchi-lab.org; yamazaki@takeuchi-lab.org; tokutomi@takeuchi-lab.org; takeuchi@takeuchi-lab.org			CREST/JST	This work was supported in part by CREST/JST. This paper was recommended by Associate Editor V. Chandra.	Park M, 2009, IEEE ELECTR DEVICE L, V30, P174, DOI 10.1109/LED.2008.2009555; Lee JD, 2002, IEEE ELECTR DEVICE L, V23, P264; Mielke N, 2008, INT RELIAB PHY SYM, P9, DOI 10.1109/RELPHY.2008.4558857; MacKay DJC, 1999, IEEE T INFORM THEORY, V45, P399, DOI 10.1109/18.748992; Mielke N, 2004, IEEE T DEVICE MAT RE, V4, P335, DOI 10.1109/TDMR.2004.836721; Aritome S, 2012, IEEE T ELECTRON DEV, V59, P2950, DOI 10.1109/TED.2012.2212198; Bates S., 2013, P FLASH MEM SUMM AUG; GALLAGER RG, 1962, IRE T INFORM THEOR, V8, P21, DOI 10.1109/TIT.1962.1057683; Hachiya S., 2013, 2013 INT C SOL STAT, P894; Kim YS, 2010, INT REL PHY, P599, DOI 10.1109/IRPS.2010.5488765; Lee Y., 2012, IEEE INT SOL STAT CI, P426; MacKay D. J. C., 2003, INFORM THEORY INFERE, P162; MacKay D. J. C., 2003, INFORM THEORY INFERE, P67; Miccoli C., 2013, P IEEE IRPS APR; Micheloni R., 2008, ERROR CORRECTION COD, P167, DOI 10.1007/978-1-4020-8391-4_8; Min I., 2014, P FLASH MEM SUMM AUG; Motwani R., 2011, P FLASH MEM SUMM AUG; Shin S.-H., 2012, P S VLSI TECHN CIRC, P132; Shirota R., 2014, P IEEE INT MEM WORKS, P55; Takeuchi K, 1998, IEEE J SOLID-ST CIRC, V33, P1228, DOI 10.1109/4.705361; Tanakamaru S., 2014, P IEEE S VLSI CIRC J, P103; Tanakamaru S., 2013, P IEEE INT REL PHYS; Tanakamaru S., 2014, IEEE INT SOL STAT CI, P336; Tanakamaru S, 2012, IEEE J SOLID-ST CIRC, V47, P85, DOI 10.1109/JSSC.2011.2170637; Tanakamaru S., 2014, P IEEE INT MEM WORKS, P154; Taylor J., 2013, P FLASH MEM SUMM AUG; Weingarten H., 2011, P FLASH MEM SUMM AUG; Yuan Y., 2009, P S VLSI CIRC, P26	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	MAR	2015	62	3					771	780		10.1109/TCSI.2014.2380640		10	Engineering, Electrical & Electronic	Engineering	CD0YB	WOS:000350799100018		
J	Tanakamaru, S; Yamazawa, H; Tokutomi, T; Ning, SY; Takeuchi, K				Tanakamaru, Shuhei; Yamazawa, Hiroki; Tokutomi, Tsukasa; Ning, Sheyang; Takeuchi, Ken			Design Methodology for Highly Reliable, High Performance ReRAM and 3-Bit/Cell MLC NAND Flash Solid-State Storage	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						NAND flash memory; performance; reliability; ReRAM; storage; 3-bit/cell multi-level cell		This paper proposes design methodology for highly reliable, high performance ReRAM and 3-bit/cell multi-level cell (MLC) NAND flash solid-state storage. Six techniques, calibrated (CR), flexible (FR), adaptive asymmetric coding (AAC), verify trials reduction (VTR), bits/cell optimization (BCO), and balanced RAID-5/6 are proposed. CR, FR, AAC, and VTR are for ReRAM. CR and FR change the read-reference resistance to reduce the BER. AAC first increases the population of Set and then Reset. The BER reduction with FR and AAC is 69 and 78% with 60 and 75% asymmetry, respectively. In VTR, by changing the number of acceptable bit-errors, the total Reset time is reduced by 97% at maximum with small ECC calculation overhead. The reliability of 3-bit/cell MLC NAND flash memory is improved by BCO and balanced RAID-5/6. BCO reallocates 3-bit/cell MLC to 2-bit/cell MLC and single-level cell (SLC) and the write/erase cycle increases by over 22-times. Balanced RAID-5/6 evenly allocates upper/middle/lower pages to a stripe to reduce the RAID failure rate by 98%.	[Tanakamaru, Shuhei] Chuo Univ, Res & Dev Initiat, Tokyo 1128551, Japan; [Tanakamaru, Shuhei; Ning, Sheyang] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Yamazawa, Hiroki; Tokutomi, Tsukasa; Ning, Sheyang; Takeuchi, Ken] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan	Tanakamaru, S (reprint author), Chuo Univ, Res & Dev Initiat, Tokyo 1128551, Japan.	tanakamaru@takeuchi-lab.org; yamazawa@takeuchi-lab.org; toku-tomi@takeuchi-lab.org; ning@takeuchi-lab.org; takeuchi@takeuchi-lab.org			CREST/JST	This work was supported in part by CREST/JST.	Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Im S, 2011, IEEE T COMPUT, V60, P80, DOI 10.1109/TC.2010.198; Jimenez X, 2012, DES AUT CON, P229; Mielke N, 2008, INT RELIAB PHY SYM, P9, DOI 10.1109/RELPHY.2008.4558857; BLAUM M, 1995, IEEE T COMPUT, V44, P192, DOI 10.1109/12.364531; Balakrishnan M., 2010, P 5 EUR C COMP SYST; Cai Y., 2013, P DES AUT TEST EUR M, P1285; Chen Y. S., 2011, IEDM, P717; Fackenthal R., 2014, ISSCC, V2014, P338; Fujii H., 2012, P IEEE S VLSI CIRC J, P134; Hachiya S., 2013, 2013 INT C SOL STAT, P894; Higuchi K., 2012, P IEEE INT MEM WORKS; Kawa A, 2012, LECT NOTES ARTIF INT, V7196, P432, DOI 10.1007/978-3-642-28487-8_45; Kawahara A., 2013, ISSCC, P220; Lee Y., 2012, IEEE INT SOL STAT CI, P426; Patterson D.A., 1988, P ACM SIGMOD INT C M, V1, P109; Schroeder B., 2010, P USENIX C FIL STOR; Song YJ, 2013, COMPUTER, V46, P30; Sun C, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P64; Tanakamaru S, 2014, IEEE T CIRCUITS-I, V61, P1119, DOI 10.1109/TCSI.2013.2285891; Tanakamaru S., 2014, IEEE INT SOL STAT CI, P336; Tanakamaru S, 2012, IEEE J SOLID-ST CIRC, V47, P85, DOI 10.1109/JSSC.2011.2170637; Yoo H., 2014, P AS S PAC DES AUT C, P37	23	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	MAR	2015	62	3					844	853		10.1109/TCSI.2014.2370171		10	Engineering, Electrical & Electronic	Engineering	CD0YB	WOS:000350799100026		
J	Namba, K; Lombardi, F				Namba, Kazuteru; Lombardi, Fabrizio			A Single and Adjacent Symbol Error-Correcting Parallel Decoder for Reed-Solomon Codes	IEEE TRANSACTIONS ON DEVICE AND MATERIALS RELIABILITY			English	Article						Error correcting code (ECC); adjacent error correction (AEC); Reed-Solomon (RS) codes; parallel decoder	PHASE-CHANGE MEMORY; RESISTANCE; DRIFT; COST	This paper presents a novel high-speed Reed-Solomon (RS) decoder. The proposed decoder corrects in parallel adjacent and single-symbol errors; moreover, it serially corrects multiple-symbol errors other than adjacent errors. Its operation is based on a novel scheme that extends an existing binary BCH decoder such that a nonbinary RS code can be targeted. The proposed scheme, however, differs from previous schemes in the algorithm and construction of the parallel decoder; the proposed decoder is efficient for multilevel memory systems such as those utilizing phase change memory devices. Simulation results show that the proposed scheme requires a significantly smaller area and lower power than a traditional fully parallelized RS decoder capable of correcting any double-symbol errors in parallel. Furthermore, it is also shown that it requires a smaller area than a parallel error correction scheme using a nonbinary double-error-correcting orthogonal Latin square code.	[Namba, Kazuteru] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2630022, Japan; [Lombardi, Fabrizio] Northeastern Univ, Dept Elect & Comp Engn, Coll Engn, Boston, MA 02115 USA	Namba, K (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2630022, Japan.	namba@ieee.org; lombardi@ece.neu.edu					Xu W, 2011, IEEE T VLSI SYST, V19, P1357, DOI 10.1109/TVLSI.2010.2052640; Satoh S, 2000, IEEE ELECTR DEVICE L, V21, P310, DOI 10.1109/55.843160; Ielmini D, 2007, IEEE T ELECTRON DEV, V54, P308, DOI 10.1109/TED.2006.888752; Wilkerson C, 2010, CONF PROC INT SYMP C, P83; Radaelli D, 2005, IEEE T NUCL SCI, V52, P2433, DOI 10.1109/TNS.2005.860675; Argyrides C, 2011, IEEE T VLSI SYST, V19, P420, DOI 10.1109/TVLSI.2009.2036362; Boniardi M, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P122, DOI 10.1109/IRPS.2009.5173236; Chen Y.-S., 2012, B NETWORKING COMPUTI, V1, P1, DOI DOI 10.1039/C4CS00300D; Costello Jr D.J., 2004, ERROR CONTROL CODING; Datta R, 2011, IEEE VLSI TEST SYMP, P134, DOI 10.1109/VTS.2011.5783773; Fujiwara E., 2006, CODE DESIGN DEPENDAB; Ibe E, 2010, IEEE T ELECTRON DEV, V57, P1527, DOI 10.1109/TED.2010.2047907; Jang S.-C., 2008, P IEEE INT SOC DES C; Junsangsri P, 2012, IEEE INT SYMP NANO, P77; Maiz J., 2003, IEDM; Namba K, 2015, IEEE T COMPUT, V64, P2092, DOI 10.1109/TC.2014.2346182; Papandreou N, 2010, Proceedings of the 2010 17th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2010), DOI 10.1109/ICECS.2010.5724687; Rajendran B., 2011, P IEEE INT MEM WORKS, P1; Reviriego P, 2011, IEEE T NUCL SCI, V58, P981, DOI 10.1109/TNS.2011.2109965	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-4388	1558-2574		IEEE T DEVICE MAT RE	IEEE Trans. Device Mater. Reliab.	MAR	2015	15	1					75	81		10.1109/TDMR.2014.2379513		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CD5PU	WOS:000351141100010		
J	Xiang, JW; Machida, F; Tadano, K; Maeno, Y				Xiang, Jianwen; Machida, Fumio; Tadano, Kumiko; Maeno, Yoshiharu			An Imperfect Fault Coverage Model With Coverage of Irrelevant Components	IEEE TRANSACTIONS ON RELIABILITY			English	Article						Imperfect fault coverage; fault tree; irrelevancy; irrelevancy trigger; coherent systems	COMPETING FAILURES; SYSTEMS SUBJECT; RELIABILITY; TREES	This paper addresses the coverage (including identification and isolation) of irrelevant components in systems with imperfect fault coverage (IFC). In fault-tolerant systems, a single not-covered component fault may thwart the automatic recovery mechanisms, and lead to a system or subsystem failure. The models that consider the effects of IFC are known as coverage models (CMs). In traditional CMs, except those considering functional dependency (a similar concept to relevancy but with different assumptions and semantics), coverage is typically limited to faulty components regardless of their relevancies. Consequently, an operational but irrelevant component will not be isolated, and may threaten the system by its future uncovered (not-covered) failures. Although the system is generally assumed to be coherent, which implies the relevancy of each component in the initial system state, the traditional CMs do not consider the fact that an initially relevant component could become irrelevant after the failures of other components. We propose the irrelevancy coverage model (ICM) to cover the irrelevant components in addition to the faulty components. In the ICM, a component will be isolated from the system whenever it becomes irrelevant (even it is not failed), such that its future not-covered failures will not affect the system anymore. By incorporating the coverage of irrelevant components, the ICM opens up a new cost-effective approach to improve system reliability without additional redundancy.	[Xiang, Jianwen] Wuhan Univ Technol, Wuhan 430070, Hubei, Peoples R China; [Xiang, Jianwen; Machida, Fumio; Tadano, Kumiko; Maeno, Yoshiharu] NEC Corp Ltd, Kawasaki, Kanagawa 2118666, Japan	Xiang, JW (reprint author), Wuhan Univ Technol, Wuhan 430070, Hubei, Peoples R China.	xiangjw@gmail.com; f-machida@ab.jp.nec.com; k-tadano@bq.jp.nec.com; y-maeno@aj.jp.nec.com					Amari S. V., 2008, HDB PERFORMABILITY E; Amari SV, 1999, IEEE T RELIAB, V48, P275, DOI 10.1109/24.799899; Amari SV, 1999, IEEE T RELIAB, V48, P267, DOI 10.1109/24.799898; Bouissou M, 2003, RELIAB ENG SYST SAFE, V82, P149, DOI 10.1016/S0951-8320(03)00143-1; Xing LD, 2010, RELIAB ENG SYST SAFE, V95, P1210, DOI 10.1016/j.ress.2010.06.014; Merle G, 2010, IEEE T RELIAB, V59, P250, DOI 10.1109/TR.2009.2035793; Rauzy A, 1997, RELIAB ENG SYST SAFE, V58, P127, DOI 10.1016/S0951-8320(97)00034-3; DUGAN JB, 1989, IEEE T COMPUT, V38, P775, DOI 10.1109/12.24286; Arnold T. F., 1973, IEEE T COMPUT, VC-22, P325; Doyle S. A., 1998, P 25 IEEE INT S FAUL, P249; DOYLE SA, 1993, P A REL MAI, P214, DOI 10.1109/RAMS.1993.296853; DOYLE SA, 1995, IEEE T RELIAB, V44, P87, DOI 10.1109/24.376525; Doyle S.A., 1993, P AIAA COMP AER OCT, P668; DUGAN JB, 1990, P REL MAINT S, P286; DUGAN JB, 1992, IEEE T RELIAB, V41, P363, DOI 10.1109/24.159800; Izukura S, 2011, LECT NOTES COMPUT SC, V6981, P563, DOI 10.1007/978-3-642-24485-8_41; RAUZY A, 1993, RELIAB ENG SYST SAFE, V40, P203, DOI 10.1016/0951-8320(93)90060-C; Trivedi K. S., 2002, PROBABILITY STAT REL; Wang CN, 2013, RELIAB ENG SYST SAFE, V111, P9, DOI 10.1016/j.ress.2012.10.001; Xiang J., 2011, P 5 INT C SEC SOFTW, P127; Xiang JW, 2013, 2013 SIXTH LATIN-AMERICAN SYMPOSIUM ON DEPENDABLE COMPUTING (LADC), P58, DOI 10.1109/LADC.2013.14; Xiang JW, 2013, IEICE T FUND ELECTR, VE96A, P1649, DOI 10.1587/transfun.E96.A.1649; Xing L., 2002, P 6 INT C PROB SAF A; Xing L., 2010, P 56 ANN REL MAINT S, P1, DOI DOI 10.1109/RAMS.2010.5447994; Xing LD, 2004, IEEE T RELIAB, V53, P174, DOI 10.1109/TR.2004.829137	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9529	1558-1721		IEEE T RELIAB	IEEE Trans. Reliab.	MAR	2015	64	1					320	332		10.1109/TR.2014.2363155		13	Computer Science, Hardware & Architecture; Computer Science, Software Engineering; Engineering, Electrical & Electronic	Computer Science; Engineering	CD1WT	WOS:000350865900026		
J	Takahashi, R; Tashiro, K; Hikihara, T				Takahashi, Ryo; Tashiro, Keiji; Hikihara, Takashi			Router for Power Packet Distribution Network: Design and Experimental Verification	IEEE TRANSACTIONS ON SMART GRID			English	Article						Power distribution system; power packet; power routing		A power packet dispatching system is expected to be one of the advanced power distribution systems for controlling electric power, providing energy on demand, and reducing wasted energy consumption. In this paper, power packet routers are designed and experimentally verified for realizing a networked power packet distribution system. While the previously developed router directly forwards the power packet to a load, the new router forwards the packet to the other router with an information tag reattached to the power payload. In addition, the new router can adjust the starting time for forwarding the received power packet to the other site, thus utilizing storage capacity integrated into the router. The results successfully clarify the feasibility of the power packet distribution network.	[Takahashi, Ryo; Tashiro, Keiji; Hikihara, Takashi] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan	Takahashi, R (reprint author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	takahashi.ryo.2n@kyoto-u.ac.jp	Hikihara, Takashi/B-6555-2015	Hikihara, Takashi/0000-0002-0029-4358	National Institute of Information and Communications Technology, Japan; Japan Society for the Promotion of Science [26820144]	This work was supported by the National Institute of Information and Communications Technology, Japan. The work of R. Takahashi was supported by the Japan Society for the Promotion of Science Grand-in-Aid for Young Scientists (B) under Grant No. 26820144.	Alur R., 2004, LECT NOTES COMPUTER, V2993; Miyake H, 2012, IEEE ELECTR DEVICE L, V33, P1598, DOI 10.1109/LED.2012.2215004; Takuno T, 2011, ENERGIES, V4, P717, DOI 10.3390/en4050717; Di Benedetto M. D., 2001, LECT NOTES COMPUTER, V2034; Funaki T, 2007, IEEE T POWER ELECTR, V22, P1321, DOI 10.1109/TPEL.2007.900561; Gelenbe E., 2012, P 2 INT WORKSH CLOUD, P1; Gelenbe E, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS WORKSHOPS (PERCOM WORKSHOPS), P453; He M. M., 2008, P IEEE EN 2030 C ATL, P1; Hikihara T., 2012, P AIAA 10 INT EN CON, P1; Hikihara T., 2010, SANT BARB SUMM EN EF; Kordonis A., 2013, P IEEE 2 GLOB C CONS, P158; Miyamoto T, 2012, 2012 IEEE/IPSJ 12TH INTERNATIONAL SYMPOSIUM ON APPLICATIONS AND THE INTERNET (SAINT), P138, DOI 10.1109/SAINT.2012.27; Nawata S., 2014, IEICE T FUND ELECTR, VJ97-A, P584; Nawata S., 2014, P INT S NONL THEOR A, P60; Sakai K., 2011, P 2011 IEEE CONS COM, P1041; Stalling BP, 2012, 2012 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P587, DOI 10.1109/ECCE.2012.6342768; Takahashi R, 2013, ENERGIES, V6, P6293, DOI 10.3390/en6126293; Takahashi R, 2012, ENERGIES, V5, P2141, DOI 10.3390/en5072141; Takahashi R, 2013, P AMER CONTR CONF, P4368; Takuno T., 2009, P 13 EUR C POW EL AP, P1; Takuno T, 2010, 2010 IEEE 1ST INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P427, DOI 10.1109/SMARTGRID.2010.5622079; Tashiro K, 2012, 2012 IEEE THIRD INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P401, DOI 10.1109/SmartGridComm.2012.6486017; Toyoda J, 1998, IEEE CONF R, P218, DOI 10.1109/EMPD.1998.705515; Yoshihisa T., 2012, P 2012 IEEE 1 GLOB C, P248; Zhou Y., IEICE T FUN IN PRESS	25	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	MAR	2015	6	2					618	626		10.1109/TSG.2014.2384491		9	Engineering, Electrical & Electronic	Engineering	CC4QN	WOS:000350338100013		
J	Inoue, T; Yasuda, N; Kawano, S; Takenobu, Y; Minato, S; Hayashi, Y				Inoue, Takeru; Yasuda, Norihito; Kawano, Shunsuke; Takenobu, Yuji; Minato, Shin-ichi; Hayashi, Yasuhiro			Distribution Network Verification for Secure Restoration by Enumerating All Critical Failures	IEEE TRANSACTIONS ON SMART GRID			English	Article						Distribution network; hitting set; network reconfiguration; restoration; zero-suppressed binary decision diagram (ZDD)	DISTRIBUTION-SYSTEMS; SERVICE RESTORATION; LOSS REDUCTION; RELIABILITY EVALUATION; RECONFIGURATION	If several feeders are interrupted in a severe accident, distribution networks should be restored by reconfiguring switches automatically with smart grid technologies. Although there have been several restoration algorithms developed to find the new network configuration, they might fail to restore the whole network if the network were critically damaged. The network's design has to guarantee that it is restorable under any possible failure for secure power delivery, but it is a computationally hard task to examine all possible failures in a large-scale network with complex electrical constraints. This paper proposes a novel method to find all the critical (unrestorable) line cuts with great efficiency to verify the network design. The proposed method first runs a fast screening algorithm based on hitting set enumeration; the algorithm selects suspicious cuts without naively examining all possible cuts. Next, unrestorable cuts are identified from the suspicious ones with another algorithm, which strictly tests the restorability of the network under each suspicious cut without redundantly repeating heavy power flow calculations. Thorough experiments on two distribution networks reveal that the proposed method can find thousands of unrestorable cuts from the trillions of possible cuts in a large 432-Bus network with no significant false negatives.	[Inoue, Takeru; Yasuda, Norihito] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Minato Discrete Struct Manipulat Syst Project, Sapporo, Hokkaido 0600814, Japan; [Kawano, Shunsuke; Takenobu, Yuji; Hayashi, Yasuhiro] Waseda Univ, Fac Sci & Engn, Tokyo 1698050, Japan; [Minato, Shin-ichi] Japan Sci & Technol Agcy, ERATO, Minato Discrete Struct Manipulat Syst Project, Sapporo, Hokkaido 0600814, Japan; [Minato, Shin-ichi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600808, Japan	Inoue, T (reprint author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Minato Discrete Struct Manipulat Syst Project, Sapporo, Hokkaido 0600814, Japan.	takeru.inoue@ieee.org					DIALYNAS EN, 1991, IEEE T POWER DELIVER, V6, P1891, DOI 10.1109/61.97737; Inoue T, 2014, IEEE T SMART GRID, V5, P102, DOI 10.1109/TSG.2013.2288976; Perez-Guerrero R, 2008, IEEE T POWER DELIVER, V23, P1589, DOI 10.1109/TPWRD.2007.916112; BARAN ME, 1989, IEEE T POWER DELIVER, V4, P1401, DOI 10.1109/61.25627; Li WX, 2004, IEEE T POWER DELIVER, V19, P753, DOI 10.1109/TPWRD.2003.822960; Kumar Y, 2008, IEEE T POWER DELIVER, V23, P261, DOI 10.1109/TPWRD.2007.905412; NARA K, 1992, IEEE T POWER SYST, V7, P1044, DOI 10.1109/59.207317; Perez-Guerrero RE, 2008, IEEE T POWER SYST, V23, P1162, DOI 10.1109/TPWRS.2008.926471; Billinton R, 1998, IEE P-GENER TRANSM D, V145, P149, DOI 10.1049/ip-gtd:19981828; Hayashi Y, 2004, IEEE T POWER SYST, V19, P636, DOI 10.1109/TPWRS.2003.821438; Hayashi Y., 2006, IEEJ T PE, V126, P1013, DOI 10.1541/ieejpes.126.1013; Inoue T., 2013, TCSTRA1365 HOKK U DI; Jonsson H., 2008, J RISK RELIABILITY, V222, P235; Kazemi S., 2011, THESIS AALTO U ESPOO; Knuth D. E., 2011, ART COMPUTER PRO A 1, V4A; Lavaei J., 2011, P 18 IFAC WORLD C AU, P10481; Lin WM, 1998, IEEE T POWER DELIVER, V13, P870; LIU CC, 1988, IEEE T POWER SYST, V3, P619, DOI 10.1109/59.192914; Minato S, 1993, P 30 ACM IEEE DES AU, P272, DOI 10.1145/157485.164890; Nguyen CP, 2012, IEEE T SMART GRID, V3, P1029, DOI 10.1109/TSG.2012.2186833; SHIRMOHAMMADI D, 1992, IEEE T POWER DELIVER, V7, P952, DOI 10.1109/61.127104; Toda T., 2013, LNCS, V7933, P91	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	MAR	2015	6	2					843	852		10.1109/TSG.2014.2359114		10	Engineering, Electrical & Electronic	Engineering	CC4QN	WOS:000350338100036		
J	Sadamoto, T; Ishizaki, T; Koike, M; Ueda, Y; Imura, J				Sadamoto, Tomonori; Ishizaki, Takayuki; Koike, Masakazu; Ueda, Yuzuru; Imura, Jun-ichi			Spatiotemporally Multiresolutional Optimization Toward Supply-Demand-Storage Balancing Under PV Prediction Uncertainty	IEEE TRANSACTIONS ON SMART GRID			English	Article						Photovoltaic (PV) power generation; prediction uncertainty; spatiotemporally multiresolutional optimization; supply-demand-storage balancing	SYSTEMS	Large-scale penetration of photovoltaic (PV) power generators and storage batteries is expected in recently constructed power systems. For the realization of smart energy management, we need to make an appropriate day-ahead schedule of power generation and battery charge cycles based on the prediction of demand and PV power generation, which inevitably involves nontrivial prediction errors. With this background, a novel framework is proposed to maintain the balance among the total amounts of power generation, demand, and battery charging power with explicit consideration of the prediction uncertainty, assuming that consumer storage batteries are not directly controllable by a supplier. The proposed framework consists of the following three steps: 1) the day-ahead scheduling of the total amount of generation power and battery charging power; 2) the day-ahead scheduling of utility energy consumption requests to individual consumers, which aim to regulate battery charging cycles on the consumer side; and 3) the incentive-based management of the entire power system on the day of interest. In this paper, we especially focus on the day-ahead scheduling problems in steps 1) and 2), and show that they can be analyzed in a manner originating from spatiotemporal aggregation. Finally, we demonstrate the validity of the proposed framework through numerical verification of the power system management.	[Sadamoto, Tomonori; Ishizaki, Takayuki; Koike, Masakazu; Imura, Jun-ichi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 1528552, Japan; [Sadamoto, Tomonori; Ishizaki, Takayuki; Koike, Masakazu; Ueda, Yuzuru; Imura, Jun-ichi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Ueda, Yuzuru] Tokyo Univ Sci, Dept Elect Engn, Tokyo 1258585, Japan	Sadamoto, T (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 1528552, Japan.	sadamoto@cyb.mei.titech.ac.jp					REID GF, 1973, IEEE T POWER AP SYST, VPA92, P2015, DOI 10.1109/TPAS.1973.293582; Masuta T, 2012, IEEE T SMART GRID, V3, P1253, DOI 10.1109/TSG.2012.2194746; [Anonymous], 2014, SPECIFICATION LITHIU; Meibom P, 2011, IEEE T POWER SYST, V26, P1367, DOI 10.1109/TPWRS.2010.2070848; Wiemken E, 2001, SOL ENERGY, V70, P513, DOI 10.1016/S0038-092X(00)00146-8; [Anonymous], 2014, G8 HOKKAIDO TOYAKO S; Arnold M., 2011, P POW SYST COMP C PS; BenTal A, 2009, PRINC SER APPL MATH, P1; Bienstock D., P 2013 IEEE 52 ANN C, P4335; Blackmore L., 2006, P AM CONTR C MINN MN, P7; Di Bella G., P 2013 IEEE 52 ANN C, P6280; Hardle WK, 2007, APPL MULTIVARIATE ST; Nayyar A., P 2013 IEEE 52 ANN C, P5600; Ohtake H, 2013, SOL ENERGY, V98, P138, DOI 10.1016/j.solener.2012.10.007; Oozeki T., P 2009 34 IEEE PHOT, P2250; Patel M. R., 2012, WIND SOLAR POWER SYS; Paulescu M, 2012, WEATHER MODELING FOR; Sadamoto T., 2014, P 19 IFAC WORLD C CA, P4571; Sturt A, 2012, IEEE T POWER SYST, V27, P323, DOI 10.1109/TPWRS.2011.2164558; Zhu J., 2009, OPTIMIZATION POWER S	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	MAR	2015	6	2					853	865		10.1109/TSG.2014.2377241		13	Engineering, Electrical & Electronic	Engineering	CC4QN	WOS:000350338100037		
J	Tsutsui-Takeuchi, M; Ushio, H; Fukuda, M; Yamada, T; Niyonsaba, F; Okumura, K; Ogawa, H; Ikeda, S				Tsutsui-Takeuchi, Mizuho; Ushio, Hiroko; Fukuda, Minoru; Yamada, Takahiko; Niyonsaba, Francois; Okumura, Ko; Ogawa, Hideoki; Ikeda, Shigaku			Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection	IMMUNOLOGIC RESEARCH			English	Article						Mast cells; Virus; Retinoic acid-inducible gene-I-like receptors; Toll-like receptors; 2 '-5 ' Oligoadenylate synthetase	ANTIVIRAL INNATE IMMUNITY; DOUBLE-STRANDED-RNA; RIG-I; HOST-DEFENSE; VIRUS; ACTIVATION; CHEMOKINES; ALPHA; SURVEILLANCE; RECRUITMENT	To investigate the anti-viral responses of human mast cells, we performed PCR array analysis of these cells after infection with vesicular stomatitis virus (VSV). PCR array analysis revealed that human mast cells up-regulated several anti-viral genes, including melanoma differentiation-associated gene 5, retinoic acid-inducible gene-I, and Toll-like receptor 3, together with type I interferons and chemokines, upon VSV infection. Additionally, we found that 2'-5' oligoadenylate synthetase, which also works as a virus recognition receptor by activating the latent form of RNase L, leading to viral RNA degradation, was up-regulated in human mast cells upon VSV infection. Moreover, small interfering RNA analysis to identify the receptors responsible for mast cell activation by VSV revealed that these receptors reciprocally cooperate to produce anti-viral cytokines and chemokines, inhibiting VSV replication. Our findings suggest that human mast cells produce cytokines and chemokines using several viral recognition receptors, leading to the inhibition of viral replication. These data provide novel information that improves our understanding of the roles of human mast cells in immune responses against viruses.	[Tsutsui-Takeuchi, Mizuho; Yamada, Takahiko; Ikeda, Shigaku] Juntendo Univ, Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138421, Japan; [Tsutsui-Takeuchi, Mizuho; Ushio, Hiroko; Yamada, Takahiko; Niyonsaba, Francois; Okumura, Ko; Ogawa, Hideoki; Ikeda, Shigaku] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Fukuda, Minoru] Juntendo Univ, Sch Med, Dept Infect Control Sci, Bunkyo Ku, Tokyo 1138421, Japan	Ushio, H (reprint author), Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hushio@juntendo.ac.jp			MEXT	This work was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University). The authors thank Drs. K. Honda and H. Yanai for providing viruses. We also thank the members of the Atopy Research Center and the Department of Immunology for fruitful discussions and technical assistance and Ms. Michiyo Matsumoto for secretarial assistance.	Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Christensen JE, 2006, J IMMUNOL, V176, P4235; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Supajatura V, 2001, J IMMUNOL, V167, P2250; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; McCurdy JD, 2003, J IMMUNOL, V170, P1625; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Matsushima H, 2004, J IMMUNOL, V173, P531; Marshall JS, 2003, CURR PHARM DESIGN, V9, P11, DOI 10.2174/1381612033392413; Patella V, 2000, J IMMUNOL, V164, P589; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Verbist KC, 2012, CYTOKINE, V59, P467, DOI 10.1016/j.cyto.2012.05.020; Bonini S, 2005, OPHTHALMOLOGY, V112, P1528, DOI 10.1016/j.ophtha.2005.04.009; SUGIYAMA K, 1977, NATURE, V270, P614, DOI 10.1038/270614a0; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Yoneyama M, 2005, J IMMUNOL, V175, P2851; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Aoki R, 2013, J INVEST DERMATOL, V133, P2170, DOI 10.1038/jid.2013.150; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Fukuda M, 2013, J INNATE IMMUN, V5, P163, DOI 10.1159/000343895; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Glass William G, 2003, Curr Opin Allergy Clin Immunol, V3, P467, DOI 10.1097/00130832-200312000-00008; Hamilton NHR, 2004, SCAND J IMMUNOL, V59, P246, DOI 10.1111/j.0300-9475.2004.01391.x; Harvey SAK, 2005, INVEST OPHTH VIS SCI, V46, P3657, DOI 10.1167/iovs.05-0438; Kallal LE, 2008, CURR ALLERGY ASTHM R, V8, P443, DOI 10.1007/s11882-008-0084-9; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Kulka M, 2010, CURR PROTOC IMMUNOL; Lappalainen J, 2013, CLIN EXP IMMUNOL, V172, P121, DOI 10.1111/cei.12042; Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005	51	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0257-277X	1559-0755		IMMUNOL RES	Immunol. Res.	MAR	2015	61	3					240	249		10.1007/s12026-014-8617-x		10	Immunology	Immunology	CC4BO	WOS:000350295900007		
J	Obata, Y; Furusawa, Y; Hase, K				Obata, Yuuki; Furusawa, Yukihiro; Hase, Koji			Epigenetic modifications of the immune system in health and disease	IMMUNOLOGY AND CELL BIOLOGY			English	Review							REGULATORY T-CELLS; INTESTINAL EPITHELIAL-CELLS; CHAIN FATTY-ACIDS; DNA METHYLATION; HELICOBACTER-PYLORI; COMMENSAL-BACTERIA; HISTONE H3; MACROPHAGE POLARIZATION; GASTRIC MUCOSAE; METABOLITE BUTYRATE	Vertebrate animals have developed sophisticated host defense mechanisms against potentially hostile antigens. These mechanisms mainly involve the immune system and the epithelial cells that cover the body surface. Accumulating studies have revealed that epigenetic mechanisms in collaboration with signal transduction networks regulate gene expression over the course of differentiation, proliferation and function of immune and epithelial cells. The epigenetic status of these cells is fine-tuned under physiological conditions; however, its disturbance often results in the development of immunological disorders, namely inflammation. Certain environmental factors influence the differentiation and function of immune cells through epigenetic alterations. For example, commensal microbiota-derived metabolites inhibit histone deacetylases to induce regulatory T cells, whereas some infectious agents induce DNA methylation, resulting in the development of cancer. These data imply that epigenetic regulation of host defense cells, which are usually the first to encounter external antigens, is implicated in disease development. Here, we highlight recent advances in our understanding of the molecular mechanisms by which the epigenetic status of immune and epithelial cells is controlled.	[Obata, Yuuki; Furusawa, Yukihiro; Hase, Koji] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Mucosal Barriol, Tokyo, Japan; [Obata, Yuuki] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Dept Immune Regulat, Chiba, Japan; [Furusawa, Yukihiro; Hase, Koji] Keio Univ, Fac Pharm, Dept Biochem, Tokyo 1058512, Japan	Hase, K (reprint author), Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	hase-kj@pha.keio.ac.jp					Aagaard K., 2014, SCI TRANSL MED, V6, P237, DOI DOI 10.1126/SCITRANSLMED.3008599; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Ernst P, 2012, BRIEF FUNCT GENOMICS, V11, P217, DOI 10.1093/bfgp/els017; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; KANTOR AF, 1984, AM J EPIDEMIOL, V119, P510; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Austenaa L, 2012, IMMUNITY, V36, P572, DOI 10.1016/j.immuni.2012.02.016; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Thompson CL, 2010, CANCER CAUSE CONTROL, V21, P1165, DOI 10.1007/s10552-010-9542-5; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Yin L, 2011, MUCOSAL IMMUNOL, V4, P409, DOI 10.1038/mi.2010.83; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Cheng ASL, 2013, GASTROENTEROLOGY, V144, P122, DOI 10.1053/j.gastro.2012.10.002; Leng J, 2009, J IMMUNOL, V182, P489; Yang WC, 2005, ONCOGENE, V24, P2104, DOI 10.1038/sj.onc.1208444; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Annison G, 2003, J NUTR, V133, P3523; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Tang Y, 2014, CELL DEATH DIFFER, V21, P369, DOI 10.1038/cdd.2013.159; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bobetsis YA, 2007, J DENT RES, V86, P169; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488; Jiang X, 2009, BRIT J CANCER, V100, P834, DOI 10.1038/sj.bjc.6604889; Khan YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095051; Kiga K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5497; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Licciardi PV, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-24; Murata M, 2007, MICROBIOL-SGM, V153, P585, DOI 10.1099/mic.0.29213-0; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI [10.4049/jimmunol.1101128, 10.4049/jimmunol.101128]; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Suetake L, 2001, Cell Struct Funct, V26, P79; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Zediak VP, 2011, CURR OPIN GENET DEV, V21, P154, DOI 10.1016/j.gde.2011.01.016; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	91	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0818-9641	1440-1711		IMMUNOL CELL BIOL	Immunol. Cell Biol.	MAR	2015	93	3					226	232		10.1038/icb.2014.114		7	Cell Biology; Immunology	Cell Biology; Immunology	CD6OM	WOS:000351208600004		
J	Hoa-Tran, TN; Nakagomi, T; Sano, D; Sherchand, JB; Pandey, BD; Cunliffe, NA; Nakagomi, O				Thi Nguyen Hoa-Tran; Nakagomi, Toyoko; Sano, Daisuke; Sherchand, Jeevan B.; Pandey, Basu D.; Cunliffe, Nigel A.; Nakagomi, Osamu			Molecular epidemiology of noroviruses detected in Nepalese children with acute diarrhea between 2005 and 2011: Increase and predominance of minor genotype GII.13	INFECTION GENETICS AND EVOLUTION			English	Article						Gastroenteritis; Norovirus; GII.13; GII.P16/GII.13; Histo-blood group antigen; Recombination	BLOOD GROUP ANTIGENS; NORWALK-LIKE VIRUSES; ACUTE GASTROENTERITIS; EPOCHAL EVOLUTION; GENETIC-ANALYSIS; SWISS-MODEL; OSAKA CITY; INFECTIONS; OUTBREAKS; VARIANT	Noroviruses, an important cause of acute gastroenteritis, possess a highly divergent genome which was classified into five genogroups and dozens of genotypes. However, changes in genotype distribution over time were poorly understood, particularly in developing countries. We therefore conducted a molecular epidemiological study which characterized the norovirus strains detected in 4437 Nepalese children with acute diarrhea between November 2005 and January 2011 to gain insight into how their genotypes changed over time. Of the 356 samples positive for noroviruses, 277 (78%) were successfully genotyped into 22 capsid genotypes; GII.4 (n = 113), GII.3 (n = 38) and GII.13 (n = 37) were the majority. Interestingly, GII.13 accounted for only 1.7% (4/230) between 2005 and 2008 (period 1) but increased substantially to 26.2% (33/126) between 2009 and 2011 (period 2). Phylogenetic analysis of the VP1 nucleotide sequences of 35 GII.13 strains indicated that they clustered into two lineages named NPL2008 and NPL2009 to which two period 1 strains and 33 period 2 strains belonged, respectively. Lineage NPL2009 contained GII.13 strains that were detected in a large-scale gastroenteritis outbreak in Germany in 2012. Both Nepalese and German VP1 sequences carried two substitutions, H378N and V394Q in the putative histo-blood group antigen (HBGA)-binding sites. As to the polymerase genotypes of Nepalese strains, the period 1 strains possessed GII.Pm, but the period 2 strains possessed GII.P13, GII.P16, and GII.P21. Together with recent reports on the predominance of GII.P13/GII.13 and GII.P16/GII.13 in India and GII.P16/GII.13 in European countries, this study predicts that genotype GII.13 which was previously regarded as a minor genotype has a potential to become an epidemiologically important genotype. (C) 2014 Elsevier B.V. All rights reserved.	[Thi Nguyen Hoa-Tran; Nakagomi, Toyoko; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan; [Nakagomi, Toyoko; Cunliffe, Nigel A.; Nakagomi, Osamu] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Sano, Daisuke] Hokkaido Univ, Fac Engn, Div Environm Engn, Sapporo, Hokkaido 060, Japan; [Sherchand, Jeevan B.] Tribhuvan Univ, Trop Dis Res & Prevent Ctr, Kathmandu, Nepal; [Pandey, Basu D.] Sukra Raj Trop & Infect Dis Hosp, Kathmandu, Nepal	Nakagomi, O (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	onakagom@nagasaki-u.ac.jp	Sano, Daisuke/E-5819-2011	Sano, Daisuke/0000-0001-8075-6972	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Sciences [16406016, 20406013]; Ministry of Health, Labour, and Welfare, Japan, a Grant from Japan Initiative for Global Research Network on Infectious Diseases; Global Center of Excellence Program	Thi Nguyen Hoa-Tran was a Ph.D. student supported by a scholarship from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Nigel A. Cunliffe and Miren Iturriza-Gomara involved in this study under the Agreement on Academic Partnership between the University of Liverpool and Nagasaki University. We thank Winifred Dove for her excellent technical support in strain characterization.; This study was supported in part by grants-in-aid for general scientific research by the Japan Society for the Promotion of Sciences (16406016 and 20406013 awarded to O.N.), the grants in-aid for scientific research from the Ministry of Health, Labour, and Welfare, Japan, a Grant from Japan Initiative for Global Research Network on Infectious Diseases, and a Global Center of Excellence Program, entitled Integrated Global strategy for the Control of Tropical and Emerging Infectious Diseases, awarded to Nagasaki University.	Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Bruggink LD, 2009, J MED VIROL, V81, P1652, DOI 10.1002/jmv.21582; Kim SH, 2005, J CLIN MICROBIOL, V43, P4836, DOI 10.1128/JCM..43.9.4836-4839.2005; Okada M, 2006, ARCH VIROL, V151, P1635, DOI 10.1007/s00705-006-0739-6; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Nataraju SM, 2011, EPIDEMIOL INFECT, V139, P910, DOI 10.1017/S0950268810001731; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Kaplan NM, 2011, ARCH VIROL, V156, P1477, DOI 10.1007/s00705-011-0996-x; Made D, 2013, FOOD ENVIRON VIROL, V5, P162, DOI 10.1007/s12560-013-9118-0; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Kamel AH, 2009, J CLIN MICROBIOL, V47, P1037, DOI 10.1128/JCM.01381-08; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Iritani N, 2010, J MED VIROL, V82, P2097, DOI 10.1002/jmv.21915; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Park KS, 2010, ARCH VIROL, V155, P635, DOI 10.1007/s00705-010-0627-y; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Iritani N, 2012, J MED VIROL, V84, P517, DOI 10.1002/jmv.23211; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Chan-It W, 2012, J MED VIROL, V84, P1089, DOI 10.1002/jmv.23309; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Lole KS, 1999, J VIROL, V73, P152; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Trang NV, 2012, J MED VIROL, V84, P290, DOI 10.1002/jmv.23185; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; Han T.H., 2010, ARCH VIROL, V156, P323; Hoa Iran T.N., 2013, J CLIN VIROL, V56, P269; Kirby A, 2011, TROP MED INT HEALTH, V16, P680, DOI 10.1111/j.1365-3156.2011.02756.x; Knipe DM, 2013, FIELDS VIROLOGY, V1, P582; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Medici M. C., 2014, EPIDEMIOL INFECT, V20, P1; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Nataraju Seegekote Mariyappa, 2011, Int J Mol Epidemiol Genet, V2, P130; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696	48	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	MAR	2015	30						27	36		10.1016/j.meegid.2014.12.003		10	Infectious Diseases	Infectious Diseases	CC7CN	WOS:000350525400005		
J	Yokoyama, N; Sivakumar, T; Tuvshintulga, B; Hayashida, K; Igarashi, I; Inoue, N; Long, PT; Lan, DTB				Yokoyama, Naoaki; Sivakumar, Thillaiampalam; Tuvshintulga, Bumduuren; Hayashida, Kyoko; Igarashi, Ikuo; Inoue, Noboru; Phung Thang Long; Dinh Thi Bich Lan			Genetic variations in merozoite surface antigen genes of Babesia bovis detected in Vietnamese cattle and water buffaloes	INFECTION GENETICS AND EVOLUTION			English	Article						Babesia bovis; Cattle; Genetic diversity; Merozoite surface antigen genes; Vietnam; Water buffalo	RECOMBINANT SEQUENCES; THEILERIA PARASITES; MOSAIC STRUCTURE; DNA-SEQUENCES; DAIRY-CATTLE; DIVERSITY; PROTEINS; BIGEMINA; VACCINE; BLOOD	The genes that encode merozoite surface antigens (MSAs) in Babesia bovis are genetically diverse. In this study, we analyzed the genetic diversity of B. bovis MSA-1, MSA-2b, and MSA-2c genes in Vietnamese cattle and water buffaloes. Blood DNA samples from 258 cattle and 49 water buffaloes reared in the Thua Thien Hue province of Vietnam were screened with a B. bovis-specific diagnostic PCR assay. The B. bovis-positive DNA samples (23 cattle and 16 water buffaloes) were then subjected to PCR assays to amplify the MSA-1, MSA-2b, and MSA-2c genes. Sequencing analyses showed that the Vietnamese MSA-1 and MSA-2b sequences are genetically diverse, whereas MSA-2c is relatively conserved. The nucleotide identity values for these MSA gene sequences were similar in the cattle and water buffaloes. Consistent with the sequencing data, the Vietnamese MSA-1 and MSA-2b sequences were dispersed across several clades in the corresponding phylogenetic trees, whereas the MSA-2c sequences occurred in a single clade. Cattle- and water-buffalo-derived sequences also often clustered together on the phylogenetic trees. The Vietnamese MSA-1, MSA-2b, and MSA-2c sequences were then screened for recombination with automated methods. Of the seven recombination events detected, five and two were associated with the MSA-2b and MSA-2c recombinant sequences, respectively, whereas no MSA-1 recombinants were detected among the sequences analyzed. Recombination between the sequences derived from cattle and water buffaloes was very common, and the resultant recombinant sequences were found in both host animals. These data indicate that the genetic diversity of the MSA sequences does not differ between cattle and water buffaloes in Vietnam. They also suggest that recombination between the B. bovis MSA sequences in both cattle and water buffaloes might contribute to the genetic variation in these genes in Vietnam. (C) 2015 Elsevier B.V. All rights reserved.	[Yokoyama, Naoaki; Sivakumar, Thillaiampalam; Tuvshintulga, Bumduuren; Hayashida, Kyoko; Igarashi, Ikuo; Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Phung Thang Long] Hue Univ Agr & Forestry, Hue, Vietnam; [Dinh Thi Bich Lan] Hue Univ, Inst Biotechnol, Hue, Vietnam	Yokoyama, N (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	yokoyama@obihiro.ac.jp			JSPS KAKENHI [23405041, 25660235]; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS)	We thank all the staff and farmers on the farms surveyed in Vietnam. We are also grateful to Ms. Hiroko Yamamoto, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, for her excellent technical assistance. This study was supported by grants from JSPS KAKENHI (23405041 and 25660235) and the JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS).	FIGUEROA JV, 1993, VET PARASITOL, V50, P69, DOI 10.1016/0304-4017(93)90008-B; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Simking P, 2013, VET PARASITOL, V197, P642, DOI 10.1016/j.vetpar.2013.07.015; He L, 2012, VET PARASITOL, V186, P490, DOI 10.1016/j.vetpar.2011.11.021; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Altangerel K, 2012, VET PARASITOL, V184, P309, DOI 10.1016/j.vetpar.2011.09.021; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Ramos CAN, 2012, VET PARASITOL, V187, P548, DOI 10.1016/j.vetpar.2012.01.020; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; EVERITT JI, 1986, VET PATHOL, V23, P556; Sivakumar T, 2012, VET PARASITOL, V190, P263, DOI 10.1016/j.vetpar.2012.05.014; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; SMITH JM, 1992, J MOL EVOL, V34, P126; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Sivakumar T, 2012, VET PARASITOL, V187, P17, DOI 10.1016/j.vetpar.2012.01.008; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Khukhuu A, 2011, J VET MED SCI, V73, P701, DOI 10.1292/jvms.10-0472; Berens SJ, 2005, INFECT IMMUN, V73, P7180, DOI 10.1128/IAI.73.11.7180-7189.2005; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Sivakumar T, 2013, J VET MED SCI, V75, P1455, DOI 10.1292/jvms.13-0221; LeRoith T, 2005, INFECT IMMUN, V73, P5388, DOI 10.1128/IAI.73.9.5388-5394.2005; Nagano D, 2013, J VET MED SCI, V75, P1463, DOI 10.1292/jvms.13-0251; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Bock RE, 2001, AUST VET J, V79, P832, DOI 10.1111/j.1751-0813.2001.tb10931.x; Borgonio V, 2008, ANN NY ACAD SCI, V1149, P145, DOI 10.1196/annals.1428.035; Brown WC, 1999, PARASITOL TODAY, V15, P275, DOI 10.1016/S0169-4758(99)01471-4; da Silva JB, 2013, VET PARASITOL, V197, P678, DOI 10.1016/j.vetpar.2013.05.020; Dominguez M, 2010, VET PARASITOL, V167, P216, DOI 10.1016/j.vetpar.2009.09.023; Elsify A, 2015, PARASITOL INT, V64, P79, DOI 10.1016/j.parint.2014.10.002; Florin-Christensen M, 2002, INFECT IMMUN, V70, P3566, DOI 10.1128/IAI.70.7.3566-3575.2002; Genis AD, 2008, ANN NY ACAD SCI, V1149, P121, DOI 10.1196/annals.1428.070; Genis AD, 2009, INFECT GENET EVOL, V9, P1102, DOI 10.1016/j.meegid.2009.03.012; Geurden T, 2008, VET PARASITOL, V153, P384, DOI 10.1016/j.vetpar.2008.01.031; Hau N. V., 1999, KHOA HOC KY THUAT TH, V6, P48; HINES SA, 1992, MOL BIOCHEM PARASIT, V55, P85, DOI 10.1016/0166-6851(92)90129-8; Jukes T, 1969, EVOLUTION PROTEIN MO, P21; Lau AOT, 2010, MOL BIOCHEM PARASIT, V172, P107, DOI 10.1016/j.molbiopara.2010.03.017; Molad T, 2014, VET PARASITOL, V205, P20, DOI 10.1016/j.vetpar.2014.07.016; PALMER GH, 1995, VET PARASITOL, V57, P233, DOI 10.1016/0304-4017(94)03123-E; Ristic M., 1981, Diseases of cattle in the tropics. Economic and zoonotic relevance. (Current Topics in Veterinary Medicine and Animal Science, Vol. 6.), P443; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Simuunza M, 2011, MOL BIOCHEM PARASIT, V177, P106, DOI 10.1016/j.molbiopara.2011.02.002; Sivakumar T, 2013, INFECT GENET EVOL, V19, P134, DOI 10.1016/j.meegid.2013.07.001; Smith RD, 2000, ANN NY ACAD SCI, V916, P510; Suarez C. E., 2000, INFECT IMMUN, V68, P6665; Tattiyapong M, 2014, PARASITOL INT, V63, P57, DOI 10.1016/j.parint.2013.09.003	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	MAR	2015	30						288	295		10.1016/j.meegid.2014.12.035		8	Infectious Diseases	Infectious Diseases	CC7CN	WOS:000350525400037		
J	Marco, JD; Barroso, PA; Locatelli, FM; Cajal, SP; Hoyos, CL; Nevot, MC; Lauthier, JJ; Tomasini, N; Juarez, M; Estevez, JO; Korenaga, M; Nasser, JR; Hashiguchi, Y; Ruybal, P				Marco, Jorge D.; Barroso, Paola A.; Locatelli, Fabricio M.; Cajal, S. Pamela; Hoyos, Carlos L.; Nevot, M. Cecilia; Lauthier, Juan J.; Tomasini, Nicolas; Juarez, Marisa; Estevez, J. Octavio; Korenaga, Masataka; Nasser, Julio R.; Hashiguchi, Yoshihisa; Ruybal, Paula			Multilocus sequence typing approach for a broader range of species of Leishmania genus: Describing parasite diversity in Argentina	INFECTION GENETICS AND EVOLUTION			English	Article						Leishmania; Argentina; Multilocus sequence typing	AMERICAN TEGUMENTARY LEISHMANIASIS; CYTOCHROME-B GENE; VISCERAL LEISHMANIASIS; ENZYME ELECTROPHORESIS; POPULATION-GENETICS; DONOVANI COMPLEX; SPP.; IDENTIFICATION; PHYLOGENY; EVOLUTION	Leishmaniasis is a vector-borne protozoan infection affecting over 350 million people around the world. In Argentina cutaneous leishmaniasis is endemic in nine provinces and visceral leishmaniasis is spreading from autochthonous transmission foci in seven provinces. However, there is limited information about the diversity of the parasite in this country. Implementation of molecular strategies for parasite typing, particularly multilocus sequence typing (MLST), represents an improved approach for genetic variability and population dynamics analyses. We selected six loci as candidates implemented in reference strains and Argentinean isolates. Phylogenetic analysis showed high correlation with taxonomic classification of the parasite. Autochthonous Leishmania (Viannia) braziliensis showed higher genetic diversity than L. (Leishmania) infantum but low support was obtained for intra-L. braziliensis complex variants suggesting the need of new loci that contribute to phylogenetic resolution for an improved MLST or nested-MLST scheme. This study represents the first characterization of genetic variability of Leishmania spp. in Argentina. (C) 2014 Elsevier B.V. All rights reserved.	[Marco, Jorge D.; Barroso, Paola A.; Lauthier, Juan J.; Tomasini, Nicolas] Univ Nacl Salta, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Salud, Inst Patol Expt, Salta, Argentina; [Marco, Jorge D.; Barroso, Paola A.; Cajal, S. Pamela; Hoyos, Carlos L.; Juarez, Marisa; Nasser, Julio R.] Univ Nacl Salta, Sede Reg Oran, Inst Invest Enfermedades Trop, San Ramon De La Nueva Or, Salta, Argentina; [Locatelli, Fabricio M.; Korenaga, Masataka; Hashiguchi, Yoshihisa] Kochi Univ, Kochi Med Sch, Dept Parasitol, Nankoku, Kochi 7838505, Japan; [Nevot, M. Cecilia; Estevez, J. Octavio] Vet Oeste, Misiones, Argentina; [Hashiguchi, Yoshihisa] Univ Cent Ecuador & Proyecto Prometeo, Ctr Biomed, Quito, Ecuador; [Ruybal, Paula] Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, Consejo Nacl Invest Cient & Tecn, RA-1053 Buenos Aires, DF, Argentina	Ruybal, P (reprint author), Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, IMPAM, CONICET UBA,Fac Med, Paraguay 2155,Piso 13, RA-1053 Buenos Aires, DF, Argentina.	diegomarcoar@gmail.com; paobarar@yahoo.com; fm.locatelli@gmail.com; spcajal@yahoo.com.ar; carloslhoyos@gmail.com; cecilianevot@yahoo.com.ar; juanjoselauthier@gmail.com; biol.nicolas.tomasini@gmail.com; marjualu@yahoo.com.ar; octavioes2003@yahoo.com.ar; korenaga@kochi-u.ac.jp; jrnasser@hotmail.com; yhashiguchi42@yahoo.co.jp; pruybal@gmail.com			National Agency for Science and Technology, Argentina [PICT 2009-0135, PICTO-GLAXO 2011-0017]; Research Council of the National University of Salta [2041]	Financial support was obtained from the National Agency for Science and Technology, Argentina (PICT 2009-0135, PICTO-GLAXO 2011-0017); The Research Council of the National University of Salta (Grant No. 2041).	Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Gould IT, 2013, MEDICINA-BUENOS AIRE, V73, P104; Fraga J, 2013, INFECT GENET EVOL, V18, P229, DOI 10.1016/j.meegid.2013.05.020; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Luyo-Acero GE, 2004, PARASITOLOGY, V128, P483, DOI 10.1017/S0031182004004792; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Barrio A, 2012, EMERG INFECT DIS, V18, P354, DOI [10.3291/eid1802.110924, 10.3201/eid1802.110924]; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Marco JD, 2005, AM J TROP MED HYG, V72, P606; Marco JD, 2006, AM J TROP MED HYG, V75, P256; Zemanova E, 2007, INT J PARASITOL, V37, P149, DOI 10.1016/j.ijpara.2006.08.008; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; Azmi K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002464; Boite MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001888; Control of the Leishmaniases, 2010, M WHO EXP COMM CONTR; El Baidouri F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002255; Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242; Frank FM, 2003, PARASITOLOGY, V126, P31, DOI 10.1017/S0031182002002585; Kulhs K., 2011, PLOS NEGLECT TROP D, V5, pe1155; Locatelli FM, 2014, ACTA TROP, V131, P16, DOI 10.1016/j.actatropica.2013.11.015; Marco JD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-191; Salomon OD, 2001, MEDICINA-BUENOS AIRE, V61, P284; Tsukayama P, 2009, INT J PARASITOL, V39, P355, DOI 10.1016/j.ijpara.2008.08.004	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	MAR	2015	30						308	317		10.1016/j.meegid.2014.12.031		10	Infectious Diseases	Infectious Diseases	CC7CN	WOS:000350525400039		
J	Mizoguchi, A; Kamimura, M; Kiuchi, M; Kataoka, H				Mizoguchi, Akira; Kamimura, Manabu; Kiuchi, Makoto; Kataoka, Hiroshi			Positive feedback regulation of prothoracicotropic hormone secretion by ecdysteroid - A mechanism that determines the timing of metamorphosis	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Prothoracicotropic hormone; Ecdysteroid; Positive feedback; Metamorphosis; Bombyx mori	SILKWORM BOMBYX-MORI; LAST-LARVAL INSTAR; JUVENILE-HORMONE; ENDOCRINE EVENTS; TEMPORAL ORGANIZATION; TOBACCO HORNWORM; MANDUCA-SEXTA; PUPAL METAMORPHOSIS; ECDYSONE SECRETION; ADULT DEVELOPMENT	When insect larvae have fully grown, prothoracicotropic hormone (PTTH) is released from the brain, triggering the initiation of metamorphic development through stimulation of ecdysteroid secretion by the prothoracic glands. The present study analyzes the mechanism that regulates the occurrence of this PTTH surge. In the silkworm Bombyx mori, the PITH surge occurs on day 6 of the fifth instar and is preceded by a small rise in hemolymph ecdysteroid titer, which occurs late on day 5. We therefore hypothesized that this rise of ecdysteroid titer is involved in the induction of the PITH surge. To test this hypothesis, two experiments were conducted. First, a small amount of 20-hydroxyecdysone was injected on day 4, two days before the expected day of the PITH surge, to simulate the small rise in hemolymph ecdysteroid titer on day 5. This injection led to a precocious surge of PITH the next day. Next, the hemolymph ecdysteroid titer on day 5 was artificially lowered by injecting ecdysteroid-22-oxidase, which inactivates 20-hydroxyecdysone. After this treatment, the PITH surge did not occur on day 6 in 80% of the animals. These results indicate that a small rise of the hemolymph ecdysteroid titer plays a critical role in the induction of the PITH surge. Since basal ecdysteroidogenic activity of the prothoracic glands increases with larval growth, a circulating level of ecdysteroids may convey information about larval maturity to the brain, to coordinate larval growth and metamorphosis. This is the first report in invertebrates to demonstrate positive feedback regulation of the surge of a tropic hormone by a downstream steroid hormone. (C) 2015 Elsevier Ltd. All rights reserved.	[Mizoguchi, Akira] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kamimura, Manabu; Kiuchi, Makoto] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Mizoguchi, A (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	mizoguch@bio.nagoya-u.ac.jp			JSPS KAKENHI Grant [26660266]	We thank Dr. Megumi Fuse, San Francisco State University, for critical reading of the manuscript. This work was supported in part by JSPS KAKENHI Grant number 26660266.	Akai H., 1971, Applied Entomology and Zoology, V6, P138; SAKURAI S, 1989, GEN COMP ENDOCR, V75, P222, DOI 10.1016/0016-6480(89)90074-9; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; SAFRANEK L, 1980, BIOL BULL, V158, P248, DOI 10.2307/1540934; Sakurai S, 1998, J INSECT PHYSIOL, V44, P867, DOI 10.1016/S0022-1910(98)00075-4; OKUDA M, 1985, J INSECT PHYSIOL, V31, P455, DOI 10.1016/0022-1910(85)90092-7; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Gu SH, 1997, MOL CELL ENDOCRINOL, V127, P109, DOI 10.1016/S0303-7207(96)03995-0; Mahesh VB, 1998, STEROIDS, V63, P616, DOI 10.1016/S0039-128X(98)00075-0; Mizoguchi A, 2001, J INSECT PHYSIOL, V47, P767, DOI 10.1016/S0022-1910(01)00052-X; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; JUNGREIS AM, 1973, J INSECT PHYSIOL, V19, P225, DOI 10.1016/0022-1910(73)90235-7; TRUMAN JW, 1972, J EXP BIOL, V57, P805; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73; Bollenbacher W.E., 1985, P109; CYMBOROWSKI B, 1979, J INSECT PHYSIOL, V25, P939, DOI 10.1016/0022-1910(79)90106-9; FUJISHITA M, 1982, J INSECT PHYSIOL, V28, P77, DOI 10.1016/0022-1910(82)90025-7; Gilbert Lawrence I., 1996, P59; Gu SH, 2005, J EXP ZOOL PART A, V303A, P249, DOI 10.1002/jez.a.142; HIKINO H, 1975, J INSECT PHYSIOL, V21, P1953, DOI 10.1016/0022-1910(75)90228-0; Hone Y., 1971, J SERIC SCI JPN, V40, P330; ISHIBASHI J, 1994, BIOCHEMISTRY-US, V33, P5912, DOI 10.1021/bi00185a031; Kamimura M, 1998, APPL ENTOMOL ZOOL, V33, P333; Kamimura M, 2012, J BIOL CHEM, V287, P16488, DOI 10.1074/jbc.M112.341180; KIGUCHI K, 1983, JARQ-JPN AGR RES Q, V17, P41; Kiuchi M, 2003, ARCH INSECT BIOCHEM, V52, P35, DOI 10.1002/arch.10060; MIZOGUCHI A, 1990, DEV GROWTH DIFFER, V32, P591; Mizoguchi A, 2002, GEN COMP ENDOCR, V127, P181, DOI 10.1016/S0016-6480(02)00043-6; Mizoguchi A, 2005, J INSECT PHYSIOL, V51, P871, DOI 10.1016/j.jinsphys.2005.04.002; Niimi S, 1997, J INSECT PHYSIOL, V43, P875, DOI 10.1016/S0022-1910(97)00021-8; SAKURAI S, 1983, J INSECT PHYSIOL, V29, P919, DOI 10.1016/0022-1910(83)90055-0; SAKURAI S, 1989, GEN COMP ENDOCR, V75, P204, DOI 10.1016/0016-6480(89)90072-5; SAKURAI S, 1984, J INSECT PHYSIOL, V30, P657, DOI 10.1016/0022-1910(84)90051-9; SEHNAL F, 1981, J INSECT PHYSIOL, V27, P535, DOI 10.1016/0022-1910(81)90041-X; Vafopoulou X, 1996, GEN COMP ENDOCR, V102, P123, DOI 10.1006/gcen.1996.0053	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	MAR	2015	58						39	45		10.1016/j.ibmb.2015.01.001		7	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CC9SH	WOS:000350711000004		
J	Mitsudome, T; Mon, H; Xu, J; Li, ZQ; Lee, JM; Patil, AA; Masuda, A; Iiyama, K; Morokuma, D; Kusakabe, T				Mitsudome, Takumi; Mon, Hiroaki; Xu, Jian; Li, Zhiqing; Lee, Jae Man; Patil, Anandrao Ashok; Masuda, Atsushi; Iiyama, Kazuhiro; Morokuma, Daisuke; Kusakabe, Takahiro			Biochemical characterization of maintenance DNA methyltransferase DNMT-1 from silkworm, Bombyx mori	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						DNA methylation; Maintenance methylation; DNA methyltransferase-1; Dimerization; Bombyx mori; MspJI	DEPENDENT RESTRICTION ENDONUCLEASES; HEMIMETHYLATED CPG SITES; MURINE DNA; DE-NOVO; CYTOSINE-C-5 METHYLTRANSFERASE; SPODOPTERA-FRUGIPERDA; RNA INTERFERENCE; CATALYTIC DOMAIN; METHYLATION; PURIFICATION	DNA methylation is an important epigenetic mechanism involved in gene expression of vertebrates and invertebrates. In general, DNA methylation profile is established by de novo DNA methyltransferases (DNMT-3A, -3B) and maintainance DNA methyltransferase (DNMT-1). DNMT-1 has a strong substrate preference for hemimethylated DNA over the unmethylated one. Because the silkworm genome lacks an apparent homologue of de novo DNMT, it is still unclear that how silkworm chromosome establishes and maintains its DNA methylation profile. As the first step to unravel this enigma, we purified recombinant BmDNMT-1 using baculovirus expression system and characterized its DNA-binding and DNA methylation activity. We found that the BmDNMT-1 preferentially methylates hemimethylated DNA despite binding to both unmethylated and hemimethylated DNA. Interestingly, BmDNMT-1 formed a complex with DNA in the presence or absence of methyl group donor, S-Adenosylmethionine (AdoMet) and the AdoMet-dependent complex formation was facilitated by Zn2+ and Mn2+. Our results provide clear evidence that BmDNMT-1 retained the function as maintenance DNMT but its sensitivity to metal ions is different from mammalian DNMT-1. (C) 2015 Elsevier Ltd. All rights reserved.	[Mitsudome, Takumi; Mon, Hiroaki; Xu, Jian; Li, Zhiqing; Lee, Jae Man; Patil, Anandrao Ashok; Masuda, Atsushi; Morokuma, Daisuke; Kusakabe, Takahiro] Kyushu Univ, Lab Insect Genome Sci, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Iiyama, Kazuhiro] Kyushu Univ, Inst Biol Control, Fac Agr, Lab Insect Pathol & Microbial Control,Grad Sch, Fukuoka 8128581, Japan	Kusakabe, T (reprint author), Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	kusakabe@agr.kyushu-u.ac.jp	Xu, Jian/G-6684-2015		KAKENHI from the Japan Society for the Promotion of Science [26660269]	This work was supported in part by a grant KAKENHI No. 26660269 from the Japan Society for the Promotion of Science.	Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Xu J, 2013, APPL MICROBIOL BIOT, V97, P10435, DOI 10.1007/s00253-013-5279-x; Flynn J, 1998, J MOL BIOL, V279, P101, DOI 10.1006/jmbi.1998.1761; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Chen CC, 2013, J BIOL CHEM, V288, P9084, DOI 10.1074/jbc.M112.445585; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Li-Byarlay H, 2013, P NATL ACAD SCI USA, V110, P12750, DOI 10.1073/pnas.1310735110; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Kar S, 2012, EPIGENETICS-US, V7, P994, DOI 10.4161/epi.21568; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Mitsudome T, 2014, APPL BIOCHEM BIOTECH, V172, P3978, DOI 10.1007/s12010-014-0814-5; Bashtrykov R., 2014, CHEMBIOCHEM, V15, P743; BOLDEN A, 1984, J BIOL CHEM, V259, P2437; Brank AS, 2002, PROTEIN EXPRES PURIF, V25, P31, DOI 10.1006/prep.2001.1606; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; Glickman JF, 1997, BIOCHEM BIOPH RES CO, V230, P280, DOI 10.1006/bbrc.1996.5943; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Huang X., 2013, BMC GENET, V14; Jurkowski T. P., 2011, PLOS ONE, V6; Krauss V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007223; Kucharski R, 2008, SCIENCE, V319, P1827; Li SS, 2013, J MOL CELL BIOL, V5, P64, DOI 10.1093/jmcb/mjs057; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Ryazanova A. Yu., 2012, METHYLATION DNA RNA; Wang V., 2006, SCIENCE, V314, P645; Xiang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-646; Yokochi T, 2004, BIOORG CHEM, V32, P234, DOI 10.1016/j.bioorg.2004.04.005	47	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	MAR	2015	58						55	65		10.1016/j.ibmb.2015.01.008		11	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CC9SH	WOS:000350711000006		
J	Kuriyama, A; Umakoshi, N; Fujinaga, J; Takada, T				Kuriyama, Akira; Umakoshi, Noriyuki; Fujinaga, Jun; Takada, Tadaaki			Impact of closed versus open tracheal suctioning systems for mechanically ventilated adults: a systematic review and meta-analysis	INTENSIVE CARE MEDICINE			English	Review						Endotracheal suctioning; Closed tracheal suctioning systems; Adults; Ventilator-associated pneumonia; Meta-analysis; Systematic review; Trial sequential analysis	RANDOMIZED CONTROLLED-TRIALS; NOSOCOMIAL PNEUMONIA; INFORMATION SIZE; PREVENTION; MORTALITY; CONTAMINATION; CONSEQUENCES; CATHETERS; COSTS	Whether closed tracheal suctioning systems (CTSS) reduce the incidence of ventilator-associated pneumonia (VAP) compared with open tracheal suctioning systems (OTSS) is inconclusive. We conducted a systematic review and meta-analysis of randomized controlled trials that compared CTSS and OTSS. PubMed, the Cochrane Central Register of Controlled Trials, the Web of Science, Google Scholar, and a clinical trial registry from inception to October 2014 were searched without language restrictions. Randomized controlled trials of CTSS and OTSS that compared VAP in mechanically ventilated adult patients were included. The primary outcome was the incidence of VAP. Secondary outcomes were mortality and length of mechanical ventilation. Data were pooled using the random effects model. Sixteen trials with 1,929 participants were included. Compared with OTSS, CTSS was associated with a reduced incidence of VAP (RR 0.69; 95 % CI 0.54-0.87; Q = 26.14; I (2) = 46.4 %). Compared with OTSS, CTSS was not associated with reduction of mortality (RR 0.96; 95 % CI 0.83-1.12; Q = 2.27; I (2) = 0.0 %) or reduced length of mechanical ventilation (WMD -0.45 days; 95 % CI -1.25 to 0.36; Q = 6.37; I (2) = 5.8 %). Trial sequential analysis suggested a lack of firm evidence for 20 % RR reduction in the incidence of VAP. The limitations of this review included underreporting and low quality of the included trials, as well as variations in study procedures and characteristics. Based on current, albeit limited evidence, it is unlikely that CTSS is inferior to OTSS regarding VAP prevention; however, further trials at low risk of bias are needed to confirm or refute this finding.	[Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama 7108602, Japan; [Umakoshi, Noriyuki; Fujinaga, Jun] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama 7108602, Japan; [Takada, Tadaaki] Urasoe Gen Hosp, Dept Emergency & Crit Care Med, Okinawa, Japan	Kuriyama, A (reprint author), Kurashiki Cent Hosp, Dept Gen Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	nrk40448@nifty.com					Adams D H, 1997, Intensive Crit Care Nurs, V13, P72, DOI 10.1016/S0964-3397(97)80135-8; Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Association of Respiratory Care, 2010, RESP CARE, V55, P758; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Cereda M, 2001, INTENS CARE MED, V27, P648, DOI 10.1007/s001340100897; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Maggiore SM, 2003, AM J RESP CRIT CARE, V167, P1215, DOI 10.1164/rccm.200203-1950C; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Jongerden IP, 2007, CRIT CARE MED, V35, P260, DOI 10.1097/01.CCM.0000251126.45980.E8; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Egger M, 1997, BRIT MED J, V315, P629; Lorente L, 2005, CRIT CARE MED, V33, P115, DOI 10.1097/01.CCM.0000150267.40396.90; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Muscedere J, 2008, J CRIT CARE, V23, P126, DOI 10.1016/j.jcrc.2007.11.014; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Vonberg RP, 2006, INTENS CARE MED, V32, P1329, DOI 10.1007/s00134-006-0241-3; JOHNSON KL, 1994, CRIT CARE MED, V22, P658, DOI 10.1097/00003246-199404000-00023; Lorente L, 2006, INTENS CARE MED, V32, P538, DOI 10.1007/s00134-005-0057-6; Dodek P, 2004, ANN INTERN MED, V141, P305; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Muscedere J, 2011, CRIT CARE MED, V39, P1985, DOI 10.1097/CCM.0b013e318218a4d9; Kollef MH, 1997, AM J RESP CRIT CARE, V156, P466; Apostolopoulou Eleni, 2003, Respir Care, V48, P681; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; COBLEY M, 1991, ANAESTHESIA, V46, P957, DOI 10.1111/j.1365-2044.1991.tb09858.x; Combes P, 2000, INTENS CARE MED, V26, P878, DOI 10.1007/s001340051276; Conrad SA, 1989, CHEST, V96, p184S; Darvas Jenny A, 2003, Aust Crit Care, V16, P86, DOI 10.1016/S1036-7314(03)80005-X; David D, 2011, J CRIT CARE, V26, P482, DOI 10.1016/j.jcrc.2010.10.002; DEPPE SA, 1990, CRIT CARE MED, V18, P1389, DOI 10.1097/00003246-199012000-00016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fakhar HRE, 2010, SCI J KURD UNIV MED, V15, P79; Hess Dean R, 2003, Respir Care, V48, P869; Higgins JPT., 2008, COCHRANE HANDBOOK FO; Lee Eun-Sook, 2004, Taehan Kanho Hakhoe Chi, V34, P1315; Li JQ, 2007, J NURS SCI, V12, P20; Niel-Weise BS, 2007, INFECT CONT HOSP EP, V28, P531, DOI 10.1086/513726; Overend Tom J, 2009, Can Respir J, V16, pe6; Peter John Victor, 2007, Indian J Med Sci, V61, P201; Rabitsch W, 2004, ANESTH ANALG, V99, P886, DOI 10.1213/01.ANE.0000131973.99804.61; Rello J, 1997, CRIT CARE MED, V25, P1862, DOI 10.1097/00003246-199711000-00026; Siempos II, 2008, BRIT J ANAESTH, V100, P299, DOI 10.1093/bja/aem403; Subirana M, 2007, THE COCHRANE DATABAS; Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Topeli A, 2004, J HOSP INFECT, V58, P14, DOI 10.1016/j.jhin.2004.05.005; Torres A, 2001, EUR RESPIR J, V17, P1034; Wang L, 2006, SHAN DONG YI YAO, V46, P50; Welte T, 1997, EUROPEAN RESP J S, V10, P319; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Zeitoun SS, 2003, J CLIN NURS, V12, P484; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	55	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAR	2015	41	3					402	411		10.1007/s00134-014-3565-4		10	Critical Care Medicine	General & Internal Medicine	CC9MS	WOS:000350695300002		
J	Matsui, H; Kitamura, M; Kurosaka, N; Honma, H				Matsui, Hikoro; Kitamura, Masatomo; Kurosaka, Norimasa; Honma, Hitoshi			Transhepatic diaphragm echography for diaphragm paralysis in infants	INTENSIVE CARE MEDICINE			English	Editorial Material									[Matsui, Hikoro; Kitamura, Masatomo; Kurosaka, Norimasa; Honma, Hitoshi] Nagano Childrens Hosp, Dept Pediat Intens Care, Azumino City, Nagano 3998288, Japan	Matsui, H (reprint author), Nagano Childrens Hosp, Dept Pediat Intens Care, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	hikoromatsui@googlemail.com						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAR	2015	41	3					523	524		10.1007/s00134-014-3547-6		2	Critical Care Medicine	General & Internal Medicine	CC9MS	WOS:000350695300020		
J	Koide, N; Kaneda, A; Yokochi, T; Umezawa, K				Koide, Naoki; Kaneda, Ayumi; Yokochi, Takashi; Umezawa, Kazuo			Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-kappa B inhibitor DTCM-glutarimide	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Osteoclastogenesis; DTCM-glutarimide; RANKL; LPS; Akt; NF-kappa B	GLYCOGEN-SYNTHASE KINASE-3; NFATC1 INDUCTION; DOWN-REGULATION; NUCLEAR-FACTOR; BONE; ACTIVATION; LIGAND; REQUIRES; BINDING; CELLS	We have isolated 9-methylstreptimidone from microorganism as a new NF-kappa B inhibitor. Later, we designed 3-[(dodecylthiocarbonyl) methyl]-glutarimide (DTCM-glutarimide) as an analog of this compound, which shows anti-inflammatory activity in vivo. In the present research, we found that DTCM-glutarimide inhibited receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclast differentiation of mouse bone marrow-derived macrophages and RANKL- or lipopolysaccharide (LPS)-induced osteoclast differentiation of RAW 264.7 cells without any toxicity. It also inhibited the RANKL-induced NFATc1 expression. Upstream signaling involving phosphorylation of Akt and GSK-3 beta was induced by RANKL, of which the signaling was inhibited by DTCM-glutarimide. Then DTCM-glutarimide was confirmed to inhibit RANKL-induced NF-kappa B activity, possibly by inhibiting the Akt-mediated activation of IKK. Thus, DTCM-glutarimide inhibited osteodastogenesis by blocking both the Akt-GSK3 beta-NFATc1 and NF-kappa B-NFATc1 pathways. DTCM-glutarimide may be a candidate as a chemotherapeutic agent for severe bone resorption diseases. (C) 2015 Elsevier B.V. All rights reserved.	[Koide, Naoki; Yokochi, Takashi] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Kaneda, Ayumi] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2230061, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, Nagakute, Aichi 4801195, Japan	Umezawa, K (reprint author), Aichi Med Univ, Sch Med, Dept Mol Target Med, Nagakute, Aichi 4801195, Japan.	umezawa@aichi-med-u.ac.jp			MEXT [B 23310163]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, Aichi Medical University [S1101027]	This work was supported in part by grants from the programs Grants-in-Aid for Scientific Research (B 23310163) from MEXT and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, Aichi Medical University, for the years 2011-2015 (S1101027).	Abu-Amer Y, 2001, J BIOL CHEM, V276, P30449; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Takayanagi H, 2005, J MOL MED-JMM, V83, P170, DOI 10.1007/s00109-004-0612-6; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wagner EF, 2003, ANN RHEUM DIS, V62, P83; Ishikawa Y, 2009, BIOORG MED CHEM LETT, V19, P1726, DOI 10.1016/j.bmcl.2009.01.107; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Ozes ON, 1999, NATURE, V401, P82; Takeiri M, 2011, INFLAMM RES, V60, P879, DOI 10.1007/s00011-011-0348-z; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; BURGER EH, 1982, J EXP MED, V156, P1604, DOI 10.1084/jem.156.6.1604; Chow W, 2008, EXP CELL RES, V314, P2919, DOI 10.1016/j.yexcr.2008.07.010; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, P131; Clohisy JC, 2003, J IMMUNOL, V171, P5547; El-Salhy M, 2014, SCI WORLD J, V1, P804; Kaneda A, 2012, CREATIVE SURG ONCOLO, V1, P4; Koide N, 2014, IMMUNOL LETT, V161, P31, DOI 10.1016/j.imlet.2014.04.006; Matsuo Koichi, 2004, Keio Journal of Medicine, V53, P78, DOI 10.2302/kjm.53.78; Moon JB, 2011, J IMMUNOL, V188, P163; Park CK, 2008, BIOCHEM PHARMACOL, V75, P2175, DOI 10.1016/j.bcp.2008.03.007; Shibasaki S, 2013, TRANSPLANTATION, V95, P542, DOI 10.1097/TP.0b013e31827b3d90; Wang ZC, 2006, HETEROCYCLES, V69, P377; Zaitsu M, 2015, TRANSPLANTA IN PRESS	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAR	2015	25	1					162	168		10.1016/j.intimp.2015.01.004		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CD2UL	WOS:000350934400020		
J	Funakoshi-Tago, M; Okamoto, K; Izumi, R; Tago, K; Yanagisawa, K; Narukawa, Y; Kiuchi, F; Kasahara, T; Tamura, H				Funakoshi-Tago, Megumi; Okamoto, Kazuhi; Izumi, Rika; Tago, Kenji; Yanagisawa, Ken; Narukawa, Yuji; Kiuchi, Fumiyuld; Kasahara, Tadashi; Tamura, Hiroomi			Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Propolis; Flavonoid; IL-33; NF-kappa B; IKK; Anti-inflammatory activity	NF-KAPPA-B; INDUCED NUCLEAR TRANSLOCATION; TUMOR-NECROSIS-FACTOR; MAST-CELLS; INFLAMMATORY MEDIATORS; CHEMICAL-CONSTITUENTS; ACTIVATION; ALPHA; EXPRESSION; CYTOKINE	Propolis has been used in folk medicine to improve health and prevent inflammatory diseases; however, the components that exhibit its anti-inflammatory activity remain unknown. We herein investigated the effects of flavonoids isolated from Nepalese propolis on the IL-33 signaling pathway to clarify the anti-inflammatory mechanism involved. Of the 8 types of flavonoids isolated from Nepalese propolis, 4 types of compounds, such as 3',4'-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin, markedly inhibited the IL-33-induced mRNA expression of inflammatory genes including IL-6, TNF alpha. and IL-13 in bone marrow-derived mast cells (BMMC). These four flavonoids also inhibited the IL-33-induced activation of nudear factor kappa B (NF-kappa B), which was consistent with their inhibitory effects on cytokine expression. The effects of these flavonoids are attributed to inhibition of IL-33-induced activation of IKK, which leads to the degradation of I kappa B alpha and nuclear localization of NF-kappa B. On the other hand, other flavonoids isolated from Nepalese propolis, such as isoliquiritigenin, plathymenin, 7-hydroxyflavanone, and (+)-medicarpin, had no effect on the IL-33 signaling pathway or cytokine expression. Therefore, these results indicate that 3',4'-dihydroxy-4-methoxydalbergione, 4-methoxydalbergion, cearoin, and chrysin are the substances responsible for the anti-inflammatory activity of Nepalese propolis. (C) 2015 Elsevier B.V. All rights reserved.	[Funakoshi-Tago, Megumi; Okamoto, Kazuhi; Izumi, Rika; Narukawa, Yuji; Kiuchi, Fumiyuld; Kasahara, Tadashi; Tamura, Hiroomi] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji; Yanagisawa, Ken] Jichi Med Univ, Sch Med, Dept Biochem, Div Struct Biochem, Shimotsuke, Tochigi 3290498, Japan	Funakoshi-Tago, M (reprint author), Keio Univ, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp			MEXT [25460073]; Takeda Science Foundation; Uehara Memorial Foundation; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	We thank Dr. Kazuo Umezawa (School of Medicine, Aichi Medical University) for the gift of DHMEQ. This work was supported in part by grants (25460073) from MEXT, Takeda Science Foundation, Uehara Memorial Foundation, and Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research. This work was also supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	All S, 2007, P NATL ACAD SCI USA, V104, P18660; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Bae Y, 2011, TOXICOL APPL PHARM, V254, P56, DOI 10.1016/j.taap.2011.04.008; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Mamadalieva NZ, 2011, J PHARM PHARMACOL, V63, P1346, DOI 10.1111/j.2042-7158.2011.01336.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Yanaba K, 2011, CLIN RHEUMATOL, V30, P825, DOI 10.1007/s10067-011-1686-5; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Ariga A, 2002, J BIOL CHEM, V277, P24625, DOI 10.1074/jbc.M112063200; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; Ben Sghaier M, 2011, ENVIRON TOXICOL PHAR, V32, P336, DOI 10.1016/j.etap.2011.07.003; Ragazzon PA, 2009, ANTICANCER RES, V29, P2273; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; Beyaert R, 1996, EMBO J, V15, P1914; Rodriguez J, 2002, MELANOMA RES, V12, P99, DOI 10.1097/00008390-200204000-00001; Li X, 2010, CANCER LETT, V293, P109, DOI 10.1016/j.canlet.2010.01.002; Shrestha SP, 2007, CHEM PHARM BULL, V55, P926, DOI 10.1248/cpb.55.926; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Shrestha SP, 2007, J NAT MED, V61, P73, DOI 10.1007/s11418-006-0024-8; de Farias JHC, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/951478; DOKTER WHA, 1995, LEUKEMIA, V9, P425; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Kempuraj D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056866; Nakamura R, 2010, INT IMMUNOPHARMACOL, V10, P1107, DOI 10.1016/j.intimp.2010.06.013; Neiva KG, 2014, DENT TRAUMATOL, V30, P362, DOI 10.1111/edt.12096; Pastorelli I., 2010, P NATL ACAD SCI USA, V107, P8017; PEARCE FL, 1984, J ALLERGY CLIN IMMUN, V73, P819, DOI 10.1016/0091-6749(84)90453-6; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Teerasripreecha D, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-27	47	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAR	2015	25	1					189	198		10.1016/j.intimp.2015.01.012		10	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CD2UL	WOS:000350934400024		
J	Umbrello, D; Rotella, G; Matsumura, T; Musha, Y				Umbrello, D.; Rotella, G.; Matsumura, T.; Musha, Y.			Evaluation of microstructural changes by X-ray diffraction peak profile and focused ion beam/scanning ion microscope analysis	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Hard machining; Cryogenic cooling; Surface integrity; AISI 52100; FIB-SIM; XRD	WHITE LAYER FORMATION; AISI-52100 STEEL; SURFACES; BEHAVIOR; DRY	Microstructure in subsurface is investigated to understand the effect of cryogenic coolant in hard machining of hardened AISI 52100 bearing steel. The cutting experiments were performed under dry and cryogenic cooling conditions using cubic boron nitride (CBN) tool inserts. The change in the microstructure was analyzed at varying of the tool shape and cutting speed for different initial hardness of the workpiece. The machined surfaces and subsurface were analyzed by several investigation techniques. The affected layer depth was observed with a scanning electron microscope (SEM), while the phase composition was analyzed by X-ray diffraction (XRD). The grain size has been directly measured with a focused ion beam and scanning ion microscope (FIB-SIM) and compared with an indirect method of analysis: X-ray diffraction peak profile (XDPP). The experimental results show that the microstructural phase strongly depends on the cutting process parameters. Furthermore, when the cryogenic cooling is applied, martensitic structure disappears in some cases. The grain size on the machined surfaces is also influenced by the material properties and the process parameters. In addition, it is demonstrated that the XDPP indirect method for grain size analysis is a valid alternative to the direct method.	[Umbrello, D.; Rotella, G.] Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, CS, Italy; [Matsumura, T.; Musha, Y.] Tokyo Denki Univ, Dept Mech Engn, Adachi Ku, Tokyo 1208551, Japan	Umbrello, D (reprint author), Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, CS, Italy.	domenico.umbrello@unical.it	Umbrello, Domenico/C-5519-2012				Chou YK, 1999, INT J MACH TOOL MANU, V39, P1863, DOI 10.1016/S0890-6955(99)00036-X; Guo YB, 2004, INT J MACH TOOL MANU, V44, P135, DOI 10.1016/j.ijmachtools.2003.10.009; Ramesh A, 2005, MAT SCI ENG A-STRUCT, V390, P88, DOI 10.1016/j.msea.2004.08.052; Ramesh A, 2008, INT J MACH TOOL MANU, V48, P402, DOI 10.1016/j.ijmachtools.2007.09.007; Umbrello D, 2012, CIRP ANN-MANUF TECHN, V61, P103, DOI 10.1016/j.cirp.2012.03.052; WARREN BE, 1959, PROG MET PHYS, V8, P147, DOI 10.1016/0502-8205(59)90015-2; Barry J, 2002, J MAT SCI ENG A, V25, P356; GRIFFITHS BJ, 1985, J TRIBOL-T ASME, V107, P165; Gubicza J, 2007, Z KRISTALLOGR, V222, P567, DOI 10.1524/zkri.2007.222.11.567; Guo YB, 2004, T NAMRI SME, V32, P367; Howard SA, 1989, REV MINERALOGY, V20; Jayal AD, 2010, T NAMRI SME, V38, P57; Joint Committee on Powder Diffraction Standards (JCPDS), 1990, POWD DIFFR FIL, P283; Joint Committee on Powder Diffraction Standards (JCPDS), 1980, POWD DIFFR FIL IN VO, P150; Klug H.P., 1974, XRAY DIFFRACTION PRO; Konig W, 1990, CIRP ANN-MANUF TECHN, V57, P61; Laitilia EA, 2008, JCPDS INT CTR DIFFRA, P104; Ribarik G, 2004, MAT SCI ENG A-STRUCT, V387, P343, DOI 10.1016/j.msea.2004.01.089; Rotella G, 2012, SUSTAINABLE MANUFACT, P95; Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98; Umbrello D, 2012, MATER SCI TECH-LOND, V28, P205, DOI 10.1179/1743284711Y.0000000020; Umbrello D, 2013, INT J ADV MANUF TECH, V64, P633, DOI 10.1007/s00170-012-4073-8; Umbrello D, 2012, MATER SCI TECH-LOND, V28, P1320, DOI 10.1179/1743284712Y.0000000052; Ungar T, 2004, SCRIPTA MATER, V51, P777, DOI 10.1016/j.scriptamat.2004.05.007; Van der Gaast SJ, 1981, CLAY MINER, P383; Wang Y, 1999, WEAR, V231, P20, DOI 10.1016/S0043-1648(99)00117-9; Warren AW, 2006, SURF COAT TECH, V200, P3459, DOI 10.1016/j.surfcoat.2004.12.028; Zurecki Z., 2003, ASME INT MECH ENG C, P16	28	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	MAR	2015	77	5-8					1465	1474		10.1007/s00170-014-6471-6		10	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CC1RK	WOS:000350120000055		
J	Suzuki, T; Liang, B; Yamaguchi, T; Sumi, H; Hamamoto, K; Fujishiro, Y; Sammes, NM				Suzuki, Toshio; Liang, Bo; Yamaguchi, Toshiaki; Sumi, Hirofumi; Hamamoto, Koichi; Fujishiro, Yoshinobu; Sammes, Nigel M.			Performance of Ni-Based Anode-Supported SOFCs with Doped Ceria Electrolyte at Low Temperatures Between 294 and 542 degrees C	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article							OXIDE FUEL-CELLS; INTERMEDIATE-TEMPERATURE; FABRICATION; MEMBRANES; CATHODE; STACK; FILM	The performance of a conventional anode-supported microtubular SOFC using doped ceria as an electrolyte and Ni-based cermet as an anode is evaluated at low operating temperature between 294 and 542 degrees C. An open-circuit voltage (OCV) of >0.9V is obtained at all measured operating temperatures, and power generation is observed at temperatures as low as 294 degrees C. The power density of the cell is 0.6W/cm(2) at 542 degrees C operating temperature with 47% fuel utilization and is 5mW/cm(2) at 294 degrees C operating temperature with an open-circuit voltage of 0.95V. According to impedance spectroscopy, a greater influence of gas flow rate, on the cell performance, is observed at higher operating temperature.	[Suzuki, Toshio; Liang, Bo; Yamaguchi, Toshiaki; Sumi, Hirofumi; Hamamoto, Koichi; Fujishiro, Yoshinobu; Sammes, Nigel M.] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Sammes, Nigel M.] POSTECH, Dept Chem Engn, Pohang 790784, Gyeongbuk, South Korea	Suzuki, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora Shimo Shidami, Nagoya, Aichi 4638560, Japan.	toshio.suzuki@aist.go.jp	Sumi, Hirofumi/B-5403-2012	Sumi, Hirofumi/0000-0002-8439-0127			Kendall K, 1998, J POWER SOURCES, V71, P268, DOI 10.1016/S0378-7753(97)02761-4; Adler SB, 1998, SOLID STATE IONICS, V111, P125, DOI 10.1016/S0167-2738(98)00179-9; Minh NQ, 2004, SOLID STATE IONICS, V174, P271, DOI 10.1016/j.ssi.2004.07.042; Tsuchiya M, 2011, NAT NANOTECHNOL, V6, P282, DOI [10.1038/nnano.2011.43, 10.1038/NNANO.2011.43]; Tao SW, 2003, NAT MATER, V2, P320, DOI 10.1038/nmat871; Yashiro K, 2002, ELECTROCHEMISTRY, V70, P958; Sammes NM, 2005, J POWER SOURCES, V145, P428, DOI 10.1016/j.jpowsour.2005.01.079; Mukhopadhyay M, 2012, INT J APPL CERAM TEC, V9, P999, DOI 10.1111/j.1744-7402.2011.02646.x; Hibino T, 2002, J ELECTROCHEM SOC, V149, pA1503, DOI 10.1149/1.1513983; Singhal SC, 2002, SOLID STATE IONICS, V152, P405, DOI 10.1016/S0167-2738(02)00349-1; Haile SM, 2003, ACTA MATER, V51, P5981, DOI 10.1016/j.actamat.2003.08.004; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Hibino T, 2002, ELECTROCHEM SOLID ST, V5, pA242, DOI 10.1149/1.1508551; Suzuki T, 2009, SCIENCE, V325, P852, DOI 10.1126/science.1176404; Yokokawa H, 2005, MRS BULL, V30, P591, DOI 10.1557/mrs2005.166; EGUCHI K, 1992, SOLID STATE IONICS, V52, P165, DOI 10.1016/0167-2738(92)90102-U; Han F, 2012, J POWER SOURCES, V218, P157, DOI 10.1016/j.jpowsour.2012.06.087; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Suzuki T, 2006, J POWER SOURCES, V160, P73, DOI 10.1016/j.jpowsour.2006.01.037; Wachsman ED, 2002, SOLID STATE IONICS, V152, P657, DOI 10.1016/S0167-2738(02)00405-8; Weber A., 2002, J POWER SOURCES, V110, P186; Yamamoto O, 2000, ELECTROCHIM ACTA, V45, P2423, DOI 10.1016/S0013-4686(00)00330-3; Yan JW, 2005, ELECTROCHEM SOLID ST, V8, pA389, DOI 10.1149/1.1943568; Zhao F, 2005, J POWER SOURCES, V141, P79, DOI 10.1016/j.jpowsour.2004.08.057	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	MAR-APR	2015	12	2					358	362		10.1111/ijac.12163		5	Materials Science, Ceramics	Materials Science	CD4JZ	WOS:000351049900013		
J	Kondo, N; Hotta, M; Ohji, T				Kondo, Naoki; Hotta, Mikinori; Ohji, Tatsuki			Low-Cost Silicon Nitride from beta-Silicon Nitride Powder and by Low-Temperature Sintering	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article							IMPROVED FRACTURE-TOUGHNESS; MICROSTRUCTURAL DESIGN; CERAMICS; SI3N4; ADDITIVES	Aiming to manufacture low-cost silicon nitride components, a low-cost powder was chosen as a raw powder and low-temperature sintering at 1550-1600 degrees C under atmospheric pressure nitrogen was carried out. The silicon nitride from powder with 5wt% Y2O3 and 5wt% MgAl2O4 additives and sintered at 1600 degrees C for 8h was successfully densified, and it exhibited moderate strength and toughness of 553MPa +/- 22 and 3.5MPa m(1/2), respectively. The results indicate that the low-temperature sintering of the low-cost powder has a potential to reduce cost of components.	[Kondo, Naoki; Hotta, Mikinori; Ohji, Tatsuki] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Kondo, N (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	naoki-kondo@aist.go.jp					LEE DD, 1990, J AM CERAM SOC, V73, P767, DOI 10.1111/j.1151-2916.1990.tb06591.x; Sun EY, 1998, J AM CERAM SOC, V81, P2831; Becher PF, 1998, J AM CERAM SOC, V81, P2821; BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x; MITOMO M, 1991, J MATER SCI, V26, P3940, DOI 10.1007/BF01184995; HIRAO K, 1994, J AM CERAM SOC, V77, P1857, DOI 10.1111/j.1151-2916.1994.tb07062.x; HIROSAKI N, 1994, NIPPON SERAM KYO GAK, V102, P790; HOFFMANN MJ, 1994, PURE APPL CHEM, V66, P1807, DOI 10.1351/pac199466091807; Kitayama M, 2006, J AM CERAM SOC, V89, P2612, DOI 10.1111/j.1551-2916.2006.01106.x; MITOMO M, 1990, J AM CERAM SOC, V73, P2441, DOI 10.1111/j.1151-2916.1990.tb07610.x; MITOMO M, 1976, J MATER SCI, V11, P1103, DOI 10.1007/BF00553119; SUZUKI K, 1984, NIPPON SERAM KYO GAK, V92, P101; Wangmooklang N, 2007, J CERAM SOC JPN, V115, P974, DOI 10.2109/jcersj2.115.974; Yamaguchi H., 2012, CERAMICS, V47, P32	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	MAR-APR	2015	12	2					377	382		10.1111/ijac.12157		6	Materials Science, Ceramics	Materials Science	CD4JZ	WOS:000351049900016		
J	Fujihara, S; Takano, Y; Kitsuda, M				Fujihara, Shinobu; Takano, Yuina; Kitsuda, Mami			Microstructural Aspects of the CePO4:Tb3+ Phosphor for Luminescence Sensing	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article							NANOWIRES	Ceramic powders and thin films of cerium phosphate doped with trivalent terbium ions (CePO4:Tb3+) were synthesized from liquid phases, and their microstructures were modulated to investigate the relationship between the structure and the luminescence switching property responsive to redox reactions. Aqueous KMnO4 and L(+)-ascorbic acid solutions were used to evaluate the redox response of CePO4:Tb3+, appearing as luminescence quenching and recovering, respectively. The particle shape and size of the powder samples depended on heat-treatment conditions, which had also a large influence on the switching property. As-prepared nanorod particles were more sensitive to the redox reactions than heat-treated larger spherical particles, indicating that the switching was governed by the surface state of the particles. The thickness of the thin-film samples was also an important factor to determine the response to the redox reactions. In any case, our results demonstrate that it is important to control the microstructure of the CePO4:Tb3+ materials for their use in luminescence switching devices for the redox monitoring.	[Fujihara, Shinobu; Takano, Yuina; Kitsuda, Mami] Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan	Fujihara, S (reprint author), Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan.	shinobu@applc.keio.ac.jp			Nippon Sheet Glass Foundation for Materials Science and Engineering	This work was supported by Nippon Sheet Glass Foundation for Materials Science and Engineering.	TSIVGOULIS GM, 1995, ANGEW CHEM INT EDIT, V34, P1119, DOI 10.1002/anie.199511191; Di WH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/7/075709; Takano Y, 2012, ECS J SOLID STATE SC, V1, pR169, DOI 10.1149/2.028206jss; Riwotzki K, 2000, J PHYS CHEM B, V104, P2824, DOI 10.1021/jp993581r; Li Q, 2007, ANGEW CHEM INT EDIT, V46, P3486, DOI 10.1002/anie.200604973; Kitsuda M, 2011, J PHYS CHEM C, V115, P8808, DOI 10.1021/jp201406y; Fang YP, 2003, J AM CHEM SOC, V125, P16025, DOI 10.1021/ja037280d; Mutai T, 2008, ANGEW CHEM INT EDIT, V47, P9522, DOI 10.1002/anie.200803975; Chen HQ, 2012, ANALYST, V137, P1899, DOI 10.1039/c2an16202d; Di WH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/36/365501; Grahmaier R., 1994, LUMINESCENT MAT; Tsivgoulis GM, 1996, CHEM-EUR J, V2, P1399, DOI 10.1002/chem.19960021112	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	MAR-APR	2015	12	2					411	417		10.1111/ijac.12173		7	Materials Science, Ceramics	Materials Science	CD4JZ	WOS:000351049900021		
J	Morozumi, H; Nakano, H; Yoshida, S; Matsuoka, J				Morozumi, Hidekatsu; Nakano, Hirotaka; Yoshida, Satoshi; Matsuoka, Jun			Crack Initiation Tendency of Chemically Strengthened Glasses	INTERNATIONAL JOURNAL OF APPLIED GLASS SCIENCE			English	Article							ION-EXCHANGE; BEHAVIOR; FRACTURE	The relationship between crack initiation tendency before chemical strengthening and fracture strength of chemically strengthened glass was investigated. Four kinds of glass compositions were used in this study: soda-lime silicate (SLS), aluminosilicate (ALS-1, ALS-2), and aluminoborosilicate (ALBS) glasses. The fracture strength of sheet glass was measured by the four-point bending test, the ring-on-ring test, the ball drop test, and the predamaged four-point bending test. ALBS glass, which has the lowest crack formation probability before chemical strengthening, is more damage tolerant than other glasses, and one of the best candidates for chemical strengthening.	[Morozumi, Hidekatsu; Nakano, Hirotaka] Ishizuka Glass Co Ltd, Glass Dev Grp, Iwakura, Aichi 4828510, Japan; [Morozumi, Hidekatsu; Yoshida, Satoshi; Matsuoka, Jun] Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan	Matsuoka, J (reprint author), Univ Shiga Prefecture, Dept Mat Sci, Hassaka 2500, Hikone, Shiga 5228533, Japan.	morozumi@ishizuka.co.jp					Varshneya AK, 2010, INT J APPL GLASS SCI, V1, P131, DOI 10.1111/j.2041-1294.2010.00010.x; Kato Y, 2010, J NON-CRYST SOLIDS, V356, P1768, DOI 10.1016/j.jnoncrysol.2010.07.015; NORDBERG ME, 1964, J AM CERAM SOC, V47, P215, DOI 10.1111/j.1151-2916.1964.tb14399.x; Sehgal J, 1998, J AM CERAM SOC, V81, P2485; CONNOLLY D, 1989, J AM CERAM SOC, V72, P1162, DOI 10.1111/j.1151-2916.1989.tb09701.x; [Anonymous], 2010, REPORTS; Karlsson S, 2010, GLASS TECHNOL-PART A, V51, P41; ARORA A, 1979, J NON-CRYST SOLIDS, V31, P415, DOI 10.1016/0022-3093(79)90154-6; Barefoot K. L., 2011, US Patent, Patent No. 8075999; Burggraaf A.J., 1964, Physics and Chemistry of Glasses, V5; Garfinkel H. M., 1971, US Patent, Patent No. 3630704; Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221; Gy R, 2008, MATER SCI ENG B-ADV, V149, P159, DOI 10.1016/j.mseb.2007.11.029; Ito S, 2004, J CERAM SOC JPN, V112, P477, DOI 10.2109/jcersj.112.477; Japanese Industrial Standards, 1995, 1602 JAP IND STAND; Japanese Industrial Standards, 2008, 1601 JAP IND STAND; Koike A, 2007, J NON-CRYST SOLIDS, V353, P2675, DOI 10.1016/j.jnoncrysol.2007.05.006; Marusak F. J., 1968, US Patent, Patent No. 3410673; Roach D. H., 1988, Journal of the American Ceramic Society, V71, DOI 10.1111/j.1151-2916.1988.tb05872.x; Tandon R, 2005, FRACT MECH, V14, P77; Wada M., 1974, P 10 INT C GLASS, V11, P39; Yoshida S, 2004, J NON-CRYST SOLIDS, V344, P37, DOI 10.1016/j.jnoncrysol.2004.07.019	22	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-1286	2041-1294		INT J APPL GLASS SCI	Int. J. Appl. Glass Sci.	MAR	2015	6	1			SI		64	71		10.1111/ijag.12089		8	Materials Science, Ceramics	Materials Science	CC8ZH	WOS:000350656600008		
J	Uchida, M; Hayakawa, T; Suhara, T; Duclere, JR; Thomas, P				Uchida, Masayuki; Hayakawa, Tomokatsu; Suhara, Toshiki; Duclere, Jean-Rene; Thomas, Philippe			Strong Influences of Melting Time and Tm3+ Concentration on Blue Up-Conversion Photoluminescence for Tm3+/Yb3+ Co-Doped TeO2-TlO0.5-ZnO Glass	INTERNATIONAL JOURNAL OF APPLIED GLASS SCIENCE			English	Article							RARE-EARTH IONS; OPTICAL-PROPERTIES; TELLURITE GLASSES; MU-M; YB3+; SPECTROSCOPY; INTENSITIES; EMISSION; ER3+; NANOCRYSTALS	In this study, by a conventional melt quenching method, we synthesized novel up-conversion phosphors of 60TeO(2)-30TlO(0.5)-(9-x)ZnO-xTm(2)O(3)-1Yb(2)O(3) (x=0.1-0.5) glasses, whose system was recently developed in our collaborative group, and their blue up-conversion photoluminescence (UCPL) of Tm3+ ions via three-step energy transfer from near-infrared (NIR) sensitizer of Yb3+ ions was observed. In particular, the substantial rate of the energy transfer <(d5)> in the third step from Yb3+ to Tm3+ under excitation at 975nm, which determined the final blue UCPL intensity, was estimated as a function of the rare-earth concentration. With an aid of analytical methods of PL lifetime and Judd-Ofelt theory, it was revealed that the highest energy transfer rate <(d5)> was achieved to be 2.07x10(-17)cm(3)/s for x=0.2, and further increasing Tm2O3 content x in the fixed Yb2O3 resulted in the decrease in the energy transfer rate <(d5)>. One of the plausible causes was concentration quenching of Yb3+ ions. The other was back-transfer from Tm3+ to Yb3+ ions. The influence of the condition of glass synthesis and the melting time on <(d5)> was also discussed.	[Uchida, Masayuki; Hayakawa, Tomokatsu; Suhara, Toshiki] Nagoya Inst Technol, Field Adv Energy Convers, Dept Frontier Mat, Nagoya, Aichi, Japan; [Duclere, Jean-Rene; Thomas, Philippe] Univ Limoges, UMR CNRS 7315, Fac Sci, Ctr Europeen Ceram,SPCTS, F-87068 Limoges, France	Hayakawa, T (reprint author), Nagoya Inst Technol, Field Adv Energy Convers, Dept Frontier Mat, Nagoya, Aichi, Japan.	hayatomo@nitech.ac.jp			JSPS; Institute of Ceramics Research and Education (ICRE) in Nagoya Institute of Technology	This work was supported by the JSPS International Training Program (ITP), "Young Scientist-Training Program for World Ceramics Networks" and by grant from Institute of Ceramics Research and Education (ICRE) in Nagoya Institute of Technology.	Oo HM, 2012, INT J MOL SCI, V13, P4623, DOI 10.3390/ijms13044623; Quintanilla M, 2011, NANOSCALE, V3, P1046, DOI 10.1039/c0nr00676a; Wang HQ, 2011, ADV MATER, V23, P2675, DOI 10.1002/adma.201100511; CARNALL WT, 1968, J CHEM PHYS, V49, P4424, DOI 10.1063/1.1669893; Balda R, 2008, OPT EXPRESS, V16, P11836, DOI 10.1364/OE.16.011836; Barney ER, 2013, J PHYS CHEM LETT, V4, P2312, DOI 10.1021/jz4010637; Gai SL, 2010, ADV FUNCT MATER, V20, P1166, DOI 10.1002/adfm.200902274; Wang HS, 2008, J PHYS CHEM C, V112, P16651, DOI 10.1021/jp8046505; Uchida M, 2014, OPT MATER EXPRESS, V4, P823, DOI 10.1364/OME.4.000823; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Singh BP, 2013, PHYS CHEM CHEM PHYS, V15, P3480, DOI 10.1039/c2cp44195k; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Shen ZJ, 1997, J MATER SCI LETT, V16, P263, DOI 10.1023/A:1018532630462; Blackburn OA, 2012, PHYS CHEM CHEM PHYS, V14, P13378, DOI [10.1039/c2cp42228j, 10.1039/c2cp42228]; Manzani D, 2012, J MATER CHEM, V22, P16540, DOI 10.1039/c2jm33057a; Reinhard C, 2002, INORG CHEM, V41, P1048, DOI 10.1021/ic0108484; Vetrone F, 2009, CHEM MATER, V21, P1847, DOI 10.1021/cm900313s; CARNALL WT, 1965, J CHEM PHYS, V42, P3797, DOI 10.1063/1.1695840; Linda D, 2013, J ALLOY COMPD, V561, P151, DOI 10.1016/j.jallcom.2013.01.172; Braud A, 2000, PHYS REV B, V61, P5280, DOI 10.1103/PhysRevB.61.5280; Fargin E, 1996, J NON-CRYST SOLIDS, V203, P96, DOI 10.1016/0022-3093(96)00338-9; Guo WJ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2912983; Hayakawa T, 2001, J APPL PHYS, V90, P2200, DOI 10.1063/1.1384491; Jia GH, 2004, J APPL PHYS, V96, P6262, DOI 10.1063/1.1814173; KRUPKE WF, 1974, IEEE J QUANTUM ELECT, VQE10, P450, DOI 10.1109/JQE.1974.1068162; KRUPKE WF, 1971, IEEE J QUANTUM ELECT, VQE 7, P153, DOI 10.1109/JQE.1971.1076623; Quintanilla M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.022601; Silva H. M., 2011, J APPL PHYS, V109; Silva WF, 2008, J LUMIN, V128, P744, DOI 10.1016/j.jlumin.2007.10.017; Soulis M, 2010, MATER RES BULL, V45, P551, DOI 10.1016/j.materresbull.2010.01.024; Tuyen VP, 2010, J SOLID STATE CHEM, V183, P2714, DOI 10.1016/j.jssc.2010.08.025	32	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-1286	2041-1294		INT J APPL GLASS SCI	Int. J. Appl. Glass Sci.	MAR	2015	6	1			SI		83	93		10.1111/ijag.12085		11	Materials Science, Ceramics	Materials Science	CC8ZH	WOS:000350656600010		
J	Asano, S				Asano, Shigetaka			Donald Metcalf, 'Father of CSF' (1929-2014)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Biographical-Item									[Asano, Shigetaka] Japanese Soc Hematol, Tokyo, Japan		asgtkmd@waseda.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					209	210		10.1007/s12185-015-1753-9		2	Hematology	Hematology	CD2IH	WOS:000350899600001		
J	Yanada, M				Yanada, Masamitsu			Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Allogeneic hematopoietic cell transplantation; Acute myeloid leukemia; First complete remission	BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; TOTAL-BODY IRRADIATION; ACUTE MYELOBLASTIC-LEUKEMIA; HLA-IDENTICAL SIBLINGS; UNRELATED DONOR TRANSPLANTATION; INTERNAL TANDEM DUPLICATION; RESIDUAL DISEASE DETECTION; MISMATCHED FAMILY DONORS; UMBILICAL-CORD BLOOD	Allogeneic hematopoietic cell transplantation (HCT) is the most potent therapy for preventing relapse of acute myeloid leukemia (AML). Although its efficacy is compromised by a high risk of treatment-related morbidity and mortality, an accumulating body of evidence has led to the general recommendation favoring allogeneic HCT from a matched sibling donor during first complete remission (CR1) for younger patients with cytogenetically intermediate- or high-risk AML. Over the past few decades, this field has seen a great many advancements. The indications for allogeneic HCT have been refined by taking into account the molecular profiles of leukemic cells and the degree of comorbidities. The introduction of high-resolution human leukocyte antigen-typing technology and advances in immunosuppressive therapy and supportive care measures have improved outcomes in alternative donor transplantation, while the parallel growth of unrelated donor registries and greater use of umbilical cord blood and haploidentical donors have considerably improved the chance of finding an alternative donor. The development of reduced-intensity and non-myeloablative conditioning has made it possible to receive allogeneic HCT for patients who might once have been considered ineligible due to advanced age or comorbidities. Thanks to these advances, the role of allogeneic HCT during CR1 has become progressively more important in the treatment of AML.	Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701192, Japan	Yanada, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	myanada@fujita-hu.ac.jp					Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Kanda Y, 2003, BLOOD, V102, P1541, DOI 10.1182/blood-2003-02-0430; Deeg HJ, 2002, BLOOD, V100, P1201, DOI 10.1182/blood-2002-02-0527; McSweeney PA, 2001, BLOOD, V97, P3390, DOI 10.1182/blood.V97.11.3390; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Socie G, 2001, BLOOD, V98, P3569, DOI 10.1182/blood.V98.13.3569; Hegenbart U, 2006, J CLIN ONCOL, V24, P444, DOI 10.1200/JCO.2005.03.1765; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Schetelig J, 2008, J CLIN ONCOL, V26, P5183, DOI 10.1200/JCO.2007.15.5184; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Keating S, 1998, BRIT J HAEMATOL, V102, P1344; GALE RP, 1995, BONE MARROW TRANSPL, V16, P203; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Andersson BS, 2002, BIOL BLOOD MARROW TR, V8, P145, DOI 10.1053/bbmt.2002.v8.pm11939604; RINGDEN O, 1994, BLOOD, V83, P2723; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Green CL, 2010, BLOOD, V116, P2779, DOI 10.1182/blood-2010-02-270926; Mehta J, 2004, BONE MARROW TRANSPL, V33, P389, DOI 10.1038/sj.bmt.1704391; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Kanda Y, 2013, BRIT J HAEMATOL, V161, P566, DOI 10.1111/bjh.12279; Forman SJ, 2013, BLOOD, V121, P1077, DOI 10.1182/blood-2012-08-234492; CASSILETH PA, 1988, J CLIN ONCOL, V6, P583; ANASETTI C, 1990, HUM IMMUNOL, V29, P79, DOI 10.1016/0198-8859(90)90071-V; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; POWLES RL, 1983, LANCET, V1, P612; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Huang XJ, 2012, BLOOD, V119, P5584, DOI 10.1182/blood-2011-11-389809; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Sakamaki H, 2010, INT J HEMATOL, V91, P284, DOI 10.1007/s12185-009-0483-2; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; Ferrant A, 1997, BLOOD, V90, P2931; Renneville A, 2012, LEUKEMIA, V26, P1247, DOI 10.1038/leu.2011.382; Yeshurun M, 2014, CANCER-AM CANCER SOC, V120, P855, DOI 10.1002/cncr.28498; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Terwijn M, 2013, J CLIN ONCOL, V31, P3889, DOI 10.1200/JCO.2012.45.9628; Bornhauser M, 2012, LANCET ONCOL, V13, P1035, DOI 10.1016/S1470-2045(12)70349-2; Kurosawa S, 2010, HAEMATOL-HEMATOL J, V95, P1857, DOI 10.3324/haematol.2010.027516; Tallman MS, 2000, BLOOD, V96, P1254; Nagler A, 2013, J CLIN ONCOL, V31, P3549, DOI 10.1200/JCO.2013.48.8114; Martino R, 2013, BONE MARROW TRANSPL, V48, P761, DOI 10.1038/bmt.2012.236; Kayser S, 2012, BLOOD, V119, P551, DOI 10.1182/blood-2011-07-367508; Farag SS, 2011, BIOL BLOOD MARROW TR, V17, P1796, DOI 10.1016/j.bbmt.2011.06.005; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Slavin S, 1998, BLOOD, V91, P756; Medeiros BC, 2010, BLOOD, V116, P2224, DOI 10.1182/blood-2010-02-270330; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Lazarus HM, 2006, BRIT J HAEMATOL, V132, P755, DOI 10.1111/j.1365-2141.2005.05947.x; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Renneville A, 2009, BLOOD, V113, P5090, DOI 10.1182/blood-2008-12-194704; Fang M, 2011, BLOOD, V118, P1490, DOI 10.1182/blood-2011-02-339721; Luger SM, 2012, BONE MARROW TRANSPL, V47, P203, DOI 10.1038/bmt.2011.69; BLAISE D, 1992, BLOOD, V79, P2578; Kihara R, 2014, LEUKEMIA, V28, P1586, DOI 10.1038/leu.2014.55; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Grossmann V, 2012, BLOOD, V120, P2963, DOI 10.1182/blood-2012-03-419622; Cahn JY, 2000, BRIT J HAEMATOL, V110, P308, DOI 10.1046/j.1365-2141.2000.02178.x; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Reiffers J, 1996, LEUKEMIA, V10, P1874; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Gratwohl A, 2009, CANCER, V115, P4715, DOI 10.1002/cncr.24531; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Kanda J, 2012, BLOOD, V119, P2409, DOI 10.1182/blood-2011-08-372573; Brunet S, 2012, J CLIN ONCOL, V30, P735, DOI 10.1200/JCO.2011.36.9868; Kiyoi H, 1999, BLOOD, V93, P3074; Mohty M, 2005, LEUKEMIA, V19, P916, DOI 10.1038/sj.leu.2403770; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31; Bashey A, 2013, J CLIN ONCOL, V31, P1310, DOI 10.1200/JCO.2012.44.3523; CLIFT RA, 1994, BLOOD, V84, P2036; Burnett AK, 2002, BRIT J HAEMATOL, V118, P385, DOI 10.1046/j.1365-2141.2002.03724.x; DEVERGIE A, 1995, BLOOD, V85, P2263; Basara N, 2009, LEUKEMIA, V23, P635, DOI 10.1038/leu.2008.352; Giralt S, 1997, BLOOD, V89, P4531; Burnett AK, 2013, J CLIN ONCOL, V31, P1293, DOI 10.1200/JCO.2011.40.5977; Sobecks RM, 2012, BONE MARROW TRANSPL, V47, P633, DOI 10.1038/bmt.2011.167; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Szydlo R, 1997, J CLIN ONCOL, V15, P1767; Stelljes M, 2011, HAEMATOL-HEMATOL J, V96, P972, DOI 10.3324/haematol.2011.041004; Yanada M, 2013, BONE MARROW TRANSPL, V48, P390, DOI 10.1038/bmt.2012.159; Slovak ML, 2000, BLOOD, V96, P4075; Freeman SD, 2013, J CLIN ONCOL, V31, P4123, DOI 10.1200/JCO.2013.49.1753; Walter RB, 2010, LEUKEMIA, V24, P1276, DOI 10.1038/leu.2010.102; Gupta V, 2010, BLOOD, V116, P1839, DOI 10.1182/blood-2010-04-278317; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Warlick ED, 2014, BIOL BLOOD MARROW TR, V20, P202, DOI 10.1016/j.bbmt.2013.10.023; Radich JP, 2003, BLOOD, V102, P31, DOI 10.1182/blood-08-2619; Aoudjhane M, 2005, LEUKEMIA, V19, P2304, DOI 10.1038/sj.leu.2403967; Armand P, 2007, BIOL BLOOD MARROW TR, V13, P655, DOI 10.1016/j.bbmt.2007.01.079; ASH RC, 1991, BONE MARROW TRANSPL, V7, P443; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Boissel N, 2002, LEUKEMIA, V16, P1699, DOI 10.1038/sj.leu.2402622; Copelan EA, 2013, BLOOD, V122, P3863, DOI 10.1182/blood-2013-07-514448; Cornelissen JJ, 2012, J CLIN ONCOL, V30, P2140, DOI 10.1200/JCO.2011.39.6499; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Jourdan E, 2005, J CLIN ONCOL, V23, P7676, DOI 10.1200/JCO.2005.02.5940; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Labopin M, 2014, BONE MARROW TRANSPL, V49, P376, DOI 10.1038/bmt.2013.178; Mawad R, 2013, J CLIN ONCOL, V31, P3883, DOI 10.1200/JCO.2013.50.2567; Oran B, 2011, BIOL BLOOD MARROW TR, V17, P356, DOI 10.1016/j.bbmt.2010.05.012; Sproat L, 2010, LEUKEMIA LYMPHOMA, V51, P1699, DOI 10.3109/10428194.2010.500431; Valcarel D, 2008, J CLIN ONCOL, V26, P577, DOI 10.1200/JCO.2007.11.1641; Yanada M, 2005, CANCER-AM CANCER SOC, V103, P1652, DOI 10.1002/cncr.20945; Yanada M, 2013, CANCER-AM CANCER SOC, V119, P3326, DOI 10.1002/cncr.28212; Yanada M, 2012, HAEMATOL-HEMATOL J, V97, P915, DOI 10.3324/haematol.2011.058289; Yanada M, 2012, INT J HEMATOL, V96, P186, DOI 10.1007/s12185-012-1137-3	117	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					243	254		10.1007/s12185-014-1657-0		12	Hematology	Hematology	CD2IH	WOS:000350899600006		
J	Nagata, A; Sekiguchi, N; Kurimoto, M; Noto, S; Takezako, N				Nagata, Akihisa; Sekiguchi, Naohiro; Kurimoto, Miwa; Noto, Satoshi; Takezako, Naoki			Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H-pylori-infected patients	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						ITP; H. pylori; Eradication; Lymphocyte; Response; Initial	IDIOPATHIC THROMBOCYTOPENIC PURPURA; HELICOBACTER-PYLORI; IMMUNE THROMBOCYTOPENIA; ERADICATION; PATHOGENESIS; PROFILES; REGIMEN; TYPE-1	Immune thrombocytopenic purpura (ITP) is an acquired disorder characterized by thrombocytopenia, increased platelet destruction, and the inhibition of platelet production by specific autoantibodies. Previous studies have reported improvements in ITP following the eradication of Helicobacter pylori (H. pylori) infection. We, herein, investigated the relationship between initial therapy for ITP and lymphocyte counts at diagnosis. We retrospectively examined 52 adult patients with ITP between March 1998 and March 2013. Standard H. pylori eradication therapy was performed in 31 patients, and lymphocyte counts were compared before and after this therapy. At the diagnosis of ITP, lymphocyte counts in H. pylori-infected patients were significantly higher than those in H. pylori-negative patients (1.92 +/- A 0.68 x 10(9)/L vs. 1.42 +/- A 0.67 x 10(9)/L; p = 0.010). H. pylori eradication was successful in 6/11 patients (54.5 %) and the platelet count increased in 4/11 H. pylori-positive patients (36.4 %) who received eradication therapy. On the other hand, eradication therapy was also administered to 15 patients without H. pylori infection, and responses were obtained in some H. pylori-negative patients receiving eradication therapy (9/15). Furthermore, lymphocyte counts were significantly higher in patients who achieved a complete response receiving H. pylori eradication therapy than in patients who did not achieve a complete response (2.4 +/- A 0.59 x 10(9)/L vs. 1.37 +/- A 0.60 x 10(9)/L, p = 0.0023). The response of ITP patients to the initial treatment may be predicted by measuring the lymphocyte count at diagnosis. Further studies that analyze lymphocyte subsets and the cytokine network are needed to elucidate the underlying mechanisms.	[Nagata, Akihisa; Sekiguchi, Naohiro; Kurimoto, Miwa; Noto, Satoshi; Takezako, Naoki] Natl Hosp Org, Disaster Med Ctr Japan, Dept Hematol, Tachikawa, Tokyo 1900014, Japan; [Takezako, Naoki] Natl Hosp Org, Disaster Med Ctr Japan, Dept Med Informat, Tachikawa, Tokyo 1900014, Japan	Takezako, N (reprint author), Natl Hosp Org, Disaster Med Ctr Japan, Dept Hematol, Tachikawa, Tokyo 1900014, Japan.	ntakezak@tdmc.hosp.go.jp					Ando T, 2004, HELICOBACTER, V9, P443, DOI 10.1111/j.1083-4389.2004.00261.x; Panitsas FP, 2004, BLOOD, V103, P2645, DOI 10.1182/blood-2003-07-2268; Wang TT, 2005, HAEMATOL-HEMATOL J, V90, P914; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Arnold DM, 2009, HAEMATOL-HEMATOL J, V94, P850, DOI 10.3324/haematol.2008.005348; Arnold DM, 2012, BLOOD, V119, P1356, DOI 10.1182/blood-2011-08-374777; Shirasugi Y, 2012, INT J HEMATOL, V95, P652, DOI 10.1007/s12185-012-1065-2; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Franchini M, 2003, HAEMATOLOGICA, V88, P1087; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Yamanishi S, 2006, INFECT IMMUN, V74, P248, DOI 10.1128/IAI.74.1.248-256.2006; Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x; Stasi R, 2009, BLOOD, V113, P1231, DOI 10.1182/blood-2008-07-167155; Satoh K, 2002, J GASTROENTEROL, V37, P34, DOI 10.1007/BF02990097; Arnold DM, 2013, PEDIATR BLOOD CANCER, V60, pS19, DOI 10.1002/pbc.24341; Asahi A, 2006, HAEMATOL-HEMATOL J, V91, P1436; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Emilia G, 2007, BLOOD, V110, P3833, DOI 10.1182/blood-2006-12-063222; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P463, DOI 10.1055/s-0032-1305781; Franchini M, 2005, MED HYPOTHESES, V65, P1128, DOI 10.1016/j.mehy.2005.06.015; Gasbarrini A, 1998, LANCET, V352, P878, DOI 10.1016/S0140-6736(05)60004-9; Jarque I., 2001, British Journal of Haematology, V115, P1002, DOI 10.1046/j.1365-2141.2001.03194.x; Johnsen J, 2012, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2012.1.306; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; McCrae KR, 2001, HEMATOL-AM SOC HEMAT, V2001, P282, DOI 10.1182/asheducation-2001.1.282; Michel M, 2004, BLOOD, V103, P890, DOI 10.1182/blood-2003-03-0900; Ohe Masashi, 2003, Rinsho Ketsueki, V44, P1044; TAKEZAKO N, 2013, OPEN J BLOOD DIS, V3, P32	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					268	272		10.1007/s12185-015-1737-9		5	Hematology	Hematology	CD2IH	WOS:000350899600009		
J	Suzuki, K; Ogura, M; Abe, Y; Suzuki, T; Tobinai, K; Ando, K; Taniwaki, M; Maruyama, D; Kojima, M; Kuroda, J; Achira, M; Iizuka, K				Suzuki, Kenshi; Ogura, Michinori; Abe, Yu; Suzuki, Tatsuya; Tobinai, Kensei; Ando, Kiyoshi; Taniwaki, Masafumi; Maruyama, Dai; Kojima, Minoru; Kuroda, Junya; Achira, Meguru; Iizuka, Koho			Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Bortezomib; Dexamethasone; Interleukin 6; Multiple myeloma; Siltuximab	CASTLEMANS-DISEASE; PRECLINICAL MODELS; CELL-DEATH; INTERLEUKIN-6; DEXAMETHASONE; INHIBITION; APOPTOSIS	Siltuximab, a chimeric monoclonal antibody with high affinity and specificity for interleukin-6, has been shown to enhance anti-multiple myeloma activity of bortezomib and corticosteroid in vitro. We evaluated the safety, pharmacokinetics, immunogenicity, and antitumor effect of siltuximab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma. This open-label, phase 1, dose-escalating study used two doses of siltuximab: 5.5 and 11.0 mg/kg (administered on day 1 of each 21-day cycle). In total, nine patients were treated. The most common grade 3/4 adverse events, lymphopenia (89 %) and thrombocytopenia (44 %), occurred in patients receiving both doses of siltuximab; however, no dose-limiting toxicities (DLTs) were observed. Following intravenous administration of siltuximab at 5.5 and 11.0 mg/kg, the maximum serum concentration and the area under the curve from 0 to 21 days and from 0 to infinity increased in an approximately dose-proportional manner. Mean half-life, total systemic clearance, and volume of distribution were similar at doses of 5.5 and 11.0 mg/kg. Across both doses, six of the nine patients had complete or partial response (22 and 44 %, respectively). In conclusion, as no DLT was observed, the recommended dose for this combination is 11.0 mg/kg once every 3 weeks. The study is registered at as NCT01309412.	[Suzuki, Kenshi; Abe, Yu] Japanese Red Cross Med Ctr, Dept Hematol, Shibuya Ku, Tokyo 1508935, Japan; [Ogura, Michinori; Suzuki, Tatsuya] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Tobinai, Kensei; Maruyama, Dai] Natl Canc Ctr, Dept Hematol, Tokyo, Japan; [Ando, Kiyoshi; Kojima, Minoru] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Taniwaki, Masafumi; Kuroda, Junya] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto, Japan; [Achira, Meguru] Janssen Pharmaceut KK, Res & Dev, Dept Clin Pharmacol, Quantitat Sci Div, Tokyo, Japan; [Iizuka, Koho] Janssen Pharmaceut KK, Res & Dev, Dept Oncol, Div Clin Sci, Tokyo, Japan	Suzuki, K (reprint author), Japanese Red Cross Med Ctr, Dept Hematol, Shibuya Ku, Hiroo 4-1-22, Tokyo 1508935, Japan.	ken-suzuki@mtb.biglobe.ne.jp			Janssen	The authors thank all the patients who participated in this study and their families, the investigators, the nursing staff and study support staff from their sites, Niigata Cancer Center Hospital led by Dr. Takaaki Chou, and the employees of Janssen who contributed to the design and implementation of this study. They would also like to thank Dr. Kiyohiko Hatake of Cancer Institute Hospital for his contribution as an independent expert and Hisaya Otani of the clinical pharmacology department, Janssen Pharmaceutical K.K., who contributed to PK and immunogenicity analyses. Editorial support was sponsored by Janssen and provided by Veejaye Sinha, PharmD, of AlphaBioCom, King of Prussia, PA, USA, and Miyuki Ueda of Janssen Pharmaceutical K.K.	Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Voorhees PM, 2013, BRIT J HAEMATOL, V161, P357, DOI 10.1111/bjh.12266; Fulciniti M, 2009, CLIN CANCER RES, V15, P7144, DOI 10.1158/1078-0432.CCR-09-1483; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KLEIN B, 1995, BLOOD, V85, P863; Kurzrock R, 2013, CLIN CANCER RES, V19, P3659, DOI 10.1158/1078-0432.CCR-12-3349; El-Osta HE, 2011, ONCOLOGIST, V16, P497, DOI 10.1634/theoncologist.2010-0212; Voorhees PM, 2007, CLIN CANCER RES, V13, P6469, DOI 10.1158/1078-0432.CCR-07-1293; Liu TE, 2013, LEUKEMIA RES, V37, P1322, DOI 10.1016/j.leukres.2013.06.026; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; Angevin E, 2014, CLIN CANCER RES, V20, P2192, DOI 10.1158/1078-0432.CCR-13-2200; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Chauhan D, 2000, J BIOL CHEM, V275, P27845; HARDIN J, 1994, BLOOD, V84, P3063; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Orlowski RZ, 2012, J CLIN ONCOL, V30, P8018; Rowley M, 2000, BLOOD, V96, P3175; Voorhees PM, 2009, BRIT J HAEMATOL, V145, P481, DOI 10.1111/j.1365-2141.2009.07647.x; Wong RS, 2013, BLOOD, V122	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					286	294		10.1007/s12185-015-1743-y		9	Hematology	Hematology	CD2IH	WOS:000350899600012		
J	Oritani, K; Okamoto, S; Tauchi, T; Saito, S; Ohishi, K; Handa, H; Takenaka, K; Gopalakrishna, P; Amagasaki, T; Ito, K; Akashi, K				Oritani, Kenji; Okamoto, Shinichiro; Tauchi, Tetsuzo; Saito, Shigeki; Ohishi, Kohshi; Handa, Hiroshi; Takenaka, Katsuto; Gopalakrishna, Prashanth; Amagasaki, Taro; Ito, Kazuo; Akashi, Koichi			A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myelofibrosis; Ruxolitinib; JAK inhibitor; Japan	QUALITY-OF-LIFE; INTERNATIONAL WORKING GROUP; WORLD-HEALTH-ORGANIZATION; PLACEBO-CONTROLLED TRIAL; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; AVAILABLE THERAPY; DOUBLE-BLIND; JAK2 V617F	Ruxolitinib is a potent Janus kinase (JAK) 1/JAK2 inhibitor that has demonstrated rapid and durable improvements in splenomegaly and symptoms and a survival benefit in 2 phase 3 trials in patients with myelofibrosis. Ruxolitinib was well tolerated and effectively reduced splenomegaly and symptom burden in Asian patients with myelofibrosis in the Asian multinational, phase 2 Study A2202. We present a subset analysis of Japanese patients (n = 30) in Study A2202. At data cutoff, 22 patients were ongoing; 8 discontinued, mainly due to adverse events (n = 4). At week 24, 33 % of patients achieved a parts per thousand yen35 % reduction from baseline in spleen volume; 56.0 % achieved a parts per thousand yen50 % reduction from baseline in total symptom score, as measured by the 7-day Myelofibrosis Symptom Assessment Form v2.0. The most common adverse events were anemia (63 %), thrombocytopenia (40 %), nasopharyngitis (37 %), decreased platelet counts (30 %), and diarrhea (30 %). Dose reductions or interruptions due to hemoglobin decreases were more frequent in Japanese patients; no loss of efficacy and no discontinuations due to hematologic abnormalities were observed. Ruxolitinib was well tolerated in Japanese patients and provided substantial reductions in splenomegaly and myelofibrosis-related symptoms similar to those observed in the overall Asian population and phase 3 COMFORT studies.	[Oritani, Kenji] Osaka Univ Hosp, Suita, Osaka 5650871, Japan; [Okamoto, Shinichiro] Keio Univ Hosp, Tokyo, Japan; [Tauchi, Tetsuzo] Tokyo Med Univ Hosp, Tokyo, Japan; [Saito, Shigeki] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Saito, Shigeki] Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; [Ohishi, Kohshi] Mie Univ Hosp, Tsu, Mie, Japan; [Handa, Hiroshi] Gunma Univ Hosp, Maebashi, Gunma, Japan; [Takenaka, Katsuto; Akashi, Koichi] Kyushu Univ Hosp, Fukuoka 812, Japan; [Gopalakrishna, Prashanth] Novartis Pharma AG, Basel, Switzerland; [Amagasaki, Taro; Ito, Kazuo] Novartis Pharma KK, Tokyo, Japan	Oritani, K (reprint author), Osaka Univ Hosp, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	oritani@bldon.med.osaka-u.ac.jp			Novartis	We would like to thank Professor Mineo Kurokawa for his contributions as a study investigator (University of Tokyo Hospital, Tokyo, Japan). Editorial assistance was provided by Karen Chinchilla, PhD, and was supported by Novartis.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Mesa RA, 2007, CANCER, V109, P68, DOI 10.1002/cncr.22365; Osoba D, 1998, J CLIN ONCOL, V16, P139; Oh ST, 2010, EXPERT REV HEMATOL, V3, P323, DOI [10.1586/ehm.10.28, 10.1586/EHM.10.28]; Mesa RA, 2013, J CLIN ONCOL, V31, P1285, DOI 10.1200/JCO.2012.44.4489; Mascarenhas J, 2012, CURR MED CHEM, V19, P4399; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Barosi G, 2008, LEUKEMIA, V22, P437, DOI 10.1038/sj.leu.2404914; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Hitoshi Y, 2010, INT J HEMATOL, V91, P189, DOI 10.1007/s12185-010-0531-y; Mesa RA, 2011, LEUKEMIA RES, V35, P12, DOI 10.1016/j.leukres.2010.07.019; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Wadleigh M, 2010, INT J HEMATOL, V91, P174, DOI 10.1007/s12185-010-0529-5; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Tefferi A, 2013, AM J HEMATOL, V88, P141, DOI 10.1002/ajh.23384; Barosi G, 2011, EXPERT OPIN PHARMACO, V12, P1597, DOI 10.1517/14656566.2011.568939; Cervantes F, 2013, BLOOD, V122, P4047, DOI 10.1182/blood-2013-02-485888; Jung C.W., 2014, LEUKEMIA LYMPHOMA, P1; Kiladjian J, 2012, HAEMATOLOGICA, V97; Milosevic JD, 2013, INT J HEMATOL, V97, P183, DOI 10.1007/s12185-012-1235-2; Ogama Y, 2013, INT J HEMATOL, V97, P351, DOI 10.1007/s12185-013-1280-5; Verstovsek S, 2013, BLOOD, V122	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					295	304		10.1007/s12185-015-1746-8		10	Hematology	Hematology	CD2IH	WOS:000350899600013		
J	Mitsuiki, N; Yang, X; Bartol, SJW; Grosserichter-Wagener, C; Kosaka, Y; Takada, H; Imai, K; Kanegane, H; Mizutani, S; van der Burg, M; van Zelm, MC; Ohara, O; Morio, T				Mitsuiki, Noriko; Yang, Xi; Bartol, Sophinus J. W.; Grosserichter-Wagener, Christina; Kosaka, Yoshiyuki; Takada, Hidetoshi; Imai, Kohsuke; Kanegane, Hirokazu; Mizutani, Shuki; van der Burg, Mirjam; van Zelm, Menno C.; Ohara, Osamu; Morio, Tomohiro			Mutations in Bruton's tyrosine kinase impair IgA responses	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Bruton's tyrosine kinase; X-linked agammaglobulinemia; IgA deficiency; Class switch recombination; Somatic hypermutation	X-LINKED AGAMMAGLOBULINEMIA; B-CELL DEVELOPMENT; COMMON VARIABLE IMMUNODEFICIENCY; TRANSMEMBRANE ACTIVATOR; ANTIGEN-RECEPTOR; BTK; IMMUNOGLOBULIN; HETEROZYGOTES; STIMULATION; LYMPHOCYTES	X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by mutations in Bruton's tyrosine kinase (BTK), and is characterized by markedly decreased numbers of blood B cells and an absence of all immunoglobulin isotypes. We performed whole exome sequencing in a male pediatric patient with dysgammaglobulinemia with IgA deficiency. Genetic analysis revealed a BTK missense mutation (Thr316Ala). To investigate whether a BTK mutation underlay this antibody deficiency with marked decrease of IgA in this patient, we performed functional analyses of B cells and phagocytes, and molecular analyses of somatic hypermutation and class switch recombination. The BTK missense mutation resulted in B cells with reduced BTK and high IgM expression. Equal proportions of CD19(low) and CD19(normal) fractions were observed, and both included na < ve and memory B cells. Calcium influx and phospholipase C gamma 2 phosphorylation upon IgM stimulation were marginally impaired in CD19(low), but not in CD19(+) B cells. Similar to XLA patients, IgA transcripts showed low SHM levels, whereas IgG transcripts were hardly affected. Our analyses suggest that the BTK mutation likely underlies the disease in this case, and that hypomorphic BTK mutations can result in normal circulating B cell numbers, but specifically impair IgA responses.	[Mitsuiki, Noriko; Imai, Kohsuke; Mizutani, Shuki; Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Yang, Xi; Kanegane, Hirokazu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Bartol, Sophinus J. W.; Grosserichter-Wagener, Christina; van der Burg, Mirjam; van Zelm, Menno C.] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Kosaka, Yoshiyuki] Hyogo Prefectural Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan; [Takada, Hidetoshi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Technol, Chiba, Japan; [Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Lab Immunogen, Kanagawa, Japan	Morio, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tmorio.ped@tmd.ac.jp	van Zelm, Menno/O-4404-2015	van Zelm, Menno/0000-0003-4161-1919			Abbott JK, 2013, J ALLERGY CLIN IMMUN, V132, P1246, DOI 10.1016/j.jaci.2013.07.019; ANKER R, 1989, J EXP MED, V169, P2109, DOI 10.1084/jem.169.6.2109; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1111/j.1600-065X.2000.imr017504.x; Maekawa K, 2010, BLOOD CELL MOL DIS, V44, P300, DOI 10.1016/j.bcmd.2010.01.004; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Martinez-Gallo M, 2013, J ALLERGY CLIN IMMUN, V131, P468, DOI 10.1016/j.jaci.2012.10.029; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Mohiuddin MS, 2013, J ALLERGY CLIN IMMUN, V131, P1717, DOI 10.1016/j.jaci.2013.03.045; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Ochs HD, 1996, MEDICINE, V75, P287, DOI 10.1097/00005792-199611000-00001; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Brunner C, 2002, J CLIN IMMUNOL, V22, P244, DOI 10.1023/A:1016097010274; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; CONLEY ME, 1985, J IMMUNOL, V134, P3070; Conley ME, 2009, CURR OPIN IMMUNOL, V21, P466, DOI 10.1016/j.coi.2009.07.003; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Dobbs AK, 2011, BLOOD, V118, P1828, DOI 10.1182/blood-2011-01-330472; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Fleisher TA, 2008, CLIN IMMUNOL, V128, P285, DOI 10.1016/j.clim.2008.04.013; Graziani S, 2008, CLIN IMMUNOL, V128, P322, DOI 10.1016/j.clim.2008.05.012; Haxhinasto SA, 2004, J BIOL CHEM, V279, P2575, DOI 10.1074/jbc.M310628200; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Nomura K, 2000, BLOOD, V96, P610; Nonoyama S, 1998, J IMMUNOL, V161, P3925; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, p[477, e1, e1]; Teimourian S, 2008, J PEDIAT HEMATOL ONC, V30, P679, DOI 10.1097/MPH.0b013e318180bb45; Zelm MCv, 2013, J ALLERGY C IN PRESS; Zelm MCv, 2006, NEW ENGL J MED, V354, P1901	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAR	2015	101	3					305	313		10.1007/s12185-015-1732-1		9	Hematology	Hematology	CD2IH	WOS:000350899600014		
J	Miyazaki, T; Sasaki, T				Miyazaki, Toshiyuki; Sasaki, Toshihiko			X-ray stress measurement from an imperfect Debye-Scherrer ring	INTERNATIONAL JOURNAL OF MATERIALS RESEARCH			English	Article						X-ray stress measurement; Debye-Scherrer ring; Fourier series; Inverse problem; Singular value decomposition		A technique to measure the stress from an imperfect Debye-Scherrer ring is reported. In a previous work, the authors reported a technique to calculate the stress from the Fourier series of a normal strain of a Debye-Scherrer ring and suggested that it is possible to calculate the stress from an imperfect Debye-Scherrer ring if the Fourier series is obtained. The present work presents a technique to calculate the Fourier series of an imperfect Debye-Scherrer ring. Industrially, this is important because the object of interest is often covered by other objects or engraved. The aim of this work is to develop a technique that extends the application range of the X-ray stress measurement.	[Miyazaki, Toshiyuki; Sasaki, Toshihiko] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan	Miyazaki, T (reprint author), Kanazawa Univ, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	trmiyazaki@staff.kanazawa-u.ac.jp	Miyazaki, Toshiyuki/L-6587-2015	Miyazaki, Toshiyuki/0000-0002-1727-7562	Ministry of Education, Culture, Sports, Science and Technology in Japan [120804]	This work was partially supported by a Grant-in-Aid for the Innovative Nuclear Research and Development Program (No. 120804) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The authors thank Yohei Fujimoto and Noriki Inui for their help with the experiments.	Welzel U, 2005, J APPL CRYSTALLOGR, V38, P1, DOI 10.1107/S0021889804029516; LODE W, 1981, METALL, V35, P758; Noyan I. C., 1987, RESIDUAL STRESS, DOI [10.1007/978-1-4613-9570-6, DOI 10.1007/978-1-4613-9570-6]; Miyazaki T, 2014, INT J MATER RES, V105, P922, DOI 10.3139/146.111101; Taira S., 1978, Journal of the Society of Materials Science, Japan, V27; WAGNER CNJ, 1983, ADV X RAY ANAL, V26, P275	6	1	1	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	1862-5282	2195-8556		INT J MATER RES	Int. J. Mater. Res.	MAR	2015	106	3					237	241		10.3139/146.111179		5	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CD3QB	WOS:000350993200002		
J	Hebiguchi, T; Mezaki, Y; Morii, M; Watanabe, R; Yoshikawa, K; Miura, M; Imai, K; Senoo, H; Yoshino, H				Hebiguchi, Taku; Mezaki, Yoshihiro; Morii, Mayako; Watanabe, Ryo; Yoshikawa, Kiwamu; Miura, Mitsutaka; Imai, Katsuyuki; Senoo, Haruki; Yoshino, Hiroaki			Massive bowel resection upregulates the intestinal mRNA expression levels of cellular retinol-binding protein II and apolipoprotein A-IV and alters the intestinal vitamin A status in rats	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						short bowel syndrome; vitamin A; cellular retinol-binding protein II; lecithin retinol acyltransferase; apolipoprotein A; intestinal adaptation	HEPATIC-FIBROSIS; ADAPTATION; ACYLTRANSFERASE; METABOLISM; LECITHIN; LIVER; CDNA; ACID; ESTERIFICATION; PURIFICATION	Short bowel (SB) syndrome causes the malabsorption of various nutrients. Among these, vitamin A is important for a number of physiological activities. Vitamin A is absorbed by epithelial cells of the small intestine and is discharged into the lymphatic vessels as a component of chylomicrons and is delivered to the liver. In the present study, we used a rat model of SB syndrome in order to assess its effects on the expression of genes associated with the absorption, transport and metabolism of vitamin A. In the rats with SB, the intestinal mRNA expression levels of cellular retinol-binding protein II (CRBP II, gene symbol Rbp2) and apolipoprotein A-IV (gene symbol Apoa4) were higher than those in the sham-operated rats, as shown by RT-qPCR. Immunohistochemical analysis revealed that absorptive epithelial cells stained positive for both CRBP II and lecithin retinol acyltransferase, which are both required for the effective esterification of vitamin A. In the rats with SB, the retinol content in the ileum and the retinyl ester content in the jejunum were lower than those in the sham-operated rats, as shown by quantitative analysis of retinol and retinyl esters by high performance liquid chromatography. These results suggest that the elevated mRNA expression levels of Rbp2 and Apoa4 in the rats with SB contribute to the effective esterification and transport of vitamin A.	[Hebiguchi, Taku; Morii, Mayako; Watanabe, Ryo; Yoshino, Hiroaki] Akita Univ, Grad Sch Med, Dept Pediat Surg, Akita 0108543, Japan; [Mezaki, Yoshihiro; Yoshikawa, Kiwamu; Miura, Mitsutaka; Imai, Katsuyuki; Senoo, Haruki] Akita Univ, Grad Sch Med, Dept Cell Biol & Morphol, Akita 0108543, Japan	Mezaki, Y (reprint author), Akita Univ, Grad Sch Med, Dept Cell Biol & Morphol, 1-1-1 Hondo, Akita 0108543, Japan.	mezaki@gipc.akita-u.ac.jp; hiroyosi@med.akita-u.ac.jp			JSPS KAKENHI [23592623, 25504001, 23590228]	This study was supported by the JSPS KAKENHI grant nos. 23592623, 25504001 and 23590228.	Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; SENOO H, 1985, LAB INVEST, V52, P182; Shaw D, 2012, WORLD J GASTROENTERO, V18, P6357, DOI 10.3748/wjg.v18.i44.6357; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; GOODMAN DS, 1965, J LIPID RES, V6, P390; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Rubin DC, 1996, AM J PHYSIOL-GASTR L, V270, pG143; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; COLANTUONI V, 1985, BIOCHEM BIOPH RES CO, V130, P431, DOI 10.1016/0006-291X(85)90435-8; Dodson BD, 1996, AM J PHYSIOL-GASTR L, V271, pG347; Hebiguchi T, 2001, J PEDIATR GASTR NUTR, V32, P586, DOI 10.1097/00005176-200105000-00018; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; NEWCOMER ME, 1995, FASEB J, V9, P229; ONG DE, 1978, J BIOL CHEM, V253, P828; ONG DE, 1987, J BIOL CHEM, V262, P2729; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3; Senoo H, 2013, CELL BIOL INT, V37, P1171, DOI 10.1002/cbin.10140; SHERMAN DR, 1987, P NATL ACAD SCI USA, V84, P3209, DOI 10.1073/pnas.84.10.3209; Taguchi S, 2005, J PEDIATR SURG, V40, P1592, DOI 10.1016/j.jpedsurg.2005.06.037; TAKASE S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P223, DOI 10.1016/0304-4165(93)90140-4; WAKABAYASHI Y, 1994, J BIOL CHEM, V269, P32667; Wall EA, 2013, J ACAD NUTR DIET, V113, P1200, DOI 10.1016/j.jand.2013.05.001; Wang JL, 1997, J NUTR, V127, P1297; Wang L, 2007, AM J PHYSIOL-GASTR L, V292, pG1559, DOI 10.1152/ajpgi.00567.2006; YOST RW, 1988, J BIOL CHEM, V263, P18693; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAR	2015	35	3					724	730		10.3892/ijmm.2015.2066		7	Medicine, Research & Experimental	Research & Experimental Medicine	CD2OD	WOS:000350918000018		
J	Wu, YY; Sato, H; Suzuki, T; Yoshizawa, T; Morohashi, S; Seino, H; Kawamoto, T; Fujimoto, K; Kato, Y; Kijima, H				Wu, Yunyan; Sato, Hidenobu; Suzuki, Takahiro; Yoshizawa, Tadashi; Morohashi, Satoko; Seino, Hiroko; Kawamoto, Takeshi; Fujimoto, Katsumi; Kato, Yukio; Kijima, Hiroshi			Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						differentiated embryonic chondrocyte expressed gene 1; differentiated embryonic chondrocyte expressed gene 2; hypoxia; MCF-7	TUMOR HYPOXIA; GENE-EXPRESSION; MOLECULAR CLOCK; APOPTOSIS; TARGET; DOWNSTREAM; METABOLISM; MECHANISMS; REPRESSION; THERAPY	Differentiated embryonic chondrocyte expressed gene 1 (DEC1; BHLHE40/STRA13/SHARP2) and differentiated embryonic chondrocyte expressed gene 2 (DEC2; BHLHE41/SHARP 1) are basic helix-loop-helix (bHLH) transcriptional factors that are involved in the regulation of cell differentiation, circadian rhythms, response to hypoxia and carcinogenesis. Previous studies have demonstrated that the expression of DECs is induced under hypoxic conditions in various normal and cancer cell lines. In the present study, using RT-qPCR and western blot analysis, we demonstrated that hypoxia induced the expression of DEC1 and DEC2 in MCF-7 human breast cancer cells; their expression levels reached a peak at different time points. In particular, we found that the expression pattern of the hypoxia-inducible factor (HIF)-1 alpha protein was similar to DEC1, and that of the HIF-2 alpha protein was identical to that of DEC2. The knockdown of HIF-2a using siRNA suppressed the phosphorylation of Akt, as well as the expression of DEC2 and c-Myc. Hypoxia failed to affect the expression of DEC2 and c-Myc when the PI3K/Akt signaling pathway was blocked. In addition, the overexpression of DEC1 and DEC2 was induced by transfecting the cells with a pcDNA vector. The overexpression of DEC2, but not that of DEC1, increased the proliferation of the MCF-7. cells under both normoxic and hypoxic conditions. Concomitantly, the expression of c-Myc was upregulated by exposure to hypoxia and by the overexpression of DEC2. In conclusion, DEC2 participates in hypoxia-induced cell proliferation by functioning as a target gene of the PI3K/Akt signaling pathway and regulating the expression of c-Myc.	[Wu, Yunyan; Sato, Hidenobu; Suzuki, Takahiro; Yoshizawa, Tadashi; Morohashi, Satoko; Seino, Hiroko; Kijima, Hiroshi] Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, Hirosaki, Aomori 0368562, Japan; [Kawamoto, Takeshi; Fujimoto, Katsumi; Kato, Yukio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan	Wu, YY (reprint author), Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yunyanwu@cc.hirosaki-u.ac.jp	Kawamoto, Takeshi/D-7938-2015	Kawamoto, Takeshi/0000-0003-3337-1775	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for Hirosaki University Institutional Research; Fund for the Promotion of International Scientific Research	The present study was supported by Grants-in-Aid for Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant for Hirosaki University Institutional Research and the Fund for the Promotion of International Scientific Research.	Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01038; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.20.3.680; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Hoffman B, 1998, ONCOGENE, V17, P3351; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.271714999; Yamada K, 2003, J BIOL CHEM, V278, P30719, DOI 10.1074/jbc.M301597200; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Wu YY, 2011, INT J MOL MED, V27, P491, DOI 10.3892/ijmm.2011.617; Wu YY, 2012, INT J ONCOL, V41, P1337, DOI 10.3892/ijo.2012.1559; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Fujimoto K, 2007, INT J MOL MED, V19, P925; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; BISHOP JM, 1982, ADV CANCER RES, V37, P1, DOI 10.1016/S0065-230X(08)60880-5; Weng WH, 2011, BIOCHEM BIOPH RES CO, V405, P278, DOI 10.1016/j.bbrc.2011.01.028; Hamaguchi H, 2004, BIOCHEM J, V382, P43; Hockel M, 1996, CANCER RES, V56, P4509; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Yamada K, 2005, FRONT BIOSCI, V10, P3151, DOI 10.2741/1772; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; PACKHAM G, 1995, BBA-REV CANCER, V1242, P11, DOI 10.1016/0304-419X(94)00015-T; Zhang L, 2007, ACTA PHARMACOL SIN, V28, P549, DOI 10.1111/j.1745-7254.2007.00516.x	41	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAR	2015	35	3					815	820		10.3892/ijmm.2014.2042		6	Medicine, Research & Experimental	Research & Experimental Medicine	CD2OD	WOS:000350918000031		
J	Iwata, H; Mori, E; Tsuchiya, M; Sakajo, A; Saeki, A; Maehara, K; Ozawa, H; Morita, A; Maekawa, T				Iwata, Hiroko; Mori, Emi; Tsuchiya, Miyako; Sakajo, Akiko; Saeki, Akiko; Maehara, Kunie; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko			Objective sleep of older primiparous Japanese women during the first 4 months postpartum: An actigraphic study	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						actigraphy; maternal age; postpartum; sleep; sleep deprivation	MATERNAL AGE; PREGNANCY; DEPRESSION; QUALITY; MOTHER; RHYTHM; LOGS	This longitudinal study was designed to examine objective sleep parameters of older primiparous Japanese women during the first 4 months postpartum using actigraphy. The participants were 18 older primiparae (Mean (SD)=37.06 (2.62) years, range 35-44 years) who gave birth to healthy neonates at one of three urban Japanese hospitals. Objective sleep quality was measured using actigraphy for 48h at 1, 2 and 4 months postpartum. The Friedman test was used to test for differences in sleep parameters across time. Sleep duration (SMIN) increased significantly from 2 months (Mean (M)=301.94min) to 4 months (M=372.78min). Sleep efficiency (SE) increased significantly from 1 month (73.52%) to 2 (86.66%) and 4 months (89.05%). Waking after sleep onset (WASO) decreased significantly from 1 month (M=114.64min) to 2 (M=40.18min) and 4 months (M=38.36min) and long waking episodes (LWEP) significantly decreased from 1 month (4.67) to 2 (2.69) and 4 months (3.12). Persistent postpartum sleep problems can be a sign of postpartum depression as well as health problems among infants.	[Iwata, Hiroko; Mori, Emi; Tsuchiya, Miyako; Sakajo, Akiko; Saeki, Akiko; Maehara, Kunie; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko] Chiba Univ, Grad Sch Nursing, Chiba, Japan	Iwata, H (reprint author), Chiba Univ, Grad Sch Nursing, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608672, Japan.	iwthiroko@faculty.chiba-u.jp			Funding Program for the Next Generation World-Leading Research from Cabinet Office, Japan [LS022]	This study was supported by the Funding Program for the Next Generation World-Leading Research (No. LS022) from the Cabinet Office, Japan.	Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Posmontier B, 2008, JOGNN-J OBST GYN NEO, V37, P722, DOI 10.1111/j.1552-6909.2008.00298.x; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Treacy A, 2006, AM J OBSTET GYNECOL, V195, P760, DOI 10.1016/j.ajog.2006.05.052; Matsumoto K, 2011, J AFFECT DISORDERS, V133, P607, DOI 10.1016/j.jad.2011.04.024; Mori E, 2014, INT J NURS PRACT, V20, P20, DOI 10.1111/ijn.12246; Matsumoto K, 2003, BIOL RHYTHM RES, V34, P265; Carolan M, 2003, JOGNN, V32, P19, DOI 10.1177/0884217502239797; COLE RJ, 1992, SLEEP, V15, P461; Nishihara K, 2002, PHYSIOL BEHAV, V77, P91, DOI 10.1016/S0031-9384(02)00846-6; Carolan Mary, 2004, Contemp Nurse, V18, P133; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Horiuchi S, 1990, JAPAN J NURSING SCI, V10, P8; Horiuchi S, 1994, JPN ACAD NURS SCI, V14, P38; Horiuchi S, 1999, PSYCHIAT CLIN NEUROS, V53, P137, DOI 10.1046/j.1440-1819.1999.00519.x; Horiuchi S, 2002, ST LUKES COLL B, V28, P18; Inui T, 2008, J JAPAN ACAD MIDWIFE, V22, P189; Israel SA, 2003, SLEEP, V26, P342; Japanese Society of Sleep Research, 2009, HDB SLEEP RES; Ministry of Health Labor and Welfare, 2006, DEM SURV FISC YEAR 2; Motono S, 2013, JOSANZASSHI, V67, P721; Rychnovsky J, 2009, WOMEN HEALTH ISS, V19, P38, DOI 10.1016/j.whi.2008.07.015; Shinkoda H, 2000, MEMOIRS KYUSHU U SCH, p[27, 47]; Shinkoda H, 2002, MEMOIRS KYUSHU U SCH, V29, P97; Signal TL, 2007, AUST NZ J OBSTET GYN, V47, P16, DOI 10.1111/j.1479-828X.2006.00672.x; Sugiura M, 2013, PERINATAL MED, V43, P829; Tsai SY, 2011, BIOL RES NURS, V13, P80, DOI 10.1177/1099800410378889; Yamazaki A, 2005, JOGNN-J OBST GYN NEO, V34, P342, DOI 10.1177/0884217505276156	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	MAR	2015	21			1	SI		2	9		10.1111/ijn.12391		8	Nursing	Nursing	CD5YG	WOS:000351164100002		
J	Mori, E; Maehara, K; Iwata, H; Sakajo, A; Tsuchiya, M; Ozawa, H; Morita, A; Maekawa, T; Saeki, A				Mori, Emi; Maehara, Kunie; Iwata, Hiroko; Sakajo, Akiko; Tsuchiya, Miyako; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko; Saeki, Akiko			Comparing older and younger Japanese primiparae: Fatigue, depression and biomarkers of stress	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						fatigue; depression; stress; Japanese; primiparity; middle age	ADVANCED MATERNAL AGE; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; WOMEN; BIRTH; CHILDBEARING; EXPERIENCES; RISK	This cohort study of primiparae was conducted to answer the following questions: Do older (35 years) and younger (20-29 years) Japanese primiparous mothers differ when comparing biomarkers of stress and measures of fatigue and depression? Are there changes in fatigue, depression and stress biomarkers when comparing older and younger mothers during the postpartum period? The Postnatal Accumulated Fatigue Scale and the Edinburgh Postnatal Depression Scale were administered in a time-series method four times: shortly after birth and monthly afterwards. Assays to measure biomarkers of stress, urinary 17-ketosteroids, urinary 17-hydroxycorticosteroids and salivary chromogranin-A, were collected shortly after delivery and at 1 month postpartum in both groups and a third time in older mothers at the 4th month. Statistical testing showed very little difference in fatigue, depression or stress biomarkers between older and younger mothers shortly after birth or 1 month later. Accumulated fatigue and depression scores of older mothers were highest 1 month after delivery. Additional cohort studies are required to characterize physical/psychological well-being of older Japanese primiparae.	[Mori, Emi; Maehara, Kunie; Iwata, Hiroko; Sakajo, Akiko; Tsuchiya, Miyako; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko; Saeki, Akiko] Chiba Univ, Grad Sch Nursing, Chiba, Japan	Mori, E (reprint author), Chiba Univ, Grad Sch Nursing, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608762, Japan.	mori@faculty.chiba-u.jp			Funding Program for the Next Generation World-Leading Research, Cabinet Office, Japan [LS022]	The researchers would like to sincerely thank the mothers who participated in this study and the staffs at the institutions involved in this survey. This study was supported by the Funding Program for the Next Generation World-Leading Research (No. LS022), Cabinet Office, Japan.	Yoshida K, 1997, J AFFECT DISORDERS, V43, P69, DOI 10.1016/S0165-0327(96)01419-X; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; Matsumoto K, 2011, J AFFECT DISORDERS, V133, P607, DOI 10.1016/j.jad.2011.04.024; Amir LH, 1996, J PSYCHOSOM OBST GYN, V17, P53, DOI 10.3109/01674829609025664; Windridge KC, 1999, BIRTH-ISS PERINAT C, V26, P16, DOI 10.1046/j.1523-536x.1999.00016.x; PUGH LC, 1995, APPL NURS RES, V8, P140, DOI 10.1016/S0897-1897(95)80593-1; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Mori E, 2014, INT J NURS PRACT, V20, P20, DOI 10.1111/ijn.12246; Reece SM, 1996, APPL NURS RES, V9, P148, DOI 10.1016/S0897-1897(96)80278-3; Biro MA, 2012, AUST NZ J OBSTET GYN, V52, P229, DOI 10.1111/j.1479-828X.2012.01427.x; Satoh A, 2009, JPN J NURS SCI, V6, P27, DOI 10.1111/j.1742-7924.2009.00121.x; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Bozoky I, 2002, JOGNN, V31, P436, DOI 10.1111/j.1552-6909.2002.tb00066.x; Carolan Mary, 2003, Aust J Midwifery, V16, P17, DOI 10.1016/S1031-170X(03)80004-1; Fujioka N, 2014, JAPANESE J MATERNAL, V54, P563; Furuya E, 1998, JPN J CLIN PATHOL, V46, P529; Maehara N, 2004, JOB STRESS RES, V11, P219; Ministry of Health Labour and Welfare, 2014, VIT STAT JAP; Ministry of Health Labour and Welfare, 2003, SELF ADM CHECKL CUM; Mothers' & Children's Health & Welfare Association, 2003, MAT CHILD HLTH STAT, P48; Murakami A, 2008, J JAPAN ACAD MIDWIFE, V22, P136; Nakane H, 1999, R D REV TOYOTA CRDL, V34, P17; Nishikawa Y, 1998, BIOMED RES-TOKYO, V19, P245; Nishikaze O, 1995, JOB STRESS RES, V3, P55; Nishikaze Osamu, 1998, Journal of UOEH, V20, P273; Nishiumi H, 2012, JAPANESE J MATERNAL, V53, P277; Ohga A, 2009, YOKOHAMA J NURSING, V2, P64; Okano T MM, 1996, ARCH PSYCHIAT DIAGN, V7, P525; Rychnovsky J, 2009, WOMEN HEALTH ISS, V19, P38, DOI 10.1016/j.whi.2008.07.015; Tabata J, 2009, WOMENS HLTH SOC J JA, V8, P59; Tamaki R, 1997, PSYCHIAT CLIN NEUROS, V51, P93, DOI 10.1111/j.1440-1819.1997.tb02368.x	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	MAR	2015	21			1	SI		10	20		10.1111/ijn.12392		11	Nursing	Nursing	CD5YG	WOS:000351164100003		
J	Gonzales, L; Koci, A; Gee, RM; Noji, A; Glaser, D; Marsh, AK; Marsh, KK; Altman, AM; Al Salmi, N; Al Sabei, S				Gonzales, Lucia; Koci, Anne; Gee, Rose Mary; Noji, Ariko; Glaser, Dale; Marsh, Allison K.; Marsh, Kathy K.; Altman, Amara Michella; Al Salmi, Nasser; Al Sabei, Sulaiman			Caring for women globally: Psychometric testing of two instruments translated into five languages for use in cardiovascular recovery	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						cardiovascular disease; female; marginality; religion; social isolation; social support	HEART-FAILURE; CARDIAC REHABILITATION; MYOCARDIAL-INFARCTION; OLDER-ADULTS; DISEASE; PREDICTORS; OUTCOMES; HEALTH; RELIGIOUSNESS/SPIRITUALITY; ASSOCIATION	Among women, cardiovascular disease is the leading cause of mortality worldwide. After experiencing an acute cardiovascular event, a woman's physical health, the prevalence of morbidities, likelihood of being treated with coronary artery bypass graft surgery, likelihood for referral for cardiac rehabilitation are less favourable than men. The social support resources of marginality and religiousness are associated with physical and mental health outcomes following cardiovascular crises. This study aimed to evaluate the reliability and validity of the translated versions (Japanese, Ukrainian, Tagalog, Hispanic and Arabic) of the Koci Marginality Index and the Duke University Religion Index among 282 women (aged 35-92 years) representing seven cultures. Results showed that reliability and validity were strong (coefficient alpha of 0.79 and 0.84). Understanding a woman's social isolation and whether she has a connection to religious groups assists health-care professionals to identify a woman's social support resources during recovery following acute cardiovascular episodes.	[Gonzales, Lucia; Marsh, Kathy K.; Altman, Amara Michella] Univ San Diego, San Diego, CA 92110 USA; [Koci, Anne] Texas Womans Univ, Houston, TX USA; [Gee, Rose Mary] Georgia So Univ, Statesboro, GA 30460 USA; [Noji, Ariko] Chiba Univ, Chiba, Japan; [Glaser, Dale] Glaser Consulting, San Diego, CA USA; [Marsh, Allison K.] Harlem Childrens Zone, New York, NY USA; [Al Salmi, Nasser] Sultan Qaboos Univ, Coll Nursing, Muscat, Oman; [Al Sabei, Sulaiman] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Gonzales, L (reprint author), Univ San Diego, Hahn Sch Nursing, Betty & Bob Beyster Inst Nursing Res Adv Practice, 5998 Alcala Pk, San Diego, CA 92110 USA.	lgonzales@sandiego.edu			Georgia Southern University	Francisco Magno, PhD, Assistant Professor, De La Salle University, Manila, Philippines; Alexey Nogovitsyn, Chief Language Teacher, Institute of Languages, Moscow, Russia; Amado Marquez, B.S., Coordinator, Los Angeles, Tagalog Focus Group; Olga Yanochik, Advisor, Statesboro, GA, Ukrainian Focus Group; Alexander Malov, Director of International Affairs, Ukraine; Harold Previl MD, Medical Director of Hopitel Sacre Coeur, Milot, Haiti; Emmanuela Beliard RN, Charge Nurse, Milot, Haiti; Susie Hutchins DNP, Associate Clinical Professor, University of San Diego; Fujiko Miyahara, President, Gender Research Association, Tokyo, Japan. University of San Diego Masters nursing students: Jason Malig, Derrick Duarte, Sarah Moore, Elizabeth Cianci, Brooke Sullivan, Alison Dorsey, Amanda O'Keefe, Lisa Kass, Allegra Conway, Allie Floyd, Kathryn Jepsen, Ana Kaviani, Lynell Lemon, Mike Manriquez, Mariana Mendez, Christina Nichols, Briana Riordan, Anthony Rodelo, Terri Phan, Brian Wilson, A. J. Tio, Nathan Figueroa, Scott Teerlink, Regina Phorn, Theresa Timony, Khristine Vinluan, Jillian Oliver, Anna Prendergast, Casey Hines, Jane Sorrentino, Melissa Meadows, Ariane Palma, Mary Ghattas, Madeline Pratt, Tatiana Guertin, Natalie Pung, Alicia Andrews, Shannon Nunnery Carter; Sally Brosz Hardin Dean's Faculty Award, Hahn School of Nursing, Betty and Bob Beyster Institute for Nursing Research, Advanced Practice and Simulation, University of San Diego, San Diego, California and Intramural funding from the Georgia Southern University.	Ai AL, 2011, J BEHAV MED, V34, P532, DOI 10.1007/s10865-011-9334-8; Daniel M, 2008, HEALTH PLACE, V14, P117, DOI 10.1016/j.healthplace.2007.05.003; PRESSMAN P, 1990, AM J PSYCHIAT, V147, P758; Contrada RJ, 2008, HEALTH PSYCHOL, V27, P309, DOI 10.1037/0278-6133.27.3.309; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Zeng Y, 2011, RES AGING, V33, P51, DOI 10.1177/0164027510383584; Masters KS, 2013, J CONSULT CLIN PSYCH, V81, P206, DOI 10.1037/a0030813; Perelman J, 2010, SOC SCI MED, V71, P25, DOI 10.1016/j.socscimed.2010.03.026; Koenig HG, 1998, INT J PSYCHIAT MED, V28, P189; Davidson P, 2008, J WOMENS HEALTH, V17, P123, DOI 10.1089/jwh.2007.0386; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Rozanski A, 1999, CIRCULATION, V99, P2192; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; Bustreo F, 2013, B WORLD HEALTH ORGAN, V91, P623; Eliassen BM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-522; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hybels CF, 2014, J AGING HEALTH, V26, P679, DOI 10.1177/0898264314527479; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Kamm-Steigelman Lucia, 2006, Issues Ment Health Nurs, V27, P141, DOI 10.1080/01612840500436925; King A, 2011, NAT REV CARDIOL, V8, P239, DOI 10.1038/nrcardio.2011.49; Kline R. B., 2005, PRINCIPLES PRACTICE; Koci Anne Floyd, 2012, Issues Ment Health Nurs, V33, P858, DOI 10.3109/01612840.2012.713081; Koci A, 2004, THESIS EMORY U ATLAN; Koci AF, 2004, THESIS; Koenig HG, 2008, MED RELIG HLTH; Koenig HG, 2011, HDB RELIG HLTH; Lei P.W., 2012, HDB STRUCTURAL EQUAT, P164; Lorber J, 2002, GENDER SOCIAL CONSTR; Maric C, 2010, GENDER MED, V7, P551, DOI 10.1016/j.genm.2010.11.007; Martin Lisa M, 2012, Cardiovasc Revasc Med, V13, P321, DOI 10.1016/j.carrev.2012.09.002; Mosca Lori, 2011, Circulation, V123, P1243, DOI 10.1161/CIR.0b013e31820faaf8; Parashar S, 2012, CIRCULATION, V126, P1587, DOI 10.1161/CIRCULATIONAHA.111.088799; Park CL, 2014, J RELIG HEALTH, V53, P579, DOI 10.1007/s10943-013-9714-1; Plach Sandra K, 2003, Health Care Women Int, V24, P327, DOI 10.1080/07399330390191698; Plach SK, 2006, RES NURS HEALTH, V29, P452, DOI 10.1002/nur.20156; Sacco SJ, 2014, HEART LUNG, V43, P213, DOI 10.1016/j.hrtlng.2014.01.012; Strickland O, 2001, J NURSING MEASUREMEN, V9, P111; Thombs BD, 2008, HEALTH PSYCHOL, V27, P1, DOI 10.1037/0278-6133.27.1.1a; United Nations Secretary General's Millennium Development Goals Advocacy Group, 2014, ACC ACT GLOB LEAD CH; United States Department of State, 2004, US DEP STAT COUNTR R; US Census Bureau, 2012, STAT ABSTR US 2012; Wenger N, 2010, CARDIOLOGY TODAY; West S. G., 2012, HDB STRUCTURAL EQUAT, P209; WHO, 2008, GLOB BURD DIS 2004 U; WHO, 2010, CAUS DEATH 2008 DAT; World Bank, 2014, GDP PER CAP CURR US; ZUCKERMAN DM, 1984, AM J EPIDEMIOL, V119, P410	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	MAR	2015	21			1	SI		27	37		10.1111/ijn.12393		11	Nursing	Nursing	CD5YG	WOS:000351164100005		
J	Guo, XD; Saito, S; Yamamoto, T				Guo, Xiaodong; Saito, Shinobu; Yamamoto, Toshie			Strengths and capabilities of Chinese patients with severe ocular injuries: A qualitative study	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						blindness; eye injury; nursing; patient education; qualitative research; rehabilitation		The purpose of this qualitative study is to illustrate health-centred nursing by assessing the capabilities of patients with acute and severe ocular injuries. This study draws upon analyzing 17 nursing encounters with four adult male patients admitted to the ophthalmological ward of a university hospital in a rural Chinese city. The analysis identified that patients demonstrated the following strengths: (i) comprehension; (ii) self-reflection and examination; (iii) cooperation; (iv) patience and self-control; (v) self-efficacy; (vi) proactive acceptance; (vii) independence and a positive attitude towards challenges; (viii) support from family members; (ix) volition; and (x) flexibility. The results of this study highlight the importance of observing patients, assessing their abilities and helping them mobilize these strengths for recovery.	[Guo, Xiaodong] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Saito, Shinobu] Minist Educ Culture Sports Sci & Technol Japan, Nursing Educ, Med Educ Div, Higher Educ Bur, Tokyo, Japan; [Yamamoto, Toshie] Chiba Univ, Sch Nursing, Dept Fundamental Nursing, Chiba, Japan	Yamamoto, T (reprint author), Chiba Univ, Sch Nursing, Dept Fundamental Nursing, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608672, Japan.	ytoshie@faculty.chiba-u.jp					Guo YH, 2011, CHINESE HOSP, V15, P2; Hayashi S., 1995, STRESS COPING INTRO, P21; Imagawa E, 1995, NURSING TECHNOLOGY, V41, P1612; Imagawa E, 2004, J JAPAN SOC NURSING, V14, P20; Ishii H., 1996, NURSING TECHNOLOGY, V41, P1568; Liu MP., 2011, BASIC NURSING, P5; Usui H., 1997, KAGAKUTEKI KANGORON; Usui H., 1994, FOCUS POISONING DECA, P6; Xu JF, 2004, INT J OPHTHALMOLOGY, V4, P95; Yuan LJ, 2008, J HARBIN MED U, V42, P102; Zhang WB, 2001, CHINESE PRIMARY HLTH, V15, P22; Zhou HZ, 2002, J INJURIES OCCUPATIO, V24, P33	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	MAR	2015	21			1	SI		38	44		10.1111/ijn.12397		7	Nursing	Nursing	CD5YG	WOS:000351164100006		
J	Morse, JM; Clark, L; Haynes, T; Noji, A				Morse, Janice M.; Clark, Lauren; Haynes, Tracii; Noji, Ariko			Providing cultural care behind the spotlight at the Olympic Games	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						emergency care; epidemiology; Olympics; nursing; transcultural care	SPORTS INJURIES; STATEMENT; ILLNESS	The Olympic Games constitutes the world's largest sporting event. Nurses play an important, but poorly discussed, role in emergency care, routine clinical care and preventive care for athletes from many cultures as well as an enormous influx of spectators. In this article, we discuss five important considerations when preparing nurses to provide safe care for Olympians: elite athletes as a cultural group; caring for the Olympic family; disaster preparedness and security; infection control; and principles of transcultural nursing. Because of the nature of the sports and types of injuries and the effects of climate, these challenges differ somewhat between the summer and winter Olympics. Nevertheless, the Olympic games provide a tremendous opportunity to experience transcultural nursing and to highlight how nurses play a significant role in the care of the athletes, the Olympic family, and the spectators.	[Morse, Janice M.; Clark, Lauren; Haynes, Tracii] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA; [Noji, Ariko] Chiba Univ, Grad Sch Nursing, Chiba, Japan	Morse, JM (reprint author), Univ Utah, Coll Nursing, 10 South 2000 East, Salt Lake City, UT 84112 USA.	Janice.Morse@nurs.utah.edu			Ministry of Education, Science, Sports and Culture, Japan [2013-2016(25253107)]	This article was developed from a presentation at the 1st Asian Nurses Cultural Competence Conference, Chiba, Japan, 8-9 March 2014, supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research(A), 2013-2016(25253107, to Ariko Noji). We thank Pam Proctor, MSc, for her assistance with this article.	Allen TL, 2006, J EMERG MED, V30, P197, DOI 10.1016/j.jemermed.2005.07.006; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; [Anonymous], 2004, ASS PRESS       0213; Harris M, 2012, QUAL HEALTH RES, V22, P31, DOI 10.1177/1049732311420579; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Gundlapalli AV, 2007, AM J INFECT CONTROL, V35, P163, DOI 10.1016/j.ajic.2006.08.003; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144; Bosanquet J, 2012, NURSING STANDARD, V26, P20; Dean Erin, 2012, Emerg Nurse, V20, P22; Duffin Christian, 2011, Nurs Stand, V25, P22; Feiner JR, 2007, ANESTH ANALG, V105, pS18, DOI 10.1213/01.ane.0000285988.35174.d9; Fimrite R, 1996, OLYMPIC DAILY; Kleinman A., 1980, PATIENTS HEALERS CON; Leininger M M, 1988, Nurs Sci Q, V1, P152, DOI 10.1177/089431848800100408; MCCAFFERY M, 1988, CAN MED ASSOC J, V138, P151; Pabani Aysha, 2012, Br J Nurs, V21, P935; Persson A, 2014, QUAL HEALTH RES, V24, P6, DOI 10.1177/1049732313514139; Reeser Jonathan C, 2003, WMJ, V102, P20; Samatas M., 2007, INT CRIMINAL JUSTICE, V17, P220, DOI 10.1177/1057567707306649; Taunton J, 2011, BRIT J SPORT MED, V45, P376; United Press International (UPI), 1983, NEW YORK TIM SP 0717; Venning Pam, 2012, Br J Nurs, V21, P173; World Anti-Doping Agency, 2015, WORLD ANT COD; Zborowski M., 1969, PEOPLE IN PAIN, V1st; Zhang X., 2009, MANAGEMENT NURSING P	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	MAR	2015	21			1	SI		45	51		10.1111/ijn.12394		7	Nursing	Nursing	CD5YG	WOS:000351164100007		
J	Tan, SL; Shimizu, Y; Meguro, T; Ito, S; Gao, W				Tan, Siew Leng; Shimizu, Yuki; Meguro, Takayuki; Ito, So; Gao, Wei			Design of a Laser Autocollimator-based Optical Sensor with a Rangefinder for Error Correction of Precision Slide Guideways	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Autocollimator; Laser rangefinder; Linear slide; Measurement; Position; Tilt angle	DISTANCE MEASUREMENT; SURFACE ENCODER; STAGE; MOTION; SYSTEM	This paper presents the design and construction of a laser autocollimator-based optical sensor for measurement of the tilt angles of a reflector mounted on the guideways or the moving table of a precision linear slide in the production process of the slide, where the measurement is repeatedly carried out together with a hand scraping operation for correction of the form errors of the slide guideways. Differing from a conventional autocollimator, a laser rangefinder unit is integrated with the autocollimation unit for detection of the positions of the reflector, which is necessary for the efficient error correction of the slide guideways. The autocollimation unit and the rangefinder unit share the same light source for a compact optical design. The optical power of the laser beam is first set to be constant for tilt angles measurement. Then the optical power is modulated with a frequency of 66.7 MHz for measuring the position/distance based on the phase shift method. The resolution of the laser autocollimator is confirmed to be 0.2 arc-second over a range of +/-50 arc-seconds while the measurement positions can be detected with a resolution of 1 mm by the rangefinder, which satisfies the requirements from production of the slide.	[Tan, Siew Leng; Shimizu, Yuki; Meguro, Takayuki; Ito, So; Gao, Wei] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan	Shimizu, Y (reprint author), Tohoku Univ, Dept Nanomech, Aoba Ku, 6-6-01 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	yuki.shimizu@nano.mech.tohoku.ac.jp					Kim WJ, 2007, PRECIS ENG, V31, P337, DOI 10.1016/j.precisioneng.2007.02.001; Gao W, 2011, CIRP ANN-MANUF TECHN, V60, P515, DOI 10.1016/j.cirp.2011.03.052; Gao W, 2006, PRECIS ENG, V30, P96, DOI 10.1016/j.precisioneng.2005.06.003; Joo KN, 2006, OPT EXPRESS, V14, P5954, DOI 10.1364/OE.14.005954; Li XH, 2013, PRECIS ENG, V37, P771, DOI 10.1016/j.precisioneng.2013.03.005; Buice ES, 2009, PRECIS ENG, V33, P418, DOI 10.1016/j.precisioneng.2008.11.001; Kimura A, 2012, PRECIS ENG, V36, P576, DOI 10.1016/j.precisioneng.2012.04.005; Otsuka J, 2005, MEAS SCI TECHNOL, V16, P2186, DOI 10.1088/0957-0233/16/11/008; ENNOS AE, 1982, PRECIS ENG, V4, P5, DOI 10.1016/0141-6359(82)90106-4; Amann MC, 2001, OPT ENG, V40, P10, DOI 10.1117/1.1330700; Fan KC, 2012, MEASUREMENT, V45, P384, DOI 10.1016/j.measurement.2011.11.006; Farago F. T., 1994, HDB DIMENSIONAL MEAS, P302; GAO W, 2010, SPRINGER SER ADV MAN, P1; Gueuning FE, 1997, IEEE T INSTRUM MEAS, V46, P1236, DOI 10.1109/19.668260; Hecht E., 2002, OPTICS, P583; Hwang J, 2007, INT J MACH TOOL MANU, V47, P1053, DOI 10.1016/j.ijmachtools.2006.10.003; Kunzmann H, 1993, CIRP ANN-MANUF TECHN, V42, P753, DOI 10.1016/S0007-8506(07)62538-4; Leica Geosystems, DISTO LITE5 MAN VERS; Mitsui Seiki Co. Ltd, TOPICS SCRAPING; Moore W. R., 1970, FDN MECH ACCURACY; Oiwa T., 2011, INT J AUTOMATION TEC, V5, P766; Saito Y, 2009, SENSOR ACTUAT A-PHYS, V150, P175, DOI 10.1016/j.sna.2008.12.019; Saito Y, 2007, INT J PRECIS ENG MAN, V8, P14; Saito Y, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/5/054006; Slocum A. H., 1992, PRECISION MACHINE DE; Zhang JH, 1999, MEAS SCI TECHNOL, V10, P1247, DOI 10.1088/0957-0233/10/12/317	26	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	MAR	2015	16	3					423	431		10.1007/s12541-015-0058-5		9	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CD2QI	WOS:000350923700002		
J	Uchimura, K; Ngamvithayapong-Yanai, J; Kawatsu, L; Ohkado, A; Yoshiyama, T; Ito, K; Ishikawa, N				Uchimura, K.; Ngamvithayapong-Yanai, J.; Kawatsu, L.; Ohkado, A.; Yoshiyama, T.; Ito, K.; Ishikawa, N.			Permanent employment or public assistance may increase tuberculosis survival among working-age patients in Japan	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						TB; death; employment; health insurance; public assistance	RISK-FACTORS; HEALTH; DEATH; MORTALITY; WORKERS; RUSSIA; STATES	OBJECTIVES: To measure the effect of employment and health insurance status on the survival of working age tuberculosis (TB) patients in Japan. METHODS: Retrospective cohort analysis of new smear-positive pulmonary TB patients aged 15-59 years registered in the Japanese national TB surveillance system between 2007 and 2010. We performed univariate and multivariate Cox proportional hazard model analysis. The survival curves for employment and health insurance status were calculated using Kaplan-Meier analysis. RESULTS: Of 9097 patients studied, 267 (2.9%) died of TB within 12 months. After adjustment with a multivariate model, employment and health insurance status were independently associated with increased risk of TB death: unemployment (HR 2.80, 95 %CI 2.11-3.72), absence of insurance (HR 1.48, 95%Cl 1.02-2.15). The analysis of survival curves indicated that those with public assistance had almost the same survival rate as insured patients in the unemployed group. Permanent workers (employed >30 days) had the highest survival rates, followed by casual workers (employed <30 days) and the unemployed in the insured group. CONCLUSION: Patients with permanent jobs had better survival rates than unemployed patients and casual workers. Despite being unemployed, receiving public assistance could improve survival. Health measures are required for the unemployed and casual workers.	[Uchimura, K.; Ngamvithayapong-Yanai, J.; Kawatsu, L.; Ohkado, A.; Ito, K.; Ishikawa, N.] Japan AntiTB Assoc RIT JATA, Res Inst TB, Kiyose, Tokyo 2048533, Japan; [Yoshiyama, T.] Fukujuji Hosp, RIT JATA, Tokyo, Japan	Uchimura, K (reprint author), Japan AntiTB Assoc RIT JATA, Res Inst TB, 3-1-24 Matsuyama, Kiyose, Tokyo 2048533, Japan.	uchimura@jata.or.jp			Ministry of Health, Labour, and Welfare, Tokyo, Japan	This study was supported by the Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare, Tokyo, Japan.	Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Diel R, 2003, INT J TUBERC LUNG D, V7, P124; Fukuda Y, 2007, PUBLIC HEALTH, V121, P163, DOI 10.1016/j.puhe.2006.10.015; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Nishikitani M, 2012, SOC SCI MED, V75, P439, DOI 10.1016/j.socscimed.2011.11.039; Wang WB, 2013, INT J TUBERC LUNG D, V17, P493, DOI 10.5588/ijtld.12.0400; Kim IH, 2012, HEALTH POLICY, V104, P99, DOI 10.1016/j.healthpol.2011.11.002; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244; Danno K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001489; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; Gray KA, 2005, AFFILIA J WOM SOC WO, V20, P329, DOI 10.1177/0886109905277752; Inoue M, 2012, AM J IND MED, V55, P884, DOI 10.1002/ajim.22090; Japan Ministry of Internal Affairs and Communications, 2013, LAB FORC SURV 2013; Kawasaki Takeshi, 2009, Kekkaku, V84, P667; Kuba M, 1996, Kekkaku, V71, P293; Matsumoto Kenji, 2011, Kekkaku, V86, P815; Ministry of Health Labour and Welfare, 2010, EST LOW INC HOUS PUB; Ministry of Health Labour and Welfare, 2012, REP SOC WELF ADM SER; National Institute of Population and Social Security Research, 2011, SOC SEC JAP 2011; Nishikiori Nobuyuki, 2013, Western Pac Surveill Response J, V4, P1, DOI 10.5365/WPSAR.2013.4.1.007; Okumura Masao, 2011, Kekkaku, V86, P863; Ploubidis GB, 2012, EUR RESPIR J, V40, P925, DOI 10.1183/09031936.00184011; Rice MC, 2007, NURS OUTLOOK, V55, P220, DOI 10.1016/j.outlook.2006.10.003; Sasaki Y, 1996, Kekkaku, V71, P427; Shen X, 2009, BMC INFECT DIS, V17, P995; Shikato M, 2011, CHUNENNREISOUDANSEI; Siddiqi K, 2001, Commun Dis Public Health, V4, P242; Tocque K, 1999, EUR RESPIR J, V13, P541, DOI 10.1183/09031936.99.13354199; Tsutsumi A, 2009, J OCCUP HEALTH, V51, P89; Uchimura Kazuhiro, 2013, Western Pac Surveill Response J, V4, P11, DOI 10.5365/WPSAR.2012.3.4.016; World Bank, 2012, WORLD DEV REP 2013, DOI DOI 10.1596/978-0-8213-9575-2	35	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	MAR	2015	19	3					312	318		10.5588/ijtld.14.0104		7	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CC9SO	WOS:000350711700015		
J	Okumachi, E; Lee, SY; Niikura, T; Iwakura, T; Dogaki, Y; Waki, T; Takahara, S; Ueha, T; Sakai, Y; Kuroda, R; Kurosaka, M				Okumachi, Etsuko; Lee, Sang Yang; Niikura, Takahiro; Iwakura, Takashi; Dogaki, Yoshihiro; Waki, Takahiro; Takahara, Shunsuke; Ueha, Takeshi; Sakai, Yoshitada; Kuroda, Ryosuke; Kurosaka, Masahiro			Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro	INTERNATIONAL ORTHOPAEDICS			English	Article						Mesenchymal stem cell; Skeletal muscle; Slow muscle; Fast muscle; Osteogenic; Bone regeneration	PROGENITOR CELLS; SATELLITE CELLS; BONE-MARROW; TISSUE; IDENTIFICATION; REGENERATION; REPAIR	Purpose Skeletal muscle comprises different kinds of muscle fibres that can be classified as slow and fast fibres. The purpose of this study was to compare the yield, proliferation, and multi-potentiality of rat mesenchymal stem cells (MSCs) from the tibialis anterior (TA; fast muscle) and soleus (SO; slow muscle) in vitro. Methods The TA and SO muscles were harvested, and isolated cells were plated. After two hours, the cells were washed extensively to remove any cell that did not adhere to the cell culture plate. The adherent cells, namely MSCs, were then cultured. Both types of MSCs were differentiated toward the osteogenic, chondrogenic and adipogenic lineages using lineage specific induction factors. Results The colony-forming unit fibroblast (CFU-F) assay revealed that the SO contained significantly higher quantities of MSCs than the TA. The self-renewal capacity of MSCs derived from the TA was significantly higher at later passages (passage 9-11). Both types of MSCs exhibited similar cell surface antigens to bone marrow (BM)-derived MSCs and were positive for CD29, CD44, and CD90 and negative for CD11b, CD34, and CD45. TA-derived MSCs were superior in terms of osteogenic differentiation capacity, but there was no significant difference in chondrogenic and adipogenic differentiation capacity. Conclusion Our results demonstrated significant differences in the properties of muscle-derived MSCs from different muscle types (i.e. fast or slow muscles). The greater expandability and osteogenic differentiation ability of TA-derived MSCs suggests that fast muscle may be a better source for generating large numbers of MSCs for bone regeneration.	[Okumachi, Etsuko; Lee, Sang Yang; Niikura, Takahiro; Iwakura, Takashi; Dogaki, Yoshihiro; Waki, Takahiro; Takahara, Shunsuke; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ueha, Takeshi; Sakai, Yoshitada] Kobe Univ, Grad Sch Med, Div Rehabil Med, Kobe, Hyogo 6500017, Japan	Lee, SY (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sangyang@beige.plala.or.jp					Mravic M, 2014, INT ORTHOP, V38, P1819, DOI 10.1007/s00264-014-2295-0; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Marmotti A, 2014, INT ORTHOP, V38, P1787, DOI 10.1007/s00264-014-2445-4; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Da Silva ML, 2008, STEM CELLS, V26, P2287, DOI DOI 10.1634/STEMCELLS.2007-1122; Da Silva ML, 2009, TISSUE ENG PART A, V15, P221, DOI DOI 10.1089/TEN.TEA.2008.0103; ENNION S, 1995, J MUSCLE RES CELL M, V16, P35, DOI 10.1007/BF00125308; HUDLICKA O, 1982, CIRC RES, V50, P451; Ivkovic Alan, 2011, Front Biosci (Elite Ed), V3, P923; Lee SY, 2007, J CELL PHYSIOL, V210, P561, DOI 10.1002/jcp.20890; Li GH, 2011, J MOL CELL BIOL, V3, P369, DOI 10.1093/jmcb/mjr014; Manzano R, 2011, J CELL BIOCHEM, V112, P2825, DOI 10.1002/jcb.23197; Pecina M, 2014, INT ORTHOP, V38, P1757, DOI 10.1007/s00264-014-2477-9; SIMS DE, 1986, TISSUE CELL, V18, P153, DOI 10.1016/0040-8166(86)90026-1	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	MAR	2015	39	3					569	576		10.1007/s00264-014-2569-6		8	Orthopedics	Orthopedics	CC5AS	WOS:000350369800028		
J	Phua, J; Joynt, GM; Nishimura, M; Deng, YY; Myatra, SN; Chan, YH; Binh, NG; Tan, CC; Faruq, MO; Arabi, YM; Wahjuprajitno, B; Liu, SF; Hashemian, SMR; Kashif, W; Staworn, D; Palo, JE; Koh, Y				Phua, Jason; Joynt, Gavin M.; Nishimura, Masaji; Deng, Yiyun; Myatra, Sheila Nainan; Chan, Yiong Huak; Nguyen Gia Binh; Tan, Cheng Cheng; Faruq, Mohammad Omar; Arabi, Yaseen M.; Wahjuprajitno, Bambang; Liu, Shih-Feng; Hashemian, Seyed Mohammad Reza; Kashif, Waqar; Staworn, Dusit; Palo, Jose Emmanuel; Koh, Younsuck		ACME Study Investigators; Asian Critical Care Clinical Trial	Withholding and Withdrawal of Life-Sustaining Treatments in Intensive Care Units in Asia	JAMA INTERNAL MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; ETHICAL QUESTIONNAIRE; DECISION-MAKING; END; ATTITUDES; SUPPORT; CONSENSUS; LIMITATION; FREQUENCY; CLINICIAN	IMPORTANCE Little data exist on end-of-life care practices in intensive care units (ICUs) in Asia. OBJECTIVE To describe physicians' attitudes toward withholding and withdrawal of life-sustaining treatments in end-of-life care and to evaluate factors associated with observed attitudes. DESIGN, SETTING, AND PARTICIPANTS Self-administered structured and scenario-based survey conducted among 1465 physicians (response rate, 59.6%) who manage patients in ICUs (May-December 2012) at 466 ICUs (response rate, 59.4%) in 16 Asian countries and regions. RESULTS For patients with no real chance of recovering a meaningful life, 1029 respondents (70.2%) reported almost always or often withholding whereas 303 (20.7%) reported almost always or often withdrawing life-sustaining treatments; 1092 respondents (74.5%) deemed withholding and withdrawal ethically different. The majority of respondents reported that vasopressors, he modialysis, and antibiotics could usually be withheld or withdrawn in end-of-life care, but not enteral feeding, intravenous fluids, and oral suctioning. For severe hypoxic-ischemic encephalopathy after cardiac arrest, 1201 respondents (82.0% [range between countries, 48.4%-100%]) would implement do-not-resuscitate orders, but 788 (53.8% [range, 6.1%-87.2%]) would maintain mechanical ventilation and start antibiotics and vasopressors if indicated. On multivariable analysis, refusal to implement do-not-resuscitate orders was more likely with physicians who did not value families' or surrogates' requests (adjusted odds ratio [AOR], 1.67 [95% CI, 1.16-2.40]; P = .006), who were uncomfortable discussing end-of-life care (AOR, 2.38 [95% CI, 1.62-3.51]; P < .001), who perceived greater legal risk (AOR, 1.92 [95% CI, 1.26-2.94]; P = .002), and in low-to middle-income economies (AOR, 2.73 [95% CI, 1.56-4.76]; P < .001). Nonimplementation was less likely with physicians of Protestant (AOR, 0.36 [95% CI, 0.16-0.80]; P = .01) and Catholic (AOR, 0.22 [95% CI, 0.09-0.58]; P = .002) faiths, and when out-of-pocket health care expenditure increased (AOR, 0.98 per percentage of total health care expenditure [95% CI, 0.97-0.99]; P = .02). CONCLUSIONS AND RELEVANCE Whereas physicians in ICUs in Asia reported that they often withheld but seldom withdrew life-sustaining treatments at the end of life, attitudes and practice varied widely across countries and regions. Multiple factors related to country or region, including economic, cultural, religious, and legal differences, as well as personal attitudes, were associated with these variations. Initiatives to improve end-of-life care in Asia must begin with a thorough understanding of these factors.	[Phua, Jason] Natl Univ Hlth Syst, Natl Univ Hosp, Div Resp & Crit Care Med, Singapore, Singapore; [Joynt, Gavin M.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Nishimura, Masaji] Univ Tokushima, Grad Sch, Emergency & Crit Care Med, Tokushima 770, Japan; [Deng, Yiyun] Sichuan Univ, Intens Care Unit, West China Hosp, Chengdu, Sichuan, Peoples R China; [Myatra, Sheila Nainan] Tata Mem Hosp, Dept Anaesthesia Crit Care & Pain, Bombay 400012, Maharashtra, India; [Chan, Yiong Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore 117595, Singapore; [Nguyen Gia Binh] Bach Mai Hosp, Dept Intens Care, Hanoi, Vietnam; [Tan, Cheng Cheng] Sultanah Aminah Hosp, Dept Anaesthesia & Intens Care, Johor Baharu, Malaysia; [Faruq, Mohammad Omar] BIRDEM Gen Hosp, Dept Crit Care Med, Ibrahim Med Coll, Dhaka, Bangladesh; [Arabi, Yaseen M.] Kian Saud Bin Abdulaziz Univ Hlth Sci, Dept Intens Care, King Abdulaziz Med City, Riyadh, Saudi Arabia; [Wahjuprajitno, Bambang] Univ Airlangga, Dr Soetomo Gen Hosp, Dept Anesthesiol & Reanimat, Surabaya, Indonesia; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Hashemian, Seyed Mohammad Reza] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Masih Daneshvari Hosp, Chron Resp Dis Res Ctr, Tehran, Iran; [Kashif, Waqar] Aga Khan Univ & Hosp, Sect Nephrol Pulm & Crit Care, Dept Med, Karachi, Pakistan; [Staworn, Dusit] Phramongkutklao Hosp, Bangkok, Thailand; [Palo, Jose Emmanuel] Med City, Sect Adult Crit Care Med, Dept Med, Pasig, Philippines; [Koh, Younsuck] Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul 138736, South Korea	Koh, Y (reprint author), Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, 388-1 Pungnap Dong, Seoul 138736, South Korea.	yskoh@amc.seoul.kr	Joynt, Gavin/C-7606-2009	Joynt, Gavin/0000-0002-5823-3435			Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Yazigi A, 2005, INTENS CARE MED, V31, P562, DOI 10.1007/s00134-005-2578-4; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Huynh TN, 2013, JAMA INTERN MED, V173, P1887, DOI 10.1001/jamainternmed.2013.10261; Chai HZ, 2014, AM J HOSP PALLIAT ME, V31, P166, DOI 10.1177/1049909113480883; Levy MM, 2008, ANN INTERN MED, V148, P801; Alsolamy S, 2014, BIOETHICS, V28, P96, DOI 10.1111/j.1467-8519.2012.01996.x; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Kwak J, 2005, GERONTOLOGIST, V45, P634; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Cook D, 2014, NEW ENGL J MED, V370, P2506, DOI 10.1056/NEJMra1208795; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI [10.1503/cmaj.080372, 10.1503/cmaj.080327]; Chan HM, 2004, BIOETHICS, V18, P87, DOI 10.1111/j.1467-8519.2004.00383.x; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Bulow HH, 2008, INTENS CARE MED, V34, P423, DOI 10.1007/s00134-007-0973-8; Weng L, 2011, INTENS CARE MED, V37, P655, DOI 10.1007/s00134-010-2124-x; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Matsumura S, 2002, J GEN INTERN MED, V17, P531, DOI 10.1046/j.1525-1497.2002.10734.x; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; CHRISTAKIS NA, 1995, AM J PUBLIC HEALTH, V85, P367, DOI 10.2105/AJPH.85.3.367; ASAI A, 1995, LANCET, V346, P356, DOI 10.1016/S0140-6736(95)92230-X; Buckley TA, 2004, CRIT CARE MED, V32, P415, DOI 10.1097/01.CCM.0000110675.34569.A9; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Crawley LM, 2002, ANN INTERN MED, V136, P673; Curtis JR, 2001, CRIT CARE MED, V29, pN26, DOI 10.1097/00003246-200102001-00006; Curtis JR, 2010, LANCET, V375, P1347, DOI DOI 10.1016/S0140-6736(10)60143-2; Food and Health Bureau the Government of the Hong Kong Special Administrative Region, HONG KONGS DOM HLTH; Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Kapadia F, 2005, CRIT CARE MED, V33, P1272, DOI 10.1097/01.CCM.0000165557.02879.29; Luce JM, 2007, AM J RESP CRIT CARE, V175, P1104, DOI 10.1164/rccm.200609-1397CP; Luce JM, 2009, CRIT CARE CLIN, V25, P221, DOI 10.1016/j.ccc.2008.10.002; Mani RK, 2009, INTENS CARE MED, V35, P1713, DOI 10.1007/s00134-009-1561-x; Ministry of Health and Welfare Taiwan, NAT HLTH EXP 2012; Moselli NM, 2006, ACTA ANAESTH SCAND, V50, P1177, DOI 10.1111/j.1399-6576.2006.01150.x; Myatra Sheila Nainan, 2014, Indian J Crit Care Med, V18, P615, DOI 10.4103/0972-5229.140155; Pope Thaddeus Mason, 2012, J Clin Ethics, V23, P353; Salahuddin N, 2008, INTERN MED J, V38, P307, DOI 10.1111/j.1445-5994.2007.01595.x; Sprung CL, 2014, AM J RESP CRIT CARE, V190, P855, DOI 10.1164/rccm.201403-0593CC; VINCENT JL, 1990, INTENS CARE MED, V16, P256, DOI 10.1007/BF01705162; World Health Organization, GLOB HLTH EXP DAT NA; Yap H. Y., 2004, Hong Kong Medical Journal, V10, P244	47	5	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6106	2168-6114		JAMA INTERN MED	JAMA Intern. Med.	MAR	2015	175	3					363	371		10.1001/jamainternmed.2014.7386		9	Medicine, General & Internal	General & Internal Medicine	CD0YF	WOS:000350799600012		
J	Eura, N; Sugie, K; Kiriyama, T; Ueno, S				Eura, Nobuyuki; Sugie, Kazuma; Kiriyama, Takao; Ueno, Satoshi			Characteristic Dysphagia as a Manifestation of Dermatomyositis on Oropharyngeal Muscle Imaging	JCR-JOURNAL OF CLINICAL RHEUMATOLOGY			English	Editorial Material							POLYMYOSITIS		[Eura, Nobuyuki; Sugie, Kazuma; Kiriyama, Takao; Ueno, Satoshi] Nara Med Univ, Sch Med, Dept Neurol, Kashihara, Nara 6348521, Japan	Sugie, K (reprint author), Nara Med Univ, Sch Med, Dept Neurol, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	ksugie@naramed-u.ac.jp					Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Ebert EC, 2010, ALIMENT PHARM THER, V31, P359, DOI 10.1111/j.1365-2036.2009.04190.x; JACOB H, 1983, ARCH INTERN MED, V143, P2262, DOI 10.1001/archinte.143.12.2262; Langdon PC, 2012, DYSPHAGIA, V27, P408, DOI 10.1007/s00455-011-9384-7	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-1608	1536-7355		JCR-J CLIN RHEUMATOL	JCR-J. Clin. Rheumatol.	MAR	2015	21	2					105	106		10.1097/RHU.0000000000000225		2	Rheumatology	Rheumatology	CD0KX	WOS:000350762600013		
J	Ohta, S				Ohta, Shin-ichi			Splitting theorems for Finsler manifolds of nonnegative Ricci curvature	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							METRIC-MEASURE-SPACES; MEASURE CONTRACTION PROPERTY; ALEXANDROV SPACES; HEAT-FLOW; GEOMETRY; INEQUALITIES; TRANSPORT	We investigate the structure of a Finsler manifold of nonnegative weighted Ricci curvature including a straight line, and extend the classical Cheeger-Gromoll-Lichnerowicz Splitting Theorem. Such a space admits a diffeomorphic, measure-preserving splitting in general. As for a special class of Berwald spaces, we can perform the isometric splitting in the sense that there is a one-parameter family of isometries generated from the gradient vector field of the Busemann function. A Betti number estimate is also given for Berwald spaces.	Kyoto Univ, Dept Math, Kyoto 6068502, Japan	Ohta, S (reprint author), Kyoto Univ, Dept Math, Kyoto 6068502, Japan.	sohta@math.kyoto-u.ac.jp			 [23740048]	Supported in part by the Grant-in-Aid for Young Scientists (B) 23740048.	Ambrosio L., 2011, PREPRINT; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P133, DOI 10.1007/s11511-006-0003-7; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P65, DOI 10.1007/s11511-006-0002-8; Wei GF, 2009, J DIFFER GEOM, V83, P377; Ohta S, 2011, DIFFER GEOM APPL, V29, P174, DOI 10.1016/j.difgeo.2010.12.007; Lott J, 2009, ANN MATH, V169, P903; Ohta S, 2009, CALC VAR PARTIAL DIF, V36, P211, DOI 10.1007/s00526-009-0227-4; Gigli N, 2013, COMMUN PUR APPL MATH, V66, P307, DOI 10.1002/cpa.21431; Sturm KT, 2005, J MATH PURE APPL, V84, P149, DOI 10.1016/j.matpur.2004.11.002; Fang FQ, 2009, ANN I FOURIER, V59, P563; Ohta S, 2007, COMMENT MATH HELV, V82, P805; Bao D., 2000, INTRO RIEMANN FINSLE; CHEEGER J, 1972, ANN MATH, V96, P413, DOI 10.2307/1970819; Cheeger Jeff, 1971, J DIFFER GEOM, V6, P119; Damascelli L., 1998, DIFFERENTIAL INTEGRA, V11, P493; Eschenburg Jost, 1984, ANN GLOB ANAL GEOM, V2, P141, DOI 10.1007/BF01876506; Ge YX, 2001, P LOND MATH SOC, V82, P725, DOI 10.1112/plms/82.3.725; ICHIJYO Y., 1976, J MATH KYOTO U, V16, P639; Kuwae K, 2011, TOHOKU MATH J, V63, P59; Lichnerowicz Andre, 1970, C R ACAD SCI PARIS A, V271, pA650; Lott J, 2007, J FUNCT ANAL, V245, P311, DOI 10.1016/j.jfa.2006.10.018; Ohta S., 2011, PREPRINT; Ohta S, 2012, ARCH RATION MECH AN, V204, P917, DOI 10.1007/s00205-012-0493-8; Ohta SI, 2007, J LOND MATH SOC, V76, P225, DOI 10.1112/jlms/jdm057; Ohta SI, 2009, COMMUN PUR APPL MATH, V62, P1386; Shen Z., 2001, LECT FINSLER GEOMETR; Shen Z., 1997, PREPRINT; Shiohama K., 2003, GEOMETRY TOTAL CURVA; Szabo Z. I., 2008, PREPRINT; Szabo Z.I., 1981, TENSOR, V38, P25; Von Renesse MK, 2005, COMMUN PUR APPL MATH, V58, P923, DOI 10.1002/cpa.20060; Zhang HC, 2010, COMMUN ANAL GEOM, V18, P503	32	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	MAR	2015	700						155	174		10.1515/crelle-2013-0011		20	Mathematics	Mathematics	CC8TK	WOS:000350640900006		
J	Proskurnin, MA; Volkov, DS; Gor'kova, TA; Bendrysheva, SN; Smirnova, AP; Nedosekin, DA				Proskurnin, M. A.; Volkov, D. S.; Gor'kova, T. A.; Bendrysheva, S. N.; Smirnova, A. P.; Nedosekin, D. A.			Advances in thermal lens spectrometry	JOURNAL OF ANALYTICAL CHEMISTRY			English	Review						thermal lens spectrometry; thermal lens microscopy; microfluid chips	PHOTOACOUSTIC FLOW-CYTOMETRY; Z-SCAN TECHNIQUE; CAPILLARY ELECTROPHORETIC SEPARATION; PHOTOTHERMAL DEFLECTION SPECTROSCOPY; THERMOOPTICAL ABSORBENCY DETECTION; PHENYLTHIOHYDANTOIN-AMINO ACIDS; BEAM INTERFERENCE DETECTION; HIGH SCATTERING BACKGROUNDS; MULTIPHASE LAMINAR FLOWS; LABEL-FREE DETECTION	The main examples of the application of thermal lens spectrometry and thermal lens microscopy as highly sensitive power-based thermooptical (photothermal) methods of molecular absorption spectroscopy to photometric, chromatographic, and electromigration methods of analysis and to solving problems related to the use of microfluid chips are considered. The fundamentals and characteristics of the thermooptical methods and instruments and the problems and prospects of their development are discussed. Examples are provided for illustrating the sensitivity and selectivity of combined methods and multidisciplinary studies performed with the aid of thermal lens spectrometry.	[Proskurnin, M. A.; Volkov, D. S.; Gor'kova, T. A.; Bendrysheva, S. N.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia; [Volkov, D. S.] Moscow MV Lomonosov State Univ, Analyt Ctr, Moscow 119991, Russia; [Smirnova, A. P.] Univ Tokyo, Dept Mech Engn, Fluids Engn Lab, Bunkyo Ku, Tokyo 1138656, Japan; [Nedosekin, D. A.] Univ Arkansas Med Sci, Dept Otolaryngol, Philips Class Laser & Nanomed Labs, Little Rock, AR 72205 USA	Proskurnin, MA (reprint author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia.	proskurnin@gmail.com	Volkov, Dmitry/B-6444-2011; Proskurnin, Mikhail/E-9704-2011	Proskurnin, Mikhail/0000-0001-5577-6883	Russian Science Foundation [14-23-00012]	This work was supported by the Russian Science Foundation (grant no. 14-23-00012).	Akkin T, 2003, LASER SURG MED, V33, P219, DOI 10.1002/lsm.10221; Alves LP, 2013, PROC SPIE, V8596, DOI 10.1117/12.2003737; Boyer D, 2002, SCIENCE, V297, P1160, DOI 10.1126/science.1073765; Pogacnik L, 2003, BIOSENS BIOELECTRON, V18, P1, DOI 10.1016/S0956-5663(02)00056-8; Zharov VP, 2011, NAT PHOTONICS, V5, P110, DOI [10.1038/nphoton.2010.280, 10.1038/NPHOTON.2010.280]; Zharov VP, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793746; Berciaud S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257402; Yang JY, 2009, OPT LETT, V34, P157; Natoli JY, 2003, OPT EXPRESS, V11, P824, DOI 10.1364/OE.11.000824; Mogensen KB, 2004, ELECTROPHORESIS, V25, P3498, DOI 10.1002/elps.200406108; Araki Y, 2005, J PHYS CHEM B, V109, P9843, DOI 10.1021/jp044410b; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Xu XA, 2011, LASER MED SCI, V26, P213, DOI 10.1007/s10103-010-0828-3; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Berciaud S, 2005, NANO LETT, V5, P515, DOI 10.1021/nl050062t; Uchiyama Y, 2000, LANGMUIR, V16, P6597, DOI 10.1021/la9913295; Gavrilenko NA, 2009, J ANAL CHEM+, V64, P226, DOI 10.1134/S1061934809030034; Link S, 2000, INT REV PHYS CHEM, V19, P409, DOI 10.1080/01442350050034180; Tuchin VV, 2011, CYTOM PART A, V79A, P737, DOI 10.1002/cyto.a.21143; Kimura H, 1996, ANAL CHEM, V68, P3063, DOI 10.1021/ac9511962; Hiki S, 2006, ANAL CHEM, V78, P2859, DOI 10.1021/ac051967u; Berciaud S, 2005, NANO LETT, V5, P2160, DOI 10.1021/nl051805d; Nedosekin DA, 2009, TALANTA, V78, P682, DOI 10.1016/j.talanta.2008.12.020; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Weber R, 1999, OPT MATER, V11, P245, DOI 10.1016/S0925-3467(98)00047-0; Smirnova A, 2006, ANAL CHIM ACTA, V558, P69, DOI 10.1016/j.aca.2005.10.073; Nedosekin DA, 2014, SMALL, V10, P135, DOI 10.1002/smll.201300024; Jacinto C, 2006, J NON-CRYST SOLIDS, V352, P3582, DOI 10.1016/j.jnoncrysol.2006.04.025; Zharov V, 2003, REV SCI INSTRUM, V74, P785, DOI 10.1063/1.1520322; Adler DC, 2008, OPT EXPRESS, V16, P4376, DOI 10.1364/OE.16.004376; Tamaki E, 2002, ANAL CHEM, V74, P1560, DOI 10.1021/ac011092t; Tokeshi M, 2002, ANAL CHEM, V74, P1565, DOI 10.1021/ac011111z; Blab GA, 2006, BIOPHYS J, V90, pL13, DOI 10.1529/biophysj.105.076182; Dazzi A, 2008, ULTRAMICROSCOPY, V108, P635, DOI 10.1016/j.ultramic.2007.10.008; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P425, DOI 10.1002/jbio.201200047; SNOOK RD, 1995, ANALYST, V120, P2051, DOI 10.1039/an9952002051; Lasne D, 2006, BIOPHYS J, V91, P4598, DOI 10.1529/biophysj.106.089771; Ryasnyanskiy AI, 2009, PHYS SOLID STATE+, V51, P55, DOI 10.1134/S1063783409010065; Sarimollaoglu M, 2011, OPT LETT, V36, P4086, DOI 10.1364/OL.36.004086; Sanders GHW, 2000, TRAC-TREND ANAL CHEM, V19, P364, DOI 10.1016/S0165-9936(00)00011-X; Hibara A, 2001, ANAL SCI, V17, P89, DOI 10.2116/analsci.17.89; Brusnichkin AV, 2010, J BIOPHOTONICS, V3, P791, DOI 10.1002/jbio.201000012; Fischer M, 1996, ANAL CHIM ACTA, V322, P117, DOI 10.1016/0003-2670(95)00531-5; Lima SM, 2000, J NON-CRYST SOLIDS, V273, P215, DOI 10.1016/S0022-3093(00)00169-1; SHEN J, 1995, J APPL PHYS, V78, P700, DOI 10.1063/1.360329; Cognet L, 2003, P NATL ACAD SCI USA, V100, P11350, DOI 10.1073/pnas.1534635100; Brusnichkin AV, 2007, APPL SPECTROSC, V61, P1191, DOI 10.1366/000370207782597175; Franko M, 2001, TALANTA, V54, P1, DOI 10.1016/S0039-9140(00)00608-1; Li XF, 2000, J CHROMATOGR A, V895, P81, DOI 10.1016/S0021-9673(00)00661-0; Galanzha EI, 2011, CYTOM PART A, V79A, P746, DOI 10.1002/cyto.a.21133; Pogacnik L, 1999, BIOSENS BIOELECTRON, V14, P569, DOI 10.1016/S0956-5663(99)00029-9; Galanzha EI, 2008, CYTOM PART A, V73A, P884, DOI 10.1002/cyto.a.20587; Papernov S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3594713; Menyaev YA, 2013, BIOMED OPT EXPRESS, V4, P3030, DOI 10.1364/BOE.4.003030; Sorouraddin HM, 2001, FRESEN J ANAL CHEM, V371, P91, DOI 10.1007/s002160100998; Yi CQ, 2006, ANAL CHIM ACTA, V560, P1, DOI 10.1016/j.aca.2005.12.037; Zharov VP, 2005, OPT LETT, V30, P628, DOI 10.1364/OL.30.6.000628; Swinney K, 2000, CRIT REV ANAL CHEM, V30, P1, DOI 10.1080/10408340091164162; Tsar'kov DS, 2011, J ANAL CHEM+, V66, P166, DOI 10.1134/S106193481102016X; Tanaka Y, 2000, J CHROMATOGR A, V894, P45, DOI 10.1016/S0021-9673(00)00593-8; Arnaud N, 2001, ANAL CHIM ACTA, V445, P239, DOI 10.1016/S0003-2670(01)01260-0; Jones CD, 2003, J AM CHEM SOC, V125, P460, DOI 10.1021/ja027431x; Khodakovskaya MV, 2011, P NATL ACAD SCI USA, V108, P1028, DOI 10.1073/pnas.1008856108; Berciaud S, 2007, NANO LETT, V7, P1203, DOI 10.1021/nl062933k; Guzsvany V, 2007, ENVIRON CHEM LETT, V5, P203, DOI 10.1007/s10311-007-0102-5; Basheer NS, 2013, J LUMIN, V137, P225, DOI 10.1016/j.jlumin.2012.12.052; Tokeshi M, 2000, ANAL CHEM, V72, P1711, DOI 10.1021/ac991147f; Galanzha EI, 2012, METHODS, V57, P280, DOI 10.1016/j.ymeth.2012.06.009; Korte D, 2011, INT J THERMOPHYS, V32, P818, DOI 10.1007/s10765-010-0856-z; de Gans BJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.245501; Sikovec M, 2001, J CHROMATOGR A, V920, P119; Franko M, 2008, APPL SPECTROSC REV, V43, P358, DOI 10.1080/05704920802108032; Qi M, 1999, J CHROMATOGR A, V853, P131, DOI 10.1016/S0021-9673(99)00688-3; Zharov VP, 2006, BIOPHYS J, V90, P619, DOI 10.1529/biophysj.105.061895; Aota A, 2010, ADV CHEM ENG, V38, P1, DOI 10.1016/S0065-2377(10)38001-X; Arnaud N, 2001, SPECTROCHIM ACTA A, V57, P1085, DOI 10.1016/S1386-1425(00)00425-X; Arnaud N, 2001, SPECTROCHIM ACTA A, V57, P1295, DOI 10.1016/S1386-1425(00)00465-0; Balcerzak M., 2001, SEPARATION PRECONCEN; Barker BD, 2001, J INORG BIOCHEM, V85, P107, DOI 10.1016/S0162-0134(01)00190-8; Bavcon KraljM, 2007, CHEMOSPHERE, V67, P99; Benitez M, 2009, OPT ENG, V48, DOI 10.1117/1.3119306; Berciaud S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045424; Bialkowski S. E., 1996, PHOTOTHERMAL SPECTRO; BIALKOWSKI SE, 1987, ANAL CHEM, V59, P873, DOI 10.1021/ac00133a019; Bialkowski SE, 1998, TRAC-TREND ANAL CHEM, V17, P520, DOI 10.1016/S0165-9936(98)00045-4; BIALKOWSKI SE, 1985, APPL OPTICS, V24, P2792; Bindhu CV, 2000, APPL PHYS B-LASERS O, V70, P429, DOI 10.1007/s003400050069; [Бородин Андрей Викторович Borodin A.V], 2009, [Вестник Московского университета. Серия 2: Химия, Vestnik Moskovskogo universiteta. Seriya 2: Khimiya], V50, P252; Boskin A, 2009, ENVIRON CHEM LETT, V7, P267, DOI 10.1007/s10311-008-0161-2; Bourgoin JP, 2008, APPL OPTICS, V47, P6530, DOI 10.1364/AO.47.006530; Bruin GJM, 2000, ELECTROPHORESIS, V21, P3931, DOI 10.1002/1522-2683(200012)21:18<3931::AID-ELPS3931>3.0.CO;2-M; CALMETTES P, 1976, OPT COMMUN, V19, P257, DOI 10.1016/0030-4018(76)90355-2; Chanlon S, 2002, SPECTROCHIM ACTA A, V58, P1607, DOI 10.1016/S1386-1425(01)00612-6; Chartier A, 2001, APPL SPECTROSC, V55, P84, DOI 10.1366/0003702011951290; Dada OO, 2008, APPL SPECTROSC, V62, P1336, DOI 10.1366/000370208786822340; Dada OO, 2011, APPL SPECTROSC, V65, P201, DOI 10.1366/10-06000; Dada OO, 2011, APPL OPTICS, V50, P6336, DOI 10.1364/AO.50.006336; Demko MT, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2912943; Dudko VS, 2011, J ANAL CHEM+, V66, P1035, DOI 10.1134/S1061934811110050; Dudko V.S., 2011, ROSS KHIM ZH, V55, P111; EDEN G, 1987, OPT COMMUN, V63, P135, DOI 10.1016/0030-4018(87)90274-4; Espinosa DHG, 2012, PHYSCS PROC, V28, P33, DOI 10.1016/j.phpro.2012.03.666; Fournier D., 2001, ANAL SCI, V17, P490; FRANKO M, 1991, J PHYS CHEM-US, V95, P6688, DOI 10.1021/j100170a057; Galanzha EI, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2060567; Galitovsky V, 2004, LIFE SCI, V75, P2677, DOI 10.1016/j.lfs.2004.05.022; [Галкин Максим Вадимович Galkin M.V.], 2010, [Вестник Московского университета. Серия 2: Химия, Vestnik Moskovskogo universiteta. Seriya 2: Khimiya], V51, P115; Gavrilenko NA, 2007, J ANAL CHEM+, V62, P832, DOI 10.1134/S1061934807090043; Gavrilenko NA, 2010, J ANAL CHEM+, V65, P148, DOI 10.1134/S1061934810020085; Georges J, 1999, TALANTA, V48, P501, DOI 10.1016/S0039-9140(98)00242-2; Ghaleb KA, 2006, APPL SPECTROSC, V60, P564, DOI 10.1366/000370206777412211; Grishko V.I., 1992, LAZERNAYA ANALITICHE; Grishko VI, 2002, APPL OPTICS, V41, P5814, DOI 10.1364/AO.41.005814; Han Q, 2002, PROG CHEM, V14, P24; Harada M, 1999, ANAL SCI, V15, P647, DOI 10.2116/analsci.15.647; Harilal SS, 1999, J APPL PHYS, V86, P1388, DOI 10.1063/1.370899; Hibara A, 2003, J AM CHEM SOC, V125, P14954, DOI 10.1021/ja037308l; Hiki S, 2003, BUNSEKI KAGAKU, V52, P569, DOI 10.2116/bunsekikagaku.52.569; Hiki S, 2007, BUNSEKI KAGAKU, V56, P1, DOI 10.2116/bunsekikagaku.56.1; Hisamoto H, 2001, ANAL CHEM, V73, P1382, DOI 10.1021/ac001271v; Hleb EY, 2008, NANOMEDICINE-UK, V3, P797, DOI 10.2217/17435889.3.6.797; Hleb E.Y., 2008, NANOTECNOLOGY, V19; Ith M, 2001, APPL OPTICS, V40, P2216, DOI 10.1364/AO.40.002216; Juratli M.A., 2013, P SPIE INT SOC OPT E, V8581, P85814; Juratli M.A., 2013, P SPIE INT SOC OPT E, V8565, P85652; Kalogiannakis G, 2003, REV SCI INSTRUM, V74, P462, DOI 10.1063/1.1517738; Kikutani Y, 2004, LAB CHIP, V4, P328, DOI 10.1039/b400233d; Kikutani Y, 2009, MICROCHIM ACTA, V164, P241, DOI 10.1007/s00604-008-0065-7; Kimura H, 2000, ANAL BIOCHEM, V283, P27, DOI 10.1006/abio.2000.4614; Kitagawa F, 2006, J CHROMATOGR A, V1106, P36, DOI 10.1016/j.chroma.2005.08.019; Kitagawa F, 2009, J CHROMATOGR A, V1216, P2943, DOI 10.1016/j.chroma.2008.08.024; Kitamori T., 2004, ANAL CHEM A, V76, P52; Kitamori T, 2001, FRESEN J ANAL CHEM, V371, P89, DOI 10.1007/s002160101024; Klapshina LG, 2006, NEW J CHEM, V30, P615, DOI 10.1039/b513465j; Kralj AB, 2007, CHEMOSPHERE, V67, P99, DOI 10.1016/j.chemosphere.2006.09.039; Kumar BR, 2013, INT J THERMOPHYS, V34, P1982, DOI 10.1007/s10765-013-1514-z; Kumar B.R., 2012, IEEE 3 INT C PHOT IC, P149; Ladislav F, 2005, CURR ANAL CHEM, V1, P93; LANGFORD CH, 1992, ANAL CHIM ACTA, V256, P183, DOI 10.1016/0003-2670(92)85343-5; Lapotko D, 2002, J BIOMED OPT, V7, P425, DOI 10.1117/1.1481902; Lapotko D, 2004, CYTOM PART A, V58A, P111, DOI 10.1002/cyto.a.20001; Lapotko D, 1996, CYTOMETRY, V24, P198, DOI 10.1002/(SICI)1097-0320(19960701)24:3<198::AID-CYTO2>3.3.CO;2-L; Lapotko DO, 2002, LASER SURG MED, V31, P53, DOI 10.1002/lsm.10068; Lapotko DO, 2005, LASER SURG MED, V36, P22, DOI 10.1002/lsm.20119; Laufer JG, 2002, REV SCI INSTRUM, V73, P3345, DOI 10.1063/1.1499759; Legeai S, 2000, ANAL LETT, V33, P3153; LEITE RCC, 1964, APPL PHYS LETT, V5, P141, DOI 10.1063/1.1754089; LEITE RCC, 1967, APPL PHYS LETT, V10, P100, DOI 10.1063/1.1754849; Levick A., 2001, ANAL SCI, V17, P438; Li N, 2002, CHINESE J ANAL CHEM, V30, P1348; Li PCH, 2006, CHROMATOGR SCI SER, V94, P1; Li XF, 1998, ELECTROPHORESIS, V19, P3178, DOI 10.1002/elps.1150191821; Li XS, 2011, PHOTOCH PHOTOBIO SCI, V10, P817, DOI 10.1039/c0pp00306a; Liu MQ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3682481; Lu J.-T., 2011, ACTA PHYS SIN, V60; Luterotti S, 2002, ANAL CHIM ACTA, V460, P193, DOI 10.1016/S0003-2670(02)00228-3; Luterotti S, 1999, J PHARMACEUT BIOMED, V21, P901, DOI 10.1016/S0731-7085(99)00185-5; Madzgalj A, 2008, EUR PHYS J-SPEC TOP, V153, P503, DOI 10.1140/epjst/e2008-00494-4; Madzgalj A, 2012, J ENVIRON PROT ECOL, V13, P33; Maims C, 2001, SENSOR ACTUAT B-CHEM, V77, P671, DOI 10.1016/S0925-4005(01)00773-0; Majaron B, 2000, PHYS MED BIOL, V45, P1913, DOI 10.1088/0031-9155/45/7/315; Malacarne LC, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309762; Malik AK, 2000, CHEM SOC REV, V29, P275, DOI 10.1039/a907422h; Marcano AO, 2011, J OPT SOC AM B, V28, P281, DOI 10.1364/JOSAB.28.000281; Marcano O.A., 2007, APPL SPECTROSC, V61, P659; Marcano O. A., 2006, Applied Spectroscopy, V60, DOI 10.1366/000370206777412077; MartinBiosca Y, 1997, TRAC-TREND ANAL CHEM, V16, P342, DOI 10.1016/S0165-9936(97)00041-1; Mawatari K, 2012, EXTENDED-NANOFLUIDIC SYSTEMS FOR CHEMISTRY AND BIOTECHNOLOGY, P1; Mawatari K, 2011, ANALYST, V136, P3051, DOI 10.1039/c0an00840k; Mawatari K, 2006, ANAL SCI, V22, P781, DOI 10.2116/analsci.22.781; Mawatari K, 2011, LAB CHIP, V11, P2990, DOI 10.1039/c1lc20175a; Mawatari K, 1998, ANAL CHEM, V70, P5037, DOI 10.1021/ac980250m; Min JH, 2003, J IND ENG CHEM, V9, P1; Minteer S.D., 2006, MICROFLUIDIC TECHNIQ, P248; Muller O, 2010, APPL OPTICS, V49, P1097, DOI 10.1364/AO.49.001097; Nedosekin D.A., 2013, P SPIE INT SOC OPT E, V8581, P85814; Nedosekin DA, 2006, TALANTA, V68, P1474, DOI 10.1016/j.talanta.2005.08.010; Nedosekin DA, 2011, APPL SPECTROSC, V65, P1275, DOI 10.1366/10-06151; Nedosekin DA, 2011, CYTOM PART A, V79A, P855, DOI 10.1002/cyto.a.21128; Nedosekin DA, 2009, ANAL SCI, V25, P611; Nedosekin DA, 2007, TALANTA, V71, P1788, DOI 10.1016/j.talanta.2006.08.016; Nedosekin DA, 2011, CYTOM PART A, V79A, P825, DOI 10.1002/cyto.a.21102; Nedosekin DA, 2005, APPL OPTICS, V44, P6296, DOI 10.1364/AO.44.006296; Nedosekin DA, 2010, APPL SPECTROSC, V64, P942, DOI 10.1366/000370210792081136; Nedosekin DA, 2012, BIOPHYS J, V102, P1235, DOI 10.1016/j.bpj.2012.02.012; Nedosekin DA, 2008, EUR PHYS J-SPEC TOP, V153, P25, DOI 10.1140/epjst/e2008-00385-8; Nedosekin DA, 2010, CYTOM PART A, V77A, P1049, DOI 10.1002/cyto.a.20977; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P523, DOI 10.1002/jbio.201200242; Nedosekin DA, 2011, BIOPHYS J, V100, P316; Nedosekin DA, 2012, BIOPHYS J, V102, P672, DOI 10.1016/j.bpj.2011.12.035; Nedosekin DA, 2013, APPL SPECTROSC, V67, P709, DOI 10.1366/12-06812; Nedosekin D.A., 2012, J BIOPHOTONICS, P425; Nedosekin DA, 2009, J ANAL CHEM+, V64, P247, DOI 10.1134/S1061934809030071; Nestoros M, 2011, OPTOELECTRON ADV MAT, V5, P505; Olivares JA, 2005, J PHYS IV, V125, P153, DOI 10.1051/jp4:2005125035; Perez JLJ, 2008, EUR PHYS J-SPEC TOP, V153, P159, DOI 10.1140/epjst/e2008-00417-5; Pogacnik L, 2001, TALANTA, V54, P631, DOI 10.1016/S0039-9140(01)00314-9; Proskurnin MA, 2010, J PHYS CONF SER, V214, DOI 10.1088/1742-6596/214/1/012118; Proskurnin MA, 2008, APPL SPECTROSC, V62, P439, DOI 10.1366/000370208784046867; Proskurnin MA, 2010, J ANAL CHEM+, V65, P713, DOI 10.1134/S1061934810070105; Proskurnin MA, 2003, ANAL CHIM ACTA, V480, P79, DOI 10.1016/S0003-2670(02)01546-5; Proskurnin M.A., 2012, P INT C ADV LAS TECH, V1; Proskurnin MA, 2011, ANAL SCI, V27, P381; Proskurnin MA, 2011, CYTOM PART A, V79A, P834, DOI 10.1002/cyto.a.21127; Proskurnin M.A., 2014, PHOTOTHERMAL SPECTRO; Proskurnin MA, 2005, APPL SPECTROSC, V59, P1470, DOI 10.1366/000370205775142494; Proskurnin MA, 2004, USP KHIM+, V73, P1235; Proskurnin MA, 2004, J ANAL CHEM+, V59, P818, DOI 10.1023/B:JANC.0000040695.95051.be; Ragozina N, 2002, ANAL CHEM, V74, P4480, DOI 10.1021/ac020095i; Ragozina NY, 2004, ANAL CHEM, V76, P3804, DOI 10.1021/ac0304222; Rashidi-Huyeh M, 2004, J APPL PHYS, V96, P4475, DOI 10.1063/1.1794894; Ren HJ, 1998, J CHROMATOGR A, V817, P307, DOI 10.1016/S0021-9673(98)00366-5; Rossteuscher TTJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116137; Ryasnyansky A, 2005, APPL OPTICS, V44, P2839, DOI 10.1364/AO.44.002839; Saranchina NV, 2011, J ANAL CHEM+, V66, P623, DOI 10.1134/S1061934811060189; Sarimollaoglu M, 2013, PROC SPIE, V8581, DOI 10.1117/12.2007964; Sarimollaoglu M., 2012, P SPIE INT SOC OPT E, V8427, P84273; Seidel BS, 1998, J CHROMATOGR A, V817, P223, DOI 10.1016/S0021-9673(98)00243-X; Seidel B S, 1997, J Biomed Opt, V2, P326, DOI 10.1117/12.275450; Senyuta V.V., 2009, J ANAL CHEM+, V64, P1174; Seta N, 2009, ANAL SCI, V25, P275; Shahriari E, 2013, J EUR OPT SOC-RAPID, V8, DOI 10.2971/jeos.2013.13026; Shao JW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01293; Shen J., 1992, Chemical Physics, V165, DOI 10.1016/0301-0104(92)87053-C; Shimizu H, 2009, ANAL CHEM, V81, P9802, DOI 10.1021/ac901888u; Shimizu H, 2011, J SEP SCI, V34, P2920, DOI 10.1002/jssc.201100501; Shimosaka T, 2000, ANAL CHEM, V72, P3532, DOI 10.1021/ac991271z; Sinha S, 2007, APPL PHYS B-LASERS O, V87, P145, DOI 10.1007/s00340-006-2530-5; Slyadnev MN, 2001, ANAL CHEM, V73, P4037, DOI 10.1021/ac010318p; Smirnova A, 2012, ELECTROPHORESIS, V33, P2748, DOI 10.1002/elps.201200065; Smirnova A, 2008, ELECTROPHORESIS, V29, P2741, DOI 10.1002/elps.200700914; Snook R, 1997, CHEM SOC REV, V26, P319, DOI 10.1039/cs9972600319; Snook RD, 2000, ANALYST, V125, P45, DOI 10.1039/a908809a; Sreelekha G, 2013, OPTIK, V124, P3138, DOI 10.1016/j.ijleo.2012.09.022; Sueyoshi K, 2008, J SEP SCI, V31, P2650, DOI 10.1002/jssc.200800272; Surmeian M, 2001, ANAL LETT, V34, P1421, DOI 10.1081/AL-100104916; Surmeian M, 2002, ANAL CHEM, V74, P2014, DOI 10.1021/ac0112317; Tamaki E, 2003, J CHROMATOGR A, V987, P197, DOI 10.1016/S0021-9673(02)01661-8; Telenkov SA, 2002, PHYS MED BIOL, V47, P657, DOI 10.1088/0031-9155/47/4/308; Telenkov SA, 2004, PHYS MED BIOL, V49, P111, DOI 10.1088/0031-9155/49/1/008; Telenkov SA, 1999, IEEE J SEL TOP QUANT, V5, P1193, DOI 10.1109/2944.796346; Terazima M, 2004, PURE APPL CHEM, V76, P1083, DOI 10.1351/pac200476061083; THORNE JB, 1993, APPL SPECTROSC, V47, P360, DOI 10.1366/0003702934066785; Tokeshi M, 2000, ELECTROCHEMISTRY, V68, P192; Tokeshi M, 2003, ELECTROPHORESIS, V24, P3583, DOI 10.1002/elps.200305661; Tokeshi M, 2001, ANAL CHEM, V73, P2112, DOI 10.1021/ac001479g; Tokeshi M, 2005, ANAL CHEM, V77, P626, DOI 10.1021/ac049011r; Uchiyama K, 2005, ANAL SCI, V21, P49, DOI 10.2116/analsci.21.49; Uchiyama K, 1999, BUNSEKI KAGAKU, V48, P737; Uchiyama K, 2003, ELECTROPHORESIS, V24, P179, DOI 10.1002/elps.200390011; Volkov DS, 2012, J ANAL CHEM+, V67, P842, DOI 10.1134/S1061934812100115; WALDRON KC, 1992, ANAL CHEM, V64, P1396, DOI 10.1021/ac00037a017; Waldron KC, 1996, J CHROMATOGR B, V683, P47, DOI 10.1016/0378-4347(96)00068-0; Wei JS, 2003, OPT COMMUN, V219, P261, DOI 10.1016/S0030-4018(03)01255-0; Whitney JR, 2012, NANOMEDICINE-UK, V7, P1729, DOI [10.2217/nnm.12.66, 10.2217/NNM.12.66]; Xiong B, 2012, TALANTA, V88, P168, DOI 10.1016/j.talanta.2011.10.027; Xiong B, 2008, J CHROMATOGR A, V1209, P260, DOI 10.1016/j.chroma.2008.09.042; Xu HY, 2010, SCI CHINA CHEM, V53, P2250, DOI 10.1007/s11426-010-4117-6; Xu XD, 2002, MICROW OPT TECHN LET, V35, P140, DOI 10.1002/mop.10540; Yamamoto T, 2011, J SYN ORG CHEM JPN, V69, P526; Yamauchi M, 2006, J CHROMATOGR A, V1106, P89, DOI 10.1016/j.chroma.2005.09.091; Yamauchi M, 2006, ANAL CHEM, V78, P2646, DOI 10.1021/ac0519920; Yan XP, 2009, OPT COMMUN, V282, P1851, DOI 10.1016/j.optcom.2009.01.019; Yang JY, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/22/225404; Yu F, 2009, J CHROMATOGR A, V1216, P3423, DOI 10.1016/j.chroma.2008.05.096; YU M, 1989, APPL SPECTROSC, V43, P196, DOI 10.1366/0003702894203156; Zachariah TP, 2008, INT J POLYM MATER, V57, P607, DOI 10.1080/00914030801891351; Zamiri R, 2012, J EUR OPT SOC-RAPID, V7, DOI 10.2971/jeos.2012.12022; Zamiri R, 2011, J LASER APPL, V23, DOI 10.2351/1.3622205; Zamiri R, 2010, J OPTOELECTRON ADV M, V12, P1083; Zharov V, 2002, LASER SURG MED, P86; Zharov V. P., 2005, BIOL MED, V1, P326; Zharov V.P., 1984, LAZERNAYA OPTIKOAKUS; Zharov VP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1990200; Zharov VP, 2006, J CELL BIOCHEM, V97, P916, DOI 10.1002/jcb.20766; Zharov VP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070167; Zhirkov AA, 2010, J ANAL CHEM+, V65, P596, DOI 10.1134/S1061934810060080; Zhirkov AA, 2011, J ANAL CHEM+, V66, P1180, DOI 10.1134/S106193481109022X; Zhirkov AA, 2012, J ANAL CHEM+, V67, P290, DOI 10.1134/S1061934812010212; Zuev BK, 2009, J ANAL CHEM+, V64, P379, DOI 10.1134/S1061934809040108	280	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1061-9348	1608-3199		J ANAL CHEM+	J. Anal. Chem.	MAR	2015	70	3					249	276		10.1134/S1061934815030168		28	Chemistry, Analytical	Chemistry	CD2DN	WOS:000350884400001		
J	Higashi, Y; Fujii, Y				Higashi, Yasuhiko; Fujii, Youichi			Determination of three phenylphenols in grapefruit juice by HPLC after pre-column derivatization with 4-fluoro-7-nitro-2,1,3-benzoxadiazole	JOURNAL OF ANALYTICAL CHEMISTRY			English	Article						phenylphenol; 4-fluoro-7-nitro-2,1,3-benzoxadiazole; high-performance liquid chromatography (HPLC); cholester column; grapefruit juice	PERFORMANCE LIQUID-CHROMATOGRAPHY; O-PHENYLPHENOL; FLUORESCENCE DETECTION; GAS-CHROMATOGRAPHY; UV ANALYSIS; COLUMN; RESIDUES; FRUITS; AGENTS; ASSAY	o-Phenylphenol is generally utilized as a disinfectant for citrus fruits. The purpose of this study is to develop a high-performance liquid chromatography coupled with ultraviolet detection (380 nm) method for simultaneous determination of o-phenylphenol, and its analogues (m-phenylphenol and p-phenylphenol) in grapefruit juice after pre-column derivatization with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F). 2-Hydroxyfluorene was used as an internal standard (IS). Standard curves were obtained after derivatization with NBD-F in borate buffer (pH 8.0) at room temperature for 5 min. The three NBD-F derivatives were almost completely separated on a Cholester column (5 mu m, 3.0 mm i.d. x 150 mm). Calibration plots were linear in the range of absolute amount of 1.04 2.08 to 41.6 ng/50 mu L injection volume, with r (2) values a parts per thousand yen0.9981, for the three compounds. The lower limits of detection were 0.3 to 0.7 ng/50 mu L injection volume (signal-to-noise ratio of 3 : 1). The coefficients of variation were less than 11.1%. After extraction of grapefruit juice (2.0 mL) with n-pentane, the level of o-phenylphenol in the juice was estimated to be 20.2 +/- 2.0 ng/mL (n = 6, mean +/- SD), while m-phenylphenol and p-phenylphenol were below the lower limits of quantification. The recovery values of the three phenylphenols from samples spiked with a standard mixture of authentic compounds and IS were satisfactory (99.1 to 118.7%).	[Higashi, Yasuhiko; Fujii, Youichi] Hokuriku Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Kanazawa, Ishikawa 9201181, Japan	Higashi, Y (reprint author), Hokuriku Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Ho-3,Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan.	y-higashi@hokuriku-u.ac.jp					Higashi Y, 2007, J LIQ CHROMATOGR R T, V30, P2747, DOI 10.1080/10826070701560850; Bomhard EM, 2002, CRIT REV TOXICOL, V32, P551, DOI 10.1080/20024091064318; Higashi Y, 2009, J LIQ CHROMATOGR R T, V32, P2372, DOI 10.1080/10826070903188013; Toyo'oka T, 2003, BIOMED CHROMATOGR, V17, P133, DOI 10.1002/bmc.223; Imai K, 2003, YAKUGAKU ZASSHI, V123, P901, DOI 10.1248/yakushi.123.901; Blasco C, 2002, J CHROMATOGR A, V947, P227, DOI 10.1016/S0021-9673(02)00009-2; Higashi Y, 2006, BIOMED CHROMATOGR, V20, P423, DOI 10.1002/bmc.577; [Anonymous], 2006, WHO GUID DRINK WAT Q, V1, P427; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Higashi Y, 2009, J LIQ CHROMATOGR R T, V32, P1141, DOI 10.1080/10826070902841844; Davoren M., 2007, TOXICOL IN VITRO, V20, P1190; Higashi Y, 2011, J LIQ CHROMATOGR R T, V34, P18, DOI 10.1080/10826076.2011.534689; Kolbe N, 2006, J AGR FOOD CHEM, V54, P5736, DOI 10.1021/jf060753q; POWIS G, 1987, ANAL BIOCHEM, V167, P191, DOI 10.1016/0003-2697(87)90151-5; Thompson RD, 2001, J AOAC INT, V84, P815; Yamazaki Y, 1999, J AOAC INT, V82, P1474; Yang L, 2004, ANAL SCI, V20, P199, DOI 10.2116/analsci.20.199	17	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1061-9348	1608-3199		J ANAL CHEM+	J. Anal. Chem.	MAR	2015	70	3					346	350		10.1134/S1061934815030235		5	Chemistry, Analytical	Chemistry	CD2DN	WOS:000350884400013		
J	Takaya, A; Kimura, A; Sato, Y; Ishiwada, N; Watanabe, M; Matsui, M; Shibayama, K; Yamamoto, T				Takaya, Akiko; Kimura, Asahi; Sato, Yoshiharu; Ishiwada, Naruhiko; Watanabe, Masaharu; Matsui, Mari; Shibayama, Keigo; Yamamoto, Tomoko			Molecular characterization of linezolid-resistant CoNS isolates in Japan	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article						S. capitis; ribosomal mutations; rlmN	23S RIBOSOMAL-RNA; STAPHYLOCOCCUS-AUREUS; OXAZOLIDINONE ANTIBIOTICS; GENE DOSAGE; EPIDERMIDIS; STABILITY; MECHANISM; BACTERIA; MUTATION; STRAIN	Objectives: Linezolid has been reported to remain active against 98% of staphylococci with resistance identified in 0.05% of Staphylococcus aureus and 1.4% of CoNS. The objective of this study was to characterize the linezolid-resistance mechanisms in the linezolid-resistant CoNS strains isolated in Japan. Methods: Staphylococcus capitis strains exhibiting linezolid MICs >8 mg/L isolated from inpatients between 2012 and 2014 were screened for cfr and mutations in 23S rRNA, L3 and L4 by PCR/sequencing. Isolates were also examined for mutations in the rlmN gene. Results: S. capitis had six 23S rRNA alleles. Five S. capitis isolates displayed linezolid MICs of 8, 16 and 32 mg/L. G2576U mutations were detected in three, four or five copies of 23S rRNA in all isolates. In two isolates exhibiting the highest linezolid MIC (32 mg/L) there was a large deletion in a single copy of 23S rRNA. Repeated 10 bp sequences were found in both 16S and 23S rRNAs, suggesting deletion by recombination between the repeats. One isolate had the mutation Ala-142 -> Thr in the ribosomal protein L3. All linezolid-resistant isolates also demonstrated mutations in the gene encoding RlmN methyltransferase, leading to Thr-62 -> Met and Gly-148 -> Ser. Conclusions: Multiple mechanisms appeared to be responsible for the elevated linezolid resistance in S. capitis isolates: a G2576U mutation in different numbers of copies of 23S rRNA, loss of a single copy of 23S rRNA and a mutation in the ribosomal protein L3, suggesting the accumulation of independent mutational events.	[Takaya, Akiko; Kimura, Asahi; Sato, Yoshiharu; Yamamoto, Tomoko] Chiba Univ, Grad Sch Pharmaceut Sci, Dep Microbiol & Mol Genet, Chiba 2608675, Japan; [Ishiwada, Naruhiko] Chiba Univ Hosp, Div Control & Treatment Infect Dis, Chiba 2608677, Japan; [Watanabe, Masaharu] Chiba Univ Hosp, Div Lab Med, Chiba 2608677, Japan; [Matsui, Mari; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo 2080011, Japan	Yamamoto, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dep Microbiol & Mol Genet, Chiba 2608675, Japan.	tomoko-y@faculty.chiba-u.jp			Ministry of Health, Labor and Welfare of Japan [H24-Shinkou-Ippan-010]	This work was supported by a grant (H24-Shinkou-Ippan-010) from the Ministry of Health, Labor and Welfare of Japan.	Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Hutchinson DK, 2003, CURR TOP MED CHEM, V3, P1021, DOI 10.2174/1568026033452195; Wilson DN, 2008, P NATL ACAD SCI USA, V105, P13339, DOI 10.1073/pnas.0804276105; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Shinabarger DL, 1997, ANTIMICROB AGENTS CH, V41, P2132; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; WADA A, 1993, J BACTERIOL, V175, P7483; Mazzariol A, 2012, EUR J CLIN MICROBIOL, V31, P523, DOI 10.1007/s10096-011-1343-6; de Almeida LM, 2013, ANTIMICROB AGENTS CH, V57, P4082, DOI 10.1128/AAC.00437-13; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Besier S, 2008, ANTIMICROB AGENTS CH, V52, P1570, DOI 10.1128/AAC.01098-07; Pillai SK, 2002, J INFECT DIS, V186, P1603, DOI 10.1086/345368; Marshall SH, 2002, ANTIMICROB AGENTS CH, V46, P3334, DOI 10.1128/AAC.46.10.3334-3336.2002; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; Van Der Zwet WC, 2002, J CLIN MICROBIOL, V40, P2520, DOI 10.1128/JCM.40.7.2520-2525.2002; Gu B, 2013, J ANTIMICROB CHEMOTH, V68, P4, DOI 10.1093/jac/dks354; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Yang XJ, 2013, J MED MICROBIOL, V62, P845, DOI 10.1099/jmm.0.051003-0; Schnellmann C, 2006, J CLIN MICROBIOL, V44, P4444, DOI 10.1128/JCM.00868-06; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Clinical and Laboratory Standards Institute, 2009, M7A8 CLSI; Cui LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057096; Diekema DJ, 2000, DRUGS, V59, P7, DOI 10.2165/00003495-200059010-00002; Dotis J, 2010, INT J INFECT DIS, V14, pE638, DOI 10.1016/j.ijid.2009.10.002; Febler AT, 2014, J ANTIMICROB CHEMOTH, V69, P268; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Ikeda- Dantsuji Y, 2011, J INFECT CHEMOTHER, V17, P45; Jones RN, 2009, DIAGN MICROBIOL INFE, V65, P404; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Liakopoulos A, 2009, J ANTIMICROB CHEMOTH, V64, P206, DOI 10.1093/jac/dkp167; Nalmas S, 2008, HEART LUNG, V37, P380, DOI 10.1016/j.hrtlng.2007.09.005; Rasigade JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031548; Rodriguez- Aranda A, 2009, DIAGN MICROBIOL INFE, V63, P398; Tewhey R, 2014, MBIO, V5; Yoshida K, 2009, J INFECT CHEMOTHER, V15, P417, DOI 10.1007/s10156-009-0727-3	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	MAR	2015	70	3					658	663		10.1093/jac/dku443		6	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CC2ZV	WOS:000350214700005		
J	Masuki, S; Mori, M; Tabara, Y; Sakurai, A; Hashimoto, S; Morikawa, M; Miyagawa, K; Sumiyoshi, E; Miki, T; Higuchi, K; Nose, H				Masuki, Shizue; Mori, Masayuki; Tabara, Yasuharu; Sakurai, Akihiro; Hashimoto, Shigenari; Morikawa, Mayuko; Miyagawa, Ken; Sumiyoshi, Eri; Miki, Tetsuro; Higuchi, Keiichi; Nose, Hiroshi		Shinshu Univ Genetic Res Consortiu	The factors affecting adherence to a long-term interval walking training program in middle-aged and older people	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						exercise training; aging; remotely supervised system; genetics; vasopressin	1A RECEPTOR AVPR1A; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; LIFE-STYLE; KNEE OSTEOARTHRITIS; EDUCATION-PROGRAM; RANDOMIZED-TRIAL; PROMOTER REGION; VASOPRESSIN; FITNESS	No long-term exercise training regimen with high adherence and effectiveness in middle-aged and older people is broadly available in the field. We assessed the adherence to, and effects of, our long-term training program comprising an interval walking training (IWT) and an information technology network system and the factors affecting adherence. Middle-aged and older men and women [n = 696, aged 65 +/- 7(SD) yr] underwent IWT. The subjects were instructed to repeat five or more sets of fast and slow walking for 3 min each at >= 70 and 40% peak aerobic capacity for walking (<(V)over dot>(O2peak)), respectively, per day >= 4 days/wk for 22 mo. Adherence was assessed as training days accomplished relative to the target of 4 days/wk over 22 mo. The effects on the <(V)over dot>(O2peak) and lifestyle-related disease score were evaluated every 6 mo. The independent factors affecting adherence were assessed by multiple-regression analysis after adjustment for baseline physical characteristics and other possible covariates, including vasopressin V1a receptor polymorphisms. The adherence over 22 mo averaged 70% and was highly correlated with a 13% reduction in the lifestyle-related disease score (R-2 = 0.94, P = 0.006) and with a 12% increase in <(V)over dot>(O2peak) (R-2 = 0.94, P = 0.006). The major determinant of higher adherence was lower baseline body mass index (BMI) (P < 0.0001) and male sex (P < 0.0001). For men, in addition to BMI, nonsmokers (P = 0.031) and V1a receptor polymorphisms (P = 0.033) were independent determinants of higher adherence. Thus the long-term IWT program is an effective regimen. Moreover, baseline BMI and sex for all subjects, and smoking and V1a receptor polymorphisms for men, were associated with adherence.	[Masuki, Shizue; Morikawa, Mayuko; Miyagawa, Ken; Sumiyoshi, Eri; Nose, Hiroshi] Shinshu Univ, Dept Sports Med Sci, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Mori, Masayuki; Higuchi, Keiichi] Shinshu Univ, Dept Aging Biol, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Masuki, Shizue; Mori, Masayuki; Higuchi, Keiichi; Nose, Hiroshi] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan; [Sakurai, Akihiro] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan; [Hashimoto, Shigenari] Shinshu Univ Hosp, Adv Prevent Med Ctr, Matsumoto, Nagano, Japan; [Morikawa, Mayuko; Miyagawa, Ken] Jukunen Taiikudaigaku Res Ctr, Matsumoto, Nagano, Japan; [Tabara, Yasuharu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Japan; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Japan; [Tabara, Yasuharu; Miki, Tetsuro] Ehime Proteomed Res Ctr, Div Antiaging Genom, Toon, Japan	Nose, H (reprint author), Shinshu Univ, Dept Sports Med Sci, Grad Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	nosehir@shinshu-u.ac.jp			Shinshu University; Jukunen Taiikudaigaku Research Center; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790224]; Matsumoto City; Ministry of Health, Labor and Welfare of Japan [H17-Chohju-Ippan-016]; Japan Society for the Promotion of Science [24689014]	This research was supported in part by the Shinshu University Partnership Project between Shinshu University; Jukunen Taiikudaigaku Research Center; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and Matsumoto City. This research was also supported by the Ministry of Health, Labor and Welfare of Japan (H17-Chohju-Ippan-016); the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21790224); and the Japan Society for the Promotion of Science (24689014).	Rhodes RE, 1999, SPORTS MED, V28, P397, DOI 10.2165/00007256-199928060-00003; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Nemoto K, 2007, MAYO CLIN PROC, V82, P803; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; Ekkekakis P, 2006, INT J OBESITY, V30, P652, DOI 10.1038/sj.ijo.0803052; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; Wallace JP, 1995, J SPORT MED PHYS FIT, V35, P206; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Messier SP, 2004, ARTHRITIS RHEUM, V50, P1501, DOI 10.1002/art.20256; Masuki S, 2010, HYPERTENSION, V55, P747, DOI 10.1161/HYPERTENSIONAHA.109.147728; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Morikawa M, 2011, BRIT J SPORT MED, V45, P216, DOI 10.1136/bjsm.2009.064816; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; [Anonymous], 2002, CIRCULATION, V106, P3143; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Chaput Jean-Philippe, 2014, Curr Obes Rep, V3, P54, DOI 10.1007/s13679-013-0086-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Committee to Evaluate Diagnostic Standards for Metabolic Syndrome, 2005, NIPPON NAIKA GAKKAI, V94, P794; Cooper TV, 2007, ADDICT BEHAV, V32, P2268, DOI 10.1016/j.addbeh.2007.01.007; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Haskell WL, 1998, 1997 NAG S SPORTS SC, P399; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Japan Statistics Bureau, 2013, LAB FORC SURV; KING AC, 1995, CIRCULATION, V91, P2596; Laboratory of Physical Fitness Standards Tokyo Metropolitan University, 2000, NEW PHYS FITN STAND, P1; Levin R, 2009, PSYCHONEUROENDOCRINO, V34, P901, DOI 10.1016/j.psyneuen.2008.12.014; Masuki S, 2013, J PHYSIOL-LONDON, V591, P3651, DOI 10.1113/jphysiol.2013.251876; Matsuoka K, 2000, DIABETES RES CLIN PR, V50, pS17, DOI 10.1016/S0168-8227(00)00174-1; Ministry of Health Labour and Welfare of Japan, 2010, DIET REF INT JAP 201, P43; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; Nose H, 2009, J PHYSIOL-LONDON, V587, P5569, DOI 10.1113/jphysiol.2009.179499; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Swain DP, 2014, ACSMS RESOURCE MANUA, P465; Tansey KE, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-3; Thompson WR, 2010, ACSMS GUIDELINES EXE, P152; Vangjeli C, 2010, CIRC-CARDIOVASC GENE, V3, P53, DOI 10.1161/CIRCGENETICS.109.899930; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Yamazaki T, 2009, MED SCI SPORT EXER, V41, P2213, DOI 10.1249/MSS.0b013e3181a9c452	46	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	MAR 1	2015	118	5					595	603		10.1152/japplphysiol.00819.2014		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CC9OY	WOS:000350701300010		
J	Sawa, Y; Matsuda, K; Tatsumi, E; Matsumiya, G; Abe, T; Fukunaga, K; Kishida, A; Kokubo, K; Masuzawa, T; Myoui, A; Nishimura, M; Nishimura, T; Nishinaka, T; Okamoto, E; Tokunaga, S; Tomo, T; Tsukiya, T; Yagi, Y; Yamaoka, T				Sawa, Y.; Matsuda, K.; Tatsumi, E.; Matsumiya, G.; Abe, T.; Fukunaga, K.; Kishida, A.; Kokubo, K.; Masuzawa, T.; Myoui, A.; Nishimura, M.; Nishimura, T.; Nishinaka, T.; Okamoto, E.; Tokunaga, S.; Tomo, T.; Tsukiya, T.; Yagi, Y.; Yamaoka, T.		Journal Artificial Organs	Journal of Artificial Organs 2014: the year in review Journal of Artificial Organs Editorial Committee	JOURNAL OF ARTIFICIAL ORGANS			English	Review							VENTRICULAR ASSIST DEVICE; EXTRACORPOREAL MEMBRANE-OXYGENATION; INITIAL-EXPERIENCE; LIFE-SUPPORT; BLOOD PUMP; SHORT-TERM; IMPLANTATION; SYSTEM; PATIENT; RECONSTRUCTION		[Sawa, Y.] Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan; [Matsuda, K.] Univ Yamanashi Hosp, Emergency & Crit Care Med, Yamanashi, Japan; [Tatsumi, E.; Tsukiya, T.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Artificial Organs, Osaka, Japan; [Matsumiya, G.] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chiba, Japan; [Abe, T.] Iwate Med Univ, Sch Med, Dept Urol, Morioka, Iwate, Japan; [Fukunaga, K.] Kyorin Univ, Fac Hlth Sci, Tokyo, Japan; [Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Kokubo, K.] Kitasato Univ, Dept Med Engn & Technol, Sch Allied Hlth Sci, Tokyo, Kanagawa, Japan; [Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Ibaraki, Japan; [Myoui, A.] Osaka Univ Hosp, Med Ctr Translat Res, Osaka 553, Japan; [Nishimura, M.] Tottori Univ, Fac Med, Div Organ Regenerat Surg, Tottori 680, Japan; [Nishimura, T.] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Nishinaka, T.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Okamoto, E.] Tokai Univ, Sch Biosci & Engn, Dept Human Sci & Informat, Sapporo, Hokkaido, Japan; [Tokunaga, S.] Kanagawa Cardiovasc & Resp Ctr, Dept Cardiovasc Surg, Yokohama, Kanagawa, Japan; [Tomo, T.] Oita Univ, Fac Med, Dept Internal Med 2, Oita 87011, Japan; [Yagi, Y.] Kyoto Prefectural Univ Med, Dept Clin Engn, Kyoto, Japan; [Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Osaka, Japan		sawa@surg1.med.osaka-u.ac.jp					Mohite PN, 2014, J ARTIF ORGANS, V17, P228, DOI 10.1007/s10047-014-0773-1; Masuda Y, 2014, J ARTIF ORGANS, V17, P106, DOI 10.1007/s10047-013-0742-0; Imamura T, 2014, J ARTIF ORGANS, V17, P23, DOI 10.1007/s10047-013-0748-7; Nishi H, 2014, J ARTIF ORGANS, V17, P149, DOI 10.1007/s10047-013-0753-x; Kushida S, 2014, J ARTIF ORGANS, V17, P186, DOI 10.1007/s10047-014-0761-5; Suwa H, 2014, J ARTIF ORGANS, V17, P16, DOI 10.1007/s10047-013-0731-3; Aoyama N, 2014, J ARTIF ORGANS, V17, P33, DOI 10.1007/s10047-013-0735-z; Hayes D, 2014, J ARTIF ORGANS, V17, P103, DOI 10.1007/s10047-013-0738-9; Arakawa M, 2014, J ARTIF ORGANS, V17, P135, DOI 10.1007/s10047-014-0757-1; Chen JL, 2014, J ARTIF ORGANS, V17, P202, DOI 10.1007/s10047-013-0750-0; Choi SJ, 2014, J ARTIF ORGANS, V17, P344, DOI 10.1007/s10047-014-0778-9; Development and Management of Human Resources, 2008, J ARTIF ORGANS, V10, P4; Ehashi T, 2014, J ARTIF ORGANS, V17, P321, DOI 10.1007/s10047-014-0791-z; Fatullayev J, 2014, J ARTIF ORGANS, V17, P370, DOI 10.1007/s10047-014-0785-x; Hoashi T, 2014, J ARTIF ORGANS, V17, P315, DOI 10.1007/s10047-014-0786-9; Inoue T, 2014, J ARTIF ORGANS, V17, P95, DOI 10.1007/s10047-013-0740-2; Journal of Artificial Organs Editorial Committee, 2013, J ARTIF ORGANS, V16, P1; Journal of Artificial Organs Editorial Committee, 2006, J ARTIF ORGANS, V9, P1; Journal of Artificial Organs Editorial Committee, 2011, J ARTIF ORGANS, V14, P1; Journal of Artificial Organs Editorial Committee, 2012, J ARTIF ORGANS, V15, P11; Journal of Artificial Organs Editorial Committee, 2007, J ARTIF ORGANS, V10, P53; Journal of Artificial Organs Editorial Committee, 2009, J ARTIF ORGANS, V12, P1; Journal of Artificial Organs Editorial Committee, 2010, J ARTIF ORGANS, V13, P1; Kashiyama N, 2014, J ARTIF ORGANS, V17, P366, DOI 10.1007/s10047-014-0784-y; Kusajima K, 2014, J ARTIF ORGANS, V17, P99, DOI 10.1007/s10047-013-0747-8; Liu F, 2014, J ARTIF ORGANS, V17, P337, DOI 10.1007/s10047-014-0777-x; Mizutani N, 2014, J ARTIF ORGANS, V17, P50, DOI 10.1007/s10047-013-0736-y; Mohite PN, 2014, J ARTIF ORGANS, V17, P272, DOI 10.1007/s10047-014-0763-3; Nakahara I, 2014, J ARTIF ORGANS, V17, P358, DOI 10.1007/s10047-014-0789-6; Nakajima S, 2014, J ARTIF ORGANS, V17, P197, DOI 10.1007/s10047-014-0758-0; Nakamoto H, 2014, J ARTIF ORGANS, V17, P60, DOI 10.1007/s10047-013-0741-1; Narayan R, 2014, J ARTIF ORGANS, V17, P206, DOI 10.1007/s10047-014-0754-4; Nishimura H, 2014, J ARTIF ORGANS, V17, P110, DOI 10.1007/s10047-013-0733-1; Sakakibara S, 2014, J ARTIF ORGANS, V17, P169, DOI 10.1007/s10047-014-0760-6; Sato M, 2014, J ARTIF ORGANS, V17, P265, DOI 10.1007/s10047-014-0768-y; Sonoo T, 2014, J ARTIF ORGANS, V17, P281, DOI 10.1007/s10047-014-0776-y; Suzuki K, 2014, J ARTIF ORGANS, V17, P157, DOI 10.1007/s10047-014-0762-4; Taguchi T, 2014, J ARTIF ORGANS, V17, P285, DOI 10.1007/s10047-014-0775-z; Tan T.-S., 2014, J ARTIF ORGANS, V4; Teshima H, 2014, J ARTIF ORGANS, V17, P258, DOI 10.1007/s10047-014-0770-4; Ushijima T, 2014, J ARTIF ORGANS, V17, P250, DOI 10.1007/s10047-014-0769-x; Wu SY, 2014, J ARTIF ORGANS, V17, P301, DOI 10.1007/s10047-014-0788-7; Yen JH, 2014, J ARTIF ORGANS, V17, P178, DOI 10.1007/s10047-014-0755-3; Yoshida S, 2014, J ARTIF ORGANS, V17, P243, DOI 10.1007/s10047-014-0765-1; Yoshioka D, 2014, J ARTIF ORGANS, V17, P308, DOI 10.1007/s10047-014-0783-z	45	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					1	7		10.1007/s10047-015-0821-5		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800001		
J	Imamura, T; Kinugawa, K; Nitta, D; Fujino, T; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Kyo, S; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Kyo, Shunei; Ono, Minoru			Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Heart failure; Autonomic nerve; Heart rate variability; Reverse remodeling	CONGESTIVE-HEART-FAILURE; CARVEDILOL; BISOPROLOL; PROGNOSIS	Although the suppression of sympathetic activity is an essential mission for the current heart failure treatment strategy, little is known about the relationship between the rotation speed setting and autonomic nervous activity during continuous-flow left ventricular assist device (LVAD) treatment. We evaluated 23 adult patients with sinus rhythm (36 +/- A 13 years) who had received continuous-flow LVAD and been followed at our institute between March 2013 and August 2014. Heart rate variability measurement was executed along with hemodynamic study at 3 rotation speeds (low, middle, and high) at 5 weeks after LVAD implantation. Lower rotation speed was associated with higher ratio of low-frequency over high-frequency spectral level (LF/HF), representing enhanced sympathetic activation (p < 0.05 by repeated analyses of variance). Among hemodynamic parameters, cardiac index was exclusively associated with LFNU = LF/(LF + HF), representing relative sympathetic activity over parasympathetic one (p < 0.05). After 6 months LVAD support at middle rotation speed, 19 patients with higher LFNU eventually had higher plasma levels of B-type natriuretic peptide and achieved less LV reverse remodeling. A logistic regression analysis demonstrated that lower LFNU was significantly associated with improvement of LV reverse remodeling (p = 0.021, odds ratio 0.903) with a cut-off level of 55 % calculated by the ROC analysis (AUC 0.869). In conclusion, autonomic activity can vary in various rotation speeds. Patients with higher LFNU may better be controlled at higher rotation speed with the view point to suppress sympathetic activity and achieve LV reverse remodeling.	[Imamura, Teruhiko; Kinugawa, Koichiro; Kyo, Shunei] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, Tokyo 1138655, Japan; [Nitta, Daisuke; Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138655, Japan	Imamura, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	te.imamu@gmail.com; kinugawa-tky@umin.ac.jp					AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Floras JS, 2003, ACTA PHYSIOL SCAND, V177, P391, DOI 10.1046/j.1365-201X.2003.01087.x; [Anonymous], 1996, EUR HEART J, V17, P354; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; PAGANI M, 1986, CIRC RES, V59, P178; Sawada Y, 1997, MED BIOL ENG COMPUT, V35, P318, DOI 10.1007/BF02534083; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; McKelvie RS, 1999, CIRCULATION, V100, P1056; George RS, 2013, EUR J HEART FAIL, V15, P1035, DOI 10.1093/eurjhf/hft059; Eichhorn EJ, 1996, CIRCULATION, V94, P2285; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Bristow MR, 1997, AM J CARDIOL, V80, P26; FRYE RL, 1960, J CLIN INVEST, V39, P1043, DOI 10.1172/JCI104119; Hori M, 2014, HEART VESSELS, V29, P238, DOI 10.1007/s00380-013-0340-3; LOWN B, 1976, NEW ENGL J MED, V294, P1165; Lechat P, 1999, LANCET, V353, P9; Metra M, 2000, AM HEART J, V139, P511, DOI 10.1067/mhj.2000.103544; SKORECKI KL, 1981, AM J MED, V70, P77, DOI 10.1016/0002-9343(81)90414-9; Slaughter MS, 2010, J HEART LUNG TRANSPL, V29, pS1, DOI 10.1016/j.healun.2010.01.011	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					20	26		10.1007/s10047-014-0800-2		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800003		
J	Saito, S; Toda, K; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Sakata, Y; Mizote, I; Daimon, T; Sawa, Y				Saito, Shunsuke; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Sakata, Yasushi; Mizote, Isamu; Daimon, Takashi; Sawa, Yoshiki			Hemodynamic changes during left ventricular assist device-off test correlate with the degree of cardiac fibrosis and predict the outcome after device explantation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Left ventricular assist device; Bridge to recovery; LVAD-off test; Fibrosis	IDIOPATHIC DILATED CARDIOMYOPATHY; MYOCARDIAL RECOVERY; HEART-FAILURE; BRIDGE; FLOW; SUPPORT	Myocardial recovery occurs in a small cohort of patients receiving left ventricular assist device (LVAD) support, but identification of candidates for device removal remains challenging. We hypothesized that hemodynamic evaluation using echocardiography and right heart catheter during temporary suspension of LVAD support (LVAD-off test) can assess cardiac recovery to predict successful device removal. To prove this hypothesis, we reviewed 44 patients who underwent LVAD-off test from January 2000 to March 2011 at Osaka University Hospital. Twenty-two of them underwent LVAD explant, 9 showed sustaining recovery (successful explant, SE-group); whereas 13 had a recurrent heart failure (failed explant, FE-group). The other 22 patients remained LVAD dependent (nonrecovery, NR-group). Echocardiography showed significant lower ejection fraction (LVEF) in NR-group than in SE- and FE-group after termination of LVAD support, but there was no difference between SE- and FE-group. On the other hand, elevation in pulmonary capillary wedge pressure (Delta PCWP) was significantly smaller in SE-group than in FE- and NR-groups. The degree of cardiac fibrosis significantly increased in FE- and NR-group during the LVAD support, while it did not increase in SE-group. The degree of cardiac fibrosis at the time of LVAD explantation correlated significantly with PCWP at LVAD halt and Delta PCWP, and it had significant impact on the outcome after LVAD weaning. In conclusion, the data obtained during LVAD-off test using echocardiography and right heart catheter significantly correlated with the degree of cardiac fibrosis at the time of LVAD explantation. LVAD-off test is a useful method to predict the successful LVAD explantation.	[Saito, Shunsuke; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Sakata, Yasushi; Mizote, Isamu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan	Saito, S (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	shunsaito@ymail.plala.or.jp; sawa@surg1.med.osaka-u.ac.jp					Ando M, 2011, J ARTIF ORGANS, V14, P70, DOI 10.1007/s10047-010-0543-7; Dandel M, 2011, EUR HEART J, V32, P1148, DOI 10.1093/eurheartj/ehq353; Matsumiya G, 2005, J THORAC CARDIOV SUR, V130, P699, DOI 10.1016/j.jtcvs.2005.05.016; Krabatsch T, 2011, ANN THORAC SURG, V91, P1335, DOI 10.1016/j.athoracsur.2011.01.027; Kato TS, 2011, CIRC-HEART FAIL, V4, P546, DOI 10.1161/CIRCHEARTFAILURE.111.962142; Mancini DM, 1998, CIRCULATION, V98, P2383; George RS, 2007, J HEART LUNG TRANSPL, V26, P967, DOI 10.1016/j.healun.2007.07.021; Dandel M, 2005, CIRCULATION, V112, pI37, DOI 10.1161/CIRCULATIONAHA.104.525352; Myers TJ, 2006, J HEART LUNG TRANSPL, V25, P379, DOI 10.1016/j.healun.2005.11.459; Saito S, 2010, J HEART LUNG TRANSPL, V29, P672, DOI 10.1016/j.healun.2010.01.007; Dandel M, 2008, CIRCULATION, V118, pS94, DOI 10.1161/CIRCULATIONAHA.107.755983; Yacoub MH, 2001, EUR HEART J, V22, P534, DOI 10.1053/euhj.2000.2613	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					27	34		10.1007/s10047-014-0802-0		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800004		
J	Fujii, Y; Shirai, M; Inamori, S; Takewa, Y; Tatsumi, E				Fujii, Yutaka; Shirai, Mikiyasu; Inamori, Shuji; Takewa, Yoshiaki; Tatsumi, Eisuke			A novel small animal extracorporeal circulation model for studying pathophysiology of cardiopulmonary bypass	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Extracorporeal circulation; Rat ECC model; Inflammatory response; Biological reaction	INFLAMMATORY RESPONSE; RAT MODEL	Extracorporeal circulation (ECC) is indispensable for cardiac surgery. Despite the fact that ECCcauses damage to blood components and is non-physiologic, its pathophysiology has not been fully elucidated. This is because difficulty in clinical research and animal experiments keeps the knowledge insufficient. Therefore, it is desirable to have a miniature ECC model for small animals, which enables repetitive experiments, to study the mechanism of pathophysiological changes during ECC. We developed a miniature ECC system and applied it to the rat. We measured changes in hemodynamics, blood gases and hemoglobin (Hb) concentration, serum cytokines (TNF-alpha, IL-6, IL-10), biochemical markers (LDH, AST, ALT), and the wet-to-dry weight (W/D) ratio of the lung for assessing whether the rat ECC model is comparable to the human ECC. The ECC system consisted of a membranous oxygenator (polypropylene, 0.03 m(2)), tubing line (polyvinyl chloride), and roller pump. Priming volume of this system is only 8 ml. Rats (400-450 g) were divided into the SHAM group (n = 7) and the ECC group (n = 7). Blood samples were collected before, 60 and 120 min after initiation of ECC. During ECC, blood pressure and Hb were maintained around 80 mmHg and 10 g/dL, respectively. The levels of the inflammatory and biochemical markers and the W/D ratio were significantly elevated in the ECC group, indicating some organ damages and systemic inflammatory responses during ECC. We successfully established the ECC for the rat. This miniature ECC model could be a useful approach for studying the mechanism of pathophysiology during ECC and basic assessment of the ECC devices.	[Fujii, Yutaka; Takewa, Yoshiaki; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr, Dept Artificial Organs, Res Inst, Suita, Osaka 5658565, Japan; [Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Res Inst, Suita, Osaka 5658565, Japan; [Inamori, Shuji] Hiroshima Int Univ, Dept Clin Engn, Fac Hlth Sci, Hiroshima 7392631, Japan	Fujii, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Artificial Organs, Res Inst, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	yfujii@ncvc.go.jp					Aebert H, 2000, EUR J CARDIO-THORAC, V18, P589, DOI 10.1016/S1010-7940(00)00565-0; Jiang HC, 2007, SURGERY, V141, P32, DOI 10.1016/j.surg.2006.03.024; Fujii Y, 2013, ARTIF ORGANS, V37, P136, DOI 10.1111/j.1525-1594.2012.01535.x; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; BUTLER J, 1993, ANN THORAC SURG, V55, P552; Cremer J, 1996, ANN THORAC SURG, V61, P1714, DOI 10.1016/0003-4975(96)00055-0; de Gast-Bakker DH, 2013, INTENS CARE MED, V39, P2011, DOI 10.1007/s00134-013-3085-7; Boyle EM, 1997, ANN THORAC SURG, V63, P277; ENGELMAN RM, 1995, ANN THORAC SURG, V60, P801, DOI 10.1016/0003-4975(95)00211-3; Fujii Y, 2013, ARTIF ORGANS, V37, P1034, DOI 10.1111/aor.12125; Gao DX, 2003, ANN THORAC SURG, V75, P74, DOI 10.1016/S0003-4975(02)04163-2; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; Walker Gregor, 2003, Paediatr Respir Rev, V4, P147, DOI 10.1016/S1526-0542(03)00021-6	13	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					35	39		10.1007/s10047-014-0804-y		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800005		
J	Funayama, M; Takewa, Y; Oie, T; Matsui, Y; Tatsumi, E; Nakayama, Y				Funayama, Marina; Takewa, Yoshiaki; Oie, Tomonori; Matsui, Yuichi; Tatsumi, Eisuke; Nakayama, Yasuhide			In situ observation and enhancement of leaflet tissue formation in bioprosthetic "biovalve"	JOURNAL OF ARTIFICIAL ORGANS			English	Article						In vivo tissue engineering; Biovalve; Heart valve; Tissue formation; Endoscope	AUTOLOGOUS VALVED CONDUIT; FOREIGN-BODY REACTION; HEART-VALVE; GROWTH-FACTORS; AORTIC-VALVE; ADIPOSE-TISSUE; REPLACEMENT; FAT; ARCHITECTURE; CELLS	Biovalves, autologous tri-leaflet valved conduits, are formed in the subcutaneous spaces of animals. The valves are formed using molds encapsulated with autologous connective tissues. However, tissue migration into the small apertures in the molds for leaflet formation is generally slower than that for conduit formation around the molds. In this study, the formation of the leaflet tissues was directly and non-invasively observed using a wireless capsule endoscope. The molds were assembled from 6 parts, one of which was impregnated with the endoscope, and embedded into subcutaneous pouches in goats (n = 30). Tissue ingrowth into the apertures gradually occurred from the edges of the leaflet parts. Tissue formation was accompanied by capillary formation. At 63.1 +/- A 17.1 days after embedding, the apertures were completely replaced with autologous connective tissue, forming the leaflet tissues. Leaflet formation was enhanced by including fat tissue (46.7 +/- A 4.2 days) or blood (41.1 +/- A 6.9 days) in the apertures before embedding. The creation of slit openings, in conjunction with addition of blood to the apertures, further enhanced leaflet formation (37.0 +/- A 2.8 days). Since leaflet formation could be observed endoscopically, the appropriate embedding period for complete biovalve formation could be determined.	[Funayama, Marina; Oie, Tomonori; Matsui, Yuichi; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan; [Funayama, Marina] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Takewa, Yoshiaki; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Artificial Organs, Suita, Osaka 5658565, Japan; [Oie, Tomonori] Shinkan Kogyo Co, Osaka, Japan	Nakayama, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	takewa@ncvc.go.jp; nakayama@ri.ncvc.go.jp					Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Sumikura H, 2014, ARTIF ORGANS, V38, P282, DOI 10.1111/aor.12173; Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903; Hayashida K, 2008, J BIOMED MATER RES B, V86B, P1, DOI 10.1002/jbm.b.30981; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Li W, 2004, MOL BIOL CELL, V15, P294; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762; Yamanami M, 2010, J ARTIF ORGANS, V13, P106, DOI 10.1007/s10047-010-0491-2; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Clark RAF, 1996, AM J PATHOL, V148, P1407; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Kishi A, 2010, ARTIF ORGANS, V34, P1125, DOI 10.1111/j.1525-1594.2010.00997.x; Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JC132239; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; Diegelmann RF, 2004, FRONT BIOSCI, V9, P283, DOI 10.2741/1184; Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15; Le Tourneau T, 1999, CIRCULATION, V100, P11; Mizuno T, 2014, J BIOMED B IN PRESS; Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P135, DOI 10.1002/jbm.b.31880; Watanabe T, 2007, J ARTIF ORGANS, V10, P10, DOI 10.1007/s10047-006-0361-0; Zhao JH, 2013, PLAST RECONSTR SURG, V132, P1149, DOI 10.1097/PRS.0b013e3182a48b6c	42	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					40	47		10.1007/s10047-014-0793-x		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800006		
J	Kawajiri, H; Mizuno, T; Moriwaki, T; Iwai, R; Ishibashi-Ueda, H; Yamanami, M; Kanda, K; Yaku, H; Nakayama, Y				Kawajiri, Hidetake; Mizuno, Takeshi; Moriwaki, Takeshi; Iwai, Ryosuke; Ishibashi-Ueda, Hatsue; Yamanami, Masashi; Kanda, Keiichi; Yaku, Hitoshi; Nakayama, Yasuhide			Implantation study of a tissue-engineered self-expanding aortic stent graft (bio stent graft) in a beagle model	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Endovascular aortic repair (EVAR); Covered stents; Connective tissue; In vivo tissue engineering; Stent graft	FIBROBLAST-GROWTH-FACTOR; ANEURYSM REPAIR; CLINICAL-TRIALS; IN-BODY; ARGATROBAN; RELEASE	The use of stent grafts for endovascular aortic repair has become an important treatment option for aortic aneurysms requiring surgery. This treatment has achieved excellent outcomes; however, problems like type 1 endoleaks and stent graft migration remain. Bio stent grafts (BSGs), which are self-expanding stents covered with connective tissue, were previously developed using "in-body tissue architecture" technology. We assessed their early adaptation to the aorta after transcatheter implantation in a beagle model. BSGs were prepared by subcutaneous embedding of acryl rods mounted with self-expanding nitinol stents in three beagles for 4 weeks (n = 3/dog). The BSGs were implanted as allografts into infrarenal abdominal aortas via the femoral artery of three other beagles. After 1 month of implantation, aortography revealed no stenosis or aneurysmal changes. The luminal surface of the BSGs was completely covered with neointimal tissue, including endothelialization, without any thrombus formation. The cover tissue could fuse the luminal surface of the native aorta with tight conjunctions even at both ends of the stents, resulting in complete impregnation of the strut into the reconstructed vascular wall, which is expected to prevent endoleaks and migration in clinical applications.	[Kawajiri, Hidetake; Mizuno, Takeshi; Moriwaki, Takeshi; Iwai, Ryosuke; Yamanami, Masashi; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan; [Kawajiri, Hidetake; Yamanami, Masashi; Kanda, Keiichi; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan	Kawajiri, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kawajiricvs@yahoo.co.jp; ny@ncvc.go.jp					Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Torsello G, 2011, J VASC SURG, V54, P300, DOI 10.1016/j.jvs.2010.12.062; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510; Hoshina K, 2011, INT ANGIOL, V30, P467; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Bashar M, 2002, J ENDOVASC THER, V9, P320; Brinster CJ, 2011, J VASC SURG, V54, P42, DOI 10.1016/j.jvs.2010.12.042; Garcia-Toca M, 2010, J VASC SURG, V52, p22S, DOI 10.1016/j.jvs.2010.06.140; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Kajimoto M, 2008, J VASC SURG, V48, P1306, DOI 10.1016/j.jvs.2008.05.060; Kawajiri H, 2013, INTERACT CARDIOV TH, V17, P895, DOI 10.1093/icvts/ivt336; Kawajiri H, 2014, J BIOMED B IN PRESS; Knepper J, 2010, SEMIN VASC SURG, V23, P170, DOI 10.1053/j.semvascsurg.2010.05.005; Kusanagi M, 2007, J ENDOVASC THER, V14, P785, DOI 10.1583/07-2189.1; Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P420, DOI 10.1002/jbm.b.31914; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Szeto WY, 2013, J THORAC CARDIOVASC, V145, P165; Zahn R, 2013, J ENDOVASC THER, V20, P265, DOI 10.1583/12-4107R.1	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					48	54		10.1007/s10047-014-0796-7		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800007		
J	Hori, H; Iwamoto, U; Niimi, G; Shinzato, M; Hiki, Y; Tokushima, Y; Kawaguchi, K; Ohashi, A; Nakai, S; Yasutake, M; Kitaguchi, N				Hori, Hideo; Iwamoto, Ushio; Niimi, Gen; Shinzato, Masanori; Hiki, Yoshiyuki; Tokushima, Yasuo; Kawaguchi, Kazunori; Ohashi, Atsushi; Nakai, Shigeru; Yasutake, Mikitomo; Kitaguchi, Nobuya			Appropriate nonwoven filters effectively capture human peripheral blood cells and mesenchymal stem cells, which show enhanced production of growth factors	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Nonwoven filter; Human peripheral blood cells; Vascular endothelial growth factor; Mesenchymal stem cells; Transforming growth factor beta 1	CYTOKINES	Scaffolds, growth factors, and cells are three essential components in regenerative medicine. Nonwoven filters, which capture cells, provide a scaffold that localizes and concentrates cells near injured tissues. Further, the cells captured on the filters are expected to serve as a local supply of growth factors. In this study, we investigated the growth factors produced by cells captured on nonwoven filters. Nonwoven filters made of polyethylene terephthalate (PET), biodegradable polylactic acid (PLA), or chitin (1.2-22 mu m fiber diameter) were cut out as 13 mm disks and placed into cell-capturing devices. Human mesenchymal stem cells derived from adipose tissues (h-ASCs) and peripheral blood cells (h-PBCs) were captured on the filter and cultured to evaluate growth factor production. The cell-capture rates strongly depended on the fiber diameter and the number of filter disks. Nonwoven filter disks were composed of PET or PLA fibers with fiber diameters of 1.2-1.8 mu m captured over 70 % of leukocytes or 90 % of h-ASCs added. The production of vascular endothelial growth factor (VEGF), transforming growth factor beta 1, and platelet-derived growth factor AB were significantly enhanced by the h-PBCs captured on PET or PLA filters. h-ASCs on PLA filters showed significantly enhanced production of VEGF. These enhancements varied with the combination of the nonwoven filter and cells. Because of the enhanced growth factor production, the proliferation of human fibroblasts increased in conditioned medium from h-PBCs on PET filters. This device consisting of nonwoven filters and cells should be investigated further for possible use in the regeneration of impaired tissues.	[Hori, Hideo; Hiki, Yoshiyuki; Kawaguchi, Kazunori; Ohashi, Atsushi; Nakai, Shigeru; Kitaguchi, Nobuya] Fujita Hlth Univ, Sch Hlth Sci, Fac Clin Engn, Toyoake, Aichi 4701192, Japan; [Iwamoto, Ushio; Yasutake, Mikitomo] Asahi Kasei Corp, Healthcare R&D Ctr, Tokyo, Japan; [Niimi, Gen] Fujita Hlth Univ, Fac Joint Res Lab, Toyoake, Aichi 4701192, Japan; [Shinzato, Masanori] Fujita Hlth Univ, Sch Hlth Sci, Fac Med Management & Informat Sci, Toyoake, Aichi 4701192, Japan; [Tokushima, Yasuo] Asahi Kasei Med Co Ltd, Therapeut Apheresis Div, Tokyo, Japan	Kitaguchi, N (reprint author), Fujita Hlth Univ, Sch Hlth Sci, Fac Clin Engn, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	nkitaguc@fujita-hu.ac.jp			Aichi Kidney Foundation; JSPS KAKENHI [25410232]	The authors thank Mr. Tomohisa Inoue of Shinwa Co., Ltd., Mr. Yoshio Katsuta of Fusyokufu Joho, and Ms. Mikiko Ariga of Asahi Kasei Fibers Corporation for providing the nonwoven filters. The authors also thank Ms. Kasumi Suzuki, Ms. Takami Kobayashi, Ms. Miwa Sakata, Mr. Tomoyuki Miyazaki, Mr. Yuta Saito, and Mr. Shun Kobayashi for technical assistance. This work was partly supported by a research grant from Aichi Kidney Foundation and JSPS KAKENHI Grant Number 25410232.	ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.10007/10_2010_93, 10.1007/10_2010_93]; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Li Y, 2001, BIOMATERIALS, V22, P609, DOI 10.1016/S0142-9612(00)00224-6; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001; Matsumoto K, 2001, KIDNEY INT, V59, P2023; Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228; Gregory Carl A, 2005, Sci STKE, V2005, ppe37, DOI 10.1126/stke.2942005pe37; Ito K, 2010, TISSUE ENG PART C-ME, V16, P81, DOI 10.1089/ten.TEC.2008.0693; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Nishimura N, 1988, P INT WORKSH ROL LEU, P35; Shimizu A, 2004, J AM SOC NEPHROL, V15, P2655, DOI 10.1097/01.ASN.0000141038.28733.F2; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Takenaka Y, 1996, ARTIF ORGANS, V20, P914, DOI 10.1111/j.1525-1594.1996.tb04569.x	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					55	63		10.1007/s10047-014-0794-9		9	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800008		
J	Notodihardjo, PV; Morimoto, N; Kakudo, N; Matsui, M; Sakamoto, M; Liem, PH; Suzuki, K; Tabata, Y; Kusumoto, K				Notodihardjo, Priscilla Valentin; Morimoto, Naoki; Kakudo, Natsuko; Matsui, Makoto; Sakamoto, Michiharu; Liem, Pham Hieu; Suzuki, Kenji; Tabata, Yasuhiko; Kusumoto, Kenji			Gelatin hydrogel impregnated with platelet-rich plasma releasate promotes angiogenesis and wound healing in murine model	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Platelet-rich plasma; Biomaterial; Gelatin hydrogel; Growth factors; Wound healing	FIBROBLAST-GROWTH-FACTOR; BONE REGENERATION; SCAFFOLD; DEFECTS; CELLS	Platelet-rich plasma (PRP) contains numerous growth factors to promote wound healing and angiogenesis. The objective of this study was to explore the efficacy of biodegradable gelatin hydrogel impregnated with PRP releasate (PRPr) in the wound healing process compared with the single application of PRPr prepared from mouse PRP centrifuged by a double-spin method. Gelatin hydrogel disks with an isoelectric point of 5.0 were used in this study. A total of 180 mice (n = 45/group) were randomly assigned to the following 4 experimental groups: control group, biodegradable gelatin hydrogel group, PRPr group and gelatin hydrogel impregnated with PRPr (PRPrG) group. Wound area and epithelialization were compared on days 1, 5, 7, 14 and 21 post-wounding. After complete epithelialization, wound contraction was also evaluated. Neovascularization using immunohistochemical staining of von Willebrand factor was analyzed on day 14. The wound area of PRPrG on days 5, 7 and 14 was smaller than that in the other groups (p < 0.01). The epithelialization lengths of PRPrG on days 7 and 14 were significantly longer than the others (p < 0.01). The capillary formation of PRPrG was also superior to those in all other groups on day 14. On day 21, all wounds were completely epithelialized and PRPrG prevented wound contraction the most. It is concluded that the sustained-release system of gelatin impregnated with PRPr can stimulate angiogenesis and accelerate wound healing compared with the single application of PRP.	[Notodihardjo, Priscilla Valentin; Morimoto, Naoki; Kakudo, Natsuko; Suzuki, Kenji; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka 5731010, Japan; [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci, Kyoto, Japan; [Sakamoto, Michiharu; Liem, Pham Hieu] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan	Notodihardjo, PV (reprint author), Kansai Med Univ, Dept Plast & Reconstruct Surg, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	priscilla.valentin@gmail.com; mnaoki22@kuhp.kyoto-u.ac.jp			Kansai Medical University	This study was supported by a research Grant from Kansai Medical University.	Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193; Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016; Hong L, 2000, J NEUROSURG, V92, P315, DOI 10.3171/jns.2000.92.2.0315; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Ozeki M, 2002, TISSUE ENG, V8, P359, DOI 10.1089/107632702760184637; Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016; Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.TEA.2012.0634, 10.1089/ten.tea.2012.0634]; Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042; Liem PH, 2013, J SURG RES, V182, P353, DOI 10.1016/j.jss.2012.10.018; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Sugimori E, 2006, DENT MATER J, V25, P591; Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046; Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224; Iacopetti I, 2012, J EQUINE VET SCI, V32, P123, DOI 10.1016/j.jevs.2011.08.012; Ito R, 2013, TISSUE ENG PART A, V19, P140; Martinez-Zapata MJ, 2012, COCHRANE DB SYST REV, V10; Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709	19	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					64	71		10.1007/s10047-014-0795-8		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800009		
J	Hirai, K; Ookawara, S; Miyazawa, H; Ito, K; Ueda, Y; Kaku, Y; Hoshino, T; Yoshida, I; Tabei, K				Hirai, Keiji; Ookawara, Susumu; Miyazawa, Haruhisa; Ito, Kiyonori; Ueda, Yuichirou; Kaku, Yoshio; Hoshino, Taro; Yoshida, Izumi; Tabei, Kaoru			Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism	JOURNAL OF ARTIFICIAL ORGANS			English	Article						LDL apheresis; Cholesterol crystal embolism; Renal dysfunction; eGFR	LDL-APHERESIS; DISEASE; BRADYKININ	The incidence of cholesterol crystal embolism (CCE) has increased along with increases in the prevalence of atheromatous diseases and intravascular procedures. CCE frequently results in the deterioration of renal function, which sometimes leads to end-stage renal failure. Although there has been no established therapy for CCE, the possibility that low-density lipoprotein apheresis (LDL-A) is an effective therapy for renal CCE was previously reported. However, whether LDL-A improves renal CCE remains uncertain. This study aimed to evaluate the effectiveness of LDL-A in renal CCE patients. Twelve renal CCE patients (9 men and 3 women, mean age 70.6 +/- A 1.7 years) were included in this retrospective study. All patients had received LDL-A therapy, and estimated glomerular filtration rate (eGFR) values were examined before and after LDL-A. In addition, monthly changes in eGFR before and after LDL-A were calculated for each patient. At initial diagnosis of renal CCE, the eGFR was 35.2 +/- A 4.8 mL/min/1.73 m(2). At the initiation of LDL-A, the eGFR significantly decreased to 11.0 +/- A 1.2 mL/min/1.73 m(2), and monthly changes in eGFR reached -7.2 +/- A 2.5 mL/min/1.73 m(2)/month. After the initiation of LDL-A, the progression of renal dysfunction stabilized in nearly two-thirds of patients, and monthly changes in eGFR after LDL-A significantly diminished to -0.3 +/- A 0.7 mL/min/1.73 m(2)/month (p < 0.05 vs. before LDL-A). Although 4 patients had to undergo hemodialysis, all patients were alive over 1 year after the initiation of LDL-A. LDL-A therapy ameliorated renal dysfunction in renal CCE patients.	[Hirai, Keiji; Ookawara, Susumu; Miyazawa, Haruhisa; Ito, Kiyonori; Ueda, Yuichirou; Kaku, Yoshio; Hoshino, Taro; Yoshida, Izumi; Tabei, Kaoru] Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol,Omiya Ku, Saitama, Saitama 3308503, Japan	Hirai, K (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol,Omiya Ku, 1-847 Amanuma Cho, Saitama, Saitama 3308503, Japan.	keijihirai@kfy.biglobe.jp; su-ooka@hb.tp1.jp					Sanai T, 2006, ANGIOLOGY, V57, P379, DOI 10.1177/000331970605700316; Sulowicz Wladyslaw, 2003, Nephrology Dialysis Transplantation, V18, pv59, DOI 10.1093/ndt/gfg1050; Ardiles L, 2013, AM J PHYSIOL-RENAL, V304, pF1399, DOI 10.1152/ajprenal.00604.2012; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; Woolfson RG, 1998, LANCET, V351, P1331, DOI 10.1016/S0140-6736(05)79058-9; Imamura S, 2013, TOHOKU J EXP MED, V231, P57, DOI 10.1620/tjem.231.57; Scolari F, 2003, J AM SOC NEPHROL, V14, P1584, DOI 10.1097/01.ASN.0000069220.60954.F1; Belenfant X, 1999, AM J KIDNEY DIS, V33, P840, DOI 10.1016/S0272-6386(99)70415-4; Scolari F, 2007, CIRCULATION, V116, P298, DOI 10.1161/CIRCULATIONAHA.107.680991; Scolari F, 2010, LANCET, V375, P1650, DOI 10.1016/S0140-6736(09)62073-0; Bartholomew JR, 1996, PERIPHERAL VASCULAR, P261; Enomae M, 2007, INTERNAL MED, V46, P1123, DOI 10.2169/internalmedicine.46.0102; Hara Seiichiro, 2002, J Atheroscler Thromb, V9, P288; Japan Nephrology Society, 2012, NIHON JINZO GAKKAI S, V54, P1034; Kojima S, 1997, INT J ARTIF ORGANS, V20, P178; Lien YP, 2005, VASC MED, V10, P309; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Modi KS, 2001, J AM SOC NEPHROL, V12, P1781; Scolari F, 2000, AM J KIDNEY DIS, V36, P1089, DOI 10.1053/ajkd.2000.19809	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					72	78		10.1007/s10047-014-0801-1		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800010		
J	Higa, M; Tanino, H; Nishimura, I; Mitamura, Y; Matsuno, T; Ito, H				Higa, Masaru; Tanino, Hiromasa; Nishimura, Ikuya; Mitamura, Yoshinori; Matsuno, Takeo; Ito, Hiroshi			Three-dimensional shape optimization of a cemented hip stem and experimental validations	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Optimization; Total hip arthroplasty; Finite element method; Adaptive p-method; Stem design	FINITE-ELEMENT-ANALYSIS; ACRYLIC BONE-CEMENT; FEMORAL COMPONENTS; MANTLE THICKNESS; FATIGUE FAILURE; ARTHROPLASTY; RECONSTRUCTIONS; SENSITIVITY; SECTIONS	This study proposes novel optimized stem geometry with low stress values in the cement using a finite element (FE) analysis combined with an optimization procedure and experimental measurements of cement stress in vitro. We first optimized an existing stem geometry using a three-dimensional FE analysis combined with a shape optimization technique. One of the most important factors in the cemented stem design is to reduce stress in the cement. Hence, in the optimization study, we minimized the largest tensile principal stress in the cement mantle under a physiological loading condition by changing the stem geometry. As the next step, the optimized stem and the existing stem were manufactured to validate the usefulness of the numerical models and the results of the optimization in vitro. In the experimental study, strain gauges were embedded in the cement mantle to measure the strain in the cement mantle adjacent to the stems. The overall trend of the experimental study was in good agreement with the results of the numerical study, and we were able to reduce the largest stress by more than 50 % in both shape optimization and strain gauge measurements. Thus, we could validate the usefulness of the numerical models and the results of the optimization using the experimental models. The optimization employed in this study is a useful approach for developing new stem designs.	[Higa, Masaru] Univ Hyogo, Mech Engn, Himeji, Hyogo 6712280, Japan; [Tanino, Hiromasa; Matsuno, Takeo; Ito, Hiroshi] Asahikawa Med Univ, Orthopaed Surg, Asahikawa, Hokkaido, Japan; [Nishimura, Ikuya; Mitamura, Yoshinori] Hokkaido Univ, Informat Sci & Technol, Sapporo, Hokkaido, Japan	Higa, M (reprint author), Univ Hyogo, Mech Engn, Shosha 21267, Himeji, Hyogo 6712280, Japan.	higa@eng.u-hyogo.ac.jp; tanino@asahikawa-med.ac.jp					Tanino H, 2006, J BIOMECH, V39, P1948, DOI 10.1016/j.jbiomech.2005.05.024; Lewis G, 2003, J BIOMED MATER RES B, V66B, P457, DOI 10.1002/jbm.b.10018; Stolk J, 2002, J BIOMECH, V35, P499, DOI 10.1016/S0021-9290(01)00213-5; Lennon AB, 2007, J ORTHOP RES, V25, P779, DOI 10.1002/jor.20346; Kawate K, 2001, J ARTHROPLASTY, V16, P998, DOI 10.1054/arth.2001.26592; Janssen D, 2009, ACTA ORTHOP, V80, P319, DOI 10.3109/17453670902947465; Berli BJ, 2005, J BONE JOINT SURG BR, V87B, P928, DOI 10.1302/0301-620X.87B7.16149; Cristofolini L, 2010, CLIN BIOMECH, V25, P899, DOI 10.1016/j.clinbiomech.2010.07.003; Dally J. W., 1965, EXPT STRESS ANAL; Gunn Elizabeth, 2012, Biomatter, V2, P87, DOI 10.4161/biom.20709; HARRIGAN TP, 1992, J ORTHOPAED RES, V10, P134, DOI 10.1002/jor.1100100116; Hertzler J, 2002, J ORTHOPAED RES, V20, P676, DOI 10.1016/S0736-0266(02)00004-9; Ishida T, 2011, ARTIF ORGANS, V35, P404, DOI 10.1111/j.1525-1594.2010.01117.x; Ito H, 2011, INT ORTHOP, V35, P1289, DOI 10.1007/s00264-010-1096-3; Jeffers JRT, 2007, J BIOMECH, V40, P1525, DOI 10.1016/j.jbiomech.2006.07.029; Katoozian H, 2000, MED ENG PHYS, V22, P243, DOI 10.1016/S1350-4533(00)00030-8; Malchau H, 2005, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000193517.19556.e4; MALONEY WJ, 1989, CLIN ORTHOP RELAT R, P129; Ruben RB, 2007, STRUCT MULTIDISCIP O, V34, P261, DOI 10.1007/s00158-006-0072-4; Sabatini AL, 2008, MATER DESIGN, V29, P1438, DOI 10.1016/j.matdes.2007.09.002; Stolk J, 2004, ENG FRACT MECH, V71, P513, DOI 10.1016/S0013-7944(03)00048-1; Waanders D, 2012, J MATER SCI-MATER M, V23, P2023, DOI 10.1007/s10856-012-4626-2; Waide V, 2004, J BIOMECH, V37, P13, DOI 10.1016/S0021-9290(03)00258-6	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					79	85		10.1007/s10047-014-0792-y		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800011		
J	Goto, J; Matsuda, K; Harii, N; Moriguchi, T; Yanagisawa, M; Sakata, O				Goto, Junko; Matsuda, Kenichi; Harii, Norikazu; Moriguchi, Takeshi; Yanagisawa, Masahiko; Sakata, Osamu			Usefulness of a real-time bowel sound analysis system in patients with severe sepsis (pilot study)	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Bowel sound analysis; IL-6; Enteral nutrition; Critical care; Sepsis	RECEIVING MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; ENTERAL NUTRITION; ORGAN FAILURE; SEPTIC SHOCK; GUIDELINES; CARE; AUSCULTATION; DEFINITIONS; MOTILITY	Healthy bowel function is an important factor when judging the advisability of early enteral nutrition in critically ill patients, but long-term observation and objective evaluation of gastrointestinal motility are difficult. In the study, real-time continuous measurement of gastrointestinal motility was performed in patients with severe sepsis using a developed bowel sound analysis system, and the correlation between bowel sounds and changes over time in blood concentrations of interleukin (IL)-6, which is associated with sepsis severity, was evaluated. The subjects were five adult patients in the acute phase of severe sepsis on a mechanical ventilator, with IL-6 blood concentrations a parts per thousand yen100 pg/mL, who had consented to participate in the study. Gastrointestinal motility was measured for a total of 62,399 min: 31,544 min in 3 subjects in the no-steroids group and 30,855 min in 2 subjects in the steroid treatment group. In the no-steroids group, the bowel sound counts were negatively correlated with IL-6 blood concentration, suggesting that gastrointestinal motility was suppressed as IL-6 blood concentration increased. However, in the steroid treatment group, gastrointestinal motility showed no correlation with IL-6 blood concentration (r = -0.25, p = 0.27). The IL-6 blood concentration appears to have decreased with steroid treatment irrespective of changes in the state of sepsis, whereas bowel sound counts with the monitoring system reflected the changes in the state of sepsis, resulting in no correlation. This monitoring system provides a useful method of continuously, quantitatively, and non-invasively evaluating gastrointestinal motility in patients with severe sepsis. Gastrointestinal motility might be useful as a parameter reflecting disease severity, particularly in patients treated with steroids.	[Goto, Junko; Matsuda, Kenichi; Harii, Norikazu; Moriguchi, Takeshi; Yanagisawa, Masahiko] Univ Yamanashi, Dept Emergency & Crit Care Med, Fac Med, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Sakata, Osamu] Univ Yamanashi, Dept Mechatron, Fac Engn, Kofu, Yamanashi 4008511, Japan	Matsuda, K (reprint author), Univ Yamanashi, Dept Emergency & Crit Care Med, Fac Med, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	junkog@yamanashi.ac.jp; matsudak@yamanashi.ac.jp; osakata@yamanashi.ac.jp					KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Dhaliwal R, 2014, NUTR CLIN PRACT, V29, P29, DOI 10.1177/0884533613510948; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; Mutlu GM, 2001, CHEST, V119, P1222, DOI 10.1378/chest.119.4.1222; DIVE A, 1994, CRIT CARE MED, V22, P441, DOI 10.1097/00003246-199403000-00014; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cannon WB, 1905, AM J PHYSIOL, V14, P339; DALLE D, 1975, Computers in Biology and Medicine, V4, P247, DOI 10.1016/0010-4825(75)90036-0; Dimoulas C, 2006, BIOMED SIGNAL PROCES, V1, P177, DOI 10.1016/j.bspc.2006.08.004; Groeneveld ABJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1189, DOI 10.1128/CDLI.8.6.1189-1195.2001; Kozar RA, 2002, J SURG RES, V104, P70, DOI 10.1006/jsre.2002.6409; Mancl EE, 2013, JPEN-PARENTER ENTER, V37, P641, DOI 10.1177/0148607112470460; Matsuda K, 2001, THER APHER, V5, P306, DOI 10.1046/j.1526-0968.2001.00361.x; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; Richardson Lydia, 2008, Interact Cardiovasc Thorac Surg, V7, P898, DOI 10.1510/icvts.2008.185504; Sakata O, 2013, J ARTIF ORGANS, V16, P83, DOI 10.1007/s10047-012-0666-0; Sakata O, 2011, 2011 IEEE REGION 10 CONFERENCE TENCON 2011, P1203; Takahashi T, 2003, INTENS CARE MED, V29, P309, DOI 10.1007/s00134-002-1580-3; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yamaguchi K, 2006, J GASTROEN HEPATOL, V21, P510, DOI 10.1111/j.1440-1746.2005.03997.x	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					86	91		10.1007/s10047-014-0799-4		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800012		
J	Kitamura, T; Torii, S; Oka, N; Horai, T; Itatani, K; Yoshii, T; Nakamura, Y; Shibata, M; Tamura, T; Araki, H; Matsunaga, Y; Miyaji, K				Kitamura, Tadashi; Torii, Shinzo; Oka, Norihiko; Horai, Tetsuya; Itatani, Keiichi; Yoshii, Takeshi; Nakamura, Yuki; Shibata, Miyuki; Tamura, Tomoki; Araki, Haruna; Matsunaga, Yoshikiyo; Miyaji, Kagami			Seventeen-month-long paracorporeal biventricular mechanical support as a bridge to transplantation for severe dilated cardiomyopathy	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Biventricular assist device; Paracorporeal pulsatile pump; Bridge to transplantation	VENTRICULAR ASSIST DEVICE; HEART; PUMP	The long-term management of paracorporeal biventricular assist devices (BiVAD) is difficult because of significant risks of bleeding, thrombosis, and infection. Here we report the case of a 41-year-old woman with severe dilated cardiomyopathy who developed serious cerebral bleeding after receiving a paracorporeal BiVAD but recovered well after treatment. She eventually underwent cardiac transplantation 17 months after implantation of the paracorporeal BiVAD.	[Kitamura, Tadashi; Torii, Shinzo; Oka, Norihiko; Horai, Tetsuya; Itatani, Keiichi; Yoshii, Takeshi; Nakamura, Yuki; Shibata, Miyuki; Tamura, Tomoki; Araki, Haruna; Matsunaga, Yoshikiyo; Miyaji, Kagami] Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Kitamura, T (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	funcorogash@hotmail.com					Nishimura T, 2014, J ARTIF ORGANS, V17, P211, DOI 10.1007/s10047-014-0779-8; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Farrar DJ, 1997, J THORAC CARDIOV SUR, V113, P202, DOI 10.1016/S0022-5223(97)70416-1; Inoue T, 2014, J ARTIF ORGANS, V17, P95, DOI 10.1007/s10047-013-0740-2; Kurihara C, 2011, J ARTIF ORGANS, V14, P367, DOI 10.1007/s10047-011-0593-5; Oto O, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-229; Saito S, 2012, J HEART LUNG TRANSPL, V31, P858, DOI 10.1016/j.healun.2012.03.002; Sakaguchi T, 2013, J THORAC CARDIOV SUR, V146, pE29, DOI 10.1016/j.jtcvs.2013.06.015	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	MAR	2015	18	1					92	94		10.1007/s10047-014-0797-6		3	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CD2DQ	WOS:000350884800013		
J	Abe, Y; Iba, K; Sasaki, K; Chiba, H; Kanaya, K; Kawamata, T; Oda, K; Amizuka, N; Sasaki, M; Yamashita, T				Abe, Yasuhisa; Iba, Kousuke; Sasaki, Koichi; Chiba, Hironori; Kanaya, Kumiko; Kawamata, Tomoyuki; Oda, Kimimitsu; Amizuka, Norio; Sasaki, Muneteru; Yamashita, Toshihiko			Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Pain; Osteoporosis; Osteoclast; Bisphosphonate; Transient receptor potential channel vanilloid subfamily member 1 (TRPV1)	FOS-LIKE PROTEIN; BONE-RESORPTION; IN-VITRO; MOLECULAR-MECHANISMS; SYSTEMIC MORPHINE; CANCER PAIN; BACK-PAIN; OSTEOPOROSIS; RAT; RISEDRONATE	The aim of this study was to evaluate skeletal pain associated with osteoporosis and to examine the inhibitory effect of bisphosphonate (BP) on pain in an ovariectomized (OVX) mouse model. We evaluated skeletal pain in OVX mice through an examination of pain-like behavior as well as immunohistochemical findings. In addition, we assessed the effects of alendronate (ALN), a potent osteoclast inhibitor, on those parameters. The OVX mice showed a decrease in the pain threshold value, and an increase in the number of c-Fos immunoreactive neurons in laminae I-II of the dorsal horn of the spinal cord. Alendronate caused an increase in the pain threshold value and inhibited c-Fos expression. The serum level of tartrate-resistant acid phosphatase 5b, a marker of osteoclast activity, was significantly negatively correlated with the pain threshold value. Furthermore, we found that an antagonist of the transient receptor potential channel vanilloid subfamily member 1, which is an acid-sensing nociceptor, improved pain-like behavior in OVX mice. These results indicated that the inhibitory effect of BP on osteoclast function might contribute to an improvement in skeletal pain in osteoporosis patients.	[Abe, Yasuhisa; Iba, Kousuke; Sasaki, Koichi; Chiba, Hironori; Kanaya, Kumiko; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthopaed Surg, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Kawamata, Tomoyuki] Shinshu Univ, Dept Anesthesiol & Resuscitol, Sch Med, Matsumoto, Nagano, Japan; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata, Japan; [Amizuka, Norio; Sasaki, Muneteru] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan	Iba, K (reprint author), Sapporo Med Univ, Sch Med, Dept Orthopaed Surg, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	iba@sapmed.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; MSD K.K. (Tokyo, Japan)	We would like to thank Prof. Moriyama, Department of Membrane Biochemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan, for kindly providing the antibody to V-ATPase. This study was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant for scientific research from MSD K.K. (Tokyo, Japan).	Akesson K, 2003, B WORLD HEALTH ORGAN, V81, P657; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Astrom E, 2002, ARCH DIS CHILD, V86, P356, DOI 10.1136/adc.86.5.356; Shoji S, 2010, CALCIFIED TISSUE INT, V87, P181, DOI 10.1007/s00223-010-9384-x; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; Oda K, 1999, J BIOCHEM-TOKYO, V126, P694; KANN P, 1993, MED KLIN, V88, P9; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Wright LE, 2008, J BONE MINER RES, V23, P1296, DOI [10.1359/jbmr.080309, 10.1359/JBMR.080309]; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; Kawamata T, 2009, NEUROREPORT, V20, P233, DOI 10.1097/WNR.0b013e32831befa5; Ohtori S, 2010, J CLIN NEUROSCI, V17, P209, DOI 10.1016/j.jocn.2009.06.013; Sanoja R, 2010, AUTON NEUROSCI-BASIC, V153, P84, DOI 10.1016/j.autneu.2009.07.001; Nagae M, 2006, BONE, V39, P1107, DOI 10.1016/j.bone.2006.04.033; Varga A, 2005, NEUROSCI LETT, V385, P137, DOI 10.1016/j.neulet.2005.05.015; Caterina MJ, 1997, NATURE, V389, P816; Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3; Iwamoto J, 2004, CLIN RHEUMATOL, V23, P383, DOI 10.1007/s10067-004-0881-z; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5; Wang XX, 2003, J BONE MINER METAB, V21, P268, DOI 10.1007/s00774-003-0420-z; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Benford HL, 2001, BONE, V28, P465, DOI 10.1016/S8756-3282(01)00412-4; Bonabello A, 2001, PAIN, V91, P269, DOI 10.1016/S0304-3959(00)00447-4; Carvalho AP, 2006, CLIN EXP PHARMACOL P, V33, P601, DOI 10.1111/j.1440-1681.2006.04413.x; Furuya Y, 2011, J BIOL CHEM, V286, P37023, DOI 10.1074/jbc.M111.246280; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; Ghinoi Valentina, 2002, Expert Opin Pharmacother, V3, P1643, DOI 10.1517/14656566.3.11.1643; HAMBA M, 1994, BRAIN RES BULL, V34, P61, DOI 10.1016/0361-9230(94)90187-2; Iba Kousuke, 2010, J Med Case Rep, V4, P166, DOI 10.1186/1752-1947-4-166; Kawamata T, 2008, NEUROSCIENCE, V15, P1067; Kojima T, 2007, BIOMED RES-TOKYO, V28, P219, DOI 10.2220/biomedres.28.219; Laitala-Leinonen T, 1999, J CELL SCI, V112, P3657; Le Goff Benoit, 2011, Expert Rev Clin Pharmacol, V4, P633; National Osteoporosis Foundation, 2010, CLIN GUID PREV TREAT; Niiyama Y, 2009, BRIT J ANAESTH, V102, P251, DOI 10.1093/bja/aen347; Orita S, 2010, SPINE, V35, P1974, DOI 10.1097/BRS.0b013e3181d5959e; Ringe JD, 2007, CLIN EXP RHEUMATOL, V25, P766; Sanoja R, 2005, PAIN, V118, P243, DOI 10.1016/j.pain.2005.08.021; Takayama B, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-164; Van Offel JF, 2001, CLIN EXP RHEUMATOL, V19, P13; Washimi Y, 2010, J ENDOCRINOL INVEST, V33, P395, DOI 10.3275/6623	45	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					125	134		10.1007/s00774-014-0574-x		10	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000001		
J	Kanagawa, H; Niki, Y; Kobayashi, T; Sato, Y; Katsuyama, E; Fujie, A; Hao, W; Miyamoto, K; Tando, T; Watanabe, R; Morita, M; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Kanagawa, Hiroya; Niki, Yasuo; Kobayashi, Tami; Sato, Yuiko; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Miyamoto, Kana; Tando, Toshimi; Watanabe, Ryuichi; Morita, Mayu; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			Mycobacterium tuberculosis promotes arthritis development through toll-like receptor 2	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Mycobacterium tuberculosis; Rheumatoid arthritis; Toll-like receptor 2; IL-6	MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; POSTMARKETING SURVEILLANCE; EULAR RECOMMENDATIONS; DISEASE; INFLAMMATION; MODEL; MICE; TLR2; EPIDEMIOLOGY	Rheumatoid arthritis (RA) is a multifactorial disease caused by genetic and environmental factors: however, precise molecular mechanisms underlying its pathogenesis remain largely unknown. Treatment of RA patients with disease-modifying biological agents occasionally promotes Mycobacterium tuberculosis infection or recurrence of M. tuberculosis, although how infection promotes arthritis has not been characterized. Here, we found that arthritis phenotypes in a collagen-induced mouse model were evident only when killed M. tuberculosis was co-administered. Treatment of cultured macrophages with killed M. tuberculosis promoted production of IL-6, a major inflammatory cytokine in RA patients, while similar treatment of TLR2-deficient macrophages failed to induce IL-6 expression. Arthritis scores, joint destruction, and serum IL-6 levels were all significantly ameliorated in TLR2-deficient compared with wild-type mice, even in animals treated with killed M. tuberculosis. These results suggest that M. tuberculosis infection enhances arthritis development and that TLR2 could serve as a therapeutic target for some forms of the disease.	[Kanagawa, Hiroya; Niki, Yasuo; Kobayashi, Tami; Sato, Yuiko; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Miyamoto, Kana; Tando, Toshimi; Watanabe, Ryuichi; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Miyamoto, T (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp			Takeda Science Foundation, Japan	T. Miyamoto was supported by a Grant-in-Aid for Scientific Research, from the Takeda Science Foundation, Japan.	Abdollahi-Roodsaz S, 2013, ARTHRITIS RHEUM-US, V65, P2583, DOI 10.1002/art.38087; Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Alzabin S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3875; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JC1200215582; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Joosten LAB, 2003, J IMMUNOL, V171, P6145; Louie GH, 2010, ANN RHEUM DIS, V69, P868, DOI 10.1136/ard.2009.112474; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Frasnelli ME, 2005, ARTHRITIS RES THER, V7, pR370, DOI 10.1186/ar1494; Symmons DPM, 2002, BEST PRACT RES CL RH, V16, P707, DOI 10.1053/berh.2002.0257; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Da Silva E, 2003, ARTHRIT RHEUM-ARTHR, V49, P216, DOI 10.1002/art.10998; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Koike T, 2011, ANN RHEUM DIS, V70, P2148, DOI 10.1136/ard.2011.151092; Norbis L, 2013, NEW MICROBIOL, V36, P111; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Rosenzweig HL, 2010, ARTHRITIS RHEUM-US, V62, P1051, DOI 10.1002/art.27335; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Tanaka E, 2005, ARTHRIT RHEUM-ARTHR, V53, P864, DOI 10.1002/art.21589; Wang GQ, 2004, FEMS MICROBIOL LETT, V231, P219, DOI 10.1016/S0378-1097(03)00960-1; Zhang Y, 2013, PLOS ONE, V14	33	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					135	141		10.1007/s00774-014-0575-9		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000002		
J	Matsumura, H; Nakayama, Y; Takai, H; Ogata, Y				Matsumura, Hiroyoshi; Nakayama, Yohei; Takai, Hideki; Ogata, Yorimasa			Effects of interleukin-11 on the expression of human bone sialoprotein gene	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bone sialoprotein; Interleukin-11; Osteoblasts; Transcription	LEUKEMIA-INHIBITORY FACTOR; DEPENDENT PROTEIN-KINASE; INVERTED CCAAT BOX; RAT BSP GENE; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DEVELOPMENT; SIGNALING PATHWAYS; PROXIMAL PROMOTER; MOLECULAR-CLONING; RESPONSE ELEMENTS	Interleukin-11 (IL-11) is a bone marrow stromal fibroblast-derived cytokine with a wide spectrum of activities in different biological systems. IL-11 and IL-6 are two cytokines known to rely on osteoblast-osteoclast communication for their effects on osteoclast differentiation. Bone sialoprotein (BSP) is a mineralized connective tissue-specific protein expressed in differentiated osteoblasts, odontoblasts, and cementoblasts. To determine the molecular basis of the transcriptional regulation of the human BSP gene by IL-11, we conducted real-time polymerase chain reactions (PCR), transient transfection analyses with chimeric constructs of the human BSP gene promoter linked to a luciferase reporter gene, gel mobility shift assays, and a chromatin immunoprecipitation assay using human osteoblast-like Saos2 cells. IL-11 (20 ng/ml) increased BSP, Runx2, and Osterix mRNA levels at 6 h and the alkaline phosphatase (ALP) mRNA level at 12 h in osteoblast-like Saos2 cells. In a transient transfection assay, IL-11 (20 ng/ml, 12 h) increased luciferase activities of constructs between -60LUC and -868LUC including the human BSP gene promoter. Transcriptional stimulations by IL-11 were partially inhibited in the constructs that included 2-bp mutations in the cAMP response element 1 (CRE1, -72 to -79) and CRE2 (-667 to -674). When mutations were made in pairs of CRE1 and CRE2 in -868LUC, the effect of IL-11 on luciferase activity was almost totally abrogated. Transcriptional activities induced by IL-11 were inhibited by protein kinase A, tyrosine kinase, ERK1/2, and PI3-kinase inhibitors. Gel mobility shift analyses showed that IL-11 increased nuclear proteins binding to CRE1 and CRE2. CREB1, phospho-CREB1, c-Fos, and c-Jun antibodies disrupted the formation of CRE1 and CRE2 protein complexes. These data demonstrate that IL-11 stimulates BSP gene transcription via CRE1 and CRE2 elements in the human BSP gene promoter.	[Matsumura, Hiroyoshi; Nakayama, Yohei; Takai, Hideki; Ogata, Yorimasa] Nihon Univ, Sch Dent Matsudo, Dept Periodontol, Matsudo, Chiba 2718587, Japan; [Nakayama, Yohei; Takai, Hideki; Ogata, Yorimasa] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Sci, Matsudo, Chiba 2718587, Japan	Ogata, Y (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Periodontol, Matsudo, Chiba 2718587, Japan.	ogata.yorimasa@nihon-u.ac.jp			Nihon University School of Dentistry at Matsudo [25862059, 13302018, 25463229]; Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1001024]	This work was supported in part by the Grant-in-Aid for Scientific Research (Young Scientists (B); No. 25862059, 13302018, Scientific Research (C); No. 25463229), a supportive grant for young investigators from Nihon University School of Dentistry at Matsudo, a grant from the Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024).	Anggakusuma Y, 2010, J DERMATOL SCI, V57, P114; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ogata Y, 2008, J PERIODONTAL RES, V43, P127, DOI 10.1111/j.1600-0765.2007.01014.x; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; KAWASHIMA I, 1991, FEBS LETT, V283, P199, DOI 10.1016/0014-5793(91)80587-S; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Kuzniewska B, 2013, MOL CELL BIOL, V33, P2149, DOI 10.1128/MCB.00008-13; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; KERR JM, 1993, GENOMICS, V17, P408, DOI 10.1006/geno.1993.1340; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Mezawa M, 2009, GENE, V435, P80, DOI 10.1016/j.gene.2008.12.020; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; FISHER LW, 1990, J BIOL CHEM, V265, P2347; CHEN JK, 1992, J BONE MINER RES, V7, P987; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1259/JBMR.050209; GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79; ALLAN EH, 1990, J CELL PHYSIOL, V145, P110, DOI 10.1002/jcp.1041450116; LOWIK CWGM, 1989, BIOCHEM BIOPH RES CO, V162, P1546, DOI 10.1016/0006-291X(89)90851-6; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Araki S, 2009, J CELL BIOCHEM, V106, P618, DOI 10.1002/jcb.22039; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; Detry C, 2008, BONE, V42, P422, DOI 10.1016/j.bone.2007.10.016; Elias JA, 1995, ENDOCRINOLOGY, V136, P531; Han J, 2009, J CELL BIOCHEM, V107, P1198, DOI 10.1002/jcb.22224; Hill PA, 1998, ENDOCRINOLOGY, V139, P1564, DOI 10.1210/en.139.4.1564; Kim RH, 1999, CANCER RES, V59, P565; KIM RH, 1994, MATRIX BIOL, V14, P31, DOI 10.1016/0945-053X(94)90027-2; Kiyoshima T, 2002, GENE, V299, P205, DOI 10.1016/S0378-1119(02)01074-0; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LI JJ, 1993, BIOCHEM J, V289, P625; Li ZY, 2011, GENE, V471, P1, DOI 10.1016/j.gene.2010.09.009; LITTLEWOOD AJ, 1991, ENDOCRINOLOGY, V129, P1513; LIU AYC, 1982, J BIOL CHEM, V257, P298; Nakayama Y, 2006, J CELL PHYSIOL, V208, P326, DOI 10.1002/jcp.20664; Nakayama Y, 2004, CELL BIOL INT, V28, P653, DOI 10.1016/j.cellbi.2004.06.003; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; PAUL SR, 1991, BLOOD, V77, P1723; QUESNIAUX VFJ, 1992, RES IMMUNOL, V143, P385, DOI 10.1016/S0923-2494(05)80071-9; REID IR, 1990, ENDOCRINOLOGY, V126, P1416; Samoto H, 2003, J BIOL CHEM, V278, P28659, DOI 10.1074/jbc.M300671200; SCHWARTZ DA, 1983, J BIOL CHEM, V258, P777; Shimizu E, 2002, J CELL BIOCHEM, V86, P35, DOI 10.1002/jcb.10194; Shimizu E, 2006, BONE, V39, P42, DOI 10.1016/j.bone.2005.12.011; Shimizu-Sasaki Emi, 2001, Journal of Biological Chemistry, V276, P5459, DOI 10.1074/jbc.M008971200; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Waltregny D, 2000, J BONE MINER RES, V15, P834, DOI 10.1359/jbmr.2000.15.5.834; Wang S, 2011, GENE, V476, P46, DOI 10.1016/j.gene.2011.01.016; YANG YC, 1992, BIOFACTORS, V4, P15; YIN TG, 1993, J IMMUNOL, V151, P2555	56	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					142	153		10.1007/s00774-014-0576-8		12	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000003		
J	Yoshimura, N; Akune, T; Fujiwara, S; Shimizu, Y; Yoshida, H; Nishiwaki, Y; Sudo, A; Omori, G; Yoshida, M; Shimokata, H; Suzuki, T; Muraki, S; Oka, H; Nakamura, K				Yoshimura, Noriko; Akune, Toru; Fujiwara, Saeko; Shimizu, Yoko; Yoshida, Hideyo; Nishiwaki, Yuji; Sudo, Akihiro; Omori, Go; Yoshida, Munehito; Shimokata, Hiroshi; Suzuki, Takao; Muraki, Shigeyuki; Oka, Hiroyuki; Nakamura, Kozo			Incidence of disability and its associated factors in Japanese men and women: the Longitudinal Cohorts of Motor System Organ (LOCOMO) study	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Nation-wide population-based cohort study; Epidemiology; Incidence; Disability; Body build	BODY-MASS INDEX; KNEE OSTEOARTHRITIS; HIP FRACTURE; RISK-FACTORS; OBESITY; POPULATION; MORTALITY	We investigated the incidence of disability and its risk factors in older Japanese adults to establish an evidence-based disability prevention strategy for this population. For this purpose, we used data from the Longitudinal Cohorts of Motor System Organ (LOCOMO) study, initiated in 2008 to integrate information from cohorts in nine communities across Japan: Tokyo (two regions), Wakayama (two regions), Hiroshima, Niigata, Mie, Akita, and Gunma prefectures. We examined the annual occurrence of disability from 8,454 individuals (2,705 men and 5,749 women) aged a parts per thousand yen65 years. The estimated incidence of disability was 3.58/100 person-years (p-y) (men: 3.17/100 p-y; women: 3.78/100 p-y). To determine factors associated with disability, Cox's proportional hazard model was used, with the occurrence of disability as an objective variable and age (+1 year), gender (vs. women), body build (0: normal/overweight range, BMI 18.5-27.5 kg/m(2); 1: emaciation, BMI < 18.5 kg/m(2); 2: obesity, BMI > 27.5 kg/m(2)), and regional differences (0: rural areas including Wakayama, Niigata, Mie, Akita, and Gunma vs. 1: urban areas including Tokyo and Hiroshima) as explanatory variables. Age, body build, and regional difference significantly influenced the occurrence of disability (age, +1 year: hazard ratio 1.13, 95 % confidence interval 1.12-1.15, p < 0.001; body build, vs. emaciation: 1.24, 1.01-1.53, p = 0.041; body build, vs. obesity: 1.36, 1.08-1.71, p = 0.009; residence, vs. living in rural areas: 1.59, 1.37-1.85, p < 0.001). We concluded that higher age, both emaciation and obesity, and living in rural areas would be risk factors for the occurrence of disability.	[Yoshimura, Noriko; Oka, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Joint Dis Res,22nd Century Med & Res Ctr, Bunkyo Ku, Tokyo 1138655, Japan; [Akune, Toru; Muraki, Shigeyuki] Univ Tokyo, Grad Sch Med, Dept Clin Motor Syst Med, 22nd Century Med & Res Ctr, Tokyo 1138655, Japan; [Fujiwara, Saeko] Hiroshima Atom Bomb Causal Council, Hiroshima, Japan; [Shimizu, Yoko; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Nishiwaki, Yuji] Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Tokyo, Japan; [Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Omori, Go] Niigata Univ, Inst Res Promot, Ctr Transdisciplinary Res, Niigata, Japan; [Yoshida, Munehito] Wakayama Med Univ, Sch Med, Dept Orthoped Surg, Wakayama, Japan; [Shimokata, Hiroshi] Nagoya Univ Arts & Sci, Grad Sch Nutr Sci, Nagoya, Aichi, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Nagoya, Aichi, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Saitama, Japan	Yoshimura, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Joint Dis Res,22nd Century Med & Res Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yoshimuran-ort@h.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare [H17-Men-eki-009, H20-Choujyu-009, H23-Choujyu-002, H-25-Chojyu-007]; Ministry of Education, Culture, Sports, Science and Technology in Japan [B24659317, B23390172, B20390182, 24659317, B23390357, C20591737, B23390356, C20591774, 23659580, 24659666, 21659349, A18689031]; NSF from the Ministry of Education, Culture, Sports, Science and Technology in Japan [08033011-00262]	This work was supported by grants from Grant-in-Aid for H17-Men-eki-009 (Director, Kozo Nakamura), H20-Choujyu-009 (Director, Noriko Yoshimura), H23-Choujyu-002 (Director, Toru Akune), and H-25-Chojyu-007 (Director, Noriko Yoshimura) of the Ministry of Health, Labour and Welfare. Further grants were provided by Scientific Research B24659317, B23390172, B20390182, and Challenging Exploratory Research 24659317 to Noriko Yoshimura; B23390357 and C20591737 to Toru Akune; B23390356, C20591774, and Challenging Exploratory Research 23659580 to Shigeyuki Muraki; Challenging Exploratory Research 24659666, 21659349, and Young Scientists A18689031 to Hiroyuki Oka, and collaborative research with NSF 08033011-00262 (Director, Noriko Yoshimura) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The sponsors did not contribute to the study design, data collection, data analysis, data interpretation, or the writing of the manuscript.	Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; HART DJ, 1993, J RHEUMATOL, V20, P331; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; VANSAASE JLCM, 1988, J RHEUMATOL, V15, P1152; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; FELSON DT, 1988, ANN INTERN MED, V109, P18; Barba C, 2004, LANCET, V363, P157; Kobayashi T, 2011, OTSUMA WOMENS U B FA, V13, P117; Magliano Malgorzata, 2008, Menopause Int, V14, P149, DOI 10.1258/mi.2008.008018; Ministry of Health Labour and Welfare., LONG TERM CAR INS JA; Ministry of Health Labour and Welfare, 2010, OUTL RES NAT LIV SUR; Nakamura H, 2006, J HLTH WELF STAT, V53, P1; National Institute of Population and Society Research, 2012, POP PROJ JAP JAN 201; Orimo H, 2000, J BONE MINER METAB, V18, P126, DOI 10.1007/PL00010636; Orimo H, 2009, ARCH OSTEOPOROS, V4, P71; Shimitutani S, 2007, GOVT AUDITING REV, V14, P27; Statistical Bureau Ministry of Internal Affairs and Communication., 2010, POP COUNT BAS 2010 C; UESHIMA H, 1986, STROKE, V17, P19; Yoshimura N, 2005, J BONE MINER METAB, V23, P78; Yoshimura N, 2013, NIPPON RINSHO, V71, P642	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					186	191		10.1007/s00774-014-0573-y		6	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000008		
J	Sasaki, N; Tsunoda, M; Ikee, R; Hashimoto, N				Sasaki, Naomi; Tsunoda, Masataka; Ikee, Ryota; Hashimoto, Nobuo			Efficacy and safety of eldecalcitol, a new active vitamin D-3 analog, in the bone metabolism of postmenopausal women receiving maintenance hemodialysis	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Eldecalcitol; Bone metabolism; Postmenopausal; Dialysis	STAGE RENAL-DISEASE; DIALYSIS OUTCOMES; PRACTICE PATTERNS; VASCULAR CALCIFICATIONS; MINERAL METABOLISM; DOUBLE-BLIND; RISK; FRACTURE; CALCIUM; RALOXIFENE	Eldecalcitol (ELD), a new active vitamin D-3 analog developed in Japan, has attracted attention as an effective osteoporotic therapeutic drug. However, because ELD leads to greater calcium absorption than does conventional active vitamin D-3, it has yet to be used in patients with renal insufficiency. Therefore, we evaluated the efficacy and safety of ELD treatment in 27 postmenopausal women receiving maintenance dialysis in our institution and underwent ELD treatment (starting at 0.5 mu g/day) for 6 months. The mean serum albumin-corrected calcium (Ca-alb) level was significantly increased following treatment (9.01 +/- A 0.60 before versus 9.56 +/- A 0.55 after treatment, mean +/- A SD). Severe hypercalcemia was prevented through cessation or adjustment of the dosage of calcium-containing phosphate binders or existing active vitamin D. The mean serum phosphorus and intact parathyroid hormone levels were well-controlled throughout. The median levels of bone turnover markers, bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase-5b were significantly decreased. The mean lumbar spine bone mineral density (BMD) was increased, a significant difference being observed in age-matched Z-scores (-0.60 +/- A 1.6 versus -0.36 +/- A 1.5, p = 0.018). The average change in lumbar spine BMD after ELD treatment was 3.10 %, and in patients with a T-score of <-4.0, it was 5.63 %. There was no effect on forearm BMD. Although this study is based on short-term observation in a single institution, our results suggest that ELD could be used to increase bone density in dialysis patients.	[Sasaki, Naomi; Hashimoto, Nobuo] HN MEDIC, Dept Nephrol & Dialysis, Atsubetsu Ku, Sapporo, Hokkaido 0040055, Japan; [Tsunoda, Masataka] HN MEDIC Sapporohigashi, Dept Nephrol & Dialysis, Sapporo, Hokkaido, Japan; [Ikee, Ryota] HN MEDIC Kitahiroshima, Dept Nephrol & Dialysis, Kitahiroshima, Japan	Sasaki, N (reprint author), HN MEDIC, Dept Nephrol & Dialysis, Atsubetsu Ku, 6-1-5 Atsubetsuchuo 5, Sapporo, Hokkaido 0040055, Japan.	n.sasaki@hnmedic.jp					Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Tentori F, 2009, NEPHROL DIAL TRANSPL, V24, P963, DOI 10.1093/ndt/gfn592; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Hernandez E, 2003, KIDNEY INT, V63, P2269, DOI 10.1046/j.1523-1755.2003.00005.x; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Tanaka M, 2011, THER APHER DIAL, V15, P62, DOI 10.1111/j.1744-9987.2011.00929.x; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Rodriguez-Garcia M, 2009, NEPHROL DIAL TRANSPL, V24, P239, DOI 10.1093/ndt/gfn466; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Brown A.R., 2011, AAPG MEMOIR, V9, P1, DOI DOI 10.1080/01446193.2010.531028; Chertow GM, 2003, AM J NEPHROL, V23, P307, DOI 10.1159/000072822; Harada S, 2010, J STEROID BIOCHEM, V121, P281, DOI 10.1016/j.jsbmb.2010.04.001; Jamal SA, 2007, AM J KIDNEY DIS, V49, P671; Japanese Society for Dialysis Therapy, 2008, OV REG DIAL TREATM J, P90; Japanese Society for Dialysis Therapy, 2009, OV REG DAIL TREATM J, P90; Kidney disease: Improving global outcomes (KDIGO) CKDMBD Work Group, 2009, KIDNEY INT S113, V76, pS1; Koizumi M, 1997, HORMONE RINSHO, V45, P75; Matsumoto T, 2010, J STEROID BIOCHEM, V121, P261, DOI 10.1016/j.jsbmb.2010.03.035; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Ott SM, 2009, NEPHROLOGY, V14, P395, DOI 10.1111/j.1440-1797.2009.01159.x; Ritter CS, 2011, J CELL BIOCHEM, V112, P1348, DOI 10.1002/jcb.23051	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					213	220		10.1007/s00774-014-0582-x		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000012		
J	Kagotani, R; Yoshida, M; Muraki, S; Oka, H; Hashizume, H; Yamada, H; Enyo, Y; Nagata, K; Ishimoto, Y; Teraguchi, M; Tanaka, S; Nakamura, K; Kawaguchi, H; Akune, T; Yoshimura, N				Kagotani, Ryohei; Yoshida, Munehito; Muraki, Shigeyuki; Oka, Hiroyuki; Hashizume, Hiroshi; Yamada, Hiroshi; Enyo, Yoshio; Nagata, Keiji; Ishimoto, Yuyu; Teraguchi, Masatoshi; Tanaka, Sakae; Nakamura, Kozo; Kawaguchi, Hiroshi; Akune, Toru; Yoshimura, Noriko			Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) of the whole spine and its association with lumbar spondylosis and knee osteoarthritis: the ROAD study	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Prevalence; Diffuse idiopathic skeletal hyperostosis; Knee osteoarthritis; Lumbar spondylosis; ROAD study	POSTERIOR LONGITUDINAL LIGAMENT; METABOLIC SYNDROME; RISK-FACTORS; POPULATION; OSSIFICATION; MANIFESTATIONS; FRACTURES; HUNGARY; INSULIN	We aimed to assess the prevalence of diffuse idiopathic skeletal hyperostosis (DISH) and its association with lumbar spondylosis (LS) and knee osteoarthritis (KOA) using a population-based cohort study entitled Research on Osteoarthritis/osteoporosis Against Disability (ROAD). In the baseline ROAD study, which was performed between 2005 and 2007, 1,690 participants in mountainous and coastal areas underwent anthropometric measurements and radiographic examinations of the whole spine (cervical, thoracic, and lumbar) and both knees. They also completed an interviewer-administered questionnaire. Presence of DISH was diagnosed according to Resnick criteria, and LS and KOA were defined as Kellgren-Lawrence (KL) grade a parts per thousand yen3. Among the 1,690 participants, whole-spine radiographs of 1,647 individuals (97.5 %; 573 men, 1,074 women; mean age, 65.3 years) were evaluated. Prevalence of DISH was 10.8 % (men 22.0 %, women 4.8 %), and was significantly higher in older participants (presence of DISH 72.3 years, absence of DISH 64.4 years) and mainly distributed at the thoracic spine (88.7 %). Logistic regression analysis revealed that presence of DISH was significantly associated with older age [+1 year, odds ratio (OR): 1.06, 95 % confidence interval (CI): 1.03-1.14], male sex (OR: 5.55, 95 % CI: 3.57-8.63), higher body mass index (+1 kg/m(2), OR: 1.08, 95 % CI: 1.02-1.14), presence of LS (KL2 vs KL0: 1, OR: 5.50, 95 % CI: 2.81-10.8) (KL a parts per thousand yen3 vs KL0: 1, OR: 4.09, 95 % CI: 2.08-8.03), and presence of KOA (KL a parts per thousand yen3 vs KL0: 1, OR: 1.89, 95 % CI: 1.14-3.10) after adjusting for smoking, alcohol consumption, and residential area (mountainous vs coastal). This cross-sectional population-based study clarified the prevalence of DISH in general inhabitants and its significant association with LS and severe KOA.	[Kagotani, Ryohei; Yoshida, Munehito; Hashizume, Hiroshi; Yamada, Hiroshi; Enyo, Yoshio; Nagata, Keiji; Ishimoto, Yuyu; Teraguchi, Masatoshi] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418509, Japan; [Muraki, Shigeyuki; Akune, Toru] Univ Tokyo, Grad Sch Med, Dept Clin Motor Syst Med, 22nd Century Med & Res Ctr, Tokyo, Japan; [Oka, Hiroyuki; Yoshimura, Noriko] Univ Tokyo, Grad Sch Med, Dept Joint Dis Res, 22nd Century Med & Res Ctr, Tokyo, Japan; [Tanaka, Sakae; Kawaguchi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, Tokorozawa, Saitama, Japan	Yoshida, M (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshimunenoriko@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology [B23390172, B20390182, C20591737, C20591774, A18689031]; NSF from the Ministry of Education, Culture, Sports, Science and Technology [08033011-00262]; Ministry of Health, Labour and Welfare in Japan [H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H23-Chojyu-002, H25-Chojyu-007]; Japan Osteoporosis Society; Japanese Orthopaedic Association (JOA) [2006-1, 2010-2]	This work was supported by Grants-in-Aid for Scientific Research B23390172 and B20390182 to NY, C20591737 to TA, and C20591774 to SM, for Young Scientists A18689031 to HO, and Collaborating Research with NSF 08033011-00262 (Director, NY) from the Ministry of Education, Culture, Sports, Science and Technology; and H17-Men-eki-009 (Director, KN), H18-Choujyu-037 (Director, TN), H20-Choujyu-009 (Director, NY), H23-Chojyu-002 (Director, TA), and H25-Chojyu-007 (Director, NY) from the Ministry of Health, Labour and Welfare in Japan. This study also was supported by grants from the Japan Osteoporosis Society (NY, SM, HO, and TA) and research aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 and 2010-2 [Director, HK]). The authors wish to thank Dr. Takako Nojiri and Mr. Kazuhiro Hatanaka of the Gobo Public Health Centre; Dr. Naoki Hirabayashi of the Kawakami Clinic, Hidakagawa Town; Mrs. Tomoko Takijiri, Mrs. Kumiko Shinou, Mrs. Rie Takiguchi, Mrs. Kyoko Maeda, Ms. Ikuyo Ueyama, Mrs. Michiko Mori, Mrs. Hisayo Sugimoto, and other members of the public office in Hidakagawa Town; Dr. Shinji Matsuda of the Shingu Public Health Centre; and Mrs. Tamako Tsutsumi, Mrs. Kanami Maeda, Mr. Shoichi Shimoichi, Mrs. Megumi Takino, Mrs. Shuko Okada, Mrs. Kazuyo Setoh, Mrs. Chise Ryouno, Mrs. Miki Shimosaki, Mrs. Chika Yamaguchi, Mrs. Yuki Shimoji, and other members of the public office in Taiji Town for their assistance in locating and scheduling participants for examinations. We also thank Ms. Kyoko Yoshimura, Mrs. Toki Sakurai, and Mrs. Saeko Sahara for their assistance with data reduction and administration.	Albert TJ, 2002, SEMIN ARTHR RHEUM, V32, P130; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Mader R, 2009, SEMIN ARTHRITIS RHEU, V38, P361, DOI 10.1016/j.semarthrit.2008.01.010; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Kim SK, 2004, J RHEUMATOL, V31, P2032; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222; Mata S, 1998, SEMIN ARTHRITIS RHEU, V28, P88, DOI 10.1016/S0049-0172(98)80041-3; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; [Anonymous], 1999, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199902000-00006; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; RESNICK D, 1976, RADIOLOGY, V119, P559; Ehara S, 1998, EUR J RADIOL, V27, P196, DOI 10.1016/S0720-048X(97)00164-2; Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; ONO M, 1982, RADIOLOGY, V143, P469; RESNICK D, 1978, AM J ROENTGENOL, V131, P1049; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Holton KF, 2011, SEMIN ARTHRITIS RHEU, V41, P131, DOI 10.1016/j.semarthrit.2011.01.001; BLOOM RA, 1984, SCAND J RHEUMATOL, V13, P181; CASSIM B, 1990, BRIT J RHEUMATOL, V29, P131; DENKO CW, 1994, J RHEUMATOL, V21, P1725; Hannallah D, 2007, OPER TECH ORTHOP, V17, P174, DOI 10.1053/j.oto.2007.03.001; HENDRIX RW, 1994, AM J ROENTGENOL, V162, P899; Kiss C, 2002, RHEUMATOLOGY, V41, P1335, DOI 10.1093/rheumatology/41.11.1335; Kiss C, 2002, RHEUMATOLOGY, V41, P27, DOI 10.1093/rheumatology/41.1.27; Kiss C, 2002, SCAND J RHEUMATOL, V31, P226; LITTLEJOHN GO, 1985, CLIN RHEUMATOL, V4, P294, DOI 10.1007/BF02031611; Muraki S, 2009, ARTHRIT RHEUM-ARTHR, V61, P779, DOI 10.1002/art.24514; TSUKAMOTO Y, 1977, AM J ROENTGENOL, V129, P913; Vezyroglou G, 1996, J RHEUMATOL, V23, P672; Yoshimura N, 2013, OSTEOPOROS INT	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAR	2015	33	2					221	229		10.1007/s00774-014-0583-9		9	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CC9NH	WOS:000350697000013		
J	Nagatomo, Y; Yoshikawa, T; Okamoto, H; Kitabatake, A; Hori, M				Nagatomo, Yuji; Yoshikawa, Tsutomu; Okamoto, Hiroshi; Kitabatake, Akira; Hori, Masatsugu		Japanese Chronic Heart Failure	Presence of Autoantibody Directed Against beta(1)-Adrenergic Receptors Is Associated With Amelioration of Cardiac Function in Response to Carvedilol: Japanese Chronic Heart Failure (J-CHF) Study	JOURNAL OF CARDIAC FAILURE			English	Article						Autoimmunity; beta-blocker; responder; reverse remodeling	IDIOPATHIC DILATED CARDIOMYOPATHY; 2ND EXTRACELLULAR LOOP; ISOLATED CARDIOMYOCYTES; BETA-1-ADRENERGIC RECEPTOR; AUTOIMMUNE EPITOPE; ANTIBODIES; IMMUNOADSORPTION; MORTALITY; THERAPY; PROBNP	Background: Autoantibody against beta(1)-adrenergic receptors (beta(1)-AAb) exerts agonist-like action inducing receptor uncoupling and myocardial damage. We attempted to determine the significance of beta(1)-AAb in chronic heart failure (CHF) patients who received carvedilol in a substudy of the Japanese Chronic Heart Failure study. Methods and Results: In this prospective, randomized, multicenter trial, 117 patients were assigned to 2.5 mg, 5 mg, and 20 mg (n = 38, 36, and 43) carvedilol groups according to the target dose. beta(1)-AAb was positive in 51 patients (44%, P) and negative in 66 (56%, N). The percentage increase of left ventricular ejection fraction over 56 weeks (Delta LVEF) was larger in P than in N (P = .050) and in the high-titer group (H) than in the low-titer group (L; P = .04). Left ventricular (LV) volume decreased to a greater extent in H than in L over 56 weeks. beta(1)-AAb titer was significantly correlated with Delta LVEF and the percentage change of LV volume and was an independent predictor of them. No difference was seen in the composite end point (all-cause mortality and hospitalization for cardiovascular diseases or heart failure). However, in patients with dilated cardiomyopathy, it was more common in the 2.5 mg group than in the other groups in N, and it was similar among the 3 groups in P. Conclusions: Our data suggest that the presence of beta(1)-AAb is associated with favorable response to carvedilol in CHF.	[Nagatomo, Yuji] Cleveland Clin Fdn, Lenzer Res Inst, Cleveland, OH 44195 USA; [Yoshikawa, Tsutomu] Sakakibara Heart Inst, Dept Cardiol, Fuchu, Tokyo 1830003, Japan; [Okamoto, Hiroshi] Hokkaido Med Ctr, Natl Hosp Org, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Kitabatake, Akira] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Hori, Masatsugu] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Yoshikawa, T (reprint author), Sakakibara Heart Inst, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	tyoshi@shi.heart.or.jp			Ministry of Health, Labor, and Welfare of Japan [14C-2]; Japan Heart Foundation	Grants from the Ministry of Health, Labor, and Welfare of Japan (14C-2) and the Japan Heart Foundation.	Dandel M, 2012, EUR J HEART FAIL, V14, P1374, DOI 10.1093/eurjhf/hfs123; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Mobini R, 2000, HYBRIDOMA, V19, P135, DOI 10.1089/02724570050031176; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; Podlowski S, 1998, CIRCULATION, V98, P2470; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Baudhuin LM, 2010, AM J CARDIOL, V106, P402, DOI 10.1016/j.amjcard.2010.03.041; Talameh JA, 2012, J CARD FAIL, V18, P338, DOI 10.1016/j.cardfail.2012.01.002; Masson S, 2006, CLIN CHEM, V52, P1528, DOI 10.1373/clinchem.2006.069575; Brisinda D, 2012, CIRC J, V76, P1345, DOI 10.1253/circj.CJ-11-1374; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Staudt Y, 2003, EUR J PHARMACOL, V466, P1, DOI 10.1016/S0014-2999(03)01431-6; Jahns R, 1999, CIRCULATION, V99, P649; Staudt A, 2001, EUR J PHARMACOL, V423, P115, DOI 10.1016/S0014-2999(01)01113-X; Baba A, 2010, CIRC J, V74, P1372, DOI 10.1253/circj.CJ-09-0748; Christ T, 2001, J MOL CELL CARDIOL, V33, P1515, DOI 10.1006/jmcc.2001.1414; Du YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052911; Fukuda Y, 2004, J AM COLL CARDIOL, V43, P1090, DOI 10.1016/j.jacc.2003.09.057; Hogenhuis J, 2007, EUR J HEART FAIL, V9, P787, DOI 10.1016/j.ejheart.2007.04.001; Iwata M, 2001, CIRC RES, V88, P578; Jahns R, 2000, J AM COLL CARDIOL, V36, P1280, DOI 10.1016/S0735-1097(00)00881-0; Jahns R, 1999, J AM COLL CARDIOL, V34, P1545, DOI 10.1016/S0735-1097(99)00381-2; Mialet PJ, 2003, NAT MED, V9, P1300; Miao GB, 2006, EUR J CLIN INVEST, V36, P614, DOI 10.1111/j.1365-2362.2006.01705.x; Mobini R, 1999, J AUTOIMMUN, V13, P179, DOI 10.1006/jaut.1999.0310; Nagatomo Y, 2009, J CARD FAIL, V15, P224, DOI 10.1016/j.cardfail.2008.10.027; Nagatomo Y, 2011, J CLIN APHERESIS, V26, P1, DOI 10.1002/jca.20268; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Okamoto H, 2013, INT J CARDIOL, V164, P238, DOI 10.1016/j.ijcard.2012.11.051; Stork S, 2006, AM HEART J, V152, P697, DOI 10.1016/j.ahj.2006.05.004; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; Wallukat G, 2002, NEW ENGL J MED, V347, P1806, DOI 10.1056/NEJM200211283472220; Wallukat G, 2012, CIRC J, V76, P2449, DOI 10.1253/circj.CJ-12-0212; Yoshikawa T, 1996, EUR HEART J, V17, P8	38	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	MAR	2015	21	3					198	207		10.1016/j.cardfail.2014.12.005		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD1ML	WOS:000350838900003		
J	Miyazaki, S; Ichihara, N; Taniguchi, H; Hachiya, H; Nakamura, H; Usui, E; Kanaji, Y; Takagi, T; Iwasawa, J; Kuroi, A; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Ichihara, Noboru; Taniguchi, Hiroshi; Hachiya, Hitoshi; Nakamura, Hiroaki; Usui, Eisuke; Kanaji, Yoshihisa; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Hirao, Kenzo; Iesaka, Yoshito			Evaluation of Diaphragmatic Electromyograms in Radiofrequency Ablation of Atrial Fibrillation: Prospective Study Comparing Different Monitoring Techniques	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						phrenic nerve injury; diaphragmatic electromyogram; superior vena cava; catheter ablation; atrial fibrillation; pulmonary vein isolation	PHRENIC-NERVE INJURY; SUPERIOR VENA-CAVA; PULMONARY VEIN ISOLATION; CRYOBALLOON ABLATION; ELECTRICAL ISOLATION; CATHETER ABLATION; PREVALENCE	Diaphragmatic Electromyograms During AF Ablation BackgroundThe utility of compound motor action potential (CMAP) monitoring for anticipating phrenic nerve injury (PNI) during cryoballoon ablation has been reported. We sought to compare two different CMAP recording techniques and evaluated the feasibility during pulmonary vein antrum isolation (PVAI) and superior vena cava isolation (SVCI) using radiofrequency energy. Methods and ResultsForty-two patients undergoing paroxysmal atrial fibrillation ablation were prospectively enrolled. SVCI was performed following PVAI if SVC potentials were observed. CMAPs were recorded 3 times (before and after PVAI, and after SVCI) simultaneously from surface electrodes (CMAPsuf) and a decapolar catheter in the subdiaphragmatic hepatic vein (CMAPabd). The baseline CMAPsuf and CMAPabd were 0.92 0.36 and 0.65 +/- 0.43 mV except in one case with catheter inaccessibility. The CMAPsuf did not correlate with the body mass index, or CMAPabd. In 2 and 9 patients, the CMAPsuf and CMAPabd amplitudes were < 0.5 and < 0.3 mV, respectively. The diaphragm to catheter distance was significantly longer in cases with a CMAPabd < 0.3 mV than one > 0.3 mV (39.2 +/- 10.8 vs. 21.5 +/- 6.6 mm, P < 0.0001). Two cases with a CMAPsuf < 0.5 mV had larger amplitudes on the CMAPabd. In 1 patient, apparent PNI occurred during the SVCI, and the CMAP disappeared after the SVCI in both techniques. The CMAPs did not significantly decrease after the PVAI and SVCI; however, a >30% decrease was observed in 2 patients in both techniques. In both, no PNI was apparent on fluoroscopy or chest X-ray. ConclusionsStable evaluable CMAPs were obtained with the CMAPsuf in most patients. Monitoring with the CMAPabd could be an alternative and complementary method.	[Miyazaki, Shinsuke; Ichihara, Noboru; Taniguchi, Hiroshi; Hachiya, Hitoshi; Nakamura, Hiroaki; Usui, Eisuke; Kanaji, Yoshihisa; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Mondesert B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P605, DOI 10.1161/CIRCEP.113.001238; Franceschi F, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1109, DOI 10.1161/CIRCEP.113.000517; Arruda M, 2007, J CARDIOVASC ELECTR, V18, P1261, DOI 10.1111/j.1540-8167.2007.00953.x; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Franceschi F, 2011, HEART RHYTHM, V8, P1068, DOI 10.1016/j.hrthm.2011.01.047; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Miyazaki S, 2013, CIRC J, V77, P352, DOI 10.1253/circj.CJ-12-0951; Ji SY, 2013, J CARDIOVASC ELECTR, V24, P1086, DOI 10.1111/jce.12210; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Miyazaki S, 2011, HEART, V97, P668, DOI 10.1136/hrt.2009.186874; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Dionne A, 2009, MUSCLE NERVE, V40, P37, DOI 10.1002/mus.21290; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Lakhani M, 2014, HEART RHYTHM, V11, P369, DOI 10.1016/j.hrthm.2013.11.015; Miyazaki S, 2014, AM HEART J, V168, P846, DOI 10.1016/j.ahj.2014.09.011	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAR	2015	26	3					260	265		10.1111/jce.12571		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD6OQ	WOS:000351209100004		
J	Yoshitani, K; Miyamoto, T; Sato, Y; Takatsu, Y				Yoshitani, Kazuyasu; Miyamoto, Tadashi; Sato, Yukihito; Takatsu, Yoshiki			Another Gate Keeper to Protect the Mitral Isthmus?: Importance of the Vein of Marshall	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						atrial fibrillation; catheter ablation; left atrial flutter; mitral isthmus; vein of Marshall			[Yoshitani, Kazuyasu; Miyamoto, Tadashi; Sato, Yukihito; Takatsu, Yoshiki] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Med, Amagasaki, Hyogo 6600828, Japan	Yoshitani, K (reprint author), Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Med, 1-1-1 Higashidaimotsu, Amagasaki, Hyogo 6600828, Japan.	kazuyasu.y@gmail.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAR	2015	26	3					352	353		10.1111/jce.12576		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD6OQ	WOS:000351209100019		
J	Mochizuki, D; Sasaki, R; Maitani, MM; Okamoto, M; Suzuki, E; Wada, Y				Mochizuki, Dai; Sasaki, Ryo; Maitani, Masato M.; Okamoto, Masaki; Suzuki, Eiichi; Wada, Yuji			Catalytic reactions enhanced under microwave-induced local thermal non-equilibrium in a core-shell, carbon-filled zeolite@zeolite	JOURNAL OF CATALYSIS			English	Article						Core-shell; Zeolite; Microwave; Dehydration	ASSISTED ORGANIC-SYNTHESIS; ELECTROCHEMICAL PROCESSES; CHEMISTRY; MAGTRIEVE(TM); OVERGROWTH; ACTIVATION; OXIDATION; MEDIA; OVENS	A core-shell, carbon-filled zeolite@zeolite was created through the epitaxial growth of shell zeolite on a core zeolite filled with carbon. The catalytic dehydrations of alcohols on the core-shell structure were enhanced under microwave irradiation by comparison with conventional heating using an oil bath at the same solution temperatures; however, the dehydrations on the sole core zeolite were not enhanced under microwave irradiation, which indicated the presence of a higher temperature area in the shell near the border with the core. The core-shell structure exhibited thermal non-equilibrium with microwave irradiation because of the extremely different dielectric losses of the core and the shell; that is, the carbon in the core generated much heat from microwaves, but the shell did not. (C) 2014 Elsevier Inc. All rights reserved.	[Mochizuki, Dai; Sasaki, Ryo; Maitani, Masato M.; Okamoto, Masaki; Suzuki, Eiichi; Wada, Yuji] Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, Tokyo 152, Japan	Mochizuki, D (reprint author), Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, 2-12-1 Ookayama, Tokyo 152, Japan.		Mochizuki, Dai/J-2433-2014	Mochizuki, Dai/0000-0002-3547-923X	MEXT, Japan [25249113, 40182985, 26410235, 24760637]	We thank Dr. M. Tada, J. Koki, Y. Ohtsuka, and K. Hori (Center for Advanced Materials Analysis, Tokyo Institute of Tech.) for Auger, ICP, and TEM measurements. This work was supported in part by Grant-in-Aid for Scientific Research (A) (25249113), Grant-in-Aid for Exploratory Research (40182985), Grant-in-Aid for Scientific Research (C) (26410235) and Grant-in-Aid for Young Scientists (B) (24760637) from MEXT, Japan.	de la Hoz A, 2005, CHEM SOC REV, V34, P164, DOI 10.1039/b411438h; STRAUSS CR, 1995, AUST J CHEM, V48, P1665, DOI 10.1071/CH9951665; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Kappe CO, 2013, ANGEW CHEM INT EDIT, V52, P1088, DOI 10.1002/anie.201204103; BINNER JGP, 1995, J MATER SCI, V30, P5389, DOI 10.1007/BF00351548; Bouizi Y, 2006, CHEM MATER, V18, P4959, DOI 10.1021/cm0611744; Polshettiwar V, 2008, ACCOUNTS CHEM RES, V41, P629, DOI 10.1021/ar700238s; Tsai YC, 2002, J AM CHEM SOC, V124, P9784, DOI 10.1021/ja026037w; Rosana MR, 2012, CHEM SCI, V3, P1240, DOI 10.1039/c2sc01003h; Dressen MHCL, 2007, ORG PROCESS RES DEV, V11, P865, DOI 10.1021/op700080t; Huang W, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139519; GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9; Galema SA, 1997, CHEM SOC REV, V26, P233, DOI 10.1039/cs9972600233; Okada T, 2005, J MATER CHEM, V15, P987, DOI 10.1039/b412707b; Horikoshi S, 2011, J PHYS CHEM C, V115, P23030, DOI 10.1021/jp2076269; Kyotani T, 1997, CHEM MATER, V9, P609, DOI 10.1021/cm960430h; Arvela RK, 2005, J ORG CHEM, V70, P161, DOI 10.1021/jo048531j; Kappe CO, 2009, MOL DIVERS, V13, P71, DOI 10.1007/s11030-009-9138-8; Menendez JA, 2010, FUEL PROCESS TECHNOL, V91, P1, DOI 10.1016/j.fuproc.2009.08.021; GIGUERE RJ, 1986, TETRAHEDRON LETT, V27, P4945, DOI 10.1016/S0040-4039(00)85103-5; Perreux L, 2001, TETRAHEDRON, V57, P9199, DOI 10.1016/S0040-4020(01)00905-X; Schmink JR, 2009, ORG LETT, V11, P365, DOI 10.1021/ol802594s; Bouizi Y, 2006, MICROPOR MESOPOR MAT, V91, P70, DOI 10.1016/j.micromeso.2005.11.016; Suzuki K, 2007, J PHYS CHEM C, V111, P894, DOI 10.1021/jp065054v; Hunt J, 2013, J PHYS CHEM C, V117, P26871, DOI 10.1021/jp4076965; DELPRATO F, 1990, ZEOLITES, V10, P546, DOI 10.1016/S0144-2449(05)80310-0; Atwater JE, 2004, APPL PHYS A-MATER, V79, P125, DOI 10.1007/s00339-003-2329-8; Berger C, 2005, MICROPOR MESOPOR MAT, V83, P333, DOI 10.1016/j.micromeso.2005.04.009; Bogdal D, 2003, TETRAHEDRON, V59, P649, DOI 10.1016/S0040-4020(02)01533-8; Lukasiewicz M, 2003, ADV SYNTH CATAL, V345, P1269, DOI 10.1002/adsc.200303131; Chen W, 2012, CHEMSTRYOPEN, V1, P39, DOI 10.1002/open.201100013; Compton RG, 1998, CHEM COMMUN, P2595, DOI 10.1039/a806511j; de la Hoz A., 2012, MICROWAVES ORGANIC S; Dressen MHCL, 2011, ORG PROCESS RES DEV, V15, P140, DOI 10.1021/op100202j; Dressen MHCL, 2009, ORG PROCESS RES DEV, V13, P888, DOI 10.1021/op9001356; Feijen EJP, 1996, J CHEM SOC FARADAY T, V92, P3281, DOI 10.1039/ft9969203281; Ferrari A, 2014, J PHYS CHEM C, V118, P9346, DOI 10.1021/jp501206n; Gawande MB, 2014, ACCOUNTS CHEM RES, V47, P1338, DOI 10.1021/ar400309b; Goossens AM, 2001, EUR J INORG CHEM, P1167; HESTON WM, 1950, J AM CHEM SOC, V72, P99, DOI 10.1021/ja01157a028; Inagaki S, 2011, B CHEM SOC JPN, V84, P1136, DOI 10.1246/bcsj.20110164; Irfan M, 2009, CHEM-EUR J, V15, P11608, DOI 10.1002/chem.200902044; Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655; Leadbeater NE, 2003, ANGEW CHEM INT EDIT, V42, P1407, DOI 10.1002/anie.200390362; Michael D, 1991, CHEM SOC REV, V20, P1; Mochizuki D, 2012, CHEM LETT, V41, P1409, DOI 10.1246/cl.2012.1409; Nushiro K, 2013, CHEM COMMUN, V49, P8371, DOI 10.1039/c3cc44610g; Okamoto M, 2011, MICROPOR MESOPOR MAT, V143, P413, DOI 10.1016/j.micromeso.2011.03.032; RANER KD, 1995, J ORG CHEM, V60, P2456, DOI 10.1021/jo00113a028; Ritter SK, 2014, CHEM ENG NEWS, V92, P26; Stuerga D, 1996, TETRAHEDRON, V52, P5505, DOI 10.1016/0040-4020(96)00241-4; Tsukahara Y, 2010, J PHYS CHEM C, V114, P8965, DOI 10.1021/jp100509h; Vu D.V., 2008, MICROPOR MESOPOR MAT, V115, P106, DOI 10.1016/j.micromeso.2007.12.034; Zhang XL, 1999, CHEM COMMUN, P975, DOI 10.1039/a901245a	54	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	MAR	2015	323						1	9		10.1016/j.jcat.2014.12.003		9	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CD0PY	WOS:000350777600001		
J	Hongo, K; Watson, MA; Iitaka, T; Aspuru-Guzik, A; Maezono, R				Hongo, Kenta; Watson, Mark A.; Iitaka, Toshiaki; Aspuru-Guzik, Alan; Maezono, Ryo			Diffusion Monte Carlo Study of Para-Diiodobenzene Polymorphism Revisited	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							MOLECULAR-CRYSTAL POLYMORPHISM; DENSITY-FUNCTIONAL THEORY; HARTREE-FOCK PSEUDOPOTENTIALS; DISPERSION-CORRECTED DFT; COMPUTATIONAL PREDICTION; NONCOVALENT INTERACTIONS; OXALYL DIHYDRAZIDE; CORRELATION-ENERGY; P-DIIODOBENZENE; ELECTRON-GAS	We revisit our investigation of the diffusion Monte Carlo (DMC) simulation of para-diiodobenzene (p-DIB) molecular crystal polymorphism. [See J. Phys. Chem. Lett. 2010, 1, 17891794.] We perform, for the first time, a rigorous study of finite-size effects and choice of nodal surface on the prediction of polymorph stability in molecular crystals using fixed-node DMC. Our calculations are the largest that are currently feasible using the resources of the K-computer and provide insights into the formidable challenge of predicting such properties from first principles. In particular, we show that finite-size effects can influence the trial nodal surface of a small (1 x 1 x 1) simulation cell considerably. Therefore, we repeated our DMC simulations with a 1 x 3 x 3 simulation cell, which is the largest such calculation to date. We used a density functional theory (DFT) nodal surface generated with the PBE functional, and we accumulated statistical samples with similar to 6.4 x 10(5) core hours for each polymorph. Our final results predict a polymorph stability that is consistent with experiment, but they also indicate that the results in our previous paper were somewhat fortuitous. We analyze the finite-size errors using model periodic Coulomb (MPC) interactions and kinetic energy corrections, according to the CCMH scheme of Chiesa, Ceperley, Martin, and Holzmann. We investigate the dependence of the finite-size errors on different aspect ratios of the simulation cell (k-mesh convergence) in order to understand how to choose an appropriate ratio for the DMC calculations. Even in the most expensive simulations currently possible, we show that the finite size errors in the DMC total energies are much larger than the energy difference between the two polymorphs, although error cancellation means that the polymorph prediction is accurate. Finally, we found that the T-move scheme is essential for these massive DMC simulations in order to circumvent population explosions and large time-step biases.	[Hongo, Kenta; Maezono, Ryo] JAIST, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan; [Watson, Mark A.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Iitaka, Toshiaki] RIKEN, Computat Astrophys Lab, Wako, Saitama 3510198, Japan; [Aspuru-Guzik, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Hongo, K (reprint author), JAIST, Sch Informat Sci, Asahidai 1-1, Nomi, Ishikawa 9231292, Japan.	kenta_hongo@mac.com			KAKENHI [23104714, 22104011, 25600156]; Tokuyama Science Foundation	Computations have been performed using the K-computer at the RIKEN Advanced Institute for Computational Science and the computer facilities at the Research Center for Advanced Computing Infrastructure, JAIST. R.M. is grateful for financial support from KAKENHI grants (Nos. 23104714, 22104011, and 25600156), and from the Tokuyama Science Foundation.	Alfe D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161101; Allen M. P., 1990, COMPUTER SIMULATION; Hirata S, 2010, MOL PHYS, V108, P3113, DOI 10.1080/00268976.2010.516278; Chiesa S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.076404; Santra B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.185701; Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007; MITAS L, 1991, J CHEM PHYS, V95, P3467; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Reilly AM, 2013, J PHYS CHEM LETT, V4, P1028, DOI 10.1021/jz400226x; RAJAGOPAL G, 1994, PHYS REV LETT, V73, P1959, DOI 10.1103/PhysRevLett.73.1959; Drummond ND, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.235119; ALCOBE X, 1994, J SOLID STATE CHEM, V110, P20, DOI 10.1006/jssc.1994.1129; Taylor CR, 2012, PHYS CHEM CHEM PHYS, V14, P7739, DOI [10.1039/c2cp24090d, 10.1039/c2cp4090d]; Williamson AJ, 1997, PHYS REV B, V55, pR4851; RAJAGOPAL G, 1995, PHYS REV B, V51, P10591, DOI 10.1103/PhysRevB.51.10591; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Cohen AJ, 2012, CHEM REV, V112, P289, DOI 10.1021/cr200107z; Austin BM, 2012, CHEM REV, V112, P263, DOI 10.1021/cr2001564; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Trail JR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1888569; Taylor DE, 2011, PHYS CHEM CHEM PHYS, V13, P16629, DOI 10.1039/c1cp21342c; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Kolorenc J, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/2/026502; Umrigar CJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150201; Uejima Y, 2011, J COMPUT CHEM, V32, P2264, DOI 10.1002/jcc.21809; Presti D, 2014, CRYSTENGCOMM, V16, P102, DOI 10.1039/c3ce41758a; Moellmann J, 2010, PHYS CHEM CHEM PHYS, V12, P8500, DOI 10.1039/c003432k; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Drummond ND, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125106; Azadi S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113005; Sode O, 2009, INT J QUANTUM CHEM, V109, P1928, DOI 10.1002/qua.22022; Price SL, 2004, ADV DRUG DELIVER REV, V56, P301, DOI 10.1016/j.addr.2003.10.006; Gothandaraman A, 2008, PARALLEL COMPUT, V34, P278, DOI 10.1016/j.parco.2008.01.009; Hood RQ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134109; Wen SH, 2012, J CHEM THEORY COMPUT, V8, P2698, DOI 10.1021/ct300484h; Woodley SM, 2008, NAT MATER, V7, P937, DOI 10.1038/nmat2321; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Korth M, 2008, J PHYS CHEM A, V112, P2104, DOI 10.1021/jp077592t; Ertekin E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155210; Gonze X, 2005, Z KRISTALLOGR, V220, P558, DOI 10.1524/zkri.220.5.558.65066; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Pedone A, 2012, CHEM PHYS LETT, V541, P12, DOI 10.1016/j.cplett.2012.05.049; Luchow A, 2011, WIRES COMPUT MOL SCI, V1, P388, DOI 10.1002/wcms.40; Trail JR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829049; Shulenburger L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245117; Uejima Y, 2013, J COMPUT CHEM, V34, P83, DOI 10.1002/jcc.23106; Sudheer CD, 2013, COMPUT PHYS COMMUN, V184, P284, DOI 10.1016/j.cpc.2012.09.008; Tkatchenko A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.236402; Wen SH, 2012, CRYST GROWTH DES, V12, P2169, DOI 10.1021/cg300358n; Price SL, 2008, INT REV PHYS CHEM, V27, P541, DOI 10.1080/01442350802102387; REYNOLDS PJ, 1982, J CHEM PHYS, V77, P5593, DOI 10.1063/1.443766; Bygrave PJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759079; Hesselmann A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1824898; Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005; Neumann MA, 2009, CRYSTENGCOMM, V11, P2475, DOI 10.1039/b909819d; Fraser LM, 1996, PHYS REV B, V53, P1814, DOI 10.1103/PhysRevB.53.1814; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Lin C, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016702; Hirata S, 2014, ACCOUNTS CHEM RES, V47, P2721, DOI 10.1021/ar500041m; Neumann MA, 2008, ANGEW CHEM INT EDIT, V47, P2427, DOI 10.1002/anie.200704247; Watson MA, 2012, ACS SYM SER, V1094, P101; Nanda KD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764063; Hasegawa M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104426; Kwee H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126404; Zhao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126975; Dubecky M, 2013, J CHEM THEORY COMPUT, V9, P4287, DOI 10.1021/ct4006739; Brillante A, 2005, J AM CHEM SOC, V127, P3038, DOI 10.1021/ja0432416; Ouma CNM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.104115; JASTROW R, 1955, PHYS REV, V98, P1479, DOI 10.1103/PhysRev.98.1479; Ehrlich S, 2013, ACCOUNTS CHEM RES, V46, P916, DOI 10.1021/ar3000844; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Tkatchenko A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045116; Habgood M, 2011, J CHEM THEORY COMPUT, V7, P2685, DOI 10.1021/ct200354t; Weber R, 2011, IEEE T PARALL DISTR, V22, P58, DOI 10.1109/TPDS.2010.125; Beran GJO, 2010, J PHYS CHEM LETT, V1, P3480, DOI 10.1021/jz101383z; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Needs RJ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/023201; UMRIGAR CJ, 1993, J CHEM PHYS, V99, P2865, DOI 10.1063/1.465195; Marom N, 2013, ANGEW CHEM INT EDIT, V52, P6629, DOI 10.1002/anie.201301938; ALIEV AE, 1993, J CHEM SOC FARADAY T, V89, P3797, DOI 10.1039/ft9938903797; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Wen SH, 2011, J CHEM THEORY COMPUT, V7, P3733, DOI 10.1021/ct200541h; Bernstein J., 2002, POLYMORPHISM MOL CRY; Casula M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161102; de-la Roza AO, 2012, J CHEM PHYS, V137; Drummond ND, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085124; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Gillan M. J., 2011, PETASCALE COMPUTING; Grossman JC, 2002, J CHEM PHYS, V117, P1434, DOI 10.1063/1.1487829; Helgaker T., 2000, MOL ELECT STRUCTURE; Hirata S, 2009, PHYS CHEM CHEM PHYS, V11, P8397, DOI 10.1039/b905812p; Hongo K, 2010, J PHYS CHEM LETT, V1, P1789, DOI 10.1021/jz100418p; Hongo K, 2013, J CHEM THEORY COMPUT, V9, P1081, DOI 10.1021/ct301065f; Horvathova L, 2013, J CHEM THEORY COMPUT, V9, P390, DOI 10.1021/ct300887t; Jacobsen H, 2011, J CHEM THEORY COMPUT, V7, P3019, DOI 10.1021/ct200476u; KATO T, 1957, COMMUN PUR APPL MATH, V10, P151, DOI 10.1002/cpa.3160100201; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Ma FJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155130; Maezono R., 2013, COMMUNICATION; Peverati R, 2011, J PHYS CHEM LETT, V2, P2810, DOI 10.1021/jz201170d; Podeszwa R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.115503; Sancho-Garcia JC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766933; Sharkas K., 2014, J CHEM PHYS, V141; Szalewicz K, 2012, WIRES COMPUT MOL SCI, V2, P254, DOI 10.1002/wcms.86; Wen SH, 2012, PHYS CHEM CHEM PHYS, V14, P7578, DOI 10.1039/c2cp23949c	107	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	MAR	2015	11	3					907	917		10.1021/ct500401p		11	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CD2OG	WOS:000350918300008		
J	Takahashi, H; Suzuoka, D; Morita, A				Takahashi, Hideaki; Suzuoka, Daiki; Morita, Akihiro			Why is Benzene Soluble in Water? Role of OH/pi Interaction in Solvation	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							CATION-PI INTERACTIONS; DIFFERENCE-PSEUDOPOTENTIAL METHOD; ELECTRONIC-STRUCTURE CALCULATIONS; REAL-SPACE GRIDS; ENERGY REPRESENTATION; AQUEOUS-SOLUTION; AB-INITIO; AROMATIC RINGS; HYDROGEN-BONDS; QM/MM-ER	The XH/pi interaction (X = C, N, or O) plays an essential role in a variety of fundamental processes in condensed phase, and it attracts broad interests in the fields of chemistry and biochemistry in recent years. This issue has a direct relevance to an intriguing phenomenon that a benzene molecule exhibits a negative solvation free energy of -0.87 kcal/mol in ambient water though it is a typical nonpolar organic solute. In this work, we developed a novel method to analyze the free energy delta mu due to the electron density fluctuation of a solute in solution to clarify the mechanism responsible for the affinity of benzene to bulk water. Explicitly, the free energy delta mu is decomposed into contributions from sigma and pi electrons in pi-conjugated systems on the basis of the QM/MM method combined with a theory of solutions. With our analyses, the free energy delta mu(pi) arising from the fluctuation of pi electrons in benzene was obtained as -0.94 kcal/mol and found to be the major source of the affinity of benzene to water. Thus, the role of pi electrons in hydration is quantified for the first time with our analyses. Our method was applied to phenyl methyl ether (PME) in water solution to examine the substituent effects of the electron donating group (EDG) on the hydration of a pi-conjugated system. The delocalization effect of the pi electrons on hydration was also investigated performing the decomposition analyses for ethene and 1,3-butadiene molecules in water solutions. It was revealed that the stabilization due to delta mu(pi) for butadiene (-0.76 kcal/mol) is about three times as large as that for ethene (-0.26 kcal/mol), which suggests the importance of the delocalization effect of the pi electrons in mediating the affinity to polar solvent.	[Takahashi, Hideaki; Suzuoka, Daiki; Morita, Akihiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Takahashi, H (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	hideaki@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23118701]; Japan Society for the Promotion of Science (JSPS) [25620004]; Nanoscience Program and the Computational Materials Science Initiative of the Next-Generation Supercomputing Project	This work is supported by the Grant-in-Aid for Scientific Research on Innovative Areas (No. 23118701) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and by the Grant-in-Aid for Challenging Exploratory Research (No. 25620004) from the Japan Society for the Promotion of Science (JSPS), and by the Nanoscience Program and the Computational Materials Science Initiative of the Next-Generation Supercomputing Project.	ALLEN LC, 1960, PHYS REV, V118, P167, DOI 10.1103/PhysRev.118.167; Allen M. P., 1987, COMPUTER SIMULATION; Allesch M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2806288; [Anonymous], 1989, CHEM PHYS; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Allesch M, 2007, J PHYS CHEM B, V111, P1081, DOI 10.1021/jp065429c; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; TEN-NO S, 1994, J CHEM PHYS, V100, P7443, DOI 10.1063/1.466888; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Hu H, 2008, ANNU REV PHYS CHEM, V59, P573, DOI 10.1146/annurev.physchem.59.032607.093618; SUZUKI S, 1992, SCIENCE, V257, P942, DOI 10.1126/science.257.5072.942; Ono T, 1999, PHYS REV LETT, V82, P5016, DOI 10.1103/PhysRevLett.82.5016; CHELIKOWSKY JR, 1994, PHYS REV B, V50, P11355, DOI 10.1103/PhysRevB.50.11355; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Harigai M, 2006, J AM CHEM SOC, V128, P10646, DOI 10.1021/ja062125v; Sponer J, 2008, PHYS CHEM CHEM PHYS, V10, P2595, DOI 10.1039/b719370j; Tsuzuki S, 2000, J AM CHEM SOC, V122, P11450, DOI 10.1021/ja001901a; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Tsuzuki S, 2008, PHYS CHEM CHEM PHYS, V10, P2584, DOI 10.1039/b718656h; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Raschke TM, 2005, P NATL ACAD SCI USA, V102, P6777, DOI 10.1073/pnas.0500225102; GAO JL, 1992, SCIENCE, V258, P631, DOI 10.1126/science.1411573; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; Tatko CD, 2004, J AM CHEM SOC, V126, P2028, DOI 10.1021/ja038258n; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Becke AD, 1993, CHEM PHYS, V98, P5648, DOI DOI 10.1063/1.464913; Berne BJ, 1998, CLASSICAL QUANTUM DY; Canuto S, 2010, COMBINING QUANTUM ME, V59; Canuto S, 2008, SOLVATION EFFECTS MO, V6; CHELIKOWSKY JR, 1994, PHYS REV LETT, V72, P1240, DOI 10.1103/PhysRevLett.72.1240; Cramer C. J., 1994, ACS S SERIES, V568; Cubero E, 2003, J PHYS CHEM B, V107, P1664, DOI 10.1021/jp026874k; FRANCL MM, 1985, J PHYS CHEM-US, V89, P428, DOI 10.1021/j100249a012; Frenkel D., 1996, UNDERSTANDING MOL SI; Frisch M J, 2010, GAUSSIAN 09 REVISION; Gilli G., 2009, NATURE HYDROGEN BOND; Graziano G, 2006, CHEM PHYS LETT, V429, P114, DOI 10.1016/j.cplett.2006.08.006; Hagiwara Y, 2011, J CHEM THEORY COMPUT, V7, P2593, DOI 10.1021/ct100752y; Hansen P., 2006, THEORY SIMPLE LIQUID; Hobza P., 2008, PHYS CHEM CHEM PHYS, V19, P2561; Hobza P, 2010, RSC THEOR COMPUT CHE, P1; Hori T, 2007, J PHYS CHEM B, V111, P581, DOI 10.1021/jp066334d; Hori T., 2005, CHEM PHYS LETT, V419, P240; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Karino Y, 2010, CHEM PHYS LETT, V496, P351, DOI 10.1016/j.cplett.2010.07.054; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kuwajima K., 2009, WATER BIOMOLECULES; Luque FJ, 1998, J COMPUT CHEM, V19, P866, DOI 10.1002/(SICI)1096-987X(199806)19:8<866::AID-JCC6>3.0.CO;2-N; Matubayasi N, 2002, J CHEM PHYS, V117, P3605, DOI 10.1063/1.1495850; Matubayasi N, 2003, J CHEM PHYS, V118, P2446, DOI 10.1063/1.1533752; Matubayasi N, 2003, J CHEM PHYS, V119, P9686, DOI 10.1063/1.1613938; Matubayasi N, 2000, J CHEM PHYS, V113, P6070, DOI 10.1063/1.1309013; Nishio M., 1993, BIOORGAN MED CHEM, V6, P493; Nishio M., 1998, CH PI INTERACTION EV; Parr R. G., 1989, DENSITY FUNCTIONAL T; RAVISHANKER G, 1984, J AM CHEM SOC, V106, P4102, DOI 10.1021/ja00327a006; Ruiz-Lopez M. F, 2003, MOL STRUCT THEOCHEM, V632, P1; Sakuraba S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3637036; Sato H, 1999, J PHYS CHEM B, V103, P6596, DOI 10.1021/jp9911806; Schravendijk P, 2005, J CHEM THEORY COMPUT, V1, P643, DOI 10.1021/ct049841c; Suzuoka D, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4870037; Takahashi H, 2001, J PHYS CHEM A, V105, P4351, DOI 10.1021/jp004348s; Takahashi H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2008234; Takahashi H, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2566834; Takahashi H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026506; Takahashi H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839858; Takahashi H, 2008, CHEM PHYS LETT, V456, P176, DOI 10.1016/j.cplett.2008.03.038; Takahashi H, 2004, J CHEM PHYS, V121, P3989, DOI 10.1063/1.1774981; Takahashi H, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4722347; Takahashi H, 2011, INT J QUANTUM CHEM, V111, P1748, DOI 10.1002/qua.22814; Takahashi H, 2009, J MATH CHEM, V46, P781, DOI 10.1007/s10910-009-9544-2; Takahashi H, 2001, J COMPUT CHEM, V22, P1252, DOI 10.1002/jcc.1082; Takahashi H, 2011, J PHYS CHEM B, V115, P4745, DOI 10.1021/jp2015676; Takahashi H, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2825600; Takahashi H, 2000, CHEM LETT, P222; Tapia O., 1996, SOLVENT EFFECTS CHEM; van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT; Voth GA, 2006, ACCOUNTS CHEM RES, V39, P143, DOI 10.1021/ar0402098; Warshel A., 1991, COMPUTER MODELING CH; Yonezawa Y., 2006, CHEM PHYS LETT, V428, P74	86	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	MAR	2015	11	3					1181	1194		10.1021/ct501133u		14	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CD2OG	WOS:000350918300036		
J	Masunaga, R; Nakamura, H; Miyasaka, T; Nishii, K; Tanimoto, Y				Masunaga, Ryusuke; Nakamura, Hisashi; Miyasaka, Takafumi; Nishii, Kazuaki; Tanimoto, Youichi			Separation of Climatological Imprints of the Kuroshio Extension and Oyashio Fronts on the Wintertime Atmospheric Boundary Layer: Their Sensitivity to SST Resolution Prescribed for Atmospheric Reanalysis	JOURNAL OF CLIMATE			English	Article							SEA-SURFACE TEMPERATURE; EASTERN EQUATORIAL PACIFIC; WIND STRESS; SATELLITE-OBSERVATIONS; HEAT EXCHANGES; GULF-STREAM; OCEAN; VARIABILITY; MODEL; FRONTOGENESIS	Mesoscale structures of the wintertime marine atmospheric boundary layer (MABL) as climatological imprints of oceanic fronts within the Kuroshio Oyashio Extension (KOE) region east of Japan are investigated by taking advantage of high horizontal resolution of the ERA-Interim global atmospheric reanalysis data, for which the resolution of sea surface temperature (SST) data has been improved. These imprints, including locally enhanced sensible and latent heat fluxes and local maxima in cloudiness and precipitation in association with locally strengthened surface-wind convergence in the vicinities of SST fronts along the warm Kuroshio Extension and cool Oyashio to its north, are also identified in high-resolution satellite data. In addition to these mesoscale MABL features, meridionally confined near-surface baroclinic zones and zonally oriented sea level pressure (SLP) minima associated with the dual SST fronts are represented in ERA-Interim only in the period of high-resolution SST, but those imprints of the Oyashio front are missing in the low-resolution SST period. In the presence of the prevailing monsoonal northerlies, latitudinal displacements of the SLP trough, baroclinic zone, and the peak meridional gradient of the turbulent heat fluxes from each of the corresponding SST fronts are also found to be sensitive to the frontal width that depends on the SST resolution. The analysis herein suggests that the converging surface northerlies into the SLP minima can contribute positively to the formation of a surface baroclinic zone along the Kuroshio Extension, while a stronger baroclinic zone along the Oyashio front is maintained primarily through the pronounced cross-frontal contrast in sensible heat release from the ocean.	[Masunaga, Ryusuke; Nakamura, Hisashi; Miyasaka, Takafumi; Nishii, Kazuaki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Nakamura, Hisashi; Tanimoto, Youichi] JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Tanimoto, Youichi] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Tanimoto, Youichi] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan	Masunaga, R (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	masunaga@atmos.rcast.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports Science and Technology (MEXT) [2205, 2409]; Japanese Ministry of Environment through the Environment Research and Technology Department Fund [A1201]	We thank Dr. N. Komori for the information of the SCOW dataset. We also thank Drs. A. Kuwano-Yoshida, B. Taguchi, M. Nonaka, T. Miyama, and K. Takaya for their variable comments. The four anonymous reviewers provided useful and constructive comments that have led our paper to its substantial improvement. This study is supported in part by Japanese Ministry of Education, Culture, Sports Science and Technology (MEXT) through Grants-in-Aid for Scientific Research in Innovative Areas 2205 and 2409, and by the Japanese Ministry of Environment through the Environment Research and Technology Department Fund A1201.	Frankignoul C, 2011, J CLIMATE, V24, P762, DOI 10.1175/2010JCLI3731.1; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; Nonaka M, 2006, J CLIMATE, V19, P1970, DOI 10.1175/JCLI3793.1; Nakamura H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034010; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Koseki S, 2010, J CLIMATE, V23, P2492, DOI 10.1175/2009JCLI2915.1; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; MILLER JE, 1948, J METEOROL, V5, P169, DOI 10.1175/1520-0469(1948)005<0169:OTCOF>2.0.CO;2; Hotta D, 2011, J CLIMATE, V24, P3377, DOI 10.1175/2010JCLI3910.1; Milliff RF, 2001, J ATMOS SCI, V58, P109, DOI 10.1175/1520-0469(2001)058<0109:TGDOTT>2.0.CO;2; Seo Y, 2014, J CLIMATE, V27, P5929, DOI 10.1175/JCLI-D-13-00641.1; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Sampe T, 2010, J CLIMATE, V23, P1793, DOI 10.1175/2009JCLI3163.1; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Nonaka M, 2009, J CLIMATE, V22, P6515, DOI 10.1175/2009JCLI2960.1; O'Neill LW, 2010, J CLIMATE, V23, P559, DOI 10.1175/2009JCLI2662.1; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Small RJ, 2003, J CLIMATE, V16, P3723, DOI 10.1175/1520-0442(2003)016<3723:NSOART>2.0.CO;2; Taguchi B, 2012, J CLIMATE, V25, P111, DOI 10.1175/JCLI-D-11-00046.1; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Samelson RM, 2006, J CLIMATE, V19, P1557, DOI 10.1175/JCLI3682.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; HAYES SP, 1989, J CLIMATE, V2, P1500, DOI 10.1175/1520-0442(1989)002<1500:TIOSST>2.0.CO;2; Chelton DB, 2005, J CLIMATE, V18, P530, DOI 10.1175/JCLI-3275.1; ECMWF, 2007, CY31R1 ECMWF IFS; Hoskins B. J., 1985, J ROY METEOR SOC, V111, P877, DOI [10.1002/qj.49711147002, DOI 10.1002/QJ.49711147002]; HOSKINS BJ, 1982, ANNU REV FLUID MECH, V14, P131, DOI 10.1146/annurev.fl.14.010182.001023; Hubanks PA, 2008, ATBDMOD30; Iizuka S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012576; Kubota M., 2007, FLUX NEWS, V4, P13; Nakamura H, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000085; OGURA Y, 1982, J ATMOS SCI, V39, P2773, DOI 10.1175/1520-0469(1982)039<2773:SOTCFO>2.0.CO;2; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625	44	5	5	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAR 1	2015	28	5					1764	1787		10.1175/JCLI-D-14-00314.1		24	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD1MP	WOS:000350839300003		
J	Villafuerte, MQ; Matsumoto, J				Villafuerte, Marcelino Q., II; Matsumoto, Jun			Significant Influences of Global Mean Temperature and ENSO on Extreme Rainfall in Southeast Asia	JOURNAL OF CLIMATE			English	Article							GRIDDED PRECIPITATION DATASET; MAXIMUM DAILY PRECIPITATION; TROPICAL CYCLONE GENESIS; WESTERN NORTH PACIFIC; CLIMATE-CHANGE; DENSE NETWORK; EL-NINO; IMPACTS; MONSOON; TRENDS	This study investigates the changes in annual and seasonal maximum daily rainfall (RX1day) in Southeast Asia, obtained from gauge-based gridded precipitation data, to address the increasing concerns about climate change in the region. First, the nonparametric Mann-Kendall test was employed to detect significant trends in RX1day. Then, maximum likelihood modeling, which allows the incorporation of covariates in the location parameter of the generalized extreme value (GEV) distribution, was conducted to determine whether the rising global mean temperature, as well as El Nino-Southern Oscillation (ENSO), is influencing extreme rainfall over the region. The findings revealed that annual and seasonal RX1day is significantly increasing in Indochina and east-central Philippines while decreasing in most parts of the Maritime Continent during the past 57 yr (1951-2007). The trends in RX1day were further linked to the rising global mean temperature. It was shown that the location parameter of the GEV and hence the RX1day on average has significantly covaried with the annually averaged near-surface global mean temperature anomaly. Such covariation is pronouncedly observed over the regions where significant trends in RX1day were detected. Furthermore, the results demonstrated that, as ENSO develops in July September, negative covariations between the location parameter of the GEV and the ENSO index, implying a higher (lower) likelihood of extreme rainfall during La Nina (El Nino), were observed over the Maritime Continent. Such conditions progress northward to the regions of Indochina and the Philippines as ENSO approaches its maturity in October December and then retreat southward as the ENSO weakens in the ensuing seasons.	[Villafuerte, Marcelino Q., II; Matsumoto, Jun] Tokyo Metropolitan Univ, Dept Geog, Hachioji, Tokyo 1920372, Japan; [Villafuerte, Marcelino Q., II] Philippine Atmospher Geophys & Astron Serv Adm, Dept Sci & Technol, Quezon City, Philippines; [Matsumoto, Jun] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Villafuerte, MQ (reprint author), Tokyo Metropolitan Univ, 1-1 Minami Osawa, Hachioji, Tokyo 1920372, Japan.	mvillafuerte@pagasa.dost.gov.ph			"Asian Human Resources Fund" from the Tokyo Metropolitan Government; Green Network of Excellence (GRENE) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [23240122, 26220202]	This research is conducted under the Monsoon Asian Hydro-Atmosphere Scientific Research and Prediction Initiative (MAHASRI) program and is supported by the "Asian Human Resources Fund" from the Tokyo Metropolitan Government; the Green Network of Excellence (GRENE) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); and the Grants in Aid for Scientific Research 23240122 and 26220202 from the Japan Society for the Promotion of Science (JSPS). We thank the reviewers for providing insightful comments that improved the overall content of this article.	Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Zhang XB, 2010, J CLIMATE, V23, P2902, DOI 10.1175/2010JCLI3249.1; Feng S, 2007, J METEOROL SOC JPN, V85, P599, DOI 10.2151/jmsj.85.599; Caesar J, 2011, INT J CLIMATOL, V31, P791, DOI 10.1002/joc.2118; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Wang GH, 2007, J MARINE SYST, V68, P318, DOI 10.1016/j.jmarsys.2006.12.002; PRESCOTT P, 1980, BIOMETRIKA, V67, P723; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Kenyon J, 2010, J CLIMATE, V23, P6248, DOI 10.1175/2010JCLI3617.1; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Alexander LV, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012301; Westra S, 2013, J CLIMATE, V26, P3904, DOI 10.1175/JCLI-D-12-00502.1; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; HOSKING JRM, 1985, TECHNOMETRICS, V27, P251, DOI 10.2307/1269706; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Juneng L, 2005, CLIM DYNAM, V25, P337, DOI 10.1007/s00382-005-0031-6; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Stowasser M, 2007, J CLIMATE, V20, P2378, DOI 10.1175/JCLI4126.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Bayr T, 2014, CLIM DYNAM, V43, P2747, DOI 10.1007/s00382-014-2091-y; Trenberth KE, 1998, CLIMATIC CHANGE, V39, P667, DOI 10.1023/A:1005319109110; Park JS, 2011, INT J CLIMATOL, V31, P2290, DOI 10.1002/joc.2236; Pall P, 2007, CLIM DYNAM, V28, P351, DOI 10.1007/S00382-006-0180-2; Chotamonsak C, 2011, ATMOS SCI LETT, V12, P213, DOI 10.1002/asl.313; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Nadarajah S, 2005, CLIMATIC CHANGE, V69, P325, DOI 10.1007/s10584-005-1812-y; Chang CP, 2005, J CLIMATE, V18, P287, DOI 10.1175/JCLI-3257.1; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; Choi G, 2009, INT J CLIMATOL, V29, P1906, DOI 10.1002/joc.1979; Vastila K, 2010, J WATER CLIM CHANGE, V1, P67, DOI 10.2166/wcc.2010.008; Yokoi S, 2008, MON WEATHER REV, V136, P3275, DOI 10.1175/2008MWR2456.1; Chen CT, 2008, J CLIMATE, V21, P1605, DOI 10.1175/2007JCLI1494.1; Chu PS, 2010, J CLIMATE, V23, P4881, DOI 10.1175/2010JCLI3484.1; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Endo N, 2009, SOLA, V5, P168, DOI 10.2151/sola.2009-043; Lacombe G, 2012, CLIMATIC CHANGE, V113, P285, DOI 10.1007/s10584-011-0359-3; Saji NH, 2003, CLIMATE RES, V25, P151, DOI 10.3354/cr025151; King AD, 2013, INT J CLIMATOL, V33, P2376, DOI 10.1002/joc.3588; Villafuerte MQ, 2014, ATMOS RES, V137, P1, DOI 10.1016/j.atmosres.2013.09.021; Chan Johnny C L, 2006, Science, V311, P1713; Chen TC, 2013, J CLIMATE, V26, P936, DOI 10.1175/JCLI-D-12-00174.1; Coles S., 2001, AN INTRODUCTION TO S; Donat MG, 2013, J GEOPHYS RES-ATMOS, V118, P2098, DOI 10.1002/jgrd.50150; Feng JA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014761; Hartmann D. L., 2014, CLIMATE CHANGE 2013, P159; Landsea C, 2007, EOS T AGU, V88, P197, DOI DOI 10.1029/2007EO180001; Matsumoto J, 1997, ADV ATMOS SCI, V14, P231, DOI 10.1007/s00376-997-0022-0; Nguyen-Tin H. A., 2012, J AGROFOR ENV, V6, P89; R Core Team, 2013, R LANG ENV STAT COMP; Salimun E, 2014, INT J CLIMATOL, V34, P2763, DOI 10.1002/joc.3873; Tokinaga H, 2012, J CLIMATE, V25, P1689, DOI 10.1175/JCLI-D-11-00263.1; Villafuerte M. Q., 2015, INT J CLIMATOL IN PR, DOI [10.1002/joc.4105, DOI 10.1002/J0C.4105]; vonStorch H, 1995, ANALYSIS OF CLIMATE VARIABILITY, P11; Wilks D., 2011, STATISTICAL METHODS; World Bank, 2013, POSTDAM INSTITUTE FO; Wu PM, 2007, SOLA, V3, P93, DOI 10.2151/sola.2007-024; Yao C, 2010, METEOROL ATMOS PHYS, V106, P57, DOI 10.1007/s00703-009-0052-5; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035; Yokoi S, 2012, SOLA, V8, DOI 10.2151/sola.2012-034	65	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAR 1	2015	28	5					1905	1919		10.1175/JCLI-D-14-00531.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD1MP	WOS:000350839300010		
J	Li, T; Zhao, CB; Hsu, PC; Nasuno, T				Li, Tim; Zhao, Chongbo; Hsu, Pang-Chi; Nasuno, Tomoe			MJO Initiation Processes over the Tropical Indian Ocean during DYNAMO/CINDY2011	JOURNAL OF CLIMATE			English	Article							MADDEN-JULIAN OSCILLATION; OUTGOING LONGWAVE RADIATION; INTRASEASONAL OSCILLATION; EASTWARD PROPAGATION; SUMMER; CIRCULATION; EXTRATROPICS; TEMPERATURE; DYNAMICS; TRACKING	A multination joint field campaign called the Dynamics of MJO/Cooperative Indian Ocean Experiment on Intraseasonal Variability in Year 2011 (DYNAMO/CINDY2011) took place in the equatorial Indian Ocean (IO) in late 2011. During the campaign period, two strong MJO events occurred from the middle of October to the middle of December (referred to as MJO I and MJO II, respectively). Both the events were initiated over the western equatorial Indian Ocean (WIO) around 50 degrees-60 degrees E. Using multiple observational data products (ERA-Interim, the ECMWF final analysis, and NASA MERRA), the authors unveil specific processes that triggered the MJO convection in the WIO. It is found that, 10 days prior to MJO I initiation, a marked large-scale ascending motion anomaly appeared in the lower troposphere over the WIO. The cause of this intraseasonal vertical motion anomaly was attributed to anomalous warm advection by a cyclonic gyre anomaly over the northern IO. The MJO II initiation was preceded by a low-level specific humidity anomaly. This lower-tropospheric moistening was attributed to the advection of mean moisture by anomalous easterlies over the equatorial IO. The contrast of anomalous precursor winds at the equator (westerly versus easterly) implies different triggering mechanisms for the MJO I and II events. It was found that upper-tropospheric circumnavigating signals did not contribute the initiation of both the MJO events. The EOF-based real-time multivariate MJO (RMM) indices should not be used to determine MJO initiation time and location because they are primarily used to capture large zonal scale and eastward-propagating signals, not localized features.	[Li, Tim; Hsu, Pang-Chi] Nanjing Univ Informat Sci & Technol, Climate Dynam Res Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Tim; Hsu, Pang-Chi] Nanjing Univ Informat Sci & Technol, Earth Syst Modeling Ctr, Int Lab Climate & Environm Change, Nanjing, Jiangsu, Peoples R China; [Li, Tim] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Li, Tim] Univ Hawaii Manoa, Dept Atmospher Sci, Honolulu, HI 96822 USA; [Zhao, Chongbo] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Nasuno, Tomoe] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan	Li, T (reprint author), Univ Hawaii Manoa, Int Pacific Res Ctr, 2525 Correa Rd, Honolulu, HI 96822 USA.	timli@hawaii.edu			China National 973 Project [2015CB453200]; NSFC [41475084/41375100]; NSF [AGS-1106536]; International Pacific Research Center - Japan Agency for Marine-Earth Science and Technology (JAMSTEC)	We thank anonymous reviewers for constructive comments and Steve Williams, DYNAMO data manager at NCAR EOL, for sharing the ECMWF FNL dataset. This work was supported by China National 973 Project 2015CB453200; NSFC 41475084/41375100; NSF AGS-1106536; and the International Pacific Research Center, which is sponsored by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC).	Ling J, 2013, J ATMOS SCI, V70, P2696, DOI 10.1175/JAS-D-13-029.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; [Anonymous], MON WEA REV, V142, P1697, DOI [10.1175/MWR-D-13-00301.1, DOI 10.1175/MWR-D-13-00301.1]; KRISHNAMURTI TN, 1982, J ATMOS SCI, V39, P2088, DOI 10.1175/1520-0469(1982)039<2088:TDMAMD>2.0.CO;2; Hsu PC, 2011, J CLIMATE, V24, P942, DOI 10.1175/2010JCLI3834.1; Annamalai H, 2001, CLIM DYNAM, V18, P85, DOI 10.1007/s003820100161; Matthews AJ, 1999, MON WEATHER REV, V127, P661, DOI 10.1175/1520-0493(1999)127<0661:TTEIBH>2.0.CO;2; Matthews AJ, 2008, Q J ROY METEOR SOC, V134, P439, DOI 10.1002/qj.224; Johnson RH, 2013, J ATMOS SCI, V70, P3157, DOI 10.1175/JAS-D-13-065.1; Gottschalck J, 2013, MON WEATHER REV, V141, P4173, DOI 10.1175/MWR-D-13-00022.1; Kiladis GN, 2014, MON WEATHER REV, V142, P1697, DOI 10.1175/MWR-D-13-00301.1; Yoneyama K, 2013, B AM METEOROL SOC, V94, P1871, DOI 10.1175/BAMS-D-12-00157.1; Kemball-Cook SR, 2001, J CLIMATE, V14, P780, DOI 10.1175/1520-0442(2001)014<0780:TOOCIT>2.0.CO;2; Hsu PC, 2012, J CLIMATE, V25, P4914, DOI 10.1175/JCLI-D-11-00310.1; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Li T, 2005, TERR ATMOS OCEAN SCI, V16, P285; Zhao CB, 2013, J CLIMATE, V26, P291, DOI 10.1175/JCLI-D-12-00113.1; WANG B, 1994, J ATMOS SCI, V51, P1386, DOI 10.1175/1520-0469(1994)051<1386:CIWBLD>2.0.CO;2; LI TM, 1994, MON WEATHER REV, V122, P2349, DOI 10.1175/1520-0493(1994)122<2349:TIOSST>2.0.CO;2; HSU HH, 1990, J ATMOS SCI, V47, P823, DOI 10.1175/1520-0469(1990)047<0823:TIOATR>2.0.CO;2; Sobel A, 2014, J ATMOS SCI, V71, P4276, DOI 10.1175/JAS-D-14-0052.1; Li T, 2014, J METEOROL RES-PRC, V28, P1, DOI 10.1007/s13351-014-3087-6; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Wheeler M, 1999, J ATMOS SCI, V56, P374, DOI 10.1175/1520-0469(1999)056<0374:CCEWAO>2.0.CO;2; Straub KH, 2013, J CLIMATE, V26, P1130, DOI 10.1175/JCLI-D-12-00074.1; Ray P, 2009, J ATMOS SCI, V66, P310, DOI 10.1175/2008JAS2701.1; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Hsu HH, 2005, J CLIMATE, V18, P795, DOI 10.1175/JCLI-3292.1; MURAKAMI T, 1985, J ATMOS SCI, V42, P1107, DOI 10.1175/1520-0469(1985)042<1107:TDODTN>2.0.CO;2; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Li T, 2009, J ATMOS SCI, V66, P2429, DOI 10.1175/2009JAS2968.1; LAU KM, 1986, MON WEATHER REV, V114, P1354, DOI 10.1175/1520-0493(1986)114<1354:AOTDOD>2.0.CO;2; Holton J. R., 2004, INTRO DYNAMIC METEOR; Jiang XA, 2005, J CLIMATE, V18, P3777, DOI 10.1175/JCLI3516.1; LAU KM, 1987, J ATMOS SCI, V44, P950, DOI 10.1175/1520-0469(1987)044<0950:OOLFOI>2.0.CO;2; Lau WKM, 2005, S-P B ENVIRON SCI, P1, DOI 10.1007/b138817; Li T., 2008, ATMOS OCEANIC SCI LE, V1, P18; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Matthews AJ, 2000, Q J ROY METEOR SOC, V126, P2637, DOI 10.1002/qj.49712656902; Pan LL, 2008, CLIM DYNAM, V31, P375, DOI 10.1007/s00382-007-0272-7; Ray P, 2013, J ATMOS SCI, V70, P876, DOI 10.1175/JAS-D-12-0153.1; Seo KH, 2012, MON WEATHER REV, V140, P1748, DOI 10.1175/MWR-D-11-00105.1; Waliser D. E., 2006, ASIAN MONSOON, P203, DOI DOI 10.1007/3-540-37722-0/; Wang SG, 2015, J CLIMATE, V28, P2097, DOI 10.1175/JCLI-D-14-00294.1; WEICKMANN KM, 1983, MON WEATHER REV, V111, P1838, DOI 10.1175/1520-0493(1983)111<1838:ICAOLR>2.0.CO;2	47	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAR	2015	28	6					2121	2135		10.1175/JCLI-D-14-00328.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD3MV	WOS:000350983700002		
J	Seiki, T; Kodama, C; Noda, AT; Satoh, M				Seiki, Tatsuya; Kodama, Chihiro; Noda, Akira T.; Satoh, Masaki			Improvement in Global Cloud-System-Resolving Simulations by Using a Double-Moment Bulk Cloud Microphysics Scheme	JOURNAL OF CLIMATE			English	Article							COMMUNITY ATMOSPHERE MODEL; GENERAL-CIRCULATION MODELS; STRATIFORM CLOUD; CIRRUS CLOUDS; RADIATIVE PROPERTIES; CONVECTIVE SYSTEMS; CLIMATE MODELS; ACCURATE PARAMETERIZATION; RADAR REFLECTIVITIES; TROPICAL TROPOPAUSE	This study examines the impact of an alteration of a cloud microphysics scheme on the representation of longwave cloud radiative forcing (LWCRF) and its impact on the atmosphere in global cloud-system-resolving simulations. A new double-moment bulk cloud microphysics scheme is used, and the simulated results are compared with those of a previous study. It is demonstrated that improvements within the new cloud microphysics scheme have the potential to substantially improve climate simulations. The new cloud microphysics scheme represents a realistic spatial distribution of the cloud fraction and LWCRF, particularly near the tropopause. The improvement in the cirrus cloud-top height by the new cloud microphysics scheme substantially reduces the warm bias in atmospheric temperature from the previous simulation via LWCRF by the cirrus clouds. The conversion rate of cloud ice to snow and gravitational sedimentation of cloud ice are the most important parameters for determining the strength of the radiative heating near the tropopause and its impact on atmospheric temperature.	[Seiki, Tatsuya; Kodama, Chihiro; Noda, Akira T.; Satoh, Masaki] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Satoh, Masaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan	Seiki, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Project Team Risk Informat Climate Change, Kanazawa Ku, 3173-15 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	tseiki@jamstec.go.jp	Satoh, Masaki/G-3325-2015	Satoh, Masaki/0000-0003-3580-8897	"Prediction and Diagnosis of Imminent Global Climate Change'' in the Program for Risk Information on Climate Change (SOUSEI Program) - Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	The authors wish to thank the NICAM development members for their helpful comments and discussions. We thank the three anonymous reviewers for their comments that helped to improve the manuscript. The satellite datasets from A-Train were obtained from the NASA Langley Research Center Atmospheric Science Data Center. The ISCCP D1 data were obtained from the International Satellite Cloud Climatology Project web site (http://isccp.giss.nasa.gov) maintained by the ISCCP research group at the NASA Goddard Institute for Space Studies, New York, NY, in January 2005. "The reanalysis dataset of Global Rainfall Map (GSMaP_MVK) by JAXA Global Rainfall Watch'' was produced and distributed by the Earth Observation Research Center, Japan Aerospace Exploration Agency. The numerical experiments were performed using The Earth Simulator at the Japan Agency for Marine-Earth Science and Technology. The present study was supported by "Prediction and Diagnosis of Imminent Global Climate Change'' in the Program for Risk Information on Climate Change (SOUSEI Program), funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	ACKERMAN TP, 1988, J ATMOS SCI, V45, P1606, DOI 10.1175/1520-0469(1988)045<1606:HRITA>2.0.CO;2; Seifert A, 2006, ATMOS RES, V80, P46, DOI 10.1016/j.atmosres.2005.06.009; Ushio T, 2009, J METEOROL SOC JPN, V87A, P137, DOI 10.2151/jmsj.87A.137; Fu QA, 1996, J CLIMATE, V9, P2058, DOI 10.1175/1520-0442(1996)009<2058:AAPOTS>2.0.CO;2; Khairoutdinov M, 2008, J CLIMATE, V21, P413, DOI 10.1175/2007JCLI1630.1; Williams KD, 2013, J CLIMATE, V26, P3258, DOI 10.1175/JCLI-D-12-00429.1; Rougier J, 2009, J CLIMATE, V22, P3540, DOI 10.1175/2008JCLI2533.1; Field PR, 2007, J ATMOS SCI, V64, P4346, DOI 10.1175/2007JAS2344.1; Tomita H, 2008, J METEOROL SOC JPN, V86A, P121; Wang M, 2011, GEOSCI MODEL DEV, V4, P137, DOI 10.5194/gmd-4-137-2011; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Seifert A, 2006, METEOROL ATMOS PHYS, V92, P45, DOI 10.1007/s00703-005-0112-4; CESS RD, 1989, SCIENCE, V245, P513, DOI 10.1126/science.245.4917.513; LOUIS JF, 1979, BOUND-LAY METEOROL, V17, P187, DOI 10.1007/BF00117978; Klein SA, 1999, MON WEATHER REV, V127, P2514, DOI 10.1175/1520-0493(1999)127<2514:VASOFC>2.0.CO;2; Sato K, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015885; Abel SJ, 2012, Q J ROY METEOR SOC, V138, P2151, DOI 10.1002/qj.1949; Matsui T, 2009, J ATMOS OCEAN TECH, V26, P1261, DOI 10.1175/2008JTECHA1168.1; Martin GM, 2010, J CLIMATE, V23, P5933, DOI 10.1175/2010JCLI3541.1; Gettelman A, 2008, J CLIMATE, V21, P3660, DOI 10.1175/2008JCLI2116.1; Tomita H, 2004, FLUID DYN RES, V34, P357, DOI 10.1016/j.fluiddyn.2004.03.003; Sekiguchi M, 2008, J QUANT SPECTROSC RA, V109, P2779, DOI 10.1016/j.jqsrt.2008.07.013; Morrison H, 2008, J CLIMATE, V21, P3642, DOI 10.1175/2008JCLI2105.1; Mitchell DL, 1996, J ATMOS SCI, V53, P1710, DOI 10.1175/1520-0469(1996)053<1710:UOMAAD>2.0.CO;2; Lang SE, 2014, J ATMOS SCI, V71, P3583, DOI 10.1175/JAS-D-13-0330.1; Takata K, 2003, GLOBAL PLANET CHANGE, V38, P209, DOI 10.1016/S0921-8181(03)00030-4; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; FU Q, 1992, J ATMOS SCI, V49, P2139, DOI 10.1175/1520-0469(1992)049<2139:OTCDMF>2.0.CO;2; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Phillips VTJ, 2007, J ATMOS SCI, V64, P738, DOI 10.1175/JAS3869.1; Tao WK, 2009, B AM METEOROL SOC, V90, P515, DOI 10.1175/2008BAMS2542.1; Fu Q, 1998, J CLIMATE, V11, P2223, DOI 10.1175/1520-0442(1998)011<2223:AAPOTI>2.0.CO;2; Noda AT, 2010, ATMOS RES, V96, P208, DOI 10.1016/j.atmosres.2009.05.007; Milbrandt JA, 2005, J ATMOS SCI, V62, P3051, DOI 10.1175/JAS3534.1; Seiki T, 2014, J ATMOS SCI, V71, P833, DOI 10.1175/JAS-D-12-0195.1; Nakajima T, 2000, APPL OPTICS, V39, P4869, DOI 10.1364/AO.39.004869; BERRY EX, 1974, J ATMOS SCI, V31, P1825, DOI 10.1175/1520-0469(1974)031<1825:AAOCDG>2.0.CO;2; FU Q, 1993, J ATMOS SCI, V50, P2008, DOI 10.1175/1520-0469(1993)050<2008:POTRPO>2.0.CO;2; Hartmann DL, 2001, GEOPHYS RES LETT, V28, P1969, DOI 10.1029/2000GL012833; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Field PR, 2005, Q J ROY METEOR SOC, V131, P1997, DOI 10.1256/qj.04.134; RUTLEDGE SA, 1983, J ATMOS SCI, V40, P1185, DOI 10.1175/1520-0469(1983)040<1185:TMAMSA>2.0.CO;2; Kodama C, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017317; Wang M, 2011, ATMOS CHEM PHYS, V11, P5431, DOI 10.5194/acp-11-5431-2011; Satoh M, 2012, CLIM DYNAM, V39, P2185, DOI 10.1007/s00382-011-1235-6; Muller CJ, 2011, NAT CLIM CHANGE, V1, P266, DOI 10.1038/NCLIMATE1169; Doelling DR, 2013, J ATMOS OCEAN TECH, V30, P1072, DOI 10.1175/JTECH-D-12-00136.1; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; DeMott PJ, 2003, P NATL ACAD SCI USA, V100, P14655, DOI 10.1073/pnas.2532677100; Mansell ER, 2010, J ATMOS SCI, V67, P3084, DOI 10.1175/2010JAS3341.1; Seifert A, 2008, J ATMOS SCI, V65, P3608, DOI 10.1175/2008JAS2586.1; Heymsfield AJ, 2000, J ATMOS SCI, V57, P916, DOI 10.1175/1520-0469(2000)057<0916:CCTV>2.0.CO;2; Thompson G, 2008, MON WEATHER REV, V136, P5095, DOI 10.1175/2008MWR2387.1; Roh W, 2014, J ATMOS SCI, V71, P2654, DOI 10.1175/JAS-D-13-0252.1; Khairoutdinov MF, 2003, J ATMOS SCI, V60, P607, DOI 10.1175/1520-0469(2003)060<0607:CRMOTA>2.0.CO;2; Milbrandt JA, 2010, J ATMOS SCI, V67, P3931, DOI 10.1175/2010JAS3541.1; Phillips TJ, 2004, B AM METEOROL SOC, V85, P1903, DOI 10.1175/BAMS-85-12-1903; Webb M, 2001, CLIM DYNAM, V17, P905, DOI 10.1007/s003820100157; Seifert A, 2001, ATMOS RES, V59, P265, DOI 10.1016/S0169-8095(01)00126-0; Austin RT, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010049; Austin RT, 2001, J GEOPHYS RES-ATMOS, V106, P28233, DOI 10.1029/2000JD000293; Grabowski G. G, 2001, J ATMOS SCI, V58, P978, DOI [10.1175/ 1520- 0469( 2001) 058,0978: CCPWTL. 2.0. CO; 2., DOI 10.1175/1520-0469(2001)058]; Grabowski G. G., 1998, J ATMOS SCI, V55, P3283, DOI [10.1175/1520-0469(1998)055<3283:TCRMOL>2.0.CO;2, DOI 10.1175/1520-0469(1998)055<3283:TCRMOL>2.0.CO;2]; Iga S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031048; IKAWA M, 1991, J METEOROL SOC JPN, V69, P641; Jensen EJ, 1996, J GEOPHYS RES-ATMOS, V101, P21361, DOI 10.1029/95JD03575; Kato S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016050; Lang SE, 2011, J ATMOS SCI, V68, P2306, DOI 10.1175/JAS-D-10-05000.1; LIN YL, 1983, J CLIM APPL METEOROL, V22, P1065, DOI 10.1175/1520-0450(1983)022<1065:BPOTSF>2.0.CO;2; Liou K. N., 2002, INTRO ATMOSPHERIC RA; Okamoto H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013383; Rossow B. R., 1999, B AM METEOROL SOC, V80, P2261, DOI DOI 10.1175/1520-0477(1999)080; Salzmann M, 2010, ATMOS CHEM PHYS, V10, P8037, DOI 10.5194/acp-10-8037-2010; Satoh M., 2014, PROGR EARTH PLANETAR, V1, P1, DOI [10.1186/s40645-014-0018-1, DOI 10.1186/S40645-014-0018-1]; Satoh M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012247; Seiki T, 2014, J GEOPHYS RES-ATMOS, V119, P6681, DOI 10.1002/2013JD021086; Tao WK, 2014, ATMOS RES, V143, P392, DOI 10.1016/j.atmosres.2014.03.005; Twomey S., 1959, PURE APPL GEOPHYS, V43, P243, DOI DOI 10.1007/BF01993560; Wacker W., 2001, ATMOS RES, V58, P19, DOI [10.1016/S0169-8095(01)00081-3, DOI 10.1016/S0169-8095(01)00081-3]	79	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAR	2015	28	6					2405	2419		10.1175/JCLI-D-14-00241.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD3MV	WOS:000350983700018		
J	Liu, JH; Walker, NM; Ootani, A; Strubberg, AM; Clarke, LL				Liu, Jinghua; Walker, Nancy M.; Ootani, Akifumi; Strubberg, Ashlee M.; Clarke, Lane L.			Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease	JOURNAL OF CLINICAL INVESTIGATION			English	Article							MOUSE SMALL-INTESTINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; FUNCTIONAL CFTR CHANNEL; EPITHELIAL-CELLS; MUC2 MUCIN; INTRACELLULAR ORGANELLES; SECRETORY GRANULES; KNOCKOUT MICE; CA2+ RELEASE; PH	Cystic fibrosis (CF) intestinal disease is associated with the pathological manifestation mucoviscidosis, which is the secretion of tenacious, viscid mucus that plugs ducts and glands of epithelial-lined organs. Goblet cells are the principal cell type involved in exocytosis of mucin granules; however, little is known about the exocytotic process of goblet cells in the CF intestine. Using intestinal organoids from a CF mouse model, we determined that CF goblet cells have altered exocytotic dynamics, which involved intrathecal granule swelling that was abruptly followed by incomplete release of partially decondensated mucus. Some CF goblet cells exhibited an ectopic granule location and distorted cellular morphology, a phenotype that is consistent with retrograde intracellular granule movement during exocytosis. Increasing the luminal concentration of bicarbonate, which mimics CF transmembrane conductance regulator-mediated anion secretion, increased spontaneous degranulation in WT goblet cells and improved exocytotic dynamics in CF goblet cells; however, there was still an apparent incoordination between granule decondensation and exocytosis in the CF goblet cells. Compared with those within WT goblet cells, mucin granules within CF goblet cells had an alkaline pH, which may adversely affect the polyionic composition of the mucins. Together, these findings indicate that goblet cell dysfunction is an epithelial-autonomous defect in the CF intestine that likely contributes to the pathology of mucoviscidosis and the intestinal manifestations of obstruction and inflammation.	[Liu, Jinghua; Walker, Nancy M.; Clarke, Lane L.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Ootani, Akifumi] Akimoto Hosp, Fukuoka, Japan; [Strubberg, Ashlee M.; Clarke, Lane L.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA	Clarke, LL (reprint author), Univ Missouri, Dalton Cardiovasc Res Ctr 324D, 134 Res Pk Dr, Columbia, MO 65211 USA.	clarkel@missouri.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK48816-14]; Cystic Fibrosis Foundation [CLARKE11G0, LIU13F0]	The authors would like to thank Emily Bradford (University of Kentucky) for helpful advice about IHC. We would also like to acknowledge the assistance of staff at the University of Missouri Electron Microscopy Core and the Dalton Cardiovascular Research Center Live Cell Imaging Core. This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant DK48816-14 (to L.L. Clarke) and Cystic Fibrosis Foundation grants CLARKE11G0 (to L.L. Clarke) and LIU13F0 (to J. Liu).	ALAWQATI Q, 1992, J EXP BIOL, V172, P245; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Kuver R, 2006, AM J PHYSIOL-GASTR L, V291, pG1148, DOI 10.1152/ajpgi.00547.2005; Baconnais S, 2005, EXP CELL RES, V309, P296, DOI 10.1016/j.yexcr.2005.06.010; Grubb BR, 1997, AM J PHYSIOL-GASTR L, V273, pG258; Chanson M, 1999, J CLIN INVEST, V103, P1677, DOI 10.1172/JCI5645; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Canale-Zambrano JC, 2007, AM J PHYSIOL-GASTR L, V293, pG222, DOI 10.1152/ajpgi.00405.2006; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Sbarbati A, 1998, PEDIATR RES, V43, P234, DOI 10.1203/00006450-199802000-00013; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; De Lisle RC, 2007, AM J PHYSIOL-GASTR L, V293, pG577, DOI 10.1152/ajpgi.00195.2007; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1094/mbc.E04-11-1010; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Martins JR, 2011, BBA-MOL BASIS DIS, V1812, P1385, DOI 10.1016/j.bbadis.2011.08.008; Groneberg DA, 2002, RESP MED, V96, P81, DOI 10.1053/rmed.2001.1221; Liu J, 2012, AM J PHYSIOL-CELL PH, V303, pC160, DOI 10.1152/ajpcell.00278.2011; Dickson EJ, 2012, P NATL ACAD SCI USA, V109, pE3539, DOI 10.1073/pnas.1218247109; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; Hays SR, 2006, AM J RESP CRIT CARE, V174, P1018, DOI 10.1164/rccm.200603-310OC; Antigny F, 2011, AM J RESP CELL MOL, V44, P83, DOI 10.1165/rcmb.2009-0347OC; Norkina O, 2004, INFECT IMMUN, V72, P6040, DOI 10.1128/IAI.72.10.6040-6049.2004; Reeves EP, 2012, SCI WORLD J, DOI 10.1100/2012/465230; LeSimple P, 2013, AM J RESP CELL MOL, V49, P511, DOI 10.1165/rcmb.2012-0419RC; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Carlyle BE, 2012, J PEDIATR SURG, V47, P772, DOI 10.1016/j.jpedsurg.2012.02.019; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Seksek O, 1996, J BIOL CHEM, V271, P15542; Antigny F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00067; Balghi H, 2011, FASEB J, V25, P4274, DOI 10.1096/fj.11-187682; BARASCH J, 1993, J CELL SCI, P229; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; Borowitz D, 2005, J PEDIATR GASTR NUTR, V41, P273, DOI 10.1097/01.mpg.0000178439.64675.8d; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Canale-Zambrano JC, 2010, AM J PHYSIOL-GASTR L, V299, pG381, DOI 10.1152/ajpgi.00003.2010; CHENG PW, 1989, J CLIN INVEST, V84, P68, DOI 10.1172/JCI114171; Chin WC, 2002, NOVART FDN SYMP, V248, P132; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; Clarke LL, 1996, LAB ANIM SCI, V46, P612; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Gawenis LR, 2003, GASTROENTEROLOGY, V125, P1148, DOI 10.1053/S0016-5085(03)01212-5; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011., 10.1152/ajpgi.00405.2011]; Halm DR, 2000, AM J PHYSIOL-CELL PH, V278, pC212; Han WP, 1999, J NEUROSCI, V19, P900; Hogan DL, 1997, AM J PHYSIOL-GASTR L, V272, pG872; Horiuchi K, 2005, ARCH HISTOL CYTOL, V68, P51, DOI 10.1679/aohc.68.51; De Lisle RC, 2003, GASTROENTEROLOGY, V124, pA498, DOI 10.1016/S0016-5085(03)82522-2; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kaur S, 2004, AM J PHYSIOL-GASTR L, V287, pG480, DOI 10.1152/ajpgi.00035.2004; King SL, 2013, AM J PHYSIOL-GASTR L, V305, pG151, DOI 10.1152/ajpgi.00441.2012; Kuver R, 2000, GLYCOBIOLOGY, V10, P149, DOI 10.1093/glycob/10.2.149; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; LIU J, 2011, PEDIAT PULMONOL S, P236; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Madara James L., 1994, P1577; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastrp.2003.10.049; Perez-Vilar J, 2005, J BIOL CHEM, V280, P16858; Perez-Vilar J, 2006, J BIOL CHEM, V281, P4844, DOI 10.1074/jbc.M510520200; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Simpson JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1241, DOI 10.1152/ajpgi.00493.2004; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; Verdugo P., 1991, AM REV RESPIR DIS, V144, P533; VERDUGO P, 2012, COLD SPRING HARB PER, V2, P1; Verdugo P, 1998, CILIA, MUCUS, AND MUCOCILIARY INTERACTIONS, P167; Weiss AA, 1996, J HISTOCHEM CYTOCHEM, V44, P1161; Zhang YL, 1998, HUM GENE THER, V9, P635, DOI 10.1089/hum.1998.9.5-635	84	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAR	2015	125	3					1056	1068		10.1172/JCI73193		13	Medicine, Research & Experimental	Research & Experimental Medicine	CC8KF	WOS:000350616500022		
J	Saleh, MA; McMaster, WG; Wu, J; Norlander, AE; Funt, SA; Thabet, SR; Kirabo, A; Xiao, L; Chen, W; Itani, HA; Michell, D; Huan, TX; Zhang, YH; Takaki, S; Titze, J; Levy, D; Harrison, DG; Madhur, MS				Saleh, Mohamed A.; McMaster, William G.; Wu, Jing; Norlander, Allison E.; Funt, Samuel A.; Thabet, Salim R.; Kirabo, Annet; Xiao, Liang; Chen, Wei; Itani, Hana A.; Michell, Danielle; Huan, Tianxiao; Zhang, Yahua; Takaki, Satoshi; Titze, Jens; Levy, Daniel; Harrison, David G.; Madhur, Meena S.			Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation	JOURNAL OF CLINICAL INVESTIGATION			English	Article							II-INDUCED HYPERTENSION; VASCULAR DYSFUNCTION; PRESSURE; CELLS; TISSUES; DAMAGE; SCAN	The lymphocyte adaptor protein LNK (also known as SH2B3) is primarily expressed in hematopoietic and endothelial cells, where it functions as a negative regulator of cytokine signaling and cell proliferation. Single-nucleotide polymorphisms in the gene encoding LNK are associated with autoimmune and cardiovascular disorders; however, it is not known how LNK contributes to hypertension. Here, we determined that loss of LNK exacerbates angiotensin II-induced (Ang II-induced) hypertension and the associated renal and vascular dysfunction. At baseline, kidneys from Lnk(-/-) mice exhibited greater levels of inflammation, oxidative stress, and glomerular injury compared with WT animals, and these parameters were further exacerbated by Ang H infusion. Aortas from Lnk(-/-) mice exhibited enhanced inflammation, reduced nitric oxide levels, and impaired endothelial-dependent relaxation. Bone marrow transplantation studies demonstrated that loss of LNK in hematopoietic cells is primarily responsible for the observed renal and vascular inflammation and predisposition to hypertension. Ang II infusion increased IFN-gamma-producing CD8(+) T cells in the spleen and kidneys of Lnk(-/-) mice compared with WT mice. Moreover, IFN-gamma deficiency resulted in blunted hypertension in response to Ang II infusion. Together, these results suggest that LNK is a potential therapeutic target for hypertension and its associated renal and vascular sequela.	[Saleh, Mohamed A.; McMaster, William G.; Wu, Jing; Norlander, Allison E.; Thabet, Salim R.; Kirabo, Annet; Xiao, Liang; Chen, Wei; Itani, Hana A.; Michell, Danielle; Zhang, Yahua; Titze, Jens; Harrison, David G.; Madhur, Meena S.] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Saleh, Mohamed A.] Mansoura Univ, Fac Pharm, Dept Pharmacol & Toxicol, Mansoura, Egypt; [Funt, Samuel A.; Thabet, Salim R.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Funt, Samuel A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Huan, Tianxiao; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA USA; [Huan, Tianxiao; Levy, Daniel] NHLBI, Populat Sci Branch, Bethesda, MD 20892 USA; [Huan, Tianxiao; Levy, Daniel] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Takaki, Satoshi] Natl Ctr Global Hlth & Med, Res Inst, Dept Immune Regulat, Tokyo, Japan	Madhur, MS (reprint author), 2215 Garland Ave,P415D Med Res Bldg 4, Nashville, TN 37232 USA.	meena.madhur@vanderbilt.edu			American Heart Association [14POST20420025]; NIH [HL105294, HL039006, P01 HL58000, GM015431, K08HL121671]; Vanderbilt Physician Scientist Development Award	This work was supported by American Heart Association fellowship 14POST20420025 (to M.A. Saleh), NIH grants HL105294 and HL039006, Program Project grants P01 HL58000 and GM015431 (to D.G. Harrison), and NIH grant K08HL121671 and a Vanderbilt Physician Scientist Development Award (to M.S. Madhur).	Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Garcia AG, 2012, AM J PHYSIOL-HEART C, V303, pH587, DOI 10.1152/ajpheart.00298.2012; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; Marko L, 2012, HYPERTENSION, V60, P1430, DOI 10.1161/HYPERTENSIONAHA.112.199265; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; Hall J E, 1996, Kidney Int Suppl, V55, pS35; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Mattson DL, 2013, AM J PHYSIOL-REG I, V304, pR407, DOI 10.1152/ajpregu.00304.2012; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Araujo M, 2014, ANTIOXID REDOX SIGN, V20, P74, DOI 10.1089/ars.2013.5259; Trott DW, 2014, HYPERTENSION, V64, P1108, DOI 10.1161/HYPERTENSIONAHA.114.04147; Crowley SD, 2010, AM J PHYSIOL-REG I, V298, pR1089, DOI 10.1152/ajpregu.00373.2009; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Levy D, 2000, HYPERTENSION, V36, P477; Katayama H, 2014, EUR J IMMUNOL, V44, P1622, DOI 10.1002/eji.201343883; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Chobanian AV, 2009, NEW ENGL J MED, V361, P878, DOI 10.1056/NEJMsa0903829; Dikalov S, 2005, METHOD ENZYMOL, V396, P597, DOI 10.1016/S0076-6879(05)96052-7; Gery S, 2013, ONCOGENE, V32, P3111, DOI 10.1038/onc.2012.435; Jermendy G, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-96	24	5	5	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAR	2015	125	3					1189	1202		10.1172/JCI76327		14	Medicine, Research & Experimental	Research & Experimental Medicine	CC8KF	WOS:000350616500032		
J	Takeda, S; Sasagawa, S; Oyama, T; Searleman, AC; Westergard, TD; Cheng, EH; Hsieh, JJ				Takeda, Shugaku; Sasagawa, Satoru; Oyama, Toshinao; Searleman, Adam C.; Westergard, Todd D.; Cheng, Emily H.; Hsieh, James J.			Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription	JOURNAL OF CLINICAL INVESTIGATION			English	Article							DEVELOPING CEREBRAL-CORTEX; TATA-BINDING PROTEIN; RNA-POLYMERASE-II; CELL-CYCLE; VISCERAL ENDODERM; MOUSE DEVELOPMENT; BRAIN-DEVELOPMENT; GENE-EXPRESSION; CORE PROMOTER; NEURAL CREST	Head morphogenesis requires complex signal relays to enable precisely coordinated proliferation., migration, and patterning. Here, we demonstrate that, during mouse head formation, taspase1-Mediated (TASP1-Mediated) cleavage of the general transcription factor TFIIA ensures proper coordination of rapid cell proliferation and morphogenesis by maintaining limited transcription of the negative cell cycle regulators p16Ink4a and p19Arf from the Cdkn2a lotus, In Mice, loss of TASP1 function led to catastrophic-craniofacial malformations that were associated with inadequate tell-proliferation. Compound deficiency of Cdkn2a, especially p16Ink4a deficiency, markedly reduced the craniofacial anomalies of TASP1-deficent mite. Furthermore, evaluation of Mice-expressing noncleavable TASP1 targets revealed that TFIIA is the principal TASP1 substrate that orchestrates craniofacial morphogenesis. ChIP analyses determined that noncleaved TFIIA accumulates at the p16Ink4a and p19Arf promoters to drive transcription of these negative regulators. In summary, our study elucidates a regulatory circuit comprising proteolysis, transcription, and proliferation that is pivotal for construction of the mammalian head.	[Takeda, Shugaku; Oyama, Toshinao; Cheng, Emily H.; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Sasagawa, Satoru] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biol, Osaka, Japan; [Searleman, Adam C.; Westergard, Todd D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Cheng, Emily H.] Cornell Univ, Dept Pathol, Weill Med Coll, New York, NY 10021 USA; [Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hsieh, James J.] Cornell Univ, Dept Med, Weill Med Coll, New York, NY 10021 USA	Hsieh, JJ (reprint author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA.	hsiehj@mskcc.org			NIH [CA119008, CA138505]	This work was supported by NIH grants CA119008 and CA138505 to J.J. Hsieh. We thank Can G. Pham and Patricia I. Wang for their expert editorial recommendations.	Sjodal M, 2007, DEV CELL, V13, P141, DOI 10.1016/j.devcel.2007.04.020; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Nishioka N, 2005, DEVELOPMENT, V132, P2535, DOI 10.1242/dev.018144; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Chen DY, 2012, CANCER RES, V72, P736, DOI 10.1158/0008-5472.CAN-11-2584; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006; Mudgett JS, 1998, ARTHRITIS RHEUM, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Chen DY, 2010, CANCER RES, V70, P5358, DOI 10.1158/0008-5472.CAN-10-0027; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; DESMOND ME, 1981, ANAT EMBRYOL, V162, P137, DOI 10.1007/BF00306486; Dong YY, 2014, CELL RES, V24, P1354, DOI 10.1038/cr.2014.129; Hoiby T, 2004, EMBO J, V23, P3083, DOI 10.1038/sj.emboj.7600304; INOSTROZA JA, 1992, CELL, V70, P477; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kahane N, 1998, CELL TISSUE RES, V294, P297, DOI 10.1007/s004410051180; Kokubo T, 1998, MOL CELL BIOL, V18, P1003; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Mitsiou DJ, 2000, MOL CELL, V6, P527, DOI 10.1016/S1097-2765(00)00052-6; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Oyama T, 2013, DEV CELL, V27, P188, DOI 10.1016/j.devcel.2013.09.025; Pombero A, 2009, J COMP NEUROL, V512, P784, DOI 10.1002/cne.21933; Rhinn M, 1998, DEVELOPMENT, V125, P845; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05-2005; SUN XQ, 1994, GENE DEV, V8, P2336, DOI 10.1101/gad.8.19.2336; Takeda S, 2013, J CLIN INVEST, V123, P3154, DOI 10.1172/JCI65566; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; TUCKETT F, 1985, J EMBRYOL EXP MORPH, V85, P111; Veenstra GJC, 2001, TRENDS BIOCHEM SCI, V26, P665, DOI 10.1016/S0968-0004(01)01970-3; Xiao LJ, 2006, GENE EXPR PATTERNS, V6, P409, DOI 10.1016/j.modgep.2005.09.005; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	61	1	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAR	2015	125	3					1203	1214		10.1172/JCI77075		12	Medicine, Research & Experimental	Research & Experimental Medicine	CC8KF	WOS:000350616500033		
J	Lu, AK; Zuo, CJ; He, YH; Chen, GL; Piao, LJ; Zhang, J; Xiao, B; Shen, YJ; Tang, J; Kong, DP; Alberti, S; Chen, D; Zuo, SK; Zhang, QQ; Yan, S; Fei, XC; Yuan, F; Zhou, B; Duan, SZ; Yu, Y; Lazarus, M; Su, YC; Breyer, RM; Funk, CD; Yu, Y				Lu, Ankang; Zuo, Caojian; He, Yuhu; Chen, Guilin; Piao, Lingjuan; Zhang, Jian; Xiao, Bing; Shen, Yujun; Tang, Juan; Kong, Deping; Alberti, Sara; Chen, Di; Zuo, Shenkai; Zhang, Qianqian; Yan, Shuai; Fei, Xiaochun; Yuan, Fei; Zhou, Bin; Duan, Shengzhong; Yu, Yu; Lazarus, Michael; Su, Yunchao; Breyer, Richard M.; Funk, Colin D.; Yu, Ying			EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-beta 1 signaling	JOURNAL OF CLINICAL INVESTIGATION			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; RHO-KINASE INHIBITOR; SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; PROSTANOID RECEPTORS; PROSTACYCLIN ANALOGS; MATRIX-METALLOPROTEINASE; PROSTAGLANDIN RECEPTORS; EXTRACELLULAR-MATRIX	Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmonary disease (COPD). Prostacyclin analogs are widely used in the management of PAH patients; however, clinical efficacy and long-term tolerability of some prostacyclin analogs may be compromised by concomitant activation of the E-prostanoid 3 (EP3) receptor. Here, we found that EP3 expression is upregulated in pulmonary arterial smooth muscle cells (PASMCs) and human distal pulmonary arteries (PAs) in response to hypoxia. Either pharmacological inhibition of EP3 or Ep3 deletion attenuated both hypoxia and monocrotaline-induced pulmonary hypertension and restrained extracellular matrix accumulation in PAs in rodent models. In a murine PAH model, Ep3 deletion in SMCs, but not endothelial cells, retarded PA medial thickness. Knockdown of EP3 alpha and EP3 beta, but not EP3 gamma, isoforms diminished hypoxia-induced TGF-beta 1 activation. Expression of either EP3 alpha or EP3 beta in EP3-deficient PASMCs restored TGF-beta 1 activation in response to hypoxia. EP3 alpha/beta activation in PASMCs increased RhoA-dependent membrane type1 extracellular matrix metalloproteinase (MMP) translocation to the cell surface, subsequently activating pro-MMP-2 and promoting TGF-beta 1 signaling. Activation or disruption of EP3 did not influence PASMC proliferation. Together, our results indicate that EP3 activation facilitates hypoxia-induced vascular remodeling and pulmonary hypertension in mice and suggest EP3 inhibition as a potential therapeutic strategy for pulmonary hypertension.	[Lu, Ankang; Zuo, Caojian; He, Yuhu; Chen, Guilin; Piao, Lingjuan; Zhang, Jian; Xiao, Bing; Shen, Yujun; Tang, Juan; Kong, Deping; Alberti, Sara; Chen, Di; Zuo, Shenkai; Zhang, Qianqian; Yan, Shuai; Zhou, Bin; Duan, Shengzhong; Yu, Yu; Yu, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China; [Lu, Ankang; Zuo, Caojian; He, Yuhu] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Zuo, Caojian] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China; [Zuo, Caojian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China; [Piao, Lingjuan] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Alberti, Sara] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Sect Cardiovasc & Pharmacol Sci, Chieti, Italy; [Alberti, Sara] Univ G DAnnunzio, Ctr Excellence Aging CeSI, Chieti, Italy; [Fei, Xiaochun; Yuan, Fei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Lazarus, Michael] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA; [Breyer, Richard M.] Tennessee Valley Hlth Author, Dept Vet Affairs, Nashville, TN USA; [Breyer, Richard M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Yu, Y (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	yuying@sibs.ac.cn			Ministry of Science and Technology of China [2012CB945100, 2011CB503906]; National Natural Science Foundation of China [91439204, 31371154]; Natural Science Foundation of China (NSFC)/Canadian Institutes of Health Research (CIHR) [NSFC81161120538, CIHR-CCI117951]; Science and Technology Commission of Shanghai Municipality [14JC1407400, 13ZR1425700]; One Hundred Talents Program of the Chinese Academy of Sciences [20100HTP10]; Department of Veterans Affairs [1BX000616]; Ontario Heart and Stroke Foundation	This work was supported by the Ministry of Science and Technology of China (2012CB945100 and 2011CB503906); the National Natural Science Foundation of China (91439204 and 31371154); a Natural Science Foundation of China (NSFC)/Canadian Institutes of Health Research (CIHR) joint grant (NSFC81161120538 and CIHR-CCI117951); the Science and Technology Commission of Shanghai Municipality (14JC1407400 and 13ZR1425700); and by the One Hundred Talents Program of the Chinese Academy of Sciences (20100HTP10). Y. Yu is a Fellow at the Jiangsu Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. R.M. Breyer is a recipient of a Merit Award (1BX000616) from the Department of Veterans Affairs. C.D. Funk holds a Canada Research Chair and is a recipient of an Ontario Heart and Stroke Foundation Career Investigator award.	Abe K, 2006, J CARDIOVASC PHARM, V48, P280, DOI 10.1097/01.fjc.0000248244.64430.4a; Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schram K, 2008, J MOL CELL CARDIOL, V44, P874, DOI 10.1016/j.yjmcc.2008.03.005; Kobayashi K, 2011, EUR J PHARMACOL, V660, P375, DOI 10.1016/j.ejphar.2011.03.032; Hatae N, 2002, J BIOCHEM, V131, P781; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; IRIE A, 1994, EUR J BIOCHEM, V224, P161, DOI 10.1111/j.1432-1033.1994.tb20007.x; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925; Orie NN, 2011, EUR J PHARMACOL, V654, P258, DOI 10.1016/j.ejphar.2010.12.005; Olschewski H, 2004, PHARMACOL THERAPEUT, V102, P139, DOI 10.1016/j.pharmthera.2004.01.003; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; McKenzie C, 2009, BRIT J PHARMACOL, V157, P581, DOI 10.1111/j.1476-5381.2008.00084.x; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Jones RL, 2011, BRIT J PHARMACOL, V162, P863, DOI 10.1111/j.1476-5381.2010.01087.x; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Cracowski JL, 2012, CHEST, V142, P869, DOI 10.1378/chest.11-1267; Whittle BJ, 2012, BIOCHEM PHARMACOL, V84, P68, DOI 10.1016/j.bcp.2012.03.012; Kuwano K, 2008, J PHARMACOL EXP THER, V326, P691, DOI 10.1124/jpet.108.138305; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Wang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078569; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Hoshikawa Y, 2001, AM J RESP CRIT CARE, V164, P314; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI [10.1210/en.2010-1166, 10.1210/n.2010-1166]; Morrison K, 2012, J PHARMACOL EXP THER, V343, P547, DOI 10.1124/jpet.112.197152; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Geraci MW, 1999, J CLIN INVEST, V103, P1509, DOI 10.1172/JCI5911; Mubarak KK, 2010, RESP MED, V104, P9, DOI 10.1016/j.rmed.2009.07.015; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Fukumoto Y, 2013, CIRC J, V77, P2619, DOI 10.1253/circj.CJ-13-0443; ARCOT SS, 1993, BIOCHEM PHARMACOL, V46, P1086, DOI 10.1016/0006-2952(93)90675-M; BOTNEY MD, 1994, AM J PATHOL, V144, P286; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Cracowski JL, 2001, AM J RESP CRIT CARE, V164, P1038; Delannoy E, 2010, CARDIOVASC RES, V85, P582, DOI 10.1093/cvr/cvp292; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Geraci M, 1998, CHEST, V114, p99S; Hasegawa H, 2000, FEBS LETT, V473, P76, DOI 10.1016/S0014-5793(00)01508-8; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jaac.2004.02.029; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jourdan KB, 1997, BRIT J PHARMACOL, V120, P1280, DOI 10.1038/sj.bjp.0701052; Kotelevets L, 2007, PROSTAG LEUKOTR ESS, V77, P195, DOI 10.1016/j.plefa.2007.09.005; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Kozlowska H, 2012, PHARMACOL REP, V64, P1526; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Loukanov T, 2013, THORAC CARDIOV SURG, V61, P307, DOI 10.1055/s-0033-1337446; Lourenco AP, 2012, INT J CARDIOL, V155, P350, DOI 10.1016/j.ijcard.2011.05.066; Ma WL, 2011, J CLIN INVEST, V121, P4548, DOI 10.1172/JCI57734; Macias-Perez IM, 2008, J BIOL CHEM, V283, P12538, DOI 10.1074/jbc.M800105200; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; PERKETT EA, 1990, J CLIN INVEST, V86, P1459, DOI 10.1172/JCI114862; QIAN YM, 1994, BRIT J PHARMACOL, V113, P369; Seta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023439; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Tam FSF, 1997, BRIT J PHARMACOL, V121, P1413, DOI 10.1038/sj.bjp.0701275; Wu XQ, 2006, CIRC RES, V99, P240, DOI 10.1161/01.RES.0000237021.65103.24; Yan GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073839	70	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAR	2015	125	3					1228	1242		10.1172/JCI77656		15	Medicine, Research & Experimental	Research & Experimental Medicine	CC8KF	WOS:000350616500035		
J	Cheng, H; Uno, S; Nakazato, K				Cheng, He; Uno, Shigeyasu; Nakazato, Kazuo			Analytic compact model of ballistic and quasi-ballistic transport for cylindrical gate-all-around MOSFET including drain-induced barrier lowering effect	JOURNAL OF COMPUTATIONAL ELECTRONICS			English	Article						Ballistic and quasi-ballistic transport; Cylindrical GAA MOSFET; Compact model; The DIBL effect	NANOWIRE TRANSISTORS	We propose an analytic compact model of drain current in the ballistic and quasi-ballistic modes for cylindrical gate-all-around MOSFETs incorporating drain-induced barrier lowering (DIBL) effect. The model is based on our previous work addressing an analytic compact model for all operation regions, where electrostatic potential profile along the channel has not been taken into account. In this paper, we introduce variation of electrostatic potential along the channel to model the DIBL effect in the subthreshold region. The resulting analytic compact model is tested against TCAD simulation, and good accuracy is demonstrated.	[Cheng, He; Nakazato, Kazuo] Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Uno, Shigeyasu] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Cheng, He; Uno, Shigeyasu] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Cheng, H (reprint author), Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	teigach@hotmail.com; suno@fc.ritsumei.ac.jp; nakazato@nuee.nagoya-u.ac.jp					Yu B, 2008, IEEE T ELECTRON DEV, V55, P2846, DOI 10.1109/TED.2008.2005163; Cousin B, 2011, SOLID STATE ELECTRON, V56, P40, DOI 10.1016/j.sse.2010.11.008; Colinge JP, 2004, SOLID STATE ELECTRON, V48, P897, DOI 10.1016/j.sse.2003.12.020; Wu YS, 2008, IEEE T ELECTRON DEV, V55, P3042, DOI 10.1109/TED.2008.2008012; Natori K, 2005, J APPL PHYS, V97, DOI 10.1063/1.1840096; Lundstrom M, 1997, IEEE ELECTR DEVICE L, V18, P361, DOI 10.1109/55.596937; Jimenez D, 2004, IEEE ELECTR DEVICE L, V25, P314, DOI 10.1109/LED.2004.826526; Wang J, 2004, J APPL PHYS, V96, P2192, DOI 10.1063/1.1769089; Gautam R, 2012, J COMPUT THEOR NANOS, V9, P602, DOI 10.1166/jctn.2012.2068; Lundstrom M, 2002, IEEE T ELECTRON DEV, V49, P133, DOI 10.1109/16.974760; Bangsaruntip S., 2013, INT EL DEV M, P2021; Chaudhry Amit, 2010, Journal of Electronic Science and Technology, V8, DOI 10.3969/j.issn.1674-862X.2010.04.010; Cheng H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CN03; Cui N, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.044303; Electronic Archive, 2011, EL ARCH ATL US MAN, P754; Hamid H. A. E., 2007, IEEE Transactions on Electron Devices, V54, DOI 10.1109/TED.2006.890595; Hosseini R., 2012, INT J PHYS SCI, V7, P5054; International Technology Roadmap for Semiconductors, 2013, TABL PIDS; Kawaura H, 2001, IEICE T ELECTRON, VE84C, P1037; Natori K, 2008, IEEE T ELECTRON DEV, V55, P2877, DOI 10.1109/TED.2008.2008009; Natori K, 2001, IEICE T ELECTRON, VE84C, P1029; Numata T., 2013, IEICE ELECTRON EXPR, V10, P1; Numata T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DN05; Numata T, 2013, IEEE T ELECTRON DEV, V60, P856, DOI 10.1109/TED.2012.2232928; Riley KJ, 2006, MATH METHODS PHYS EN; Timp G., 1999, International Electron Devices Meeting 1999. Technical Digest (Cat. No.99CH36318), DOI 10.1109/IEDM.1999.823845; Wu S.-Y., 2013, IEEE INT EL DEV M; Wu YS, 2009, IEEE T ELECTRON DEV, V56, P2720, DOI 10.1109/TED.2009.2030714; Yu B, 2007, IEEE T ELECTRON DEV, V54, P492, DOI 10.1109/TED.2006.890264	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1569-8025			J COMPUT ELECTRON	J. Comput. Electron.	MAR	2015	14	1			SI		321	328		10.1007/s10825-014-0659-8		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CC7NG	WOS:000350554200036		
J	Jia, LJ; Kuwamura, H				Jia, Liang-Jiu; Kuwamura, Hitoshi			Ductile fracture model for structural steel under cyclic large strain loading	JOURNAL OF CONSTRUCTIONAL STEEL RESEARCH			English	Article						Ductile fracture; Cyclic loading; Structural steel; Chaboche model; Yoshida-Uemori model	VOID GROWTH-MODEL; HYDROSTATIC-PRESSURE; TENSILE FRACTURE; PLASTICITY; INITIATION; DAMAGE; INSTABILITY; SPECIMENS; CRITERIA; FATIGUE	This paper aims to predict ductile fracture of mild steel under cyclic large strain loading (CLSL) using only tensile coupon test results. A micromechanics-based fracture model which adopts void growth model and Miner's rule in incremental form is proposed, where fracture is assumed to occur when a damage index reaches unit. Damage is postulated not to accumulate when stress triaxiality is less than a threshold. To calibrate the fracture model, cyclic experimental and numerical studies on hourglass-type coupons are conducted under various loading histories. Since cyclic plasticity models play an important role on the simulation results, two cyclic plasticity models are employed to carry out the simulation, in which the proposed fracture model is employed. The predicted fracture displacements using either of the plasticity models compare with the experimental results with acceptable accuracy. (C) 2014 Elsevier Ltd. All rights reserved.	[Jia, Liang-Jiu] Tongji Univ, Res Inst Struct Engn & Disaster Reduct, Shanghai 200092, Peoples R China; [Jia, Liang-Jiu] Meijo Univ, Adv Res Ctr Nat Disaster Risk Reduct, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Kuwamura, Hitoshi] Univ Tokyo, Sch Engn, Dept Architecture, Bunkyo Ku, Tokyo 1138656, Japan	Jia, LJ (reprint author), Tongji Univ, Res Inst Struct Engn & Disaster Reduct, Shanghai 200092, Peoples R China.	lj_jia@hotmail.com			Ministry of Education [23246097]	The research reported herein was sponsored by the Ministry of Education under the Grant-in-Aid for Scientific Research (A) No. 23246097 with the title "Study on the coupling of buckling and fracture of steel structural members". This financial support is sincerely acknowledged. The experimental support by Dr. Koyama is greatly appreciated.	Besson J, 2001, INT J SOLIDS STRUCT, V38, P8259, DOI 10.1016/S0020-7683(01)00167-6; ROUSSELIER G, 1987, NUCL ENG DES, V105, P97, DOI 10.1016/0029-5493(87)90234-2; DAFALIAS YF, 1975, ACTA MECH, V21, P173, DOI 10.1007/BF01181053; Bao YB, 2004, J ENG MATER-T ASME, V126, P314, DOI 10.1115/1.1755244; Yoshida F, 2002, INT J PLASTICITY, V18, P661, DOI 10.1016/S0749-6419(01)00050-X; OHNO N, 1982, J APPL MECH-T ASME, V49, P721; Kanvinde AM, 2007, J ENG MECH-ASCE, V133, P701, DOI 10.1061/(ASCE)0733-9399(2007)133:6(701); Nahshon K, 2008, EUR J MECH A-SOLID, V27, P1, DOI [10.1016/j.euromechsol.2007.08.002, 10.1016/j.euromechso1.2007.08.002]; Bao YB, 2005, ENG FRACT MECH, V72, P1049, DOI 10.1016/j.engfracmech.2004.07.011; [Anonymous], 2010, ABAQUS STAND MAN VER; Takeuchi T, 2011, J STRUCT ENG-ASCE, V137, P1311, DOI 10.1061/(ASCE)ST.1943-541X.0000380; Fell BV, 2009, J STRUCT ENG-ASCE, V135, P19, DOI 10.1061/(ASCE)0733-9445(2009)135:1(19); DAFALIAS YF, 1976, J APPL MECH-T ASME, V43, P645; Mahin SA, 1998, ENG STRUCT, V20, P261, DOI 10.1016/S0141-0296(97)00032-1; Kanvinde AM, 2006, J STRUCT ENG-ASCE, V132, P1907, DOI 10.1061/(ASCE)0733-9445(2006)132:12(1907); Kuwamura H, 1997, J STRUCT ENG-ASCE, V123, P864, DOI 10.1061/(ASCE)0733-9445(1997)123:7(864); RICE JR, 1969, J MECH PHYS SOLIDS, V17, P201, DOI 10.1016/0022-5096(69)90033-7; CHABOCHE JL, 1988, J APPL MECH-T ASME, V55, P59; Kanvinde AM, 2008, J STRUCT ENG-ASCE, V134, P1528, DOI 10.1061/(ASCE)0733-9445(2008)134:9(1528); Aoi K., 1967, J JPN SOC TECH PLAST, V8, P17; Armstrong P. J., 1966, RDBN731 CEGB; Bridgman P. W., 1952, STUDIES LARGE PLASTI; CHABOCHE JL, 1986, INT J PLASTICITY, V2, P149, DOI 10.1016/0749-6419(86)90010-0; Chaboche JL, 1979, SMIRT5; Enami K, 2005, ENG FRACT MECH, V72, P1089, DOI 10.1016/j.engfracmech.2004.07.012; FRENCH IE, 1973, ACTA METALL MATER, V21, P1533, DOI 10.1016/0001-6160(73)90183-1; FRENCH IE, 1975, METALL TRANS, VA  6, P785, DOI 10.1007/BF02672300; FRENCH IE, 1975, METALL TRANS A, V6, P1165, DOI 10.1007/BF02658524; FRENCH IE, 1973, ACTA METALL MATER, V21, P1045, DOI 10.1016/0001-6160(73)90020-5; GHOSH AK, 1977, ACTA METALL MATER, V25, P1413, DOI 10.1016/0001-6160(77)90072-4; Goggins JM, 2006, J CONSTR STEEL RES, V62, P121, DOI 10.1016/j.jcsr.2005.04.612; Jia LJ, 2014, J STRUCT ENG, V140, DOI 10.1061/(ASCE)ST.1943-541X.0000944; JIA U, 2014, J STRUCT ENG-ASCE, V140; Jiao Y, 2011, EARTHQ ENG STRUCT D, V40, P1553, DOI 10.1002/eqe.1103; KRIEG RD, 1975, J APPL MECH-T ASME, V42, P641; Kuwamura Laboratory, 1995, FIELD SURV REP STRUC; MINER MA, 1945, J APPL MECH-T ASME, V12, pA159; NEEDLEMA.A, 1972, J MECH PHYS SOLIDS, V20, P111, DOI 10.1016/0022-5096(72)90035-X; Ohata M, 2004, SCI TECHNOL ADV MAT, V5, P241, DOI 10.1016/j.stam.2003.10.007; Panontin T. L., 1995, ASTM STP, P54; Shi M, 2008, NUMISHEET, P137; THOMASON PF, 1969, INT J MECH SCI, V11, P187, DOI 10.1016/0020-7403(69)90004-6; Toyoda M, 2000, P 3 INT PIP TECHN C, P87; Yasuda O, 2004, Q J JPN WELD SOC, V22, P467, DOI 10.2207/qjjws.22.467; Zaverl JR, 1978, J NUCL MATER, V75, P14	45	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-974X	1873-5983		J CONSTR STEEL RES	J. Constr. Steel. Res.	MAR	2015	106						110	121		10.1016/j.jcsr.2014.12.002		12	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CC9RB	WOS:000350707200011		
J	Nakamura, A; Terauchi, Y				Nakamura, Akinobu; Terauchi, Yasuo			Present status of clinical deployment of glucokinase activators	JOURNAL OF DIABETES INVESTIGATION			English	Review						Glucokinase; Glucokinase activators; beta-Cell proliferation	TYPE-2 DIABETES-MELLITUS; FASTING PLASMA-GLUCOSE; BETA-CELL HYPERPLASIA; HIGH-FAT DIET; INSULIN-RESISTANCE; REGULATORY PROTEIN; TRANSGENIC MICE; BLOOD-GLUCOSE; HOMEOSTASIS; GENE	Glucokinase is one of four members of the hexokinase family of enzymes. Its expression is limited to the major organs (such as the pancreas, liver, brain and the gastrointestinal tract) that are thought to have an integrated role in glucose sensing. In the liver, phosphorylation of glucose by glucokinase promotes glycogen synthesis, whereas in the -cells, it results in insulin release. Studies of glucokinase-linked genetically-modified mice and mutations in humans have illustrated the important roles played by glucokinase in whole-body glucose homeostasis, and suggest that the use of pharmacological agents that augment glucokinase activity could represent a viable treatment strategy in patients with type 2 diabetes. Since 2003, many glucokinase activators (GKAs) have been developed, and their ability to lower the blood glucose has been shown in several animal models of type 2 diabetes. Also, we and others have shown in mouse models that GKAs also have the effect of stimulating the proliferation of -cells. However, the results of recent phase II trials have shown that GKAs lose their efficacy within several months of use, and that their use is associated with a high incidence of hypoglycemia; furthermore, patients treated with GKAs frequently developed dyslipidemia. A better understanding of the role of glucokinase in metabolic effects is required to resolve several issues identified in clinical trials.	[Nakamura, Akinobu] Hokkaido Univ, Div Immunol & Metab, Grad Sch Med, Sapporo, Hokkaido, Japan; [Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan	Terauchi, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan.	terauchi-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21390282, 24390235]; Medical Award from the Japan Medical Association; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Takeda Life Foundation; MEXT, Japan [26860683]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) 21390282 and (B) 24390235 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; a Medical Award from the Japan Medical Association; a Grant-in-Aid from the Uehara Memorial Foundation; a Grant-in-Aid from the Daiichi-Sankyo Foundation of Life Science; a Grant-in-Aid from the Naito Foundation; a Grant-in-Aid from the Takeda Life Foundation (to YT); and a Grant-in-aid for Young Scientists (B) 26860683 from the MEXT, Japan (to AN). The authors declare no conflict of interest.	Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Wilding JPH, 2013, DIABETES OBES METAB, V15, P750, DOI 10.1111/dom.12088; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Terauchi Y, 1995, J BIOL CHEM, V270, P30253; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Futamura M, 2012, DIABETOLOGIA, V55, P1071, DOI 10.1007/s00125-011-2439-3; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Hussain K, 2010, REV ENDOCR METAB DIS, V11, P179, DOI 10.1007/s11154-010-9147-z; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Oh YS, 2014, EUR J PHARM SCI, V51, P137, DOI 10.1016/j.ejps.2013.09.005; Fyfe MCT, 2007, DIABETOLOGIA, V50, P1277, DOI 10.1007/s00125-007-0646-8; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Doliba NM, 2012, DIABETES OBES METAB, V14, P109, DOI 10.1111/j.1463-1326.2012.01652.x; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; Matschinsky FM, 2013, TRENDS PHARMACOL SCI, V34, P90, DOI 10.1016/j.tips.2012.11.007; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Withers DJ, 1998, NATURE, V391, P900; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Pfefferkorn JA, 2013, EXPERT OPIN DRUG DIS, V8, P319, DOI 10.1517/17460441.2013.748744; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; Coope GJ, 2006, BRIT J PHARMACOL, V149, P328, DOI 10.1038/sj.bjp.0706848; Dhanesha N, 2013, EUR J PHARMACOL, V714, P188, DOI 10.1016/j.ejphar.2013.06.015; Wei P, 2009, DIABETOLOGIA, V52, P2142, DOI 10.1007/s00125-009-1446-0; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, P627; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DesCeuninck F., 2013, BRIT J PHARMACOL, V168, P339; Efanov AM, 2005, ENDOCRINOLOGY, V146, P3696, DOI 10.1210/en.2005-0377; Erion DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097139; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Filipski KJ, 2014, EXPERT OPIN THER PAT, V24, P875, DOI 10.1517/13543776.2014.918957; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; Gorman T, 2008, DIABETES OBES METAB, V10, P885, DOI 10.1111/j.1463-1326.2007.00819.x; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; Khan S.E., 2006, NEW ENGL J MED, V355, P2427; Lu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088431; Matschinsky FM, 2006, DIABETES, V55, P1; Nakamura A, 2011, J DIABETES INVEST, V2, P276, DOI 10.1111/j.2040-1124.2011.00104.x; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; Ohyama S, 2010, EUR J PHARMACOL, V640, P250, DOI 10.1016/j.ejphar.2010.04.054; Pfefferkorn JA, 2011, MEDCHEMCOMM, V2, P828, DOI 10.1039/c1md00116g; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Shirakawa J, 2013, DIABETES, V62, P3448, DOI 10.2337/db13-0052; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					124	132		10.1111/jdi.12294		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700003		
J	Takei, M; Komatsu, M; Aizawa, T				Takei, Masahiro; Komatsu, Mitsuhisa; Aizawa, Toru			Intracellular free fatty acid upholds beta-cell glucose competence: The role of peroxisome proliferator-activated receptor delta and mitochondrial metabolism	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material							RAT PANCREATIC-ISLETS; INSULIN-SECRETION; AUGMENTATION; RELEASE		[Takei, Masahiro; Komatsu, Mitsuhisa] Shinshu Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Matsumoto, Nagano 390, Japan; [Aizawa, Toru] Aizawa Hosp, Diabet Ctr, Matsumoto, Nagano, Japan	Aizawa, T (reprint author), Aizawa Hosp, Diabet Ctr, Matsumoto, Nagano, Japan.	taizawax@ai-hosp.or.jp					Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Tang TY, 2013, CELL METAB, V18, P883, DOI 10.1016/j.cmet.2013.10.012; Komatsu M, 1999, DIABETES, V48, P1543, DOI 10.2337/diabetes.48.8.1543; ISHIHARA F, 1994, J ENDOCRINOL, V143, P497, DOI 10.1677/joe.0.1430497; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Yamada S, 2003, ENDOCRINOLOGY, V144, P5232, DOI 10.1210/en.2003-0719	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					133	136		10.1111/jdi.12257		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700004		
J	Nishikawa, T; Brownlee, M; Araki, E				Nishikawa, Takeshi; Brownlee, Michael; Araki, Eiichi			Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material							SUPEROXIDE; OVEREXPRESSION; STRESS; DAMAGE; SIRT1		[Nishikawa, Takeshi; Araki, Eiichi] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan; [Nishikawa, Takeshi] Kumamoto Univ, Fac Life Sci, Dept Mol Diabetol, Kumamoto, Japan; [Brownlee, Michael] Albert Einstein Coll Med, Ctr Diabet Res, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Internal Med, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Nishikawa, T (reprint author), Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan.	takeshi@kumamoto-u.ac.jp					Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Nishikawa T, 2000, NATURE, V404, P787; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Jagtap P, 2001, NAT MED, V7, P108	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					137	139		10.1111/jdi.12258		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700005		
J	Kondo, M; Kamiya, H; Himeno, T; Naruse, K; Nakashima, E; Watarai, A; Shibata, T; Tosaki, T; Kato, J; Okawa, T; Hamada, Y; Isobe, K; Oiso, Y; Nakamura, J				Kondo, Masaki; Kamiya, Hideki; Himeno, Tatsuhito; Naruse, Keiko; Nakashima, Eitaro; Watarai, Atsuko; Shibata, Taiga; Tosaki, Takahiro; Kato, Jiro; Okawa, Tetsuji; Hamada, Yoji; Isobe, Ken-ichi; Oiso, Yutaka; Nakamura, Jiro			Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes	JOURNAL OF DIABETES INVESTIGATION			English	Article						Aging; Diabetic polyneuropathy; Neurotrophic factors	ENDOTHELIAL PROGENITOR CELLS; NERVE GROWTH-FACTOR; AUTOLOGOUS TRANSPLANTATION; LIMB ISCHEMIA; STROMAL CELLS; GENE-TRANSFER; NEUROPATHY; RATS; BLOOD; TRIAL	Aims/IntroductionRecent studies have shown that cell transplantation therapies, such as endothelial precursor cells, bone marrow-derived mononuclear cells (BM-MNCs) and mesenchymal stem cells, are effective on diabetic polyneuropathy through ameliorating impaired nerve blood flow in diabetic rats. Here, we investigated the effects of BM-MNCs transplantation in diabetic polyneuropathy using BM-MNCs derived from adult (16-week-old) diabetic (AD), adult non-diabetic (AN) or young (8-week-old) non-diabetic (YN) rats. Materials and MethodsBM-MNCs of AD and AN were isolated after an 8-week diabetes duration. The BM-MNCs were characterized using flow cytometry analysis of cell surface markers and reverse transcription polymerase chain reaction of several cytokines. BM-MNCs or saline were injected into hind limb muscles. Four weeks later, the thermal plantar test, nerve conduction velocity, blood flow of the sciatic nerve and capillary-to-muscle fiber ratio were evaluated. ResultsThe number of CD29(+)/CD90(+) cells that host mesenchymal stem cells in BM-MNCs decreased in AD compared with AN or YN, and transcript expressions of basic fibroblast growth factor and nerve growth factor in BM-MNCs decreased in AD compared with AN or YN. Impaired thermal sensation, decreased blood flow of the sciatic nerve and delayed nerve conduction velocity in 8-week-diabetic rats were significantly ameliorated by BM-MNCs derived from YN, whereas BM-MNCs from AD or AN rats did not show any beneficial effect in these functional tests. ConclusionsThese results show that cytokine production abilities and the mesenchymal stem cell population of BM-MNCs would be modified by aging and metabolic changes in diabetes, and that these differences could explain the disparity of the therapeutic efficacy of BM-MNCs between young and adult or diabetic and non-diabetic patients in diabetic polyneuropathy.	[Kondo, Masaki; Kamiya, Hideki; Himeno, Tatsuhito; Naruse, Keiko; Nakashima, Eitaro; Watarai, Atsuko; Shibata, Taiga; Tosaki, Takahiro; Kato, Jiro; Okawa, Tetsuji; Oiso, Yutaka; Nakamura, Jiro] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Kondo, Masaki; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi 4648601, Japan; [Kamiya, Hideki] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi 4648601, Japan; [Hamada, Yoji] Nagoya Univ, Grad Sch Med, Dept Metab Med, Nagoya, Aichi 4648601, Japan	Kamiya, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan.	hkamiya@aichi-med-u.ac.jp					Blum A, 2012, ATHEROSCLEROSIS, V223, P269, DOI 10.1016/j.atherosclerosis.2012.03.017; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Yan JL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002238; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Desouza CV, 2011, DIABETES, V60, P1286, DOI 10.2337/db10-0875; Parker SJ, 2012, PHYSIOL GENOMICS, V44, P925, DOI 10.1152/physiolgenomics.00170.2011; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Bongaerts BWC, 2012, DIABETES CARE, V35, P1891, DOI 10.2337/dc11-2028; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Naruse K, 2005, DIABETES, V54, P1823, DOI 10.2337/diabetes.54.6.1823; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Apfel SC, 2000, JAMA-J AM MED ASSOC, V284, P2215, DOI 10.1001/jama.284.17.2215; Boxall SA, 2012, STEM CELLS INT, V2012; Cristofaro B, 2010, ARTERIOSCL THROM VAS, V30, P1143, DOI 10.1161/ATVBAHA.109.205468; Ekström A R, 1989, J Neurol Sci, V93, P231; Elias KA, 1998, DIABETES, V47, P1637, DOI 10.2337/diabetes.47.10.1637; Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87; KOSHU K, 1982, STROKE, V13, P483; Lombardo MF, 2012, CYTOM PART A, V81A, P856, DOI 10.1002/cyto.a.22109; Madhira SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048061; Motukuru V, 2008, J VASC SURG, V48, p53S, DOI 10.1016/j.jvs.2008.09.005; Nakae M, 2006, DIABETES, V55, P1470, DOI 10.2337/db05-1160; Nakamura J, 1999, DIABETES, V48, P2090, DOI 10.2337/diabetes.48.10.2090; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Pittenger F, 2005, SCIENCE, V284, P143; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Seitz M, 2011, NEUROSCIENCE, V182, P241, DOI 10.1016/j.neuroscience.2011.03.032; Stlozing A, 2008, MECH AGEING DEV, V129, P163; Tahergorabi Zoya, 2012, Int J Prev Med, V3, P827; Tomlinson DR, 1997, DIABETES, V46, pS43; Tomlinson DR, 1996, DIABETIC MED, V13, P679, DOI 10.1002/(SICI)1096-9136(199607)13:7<679::AID-DIA4138>3.3.CO;2-M; Wang XH, 2012, PROG MOL BIOL TRANSL, V111, P195, DOI 10.1016/B978-0-12-398459-3.00009-5; Yamagishi SI, 2008, J NEUROCHEM, V104, P491, DOI 10.1111/j.1471-4159.2007.05050.x; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					140	149		10.1111/jdi.12272		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700006		
J	Gushiken, M; Komiya, I; Ueda, S; Kobayashi, J				Gushiken, Michiko; Komiya, Ichiro; Ueda, Shinichiro; Kobayashi, Jun			Heel bone strength is related to lifestyle factors in Okinawan men with type 2 diabetes mellitus	JOURNAL OF DIABETES INVESTIGATION			English	Article						Heel bone stiffness; Male; Type 2 diabetes mellitus	CHRONIC KIDNEY-DISEASE; QUANTITATIVE ULTRASOUND; OLDER WOMEN; CIGARETTE-SMOKING; AMERICAN-COLLEGE; MINERAL DENSITY; HIP FRACTURE; OSTEOPOROSIS; METAANALYSIS; RISK	Aims/IntroductionAlthough male diabetic patients have an increased risk of fracture, there is little information about this in the literature. The association between heel bone stiffness and the lifestyle of male patients with diabetes was evaluated. Materials and MethodsThe study included 108 participants with type 2 diabetes mellitus patients and 168 age-adjusted, healthy male volunteers. None of the participants had a history of osteoporosis or other severe diseases. Heel bone stiffness was examined by quantitative ultrasound, and each participant completed a health interview survey questionnaire. Bone stiffness was taken as an indicator of bone strength. Stepwise regression analysis was used to investigate associations between bone stiffness and lifestyle-related factors, such as sunlight exposure, intake of milk or small fish, regular exercise, cigarette smoking, consumption of alcohol, and number of remaining teeth. ResultsBone stiffness showed a significant negative association with cigarette smoking [standardized coefficient (SC)=-0.297, F-value (F)=10.059] and age (SC=-0.207, F=7.565) in diabetic patients. Bone stiffness showed a significant negative association with age (SC=-0.371, F=12.076) and height (SC=-0.193, F=7.898), as well as a significant positive association with sunlight exposure (SC=0.182, F=9.589) and intake of small fish (SC=0.170, F=7.393) in controls. ConclusionsThese findings suggest that cigarette smoking and age are negatively associated with bone stiffness in Okinawan male patients with type 2 diabetes mellitus.	[Gushiken, Michiko; Kobayashi, Jun] Univ Ryukyus, Sch Hlth Sci, Fac Med, Dept Maternal Nursing, Nishihara, Okinawa 90301, Japan; [Gushiken, Michiko; Kobayashi, Jun] Univ Ryukyus, Sch Hlth Sci, Fac Med, Dept Child Nursing, Nishihara, Okinawa 90301, Japan; [Komiya, Ichiro] Univ Ryukyus, Dept Community Healthcare Syst, Grad Sch Med, Nishihara, Okinawa 90301, Japan; [Ueda, Shinichiro] Univ Ryukyus, Dept Clin Pharmacol & Therapeut, Grad Sch Med, Nishihara, Okinawa 90301, Japan	Gushiken, M (reprint author), Univ Ryukyus, Sch Hlth Sci, Fac Med, Dept Maternal Nursing, Nishihara, Okinawa 90301, Japan.	boshi@med.u-ryukyu.ac.jp	Kobayashi, Junjiro/J-8547-2015				American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; ROSS PD, 1991, AM J EPIDEMIOL, V133, P801; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; [Anonymous], 2013, KIDNEY INT S, V3, P1, DOI DOI 10.1038/KISUP.2012.73; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Qaseem A, 2008, ANN INTERN MED, V148, P680; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Ivers RQ, 2001, DIABETES CARE, V24, P1198, DOI 10.2337/diacare.24.7.1198; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Gluer CC, 1997, J BONE MINER RES, V12, P1280, DOI 10.1359/jbmr.1997.12.8.1280; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Carole W, 2007, JAMA-J AM MED ASSOC, V298, P2654; Davis MD, 1977, CURRENT DIAGNOSIS MA, P179; Didier H, 2009, SALUD PUBLICA MEXICO, V51, P525; Donadio C, 2007, CLIN NEPHROL, V67, P131; Gushiken M, 2003, JPN J HLTH HUM ECOL, V69, P57; IMURA H, 1987, Journal of the Japan Diabetes Society, V30, P929; Liu H, 2008, ANN INTERN MED, V148, P685; Ministry of Education Culture Sports Science and Technology; the Government of Japan, 2010, STAND TABL FOOD COMP; Ministry of Health Labour and Welfare, 2013, NAT HLTH NUTR SURV 2; Rigalleau V, 2007, DIABETIC MED, V24, P91, DOI 10.1111/j.1464-5491.2007.02026.x; Tan BK, 2007, AUST J PHYSIOTHER, V53, P290; The Department of Welfare and Health in Okinawa prefecture, 2013, OK PREF HLTH NUTR SU; The Ministry of Land Infrastructure and Transport, SOL INFR RAD DAT; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.1059/0003-4819-154-5-201103010-00307; World Health Organization International Society of Hypertension Writing Group, 2003, J HYPERTENS, V21, P1983; Zhang Y, 2007, J EPIDEMIOL, V17, P45, DOI 10.2188/jea.17.45	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					150	157		10.1111/jdi.12285		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700007		
J	Kato, K; Takeshita, Y; Misu, H; Zen, Y; Kaneko, S; Takamura, T				Kato, Ken-ichiro; Takeshita, Yumie; Misu, Hirofumi; Zen, Yoh; Kaneko, Shuichi; Takamura, Toshinari			Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease	JOURNAL OF DIABETES INVESTIGATION			English	Article						Hepatic and muscle insulin resistance; Liver steatosis; Non-alcoholic fatty liver disease	DEPENDENT DIABETES-MELLITUS; GLUCOSE-TOLERANCE TEST; HEPATIC STEATOSIS; SENSITIVITY; MICE; STEATOHEPATITIS; OBESITY; CLAMP	Aims/IntroductionTo examine the association between liver histological features and organ-specific insulin resistance indices calculated from 75-g oral glucose tolerance test data in patients with non-alcoholic fatty liver disease. Materials and MethodsLiver biopsy specimens were obtained from 72 patients with non-alcoholic fatty liver disease, and were scored for steatosis, grade and stage. Hepatic and skeletal muscle insulin resistance indices (hepatic insulin resistance index and Matsuda index, respectively) were calculated from 75-g oral glucose tolerance test data, and metabolic clearance rate was measured using the euglycemic hyperinsulinemic clamp method. ResultsThe degree of hepatic steatosis, and grade and stage of non-alcoholic steatohepatitis were significantly correlated with Matsuda index (steatosis r=-0.45, P<0.001; grade r=-0.54, P<0.001; stage r=-0.37, P<0.01), but not with hepatic insulin resistance index. Multiple regression analyses adjusted for age, sex, body mass index and each histological score showed that the degree of hepatic steatosis (coefficient=-0.22, P<0.05) and grade (coefficient=-0.40, P<0.01) were associated with Matsuda index, whereas the association between stage and Matsuda index (coefficient=-0.07, P=0.593) was no longer significant. A similar trend was observed for the association between steatosis and metabolic clearance rate (coefficient=-0.62, P=0.059). ConclusionsLiver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in patients with non-alcoholic fatty liver disease, suggesting a central role of fatty liver in the development of peripheral insulin resistance and the existence of a network between the liver and skeletal muscle.	[Kato, Ken-ichiro; Takeshita, Yumie; Misu, Hirofumi; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Misu, Hirofumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Comprehens Metabol, Kanazawa, Ishikawa, Japan; [Zen, Yoh] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo 657, Japan	Takamura, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by a grant-in-aid to TT from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Dr Tatsuya Yamashita and Dr Kuniaki Arai for carrying out the liver biopsies. The authors declare no conflict of interest.	American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Kato K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092170; Sakurai M, 2007, J GASTROENTEROL, V42, P312, DOI 10.1007/s00535-006-1948-1; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					158	163		10.1111/jdi.12271		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700008		
J	Watanabe, T; Tamura, Y; Kakehi, S; Funayama, T; Gastaldelli, A; Takeno, K; Kawaguchi, M; Yamamoto, R; Sato, F; Ikeda, S; Taka, H; Fujimura, T; Fujitani, Y; Kawamori, R; Watada, H				Watanabe, Takahiro; Tamura, Yoshifumi; Kakehi, Saori; Funayama, Takashi; Gastaldelli, Amalia; Takeno, Kageumi; Kawaguchi, Minako; Yamamoto, Risako; Sato, Fumihiko; Ikeda, Shin-ichi; Taka, Hikari; Fujimura, Tsutomu; Fujitani, Yoshio; Kawamori, Ryuzo; Watada, Hirotaka			Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study	JOURNAL OF DIABETES INVESTIGATION			English	Article						Dipeptidyl peptidase-4 inhibitor; Double tracer; Fatty liver	HEPATIC INSULIN-RESISTANCE; DIPEPTIDYL-PEPTIDASE-IV; MODERATE WEIGHT-REDUCTION; NONALCOHOLIC STEATOHEPATITIS; FASTING HYPERGLYCEMIA; HEALTHY-SUBJECTS; DOUBLE-BLIND; MELLITUS; INHIBITION; RECEPTOR	Aims/IntroductionRecent data have shown that ectopic fat accumulation in the liver worsens hepatic glucose metabolism, suggesting that fatty liver in patients with type2 diabetes is a therapeutic target. Glucagon-like peptide (GLP)-1 improves fatty liver, but the effect of dipeptidyl peptidase-4 inhibitor on fatty liver is still unclear. The present pilot study determined the effects of 12-week treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor, on liver fat content in type 2 diabetes with fatty liver. We also evaluated intramyocellular lipid (IMCL) and glucose kinetics during oral glucose tolerance test (OGTT) before and after the treatment. Materials and MethodsThe study participants were seven type 2 diabetes patients with fatty liver who were studied at baseline and 12weeks after sitagliptin treatment. Intrahepatic lipid (IHL) and IMCL were assessed by H-1 magnetic resonance spectroscopy. Glucose kinetics was assessed during double-tracer OGTT (U-[C-13]-glucose orally and 6,6-[H-2(2)]-glucose intravenously). ResultsSitagliptin significantly reduced glycated hemoglobin (from 7.10.2 to 6.5 +/- 0.3%, P<0.005), but had no effects on IHL and IMCL. The glucose level diminished, whereas GLP-1 concentration increased during OGTT at the end of treatment. These changes were not accompanied by significant changes in insulin or glucagon levels. However, long-term sitagliptin treatment partially decreased the rate of appearance of oral glucose during OGTT, but did not affect endogenous glucose production or the rate of disappearance. ConclusionsIt was found that 12-week sitagliptin treatment improved glycated hemoglobin and glucose excursion during OGTT in type 2 diabetes with fatty liver, independent of changes in lipid accumulation in the liver. This trial was registered with the Japan Clinical Trials Registry (UMIN-CTR000005666).	[Watanabe, Takahiro; Tamura, Yoshifumi; Kakehi, Saori; Funayama, Takashi; Takeno, Kageumi; Kawaguchi, Minako; Yamamoto, Risako; Sato, Fumihiko; Ikeda, Shin-ichi; Fujitani, Yoshio; Kawamori, Ryuzo; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Dept Metab & Endocrinol, Tokyo, Japan; [Tamura, Yoshifumi; Kakehi, Saori; Yamamoto, Risako; Ikeda, Shin-ichi; Kawamori, Ryuzo; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Sportol Ctr, Tokyo, Japan; [Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Ctr Mol Diabetol, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Ctr Beta Cell Biol & Regenerat, Tokyo, Japan; [Taka, Hikari; Fujimura, Tsutomu] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Prote & Biomol Sci, Tokyo, Japan; [Gastaldelli, Amalia] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	Tamura, Y (reprint author), Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Dept Metab & Endocrinol, Tokyo, Japan.	ys-tamur@juntendo.ac.jp			Research Conference on Japanese Diabetes Mellitus; Takeda Pharmaceutical Company; MSD; Boehringer Ingelheim; Sanofi-Aventis; Eli Lilly Japan; Novartis Pharmaceuticals; Kissei Pharmaceutical; Amylin; Daiichi Sankyo, Inc; Dainippon-Sumitomo pharmaceutical company; Novo Nordisk Pharma; Bayer; Astellas Pharma Inc.; Sanwakagaku; Astra Zeneca PLC; Pfizer Inc; Shionogi Inc	The authors thank Mutsuko Yoshikawa, Naoko Daimaru, Eriko Magoshi and Kiyomi Nakamura for their excellent technical assistance. This study was supported by a Research Conference on Japanese Diabetes Mellitus. YT has received lecture fees from Takeda Pharmaceutical Company, MSD, Boehringer Ingelheim, Sanofi-Aventis, Eli Lilly Japan, Novartis Pharmaceuticals and Kissei Pharmaceutical. AG is a consultant for Roche and Eli Lilly, and has received research funding from Amylin. YF has received lecture fees from Eli Lilly Japan. RK has received lecture fees from Daiichi Sankyo, Inc, Takeda Pharmaceutical Company, Dainippon-Sumitomo pharmaceutical company, MSD, Novo Nordisk Pharma, Boehringer Ingelheim, Sanofi-Aventis, Eli Lilly Japan and Novartis Pharmaceuticals. HW has received lecture fees from Daiichi Sankyo, Inc, Takeda Pharmaceutical Company, MSD, Novo Nordisk Pharma, Boehringer Ingelheim, Bayer, Sanofi-Aventis, Eli Lilly Japan, Novartis Pharmaceuticals, research funding from Novo Nordisk Pharma, Boehringer Ingelheim, Astellas Pharma Inc. Dainippon Sumitomo Pharma, Sanwakagaku, Astra Zeneca PLC, Novartis Pharmaceuticals, Bayer, Sanofi-Aventis, Pfizer Inc, Shionogi Inc, Daiichi Sankyo, Inc, MSD, Takeda Pharmaceutical Company and Eli Lilly Japan. The other authors declare no conflict of interest.	Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Seghieri M, 2013, DIABETOLOGIA, V56, P156, DOI 10.1007/s00125-012-2738-3; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; MITRAKOU A, 1990, DIABETES, V39, P1381, DOI 10.2337/diabetes.39.11.1381; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Muscelli E, 2012, J CLIN ENDOCR METAB, V97, P2818, DOI 10.1210/jc.2012-1205; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.00327.2001; Bergman AJ, 2006, CLIN THER, V28, P55, DOI 10.1016/j.clinthera.2006.01.015; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Iwasaki T, 2011, HEPATO-GASTROENTEROL, V58, P2103, DOI 10.5754/hge11263; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Balas B, 2007, J CLIN ENDOCR METAB, V92, P1249, DOI 10.1210/jc.2006-1882; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Yilmaz Y, 2012, ACTA GASTRO-ENT BELG, V75, P240; Dardevet D, 2005, AM J PHYSIOL-GASTR L, V289, pG806, DOI 10.1152/ajpgi.00121.2005; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612; Musso G, 2009, AM J CLIN NUTR, V89, P558, DOI 10.3945/ajcn.2008.26720; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Gastaldelli A, 2007, CLIN PHARMACOL THER, V81, P205, DOI 10.1038/sj.clpt.6100034; Aulinger BA, 2014, DIABETES, V63, P1079, DOI 10.2337/db13-1455; Cersosimo E, 2011, J CLIN ENDOCR METAB, V96, P1763, DOI 10.1210/jc.2010-2146; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; Dhanesha N, 2012, PHARMACOL REP, V64, P140; Edgerton DS, 2009, DIABETES, V58, P243, DOI 10.2337/db08-0515; Im Seung-Soon, 2006, Curr Diabetes Rev, V2, P11, DOI 10.2174/157339906775473581; KAWAMORI R, 1994, DIABETES RES CLIN PR, V23, P155, DOI 10.1016/0168-8227(94)90099-X	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					164	172		10.1111/jdi.12262		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700009		
J	Matsui, M; Takahashi, Y; Takebe, N; Takahashi, K; Nagasawa, K; Honma, H; Oda, T; Ono, M; Nakagawa, R; Sasai, T; Togashi, H; Hangai, M; Kajiwara, T; Taneichi, H; Ishigaki, Y; Satoh, J				Matsui, Mizue; Takahashi, Yoshihiko; Takebe, Noriko; Takahashi, Kazuma; Nagasawa, Kan; Honma, Hiroyuki; Oda, Tomoyasu; Ono, Mitsutaka; Nakagawa, Riyuki; Sasai, Takayoshi; Togashi, Hirobumi; Hangai, Mari; Kajiwara, Takashi; Taneichi, Haruhito; Ishigaki, Yasushi; Satoh, Jo			Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activity	JOURNAL OF DIABETES INVESTIGATION			English	Article						Glucagon-like peptide-1; Interleukin-6; Single nucleotide polymorphism	C-REACTIVE PROTEIN; GLYCATED HEMOGLOBIN; METABOLIC SYNDROME; INSULIN-SECRETION; EFFICACY; SITAGLIPTIN; POPULATION; REDUCTION; OBESITY; EXPRESSION	Aims/IntroductionMuscle-derived interleukin-6 (IL-6) has been reported to promote glucagon-like peptide-1 (GLP-1) secretion, and we explored the association of single nucleotide polymorphisms (SNPs) in the human IL-6 promoter region with the responsiveness to dipeptidyl peptidase-4 inhibitors (DPP-4Is), drugs that increase circulating GLP-1. Materials and MethodsThe present observational study enrolled Japanese patients with type 2 diabetes who took a DPP-4I over 3months, and most of the clinical information was collected retrospectively. We defined non-responders as those having less than a 0.2% decrease of the glycated hemoglobin level at 3 or 4months after starting DPP-4I treatment. Physical activity was retrospectively estimated by the Japanese short version of International Physical Activity Questionnaire. ResultsWe studied 316 patients whose physical activity corresponding to the season of the DPP-4I administration was estimated. The non-responder rate was 29.7%. We analyzed rs1800796 and rs2097677, both are suggested to be functional in Japanese. Multivariate analysis for all patients showed that the adjusted odds ratio for the non-responder risk of the diplotype rs1800796 G/*-rs2097677 A/* against C/C-G/G (OR_G*A*) was 0.445 (P=0.068). When patients were stratified by the International Physical Activity Questionnaire into low (n=149) and moderate/high (n=167) activity groups, however, OR_G*A* in each group was 1.58 (P=0.615) and 0.153 (P=0.003), respectively. ConclusionsThe diplotype rs1800796 G/*-rs2097677 A/* might contribute to responsiveness to DPP-4Is in Japanese patients with type 2 diabetes under a certain level of physical activity. However, further investigation is warranted to confirm this.	[Matsui, Mizue; Takahashi, Yoshihiko; Takebe, Noriko; Takahashi, Kazuma; Nagasawa, Kan; Honma, Hiroyuki; Oda, Tomoyasu; Ono, Mitsutaka; Nakagawa, Riyuki; Sasai, Takayoshi; Togashi, Hirobumi; Hangai, Mari; Kajiwara, Takashi; Taneichi, Haruhito; Ishigaki, Yasushi; Satoh, Jo] Iwate Med Univ, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan	Takahashi, Y (reprint author), Iwate Med Univ, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan.	ytakaha@iwate-med.ac.jp					Chung HS, 2014, J DIABETES INVEST, V5, P51, DOI 10.1111/jdi.12127; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Ueda S, 2009, J ENDOCRINOL, V201, P151, DOI 10.1677/JOE-08-0500; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Jiang LQ, 2013, DIABETES, V62, P355, DOI 10.2337/db11-1790; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tajiri Y, 2012, ENDOCR J, V59, P197; Nomiyama T, 2012, DIABETES RES CLIN PR, V95, pE27, DOI 10.1016/j.diabres.2011.08.016; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Kitamura A, 2002, DIABETIC MED, V19, P1000, DOI 10.1046/j.1464-5491.2002.00844.x; ABBOTT CA, 1994, IMMUNOGENETICS, V40, P331, DOI 10.1007/BF01246674; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Ognjanovic S, 2010, CANCER CAUSE CONTROL, V21, P1131, DOI 10.1007/s10552-010-9540-7; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Aoki K, 2012, ACTA DIABETOL, V49, P225, DOI 10.1007/s00592-011-0322-9; Cheung BMY, 2011, AM J HYPERTENS, V24, P1331, DOI 10.1038/ajh.2011.141; Hara K, 2006, DIABETES, V55, P1260, DOI 10.2337/db05-0620; Harashima SI, 2012, INT J CLIN PRACT, V66, P465, DOI 10.1111/j.1742-1241.2012.02903.x; Iwasaki M, 2012, J DIABETES INVEST, V3, P464, DOI 10.1111/j.2040-1124.2012.00214.x; Kim Soon Ae, 2011, Diabetes Metab J, V35, P159, DOI 10.4093/dmj.2011.35.2.159; Laval ELG, 2005, EVOLUTIONARY BIOINFO, V1, P47; Maeda H, 2012, DIABETES RES CLIN PR, V95, pE20, DOI 10.1016/j.diabres.2011.10.011; Murase N, 2002, J HLTH WELFARE STAT, V49, P1; Pan M, 2011, J INVEST MED, V59, P272, DOI 10.231/JIM.0b013e318206ffad; Smith AJP, 2012, GENES IMMUN, V13, P583, DOI 10.1038/gene.2012.32; Woo P, 2013, J CLIN INVEST, V123, P1413, DOI 10.1172/JCI67221; Zhang XF, 2011, ENDOCRINE, V40, P124, DOI 10.1007/s12020-011-9442-9	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	MAR	2015	6	2					173	181		10.1111/jdi.12260		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8VM	WOS:000350646700010		
